data_2rui_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2rui _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.19 0 CA-C-O 121.254 0.549 . . . . 0.0 111.04 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 2.9 p -79.93 17.01 1.03 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.924 -179.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -99.64 9.76 42.55 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 120.901 0.382 . . . . 0.0 111.858 -179.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.8 mt -55.6 139.98 14.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 122.034 0.921 . . . . 0.0 112.988 -177.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.408 ' OD1' ' N ' ' A' ' 63' ' ' GLN . 60.4 t0 -77.59 129.15 35.26 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 114.169 -1.378 . . . . 0.0 109.567 179.166 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.533 ' NE2' ' O ' ' A' ' 64' ' ' PRO . 1.4 tt0 -76.81 119.71 78.62 Favored Pre-proline 0 CA--C 1.541 0.609 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.504 -179.137 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.533 ' O ' ' NE2' ' A' ' 63' ' ' GLN . 73.5 Cg_exo -47.86 162.31 0.28 Allowed 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 122.491 2.127 . . . . 0.0 112.811 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -52.6 168.96 0.09 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.873 0.844 . . . . 0.0 112.308 -178.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 97.4 mt -71.13 -12.08 61.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 114.516 -1.22 . . . . 0.0 111.979 -179.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.592 ' O ' ' ND2' ' A' ' 71' ' ' ASN . . . -68.21 -41.89 80.63 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.306 0.574 . . . . 0.0 110.492 179.204 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.467 ' O ' ' CB ' ' A' ' 72' ' ' ALA . 98.2 mt-10 -70.7 -23.05 62.4 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.203 179.321 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 76.6 t -71.31 -43.88 73.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.814 -178.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -92.76 -8.82 42.68 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.411 -179.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.592 ' ND2' ' O ' ' A' ' 67' ' ' ALA . 84.9 m-20 -106.94 -10.17 16.06 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 121.15 0.5 . . . . 0.0 110.893 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.467 ' CB ' ' O ' ' A' ' 68' ' ' GLU . . . -69.65 135.54 50.04 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.425 0.631 . . . . 0.0 112.272 -179.134 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 43.7 t -59.71 93.65 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.435 ' CD2' ' C ' ' A' ' 74' ' ' LEU . 6.9 tt -66.79 126.29 28.56 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.297 0.57 . . . . 0.0 111.449 -178.147 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -93.74 79.51 4.23 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.564 -0.743 . . . . 0.0 110.379 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -64.75 -34.12 77.58 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.747 -0.661 . . . . 0.0 112.095 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.448 ' HD3' ' N ' ' A' ' 77' ' ' LYS . 8.0 mmtt -70.01 -13.12 62.08 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 121.428 0.633 . . . . 0.0 109.901 -176.497 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -93.9 -5.24 48.37 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.734 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 72.4 t -73.69 128.63 36.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.068 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 12.6 pt -110.57 -6.59 11.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 120.592 -0.443 . . . . 0.0 111.723 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -174.79 174.8 46.84 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 120.398 -0.906 . . . . 0.0 111.725 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 73.2 ttp85 -135.3 156.89 48.19 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 121.158 0.504 . . . . 0.0 111.157 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 20.9 tt -125.6 139.32 51.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 179.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.5 t -137.59 134.55 35.69 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 -178.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 3.2 mp -137.26 87.58 18.16 Favored Pre-proline 0 CA--C 1.538 0.498 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.415 179.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -55.98 -32.56 86.33 Favored 'Trans proline' 0 N--CA 1.5 1.873 0 C-N-CA 123.205 2.604 . . . . 0.0 112.68 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 8.9 t -54.63 -41.63 70.26 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.244 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 11.2 m -113.93 14.44 8.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 CA-C-O 121.261 0.553 . . . . 0.0 110.635 179.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.8 p 46.58 52.0 11.46 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.128 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 55.7 tp -117.78 133.29 56.08 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.321 0.581 . . . . 0.0 110.604 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.465 ' O ' ' CD2' ' A' ' 92' ' ' LEU . 93.7 mt-10 -147.94 125.32 11.6 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.925 -179.292 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.465 ' CD2' ' O ' ' A' ' 91' ' ' GLU . 7.8 mt -148.89 148.48 27.59 Favored Pre-proline 0 CA--C 1.537 0.457 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.421 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -75.36 147.75 33.03 Favored 'Trans proline' 0 N--CA 1.493 1.465 0 C-N-CA 122.68 2.253 . . . . 0.0 110.878 178.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 92.3 t -93.51 119.86 41.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.189 0.519 . . . . 0.0 110.649 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.47 ' N ' ' CD1' ' A' ' 95' ' ' LEU . 10.6 mp -97.82 126.09 43.01 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.72 0.772 . . . . 0.0 110.842 -179.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.527 ' O ' ' OG1' ' A' ' 109' ' ' THR . 86.7 tttt -63.64 -38.41 91.0 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.827 -1.078 . . . . 0.0 112.043 -178.581 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.497 ' CB ' ' ND2' ' A' ' 102' ' ' ASN . 2.7 m -79.76 126.43 30.94 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 121.636 0.731 . . . . 0.0 112.463 -178.582 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.465 ' OG ' ' O ' ' A' ' 109' ' ' THR . 0.9 OUTLIER -89.13 44.5 1.22 Allowed 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.714 179.687 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.571 ' OG1' ' ND2' ' A' ' 102' ' ' ASN . 71.4 p -89.48 171.78 9.47 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.03 179.121 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -66.06 -39.62 90.25 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.161 0.505 . . . . 0.0 110.143 179.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -64.43 -41.75 96.41 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.147 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.571 ' ND2' ' OG1' ' A' ' 99' ' ' THR . 54.0 m-80 -65.15 -34.83 79.33 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.6 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 42.0 mt -65.13 -16.54 63.6 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.634 -179.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 91.5 mt -73.76 -15.47 61.2 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.381 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 93.9 p -82.11 -2.84 53.3 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.198 0.523 . . . . 0.0 110.431 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.592 ' O ' ' CE1' ' A' ' 135' ' ' PHE . . . 93.31 -19.53 51.87 Favored Glycine 0 CA--C 1.527 0.799 0 CA-C-N 115.854 -0.612 . . . . 0.0 113.08 178.105 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -146.56 125.53 12.8 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 119.483 -0.887 . . . . 0.0 112.382 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -143.24 142.38 31.37 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.833 178.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.527 ' OG1' ' O ' ' A' ' 96' ' ' LYS . 58.5 p -65.37 132.44 49.0 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.46 0.648 . . . . 0.0 111.288 -178.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 78.9 t -78.38 -55.2 10.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.655 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.554 ' H ' ' NE2' ' A' ' 114' ' ' GLN . 83.5 mttt -107.04 139.74 40.96 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 122.048 0.928 . . . . 0.0 112.162 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -66.25 -34.48 78.11 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.444 -1.253 . . . . 0.0 112.165 -178.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -85.7 20.77 2.04 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 113.075 0.769 . . . . 0.0 113.075 -178.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . 0.554 ' NE2' ' H ' ' A' ' 111' ' ' LYS . 34.3 mt-30 -77.9 140.58 39.31 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.048 0.451 . . . . 0.0 111.034 179.635 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.2 t -125.91 108.54 19.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.965 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 73.3 mtp -56.25 126.61 26.94 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 121.121 0.486 . . . . 0.0 111.039 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 97.01 -11.76 65.79 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 121.133 -0.556 . . . . 0.0 111.825 179.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -143.72 137.29 28.04 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 121.055 0.455 . . . . 0.0 111.53 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 76.27 -170.7 54.83 Favored Glycine 0 CA--C 1.531 1.069 0 N-CA-C 111.675 -0.57 . . . . 0.0 111.675 179.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 54.5 t-20 -88.52 104.56 16.93 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 121.304 0.573 . . . . 0.0 110.576 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -86.99 145.97 26.31 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.4 179.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -147.58 143.76 27.98 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 119.493 -0.883 . . . . 0.0 111.841 -179.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 63.8 mt -138.29 143.75 40.16 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 114.823 -1.081 . . . . 0.0 110.181 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -111.71 138.35 48.4 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -132.03 145.34 17.11 Favored Glycine 0 CA--C 1.531 1.046 0 N-CA-C 110.386 -1.086 . . . . 0.0 110.386 -179.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 10.1 m-70 -88.63 124.1 33.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.449 0.642 . . . . 0.0 112.258 -179.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . 0.8 HD21 ' HG ' ' A' ' 136' ' ' SER . 2.6 t-20 -122.83 121.82 37.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.251 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 75.9 mtm -95.85 2.22 53.58 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 121.263 0.554 . . . . 0.0 110.748 179.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.493 ' H ' ' ND2' ' A' ' 127' ' ' ASN . 0.1 OUTLIER 76.04 10.5 3.14 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.543 179.114 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.497 ' O ' ' CG1' ' A' ' 133' ' ' VAL . 5.6 ptmt -110.51 114.16 27.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.878 0.847 . . . . 0.0 112.395 -179.352 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 6.1 tmtt? -37.72 120.28 0.81 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.661 -1.154 . . . . 0.0 111.7 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 113.13 -11.94 24.34 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.542 ' CG1' ' OG ' ' A' ' 136' ' ' SER . 11.8 p -91.71 164.31 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 CA-C-N 115.048 -0.576 . . . . 0.0 110.267 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.75 140.16 51.27 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.872 0.844 . . . . 0.0 112.645 -177.355 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.592 ' CE1' ' O ' ' A' ' 106' ' ' GLY . 3.2 m-85 66.43 5.3 3.68 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 113.977 -1.465 . . . . 0.0 113.796 177.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' SER . . . . . 0.8 ' HG ' HD21 ' A' ' 127' ' ' ASN . 0.4 OUTLIER -68.14 -40.48 82.4 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 112.373 0.509 . . . . 0.0 112.373 179.131 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . 0.51 ' O ' ' OG ' ' A' ' 140' ' ' SER . 48.6 p-10 -88.95 -1.34 58.06 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 121.251 0.548 . . . . 0.0 111.439 -178.215 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.401 HD12 ' CD2' ' A' ' 135' ' ' PHE . 0.3 OUTLIER -65.24 -35.71 76.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-O 121.158 0.504 . . . . 0.0 110.254 178.957 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -66.83 -11.44 55.44 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.052 0.453 . . . . 0.0 110.926 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.51 ' OG ' ' O ' ' A' ' 137' ' ' ASP . 59.6 p -84.35 -1.91 56.23 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 121.199 0.524 . . . . 0.0 110.756 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 66.1 mt -63.54 138.72 58.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.237 -179.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -113.48 154.46 27.0 Favored 'General case' 0 CA--C 1.535 0.365 0 CA-C-O 121.425 0.631 . . . . 0.0 111.351 -179.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -51.3 133.71 28.62 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.751 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.561 ' N ' ' O ' ' A' ' 160' ' ' VAL . . . 79.32 7.95 88.13 Favored Glycine 0 CA--C 1.527 0.84 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.554 179.14 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -70.12 132.8 46.38 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 119.88 -0.728 . . . . 0.0 109.852 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -78.59 138.32 38.3 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.76 0.79 . . . . 0.0 111.773 -178.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 95.9 mt -135.8 136.41 50.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 114.817 -1.083 . . . . 0.0 108.382 178.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -117.81 135.0 54.36 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.906 0.86 . . . . 0.0 112.842 -178.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -110.84 133.57 53.24 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 114.528 -1.215 . . . . 0.0 108.445 178.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.601 ' CZ ' ' OE2' ' A' ' 155' ' ' GLU . 79.8 m-85 -116.93 110.52 18.41 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 120.202 -0.599 . . . . 0.0 111.581 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . 0.466 ' OD1' ' N ' ' A' ' 152' ' ' ASN . 52.4 t0 -89.25 164.94 14.74 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 177.176 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . 0.466 ' N ' ' OD1' ' A' ' 151' ' ' ASP . 34.5 p30 -58.85 -19.12 38.76 Favored 'General case' 0 C--N 1.314 -0.967 0 C-N-CA 119.286 -0.965 . . . . 0.0 111.031 -178.119 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -112.28 -28.08 8.07 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -178.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . 0.414 ' O ' ' N ' ' A' ' 151' ' ' ASP . 0.4 OUTLIER -148.67 -175.64 5.01 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 -176.333 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.601 ' OE2' ' CZ ' ' A' ' 150' ' ' TYR . 87.7 tt0 -132.46 133.77 44.25 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 114.072 -1.422 . . . . 0.0 110.237 178.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -112.59 140.22 47.53 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 120.846 0.355 . . . . 0.0 110.315 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -99.87 117.98 35.34 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 121.047 0.451 . . . . 0.0 112.051 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -114.75 148.82 37.83 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 121.178 0.513 . . . . 0.0 111.416 179.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -121.03 120.85 36.58 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.713 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.561 ' O ' ' N ' ' A' ' 144' ' ' GLY . 91.0 t -59.59 136.77 22.86 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.292 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.743 178.199 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 15.1 p -105.63 -24.05 12.63 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.786 178.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 154.86 -163.43 31.32 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 120.682 -0.771 . . . . 0.0 111.62 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 35.5 m -135.76 158.07 39.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-N 115.343 -0.428 . . . . 0.0 110.004 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 81.6 p -145.95 165.78 27.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.118 0.485 . . . . 0.0 110.924 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -101.85 115.2 30.02 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.898 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . 0.542 ' O ' ' O ' ' A' ' 196' ' ' ARG . 23.8 m -137.98 162.76 30.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.989 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -86.48 157.01 56.22 Favored Pre-proline 0 CA--C 1.54 0.575 0 CA-C-O 121.16 0.505 . . . . 0.0 111.431 -179.443 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . 0.413 ' O ' ' CG ' ' B' ' 702' ' ' LEU . 36.5 Cg_endo -67.86 -9.98 27.34 Favored 'Trans proline' 0 N--CA 1.5 1.862 0 C-N-CA 123.398 2.732 . . . . 0.0 112.861 -179.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . 0.424 ' OD1' ' C ' ' A' ' 169' ' ' ASP . 40.2 p-10 -95.01 -4.0 47.35 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.236 0.541 . . . . 0.0 110.924 179.018 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -75.69 82.83 2.68 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.533 -178.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 40.4 p-90 -76.72 -12.08 59.94 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 121.356 0.598 . . . . 0.0 110.594 178.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 76.4 tt0 -61.0 -36.58 79.86 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.988 -179.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 11.6 p -62.44 -25.97 39.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 CA-C-O 121.107 0.479 . . . . 0.0 110.77 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 20.1 t -93.1 -8.49 10.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.945 -179.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.525 ' OE1' ' O ' ' A' ' 176' ' ' ASP . 0.6 OUTLIER -73.5 146.77 44.64 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 120.935 0.398 . . . . 0.0 111.076 -179.766 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . 0.525 ' O ' ' OE1' ' A' ' 175' ' ' GLU . 48.1 p-10 -66.27 128.29 35.54 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.281 0.563 . . . . 0.0 111.857 -179.169 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 21.4 m80 -111.49 24.66 12.52 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.965 -0.561 . . . . 0.0 112.119 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 60.21 35.79 88.94 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 120.724 -0.75 . . . . 0.0 111.247 179.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -154.15 161.41 41.88 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 110.208 -0.293 . . . . 0.0 110.208 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -89.35 105.25 17.67 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.897 179.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 -139.21 167.02 23.0 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.569 0.699 . . . . 0.0 112.154 179.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 18.9 tt -130.08 138.02 55.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 114.827 -1.079 . . . . 0.0 109.917 179.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 39.8 m -130.98 122.64 27.22 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.176 0.512 . . . . 0.0 111.079 -179.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 93.9 mt -109.43 136.29 49.08 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.631 178.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 70.0 mt -105.68 115.71 47.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 C-N-CA 120.206 -0.598 . . . . 0.0 110.179 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 77.1 m -126.79 132.63 51.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.275 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -84.03 140.8 31.62 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 73.7 t -61.19 -49.05 86.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.161 0.505 . . . . 0.0 111.257 -178.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' SER . . . . . 0.463 ' HG ' ' H ' ' A' ' 192' ' ' ASP . 34.7 p -168.52 163.84 12.47 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.282 0.563 . . . . 0.0 111.009 -179.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 31.3 m -76.85 -9.89 12.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.349 179.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -101.37 -23.49 14.36 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.852 178.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . 0.463 ' H ' ' HG ' ' A' ' 189' ' ' SER . 60.4 t0 -96.68 105.77 17.93 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.04 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -109.77 5.92 23.12 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.177 0.513 . . . . 0.0 110.632 179.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 85.9 p -68.43 -59.76 2.94 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.677 -179.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -147.49 155.77 42.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.17 0.51 . . . . 0.0 111.25 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . 0.542 ' O ' ' O ' ' A' ' 166' ' ' VAL . 99.8 mtt180 -129.58 143.78 50.98 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.533 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . 0.421 ' CD1' ' C ' ' A' ' 197' ' ' TYR . 36.4 p90 -93.16 152.07 19.46 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.425 0.631 . . . . 0.0 111.314 -179.335 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 48.4 t -123.7 132.93 70.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.378 179.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 40.7 t -94.0 132.32 38.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.989 -179.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -119.3 145.0 46.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.465 0.65 . . . . 0.0 111.393 -179.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -142.8 146.08 16.62 Favored Glycine 0 CA--C 1.529 0.945 0 N-CA-C 110.451 -1.06 . . . . 0.0 110.451 179.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 48.9 p-10 -109.04 151.66 26.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.175 0.512 . . . . 0.0 111.427 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 51.0 tp -72.48 132.36 43.76 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 178.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 2.6 p -115.25 -19.19 6.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 120.74 -0.384 . . . . 0.0 111.493 -179.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -178.3 174.64 46.89 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 120.804 -0.712 . . . . 0.0 111.66 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 60.3 m -141.04 136.3 31.91 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-O 120.662 0.268 . . . . 0.0 110.652 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -143.96 115.62 8.18 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 120.153 -0.619 . . . . 0.0 112.309 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -64.3 147.57 52.2 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.256 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 8.4 ttpt -80.34 109.53 14.92 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.365 178.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 98.0 mttt . . . . . 0 C--O 1.221 -0.428 0 CA-C-O 117.837 -1.078 . . . . 0.0 110.536 179.142 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 702' ' ' LEU . . . . . 0.413 ' CG ' ' O ' ' A' ' 168' ' ' PRO . 0.2 OUTLIER . . . . . 0 CA--C 1.539 0.539 0 CA-C-O 121.628 0.728 . . . . 20.0 110.892 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 703' ' ' PRO . . . . . 0.547 ' O ' ' O ' ' B' ' 704' ' ' ALA . 3.7 Cg_exo -72.18 -171.04 0.63 Allowed 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 123.84 3.027 . . . . 20.0 112.982 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 704' ' ' ALA . . . . . 0.547 ' O ' ' O ' ' B' ' 703' ' ' PRO . . . . . . . . 0 CA--C 1.534 0.34 0 CA-C-N 115.079 -0.964 . . . . 20.0 113.129 -178.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.256 0 CA-C-O 121.42 0.628 . . . . 0.0 110.17 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.41 ' H ' ' HG ' ' A' ' 59' ' ' SER . 5.4 p -82.6 10.08 8.14 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.546 -179.616 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -96.74 8.56 44.0 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.238 0.542 . . . . 0.0 110.869 -179.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 59.0 mt -55.19 142.72 9.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.953 0.882 . . . . 0.0 111.68 -177.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -75.48 126.95 32.05 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 114.142 -1.39 . . . . 0.0 108.775 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.606 ' H ' ' CD ' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -78.72 130.87 69.32 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.708 -178.867 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_exo -51.14 150.52 13.85 Favored 'Trans proline' 0 N--CA 1.493 1.471 0 C-N-CA 121.695 1.597 . . . . 0.0 111.767 178.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.479 ' CG ' ' H ' ' A' ' 66' ' ' LEU . 45.0 t0 -52.41 177.51 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 121.198 0.523 . . . . 0.0 111.506 -178.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.479 ' H ' ' CG ' ' A' ' 65' ' ' ASP . 94.5 mt -65.95 -45.25 82.5 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.672 -178.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.63 -30.59 70.81 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.229 -0.588 . . . . 0.0 110.704 -178.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -62.82 -30.36 71.42 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.431 178.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 37.3 t -77.84 -46.27 27.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.131 -0.94 . . . . 0.0 110.685 179.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.08 -9.58 58.29 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.144 -0.935 . . . . 0.0 111.244 -179.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -109.35 -13.61 14.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.318 0.58 . . . . 0.0 110.095 178.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.37 135.44 51.8 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.712 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 33.0 t -59.47 103.01 0.16 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.647 -179.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.85 125.95 28.25 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.591 -179.546 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -98.49 83.77 3.07 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 121.382 0.611 . . . . 0.0 109.95 178.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -62.82 -38.28 90.11 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.376 -179.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.487 ' CD ' ' H ' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -71.51 -12.03 61.17 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 120.471 -0.492 . . . . 0.0 110.999 -177.347 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -93.05 0.71 57.4 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.423 0.63 . . . . 0.0 110.203 178.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 88.3 t -86.11 128.31 39.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.132 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 16.5 pt -107.35 -7.9 10.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.239 -179.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -170.95 179.33 42.91 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 120.454 -0.879 . . . . 0.0 111.808 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 56.4 ttp180 -140.24 156.26 46.56 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 121.378 0.609 . . . . 0.0 111.315 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 16.8 tt -125.29 141.98 43.56 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 CA-C-O 121.437 0.637 . . . . 0.0 110.464 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 66.5 m -135.31 130.31 34.86 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.093 -0.958 . . . . 0.0 111.258 -178.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 22.6 mt -133.79 88.73 32.12 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.121 -178.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -54.9 -35.36 89.03 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 123.278 2.652 . . . . 0.0 112.644 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 44.4 t -55.88 -43.41 77.15 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.192 -0.458 . . . . 0.0 112.212 -179.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 21.7 m -112.21 6.36 8.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.285 0.564 . . . . 0.0 110.731 179.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.7 m 56.05 53.01 9.61 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.196 179.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 58.1 tp -116.7 135.52 53.71 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.309 0.576 . . . . 0.0 110.779 179.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -146.44 117.06 7.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.115 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 75.5 mt -150.27 151.45 31.49 Favored Pre-proline 0 CA--C 1.539 0.538 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.481 -179.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -74.2 147.0 37.02 Favored 'Trans proline' 0 N--CA 1.493 1.475 0 C-N-CA 122.833 2.355 . . . . 0.0 111.827 179.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 74.2 t -92.46 122.22 43.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.083 0.468 . . . . 0.0 110.228 179.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.479 ' N ' ' CD1' ' A' ' 95' ' ' LEU . 10.2 mp -100.67 126.66 47.2 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.806 0.812 . . . . 0.0 110.672 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -63.02 -46.45 87.56 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.34 -1.3 . . . . 0.0 112.835 -178.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 4.3 m -86.25 132.09 34.07 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 121.123 0.487 . . . . 0.0 111.75 -179.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -87.17 60.41 6.14 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.352 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.414 ' CG2' ' N ' ' A' ' 100' ' ' GLU . 54.1 m -88.11 163.31 16.28 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 178.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.414 ' N ' ' CG2' ' A' ' 99' ' ' THR . 94.5 mt-10 -58.56 -44.56 89.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.284 0.564 . . . . 0.0 110.232 -179.424 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.41 ' H ' HG23 ' A' ' 99' ' ' THR . 66.3 mttm -64.8 -40.33 95.05 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.717 0.77 . . . . 0.0 110.077 178.197 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.438 ' O ' ' OG ' ' A' ' 105' ' ' SER . 95.9 m-20 -63.25 -36.42 83.62 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.054 -0.975 . . . . 0.0 111.711 -179.336 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 74.6 mt -61.89 -25.53 67.61 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 120.809 -0.357 . . . . 0.0 111.223 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 84.6 mt -73.15 -13.32 61.15 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.908 0.385 . . . . 0.0 111.029 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.438 ' OG ' ' O ' ' A' ' 102' ' ' ASN . 94.4 p -73.98 -9.01 58.21 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.392 0.615 . . . . 0.0 110.158 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.524 ' O ' ' CE1' ' A' ' 135' ' ' PHE . . . 95.31 -20.86 47.36 Favored Glycine 0 CA--C 1.526 0.779 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.884 178.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -146.92 125.48 12.47 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.215 -0.594 . . . . 0.0 111.376 179.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -144.15 129.11 18.5 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.116 179.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.511 ' CG2' ' NE2' ' A' ' 114' ' ' GLN . 27.7 m -66.96 131.55 46.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.897 -179.483 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 92.7 t -79.07 -53.31 13.74 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.91 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.756 ' H ' ' NE2' ' A' ' 114' ' ' GLN . 73.3 mmtt -100.73 131.68 46.5 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 122.134 0.969 . . . . 0.0 111.949 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -66.09 -27.94 68.44 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 114.627 -1.17 . . . . 0.0 113.076 -178.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -84.14 12.97 5.6 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 113.863 1.06 . . . . 0.0 113.863 -177.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . 0.756 ' NE2' ' H ' ' A' ' 111' ' ' LYS . 45.5 mt-30 -77.96 143.28 37.75 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.348 0.595 . . . . 0.0 112.502 -179.622 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 53.0 t -123.56 124.64 69.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.046 178.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 63.6 mtt -58.42 130.5 47.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.417 179.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 84.19 -1.13 89.13 Favored Glycine 0 CA--C 1.529 0.933 0 N-CA-C 111.551 -0.619 . . . . 0.0 111.551 179.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -143.85 128.18 17.82 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 121.048 0.451 . . . . 0.0 110.787 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 78.76 -177.68 53.83 Favored Glycine 0 CA--C 1.532 1.117 0 N-CA-C 111.82 -0.512 . . . . 0.0 111.82 179.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 61.7 t-20 -84.97 105.4 15.7 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 120.943 0.402 . . . . 0.0 110.131 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -86.6 99.69 11.89 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.012 0.434 . . . . 0.0 110.386 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.473 ' N ' ' OE1' ' A' ' 114' ' ' GLN . . . -93.09 137.11 32.74 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 121.08 0.467 . . . . 0.0 111.628 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 61.1 mt -136.26 142.56 43.99 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.59 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -107.38 139.59 41.63 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 178.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -137.52 148.07 19.6 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 109.254 -1.538 . . . . 0.0 109.254 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 12.6 m-70 -92.26 123.68 35.77 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.744 0.783 . . . . 0.0 112.411 -178.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . 0.467 ' OD1' ' N ' ' A' ' 129' ' ' SER . 52.0 t-20 -116.27 119.71 36.6 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.086 179.282 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 68.6 mtt -94.92 -2.75 49.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.351 0.596 . . . . 0.0 109.923 179.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.467 ' N ' ' OD1' ' A' ' 127' ' ' ASN . 0.2 OUTLIER 74.55 6.56 4.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.07 179.585 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.561 ' O ' ' CG1' ' A' ' 133' ' ' VAL . 11.4 ptpt -113.43 120.71 41.98 Favored 'General case' 0 C--O 1.225 -0.235 0 CA-C-O 121.33 0.586 . . . . 0.0 112.224 -179.379 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.51 ' O ' ' O ' ' A' ' 130' ' ' LYS . 18.2 tptt -31.93 155.13 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.616 179.316 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.404 ' H ' ' HG3' ' A' ' 131' ' ' LYS . . . 77.39 -17.01 5.51 Favored Glycine 0 CA--C 1.529 0.913 0 N-CA-C 110.819 -0.912 . . . . 0.0 110.819 179.462 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.561 ' CG1' ' O ' ' A' ' 130' ' ' LYS . 7.8 p -91.62 150.88 3.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 120.057 -0.657 . . . . 0.0 109.732 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.667 ' CD2' ' H ' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -68.27 146.18 53.57 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 122.035 0.922 . . . . 0.0 113.245 -177.112 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.524 ' CE1' ' O ' ' A' ' 106' ' ' GLY . 3.2 m-85 65.12 5.38 2.97 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 113.787 -1.551 . . . . 0.0 113.865 178.143 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' SER . . . . . 0.519 ' OG ' ' CG1' ' A' ' 133' ' ' VAL . 0.5 OUTLIER -71.65 -38.94 70.64 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 121.692 -0.63 . . . . 0.0 112.593 179.465 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 79.0 m-20 -93.46 0.73 56.86 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 114.9 1.444 . . . . 0.0 114.9 -177.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 38.4 pt -63.87 -22.83 31.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 119.038 -1.065 . . . . 0.0 110.471 -178.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -69.49 -10.86 59.85 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.268 0.556 . . . . 0.0 110.086 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 1.4 m -84.45 -5.21 59.26 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.572 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 82.1 mt -64.75 145.55 56.07 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.409 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -120.71 157.59 29.32 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 121.455 0.645 . . . . 0.0 112.148 -178.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -50.67 131.97 25.79 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.6 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 160' ' ' VAL . . . 80.17 7.37 88.59 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 120.648 -0.787 . . . . 0.0 111.149 179.05 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.489 ' OD1' ' N ' ' A' ' 146' ' ' LYS . 64.9 t0 -73.73 131.56 41.73 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 119.89 -0.724 . . . . 0.0 110.007 -179.705 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.489 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 73.6 mmtt -76.95 140.06 40.34 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.616 0.722 . . . . 0.0 112.124 -178.272 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 48.9 mm -131.51 134.42 60.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 177.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -112.49 127.49 56.07 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 119.747 -0.781 . . . . 0.0 112.424 -178.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -110.79 132.43 54.2 Favored 'General case' 0 C--O 1.224 -0.279 0 CA-C-N 114.943 -1.026 . . . . 0.0 108.658 178.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.594 ' CE2' ' OE1' ' A' ' 155' ' ' GLU . 61.2 m-85 -117.21 112.14 20.41 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.204 -0.598 . . . . 0.0 112.569 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . 0.563 ' OD1' ' N ' ' A' ' 152' ' ' ASN . 54.6 t0 -91.2 164.81 13.77 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 176.56 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . 0.563 ' N ' ' OD1' ' A' ' 151' ' ' ASP . 65.8 m-20 -57.61 -23.93 53.66 Favored 'General case' 0 C--N 1.311 -1.074 0 C-N-CA 120.106 -0.637 . . . . 0.0 111.112 -178.023 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -108.3 -29.68 8.74 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 119.762 -0.775 . . . . 0.0 112.839 -178.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . 0.433 ' O ' ' N ' ' A' ' 151' ' ' ASP . 0.3 OUTLIER -149.51 -177.51 5.9 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 113.723 1.008 . . . . 0.0 113.723 -177.779 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.594 ' OE1' ' CE2' ' A' ' 150' ' ' TYR . 80.0 tt0 -128.76 138.09 51.91 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 114.209 -1.36 . . . . 0.0 110.066 179.143 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -111.56 134.0 53.44 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 121.354 0.597 . . . . 0.0 111.383 -179.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -89.65 108.25 19.56 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.453 178.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -112.02 147.22 36.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.026 0.441 . . . . 0.0 111.187 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -124.32 123.39 40.1 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 121.047 0.451 . . . . 0.0 110.917 179.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.51 ' O ' ' N ' ' A' ' 144' ' ' GLY . 81.2 t -59.45 135.09 24.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 178.07 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 42.6 p -105.29 -26.04 12.17 Favored 'General case' 0 C--N 1.33 -0.263 0 O-C-N 123.325 0.39 . . . . 0.0 110.674 179.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 162.69 -169.72 38.02 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 120.452 -0.88 . . . . 0.0 111.992 179.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 3.0 p -135.11 149.92 29.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.068 -0.566 . . . . 0.0 110.15 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 50.7 m -139.54 163.58 32.17 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.427 0.632 . . . . 0.0 111.187 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -100.22 121.57 41.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.266 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 27.1 m -136.72 161.3 36.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.386 -179.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -92.68 165.03 20.03 Favored Pre-proline 0 CA--C 1.538 0.501 0 C-N-CA 120.662 -0.415 . . . . 0.0 111.054 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . 0.431 ' O ' ' CB ' ' B' ' 702' ' ' LEU . 25.0 Cg_exo -62.52 -19.72 68.52 Favored 'Trans proline' 0 N--CA 1.499 1.852 0 C-N-CA 122.489 2.126 . . . . 0.0 112.998 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 46.7 p-10 -94.76 -5.85 44.36 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -75.95 88.82 2.93 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 119.655 -0.818 . . . . 0.0 111.657 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 4.9 p90 -76.89 -14.49 59.87 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.467 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -57.59 -35.53 70.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.47 -179.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 27.6 m -64.16 -15.56 17.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 C-N-CA 120.771 -0.372 . . . . 0.0 111.253 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 78.6 t -103.96 -16.1 7.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -179.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -74.57 144.33 44.04 Favored 'General case' 0 CA--C 1.533 0.319 0 O-C-N 121.816 -0.552 . . . . 0.0 110.956 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . 0.501 ' OD1' ' O ' ' A' ' 176' ' ' ASP . 55.7 p-10 -64.95 145.16 56.69 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.456 179.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 68.9 m80 -120.7 31.73 6.3 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 121.035 0.445 . . . . 0.0 111.759 -179.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 59.93 39.79 96.02 Favored Glycine 0 CA--C 1.534 1.228 0 N-CA-C 111.257 -0.737 . . . . 0.0 111.257 179.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -155.89 165.72 35.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.028 0.442 . . . . 0.0 110.781 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -88.56 102.03 14.53 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 177.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . 0.43 ' HG2' ' N ' ' A' ' 182' ' ' ILE . 84.4 tt0 -138.27 163.54 31.51 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.663 0.744 . . . . 0.0 111.909 -178.335 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.43 ' N ' ' HG2' ' A' ' 181' ' ' GLU . 18.6 tt -130.65 138.93 52.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.13 178.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 86.0 m -130.3 125.49 34.87 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.477 0.656 . . . . 0.0 111.639 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 93.2 mt -109.54 131.58 54.93 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.111 178.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 82.6 mt -113.91 125.39 71.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.465 0.65 . . . . 0.0 111.889 -177.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 3.4 t -140.98 161.95 36.62 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.547 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' CYS . . . . . . . . . . . . . 1.9 m -96.94 146.43 24.97 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.379 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . 0.4 ' CG1' ' N ' ' A' ' 189' ' ' SER . 8.0 p -63.8 -43.51 97.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.196 0.522 . . . . 0.0 111.353 -179.322 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' SER . . . . . 0.4 ' N ' ' CG1' ' A' ' 188' ' ' VAL . 13.6 p -162.76 160.88 25.88 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.483 -179.306 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 9.5 p -79.18 -11.75 13.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.83 179.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -97.97 -19.85 17.79 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.052 0.453 . . . . 0.0 111.083 179.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 67.2 t0 -132.64 103.67 6.25 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.103 0.478 . . . . 0.0 111.403 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -104.29 10.84 35.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.875 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 44.2 t -60.72 -43.7 97.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.078 0.466 . . . . 0.0 111.109 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -125.03 144.33 50.45 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.05 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -124.47 143.54 50.59 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.852 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -98.67 133.51 42.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.023 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 30.0 t -120.3 131.17 73.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 CA-C-O 121.426 0.631 . . . . 0.0 110.936 179.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 31.7 t -104.28 132.07 51.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.194 179.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -113.78 144.38 43.07 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.368 0.604 . . . . 0.0 111.556 -179.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -136.46 139.32 10.55 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 110.356 -1.098 . . . . 0.0 110.356 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -103.47 138.65 39.9 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.145 0.497 . . . . 0.0 110.816 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 66.0 tp -62.83 131.52 49.08 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 2.8 t -115.37 -19.81 6.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 C-N-CA 120.762 -0.375 . . . . 0.0 111.503 -178.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -178.13 173.53 46.01 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 120.649 -0.786 . . . . 0.0 111.716 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 24.7 m -140.87 137.02 32.91 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.584 -0.525 . . . . 0.0 109.584 179.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -143.92 117.27 9.05 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.335 0.588 . . . . 0.0 112.075 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -62.43 141.71 58.23 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.991 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 8.9 ttpt -78.52 109.52 12.77 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.224 178.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 99.8 mttt . . . . . 0 C--N 1.322 -0.606 0 CA-C-O 117.914 -1.041 . . . . 0.0 110.828 -179.293 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 702' ' ' LEU . . . . . 0.431 ' CB ' ' O ' ' A' ' 168' ' ' PRO . 0.4 OUTLIER . . . . . 0 CA--C 1.543 0.681 0 N-CA-C 110.125 -0.324 . . . . 20.0 110.125 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 703' ' ' PRO . . . . . 0.504 ' O ' ' O ' ' B' ' 704' ' ' ALA . 2.8 Cg_endo -65.68 -176.83 0.61 Allowed 'Trans proline' 0 N--CA 1.489 1.249 0 C-N-CA 121.663 1.575 . . . . 20.0 113.047 -179.131 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 704' ' ' ALA . . . . . 0.504 ' O ' ' O ' ' B' ' 703' ' ' PRO . . . . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 114.319 -1.31 . . . . 20.0 113.527 -179.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.172 0 CA-C-O 121.058 0.456 . . . . 0.0 111.524 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 98.4 p -87.72 1.59 53.39 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.587 0.708 . . . . 0.0 110.077 178.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -100.26 10.27 41.49 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.038 -178.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 95.7 mt -56.04 135.22 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-O 122.159 0.981 . . . . 0.0 112.948 -176.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 85.0 m-20 -75.94 130.61 38.73 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 113.881 -1.509 . . . . 0.0 108.913 178.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.59 ' NE2' ' O ' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -82.25 152.49 67.88 Favored Pre-proline 0 C--N 1.328 -0.348 0 C-N-CA 120.15 -0.62 . . . . 0.0 110.49 -179.66 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -72.43 169.92 20.54 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 123.135 2.557 . . . . 0.0 112.76 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -54.65 169.61 0.2 Allowed 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.416 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 57.2 tp -64.3 -45.4 88.14 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.688 -179.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.73 -36.14 75.99 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.09 -0.644 . . . . 0.0 111.157 -177.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.604 ' N ' ' OE1' ' A' ' 68' ' ' GLU . 4.9 mp0 -55.88 -28.84 58.53 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.444 0.64 . . . . 0.0 109.511 178.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 38.3 t -76.59 -44.41 34.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-N 115.342 -0.844 . . . . 0.0 110.823 179.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -79.7 -8.08 59.0 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.974 -179.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -105.89 -13.14 15.59 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.337 0.589 . . . . 0.0 109.926 178.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -70.03 138.22 51.97 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.516 -0.766 . . . . 0.0 111.31 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 37.4 t -59.54 100.31 0.08 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.447 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.487 ' CD1' ' C ' ' A' ' 74' ' ' LEU . 2.8 tm? -71.12 122.87 20.92 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.137 -179.115 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -92.66 80.59 4.77 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 121.299 0.571 . . . . 0.0 110.501 178.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 51.8 tptt -65.83 -32.88 74.65 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.052 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.427 ' H ' ' HE3' ' A' ' 77' ' ' LYS . 3.0 mtmt -72.63 -18.31 61.59 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.414 -177.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -90.54 -9.51 46.92 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.033 0.444 . . . . 0.0 110.836 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 96.5 t -70.25 130.27 34.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.404 0.621 . . . . 0.0 111.263 -179.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 42.9 pt -118.13 -11.86 11.19 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.579 -179.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -159.83 170.02 35.92 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 111.154 -0.779 . . . . 0.0 111.154 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 61.9 ttp180 -143.61 151.35 40.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.542 0.686 . . . . 0.0 112.154 -179.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 21.0 tt -112.79 138.01 43.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.546 178.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 33.3 t -135.64 128.7 31.58 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 121.518 0.675 . . . . 0.0 111.903 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 85.1 mt -138.16 86.07 17.89 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.182 179.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -55.96 -29.85 75.27 Favored 'Trans proline' 0 N--CA 1.497 1.703 0 C-N-CA 123.091 2.527 . . . . 0.0 113.16 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 95.9 p -53.45 -38.43 63.55 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 120.537 -0.465 . . . . 0.0 111.005 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 23.7 m -117.47 12.2 7.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.387 0.613 . . . . 0.0 110.001 178.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 48.21 53.55 11.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.762 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 58.0 tp -114.93 132.47 56.54 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.318 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -145.78 122.36 11.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.649 -179.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 8.6 mt -146.81 147.74 30.79 Favored Pre-proline 0 CA--C 1.54 0.56 0 C-N-CA 120.198 -0.601 . . . . 0.0 111.95 -179.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -77.15 151.57 30.38 Favored 'Trans proline' 0 N--CA 1.497 1.688 0 C-N-CA 123.059 2.506 . . . . 0.0 112.478 178.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 87.7 t -95.52 113.24 29.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-O 121.065 0.46 . . . . 0.0 111.613 179.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.435 ' N ' ' CD1' ' A' ' 95' ' ' LEU . 11.1 mp -98.87 139.82 33.96 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.96 179.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.509 ' O ' ' OG1' ' A' ' 109' ' ' THR . 98.8 mttt -63.79 -80.97 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -178.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 33.6 t -60.86 131.14 49.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.186 0.517 . . . . 0.0 111.838 -178.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 35.3 p -89.72 71.68 7.73 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.99 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 26.1 m -92.21 169.53 10.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.505 -0.771 . . . . 0.0 109.251 178.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -61.65 -44.43 96.98 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 119.776 -0.77 . . . . 0.0 110.059 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -65.7 -40.99 92.86 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 121.33 0.586 . . . . 0.0 110.955 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -63.92 -38.7 92.05 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.149 -179.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 64.9 mt -62.63 -18.86 63.08 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.608 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 75.2 mt -70.74 -18.37 62.78 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.998 0.428 . . . . 0.0 110.39 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 88.9 p -74.45 -8.77 57.38 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.555 0.693 . . . . 0.0 109.286 179.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.608 ' O ' ' CE1' ' A' ' 135' ' ' PHE . . . 93.01 -19.15 53.98 Favored Glycine 0 CA--C 1.53 0.974 0 CA-C-N 115.123 -0.944 . . . . 0.0 112.337 178.616 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -146.25 126.76 14.13 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 119.659 -0.816 . . . . 0.0 112.745 -179.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -143.54 138.85 29.43 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.042 178.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.509 ' OG1' ' O ' ' A' ' 96' ' ' LYS . 30.0 p -65.67 133.03 50.25 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 121.271 0.558 . . . . 0.0 110.718 -179.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.472 ' N ' HE22 ' A' ' 114' ' ' GLN . 44.4 t -80.52 -50.4 17.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.385 -179.168 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.71 ' H ' ' NE2' ' A' ' 114' ' ' GLN . 76.8 mttt -105.65 141.22 37.47 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.835 0.826 . . . . 0.0 112.631 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -66.8 -36.26 81.97 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.174 -0.921 . . . . 0.0 112.917 -178.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 17.0 p30 -82.13 15.88 2.19 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -178.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . 0.71 ' NE2' ' H ' ' A' ' 111' ' ' LYS . 32.9 mt-30 -78.2 137.42 38.13 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 122.031 -0.418 . . . . 0.0 110.482 179.487 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 69.0 t -124.24 125.87 71.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.269 -0.423 . . . . 0.0 109.994 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' MET . . . . . 0.598 ' SD ' ' CZ ' ' A' ' 121' ' ' TYR . 91.7 mmm -56.53 125.75 23.48 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.097 0.475 . . . . 0.0 111.467 -179.605 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 82.59 -0.66 89.11 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-N 115.905 -0.589 . . . . 0.0 112.294 178.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -138.07 130.56 29.29 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 119.998 -0.681 . . . . 0.0 110.637 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 74.2 -169.47 53.91 Favored Glycine 0 CA--C 1.53 1.006 0 N-CA-C 110.518 -1.033 . . . . 0.0 110.518 -179.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 58.8 t-20 -89.39 105.62 17.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.992 0.425 . . . . 0.0 110.04 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.598 ' CZ ' ' SD ' ' A' ' 116' ' ' MET . 11.4 t80 -88.45 100.44 13.05 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.015 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.14 137.71 32.12 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 121.276 0.56 . . . . 0.0 111.745 -178.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 62.7 mt -135.21 137.33 42.53 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.923 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -112.07 135.69 52.4 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -130.75 134.22 7.67 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 110.601 -1.0 . . . . 0.0 110.601 -179.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -82.14 138.46 34.74 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.504 0.669 . . . . 0.0 111.627 -179.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . 0.632 HD22 ' N ' ' A' ' 187' ' ' CYS . 32.1 p30 -141.47 161.0 38.98 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.14 -0.937 . . . . 0.0 110.388 179.568 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' MET . . . . . 0.445 ' O ' ' CB ' ' A' ' 129' ' ' SER . 70.7 mtm -124.28 1.19 8.43 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.575 178.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.445 ' CB ' ' O ' ' A' ' 128' ' ' MET . 0.2 OUTLIER 76.93 12.37 2.31 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.764 179.361 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.56 ' O ' ' CG1' ' A' ' 133' ' ' VAL . 9.3 ptpt -115.21 119.54 36.71 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.465 0.65 . . . . 0.0 112.295 -179.254 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.536 ' O ' ' O ' ' A' ' 130' ' ' LYS . 74.7 mmtt -29.07 154.73 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.893 -1.048 . . . . 0.0 111.611 179.453 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 75.34 -15.09 4.64 Favored Glycine 0 CA--C 1.529 0.94 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.964 179.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.56 ' CG1' ' O ' ' A' ' 130' ' ' LYS . 9.8 p -91.27 153.8 3.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 C-N-CA 120.371 -0.532 . . . . 0.0 109.785 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.62 ' CD2' ' H ' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -70.69 144.47 51.02 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 113.97 1.1 . . . . 0.0 113.97 -177.396 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.608 ' CE1' ' O ' ' A' ' 106' ' ' GLY . 3.9 m-85 68.7 -0.94 2.14 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 113.67 -1.605 . . . . 0.0 113.598 178.579 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 6.7 t -69.4 -39.43 77.94 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 179.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -89.36 -6.99 56.16 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.355 0.598 . . . . 0.0 111.252 -178.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.405 HD12 ' CD1' ' A' ' 135' ' ' PHE . 8.0 mt -62.86 -42.32 95.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.433 179.329 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -63.38 -12.02 27.33 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 120.238 -0.585 . . . . 0.0 110.337 179.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 1.9 m -82.36 -6.19 59.1 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.325 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 81.4 mt -63.27 142.02 58.54 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.212 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -116.76 163.62 15.87 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.701 0.762 . . . . 0.0 111.81 -179.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -52.08 134.97 32.15 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.868 -1.06 . . . . 0.0 112.158 179.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.598 ' N ' ' O ' ' A' ' 160' ' ' VAL . . . 77.14 7.97 86.85 Favored Glycine 0 CA--C 1.527 0.818 0 CA-C-N 115.541 -0.754 . . . . 0.0 112.313 178.011 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 50.6 t0 -72.62 132.93 44.37 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 119.541 -0.864 . . . . 0.0 109.804 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -77.45 138.1 39.05 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 121.663 0.744 . . . . 0.0 111.716 -178.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.405 HG23 HD11 ' A' ' 147' ' ' ILE . 87.2 mt -133.42 135.4 56.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 114.958 -1.019 . . . . 0.0 108.342 178.637 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 -115.64 133.52 55.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.535 0.683 . . . . 0.0 112.689 -178.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -115.64 133.02 56.44 Favored 'General case' 0 C--O 1.225 -0.229 0 CA-C-N 115.158 -0.928 . . . . 0.0 108.872 177.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.592 ' CZ ' ' OE2' ' A' ' 155' ' ' GLU . 93.4 m-85 -116.39 114.0 23.68 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.315 -0.554 . . . . 0.0 111.138 179.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . 0.467 ' OD1' ' N ' ' A' ' 152' ' ' ASN . 54.1 t0 -93.29 172.3 8.38 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 177.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . 0.467 ' N ' ' OD1' ' A' ' 151' ' ' ASP . 68.6 m-20 -58.04 -26.85 63.0 Favored 'General case' 0 C--N 1.318 -0.764 0 C-N-CA 120.483 -0.487 . . . . 0.0 111.477 -177.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -115.08 -24.19 8.67 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 -178.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -146.86 177.73 8.89 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -176.159 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.592 ' OE2' ' CZ ' ' A' ' 150' ' ' TYR . 83.8 tt0 -126.99 138.0 53.19 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 114.644 -1.162 . . . . 0.0 110.323 178.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -115.12 133.97 55.58 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 121.089 0.471 . . . . 0.0 111.676 -179.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -92.95 109.55 21.0 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.482 179.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -112.82 148.64 34.43 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.091 0.472 . . . . 0.0 111.168 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -125.23 124.46 41.74 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 121.331 0.586 . . . . 0.0 111.226 179.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.598 ' O ' ' N ' ' A' ' 144' ' ' GLY . 77.5 t -59.06 136.47 22.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.918 178.152 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 66.8 p -104.43 -24.81 13.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.09 0.472 . . . . 0.0 110.918 179.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 157.97 -167.7 34.35 Favored Glycine 0 CA--C 1.529 0.939 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 2.8 m -133.55 158.55 42.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 69.8 m -142.62 164.27 30.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.479 0.657 . . . . 0.0 111.731 -179.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -99.59 114.43 27.46 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.682 179.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 20.5 m -136.79 158.12 36.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.42 0.629 . . . . 0.0 111.582 -179.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -87.65 159.01 50.38 Favored Pre-proline 0 CA--C 1.536 0.423 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.996 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . 0.404 ' O ' ' CG ' ' B' ' 702' ' ' LEU . 37.2 Cg_endo -64.81 -10.54 25.41 Favored 'Trans proline' 0 N--CA 1.498 1.739 0 C-N-CA 122.861 2.374 . . . . 0.0 112.98 -179.416 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 45.5 p-10 -95.44 -8.24 35.99 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -77.13 86.73 3.6 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 121.75 0.786 . . . . 0.0 112.256 -179.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' TRP . . . . . 0.51 ' CE2' ' OE2' ' A' ' 175' ' ' GLU . 1.2 p-90 -80.47 -9.25 59.77 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.798 -1.092 . . . . 0.0 110.883 179.583 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -63.89 -32.11 73.52 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.818 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 35.0 m -63.13 -18.71 22.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-N 116.112 -0.495 . . . . 0.0 112.137 -179.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 34.8 m -106.47 -0.36 9.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -179.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.51 ' OE2' ' CE2' ' A' ' 171' ' ' TRP . 96.7 mt-10 -74.0 149.21 41.4 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 121.138 0.494 . . . . 0.0 111.51 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . 0.464 ' OD1' ' O ' ' A' ' 176' ' ' ASP . 46.8 p-10 -68.4 135.0 51.08 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.531 179.23 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 41.9 m80 -117.32 28.68 8.33 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 120.704 -0.398 . . . . 0.0 111.255 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 62.82 34.35 89.53 Favored Glycine 0 CA--C 1.531 1.031 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 179.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -152.69 163.63 39.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.842 0.353 . . . . 0.0 110.422 179.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -88.14 106.41 18.16 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 177.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . 0.413 ' HG2' ' N ' ' A' ' 182' ' ' ILE . 82.7 tt0 -136.18 161.32 36.06 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.421 0.629 . . . . 0.0 111.275 -178.511 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.413 ' N ' ' HG2' ' A' ' 181' ' ' GLU . 17.3 tt -130.11 137.18 57.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.463 -0.789 . . . . 0.0 108.947 178.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 85.0 m -131.03 128.02 39.45 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.076 0.465 . . . . 0.0 111.493 -179.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 68.4 mt -112.95 133.39 54.94 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.742 178.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 82.0 mt -109.48 120.11 60.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.23 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' THR . . . . . 0.52 ' OG1' ' ND2' ' A' ' 127' ' ' ASN . 8.8 t -133.28 147.74 51.92 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.709 179.601 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' CYS . . . . . 0.632 ' N ' HD22 ' A' ' 127' ' ' ASN . 2.1 m -87.65 142.31 27.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.863 -179.718 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . 0.424 ' CG1' ' N ' ' A' ' 189' ' ' SER . 14.3 p -62.35 -44.7 99.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.888 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' SER . . . . . 0.707 ' HG ' ' H ' ' A' ' 191' ' ' LYS . 24.9 t -170.69 148.72 3.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.122 0.487 . . . . 0.0 111.104 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 8.7 p -68.77 -14.86 19.02 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 CA-C-O 121.187 0.518 . . . . 0.0 110.493 179.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . 0.707 ' H ' ' HG ' ' A' ' 189' ' ' SER . 75.4 mmtt -95.61 -11.74 26.77 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.574 179.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -135.67 102.2 5.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.223 0.535 . . . . 0.0 110.87 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -102.99 11.25 37.57 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.845 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 12.3 t -60.8 -45.0 96.13 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.639 -178.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 64.7 pttt -142.59 159.82 41.49 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 120.946 0.403 . . . . 0.0 110.635 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . 0.48 ' NH1' ' SG ' ' A' ' 187' ' ' CYS . 94.5 mtt-85 -132.32 147.59 52.4 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 121.053 0.454 . . . . 0.0 111.451 -178.439 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -97.19 135.47 39.09 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 121.164 0.507 . . . . 0.0 111.413 179.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 38.9 t -120.53 129.46 75.56 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.914 179.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 54.1 t -100.12 133.27 43.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.527 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -122.64 152.52 40.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.522 0.677 . . . . 0.0 111.584 -179.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -147.41 149.85 22.03 Favored Glycine 0 CA--C 1.532 1.107 0 N-CA-C 110.33 -1.108 . . . . 0.0 110.33 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -106.28 148.89 27.45 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.927 0.394 . . . . 0.0 111.007 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 62.4 tp -66.23 130.39 43.05 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 178.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 46.9 t -110.32 -24.19 4.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 C-N-CA 120.8 -0.36 . . . . 0.0 111.609 -178.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -178.47 173.74 46.08 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 111.164 -0.775 . . . . 0.0 111.164 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 19.6 m -142.89 141.76 31.59 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.135 0.493 . . . . 0.0 110.254 179.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -141.43 114.55 8.66 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.262 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -64.74 148.1 51.81 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.829 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.466 ' HZ1' ' C ' ' A' ' 152' ' ' ASN . 55.8 mtmt -77.06 154.99 32.82 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.543 178.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 53.9 mtmt . . . . . 0 C--O 1.22 -0.479 0 CA-C-O 117.919 -1.039 . . . . 0.0 110.832 179.573 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 702' ' ' LEU . . . . . 0.404 ' CG ' ' O ' ' A' ' 168' ' ' PRO . 0.2 OUTLIER . . . . . 0 CA--C 1.537 0.476 0 CA-C-O 121.505 0.669 . . . . 20.0 111.046 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 703' ' ' PRO . . . . . 0.55 ' O ' ' O ' ' B' ' 704' ' ' ALA . 3.1 Cg_exo -73.72 -165.43 0.25 Allowed 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 123.576 2.851 . . . . 20.0 112.898 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 704' ' ' ALA . . . . . 0.55 ' O ' ' O ' ' B' ' 703' ' ' PRO . . . . . . . . 0 CA--C 1.537 0.47 0 CA-C-N 115.008 -0.996 . . . . 20.0 113.081 -179.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.239 0 CA-C-O 121.145 0.497 . . . . 0.0 110.828 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 92.4 p -85.25 1.49 48.03 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.242 -178.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.406 ' HG2' HH21 ' A' ' 196' ' ' ARG . 99.5 mttt -99.05 17.54 19.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.069 0.462 . . . . 0.0 111.602 -179.361 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 14.7 mm -55.74 136.62 18.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 122.449 1.119 . . . . 0.0 112.231 -177.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -80.12 126.23 30.81 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 113.346 -1.752 . . . . 0.0 109.894 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -78.17 123.17 86.03 Favored Pre-proline 0 CA--C 1.533 0.322 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -44.0 170.38 0.02 OUTLIER 'Trans proline' 0 C--N 1.313 -1.341 0 C-N-CA 121.886 1.724 . . . . 0.0 112.318 -179.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -52.18 163.16 0.4 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.15 -179.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 55.0 tp -62.58 -44.84 95.32 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.786 -177.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -60.43 -38.51 84.31 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.226 -0.589 . . . . 0.0 111.603 -178.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 66.3 tt0 -60.85 -25.17 66.45 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.14 -0.624 . . . . 0.0 110.027 179.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 36.1 t -77.83 -47.15 25.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.633 0.73 . . . . 0.0 109.774 178.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -73.43 -8.53 56.26 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 114.86 -1.064 . . . . 0.0 110.811 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -103.62 -16.95 15.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.502 0.668 . . . . 0.0 110.255 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -69.4 142.7 53.85 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.898 -179.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 33.6 t -58.56 97.52 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.564 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -67.79 136.15 53.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.109 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.446 ' OD2' ' CD ' ' A' ' 78' ' ' GLN . 37.6 t0 -103.55 79.11 1.65 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.334 178.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -71.76 -35.37 70.05 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.471 0.653 . . . . 0.0 111.962 179.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 43.8 mmtt -67.95 -31.12 70.63 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.058 -0.973 . . . . 0.0 112.781 -174.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.446 ' CD ' ' OD2' ' A' ' 75' ' ' ASP . 86.4 mt-30 -87.34 6.3 34.29 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.219 -0.593 . . . . 0.0 111.621 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 59.3 t -78.42 130.13 36.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 120.434 -0.506 . . . . 0.0 109.661 179.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 43.4 pt -110.3 -4.71 10.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.778 -179.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -163.56 166.0 37.07 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 120.499 -0.858 . . . . 0.0 111.605 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 72.0 ttp85 -137.66 141.29 41.15 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 121.095 0.474 . . . . 0.0 111.191 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 19.9 tt -105.08 141.43 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.984 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 7.9 t -137.63 131.79 32.05 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 121.4 0.619 . . . . 0.0 112.219 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.426 HG22 HD11 ' A' ' 85' ' ' ILE . 87.2 mt -136.71 88.05 19.65 Favored Pre-proline 0 CA--C 1.537 0.465 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.805 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -55.4 -32.01 80.01 Favored 'Trans proline' 0 N--CA 1.5 1.881 0 C-N-CA 123.155 2.57 . . . . 0.0 112.571 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 67.3 m -54.3 -42.71 70.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.26 0.552 . . . . 0.0 110.678 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 19.7 m -112.43 6.84 8.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.371 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 50.65 52.25 15.27 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.879 0.847 . . . . 0.0 110.187 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 52.8 tp -118.32 133.85 55.54 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.185 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -145.05 126.96 15.43 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.734 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 80.1 mt -149.06 151.01 33.55 Favored Pre-proline 0 CA--C 1.538 0.497 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.493 -178.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -76.53 148.82 29.95 Favored 'Trans proline' 0 N--CA 1.496 1.66 0 C-N-CA 122.839 2.359 . . . . 0.0 111.804 178.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 73.8 t -97.3 117.97 42.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-O 121.047 0.451 . . . . 0.0 111.579 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.487 ' N ' ' CD1' ' A' ' 95' ' ' LEU . 9.4 mp -102.74 134.1 46.68 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.889 179.437 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.492 ' O ' ' OG1' ' A' ' 109' ' ' THR . 98.1 mttt -58.55 -83.4 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 121.26 0.552 . . . . 0.0 111.934 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 18.7 m -61.33 138.31 58.25 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.527 0.679 . . . . 0.0 111.666 -178.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 3.1 m -95.4 70.62 3.15 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.17 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 8.7 p -88.54 166.65 14.02 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 177.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -59.13 -40.61 85.99 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 119.931 -0.707 . . . . 0.0 109.994 179.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -65.49 -42.18 92.45 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 121.321 0.581 . . . . 0.0 110.709 178.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -64.36 -37.05 86.13 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.477 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 84.7 mt -62.93 -18.02 62.57 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.857 -179.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 98.0 mt -74.73 -18.0 60.56 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.846 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 50.5 m -74.36 -4.9 39.19 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-O 121.728 0.775 . . . . 0.0 109.366 179.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 86.48 -19.78 26.26 Favored Glycine 0 CA--C 1.532 1.134 0 CA-C-N 114.826 -1.079 . . . . 0.0 112.803 178.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -145.91 123.98 12.12 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 119.585 -0.846 . . . . 0.0 112.472 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -145.9 141.55 27.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.362 -0.836 . . . . 0.0 109.968 178.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.492 ' OG1' ' O ' ' A' ' 96' ' ' LYS . 20.5 p -65.9 136.39 56.05 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.135 -0.626 . . . . 0.0 109.583 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 76.1 t -76.78 -46.12 30.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.928 -179.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 43.3 mtpt -99.09 142.82 30.08 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 122.013 0.911 . . . . 0.0 112.036 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -67.42 -36.09 80.57 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.594 -1.184 . . . . 0.0 111.956 -179.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 72.8 m-80 -86.76 22.18 2.02 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 114.203 1.186 . . . . 0.0 114.203 -177.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . 0.438 ' OE1' ' O ' ' A' ' 120' ' ' ASN . 94.5 mm-40 -78.37 137.28 37.94 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 121.797 -0.564 . . . . 0.0 112.312 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 61.5 t -128.18 123.96 61.4 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.868 179.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 55.6 mtt -58.55 130.91 49.07 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 121.133 0.492 . . . . 0.0 111.924 179.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 78.23 -0.51 73.87 Favored Glycine 0 CA--C 1.531 1.051 0 CA-C-N 116.04 -0.527 . . . . 0.0 112.789 178.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -138.38 124.99 20.79 Favored 'General case' 0 C--N 1.329 -0.317 0 O-C-N 122.047 -0.678 . . . . 0.0 111.1 -179.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 76.12 -165.31 54.01 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 110.337 -1.105 . . . . 0.0 110.337 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . 0.438 ' O ' ' OE1' ' A' ' 114' ' ' GLN . 59.0 t-20 -91.73 105.34 17.65 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.041 0.448 . . . . 0.0 109.864 179.414 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -85.43 144.91 27.71 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 179.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -146.8 145.61 29.97 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 119.842 -0.743 . . . . 0.0 111.944 -178.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.4 mp -139.61 145.25 38.3 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.918 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -110.23 135.73 50.53 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 178.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -136.72 148.99 20.02 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 110.294 -1.122 . . . . 0.0 110.294 -179.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . 0.489 ' O ' ' O ' ' A' ' 134' ' ' LEU . 21.6 m-70 -86.79 142.52 28.05 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.616 0.722 . . . . 0.0 111.935 -179.157 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 49.5 t-20 -131.51 120.79 23.44 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.142 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' MET . . . . . 0.466 ' O ' ' CB ' ' A' ' 129' ' ' SER . 62.9 mtt -94.4 -2.77 51.42 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.227 0.537 . . . . 0.0 110.662 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.466 ' CB ' ' O ' ' A' ' 128' ' ' MET . 0.7 OUTLIER 77.43 3.97 3.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.318 179.123 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.571 ' O ' ' CG1' ' A' ' 133' ' ' VAL . 61.8 pttt -118.16 130.72 56.27 Favored 'General case' 0 C--O 1.222 -0.357 0 CA-C-O 121.623 0.725 . . . . 0.0 112.817 -178.578 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.473 ' O ' ' O ' ' A' ' 130' ' ' LYS . 74.9 mmtt -41.12 163.66 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.354 0.597 . . . . 0.0 109.616 179.026 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 74.93 -22.51 1.47 Allowed Glycine 0 CA--C 1.53 1.007 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.571 ' CG1' ' O ' ' A' ' 130' ' ' LYS . 3.7 p -90.25 156.84 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 119.776 -0.77 . . . . 0.0 110.746 -179.36 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.662 ' H ' ' CD1' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -70.79 146.25 49.87 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 115.023 1.49 . . . . 0.0 115.023 -176.803 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 59.68 7.77 1.14 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 112.504 -2.135 . . . . 0.0 114.153 177.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 5.4 t -69.9 -33.27 71.97 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 119.99 -0.684 . . . . 0.0 112.371 179.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -89.52 0.65 56.75 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 -178.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 2.1 pp -58.2 -31.52 42.29 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 C-N-CA 119.874 -0.73 . . . . 0.0 110.965 -179.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -65.1 -13.89 59.16 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.962 0.411 . . . . 0.0 110.876 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 49.3 m -81.52 -4.0 54.74 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.152 -179.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 92.9 mt -64.57 142.12 58.54 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -120.52 156.01 32.44 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.223 0.535 . . . . 0.0 110.185 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -49.63 130.34 20.58 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.848 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.598 ' N ' ' O ' ' A' ' 160' ' ' VAL . . . 80.76 8.46 87.47 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 120.837 -0.697 . . . . 0.0 111.914 178.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.498 ' OD1' ' N ' ' A' ' 146' ' ' LYS . 63.8 t0 -71.77 133.95 45.88 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 119.737 -0.785 . . . . 0.0 109.928 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.498 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 73.2 mmtt -78.97 140.52 38.0 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.764 0.792 . . . . 0.0 112.749 -178.235 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 96.3 mt -134.35 134.32 54.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 114.718 -1.128 . . . . 0.0 108.014 178.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -115.45 133.7 55.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.648 0.737 . . . . 0.0 112.706 -178.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -114.7 132.64 56.35 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.97 -1.014 . . . . 0.0 108.397 177.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.494 ' CZ ' ' OE2' ' A' ' 155' ' ' GLU . 94.1 m-85 -115.51 110.13 18.82 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 119.985 -0.686 . . . . 0.0 111.673 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . 0.57 ' OD1' ' N ' ' A' ' 152' ' ' ASN . 62.3 t0 -88.3 165.67 14.84 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 177.015 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . 0.57 ' N ' ' OD1' ' A' ' 151' ' ' ASP . 36.5 p-10 -58.18 -20.35 40.49 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 119.466 -0.894 . . . . 0.0 111.219 -178.21 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -115.03 -27.88 7.19 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 -178.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -147.52 176.33 10.14 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 118.963 -1.095 . . . . 0.0 113.455 -176.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.494 ' OE2' ' CZ ' ' A' ' 150' ' ' TYR . 83.8 tt0 -125.02 133.48 52.95 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 114.604 -1.18 . . . . 0.0 110.141 178.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -107.94 133.55 52.12 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 120.967 0.413 . . . . 0.0 111.271 -179.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -91.7 110.11 21.44 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.352 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -113.36 146.47 39.41 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.015 0.436 . . . . 0.0 111.137 179.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -126.12 125.68 42.92 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 121.133 0.492 . . . . 0.0 111.132 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.598 ' O ' ' N ' ' A' ' 144' ' ' GLY . 83.0 t -58.27 133.63 23.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.667 178.425 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 70.5 p -115.49 11.3 15.91 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 139.6 171.6 12.36 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 119.972 -1.109 . . . . 0.0 112.923 178.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 42.1 t -125.63 135.43 63.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 114.305 -0.948 . . . . 0.0 108.874 178.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 30.8 m -131.98 162.32 30.99 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.504 0.668 . . . . 0.0 111.85 -179.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . 0.405 ' HG2' ' CE2' ' A' ' 197' ' ' TYR . 99.1 mt-10 -108.22 121.19 44.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.606 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 29.1 m -136.38 157.45 37.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.431 0.634 . . . . 0.0 111.349 -179.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' THR . . . . . 0.496 ' H ' ' HG1' ' A' ' 167' ' ' THR . 0.2 OUTLIER -80.26 159.39 70.34 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.755 179.169 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . 0.51 ' O ' ' CB ' ' B' ' 702' ' ' LEU . 37.8 Cg_endo -65.66 -15.55 49.79 Favored 'Trans proline' 0 C--N 1.302 -1.891 0 C-N-CA 123.114 2.543 . . . . 0.0 113.227 -179.652 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 50.8 p-10 -92.26 -3.78 54.99 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 119.808 -0.757 . . . . 0.0 111.842 179.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -74.43 80.45 1.91 Allowed 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.261 -0.575 . . . . 0.0 110.634 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' TRP . . . . . 0.466 ' CD1' ' N ' ' A' ' 171' ' ' TRP . 33.8 m0 -69.17 -17.63 63.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.87 179.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -61.18 -30.52 70.46 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.73 -178.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 30.8 m -63.27 -15.88 16.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.188 0.518 . . . . 0.0 111.008 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 78.3 t -111.16 -11.05 11.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.131 -179.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -73.46 152.53 40.7 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.201 0.524 . . . . 0.0 111.224 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . 0.523 ' OD1' ' O ' ' A' ' 176' ' ' ASP . 49.5 p30 -70.19 136.74 50.33 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 121.347 0.594 . . . . 0.0 111.41 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 77.9 m80 -107.4 -18.89 13.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.469 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 102.49 37.55 3.24 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -178.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 11.6 ptmt -157.38 170.21 22.97 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.089 -0.556 . . . . 0.0 111.063 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -87.79 100.28 12.73 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 177.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . 0.426 ' HG2' ' N ' ' A' ' 182' ' ' ILE . 79.4 tt0 -136.32 161.22 36.4 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.403 0.62 . . . . 0.0 111.272 -179.119 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.426 ' N ' ' HG2' ' A' ' 181' ' ' GLU . 20.7 tt -129.6 138.35 54.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.249 -0.887 . . . . 0.0 108.782 178.404 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 97.8 m -128.04 126.02 40.47 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.199 0.523 . . . . 0.0 112.17 -178.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.419 ' N ' ' CD1' ' A' ' 184' ' ' LEU . 10.2 mp -107.94 127.41 53.73 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.119 178.341 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 93.3 mt -114.29 123.98 70.49 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-O 121.362 0.601 . . . . 0.0 111.545 -178.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -142.54 161.55 37.77 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.597 179.425 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -98.63 139.98 33.54 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 178.172 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . 0.409 ' CG1' ' N ' ' A' ' 189' ' ' SER . 7.4 p -59.76 -47.26 91.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.807 -178.501 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' SER . . . . . 0.429 ' HG ' ' H ' ' A' ' 192' ' ' ASP . 23.1 p -160.52 157.85 28.2 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.1 0.476 . . . . 0.0 110.761 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 27.8 m -76.87 -9.21 12.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.212 0.53 . . . . 0.0 110.24 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -96.95 -18.95 19.14 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.978 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . 0.429 ' H ' ' HG ' ' A' ' 189' ' ' SER . 65.9 t0 -136.8 98.79 3.87 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.09 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -101.44 11.35 39.27 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 121.131 0.491 . . . . 0.0 110.902 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 47.1 t -59.92 -43.25 95.01 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.476 -179.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 51.6 mtmt -132.06 146.3 51.97 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 121.185 0.517 . . . . 0.0 111.211 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . 0.406 HH21 ' HG2' ' A' ' 60' ' ' LYS . 99.9 mtt180 -121.32 145.41 47.91 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.926 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . 0.405 ' CE2' ' HG2' ' A' ' 165' ' ' GLU . 36.4 m-85 -94.87 140.79 29.43 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.727 179.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 55.8 t -130.85 132.35 64.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.298 0.57 . . . . 0.0 111.041 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 47.8 t -100.19 133.93 41.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.07 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -108.07 132.84 53.14 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.266 0.555 . . . . 0.0 110.93 -179.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -132.2 140.59 11.95 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . 0.558 ' OD1' ' N ' ' A' ' 203' ' ' LEU . 67.9 t0 -111.5 138.49 47.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.123 0.487 . . . . 0.0 111.151 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . 0.558 ' N ' ' OD1' ' A' ' 202' ' ' ASP . 53.8 tp -62.69 128.9 38.1 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 1.3 p -114.38 -19.94 6.39 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 120.848 -0.341 . . . . 0.0 111.548 -178.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -175.87 170.94 44.0 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 120.768 -0.729 . . . . 0.0 111.858 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 18.2 m -143.71 139.68 29.62 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 179.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -144.81 120.23 10.31 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.43 0.633 . . . . 0.0 111.991 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -64.28 142.91 58.25 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.388 -179.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -80.75 110.48 16.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.68 179.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 99.4 mttt . . . . . 0 C--O 1.221 -0.42 0 CA-C-O 117.88 -1.057 . . . . 0.0 110.994 -179.757 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 702' ' ' LEU . . . . . 0.51 ' CB ' ' O ' ' A' ' 168' ' ' PRO . 2.0 mt . . . . . 0 CA--C 1.54 0.573 0 CA-C-O 120.672 0.272 . . . . 20.0 110.726 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 703' ' ' PRO . . . . . 0.581 ' O ' ' O ' ' B' ' 704' ' ' ALA . 4.2 Cg_exo -67.17 -169.02 0.18 Allowed 'Trans proline' 0 N--CA 1.489 1.25 0 C-N-CA 122.527 2.151 . . . . 20.0 114.006 -179.287 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 704' ' ' ALA . . . . . 0.581 ' O ' ' O ' ' B' ' 703' ' ' PRO . . . . . . . . 0 N--CA 1.464 0.271 0 CA-C-N 113.798 -1.546 . . . . 20.0 113.792 -179.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.249 0 CA-C-O 121.097 0.475 . . . . 0.0 111.356 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.51 ' CB ' ' O ' ' B' ' 702' ' ' LEU . 5.5 p -81.28 20.06 0.89 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.356 0.598 . . . . 0.0 111.158 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -102.64 18.48 21.22 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.205 -179.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.9 mt -56.26 139.5 15.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 122.415 1.103 . . . . 0.0 113.405 -176.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -77.42 130.69 37.39 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 113.525 -1.671 . . . . 0.0 108.865 178.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.544 ' H ' ' CD ' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -81.28 154.9 72.14 Favored Pre-proline 0 C--N 1.32 -0.688 0 C-N-CA 120.364 -0.534 . . . . 0.0 110.513 -179.139 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -72.2 166.48 29.56 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 123.249 2.632 . . . . 0.0 113.34 -178.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -52.62 164.45 0.35 Allowed 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 120.975 0.417 . . . . 0.0 110.491 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 56.5 tp -64.27 -47.05 81.05 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.321 -179.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.412 ' O ' ' N ' ' A' ' 71' ' ' ASN . . . -62.65 -36.46 82.92 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 119.863 -0.735 . . . . 0.0 110.773 -178.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -62.46 -28.81 70.07 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.526 0.679 . . . . 0.0 109.223 178.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.432 ' CG1' ' O ' ' A' ' 104' ' ' LEU . 46.7 t -76.7 -44.38 33.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.862 178.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -79.38 -8.88 59.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.0 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.412 ' N ' ' O ' ' A' ' 67' ' ' ALA . 10.3 m120 -102.82 -13.28 17.06 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.397 0.618 . . . . 0.0 110.177 179.34 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.91 145.44 53.66 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.172 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 32.9 m -57.85 110.17 0.86 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.784 -179.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.497 ' CD1' ' C ' ' A' ' 74' ' ' LEU . 3.0 tm? -70.88 119.34 14.86 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.338 0.59 . . . . 0.0 110.535 -179.611 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -94.92 78.76 3.62 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.481 -0.782 . . . . 0.0 109.812 179.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -65.07 -32.85 74.76 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.267 -0.879 . . . . 0.0 112.055 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 36.9 mmtt -70.15 -10.16 57.93 Favored 'General case' 0 C--N 1.314 -0.955 0 C-N-CA 120.401 -0.52 . . . . 0.0 110.509 -177.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -96.65 -3.8 42.11 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.474 178.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.41 ' O ' ' CG1' ' A' ' 79' ' ' VAL . 3.1 p -81.39 130.14 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-O 121.315 0.579 . . . . 0.0 111.386 -179.368 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 10.0 pt -108.66 -6.75 10.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.982 179.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -174.15 -180.0 45.13 Favored Glycine 0 CA--C 1.53 1.012 0 N-CA-C 111.326 -0.71 . . . . 0.0 111.326 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 61.4 ttp180 -136.74 156.88 47.93 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 179.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 19.5 tt -124.2 141.96 42.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.113 0.482 . . . . 0.0 110.362 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 74.5 m -135.5 131.05 35.58 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 121.66 0.743 . . . . 0.0 112.332 -178.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 92.5 mt -137.33 86.06 20.4 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.082 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -57.48 -30.12 87.11 Favored 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 122.769 2.312 . . . . 0.0 113.063 -179.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 70.6 m -52.9 -40.67 63.72 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 121.22 0.533 . . . . 0.0 110.457 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 26.7 m -113.58 8.09 7.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.346 179.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 52.59 54.45 10.59 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.501 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 60.1 tp -119.99 135.29 54.97 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.629 0.728 . . . . 0.0 111.337 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -146.31 124.21 12.0 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.186 -0.915 . . . . 0.0 109.224 179.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 82.3 mt -149.36 148.07 25.26 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.716 -178.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -73.04 146.24 41.08 Favored 'Trans proline' 0 C--N 1.313 -1.313 0 C-N-CA 122.176 1.918 . . . . 0.0 111.318 179.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 43.8 t -96.55 122.11 47.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.28 0.562 . . . . 0.0 111.081 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.427 ' N ' ' CD1' ' A' ' 95' ' ' LEU . 11.1 mp -99.68 134.73 42.14 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.199 179.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.453 ' O ' ' OG1' ' A' ' 109' ' ' THR . 82.6 tttt -62.63 -79.03 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.499 -177.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 7.5 m -66.98 145.01 55.86 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 121.041 0.448 . . . . 0.0 111.611 -179.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 7.2 t -95.43 68.14 2.97 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-O 121.186 0.517 . . . . 0.0 111.51 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 12.9 m -88.54 166.99 13.79 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 178.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -60.99 -43.9 98.19 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.022 -0.671 . . . . 0.0 109.881 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -65.14 -38.38 90.43 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.483 0.659 . . . . 0.0 110.253 178.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -63.82 -39.27 93.83 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.057 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 78.2 mt -62.92 -12.01 22.41 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.015 -0.539 . . . . 0.0 112.001 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.432 ' O ' ' CG1' ' A' ' 69' ' ' VAL . 96.9 mt -73.28 -22.6 60.33 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 121.052 0.454 . . . . 0.0 111.15 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 95.7 p -73.84 -3.69 30.3 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.349 0.595 . . . . 0.0 110.498 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 86.85 -18.87 32.67 Favored Glycine 0 CA--C 1.531 1.06 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.509 178.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -145.62 127.07 15.0 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 119.941 -0.704 . . . . 0.0 112.103 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -147.74 142.8 27.05 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.551 178.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.453 ' OG1' ' O ' ' A' ' 96' ' ' LYS . 3.4 p -73.6 140.79 46.45 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.271 0.557 . . . . 0.0 111.65 -179.27 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 58.1 t -78.64 -52.37 15.64 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.973 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.726 ' H ' ' NE2' ' A' ' 114' ' ' GLN . 49.0 mtmt -100.32 136.67 39.85 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 122.221 1.01 . . . . 0.0 112.526 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -66.16 -31.98 73.15 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 113.978 -1.465 . . . . 0.0 112.627 -178.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 71.5 m-80 -85.33 13.7 6.24 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 -177.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . 0.726 ' NE2' ' H ' ' A' ' 111' ' ' LYS . 32.7 mt-30 -79.87 143.5 34.26 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.383 0.611 . . . . 0.0 112.363 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 65.1 t -123.69 123.42 67.12 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.183 178.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' MET . . . . . 0.445 ' CG ' ' CZ ' ' A' ' 121' ' ' TYR . 98.9 mtp -57.65 133.82 55.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.195 0.521 . . . . 0.0 111.509 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.496 ' O ' ' OD2' ' A' ' 180' ' ' ASP . . . 81.69 -2.45 82.92 Favored Glycine 0 CA--C 1.53 0.969 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.55 179.557 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -142.87 135.81 28.06 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.213 0.53 . . . . 0.0 111.263 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 72.47 -166.77 53.82 Favored Glycine 0 CA--C 1.529 0.925 0 N-CA-C 110.495 -1.042 . . . . 0.0 110.495 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 64.8 t-20 -92.24 103.49 15.95 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.075 0.464 . . . . 0.0 110.676 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.445 ' CZ ' ' CG ' ' A' ' 116' ' ' MET . 2.5 t80 -88.64 99.04 12.02 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 121.118 0.485 . . . . 0.0 110.1 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -91.51 138.43 31.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.091 0.472 . . . . 0.0 111.536 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 46.0 mt -134.33 139.59 45.78 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.415 -0.514 . . . . 0.0 110.913 179.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -107.89 133.24 52.53 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.655 179.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -134.3 142.98 14.53 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . 0.517 ' O ' ' O ' ' A' ' 134' ' ' LEU . 23.2 m-70 -78.4 142.01 37.92 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.321 0.581 . . . . 0.0 112.39 -178.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . 0.72 ' ND2' ' H ' ' A' ' 129' ' ' SER . 3.0 t-20 -138.76 121.34 16.23 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.816 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' MET . . . . . 0.522 ' C ' ' HG ' ' A' ' 129' ' ' SER . 63.4 mtt -97.81 -4.43 36.87 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.744 -179.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.72 ' H ' ' ND2' ' A' ' 127' ' ' ASN . 0.9 OUTLIER 79.14 4.16 2.32 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.967 179.281 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.532 ' O ' ' CG1' ' A' ' 133' ' ' VAL . 62.8 pttt -111.99 133.62 54.05 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 122.041 0.924 . . . . 0.0 113.206 -178.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.426 ' C ' ' O ' ' A' ' 130' ' ' LYS . 28.6 tptt -40.26 152.69 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.742 178.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 75.08 -14.75 4.57 Favored Glycine 0 CA--C 1.535 1.337 0 C-N-CA 121.077 -0.583 . . . . 0.0 112.71 178.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.532 ' CG1' ' O ' ' A' ' 130' ' ' LYS . 6.3 p -88.55 172.47 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 119.331 -0.947 . . . . 0.0 111.044 -179.258 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.517 ' O ' ' O ' ' A' ' 126' ' ' HIS . 3.8 mm? -68.64 133.69 48.83 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 115.495 1.665 . . . . 0.0 115.495 -176.363 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 56.84 12.49 1.18 Allowed 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 113.859 -1.519 . . . . 0.0 114.718 176.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 2.8 p -69.21 -32.35 71.54 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 121.64 -0.663 . . . . 0.0 112.784 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -89.21 2.15 54.66 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 -178.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 1.8 pp -63.45 -30.21 49.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 C-N-CA 120.206 -0.597 . . . . 0.0 111.046 -179.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -67.4 -11.06 56.82 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.94 0.4 . . . . 0.0 110.64 -179.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 56.8 m -82.45 -6.15 59.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.147 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 97.8 mt -65.33 143.83 57.5 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 121.165 0.507 . . . . 0.0 111.411 -179.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.402 ' HG2' ' N ' ' A' ' 143' ' ' LYS . 88.8 tttt -119.82 157.13 29.29 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 121.249 0.547 . . . . 0.0 111.091 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . 0.402 ' N ' ' HG2' ' A' ' 142' ' ' LYS . 88.7 tttt -49.76 136.08 18.24 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.178 179.515 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.507 ' N ' ' O ' ' A' ' 160' ' ' VAL . . . 77.24 8.05 86.93 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 120.823 -0.703 . . . . 0.0 111.953 178.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -70.79 131.19 43.44 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 119.68 -0.808 . . . . 0.0 110.072 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -77.87 140.32 39.33 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 121.551 0.691 . . . . 0.0 111.926 -178.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 98.4 mt -139.08 140.58 38.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-N 114.851 -1.068 . . . . 0.0 108.711 178.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 -126.07 139.52 53.33 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 119.748 -0.781 . . . . 0.0 112.794 -178.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -117.97 134.9 54.52 Favored 'General case' 0 C--O 1.226 -0.164 0 CA-C-N 114.983 -1.008 . . . . 0.0 108.633 178.245 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.558 ' CE2' ' CD ' ' A' ' 155' ' ' GLU . 92.4 m-85 -110.53 113.73 26.59 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.319 -0.552 . . . . 0.0 110.938 179.288 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . 0.441 ' OD1' ' N ' ' A' ' 152' ' ' ASN . 54.7 t0 -90.5 167.88 12.26 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 177.354 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . 0.441 ' N ' ' OD1' ' A' ' 151' ' ' ASP . 71.8 m-20 -55.53 -24.47 32.16 Favored 'General case' 0 C--N 1.317 -0.805 0 C-N-CA 119.971 -0.691 . . . . 0.0 111.28 -177.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -112.23 -26.99 8.51 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 114.243 1.201 . . . . 0.0 114.243 -178.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -149.82 -177.02 5.65 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 118.764 -1.174 . . . . 0.0 114.018 -176.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.558 ' CD ' ' CE2' ' A' ' 150' ' ' TYR . 84.6 tt0 -129.51 141.66 50.94 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 114.582 -1.19 . . . . 0.0 110.467 179.242 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -117.68 138.07 52.24 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 120.829 0.347 . . . . 0.0 111.75 -179.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -94.44 111.93 23.69 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.279 179.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.462 ' OH ' ' OD1' ' A' ' 180' ' ' ASP . 35.1 m-85 -112.56 148.23 34.98 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.053 0.454 . . . . 0.0 111.696 179.489 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -123.64 122.65 38.68 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 121.145 0.498 . . . . 0.0 111.456 179.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.507 ' O ' ' N ' ' A' ' 144' ' ' GLY . 95.4 t -58.84 135.24 23.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 177.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 80.9 p -106.32 -26.51 11.47 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 120.525 -0.47 . . . . 0.0 111.413 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 161.39 -169.65 36.97 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 120.481 -0.866 . . . . 0.0 111.89 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 28.5 m -135.39 162.6 37.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.017 0.437 . . . . 0.0 110.177 179.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 81.7 p -148.95 164.96 33.02 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.345 0.593 . . . . 0.0 111.324 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -104.79 115.76 30.86 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.062 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 24.4 m -137.09 160.95 36.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.48 0.657 . . . . 0.0 111.204 -179.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' THR . . . . . 0.502 ' OG1' ' OD1' ' A' ' 169' ' ' ASP . 0.1 OUTLIER -88.95 160.82 42.74 Favored Pre-proline 0 CA--C 1.539 0.533 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.933 179.364 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . 0.551 ' O ' ' CB ' ' B' ' 702' ' ' LEU . 55.4 Cg_endo -67.69 -15.81 45.23 Favored 'Trans proline' 0 N--CA 1.5 1.909 0 C-N-CA 123.074 2.516 . . . . 0.0 114.031 -178.346 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . 0.502 ' OD1' ' OG1' ' A' ' 167' ' ' THR . 38.4 p-10 -91.06 -2.55 57.62 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 119.58 -0.848 . . . . 0.0 110.803 179.483 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.406 ' O ' ' CG2' ' A' ' 173' ' ' VAL . 73.0 mmtt -73.53 69.6 1.24 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.445 0.641 . . . . 0.0 110.208 179.41 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' TRP . . . . . 0.575 ' CZ3' ' OE2' ' A' ' 175' ' ' GLU . 57.3 t90 -60.13 -17.72 42.35 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.303 179.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -63.72 -28.78 70.12 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.602 -0.727 . . . . 0.0 111.936 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . 0.406 ' CG2' ' O ' ' A' ' 170' ' ' LYS . 34.6 m -62.33 -20.79 25.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 120.692 -0.403 . . . . 0.0 111.05 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 7.8 t -99.81 -6.02 9.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.648 -179.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.575 ' OE2' ' CZ3' ' A' ' 171' ' ' TRP . 93.0 mt-10 -73.71 143.91 45.96 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 121.199 0.523 . . . . 0.0 111.419 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 44.8 p-10 -70.94 144.0 50.72 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.776 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 50.4 m80 -119.31 28.02 8.46 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 62.34 37.71 95.05 Favored Glycine 0 CA--C 1.528 0.88 0 N-CA-C 111.272 -0.731 . . . . 0.0 111.272 179.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -153.69 161.68 41.92 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . 0.496 ' OD2' ' O ' ' A' ' 117' ' ' GLY . 56.8 t0 -87.37 101.6 13.72 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 178.225 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . 0.436 ' HG2' ' N ' ' A' ' 182' ' ' ILE . 72.5 tt0 -130.78 163.43 27.36 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.469 0.652 . . . . 0.0 111.524 -178.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.436 ' N ' ' HG2' ' A' ' 181' ' ' GLU . 20.2 tt -130.07 138.5 53.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 57.0 m -130.83 125.44 33.68 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.504 -0.478 . . . . 0.0 111.29 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 85.5 mt -109.28 130.87 55.48 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 96.7 mt -115.7 128.87 72.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.533 0.682 . . . . 0.0 111.527 -179.112 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 3.7 t -141.83 162.16 36.16 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.297 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' CYS . . . . . 0.447 ' O ' ' OD1' ' A' ' 127' ' ' ASN . 33.1 m -87.15 135.27 33.36 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.952 0.406 . . . . 0.0 110.086 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . 0.473 ' CG1' ' N ' ' A' ' 189' ' ' SER . 11.9 p -61.54 -45.24 99.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-O 121.411 0.624 . . . . 0.0 110.308 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' SER . . . . . 0.473 ' N ' ' CG1' ' A' ' 188' ' ' VAL . 35.5 t -172.18 144.95 1.68 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.869 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 33.9 m -70.89 -13.01 16.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.124 0.488 . . . . 0.0 110.627 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 63.1 mttm -94.03 -12.8 27.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.121 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . 0.412 ' C ' ' OD1' ' A' ' 192' ' ' ASP . 64.2 t0 -140.19 109.03 5.98 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.517 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 46.9 p-10 -107.5 11.72 28.52 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.303 179.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 35.0 t -59.89 -43.78 94.59 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.144 -178.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -145.83 155.61 43.02 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 121.28 0.562 . . . . 0.0 111.714 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . 0.4 HH12 ' HG3' ' A' ' 168' ' ' PRO . 85.1 mtt85 -128.03 146.91 50.52 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 121.383 0.611 . . . . 0.0 111.603 -179.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -91.15 146.51 23.78 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.873 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 47.8 t -130.28 134.21 62.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.639 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 54.1 t -105.87 132.14 53.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.348 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -116.05 139.03 50.69 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.246 0.546 . . . . 0.0 110.084 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -140.74 142.65 12.5 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.739 -0.945 . . . . 0.0 110.739 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 35.5 p30 -109.03 155.5 20.84 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.318 0.58 . . . . 0.0 111.544 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 49.3 tp -74.13 131.3 41.16 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.478 179.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 3.9 p -113.83 -20.25 6.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 120.319 -0.553 . . . . 0.0 111.181 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -174.2 169.22 42.21 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 120.486 -0.864 . . . . 0.0 111.779 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 63.6 m -142.65 137.16 29.77 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 179.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 54.4 pttt -149.19 123.48 9.58 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.592 0.71 . . . . 0.0 112.31 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -62.97 143.59 57.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.554 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 14.7 ptpt -79.26 111.04 15.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.527 178.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 64.8 mttp . . . . . 0 C--O 1.22 -0.493 0 CA-C-O 118.216 -0.897 . . . . 0.0 110.322 -179.966 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 702' ' ' LEU . . . . . 0.551 ' CB ' ' O ' ' A' ' 168' ' ' PRO . 0.0 OUTLIER . . . . . 0 CA--C 1.544 0.737 0 N-CA-C 109.635 -0.506 . . . . 20.0 109.635 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 703' ' ' PRO . . . . . 0.498 ' O ' ' O ' ' B' ' 704' ' ' ALA . 3.1 Cg_exo -65.81 -165.81 0.09 OUTLIER 'Trans proline' 0 N--CA 1.492 1.414 0 C-N-CA 121.921 1.748 . . . . 20.0 113.219 -179.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 704' ' ' ALA . . . . . 0.498 ' O ' ' O ' ' B' ' 703' ' ' PRO . . . . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 114.89 -1.05 . . . . 20.0 112.729 -178.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.307 0 CA-C-O 120.993 0.425 . . . . 0.0 110.855 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.476 ' CB ' ' O ' ' B' ' 702' ' ' LEU . 61.0 p -80.4 22.8 0.53 Allowed 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -179.389 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -109.2 19.15 19.77 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.069 0.461 . . . . 0.0 111.719 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 98.0 mt -55.83 135.64 18.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-O 122.115 0.96 . . . . 0.0 112.668 -177.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -77.72 129.95 36.16 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.148 -1.387 . . . . 0.0 109.336 178.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.615 ' NE2' ' O ' ' A' ' 63' ' ' GLN . 1.0 OUTLIER -79.21 147.66 69.56 Favored Pre-proline 0 N--CA 1.446 -0.628 0 C-N-CA 120.087 -0.645 . . . . 0.0 109.977 -179.215 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -69.76 167.63 23.88 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 122.353 2.036 . . . . 0.0 112.477 -179.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -51.17 169.77 0.05 OUTLIER 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.568 -178.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 55.9 tp -63.4 -46.21 87.49 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.607 -1.178 . . . . 0.0 111.409 -178.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.65 -22.96 48.75 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.159 0.505 . . . . 0.0 110.448 -178.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 49.3 tp10 -68.29 -31.56 71.09 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 119.284 -0.966 . . . . 0.0 108.509 178.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 36.6 t -74.45 -44.57 47.76 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.466 179.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -73.24 -9.82 59.12 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.709 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 38.6 t30 -118.58 -1.31 11.19 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 121.052 0.454 . . . . 0.0 110.179 178.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -69.04 -172.55 0.41 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.425 -179.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.3 m -94.87 99.8 11.79 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.287 0.565 . . . . 0.0 110.033 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 49.3 tp -67.83 135.34 52.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.845 -179.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -124.89 77.21 1.59 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.461 0.648 . . . . 0.0 109.49 178.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -74.96 -41.14 60.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.37 -0.832 . . . . 0.0 112.162 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.94 -6.0 35.18 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.72 -177.062 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -96.49 -10.03 28.32 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.284 0.564 . . . . 0.0 110.506 179.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.409 ' O ' ' CG1' ' A' ' 79' ' ' VAL . 9.9 p -65.31 127.75 26.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.855 179.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 12.1 pt -104.61 -8.03 9.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.327 0.584 . . . . 0.0 109.975 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -173.35 178.55 45.25 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 120.742 -0.742 . . . . 0.0 111.291 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 58.5 ttp180 -136.45 160.92 37.29 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.336 -0.432 . . . . 0.0 110.357 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 18.6 tt -124.99 140.94 46.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 CA-C-O 121.203 0.525 . . . . 0.0 109.983 179.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 47.6 t -137.18 130.39 31.0 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.378 0.608 . . . . 0.0 111.471 -178.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 37.3 mt -137.08 85.55 22.21 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.572 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -56.25 -33.05 89.93 Favored 'Trans proline' 0 N--CA 1.496 1.621 0 C-N-CA 123.25 2.633 . . . . 0.0 112.798 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.439 ' CB ' ' OD1' ' A' ' 145' ' ' ASP . 39.5 t -55.53 -43.44 75.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.097 0.475 . . . . 0.0 111.358 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 35.5 m -110.77 7.75 8.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.522 0.677 . . . . 0.0 109.879 179.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.5 m 53.03 51.58 15.5 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.043 179.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 69.1 tp -116.11 131.12 57.03 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.294 0.568 . . . . 0.0 110.462 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -148.52 125.67 11.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.817 0.818 . . . . 0.0 110.939 -179.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -156.83 152.69 22.78 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 114.741 -1.118 . . . . 0.0 111.01 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -74.44 147.82 37.12 Favored 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 122.548 2.165 . . . . 0.0 112.132 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 90.1 t -94.89 121.36 45.4 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-O 120.901 0.381 . . . . 0.0 111.159 179.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.432 ' N ' ' CD1' ' A' ' 95' ' ' LEU . 10.9 mp -98.49 127.88 44.61 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 121.654 0.74 . . . . 0.0 111.568 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.515 ' O ' ' OG1' ' A' ' 109' ' ' THR . 88.1 tttt -62.33 -47.0 86.16 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 114.846 -1.07 . . . . 0.0 112.077 -178.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.405 ' HB3' ' ND2' ' A' ' 102' ' ' ASN . 17.4 t -77.98 128.87 34.56 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.509 0.671 . . . . 0.0 112.354 -178.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.556 ' OG ' ' O ' ' A' ' 109' ' ' THR . 0.8 OUTLIER -86.62 51.8 2.33 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.523 -179.673 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 62.1 m -88.37 162.59 16.46 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.187 -0.46 . . . . 0.0 109.998 178.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 57.6 mp0 -61.92 -43.18 99.37 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 121.133 0.492 . . . . 0.0 110.62 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -63.01 -40.66 98.43 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.228 -179.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.514 ' O ' ' OG ' ' A' ' 105' ' ' SER . 97.8 m-20 -64.67 -37.75 88.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.616 0.722 . . . . 0.0 110.671 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 16.5 mt -59.62 -24.03 63.48 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.327 -0.852 . . . . 0.0 111.188 -179.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 90.0 mt -76.03 -12.22 60.09 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.966 0.412 . . . . 0.0 110.831 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.514 ' OG ' ' O ' ' A' ' 102' ' ' ASN . 90.7 p -78.8 -5.45 53.42 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-O 121.474 0.654 . . . . 0.0 110.011 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 98.96 -19.7 53.23 Favored Glycine 0 CA--C 1.532 1.152 0 CA-C-N 115.326 -0.852 . . . . 0.0 112.758 178.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -146.96 129.63 16.07 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 119.382 -0.927 . . . . 0.0 113.039 -179.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -147.39 135.18 21.14 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.489 178.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.556 ' O ' ' OG ' ' A' ' 98' ' ' SER . 54.9 p -70.15 135.99 49.67 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.085 0.469 . . . . 0.0 111.118 -179.47 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.696 ' N ' HE22 ' A' ' 114' ' ' GLN . 54.0 t -79.74 -56.04 7.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-O 121.074 0.464 . . . . 0.0 110.76 -179.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.795 ' H ' ' NE2' ' A' ' 114' ' ' GLN . 43.7 mtpt -102.87 137.97 40.38 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 121.901 0.857 . . . . 0.0 111.717 179.229 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -63.64 -29.47 70.7 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 114.735 -1.121 . . . . 0.0 111.619 -178.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 65.1 m-80 -83.06 14.73 3.18 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -177.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . 0.795 ' NE2' ' H ' ' A' ' 111' ' ' LYS . 45.0 mt-30 -77.83 138.24 38.84 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 121.128 0.49 . . . . 0.0 112.285 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 72.9 t -126.26 119.75 54.88 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.531 178.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 97.4 mtp -58.31 128.42 37.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.566 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 85.3 -2.88 87.94 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 120.956 -0.64 . . . . 0.0 111.871 178.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -142.95 133.24 24.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.052 0.453 . . . . 0.0 111.153 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 72.24 -171.0 49.43 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 -179.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 63.2 t-20 -86.33 102.48 14.04 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.285 -0.566 . . . . 0.0 110.131 179.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -85.83 98.66 10.88 Favored 'General case' 0 N--CA 1.457 -0.097 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 179.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.573 ' N ' ' OE1' ' A' ' 114' ' ' GLN . . . -91.96 139.14 30.94 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.223 -179.372 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 81.2 mt -137.94 143.63 40.85 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 120.98 0.419 . . . . 0.0 110.684 179.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -115.26 138.86 50.49 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.187 0.518 . . . . 0.0 110.488 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -144.14 134.05 5.57 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . 0.414 ' CD2' ' OE1' ' A' ' 63' ' ' GLN . 0.2 OUTLIER -79.43 137.83 37.39 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.004 -0.678 . . . . 0.0 110.51 -179.828 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . 0.741 ' ND2' ' H ' ' A' ' 129' ' ' SER . 3.5 t-20 -130.55 121.47 25.76 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.562 -179.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' MET . . . . . 0.498 ' O ' ' CB ' ' A' ' 129' ' ' SER . 67.0 mtt -87.73 -5.83 58.48 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.133 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.741 ' H ' ' ND2' ' A' ' 127' ' ' ASN . 0.9 OUTLIER 79.78 8.77 1.57 Allowed 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 179.123 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.466 ' H ' HG12 ' A' ' 133' ' ' VAL . 65.0 pttt -105.93 128.06 53.55 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 122.111 0.957 . . . . 0.0 112.371 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 38.8 tptt -46.05 119.78 2.43 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.977 -1.011 . . . . 0.0 109.988 178.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 115.23 -18.12 16.21 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.197 -1.161 . . . . 0.0 110.197 -179.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.489 HG13 HD21 ' A' ' 127' ' ' ASN . 9.5 p -90.3 160.9 2.7 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 CA-C-O 121.256 0.55 . . . . 0.0 109.974 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.671 ' CD2' ' H ' ' A' ' 134' ' ' LEU . 0.1 OUTLIER -69.22 138.45 54.01 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -177.338 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 65.74 9.39 5.95 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 114.094 -1.412 . . . . 0.0 114.303 177.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' SER . . . . . 0.552 ' OG ' ' ND2' ' A' ' 127' ' ' ASN . 0.4 OUTLIER -67.31 -36.27 81.13 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 120.453 -0.499 . . . . 0.0 112.185 179.315 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . 0.462 ' OD1' ' N ' ' A' ' 137' ' ' ASP . 22.7 p-10 -93.97 8.93 39.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.594 0.712 . . . . 0.0 110.796 -178.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 5.5 tt -64.96 -36.35 77.57 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.534 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -70.02 -10.81 59.92 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 121.958 -0.463 . . . . 0.0 111.399 179.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 67.3 m -81.24 -2.85 50.41 Favored 'General case' 0 C--O 1.231 0.088 0 CA-C-O 121.054 0.455 . . . . 0.0 110.303 179.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 70.9 mt -63.69 142.33 58.44 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.926 179.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -123.24 157.08 33.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.734 0.778 . . . . 0.0 111.85 -178.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -48.72 129.09 16.4 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.41 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 160' ' ' VAL . . . 82.24 8.52 86.28 Favored Glycine 0 CA--C 1.534 1.256 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.574 179.053 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.439 ' OD1' ' CB ' ' A' ' 87' ' ' SER . 23.1 t70 -71.76 130.49 41.23 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 119.908 -0.717 . . . . 0.0 110.838 -179.268 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -77.98 139.9 39.18 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 121.619 0.724 . . . . 0.0 111.628 -179.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 96.4 mt -136.59 137.68 47.36 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 178.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 63.3 m-85 -118.46 135.95 54.07 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 119.966 -0.694 . . . . 0.0 111.938 -178.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -114.16 134.28 55.01 Favored 'General case' 0 C--O 1.222 -0.357 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 177.263 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.427 ' CE2' ' OE1' ' A' ' 155' ' ' GLU . 81.2 m-85 -114.48 110.07 19.27 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.136 -0.626 . . . . 0.0 111.853 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . 0.474 ' N ' ' O ' ' A' ' 154' ' ' ASN . 22.4 t0 -88.4 167.92 13.08 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 177.521 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 65.2 m-20 -60.29 -23.77 64.43 Favored 'General case' 0 C--N 1.316 -0.872 0 C-N-CA 119.793 -0.763 . . . . 0.0 111.449 -178.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -113.02 -26.3 8.55 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -178.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . 0.474 ' O ' ' N ' ' A' ' 151' ' ' ASP . 0.3 OUTLIER -148.1 -177.0 5.5 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 119.115 -1.034 . . . . 0.0 112.639 -177.197 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.427 ' OE1' ' CE2' ' A' ' 150' ' ' TYR . 15.2 pt-20 -137.98 145.52 42.04 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 114.403 -1.271 . . . . 0.0 109.891 178.574 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -118.5 138.41 52.53 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 121.255 0.55 . . . . 0.0 112.312 -178.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -95.56 114.91 26.72 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.455 179.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -118.24 151.73 37.09 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.792 0.329 . . . . 0.0 111.633 179.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -124.59 125.15 43.7 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.334 178.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.487 ' O ' ' N ' ' A' ' 144' ' ' GLY . 92.3 t -59.95 137.25 22.62 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 177.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 77.7 p -106.6 -24.81 12.05 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 123.436 0.46 . . . . 0.0 110.792 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 158.83 -167.93 34.85 Favored Glycine 0 CA--C 1.533 1.218 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 44.4 t -129.99 128.27 64.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.452 -0.374 . . . . 0.0 109.998 178.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 18.2 m -107.74 157.34 18.2 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.479 0.657 . . . . 0.0 112.06 -179.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -101.67 113.44 26.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.253 179.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 22.9 m -135.48 163.3 35.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.682 0.754 . . . . 0.0 112.187 -178.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -90.06 155.86 46.93 Favored Pre-proline 0 CA--C 1.538 0.505 0 CA-C-N 114.944 -1.026 . . . . 0.0 110.335 179.133 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . 0.581 ' O ' ' CB ' ' B' ' 702' ' ' LEU . 37.0 Cg_endo -65.91 -16.49 52.96 Favored 'Trans proline' 0 N--CA 1.502 1.984 0 C-N-CA 123.273 2.648 . . . . 0.0 113.995 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . 0.418 ' O ' ' CD1' ' A' ' 171' ' ' TRP . 51.4 p-10 -91.82 -6.14 52.2 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 119.733 -0.787 . . . . 0.0 111.848 -179.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -75.24 80.84 2.35 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 119.92 -0.712 . . . . 0.0 110.234 178.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' TRP . . . . . 0.465 ' CD1' ' N ' ' A' ' 171' ' ' TRP . 26.8 m0 -67.28 -11.56 57.84 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.003 -179.204 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.489 ' OE1' ' OE1' ' A' ' 175' ' ' GLU . 79.2 mm-40 -58.56 -29.9 66.74 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.456 -179.354 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 10.6 p -60.73 -24.32 31.78 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -178.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 35.1 m -104.49 -8.55 9.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 120.086 -0.646 . . . . 0.0 112.04 -178.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.489 ' OE1' ' OE1' ' A' ' 172' ' ' GLU . 98.0 mt-10 -74.36 134.86 42.48 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 178.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . 0.489 ' OD1' ' O ' ' A' ' 176' ' ' ASP . 43.3 p-10 -66.17 130.9 44.83 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 121.098 0.475 . . . . 0.0 111.024 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 76.7 m80 -98.3 -13.63 20.64 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -179.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 100.11 34.78 4.72 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 -178.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -148.81 161.84 41.0 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.83 -0.685 . . . . 0.0 110.225 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -87.64 90.76 8.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.885 0.374 . . . . 0.0 110.087 178.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . 0.43 ' HG2' ' N ' ' A' ' 182' ' ' ILE . 79.1 tt0 -126.81 163.35 23.78 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.817 0.818 . . . . 0.0 111.811 -178.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.43 ' N ' ' HG2' ' A' ' 181' ' ' GLU . 17.9 tt -131.11 137.66 55.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.135 178.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 88.8 m -131.74 126.32 34.17 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.329 0.585 . . . . 0.0 111.353 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 84.0 mt -111.17 132.38 54.36 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.463 178.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 77.6 mt -110.14 126.85 67.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.429 0.633 . . . . 0.0 110.725 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 4.7 t -140.15 155.76 46.82 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.981 -1.009 . . . . 0.0 109.835 179.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' CYS . . . . . . . . . . . . . 4.0 m -91.9 148.89 21.87 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.546 -0.462 . . . . 0.0 110.652 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 77.8 t -61.32 -47.57 92.86 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 CA-C-O 121.058 0.456 . . . . 0.0 110.874 -179.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' SER . . . . . 0.575 ' HG ' ' H ' ' A' ' 192' ' ' ASP . 92.4 p -163.68 162.22 24.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.313 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 9.8 p -69.8 -12.94 16.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.12 0.486 . . . . 0.0 110.469 179.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -108.06 -31.39 7.97 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.132 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . 0.575 ' H ' ' HG ' ' A' ' 189' ' ' SER . 45.7 t0 -98.94 107.37 19.79 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.393 0.616 . . . . 0.0 111.244 -179.552 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -110.63 12.11 22.72 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.364 179.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 20.4 t -59.53 -47.07 86.97 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.359 -0.382 . . . . 0.0 112.028 -178.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 25.4 pttm -147.39 159.19 43.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.178 0.513 . . . . 0.0 111.332 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 83.6 mtt85 -123.53 143.97 49.85 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.407 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 -90.95 152.24 20.78 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.56 179.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 13.6 t -129.11 129.24 67.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.436 178.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 76.4 t -104.47 132.34 51.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -118.79 140.55 49.77 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.369 0.604 . . . . 0.0 111.207 -179.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -133.5 141.8 13.21 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 179.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . 0.532 ' OD1' ' N ' ' A' ' 203' ' ' LEU . 65.3 t0 -106.92 139.5 41.22 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.851 0.358 . . . . 0.0 110.164 -179.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . 0.532 ' N ' ' OD1' ' A' ' 202' ' ' ASP . 45.7 tp -64.98 131.34 46.35 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 15.4 m -113.05 -20.39 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 C-N-CA 120.665 -0.414 . . . . 0.0 111.043 -178.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -175.57 171.59 44.66 Favored Glycine 0 CA--C 1.535 1.298 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.115 179.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 11.4 m -142.98 136.33 28.37 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.596 -0.302 . . . . 0.0 110.328 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -143.44 121.29 11.97 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.452 0.644 . . . . 0.0 112.183 179.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -64.99 140.73 58.9 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.259 -0.882 . . . . 0.0 112.106 -179.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt -77.47 156.68 30.91 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.953 -1.021 . . . . 0.0 110.484 178.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 98.1 mttt . . . . . 0 C--O 1.22 -0.474 0 CA-C-O 117.934 -1.032 . . . . 0.0 110.682 179.786 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 702' ' ' LEU . . . . . 0.581 ' CB ' ' O ' ' A' ' 168' ' ' PRO . 0.0 OUTLIER . . . . . 0 CA--C 1.545 0.778 0 CA-C-O 120.607 0.242 . . . . 20.0 110.824 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 703' ' ' PRO . . . . . 0.508 ' O ' ' O ' ' B' ' 704' ' ' ALA . 3.3 Cg_exo -66.2 -173.74 0.36 Allowed 'Trans proline' 0 N--CA 1.493 1.5 0 C-N-CA 122.346 2.031 . . . . 20.0 112.603 179.392 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 704' ' ' ALA . . . . . 0.508 ' O ' ' O ' ' B' ' 703' ' ' PRO . . . . . . . . 0 N--CA 1.468 0.473 0 N-CA-C 113.601 0.963 . . . . 20.0 113.601 -178.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.246 0 CA-C-O 121.095 0.474 . . . . 0.0 110.868 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 86.6 p -86.21 10.33 14.92 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.315 0.579 . . . . 0.0 111.176 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -104.4 13.39 32.04 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.372 -179.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.2 mt -56.73 137.76 18.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 CA-C-O 122.157 0.98 . . . . 0.0 112.864 -177.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.477 ' O ' ' OD1' ' A' ' 62' ' ' ASP . 46.7 p-10 -79.49 129.87 34.87 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 113.975 -1.466 . . . . 0.0 109.162 178.107 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.667 ' NE2' ' ND1' ' A' ' 126' ' ' HIS . 0.0 OUTLIER -76.09 154.87 84.63 Favored Pre-proline 0 CA--C 1.535 0.38 0 CA-C-O 121.171 0.51 . . . . 0.0 110.302 -179.033 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -71.5 170.6 18.11 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.783 2.322 . . . . 0.0 112.975 -179.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -52.81 159.35 1.14 Allowed 'General case' 0 C--N 1.334 -0.087 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.595 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 58.6 tp -63.31 -46.45 86.63 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 120.627 -0.429 . . . . 0.0 111.322 -178.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.94 -36.72 84.36 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 119.844 -0.742 . . . . 0.0 111.153 -178.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -58.29 -26.54 63.12 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 119.871 -0.732 . . . . 0.0 109.033 178.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 25.2 t -78.98 -44.94 24.64 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.529 178.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -73.07 -9.1 58.36 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.918 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -106.76 -14.62 14.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.276 0.56 . . . . 0.0 110.475 179.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -69.44 143.19 53.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.387 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 13.7 t -62.09 99.83 0.14 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.489 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.2 tt -69.7 134.74 48.99 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.274 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.596 ' OD2' ' NE2' ' A' ' 78' ' ' GLN . 84.8 m-20 -94.98 84.28 4.11 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 121.497 0.665 . . . . 0.0 110.244 178.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 48.7 tttp -63.19 -43.08 99.21 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.27 -0.877 . . . . 0.0 112.321 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.684 ' H ' ' CE ' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -70.34 -11.36 60.86 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.792 -0.64 . . . . 0.0 112.06 -177.068 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.596 ' NE2' ' OD2' ' A' ' 75' ' ' ASP . 77.8 mt-30 -92.06 -1.6 57.12 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.047 0.451 . . . . 0.0 110.324 179.088 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 58.1 t -76.64 127.14 37.81 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.244 179.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 29.2 pt -111.05 -1.79 10.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.65 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -175.99 179.47 47.09 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 120.502 -0.856 . . . . 0.0 111.48 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.566 ' NH1' ' OE2' ' A' ' 91' ' ' GLU . 73.1 ttp85 -141.19 153.76 45.49 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 120.919 0.39 . . . . 0.0 110.971 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 18.1 tt -122.3 138.96 50.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-O 121.245 0.545 . . . . 0.0 110.317 179.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 10.3 t -137.75 130.85 30.41 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.199 0.524 . . . . 0.0 111.435 -179.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 54.3 mt -137.23 88.77 16.99 Favored Pre-proline 0 CA--C 1.541 0.604 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.987 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -56.73 -31.11 86.9 Favored 'Trans proline' 0 N--CA 1.503 2.05 0 C-N-CA 123.086 2.524 . . . . 0.0 113.41 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 22.4 m -53.23 -42.27 66.22 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 121.207 0.527 . . . . 0.0 111.162 -179.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 12.7 m -115.77 8.28 7.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.44 0.638 . . . . 0.0 110.412 179.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.5 m 54.18 49.03 19.58 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.698 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 60.0 tp -112.15 131.49 55.43 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.384 0.611 . . . . 0.0 110.844 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.566 ' OE2' ' NH1' ' A' ' 82' ' ' ARG . 80.4 tt0 -149.16 126.22 11.32 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.944 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 71.8 mt -152.24 151.98 28.54 Favored Pre-proline 0 CA--C 1.533 0.322 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.056 -179.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -74.73 147.02 34.58 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.361 2.041 . . . . 0.0 110.519 178.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 71.4 t -96.95 125.39 49.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 C-N-CA 120.434 -0.506 . . . . 0.0 110.855 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 9.5 mp -99.53 127.6 45.61 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.56 0.695 . . . . 0.0 111.472 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.514 ' O ' ' OG1' ' A' ' 109' ' ' THR . 87.5 tttt -63.71 -45.54 89.5 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 115.03 -0.986 . . . . 0.0 112.518 -178.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 3.3 m -81.38 130.99 35.26 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.267 0.556 . . . . 0.0 111.267 -179.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.433 ' OG ' ' O ' ' A' ' 98' ' ' SER . 9.8 p -91.3 53.41 2.31 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.576 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.723 ' HG1' ' ND2' ' A' ' 102' ' ' ASN . 81.2 p -88.44 166.77 14.0 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 178.576 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -64.13 -40.84 97.03 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.39 0.614 . . . . 0.0 110.453 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -63.95 -42.68 97.24 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.617 -179.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.723 ' ND2' ' HG1' ' A' ' 99' ' ' THR . 98.4 m-20 -65.7 -36.08 82.59 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.121 179.572 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 33.3 mt -61.52 -15.94 42.89 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.799 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 88.7 mt -71.94 -20.03 61.82 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.271 0.558 . . . . 0.0 109.871 179.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 83.6 p -73.29 -0.98 16.11 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.876 -179.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 82.84 -18.59 15.03 Favored Glycine 0 CA--C 1.526 0.776 0 CA-C-N 116.069 -0.514 . . . . 0.0 112.387 178.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -145.26 123.91 12.53 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.527 0.68 . . . . 0.0 111.349 179.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -147.47 149.66 33.09 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.093 179.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.514 ' OG1' ' O ' ' A' ' 96' ' ' LYS . 68.2 p -66.84 133.73 50.67 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.176 0.512 . . . . 0.0 110.561 -179.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 38.2 t -81.8 -62.0 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 C-N-CA 120.356 -0.538 . . . . 0.0 109.699 179.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.563 ' O ' ' NE2' ' A' ' 114' ' ' GLN . 85.5 tttt -94.17 133.95 37.14 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.818 179.38 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -66.37 -37.05 84.4 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -177.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -85.27 17.99 2.83 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 -178.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . 0.563 ' NE2' ' O ' ' A' ' 111' ' ' LYS . 5.5 pt20 -76.87 139.77 40.37 Favored 'General case' 0 CA--C 1.534 0.332 0 O-C-N 121.958 -0.464 . . . . 0.0 110.76 179.27 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 94.3 t -129.27 121.53 53.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.925 0.393 . . . . 0.0 110.162 178.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' MET . . . . . 0.588 ' SD ' ' OD1' ' A' ' 151' ' ' ASP . 56.1 mtt -58.06 134.34 56.34 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.173 0.511 . . . . 0.0 111.105 -179.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 78.52 -3.68 62.51 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 121.012 -0.613 . . . . 0.0 111.953 178.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -140.3 124.1 17.32 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.239 0.542 . . . . 0.0 110.759 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 76.04 -161.26 51.98 Favored Glycine 0 CA--C 1.531 1.081 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.368 179.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 63.2 t-20 -93.24 107.24 19.09 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.069 0.461 . . . . 0.0 110.977 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.444 ' CZ ' ' OE1' ' A' ' 114' ' ' GLN . 20.2 t80 -85.56 145.34 27.41 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.084 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -146.73 139.03 24.85 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 119.986 -0.686 . . . . 0.0 112.042 -178.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 72.4 mt -135.69 141.66 44.99 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.947 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -111.96 132.94 54.46 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 121.374 0.607 . . . . 0.0 109.852 178.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -134.74 152.13 20.61 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . 0.667 ' ND1' ' NE2' ' A' ' 63' ' ' GLN . 40.9 m-70 -89.47 136.08 33.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.727 0.775 . . . . 0.0 112.339 -178.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -130.09 121.05 25.63 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.62 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' MET . . . . . 0.439 ' O ' ' CB ' ' A' ' 129' ' ' SER . 53.2 mtt -94.86 -1.46 52.67 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 121.407 0.623 . . . . 0.0 110.212 179.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.439 ' CB ' ' O ' ' A' ' 128' ' ' MET . 0.9 OUTLIER 77.78 4.57 2.95 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 115.421 -0.809 . . . . 0.0 112.071 178.665 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.555 ' O ' ' CG1' ' A' ' 133' ' ' VAL . 62.4 pttt -119.65 125.7 49.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.994 0.902 . . . . 0.0 113.118 -178.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.528 ' O ' ' O ' ' A' ' 130' ' ' LYS . 0.0 OUTLIER -35.23 159.73 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.455 179.062 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 74.0 -19.66 1.65 Allowed Glycine 0 CA--C 1.534 1.264 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.555 ' CG1' ' O ' ' A' ' 130' ' ' LYS . 4.7 p -90.09 173.42 0.88 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 119.587 -0.845 . . . . 0.0 111.094 -179.394 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.437 ' N ' ' CD2' ' A' ' 134' ' ' LEU . 4.3 mm? -66.81 130.05 41.89 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 -175.531 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.8 m-30 60.98 18.28 8.74 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 114.164 -1.38 . . . . 0.0 112.545 178.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.37 -37.23 84.92 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 113.005 0.742 . . . . 0.0 113.005 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . 0.432 ' N ' ' OD1' ' A' ' 137' ' ' ASP . 31.7 p-10 -94.6 6.25 49.42 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.974 0.416 . . . . 0.0 111.88 -178.442 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 3.6 tt -63.97 -37.9 80.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 C-N-CA 120.553 -0.459 . . . . 0.0 111.786 -179.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -67.8 -10.67 54.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.803 0.335 . . . . 0.0 111.352 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 33.1 m -80.93 -4.98 56.85 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.036 0.446 . . . . 0.0 110.505 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 80.1 mt -63.91 139.52 58.78 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.037 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -115.9 156.76 25.59 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 121.478 0.656 . . . . 0.0 112.097 -178.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -48.87 130.57 18.17 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.341 -0.845 . . . . 0.0 112.647 -179.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.603 ' N ' ' O ' ' A' ' 160' ' ' VAL . . . 78.37 7.67 87.8 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.972 178.383 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -71.97 137.93 47.66 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 119.567 -0.853 . . . . 0.0 110.268 -179.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -80.76 142.06 34.16 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 122.016 0.912 . . . . 0.0 113.021 -177.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 91.6 mt -138.66 139.11 41.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 114.361 -1.291 . . . . 0.0 108.791 178.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -116.68 138.36 51.51 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 122.033 0.92 . . . . 0.0 112.821 -178.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -117.03 137.73 52.05 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.112 -1.404 . . . . 0.0 108.484 178.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -126.56 112.06 15.09 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 119.978 -0.689 . . . . 0.0 112.418 -178.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . 0.588 ' OD1' ' SD ' ' A' ' 116' ' ' MET . 20.7 m-20 -89.63 164.72 14.62 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 176.465 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 53.4 t30 -56.66 -23.5 42.12 Favored 'General case' 0 C--N 1.31 -1.118 0 C-N-CA 119.893 -0.723 . . . . 0.0 111.124 -178.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -111.0 -29.44 7.9 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 113.38 0.882 . . . . 0.0 113.38 -178.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . 0.455 ' O ' ' N ' ' A' ' 151' ' ' ASP . 0.4 OUTLIER -145.98 177.77 8.7 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 119.644 -0.822 . . . . 0.0 112.74 -176.949 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -134.32 145.8 49.38 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.099 178.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 48.3 m-85 -120.12 139.29 52.81 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 121.201 0.524 . . . . 0.0 111.486 -178.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -93.75 114.69 27.02 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.158 179.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -115.07 149.48 37.44 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.226 0.536 . . . . 0.0 111.934 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -122.86 122.17 38.0 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.617 179.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.603 ' O ' ' N ' ' A' ' 144' ' ' GLY . 86.2 t -60.37 138.62 21.04 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.218 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 177.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 20.3 p -107.22 -23.28 12.31 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.671 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 159.84 -167.63 35.37 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 120.28 -0.962 . . . . 0.0 112.033 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 42.3 t -127.4 137.57 57.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-N 115.124 -0.538 . . . . 0.0 109.74 179.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 57.9 m -123.78 157.38 34.18 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 121.317 0.58 . . . . 0.0 111.474 -178.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 28.2 mp0 -104.63 113.43 27.01 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 121.553 0.692 . . . . 0.0 110.705 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 27.6 m -139.49 163.93 24.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.234 -179.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' THR . . . . . 0.437 ' H ' ' HD2' ' A' ' 170' ' ' LYS . 0.2 OUTLIER -91.56 159.91 37.74 Favored Pre-proline 0 CA--C 1.538 0.484 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.694 178.513 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . 0.488 ' O ' ' CB ' ' B' ' 702' ' ' LEU . 35.6 Cg_endo -65.52 -15.76 50.97 Favored 'Trans proline' 0 N--CA 1.5 1.883 0 C-N-CA 122.874 2.383 . . . . 0.0 113.885 -179.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 44.1 p-10 -91.86 -7.21 50.0 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 119.466 -0.893 . . . . 0.0 111.544 179.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.437 ' HD2' ' H ' ' A' ' 167' ' ' THR . 96.7 mttt -75.64 83.11 2.65 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.808 0.813 . . . . 0.0 111.723 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 33.2 t90 -71.13 -11.31 60.87 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.636 -1.165 . . . . 0.0 110.47 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -61.57 -35.08 76.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.674 -179.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 32.7 m -63.51 -14.03 13.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.427 -179.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 12.2 t -110.58 -5.85 11.25 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -179.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.499 ' O ' ' CE1' ' A' ' 177' ' ' HIS . 94.9 mt-10 -72.36 149.12 44.64 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.345 0.593 . . . . 0.0 110.88 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . 0.52 ' OD1' ' O ' ' A' ' 176' ' ' ASP . 51.9 p-10 -67.61 128.42 36.38 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.611 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' HIS . . . . . 0.499 ' CE1' ' O ' ' A' ' 175' ' ' GLU . 76.6 m80 -110.23 22.02 16.04 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.509 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 59.94 37.45 92.65 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 110.771 -0.932 . . . . 0.0 110.771 179.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 18.3 ptmt -146.22 158.7 43.9 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -88.74 91.67 8.91 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.292 177.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -129.56 172.47 11.54 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.478 0.656 . . . . 0.0 111.259 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 18.6 tt -134.44 144.29 35.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.436 178.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 84.7 m -131.48 126.55 35.28 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.522 0.677 . . . . 0.0 111.572 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 86.1 mt -109.4 131.47 55.03 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 85.0 mt -112.87 124.19 69.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.498 0.666 . . . . 0.0 111.31 -178.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 3.9 t -137.81 153.04 49.69 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.831 179.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' CYS . . . . . . . . . . . . . 3.3 m -88.5 139.36 30.56 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.039 0.447 . . . . 0.0 110.945 -179.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 10.9 p -65.13 -44.54 95.51 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.099 -179.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 80.9 p -164.54 157.57 17.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.076 0.465 . . . . 0.0 110.795 179.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 11.4 p -81.93 -9.96 11.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.034 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -96.4 -9.97 28.71 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.284 0.564 . . . . 0.0 110.688 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -142.89 101.43 3.84 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.633 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 53.3 p-10 -102.21 10.39 39.36 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.247 0.546 . . . . 0.0 110.439 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 39.1 t -61.4 -46.16 91.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.277 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 64.4 pttt -144.86 150.95 37.97 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.453 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . 0.421 HH21 HD23 ' B' ' 702' ' ' LEU . 21.8 ptt180 -137.96 158.16 44.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.219 0.533 . . . . 0.0 111.165 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -91.75 141.35 28.78 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.839 -0.618 . . . . 0.0 111.561 -179.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 42.0 t -118.94 132.08 69.86 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.01 178.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 84.9 t -100.0 132.32 45.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -118.01 144.27 45.69 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.399 0.618 . . . . 0.0 110.996 -178.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -140.22 163.43 26.36 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 110.284 -1.127 . . . . 0.0 110.284 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . 0.57 ' OD1' ' N ' ' A' ' 203' ' ' LEU . 67.6 t0 -122.22 139.4 53.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.017 0.437 . . . . 0.0 111.888 -178.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . 0.57 ' N ' ' OD1' ' A' ' 202' ' ' ASP . 46.5 tp -62.78 131.54 49.2 Favored 'General case' 0 CA--C 1.52 -0.207 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 57.4 t -110.51 -20.72 6.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 C-N-CA 120.355 -0.538 . . . . 0.0 111.648 -178.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -178.03 174.21 46.6 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 120.546 -0.835 . . . . 0.0 111.486 -179.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 24.5 m -146.24 138.2 24.99 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.319 -0.441 . . . . 0.0 110.296 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -145.81 124.19 12.34 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.2 0.524 . . . . 0.0 110.943 178.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -65.86 147.98 52.51 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.78 0.8 . . . . 0.0 112.08 -179.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 10.1 ttmt -77.43 159.13 29.65 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.704 -1.135 . . . . 0.0 110.495 179.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 98.2 mttt . . . . . 0 C--O 1.219 -0.551 0 CA-C-O 118.089 -0.958 . . . . 0.0 110.562 179.429 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 702' ' ' LEU . . . . . 0.488 ' CB ' ' O ' ' A' ' 168' ' ' PRO . 2.3 mt . . . . . 0 CA--C 1.541 0.599 0 CA-C-O 120.55 0.214 . . . . 20.0 110.449 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 703' ' ' PRO . . . . . 0.549 ' O ' ' O ' ' B' ' 704' ' ' ALA . 2.5 Cg_endo -62.1 -173.09 0.12 Allowed 'Trans proline' 0 N--CA 1.489 1.232 0 C-N-CA 121.978 1.786 . . . . 20.0 113.061 -178.573 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 704' ' ' ALA . . . . . 0.549 ' O ' ' O ' ' B' ' 703' ' ' PRO . . . . . . . . 0 CA--C 1.532 0.259 0 CA-C-N 114.249 -1.342 . . . . 20.0 113.119 -179.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.377 0 CA-C-O 121.118 0.485 . . . . 0.0 111.896 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 29.5 p -84.73 11.15 9.57 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.346 0.498 . . . . 0.0 112.346 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -94.14 8.01 43.15 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.832 -0.347 . . . . 0.0 111.217 -179.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.5 mt -56.36 132.8 20.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 122.254 1.026 . . . . 0.0 113.689 -176.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -76.47 133.96 39.67 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 113.637 -1.62 . . . . 0.0 109.261 178.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.524 ' CD ' ' CG ' ' A' ' 126' ' ' HIS . 6.6 mm-40 -79.03 149.19 73.05 Favored Pre-proline 0 CA--C 1.537 0.47 0 CA-C-O 121.086 0.469 . . . . 0.0 111.895 -178.369 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -73.6 168.04 25.76 Favored 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 123.177 2.585 . . . . 0.0 112.173 179.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -55.1 167.36 0.43 Allowed 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 121.179 0.514 . . . . 0.0 111.481 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.446 ' N ' ' CD2' ' A' ' 66' ' ' LEU . 4.3 mm? -64.29 -42.67 96.3 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.296 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.78 -35.37 74.5 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.65 -0.42 . . . . 0.0 111.517 -177.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -61.37 -29.76 70.11 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.763 0.792 . . . . 0.0 109.655 179.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 23.0 t -75.01 -43.77 44.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.001 -0.999 . . . . 0.0 109.952 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -76.73 -9.44 58.67 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 114.948 -1.023 . . . . 0.0 111.228 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -113.17 -1.31 14.39 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.296 0.57 . . . . 0.0 110.233 178.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.43 -165.77 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.097 -179.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 69.6 p -103.72 106.51 17.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.712 178.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.418 ' CD1' ' C ' ' A' ' 74' ' ' LEU . 2.1 tm? -71.94 118.04 14.3 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.838 0.351 . . . . 0.0 110.836 -179.385 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -104.21 77.22 1.4 Allowed 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 121.459 0.647 . . . . 0.0 109.984 179.138 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.458 ' HD3' ' HZ1' ' A' ' 77' ' ' LYS . 87.9 tttt -69.19 -39.22 78.81 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.261 -0.881 . . . . 0.0 113.019 -179.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.458 ' HZ1' ' HD3' ' A' ' 76' ' ' LYS . 42.4 mmtt -70.3 -15.24 62.86 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.193 -175.207 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -91.18 -4.47 56.07 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.062 0.458 . . . . 0.0 110.931 179.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 78.0 t -80.43 128.04 38.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.068 0.461 . . . . 0.0 110.161 179.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 18.4 pt -111.66 -6.21 11.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.862 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -175.3 179.16 46.71 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 110.799 -0.92 . . . . 0.0 110.799 179.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -152.8 154.94 36.18 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.44 0.638 . . . . 0.0 111.3 179.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 17.0 tt -104.61 144.37 14.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.608 -179.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 33.1 t -135.71 127.72 29.65 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.61 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 53.0 mt -135.44 89.68 22.1 Favored Pre-proline 0 CA--C 1.537 0.456 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.403 -179.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -55.18 -33.38 84.04 Favored 'Trans proline' 0 N--CA 1.501 1.936 0 C-N-CA 123.165 2.577 . . . . 0.0 113.699 -179.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 74.1 m -52.9 -38.73 62.07 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 120.962 0.411 . . . . 0.0 111.08 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 33.1 m -117.78 13.37 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.292 179.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.8 m 49.17 49.52 19.47 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.476 -0.49 . . . . 0.0 110.457 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 62.9 tp -112.94 132.46 55.33 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.325 0.583 . . . . 0.0 110.822 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -146.19 122.03 10.61 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.743 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 94.4 mt -149.17 150.68 32.5 Favored Pre-proline 0 CA--C 1.54 0.588 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.065 -179.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -76.25 151.95 34.57 Favored 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 122.695 2.263 . . . . 0.0 112.295 179.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 98.6 t -96.83 114.65 34.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.855 0.359 . . . . 0.0 110.502 179.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.449 ' N ' ' CD1' ' A' ' 95' ' ' LEU . 10.3 mp -100.64 139.03 36.9 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.1 0.476 . . . . 0.0 111.472 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.509 ' O ' ' OG1' ' A' ' 109' ' ' THR . 98.9 mttt -66.44 -83.44 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 121.284 0.564 . . . . 0.0 112.019 -179.483 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 17.7 m -60.79 132.52 54.13 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.664 -179.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 43.6 t -88.28 74.43 8.71 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.371 0.605 . . . . 0.0 109.874 179.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.556 ' HG1' ' ND2' ' A' ' 102' ' ' ASN . 57.1 p -88.79 169.86 11.26 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.802 179.029 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -62.68 -44.34 96.51 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 120.23 -0.588 . . . . 0.0 109.952 179.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -66.61 -40.97 89.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.395 179.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.556 ' ND2' ' HG1' ' A' ' 99' ' ' THR . 95.0 m-20 -64.34 -35.71 81.76 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.816 -179.523 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 34.2 mt -60.49 -26.06 66.52 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.192 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 92.6 mt -72.74 -18.7 61.49 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.297 -179.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.409 ' OG ' ' O ' ' A' ' 102' ' ' ASN . 99.5 p -74.07 -8.25 55.48 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 121.33 0.586 . . . . 0.0 110.085 179.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 92.74 -19.57 50.5 Favored Glycine 0 CA--C 1.53 1.016 0 CA-C-N 115.721 -0.672 . . . . 0.0 114.003 177.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -145.03 127.01 15.5 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 119.556 -0.858 . . . . 0.0 111.701 -179.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -144.04 138.81 28.6 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.658 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.509 ' OG1' ' O ' ' A' ' 96' ' ' LYS . 64.5 p -73.84 135.01 43.4 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.138 0.494 . . . . 0.0 110.336 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.557 ' N ' HE22 ' A' ' 114' ' ' GLN . 77.8 t -78.97 -54.89 10.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.066 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.729 ' H ' ' NE2' ' A' ' 114' ' ' GLN . 97.5 mttt -102.15 137.43 40.43 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 122.36 1.076 . . . . 0.0 112.573 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -64.34 -29.54 70.61 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.396 -1.274 . . . . 0.0 112.491 -177.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 73.4 m-80 -84.07 17.15 2.56 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 113.669 0.988 . . . . 0.0 113.669 -178.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . 0.729 ' NE2' ' H ' ' A' ' 111' ' ' LYS . 50.1 mt-30 -78.48 134.77 37.29 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 121.966 -0.459 . . . . 0.0 111.672 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 96.3 t -124.85 119.95 57.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-O 120.993 0.425 . . . . 0.0 110.387 178.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 64.8 mtt -55.6 131.62 46.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.273 0.558 . . . . 0.0 111.488 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 84.77 -6.18 79.2 Favored Glycine 0 CA--C 1.533 1.199 0 CA-C-N 115.597 -0.728 . . . . 0.0 112.231 179.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -143.6 136.75 27.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.333 0.587 . . . . 0.0 112.068 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 75.03 -172.94 53.09 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.672 -0.971 . . . . 0.0 110.672 179.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . 0.44 HD21 ' CE1' ' A' ' 177' ' ' HIS . 52.3 t-20 -89.04 103.24 15.87 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.455 -0.498 . . . . 0.0 110.081 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -85.63 99.07 11.04 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-O 121.065 0.46 . . . . 0.0 109.773 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.502 ' N ' ' OE1' ' A' ' 114' ' ' GLN . . . -91.54 136.12 33.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.982 -179.202 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 74.6 mt -137.55 140.17 40.88 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 120.914 0.388 . . . . 0.0 111.099 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -108.43 146.23 33.41 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 178.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -148.09 156.75 27.06 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 -179.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . 0.535 ' O ' ' O ' ' A' ' 134' ' ' LEU . 77.9 m-70 -110.56 130.31 55.59 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 113.453 0.908 . . . . 0.0 113.453 -178.239 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . 0.591 ' ND2' ' O ' ' A' ' 127' ' ' ASN . 0.0 OUTLIER -134.65 121.93 21.55 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.78 177.712 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' MET . . . . . 0.488 ' O ' ' CB ' ' A' ' 129' ' ' SER . 65.0 mtt -83.83 8.19 15.61 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.057 0.456 . . . . 0.0 110.791 -179.404 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.488 ' CB ' ' O ' ' A' ' 128' ' ' MET . 0.7 OUTLIER 79.0 12.92 1.27 Allowed 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.452 179.118 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.454 ' O ' ' CG1' ' A' ' 133' ' ' VAL . 23.1 pttp -116.91 126.3 52.76 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 122.241 1.02 . . . . 0.0 112.68 -179.328 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 27.6 tptt -46.24 121.61 3.45 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.538 -1.21 . . . . 0.0 110.082 179.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 113.88 -15.14 21.56 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.563 -1.015 . . . . 0.0 110.563 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.454 ' CG1' ' O ' ' A' ' 130' ' ' LYS . 11.1 p -91.44 166.04 1.85 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.535 ' O ' ' O ' ' A' ' 126' ' ' HIS . 0.3 OUTLIER -72.75 138.2 46.36 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 122.384 1.087 . . . . 0.0 113.821 -176.239 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 62.14 9.69 3.31 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 113.67 -1.604 . . . . 0.0 114.643 177.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 4.3 p -70.4 -31.96 69.39 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 121.486 -0.759 . . . . 0.0 113.028 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -88.82 8.57 28.39 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 -177.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.454 ' CD1' ' OG1' ' A' ' 186' ' ' THR . 18.2 pt -68.7 -31.46 50.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 121.602 0.715 . . . . 0.0 110.476 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -61.98 -20.81 64.26 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.639 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 57.7 m -79.78 -3.41 47.52 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.172 -179.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 99.5 mt -65.78 145.6 55.78 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 121.071 0.462 . . . . 0.0 110.198 179.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 53.6 mttp -120.67 154.5 35.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.515 0.674 . . . . 0.0 111.254 -179.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -49.97 131.86 22.84 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.41 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 160' ' ' VAL . . . 80.71 8.23 87.72 Favored Glycine 0 CA--C 1.533 1.217 0 C-N-CA 120.682 -0.77 . . . . 0.0 111.72 179.297 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.458 ' OD1' ' N ' ' A' ' 146' ' ' LYS . 56.6 t0 -71.17 130.04 40.45 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 120.042 -0.663 . . . . 0.0 110.304 -179.513 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.458 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 74.5 mmtt -77.81 142.85 38.33 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.8 0.809 . . . . 0.0 112.263 -178.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 80.5 mt -142.64 143.44 25.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 114.562 -1.199 . . . . 0.0 108.656 178.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -126.04 139.96 52.98 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 119.599 -0.84 . . . . 0.0 112.563 -178.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 2.9 mt -110.5 134.12 52.66 Favored 'General case' 0 C--O 1.223 -0.334 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 177.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.553 ' CZ ' ' CD ' ' A' ' 155' ' ' GLU . 33.3 m-85 -110.25 107.68 17.53 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.303 -0.559 . . . . 0.0 112.078 -179.207 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . 0.477 ' OD1' ' N ' ' A' ' 152' ' ' ASN . 54.5 t0 -88.94 162.37 16.13 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 177.449 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . 0.477 ' N ' ' OD1' ' A' ' 151' ' ' ASP . 44.9 p-10 -58.27 -18.55 27.53 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 119.422 -0.911 . . . . 0.0 111.358 -178.215 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -113.77 -28.14 7.54 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -178.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . 0.438 ' ND2' ' N ' ' A' ' 154' ' ' ASN . 0.4 OUTLIER -148.58 -175.12 4.8 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 122.134 0.969 . . . . 0.0 113.477 -176.779 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.553 ' CD ' ' CZ ' ' A' ' 150' ' ' TYR . 82.5 tt0 -134.79 140.88 46.22 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 114.153 -1.385 . . . . 0.0 109.939 178.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -115.45 137.95 51.52 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -179.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -93.42 109.27 20.85 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.854 179.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 38.1 m-85 -113.27 147.51 37.42 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.08 0.467 . . . . 0.0 111.349 178.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -122.02 121.55 37.27 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.262 0.553 . . . . 0.0 111.567 179.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.511 ' O ' ' N ' ' A' ' 144' ' ' GLY . 52.1 t -59.86 136.31 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.258 178.206 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 22.5 p -105.68 -24.83 12.45 Favored 'General case' 0 CA--C 1.533 0.316 0 O-C-N 123.535 0.522 . . . . 0.0 111.623 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 159.3 -169.08 35.39 Favored Glycine 0 CA--C 1.529 0.949 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 3.6 p -136.35 155.92 35.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 68.3 m -146.1 167.51 23.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.353 0.597 . . . . 0.0 111.764 -179.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -103.14 119.1 38.24 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.119 179.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 21.0 m -136.3 158.45 38.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.452 0.644 . . . . 0.0 111.859 -178.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' THR . . . . . 0.405 ' H ' ' HD2' ' A' ' 170' ' ' LYS . 0.3 OUTLIER -86.52 158.61 54.21 Favored Pre-proline 0 CA--C 1.537 0.48 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.111 -179.634 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . 0.538 ' O ' ' CB ' ' B' ' 702' ' ' LEU . 32.6 Cg_endo -66.31 -18.7 55.8 Favored 'Trans proline' 0 N--CA 1.498 1.792 0 C-N-CA 123.471 2.781 . . . . 0.0 113.425 -179.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 44.0 p-10 -92.88 -3.14 55.13 Favored 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 119.878 -0.729 . . . . 0.0 112.187 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.405 ' HD2' ' H ' ' A' ' 167' ' ' THR . 93.6 mttt -76.74 97.29 4.44 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.466 0.65 . . . . 0.0 112.175 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 95.9 m95 -66.84 -33.62 76.01 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.254 -0.884 . . . . 0.0 110.277 178.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -44.27 -36.28 2.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.071 -0.968 . . . . 0.0 112.885 -178.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 16.1 m -63.37 -26.04 39.87 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 120.376 -0.53 . . . . 0.0 112.064 -179.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 25.6 m -108.79 -7.8 11.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 120.306 -0.558 . . . . 0.0 112.466 -179.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -75.02 153.64 38.38 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.143 0.497 . . . . 0.0 111.502 179.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . 0.412 ' O ' ' OD1' ' A' ' 176' ' ' ASP . 48.8 p-10 -64.61 138.07 58.19 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.123 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' HIS . . . . . 0.44 ' CE1' HD21 ' A' ' 120' ' ' ASN . 70.1 m80 -112.83 14.9 19.93 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.416 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 72.12 34.37 61.52 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 120.851 -0.69 . . . . 0.0 111.547 179.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 42.8 pttt -166.33 178.84 5.95 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.629 0.728 . . . . 0.0 111.722 179.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' A' ' 180' ' ' ASP . 18.3 p30 -89.77 92.99 9.27 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.835 179.201 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . 0.407 ' HG2' ' N ' ' A' ' 182' ' ' ILE . 84.3 tt0 -124.85 161.32 26.78 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.411 0.624 . . . . 0.0 111.566 -179.485 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.407 ' N ' ' HG2' ' A' ' 181' ' ' GLU . 20.5 tt -129.09 135.95 60.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 178.548 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 80.4 m -130.26 126.07 36.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.707 0.765 . . . . 0.0 112.203 -178.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.435 ' N ' ' CD1' ' A' ' 184' ' ' LEU . 10.5 mp -109.66 131.87 54.67 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.817 -1.083 . . . . 0.0 109.164 178.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . 0.401 HG21 HD12 ' A' ' 185' ' ' ILE . 96.8 mt -113.67 122.63 68.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 121.454 0.645 . . . . 0.0 111.288 -179.185 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' THR . . . . . 0.454 ' OG1' ' CD1' ' A' ' 138' ' ' ILE . 4.7 m -140.86 153.16 45.62 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.827 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' CYS . . . . . . . . . . . . . 86.4 m -87.03 153.92 21.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.269 179.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 65.8 t -61.04 -48.87 87.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.278 0.561 . . . . 0.0 110.842 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' SER . . . . . 0.458 ' HA ' ' HG ' ' A' ' 129' ' ' SER . 16.5 t -168.06 151.25 5.79 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.791 179.081 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 7.5 p -62.01 -20.69 24.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.38 0.609 . . . . 0.0 109.919 179.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 60.4 mttp -94.65 -12.13 27.94 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.047 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -138.09 103.11 4.86 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.767 179.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -104.68 11.94 33.47 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.549 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 21.3 m -63.57 -36.81 85.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.946 -179.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 57.1 mtmt -135.13 156.95 48.13 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.075 0.464 . . . . 0.0 111.709 -178.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -128.63 139.28 52.34 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.433 -179.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -94.62 144.5 25.55 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.246 0.546 . . . . 0.0 112.086 179.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 41.6 t -131.79 131.16 62.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.041 178.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 53.5 t -105.29 132.83 51.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.432 179.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -116.44 141.82 47.68 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.307 0.575 . . . . 0.0 110.836 -179.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -143.57 145.8 15.89 Favored Glycine 0 CA--C 1.528 0.903 0 N-CA-C 110.64 -0.984 . . . . 0.0 110.64 179.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -107.03 149.36 27.65 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.027 0.441 . . . . 0.0 110.594 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 49.2 tp -70.29 131.61 44.44 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 179.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 7.6 p -114.05 -20.27 6.19 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 C-N-CA 120.442 -0.503 . . . . 0.0 111.767 -179.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -174.49 172.36 45.32 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 120.711 -0.757 . . . . 0.0 111.722 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 17.5 m -142.96 136.13 28.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.44 -0.38 . . . . 0.0 110.21 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -144.52 120.62 10.77 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.284 0.564 . . . . 0.0 111.745 179.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -62.06 137.35 58.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.465 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -81.22 160.95 24.17 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.099 178.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 25.3 pttm . . . . . 0 C--O 1.22 -0.464 0 CA-C-O 118.188 -0.911 . . . . 0.0 110.869 -179.693 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 702' ' ' LEU . . . . . 0.538 ' CB ' ' O ' ' A' ' 168' ' ' PRO . 0.4 OUTLIER . . . . . 0 CA--C 1.536 0.439 0 N-CA-C 109.483 -0.562 . . . . 20.0 109.483 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 703' ' ' PRO . . . . . 0.559 ' O ' ' O ' ' B' ' 704' ' ' ALA . 3.4 Cg_exo -64.01 179.5 1.08 Allowed 'Trans proline' 0 N--CA 1.491 1.378 0 C-N-CA 122.243 1.962 . . . . 20.0 113.903 -178.589 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 704' ' ' ALA . . . . . 0.559 ' O ' ' O ' ' B' ' 703' ' ' PRO . . . . . . . . 0 CA--C 1.533 0.311 0 CA-C-N 114.175 -1.375 . . . . 20.0 113.496 -179.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.461 0.077 0 CA-C-O 121.245 0.545 . . . . 0.0 110.542 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 89.8 p -84.26 13.16 5.54 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.914 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 50.9 mtmt -107.29 18.09 22.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.635 -179.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 76.8 mt -56.17 138.97 16.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 122.244 1.021 . . . . 0.0 113.142 -177.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -76.51 132.74 39.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 113.614 -1.63 . . . . 0.0 109.199 178.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.407 ' HB3' ' CG ' ' A' ' 126' ' ' HIS . 3.2 pm0 -77.09 147.5 76.86 Favored Pre-proline 0 C--N 1.324 -0.506 0 C-N-CA 120.513 -0.475 . . . . 0.0 110.14 -179.439 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.451 ' CB ' ' OE1' ' A' ' 68' ' ' GLU . 66.9 Cg_endo -70.4 160.33 49.88 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 122.861 2.374 . . . . 0.0 112.273 -179.262 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 -52.99 172.18 0.05 Allowed 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 121.311 0.577 . . . . 0.0 111.06 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 98.8 mt -71.25 -10.59 60.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.725 -179.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -69.17 -40.55 78.07 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.408 0.623 . . . . 0.0 111.024 179.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.474 ' O ' ' CB ' ' A' ' 72' ' ' ALA . 90.1 mt-10 -71.44 -26.83 62.9 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.023 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 6.0 t -72.16 -44.25 65.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.67 -179.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -89.91 -9.88 47.25 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.925 -0.31 . . . . 0.0 111.581 -179.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -110.52 -8.0 14.68 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.647 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.474 ' CB ' ' O ' ' A' ' 68' ' ' GLU . . . -68.44 138.9 55.66 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.35 0.595 . . . . 0.0 111.731 -179.296 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 5.9 m -57.8 102.85 0.11 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.718 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.495 ' CD1' ' C ' ' A' ' 74' ' ' LEU . 2.0 tm? -68.34 119.28 12.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.39 -178.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -97.3 78.47 2.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.393 0.616 . . . . 0.0 109.44 178.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -63.77 -36.66 84.6 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.955 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.407 ' HD3' ' N ' ' A' ' 77' ' ' LYS . 0.1 OUTLIER -70.38 -14.5 62.59 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.405 -177.427 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 -90.9 -1.15 57.86 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.301 0.572 . . . . 0.0 110.634 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 74.9 t -84.67 127.21 40.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.389 179.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 18.3 pt -110.97 -11.66 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 C-N-CA 120.803 -0.359 . . . . 0.0 111.798 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -160.52 163.77 34.19 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 120.556 -0.83 . . . . 0.0 111.384 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 78.8 ttt180 -134.95 138.34 43.96 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.196 0.522 . . . . 0.0 111.35 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 20.0 tt -104.12 141.3 20.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.243 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 70.1 m -135.78 128.84 31.56 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.645 -178.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 79.5 mt -139.23 86.41 14.65 Favored Pre-proline 0 CA--C 1.538 0.501 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.09 -179.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -56.66 -29.69 80.77 Favored 'Trans proline' 0 N--CA 1.499 1.827 0 C-N-CA 123.286 2.657 . . . . 0.0 113.523 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.429 ' HG ' ' CD2' ' A' ' 141' ' ' LEU . 91.7 p -53.23 -42.01 65.98 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 121.291 0.567 . . . . 0.0 110.55 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.493 ' O ' ' OG ' ' A' ' 89' ' ' SER . 34.4 m -114.07 11.23 8.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.596 179.502 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.493 ' OG ' ' O ' ' A' ' 88' ' ' VAL . 14.9 p 51.37 52.38 14.9 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.915 -179.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 54.5 tp -118.33 134.36 55.11 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 121.535 0.683 . . . . 0.0 111.958 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -146.1 122.89 11.25 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.823 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 76.8 mt -149.81 148.88 26.59 Favored Pre-proline 0 CA--C 1.539 0.529 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.316 -179.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.18 145.86 27.99 Favored 'Trans proline' 0 N--CA 1.493 1.49 0 C-N-CA 122.436 2.091 . . . . 0.0 111.867 178.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.524 ' O ' ' CG2' ' A' ' 94' ' ' VAL . 2.0 m -94.02 118.01 38.97 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 CA-C-O 121.53 0.681 . . . . 0.0 110.996 179.428 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.424 ' N ' ' CD1' ' A' ' 95' ' ' LEU . 11.0 mp -102.6 136.23 42.8 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.098 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -64.75 -88.14 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 119.992 -0.683 . . . . 0.0 112.123 -179.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 74.0 m -51.79 134.17 30.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.898 -178.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 8.1 m -91.15 74.03 6.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.929 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 55.7 p -88.59 168.48 12.53 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 178.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -61.69 -42.53 99.05 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 119.856 -0.738 . . . . 0.0 109.903 179.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -65.86 -40.38 91.62 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.527 -0.761 . . . . 0.0 111.372 179.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -63.59 -38.93 93.01 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.168 0.508 . . . . 0.0 111.291 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 76.6 mt -61.67 -21.92 64.85 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.763 -179.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 63.1 mt -69.84 -21.43 63.36 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.944 0.402 . . . . 0.0 110.429 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.439 ' HG ' ' H ' ' A' ' 107' ' ' ALA . 95.9 p -72.98 -7.71 52.39 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 179.172 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.504 ' O ' ' CE1' ' A' ' 135' ' ' PHE . . . 91.24 -18.65 50.9 Favored Glycine 0 CA--C 1.53 0.991 0 CA-C-N 115.205 -0.907 . . . . 0.0 112.41 178.462 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.439 ' H ' ' HG ' ' A' ' 105' ' ' SER . . . -145.95 124.75 12.63 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 119.723 -0.791 . . . . 0.0 112.354 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -143.4 132.77 23.36 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.482 178.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 11.7 m -62.45 131.44 49.2 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 121.01 0.433 . . . . 0.0 110.836 -179.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 75.6 t -78.92 -54.56 11.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 C-N-CA 120.576 -0.449 . . . . 0.0 110.673 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.802 ' H ' ' NE2' ' A' ' 114' ' ' GLN . 97.5 mttt -98.39 135.94 39.26 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 122.258 1.027 . . . . 0.0 112.646 179.483 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -66.53 -30.16 70.41 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 113.71 -1.586 . . . . 0.0 113.558 -178.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -83.06 8.57 12.52 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 -177.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . 0.802 ' NE2' ' H ' ' A' ' 111' ' ' LYS . 46.0 mt-30 -80.02 139.56 36.91 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 121.913 -0.492 . . . . 0.0 112.104 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.41 ' O ' ' O ' ' A' ' 118' ' ' LYS . 55.4 t -123.62 125.65 71.71 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.971 178.307 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 97.9 mtp -59.66 129.83 43.83 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.753 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 88.52 -10.74 70.62 Favored Glycine 0 CA--C 1.531 1.062 0 N-CA-C 111.796 -0.522 . . . . 0.0 111.796 178.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.41 ' O ' ' O ' ' A' ' 115' ' ' VAL . 67.4 mttm -141.5 138.25 32.66 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.364 0.602 . . . . 0.0 111.549 179.617 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 75.03 -163.83 54.32 Favored Glycine 0 CA--C 1.53 0.979 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . 0.554 ' ND2' ' ND1' ' A' ' 177' ' ' HIS . 54.0 t-20 -93.97 104.59 16.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.932 0.396 . . . . 0.0 110.69 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 9.6 t80 -86.49 144.7 27.13 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 178.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.585 ' N ' ' OE1' ' A' ' 114' ' ' GLN . . . -147.66 140.27 24.68 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.043 -0.663 . . . . 0.0 111.248 -179.12 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 48.1 mt -137.72 142.53 41.02 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.064 -179.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -110.82 138.55 47.07 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 178.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -139.36 151.35 21.84 Favored Glycine 0 CA--C 1.53 0.983 0 N-CA-C 110.441 -1.064 . . . . 0.0 110.441 -179.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . 0.407 ' CG ' ' HB3' ' A' ' 63' ' ' GLN . 19.5 m-70 -96.92 140.44 31.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.435 0.636 . . . . 0.0 111.928 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . 0.593 ' ND2' ' OG1' ' A' ' 186' ' ' THR . 52.2 p-10 -145.55 121.42 10.61 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.537 179.019 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' MET . . . . . 0.497 ' O ' ' CB ' ' A' ' 129' ' ' SER . 74.9 mtm -87.3 4.61 42.11 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.174 0.511 . . . . 0.0 110.296 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.497 ' CB ' ' O ' ' A' ' 128' ' ' MET . 1.0 OUTLIER 78.93 13.64 1.23 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.129 179.878 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.465 ' O ' ' CG1' ' A' ' 133' ' ' VAL . 21.2 ptmt -109.72 124.42 51.21 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 122.168 0.985 . . . . 0.0 113.19 -178.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -43.99 119.49 1.77 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.628 -1.169 . . . . 0.0 110.668 179.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 115.42 -18.69 15.32 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.54 ' CG1' ' OG ' ' A' ' 136' ' ' SER . 7.6 p -88.93 154.33 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.636 ' CD2' ' H ' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -69.19 145.06 53.54 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -177.211 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.504 ' CE1' ' O ' ' A' ' 106' ' ' GLY . 3.3 m-85 65.82 6.37 3.92 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 114.017 -1.447 . . . . 0.0 114.15 178.027 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' SER . . . . . 0.54 ' OG ' ' CG1' ' A' ' 133' ' ' VAL . 2.7 m -75.24 -36.3 61.32 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 179.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 51.9 p-10 -94.48 7.1 46.73 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 114.277 1.214 . . . . 0.0 114.277 -176.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 38.6 pt -72.5 -23.79 21.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 C-N-CA 119.344 -0.943 . . . . 0.0 110.663 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -71.14 -10.34 59.58 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 121.017 0.436 . . . . 0.0 110.614 179.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 66.6 m -81.0 -7.34 59.53 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.286 0.565 . . . . 0.0 110.271 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.429 ' CD2' ' HG ' ' A' ' 87' ' ' SER . 88.6 mt -67.47 146.36 54.06 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.041 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -123.8 166.46 15.57 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.392 178.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -52.15 140.61 20.59 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.518 0.675 . . . . 0.0 112.359 179.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 77.99 7.13 87.6 Favored Glycine 0 CA--C 1.529 0.915 0 CA-C-N 115.139 -0.937 . . . . 0.0 112.283 178.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -71.97 133.9 45.62 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 118.925 -1.11 . . . . 0.0 110.165 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -79.72 136.2 36.71 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.759 0.79 . . . . 0.0 111.836 -178.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 97.8 mt -134.82 135.06 53.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 178.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 79.5 m-85 -121.98 135.57 54.86 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 119.858 -0.737 . . . . 0.0 112.632 -177.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.437 ' CD2' ' N ' ' A' ' 149' ' ' LEU . 0.3 OUTLIER -112.43 135.13 53.51 Favored 'General case' 0 C--O 1.224 -0.24 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 178.062 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.503 ' CE1' ' CD ' ' A' ' 155' ' ' GLU . 75.3 m-85 -109.71 108.95 19.51 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 120.247 -0.581 . . . . 0.0 111.712 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . 0.509 ' OD1' ' N ' ' A' ' 152' ' ' ASN . 53.8 t0 -87.74 165.23 15.51 Favored 'General case' 0 N--CA 1.447 -0.625 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 177.034 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . 0.509 ' N ' ' OD1' ' A' ' 151' ' ' ASP . 50.8 p-10 -59.28 -21.17 59.25 Favored 'General case' 0 C--N 1.312 -1.027 0 C-N-CA 119.522 -0.871 . . . . 0.0 110.978 -178.442 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.468 ' N ' ' OD1' ' A' ' 152' ' ' ASN . 95.4 mt-10 -115.92 -26.83 7.18 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 113.691 0.997 . . . . 0.0 113.691 -178.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -146.38 175.89 10.2 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 119.0 -1.08 . . . . 0.0 113.154 -176.631 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.503 ' CD ' ' CE1' ' A' ' 150' ' ' TYR . 82.5 tt0 -127.19 134.66 50.11 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 114.839 -1.073 . . . . 0.0 109.915 179.268 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -109.25 135.18 50.76 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 121.301 0.572 . . . . 0.0 112.094 -179.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -93.21 110.08 21.59 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.557 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 43.9 m-85 -113.92 148.81 36.16 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 120.91 0.386 . . . . 0.0 111.386 179.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -125.0 125.98 44.73 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.35 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 80.0 t -57.71 131.24 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 178.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 16.5 p -113.59 7.32 17.32 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 123.673 0.608 . . . . 0.0 112.529 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 135.79 177.37 14.93 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 120.108 -1.044 . . . . 0.0 112.515 178.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 5.8 p -135.3 154.26 35.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 25.8 p -144.66 166.89 23.91 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.042 -0.663 . . . . 0.0 111.722 -179.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -104.12 117.97 35.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.479 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . 0.474 ' O ' ' O ' ' A' ' 196' ' ' ARG . 27.9 m -135.84 160.1 39.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.488 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' THR . . . . . 0.52 ' H ' ' HG1' ' A' ' 167' ' ' THR . 0.2 OUTLIER -85.34 158.08 58.19 Favored Pre-proline 0 CA--C 1.538 0.508 0 CA-C-O 121.055 0.455 . . . . 0.0 110.888 -179.572 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . 0.495 ' O ' ' CB ' ' B' ' 702' ' ' LEU . 28.2 Cg_endo -64.69 -17.58 59.96 Favored 'Trans proline' 0 N--CA 1.499 1.803 0 C-N-CA 123.227 2.618 . . . . 0.0 113.038 -179.256 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 48.9 p-10 -90.88 -2.73 57.72 Favored 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 120.148 -0.621 . . . . 0.0 110.958 179.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -73.88 76.97 1.64 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.441 0.639 . . . . 0.0 111.388 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' TRP . . . . . 0.676 ' HE1' ' CE ' ' A' ' 111' ' ' LYS . 5.7 t90 -69.81 -15.74 63.16 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.334 179.506 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -63.38 -32.16 73.51 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.81 -179.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 14.6 m -62.3 -14.57 12.8 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 120.599 -0.441 . . . . 0.0 111.76 -179.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 1.8 t -103.95 -9.71 9.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -179.124 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -72.35 162.72 29.09 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.117 0.484 . . . . 0.0 110.78 -179.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . 0.418 ' N ' ' OD1' ' A' ' 176' ' ' ASP . 35.5 p-10 -65.03 141.31 58.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.897 179.55 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' HIS . . . . . 0.554 ' ND1' ' ND2' ' A' ' 120' ' ' ASN . 66.2 m80 -113.26 10.41 18.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.321 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 66.18 39.28 94.47 Favored Glycine 0 CA--C 1.53 1.008 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 179.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -165.46 171.01 13.81 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.868 0.366 . . . . 0.0 110.914 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -86.94 102.96 14.86 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 177.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -137.02 161.68 35.39 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.347 0.594 . . . . 0.0 111.512 -178.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 20.3 tt -129.93 139.01 52.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.471 178.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 86.4 m -129.24 125.02 35.97 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.188 0.518 . . . . 0.0 112.02 -178.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 84.9 mt -109.3 131.91 54.62 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 88.9 mt -116.15 125.2 73.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 CA-C-O 121.376 0.608 . . . . 0.0 111.276 -179.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' THR . . . . . 0.593 ' OG1' ' ND2' ' A' ' 127' ' ' ASN . 1.7 t -142.03 163.87 31.72 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 115.263 -0.881 . . . . 0.0 110.851 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' CYS . . . . . . . . . . . . . 1.9 m -95.86 143.51 27.0 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 120.967 0.413 . . . . 0.0 110.847 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 44.2 t -61.4 -48.45 88.79 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 CA-C-O 121.069 0.462 . . . . 0.0 111.206 -179.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 8.5 t -169.38 158.79 8.27 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.226 0.536 . . . . 0.0 110.878 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 29.2 m -71.96 -17.65 19.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.347 179.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -99.19 -4.59 31.73 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.146 179.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 53.8 t0 -139.68 97.15 3.2 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 120.991 0.424 . . . . 0.0 110.972 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 43.3 p-10 -107.88 10.19 28.61 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.357 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 69.7 m -61.2 -41.7 97.28 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 120.811 0.339 . . . . 0.0 111.414 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -144.68 155.72 43.72 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.327 0.584 . . . . 0.0 111.57 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . 0.474 ' O ' ' O ' ' A' ' 166' ' ' VAL . 99.9 mtt180 -132.56 142.2 49.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.004 -179.407 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . 0.486 ' CZ ' ' CG2' ' A' ' 186' ' ' THR . 47.8 p90 -99.08 151.67 20.69 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.315 0.578 . . . . 0.0 111.203 179.674 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 45.8 t -123.88 134.05 67.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.462 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 69.9 t -96.79 134.83 32.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.964 0.412 . . . . 0.0 110.036 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -116.3 138.29 51.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.358 0.599 . . . . 0.0 111.174 -179.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -134.83 138.0 9.69 Favored Glycine 0 CA--C 1.529 0.917 0 N-CA-C 110.179 -1.168 . . . . 0.0 110.179 179.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . 0.598 ' OD1' ' N ' ' A' ' 203' ' ' LEU . 42.5 t0 -108.89 140.53 42.24 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.15 0.5 . . . . 0.0 111.669 -179.185 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . 0.598 ' N ' ' OD1' ' A' ' 202' ' ' ASP . 54.6 tp -63.34 133.61 54.39 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.073 179.514 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -116.09 -18.88 6.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.074 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -178.36 172.94 45.43 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 120.645 -0.788 . . . . 0.0 111.824 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 31.7 m -142.94 138.91 30.47 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -145.37 122.27 11.3 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.462 -0.495 . . . . 0.0 111.629 178.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -61.98 138.77 58.41 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.391 0.615 . . . . 0.0 110.854 -179.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 13.6 ttmt -79.14 109.47 13.48 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.95 178.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 99.8 mttt . . . . . 0 C--O 1.219 -0.532 0 CA-C-O 117.953 -1.022 . . . . 0.0 110.383 -179.846 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 702' ' ' LEU . . . . . 0.495 ' CB ' ' O ' ' A' ' 168' ' ' PRO . 0.9 OUTLIER . . . . . 0 CA--C 1.545 0.751 0 CA-C-O 120.492 0.187 . . . . 20.0 111.159 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 703' ' ' PRO . . . . . 0.537 ' O ' ' O ' ' B' ' 704' ' ' ALA . 3.0 Cg_exo -65.65 -168.58 0.13 Allowed 'Trans proline' 0 N--CA 1.492 1.398 0 C-N-CA 122.377 2.052 . . . . 20.0 113.484 -179.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 704' ' ' ALA . . . . . 0.537 ' O ' ' O ' ' B' ' 703' ' ' PRO . . . . . . . . 0 C--N 1.332 -0.191 0 CA-C-N 114.501 -1.227 . . . . 20.0 113.058 -179.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.321 0 CA-C-O 121.265 0.555 . . . . 0.0 110.679 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 23.6 p -82.99 18.74 1.55 Allowed 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.735 -0.666 . . . . 0.0 112.718 -178.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -105.15 17.38 24.15 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.661 -0.416 . . . . 0.0 111.638 -179.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.6 mt -55.41 135.31 18.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 122.124 0.964 . . . . 0.0 112.479 -177.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -76.75 131.92 39.0 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 113.885 -1.507 . . . . 0.0 108.961 178.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.587 ' NE2' ' O ' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -79.23 149.82 73.28 Favored Pre-proline 0 C--N 1.326 -0.449 0 C-N-CA 120.383 -0.527 . . . . 0.0 110.634 -179.074 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -71.0 165.19 33.18 Favored 'Trans proline' 0 N--CA 1.496 1.654 0 C-N-CA 122.888 2.392 . . . . 0.0 113.338 -179.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -53.02 164.94 0.35 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.684 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 89.1 mt -63.81 -45.37 89.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.285 -179.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.17 -36.84 84.95 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.473 -0.491 . . . . 0.0 111.071 -178.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -63.04 -29.91 71.18 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.498 0.666 . . . . 0.0 109.478 178.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 38.7 t -76.71 -46.27 30.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.108 179.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -73.08 -9.01 58.27 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.811 -1.086 . . . . 0.0 111.438 -179.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 96.8 m-20 -106.43 -12.89 15.51 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.525 0.678 . . . . 0.0 109.655 178.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.4 139.71 55.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.044 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 35.5 t -59.06 103.17 0.15 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.013 179.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.433 ' CD2' ' C ' ' A' ' 74' ' ' LEU . 6.9 tt -70.16 123.79 22.49 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.266 0.555 . . . . 0.0 111.068 -179.281 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -96.35 80.11 3.16 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.044 -179.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.409 ' O ' ' CG1' ' A' ' 79' ' ' VAL . 64.5 pttt -79.49 -15.67 57.36 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.742 0.782 . . . . 0.0 109.539 178.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 21.2 mtmt -65.82 -36.28 83.04 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.764 -1.107 . . . . 0.0 111.41 -178.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -87.04 0.07 55.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.941 0.4 . . . . 0.0 111.333 -179.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.412 ' O ' ' CG1' ' A' ' 79' ' ' VAL . 2.3 p -68.36 132.43 32.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.534 0.683 . . . . 0.0 110.683 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 8.6 pt -111.4 -5.81 11.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.427 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -171.74 176.9 44.78 Favored Glycine 0 CA--C 1.531 1.036 0 N-CA-C 111.162 -0.775 . . . . 0.0 111.162 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 51.1 ttt85 -135.92 154.42 51.13 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 20.1 tt -119.07 137.02 54.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 CA-C-O 121.6 0.714 . . . . 0.0 110.124 179.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 8.6 t -135.15 125.35 26.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.771 -178.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.422 HG21 HD11 ' A' ' 85' ' ' ILE . 81.0 mt -135.56 90.23 20.5 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.203 179.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -56.38 -32.04 87.35 Favored 'Trans proline' 0 N--CA 1.494 1.535 0 C-N-CA 123.069 2.513 . . . . 0.0 112.637 -179.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 10.7 t -54.77 -42.44 71.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.294 -179.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.2 m -113.81 11.28 8.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.328 0.585 . . . . 0.0 110.351 179.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 50.19 48.08 22.68 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.265 179.611 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 47.8 tp -109.75 132.1 54.46 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.472 0.653 . . . . 0.0 110.802 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -144.13 113.78 7.13 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.083 -178.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 93.7 mt -147.36 147.44 28.34 Favored Pre-proline 0 CA--C 1.537 0.465 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.656 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -74.4 146.92 36.0 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.593 2.195 . . . . 0.0 112.411 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 78.8 t -94.44 120.14 43.42 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-O 121.002 0.429 . . . . 0.0 110.929 179.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.47 ' N ' ' CD1' ' A' ' 95' ' ' LEU . 10.6 mp -101.02 126.46 47.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.488 0.661 . . . . 0.0 110.962 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.54 ' O ' ' OG1' ' A' ' 109' ' ' THR . 87.2 tttt -64.07 -44.32 92.77 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.267 -0.879 . . . . 0.0 112.316 -178.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 4.2 m -85.59 130.83 34.48 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 121.039 0.447 . . . . 0.0 111.997 -179.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 3.5 p -90.64 59.04 4.1 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.547 179.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 3.3 m -92.72 164.74 13.26 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 179.077 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -58.21 -43.15 87.49 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 120.568 -0.453 . . . . 0.0 111.143 -179.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -64.96 -36.94 86.02 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.542 0.687 . . . . 0.0 110.009 178.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -64.4 -38.61 91.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.565 -179.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 96.9 mt -63.9 -11.97 32.72 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.913 -178.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 88.9 mt -73.95 -20.74 60.27 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.477 -0.489 . . . . 0.0 110.463 179.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 76.2 p -74.41 -4.77 38.5 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.169 -179.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 85.79 -19.25 26.15 Favored Glycine 0 CA--C 1.529 0.931 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.894 178.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -146.65 123.69 11.42 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.588 0.709 . . . . 0.0 111.804 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -146.21 137.15 24.38 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.159 178.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.54 ' OG1' ' O ' ' A' ' 96' ' ' LYS . 68.1 p -64.14 133.93 53.89 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.043 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 37.7 t -81.43 -56.92 5.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.29 0.567 . . . . 0.0 110.568 -179.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -93.07 128.44 38.97 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.988 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -67.01 -31.25 71.67 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 -177.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 72.4 m-80 -82.98 11.61 5.96 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 114.238 1.199 . . . . 0.0 114.238 -176.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . 0.461 ' OE1' ' N ' ' A' ' 122' ' ' ALA . 32.8 mt-30 -81.49 143.52 32.0 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.207 -0.597 . . . . 0.0 111.528 178.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 54.7 t -123.64 125.21 71.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.575 179.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' MET . . . . . 0.437 ' CG ' ' CZ ' ' A' ' 121' ' ' TYR . 97.3 mtp -57.58 130.43 46.31 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.99 0.424 . . . . 0.0 111.602 -179.313 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 80.64 -2.97 76.68 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 120.935 -0.65 . . . . 0.0 111.839 178.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 55.6 tttm -139.22 126.87 21.86 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.12 0.486 . . . . 0.0 110.655 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 74.86 -164.01 54.43 Favored Glycine 0 CA--C 1.529 0.962 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 -179.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 64.4 t-20 -92.7 106.79 18.71 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.978 0.418 . . . . 0.0 110.562 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.437 ' CZ ' ' CG ' ' A' ' 116' ' ' MET . 4.0 t80 -83.98 144.58 29.05 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.474 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.461 ' N ' ' OE1' ' A' ' 114' ' ' GLN . . . -146.83 140.3 25.66 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 119.777 -0.769 . . . . 0.0 112.575 -177.526 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.2 mp -139.09 144.74 38.86 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.509 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -108.51 139.9 42.6 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -144.6 159.36 27.77 Favored Glycine 0 CA--C 1.53 0.977 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 -179.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 60.5 m-70 -99.08 137.14 38.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.35 0.595 . . . . 0.0 111.932 -179.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 64.8 t-20 -131.69 120.2 22.43 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.941 179.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' MET . . . . . 0.529 ' CE ' HE21 ' A' ' 63' ' ' GLN . 64.1 mtt -92.88 -4.48 52.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.189 0.518 . . . . 0.0 111.021 -179.182 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.476 ' CB ' ' O ' ' A' ' 128' ' ' MET . 0.9 OUTLIER 79.25 11.75 1.35 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.846 -0.615 . . . . 0.0 112.149 179.03 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.527 ' O ' ' CG1' ' A' ' 133' ' ' VAL . 58.8 pttt -126.67 128.31 46.52 Favored 'General case' 0 C--O 1.222 -0.346 0 CA-C-O 122.1 0.952 . . . . 0.0 112.801 -179.574 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.482 ' O ' ' O ' ' A' ' 130' ' ' LYS . 29.5 tptt -37.54 162.64 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.833 -1.076 . . . . 0.0 110.289 178.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.47 ' H ' ' HG3' ' A' ' 131' ' ' LYS . . . 73.78 -24.18 1.02 Allowed Glycine 0 CA--C 1.529 0.911 0 N-CA-C 111.837 -0.505 . . . . 0.0 111.837 178.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.527 ' CG1' ' O ' ' A' ' 130' ' ' LYS . 2.9 p -91.16 175.86 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 O-C-N 122.325 -0.515 . . . . 0.0 111.535 -178.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.79 ' O ' ' N ' ' A' ' 136' ' ' SER . 3.9 mm? -60.11 167.09 2.49 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 121.209 0.528 . . . . 0.0 112.349 -177.61 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.7 m-30 22.4 21.01 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 113.947 -1.478 . . . . 0.0 113.868 178.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' SER . . . . . 0.79 ' N ' ' O ' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -64.37 -44.88 90.01 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 113.69 0.996 . . . . 0.0 113.69 -178.318 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . 0.406 ' O ' ' OG ' ' A' ' 140' ' ' SER . 81.1 m-20 -89.25 -3.88 58.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.98 0.419 . . . . 0.0 111.516 -178.178 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.462 HD11 HG21 ' A' ' 138' ' ' ILE . 0.2 OUTLIER -61.47 -40.69 87.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.569 179.697 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -65.26 -10.67 34.06 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 120.284 -0.567 . . . . 0.0 110.144 179.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.406 ' OG ' ' O ' ' A' ' 137' ' ' ASP . 5.9 p -85.34 -2.6 58.26 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.432 179.309 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 73.0 mt -63.39 143.44 57.81 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-O 121.203 0.525 . . . . 0.0 110.262 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.44 ' N ' ' OD2' ' A' ' 145' ' ' ASP . 89.0 tttt -119.41 155.0 32.81 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.44 0.638 . . . . 0.0 111.873 -178.442 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -50.75 133.74 25.71 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.424 179.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.56 ' N ' ' O ' ' A' ' 160' ' ' VAL . . . 79.33 7.95 88.13 Favored Glycine 0 CA--C 1.528 0.88 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.603 179.438 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.44 ' OD2' ' N ' ' A' ' 142' ' ' LYS . 77.2 m-20 -75.35 137.63 41.22 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 119.31 -0.956 . . . . 0.0 110.568 -179.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -79.12 139.99 37.92 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.526 -0.761 . . . . 0.0 112.799 -178.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.425 HG22 HD12 ' A' ' 147' ' ' ILE . 97.2 mt -139.12 137.52 41.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 114.762 -1.108 . . . . 0.0 108.346 178.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -123.65 137.58 54.7 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.022 -0.671 . . . . 0.0 112.556 -178.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -115.7 136.61 52.89 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 177.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -112.94 113.27 25.26 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 119.98 -0.688 . . . . 0.0 111.561 179.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . 0.589 ' OD1' ' N ' ' A' ' 152' ' ' ASN . 66.2 t0 -87.53 162.03 17.44 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 177.247 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . 0.589 ' N ' ' OD1' ' A' ' 151' ' ' ASP . 65.2 m-20 -55.37 -24.19 28.27 Favored 'General case' 0 C--N 1.315 -0.893 0 C-N-CA 119.337 -0.945 . . . . 0.0 110.047 -178.172 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -108.3 -30.16 8.49 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 113.699 1.0 . . . . 0.0 113.699 -177.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . 0.446 ' O ' ' N ' ' A' ' 151' ' ' ASP . 0.3 OUTLIER -148.93 -178.13 6.19 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 119.089 -1.044 . . . . 0.0 113.736 -177.328 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.43 144.33 51.33 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 114.478 -1.237 . . . . 0.0 110.05 178.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -120.97 139.89 52.63 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 120.972 0.415 . . . . 0.0 111.573 -178.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -96.43 115.65 27.77 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.564 179.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 50.1 m-85 -116.97 151.57 36.43 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.001 0.429 . . . . 0.0 111.416 179.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -124.45 124.82 43.14 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.132 179.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.56 ' O ' ' N ' ' A' ' 144' ' ' GLY . 96.4 t -60.08 136.62 23.51 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 178.103 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 7.6 p -105.1 -23.19 12.97 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.666 178.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 159.37 -168.13 35.22 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 120.488 -0.863 . . . . 0.0 111.969 179.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 15.0 p -137.73 146.72 26.98 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 179.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 28.3 m -142.3 172.03 13.24 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 120.955 0.407 . . . . 0.0 111.174 -179.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -111.26 125.74 54.15 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.477 0.656 . . . . 0.0 111.534 -179.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 30.6 m -137.36 164.74 28.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.559 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -82.69 158.73 65.08 Favored Pre-proline 0 CA--C 1.536 0.408 0 CA-C-O 121.047 0.451 . . . . 0.0 110.996 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . 0.486 ' O ' ' CB ' ' B' ' 702' ' ' LEU . 44.3 Cg_endo -67.05 -15.98 48.11 Favored 'Trans proline' 0 N--CA 1.497 1.679 0 C-N-CA 122.85 2.367 . . . . 0.0 111.6 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . 0.409 ' OD1' ' C ' ' A' ' 169' ' ' ASP . 40.9 p-10 -93.17 -6.43 47.83 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.911 179.652 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 16.7 mttm -74.64 82.65 2.05 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.46 0.648 . . . . 0.0 111.397 -179.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 21.9 t90 -73.12 -14.14 61.32 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.803 179.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.487 ' OE1' ' OE1' ' A' ' 175' ' ' GLU . 52.1 tp10 -58.58 -31.25 67.84 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 115.052 -0.976 . . . . 0.0 111.831 -179.386 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 28.2 m -64.2 -20.78 27.56 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 120.618 -0.433 . . . . 0.0 112.04 -178.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . 0.402 ' O ' ' CG1' ' A' ' 174' ' ' VAL . 49.5 t -98.74 -9.11 9.0 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -178.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.487 ' OE1' ' OE1' ' A' ' 172' ' ' GLU . 98.1 mt-10 -74.86 148.28 40.34 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 121.394 0.616 . . . . 0.0 111.585 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 46.6 p-10 -60.2 141.6 55.74 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.363 -179.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' HIS . . . . . 0.482 ' CE1' ' O ' ' A' ' 175' ' ' GLU . 80.5 m80 -117.67 16.85 14.49 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.537 -179.656 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 66.51 39.08 93.9 Favored Glycine 0 CA--C 1.532 1.102 0 N-CA-C 111.361 -0.696 . . . . 0.0 111.361 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 15.7 ptmt -163.26 167.1 22.4 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.997 -0.372 . . . . 0.0 109.997 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -87.05 92.31 9.0 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 178.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . 0.421 ' HG2' ' N ' ' A' ' 182' ' ' ILE . 82.9 tt0 -124.62 164.62 19.47 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.404 0.621 . . . . 0.0 111.441 -179.24 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.421 ' N ' ' HG2' ' A' ' 181' ' ' GLU . 18.1 tt -130.7 138.61 53.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.286 178.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 85.9 m -129.5 125.98 37.59 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 121.145 0.498 . . . . 0.0 111.877 -179.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 93.7 mt -109.53 130.59 55.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.874 178.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 83.0 mt -113.94 124.07 70.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.205 0.526 . . . . 0.0 111.287 -179.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' THR . . . . . 0.63 ' OG1' ' CZ ' ' A' ' 197' ' ' TYR . 0.1 OUTLIER -139.51 167.48 21.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.558 -0.747 . . . . 0.0 110.142 179.448 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' CYS . . . . . . . . . . . . . 8.9 m -95.49 142.2 28.12 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 45.2 t -60.66 -44.39 96.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 120.641 -0.424 . . . . 0.0 110.74 -179.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' SER . . . . . 0.4 ' HG ' ' H ' ' A' ' 191' ' ' LYS . 47.5 t -166.64 148.69 6.46 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.163 -0.615 . . . . 0.0 111.613 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 10.9 p -65.2 -22.35 31.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.403 179.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . 0.4 ' H ' ' HG ' ' A' ' 189' ' ' SER . 98.9 mttt -92.93 -13.28 29.06 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.598 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . 0.412 ' OD1' ' OG ' ' A' ' 194' ' ' SER . 66.8 t0 -143.67 98.32 3.22 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 121.179 0.514 . . . . 0.0 110.938 179.403 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -103.83 9.16 37.03 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.592 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' SER . . . . . 0.412 ' OG ' ' OD1' ' A' ' 192' ' ' ASP . 89.3 p -59.67 -33.82 72.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.018 -179.438 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -130.77 146.48 52.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.258 0.551 . . . . 0.0 110.925 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -125.36 135.42 52.42 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.28 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . 0.63 ' CZ ' ' OG1' ' A' ' 186' ' ' THR . 35.6 p90 -98.22 151.06 20.85 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.402 -0.519 . . . . 0.0 110.309 179.393 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 53.0 t -127.05 133.32 68.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.287 0.565 . . . . 0.0 111.549 -179.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 42.1 t -107.48 130.29 59.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.211 178.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -119.55 152.25 37.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.463 0.649 . . . . 0.0 111.976 -178.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . 0.41 ' H ' HG22 ' A' ' 182' ' ' ILE . . . -138.98 151.58 21.81 Favored Glycine 0 CA--C 1.533 1.175 0 N-CA-C 110.593 -1.003 . . . . 0.0 110.593 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . 0.552 ' OD1' ' N ' ' A' ' 203' ' ' LEU . 67.1 t0 -113.77 137.39 51.71 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 120.877 0.37 . . . . 0.0 111.182 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . 0.552 ' N ' ' OD1' ' A' ' 202' ' ' ASP . 53.6 tp -59.96 131.57 51.26 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 86.0 t -112.85 -19.78 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.969 -179.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -178.6 174.49 46.68 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 120.92 -0.657 . . . . 0.0 111.801 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 26.9 m -138.81 132.31 30.39 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -142.71 116.4 9.22 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.526 0.679 . . . . 0.0 112.239 -179.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -63.55 144.88 56.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.328 -0.851 . . . . 0.0 112.139 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 23.6 ttpt -78.68 109.6 13.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.528 178.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 59.2 pttt . . . . . 0 C--O 1.218 -0.565 0 CA-C-O 118.207 -0.901 . . . . 0.0 110.082 178.998 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 702' ' ' LEU . . . . . 0.486 ' CB ' ' O ' ' A' ' 168' ' ' PRO . 1.3 mt . . . . . 0 CA--C 1.542 0.663 0 CA-C-O 120.67 0.272 . . . . 20.0 111.416 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 703' ' ' PRO . . . . . 0.579 ' O ' ' O ' ' B' ' 704' ' ' ALA . 4.0 Cg_exo -64.8 -170.04 0.13 Allowed 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 121.97 1.78 . . . . 20.0 113.562 -179.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 704' ' ' ALA . . . . . 0.579 ' O ' ' O ' ' B' ' 703' ' ' PRO . . . . . . . . 0 CA--C 1.531 0.224 0 CA-C-N 114.256 -1.338 . . . . 20.0 113.458 -179.099 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.35 0 CA-C-O 121.026 0.441 . . . . 0.0 111.359 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.48 ' CB ' ' O ' ' B' ' 702' ' ' LEU . 3.9 p -82.01 21.07 0.91 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.123 -0.489 . . . . 0.0 112.073 -179.145 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 58.4 mtpt -106.73 23.67 13.93 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.137 0.494 . . . . 0.0 111.449 -179.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.6 mt -55.62 136.67 17.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 122.227 1.013 . . . . 0.0 112.189 -177.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -76.88 131.68 38.72 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 113.783 -1.553 . . . . 0.0 108.266 178.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.712 ' N ' HE21 ' A' ' 63' ' ' GLN . 0.0 OUTLIER -77.11 148.7 78.67 Favored Pre-proline 0 C--N 1.325 -0.469 0 C-N-CA 120.363 -0.535 . . . . 0.0 110.622 -178.679 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.541 ' CB ' ' OE1' ' A' ' 68' ' ' GLU . 65.2 Cg_endo -70.79 163.29 39.62 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 123.291 2.661 . . . . 0.0 113.878 -178.705 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -58.58 168.63 1.11 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.001 -1.0 . . . . 0.0 111.434 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 96.0 mt -70.36 -15.04 62.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.291 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -69.72 -40.3 76.32 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.346 0.593 . . . . 0.0 110.658 178.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.569 ' O ' ' N ' ' A' ' 72' ' ' ALA . 82.2 tt0 -66.42 -28.84 68.93 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.464 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 59.8 t -69.73 -45.29 77.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.288 179.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.42 -10.78 59.74 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.658 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -116.12 -2.81 12.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.299 0.571 . . . . 0.0 110.429 179.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.569 ' N ' ' O ' ' A' ' 68' ' ' GLU . . . -68.9 -172.34 0.38 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.712 0.767 . . . . 0.0 112.085 -178.598 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.6 p -101.4 104.38 15.35 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.016 178.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 42.8 tp -70.22 129.62 39.85 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.273 0.559 . . . . 0.0 111.503 -178.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -118.99 77.39 1.18 Allowed 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 177.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -84.46 -35.8 22.74 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.297 -0.865 . . . . 0.0 112.542 -179.368 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.404 ' H ' ' HG2' ' A' ' 77' ' ' LYS . 50.1 mmtt -75.03 -11.45 60.1 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.0 0.429 . . . . 0.0 111.132 -177.438 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -91.93 -0.51 57.5 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.09 0.471 . . . . 0.0 110.459 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 9.5 p -76.86 128.5 37.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.147 0.498 . . . . 0.0 110.941 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 18.2 pt -106.55 -8.33 10.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.307 0.575 . . . . 0.0 110.066 179.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -171.19 169.38 42.43 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 109.894 -1.283 . . . . 0.0 109.894 179.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 33.7 ptt-85 -146.71 154.58 41.59 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.364 0.602 . . . . 0.0 112.01 -179.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 19.0 tt -103.69 141.63 19.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.645 -179.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 47.9 t -136.7 129.87 31.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.671 -179.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.4 HD13 HG21 ' A' ' 85' ' ' ILE . 93.7 mt -138.07 87.25 16.53 Favored Pre-proline 0 CA--C 1.535 0.381 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.839 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_exo -56.64 -30.76 84.86 Favored 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 122.801 2.334 . . . . 0.0 112.034 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 44.2 m -53.27 -42.09 66.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.75 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.447 HG12 ' HG ' ' A' ' 140' ' ' SER . 17.6 m -114.25 11.23 7.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.719 179.675 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.511 ' O ' ' OG ' ' A' ' 89' ' ' SER . 1.6 p 51.31 51.29 17.18 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.128 179.686 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 59.0 tp -119.14 133.67 55.65 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 121.375 0.607 . . . . 0.0 111.183 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -147.09 124.94 11.91 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.102 179.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 78.0 mt -149.55 146.73 21.33 Favored Pre-proline 0 CA--C 1.539 0.524 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.341 -179.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -74.17 145.11 34.44 Favored 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 122.555 2.17 . . . . 0.0 111.389 178.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 18.3 t -96.41 120.18 45.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-O 121.137 0.494 . . . . 0.0 112.091 -179.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.474 ' N ' ' CD1' ' A' ' 95' ' ' LEU . 10.2 mp -102.67 138.71 39.21 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.735 179.376 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.518 ' O ' ' OG1' ' A' ' 109' ' ' THR . 98.2 mttt -62.12 -82.22 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.372 0.606 . . . . 0.0 112.104 -179.163 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 31.3 m -56.89 134.55 55.52 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.587 -178.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 74.0 p -92.27 70.23 5.21 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.791 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.714 ' HG1' ' H ' ' A' ' 102' ' ' ASN . 63.2 p -92.73 170.44 9.71 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.537 178.8 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -60.75 -43.07 98.42 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 178.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -65.75 -41.68 91.84 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.496 179.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.714 ' H ' ' HG1' ' A' ' 99' ' ' THR . 8.9 m120 -64.49 -37.47 87.64 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.989 -179.324 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 74.4 mt -64.71 -14.37 58.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.042 -0.526 . . . . 0.0 112.062 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 94.8 mt -72.42 -28.43 62.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.986 0.422 . . . . 0.0 111.317 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 86.8 p -73.42 -3.98 30.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.393 0.616 . . . . 0.0 109.813 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 92.29 -18.52 54.1 Favored Glycine 0 CA--C 1.533 1.209 0 CA-C-N 115.432 -0.804 . . . . 0.0 113.946 177.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -145.47 128.16 16.21 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 118.294 1.047 . . . . 0.0 113.147 -178.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -145.67 140.95 27.66 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 114.924 -1.034 . . . . 0.0 110.087 178.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.518 ' OG1' ' O ' ' A' ' 96' ' ' LYS . 30.2 p -68.6 140.25 55.55 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.311 0.577 . . . . 0.0 111.443 -179.17 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 71.6 t -79.88 -58.17 4.22 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 CA-C-N 115.723 -0.672 . . . . 0.0 111.539 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.57 ' H ' ' NE2' ' A' ' 114' ' ' GLN . 68.5 mmtt -105.06 138.69 40.87 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 121.862 0.839 . . . . 0.0 111.838 179.488 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -65.74 -30.36 71.01 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 114.848 -1.069 . . . . 0.0 113.071 -178.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -79.83 13.93 1.96 Allowed 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.373 -0.531 . . . . 0.0 112.283 -178.129 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . 0.57 ' NE2' ' H ' ' A' ' 111' ' ' LYS . 33.6 mt-30 -81.02 134.04 35.6 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 120.928 0.394 . . . . 0.0 111.599 179.336 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.408 ' O ' ' O ' ' A' ' 118' ' ' LYS . 72.4 t -125.73 126.11 69.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 178.351 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 96.1 mtp -57.15 131.18 49.18 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 121.092 0.472 . . . . 0.0 111.903 -179.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 78.75 -3.55 63.87 Favored Glycine 0 CA--C 1.531 1.033 0 N-CA-C 111.685 -0.566 . . . . 0.0 111.685 179.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.408 ' O ' ' O ' ' A' ' 115' ' ' VAL . 64.6 tttm -139.18 126.43 21.4 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.221 0.534 . . . . 0.0 110.924 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 77.16 -170.45 55.1 Favored Glycine 0 CA--C 1.531 1.039 0 N-CA-C 111.181 -0.767 . . . . 0.0 111.181 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 60.9 t-20 -87.82 104.94 17.06 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.953 0.406 . . . . 0.0 110.296 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -88.43 99.14 12.04 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 120.955 0.407 . . . . 0.0 110.574 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.433 ' N ' ' OE1' ' A' ' 114' ' ' GLN . . . -91.83 137.68 32.16 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.101 0.477 . . . . 0.0 111.314 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 78.9 mt -134.99 139.7 45.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.816 179.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -115.52 144.91 43.16 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-O 121.324 0.583 . . . . 0.0 110.757 -179.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -142.08 -162.17 9.09 Favored Glycine 0 CA--C 1.532 1.094 0 N-CA-C 110.154 -1.178 . . . . 0.0 110.154 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . 0.526 ' O ' ' O ' ' A' ' 134' ' ' LEU . 91.5 m-70 -134.6 160.24 38.71 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.411 0.624 . . . . 0.0 111.981 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . 0.44 ' OD1' ' N ' ' A' ' 129' ' ' SER . 28.7 t30 -142.12 120.23 12.16 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.275 179.219 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' MET . . . . . 0.476 ' O ' ' CB ' ' A' ' 129' ' ' SER . 61.8 mtt -96.23 -5.31 40.69 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.446 0.641 . . . . 0.0 109.757 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.476 ' CB ' ' O ' ' A' ' 128' ' ' MET . 1.1 p 78.72 17.07 1.04 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.206 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.507 ' O ' ' CG1' ' A' ' 133' ' ' VAL . 7.6 ptpt -125.76 116.87 22.29 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 121.833 0.825 . . . . 0.0 112.827 -179.01 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -45.71 130.39 9.16 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.212 179.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 109.08 -16.92 32.48 Favored Glycine 0 N--CA 1.444 -0.826 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 -179.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.507 ' CG1' ' O ' ' A' ' 130' ' ' LYS . 7.2 p -90.88 160.27 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.178 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.544 ' H ' ' CD1' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -70.69 141.95 51.56 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 115.016 1.487 . . . . 0.0 115.016 -177.122 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 59.67 9.37 1.58 Allowed 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 112.922 -1.944 . . . . 0.0 115.008 177.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 12.9 p -70.42 -30.29 67.12 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 120.041 -0.664 . . . . 0.0 112.125 179.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . 0.485 ' O ' ' OG ' ' A' ' 140' ' ' SER . 77.2 m-20 -90.59 -0.54 57.72 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 113.296 0.851 . . . . 0.0 113.296 -177.726 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 2.4 pp -58.67 -33.6 49.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 120.362 -0.535 . . . . 0.0 111.106 -179.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -66.44 -13.22 60.45 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.066 0.46 . . . . 0.0 110.954 -179.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.485 ' OG ' ' O ' ' A' ' 137' ' ' ASP . 67.0 p -83.55 -4.54 58.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.099 -179.644 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 88.9 mt -63.98 141.06 58.91 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 121.067 0.461 . . . . 0.0 110.047 179.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -117.03 154.79 30.33 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.462 0.648 . . . . 0.0 111.325 -179.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -47.42 133.7 12.46 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.849 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 160' ' ' VAL . . . 76.8 7.99 86.34 Favored Glycine 0 CA--C 1.53 0.979 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.81 178.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -70.9 135.2 47.85 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 119.832 -0.747 . . . . 0.0 110.587 -179.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -79.98 139.8 36.86 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.895 0.855 . . . . 0.0 112.354 -178.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 98.4 mt -136.48 137.51 47.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 177.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -124.29 138.13 54.42 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 119.708 -0.797 . . . . 0.0 113.061 -177.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 18.6 mt -110.72 133.13 53.6 Favored 'General case' 0 C--O 1.223 -0.3 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 177.368 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.547 ' CZ ' ' OE2' ' A' ' 155' ' ' GLU . 64.5 m-85 -109.77 107.63 17.69 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 119.957 -0.697 . . . . 0.0 111.06 179.462 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -89.19 164.43 14.98 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 178.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 69.6 m-20 -57.68 -22.72 47.65 Favored 'General case' 0 C--N 1.312 -1.034 0 C-N-CA 119.823 -0.751 . . . . 0.0 110.657 -178.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -113.21 -28.26 7.69 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 113.804 1.039 . . . . 0.0 113.804 -178.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -147.97 179.15 7.94 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 119.147 -1.021 . . . . 0.0 113.47 -176.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.547 ' OE2' ' CZ ' ' A' ' 150' ' ' TYR . 85.7 tt0 -126.58 135.69 51.57 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 114.35 -1.296 . . . . 0.0 110.002 178.466 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -109.67 132.83 53.78 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 121.157 0.503 . . . . 0.0 111.687 -179.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -94.0 112.04 23.83 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.789 -0.642 . . . . 0.0 111.943 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -114.13 148.71 36.75 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.013 0.435 . . . . 0.0 111.249 179.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -125.11 122.04 36.01 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 121.24 0.543 . . . . 0.0 110.752 179.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.544 ' O ' ' N ' ' A' ' 144' ' ' GLY . 59.9 t -60.44 137.33 22.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.7 178.3 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 81.0 p -108.8 -25.05 11.0 Favored 'General case' 0 N--CA 1.463 0.182 0 O-C-N 123.415 0.447 . . . . 0.0 111.534 179.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 159.31 -167.12 34.94 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 120.532 -0.842 . . . . 0.0 111.285 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 35.5 m -131.45 160.69 42.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.956 0.408 . . . . 0.0 110.145 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 22.8 p -141.41 162.6 35.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.439 0.637 . . . . 0.0 111.77 -178.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -103.17 115.17 30.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.577 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 17.1 m -136.77 161.78 35.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.316 0.579 . . . . 0.0 111.218 -179.027 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -86.98 157.99 53.64 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.817 -179.758 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . 0.455 ' O ' ' CB ' ' B' ' 702' ' ' LEU . 33.1 Cg_endo -64.81 -15.89 52.57 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 C-N-CA 122.996 2.464 . . . . 0.0 111.565 178.65 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . 0.46 ' O ' ' CD1' ' A' ' 171' ' ' TRP . 38.4 p-10 -96.62 -2.85 43.96 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.724 179.029 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 7.0 mttp -74.03 87.5 1.86 Allowed 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 121.433 0.635 . . . . 0.0 110.994 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' TRP . . . . . 0.514 ' CD1' ' N ' ' A' ' 171' ' ' TRP . 22.3 m0 -73.14 -14.42 61.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.1 -179.521 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -61.26 -27.04 68.17 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.825 -179.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 22.9 m -61.99 -23.85 32.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -178.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 23.3 m -107.96 -5.29 10.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -178.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -72.11 148.75 45.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.0 0.428 . . . . 0.0 110.317 179.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . 0.425 ' OD1' ' O ' ' A' ' 176' ' ' ASP . 44.1 p-10 -76.08 129.97 37.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.145 0.497 . . . . 0.0 110.957 -179.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 74.6 m80 -100.94 -17.1 16.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.781 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 104.05 36.68 3.1 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 110.109 -1.196 . . . . 0.0 110.109 -179.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -153.48 164.36 38.33 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.926 -0.637 . . . . 0.0 110.311 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -87.51 105.66 17.46 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 177.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . 0.403 ' HG2' ' N ' ' A' ' 182' ' ' ILE . 76.0 tt0 -138.79 161.69 36.61 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.507 0.67 . . . . 0.0 111.944 -177.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.403 ' N ' ' HG2' ' A' ' 181' ' ' GLU . 17.8 tt -128.99 136.92 58.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.142 178.454 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 70.9 m -129.25 123.69 32.58 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.109 0.481 . . . . 0.0 110.915 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 85.2 mt -109.47 131.71 54.81 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.349 0.595 . . . . 0.0 109.524 178.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 82.6 mt -112.46 124.38 69.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.134 -179.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 186' ' ' THR . . . . . 0.413 HG23 ' H ' ' A' ' 187' ' ' CYS . 90.8 m -138.11 156.87 47.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.152 -179.566 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 187' ' ' CYS . . . . . 0.413 ' H ' HG23 ' A' ' 186' ' ' THR . 17.4 m -87.66 139.52 30.45 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.594 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . 0.407 HG23 ' CE2' ' A' ' 197' ' ' TYR . 62.3 t -62.59 -46.86 95.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.731 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 189' ' ' SER . . . . . 0.715 ' HG ' ' H ' ' A' ' 191' ' ' LYS . 18.1 t -172.59 155.06 3.24 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.696 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 55.3 t -68.85 -17.07 21.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.395 179.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . 0.715 ' H ' ' HG ' ' A' ' 189' ' ' SER . 74.1 mmtt -98.88 -9.07 24.71 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.104 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 65.5 t0 -134.73 95.1 3.28 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.769 -0.373 . . . . 0.0 111.009 -179.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -105.98 5.89 30.81 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.135 0.493 . . . . 0.0 110.755 179.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 57.1 m -60.51 -40.9 93.09 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.484 -179.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -131.67 153.2 50.23 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.797 -0.361 . . . . 0.0 110.527 -179.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . 0.415 ' NH2' ' CD2' ' B' ' 702' ' ' LEU . 59.2 ttp180 -131.27 125.92 34.07 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 120.806 -0.358 . . . . 0.0 110.175 179.442 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . 0.407 ' CE2' HG23 ' A' ' 188' ' ' VAL . 29.2 m-85 -87.76 142.7 27.62 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.166 0.508 . . . . 0.0 110.759 -179.336 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 43.2 t -122.04 130.16 74.8 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.648 179.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 50.4 t -99.57 132.98 44.0 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.516 -179.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -118.9 149.21 41.96 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 121.166 0.508 . . . . 0.0 111.39 -179.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -145.34 146.09 15.99 Favored Glycine 0 CA--C 1.534 1.256 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -105.57 143.55 33.58 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 121.062 0.458 . . . . 0.0 111.954 -179.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 38.5 tp -65.97 132.04 47.65 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 178.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 2.1 p -112.38 -19.49 6.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 120.471 -0.492 . . . . 0.0 111.598 -179.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -179.82 173.98 45.57 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 120.497 -0.858 . . . . 0.0 112.038 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 90.8 m -142.31 139.19 31.75 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 179.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -144.03 118.36 9.61 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 120.152 -0.619 . . . . 0.0 111.233 179.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -64.19 143.28 58.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.824 -179.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 48.9 mtpt -81.64 107.7 14.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.57 178.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 20.0 pttp . . . . . 0 C--N 1.326 -0.426 0 CA-C-O 117.942 -1.027 . . . . 0.0 110.399 179.814 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 702' ' ' LEU . . . . . 0.48 ' O ' ' CB ' ' A' ' 59' ' ' SER . 2.1 mt . . . . . 0 CA--C 1.538 0.512 0 N-CA-C 110.577 -0.157 . . . . 20.0 110.577 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 703' ' ' PRO . . . . . 0.53 ' O ' ' O ' ' B' ' 704' ' ' ALA . 3.7 Cg_exo -62.93 -160.92 0.03 OUTLIER 'Trans proline' 0 N--CA 1.488 1.199 0 C-N-CA 122.303 2.002 . . . . 20.0 113.836 -179.372 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 704' ' ' ALA . . . . . 0.53 ' O ' ' O ' ' B' ' 703' ' ' PRO . . . . . . . . 0 C--N 1.327 -0.373 0 CA-C-N 114.04 -1.436 . . . . 20.0 114.708 -178.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.217 0 CA-C-O 120.894 0.378 . . . . 0.0 111.919 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.517 ' CB ' ' O ' ' B' ' 702' ' ' LEU . 93.0 p -80.35 20.07 0.72 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.955 0.407 . . . . 0.0 111.56 -179.407 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -102.69 12.72 35.93 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.633 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.1 mt -56.17 142.31 11.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 122.197 0.999 . . . . 0.0 113.078 -177.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 51.1 t0 -78.27 125.91 30.03 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 113.983 -1.462 . . . . 0.0 109.438 179.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.433 HE22 ' HB2' ' A' ' 103' ' ' LEU . 0.1 OUTLIER -79.23 128.65 75.1 Favored Pre-proline 0 C--N 1.325 -0.469 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 -179.875 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -52.37 149.87 21.88 Favored 'Trans proline' 0 N--CA 1.486 1.043 0 C-N-CA 121.307 1.338 . . . . 0.0 112.097 -179.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -51.94 175.62 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.624 0.726 . . . . 0.0 111.923 -178.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.456 ' N ' ' CD1' ' A' ' 66' ' ' LEU . 10.9 mp -70.17 -10.08 57.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.695 -178.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -67.19 -34.39 77.41 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.547 0.689 . . . . 0.0 110.007 178.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.491 ' O ' ' CB ' ' A' ' 72' ' ' ALA . 78.9 mm-40 -77.53 -20.95 53.4 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.26 -179.58 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 96.7 t -71.31 -46.58 64.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.316 0.579 . . . . 0.0 110.69 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -89.11 -10.58 46.8 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.876 -179.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -105.42 -26.16 12.06 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 120.465 -0.494 . . . . 0.0 112.132 -179.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.491 ' CB ' ' O ' ' A' ' 68' ' ' GLU . . . -68.28 136.59 53.72 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.728 0.775 . . . . 0.0 112.31 -179.02 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 7.8 m -59.82 102.8 0.17 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.133 179.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -68.62 129.15 39.1 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.104 0.478 . . . . 0.0 110.777 -179.685 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -98.02 80.48 2.72 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.171 0.51 . . . . 0.0 110.443 179.16 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -62.56 -36.57 83.07 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.311 0.577 . . . . 0.0 111.314 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.508 ' CD ' ' H ' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -70.2 -18.39 63.18 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.415 -177.062 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -90.61 0.61 57.31 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 121.239 0.542 . . . . 0.0 110.029 179.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 75.4 t -87.76 128.37 40.26 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.981 179.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 39.6 pt -111.4 -5.13 11.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.846 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -166.03 168.35 39.73 Favored Glycine 0 CA--C 1.535 1.31 0 C-N-CA 120.56 -0.829 . . . . 0.0 112.061 -179.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 61.7 ttp180 -137.85 154.91 49.45 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 121.127 0.489 . . . . 0.0 111.272 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 14.6 tt -119.52 140.65 42.78 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.955 178.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 47.5 t -136.26 130.45 33.06 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.378 0.609 . . . . 0.0 111.813 -178.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 57.2 mt -136.91 86.07 21.87 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.839 179.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -56.34 -31.97 86.8 Favored 'Trans proline' 0 N--CA 1.497 1.706 0 C-N-CA 123.076 2.517 . . . . 0.0 112.666 -179.057 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 70.9 m -53.83 -41.24 67.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.275 0.559 . . . . 0.0 110.76 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.2 m -113.78 12.83 8.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.032 178.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.7 m 48.26 48.8 18.47 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.421 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 64.5 tp -114.04 133.27 55.63 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.949 -179.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -148.07 127.51 13.15 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.862 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 90.2 mt -151.55 151.09 28.12 Favored Pre-proline 0 N--CA 1.471 0.61 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.563 -179.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -75.62 147.42 31.65 Favored 'Trans proline' 0 N--CA 1.495 1.601 0 C-N-CA 122.713 2.275 . . . . 0.0 111.712 178.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 49.6 t -97.15 119.17 44.85 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-O 121.19 0.519 . . . . 0.0 111.896 -179.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.475 ' N ' ' CD1' ' A' ' 95' ' ' LEU . 10.0 mp -104.69 141.08 37.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.527 179.182 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.51 ' O ' ' OG1' ' A' ' 109' ' ' THR . 98.5 mttt -64.37 -84.88 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -178.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.498 ' HG ' ' ND2' ' A' ' 102' ' ' ASN . 82.5 p -62.75 142.27 58.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.177 0.513 . . . . 0.0 111.502 -178.466 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 46.8 m -97.13 76.14 2.64 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.244 -179.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.443 ' CG2' ' N ' ' A' ' 100' ' ' GLU . 52.2 m -92.53 168.27 11.37 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 178.485 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.443 ' N ' ' CG2' ' A' ' 99' ' ' THR . 78.2 tt0 -57.53 -44.73 85.32 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 119.686 -0.806 . . . . 0.0 110.118 -179.532 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -62.93 -41.89 99.63 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.497 179.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.498 ' ND2' ' HG ' ' A' ' 97' ' ' SER . 98.4 m-20 -63.41 -36.66 84.46 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.681 -178.638 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.433 ' HB2' HE22 ' A' ' 63' ' ' GLN . 89.8 mt -63.26 -21.97 66.58 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.302 -0.408 . . . . 0.0 112.097 -179.224 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 96.6 mt -70.17 -23.0 62.91 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.899 0.38 . . . . 0.0 110.309 179.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 6.1 m -72.5 -10.28 59.6 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 121.271 0.558 . . . . 0.0 110.036 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 90.99 -18.23 51.98 Favored Glycine 0 CA--C 1.531 1.075 0 CA-C-N 115.642 -0.708 . . . . 0.0 113.43 177.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -145.03 124.9 13.42 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 119.418 -0.913 . . . . 0.0 112.688 -179.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -147.45 141.49 25.99 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.043 -0.98 . . . . 0.0 109.883 178.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.51 ' OG1' ' O ' ' A' ' 96' ' ' LYS . 19.0 p -69.33 136.51 51.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.243 0.544 . . . . 0.0 111.568 -179.161 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 69.4 t -75.76 -45.8 37.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.394 179.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -111.98 144.71 40.87 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 122.312 1.054 . . . . 0.0 113.11 179.273 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -66.69 -32.41 73.71 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.276 -1.329 . . . . 0.0 112.374 -178.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -85.34 18.82 2.51 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 -177.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . 0.497 ' OE1' ' O ' ' A' ' 120' ' ' ASN . 98.0 mm-40 -76.43 137.84 39.97 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 121.73 -0.606 . . . . 0.0 111.678 179.698 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 25.3 t -128.47 120.38 52.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.443 179.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' MET . . . . . 0.563 ' SD ' ' OD1' ' A' ' 151' ' ' ASP . 47.1 mtt -57.67 135.81 56.77 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.708 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.427 ' O ' ' OD2' ' A' ' 180' ' ' ASP . . . 75.15 -6.01 30.75 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 121.152 -0.546 . . . . 0.0 112.606 178.37 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -137.35 126.99 25.28 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.496 0.665 . . . . 0.0 111.436 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 77.18 -169.45 54.93 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 110.768 -0.933 . . . . 0.0 110.768 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . 0.497 ' O ' ' OE1' ' A' ' 114' ' ' GLN . 59.1 t-20 -87.97 106.34 18.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.997 0.427 . . . . 0.0 110.27 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -85.13 145.77 27.46 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 179.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -147.6 140.05 24.58 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.719 0.771 . . . . 0.0 111.587 -179.023 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 71.3 mt -137.62 144.14 41.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.475 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -106.88 136.85 46.02 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.051 0.453 . . . . 0.0 109.826 179.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -144.77 131.99 4.54 Favored Glycine 0 CA--C 1.532 1.143 0 N-CA-C 110.233 -1.147 . . . . 0.0 110.233 -179.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . 0.522 ' O ' ' O ' ' A' ' 134' ' ' LEU . 0.5 OUTLIER -78.71 151.76 31.96 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -178.651 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 46.3 t30 -141.63 121.14 13.27 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 115.415 -0.812 . . . . 0.0 110.173 178.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' MET . . . . . 0.484 ' O ' ' CB ' ' A' ' 129' ' ' SER . 61.5 mtt -97.03 -3.25 41.78 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.104 0.478 . . . . 0.0 110.66 -179.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.484 ' CB ' ' O ' ' A' ' 128' ' ' MET . 1.2 p 78.76 19.57 0.85 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.377 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.406 ' O ' ' C ' ' A' ' 131' ' ' LYS . 8.7 ptpt -123.29 104.94 9.44 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.964 0.888 . . . . 0.0 112.706 -178.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.406 ' C ' ' O ' ' A' ' 130' ' ' LYS . 29.4 tptp -34.58 125.23 0.52 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.269 -1.332 . . . . 0.0 111.067 179.451 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 109.5 -10.03 32.92 Favored Glycine 0 N--CA 1.449 -0.475 0 N-CA-C 108.973 -1.651 . . . . 0.0 108.973 -178.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 9.0 p -93.09 161.68 2.51 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.64 ' CD2' ' H ' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -69.76 139.46 53.3 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.78 0.8 . . . . 0.0 113.038 -177.686 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 63.17 9.1 3.69 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 114.434 -1.257 . . . . 0.0 113.297 178.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.18 -35.26 80.0 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -92.62 0.73 57.47 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 121.108 0.48 . . . . 0.0 111.623 -178.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.46 ' CG2' ' N ' ' A' ' 139' ' ' ALA . 3.4 tt -60.27 -37.72 74.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.069 -179.463 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.46 ' N ' ' CG2' ' A' ' 138' ' ' ILE . . . -65.99 -10.56 40.64 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.929 0.395 . . . . 0.0 111.148 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 5.8 m -82.53 -4.38 57.48 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.975 0.417 . . . . 0.0 111.126 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 76.6 mt -64.53 145.07 56.69 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 121.284 0.564 . . . . 0.0 111.258 -179.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -123.88 157.66 33.71 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.895 -179.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -50.14 134.59 22.07 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.519 -0.764 . . . . 0.0 112.085 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.604 ' N ' ' O ' ' A' ' 160' ' ' VAL . . . 77.02 7.39 86.65 Favored Glycine 0 CA--C 1.532 1.096 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.307 178.549 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -73.54 137.47 44.39 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 119.631 -0.828 . . . . 0.0 110.605 -179.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -81.16 140.48 34.97 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.667 0.746 . . . . 0.0 111.973 -178.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.412 HD11 HG23 ' A' ' 147' ' ' ILE . 88.3 mt -137.15 138.03 45.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 114.751 -1.113 . . . . 0.0 108.221 178.232 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -123.5 137.94 54.68 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 113.464 0.913 . . . . 0.0 113.464 -177.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -112.49 133.24 54.66 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 177.467 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.443 ' CZ ' ' OE2' ' A' ' 155' ' ' GLU . 58.7 m-85 -109.5 109.36 20.15 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.172 -0.611 . . . . 0.0 111.618 179.742 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . 0.563 ' OD1' ' SD ' ' A' ' 116' ' ' MET . 7.8 m-20 -89.53 166.61 13.55 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 177.439 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -58.6 -23.67 59.29 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 120.246 -0.581 . . . . 0.0 111.143 -178.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -109.78 -28.76 8.63 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -178.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -150.5 -174.95 4.91 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 -177.135 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.443 ' OE2' ' CZ ' ' A' ' 150' ' ' TYR . 86.8 tt0 -131.88 139.25 48.72 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 114.122 -1.399 . . . . 0.0 110.083 178.612 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -113.57 137.84 51.0 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 121.073 0.463 . . . . 0.0 111.648 -179.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -94.24 112.89 24.73 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.392 179.248 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -114.51 148.39 37.99 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 120.975 0.417 . . . . 0.0 111.436 179.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -121.5 121.37 37.35 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.446 179.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.604 ' O ' ' N ' ' A' ' 144' ' ' GLY . 97.4 t -59.97 137.2 22.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.942 177.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 24.1 p -105.68 -23.94 12.64 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 120.749 -0.38 . . . . 0.0 111.343 179.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 154.55 -161.67 30.3 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 120.649 -0.786 . . . . 0.0 111.355 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 25.3 m -132.58 162.41 39.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-O 120.832 0.348 . . . . 0.0 110.349 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 83.1 p -146.87 163.96 34.42 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.404 0.621 . . . . 0.0 111.518 -179.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -100.88 117.65 35.37 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.704 -179.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 16.4 m -137.8 158.79 33.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.235 0.54 . . . . 0.0 111.372 179.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -94.0 158.41 36.26 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.592 179.327 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . 0.458 ' O ' ' CB ' ' B' ' 702' ' ' LEU . 29.0 Cg_endo -61.9 -17.15 53.95 Favored 'Trans proline' 0 C--N 1.301 -1.949 0 C-N-CA 122.619 2.213 . . . . 0.0 113.555 -179.619 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 51.1 p-10 -93.02 -6.03 49.2 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 119.501 -0.879 . . . . 0.0 112.511 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -75.47 96.17 3.42 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 119.878 -0.729 . . . . 0.0 111.421 179.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' TRP . . . . . 0.432 ' CD1' ' N ' ' A' ' 171' ' ' TRP . 23.1 m0 -78.7 -15.46 58.44 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.817 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -58.28 -28.88 65.36 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.917 -179.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 10.5 p -62.39 -25.1 36.93 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 CA-C-O 121.031 0.444 . . . . 0.0 111.192 -179.237 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 59.6 t -105.56 -8.11 10.03 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -178.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.44 ' O ' ' CE1' ' A' ' 177' ' ' HIS . 96.7 mt-10 -73.49 144.2 46.3 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 122.08 -0.387 . . . . 0.0 110.663 179.72 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 34.0 p-10 -62.74 144.5 56.36 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.329 0.585 . . . . 0.0 111.661 -179.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' HIS . . . . . 0.44 ' CE1' ' O ' ' A' ' 175' ' ' GLU . 68.8 m80 -122.14 19.73 10.7 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.922 -179.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 64.7 39.06 96.4 Favored Glycine 0 CA--C 1.532 1.095 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 179.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 13.1 ptmt -161.67 166.93 26.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.858 0.361 . . . . 0.0 110.15 179.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . 0.427 ' OD2' ' O ' ' A' ' 117' ' ' GLY . 48.1 t0 -90.19 100.23 13.09 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.18 0.514 . . . . 0.0 110.195 178.625 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . 0.409 ' HG2' ' N ' ' A' ' 182' ' ' ILE . 84.1 tt0 -131.33 164.59 25.31 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.448 -179.062 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.409 ' N ' ' HG2' ' A' ' 181' ' ' GLU . 21.2 tt -128.18 137.26 57.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.928 179.251 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 94.3 m -124.64 122.44 37.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.061 -179.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 69.5 mt -111.35 128.99 56.14 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 178.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . 0.427 HG22 HD12 ' A' ' 185' ' ' ILE . 93.3 mt -110.09 123.67 66.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.397 0.618 . . . . 0.0 111.068 -179.267 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 3.6 t -138.95 158.82 43.51 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.825 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 187' ' ' CYS . . . . . . . . . . . . . 1.3 m -101.63 143.8 31.15 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.164 0.507 . . . . 0.0 111.247 -179.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 95.5 t -62.71 -47.6 92.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.691 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 189' ' ' SER . . . . . 0.686 ' HG ' ' H ' ' A' ' 191' ' ' LYS . 20.4 t -168.4 144.55 3.75 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.309 179.239 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 10.8 p -60.99 -6.28 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.138 0.494 . . . . 0.0 110.69 -179.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . 0.686 ' H ' ' HG ' ' A' ' 189' ' ' SER . 88.6 tttt -101.66 -35.43 9.11 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.848 179.527 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -99.11 110.14 22.76 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.476 -179.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -110.73 7.71 22.24 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.646 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 6.1 t -61.53 -47.18 86.75 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.995 0.426 . . . . 0.0 111.864 -178.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -146.82 158.78 44.0 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.919 -179.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 83.9 mtt85 -128.14 141.45 51.48 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.159 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -90.91 144.45 25.67 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 120.948 0.404 . . . . 0.0 110.844 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 39.4 t -127.42 133.94 66.82 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-O 121.361 0.601 . . . . 0.0 111.032 179.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 39.1 t -105.25 131.38 54.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.502 179.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -119.66 148.27 43.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.466 0.65 . . . . 0.0 111.588 -179.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -142.63 152.32 23.75 Favored Glycine 0 CA--C 1.533 1.16 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 179.296 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . 0.432 ' O ' ' OD1' ' A' ' 202' ' ' ASP . 52.7 p-10 -113.11 155.35 25.08 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.377 -0.529 . . . . 0.0 110.988 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 60.3 tp -74.3 130.22 39.28 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.314 -0.554 . . . . 0.0 109.562 179.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 16.9 m -116.6 -18.24 7.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 C-N-CA 120.371 -0.532 . . . . 0.0 111.357 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -179.98 174.65 46.05 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 120.419 -0.896 . . . . 0.0 112.304 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 40.4 m -140.61 136.59 32.91 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.486 -0.357 . . . . 0.0 110.219 179.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 51.6 mttp -141.25 114.62 8.78 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.29 -0.564 . . . . 0.0 111.996 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -64.43 145.81 55.5 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.335 0.588 . . . . 0.0 111.076 179.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 21.2 ttpt -81.07 112.44 18.45 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.616 178.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 98.7 mttt . . . . . 0 C--O 1.22 -0.457 0 CA-C-O 118.027 -0.987 . . . . 0.0 110.675 -179.879 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 702' ' ' LEU . . . . . 0.517 ' O ' ' CB ' ' A' ' 59' ' ' SER . 1.0 OUTLIER . . . . . 0 CA--C 1.541 0.611 0 N-CA-C 110.193 -0.299 . . . . 20.0 110.193 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 703' ' ' PRO . . . . . 0.527 ' O ' ' O ' ' B' ' 704' ' ' ALA . 4.0 Cg_exo -63.0 -174.4 0.18 Allowed 'Trans proline' 0 N--CA 1.492 1.441 0 C-N-CA 122.125 1.884 . . . . 20.0 113.896 -178.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 704' ' ' ALA . . . . . 0.527 ' O ' ' O ' ' B' ' 703' ' ' PRO . . . . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 114.084 -1.416 . . . . 20.0 113.26 -178.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.144 0 CA-C-O 121.237 0.541 . . . . 0.0 110.991 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.489 ' CB ' ' O ' ' B' ' 702' ' ' LEU . 52.1 p -80.65 17.64 1.1 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.532 -179.146 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 59.1 pttt -105.68 21.11 17.81 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.162 0.505 . . . . 0.0 111.334 -179.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.0 mt -56.59 139.47 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-O 122.366 1.079 . . . . 0.0 113.141 -177.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.448 ' OD1' ' N ' ' A' ' 62' ' ' ASP . 24.6 p-10 -76.84 130.08 37.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 113.576 -1.647 . . . . 0.0 109.819 179.028 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.508 ' NE2' ' O ' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -77.19 151.56 81.42 Favored Pre-proline 0 C--N 1.325 -0.472 0 C-N-CA 120.148 -0.621 . . . . 0.0 110.437 -179.393 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -72.78 168.98 23.13 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.669 2.246 . . . . 0.0 111.729 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 -52.18 166.58 0.16 Allowed 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.102 0.477 . . . . 0.0 111.685 -178.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 56.8 tp -64.9 -46.88 79.88 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.459 -178.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.22 -39.33 94.33 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.502 -0.479 . . . . 0.0 111.618 -178.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -57.13 -25.38 58.74 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.02 -0.672 . . . . 0.0 109.745 179.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.467 ' CG1' ' O ' ' A' ' 104' ' ' LEU . 20.0 t -79.42 -45.64 23.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.463 179.542 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -77.06 -9.43 58.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 114.837 -1.074 . . . . 0.0 111.796 -179.153 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 24.5 m120 -103.56 -14.24 16.25 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.371 0.605 . . . . 0.0 110.097 179.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -69.06 145.32 53.58 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.374 -0.83 . . . . 0.0 112.027 -179.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 25.9 p -59.5 104.04 0.24 Allowed 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 121.701 0.762 . . . . 0.0 111.033 -179.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.66 130.52 42.6 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.008 -0.996 . . . . 0.0 111.315 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.518 ' OD2' ' NE2' ' A' ' 78' ' ' GLN . 59.8 t0 -104.38 77.46 1.4 Allowed 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 121.168 0.509 . . . . 0.0 110.64 178.411 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -69.3 -31.11 69.38 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.898 -0.592 . . . . 0.0 112.31 179.049 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 41.0 mmtt -67.6 -29.16 68.43 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -175.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.518 ' NE2' ' OD2' ' A' ' 75' ' ' ASP . 76.7 mt-30 -88.63 -1.66 58.19 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 120.324 -0.551 . . . . 0.0 111.258 -179.703 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 53.3 t -72.72 128.91 35.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.038 178.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 36.0 pt -113.94 -4.4 11.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 C-N-CA 120.671 -0.411 . . . . 0.0 112.045 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -164.74 169.96 39.65 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 120.214 -0.993 . . . . 0.0 111.629 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 62.6 ttp180 -142.84 141.59 31.63 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.36 0.6 . . . . 0.0 111.573 -179.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 19.5 tt -103.2 140.33 21.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.263 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.408 ' HB3' ' HH ' ' A' ' 150' ' ' TYR . 47.3 t -135.6 129.95 33.68 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.274 -0.875 . . . . 0.0 111.156 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 96.7 mt -140.49 93.93 8.6 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 114.702 -1.135 . . . . 0.0 109.608 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -66.46 -22.95 51.23 Favored 'Trans proline' 0 N--CA 1.493 1.457 0 C-N-CA 121.574 1.516 . . . . 0.0 113.027 -178.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' SER . . . . . 0.628 ' HG ' ' N ' ' A' ' 88' ' ' VAL . 94.4 p -55.23 -42.26 73.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.186 0.517 . . . . 0.0 110.215 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.628 ' N ' ' HG ' ' A' ' 87' ' ' SER . 31.7 m -114.03 5.4 7.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.416 0.627 . . . . 0.0 110.294 179.046 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 2.4 m 56.12 52.57 10.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.779 179.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 54.6 tp -114.5 131.93 56.47 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.155 179.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -144.75 118.68 9.33 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.618 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 91.1 mt -148.71 151.36 35.38 Favored Pre-proline 0 CA--C 1.538 0.495 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.628 -178.042 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -79.39 146.0 19.21 Favored 'Trans proline' 0 N--CA 1.492 1.399 0 C-N-CA 122.597 2.198 . . . . 0.0 111.31 178.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.455 ' O ' ' CG2' ' A' ' 94' ' ' VAL . 3.1 m -94.4 121.08 44.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-O 121.239 0.543 . . . . 0.0 111.269 179.614 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.476 ' N ' ' CD1' ' A' ' 95' ' ' LEU . 10.7 mp -100.24 139.65 35.6 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.604 -179.604 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.537 ' O ' ' OG1' ' A' ' 109' ' ' THR . 99.0 mttt -60.54 -91.1 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 121.427 0.632 . . . . 0.0 112.01 -179.263 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.462 ' HG ' ' ND2' ' A' ' 102' ' ' ASN . 6.5 p -58.87 143.39 47.77 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 121.617 0.722 . . . . 0.0 112.742 -178.258 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 87.5 p -92.39 69.94 5.08 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.037 -0.983 . . . . 0.0 111.284 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 62.8 p -91.39 168.34 11.63 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 178.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -62.58 -43.46 98.75 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 119.797 -0.761 . . . . 0.0 109.529 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -65.84 -40.79 92.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.872 179.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.462 ' ND2' ' HG ' ' A' ' 97' ' ' SER . 93.4 m-20 -64.2 -37.38 87.25 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.984 -179.455 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 54.7 mt -68.47 -8.4 40.57 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.951 -179.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.467 ' O ' ' CG1' ' A' ' 69' ' ' VAL . 96.1 mt -72.84 -23.19 60.73 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.814 0.34 . . . . 0.0 110.444 179.07 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 95.2 p -75.32 -2.94 30.66 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.143 0.497 . . . . 0.0 110.199 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 83.76 -13.01 50.43 Favored Glycine 0 CA--C 1.531 1.036 0 CA-C-N 115.632 -0.713 . . . . 0.0 113.384 178.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -145.02 126.1 14.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 117.467 0.634 . . . . 0.0 111.81 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -148.13 141.43 25.18 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.356 178.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.537 ' OG1' ' O ' ' A' ' 96' ' ' LYS . 36.3 p -64.67 138.1 58.2 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.432 0.634 . . . . 0.0 110.888 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 42.1 t -75.76 -24.74 17.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.624 -179.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -141.23 149.51 41.45 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 122.394 1.092 . . . . 0.0 112.43 178.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 77.8 mt-10 -65.35 -32.39 74.01 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.008 -1.451 . . . . 0.0 112.296 -178.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 21.9 m120 -82.06 10.98 5.64 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 113.083 0.772 . . . . 0.0 113.083 -177.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . 0.429 ' OE1' ' O ' ' A' ' 120' ' ' ASN . 86.5 mm-40 -77.08 132.5 38.93 Favored 'General case' 0 C--N 1.329 -0.285 0 O-C-N 121.955 -0.466 . . . . 0.0 110.667 179.174 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 56.4 t -123.94 124.68 69.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.519 0 CA-C-O 121.245 0.545 . . . . 0.0 110.78 179.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' MET . . . . . 0.671 ' SD ' ' CZ ' ' A' ' 121' ' ' TYR . 94.7 mmm -54.12 126.15 21.71 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -179.389 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 72.53 6.76 67.01 Favored Glycine 0 CA--C 1.531 1.092 0 CA-C-N 115.941 -0.572 . . . . 0.0 112.751 177.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -136.93 127.99 27.74 Favored 'General case' 0 C--N 1.328 -0.341 0 O-C-N 122.389 -0.477 . . . . 0.0 111.419 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 71.76 -164.19 54.18 Favored Glycine 0 CA--C 1.531 1.069 0 N-CA-C 110.388 -1.085 . . . . 0.0 110.388 -179.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . 0.429 ' O ' ' OE1' ' A' ' 114' ' ' GLN . 64.8 t-20 -87.59 103.4 15.52 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.48 -0.488 . . . . 0.0 109.794 179.266 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.671 ' CZ ' ' SD ' ' A' ' 116' ' ' MET . 17.4 t80 -86.79 145.95 26.42 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.76 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -147.49 143.39 27.82 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.735 0.779 . . . . 0.0 111.473 -179.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 42.9 mt -139.38 145.99 39.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.765 -179.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -110.66 139.64 45.75 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -136.27 144.92 16.79 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.314 -1.114 . . . . 0.0 110.314 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . 0.463 ' O ' ' O ' ' A' ' 134' ' ' LEU . 21.7 m-70 -88.49 150.69 22.99 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.881 0.372 . . . . 0.0 111.253 -179.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . 0.634 HD22 ' N ' ' A' ' 187' ' ' CYS . 41.5 p30 -146.71 152.57 39.04 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.226 0.536 . . . . 0.0 110.43 179.183 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' MET . . . . . 0.5 ' O ' ' CB ' ' A' ' 129' ' ' SER . 58.4 mtt -116.42 -2.29 12.08 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.166 -179.764 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.5 ' CB ' ' O ' ' A' ' 128' ' ' MET . 0.7 OUTLIER 80.18 5.75 1.76 Allowed 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.201 179.83 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.506 ' O ' ' CG1' ' A' ' 133' ' ' VAL . 8.5 ptpt -114.5 122.76 47.56 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.613 0.72 . . . . 0.0 112.479 -179.61 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 14.6 tmtt? -44.3 127.51 5.74 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.202 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 106.29 -11.08 43.6 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.506 ' CG1' ' O ' ' A' ' 130' ' ' LYS . 9.0 p -94.02 172.85 0.96 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.135 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.506 ' N ' ' CD2' ' A' ' 134' ' ' LEU . 3.8 mm? -68.76 133.09 47.86 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 116.165 1.913 . . . . 0.0 116.165 -176.48 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 53.69 16.19 0.94 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 113.524 -1.671 . . . . 0.0 114.291 176.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 5.3 t -68.94 -39.07 79.77 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -91.33 2.01 56.7 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 -176.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 28.4 pt -65.86 -22.88 31.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 119.073 -1.051 . . . . 0.0 109.922 -179.326 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -70.31 -8.64 51.97 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.194 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 33.6 t -83.04 -5.29 59.05 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.589 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 86.2 mt -63.26 147.79 50.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.808 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 99.9 mttt -124.25 158.89 31.43 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.438 0.637 . . . . 0.0 111.551 -178.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -49.9 131.3 22.5 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.048 179.044 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.569 ' N ' ' O ' ' A' ' 160' ' ' VAL . . . 80.43 9.01 86.99 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 120.408 -0.901 . . . . 0.0 112.273 178.379 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.492 ' OD1' ' N ' ' A' ' 146' ' ' LYS . 62.8 t0 -75.04 131.53 40.65 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 120.219 -0.592 . . . . 0.0 110.584 -179.302 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.492 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 74.8 mmtt -77.08 137.03 38.69 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 121.84 0.828 . . . . 0.0 112.232 -178.588 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.401 HD13 HG22 ' A' ' 147' ' ' ILE . 94.7 mt -138.61 140.17 39.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 114.529 -1.214 . . . . 0.0 108.574 178.345 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 -127.3 140.99 51.83 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 119.583 -0.847 . . . . 0.0 113.196 -177.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 1.4 mt -114.54 131.72 56.56 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 177.462 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.408 ' HH ' ' HB3' ' A' ' 84' ' ' SER . 7.7 m-85 -107.67 112.68 25.5 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 120.007 -0.677 . . . . 0.0 111.007 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . 0.557 ' OD1' ' N ' ' A' ' 152' ' ' ASN . 58.4 t0 -90.21 163.1 14.93 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 177.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . 0.557 ' N ' ' OD1' ' A' ' 151' ' ' ASP . 8.6 t30 -56.32 -22.58 31.6 Favored 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 119.629 -0.828 . . . . 0.0 110.966 -178.812 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -110.36 -29.2 8.22 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -178.012 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -148.73 -176.97 5.53 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 119.359 -0.936 . . . . 0.0 113.32 -176.293 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 65.4 mt-10 -131.44 136.36 47.9 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 114.758 -1.11 . . . . 0.0 109.538 179.147 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -111.3 135.84 51.26 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.149 0.499 . . . . 0.0 111.741 -179.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -92.65 112.59 24.6 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.4 179.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -114.96 147.05 40.55 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.007 0.432 . . . . 0.0 110.523 179.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -122.85 123.46 41.05 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.063 0.459 . . . . 0.0 110.776 179.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.569 ' O ' ' N ' ' A' ' 144' ' ' GLY . 84.5 t -58.24 134.43 23.01 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.036 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 78.0 p -118.08 11.38 13.29 Favored 'General case' 0 CA--C 1.534 0.357 0 O-C-N 123.658 0.599 . . . . 0.0 111.415 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 124.78 -175.26 17.18 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 120.747 -0.739 . . . . 0.0 111.895 179.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 28.5 m -128.15 160.88 37.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 179.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 68.2 m -135.98 159.67 40.98 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.571 0.7 . . . . 0.0 111.601 -179.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -105.31 116.09 31.35 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.596 -179.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 35.5 m -133.89 162.99 38.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.148 -179.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' THR . . . . . 0.458 ' H ' ' HD2' ' A' ' 170' ' ' LYS . 0.1 OUTLIER -91.99 163.99 25.31 Favored Pre-proline 0 CA--C 1.538 0.511 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.222 179.379 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . 0.459 ' O ' ' CB ' ' B' ' 702' ' ' LEU . 36.3 Cg_exo -61.09 -19.02 61.47 Favored 'Trans proline' 0 N--CA 1.502 1.982 0 C-N-CA 122.548 2.165 . . . . 0.0 113.479 179.447 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . 0.403 ' OD1' ' C ' ' A' ' 169' ' ' ASP . 41.0 p-10 -95.68 -6.33 40.21 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -178.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.458 ' HD2' ' H ' ' A' ' 167' ' ' THR . 96.6 mttt -76.46 82.92 3.17 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 119.392 -0.923 . . . . 0.0 111.396 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 67.0 p-90 -70.72 -10.2 58.91 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.949 0.881 . . . . 0.0 109.521 179.259 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -62.69 -31.85 72.83 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.771 -1.104 . . . . 0.0 111.158 -179.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 34.6 m -62.58 -17.35 18.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-N 116.047 -0.524 . . . . 0.0 112.397 -179.081 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 30.3 m -112.87 -2.56 10.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -178.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -74.98 165.82 24.66 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 121.103 0.477 . . . . 0.0 110.949 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . 0.494 ' OD1' ' O ' ' A' ' 176' ' ' ASP . 36.5 p30 -67.33 137.49 56.07 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.075 179.582 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' HIS . . . . . 0.428 ' ND1' ' ND2' ' A' ' 120' ' ' ASN . 40.7 m80 -119.01 13.53 13.02 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.559 -179.71 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 62.39 41.61 99.75 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 121.003 -0.618 . . . . 0.0 111.627 179.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 12.9 ptmt -163.35 168.11 20.87 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.998 0.428 . . . . 0.0 110.832 179.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -88.15 93.48 9.51 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 178.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . 0.423 ' HG2' ' N ' ' A' ' 182' ' ' ILE . 84.6 tt0 -131.88 163.66 27.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.43 0.633 . . . . 0.0 112.106 -178.511 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.423 ' N ' ' HG2' ' A' ' 181' ' ' GLU . 18.0 tt -130.78 138.09 54.44 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.036 178.805 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 80.4 m -130.72 124.63 31.94 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.135 -179.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 87.6 mt -109.21 135.51 50.19 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.65 178.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 92.1 mt -113.21 127.69 70.36 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 CA-C-O 121.129 0.49 . . . . 0.0 110.983 -179.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 186' ' ' THR . . . . . 0.511 ' OG1' ' ND2' ' A' ' 127' ' ' ASN . 13.6 t -139.77 156.81 46.56 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.623 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 187' ' ' CYS . . . . . 0.634 ' N ' HD22 ' A' ' 127' ' ' ASN . 2.3 m -93.19 143.68 26.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.388 0.613 . . . . 0.0 110.257 179.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 40.5 t -61.97 -46.99 95.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.429 -179.11 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 41.3 p -164.97 161.34 19.9 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.335 0.588 . . . . 0.0 110.903 -179.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 71.4 t -71.96 -13.08 16.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.321 179.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -97.71 -13.74 21.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.338 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -142.14 99.92 3.61 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.306 -0.558 . . . . 0.0 112.085 -179.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -103.78 11.35 35.91 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.577 178.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 41.1 m -63.64 -42.0 98.19 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.684 -179.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 43.3 mtmt -123.28 149.71 44.44 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.271 0.558 . . . . 0.0 111.183 -179.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 85.0 mtt85 -133.23 139.98 47.27 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.431 -179.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -91.41 155.24 18.61 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.153 0.502 . . . . 0.0 111.021 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 3.0 m -131.46 129.25 61.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.603 178.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 58.9 t -97.12 130.43 45.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 178.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -107.81 131.71 54.19 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.217 0.532 . . . . 0.0 111.205 -178.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -132.23 131.9 6.44 Favored Glycine 0 CA--C 1.53 1.008 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -103.07 143.17 32.94 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 121.238 0.542 . . . . 0.0 111.247 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 35.8 tp -69.5 133.52 47.8 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.897 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 4.1 p -116.52 -17.53 7.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.69 -179.103 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 179.19 174.45 45.32 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 120.588 -0.815 . . . . 0.0 111.775 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 72.6 m -145.54 140.81 27.72 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.111 -0.545 . . . . 0.0 110.009 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -145.52 119.59 9.43 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 119.943 -0.703 . . . . 0.0 111.511 179.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -63.72 145.05 56.49 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.318 -0.855 . . . . 0.0 112.442 -179.191 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 8.6 ttpt -79.38 106.67 11.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.47 178.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 98.5 mttt . . . . . 0 C--O 1.22 -0.451 0 CA-C-O 117.93 -1.033 . . . . 0.0 110.287 -179.752 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 702' ' ' LEU . . . . . 0.489 ' O ' ' CB ' ' A' ' 59' ' ' SER . 0.0 OUTLIER . . . . . 0 CA--C 1.542 0.671 0 N-CA-C 110.222 -0.288 . . . . 20.0 110.222 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 703' ' ' PRO . . . . . 0.507 ' O ' ' O ' ' B' ' 704' ' ' ALA . 3.8 Cg_exo -69.43 -173.39 0.66 Allowed 'Trans proline' 0 C--N 1.316 -1.158 0 C-N-CA 122.155 1.903 . . . . 20.0 112.202 179.76 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 704' ' ' ALA . . . . . 0.507 ' O ' ' O ' ' B' ' 703' ' ' PRO . . . . . . . . 0 C--N 1.321 -0.641 0 CA-C-N 114.962 -1.017 . . . . 20.0 113.506 -178.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.242 0 CA-C-O 121.479 0.656 . . . . 0.0 109.815 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 85.2 p -85.72 4.92 34.53 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.65 -179.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -104.49 16.21 26.56 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 -178.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.0 mt -56.05 144.78 7.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 122.337 1.065 . . . . 0.0 112.931 -177.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 59.8 t0 -79.04 125.17 29.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 113.614 -1.63 . . . . 0.0 109.578 178.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.428 ' HB2' ' CG ' ' A' ' 126' ' ' HIS . 7.2 tp60 -78.7 136.17 59.35 Favored Pre-proline 0 C--N 1.322 -0.616 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -61.42 159.29 32.11 Favored 'Trans proline' 0 C--N 1.311 -1.399 0 C-N-CA 121.725 1.616 . . . . 0.0 113.083 -179.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -52.0 162.25 0.48 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.473 -178.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.435 ' N ' ' CD1' ' A' ' 66' ' ' LEU . 9.9 mp -62.75 -44.34 96.46 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.964 -178.436 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.58 -36.72 84.72 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 119.768 -0.773 . . . . 0.0 110.18 -179.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -62.91 -33.71 75.91 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.889 0.852 . . . . 0.0 108.812 177.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 60.6 t -76.09 -45.65 35.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 114.607 -1.179 . . . . 0.0 110.923 179.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -72.31 -8.88 57.26 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.749 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -105.06 -10.54 17.11 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.631 0.729 . . . . 0.0 109.363 178.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.92 138.11 57.04 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.778 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 9.0 t -57.25 99.0 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.517 ' CD1' ' C ' ' A' ' 74' ' ' LEU . 3.2 tm? -65.16 120.21 12.27 Favored 'General case' 0 C--N 1.334 -0.087 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.368 -178.692 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.454 ' OD2' ' CD ' ' A' ' 78' ' ' GLN . 34.1 t0 -99.08 82.5 2.74 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.551 0.691 . . . . 0.0 111.616 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 47.8 tttp -65.31 -32.22 73.76 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.258 -0.883 . . . . 0.0 112.429 179.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 31.4 mmtt -68.19 -16.53 64.02 Favored 'General case' 0 C--N 1.314 -0.943 0 C-N-CA 119.997 -0.681 . . . . 0.0 110.972 -175.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.454 ' CD ' ' OD2' ' A' ' 75' ' ' ASP . 94.8 mt-30 -92.02 -5.91 52.07 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 121.087 0.47 . . . . 0.0 111.388 178.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 86.0 t -78.6 129.0 38.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.19 0.519 . . . . 0.0 110.192 179.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 5.3 pt -112.02 -4.47 11.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.107 -179.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -172.68 174.96 45.82 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 120.249 -0.977 . . . . 0.0 111.717 -179.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.583 ' NH2' ' OE1' ' A' ' 91' ' ' GLU . 75.1 ttt180 -136.4 154.9 50.67 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.362 0.601 . . . . 0.0 110.836 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 19.4 tt -123.8 141.4 44.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.167 -179.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 14.6 t -136.69 130.45 32.14 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 121.43 0.634 . . . . 0.0 111.798 -178.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 89.3 mt -137.94 86.19 18.38 Favored Pre-proline 0 CA--C 1.536 0.44 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.94 -179.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -56.47 -30.15 80.91 Favored 'Trans proline' 0 N--CA 1.497 1.69 0 C-N-CA 123.221 2.614 . . . . 0.0 113.207 -178.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 18.0 m -52.8 -42.14 64.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.213 0.53 . . . . 0.0 110.704 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 23.4 m -115.53 10.91 7.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.713 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.45 ' O ' ' OG ' ' A' ' 89' ' ' SER . 5.3 p 52.04 50.49 18.41 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.047 0.451 . . . . 0.0 110.93 179.569 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 56.2 tp -116.02 133.33 56.14 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.285 0.564 . . . . 0.0 110.146 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.583 ' OE1' ' NH2' ' A' ' 82' ' ' ARG . 98.0 mt-10 -147.27 124.2 11.32 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.763 -179.186 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 71.0 mt -151.25 152.61 31.39 Favored Pre-proline 0 N--CA 1.471 0.62 0 C-N-CA 120.154 -0.618 . . . . 0.0 111.681 -179.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_endo -75.0 150.26 37.88 Favored 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 122.771 2.314 . . . . 0.0 111.244 178.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 91.1 t -98.01 123.5 50.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -178.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 9.7 mp -109.61 136.22 49.32 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-O 120.901 0.381 . . . . 0.0 111.083 178.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 85.7 mttt -67.33 -78.88 0.05 Allowed 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.439 0.638 . . . . 0.0 112.234 -179.229 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 30.6 t -61.95 139.25 58.41 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.952 -178.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 7.5 t -95.44 72.93 3.24 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.364 0.602 . . . . 0.0 110.547 -179.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 39.7 p -90.25 166.85 13.11 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 178.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -60.42 -42.21 95.53 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.68 0.752 . . . . 0.0 109.273 179.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -64.88 -41.82 95.32 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.988 179.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -65.13 -38.23 89.95 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.151 -179.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 84.2 mt -64.01 -12.92 42.54 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.784 -179.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 89.6 mt -72.41 -23.22 61.06 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.279 0.561 . . . . 0.0 109.852 179.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 96.5 p -74.46 -6.11 46.46 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 121.442 0.639 . . . . 0.0 110.893 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 87.4 -19.79 30.07 Favored Glycine 0 CA--C 1.533 1.203 0 CA-C-N 115.642 -0.708 . . . . 0.0 112.85 178.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -145.28 123.71 12.37 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 119.65 -0.82 . . . . 0.0 111.956 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -144.53 135.33 24.88 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.512 179.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 2.3 m -62.44 135.41 57.42 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 121.034 0.445 . . . . 0.0 110.765 -179.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 79.8 t -77.37 -48.84 23.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.765 179.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.464 ' CB ' ' NE2' ' A' ' 114' ' ' GLN . 69.3 mmtt -96.18 132.2 41.86 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.577 0.703 . . . . 0.0 110.854 179.59 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -65.56 -32.77 74.54 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 114.974 -1.012 . . . . 0.0 112.195 -178.315 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 69.0 m-80 -84.55 12.4 7.08 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 -178.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . 0.777 ' N ' HE21 ' A' ' 114' ' ' GLN . 0.0 OUTLIER -81.28 143.72 32.06 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.905 0.383 . . . . 0.0 111.494 179.853 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.459 ' O ' ' O ' ' A' ' 118' ' ' LYS . 41.4 t -126.38 123.79 64.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.982 179.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 98.3 mtp -57.11 137.51 55.73 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 121.241 0.543 . . . . 0.0 111.387 179.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 77.95 -5.01 55.71 Favored Glycine 0 CA--C 1.531 1.058 0 N-CA-C 111.522 -0.631 . . . . 0.0 111.522 179.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.459 ' O ' ' O ' ' A' ' 115' ' ' VAL . 98.5 mttt -141.85 132.28 25.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.208 0.528 . . . . 0.0 111.471 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 72.42 -173.23 46.78 Favored Glycine 0 CA--C 1.528 0.904 0 N-CA-C 110.524 -1.031 . . . . 0.0 110.524 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . 0.51 HD21 ' CE1' ' A' ' 177' ' ' HIS . 56.0 t-20 -84.12 101.92 12.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.165 0.507 . . . . 0.0 109.802 179.492 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 27.0 t80 -88.92 99.53 12.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.362 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -92.4 143.0 26.82 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.172 0.51 . . . . 0.0 111.634 -179.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 62.2 mt -136.7 141.42 43.1 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.835 179.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -109.66 130.83 55.48 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.373 0.606 . . . . 0.0 110.201 179.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -136.79 141.29 12.26 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . 0.518 ' O ' ' O ' ' A' ' 134' ' ' LEU . 0.3 OUTLIER -80.04 146.31 32.03 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.067 -0.653 . . . . 0.0 112.23 -178.849 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 61.8 t-20 -136.07 121.3 19.07 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.305 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' MET . . . . . 0.429 ' O ' ' CB ' ' A' ' 129' ' ' SER . 58.5 mtt -97.69 -4.51 37.15 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.04 -179.443 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.429 ' CB ' ' O ' ' A' ' 128' ' ' MET . 0.9 OUTLIER 78.09 6.59 2.63 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.419 179.527 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.509 ' O ' ' CG1' ' A' ' 133' ' ' VAL . 6.9 ptpt -113.08 116.03 29.26 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 121.468 0.651 . . . . 0.0 111.714 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -40.69 127.66 2.52 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.851 -179.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 105.44 -11.5 47.09 Favored Glycine 0 N--CA 1.444 -0.813 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.509 ' CG1' ' O ' ' A' ' 130' ' ' LYS . 7.7 p -92.43 173.84 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.058 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.518 ' O ' ' O ' ' A' ' 126' ' ' HIS . 3.8 mm? -67.26 131.57 46.02 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 115.773 1.768 . . . . 0.0 115.773 -175.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.9 m-30 50.55 21.33 0.85 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 113.266 -1.788 . . . . 0.0 113.956 176.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 4.5 t -72.18 -34.06 68.14 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 119.764 -0.774 . . . . 0.0 112.523 179.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 -88.91 -1.53 58.14 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.433 0.635 . . . . 0.0 111.388 -179.063 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 4.7 tt -62.7 -34.97 68.39 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.286 -179.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -66.43 -7.31 18.58 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 121.532 0.682 . . . . 0.0 110.234 179.432 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 4.8 m -84.67 -6.1 59.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.175 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 72.8 mt -63.39 142.17 58.49 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.014 -179.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -117.16 159.91 21.86 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 121.817 0.818 . . . . 0.0 112.243 -178.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 65.2 tttm -52.65 133.56 36.33 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.515 178.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.553 ' N ' ' O ' ' A' ' 160' ' ' VAL . . . 77.67 8.53 87.19 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 120.167 -1.016 . . . . 0.0 110.892 179.233 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -81.96 125.8 31.19 Favored 'General case' 0 C--O 1.222 -0.374 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -79.91 151.0 30.38 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 115.107 1.521 . . . . 0.0 115.107 -176.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 97.6 mt -138.37 137.96 43.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 112.518 -2.128 . . . . 0.0 108.204 179.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -121.73 135.85 54.94 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 120.094 -0.642 . . . . 0.0 111.903 -178.039 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 4.0 mt -114.59 134.29 55.16 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 177.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.56 ' CE2' ' CD ' ' A' ' 155' ' ' GLU . 94.4 m-85 -110.16 110.96 22.01 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 120.192 -0.603 . . . . 0.0 111.529 179.644 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . 0.477 ' N ' ' O ' ' A' ' 154' ' ' ASN . 9.6 m-20 -87.59 166.94 14.35 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 177.39 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -56.89 -24.2 50.24 Favored 'General case' 0 C--N 1.312 -1.031 0 C-N-CA 120.088 -0.645 . . . . 0.0 111.058 -178.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -112.69 -25.8 8.92 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 113.758 1.021 . . . . 0.0 113.758 -179.128 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . 0.477 ' O ' ' N ' ' A' ' 151' ' ' ASP . 0.3 OUTLIER -148.73 -176.3 5.27 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 118.904 -1.119 . . . . 0.0 113.533 -176.303 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.56 ' CD ' ' CE2' ' A' ' 150' ' ' TYR . 84.4 tt0 -131.94 137.39 47.92 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 114.812 -1.086 . . . . 0.0 110.197 179.038 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -110.37 136.03 50.17 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.267 0.556 . . . . 0.0 112.311 -179.038 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -94.67 110.6 22.42 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.287 179.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -113.16 146.22 39.62 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 120.918 0.389 . . . . 0.0 110.823 179.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -120.75 120.79 36.65 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.068 179.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.553 ' O ' ' N ' ' A' ' 144' ' ' GLY . 69.0 t -59.32 134.28 24.46 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.331 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 178.273 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 10.2 p -106.91 -25.03 11.83 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 123.507 0.505 . . . . 0.0 111.041 179.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 159.64 -168.08 35.37 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 120.323 -0.942 . . . . 0.0 112.111 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 35.6 m -129.47 159.41 41.54 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 179.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 47.0 t -141.16 162.32 35.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.413 0.625 . . . . 0.0 111.704 -178.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -102.31 119.09 38.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.991 -178.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 22.3 m -136.47 161.17 37.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.509 -179.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' THR . . . . . 0.482 ' OG1' ' OD1' ' A' ' 169' ' ' ASP . 0.2 OUTLIER -98.56 168.33 9.99 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.148 -179.432 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . 0.452 ' O ' ' CB ' ' B' ' 702' ' ' LEU . 31.3 Cg_exo -59.96 -22.21 68.0 Favored 'Trans proline' 0 N--CA 1.499 1.813 0 C-N-CA 122.614 2.209 . . . . 0.0 113.496 179.367 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . 0.482 ' OD1' ' OG1' ' A' ' 167' ' ' THR . 44.9 p-10 -94.16 -1.44 54.19 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -179.041 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.428 ' HD2' ' H ' ' A' ' 167' ' ' THR . 17.7 mttm -76.65 85.49 3.3 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.432 0.634 . . . . 0.0 111.613 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 59.9 p-90 -78.39 -12.11 59.99 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.479 179.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -65.54 -27.12 68.22 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.117 -179.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 33.4 m -63.01 -21.28 27.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 120.74 -0.384 . . . . 0.0 111.766 -179.132 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 26.9 m -107.49 -2.97 10.07 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 -178.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -74.84 162.98 28.16 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.2 0.524 . . . . 0.0 110.835 179.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . 0.447 ' N ' ' OD1' ' A' ' 176' ' ' ASP . 33.6 p-10 -62.88 141.69 58.58 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.82 179.762 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' HIS . . . . . 0.51 ' CE1' HD21 ' A' ' 120' ' ' ASN . 49.1 m80 -118.63 10.5 12.52 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.801 -179.494 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 62.68 41.62 99.8 Favored Glycine 0 CA--C 1.531 1.031 0 C-N-CA 121.323 -0.465 . . . . 0.0 112.195 179.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -167.94 174.49 7.39 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.771 0.319 . . . . 0.0 110.37 178.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 -86.72 97.62 10.69 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 177.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . 0.414 ' HG2' ' N ' ' A' ' 182' ' ' ILE . 83.5 tt0 -134.16 161.07 35.9 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.591 0.71 . . . . 0.0 111.877 -178.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.414 ' N ' ' HG2' ' A' ' 181' ' ' GLU . 19.5 tt -129.25 136.05 60.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 114.936 -1.029 . . . . 0.0 108.701 178.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 90.6 m -130.61 125.21 33.52 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.968 0.413 . . . . 0.0 110.717 -179.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 70.1 mt -109.36 135.36 50.55 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 179.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 99.0 mt -112.72 123.86 68.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.461 0.648 . . . . 0.0 110.84 -179.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 1.2 t -137.62 155.17 49.47 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.47 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 187' ' ' CYS . . . . . . . . . . . . . 19.9 m -88.07 140.14 29.79 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.299 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . 0.411 HG21 ' CE2' ' A' ' 197' ' ' TYR . 55.9 t -62.74 -49.0 85.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 C-N-CA 120.444 -0.502 . . . . 0.0 110.864 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 57.2 p -160.99 166.67 27.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.57 0.7 . . . . 0.0 111.245 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 27.2 t -82.67 -16.94 11.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.699 179.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . 0.48 ' O ' ' OD1' ' A' ' 192' ' ' ASP . 99.6 mttt -95.25 -13.62 24.73 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 121.055 0.455 . . . . 0.0 111.206 -179.288 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . 0.48 ' OD1' ' O ' ' A' ' 191' ' ' LYS . 91.5 m-20 -139.97 101.22 4.12 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.316 -179.683 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -97.26 7.88 45.67 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 121.552 0.691 . . . . 0.0 110.438 179.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 58.4 m -61.64 -37.1 82.76 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.462 179.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -127.1 150.33 49.53 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 121.338 0.589 . . . . 0.0 111.836 -178.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -132.89 140.53 47.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.004 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . 0.411 ' CE2' HG21 ' A' ' 188' ' ' VAL . 25.6 m-85 -93.91 139.62 30.68 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.144 0.497 . . . . 0.0 110.623 178.742 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 40.9 t -129.72 131.09 66.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.178 179.253 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 56.0 t -103.11 134.88 43.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-O 121.07 0.462 . . . . 0.0 110.736 -179.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -115.87 141.61 47.87 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.324 0.583 . . . . 0.0 110.901 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -138.58 142.55 13.17 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 110.836 -0.906 . . . . 0.0 110.836 -179.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 81.4 m-20 -105.83 142.94 34.69 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.962 0.411 . . . . 0.0 110.671 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 46.9 tp -68.29 132.64 47.45 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 64.0 t -115.14 -21.55 5.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -178.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -176.04 173.59 46.36 Favored Glycine 0 CA--C 1.523 0.58 0 C-N-CA 120.155 -1.021 . . . . 0.0 111.76 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 9.2 m -143.16 139.53 30.38 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.238 -0.481 . . . . 0.0 109.802 179.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -141.69 115.42 9.11 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 121.58 0.705 . . . . 0.0 112.335 -179.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -64.12 142.26 58.47 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.286 -0.87 . . . . 0.0 112.325 -179.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.436 ' NZ ' ' O ' ' A' ' 151' ' ' ASP . 54.7 mtmt -76.57 159.23 30.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.977 178.352 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 98.9 mttt . . . . . 0 C--O 1.222 -0.351 0 CA-C-O 117.965 -1.016 . . . . 0.0 111.154 -179.827 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 702' ' ' LEU . . . . . 0.452 ' CB ' ' O ' ' A' ' 168' ' ' PRO . 1.0 OUTLIER . . . . . 0 CA--C 1.542 0.647 0 CA-C-O 120.552 0.215 . . . . 20.0 110.735 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 703' ' ' PRO . . . . . 0.56 ' O ' ' O ' ' B' ' 704' ' ' ALA . 3.9 Cg_exo -64.8 -178.46 0.74 Allowed 'Trans proline' 0 N--CA 1.491 1.338 0 C-N-CA 122.132 1.888 . . . . 20.0 113.848 -178.756 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 704' ' ' ALA . . . . . 0.56 ' O ' ' O ' ' B' ' 703' ' ' PRO . . . . . . . . 0 N--CA 1.467 0.422 0 CA-C-N 114.238 -1.347 . . . . 20.0 114.103 -178.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.41 ' C ' ' H ' ' A' ' 60' ' ' LYS . . . . . . . . 0 CA--C 1.532 0.271 0 CA-C-O 120.936 0.398 . . . . 0.0 111.191 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 44.3 p -80.77 23.28 0.54 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 121.313 0.578 . . . . 0.0 110.814 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.41 ' H ' ' C ' ' A' ' 58' ' ' ALA . 53.4 mtmt -109.49 25.07 12.22 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.665 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 94.6 mt -56.09 136.28 18.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 122.36 1.076 . . . . 0.0 113.003 -177.05 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -79.53 128.01 32.84 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 113.552 -1.658 . . . . 0.0 108.39 177.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -79.22 149.81 73.3 Favored Pre-proline 0 C--N 1.325 -0.489 0 C-N-CA 120.546 -0.462 . . . . 0.0 110.211 -179.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -69.66 158.64 56.38 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 122.399 2.066 . . . . 0.0 112.385 -179.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -53.35 174.76 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.883 -178.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 89.8 mt -63.78 -46.78 83.67 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 -177.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.26 -37.8 86.83 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 119.819 -0.752 . . . . 0.0 111.238 -177.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.575 ' N ' ' OE1' ' A' ' 68' ' ' GLU . 35.3 mp0 -60.81 -27.54 68.11 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.416 0.627 . . . . 0.0 109.709 178.664 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 26.2 t -78.98 -46.01 24.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.476 179.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -73.3 -9.21 58.46 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.879 -1.055 . . . . 0.0 111.365 -179.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -110.14 -8.67 14.75 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.526 0.679 . . . . 0.0 109.412 178.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -71.74 144.91 49.1 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 115.137 -0.938 . . . . 0.0 112.042 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 24.1 m -56.92 109.67 0.68 Allowed 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.744 -179.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 37.9 tp -70.12 131.25 43.99 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.773 -179.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -116.4 77.75 1.13 Allowed 'General case' 0 C--O 1.232 0.157 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 176.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -82.45 -33.39 28.54 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.989 -1.005 . . . . 0.0 113.176 -178.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 48.6 mmtt -73.2 -10.61 59.95 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 119.954 -0.699 . . . . 0.0 110.905 -176.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -92.52 -1.17 57.14 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.659 179.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 13.5 t -81.64 127.84 39.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.377 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 21.6 pt -107.84 -2.65 10.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.943 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -161.9 171.23 37.79 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 120.188 -1.006 . . . . 0.0 111.632 -179.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 58.4 ttp180 -140.65 142.0 35.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.219 0.533 . . . . 0.0 111.155 -179.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 7.5 tp -105.2 136.59 38.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.976 179.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 10.0 t -137.05 127.94 27.42 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-O 121.431 0.634 . . . . 0.0 111.231 -179.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 56.1 mt -138.8 86.44 15.57 Favored Pre-proline 0 CA--C 1.537 0.47 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.291 -179.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -54.74 -30.38 66.67 Favored 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 123.044 2.496 . . . . 0.0 112.739 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 67.3 m -54.12 -41.96 68.94 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 121.118 0.485 . . . . 0.0 111.133 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.2 m -116.1 12.3 7.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.808 179.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.406 ' O ' ' OG ' ' A' ' 89' ' ' SER . 13.2 t 50.77 51.54 16.77 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.856 179.742 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 63.3 tp -115.62 132.24 56.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.27 0.557 . . . . 0.0 111.066 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -147.08 123.28 10.86 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.38 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 84.4 mt -150.97 150.67 28.17 Favored Pre-proline 0 N--CA 1.47 0.575 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.428 -179.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -72.38 146.01 44.16 Favored 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 122.511 2.141 . . . . 0.0 111.699 178.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 54.2 t -96.42 120.68 46.1 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-O 121.194 0.521 . . . . 0.0 110.86 179.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.422 ' N ' ' CD1' ' A' ' 95' ' ' LEU . 11.2 mp -99.81 138.61 36.66 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.337 -179.74 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.528 ' O ' ' OG1' ' A' ' 109' ' ' THR . 34.0 tttm -67.08 -77.86 0.07 Allowed 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.526 -179.522 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 38.2 m -61.83 136.82 58.14 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.144 0.497 . . . . 0.0 111.303 -178.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -92.79 65.6 4.22 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 121.664 0.745 . . . . 0.0 110.103 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.464 ' HG1' ' CG ' ' A' ' 102' ' ' ASN . 73.4 p -91.51 165.55 13.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.775 178.442 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 57.1 mp0 -60.39 -42.08 95.15 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.294 -0.562 . . . . 0.0 110.362 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -64.55 -40.45 95.6 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.473 0.654 . . . . 0.0 110.288 179.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.464 ' CG ' ' HG1' ' A' ' 99' ' ' THR . 8.6 m120 -65.0 -34.09 77.62 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.734 -179.353 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 65.2 mt -70.02 -10.14 57.65 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.636 -179.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 96.0 mt -74.42 -22.42 59.16 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.015 0.436 . . . . 0.0 110.352 178.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 82.8 p -77.58 -1.96 33.33 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 121.321 0.581 . . . . 0.0 110.391 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 87.53 -19.16 33.89 Favored Glycine 0 CA--C 1.534 1.226 0 CA-C-N 115.732 -0.667 . . . . 0.0 113.706 177.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -146.2 126.12 13.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 117.975 0.888 . . . . 0.0 112.729 -179.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -147.34 143.52 28.09 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.484 178.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.528 ' OG1' ' O ' ' A' ' 96' ' ' LYS . 18.9 p -68.35 138.63 55.55 Favored 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 120.338 -0.545 . . . . 0.0 109.879 179.747 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 70.2 t -76.55 -49.62 23.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.906 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.604 ' CE ' ' HE1' ' A' ' 171' ' ' TRP . 96.4 mttt -104.22 143.1 33.4 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 122.345 1.069 . . . . 0.0 113.254 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -66.47 -31.63 72.49 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 114.465 -1.243 . . . . 0.0 111.679 -178.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 21.8 m120 -84.99 14.94 4.38 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 -177.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . 0.457 ' OE1' ' O ' ' A' ' 120' ' ' ASN . 89.6 mm-40 -75.16 136.43 41.06 Favored 'General case' 0 N--CA 1.467 0.404 0 O-C-N 121.672 -0.643 . . . . 0.0 111.332 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 46.8 t -127.36 120.72 55.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.533 178.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 51.0 mtt -57.57 132.43 53.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.899 179.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 77.79 -4.48 56.93 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 121.152 -0.547 . . . . 0.0 112.211 178.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -136.91 125.21 23.23 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.308 0.575 . . . . 0.0 110.857 -179.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 76.61 -165.96 53.96 Favored Glycine 0 CA--C 1.527 0.842 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 -179.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . 0.457 ' O ' ' OE1' ' A' ' 114' ' ' GLN . 50.9 t-20 -91.81 106.47 18.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.17 0.51 . . . . 0.0 110.27 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 14.5 t80 -83.75 145.53 28.67 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.91 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -146.01 138.99 25.8 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.645 0.736 . . . . 0.0 112.465 -178.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 74.2 mt -135.11 141.57 46.03 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.319 179.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -110.68 132.52 54.12 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -134.32 146.39 18.38 Favored Glycine 0 CA--C 1.529 0.962 0 N-CA-C 111.031 -0.828 . . . . 0.0 111.031 -178.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . 0.409 ' O ' ' CB ' ' A' ' 134' ' ' LEU . 29.3 m-70 -87.24 150.37 23.95 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.443 0.64 . . . . 0.0 111.725 -179.633 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . 0.712 ' ND2' ' H ' ' A' ' 187' ' ' CYS . 2.9 p30 -147.82 159.29 44.0 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.764 178.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 65.1 mtt -124.95 4.57 8.01 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.162 0.506 . . . . 0.0 110.772 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 76.63 9.24 3.01 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.819 179.156 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.554 ' O ' ' CG1' ' A' ' 133' ' ' VAL . 62.5 pttt -123.6 131.05 53.52 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 122.01 0.909 . . . . 0.0 112.927 -178.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.501 ' O ' ' O ' ' A' ' 130' ' ' LYS . 74.4 mmtt -40.57 165.05 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.184 -0.917 . . . . 0.0 109.171 178.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 70.19 -21.04 0.53 Allowed Glycine 0 CA--C 1.532 1.103 0 C-N-CA 120.673 -0.775 . . . . 0.0 111.748 179.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.554 ' CG1' ' O ' ' A' ' 130' ' ' LYS . 3.9 p -88.65 173.57 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 C-N-CA 119.651 -0.819 . . . . 0.0 110.058 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.499 ' N ' ' CD2' ' A' ' 134' ' ' LEU . 4.0 mm? -67.49 130.44 43.04 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 115.37 1.618 . . . . 0.0 115.37 -176.361 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.4 m-30 58.08 21.94 8.45 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 113.97 -1.468 . . . . 0.0 113.21 177.017 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.28 -39.38 92.49 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -179.645 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -91.47 -1.22 57.62 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 113.904 1.075 . . . . 0.0 113.904 -177.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 1.6 pp -61.2 -30.19 47.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 119.316 -0.954 . . . . 0.0 110.911 -179.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -66.6 -10.35 44.69 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.318 0.58 . . . . 0.0 110.356 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 3.1 m -83.89 -3.01 57.59 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.849 -179.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 91.4 mt -63.65 141.85 58.61 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 121.118 0.485 . . . . 0.0 111.241 -179.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 56.7 mttp -120.42 156.8 30.67 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-O 121.556 0.693 . . . . 0.0 111.74 -179.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -50.77 133.64 25.93 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.33 179.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 160' ' ' VAL . . . 79.88 8.29 87.8 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 120.352 -0.928 . . . . 0.0 111.564 179.066 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.442 ' OD1' ' N ' ' A' ' 146' ' ' LYS . 61.8 t0 -74.38 128.3 35.19 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 120.106 -0.638 . . . . 0.0 110.394 -179.43 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.442 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 75.6 mmtt -77.89 140.18 39.29 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.817 0.818 . . . . 0.0 112.197 -178.291 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 89.7 mt -139.62 139.95 37.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 114.615 -1.175 . . . . 0.0 108.832 179.023 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -124.95 136.91 54.19 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 119.459 -0.896 . . . . 0.0 112.955 -178.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -112.11 134.34 53.72 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 177.296 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.604 ' CZ ' ' OE2' ' A' ' 155' ' ' GLU . 79.7 m-85 -110.66 112.94 25.17 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 119.966 -0.694 . . . . 0.0 111.278 -179.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . 0.445 ' N ' ' O ' ' A' ' 154' ' ' ASN . 38.1 t70 -89.03 165.42 14.55 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 177.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 66.1 m-20 -57.06 -23.98 50.59 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 119.836 -0.746 . . . . 0.0 110.568 -178.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -114.35 -25.51 8.39 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 113.534 0.939 . . . . 0.0 113.534 -178.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . 0.445 ' O ' ' N ' ' A' ' 151' ' ' ASP . 0.1 OUTLIER -146.65 -178.94 6.44 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 118.572 -1.251 . . . . 0.0 113.455 -176.859 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.604 ' OE2' ' CZ ' ' A' ' 150' ' ' TYR . 83.9 tt0 -131.27 133.79 45.76 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 114.674 -1.148 . . . . 0.0 109.988 179.082 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -110.01 136.24 49.58 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 121.109 0.481 . . . . 0.0 111.695 -179.282 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 77.1 tt0 -94.79 113.62 25.4 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.776 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 39.8 m-85 -114.86 149.03 37.75 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.172 0.51 . . . . 0.0 111.581 179.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -123.81 122.74 38.84 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.97 179.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.454 ' O ' ' N ' ' A' ' 144' ' ' GLY . 60.8 t -60.65 137.81 22.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 177.752 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 18.1 p -106.78 -24.69 12.0 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 120.801 -0.359 . . . . 0.0 111.649 179.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 160.37 -166.39 35.27 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 120.531 -0.843 . . . . 0.0 111.756 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 35.0 m -131.98 159.06 43.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-O 120.888 0.375 . . . . 0.0 110.856 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 82.2 p -147.31 162.0 39.85 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 121.095 0.474 . . . . 0.0 110.991 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . 0.456 ' OE1' ' NZ ' ' A' ' 195' ' ' LYS . 98.2 mt-10 -110.47 121.16 44.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.37 0.605 . . . . 0.0 110.843 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 28.1 m -138.43 159.75 31.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.821 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' THR . . . . . 0.508 ' H ' ' HG1' ' A' ' 167' ' ' THR . 0.2 OUTLIER -83.32 158.63 63.42 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.702 179.653 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . 0.503 ' O ' ' CB ' ' B' ' 702' ' ' LEU . 35.9 Cg_endo -64.48 -17.71 60.51 Favored 'Trans proline' 0 N--CA 1.499 1.809 0 C-N-CA 123.103 2.536 . . . . 0.0 113.035 -178.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 43.7 p-10 -91.19 -3.57 56.87 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 120.094 -0.642 . . . . 0.0 111.211 179.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -74.36 78.03 1.87 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.526 0.679 . . . . 0.0 110.804 179.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' TRP . . . . . 0.604 ' HE1' ' CE ' ' A' ' 111' ' ' LYS . 29.4 t90 -70.3 -15.25 62.87 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.046 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -64.26 -29.29 70.39 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.612 -0.722 . . . . 0.0 112.244 -179.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 14.8 m -63.24 -21.2 27.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -179.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 27.2 m -105.6 -3.48 9.83 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 C-N-CA 120.372 -0.531 . . . . 0.0 112.162 -179.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.579 ' OE2' ' CE3' ' A' ' 171' ' ' TRP . 95.7 mt-10 -71.97 150.29 44.22 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.164 0.507 . . . . 0.0 110.634 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . 0.488 ' OD1' ' O ' ' A' ' 176' ' ' ASP . 54.3 p-10 -56.74 142.27 41.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.908 -179.595 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 61.7 m80 -120.46 12.91 11.7 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.863 -179.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 62.54 42.38 99.7 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 120.666 -0.778 . . . . 0.0 111.175 179.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -164.4 168.76 18.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.89 0.376 . . . . 0.0 110.631 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -87.1 99.38 11.88 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 177.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . 0.428 ' HG2' ' N ' ' A' ' 182' ' ' ILE . 84.1 tt0 -135.3 161.91 34.07 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.259 0.552 . . . . 0.0 111.521 -178.275 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.428 ' N ' ' HG2' ' A' ' 181' ' ' GLU . 18.7 tt -129.7 139.19 52.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.741 178.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 94.0 m -130.41 125.44 34.52 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.412 0.625 . . . . 0.0 111.72 -179.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 82.7 mt -109.32 131.14 55.35 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.416 178.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 77.5 mt -111.55 122.05 65.22 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 CA-C-O 121.571 0.7 . . . . 0.0 111.384 -179.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 186' ' ' THR . . . . . 0.479 ' CG2' ' HH ' ' A' ' 197' ' ' TYR . 12.1 m -135.08 157.13 47.71 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.032 179.301 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 187' ' ' CYS . . . . . 0.712 ' H ' ' ND2' ' A' ' 127' ' ' ASN . 1.7 m -97.08 144.84 26.56 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 120.913 0.387 . . . . 0.0 110.945 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 7.6 p -62.71 -46.83 95.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-O 121.057 0.456 . . . . 0.0 110.852 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 36.3 p -159.62 162.36 35.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.113 0.483 . . . . 0.0 110.867 179.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 7.9 p -80.9 -7.67 10.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.533 179.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -96.71 -13.46 22.71 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 121.07 0.462 . . . . 0.0 110.621 179.208 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . 0.529 ' OD1' ' OG ' ' A' ' 194' ' ' SER . 67.8 t0 -148.59 103.39 3.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.315 0.579 . . . . 0.0 111.389 179.634 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -102.64 3.83 37.61 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.372 179.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 194' ' ' SER . . . . . 0.529 ' OG ' ' OD1' ' A' ' 192' ' ' ASP . 78.6 p -64.49 -24.36 67.59 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.653 -179.743 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 195' ' ' LYS . . . . . 0.456 ' NZ ' ' OE1' ' A' ' 165' ' ' GLU . 88.0 tttt -130.71 133.31 45.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.165 0.507 . . . . 0.0 110.575 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -129.01 139.65 51.98 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.515 -179.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . 0.479 ' HH ' ' CG2' ' A' ' 186' ' ' THR . 37.5 p90 -100.94 135.43 42.41 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.2 0.524 . . . . 0.0 110.021 178.59 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 25.6 t -114.18 135.49 53.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -178.1 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 57.4 t -104.3 132.63 50.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.698 179.066 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -121.28 150.03 42.0 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 121.483 0.658 . . . . 0.0 112.269 -179.028 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -149.98 159.7 28.21 Favored Glycine 0 CA--C 1.532 1.105 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 179.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 55.4 p-10 -116.37 158.7 23.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.203 0.525 . . . . 0.0 111.201 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 60.1 tp -76.01 131.17 39.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.746 179.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 15.0 t -111.98 -21.04 5.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -178.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . 0.401 ' C ' ' HG1' ' A' ' 206' ' ' THR . . . -178.55 174.64 46.83 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 120.514 -0.85 . . . . 0.0 111.988 -179.472 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 206' ' ' THR . . . . . 0.401 ' HG1' ' C ' ' A' ' 205' ' ' GLY . 23.6 m -144.55 139.86 28.45 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.38 -0.41 . . . . 0.0 110.142 179.668 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -143.24 118.2 10.01 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.155 -0.618 . . . . 0.0 111.339 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -63.88 141.96 58.58 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.408 -178.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 53.8 mtpt -77.35 159.79 29.26 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.046 178.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 53.4 mtpt . . . . . 0 C--O 1.219 -0.533 0 CA-C-O 118.037 -0.983 . . . . 0.0 110.736 179.381 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 702' ' ' LEU . . . . . 0.503 ' CB ' ' O ' ' A' ' 168' ' ' PRO . 2.3 mt . . . . . 0 CA--C 1.542 0.662 0 CA-C-O 120.795 0.331 . . . . 20.0 111.737 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 703' ' ' PRO . . . . . 0.508 ' O ' ' O ' ' B' ' 704' ' ' ALA . 4.8 Cg_exo -64.92 -164.91 0.07 OUTLIER 'Trans proline' 0 N--CA 1.491 1.355 0 C-N-CA 122.627 2.218 . . . . 20.0 113.606 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 704' ' ' ALA . . . . . 0.508 ' O ' ' O ' ' B' ' 703' ' ' PRO . . . . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 114.269 -1.332 . . . . 20.0 112.678 -179.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.421 ' C ' ' H ' ' A' ' 60' ' ' LYS . . . . . . . . 0 CA--C 1.529 0.143 0 CA-C-O 121.219 0.533 . . . . 0.0 110.48 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.595 ' C ' HH22 ' A' ' 196' ' ' ARG . 2.8 p -78.15 19.44 0.44 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.25 -179.146 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.421 ' H ' ' C ' ' A' ' 58' ' ' ALA . 99.6 mttt -95.75 13.38 26.73 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.927 179.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 94.0 mt -55.43 141.71 11.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 122.035 0.921 . . . . 0.0 112.949 -177.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.403 ' O ' ' OD1' ' A' ' 62' ' ' ASP . 35.1 p-10 -78.53 129.78 35.23 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 114.034 -1.439 . . . . 0.0 109.198 178.435 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.623 ' NE2' ' H ' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -79.98 146.87 64.55 Favored Pre-proline 0 CA--C 1.539 0.527 0 CA-C-O 120.99 0.424 . . . . 0.0 111.222 -179.071 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.23 157.97 59.4 Favored 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 123.079 2.519 . . . . 0.0 113.113 -179.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -55.45 168.67 0.36 Allowed 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.685 -179.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.4 HD12 ' HZ3' ' A' ' 130' ' ' LYS . 92.1 mt -64.18 -45.06 90.03 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.047 -178.535 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.52 -39.41 94.36 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 119.81 -0.756 . . . . 0.0 110.893 -178.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -60.75 -29.39 69.36 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 178.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 50.9 t -75.57 -45.11 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.981 179.101 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -72.6 -9.1 58.18 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.683 -1.144 . . . . 0.0 111.037 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 27.1 m120 -105.84 -10.35 16.72 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.524 0.678 . . . . 0.0 110.226 178.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.09 137.04 54.66 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.634 -179.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -60.35 98.71 0.06 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.236 0.541 . . . . 0.0 109.94 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -68.52 131.1 44.68 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.389 -179.493 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -97.88 80.65 2.77 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.395 178.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -63.95 -42.39 97.32 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -179.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.488 ' H ' ' CE ' ' A' ' 77' ' ' LYS . 1.1 mtmt -69.66 -8.21 45.67 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.446 0.641 . . . . 0.0 111.104 -176.666 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.524 ' CD ' ' N ' ' A' ' 78' ' ' GLN . 18.6 mp0 -94.56 3.85 54.59 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.784 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 14.9 p -86.91 122.71 39.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 120.434 -0.506 . . . . 0.0 111.258 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.615 ' O ' ' ND2' ' A' ' 152' ' ' ASN . 24.0 pt -108.14 -6.11 10.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.1 179.125 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -167.61 166.18 39.16 Favored Glycine 0 CA--C 1.53 1.012 0 N-CA-C 110.813 -0.915 . . . . 0.0 110.813 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 62.6 ttp180 -140.19 142.57 35.88 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 121.207 0.527 . . . . 0.0 111.646 -179.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 19.5 tt -103.9 141.71 19.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.48 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 5.0 t -136.91 129.72 30.59 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 121.335 0.588 . . . . 0.0 111.539 -179.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 89.3 mt -140.29 89.37 10.86 Favored Pre-proline 0 CA--C 1.542 0.657 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.329 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -57.86 -27.67 79.4 Favored 'Trans proline' 0 N--CA 1.502 2.016 0 C-N-CA 123.279 2.653 . . . . 0.0 113.106 -179.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 9.7 t -53.83 -43.0 69.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.262 0.553 . . . . 0.0 110.378 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.8 m -112.89 8.88 8.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.816 179.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 40.7 p 52.74 53.86 11.47 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.524 -179.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 54.8 tp -116.83 134.42 54.8 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 121.461 0.648 . . . . 0.0 111.732 -179.127 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -147.46 117.8 7.39 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.239 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 84.2 mt -149.14 149.63 30.09 Favored Pre-proline 0 CA--C 1.542 0.641 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.447 -179.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -75.18 149.6 36.2 Favored 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 123.026 2.484 . . . . 0.0 112.825 179.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.519 ' O ' ' CG2' ' A' ' 94' ' ' VAL . 3.1 m -96.75 116.56 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-O 121.029 0.442 . . . . 0.0 111.214 179.752 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.457 ' N ' ' CD1' ' A' ' 95' ' ' LEU . 10.9 mp -100.09 136.37 40.09 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 120.955 0.407 . . . . 0.0 111.294 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.497 ' O ' ' OG1' ' A' ' 109' ' ' THR . 98.4 mttt -61.72 -80.42 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.346 0.593 . . . . 0.0 111.438 -179.536 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.59 ' OG ' ' ND2' ' A' ' 102' ' ' ASN . 6.4 p -60.86 132.74 54.84 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.172 -178.81 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.452 ' OG ' ' O ' ' A' ' 109' ' ' THR . 58.1 m -93.46 73.56 4.45 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.335 0.588 . . . . 0.0 110.391 179.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.733 ' HG1' ' H ' ' A' ' 102' ' ' ASN . 44.0 p -87.38 169.68 12.05 Favored 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.585 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -58.31 -45.57 87.75 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 119.335 -0.946 . . . . 0.0 108.94 179.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -65.8 -40.31 91.78 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.979 179.19 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.733 ' H ' ' HG1' ' A' ' 99' ' ' THR . 97.9 m-20 -62.61 -39.42 93.72 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.123 0.487 . . . . 0.0 111.531 -178.749 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 62.4 mt -63.43 -19.39 64.66 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.994 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 45.3 mt -73.1 -14.16 61.33 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.629 -179.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 74.4 p -75.33 -6.98 52.69 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 178.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.49 ' O ' ' CE1' ' A' ' 135' ' ' PHE . . . 90.21 -19.44 42.99 Favored Glycine 0 CA--C 1.533 1.216 0 CA-C-N 115.116 -0.947 . . . . 0.0 112.147 179.244 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -146.27 125.64 13.12 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.264 0.554 . . . . 0.0 111.762 179.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -145.5 140.53 27.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.344 178.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.497 ' OG1' ' O ' ' A' ' 96' ' ' LYS . 21.0 p -72.0 133.0 45.06 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 119.996 -0.682 . . . . 0.0 110.684 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 39.0 t -80.57 -48.47 19.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.155 179.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.607 ' O ' ' NE2' ' A' ' 114' ' ' GLN . 87.6 tttt -89.41 128.44 35.93 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.503 0.668 . . . . 0.0 111.213 -178.69 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -66.64 -36.58 82.91 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.058 -0.974 . . . . 0.0 111.731 -178.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 68.8 m-80 -89.27 31.21 0.91 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.72 -179.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . 0.607 ' NE2' ' O ' ' A' ' 111' ' ' LYS . 0.0 OUTLIER -75.3 138.11 41.61 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 120.954 0.407 . . . . 0.0 111.719 -179.501 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 42.9 t -120.7 105.79 17.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-O 120.893 0.378 . . . . 0.0 110.714 179.434 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 85.4 mtp -55.18 130.32 41.62 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.141 0.496 . . . . 0.0 111.664 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 88.21 -4.72 85.37 Favored Glycine 0 CA--C 1.53 1.013 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.819 179.106 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -142.7 136.32 28.88 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 121.254 0.55 . . . . 0.0 111.95 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 75.11 -166.17 54.8 Favored Glycine 0 CA--C 1.534 1.243 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 -179.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 59.3 t-20 -92.0 108.34 19.86 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 121.001 0.429 . . . . 0.0 110.295 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -85.57 102.47 13.56 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 121.02 0.438 . . . . 0.0 111.009 -179.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -91.9 130.82 37.58 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.911 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 84.5 mt -132.45 137.67 47.34 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.62 179.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -113.33 144.43 42.76 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.003 0.43 . . . . 0.0 110.129 179.23 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -152.34 155.04 25.9 Favored Glycine 0 CA--C 1.531 1.057 0 N-CA-C 110.279 -1.128 . . . . 0.0 110.279 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 47.6 m-70 -100.75 145.49 28.42 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.654 0.74 . . . . 0.0 111.959 -179.19 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . 0.494 ' O ' ' OD1' ' A' ' 127' ' ' ASN . 38.0 p-10 -149.64 124.26 9.76 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.788 178.517 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' MET . . . . . 0.523 ' CG ' ' OE1' ' A' ' 63' ' ' GLN . 70.7 mtm -84.58 0.38 50.25 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.306 -0.558 . . . . 0.0 110.26 179.731 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.482 ' CB ' ' O ' ' A' ' 128' ' ' MET . 1.1 m 80.17 12.54 1.0 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.254 179.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.479 ' O ' ' CG1' ' A' ' 133' ' ' VAL . 21.3 ptmt -104.91 124.71 49.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.996 0.903 . . . . 0.0 111.91 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -46.14 120.37 2.73 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.78 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 116.29 -18.72 13.64 Favored Glycine 0 N--CA 1.445 -0.748 0 N-CA-C 109.979 -1.249 . . . . 0.0 109.979 -179.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.479 ' CG1' ' O ' ' A' ' 130' ' ' LYS . 11.4 p -88.6 159.68 2.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.654 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.663 ' CD2' ' H ' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -71.22 144.04 50.23 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 122.156 0.979 . . . . 0.0 113.639 -177.314 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.49 ' CE1' ' O ' ' A' ' 106' ' ' GLY . 4.0 m-85 59.69 9.56 1.66 Allowed 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 113.902 -1.499 . . . . 0.0 114.726 177.763 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 5.7 t -69.77 -40.46 76.07 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 179.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . 0.428 ' O ' ' OG ' ' A' ' 140' ' ' SER . 77.2 m-20 -89.17 7.36 35.67 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 -176.611 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.509 ' CG1' ' OH ' ' A' ' 197' ' ' TYR . 35.0 pt -61.78 -26.45 39.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 C-N-CA 119.185 -1.006 . . . . 0.0 109.102 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -65.92 -14.56 61.77 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.551 179.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.428 ' OG ' ' O ' ' A' ' 137' ' ' ASP . 64.3 p -83.0 -4.51 58.39 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.328 -179.391 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 81.2 mt -63.78 142.2 58.49 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 120.94 0.4 . . . . 0.0 110.977 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 63.9 mttm -118.05 153.3 33.95 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.639 0.733 . . . . 0.0 111.807 -178.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -50.21 130.74 23.24 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.955 178.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.444 ' N ' ' O ' ' A' ' 160' ' ' VAL . . . 81.42 8.7 86.77 Favored Glycine 0 CA--C 1.526 0.746 0 C-N-CA 120.219 -0.991 . . . . 0.0 110.985 179.467 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 146' ' ' LYS . 58.8 t0 -76.95 129.04 35.62 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.295 0.569 . . . . 0.0 110.229 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.504 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 72.8 mmtt -79.26 143.11 35.59 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 121.826 0.822 . . . . 0.0 112.754 -177.624 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 94.7 mt -138.1 139.31 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-N 114.608 -1.178 . . . . 0.0 108.322 178.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -121.11 136.99 54.87 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -177.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -114.0 132.74 55.88 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 177.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.573 ' CZ ' ' OE2' ' A' ' 155' ' ' GLU . 96.3 m-85 -112.02 107.94 17.08 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.006 -0.678 . . . . 0.0 111.783 -179.63 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . 0.523 ' OD1' ' N ' ' A' ' 152' ' ' ASN . 54.2 t0 -88.16 164.0 15.89 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 177.75 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . 0.651 ' N ' HD21 ' A' ' 152' ' ' ASN . 1.4 m120 -58.49 -23.66 58.47 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 119.556 -0.858 . . . . 0.0 110.993 -178.364 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -109.36 -29.75 8.31 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 -177.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . 0.459 ' O ' ' N ' ' A' ' 151' ' ' ASP . 0.2 OUTLIER -149.77 -179.26 6.98 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 119.181 -1.008 . . . . 0.0 113.503 -176.712 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.573 ' OE2' ' CZ ' ' A' ' 150' ' ' TYR . 79.1 tt0 -126.26 133.09 51.55 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 114.48 -1.236 . . . . 0.0 110.159 178.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -107.11 132.33 53.12 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 121.376 0.608 . . . . 0.0 111.323 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -93.54 112.76 24.73 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.81 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -113.05 145.29 41.14 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.01 0.434 . . . . 0.0 111.404 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -120.1 121.43 38.82 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.868 179.107 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.444 ' O ' ' N ' ' A' ' 144' ' ' GLY . 98.1 t -60.58 135.68 25.02 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 177.542 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.444 ' H ' ' HG1' ' A' ' 161' ' ' THR . 6.8 p -108.48 -24.76 11.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.174 0.511 . . . . 0.0 110.716 179.046 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 160.6 -170.43 36.55 Favored Glycine 0 CA--C 1.532 1.126 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 -179.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 35.0 m -133.49 158.79 42.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 179.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' SER . . . . . 0.553 ' HG ' ' N ' ' A' ' 165' ' ' GLU . 39.6 t -142.9 162.5 35.3 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 121.348 0.594 . . . . 0.0 111.784 -179.216 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . 0.553 ' N ' ' HG ' ' A' ' 164' ' ' SER . 95.6 mt-10 -109.31 121.24 44.75 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.79 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 31.3 m -136.12 161.08 38.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.605 -179.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.41 158.75 65.8 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.918 -179.537 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . 0.479 ' O ' ' CB ' ' B' ' 702' ' ' LEU . 36.4 Cg_endo -64.86 -16.73 56.82 Favored 'Trans proline' 0 N--CA 1.496 1.673 0 C-N-CA 123.198 2.599 . . . . 0.0 113.054 -179.155 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 32.6 p-10 -94.79 -7.22 41.03 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.185 -0.606 . . . . 0.0 112.571 -179.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -77.29 92.21 3.87 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 119.832 -0.747 . . . . 0.0 112.004 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' TRP . . . . . 0.405 ' CD1' ' N ' ' A' ' 171' ' ' TRP . 6.3 m0 -75.19 -1.87 25.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.657 0.741 . . . . 0.0 109.677 178.844 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -61.72 -37.3 83.69 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.719 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 26.9 m -63.23 -12.84 11.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.127 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 77.3 t -105.62 -23.56 4.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 N-CA-C 112.665 0.616 . . . . 0.0 112.665 -178.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -74.53 135.1 42.17 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.15 0.5 . . . . 0.0 111.148 -179.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . 0.505 ' OD1' ' O ' ' A' ' 176' ' ' ASP . 43.4 p30 -70.16 135.0 48.69 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 121.123 0.487 . . . . 0.0 110.498 179.712 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 66.8 m80 -97.89 -8.93 27.22 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.622 -0.431 . . . . 0.0 112.158 -178.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 105.11 39.9 2.21 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 109.864 -1.295 . . . . 0.0 109.864 -179.337 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 13.6 ptmt -156.42 166.01 34.68 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.919 -0.64 . . . . 0.0 110.485 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -88.6 97.18 10.96 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 178.079 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . 0.454 ' HG2' ' N ' ' A' ' 182' ' ' ILE . 73.6 tt0 -131.52 162.21 30.79 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 121.519 0.676 . . . . 0.0 111.891 -178.612 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.454 ' N ' ' HG2' ' A' ' 181' ' ' GLU . 18.6 tt -129.24 137.82 56.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.67 179.337 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 89.7 m -134.5 125.69 27.87 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 121.417 0.627 . . . . 0.0 111.778 -179.229 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 73.2 mt -106.61 132.06 53.04 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.075 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 77.0 mt -113.02 119.4 60.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.325 0.583 . . . . 0.0 110.694 -179.024 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 186' ' ' THR . . . . . 0.478 ' CG2' ' N ' ' A' ' 187' ' ' CYS . 48.7 m -141.36 167.81 21.27 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.708 179.634 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 187' ' ' CYS . . . . . 0.478 ' N ' ' CG2' ' A' ' 186' ' ' THR . 92.7 m -92.7 140.76 29.19 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.944 179.328 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 54.6 t -60.78 -47.74 91.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.14 -179.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 17.4 t -167.56 152.95 7.23 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.287 0.565 . . . . 0.0 110.507 179.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 78.2 t -67.51 -20.13 26.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.503 -179.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -96.53 -8.32 32.27 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.021 -179.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -136.92 98.8 3.85 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 121.141 0.495 . . . . 0.0 110.442 179.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 49.4 p-10 -106.61 13.92 27.63 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.6 -179.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 84.1 p -59.1 -45.14 91.64 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.91 0.386 . . . . 0.0 111.522 -178.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 26.3 pttm -142.41 149.92 39.96 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 121.269 0.557 . . . . 0.0 111.522 -179.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . 0.595 HH22 ' C ' ' A' ' 59' ' ' SER . 99.7 mtt180 -105.34 135.9 45.87 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.24 179.431 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . 0.509 ' OH ' ' CG1' ' A' ' 138' ' ' ILE . 21.0 p90 -96.11 150.3 20.66 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.491 -0.484 . . . . 0.0 110.102 179.599 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 4.4 m -130.52 138.51 53.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.11 0.481 . . . . 0.0 111.976 -178.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 49.4 t -98.79 130.69 47.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 178.188 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -116.45 140.52 49.27 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 121.261 0.553 . . . . 0.0 111.294 -179.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -136.18 151.57 20.82 Favored Glycine 0 CA--C 1.532 1.138 0 N-CA-C 110.421 -1.071 . . . . 0.0 110.421 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . 0.438 ' OD1' ' N ' ' A' ' 203' ' ' LEU . 65.0 t0 -116.99 130.43 56.69 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.152 0.501 . . . . 0.0 110.571 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . 0.438 ' N ' ' OD1' ' A' ' 202' ' ' ASP . 50.4 tp -58.33 131.09 49.63 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.217 -179.741 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 14.0 m -116.27 -16.65 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.919 -179.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -178.89 173.92 46.11 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 119.965 -1.112 . . . . 0.0 112.477 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 31.4 m -144.81 138.87 27.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.616 -0.792 . . . . 0.0 109.377 179.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -144.95 121.52 11.08 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.112 -0.635 . . . . 0.0 111.737 179.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -63.0 140.88 58.92 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.638 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 18.4 ttpt -81.0 110.96 17.04 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.308 179.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt . . . . . 0 C--O 1.219 -0.524 0 CA-C-O 118.139 -0.934 . . . . 0.0 110.717 179.997 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 702' ' ' LEU . . . . . 0.479 ' CB ' ' O ' ' A' ' 168' ' ' PRO . 1.2 mt . . . . . 0 CA--C 1.544 0.732 0 CA-C-O 120.55 0.214 . . . . 20.0 110.61 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 703' ' ' PRO . . . . . 0.535 ' O ' ' O ' ' B' ' 704' ' ' ALA . 2.9 Cg_endo -65.97 -176.91 0.67 Allowed 'Trans proline' 0 N--CA 1.491 1.361 0 C-N-CA 122.397 2.065 . . . . 20.0 113.84 -178.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 704' ' ' ALA . . . . . 0.535 ' O ' ' O ' ' B' ' 703' ' ' PRO . . . . . . . . 0 CA--C 1.536 0.436 0 CA-C-N 114.223 -1.353 . . . . 20.0 113.975 -179.136 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.421 ' C ' ' H ' ' A' ' 60' ' ' LYS . . . . . . . . 0 CA--C 1.532 0.258 0 CA-C-O 121.28 0.562 . . . . 0.0 110.76 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 10.8 p -79.53 25.66 0.32 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.017 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.421 ' H ' ' C ' ' A' ' 58' ' ' ALA . 72.2 mmtt -96.21 3.74 52.92 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.436 -179.467 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.0 mt -55.98 137.8 17.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 122.199 1.0 . . . . 0.0 113.351 -176.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -77.46 133.02 38.71 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 113.692 -1.595 . . . . 0.0 109.37 178.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.717 ' NE2' ' CE1' ' A' ' 126' ' ' HIS . 0.0 OUTLIER -79.8 150.85 73.13 Favored Pre-proline 0 CA--C 1.537 0.451 0 C-N-CA 119.901 -0.72 . . . . 0.0 109.798 -179.989 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -73.37 163.02 38.86 Favored 'Trans proline' 0 N--CA 1.499 1.826 0 C-N-CA 123.427 2.751 . . . . 0.0 114.086 -178.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -54.51 164.0 0.8 Allowed 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.753 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 53.4 tp -64.28 -47.37 79.79 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 121.102 0.477 . . . . 0.0 111.118 -178.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.43 -36.51 82.63 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.079 -0.648 . . . . 0.0 110.865 -178.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -61.21 -29.27 69.72 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.033 -0.667 . . . . 0.0 109.652 179.144 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 50.8 t -74.05 -43.71 51.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 121.825 0.821 . . . . 0.0 109.729 179.145 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -76.42 -8.23 56.71 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.745 -1.116 . . . . 0.0 111.434 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -105.41 -8.15 18.32 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.038 0.447 . . . . 0.0 110.38 179.008 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.22 137.5 54.84 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 121.369 0.604 . . . . 0.0 111.109 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 32.2 t -60.29 102.19 0.16 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.486 179.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.92 128.45 36.71 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.372 -179.4 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 -96.43 84.33 3.69 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 177.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -62.98 -41.49 99.56 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.272 0.558 . . . . 0.0 111.899 -179.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.446 ' CD ' ' H ' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -71.16 -8.5 53.96 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.869 -176.27 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -94.68 -13.34 25.9 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 121.211 0.529 . . . . 0.0 110.093 178.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 86.9 t -76.2 128.59 37.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.966 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 39.3 pt -113.54 -7.9 12.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.428 179.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -174.21 -175.12 41.57 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 110.431 -1.067 . . . . 0.0 110.431 179.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 39.9 ptt180 -152.1 166.71 30.81 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.472 0.653 . . . . 0.0 111.168 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 19.5 tt -114.5 142.87 25.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.223 178.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 66.1 m -135.64 126.89 28.26 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.47 0.653 . . . . 0.0 111.174 -179.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 43.3 mt -137.45 89.39 15.93 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.481 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_exo -56.5 -30.18 81.37 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.589 2.192 . . . . 0.0 112.831 -179.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 47.0 m -51.86 -40.94 61.42 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 121.185 0.516 . . . . 0.0 110.593 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 18.6 m -114.0 8.46 7.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.888 179.057 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.483 ' O ' ' OG ' ' A' ' 89' ' ' SER . 3.7 t 54.08 54.13 10.09 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 -179.498 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 66.5 tp -118.43 133.52 55.81 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 121.543 0.687 . . . . 0.0 111.166 -179.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -148.03 120.03 8.23 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.329 -0.851 . . . . 0.0 110.452 -179.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 74.6 mt -149.64 152.95 35.96 Favored Pre-proline 0 CA--C 1.537 0.479 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.644 -179.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -75.38 150.72 36.95 Favored 'Trans proline' 0 N--CA 1.497 1.735 0 C-N-CA 123.127 2.551 . . . . 0.0 112.471 179.142 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 53.0 t -99.17 120.91 49.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-O 121.173 0.511 . . . . 0.0 112.058 -179.261 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.459 ' N ' ' CD1' ' A' ' 95' ' ' LEU . 10.4 mp -104.38 134.5 47.48 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.324 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.503 ' O ' ' OG1' ' A' ' 109' ' ' THR . 98.7 mttt -61.7 -80.29 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.217 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 12.0 t -56.45 133.02 52.85 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.952 -178.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.465 ' OG ' ' O ' ' A' ' 109' ' ' THR . 1.8 m -92.53 70.5 5.0 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.756 179.35 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 41.2 m -92.37 169.98 10.14 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 178.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.446 ' O ' ' CD2' ' A' ' 104' ' ' LEU . 96.7 mt-10 -64.3 -42.46 96.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.264 0.554 . . . . 0.0 110.018 179.503 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 61.6 mttm -65.59 -38.67 90.14 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.887 179.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -64.75 -33.6 76.35 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.378 -0.828 . . . . 0.0 112.18 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 83.5 mt -68.83 -6.79 29.01 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -178.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.526 ' CD2' ' N ' ' A' ' 104' ' ' LEU . 3.9 mm? -74.77 -16.36 60.73 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 121.187 0.517 . . . . 0.0 109.635 178.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 79.2 p -81.18 -10.04 59.69 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.751 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.605 ' O ' ' CE1' ' A' ' 135' ' ' PHE . . . 92.87 -19.42 51.85 Favored Glycine 0 CA--C 1.532 1.151 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.636 178.7 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -145.72 127.35 15.18 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 119.605 -0.838 . . . . 0.0 112.661 -179.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -147.69 138.56 23.38 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.272 -0.877 . . . . 0.0 110.11 178.255 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.503 ' OG1' ' O ' ' A' ' 96' ' ' LYS . 12.3 p -69.06 135.49 50.89 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 121.316 0.579 . . . . 0.0 110.928 -179.751 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 78.7 t -78.0 -48.86 22.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.226 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.608 ' HZ3' ' CD ' ' A' ' 175' ' ' GLU . 98.5 mttt -99.06 140.14 33.67 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.801 0.81 . . . . 0.0 112.52 -179.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -65.86 -36.21 82.82 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.625 -1.17 . . . . 0.0 111.47 -179.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 73.7 m-80 -84.6 11.0 9.63 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -177.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . 0.667 ' N ' HE21 ' A' ' 114' ' ' GLN . 0.0 OUTLIER -78.92 139.19 38.32 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 120.799 0.333 . . . . 0.0 111.296 179.569 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 38.8 t -125.8 125.85 69.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 CA-C-O 121.069 0.461 . . . . 0.0 111.227 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' MET . . . . . 0.431 ' CG ' ' CZ ' ' A' ' 121' ' ' TYR . 93.1 mtp -57.11 133.56 55.11 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.126 0.489 . . . . 0.0 111.657 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 78.14 -2.7 64.58 Favored Glycine 0 CA--C 1.529 0.922 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.643 179.162 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -138.49 132.37 31.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.615 0.722 . . . . 0.0 111.784 179.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 71.14 -167.06 52.05 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 110.18 -1.168 . . . . 0.0 110.18 -179.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 64.7 t-20 -87.83 104.69 16.82 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.196 0.522 . . . . 0.0 109.714 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.431 ' CZ ' ' CG ' ' A' ' 116' ' ' MET . 5.3 t80 -87.06 99.37 11.86 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.115 -179.479 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.3 135.12 33.88 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.829 -179.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 68.3 mt -135.37 139.78 44.5 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.735 -179.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -111.37 140.87 45.59 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 178.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -141.16 129.66 4.15 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 110.482 -1.047 . . . . 0.0 110.482 -179.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . 0.717 ' CE1' ' NE2' ' A' ' 63' ' ' GLN . 1.8 m-70 -82.11 131.52 35.24 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.336 0.589 . . . . 0.0 112.098 -179.208 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . 0.588 ' ND2' ' OG1' ' A' ' 186' ' ' THR . 7.2 p30 -138.79 152.21 47.71 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.634 179.322 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' MET . . . . . 0.611 ' O ' ' N ' ' A' ' 130' ' ' LYS . 79.4 mtm -119.28 42.04 2.94 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.598 0.713 . . . . 0.0 110.161 179.179 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 38.64 15.84 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 114.919 -1.037 . . . . 0.0 112.304 178.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.611 ' N ' ' O ' ' A' ' 128' ' ' MET . 19.2 ptmt -110.61 127.32 55.19 Favored 'General case' 0 C--O 1.226 -0.176 0 CA-C-O 122.025 0.917 . . . . 0.0 112.323 -179.723 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.458 ' C ' ' O ' ' A' ' 130' ' ' LYS . 55.8 tptt -38.37 150.71 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.915 179.413 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 79.58 -17.56 8.32 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 121.045 -0.598 . . . . 0.0 112.127 179.224 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.561 ' CG1' ' O ' ' A' ' 130' ' ' LYS . 9.9 p -87.87 153.08 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-N 117.753 0.777 . . . . 0.0 110.342 -179.561 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.619 ' CD2' ' H ' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -69.45 143.53 53.54 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.594 0.711 . . . . 0.0 112.832 -177.889 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.605 ' CE1' ' O ' ' A' ' 106' ' ' GLY . 3.5 m-85 66.39 8.34 5.63 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 114.139 -1.391 . . . . 0.0 114.493 177.712 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 5.2 t -76.88 -42.68 38.9 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 179.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . 0.489 ' O ' ' OG ' ' A' ' 140' ' ' SER . 78.1 m-20 -91.82 1.31 57.26 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 114.055 1.132 . . . . 0.0 114.055 -176.682 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 48.6 pt -66.92 -23.73 31.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 C-N-CA 119.43 -0.908 . . . . 0.0 110.877 -179.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -66.53 -10.68 47.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.551 0.691 . . . . 0.0 109.856 179.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.489 ' OG ' ' O ' ' A' ' 137' ' ' ASP . 94.0 p -81.34 -2.77 50.47 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.625 -179.811 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 67.8 mt -62.73 143.54 57.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.47 0.652 . . . . 0.0 111.059 -179.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -121.57 156.83 32.05 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.216 -179.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -50.86 133.08 26.9 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.061 -0.972 . . . . 0.0 112.116 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 160' ' ' VAL . . . 79.96 8.69 87.44 Favored Glycine 0 CA--C 1.53 0.979 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.239 178.518 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.463 ' OD1' ' N ' ' A' ' 146' ' ' LYS . 60.5 t0 -74.12 133.47 42.82 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 120.277 -0.569 . . . . 0.0 110.277 -179.62 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.463 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 71.1 mmtt -79.06 140.44 37.89 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 121.84 0.829 . . . . 0.0 111.908 -179.033 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.429 HD13 HG22 ' A' ' 147' ' ' ILE . 92.6 mt -140.13 140.12 35.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 114.899 -1.046 . . . . 0.0 108.587 179.511 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -128.64 140.95 51.51 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 119.384 -0.927 . . . . 0.0 113.226 -177.08 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 19.1 mt -112.51 131.98 55.32 Favored 'General case' 0 CA--C 1.519 -0.233 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 176.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.608 ' CZ ' ' OE2' ' A' ' 155' ' ' GLU . 49.2 m-85 -108.18 107.87 18.68 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.028 -0.669 . . . . 0.0 112.468 -178.814 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -88.19 158.74 18.43 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 106.641 -1.615 . . . . 0.0 106.641 176.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 33.7 p-10 -57.45 -16.11 8.63 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 119.137 -1.025 . . . . 0.0 111.365 -177.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -114.22 -29.13 7.04 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -179.098 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -146.47 178.97 7.87 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 -176.616 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.608 ' OE2' ' CZ ' ' A' ' 150' ' ' TYR . 84.3 tt0 -130.65 136.03 48.43 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 114.681 -1.145 . . . . 0.0 109.597 178.537 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -108.94 133.62 52.69 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.779 0.288 . . . . 0.0 111.779 -178.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -93.2 112.51 24.47 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 121.262 0.553 . . . . 0.0 111.983 179.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -112.9 146.06 39.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.176 179.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -121.18 120.72 36.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.207 179.128 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.527 ' O ' ' N ' ' A' ' 144' ' ' GLY . 90.8 t -59.78 136.66 23.16 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.301 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 178.399 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 7.9 p -105.63 -25.39 12.28 Favored 'General case' 0 C--N 1.328 -0.356 0 O-C-N 123.581 0.551 . . . . 0.0 110.86 179.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 158.61 -166.09 34.22 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 120.622 -0.799 . . . . 0.0 111.405 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 32.7 m -134.08 163.1 38.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.036 -0.582 . . . . 0.0 109.722 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 11.8 p -148.87 161.1 42.52 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.315 0.578 . . . . 0.0 111.477 -179.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -103.39 117.18 33.89 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.759 179.151 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 22.7 m -135.18 156.16 38.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.802 -179.226 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -85.14 157.59 59.32 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.508 179.438 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . 0.502 ' O ' ' CB ' ' B' ' 702' ' ' LEU . 19.5 Cg_endo -62.71 -15.66 48.01 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 C-N-CA 122.78 2.32 . . . . 0.0 113.665 -179.685 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . 0.626 ' O ' ' NE1' ' A' ' 171' ' ' TRP . 39.3 p-10 -92.84 -6.72 48.17 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 119.48 -0.888 . . . . 0.0 111.917 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -78.1 85.07 4.32 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.357 -0.537 . . . . 0.0 111.824 179.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' TRP . . . . . 0.626 ' NE1' ' O ' ' A' ' 169' ' ' ASP . 0.0 OUTLIER -75.02 -8.51 56.72 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.428 0.632 . . . . 0.0 110.185 179.159 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 53.3 tp10 -64.77 -29.1 70.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.537 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 35.1 m -62.88 -22.21 29.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.37 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 31.5 m -105.2 -3.46 9.76 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.608 ' CD ' ' HZ3' ' A' ' 111' ' ' LYS . 63.3 mm-40 -71.96 150.68 43.88 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.31 0.576 . . . . 0.0 111.202 179.586 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 38.7 p-10 -67.97 141.8 56.17 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.051 -179.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 78.7 m80 -117.43 23.26 11.9 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.914 0.388 . . . . 0.0 111.411 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 62.06 43.2 99.47 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 110.759 -0.937 . . . . 0.0 110.759 -179.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 12.5 ptmt -164.87 168.44 17.69 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.064 0.459 . . . . 0.0 110.301 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -86.99 100.9 12.94 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 177.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 77.5 tt0 -132.55 160.95 35.09 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.335 0.588 . . . . 0.0 111.32 -178.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 18.7 tt -128.65 138.17 55.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.619 179.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 60.6 m -132.52 126.18 32.29 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.883 -179.178 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 70.7 mt -111.97 134.44 53.52 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.633 179.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 92.9 mt -115.9 123.42 71.19 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 CA-C-O 121.482 0.658 . . . . 0.0 110.732 -179.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 186' ' ' THR . . . . . 0.588 ' OG1' ' ND2' ' A' ' 127' ' ' ASN . 13.2 t -138.69 158.65 43.84 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.97 -179.774 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 187' ' ' CYS . . . . . . . . . . . . . 91.7 m -89.57 139.2 30.78 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.886 0.374 . . . . 0.0 110.591 -179.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . 0.499 ' CG1' ' O ' ' A' ' 192' ' ' ASP . 11.9 p -62.33 -44.56 99.31 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-O 120.968 0.414 . . . . 0.0 110.806 -179.259 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 189' ' ' SER . . . . . 0.466 ' N ' ' CG1' ' A' ' 188' ' ' VAL . 23.9 m -167.52 153.43 7.61 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.252 0.548 . . . . 0.0 111.286 -179.626 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 70.1 t -72.43 -17.69 18.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.256 178.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -96.04 -11.86 25.78 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.251 179.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . 0.499 ' O ' ' CG1' ' A' ' 188' ' ' VAL . 49.5 t0 -141.15 98.62 3.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.171 0.51 . . . . 0.0 111.307 -179.409 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -98.81 9.83 42.58 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.542 0.687 . . . . 0.0 109.75 179.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 25.3 m -60.13 -42.68 95.33 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.785 -178.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt -133.89 150.19 51.34 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 120.979 0.419 . . . . 0.0 111.346 -179.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . 0.436 HH21 HD11 ' B' ' 702' ' ' LEU . 42.7 mtm180 -128.26 141.45 51.45 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 121.122 0.487 . . . . 0.0 110.48 179.548 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -98.04 137.6 36.59 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.331 0.586 . . . . 0.0 111.708 -179.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 35.1 t -118.27 134.93 60.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.428 178.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 68.6 t -103.45 134.51 44.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.013 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -117.0 138.21 51.72 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 121.449 0.642 . . . . 0.0 111.666 -179.124 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -139.81 130.98 4.93 Favored Glycine 0 CA--C 1.529 0.95 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 179.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -95.89 142.07 28.57 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.253 0.549 . . . . 0.0 111.049 -179.411 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 52.0 tp -67.03 133.22 49.49 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 121.527 0.679 . . . . 0.0 110.186 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 74.9 t -105.6 -51.6 7.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.233 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -152.36 174.94 31.2 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 120.193 -1.003 . . . . 0.0 112.576 -178.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 18.0 m -142.4 138.33 31.06 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 114.892 -0.654 . . . . 0.0 110.711 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 54.6 mtmt -146.35 128.0 15.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.262 0.554 . . . . 0.0 111.885 178.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -62.04 142.07 57.73 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.61 -179.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -79.24 108.23 12.59 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.429 178.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 99.2 mttt . . . . . 0 C--O 1.218 -0.588 0 CA-C-O 117.921 -1.038 . . . . 0.0 110.537 -179.98 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 702' ' ' LEU . . . . . 0.502 ' CB ' ' O ' ' A' ' 168' ' ' PRO . 0.6 OUTLIER . . . . . 0 CA--C 1.543 0.675 0 CA-C-O 120.378 0.132 . . . . 20.0 110.81 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 703' ' ' PRO . . . . . 0.41 ' O ' ' O ' ' B' ' 704' ' ' ALA . 2.4 Cg_endo -64.55 -172.64 0.2 Allowed 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 122.053 1.835 . . . . 20.0 113.482 -178.497 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 704' ' ' ALA . . . . . 0.41 ' O ' ' O ' ' B' ' 703' ' ' PRO . . . . . . . . 0 C--N 1.326 -0.44 0 CA-C-N 114.098 -1.41 . . . . 20.0 112.424 -179.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.265 0 CA-C-O 121.049 0.452 . . . . 0.0 111.383 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 3.9 p -83.18 21.3 1.12 Allowed 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.124 0.488 . . . . 0.0 111.347 -179.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -106.04 15.8 25.94 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.877 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.407 HG21 HD12 ' A' ' 61' ' ' ILE . 96.3 mt -55.37 137.0 17.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 122.315 1.055 . . . . 0.0 112.527 -177.05 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -77.84 133.38 38.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 113.687 -1.597 . . . . 0.0 109.097 179.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.539 ' H ' ' CD ' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -77.57 152.16 80.69 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-O 121.109 0.48 . . . . 0.0 110.813 -178.476 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -74.01 156.42 47.53 Favored 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 123.249 2.632 . . . . 0.0 113.151 -179.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.442 ' O ' ' OE1' ' A' ' 68' ' ' GLU . 39.0 t70 -54.0 172.83 0.07 Allowed 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.073 179.724 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.406 ' H ' ' CG ' ' A' ' 65' ' ' ASP . 86.1 mt -69.55 -13.36 62.29 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.199 -178.509 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -68.11 -37.62 81.35 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.5 0.667 . . . . 0.0 110.455 179.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.553 ' O ' ' CB ' ' A' ' 72' ' ' ALA . 58.9 mp0 -68.16 -31.33 70.81 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.841 -1.072 . . . . 0.0 110.546 179.364 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 8.3 t -71.27 -44.85 72.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.575 -179.457 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -81.92 -13.14 57.93 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.031 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -114.88 1.45 14.06 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 121.252 0.549 . . . . 0.0 110.345 178.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.553 ' CB ' ' O ' ' A' ' 68' ' ' GLU . . . -67.77 -173.5 0.35 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.517 0.675 . . . . 0.0 112.161 -179.019 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.6 t -102.3 95.38 6.25 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 114.887 -1.051 . . . . 0.0 109.786 179.073 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.472 ' CD1' ' C ' ' A' ' 74' ' ' LEU . 0.5 OUTLIER -68.79 103.39 1.76 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.899 -179.376 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.454 ' OD2' ' CD ' ' A' ' 78' ' ' GLN . 46.0 t0 -93.2 82.62 4.54 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.623 0.725 . . . . 0.0 109.751 178.483 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -80.15 -30.32 38.91 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.068 -0.969 . . . . 0.0 112.011 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 35.7 mmtt -68.16 -30.92 70.16 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.13 -176.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.454 ' CD ' ' OD2' ' A' ' 75' ' ' ASP . 86.0 mt-30 -87.47 2.32 50.94 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.441 -0.504 . . . . 0.0 111.688 -179.101 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 67.8 t -75.65 130.51 36.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.323 0.582 . . . . 0.0 109.927 179.291 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 16.2 pt -107.29 -7.35 10.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.994 -179.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -175.27 179.27 46.62 Favored Glycine 0 CA--C 1.527 0.793 0 C-N-CA 120.693 -0.765 . . . . 0.0 111.26 179.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 38.7 ptt180 -152.69 155.35 37.09 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.474 0.654 . . . . 0.0 111.569 179.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 20.4 tt -105.05 147.83 10.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.793 -179.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 9.2 t -136.03 131.4 34.9 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.473 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 96.3 mt -137.19 88.71 17.13 Favored Pre-proline 0 CA--C 1.54 0.584 0 CA-C-N 115.41 -0.813 . . . . 0.0 110.846 -179.173 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -56.31 -31.03 83.18 Favored 'Trans proline' 0 N--CA 1.499 1.804 0 C-N-CA 123.043 2.495 . . . . 0.0 112.683 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 99.1 p -53.6 -44.18 69.23 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 121.333 0.587 . . . . 0.0 110.738 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 12.5 m -113.72 11.61 8.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.891 178.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.4 t 44.74 57.0 4.81 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.651 -179.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 57.7 tp -117.78 136.64 53.26 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.296 179.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -146.13 124.79 12.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.68 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 77.4 mt -148.72 150.13 32.45 Favored Pre-proline 0 CA--C 1.535 0.38 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.53 -178.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.07 148.11 34.57 Favored 'Trans proline' 0 N--CA 1.491 1.351 0 C-N-CA 122.526 2.151 . . . . 0.0 111.707 178.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 88.9 t -96.81 116.73 39.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 CA-C-O 121.006 0.432 . . . . 0.0 111.587 -179.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.518 ' N ' ' CD1' ' A' ' 95' ' ' LEU . 8.7 mp -100.37 138.79 36.95 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.151 0.5 . . . . 0.0 110.7 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.486 ' O ' ' OG1' ' A' ' 109' ' ' THR . 98.3 mttt -66.13 -79.28 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.425 0.631 . . . . 0.0 112.181 -179.005 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 40.7 t -57.54 133.66 55.44 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.935 -178.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 43.4 p -88.41 66.05 8.17 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.549 179.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.441 ' OG1' ' CG ' ' A' ' 102' ' ' ASN . 31.6 p -86.7 167.45 14.46 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 178.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -63.78 -41.39 97.96 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.233 0.539 . . . . 0.0 110.239 179.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -66.28 -39.83 89.66 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.589 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.441 ' CG ' ' OG1' ' A' ' 99' ' ' THR . 8.9 m120 -63.72 -34.79 78.66 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -178.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 70.4 mt -62.71 -17.16 60.23 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -178.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 10.8 mp -73.21 -16.29 61.42 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 120.286 -0.565 . . . . 0.0 110.403 179.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.5 m -78.43 -7.28 57.2 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 178.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.449 ' O ' ' CE1' ' A' ' 135' ' ' PHE . . . 91.54 -18.8 51.14 Favored Glycine 0 CA--C 1.534 1.262 0 CA-C-N 114.926 -1.034 . . . . 0.0 113.233 177.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -146.72 127.07 13.96 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 119.563 -0.855 . . . . 0.0 113.08 -179.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -144.73 137.06 26.26 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.922 178.323 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.486 ' OG1' ' O ' ' A' ' 96' ' ' LYS . 69.2 p -69.95 138.43 52.33 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.364 0.602 . . . . 0.0 111.189 -179.493 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 74.1 t -79.16 -53.05 14.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.71 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.67 ' H ' ' NE2' ' A' ' 114' ' ' GLN . 53.6 mtmt -100.69 134.71 43.26 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 121.831 0.824 . . . . 0.0 112.645 -179.002 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -66.63 -30.63 70.94 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 114.51 -1.223 . . . . 0.0 112.477 -179.194 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 75.1 m-80 -84.37 11.21 8.85 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 -177.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . 0.67 ' NE2' ' H ' ' A' ' 111' ' ' LYS . 22.2 mt-30 -81.16 143.3 32.48 Favored 'General case' 0 C--N 1.328 -0.326 0 O-C-N 121.904 -0.497 . . . . 0.0 111.347 178.762 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.424 ' O ' ' O ' ' A' ' 118' ' ' LYS . 51.4 t -122.54 124.28 70.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.246 -0.434 . . . . 0.0 109.92 178.638 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 99.3 mtp -58.25 127.0 29.92 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 121.324 0.583 . . . . 0.0 111.471 -179.281 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 91.62 -4.75 79.73 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 110.606 -0.997 . . . . 0.0 110.606 179.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.424 ' O ' ' O ' ' A' ' 115' ' ' VAL . 87.5 tttt -142.48 130.96 22.4 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.113 0.482 . . . . 0.0 110.614 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 80.39 -174.28 54.94 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 -179.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 63.9 t-20 -90.75 107.1 18.96 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 179.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -85.41 99.31 11.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.242 0.544 . . . . 0.0 110.23 -179.384 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.84 136.16 33.25 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.479 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 67.4 mt -134.07 139.14 45.77 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.491 -0.484 . . . . 0.0 111.469 -179.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -112.77 143.72 43.53 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 178.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -142.42 151.82 23.28 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.164 -1.174 . . . . 0.0 110.164 -178.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 4.7 m-70 -89.24 126.03 35.33 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.592 0.711 . . . . 0.0 111.874 -179.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . 0.424 ' ND2' ' HA ' ' A' ' 136' ' ' SER . 35.1 t30 -129.12 125.18 36.56 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 114.931 -1.031 . . . . 0.0 110.681 179.504 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' MET . . . . . 0.55 ' O ' ' OG ' ' A' ' 129' ' ' SER . 78.1 mtm -102.53 -1.72 29.94 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.351 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.55 ' OG ' ' O ' ' A' ' 128' ' ' MET . 6.2 p 77.78 10.23 2.24 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.473 179.77 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.521 ' O ' ' CG1' ' A' ' 133' ' ' VAL . 5.9 ptmt -110.42 118.15 35.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.474 0.654 . . . . 0.0 112.427 -179.274 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.496 ' C ' ' O ' ' A' ' 130' ' ' LYS . 29.1 tptt -32.98 149.89 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 114.926 -1.034 . . . . 0.0 109.554 178.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.428 ' N ' ' HG3' ' A' ' 131' ' ' LYS . . . 82.82 -15.49 31.43 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 111.064 -0.814 . . . . 0.0 111.064 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.521 ' CG1' ' O ' ' A' ' 130' ' ' LYS . 8.0 p -94.22 151.68 3.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.04 -0.664 . . . . 0.0 111.174 -179.041 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.553 ' CD2' ' H ' ' A' ' 134' ' ' LEU . 0.1 OUTLIER -68.04 147.16 52.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.88 0.848 . . . . 0.0 112.96 -177.774 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.449 ' CE1' ' O ' ' A' ' 106' ' ' GLY . 3.0 m-85 65.2 4.85 2.76 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 113.943 -1.481 . . . . 0.0 114.266 177.528 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' SER . . . . . 0.424 ' HA ' ' ND2' ' A' ' 127' ' ' ASN . 28.1 p -76.51 -35.22 58.46 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 120.147 -0.621 . . . . 0.0 111.908 178.79 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . 0.421 ' N ' ' OD1' ' A' ' 137' ' ' ASP . 36.6 p-10 -94.75 2.09 55.5 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 114.543 1.312 . . . . 0.0 114.543 -177.533 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 45.6 pt -69.22 -20.38 24.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 C-N-CA 119.06 -1.056 . . . . 0.0 110.466 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -68.38 -9.91 51.46 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.191 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 49.7 m -82.96 -5.01 58.9 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.554 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 89.0 mt -64.56 143.77 57.68 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 121.276 0.56 . . . . 0.0 110.764 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.402 ' HG2' ' N ' ' A' ' 143' ' ' LYS . 88.2 tttt -119.79 157.46 28.57 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.569 -179.003 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . 0.402 ' N ' ' HG2' ' A' ' 142' ' ' LYS . 87.8 tttt -50.02 129.52 20.78 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.381 179.366 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.541 ' N ' ' O ' ' A' ' 160' ' ' VAL . . . 83.13 8.96 84.78 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 120.358 -0.925 . . . . 0.0 112.371 178.531 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 47.5 t0 -73.66 130.25 39.63 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 120.076 -0.65 . . . . 0.0 110.679 -179.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -76.61 141.05 41.21 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 121.602 0.715 . . . . 0.0 111.485 -179.001 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.415 HD13 HG21 ' A' ' 147' ' ' ILE . 95.5 mt -137.67 138.66 44.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.063 -0.971 . . . . 0.0 108.815 178.711 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -119.89 133.94 55.41 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 -177.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -111.38 132.29 54.54 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 114.594 -1.184 . . . . 0.0 108.022 177.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -112.18 108.26 17.44 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.205 -0.598 . . . . 0.0 112.119 -178.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . 0.577 ' OD1' ' N ' ' A' ' 152' ' ' ASN . 57.1 t0 -89.42 158.35 17.78 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 177.54 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . 0.577 ' N ' ' OD1' ' A' ' 151' ' ' ASP . 36.8 p-10 -54.85 -20.07 7.9 Favored 'General case' 0 C--N 1.312 -1.042 0 C-N-CA 120.118 -0.633 . . . . 0.0 110.897 -177.817 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -112.49 -29.69 7.4 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 -178.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . 0.425 ' O ' ' N ' ' A' ' 151' ' ' ASP . 0.2 OUTLIER -148.86 -178.42 6.35 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.957 0.885 . . . . 0.0 113.244 -177.205 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -128.52 137.85 51.96 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 114.483 -1.235 . . . . 0.0 109.813 179.193 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -113.61 138.28 50.39 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 121.155 0.503 . . . . 0.0 111.296 -179.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -98.99 114.95 27.85 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 121.296 0.57 . . . . 0.0 111.917 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 45.8 m-85 -113.49 147.11 38.5 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.238 0.542 . . . . 0.0 111.033 179.108 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -120.22 120.27 35.65 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.576 179.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.541 ' O ' ' N ' ' A' ' 144' ' ' GLY . 73.1 t -58.37 136.28 21.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 178.075 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 34.0 p -105.07 -26.79 11.97 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 123.425 0.453 . . . . 0.0 111.803 -179.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 167.1 -175.95 42.16 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 120.143 -1.027 . . . . 0.0 111.882 -179.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 47.7 t -129.22 138.12 55.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 114.8 -0.7 . . . . 0.0 109.465 179.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 20.9 t -137.28 167.51 21.44 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.554 0.692 . . . . 0.0 111.91 -178.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . 0.421 ' CG ' ' CE2' ' A' ' 197' ' ' TYR . 95.5 mt-10 -107.95 122.84 47.65 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.06 -179.619 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 32.6 m -136.93 160.97 36.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.882 179.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -84.76 158.72 59.1 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.357 179.322 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.99 -13.43 39.81 Favored 'Trans proline' 0 C--N 1.303 -1.826 0 C-N-CA 123.169 2.579 . . . . 0.0 113.363 -179.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 35.7 p30 -96.54 -6.89 35.93 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 -179.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -75.55 113.22 12.73 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 -177.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' TRP . . . . . 0.405 ' N ' ' CD1' ' A' ' 171' ' ' TRP . 35.4 m0 -83.24 -22.06 33.2 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.862 179.075 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -54.53 -38.79 66.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.534 -177.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 31.0 m -64.51 -13.41 14.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.022 0.439 . . . . 0.0 111.338 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 76.4 t -111.58 -20.23 6.38 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -178.162 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.411 ' HA ' ' HZ1' ' A' ' 111' ' ' LYS . 94.1 mt-10 -70.35 142.4 52.15 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.386 0.613 . . . . 0.0 111.773 -179.384 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . 0.434 ' OD1' ' O ' ' A' ' 176' ' ' ASP . 46.0 p-10 -66.44 138.34 57.48 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 115.641 -0.708 . . . . 0.0 111.175 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 79.7 m80 -111.68 25.42 11.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.357 179.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 65.28 42.82 96.01 Favored Glycine 0 CA--C 1.532 1.102 0 N-CA-C 111.099 -0.801 . . . . 0.0 111.099 179.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 11.8 ptmt -161.4 166.93 26.61 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 120.94 0.4 . . . . 0.0 110.585 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -85.57 104.83 15.68 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 177.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . 0.43 ' HG2' ' N ' ' A' ' 182' ' ' ILE . 82.9 tt0 -136.15 162.0 34.16 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.395 0.617 . . . . 0.0 111.667 -178.411 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.43 ' N ' ' HG2' ' A' ' 181' ' ' GLU . 18.4 tt -129.32 137.79 56.07 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.038 178.078 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 52.4 m -133.94 127.4 32.35 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 120.979 0.419 . . . . 0.0 111.232 -179.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 71.2 mt -108.65 130.87 55.33 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.13 179.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 91.2 mt -113.68 125.93 71.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.136 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 2.2 t -142.08 163.22 33.46 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.884 179.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 187' ' ' CYS . . . . . . . . . . . . . 4.8 m -86.12 140.83 29.86 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . 0.558 ' CG1' ' O ' ' A' ' 192' ' ' ASP . 9.9 p -62.48 -48.55 87.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.093 0.473 . . . . 0.0 111.129 -179.198 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 189' ' ' SER . . . . . 0.439 ' N ' ' CG1' ' A' ' 188' ' ' VAL . 79.0 p -167.71 156.08 9.24 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.092 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 13.8 p -70.6 -18.81 21.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.21 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -96.84 -15.12 21.42 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . 0.558 ' O ' ' CG1' ' A' ' 188' ' ' VAL . 63.5 t0 -130.73 105.68 7.96 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 120.638 -0.425 . . . . 0.0 111.456 -179.728 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 48.8 p-10 -107.33 12.79 27.74 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 120.78 0.324 . . . . 0.0 111.345 179.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 9.6 t -60.83 -46.66 89.67 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 120.951 0.405 . . . . 0.0 111.906 -179.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 63.3 pttt -144.51 155.64 43.79 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 179.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 84.9 mtt85 -127.38 149.51 50.04 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.363 0.601 . . . . 0.0 111.914 -179.046 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . 0.421 ' CE2' ' CG ' ' A' ' 165' ' ' GLU . 53.3 m-85 -92.93 142.58 27.15 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.741 -178.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 25.0 t -129.21 133.52 65.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.696 179.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 53.0 t -101.84 132.67 47.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.236 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -118.15 147.86 42.91 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.125 0.488 . . . . 0.0 110.462 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -148.61 143.07 10.55 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 -179.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 50.9 p30 -107.1 156.3 18.93 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.282 0.563 . . . . 0.0 111.48 -179.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 46.7 tp -77.59 130.87 37.45 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.266 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 15.7 m -114.91 -15.91 9.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.376 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -178.39 173.19 45.64 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 119.522 -1.323 . . . . 0.0 113.097 179.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 57.4 m -142.26 137.95 31.04 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.238 -0.981 . . . . 0.0 109.864 179.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 52.6 mtmt -144.03 114.83 7.74 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.184 0.516 . . . . 0.0 111.529 -179.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -65.77 148.59 51.52 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.551 0.691 . . . . 0.0 111.986 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -79.63 109.1 13.7 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.848 178.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 98.0 mttt . . . . . 0 C--O 1.221 -0.422 0 CA-C-O 117.883 -1.056 . . . . 0.0 110.682 179.712 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 702' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.535 0.399 0 CA-C-O 121.34 0.591 . . . . 20.0 111.101 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 703' ' ' PRO . . . . . 0.516 ' O ' ' O ' ' B' ' 704' ' ' ALA . 3.6 Cg_exo -77.01 -161.66 0.14 Allowed 'Trans proline' 0 C--N 1.305 -1.739 0 C-N-CA 123.305 2.67 . . . . 20.0 113.831 -179.612 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 704' ' ' ALA . . . . . 0.516 ' O ' ' O ' ' B' ' 703' ' ' PRO . . . . . . . . 0 C--N 1.325 -0.475 0 CA-C-N 113.863 -1.517 . . . . 20.0 112.744 -179.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.473 ' C ' ' H ' ' A' ' 60' ' ' LYS . . . . . . . . 0 N--CA 1.454 -0.237 0 CA-C-O 121.212 0.53 . . . . 0.0 110.637 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.468 ' O ' ' NH2' ' A' ' 196' ' ' ARG . 3.7 p -79.02 22.59 0.39 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.266 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.473 ' H ' ' C ' ' A' ' 58' ' ' ALA . 98.9 mttt -102.15 9.72 39.95 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.128 -179.365 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.8 mt -55.23 139.8 13.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 122.416 1.103 . . . . 0.0 111.869 -177.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.536 ' OD1' ' N ' ' A' ' 62' ' ' ASP . 20.0 p-10 -76.45 128.69 35.29 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 113.528 -1.669 . . . . 0.0 109.551 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.475 ' CD ' ' H ' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -78.86 129.02 74.85 Favored Pre-proline 0 CA--C 1.542 0.654 0 C-N-CA 120.449 -0.5 . . . . 0.0 110.536 -179.025 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -53.41 147.86 35.79 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 C-N-CA 122.129 1.886 . . . . 0.0 112.855 178.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.452 ' CG ' ' H ' ' A' ' 66' ' ' LEU . 27.4 t70 -53.2 177.84 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.77 -179.489 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.452 ' H ' ' CG ' ' A' ' 65' ' ' ASP . 92.1 mt -63.6 -43.8 95.85 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.196 -178.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.09 -36.68 82.43 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 119.761 -0.776 . . . . 0.0 110.336 -179.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -61.31 -35.21 76.73 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.751 0.786 . . . . 0.0 109.042 178.22 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 62.0 t -73.87 -43.26 53.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.917 179.003 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -70.53 -9.71 57.38 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.624 -179.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -118.33 -1.82 11.23 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 121.526 0.679 . . . . 0.0 109.837 179.189 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -70.05 -175.51 0.96 Allowed 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.648 -179.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 6.6 t -94.9 105.42 17.34 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.119 179.15 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 42.0 tp -69.95 135.02 48.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.691 -179.016 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.417 ' OD2' ' OD1' ' A' ' 102' ' ' ASN . 91.3 m-20 -116.06 77.57 1.11 Allowed 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 121.845 0.831 . . . . 0.0 109.36 177.82 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.483 ' O ' ' CG1' ' A' ' 79' ' ' VAL . 86.5 tttt -84.89 -40.32 17.19 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.678 -1.146 . . . . 0.0 112.148 -179.753 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 52.1 mmtt -73.14 -12.89 61.05 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.707 -176.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -94.92 2.1 55.36 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.224 0.535 . . . . 0.0 110.194 179.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.487 ' O ' ' CG1' ' A' ' 79' ' ' VAL . 11.6 p -72.06 115.1 11.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 121.371 0.605 . . . . 0.0 110.833 -179.576 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 32.8 pt -102.84 -7.78 9.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.807 179.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -163.31 158.53 30.94 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 120.637 -0.792 . . . . 0.0 111.339 179.16 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 33.6 ttm180 -133.43 140.01 47.06 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 121.309 0.576 . . . . 0.0 111.334 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 5.1 tt -111.31 142.52 23.44 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.615 179.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 73.8 m -137.45 133.7 34.98 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 115.138 -0.937 . . . . 0.0 112.946 -178.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 66.6 mt -135.61 87.62 25.89 Favored Pre-proline 0 CA--C 1.54 0.558 0 CA-C-O 121.444 0.64 . . . . 0.0 111.034 179.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -55.87 -33.17 87.77 Favored 'Trans proline' 0 N--CA 1.498 1.757 0 C-N-CA 123.309 2.672 . . . . 0.0 112.431 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 28.2 m -52.78 -41.11 63.79 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 121.143 0.497 . . . . 0.0 110.415 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 30.6 m -115.51 13.0 7.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.754 179.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 2.5 p 47.37 52.24 12.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.269 0.557 . . . . 0.0 111.101 -179.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 60.0 tp -119.93 135.25 54.97 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.379 0.609 . . . . 0.0 110.834 179.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -148.92 127.46 12.35 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.866 179.338 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 83.5 mt -149.84 147.85 23.72 Favored Pre-proline 0 CA--C 1.541 0.629 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.458 -178.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -74.12 150.25 42.45 Favored 'Trans proline' 0 N--CA 1.501 1.949 0 C-N-CA 122.881 2.387 . . . . 0.0 112.117 179.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 89.4 t -95.0 125.36 47.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-O 121.26 0.553 . . . . 0.0 111.279 179.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.468 ' N ' ' CD1' ' A' ' 95' ' ' LEU . 10.1 mp -109.34 142.1 40.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.838 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.536 ' O ' ' OG1' ' A' ' 109' ' ' THR . 19.1 ttmt -74.5 -76.19 0.14 Allowed 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 116.103 -0.499 . . . . 0.0 112.148 -178.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 33.4 t -59.62 129.59 42.66 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.185 0.517 . . . . 0.0 111.982 -178.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.407 ' OG ' ' O ' ' A' ' 109' ' ' THR . 23.0 m -87.19 69.48 10.08 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.947 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.415 ' H ' ' HB2' ' A' ' 102' ' ' ASN . 44.4 m -90.27 165.1 14.11 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 178.721 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -58.2 -45.57 87.35 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 119.972 -0.691 . . . . 0.0 110.185 -179.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -65.06 -41.59 95.0 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.217 178.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.417 ' OD1' ' OD2' ' A' ' 75' ' ' ASP . 94.9 m-20 -62.98 -39.71 95.55 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.103 -179.646 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 65.3 mt -61.59 -28.39 69.31 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.695 179.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 98.6 mt -73.98 -15.73 61.1 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.194 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.434 ' HG ' ' CD2' ' A' ' 95' ' ' LEU . 0.7 OUTLIER -71.59 -7.64 48.99 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.466 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.482 ' O ' ' CE1' ' A' ' 135' ' ' PHE . . . 98.84 -22.11 42.61 Favored Glycine 0 CA--C 1.531 1.057 0 CA-C-N 114.701 -1.136 . . . . 0.0 113.447 177.039 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -147.2 125.86 12.56 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 119.643 -0.823 . . . . 0.0 112.211 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -142.03 135.99 29.79 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.698 179.235 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.536 ' OG1' ' O ' ' A' ' 96' ' ' LYS . 71.6 p -69.59 132.16 45.79 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 121.224 0.535 . . . . 0.0 110.515 -179.554 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 53.6 t -79.07 -50.7 18.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.174 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.755 ' H ' ' NE2' ' A' ' 114' ' ' GLN . 82.5 mttt -102.91 138.19 40.11 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.57 0.7 . . . . 0.0 112.349 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -66.17 -32.58 74.11 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.016 -0.993 . . . . 0.0 112.862 -178.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -82.42 13.51 3.58 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -178.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . 0.755 ' NE2' ' H ' ' A' ' 111' ' ' LYS . 31.4 mt-30 -80.22 136.06 36.39 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.238 0.542 . . . . 0.0 111.341 179.709 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 71.3 t -123.59 127.91 74.28 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.759 179.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' MET . . . . . 0.659 ' SD ' ' CE2' ' A' ' 121' ' ' TYR . 85.3 mmm -55.1 126.02 22.98 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -179.178 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 82.86 -3.27 84.31 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.456 178.098 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -137.21 131.85 33.03 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.063 -0.655 . . . . 0.0 110.867 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 75.03 -174.33 51.81 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 110.226 -1.15 . . . . 0.0 110.226 -179.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . 0.593 ' ND2' ' ND1' ' A' ' 177' ' ' HIS . 62.4 m-20 -84.53 105.04 15.05 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.363 -0.535 . . . . 0.0 109.739 179.548 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.659 ' CE2' ' SD ' ' A' ' 116' ' ' MET . 2.2 t80 -86.34 98.71 11.13 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 120.539 -0.465 . . . . 0.0 110.209 -179.797 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.59 138.05 31.87 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.275 0.56 . . . . 0.0 111.288 -179.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 67.7 mt -135.14 138.59 43.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.435 -179.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -106.82 134.95 49.19 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 178.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -134.6 148.43 19.51 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 -179.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 8.0 m-70 -91.83 136.11 33.4 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.53 0.681 . . . . 0.0 111.805 -179.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 39.2 t30 -132.6 124.96 29.36 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 114.966 -1.016 . . . . 0.0 111.341 -179.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' MET . . . . . 0.443 ' O ' ' CB ' ' A' ' 129' ' ' SER . 65.1 mtt -100.78 -5.81 25.8 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.517 0.675 . . . . 0.0 110.322 179.49 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.443 ' CB ' ' O ' ' A' ' 128' ' ' MET . 0.9 OUTLIER 77.62 12.23 2.01 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.747 178.886 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.468 ' H ' HG13 ' A' ' 133' ' ' VAL . 64.1 pttt -109.85 122.78 48.31 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 122.274 1.035 . . . . 0.0 112.303 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -44.29 119.05 1.69 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.898 179.228 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 117.42 -15.33 13.05 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 -179.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.468 HG13 ' H ' ' A' ' 130' ' ' LYS . 10.6 p -92.73 153.34 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 CA-C-O 120.991 0.424 . . . . 0.0 109.941 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.692 ' CD2' ' H ' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -71.43 146.47 48.65 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.816 0.817 . . . . 0.0 113.088 -177.936 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.482 ' CE1' ' O ' ' A' ' 106' ' ' GLY . 3.6 m-85 66.4 5.34 3.69 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 113.984 -1.462 . . . . 0.0 114.452 178.225 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 23.6 p -75.71 -29.37 58.94 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 119.936 -0.705 . . . . 0.0 112.509 179.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . 0.447 ' N ' ' OD1' ' A' ' 137' ' ' ASP . 31.6 p-10 -92.05 4.79 52.32 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 -176.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 39.2 pt -67.43 -25.73 34.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 C-N-CA 119.016 -1.073 . . . . 0.0 110.493 -179.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -68.02 -13.79 62.47 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.451 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 54.6 p -83.53 -5.63 59.22 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.164 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 88.6 mt -63.43 145.66 55.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.37 0.605 . . . . 0.0 111.275 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -119.32 151.67 38.06 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.574 -179.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -48.98 130.59 18.51 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.114 179.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.609 ' N ' ' O ' ' A' ' 160' ' ' VAL . . . 79.85 8.34 87.76 Favored Glycine 0 CA--C 1.524 0.651 0 C-N-CA 120.847 -0.692 . . . . 0.0 111.453 179.061 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.541 ' OD1' ' N ' ' A' ' 146' ' ' LYS . 53.0 t0 -71.37 130.68 41.95 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 119.519 -0.872 . . . . 0.0 109.866 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.541 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 74.8 mmtt -78.61 142.12 37.5 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 122.044 0.925 . . . . 0.0 111.958 -178.269 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 95.6 mt -136.65 138.49 46.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 114.168 -1.378 . . . . 0.0 108.538 178.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -130.54 143.13 50.56 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 119.981 -0.688 . . . . 0.0 112.537 -178.24 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.524 ' CD1' ' N ' ' A' ' 149' ' ' LEU . 0.0 OUTLIER -143.96 157.77 44.13 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.097 176.788 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.498 ' CD1' ' N ' ' A' ' 150' ' ' TYR . 0.5 OUTLIER -123.53 133.14 54.04 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -177.775 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . 0.521 ' O ' ' NZ ' ' A' ' 209' ' ' LYS . 0.7 OUTLIER -91.04 168.4 11.67 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 105.991 -1.855 . . . . 0.0 105.991 175.804 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 -58.5 -25.76 62.71 Favored 'General case' 0 C--N 1.307 -1.274 0 C-N-CA 119.183 -1.007 . . . . 0.0 110.798 -179.448 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 -110.03 -27.16 9.34 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -178.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -145.31 -172.72 3.93 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 114.608 1.336 . . . . 0.0 114.608 -176.268 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 77.5 tt0 -133.75 134.56 43.12 Favored 'General case' 0 C--N 1.339 0.145 0 CA-C-N 114.508 -1.223 . . . . 0.0 110.045 179.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -114.68 136.37 53.13 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-O 121.34 0.59 . . . . 0.0 110.92 -179.574 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -96.63 114.83 26.52 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.392 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 -114.62 147.95 38.8 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 120.755 0.312 . . . . 0.0 110.868 179.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -126.57 126.66 44.01 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.269 0.557 . . . . 0.0 110.622 178.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.609 ' O ' ' N ' ' A' ' 144' ' ' GLY . 42.8 t -59.79 134.99 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.624 178.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 68.4 p -107.49 -28.75 9.62 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.253 0.549 . . . . 0.0 110.483 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 165.97 -172.34 41.33 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 111.352 -0.699 . . . . 0.0 111.352 179.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 2.3 p -134.39 148.91 29.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 179.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' SER . . . . . 0.557 ' HG ' ' N ' ' A' ' 165' ' ' GLU . 22.9 t -138.29 167.71 21.29 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.465 0.65 . . . . 0.0 111.43 -179.358 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . 0.557 ' N ' ' HG ' ' A' ' 164' ' ' SER . 75.0 tt0 -111.35 119.43 38.83 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.796 -179.191 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . 0.444 ' O ' ' O ' ' A' ' 196' ' ' ARG . 32.3 m -136.2 157.54 37.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.01 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -80.65 160.72 66.3 Favored Pre-proline 0 C--N 1.32 -0.676 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.147 -179.418 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . 0.469 ' O ' ' CB ' ' B' ' 702' ' ' LEU . 33.8 Cg_endo -65.51 -18.11 58.81 Favored 'Trans proline' 0 N--CA 1.502 1.983 0 C-N-CA 122.977 2.451 . . . . 0.0 113.461 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 42.6 p-10 -91.23 -1.6 57.65 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 120.21 -0.596 . . . . 0.0 111.866 179.473 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -75.96 87.15 2.9 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.951 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' TRP . . . . . 0.504 ' CD1' ' N ' ' A' ' 171' ' ' TRP . 31.3 m0 -76.69 -12.12 59.95 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.43 0.633 . . . . 0.0 109.943 179.589 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -62.87 -32.59 73.87 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.365 -179.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 33.3 m -62.48 -18.32 20.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.911 -178.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 35.5 m -110.23 -4.78 10.95 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -179.162 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -73.26 139.69 46.34 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.911 0.386 . . . . 0.0 110.611 179.227 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . 0.516 ' OD1' ' O ' ' A' ' 176' ' ' ASP . 53.1 p-10 -70.83 136.22 48.59 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 121.257 0.551 . . . . 0.0 110.91 -179.649 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' HIS . . . . . 0.593 ' ND1' ' ND2' ' A' ' 120' ' ' ASN . 78.5 m80 -102.34 -15.37 16.58 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.131 0.491 . . . . 0.0 111.219 -179.543 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 105.09 39.74 2.24 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 -179.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -152.96 167.61 28.59 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 114.795 -0.702 . . . . 0.0 111.232 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -88.65 98.99 11.98 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 177.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . 0.411 ' HG2' ' N ' ' A' ' 182' ' ' ILE . 81.8 tt0 -137.24 164.03 29.49 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.694 0.759 . . . . 0.0 111.423 -178.629 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.411 ' N ' ' HG2' ' A' ' 181' ' ' GLU . 16.8 tt -130.74 140.61 48.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 114.689 -1.141 . . . . 0.0 109.258 178.686 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 51.7 m -132.96 126.57 32.32 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.203 0.525 . . . . 0.0 111.249 -179.136 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 91.4 mt -107.53 130.86 54.82 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.068 179.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 81.1 mt -109.56 121.32 62.36 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-O 121.234 0.54 . . . . 0.0 110.637 -179.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 186' ' ' THR . . . . . 0.426 ' CG2' ' N ' ' A' ' 187' ' ' CYS . 43.7 m -139.44 168.17 20.42 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.281 179.814 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 187' ' ' CYS . . . . . 0.426 ' N ' ' CG2' ' A' ' 186' ' ' THR . 1.6 m -101.91 148.46 25.31 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.288 179.701 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 71.4 t -60.85 -46.89 95.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-O 120.981 0.419 . . . . 0.0 111.44 -178.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 189' ' ' SER . . . . . 0.72 ' HG ' ' H ' ' A' ' 192' ' ' ASP . 86.0 p -170.08 159.5 7.59 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.205 179.317 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 57.7 t -65.75 -18.82 24.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.489 0.661 . . . . 0.0 109.687 179.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -96.74 -13.32 22.77 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.939 -179.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . 0.72 ' H ' ' HG ' ' A' ' 189' ' ' SER . 65.9 t0 -131.67 96.05 3.87 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.421 179.362 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 43.2 p-10 -110.29 5.01 21.35 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 112.23 0.456 . . . . 0.0 112.23 -179.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 11.5 t -63.93 -40.95 97.63 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.954 0.407 . . . . 0.0 111.326 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -126.73 151.74 47.77 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 121.158 0.504 . . . . 0.0 110.749 -179.24 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . 0.468 ' NH2' ' O ' ' A' ' 59' ' ' SER . 99.8 mtt180 -126.19 137.76 53.58 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.386 -179.503 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 43.9 p90 -98.34 144.29 27.89 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.698 178.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 50.2 t -121.27 133.39 67.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.439 0.638 . . . . 0.0 111.573 -178.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 51.0 t -103.67 132.1 50.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.638 179.233 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -118.92 147.76 43.66 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.469 0.652 . . . . 0.0 112.141 -178.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -134.82 140.27 11.58 Favored Glycine 0 CA--C 1.532 1.113 0 N-CA-C 110.422 -1.071 . . . . 0.0 110.422 179.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 54.8 t0 -100.93 136.61 40.51 Favored 'General case' 0 C--N 1.329 -0.304 0 O-C-N 122.626 -0.337 . . . . 0.0 110.804 -179.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 51.7 tp -65.29 127.25 30.96 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 28.6 m -110.52 -18.8 7.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 C-N-CA 120.6 -0.44 . . . . 0.0 112.181 -178.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -179.21 174.34 46.3 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 120.002 -1.095 . . . . 0.0 112.602 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 97.3 m -143.59 138.74 29.27 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 114.991 -0.605 . . . . 0.0 110.439 179.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -142.37 115.8 9.03 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 120.644 -0.423 . . . . 0.0 111.512 178.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -63.36 147.48 51.03 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.498 0.666 . . . . 0.0 111.467 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.521 ' NZ ' ' O ' ' A' ' 151' ' ' ASP . 52.9 mtmt -79.27 106.72 11.51 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.556 179.327 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 97.9 mttt . . . . . 0 C--O 1.219 -0.538 0 CA-C-O 117.827 -1.082 . . . . 0.0 110.613 179.794 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 702' ' ' LEU . . . . . 0.469 ' CB ' ' O ' ' A' ' 168' ' ' PRO . 0.5 OUTLIER . . . . . 0 CA--C 1.546 0.819 0 N-CA-C 110.806 -0.072 . . . . 20.0 110.806 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 703' ' ' PRO . . . . . 0.507 ' O ' ' O ' ' B' ' 704' ' ' ALA . 3.2 Cg_exo -66.15 -177.31 0.79 Allowed 'Trans proline' 0 N--CA 1.496 1.652 0 C-N-CA 122.042 1.828 . . . . 20.0 113.96 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 704' ' ' ALA . . . . . 0.507 ' O ' ' O ' ' B' ' 703' ' ' PRO . . . . . . . . 0 N--CA 1.473 0.715 0 N-CA-C 114.531 1.308 . . . . 20.0 114.531 -178.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.258 0 CA-C-O 121.308 0.575 . . . . 0.0 110.609 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 2.0 p -77.54 7.96 4.9 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.544 -178.31 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.417 ' HA ' HH21 ' A' ' 196' ' ' ARG . 59.3 pttt -85.59 26.94 0.88 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.35 0.595 . . . . 0.0 110.926 179.42 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 45.1 mm -55.89 139.76 14.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 122.345 1.069 . . . . 0.0 113.357 -176.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -81.12 124.33 29.14 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 113.584 -1.644 . . . . 0.0 108.128 178.051 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.568 ' H ' ' CD ' ' A' ' 63' ' ' GLN . 1.1 pm0 -77.52 151.71 80.54 Favored Pre-proline 0 C--N 1.324 -0.517 0 C-N-CA 120.064 -0.654 . . . . 0.0 110.855 -178.663 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -68.31 154.75 71.4 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 122.616 2.211 . . . . 0.0 112.084 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -57.98 171.4 0.52 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 121.38 0.61 . . . . 0.0 111.906 -179.027 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 89.3 mt -64.64 -45.58 86.2 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.946 -178.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.09 -37.9 89.13 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 119.924 -0.71 . . . . 0.0 110.323 -178.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -62.9 -32.81 74.16 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 178.037 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.1 t -75.85 -45.33 37.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-N 114.137 -1.392 . . . . 0.0 110.675 179.031 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -75.99 -8.98 58.21 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.819 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -106.18 -13.0 15.55 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 121.436 0.636 . . . . 0.0 109.931 179.158 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -70.22 145.73 51.19 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.41 -0.814 . . . . 0.0 112.189 -179.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.434 ' H ' ' HG ' ' A' ' 73' ' ' SER . 3.5 m -56.67 109.95 0.71 Allowed 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 115.641 -0.708 . . . . 0.0 109.991 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 32.2 tp -69.28 131.97 45.72 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.804 -178.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -109.01 76.63 1.02 Allowed 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 177.471 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -84.11 -36.53 22.89 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.524 -0.762 . . . . 0.0 112.453 -179.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 42.3 mmtt -74.64 -13.37 60.63 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.035 0.445 . . . . 0.0 111.417 -176.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -92.01 -0.1 57.47 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.377 0.608 . . . . 0.0 109.792 179.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 21.9 t -79.58 129.45 37.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.44 -179.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 11.6 pt -110.83 -10.33 11.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.805 179.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -157.81 163.64 32.78 Favored Glycine 0 CA--C 1.523 0.555 0 C-N-CA 120.225 -0.988 . . . . 0.0 111.81 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 61.8 ttp180 -133.71 156.42 47.97 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.756 -0.722 . . . . 0.0 109.91 179.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 18.6 tt -126.07 143.08 40.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.6 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 13.2 t -137.51 133.26 34.37 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 121.504 0.669 . . . . 0.0 112.305 -178.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 65.0 mt -139.33 84.37 16.48 Favored Pre-proline 0 CA--C 1.538 0.498 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.31 -179.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -57.37 -29.7 85.19 Favored 'Trans proline' 0 N--CA 1.499 1.818 0 C-N-CA 123.081 2.52 . . . . 0.0 112.919 -179.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 96.1 p -52.16 -41.66 62.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.32 0.581 . . . . 0.0 111.088 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 22.5 m -115.83 10.33 7.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.043 179.068 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.479 ' O ' ' OG ' ' A' ' 89' ' ' SER . 3.5 t 53.48 53.49 11.54 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.68 179.553 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 62.7 tp -121.98 133.73 54.82 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.656 0.741 . . . . 0.0 111.024 -179.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -148.76 130.85 15.39 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.926 179.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 84.1 mt -152.2 151.28 27.32 Favored Pre-proline 0 N--CA 1.471 0.621 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.368 -178.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -76.02 147.99 30.9 Favored 'Trans proline' 0 N--CA 1.494 1.554 0 C-N-CA 122.584 2.189 . . . . 0.0 111.516 178.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 98.5 t -96.45 118.12 42.17 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-O 120.975 0.417 . . . . 0.0 111.563 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.45 ' N ' ' CD1' ' A' ' 95' ' ' LEU . 10.6 mp -101.74 136.91 40.78 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.394 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -61.7 -81.36 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 121.253 0.549 . . . . 0.0 112.263 -179.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.75 ' HG ' HD21 ' A' ' 102' ' ' ASN . 91.1 p -62.39 135.12 57.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.488 0.661 . . . . 0.0 112.134 -178.238 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.419 ' OG ' ' O ' ' A' ' 109' ' ' THR . 1.3 m -90.83 68.66 6.39 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.219 178.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.701 ' HG1' ' H ' ' A' ' 102' ' ' ASN . 33.8 p -88.57 168.41 12.59 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.069 179.283 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.429 ' O ' ' CD1' ' A' ' 104' ' ' LEU . 52.6 tp10 -62.9 -45.5 92.24 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.169 -0.612 . . . . 0.0 110.435 179.783 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -65.12 -40.67 94.82 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 121.339 0.59 . . . . 0.0 111.487 179.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.75 HD21 ' HG ' ' A' ' 97' ' ' SER . 99.1 m-20 -65.23 -30.35 71.23 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.134 -0.485 . . . . 0.0 112.226 -179.301 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 56.7 mt -67.03 -14.02 62.49 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 120.773 -0.371 . . . . 0.0 111.673 -179.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.429 ' CD1' ' O ' ' A' ' 100' ' ' GLU . 10.5 mp -75.69 -12.17 60.14 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 121.008 -0.277 . . . . 0.0 111.44 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 92.5 p -81.17 -6.24 58.62 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 121.352 0.596 . . . . 0.0 110.356 179.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 89.76 -20.02 37.89 Favored Glycine 0 CA--C 1.533 1.196 0 CA-C-N 115.51 -0.768 . . . . 0.0 113.254 177.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -145.72 125.49 13.43 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 117.814 0.807 . . . . 0.0 112.136 -179.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -145.71 141.64 28.23 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.703 179.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.419 ' O ' ' OG ' ' A' ' 98' ' ' SER . 8.7 p -71.93 132.34 44.22 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.238 0.542 . . . . 0.0 110.667 179.631 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.3 p -81.7 -33.95 12.52 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 -179.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.506 ' O ' ' NE2' ' A' ' 114' ' ' GLN . 88.2 tttt -90.36 153.34 20.51 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 121.357 0.598 . . . . 0.0 111.939 -177.243 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -66.0 -35.06 79.54 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -178.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -141.27 53.36 1.55 Allowed 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 -176.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . 0.716 ' NE2' ' H ' ' A' ' 114' ' ' GLN . 1.6 pm0 -74.34 157.71 35.26 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 120.891 0.377 . . . . 0.0 111.192 179.151 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 61.4 t -128.64 120.89 53.65 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-O 121.149 0.499 . . . . 0.0 111.694 -179.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 66.3 mtt -60.57 134.45 57.08 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.992 -0.549 . . . . 0.0 112.226 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 77.72 -0.91 69.3 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.698 -0.561 . . . . 0.0 111.698 178.206 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -142.0 127.94 19.48 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.358 0.599 . . . . 0.0 110.851 179.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 75.28 -168.99 54.78 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 110.482 -1.047 . . . . 0.0 110.482 -179.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 42.9 t-20 -90.21 103.5 16.17 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.78 0.324 . . . . 0.0 110.2 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.467 ' CE1' ' CG ' ' A' ' 114' ' ' GLN . 11.8 t80 -89.69 99.02 12.1 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -179.696 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -91.65 137.41 32.39 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 112.462 0.541 . . . . 0.0 112.462 -178.404 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 71.6 mt -134.76 138.92 44.74 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.584 179.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -108.72 131.7 54.67 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 121.142 0.496 . . . . 0.0 110.02 179.324 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -137.22 151.08 20.93 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 110.045 -1.222 . . . . 0.0 110.045 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . 0.564 ' ND1' ' OE1' ' A' ' 63' ' ' GLN . 37.5 m-70 -88.73 144.78 26.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.61 0.719 . . . . 0.0 112.522 -178.706 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . 0.797 ' ND2' ' H ' ' A' ' 129' ' ' SER . 1.5 t-20 -137.8 121.24 17.14 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.982 178.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' MET . . . . . 0.509 ' O ' ' CB ' ' A' ' 129' ' ' SER . 57.7 mtt -95.51 -1.42 50.71 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.069 -178.578 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.797 ' H ' ' ND2' ' A' ' 127' ' ' ASN . 1.4 p 78.17 5.52 2.7 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.974 -0.29 . . . . 0.0 111.339 179.247 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.561 ' O ' ' CG1' ' A' ' 133' ' ' VAL . 62.5 pttt -120.58 130.7 54.3 Favored 'General case' 0 C--O 1.222 -0.377 0 CA-C-O 121.885 0.85 . . . . 0.0 113.105 -178.55 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.462 ' O ' ' O ' ' A' ' 130' ' ' LYS . 74.6 mmtt -41.13 162.6 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 178.232 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 76.49 -24.73 1.76 Allowed Glycine 0 CA--C 1.535 1.337 0 C-N-CA 120.396 -0.907 . . . . 0.0 111.379 179.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.561 ' CG1' ' O ' ' A' ' 130' ' ' LYS . 3.7 p -90.18 158.13 2.94 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 O-C-N 122.217 -0.578 . . . . 0.0 111.215 -178.702 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.646 ' H ' ' CD1' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -70.71 145.36 50.57 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 114.903 1.446 . . . . 0.0 114.903 -177.283 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 61.0 7.04 1.37 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 112.866 -1.97 . . . . 0.0 113.854 177.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 5.1 t -72.8 -34.07 66.66 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.143 -0.623 . . . . 0.0 112.385 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . 0.426 ' N ' ' OD1' ' A' ' 137' ' ' ASP . 44.0 p-10 -92.43 4.6 53.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.433 0.635 . . . . 0.0 110.381 -179.329 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.419 ' CG2' ' N ' ' A' ' 139' ' ' ALA . 5.2 tt -64.49 -35.83 75.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.896 -179.506 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.419 ' N ' ' CG2' ' A' ' 138' ' ' ILE . . . -70.33 -9.88 57.41 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 121.091 0.472 . . . . 0.0 111.072 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 19.1 m -81.99 -3.21 53.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.225 0.535 . . . . 0.0 110.223 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 78.5 mt -63.69 145.08 56.41 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.564 179.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -120.97 155.49 34.16 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 121.389 0.614 . . . . 0.0 112.021 -178.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 40.5 tttp -49.85 132.76 22.45 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.978 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.554 ' N ' ' O ' ' A' ' 160' ' ' VAL . . . 80.21 7.33 88.63 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.314 178.691 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -73.41 136.87 44.34 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 118.921 -1.112 . . . . 0.0 109.553 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -80.26 141.33 35.65 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.838 0.828 . . . . 0.0 112.28 -178.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 87.6 mt -137.39 137.74 45.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 114.735 -1.121 . . . . 0.0 108.679 178.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 43.0 m-85 -123.1 136.25 54.72 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.028 -0.669 . . . . 0.0 112.508 -177.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 11.7 mt -110.97 133.5 53.34 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 177.072 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . 0.526 ' CE1' ' CD ' ' A' ' 155' ' ' GLU . 82.1 m-85 -111.87 109.39 19.18 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 119.836 -0.746 . . . . 0.0 111.845 -179.638 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . 0.614 ' OD1' ' N ' ' A' ' 152' ' ' ASN . 66.3 t0 -89.59 163.87 15.0 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 177.7 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . 0.614 ' N ' ' OD1' ' A' ' 151' ' ' ASP . 34.5 p-10 -57.36 -19.61 24.02 Favored 'General case' 0 C--N 1.318 -0.785 0 C-N-CA 119.962 -0.695 . . . . 0.0 111.159 -177.706 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -114.27 -27.83 7.48 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 -178.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -148.18 179.87 7.45 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 -176.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.526 ' CD ' ' CE1' ' A' ' 150' ' ' TYR . 83.0 tt0 -127.79 132.96 49.44 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 114.366 -1.288 . . . . 0.0 109.745 179.122 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -108.44 133.87 52.02 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.027 0.442 . . . . 0.0 111.225 -179.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -93.85 113.15 25.12 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.121 179.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -115.44 150.16 36.88 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 120.828 0.347 . . . . 0.0 110.585 179.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -124.45 124.62 42.7 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.048 0.451 . . . . 0.0 111.215 179.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.554 ' O ' ' N ' ' A' ' 144' ' ' GLY . 71.4 t -60.93 135.47 25.65 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.215 177.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 22.0 p -105.36 -24.95 12.57 Favored 'General case' 0 CA--C 1.533 0.315 0 O-C-N 123.308 0.38 . . . . 0.0 110.202 178.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 157.46 -165.17 33.33 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 120.842 -0.694 . . . . 0.0 111.718 179.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 3.0 p -134.97 155.26 37.87 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 179.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 87.8 p -138.75 167.17 22.57 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.633 0.73 . . . . 0.0 112.212 -178.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -100.19 118.87 37.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 114.99 -1.004 . . . . 0.0 110.204 179.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 27.6 m -137.05 161.7 35.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.225 0.536 . . . . 0.0 111.009 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -96.73 157.07 35.83 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.32 178.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . 0.503 ' O ' ' CB ' ' B' ' 702' ' ' LEU . 20.7 Cg_endo -60.83 -18.02 54.0 Favored 'Trans proline' 0 C--N 1.3 -1.995 0 C-N-CA 122.605 2.204 . . . . 0.0 113.552 -179.627 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 45.5 p-10 -92.27 -5.26 52.71 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 119.45 -0.9 . . . . 0.0 112.313 179.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -76.1 85.56 2.97 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 121.655 0.741 . . . . 0.0 111.373 179.438 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' TRP . . . . . 0.591 ' CZ3' ' OE2' ' A' ' 175' ' ' GLU . 1.2 p-90 -73.97 -7.44 52.41 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.034 -0.984 . . . . 0.0 110.041 179.42 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -61.77 -35.83 79.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.75 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 19.8 m -63.03 -17.77 20.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.781 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 37.0 t -101.47 -17.77 6.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.922 -179.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.591 ' OE2' ' CZ3' ' A' ' 171' ' ' TRP . 76.3 mm-40 -76.26 153.94 35.58 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.246 0.546 . . . . 0.0 111.779 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . 0.491 ' OD1' ' O ' ' A' ' 176' ' ' ASP . 47.0 p-10 -60.27 142.86 53.98 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.719 0.771 . . . . 0.0 111.802 -179.345 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 73.6 m80 -115.36 12.71 16.42 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.707 179.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 64.13 41.66 98.34 Favored Glycine 0 CA--C 1.528 0.856 0 N-CA-C 111.105 -0.798 . . . . 0.0 111.105 179.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -165.2 172.47 12.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.1 0.476 . . . . 0.0 110.882 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -88.28 93.99 9.69 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 177.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . 0.426 ' HG2' ' N ' ' A' ' 182' ' ' ILE . 79.9 tt0 -130.45 161.64 30.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.85 0.833 . . . . 0.0 112.052 -178.078 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.426 ' N ' ' HG2' ' A' ' 181' ' ' GLU . 1.1 mm -125.97 134.5 66.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 114.598 -1.183 . . . . 0.0 110.55 179.608 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 86.3 m -126.3 124.41 40.26 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 121.291 0.567 . . . . 0.0 111.23 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 83.4 mt -113.32 133.41 55.14 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.7 179.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 77.0 mt -113.53 124.77 70.5 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 CA-C-O 121.36 0.6 . . . . 0.0 111.028 -179.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 5.1 t -135.56 156.34 49.03 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 115.254 -0.884 . . . . 0.0 110.492 179.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 187' ' ' CYS . . . . . . . . . . . . . 4.5 m -87.11 141.45 28.65 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.234 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . 0.412 HG22 ' CE2' ' A' ' 197' ' ' TYR . 41.9 t -61.97 -47.32 93.74 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 CA-C-O 120.945 0.402 . . . . 0.0 111.005 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 94.6 p -162.23 164.42 27.71 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 121.038 0.447 . . . . 0.0 110.977 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . 0.501 ' CG1' ' O ' ' A' ' 128' ' ' MET . 18.0 m -69.16 -17.58 21.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.244 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -101.8 -34.69 9.33 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.519 -0.472 . . . . 0.0 111.049 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 49.6 t0 -99.63 103.13 14.81 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 120.984 0.421 . . . . 0.0 111.465 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 193' ' ' ASN . . . . . 0.577 ' O ' ' NH1' ' A' ' 196' ' ' ARG . 27.2 m120 -110.45 -7.22 14.79 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 121.298 0.57 . . . . 0.0 110.639 179.058 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 76.3 p -68.4 -16.68 64.01 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.953 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -136.73 143.03 43.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.468 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . 0.577 ' NH1' ' O ' ' A' ' 193' ' ' ASN . 76.9 mtt85 -136.05 145.15 45.69 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 121.108 0.48 . . . . 0.0 111.959 -179.494 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . 0.412 ' CE2' HG22 ' A' ' 188' ' ' VAL . 35.8 m-85 -96.41 144.57 26.42 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 115.949 -0.568 . . . . 0.0 111.471 179.034 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 39.2 t -128.97 130.69 68.45 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-O 121.083 0.468 . . . . 0.0 110.645 178.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 21.6 t -102.66 134.62 43.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.866 179.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -122.32 147.66 45.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.316 0.579 . . . . 0.0 111.387 -178.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -145.01 152.6 24.63 Favored Glycine 0 CA--C 1.53 1.024 0 N-CA-C 110.079 -1.208 . . . . 0.0 110.079 179.24 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . 0.422 ' O ' ' OD1' ' A' ' 202' ' ' ASP . 51.7 p-10 -111.92 151.39 29.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.994 0.426 . . . . 0.0 110.092 179.673 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 52.7 tp -71.52 131.47 43.32 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 5.2 p -113.88 -19.5 6.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 120.333 -0.547 . . . . 0.0 111.589 -178.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -176.97 172.03 44.96 Favored Glycine 0 CA--C 1.527 0.799 0 C-N-CA 120.088 -1.053 . . . . 0.0 112.055 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 10.4 m -144.19 137.68 27.57 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.963 -0.618 . . . . 0.0 109.503 179.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -145.37 122.17 11.24 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.115 0.483 . . . . 0.0 111.276 179.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -62.39 139.83 58.55 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.491 0.662 . . . . 0.0 111.448 -179.289 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 9.5 tttt -79.2 109.32 13.42 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.552 179.563 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 98.5 mttt . . . . . 0 C--O 1.218 -0.558 0 CA-C-O 118.107 -0.949 . . . . 0.0 110.339 179.205 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 702' ' ' LEU . . . . . 0.503 ' CB ' ' O ' ' A' ' 168' ' ' PRO . 1.0 OUTLIER . . . . . 0 CA--C 1.546 0.805 0 CA-C-O 120.554 0.216 . . . . 20.0 111.323 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 703' ' ' PRO . . . . . 0.544 ' O ' ' O ' ' B' ' 704' ' ' ALA . 4.9 Cg_exo -69.41 -168.06 0.24 Allowed 'Trans proline' 0 N--CA 1.489 1.21 0 C-N-CA 122.906 2.404 . . . . 20.0 114.15 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 704' ' ' ALA . . . . . 0.544 ' O ' ' O ' ' B' ' 703' ' ' PRO . . . . . . . . 0 N--CA 1.466 0.367 0 CA-C-N 113.902 -1.499 . . . . 20.0 113.659 -179.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.414 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 38.9 t -63.1 -42.82 99.66 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.129 0.49 . . . . 0.0 111.299 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 85.1 t60 -115.05 125.65 53.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.918 -179.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 77.6 mtm -93.87 138.08 32.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.592 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.484 ' O ' ' OD1' ' A' ' 57' ' ' ASP . 34.6 p30 -68.25 150.98 47.6 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.624 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -90.02 11.41 20.71 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.254 0.549 . . . . 0.0 111.04 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 2.9 p -79.93 17.01 1.03 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.924 -179.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -99.64 9.76 42.55 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 120.901 0.382 . . . . 0.0 111.858 -179.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.8 mt -55.6 139.98 14.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 122.034 0.921 . . . . 0.0 112.988 -177.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.408 ' OD1' ' N ' ' A' ' 63' ' ' GLN . 60.4 t0 -77.59 129.15 35.26 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 114.169 -1.378 . . . . 0.0 109.567 179.166 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.533 ' NE2' ' O ' ' A' ' 64' ' ' PRO . 1.4 tt0 -76.81 119.71 78.62 Favored Pre-proline 0 CA--C 1.541 0.609 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.504 -179.137 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.533 ' O ' ' NE2' ' A' ' 63' ' ' GLN . 73.5 Cg_exo -47.86 162.31 0.28 Allowed 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 122.491 2.127 . . . . 0.0 112.811 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -52.6 168.96 0.09 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.873 0.844 . . . . 0.0 112.308 -178.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 97.4 mt -71.13 -12.08 61.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 114.516 -1.22 . . . . 0.0 111.979 -179.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.592 ' O ' ' ND2' ' A' ' 71' ' ' ASN . . . -68.21 -41.89 80.63 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.306 0.574 . . . . 0.0 110.492 179.204 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.467 ' O ' ' CB ' ' A' ' 72' ' ' ALA . 98.2 mt-10 -70.7 -23.05 62.4 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.203 179.321 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 76.6 t -71.31 -43.88 73.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.814 -178.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -92.76 -8.82 42.68 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.411 -179.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.592 ' ND2' ' O ' ' A' ' 67' ' ' ALA . 84.9 m-20 -106.94 -10.17 16.06 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 121.15 0.5 . . . . 0.0 110.893 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.467 ' CB ' ' O ' ' A' ' 68' ' ' GLU . . . -69.65 135.54 50.04 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.425 0.631 . . . . 0.0 112.272 -179.134 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 43.7 t -59.71 93.65 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.435 ' CD2' ' C ' ' A' ' 74' ' ' LEU . 6.9 tt -66.79 126.29 28.56 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.297 0.57 . . . . 0.0 111.449 -178.147 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -93.74 79.51 4.23 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.564 -0.743 . . . . 0.0 110.379 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -64.75 -34.12 77.58 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.747 -0.661 . . . . 0.0 112.095 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.448 ' HD3' ' N ' ' A' ' 77' ' ' LYS . 8.0 mmtt -70.01 -13.12 62.08 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 121.428 0.633 . . . . 0.0 109.901 -176.497 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -93.9 -5.24 48.37 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.734 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 72.4 t -73.69 128.63 36.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.068 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 12.6 pt -110.57 -6.59 11.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 120.592 -0.443 . . . . 0.0 111.723 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -174.79 174.8 46.84 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 120.398 -0.906 . . . . 0.0 111.725 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 73.2 ttp85 -135.3 156.89 48.19 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 121.158 0.504 . . . . 0.0 111.157 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 20.9 tt -125.6 139.32 51.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 179.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.5 t -137.59 134.55 35.69 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 -178.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 3.2 mp -137.26 87.58 18.16 Favored Pre-proline 0 CA--C 1.538 0.498 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.415 179.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -55.98 -32.56 86.33 Favored 'Trans proline' 0 N--CA 1.5 1.873 0 C-N-CA 123.205 2.604 . . . . 0.0 112.68 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 8.9 t -54.63 -41.63 70.26 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.244 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 11.2 m -113.93 14.44 8.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 CA-C-O 121.261 0.553 . . . . 0.0 110.635 179.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.8 p 46.58 52.0 11.46 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.128 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 55.7 tp -117.78 133.29 56.08 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.321 0.581 . . . . 0.0 110.604 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.465 ' O ' ' CD2' ' A' ' 92' ' ' LEU . 93.7 mt-10 -147.94 125.32 11.6 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.925 -179.292 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.465 ' CD2' ' O ' ' A' ' 91' ' ' GLU . 7.8 mt -148.89 148.48 27.59 Favored Pre-proline 0 CA--C 1.537 0.457 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.421 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -75.36 147.75 33.03 Favored 'Trans proline' 0 N--CA 1.493 1.465 0 C-N-CA 122.68 2.253 . . . . 0.0 110.878 178.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 92.3 t -93.51 119.86 41.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.189 0.519 . . . . 0.0 110.649 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.47 ' N ' ' CD1' ' A' ' 95' ' ' LEU . 10.6 mp -97.82 126.09 43.01 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.72 0.772 . . . . 0.0 110.842 -179.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.527 ' O ' ' OG1' ' A' ' 109' ' ' THR . 86.7 tttt -63.64 -38.41 91.0 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.827 -1.078 . . . . 0.0 112.043 -178.581 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.497 ' CB ' ' ND2' ' A' ' 102' ' ' ASN . 2.7 m -79.76 126.43 30.94 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 121.636 0.731 . . . . 0.0 112.463 -178.582 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.465 ' OG ' ' O ' ' A' ' 109' ' ' THR . 0.9 OUTLIER -89.13 44.5 1.22 Allowed 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.714 179.687 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.571 ' OG1' ' ND2' ' A' ' 102' ' ' ASN . 71.4 p -89.48 171.78 9.47 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.03 179.121 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -66.06 -39.62 90.25 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.161 0.505 . . . . 0.0 110.143 179.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -64.43 -41.75 96.41 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.147 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.571 ' ND2' ' OG1' ' A' ' 99' ' ' THR . 54.0 m-80 -65.15 -34.83 79.33 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.6 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 42.0 mt -65.13 -16.54 63.6 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.634 -179.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 91.5 mt -73.76 -15.47 61.2 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.381 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 93.9 p -82.11 -2.84 53.3 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.198 0.523 . . . . 0.0 110.431 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.592 ' O ' ' CE1' ' A' ' 135' ' ' PHE . . . 93.31 -19.53 51.87 Favored Glycine 0 CA--C 1.527 0.799 0 CA-C-N 115.854 -0.612 . . . . 0.0 113.08 178.105 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -146.56 125.53 12.8 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 119.483 -0.887 . . . . 0.0 112.382 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -143.24 142.38 31.37 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.833 178.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.527 ' OG1' ' O ' ' A' ' 96' ' ' LYS . 58.5 p -65.37 132.44 49.0 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.46 0.648 . . . . 0.0 111.288 -178.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 78.9 t -78.38 -55.2 10.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.655 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.554 ' H ' ' NE2' ' A' ' 114' ' ' GLN . 83.5 mttt -107.04 139.74 40.96 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 122.048 0.928 . . . . 0.0 112.162 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -66.25 -34.48 78.11 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.444 -1.253 . . . . 0.0 112.165 -178.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -85.7 20.77 2.04 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 113.075 0.769 . . . . 0.0 113.075 -178.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . 0.554 ' NE2' ' H ' ' A' ' 111' ' ' LYS . 34.3 mt-30 -77.9 140.58 39.31 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.048 0.451 . . . . 0.0 111.034 179.635 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.2 t -125.91 108.54 19.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.965 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 73.3 mtp -56.25 126.61 26.94 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 121.121 0.486 . . . . 0.0 111.039 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 97.01 -11.76 65.79 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 121.133 -0.556 . . . . 0.0 111.825 179.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -143.72 137.29 28.04 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 121.055 0.455 . . . . 0.0 111.53 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 76.27 -170.7 54.83 Favored Glycine 0 CA--C 1.531 1.069 0 N-CA-C 111.675 -0.57 . . . . 0.0 111.675 179.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 54.5 t-20 -88.52 104.56 16.93 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 121.304 0.573 . . . . 0.0 110.576 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -86.99 145.97 26.31 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.4 179.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -147.58 143.76 27.98 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 119.493 -0.883 . . . . 0.0 111.841 -179.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 63.8 mt -138.29 143.75 40.16 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 114.823 -1.081 . . . . 0.0 110.181 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -111.71 138.35 48.4 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -132.03 145.34 17.11 Favored Glycine 0 CA--C 1.531 1.046 0 N-CA-C 110.386 -1.086 . . . . 0.0 110.386 -179.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 10.1 m-70 -88.63 124.1 33.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.449 0.642 . . . . 0.0 112.258 -179.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.8 HD21 ' HG ' ' A' ' 136' ' ' SER . 2.6 t-20 -122.83 121.82 37.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.251 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 75.9 mtm -95.85 2.22 53.58 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 121.263 0.554 . . . . 0.0 110.748 179.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.493 ' H ' ' ND2' ' A' ' 127' ' ' ASN . 0.1 OUTLIER 76.04 10.5 3.14 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.543 179.114 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.497 ' O ' ' CG1' ' A' ' 133' ' ' VAL . 5.6 ptmt -110.51 114.16 27.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.878 0.847 . . . . 0.0 112.395 -179.352 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 6.1 tmtt? -37.72 120.28 0.81 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.661 -1.154 . . . . 0.0 111.7 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 113.13 -11.94 24.34 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.542 ' CG1' ' OG ' ' A' ' 136' ' ' SER . 11.8 p -91.71 164.31 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 CA-C-N 115.048 -0.576 . . . . 0.0 110.267 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.75 140.16 51.27 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.872 0.844 . . . . 0.0 112.645 -177.355 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.592 ' CE1' ' O ' ' A' ' 106' ' ' GLY . 3.2 m-85 66.43 5.3 3.68 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 113.977 -1.465 . . . . 0.0 113.796 177.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' SER . . . . . 0.8 ' HG ' HD21 ' A' ' 127' ' ' ASN . 0.4 OUTLIER -68.14 -40.48 82.4 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 112.373 0.509 . . . . 0.0 112.373 179.131 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.51 ' O ' ' OG ' ' A' ' 140' ' ' SER . 48.6 p-10 -88.95 -1.34 58.06 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 121.251 0.548 . . . . 0.0 111.439 -178.215 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.401 HD12 ' CD2' ' A' ' 135' ' ' PHE . 0.3 OUTLIER -65.24 -35.71 76.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-O 121.158 0.504 . . . . 0.0 110.254 178.957 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -66.83 -11.44 55.44 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.052 0.453 . . . . 0.0 110.926 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.51 ' OG ' ' O ' ' A' ' 137' ' ' ASP . 59.6 p -84.35 -1.91 56.23 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 121.199 0.524 . . . . 0.0 110.756 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 66.1 mt -63.54 138.72 58.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.237 -179.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -113.48 154.46 27.0 Favored 'General case' 0 CA--C 1.535 0.365 0 CA-C-O 121.425 0.631 . . . . 0.0 111.351 -179.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -51.3 133.71 28.62 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.751 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.561 ' N ' ' O ' ' A' ' 160' ' ' VAL . . . 79.32 7.95 88.13 Favored Glycine 0 CA--C 1.527 0.84 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.554 179.14 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -70.12 132.8 46.38 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 119.88 -0.728 . . . . 0.0 109.852 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -78.59 138.32 38.3 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.76 0.79 . . . . 0.0 111.773 -178.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 95.9 mt -135.8 136.41 50.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 114.817 -1.083 . . . . 0.0 108.382 178.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -117.81 135.0 54.36 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.906 0.86 . . . . 0.0 112.842 -178.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -110.84 133.57 53.24 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 114.528 -1.215 . . . . 0.0 108.445 178.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.601 ' CZ ' ' OE2' ' A' ' 155' ' ' GLU . 79.8 m-85 -116.93 110.52 18.41 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 120.202 -0.599 . . . . 0.0 111.581 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . 0.466 ' OD1' ' N ' ' A' ' 152' ' ' ASN . 52.4 t0 -89.25 164.94 14.74 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 177.176 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . 0.466 ' N ' ' OD1' ' A' ' 151' ' ' ASP . 34.5 p30 -58.85 -19.12 38.76 Favored 'General case' 0 C--N 1.314 -0.967 0 C-N-CA 119.286 -0.965 . . . . 0.0 111.031 -178.119 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -112.28 -28.08 8.07 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -178.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . 0.414 ' O ' ' N ' ' A' ' 151' ' ' ASP . 0.4 OUTLIER -148.67 -175.64 5.01 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 -176.333 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.601 ' OE2' ' CZ ' ' A' ' 150' ' ' TYR . 87.7 tt0 -132.46 133.77 44.25 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 114.072 -1.422 . . . . 0.0 110.237 178.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -112.59 140.22 47.53 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 120.846 0.355 . . . . 0.0 110.315 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -99.87 117.98 35.34 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 121.047 0.451 . . . . 0.0 112.051 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -114.75 148.82 37.83 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 121.178 0.513 . . . . 0.0 111.416 179.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -121.03 120.85 36.58 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.713 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.561 ' O ' ' N ' ' A' ' 144' ' ' GLY . 91.0 t -59.59 136.77 22.86 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.292 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.743 178.199 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 15.1 p -105.63 -24.05 12.63 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.786 178.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 154.86 -163.43 31.32 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 120.682 -0.771 . . . . 0.0 111.62 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 35.5 m -135.76 158.07 39.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-N 115.343 -0.428 . . . . 0.0 110.004 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 81.6 p -145.95 165.78 27.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.118 0.485 . . . . 0.0 110.924 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -101.85 115.2 30.02 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.898 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . 0.542 ' O ' ' O ' ' A' ' 196' ' ' ARG . 23.8 m -137.98 162.76 30.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.989 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -86.48 157.01 56.22 Favored Pre-proline 0 CA--C 1.54 0.575 0 CA-C-O 121.16 0.505 . . . . 0.0 111.431 -179.443 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.413 ' O ' ' CG ' ' B' ' 702' ' ' LEU . 36.5 Cg_endo -67.86 -9.98 27.34 Favored 'Trans proline' 0 N--CA 1.5 1.862 0 C-N-CA 123.398 2.732 . . . . 0.0 112.861 -179.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . 0.424 ' OD1' ' C ' ' A' ' 169' ' ' ASP . 40.2 p-10 -95.01 -4.0 47.35 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.236 0.541 . . . . 0.0 110.924 179.018 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -75.69 82.83 2.68 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.533 -178.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 40.4 p-90 -76.72 -12.08 59.94 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 121.356 0.598 . . . . 0.0 110.594 178.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 76.4 tt0 -61.0 -36.58 79.86 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.988 -179.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 11.6 p -62.44 -25.97 39.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 CA-C-O 121.107 0.479 . . . . 0.0 110.77 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 20.1 t -93.1 -8.49 10.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.945 -179.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.525 ' OE1' ' O ' ' A' ' 176' ' ' ASP . 0.6 OUTLIER -73.5 146.77 44.64 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 120.935 0.398 . . . . 0.0 111.076 -179.766 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . 0.525 ' O ' ' OE1' ' A' ' 175' ' ' GLU . 48.1 p-10 -66.27 128.29 35.54 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.281 0.563 . . . . 0.0 111.857 -179.169 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 21.4 m80 -111.49 24.66 12.52 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.965 -0.561 . . . . 0.0 112.119 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 60.21 35.79 88.94 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 120.724 -0.75 . . . . 0.0 111.247 179.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -154.15 161.41 41.88 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 110.208 -0.293 . . . . 0.0 110.208 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -89.35 105.25 17.67 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.897 179.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 -139.21 167.02 23.0 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.569 0.699 . . . . 0.0 112.154 179.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 18.9 tt -130.08 138.02 55.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 114.827 -1.079 . . . . 0.0 109.917 179.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 39.8 m -130.98 122.64 27.22 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.176 0.512 . . . . 0.0 111.079 -179.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 93.9 mt -109.43 136.29 49.08 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.631 178.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 70.0 mt -105.68 115.71 47.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 C-N-CA 120.206 -0.598 . . . . 0.0 110.179 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 77.1 m -126.79 132.63 51.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.275 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -84.03 140.8 31.62 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 73.7 t -61.19 -49.05 86.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.161 0.505 . . . . 0.0 111.257 -178.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' SER . . . . . 0.463 ' HG ' ' H ' ' A' ' 192' ' ' ASP . 34.7 p -168.52 163.84 12.47 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.282 0.563 . . . . 0.0 111.009 -179.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 31.3 m -76.85 -9.89 12.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.349 179.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -101.37 -23.49 14.36 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.852 178.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . 0.463 ' H ' ' HG ' ' A' ' 189' ' ' SER . 60.4 t0 -96.68 105.77 17.93 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.04 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -109.77 5.92 23.12 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.177 0.513 . . . . 0.0 110.632 179.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 85.9 p -68.43 -59.76 2.94 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.677 -179.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -147.49 155.77 42.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.17 0.51 . . . . 0.0 111.25 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . 0.542 ' O ' ' O ' ' A' ' 166' ' ' VAL . 99.8 mtt180 -129.58 143.78 50.98 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.533 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . 0.421 ' CD1' ' C ' ' A' ' 197' ' ' TYR . 36.4 p90 -93.16 152.07 19.46 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.425 0.631 . . . . 0.0 111.314 -179.335 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 48.4 t -123.7 132.93 70.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.378 179.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 40.7 t -94.0 132.32 38.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.989 -179.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -119.3 145.0 46.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.465 0.65 . . . . 0.0 111.393 -179.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -142.8 146.08 16.62 Favored Glycine 0 CA--C 1.529 0.945 0 N-CA-C 110.451 -1.06 . . . . 0.0 110.451 179.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 48.9 p-10 -109.04 151.66 26.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.175 0.512 . . . . 0.0 111.427 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 51.0 tp -72.48 132.36 43.76 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 178.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 2.6 p -115.25 -19.19 6.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 120.74 -0.384 . . . . 0.0 111.493 -179.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -178.3 174.64 46.89 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 120.804 -0.712 . . . . 0.0 111.66 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 60.3 m -141.04 136.3 31.91 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-O 120.662 0.268 . . . . 0.0 110.652 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -143.96 115.62 8.18 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 120.153 -0.619 . . . . 0.0 112.309 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -64.3 147.57 52.2 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.256 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 8.4 ttpt -80.34 109.53 14.92 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.365 178.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 98.0 mttt . . . . . 0 C--O 1.221 -0.428 0 CA-C-O 117.837 -1.078 . . . . 0.0 110.536 179.142 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 701' ' ' BOC . . . . . 0.532 ' H31' ' N ' ' B' ' 702' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 702' ' ' LEU . . . . . 0.532 ' N ' ' H31' ' B' ' 701' ' ' BOC . 0.2 OUTLIER 56.32 77.58 0.42 Allowed Pre-proline 0 CA--C 1.539 0.539 0 CA-C-O 121.628 0.728 . . . . 20.0 110.892 . . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 703' ' ' PRO . . . . . 0.547 ' O ' ' O ' ' B' ' 704' ' ' ALA . 3.7 Cg_exo -72.18 -171.04 0.63 Allowed 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 123.84 3.027 . . . . 20.0 112.982 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 704' ' ' ALA . . . . . 0.549 ' O ' ' OG1' ' B' ' 705' ' ' B27 . . . -39.04 178.34 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.079 -0.964 . . . . 20.0 113.129 -178.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 705' ' ' B27 . . . . . 0.549 ' OG1' ' O ' ' B' ' 704' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.259 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 58.8 m -60.81 -41.05 94.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.896 0.379 . . . . 0.0 111.717 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 44.0 m80 -69.21 -13.95 62.7 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.32 0.581 . . . . 0.0 110.391 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 11.0 ttm -104.13 121.46 43.29 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.165 179.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -66.53 143.29 57.15 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-O 121.202 0.525 . . . . 0.0 110.474 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -88.9 9.17 25.84 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.42 0.628 . . . . 0.0 110.17 179.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.41 ' H ' ' HG ' ' A' ' 59' ' ' SER . 5.4 p -82.6 10.08 8.14 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.546 -179.616 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -96.74 8.56 44.0 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.238 0.542 . . . . 0.0 110.869 -179.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 59.0 mt -55.19 142.72 9.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.953 0.882 . . . . 0.0 111.68 -177.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -75.48 126.95 32.05 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 114.142 -1.39 . . . . 0.0 108.775 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.606 ' H ' ' CD ' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -78.72 130.87 69.32 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.708 -178.867 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_exo -51.14 150.52 13.85 Favored 'Trans proline' 0 N--CA 1.493 1.471 0 C-N-CA 121.695 1.597 . . . . 0.0 111.767 178.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.479 ' CG ' ' H ' ' A' ' 66' ' ' LEU . 45.0 t0 -52.41 177.51 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 121.198 0.523 . . . . 0.0 111.506 -178.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.479 ' H ' ' CG ' ' A' ' 65' ' ' ASP . 94.5 mt -65.95 -45.25 82.5 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.672 -178.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.63 -30.59 70.81 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.229 -0.588 . . . . 0.0 110.704 -178.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -62.82 -30.36 71.42 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.431 178.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 37.3 t -77.84 -46.27 27.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.131 -0.94 . . . . 0.0 110.685 179.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.08 -9.58 58.29 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.144 -0.935 . . . . 0.0 111.244 -179.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -109.35 -13.61 14.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.318 0.58 . . . . 0.0 110.095 178.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.37 135.44 51.8 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.712 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 33.0 t -59.47 103.01 0.16 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.647 -179.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.85 125.95 28.25 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.591 -179.546 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -98.49 83.77 3.07 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 121.382 0.611 . . . . 0.0 109.95 178.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -62.82 -38.28 90.11 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.376 -179.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.487 ' CD ' ' H ' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -71.51 -12.03 61.17 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 120.471 -0.492 . . . . 0.0 110.999 -177.347 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -93.05 0.71 57.4 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.423 0.63 . . . . 0.0 110.203 178.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 88.3 t -86.11 128.31 39.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.132 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 16.5 pt -107.35 -7.9 10.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.239 -179.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -170.95 179.33 42.91 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 120.454 -0.879 . . . . 0.0 111.808 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 56.4 ttp180 -140.24 156.26 46.56 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 121.378 0.609 . . . . 0.0 111.315 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 16.8 tt -125.29 141.98 43.56 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 CA-C-O 121.437 0.637 . . . . 0.0 110.464 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 66.5 m -135.31 130.31 34.86 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.093 -0.958 . . . . 0.0 111.258 -178.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 22.6 mt -133.79 88.73 32.12 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.121 -178.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -54.9 -35.36 89.03 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 123.278 2.652 . . . . 0.0 112.644 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 44.4 t -55.88 -43.41 77.15 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.192 -0.458 . . . . 0.0 112.212 -179.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 21.7 m -112.21 6.36 8.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.285 0.564 . . . . 0.0 110.731 179.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.7 m 56.05 53.01 9.61 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.196 179.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 58.1 tp -116.7 135.52 53.71 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.309 0.576 . . . . 0.0 110.779 179.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -146.44 117.06 7.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.115 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 75.5 mt -150.27 151.45 31.49 Favored Pre-proline 0 CA--C 1.539 0.538 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.481 -179.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -74.2 147.0 37.02 Favored 'Trans proline' 0 N--CA 1.493 1.475 0 C-N-CA 122.833 2.355 . . . . 0.0 111.827 179.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 74.2 t -92.46 122.22 43.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.083 0.468 . . . . 0.0 110.228 179.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.479 ' N ' ' CD1' ' A' ' 95' ' ' LEU . 10.2 mp -100.67 126.66 47.2 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.806 0.812 . . . . 0.0 110.672 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -63.02 -46.45 87.56 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.34 -1.3 . . . . 0.0 112.835 -178.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 4.3 m -86.25 132.09 34.07 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 121.123 0.487 . . . . 0.0 111.75 -179.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -87.17 60.41 6.14 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.352 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.414 ' CG2' ' N ' ' A' ' 100' ' ' GLU . 54.1 m -88.11 163.31 16.28 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 178.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.414 ' N ' ' CG2' ' A' ' 99' ' ' THR . 94.5 mt-10 -58.56 -44.56 89.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.284 0.564 . . . . 0.0 110.232 -179.424 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.41 ' H ' HG23 ' A' ' 99' ' ' THR . 66.3 mttm -64.8 -40.33 95.05 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.717 0.77 . . . . 0.0 110.077 178.197 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.438 ' O ' ' OG ' ' A' ' 105' ' ' SER . 95.9 m-20 -63.25 -36.42 83.62 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.054 -0.975 . . . . 0.0 111.711 -179.336 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 74.6 mt -61.89 -25.53 67.61 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 120.809 -0.357 . . . . 0.0 111.223 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 84.6 mt -73.15 -13.32 61.15 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.908 0.385 . . . . 0.0 111.029 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.438 ' OG ' ' O ' ' A' ' 102' ' ' ASN . 94.4 p -73.98 -9.01 58.21 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.392 0.615 . . . . 0.0 110.158 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.524 ' O ' ' CE1' ' A' ' 135' ' ' PHE . . . 95.31 -20.86 47.36 Favored Glycine 0 CA--C 1.526 0.779 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.884 178.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -146.92 125.48 12.47 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.215 -0.594 . . . . 0.0 111.376 179.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -144.15 129.11 18.5 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.116 179.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.511 ' CG2' ' NE2' ' A' ' 114' ' ' GLN . 27.7 m -66.96 131.55 46.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.897 -179.483 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.498 ' CG1' ' H33' ' B' ' 701' ' ' BOC . 92.7 t -79.07 -53.31 13.74 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.91 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.756 ' H ' ' NE2' ' A' ' 114' ' ' GLN . 73.3 mmtt -100.73 131.68 46.5 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 122.134 0.969 . . . . 0.0 111.949 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -66.09 -27.94 68.44 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 114.627 -1.17 . . . . 0.0 113.076 -178.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -84.14 12.97 5.6 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 113.863 1.06 . . . . 0.0 113.863 -177.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . 0.756 ' NE2' ' H ' ' A' ' 111' ' ' LYS . 45.5 mt-30 -77.96 143.28 37.75 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.348 0.595 . . . . 0.0 112.502 -179.622 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 53.0 t -123.56 124.64 69.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.046 178.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 63.6 mtt -58.42 130.5 47.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.417 179.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 84.19 -1.13 89.13 Favored Glycine 0 CA--C 1.529 0.933 0 N-CA-C 111.551 -0.619 . . . . 0.0 111.551 179.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -143.85 128.18 17.82 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 121.048 0.451 . . . . 0.0 110.787 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 78.76 -177.68 53.83 Favored Glycine 0 CA--C 1.532 1.117 0 N-CA-C 111.82 -0.512 . . . . 0.0 111.82 179.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 61.7 t-20 -84.97 105.4 15.7 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 120.943 0.402 . . . . 0.0 110.131 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -86.6 99.69 11.89 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.012 0.434 . . . . 0.0 110.386 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.473 ' N ' ' OE1' ' A' ' 114' ' ' GLN . . . -93.09 137.11 32.74 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 121.08 0.467 . . . . 0.0 111.628 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 61.1 mt -136.26 142.56 43.99 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.59 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -107.38 139.59 41.63 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 178.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -137.52 148.07 19.6 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 109.254 -1.538 . . . . 0.0 109.254 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 12.6 m-70 -92.26 123.68 35.77 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.744 0.783 . . . . 0.0 112.411 -178.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.467 ' OD1' ' N ' ' A' ' 129' ' ' SER . 52.0 t-20 -116.27 119.71 36.6 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.086 179.282 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 68.6 mtt -94.92 -2.75 49.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.351 0.596 . . . . 0.0 109.923 179.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.467 ' N ' ' OD1' ' A' ' 127' ' ' ASN . 0.2 OUTLIER 74.55 6.56 4.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.07 179.585 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.561 ' O ' ' CG1' ' A' ' 133' ' ' VAL . 11.4 ptpt -113.43 120.71 41.98 Favored 'General case' 0 C--O 1.225 -0.235 0 CA-C-O 121.33 0.586 . . . . 0.0 112.224 -179.379 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.51 ' O ' ' O ' ' A' ' 130' ' ' LYS . 18.2 tptt -31.93 155.13 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.616 179.316 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.404 ' H ' ' HG3' ' A' ' 131' ' ' LYS . . . 77.39 -17.01 5.51 Favored Glycine 0 CA--C 1.529 0.913 0 N-CA-C 110.819 -0.912 . . . . 0.0 110.819 179.462 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.561 ' CG1' ' O ' ' A' ' 130' ' ' LYS . 7.8 p -91.62 150.88 3.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 120.057 -0.657 . . . . 0.0 109.732 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.667 ' CD2' ' H ' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -68.27 146.18 53.57 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 122.035 0.922 . . . . 0.0 113.245 -177.112 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.524 ' CE1' ' O ' ' A' ' 106' ' ' GLY . 3.2 m-85 65.12 5.38 2.97 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 113.787 -1.551 . . . . 0.0 113.865 178.143 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' SER . . . . . 0.519 ' OG ' ' CG1' ' A' ' 133' ' ' VAL . 0.5 OUTLIER -71.65 -38.94 70.64 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 121.692 -0.63 . . . . 0.0 112.593 179.465 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 79.0 m-20 -93.46 0.73 56.86 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 114.9 1.444 . . . . 0.0 114.9 -177.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 38.4 pt -63.87 -22.83 31.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 119.038 -1.065 . . . . 0.0 110.471 -178.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -69.49 -10.86 59.85 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.268 0.556 . . . . 0.0 110.086 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 1.4 m -84.45 -5.21 59.26 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.572 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 82.1 mt -64.75 145.55 56.07 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.409 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -120.71 157.59 29.32 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 121.455 0.645 . . . . 0.0 112.148 -178.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -50.67 131.97 25.79 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.6 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 160' ' ' VAL . . . 80.17 7.37 88.59 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 120.648 -0.787 . . . . 0.0 111.149 179.05 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.489 ' OD1' ' N ' ' A' ' 146' ' ' LYS . 64.9 t0 -73.73 131.56 41.73 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 119.89 -0.724 . . . . 0.0 110.007 -179.705 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.489 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 73.6 mmtt -76.95 140.06 40.34 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.616 0.722 . . . . 0.0 112.124 -178.272 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 48.9 mm -131.51 134.42 60.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 177.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -112.49 127.49 56.07 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 119.747 -0.781 . . . . 0.0 112.424 -178.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -110.79 132.43 54.2 Favored 'General case' 0 C--O 1.224 -0.279 0 CA-C-N 114.943 -1.026 . . . . 0.0 108.658 178.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.594 ' CE2' ' OE1' ' A' ' 155' ' ' GLU . 61.2 m-85 -117.21 112.14 20.41 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.204 -0.598 . . . . 0.0 112.569 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . 0.563 ' OD1' ' N ' ' A' ' 152' ' ' ASN . 54.6 t0 -91.2 164.81 13.77 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 176.56 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . 0.563 ' N ' ' OD1' ' A' ' 151' ' ' ASP . 65.8 m-20 -57.61 -23.93 53.66 Favored 'General case' 0 C--N 1.311 -1.074 0 C-N-CA 120.106 -0.637 . . . . 0.0 111.112 -178.023 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -108.3 -29.68 8.74 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 119.762 -0.775 . . . . 0.0 112.839 -178.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . 0.433 ' O ' ' N ' ' A' ' 151' ' ' ASP . 0.3 OUTLIER -149.51 -177.51 5.9 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 113.723 1.008 . . . . 0.0 113.723 -177.779 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.594 ' OE1' ' CE2' ' A' ' 150' ' ' TYR . 80.0 tt0 -128.76 138.09 51.91 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 114.209 -1.36 . . . . 0.0 110.066 179.143 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -111.56 134.0 53.44 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 121.354 0.597 . . . . 0.0 111.383 -179.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -89.65 108.25 19.56 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.453 178.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -112.02 147.22 36.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.026 0.441 . . . . 0.0 111.187 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -124.32 123.39 40.1 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 121.047 0.451 . . . . 0.0 110.917 179.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.51 ' O ' ' N ' ' A' ' 144' ' ' GLY . 81.2 t -59.45 135.09 24.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 178.07 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 42.6 p -105.29 -26.04 12.17 Favored 'General case' 0 C--N 1.33 -0.263 0 O-C-N 123.325 0.39 . . . . 0.0 110.674 179.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 162.69 -169.72 38.02 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 120.452 -0.88 . . . . 0.0 111.992 179.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 3.0 p -135.11 149.92 29.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.068 -0.566 . . . . 0.0 110.15 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 50.7 m -139.54 163.58 32.17 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.427 0.632 . . . . 0.0 111.187 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -100.22 121.57 41.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.266 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 27.1 m -136.72 161.3 36.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.386 -179.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -92.68 165.03 20.03 Favored Pre-proline 0 CA--C 1.538 0.501 0 C-N-CA 120.662 -0.415 . . . . 0.0 111.054 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.431 ' O ' ' CB ' ' B' ' 702' ' ' LEU . 25.0 Cg_exo -62.52 -19.72 68.52 Favored 'Trans proline' 0 N--CA 1.499 1.852 0 C-N-CA 122.489 2.126 . . . . 0.0 112.998 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 46.7 p-10 -94.76 -5.85 44.36 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -75.95 88.82 2.93 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 119.655 -0.818 . . . . 0.0 111.657 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 4.9 p90 -76.89 -14.49 59.87 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.467 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -57.59 -35.53 70.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.47 -179.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 27.6 m -64.16 -15.56 17.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 C-N-CA 120.771 -0.372 . . . . 0.0 111.253 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 78.6 t -103.96 -16.1 7.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -179.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -74.57 144.33 44.04 Favored 'General case' 0 CA--C 1.533 0.319 0 O-C-N 121.816 -0.552 . . . . 0.0 110.956 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . 0.501 ' OD1' ' O ' ' A' ' 176' ' ' ASP . 55.7 p-10 -64.95 145.16 56.69 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.456 179.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 68.9 m80 -120.7 31.73 6.3 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 121.035 0.445 . . . . 0.0 111.759 -179.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 59.93 39.79 96.02 Favored Glycine 0 CA--C 1.534 1.228 0 N-CA-C 111.257 -0.737 . . . . 0.0 111.257 179.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -155.89 165.72 35.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.028 0.442 . . . . 0.0 110.781 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -88.56 102.03 14.53 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 177.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . 0.43 ' HG2' ' N ' ' A' ' 182' ' ' ILE . 84.4 tt0 -138.27 163.54 31.51 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.663 0.744 . . . . 0.0 111.909 -178.335 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.43 ' N ' ' HG2' ' A' ' 181' ' ' GLU . 18.6 tt -130.65 138.93 52.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.13 178.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 86.0 m -130.3 125.49 34.87 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.477 0.656 . . . . 0.0 111.639 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 93.2 mt -109.54 131.58 54.93 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.111 178.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 82.6 mt -113.91 125.39 71.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.465 0.65 . . . . 0.0 111.889 -177.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' THR . . . . . 0.414 ' C ' ' SG ' ' B' ' 705' ' ' B27 . 3.4 t -140.98 161.95 36.62 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.547 179.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' CYS . . . . . 0.531 ' N ' ' SG ' ' B' ' 705' ' ' B27 . 1.9 m -96.94 146.43 24.97 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.379 179.634 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.4 ' CG1' ' N ' ' A' ' 189' ' ' SER . 8.0 p -63.8 -43.51 97.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.196 0.522 . . . . 0.0 111.353 -179.322 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' SER . . . . . 0.4 ' N ' ' CG1' ' A' ' 188' ' ' VAL . 13.6 p -162.76 160.88 25.88 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.483 -179.306 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 9.5 p -79.18 -11.75 13.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.83 179.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -97.97 -19.85 17.79 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.052 0.453 . . . . 0.0 111.083 179.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 67.2 t0 -132.64 103.67 6.25 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.103 0.478 . . . . 0.0 111.403 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -104.29 10.84 35.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.875 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 44.2 t -60.72 -43.7 97.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.078 0.466 . . . . 0.0 111.109 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -125.03 144.33 50.45 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.05 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -124.47 143.54 50.59 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.852 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -98.67 133.51 42.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.023 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 30.0 t -120.3 131.17 73.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 CA-C-O 121.426 0.631 . . . . 0.0 110.936 179.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 31.7 t -104.28 132.07 51.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.194 179.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -113.78 144.38 43.07 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.368 0.604 . . . . 0.0 111.556 -179.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -136.46 139.32 10.55 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 110.356 -1.098 . . . . 0.0 110.356 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -103.47 138.65 39.9 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.145 0.497 . . . . 0.0 110.816 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 66.0 tp -62.83 131.52 49.08 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 2.8 t -115.37 -19.81 6.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 C-N-CA 120.762 -0.375 . . . . 0.0 111.503 -178.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -178.13 173.53 46.01 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 120.649 -0.786 . . . . 0.0 111.716 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 24.7 m -140.87 137.02 32.91 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.584 -0.525 . . . . 0.0 109.584 179.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -143.92 117.27 9.05 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.335 0.588 . . . . 0.0 112.075 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -62.43 141.71 58.23 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.991 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 8.9 ttpt -78.52 109.52 12.77 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.224 178.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 99.8 mttt . . . . . 0 C--N 1.322 -0.606 0 CA-C-O 117.914 -1.041 . . . . 0.0 110.828 -179.293 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 701' ' ' BOC . . . . . 0.498 ' H33' ' CG1' ' A' ' 110' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 702' ' ' LEU . . . . . 0.431 ' CB ' ' O ' ' A' ' 168' ' ' PRO . 0.4 OUTLIER -77.93 119.59 77.98 Favored Pre-proline 0 CA--C 1.543 0.681 0 N-CA-C 110.125 -0.324 . . . . 20.0 110.125 . . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 703' ' ' PRO . . . . . 0.504 ' O ' ' O ' ' B' ' 704' ' ' ALA . 2.8 Cg_endo -65.68 -176.83 0.61 Allowed 'Trans proline' 0 N--CA 1.489 1.249 0 C-N-CA 121.663 1.575 . . . . 20.0 113.047 -179.131 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 704' ' ' ALA . . . . . 0.513 ' O ' ' OG1' ' B' ' 705' ' ' B27 . . . -41.21 -177.53 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.319 -1.31 . . . . 20.0 113.527 -179.114 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 705' ' ' B27 . . . . . 0.531 ' SG ' ' N ' ' A' ' 187' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.297 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 81.1 p -62.02 -35.54 78.88 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 120.903 0.382 . . . . 0.0 111.184 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 81.5 t60 -115.24 118.02 32.13 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.008 0.432 . . . . 0.0 110.572 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 78.1 mtm -82.59 137.13 34.64 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.731 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -61.49 118.28 6.81 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 120.543 -0.463 . . . . 0.0 110.138 -179.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -101.96 14.89 30.69 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.524 -179.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 98.4 p -87.72 1.59 53.39 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.587 0.708 . . . . 0.0 110.077 178.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -100.26 10.27 41.49 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.038 -178.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 95.7 mt -56.04 135.22 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-O 122.159 0.981 . . . . 0.0 112.948 -176.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 85.0 m-20 -75.94 130.61 38.73 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 113.881 -1.509 . . . . 0.0 108.913 178.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.59 ' NE2' ' O ' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -82.25 152.49 67.88 Favored Pre-proline 0 C--N 1.328 -0.348 0 C-N-CA 120.15 -0.62 . . . . 0.0 110.49 -179.66 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -72.43 169.92 20.54 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 123.135 2.557 . . . . 0.0 112.76 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -54.65 169.61 0.2 Allowed 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.416 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 57.2 tp -64.3 -45.4 88.14 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.688 -179.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.73 -36.14 75.99 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.09 -0.644 . . . . 0.0 111.157 -177.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.604 ' N ' ' OE1' ' A' ' 68' ' ' GLU . 4.9 mp0 -55.88 -28.84 58.53 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.444 0.64 . . . . 0.0 109.511 178.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 38.3 t -76.59 -44.41 34.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-N 115.342 -0.844 . . . . 0.0 110.823 179.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -79.7 -8.08 59.0 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.974 -179.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -105.89 -13.14 15.59 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.337 0.589 . . . . 0.0 109.926 178.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -70.03 138.22 51.97 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.516 -0.766 . . . . 0.0 111.31 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 37.4 t -59.54 100.31 0.08 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.447 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.487 ' CD1' ' C ' ' A' ' 74' ' ' LEU . 2.8 tm? -71.12 122.87 20.92 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.137 -179.115 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -92.66 80.59 4.77 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 121.299 0.571 . . . . 0.0 110.501 178.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 51.8 tptt -65.83 -32.88 74.65 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.052 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.427 ' H ' ' HE3' ' A' ' 77' ' ' LYS . 3.0 mtmt -72.63 -18.31 61.59 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.414 -177.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -90.54 -9.51 46.92 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.033 0.444 . . . . 0.0 110.836 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 96.5 t -70.25 130.27 34.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.404 0.621 . . . . 0.0 111.263 -179.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 42.9 pt -118.13 -11.86 11.19 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.579 -179.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -159.83 170.02 35.92 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 111.154 -0.779 . . . . 0.0 111.154 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 61.9 ttp180 -143.61 151.35 40.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.542 0.686 . . . . 0.0 112.154 -179.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 21.0 tt -112.79 138.01 43.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.546 178.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 33.3 t -135.64 128.7 31.58 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 121.518 0.675 . . . . 0.0 111.903 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 85.1 mt -138.16 86.07 17.89 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.182 179.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -55.96 -29.85 75.27 Favored 'Trans proline' 0 N--CA 1.497 1.703 0 C-N-CA 123.091 2.527 . . . . 0.0 113.16 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 95.9 p -53.45 -38.43 63.55 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 120.537 -0.465 . . . . 0.0 111.005 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 23.7 m -117.47 12.2 7.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.387 0.613 . . . . 0.0 110.001 178.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 48.21 53.55 11.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.762 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 58.0 tp -114.93 132.47 56.54 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.318 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -145.78 122.36 11.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.649 -179.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 8.6 mt -146.81 147.74 30.79 Favored Pre-proline 0 CA--C 1.54 0.56 0 C-N-CA 120.198 -0.601 . . . . 0.0 111.95 -179.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -77.15 151.57 30.38 Favored 'Trans proline' 0 N--CA 1.497 1.688 0 C-N-CA 123.059 2.506 . . . . 0.0 112.478 178.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 87.7 t -95.52 113.24 29.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-O 121.065 0.46 . . . . 0.0 111.613 179.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.435 ' N ' ' CD1' ' A' ' 95' ' ' LEU . 11.1 mp -98.87 139.82 33.96 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.96 179.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.509 ' O ' ' OG1' ' A' ' 109' ' ' THR . 98.8 mttt -63.79 -80.97 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -178.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 33.6 t -60.86 131.14 49.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.186 0.517 . . . . 0.0 111.838 -178.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 35.3 p -89.72 71.68 7.73 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.99 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 26.1 m -92.21 169.53 10.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.505 -0.771 . . . . 0.0 109.251 178.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -61.65 -44.43 96.98 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 119.776 -0.77 . . . . 0.0 110.059 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -65.7 -40.99 92.86 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 121.33 0.586 . . . . 0.0 110.955 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -63.92 -38.7 92.05 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.149 -179.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 64.9 mt -62.63 -18.86 63.08 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.608 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 75.2 mt -70.74 -18.37 62.78 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.998 0.428 . . . . 0.0 110.39 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 88.9 p -74.45 -8.77 57.38 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.555 0.693 . . . . 0.0 109.286 179.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.608 ' O ' ' CE1' ' A' ' 135' ' ' PHE . . . 93.01 -19.15 53.98 Favored Glycine 0 CA--C 1.53 0.974 0 CA-C-N 115.123 -0.944 . . . . 0.0 112.337 178.616 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -146.25 126.76 14.13 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 119.659 -0.816 . . . . 0.0 112.745 -179.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -143.54 138.85 29.43 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.042 178.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.509 ' OG1' ' O ' ' A' ' 96' ' ' LYS . 30.0 p -65.67 133.03 50.25 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 121.271 0.558 . . . . 0.0 110.718 -179.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.472 ' N ' HE22 ' A' ' 114' ' ' GLN . 44.4 t -80.52 -50.4 17.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.385 -179.168 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.71 ' H ' ' NE2' ' A' ' 114' ' ' GLN . 76.8 mttt -105.65 141.22 37.47 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.835 0.826 . . . . 0.0 112.631 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -66.8 -36.26 81.97 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.174 -0.921 . . . . 0.0 112.917 -178.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 17.0 p30 -82.13 15.88 2.19 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -178.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . 0.71 ' NE2' ' H ' ' A' ' 111' ' ' LYS . 32.9 mt-30 -78.2 137.42 38.13 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 122.031 -0.418 . . . . 0.0 110.482 179.487 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 69.0 t -124.24 125.87 71.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.269 -0.423 . . . . 0.0 109.994 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' MET . . . . . 0.598 ' SD ' ' CZ ' ' A' ' 121' ' ' TYR . 91.7 mmm -56.53 125.75 23.48 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.097 0.475 . . . . 0.0 111.467 -179.605 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 82.59 -0.66 89.11 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-N 115.905 -0.589 . . . . 0.0 112.294 178.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -138.07 130.56 29.29 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 119.998 -0.681 . . . . 0.0 110.637 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 74.2 -169.47 53.91 Favored Glycine 0 CA--C 1.53 1.006 0 N-CA-C 110.518 -1.033 . . . . 0.0 110.518 -179.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 58.8 t-20 -89.39 105.62 17.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.992 0.425 . . . . 0.0 110.04 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.598 ' CZ ' ' SD ' ' A' ' 116' ' ' MET . 11.4 t80 -88.45 100.44 13.05 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.015 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.14 137.71 32.12 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 121.276 0.56 . . . . 0.0 111.745 -178.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 62.7 mt -135.21 137.33 42.53 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.923 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -112.07 135.69 52.4 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -130.75 134.22 7.67 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 110.601 -1.0 . . . . 0.0 110.601 -179.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -82.14 138.46 34.74 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.504 0.669 . . . . 0.0 111.627 -179.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.632 HD22 ' N ' ' A' ' 187' ' ' CYS . 32.1 p30 -141.47 161.0 38.98 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.14 -0.937 . . . . 0.0 110.388 179.568 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' MET . . . . . 0.445 ' O ' ' CB ' ' A' ' 129' ' ' SER . 70.7 mtm -124.28 1.19 8.43 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.575 178.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.445 ' CB ' ' O ' ' A' ' 128' ' ' MET . 0.2 OUTLIER 76.93 12.37 2.31 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.764 179.361 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.56 ' O ' ' CG1' ' A' ' 133' ' ' VAL . 9.3 ptpt -115.21 119.54 36.71 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.465 0.65 . . . . 0.0 112.295 -179.254 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.536 ' O ' ' O ' ' A' ' 130' ' ' LYS . 74.7 mmtt -29.07 154.73 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.893 -1.048 . . . . 0.0 111.611 179.453 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 75.34 -15.09 4.64 Favored Glycine 0 CA--C 1.529 0.94 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.964 179.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.56 ' CG1' ' O ' ' A' ' 130' ' ' LYS . 9.8 p -91.27 153.8 3.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 C-N-CA 120.371 -0.532 . . . . 0.0 109.785 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.62 ' CD2' ' H ' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -70.69 144.47 51.02 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 113.97 1.1 . . . . 0.0 113.97 -177.396 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.608 ' CE1' ' O ' ' A' ' 106' ' ' GLY . 3.9 m-85 68.7 -0.94 2.14 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 113.67 -1.605 . . . . 0.0 113.598 178.579 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 6.7 t -69.4 -39.43 77.94 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 179.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -89.36 -6.99 56.16 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.355 0.598 . . . . 0.0 111.252 -178.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.405 HD12 ' CD1' ' A' ' 135' ' ' PHE . 8.0 mt -62.86 -42.32 95.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.433 179.329 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -63.38 -12.02 27.33 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 120.238 -0.585 . . . . 0.0 110.337 179.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 1.9 m -82.36 -6.19 59.1 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.325 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 81.4 mt -63.27 142.02 58.54 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.212 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -116.76 163.62 15.87 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.701 0.762 . . . . 0.0 111.81 -179.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -52.08 134.97 32.15 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.868 -1.06 . . . . 0.0 112.158 179.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.598 ' N ' ' O ' ' A' ' 160' ' ' VAL . . . 77.14 7.97 86.85 Favored Glycine 0 CA--C 1.527 0.818 0 CA-C-N 115.541 -0.754 . . . . 0.0 112.313 178.011 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 50.6 t0 -72.62 132.93 44.37 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 119.541 -0.864 . . . . 0.0 109.804 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -77.45 138.1 39.05 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 121.663 0.744 . . . . 0.0 111.716 -178.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.405 HG23 HD11 ' A' ' 147' ' ' ILE . 87.2 mt -133.42 135.4 56.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 114.958 -1.019 . . . . 0.0 108.342 178.637 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 -115.64 133.52 55.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.535 0.683 . . . . 0.0 112.689 -178.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -115.64 133.02 56.44 Favored 'General case' 0 C--O 1.225 -0.229 0 CA-C-N 115.158 -0.928 . . . . 0.0 108.872 177.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.592 ' CZ ' ' OE2' ' A' ' 155' ' ' GLU . 93.4 m-85 -116.39 114.0 23.68 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.315 -0.554 . . . . 0.0 111.138 179.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . 0.467 ' OD1' ' N ' ' A' ' 152' ' ' ASN . 54.1 t0 -93.29 172.3 8.38 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 177.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . 0.467 ' N ' ' OD1' ' A' ' 151' ' ' ASP . 68.6 m-20 -58.04 -26.85 63.0 Favored 'General case' 0 C--N 1.318 -0.764 0 C-N-CA 120.483 -0.487 . . . . 0.0 111.477 -177.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -115.08 -24.19 8.67 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 -178.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -146.86 177.73 8.89 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -176.159 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.592 ' OE2' ' CZ ' ' A' ' 150' ' ' TYR . 83.8 tt0 -126.99 138.0 53.19 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 114.644 -1.162 . . . . 0.0 110.323 178.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -115.12 133.97 55.58 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 121.089 0.471 . . . . 0.0 111.676 -179.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -92.95 109.55 21.0 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.482 179.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -112.82 148.64 34.43 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.091 0.472 . . . . 0.0 111.168 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -125.23 124.46 41.74 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 121.331 0.586 . . . . 0.0 111.226 179.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.598 ' O ' ' N ' ' A' ' 144' ' ' GLY . 77.5 t -59.06 136.47 22.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.918 178.152 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 66.8 p -104.43 -24.81 13.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.09 0.472 . . . . 0.0 110.918 179.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 157.97 -167.7 34.35 Favored Glycine 0 CA--C 1.529 0.939 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 2.8 m -133.55 158.55 42.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 69.8 m -142.62 164.27 30.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.479 0.657 . . . . 0.0 111.731 -179.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -99.59 114.43 27.46 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.682 179.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 20.5 m -136.79 158.12 36.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.42 0.629 . . . . 0.0 111.582 -179.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -87.65 159.01 50.38 Favored Pre-proline 0 CA--C 1.536 0.423 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.996 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.404 ' O ' ' CG ' ' B' ' 702' ' ' LEU . 37.2 Cg_endo -64.81 -10.54 25.41 Favored 'Trans proline' 0 N--CA 1.498 1.739 0 C-N-CA 122.861 2.374 . . . . 0.0 112.98 -179.416 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 45.5 p-10 -95.44 -8.24 35.99 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -77.13 86.73 3.6 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 121.75 0.786 . . . . 0.0 112.256 -179.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' TRP . . . . . 0.51 ' CE2' ' OE2' ' A' ' 175' ' ' GLU . 1.2 p-90 -80.47 -9.25 59.77 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.798 -1.092 . . . . 0.0 110.883 179.583 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -63.89 -32.11 73.52 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.818 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 35.0 m -63.13 -18.71 22.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-N 116.112 -0.495 . . . . 0.0 112.137 -179.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 34.8 m -106.47 -0.36 9.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -179.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.51 ' OE2' ' CE2' ' A' ' 171' ' ' TRP . 96.7 mt-10 -74.0 149.21 41.4 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 121.138 0.494 . . . . 0.0 111.51 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . 0.464 ' OD1' ' O ' ' A' ' 176' ' ' ASP . 46.8 p-10 -68.4 135.0 51.08 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.531 179.23 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 41.9 m80 -117.32 28.68 8.33 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 120.704 -0.398 . . . . 0.0 111.255 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 62.82 34.35 89.53 Favored Glycine 0 CA--C 1.531 1.031 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 179.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -152.69 163.63 39.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.842 0.353 . . . . 0.0 110.422 179.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -88.14 106.41 18.16 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 177.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . 0.413 ' HG2' ' N ' ' A' ' 182' ' ' ILE . 82.7 tt0 -136.18 161.32 36.06 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.421 0.629 . . . . 0.0 111.275 -178.511 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.413 ' N ' ' HG2' ' A' ' 181' ' ' GLU . 17.3 tt -130.11 137.18 57.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.463 -0.789 . . . . 0.0 108.947 178.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 85.0 m -131.03 128.02 39.45 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.076 0.465 . . . . 0.0 111.493 -179.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 68.4 mt -112.95 133.39 54.94 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.742 178.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 82.0 mt -109.48 120.11 60.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.23 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' THR . . . . . 0.52 ' OG1' ' ND2' ' A' ' 127' ' ' ASN . 8.8 t -133.28 147.74 51.92 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.709 179.601 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' CYS . . . . . 0.632 ' N ' HD22 ' A' ' 127' ' ' ASN . 2.1 m -87.65 142.31 27.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.863 -179.718 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.424 ' CG1' ' N ' ' A' ' 189' ' ' SER . 14.3 p -62.35 -44.7 99.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.888 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' SER . . . . . 0.707 ' HG ' ' H ' ' A' ' 191' ' ' LYS . 24.9 t -170.69 148.72 3.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.122 0.487 . . . . 0.0 111.104 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 8.7 p -68.77 -14.86 19.02 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 CA-C-O 121.187 0.518 . . . . 0.0 110.493 179.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.707 ' H ' ' HG ' ' A' ' 189' ' ' SER . 75.4 mmtt -95.61 -11.74 26.77 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.574 179.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -135.67 102.2 5.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.223 0.535 . . . . 0.0 110.87 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -102.99 11.25 37.57 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.845 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 12.3 t -60.8 -45.0 96.13 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.639 -178.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 64.7 pttt -142.59 159.82 41.49 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 120.946 0.403 . . . . 0.0 110.635 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . 0.502 ' NH1' ' SG ' ' B' ' 705' ' ' B27 . 94.5 mtt-85 -132.32 147.59 52.4 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 121.053 0.454 . . . . 0.0 111.451 -178.439 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -97.19 135.47 39.09 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 121.164 0.507 . . . . 0.0 111.413 179.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 38.9 t -120.53 129.46 75.56 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.914 179.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 54.1 t -100.12 133.27 43.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.527 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -122.64 152.52 40.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.522 0.677 . . . . 0.0 111.584 -179.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -147.41 149.85 22.03 Favored Glycine 0 CA--C 1.532 1.107 0 N-CA-C 110.33 -1.108 . . . . 0.0 110.33 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -106.28 148.89 27.45 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.927 0.394 . . . . 0.0 111.007 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 62.4 tp -66.23 130.39 43.05 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 178.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 46.9 t -110.32 -24.19 4.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 C-N-CA 120.8 -0.36 . . . . 0.0 111.609 -178.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -178.47 173.74 46.08 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 111.164 -0.775 . . . . 0.0 111.164 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 19.6 m -142.89 141.76 31.59 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.135 0.493 . . . . 0.0 110.254 179.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -141.43 114.55 8.66 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.262 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -64.74 148.1 51.81 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.829 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.466 ' HZ1' ' C ' ' A' ' 152' ' ' ASN . 55.8 mtmt -77.06 154.99 32.82 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.543 178.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 53.9 mtmt . . . . . 0 C--O 1.22 -0.479 0 CA-C-O 117.919 -1.039 . . . . 0.0 110.832 179.573 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 701' ' ' BOC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 702' ' ' LEU . . . . . 0.404 ' CG ' ' O ' ' A' ' 168' ' ' PRO . 0.2 OUTLIER 57.5 78.34 0.37 Allowed Pre-proline 0 CA--C 1.537 0.476 0 CA-C-O 121.505 0.669 . . . . 20.0 111.046 . . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 703' ' ' PRO . . . . . 0.55 ' O ' ' O ' ' B' ' 704' ' ' ALA . 3.1 Cg_exo -73.72 -165.43 0.25 Allowed 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 123.576 2.851 . . . . 20.0 112.898 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 704' ' ' ALA . . . . . 0.55 ' O ' ' O ' ' B' ' 703' ' ' PRO . . . -39.64 -176.21 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 115.008 -0.996 . . . . 20.0 113.081 -179.501 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 705' ' ' B27 . . . . . 0.558 ' SG ' ' N ' ' A' ' 187' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.378 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 30.8 t -136.93 136.34 38.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.971 0.415 . . . . 0.0 110.581 179.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -112.27 132.21 55.07 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.107 0.479 . . . . 0.0 110.813 179.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 78.2 mtm -101.87 140.57 35.97 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.492 179.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.494 ' OD1' ' OG ' ' A' ' 59' ' ' SER . 47.2 t0 -165.04 122.53 1.58 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.619 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -97.55 -1.58 43.65 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.145 0.497 . . . . 0.0 110.828 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.494 ' OG ' ' OD1' ' A' ' 57' ' ' ASP . 92.4 p -85.25 1.49 48.03 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.242 -178.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.406 ' HG2' HH21 ' A' ' 196' ' ' ARG . 99.5 mttt -99.05 17.54 19.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.069 0.462 . . . . 0.0 111.602 -179.361 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 14.7 mm -55.74 136.62 18.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 122.449 1.119 . . . . 0.0 112.231 -177.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -80.12 126.23 30.81 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 113.346 -1.752 . . . . 0.0 109.894 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -78.17 123.17 86.03 Favored Pre-proline 0 CA--C 1.533 0.322 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -44.0 170.38 0.02 OUTLIER 'Trans proline' 0 C--N 1.313 -1.341 0 C-N-CA 121.886 1.724 . . . . 0.0 112.318 -179.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -52.18 163.16 0.4 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.15 -179.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 55.0 tp -62.58 -44.84 95.32 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.786 -177.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -60.43 -38.51 84.31 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.226 -0.589 . . . . 0.0 111.603 -178.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 66.3 tt0 -60.85 -25.17 66.45 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.14 -0.624 . . . . 0.0 110.027 179.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 36.1 t -77.83 -47.15 25.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.633 0.73 . . . . 0.0 109.774 178.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -73.43 -8.53 56.26 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 114.86 -1.064 . . . . 0.0 110.811 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -103.62 -16.95 15.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.502 0.668 . . . . 0.0 110.255 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -69.4 142.7 53.85 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.898 -179.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 33.6 t -58.56 97.52 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.564 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -67.79 136.15 53.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.109 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.446 ' OD2' ' CD ' ' A' ' 78' ' ' GLN . 37.6 t0 -103.55 79.11 1.65 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.334 178.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -71.76 -35.37 70.05 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.471 0.653 . . . . 0.0 111.962 179.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 43.8 mmtt -67.95 -31.12 70.63 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.058 -0.973 . . . . 0.0 112.781 -174.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.446 ' CD ' ' OD2' ' A' ' 75' ' ' ASP . 86.4 mt-30 -87.34 6.3 34.29 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.219 -0.593 . . . . 0.0 111.621 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 59.3 t -78.42 130.13 36.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 120.434 -0.506 . . . . 0.0 109.661 179.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 43.4 pt -110.3 -4.71 10.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.778 -179.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -163.56 166.0 37.07 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 120.499 -0.858 . . . . 0.0 111.605 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 72.0 ttp85 -137.66 141.29 41.15 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 121.095 0.474 . . . . 0.0 111.191 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 19.9 tt -105.08 141.43 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.984 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 7.9 t -137.63 131.79 32.05 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 121.4 0.619 . . . . 0.0 112.219 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.426 HG22 HD11 ' A' ' 85' ' ' ILE . 87.2 mt -136.71 88.05 19.65 Favored Pre-proline 0 CA--C 1.537 0.465 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.805 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -55.4 -32.01 80.01 Favored 'Trans proline' 0 N--CA 1.5 1.881 0 C-N-CA 123.155 2.57 . . . . 0.0 112.571 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 67.3 m -54.3 -42.71 70.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.26 0.552 . . . . 0.0 110.678 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 19.7 m -112.43 6.84 8.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.371 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 50.65 52.25 15.27 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.879 0.847 . . . . 0.0 110.187 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 52.8 tp -118.32 133.85 55.54 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.185 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -145.05 126.96 15.43 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.734 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 80.1 mt -149.06 151.01 33.55 Favored Pre-proline 0 CA--C 1.538 0.497 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.493 -178.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -76.53 148.82 29.95 Favored 'Trans proline' 0 N--CA 1.496 1.66 0 C-N-CA 122.839 2.359 . . . . 0.0 111.804 178.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 73.8 t -97.3 117.97 42.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-O 121.047 0.451 . . . . 0.0 111.579 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.487 ' N ' ' CD1' ' A' ' 95' ' ' LEU . 9.4 mp -102.74 134.1 46.68 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.889 179.437 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.492 ' O ' ' OG1' ' A' ' 109' ' ' THR . 98.1 mttt -58.55 -83.4 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 121.26 0.552 . . . . 0.0 111.934 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 18.7 m -61.33 138.31 58.25 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.527 0.679 . . . . 0.0 111.666 -178.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 3.1 m -95.4 70.62 3.15 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.17 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 8.7 p -88.54 166.65 14.02 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 177.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -59.13 -40.61 85.99 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 119.931 -0.707 . . . . 0.0 109.994 179.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -65.49 -42.18 92.45 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 121.321 0.581 . . . . 0.0 110.709 178.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -64.36 -37.05 86.13 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.477 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 84.7 mt -62.93 -18.02 62.57 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.857 -179.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 98.0 mt -74.73 -18.0 60.56 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.846 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 50.5 m -74.36 -4.9 39.19 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-O 121.728 0.775 . . . . 0.0 109.366 179.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 86.48 -19.78 26.26 Favored Glycine 0 CA--C 1.532 1.134 0 CA-C-N 114.826 -1.079 . . . . 0.0 112.803 178.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -145.91 123.98 12.12 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 119.585 -0.846 . . . . 0.0 112.472 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -145.9 141.55 27.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.362 -0.836 . . . . 0.0 109.968 178.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.492 ' OG1' ' O ' ' A' ' 96' ' ' LYS . 20.5 p -65.9 136.39 56.05 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.135 -0.626 . . . . 0.0 109.583 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 76.1 t -76.78 -46.12 30.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.928 -179.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 43.3 mtpt -99.09 142.82 30.08 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 122.013 0.911 . . . . 0.0 112.036 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -67.42 -36.09 80.57 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.594 -1.184 . . . . 0.0 111.956 -179.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 72.8 m-80 -86.76 22.18 2.02 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 114.203 1.186 . . . . 0.0 114.203 -177.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . 0.438 ' OE1' ' O ' ' A' ' 120' ' ' ASN . 94.5 mm-40 -78.37 137.28 37.94 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 121.797 -0.564 . . . . 0.0 112.312 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 61.5 t -128.18 123.96 61.4 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.868 179.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 55.6 mtt -58.55 130.91 49.07 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 121.133 0.492 . . . . 0.0 111.924 179.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 78.23 -0.51 73.87 Favored Glycine 0 CA--C 1.531 1.051 0 CA-C-N 116.04 -0.527 . . . . 0.0 112.789 178.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -138.38 124.99 20.79 Favored 'General case' 0 C--N 1.329 -0.317 0 O-C-N 122.047 -0.678 . . . . 0.0 111.1 -179.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 76.12 -165.31 54.01 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 110.337 -1.105 . . . . 0.0 110.337 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.438 ' O ' ' OE1' ' A' ' 114' ' ' GLN . 59.0 t-20 -91.73 105.34 17.65 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.041 0.448 . . . . 0.0 109.864 179.414 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -85.43 144.91 27.71 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 179.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -146.8 145.61 29.97 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 119.842 -0.743 . . . . 0.0 111.944 -178.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.4 mp -139.61 145.25 38.3 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.918 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -110.23 135.73 50.53 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 178.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -136.72 148.99 20.02 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 110.294 -1.122 . . . . 0.0 110.294 -179.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.489 ' O ' ' O ' ' A' ' 134' ' ' LEU . 21.6 m-70 -86.79 142.52 28.05 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.616 0.722 . . . . 0.0 111.935 -179.157 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 49.5 t-20 -131.51 120.79 23.44 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.142 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' MET . . . . . 0.466 ' O ' ' CB ' ' A' ' 129' ' ' SER . 62.9 mtt -94.4 -2.77 51.42 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.227 0.537 . . . . 0.0 110.662 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.466 ' CB ' ' O ' ' A' ' 128' ' ' MET . 0.7 OUTLIER 77.43 3.97 3.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.318 179.123 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.571 ' O ' ' CG1' ' A' ' 133' ' ' VAL . 61.8 pttt -118.16 130.72 56.27 Favored 'General case' 0 C--O 1.222 -0.357 0 CA-C-O 121.623 0.725 . . . . 0.0 112.817 -178.578 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.473 ' O ' ' O ' ' A' ' 130' ' ' LYS . 74.9 mmtt -41.12 163.66 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.354 0.597 . . . . 0.0 109.616 179.026 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 74.93 -22.51 1.47 Allowed Glycine 0 CA--C 1.53 1.007 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.571 ' CG1' ' O ' ' A' ' 130' ' ' LYS . 3.7 p -90.25 156.84 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 119.776 -0.77 . . . . 0.0 110.746 -179.36 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.662 ' H ' ' CD1' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -70.79 146.25 49.87 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 115.023 1.49 . . . . 0.0 115.023 -176.803 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 59.68 7.77 1.14 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 112.504 -2.135 . . . . 0.0 114.153 177.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 5.4 t -69.9 -33.27 71.97 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 119.99 -0.684 . . . . 0.0 112.371 179.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -89.52 0.65 56.75 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 -178.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 2.1 pp -58.2 -31.52 42.29 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 C-N-CA 119.874 -0.73 . . . . 0.0 110.965 -179.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -65.1 -13.89 59.16 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.962 0.411 . . . . 0.0 110.876 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 49.3 m -81.52 -4.0 54.74 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.152 -179.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 92.9 mt -64.57 142.12 58.54 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -120.52 156.01 32.44 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.223 0.535 . . . . 0.0 110.185 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -49.63 130.34 20.58 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.848 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.598 ' N ' ' O ' ' A' ' 160' ' ' VAL . . . 80.76 8.46 87.47 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 120.837 -0.697 . . . . 0.0 111.914 178.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.498 ' OD1' ' N ' ' A' ' 146' ' ' LYS . 63.8 t0 -71.77 133.95 45.88 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 119.737 -0.785 . . . . 0.0 109.928 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.498 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 73.2 mmtt -78.97 140.52 38.0 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.764 0.792 . . . . 0.0 112.749 -178.235 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 96.3 mt -134.35 134.32 54.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 114.718 -1.128 . . . . 0.0 108.014 178.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -115.45 133.7 55.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.648 0.737 . . . . 0.0 112.706 -178.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -114.7 132.64 56.35 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.97 -1.014 . . . . 0.0 108.397 177.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.494 ' CZ ' ' OE2' ' A' ' 155' ' ' GLU . 94.1 m-85 -115.51 110.13 18.82 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 119.985 -0.686 . . . . 0.0 111.673 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . 0.57 ' OD1' ' N ' ' A' ' 152' ' ' ASN . 62.3 t0 -88.3 165.67 14.84 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 177.015 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . 0.57 ' N ' ' OD1' ' A' ' 151' ' ' ASP . 36.5 p-10 -58.18 -20.35 40.49 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 119.466 -0.894 . . . . 0.0 111.219 -178.21 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -115.03 -27.88 7.19 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 -178.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -147.52 176.33 10.14 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 118.963 -1.095 . . . . 0.0 113.455 -176.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.494 ' OE2' ' CZ ' ' A' ' 150' ' ' TYR . 83.8 tt0 -125.02 133.48 52.95 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 114.604 -1.18 . . . . 0.0 110.141 178.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -107.94 133.55 52.12 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 120.967 0.413 . . . . 0.0 111.271 -179.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -91.7 110.11 21.44 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.352 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -113.36 146.47 39.41 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.015 0.436 . . . . 0.0 111.137 179.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -126.12 125.68 42.92 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 121.133 0.492 . . . . 0.0 111.132 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.598 ' O ' ' N ' ' A' ' 144' ' ' GLY . 83.0 t -58.27 133.63 23.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.667 178.425 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 70.5 p -115.49 11.3 15.91 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 139.6 171.6 12.36 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 119.972 -1.109 . . . . 0.0 112.923 178.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 42.1 t -125.63 135.43 63.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 114.305 -0.948 . . . . 0.0 108.874 178.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 30.8 m -131.98 162.32 30.99 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.504 0.668 . . . . 0.0 111.85 -179.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . 0.405 ' HG2' ' CE2' ' A' ' 197' ' ' TYR . 99.1 mt-10 -108.22 121.19 44.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.606 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 29.1 m -136.38 157.45 37.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.431 0.634 . . . . 0.0 111.349 -179.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' THR . . . . . 0.496 ' H ' ' HG1' ' A' ' 167' ' ' THR . 0.2 OUTLIER -80.26 159.39 70.34 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.755 179.169 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.51 ' O ' ' CB ' ' B' ' 702' ' ' LEU . 37.8 Cg_endo -65.66 -15.55 49.79 Favored 'Trans proline' 0 C--N 1.302 -1.891 0 C-N-CA 123.114 2.543 . . . . 0.0 113.227 -179.652 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 50.8 p-10 -92.26 -3.78 54.99 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 119.808 -0.757 . . . . 0.0 111.842 179.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -74.43 80.45 1.91 Allowed 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.261 -0.575 . . . . 0.0 110.634 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' TRP . . . . . 0.738 ' CH2' ' H22' ' B' ' 701' ' ' BOC . 33.8 m0 -69.17 -17.63 63.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.87 179.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -61.18 -30.52 70.46 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.73 -178.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 30.8 m -63.27 -15.88 16.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.188 0.518 . . . . 0.0 111.008 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 78.3 t -111.16 -11.05 11.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.131 -179.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -73.46 152.53 40.7 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.201 0.524 . . . . 0.0 111.224 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . 0.523 ' OD1' ' O ' ' A' ' 176' ' ' ASP . 49.5 p30 -70.19 136.74 50.33 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 121.347 0.594 . . . . 0.0 111.41 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 77.9 m80 -107.4 -18.89 13.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.469 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 102.49 37.55 3.24 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -178.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 11.6 ptmt -157.38 170.21 22.97 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.089 -0.556 . . . . 0.0 111.063 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -87.79 100.28 12.73 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 177.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . 0.426 ' HG2' ' N ' ' A' ' 182' ' ' ILE . 79.4 tt0 -136.32 161.22 36.4 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.403 0.62 . . . . 0.0 111.272 -179.119 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.426 ' N ' ' HG2' ' A' ' 181' ' ' GLU . 20.7 tt -129.6 138.35 54.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.249 -0.887 . . . . 0.0 108.782 178.404 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 97.8 m -128.04 126.02 40.47 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.199 0.523 . . . . 0.0 112.17 -178.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.419 ' N ' ' CD1' ' A' ' 184' ' ' LEU . 10.2 mp -107.94 127.41 53.73 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.119 178.341 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 93.3 mt -114.29 123.98 70.49 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-O 121.362 0.601 . . . . 0.0 111.545 -178.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -142.54 161.55 37.77 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.597 179.425 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -98.63 139.98 33.54 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 178.172 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.409 ' CG1' ' N ' ' A' ' 189' ' ' SER . 7.4 p -59.76 -47.26 91.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.807 -178.501 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' SER . . . . . 0.429 ' HG ' ' H ' ' A' ' 192' ' ' ASP . 23.1 p -160.52 157.85 28.2 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.1 0.476 . . . . 0.0 110.761 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 27.8 m -76.87 -9.21 12.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.212 0.53 . . . . 0.0 110.24 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -96.95 -18.95 19.14 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.978 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . 0.429 ' H ' ' HG ' ' A' ' 189' ' ' SER . 65.9 t0 -136.8 98.79 3.87 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.09 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -101.44 11.35 39.27 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 121.131 0.491 . . . . 0.0 110.902 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 47.1 t -59.92 -43.25 95.01 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.476 -179.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 51.6 mtmt -132.06 146.3 51.97 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 121.185 0.517 . . . . 0.0 111.211 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . 0.406 HH21 ' HG2' ' A' ' 60' ' ' LYS . 99.9 mtt180 -121.32 145.41 47.91 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.926 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . 0.405 ' CE2' ' HG2' ' A' ' 165' ' ' GLU . 36.4 m-85 -94.87 140.79 29.43 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.727 179.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 55.8 t -130.85 132.35 64.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.298 0.57 . . . . 0.0 111.041 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 47.8 t -100.19 133.93 41.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.07 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -108.07 132.84 53.14 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.266 0.555 . . . . 0.0 110.93 -179.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -132.2 140.59 11.95 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . 0.558 ' OD1' ' N ' ' A' ' 203' ' ' LEU . 67.9 t0 -111.5 138.49 47.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.123 0.487 . . . . 0.0 111.151 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . 0.558 ' N ' ' OD1' ' A' ' 202' ' ' ASP . 53.8 tp -62.69 128.9 38.1 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 1.3 p -114.38 -19.94 6.39 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 120.848 -0.341 . . . . 0.0 111.548 -178.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -175.87 170.94 44.0 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 120.768 -0.729 . . . . 0.0 111.858 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 18.2 m -143.71 139.68 29.62 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 179.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -144.81 120.23 10.31 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.43 0.633 . . . . 0.0 111.991 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -64.28 142.91 58.25 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.388 -179.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -80.75 110.48 16.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.68 179.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 99.4 mttt . . . . . 0 C--O 1.221 -0.42 0 CA-C-O 117.88 -1.057 . . . . 0.0 110.994 -179.757 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 701' ' ' BOC . . . . . 0.738 ' H22' ' CH2' ' A' ' 171' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 702' ' ' LEU . . . . . 0.51 ' CB ' ' O ' ' A' ' 168' ' ' PRO . 2.0 mt -112.88 98.81 46.45 Favored Pre-proline 0 CA--C 1.54 0.573 0 CA-C-O 120.672 0.272 . . . . 20.0 110.726 . . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 703' ' ' PRO . . . . . 0.581 ' O ' ' O ' ' B' ' 704' ' ' ALA . 4.2 Cg_exo -67.17 -169.02 0.18 Allowed 'Trans proline' 0 N--CA 1.489 1.25 0 C-N-CA 122.527 2.151 . . . . 20.0 114.006 -179.287 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 704' ' ' ALA . . . . . 0.581 ' O ' ' O ' ' B' ' 703' ' ' PRO . . . -33.01 176.73 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 113.798 -1.546 . . . . 20.0 113.792 -179.459 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 705' ' ' B27 . . . . . 0.446 ' CG2' ' C ' ' B' ' 704' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.41 ' H2 ' ' H ' ' A' ' 54' ' ' SER . . . . . . . . 0 N--CA 1.489 2.169 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.41 ' H ' ' H2 ' ' A' ' 53' ' ' GLY . 17.7 p -149.75 161.0 43.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.238 0.542 . . . . 0.0 110.788 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 -115.99 131.54 56.91 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.018 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 78.4 mtm -100.54 119.14 38.07 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.268 0.556 . . . . 0.0 110.846 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -56.13 114.02 1.78 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.709 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -103.56 14.07 32.0 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.356 -179.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.51 ' CB ' ' O ' ' B' ' 702' ' ' LEU . 5.5 p -81.28 20.06 0.89 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.356 0.598 . . . . 0.0 111.158 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -102.64 18.48 21.22 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.205 -179.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.9 mt -56.26 139.5 15.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 122.415 1.103 . . . . 0.0 113.405 -176.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -77.42 130.69 37.39 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 113.525 -1.671 . . . . 0.0 108.865 178.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.544 ' H ' ' CD ' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -81.28 154.9 72.14 Favored Pre-proline 0 C--N 1.32 -0.688 0 C-N-CA 120.364 -0.534 . . . . 0.0 110.513 -179.139 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -72.2 166.48 29.56 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 123.249 2.632 . . . . 0.0 113.34 -178.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -52.62 164.45 0.35 Allowed 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 120.975 0.417 . . . . 0.0 110.491 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 56.5 tp -64.27 -47.05 81.05 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.321 -179.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.412 ' O ' ' N ' ' A' ' 71' ' ' ASN . . . -62.65 -36.46 82.92 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 119.863 -0.735 . . . . 0.0 110.773 -178.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -62.46 -28.81 70.07 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.526 0.679 . . . . 0.0 109.223 178.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.432 ' CG1' ' O ' ' A' ' 104' ' ' LEU . 46.7 t -76.7 -44.38 33.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.862 178.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -79.38 -8.88 59.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.0 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.412 ' N ' ' O ' ' A' ' 67' ' ' ALA . 10.3 m120 -102.82 -13.28 17.06 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.397 0.618 . . . . 0.0 110.177 179.34 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.91 145.44 53.66 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.172 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 32.9 m -57.85 110.17 0.86 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.784 -179.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.497 ' CD1' ' C ' ' A' ' 74' ' ' LEU . 3.0 tm? -70.88 119.34 14.86 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.338 0.59 . . . . 0.0 110.535 -179.611 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -94.92 78.76 3.62 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.481 -0.782 . . . . 0.0 109.812 179.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -65.07 -32.85 74.76 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.267 -0.879 . . . . 0.0 112.055 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 36.9 mmtt -70.15 -10.16 57.93 Favored 'General case' 0 C--N 1.314 -0.955 0 C-N-CA 120.401 -0.52 . . . . 0.0 110.509 -177.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -96.65 -3.8 42.11 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.474 178.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.41 ' O ' ' CG1' ' A' ' 79' ' ' VAL . 3.1 p -81.39 130.14 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-O 121.315 0.579 . . . . 0.0 111.386 -179.368 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 10.0 pt -108.66 -6.75 10.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.982 179.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -174.15 -180.0 45.13 Favored Glycine 0 CA--C 1.53 1.012 0 N-CA-C 111.326 -0.71 . . . . 0.0 111.326 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 61.4 ttp180 -136.74 156.88 47.93 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 179.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 19.5 tt -124.2 141.96 42.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.113 0.482 . . . . 0.0 110.362 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 74.5 m -135.5 131.05 35.58 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 121.66 0.743 . . . . 0.0 112.332 -178.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 92.5 mt -137.33 86.06 20.4 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.082 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -57.48 -30.12 87.11 Favored 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 122.769 2.312 . . . . 0.0 113.063 -179.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 70.6 m -52.9 -40.67 63.72 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 121.22 0.533 . . . . 0.0 110.457 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 26.7 m -113.58 8.09 7.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.346 179.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 52.59 54.45 10.59 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.501 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 60.1 tp -119.99 135.29 54.97 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.629 0.728 . . . . 0.0 111.337 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -146.31 124.21 12.0 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.186 -0.915 . . . . 0.0 109.224 179.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 82.3 mt -149.36 148.07 25.26 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.716 -178.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -73.04 146.24 41.08 Favored 'Trans proline' 0 C--N 1.313 -1.313 0 C-N-CA 122.176 1.918 . . . . 0.0 111.318 179.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 43.8 t -96.55 122.11 47.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.28 0.562 . . . . 0.0 111.081 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.427 ' N ' ' CD1' ' A' ' 95' ' ' LEU . 11.1 mp -99.68 134.73 42.14 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.199 179.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.453 ' O ' ' OG1' ' A' ' 109' ' ' THR . 82.6 tttt -62.63 -79.03 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.499 -177.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 7.5 m -66.98 145.01 55.86 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 121.041 0.448 . . . . 0.0 111.611 -179.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 7.2 t -95.43 68.14 2.97 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-O 121.186 0.517 . . . . 0.0 111.51 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 12.9 m -88.54 166.99 13.79 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 178.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -60.99 -43.9 98.19 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.022 -0.671 . . . . 0.0 109.881 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -65.14 -38.38 90.43 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.483 0.659 . . . . 0.0 110.253 178.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -63.82 -39.27 93.83 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.057 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 78.2 mt -62.92 -12.01 22.41 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.015 -0.539 . . . . 0.0 112.001 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.432 ' O ' ' CG1' ' A' ' 69' ' ' VAL . 96.9 mt -73.28 -22.6 60.33 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 121.052 0.454 . . . . 0.0 111.15 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 95.7 p -73.84 -3.69 30.3 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.349 0.595 . . . . 0.0 110.498 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 86.85 -18.87 32.67 Favored Glycine 0 CA--C 1.531 1.06 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.509 178.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -145.62 127.07 15.0 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 119.941 -0.704 . . . . 0.0 112.103 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -147.74 142.8 27.05 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.551 178.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.453 ' OG1' ' O ' ' A' ' 96' ' ' LYS . 3.4 p -73.6 140.79 46.45 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.271 0.557 . . . . 0.0 111.65 -179.27 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 58.1 t -78.64 -52.37 15.64 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.973 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.726 ' H ' ' NE2' ' A' ' 114' ' ' GLN . 49.0 mtmt -100.32 136.67 39.85 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 122.221 1.01 . . . . 0.0 112.526 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -66.16 -31.98 73.15 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 113.978 -1.465 . . . . 0.0 112.627 -178.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 71.5 m-80 -85.33 13.7 6.24 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 -177.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . 0.726 ' NE2' ' H ' ' A' ' 111' ' ' LYS . 32.7 mt-30 -79.87 143.5 34.26 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.383 0.611 . . . . 0.0 112.363 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 65.1 t -123.69 123.42 67.12 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.183 178.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' MET . . . . . 0.445 ' CG ' ' CZ ' ' A' ' 121' ' ' TYR . 98.9 mtp -57.65 133.82 55.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.195 0.521 . . . . 0.0 111.509 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.496 ' O ' ' OD2' ' A' ' 180' ' ' ASP . . . 81.69 -2.45 82.92 Favored Glycine 0 CA--C 1.53 0.969 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.55 179.557 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -142.87 135.81 28.06 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.213 0.53 . . . . 0.0 111.263 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 72.47 -166.77 53.82 Favored Glycine 0 CA--C 1.529 0.925 0 N-CA-C 110.495 -1.042 . . . . 0.0 110.495 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 64.8 t-20 -92.24 103.49 15.95 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.075 0.464 . . . . 0.0 110.676 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.445 ' CZ ' ' CG ' ' A' ' 116' ' ' MET . 2.5 t80 -88.64 99.04 12.02 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 121.118 0.485 . . . . 0.0 110.1 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -91.51 138.43 31.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.091 0.472 . . . . 0.0 111.536 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 46.0 mt -134.33 139.59 45.78 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.415 -0.514 . . . . 0.0 110.913 179.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -107.89 133.24 52.53 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.655 179.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -134.3 142.98 14.53 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.517 ' O ' ' O ' ' A' ' 134' ' ' LEU . 23.2 m-70 -78.4 142.01 37.92 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.321 0.581 . . . . 0.0 112.39 -178.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.72 ' ND2' ' H ' ' A' ' 129' ' ' SER . 3.0 t-20 -138.76 121.34 16.23 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.816 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' MET . . . . . 0.522 ' C ' ' HG ' ' A' ' 129' ' ' SER . 63.4 mtt -97.81 -4.43 36.87 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.744 -179.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.72 ' H ' ' ND2' ' A' ' 127' ' ' ASN . 0.9 OUTLIER 79.14 4.16 2.32 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.967 179.281 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.532 ' O ' ' CG1' ' A' ' 133' ' ' VAL . 62.8 pttt -111.99 133.62 54.05 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 122.041 0.924 . . . . 0.0 113.206 -178.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.426 ' C ' ' O ' ' A' ' 130' ' ' LYS . 28.6 tptt -40.26 152.69 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.742 178.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 75.08 -14.75 4.57 Favored Glycine 0 CA--C 1.535 1.337 0 C-N-CA 121.077 -0.583 . . . . 0.0 112.71 178.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.532 ' CG1' ' O ' ' A' ' 130' ' ' LYS . 6.3 p -88.55 172.47 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 119.331 -0.947 . . . . 0.0 111.044 -179.258 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.517 ' O ' ' O ' ' A' ' 126' ' ' HIS . 3.8 mm? -68.64 133.69 48.83 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 115.495 1.665 . . . . 0.0 115.495 -176.363 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 56.84 12.49 1.18 Allowed 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 113.859 -1.519 . . . . 0.0 114.718 176.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 2.8 p -69.21 -32.35 71.54 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 121.64 -0.663 . . . . 0.0 112.784 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -89.21 2.15 54.66 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 -178.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 1.8 pp -63.45 -30.21 49.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 C-N-CA 120.206 -0.597 . . . . 0.0 111.046 -179.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -67.4 -11.06 56.82 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.94 0.4 . . . . 0.0 110.64 -179.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 56.8 m -82.45 -6.15 59.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.147 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 97.8 mt -65.33 143.83 57.5 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 121.165 0.507 . . . . 0.0 111.411 -179.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.402 ' HG2' ' N ' ' A' ' 143' ' ' LYS . 88.8 tttt -119.82 157.13 29.29 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 121.249 0.547 . . . . 0.0 111.091 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . 0.402 ' N ' ' HG2' ' A' ' 142' ' ' LYS . 88.7 tttt -49.76 136.08 18.24 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.178 179.515 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.507 ' N ' ' O ' ' A' ' 160' ' ' VAL . . . 77.24 8.05 86.93 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 120.823 -0.703 . . . . 0.0 111.953 178.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -70.79 131.19 43.44 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 119.68 -0.808 . . . . 0.0 110.072 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -77.87 140.32 39.33 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 121.551 0.691 . . . . 0.0 111.926 -178.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 98.4 mt -139.08 140.58 38.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-N 114.851 -1.068 . . . . 0.0 108.711 178.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 -126.07 139.52 53.33 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 119.748 -0.781 . . . . 0.0 112.794 -178.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -117.97 134.9 54.52 Favored 'General case' 0 C--O 1.226 -0.164 0 CA-C-N 114.983 -1.008 . . . . 0.0 108.633 178.245 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.558 ' CE2' ' CD ' ' A' ' 155' ' ' GLU . 92.4 m-85 -110.53 113.73 26.59 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.319 -0.552 . . . . 0.0 110.938 179.288 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . 0.441 ' OD1' ' N ' ' A' ' 152' ' ' ASN . 54.7 t0 -90.5 167.88 12.26 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 177.354 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . 0.441 ' N ' ' OD1' ' A' ' 151' ' ' ASP . 71.8 m-20 -55.53 -24.47 32.16 Favored 'General case' 0 C--N 1.317 -0.805 0 C-N-CA 119.971 -0.691 . . . . 0.0 111.28 -177.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -112.23 -26.99 8.51 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 114.243 1.201 . . . . 0.0 114.243 -178.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -149.82 -177.02 5.65 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 118.764 -1.174 . . . . 0.0 114.018 -176.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.558 ' CD ' ' CE2' ' A' ' 150' ' ' TYR . 84.6 tt0 -129.51 141.66 50.94 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 114.582 -1.19 . . . . 0.0 110.467 179.242 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -117.68 138.07 52.24 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 120.829 0.347 . . . . 0.0 111.75 -179.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -94.44 111.93 23.69 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.279 179.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.462 ' OH ' ' OD1' ' A' ' 180' ' ' ASP . 35.1 m-85 -112.56 148.23 34.98 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.053 0.454 . . . . 0.0 111.696 179.489 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -123.64 122.65 38.68 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 121.145 0.498 . . . . 0.0 111.456 179.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.507 ' O ' ' N ' ' A' ' 144' ' ' GLY . 95.4 t -58.84 135.24 23.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 177.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 80.9 p -106.32 -26.51 11.47 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 120.525 -0.47 . . . . 0.0 111.413 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 161.39 -169.65 36.97 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 120.481 -0.866 . . . . 0.0 111.89 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 28.5 m -135.39 162.6 37.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.017 0.437 . . . . 0.0 110.177 179.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 81.7 p -148.95 164.96 33.02 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.345 0.593 . . . . 0.0 111.324 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -104.79 115.76 30.86 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.062 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 24.4 m -137.09 160.95 36.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.48 0.657 . . . . 0.0 111.204 -179.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' THR . . . . . 0.502 ' OG1' ' OD1' ' A' ' 169' ' ' ASP . 0.1 OUTLIER -88.95 160.82 42.74 Favored Pre-proline 0 CA--C 1.539 0.533 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.933 179.364 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.551 ' O ' ' CB ' ' B' ' 702' ' ' LEU . 55.4 Cg_endo -67.69 -15.81 45.23 Favored 'Trans proline' 0 N--CA 1.5 1.909 0 C-N-CA 123.074 2.516 . . . . 0.0 114.031 -178.346 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . 0.502 ' OD1' ' OG1' ' A' ' 167' ' ' THR . 38.4 p-10 -91.06 -2.55 57.62 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 119.58 -0.848 . . . . 0.0 110.803 179.483 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.406 ' O ' ' CG2' ' A' ' 173' ' ' VAL . 73.0 mmtt -73.53 69.6 1.24 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.445 0.641 . . . . 0.0 110.208 179.41 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' TRP . . . . . 0.603 ' CD1' ' H13' ' B' ' 701' ' ' BOC . 57.3 t90 -60.13 -17.72 42.35 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.303 179.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -63.72 -28.78 70.12 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.602 -0.727 . . . . 0.0 111.936 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . 0.406 ' CG2' ' O ' ' A' ' 170' ' ' LYS . 34.6 m -62.33 -20.79 25.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 120.692 -0.403 . . . . 0.0 111.05 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 7.8 t -99.81 -6.02 9.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.648 -179.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.575 ' OE2' ' CZ3' ' A' ' 171' ' ' TRP . 93.0 mt-10 -73.71 143.91 45.96 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 121.199 0.523 . . . . 0.0 111.419 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 44.8 p-10 -70.94 144.0 50.72 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.776 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 50.4 m80 -119.31 28.02 8.46 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 62.34 37.71 95.05 Favored Glycine 0 CA--C 1.528 0.88 0 N-CA-C 111.272 -0.731 . . . . 0.0 111.272 179.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -153.69 161.68 41.92 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . 0.496 ' OD2' ' O ' ' A' ' 117' ' ' GLY . 56.8 t0 -87.37 101.6 13.72 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 178.225 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . 0.436 ' HG2' ' N ' ' A' ' 182' ' ' ILE . 72.5 tt0 -130.78 163.43 27.36 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.469 0.652 . . . . 0.0 111.524 -178.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.436 ' N ' ' HG2' ' A' ' 181' ' ' GLU . 20.2 tt -130.07 138.5 53.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 57.0 m -130.83 125.44 33.68 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.504 -0.478 . . . . 0.0 111.29 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 85.5 mt -109.28 130.87 55.48 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 96.7 mt -115.7 128.87 72.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.533 0.682 . . . . 0.0 111.527 -179.112 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 3.7 t -141.83 162.16 36.16 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.297 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' CYS . . . . . 0.447 ' O ' ' OD1' ' A' ' 127' ' ' ASN . 33.1 m -87.15 135.27 33.36 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.952 0.406 . . . . 0.0 110.086 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.473 ' CG1' ' N ' ' A' ' 189' ' ' SER . 11.9 p -61.54 -45.24 99.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-O 121.411 0.624 . . . . 0.0 110.308 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' SER . . . . . 0.473 ' N ' ' CG1' ' A' ' 188' ' ' VAL . 35.5 t -172.18 144.95 1.68 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.869 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 33.9 m -70.89 -13.01 16.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.124 0.488 . . . . 0.0 110.627 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 63.1 mttm -94.03 -12.8 27.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.121 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . 0.412 ' C ' ' OD1' ' A' ' 192' ' ' ASP . 64.2 t0 -140.19 109.03 5.98 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.517 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 46.9 p-10 -107.5 11.72 28.52 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.303 179.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 35.0 t -59.89 -43.78 94.59 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.144 -178.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -145.83 155.61 43.02 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 121.28 0.562 . . . . 0.0 111.714 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . 0.51 ' NE ' ' SG ' ' B' ' 705' ' ' B27 . 85.1 mtt85 -128.03 146.91 50.52 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 121.383 0.611 . . . . 0.0 111.603 -179.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -91.15 146.51 23.78 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.873 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 47.8 t -130.28 134.21 62.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.639 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 54.1 t -105.87 132.14 53.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.348 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -116.05 139.03 50.69 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.246 0.546 . . . . 0.0 110.084 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -140.74 142.65 12.5 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.739 -0.945 . . . . 0.0 110.739 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 35.5 p30 -109.03 155.5 20.84 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.318 0.58 . . . . 0.0 111.544 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 49.3 tp -74.13 131.3 41.16 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.478 179.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 3.9 p -113.83 -20.25 6.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 120.319 -0.553 . . . . 0.0 111.181 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -174.2 169.22 42.21 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 120.486 -0.864 . . . . 0.0 111.779 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 63.6 m -142.65 137.16 29.77 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 179.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 54.4 pttt -149.19 123.48 9.58 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.592 0.71 . . . . 0.0 112.31 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -62.97 143.59 57.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.554 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 14.7 ptpt -79.26 111.04 15.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.527 178.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 64.8 mttp . . . . . 0 C--O 1.22 -0.493 0 CA-C-O 118.216 -0.897 . . . . 0.0 110.322 -179.966 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 701' ' ' BOC . . . . . 0.603 ' H13' ' CD1' ' A' ' 171' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 702' ' ' LEU . . . . . 0.551 ' CB ' ' O ' ' A' ' 168' ' ' PRO . 0.0 OUTLIER 56.94 102.09 0.04 OUTLIER Pre-proline 0 CA--C 1.544 0.737 0 N-CA-C 109.635 -0.506 . . . . 20.0 109.635 . . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 703' ' ' PRO . . . . . 0.498 ' O ' ' O ' ' B' ' 704' ' ' ALA . 3.1 Cg_exo -65.81 -165.81 0.09 OUTLIER 'Trans proline' 0 N--CA 1.492 1.414 0 C-N-CA 121.921 1.748 . . . . 20.0 113.219 -179.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 704' ' ' ALA . . . . . 0.498 ' O ' ' O ' ' B' ' 703' ' ' PRO . . . -44.5 -174.73 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.89 -1.05 . . . . 20.0 112.729 -178.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 705' ' ' B27 . . . . . 0.51 ' SG ' ' NE ' ' A' ' 196' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.204 0 N-CA-C 109.889 -1.284 . . . . 0.0 109.889 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 44.0 t -65.33 145.68 55.88 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.103 0.478 . . . . 0.0 110.655 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 54.1 t-80 -119.22 124.15 46.05 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.965 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 89.4 mmm -79.67 145.59 32.91 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.832 179.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.44 ' OD1' ' OG ' ' A' ' 59' ' ' SER . 46.0 t0 -159.57 114.38 2.38 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.246 -179.298 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -92.82 -5.94 49.94 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.993 0.425 . . . . 0.0 110.855 179.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.476 ' CB ' ' O ' ' B' ' 702' ' ' LEU . 61.0 p -80.4 22.8 0.53 Allowed 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -179.389 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -109.2 19.15 19.77 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.069 0.461 . . . . 0.0 111.719 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 98.0 mt -55.83 135.64 18.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-O 122.115 0.96 . . . . 0.0 112.668 -177.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -77.72 129.95 36.16 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.148 -1.387 . . . . 0.0 109.336 178.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.615 ' NE2' ' O ' ' A' ' 63' ' ' GLN . 1.0 OUTLIER -79.21 147.66 69.56 Favored Pre-proline 0 N--CA 1.446 -0.628 0 C-N-CA 120.087 -0.645 . . . . 0.0 109.977 -179.215 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -69.76 167.63 23.88 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 122.353 2.036 . . . . 0.0 112.477 -179.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -51.17 169.77 0.05 OUTLIER 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.568 -178.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 55.9 tp -63.4 -46.21 87.49 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.607 -1.178 . . . . 0.0 111.409 -178.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.65 -22.96 48.75 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.159 0.505 . . . . 0.0 110.448 -178.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 49.3 tp10 -68.29 -31.56 71.09 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 119.284 -0.966 . . . . 0.0 108.509 178.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 36.6 t -74.45 -44.57 47.76 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.466 179.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -73.24 -9.82 59.12 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.709 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 38.6 t30 -118.58 -1.31 11.19 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 121.052 0.454 . . . . 0.0 110.179 178.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -69.04 -172.55 0.41 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.425 -179.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.3 m -94.87 99.8 11.79 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.287 0.565 . . . . 0.0 110.033 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 49.3 tp -67.83 135.34 52.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.845 -179.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -124.89 77.21 1.59 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.461 0.648 . . . . 0.0 109.49 178.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -74.96 -41.14 60.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.37 -0.832 . . . . 0.0 112.162 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.94 -6.0 35.18 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.72 -177.062 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -96.49 -10.03 28.32 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.284 0.564 . . . . 0.0 110.506 179.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.409 ' O ' ' CG1' ' A' ' 79' ' ' VAL . 9.9 p -65.31 127.75 26.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.855 179.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 12.1 pt -104.61 -8.03 9.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.327 0.584 . . . . 0.0 109.975 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -173.35 178.55 45.25 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 120.742 -0.742 . . . . 0.0 111.291 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 58.5 ttp180 -136.45 160.92 37.29 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.336 -0.432 . . . . 0.0 110.357 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 18.6 tt -124.99 140.94 46.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 CA-C-O 121.203 0.525 . . . . 0.0 109.983 179.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 47.6 t -137.18 130.39 31.0 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.378 0.608 . . . . 0.0 111.471 -178.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 37.3 mt -137.08 85.55 22.21 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.572 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -56.25 -33.05 89.93 Favored 'Trans proline' 0 N--CA 1.496 1.621 0 C-N-CA 123.25 2.633 . . . . 0.0 112.798 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.439 ' CB ' ' OD1' ' A' ' 145' ' ' ASP . 39.5 t -55.53 -43.44 75.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.097 0.475 . . . . 0.0 111.358 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 35.5 m -110.77 7.75 8.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.522 0.677 . . . . 0.0 109.879 179.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.5 m 53.03 51.58 15.5 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.043 179.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 69.1 tp -116.11 131.12 57.03 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.294 0.568 . . . . 0.0 110.462 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -148.52 125.67 11.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.817 0.818 . . . . 0.0 110.939 -179.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -156.83 152.69 22.78 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 114.741 -1.118 . . . . 0.0 111.01 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -74.44 147.82 37.12 Favored 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 122.548 2.165 . . . . 0.0 112.132 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 90.1 t -94.89 121.36 45.4 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-O 120.901 0.381 . . . . 0.0 111.159 179.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.432 ' N ' ' CD1' ' A' ' 95' ' ' LEU . 10.9 mp -98.49 127.88 44.61 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 121.654 0.74 . . . . 0.0 111.568 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.515 ' O ' ' OG1' ' A' ' 109' ' ' THR . 88.1 tttt -62.33 -47.0 86.16 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 114.846 -1.07 . . . . 0.0 112.077 -178.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.405 ' HB3' ' ND2' ' A' ' 102' ' ' ASN . 17.4 t -77.98 128.87 34.56 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.509 0.671 . . . . 0.0 112.354 -178.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.556 ' OG ' ' O ' ' A' ' 109' ' ' THR . 0.8 OUTLIER -86.62 51.8 2.33 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.523 -179.673 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 62.1 m -88.37 162.59 16.46 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.187 -0.46 . . . . 0.0 109.998 178.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 57.6 mp0 -61.92 -43.18 99.37 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 121.133 0.492 . . . . 0.0 110.62 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -63.01 -40.66 98.43 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.228 -179.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.514 ' O ' ' OG ' ' A' ' 105' ' ' SER . 97.8 m-20 -64.67 -37.75 88.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.616 0.722 . . . . 0.0 110.671 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 16.5 mt -59.62 -24.03 63.48 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.327 -0.852 . . . . 0.0 111.188 -179.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 90.0 mt -76.03 -12.22 60.09 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.966 0.412 . . . . 0.0 110.831 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.514 ' OG ' ' O ' ' A' ' 102' ' ' ASN . 90.7 p -78.8 -5.45 53.42 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-O 121.474 0.654 . . . . 0.0 110.011 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 98.96 -19.7 53.23 Favored Glycine 0 CA--C 1.532 1.152 0 CA-C-N 115.326 -0.852 . . . . 0.0 112.758 178.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -146.96 129.63 16.07 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 119.382 -0.927 . . . . 0.0 113.039 -179.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -147.39 135.18 21.14 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.489 178.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.556 ' O ' ' OG ' ' A' ' 98' ' ' SER . 54.9 p -70.15 135.99 49.67 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.085 0.469 . . . . 0.0 111.118 -179.47 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.696 ' N ' HE22 ' A' ' 114' ' ' GLN . 54.0 t -79.74 -56.04 7.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-O 121.074 0.464 . . . . 0.0 110.76 -179.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.795 ' H ' ' NE2' ' A' ' 114' ' ' GLN . 43.7 mtpt -102.87 137.97 40.38 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 121.901 0.857 . . . . 0.0 111.717 179.229 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -63.64 -29.47 70.7 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 114.735 -1.121 . . . . 0.0 111.619 -178.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 65.1 m-80 -83.06 14.73 3.18 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -177.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . 0.795 ' NE2' ' H ' ' A' ' 111' ' ' LYS . 45.0 mt-30 -77.83 138.24 38.84 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 121.128 0.49 . . . . 0.0 112.285 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 72.9 t -126.26 119.75 54.88 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.531 178.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 97.4 mtp -58.31 128.42 37.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.566 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 85.3 -2.88 87.94 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 120.956 -0.64 . . . . 0.0 111.871 178.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -142.95 133.24 24.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.052 0.453 . . . . 0.0 111.153 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 72.24 -171.0 49.43 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 -179.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 63.2 t-20 -86.33 102.48 14.04 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.285 -0.566 . . . . 0.0 110.131 179.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -85.83 98.66 10.88 Favored 'General case' 0 N--CA 1.457 -0.097 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 179.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.573 ' N ' ' OE1' ' A' ' 114' ' ' GLN . . . -91.96 139.14 30.94 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.223 -179.372 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 81.2 mt -137.94 143.63 40.85 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 120.98 0.419 . . . . 0.0 110.684 179.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -115.26 138.86 50.49 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.187 0.518 . . . . 0.0 110.488 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -144.14 134.05 5.57 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.414 ' CD2' ' OE1' ' A' ' 63' ' ' GLN . 0.2 OUTLIER -79.43 137.83 37.39 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.004 -0.678 . . . . 0.0 110.51 -179.828 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.741 ' ND2' ' H ' ' A' ' 129' ' ' SER . 3.5 t-20 -130.55 121.47 25.76 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.562 -179.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' MET . . . . . 0.498 ' O ' ' CB ' ' A' ' 129' ' ' SER . 67.0 mtt -87.73 -5.83 58.48 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.133 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.741 ' H ' ' ND2' ' A' ' 127' ' ' ASN . 0.9 OUTLIER 79.78 8.77 1.57 Allowed 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 179.123 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.466 ' H ' HG12 ' A' ' 133' ' ' VAL . 65.0 pttt -105.93 128.06 53.55 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 122.111 0.957 . . . . 0.0 112.371 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 38.8 tptt -46.05 119.78 2.43 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.977 -1.011 . . . . 0.0 109.988 178.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 115.23 -18.12 16.21 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.197 -1.161 . . . . 0.0 110.197 -179.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.489 HG13 HD21 ' A' ' 127' ' ' ASN . 9.5 p -90.3 160.9 2.7 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 CA-C-O 121.256 0.55 . . . . 0.0 109.974 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.671 ' CD2' ' H ' ' A' ' 134' ' ' LEU . 0.1 OUTLIER -69.22 138.45 54.01 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -177.338 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 65.74 9.39 5.95 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 114.094 -1.412 . . . . 0.0 114.303 177.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' SER . . . . . 0.552 ' OG ' ' ND2' ' A' ' 127' ' ' ASN . 0.4 OUTLIER -67.31 -36.27 81.13 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 120.453 -0.499 . . . . 0.0 112.185 179.315 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.462 ' OD1' ' N ' ' A' ' 137' ' ' ASP . 22.7 p-10 -93.97 8.93 39.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.594 0.712 . . . . 0.0 110.796 -178.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 5.5 tt -64.96 -36.35 77.57 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.534 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -70.02 -10.81 59.92 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 121.958 -0.463 . . . . 0.0 111.399 179.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 67.3 m -81.24 -2.85 50.41 Favored 'General case' 0 C--O 1.231 0.088 0 CA-C-O 121.054 0.455 . . . . 0.0 110.303 179.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 70.9 mt -63.69 142.33 58.44 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.926 179.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -123.24 157.08 33.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.734 0.778 . . . . 0.0 111.85 -178.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -48.72 129.09 16.4 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.41 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 160' ' ' VAL . . . 82.24 8.52 86.28 Favored Glycine 0 CA--C 1.534 1.256 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.574 179.053 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.439 ' OD1' ' CB ' ' A' ' 87' ' ' SER . 23.1 t70 -71.76 130.49 41.23 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 119.908 -0.717 . . . . 0.0 110.838 -179.268 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -77.98 139.9 39.18 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 121.619 0.724 . . . . 0.0 111.628 -179.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 96.4 mt -136.59 137.68 47.36 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 178.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 63.3 m-85 -118.46 135.95 54.07 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 119.966 -0.694 . . . . 0.0 111.938 -178.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -114.16 134.28 55.01 Favored 'General case' 0 C--O 1.222 -0.357 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 177.263 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.427 ' CE2' ' OE1' ' A' ' 155' ' ' GLU . 81.2 m-85 -114.48 110.07 19.27 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.136 -0.626 . . . . 0.0 111.853 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . 0.474 ' N ' ' O ' ' A' ' 154' ' ' ASN . 22.4 t0 -88.4 167.92 13.08 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 177.521 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 65.2 m-20 -60.29 -23.77 64.43 Favored 'General case' 0 C--N 1.316 -0.872 0 C-N-CA 119.793 -0.763 . . . . 0.0 111.449 -178.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -113.02 -26.3 8.55 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -178.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . 0.474 ' O ' ' N ' ' A' ' 151' ' ' ASP . 0.3 OUTLIER -148.1 -177.0 5.5 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 119.115 -1.034 . . . . 0.0 112.639 -177.197 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.427 ' OE1' ' CE2' ' A' ' 150' ' ' TYR . 15.2 pt-20 -137.98 145.52 42.04 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 114.403 -1.271 . . . . 0.0 109.891 178.574 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -118.5 138.41 52.53 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 121.255 0.55 . . . . 0.0 112.312 -178.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -95.56 114.91 26.72 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.455 179.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -118.24 151.73 37.09 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.792 0.329 . . . . 0.0 111.633 179.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -124.59 125.15 43.7 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.334 178.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.487 ' O ' ' N ' ' A' ' 144' ' ' GLY . 92.3 t -59.95 137.25 22.62 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 177.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 77.7 p -106.6 -24.81 12.05 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 123.436 0.46 . . . . 0.0 110.792 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 158.83 -167.93 34.85 Favored Glycine 0 CA--C 1.533 1.218 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 44.4 t -129.99 128.27 64.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.452 -0.374 . . . . 0.0 109.998 178.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 18.2 m -107.74 157.34 18.2 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.479 0.657 . . . . 0.0 112.06 -179.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -101.67 113.44 26.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.253 179.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 22.9 m -135.48 163.3 35.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.682 0.754 . . . . 0.0 112.187 -178.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -90.06 155.86 46.93 Favored Pre-proline 0 CA--C 1.538 0.505 0 CA-C-N 114.944 -1.026 . . . . 0.0 110.335 179.133 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.581 ' O ' ' CB ' ' B' ' 702' ' ' LEU . 37.0 Cg_endo -65.91 -16.49 52.96 Favored 'Trans proline' 0 N--CA 1.502 1.984 0 C-N-CA 123.273 2.648 . . . . 0.0 113.995 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . 0.418 ' O ' ' CD1' ' A' ' 171' ' ' TRP . 51.4 p-10 -91.82 -6.14 52.2 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 119.733 -0.787 . . . . 0.0 111.848 -179.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -75.24 80.84 2.35 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 119.92 -0.712 . . . . 0.0 110.234 178.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' TRP . . . . . 0.633 ' CZ2' ' H12' ' B' ' 701' ' ' BOC . 26.8 m0 -67.28 -11.56 57.84 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.003 -179.204 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.489 ' OE1' ' OE1' ' A' ' 175' ' ' GLU . 79.2 mm-40 -58.56 -29.9 66.74 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.456 -179.354 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 10.6 p -60.73 -24.32 31.78 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -178.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 35.1 m -104.49 -8.55 9.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 120.086 -0.646 . . . . 0.0 112.04 -178.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.489 ' OE1' ' OE1' ' A' ' 172' ' ' GLU . 98.0 mt-10 -74.36 134.86 42.48 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 178.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . 0.489 ' OD1' ' O ' ' A' ' 176' ' ' ASP . 43.3 p-10 -66.17 130.9 44.83 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 121.098 0.475 . . . . 0.0 111.024 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 76.7 m80 -98.3 -13.63 20.64 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -179.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 100.11 34.78 4.72 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 -178.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -148.81 161.84 41.0 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.83 -0.685 . . . . 0.0 110.225 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -87.64 90.76 8.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.885 0.374 . . . . 0.0 110.087 178.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . 0.43 ' HG2' ' N ' ' A' ' 182' ' ' ILE . 79.1 tt0 -126.81 163.35 23.78 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.817 0.818 . . . . 0.0 111.811 -178.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.43 ' N ' ' HG2' ' A' ' 181' ' ' GLU . 17.9 tt -131.11 137.66 55.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.135 178.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 88.8 m -131.74 126.32 34.17 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.329 0.585 . . . . 0.0 111.353 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 84.0 mt -111.17 132.38 54.36 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.463 178.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 77.6 mt -110.14 126.85 67.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.429 0.633 . . . . 0.0 110.725 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 4.7 t -140.15 155.76 46.82 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.981 -1.009 . . . . 0.0 109.835 179.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' CYS . . . . . . . . . . . . . 4.0 m -91.9 148.89 21.87 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.546 -0.462 . . . . 0.0 110.652 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 77.8 t -61.32 -47.57 92.86 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 CA-C-O 121.058 0.456 . . . . 0.0 110.874 -179.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' SER . . . . . 0.575 ' HG ' ' H ' ' A' ' 192' ' ' ASP . 92.4 p -163.68 162.22 24.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.313 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 9.8 p -69.8 -12.94 16.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.12 0.486 . . . . 0.0 110.469 179.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -108.06 -31.39 7.97 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.132 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . 0.575 ' H ' ' HG ' ' A' ' 189' ' ' SER . 45.7 t0 -98.94 107.37 19.79 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.393 0.616 . . . . 0.0 111.244 -179.552 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -110.63 12.11 22.72 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.364 179.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 20.4 t -59.53 -47.07 86.97 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.359 -0.382 . . . . 0.0 112.028 -178.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 25.4 pttm -147.39 159.19 43.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.178 0.513 . . . . 0.0 111.332 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . 0.491 ' NE ' ' SG ' ' B' ' 705' ' ' B27 . 83.6 mtt85 -123.53 143.97 49.85 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.407 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 -90.95 152.24 20.78 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.56 179.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 13.6 t -129.11 129.24 67.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.436 178.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 76.4 t -104.47 132.34 51.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -118.79 140.55 49.77 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.369 0.604 . . . . 0.0 111.207 -179.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -133.5 141.8 13.21 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 179.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . 0.532 ' OD1' ' N ' ' A' ' 203' ' ' LEU . 65.3 t0 -106.92 139.5 41.22 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.851 0.358 . . . . 0.0 110.164 -179.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . 0.532 ' N ' ' OD1' ' A' ' 202' ' ' ASP . 45.7 tp -64.98 131.34 46.35 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 15.4 m -113.05 -20.39 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 C-N-CA 120.665 -0.414 . . . . 0.0 111.043 -178.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -175.57 171.59 44.66 Favored Glycine 0 CA--C 1.535 1.298 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.115 179.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 11.4 m -142.98 136.33 28.37 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.596 -0.302 . . . . 0.0 110.328 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -143.44 121.29 11.97 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.452 0.644 . . . . 0.0 112.183 179.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -64.99 140.73 58.9 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.259 -0.882 . . . . 0.0 112.106 -179.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt -77.47 156.68 30.91 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.953 -1.021 . . . . 0.0 110.484 178.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 98.1 mttt . . . . . 0 C--O 1.22 -0.474 0 CA-C-O 117.934 -1.032 . . . . 0.0 110.682 179.786 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 701' ' ' BOC . . . . . 0.633 ' H12' ' CZ2' ' A' ' 171' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 702' ' ' LEU . . . . . 0.581 ' CB ' ' O ' ' A' ' 168' ' ' PRO . 0.0 OUTLIER -138.34 99.03 8.93 Favored Pre-proline 0 CA--C 1.545 0.778 0 C-N-CA 121.036 -0.266 . . . . 20.0 110.824 . . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 703' ' ' PRO . . . . . 0.508 ' O ' ' O ' ' B' ' 704' ' ' ALA . 3.3 Cg_exo -66.2 -173.74 0.36 Allowed 'Trans proline' 0 N--CA 1.493 1.5 0 C-N-CA 122.346 2.031 . . . . 20.0 112.603 179.392 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 704' ' ' ALA . . . . . 0.557 ' O ' ' OG1' ' B' ' 705' ' ' B27 . . . -40.04 -179.41 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 113.601 0.963 . . . . 20.0 113.601 -178.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 705' ' ' B27 . . . . . 0.557 ' OG1' ' O ' ' B' ' 704' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.316 0 N-CA-C 109.089 -1.605 . . . . 0.0 109.089 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 46.8 t -59.89 -43.88 94.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.228 0.537 . . . . 0.0 110.553 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -70.32 -39.02 75.01 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.12 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 97.1 mtp -81.42 146.02 30.49 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 121.196 0.522 . . . . 0.0 111.511 -179.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 85.3 m-20 -64.78 144.38 57.29 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.319 -179.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -97.44 5.96 48.92 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.868 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 86.6 p -86.21 10.33 14.92 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.315 0.579 . . . . 0.0 111.176 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -104.4 13.39 32.04 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.372 -179.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.2 mt -56.73 137.76 18.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 CA-C-O 122.157 0.98 . . . . 0.0 112.864 -177.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.477 ' O ' ' OD1' ' A' ' 62' ' ' ASP . 46.7 p-10 -79.49 129.87 34.87 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 113.975 -1.466 . . . . 0.0 109.162 178.107 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.667 ' NE2' ' ND1' ' A' ' 126' ' ' HIS . 0.0 OUTLIER -76.09 154.87 84.63 Favored Pre-proline 0 CA--C 1.535 0.38 0 CA-C-O 121.171 0.51 . . . . 0.0 110.302 -179.033 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -71.5 170.6 18.11 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.783 2.322 . . . . 0.0 112.975 -179.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -52.81 159.35 1.14 Allowed 'General case' 0 C--N 1.334 -0.087 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.595 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 58.6 tp -63.31 -46.45 86.63 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 120.627 -0.429 . . . . 0.0 111.322 -178.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.94 -36.72 84.36 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 119.844 -0.742 . . . . 0.0 111.153 -178.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -58.29 -26.54 63.12 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 119.871 -0.732 . . . . 0.0 109.033 178.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 25.2 t -78.98 -44.94 24.64 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.529 178.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -73.07 -9.1 58.36 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.918 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -106.76 -14.62 14.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.276 0.56 . . . . 0.0 110.475 179.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -69.44 143.19 53.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.387 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 13.7 t -62.09 99.83 0.14 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.489 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.2 tt -69.7 134.74 48.99 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.274 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.596 ' OD2' ' NE2' ' A' ' 78' ' ' GLN . 84.8 m-20 -94.98 84.28 4.11 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 121.497 0.665 . . . . 0.0 110.244 178.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 48.7 tttp -63.19 -43.08 99.21 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.27 -0.877 . . . . 0.0 112.321 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.684 ' H ' ' CE ' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -70.34 -11.36 60.86 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.792 -0.64 . . . . 0.0 112.06 -177.068 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.596 ' NE2' ' OD2' ' A' ' 75' ' ' ASP . 77.8 mt-30 -92.06 -1.6 57.12 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.047 0.451 . . . . 0.0 110.324 179.088 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 58.1 t -76.64 127.14 37.81 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.244 179.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 29.2 pt -111.05 -1.79 10.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.65 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -175.99 179.47 47.09 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 120.502 -0.856 . . . . 0.0 111.48 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.566 ' NH1' ' OE2' ' A' ' 91' ' ' GLU . 73.1 ttp85 -141.19 153.76 45.49 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 120.919 0.39 . . . . 0.0 110.971 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 18.1 tt -122.3 138.96 50.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-O 121.245 0.545 . . . . 0.0 110.317 179.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 10.3 t -137.75 130.85 30.41 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.199 0.524 . . . . 0.0 111.435 -179.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 54.3 mt -137.23 88.77 16.99 Favored Pre-proline 0 CA--C 1.541 0.604 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.987 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -56.73 -31.11 86.9 Favored 'Trans proline' 0 N--CA 1.503 2.05 0 C-N-CA 123.086 2.524 . . . . 0.0 113.41 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 22.4 m -53.23 -42.27 66.22 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 121.207 0.527 . . . . 0.0 111.162 -179.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 12.7 m -115.77 8.28 7.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.44 0.638 . . . . 0.0 110.412 179.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.5 m 54.18 49.03 19.58 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.698 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 60.0 tp -112.15 131.49 55.43 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.384 0.611 . . . . 0.0 110.844 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.566 ' OE2' ' NH1' ' A' ' 82' ' ' ARG . 80.4 tt0 -149.16 126.22 11.32 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.944 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 71.8 mt -152.24 151.98 28.54 Favored Pre-proline 0 CA--C 1.533 0.322 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.056 -179.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -74.73 147.02 34.58 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.361 2.041 . . . . 0.0 110.519 178.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 71.4 t -96.95 125.39 49.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 C-N-CA 120.434 -0.506 . . . . 0.0 110.855 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 9.5 mp -99.53 127.6 45.61 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.56 0.695 . . . . 0.0 111.472 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.514 ' O ' ' OG1' ' A' ' 109' ' ' THR . 87.5 tttt -63.71 -45.54 89.5 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 115.03 -0.986 . . . . 0.0 112.518 -178.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 3.3 m -81.38 130.99 35.26 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.267 0.556 . . . . 0.0 111.267 -179.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.433 ' OG ' ' O ' ' A' ' 98' ' ' SER . 9.8 p -91.3 53.41 2.31 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.576 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.723 ' HG1' ' ND2' ' A' ' 102' ' ' ASN . 81.2 p -88.44 166.77 14.0 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 178.576 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -64.13 -40.84 97.03 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.39 0.614 . . . . 0.0 110.453 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -63.95 -42.68 97.24 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.617 -179.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.723 ' ND2' ' HG1' ' A' ' 99' ' ' THR . 98.4 m-20 -65.7 -36.08 82.59 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.121 179.572 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 33.3 mt -61.52 -15.94 42.89 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.799 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 88.7 mt -71.94 -20.03 61.82 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.271 0.558 . . . . 0.0 109.871 179.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 83.6 p -73.29 -0.98 16.11 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.876 -179.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 82.84 -18.59 15.03 Favored Glycine 0 CA--C 1.526 0.776 0 CA-C-N 116.069 -0.514 . . . . 0.0 112.387 178.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -145.26 123.91 12.53 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.527 0.68 . . . . 0.0 111.349 179.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -147.47 149.66 33.09 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.093 179.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.514 ' OG1' ' O ' ' A' ' 96' ' ' LYS . 68.2 p -66.84 133.73 50.67 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.176 0.512 . . . . 0.0 110.561 -179.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 38.2 t -81.8 -62.0 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 C-N-CA 120.356 -0.538 . . . . 0.0 109.699 179.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.563 ' O ' ' NE2' ' A' ' 114' ' ' GLN . 85.5 tttt -94.17 133.95 37.14 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.818 179.38 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -66.37 -37.05 84.4 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -177.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -85.27 17.99 2.83 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 -178.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . 0.563 ' NE2' ' O ' ' A' ' 111' ' ' LYS . 5.5 pt20 -76.87 139.77 40.37 Favored 'General case' 0 CA--C 1.534 0.332 0 O-C-N 121.958 -0.464 . . . . 0.0 110.76 179.27 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 94.3 t -129.27 121.53 53.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.925 0.393 . . . . 0.0 110.162 178.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' MET . . . . . 0.588 ' SD ' ' OD1' ' A' ' 151' ' ' ASP . 56.1 mtt -58.06 134.34 56.34 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.173 0.511 . . . . 0.0 111.105 -179.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 78.52 -3.68 62.51 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 121.012 -0.613 . . . . 0.0 111.953 178.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -140.3 124.1 17.32 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.239 0.542 . . . . 0.0 110.759 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 76.04 -161.26 51.98 Favored Glycine 0 CA--C 1.531 1.081 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.368 179.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 63.2 t-20 -93.24 107.24 19.09 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.069 0.461 . . . . 0.0 110.977 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.444 ' CZ ' ' OE1' ' A' ' 114' ' ' GLN . 20.2 t80 -85.56 145.34 27.41 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.084 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -146.73 139.03 24.85 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 119.986 -0.686 . . . . 0.0 112.042 -178.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 72.4 mt -135.69 141.66 44.99 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.947 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -111.96 132.94 54.46 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 121.374 0.607 . . . . 0.0 109.852 178.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -134.74 152.13 20.61 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.667 ' ND1' ' NE2' ' A' ' 63' ' ' GLN . 40.9 m-70 -89.47 136.08 33.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.727 0.775 . . . . 0.0 112.339 -178.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -130.09 121.05 25.63 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.62 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' MET . . . . . 0.439 ' O ' ' CB ' ' A' ' 129' ' ' SER . 53.2 mtt -94.86 -1.46 52.67 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 121.407 0.623 . . . . 0.0 110.212 179.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.439 ' CB ' ' O ' ' A' ' 128' ' ' MET . 0.9 OUTLIER 77.78 4.57 2.95 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 115.421 -0.809 . . . . 0.0 112.071 178.665 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.555 ' O ' ' CG1' ' A' ' 133' ' ' VAL . 62.4 pttt -119.65 125.7 49.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.994 0.902 . . . . 0.0 113.118 -178.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.528 ' O ' ' O ' ' A' ' 130' ' ' LYS . 0.0 OUTLIER -35.23 159.73 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.455 179.062 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 74.0 -19.66 1.65 Allowed Glycine 0 CA--C 1.534 1.264 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.555 ' CG1' ' O ' ' A' ' 130' ' ' LYS . 4.7 p -90.09 173.42 0.88 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 119.587 -0.845 . . . . 0.0 111.094 -179.394 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.437 ' N ' ' CD2' ' A' ' 134' ' ' LEU . 4.3 mm? -66.81 130.05 41.89 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 -175.531 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.8 m-30 60.98 18.28 8.74 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 114.164 -1.38 . . . . 0.0 112.545 178.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.37 -37.23 84.92 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 113.005 0.742 . . . . 0.0 113.005 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.432 ' N ' ' OD1' ' A' ' 137' ' ' ASP . 31.7 p-10 -94.6 6.25 49.42 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.974 0.416 . . . . 0.0 111.88 -178.442 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 3.6 tt -63.97 -37.9 80.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 C-N-CA 120.553 -0.459 . . . . 0.0 111.786 -179.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -67.8 -10.67 54.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.803 0.335 . . . . 0.0 111.352 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 33.1 m -80.93 -4.98 56.85 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.036 0.446 . . . . 0.0 110.505 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 80.1 mt -63.91 139.52 58.78 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.037 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -115.9 156.76 25.59 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 121.478 0.656 . . . . 0.0 112.097 -178.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -48.87 130.57 18.17 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.341 -0.845 . . . . 0.0 112.647 -179.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.603 ' N ' ' O ' ' A' ' 160' ' ' VAL . . . 78.37 7.67 87.8 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.972 178.383 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -71.97 137.93 47.66 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 119.567 -0.853 . . . . 0.0 110.268 -179.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -80.76 142.06 34.16 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 122.016 0.912 . . . . 0.0 113.021 -177.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 91.6 mt -138.66 139.11 41.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 114.361 -1.291 . . . . 0.0 108.791 178.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -116.68 138.36 51.51 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 122.033 0.92 . . . . 0.0 112.821 -178.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -117.03 137.73 52.05 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.112 -1.404 . . . . 0.0 108.484 178.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -126.56 112.06 15.09 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 119.978 -0.689 . . . . 0.0 112.418 -178.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . 0.588 ' OD1' ' SD ' ' A' ' 116' ' ' MET . 20.7 m-20 -89.63 164.72 14.62 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 176.465 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 53.4 t30 -56.66 -23.5 42.12 Favored 'General case' 0 C--N 1.31 -1.118 0 C-N-CA 119.893 -0.723 . . . . 0.0 111.124 -178.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -111.0 -29.44 7.9 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 113.38 0.882 . . . . 0.0 113.38 -178.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . 0.455 ' O ' ' N ' ' A' ' 151' ' ' ASP . 0.4 OUTLIER -145.98 177.77 8.7 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 119.644 -0.822 . . . . 0.0 112.74 -176.949 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -134.32 145.8 49.38 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.099 178.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 48.3 m-85 -120.12 139.29 52.81 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 121.201 0.524 . . . . 0.0 111.486 -178.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -93.75 114.69 27.02 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.158 179.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -115.07 149.48 37.44 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.226 0.536 . . . . 0.0 111.934 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -122.86 122.17 38.0 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.617 179.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.603 ' O ' ' N ' ' A' ' 144' ' ' GLY . 86.2 t -60.37 138.62 21.04 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.218 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 177.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 20.3 p -107.22 -23.28 12.31 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.671 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 159.84 -167.63 35.37 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 120.28 -0.962 . . . . 0.0 112.033 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 42.3 t -127.4 137.57 57.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-N 115.124 -0.538 . . . . 0.0 109.74 179.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 57.9 m -123.78 157.38 34.18 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 121.317 0.58 . . . . 0.0 111.474 -178.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 28.2 mp0 -104.63 113.43 27.01 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 121.553 0.692 . . . . 0.0 110.705 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 27.6 m -139.49 163.93 24.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.234 -179.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' THR . . . . . 0.437 ' H ' ' HD2' ' A' ' 170' ' ' LYS . 0.2 OUTLIER -91.56 159.91 37.74 Favored Pre-proline 0 CA--C 1.538 0.484 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.694 178.513 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.488 ' O ' ' CB ' ' B' ' 702' ' ' LEU . 35.6 Cg_endo -65.52 -15.76 50.97 Favored 'Trans proline' 0 N--CA 1.5 1.883 0 C-N-CA 122.874 2.383 . . . . 0.0 113.885 -179.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 44.1 p-10 -91.86 -7.21 50.0 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 119.466 -0.893 . . . . 0.0 111.544 179.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.437 ' HD2' ' H ' ' A' ' 167' ' ' THR . 96.7 mttt -75.64 83.11 2.65 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.808 0.813 . . . . 0.0 111.723 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 33.2 t90 -71.13 -11.31 60.87 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.636 -1.165 . . . . 0.0 110.47 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -61.57 -35.08 76.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.674 -179.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 32.7 m -63.51 -14.03 13.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.427 -179.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 12.2 t -110.58 -5.85 11.25 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -179.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.499 ' O ' ' CE1' ' A' ' 177' ' ' HIS . 94.9 mt-10 -72.36 149.12 44.64 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.345 0.593 . . . . 0.0 110.88 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . 0.52 ' OD1' ' O ' ' A' ' 176' ' ' ASP . 51.9 p-10 -67.61 128.42 36.38 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.611 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' HIS . . . . . 0.499 ' CE1' ' O ' ' A' ' 175' ' ' GLU . 76.6 m80 -110.23 22.02 16.04 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.509 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 59.94 37.45 92.65 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 110.771 -0.932 . . . . 0.0 110.771 179.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 18.3 ptmt -146.22 158.7 43.9 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -88.74 91.67 8.91 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.292 177.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -129.56 172.47 11.54 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.478 0.656 . . . . 0.0 111.259 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 18.6 tt -134.44 144.29 35.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.436 178.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 84.7 m -131.48 126.55 35.28 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.522 0.677 . . . . 0.0 111.572 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 86.1 mt -109.4 131.47 55.03 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 85.0 mt -112.87 124.19 69.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.498 0.666 . . . . 0.0 111.31 -178.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 3.9 t -137.81 153.04 49.69 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.831 179.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' CYS . . . . . . . . . . . . . 3.3 m -88.5 139.36 30.56 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.039 0.447 . . . . 0.0 110.945 -179.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 10.9 p -65.13 -44.54 95.51 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.099 -179.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 80.9 p -164.54 157.57 17.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.076 0.465 . . . . 0.0 110.795 179.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 11.4 p -81.93 -9.96 11.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.034 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -96.4 -9.97 28.71 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.284 0.564 . . . . 0.0 110.688 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -142.89 101.43 3.84 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.633 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 53.3 p-10 -102.21 10.39 39.36 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.247 0.546 . . . . 0.0 110.439 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 39.1 t -61.4 -46.16 91.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.277 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 64.4 pttt -144.86 150.95 37.97 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.453 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . 0.493 ' NH1' ' HX ' ' B' ' 705' ' ' B27 . 21.8 ptt180 -137.96 158.16 44.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.219 0.533 . . . . 0.0 111.165 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -91.75 141.35 28.78 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.839 -0.618 . . . . 0.0 111.561 -179.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 42.0 t -118.94 132.08 69.86 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.01 178.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 84.9 t -100.0 132.32 45.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -118.01 144.27 45.69 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.399 0.618 . . . . 0.0 110.996 -178.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -140.22 163.43 26.36 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 110.284 -1.127 . . . . 0.0 110.284 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . 0.57 ' OD1' ' N ' ' A' ' 203' ' ' LEU . 67.6 t0 -122.22 139.4 53.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.017 0.437 . . . . 0.0 111.888 -178.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . 0.57 ' N ' ' OD1' ' A' ' 202' ' ' ASP . 46.5 tp -62.78 131.54 49.2 Favored 'General case' 0 CA--C 1.52 -0.207 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 57.4 t -110.51 -20.72 6.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 C-N-CA 120.355 -0.538 . . . . 0.0 111.648 -178.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -178.03 174.21 46.6 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 120.546 -0.835 . . . . 0.0 111.486 -179.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 24.5 m -146.24 138.2 24.99 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.319 -0.441 . . . . 0.0 110.296 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -145.81 124.19 12.34 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.2 0.524 . . . . 0.0 110.943 178.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -65.86 147.98 52.51 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.78 0.8 . . . . 0.0 112.08 -179.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 10.1 ttmt -77.43 159.13 29.65 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.704 -1.135 . . . . 0.0 110.495 179.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 98.2 mttt . . . . . 0 C--O 1.219 -0.551 0 CA-C-O 118.089 -0.958 . . . . 0.0 110.562 179.429 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 701' ' ' BOC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 702' ' ' LEU . . . . . 0.488 ' CB ' ' O ' ' A' ' 168' ' ' PRO . 2.3 mt -42.93 108.85 0.69 Allowed Pre-proline 0 CA--C 1.541 0.599 0 C-N-CA 120.618 -0.433 . . . . 20.0 110.449 . . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 703' ' ' PRO . . . . . 0.549 ' O ' ' O ' ' B' ' 704' ' ' ALA . 2.5 Cg_endo -62.1 -173.09 0.12 Allowed 'Trans proline' 0 N--CA 1.489 1.232 0 C-N-CA 121.978 1.786 . . . . 20.0 113.061 -178.573 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 704' ' ' ALA . . . . . 0.549 ' O ' ' O ' ' B' ' 703' ' ' PRO . . . -41.7 -172.17 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 114.249 -1.342 . . . . 20.0 113.119 -179.364 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 705' ' ' B27 . . . . . 0.507 ' OG1' ' O ' ' B' ' 704' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.158 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 35.5 p -161.31 155.62 22.8 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.207 0.527 . . . . 0.0 110.325 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -122.16 150.69 41.87 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.797 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 61.4 mtt -91.81 130.76 37.52 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.656 -179.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.418 ' OD1' ' N ' ' A' ' 58' ' ' ALA . 61.6 t0 -62.46 131.67 49.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.894 179.308 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.418 ' N ' ' OD1' ' A' ' 57' ' ' ASP . . . -89.02 13.19 13.51 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.896 -178.742 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.408 ' OG ' ' CG ' ' A' ' 57' ' ' ASP . 29.5 p -84.73 11.15 9.57 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.346 0.498 . . . . 0.0 112.346 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -94.14 8.01 43.15 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.832 -0.347 . . . . 0.0 111.217 -179.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.5 mt -56.36 132.8 20.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 122.254 1.026 . . . . 0.0 113.689 -176.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -76.47 133.96 39.67 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 113.637 -1.62 . . . . 0.0 109.261 178.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.524 ' CD ' ' CG ' ' A' ' 126' ' ' HIS . 6.6 mm-40 -79.03 149.19 73.05 Favored Pre-proline 0 CA--C 1.537 0.47 0 CA-C-O 121.086 0.469 . . . . 0.0 111.895 -178.369 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -73.6 168.04 25.76 Favored 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 123.177 2.585 . . . . 0.0 112.173 179.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -55.1 167.36 0.43 Allowed 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 121.179 0.514 . . . . 0.0 111.481 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.446 ' N ' ' CD2' ' A' ' 66' ' ' LEU . 4.3 mm? -64.29 -42.67 96.3 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.296 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.78 -35.37 74.5 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.65 -0.42 . . . . 0.0 111.517 -177.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -61.37 -29.76 70.11 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.763 0.792 . . . . 0.0 109.655 179.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 23.0 t -75.01 -43.77 44.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.001 -0.999 . . . . 0.0 109.952 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -76.73 -9.44 58.67 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 114.948 -1.023 . . . . 0.0 111.228 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -113.17 -1.31 14.39 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.296 0.57 . . . . 0.0 110.233 178.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.43 -165.77 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.097 -179.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 69.6 p -103.72 106.51 17.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.712 178.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.418 ' CD1' ' C ' ' A' ' 74' ' ' LEU . 2.1 tm? -71.94 118.04 14.3 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.838 0.351 . . . . 0.0 110.836 -179.385 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -104.21 77.22 1.4 Allowed 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 121.459 0.647 . . . . 0.0 109.984 179.138 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.458 ' HD3' ' HZ1' ' A' ' 77' ' ' LYS . 87.9 tttt -69.19 -39.22 78.81 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.261 -0.881 . . . . 0.0 113.019 -179.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.458 ' HZ1' ' HD3' ' A' ' 76' ' ' LYS . 42.4 mmtt -70.3 -15.24 62.86 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.193 -175.207 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -91.18 -4.47 56.07 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.062 0.458 . . . . 0.0 110.931 179.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 78.0 t -80.43 128.04 38.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.068 0.461 . . . . 0.0 110.161 179.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 18.4 pt -111.66 -6.21 11.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.862 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -175.3 179.16 46.71 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 110.799 -0.92 . . . . 0.0 110.799 179.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -152.8 154.94 36.18 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.44 0.638 . . . . 0.0 111.3 179.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 17.0 tt -104.61 144.37 14.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.608 -179.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 33.1 t -135.71 127.72 29.65 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.61 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 53.0 mt -135.44 89.68 22.1 Favored Pre-proline 0 CA--C 1.537 0.456 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.403 -179.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -55.18 -33.38 84.04 Favored 'Trans proline' 0 N--CA 1.501 1.936 0 C-N-CA 123.165 2.577 . . . . 0.0 113.699 -179.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 74.1 m -52.9 -38.73 62.07 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 120.962 0.411 . . . . 0.0 111.08 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 33.1 m -117.78 13.37 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.292 179.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.8 m 49.17 49.52 19.47 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.476 -0.49 . . . . 0.0 110.457 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 62.9 tp -112.94 132.46 55.33 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.325 0.583 . . . . 0.0 110.822 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -146.19 122.03 10.61 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.743 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 94.4 mt -149.17 150.68 32.5 Favored Pre-proline 0 CA--C 1.54 0.588 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.065 -179.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -76.25 151.95 34.57 Favored 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 122.695 2.263 . . . . 0.0 112.295 179.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 98.6 t -96.83 114.65 34.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.855 0.359 . . . . 0.0 110.502 179.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.449 ' N ' ' CD1' ' A' ' 95' ' ' LEU . 10.3 mp -100.64 139.03 36.9 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.1 0.476 . . . . 0.0 111.472 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.509 ' O ' ' OG1' ' A' ' 109' ' ' THR . 98.9 mttt -66.44 -83.44 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 121.284 0.564 . . . . 0.0 112.019 -179.483 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 17.7 m -60.79 132.52 54.13 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.664 -179.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 43.6 t -88.28 74.43 8.71 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.371 0.605 . . . . 0.0 109.874 179.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.556 ' HG1' ' ND2' ' A' ' 102' ' ' ASN . 57.1 p -88.79 169.86 11.26 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.802 179.029 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -62.68 -44.34 96.51 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 120.23 -0.588 . . . . 0.0 109.952 179.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -66.61 -40.97 89.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.395 179.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.556 ' ND2' ' HG1' ' A' ' 99' ' ' THR . 95.0 m-20 -64.34 -35.71 81.76 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.816 -179.523 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 34.2 mt -60.49 -26.06 66.52 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.192 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 92.6 mt -72.74 -18.7 61.49 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.297 -179.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.409 ' OG ' ' O ' ' A' ' 102' ' ' ASN . 99.5 p -74.07 -8.25 55.48 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 121.33 0.586 . . . . 0.0 110.085 179.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 92.74 -19.57 50.5 Favored Glycine 0 CA--C 1.53 1.016 0 CA-C-N 115.721 -0.672 . . . . 0.0 114.003 177.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -145.03 127.01 15.5 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 119.556 -0.858 . . . . 0.0 111.701 -179.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -144.04 138.81 28.6 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.658 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.509 ' OG1' ' O ' ' A' ' 96' ' ' LYS . 64.5 p -73.84 135.01 43.4 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.138 0.494 . . . . 0.0 110.336 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.557 ' N ' HE22 ' A' ' 114' ' ' GLN . 77.8 t -78.97 -54.89 10.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.066 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.729 ' H ' ' NE2' ' A' ' 114' ' ' GLN . 97.5 mttt -102.15 137.43 40.43 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 122.36 1.076 . . . . 0.0 112.573 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -64.34 -29.54 70.61 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.396 -1.274 . . . . 0.0 112.491 -177.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 73.4 m-80 -84.07 17.15 2.56 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 113.669 0.988 . . . . 0.0 113.669 -178.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . 0.729 ' NE2' ' H ' ' A' ' 111' ' ' LYS . 50.1 mt-30 -78.48 134.77 37.29 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 121.966 -0.459 . . . . 0.0 111.672 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 96.3 t -124.85 119.95 57.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-O 120.993 0.425 . . . . 0.0 110.387 178.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 64.8 mtt -55.6 131.62 46.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.273 0.558 . . . . 0.0 111.488 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 84.77 -6.18 79.2 Favored Glycine 0 CA--C 1.533 1.199 0 CA-C-N 115.597 -0.728 . . . . 0.0 112.231 179.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -143.6 136.75 27.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.333 0.587 . . . . 0.0 112.068 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 75.03 -172.94 53.09 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.672 -0.971 . . . . 0.0 110.672 179.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.44 HD21 ' CE1' ' A' ' 177' ' ' HIS . 52.3 t-20 -89.04 103.24 15.87 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.455 -0.498 . . . . 0.0 110.081 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -85.63 99.07 11.04 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-O 121.065 0.46 . . . . 0.0 109.773 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.502 ' N ' ' OE1' ' A' ' 114' ' ' GLN . . . -91.54 136.12 33.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.982 -179.202 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 74.6 mt -137.55 140.17 40.88 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 120.914 0.388 . . . . 0.0 111.099 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -108.43 146.23 33.41 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 178.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . 0.456 ' O ' ' CG2' ' B' ' 705' ' ' B27 . . . -148.09 156.75 27.06 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 -179.524 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.535 ' O ' ' O ' ' A' ' 134' ' ' LEU . 77.9 m-70 -110.56 130.31 55.59 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 113.453 0.908 . . . . 0.0 113.453 -178.239 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.591 ' ND2' ' O ' ' A' ' 127' ' ' ASN . 0.0 OUTLIER -134.65 121.93 21.55 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.78 177.712 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' MET . . . . . 0.488 ' O ' ' CB ' ' A' ' 129' ' ' SER . 65.0 mtt -83.83 8.19 15.61 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.057 0.456 . . . . 0.0 110.791 -179.404 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.488 ' CB ' ' O ' ' A' ' 128' ' ' MET . 0.7 OUTLIER 79.0 12.92 1.27 Allowed 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.452 179.118 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.454 ' O ' ' CG1' ' A' ' 133' ' ' VAL . 23.1 pttp -116.91 126.3 52.76 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 122.241 1.02 . . . . 0.0 112.68 -179.328 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 27.6 tptt -46.24 121.61 3.45 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.538 -1.21 . . . . 0.0 110.082 179.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 113.88 -15.14 21.56 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.563 -1.015 . . . . 0.0 110.563 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.454 ' CG1' ' O ' ' A' ' 130' ' ' LYS . 11.1 p -91.44 166.04 1.85 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.535 ' O ' ' O ' ' A' ' 126' ' ' HIS . 0.3 OUTLIER -72.75 138.2 46.36 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 122.384 1.087 . . . . 0.0 113.821 -176.239 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 62.14 9.69 3.31 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 113.67 -1.604 . . . . 0.0 114.643 177.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 4.3 p -70.4 -31.96 69.39 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 121.486 -0.759 . . . . 0.0 113.028 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -88.82 8.57 28.39 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 -177.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.454 ' CD1' ' OG1' ' A' ' 186' ' ' THR . 18.2 pt -68.7 -31.46 50.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 121.602 0.715 . . . . 0.0 110.476 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -61.98 -20.81 64.26 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.639 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 57.7 m -79.78 -3.41 47.52 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.172 -179.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 99.5 mt -65.78 145.6 55.78 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 121.071 0.462 . . . . 0.0 110.198 179.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 53.6 mttp -120.67 154.5 35.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.515 0.674 . . . . 0.0 111.254 -179.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -49.97 131.86 22.84 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.41 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 160' ' ' VAL . . . 80.71 8.23 87.72 Favored Glycine 0 CA--C 1.533 1.217 0 C-N-CA 120.682 -0.77 . . . . 0.0 111.72 179.297 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.458 ' OD1' ' N ' ' A' ' 146' ' ' LYS . 56.6 t0 -71.17 130.04 40.45 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 120.042 -0.663 . . . . 0.0 110.304 -179.513 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.458 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 74.5 mmtt -77.81 142.85 38.33 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.8 0.809 . . . . 0.0 112.263 -178.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 80.5 mt -142.64 143.44 25.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 114.562 -1.199 . . . . 0.0 108.656 178.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -126.04 139.96 52.98 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 119.599 -0.84 . . . . 0.0 112.563 -178.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 2.9 mt -110.5 134.12 52.66 Favored 'General case' 0 C--O 1.223 -0.334 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 177.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.553 ' CZ ' ' CD ' ' A' ' 155' ' ' GLU . 33.3 m-85 -110.25 107.68 17.53 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.303 -0.559 . . . . 0.0 112.078 -179.207 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . 0.477 ' OD1' ' N ' ' A' ' 152' ' ' ASN . 54.5 t0 -88.94 162.37 16.13 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 177.449 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . 0.477 ' N ' ' OD1' ' A' ' 151' ' ' ASP . 44.9 p-10 -58.27 -18.55 27.53 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 119.422 -0.911 . . . . 0.0 111.358 -178.215 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -113.77 -28.14 7.54 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -178.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . 0.438 ' ND2' ' N ' ' A' ' 154' ' ' ASN . 0.4 OUTLIER -148.58 -175.12 4.8 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 122.134 0.969 . . . . 0.0 113.477 -176.779 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.553 ' CD ' ' CZ ' ' A' ' 150' ' ' TYR . 82.5 tt0 -134.79 140.88 46.22 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 114.153 -1.385 . . . . 0.0 109.939 178.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -115.45 137.95 51.52 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -179.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -93.42 109.27 20.85 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.854 179.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 38.1 m-85 -113.27 147.51 37.42 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.08 0.467 . . . . 0.0 111.349 178.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -122.02 121.55 37.27 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.262 0.553 . . . . 0.0 111.567 179.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.511 ' O ' ' N ' ' A' ' 144' ' ' GLY . 52.1 t -59.86 136.31 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.258 178.206 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 22.5 p -105.68 -24.83 12.45 Favored 'General case' 0 CA--C 1.533 0.316 0 O-C-N 123.535 0.522 . . . . 0.0 111.623 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 159.3 -169.08 35.39 Favored Glycine 0 CA--C 1.529 0.949 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 3.6 p -136.35 155.92 35.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 68.3 m -146.1 167.51 23.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.353 0.597 . . . . 0.0 111.764 -179.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -103.14 119.1 38.24 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.119 179.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 21.0 m -136.3 158.45 38.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.452 0.644 . . . . 0.0 111.859 -178.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' THR . . . . . 0.405 ' H ' ' HD2' ' A' ' 170' ' ' LYS . 0.3 OUTLIER -86.52 158.61 54.21 Favored Pre-proline 0 CA--C 1.537 0.48 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.111 -179.634 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.538 ' O ' ' CB ' ' B' ' 702' ' ' LEU . 32.6 Cg_endo -66.31 -18.7 55.8 Favored 'Trans proline' 0 N--CA 1.498 1.792 0 C-N-CA 123.471 2.781 . . . . 0.0 113.425 -179.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 44.0 p-10 -92.88 -3.14 55.13 Favored 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 119.878 -0.729 . . . . 0.0 112.187 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.405 ' HD2' ' H ' ' A' ' 167' ' ' THR . 93.6 mttt -76.74 97.29 4.44 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.466 0.65 . . . . 0.0 112.175 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' TRP . . . . . 0.458 ' CH2' ' C ' ' B' ' 701' ' ' BOC . 95.9 m95 -66.84 -33.62 76.01 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.254 -0.884 . . . . 0.0 110.277 178.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -44.27 -36.28 2.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.071 -0.968 . . . . 0.0 112.885 -178.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 16.1 m -63.37 -26.04 39.87 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 120.376 -0.53 . . . . 0.0 112.064 -179.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 25.6 m -108.79 -7.8 11.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 120.306 -0.558 . . . . 0.0 112.466 -179.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -75.02 153.64 38.38 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.143 0.497 . . . . 0.0 111.502 179.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . 0.412 ' O ' ' OD1' ' A' ' 176' ' ' ASP . 48.8 p-10 -64.61 138.07 58.19 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.123 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' HIS . . . . . 0.44 ' CE1' HD21 ' A' ' 120' ' ' ASN . 70.1 m80 -112.83 14.9 19.93 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.416 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 72.12 34.37 61.52 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 120.851 -0.69 . . . . 0.0 111.547 179.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 42.8 pttt -166.33 178.84 5.95 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.629 0.728 . . . . 0.0 111.722 179.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' A' ' 180' ' ' ASP . 18.3 p30 -89.77 92.99 9.27 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.835 179.201 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . 0.407 ' HG2' ' N ' ' A' ' 182' ' ' ILE . 84.3 tt0 -124.85 161.32 26.78 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.411 0.624 . . . . 0.0 111.566 -179.485 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.407 ' N ' ' HG2' ' A' ' 181' ' ' GLU . 20.5 tt -129.09 135.95 60.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 178.548 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 80.4 m -130.26 126.07 36.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.707 0.765 . . . . 0.0 112.203 -178.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.435 ' N ' ' CD1' ' A' ' 184' ' ' LEU . 10.5 mp -109.66 131.87 54.67 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.817 -1.083 . . . . 0.0 109.164 178.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . 0.401 HG21 HD12 ' A' ' 185' ' ' ILE . 96.8 mt -113.67 122.63 68.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 121.454 0.645 . . . . 0.0 111.288 -179.185 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' THR . . . . . 0.454 ' OG1' ' CD1' ' A' ' 138' ' ' ILE . 4.7 m -140.86 153.16 45.62 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.827 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' CYS . . . . . 0.678 ' N ' ' SG ' ' B' ' 705' ' ' B27 . 86.4 m -87.03 153.92 21.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.269 179.229 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 65.8 t -61.04 -48.87 87.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.278 0.561 . . . . 0.0 110.842 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' SER . . . . . 0.458 ' HA ' ' HG ' ' A' ' 129' ' ' SER . 16.5 t -168.06 151.25 5.79 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.791 179.081 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 7.5 p -62.01 -20.69 24.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.38 0.609 . . . . 0.0 109.919 179.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 60.4 mttp -94.65 -12.13 27.94 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.047 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -138.09 103.11 4.86 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.767 179.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -104.68 11.94 33.47 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.549 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 21.3 m -63.57 -36.81 85.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.946 -179.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 57.1 mtmt -135.13 156.95 48.13 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.075 0.464 . . . . 0.0 111.709 -178.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -128.63 139.28 52.34 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.433 -179.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -94.62 144.5 25.55 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.246 0.546 . . . . 0.0 112.086 179.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 41.6 t -131.79 131.16 62.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.041 178.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 53.5 t -105.29 132.83 51.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.432 179.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -116.44 141.82 47.68 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.307 0.575 . . . . 0.0 110.836 -179.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -143.57 145.8 15.89 Favored Glycine 0 CA--C 1.528 0.903 0 N-CA-C 110.64 -0.984 . . . . 0.0 110.64 179.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -107.03 149.36 27.65 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.027 0.441 . . . . 0.0 110.594 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 49.2 tp -70.29 131.61 44.44 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 179.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 7.6 p -114.05 -20.27 6.19 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 C-N-CA 120.442 -0.503 . . . . 0.0 111.767 -179.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -174.49 172.36 45.32 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 120.711 -0.757 . . . . 0.0 111.722 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 17.5 m -142.96 136.13 28.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.44 -0.38 . . . . 0.0 110.21 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -144.52 120.62 10.77 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.284 0.564 . . . . 0.0 111.745 179.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -62.06 137.35 58.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.465 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -81.22 160.95 24.17 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.099 178.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 25.3 pttm . . . . . 0 C--O 1.22 -0.464 0 CA-C-O 118.188 -0.911 . . . . 0.0 110.869 -179.693 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 701' ' ' BOC . . . . . 0.458 ' C ' ' CH2' ' A' ' 171' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 702' ' ' LEU . . . . . 0.538 ' CB ' ' O ' ' A' ' 168' ' ' PRO . 0.4 OUTLIER -36.33 110.56 0.46 Allowed Pre-proline 0 CA--C 1.536 0.439 0 N-CA-C 109.483 -0.562 . . . . 20.0 109.483 . . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 703' ' ' PRO . . . . . 0.559 ' O ' ' O ' ' B' ' 704' ' ' ALA . 3.4 Cg_exo -64.01 179.5 1.08 Allowed 'Trans proline' 0 N--CA 1.491 1.378 0 C-N-CA 122.243 1.962 . . . . 20.0 113.903 -178.589 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 704' ' ' ALA . . . . . 0.559 ' O ' ' O ' ' B' ' 703' ' ' PRO . . . -37.57 -178.23 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 114.175 -1.375 . . . . 20.0 113.496 -179.651 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 705' ' ' B27 . . . . . 0.678 ' SG ' ' N ' ' A' ' 187' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.359 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 78.0 p -65.17 -21.19 66.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.965 0.412 . . . . 0.0 111.063 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 75.6 m80 -66.92 -36.04 81.36 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.05 0.452 . . . . 0.0 110.575 179.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 62.5 ttp -89.92 133.99 34.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.583 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -66.14 142.19 57.84 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.439 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -101.88 11.76 38.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.245 0.545 . . . . 0.0 110.542 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 89.8 p -84.26 13.16 5.54 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.914 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 50.9 mtmt -107.29 18.09 22.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.635 -179.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 76.8 mt -56.17 138.97 16.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 122.244 1.021 . . . . 0.0 113.142 -177.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -76.51 132.74 39.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 113.614 -1.63 . . . . 0.0 109.199 178.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.407 ' HB3' ' CG ' ' A' ' 126' ' ' HIS . 3.2 pm0 -77.09 147.5 76.86 Favored Pre-proline 0 C--N 1.324 -0.506 0 C-N-CA 120.513 -0.475 . . . . 0.0 110.14 -179.439 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.451 ' CB ' ' OE1' ' A' ' 68' ' ' GLU . 66.9 Cg_endo -70.4 160.33 49.88 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 122.861 2.374 . . . . 0.0 112.273 -179.262 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 -52.99 172.18 0.05 Allowed 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 121.311 0.577 . . . . 0.0 111.06 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 98.8 mt -71.25 -10.59 60.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.725 -179.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -69.17 -40.55 78.07 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.408 0.623 . . . . 0.0 111.024 179.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.474 ' O ' ' CB ' ' A' ' 72' ' ' ALA . 90.1 mt-10 -71.44 -26.83 62.9 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.023 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 6.0 t -72.16 -44.25 65.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.67 -179.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -89.91 -9.88 47.25 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.925 -0.31 . . . . 0.0 111.581 -179.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -110.52 -8.0 14.68 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.647 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.474 ' CB ' ' O ' ' A' ' 68' ' ' GLU . . . -68.44 138.9 55.66 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.35 0.595 . . . . 0.0 111.731 -179.296 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 5.9 m -57.8 102.85 0.11 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.718 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.495 ' CD1' ' C ' ' A' ' 74' ' ' LEU . 2.0 tm? -68.34 119.28 12.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.39 -178.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -97.3 78.47 2.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.393 0.616 . . . . 0.0 109.44 178.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -63.77 -36.66 84.6 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.955 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.407 ' HD3' ' N ' ' A' ' 77' ' ' LYS . 0.1 OUTLIER -70.38 -14.5 62.59 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.405 -177.427 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 -90.9 -1.15 57.86 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.301 0.572 . . . . 0.0 110.634 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 74.9 t -84.67 127.21 40.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.389 179.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 18.3 pt -110.97 -11.66 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 C-N-CA 120.803 -0.359 . . . . 0.0 111.798 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -160.52 163.77 34.19 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 120.556 -0.83 . . . . 0.0 111.384 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 78.8 ttt180 -134.95 138.34 43.96 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.196 0.522 . . . . 0.0 111.35 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 20.0 tt -104.12 141.3 20.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.243 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 70.1 m -135.78 128.84 31.56 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.645 -178.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 79.5 mt -139.23 86.41 14.65 Favored Pre-proline 0 CA--C 1.538 0.501 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.09 -179.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -56.66 -29.69 80.77 Favored 'Trans proline' 0 N--CA 1.499 1.827 0 C-N-CA 123.286 2.657 . . . . 0.0 113.523 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.429 ' HG ' ' CD2' ' A' ' 141' ' ' LEU . 91.7 p -53.23 -42.01 65.98 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 121.291 0.567 . . . . 0.0 110.55 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.493 ' O ' ' OG ' ' A' ' 89' ' ' SER . 34.4 m -114.07 11.23 8.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.596 179.502 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.493 ' OG ' ' O ' ' A' ' 88' ' ' VAL . 14.9 p 51.37 52.38 14.9 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.915 -179.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 54.5 tp -118.33 134.36 55.11 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 121.535 0.683 . . . . 0.0 111.958 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -146.1 122.89 11.25 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.823 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 76.8 mt -149.81 148.88 26.59 Favored Pre-proline 0 CA--C 1.539 0.529 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.316 -179.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.18 145.86 27.99 Favored 'Trans proline' 0 N--CA 1.493 1.49 0 C-N-CA 122.436 2.091 . . . . 0.0 111.867 178.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.524 ' O ' ' CG2' ' A' ' 94' ' ' VAL . 2.0 m -94.02 118.01 38.97 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 CA-C-O 121.53 0.681 . . . . 0.0 110.996 179.428 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.424 ' N ' ' CD1' ' A' ' 95' ' ' LEU . 11.0 mp -102.6 136.23 42.8 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.098 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -64.75 -88.14 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 119.992 -0.683 . . . . 0.0 112.123 -179.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 74.0 m -51.79 134.17 30.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.898 -178.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 8.1 m -91.15 74.03 6.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.929 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 55.7 p -88.59 168.48 12.53 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 178.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -61.69 -42.53 99.05 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 119.856 -0.738 . . . . 0.0 109.903 179.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -65.86 -40.38 91.62 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.527 -0.761 . . . . 0.0 111.372 179.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -63.59 -38.93 93.01 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.168 0.508 . . . . 0.0 111.291 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 76.6 mt -61.67 -21.92 64.85 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.763 -179.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 63.1 mt -69.84 -21.43 63.36 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.944 0.402 . . . . 0.0 110.429 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.439 ' HG ' ' H ' ' A' ' 107' ' ' ALA . 95.9 p -72.98 -7.71 52.39 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 179.172 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.504 ' O ' ' CE1' ' A' ' 135' ' ' PHE . . . 91.24 -18.65 50.9 Favored Glycine 0 CA--C 1.53 0.991 0 CA-C-N 115.205 -0.907 . . . . 0.0 112.41 178.462 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.439 ' H ' ' HG ' ' A' ' 105' ' ' SER . . . -145.95 124.75 12.63 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 119.723 -0.791 . . . . 0.0 112.354 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -143.4 132.77 23.36 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.482 178.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 11.7 m -62.45 131.44 49.2 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 121.01 0.433 . . . . 0.0 110.836 -179.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 75.6 t -78.92 -54.56 11.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 C-N-CA 120.576 -0.449 . . . . 0.0 110.673 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.802 ' H ' ' NE2' ' A' ' 114' ' ' GLN . 97.5 mttt -98.39 135.94 39.26 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 122.258 1.027 . . . . 0.0 112.646 179.483 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -66.53 -30.16 70.41 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 113.71 -1.586 . . . . 0.0 113.558 -178.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -83.06 8.57 12.52 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 -177.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . 0.802 ' NE2' ' H ' ' A' ' 111' ' ' LYS . 46.0 mt-30 -80.02 139.56 36.91 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 121.913 -0.492 . . . . 0.0 112.104 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.41 ' O ' ' O ' ' A' ' 118' ' ' LYS . 55.4 t -123.62 125.65 71.71 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.971 178.307 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 97.9 mtp -59.66 129.83 43.83 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.753 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 88.52 -10.74 70.62 Favored Glycine 0 CA--C 1.531 1.062 0 N-CA-C 111.796 -0.522 . . . . 0.0 111.796 178.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.41 ' O ' ' O ' ' A' ' 115' ' ' VAL . 67.4 mttm -141.5 138.25 32.66 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.364 0.602 . . . . 0.0 111.549 179.617 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 75.03 -163.83 54.32 Favored Glycine 0 CA--C 1.53 0.979 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.554 ' ND2' ' ND1' ' A' ' 177' ' ' HIS . 54.0 t-20 -93.97 104.59 16.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.932 0.396 . . . . 0.0 110.69 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 9.6 t80 -86.49 144.7 27.13 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 178.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.585 ' N ' ' OE1' ' A' ' 114' ' ' GLN . . . -147.66 140.27 24.68 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.043 -0.663 . . . . 0.0 111.248 -179.12 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 48.1 mt -137.72 142.53 41.02 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.064 -179.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -110.82 138.55 47.07 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 178.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -139.36 151.35 21.84 Favored Glycine 0 CA--C 1.53 0.983 0 N-CA-C 110.441 -1.064 . . . . 0.0 110.441 -179.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.407 ' CG ' ' HB3' ' A' ' 63' ' ' GLN . 19.5 m-70 -96.92 140.44 31.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.435 0.636 . . . . 0.0 111.928 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.593 ' ND2' ' OG1' ' A' ' 186' ' ' THR . 52.2 p-10 -145.55 121.42 10.61 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.537 179.019 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' MET . . . . . 0.497 ' O ' ' CB ' ' A' ' 129' ' ' SER . 74.9 mtm -87.3 4.61 42.11 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.174 0.511 . . . . 0.0 110.296 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.497 ' CB ' ' O ' ' A' ' 128' ' ' MET . 1.0 OUTLIER 78.93 13.64 1.23 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.129 179.878 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.465 ' O ' ' CG1' ' A' ' 133' ' ' VAL . 21.2 ptmt -109.72 124.42 51.21 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 122.168 0.985 . . . . 0.0 113.19 -178.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -43.99 119.49 1.77 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.628 -1.169 . . . . 0.0 110.668 179.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 115.42 -18.69 15.32 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.54 ' CG1' ' OG ' ' A' ' 136' ' ' SER . 7.6 p -88.93 154.33 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.636 ' CD2' ' H ' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -69.19 145.06 53.54 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -177.211 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.504 ' CE1' ' O ' ' A' ' 106' ' ' GLY . 3.3 m-85 65.82 6.37 3.92 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 114.017 -1.447 . . . . 0.0 114.15 178.027 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' SER . . . . . 0.54 ' OG ' ' CG1' ' A' ' 133' ' ' VAL . 2.7 m -75.24 -36.3 61.32 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 179.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 51.9 p-10 -94.48 7.1 46.73 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 114.277 1.214 . . . . 0.0 114.277 -176.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 38.6 pt -72.5 -23.79 21.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 C-N-CA 119.344 -0.943 . . . . 0.0 110.663 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -71.14 -10.34 59.58 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 121.017 0.436 . . . . 0.0 110.614 179.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 66.6 m -81.0 -7.34 59.53 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.286 0.565 . . . . 0.0 110.271 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.429 ' CD2' ' HG ' ' A' ' 87' ' ' SER . 88.6 mt -67.47 146.36 54.06 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.041 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -123.8 166.46 15.57 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.392 178.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -52.15 140.61 20.59 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.518 0.675 . . . . 0.0 112.359 179.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 77.99 7.13 87.6 Favored Glycine 0 CA--C 1.529 0.915 0 CA-C-N 115.139 -0.937 . . . . 0.0 112.283 178.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -71.97 133.9 45.62 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 118.925 -1.11 . . . . 0.0 110.165 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -79.72 136.2 36.71 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.759 0.79 . . . . 0.0 111.836 -178.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 97.8 mt -134.82 135.06 53.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 178.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 79.5 m-85 -121.98 135.57 54.86 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 119.858 -0.737 . . . . 0.0 112.632 -177.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.437 ' CD2' ' N ' ' A' ' 149' ' ' LEU . 0.3 OUTLIER -112.43 135.13 53.51 Favored 'General case' 0 C--O 1.224 -0.24 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 178.062 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.503 ' CE1' ' CD ' ' A' ' 155' ' ' GLU . 75.3 m-85 -109.71 108.95 19.51 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 120.247 -0.581 . . . . 0.0 111.712 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . 0.509 ' OD1' ' N ' ' A' ' 152' ' ' ASN . 53.8 t0 -87.74 165.23 15.51 Favored 'General case' 0 N--CA 1.447 -0.625 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 177.034 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . 0.509 ' N ' ' OD1' ' A' ' 151' ' ' ASP . 50.8 p-10 -59.28 -21.17 59.25 Favored 'General case' 0 C--N 1.312 -1.027 0 C-N-CA 119.522 -0.871 . . . . 0.0 110.978 -178.442 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.468 ' N ' ' OD1' ' A' ' 152' ' ' ASN . 95.4 mt-10 -115.92 -26.83 7.18 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 113.691 0.997 . . . . 0.0 113.691 -178.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -146.38 175.89 10.2 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 119.0 -1.08 . . . . 0.0 113.154 -176.631 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.503 ' CD ' ' CE1' ' A' ' 150' ' ' TYR . 82.5 tt0 -127.19 134.66 50.11 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 114.839 -1.073 . . . . 0.0 109.915 179.268 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -109.25 135.18 50.76 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 121.301 0.572 . . . . 0.0 112.094 -179.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -93.21 110.08 21.59 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.557 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 43.9 m-85 -113.92 148.81 36.16 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 120.91 0.386 . . . . 0.0 111.386 179.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -125.0 125.98 44.73 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.35 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 80.0 t -57.71 131.24 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 178.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 16.5 p -113.59 7.32 17.32 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 123.673 0.608 . . . . 0.0 112.529 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 135.79 177.37 14.93 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 120.108 -1.044 . . . . 0.0 112.515 178.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 5.8 p -135.3 154.26 35.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 25.8 p -144.66 166.89 23.91 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.042 -0.663 . . . . 0.0 111.722 -179.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -104.12 117.97 35.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.479 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . 0.474 ' O ' ' O ' ' A' ' 196' ' ' ARG . 27.9 m -135.84 160.1 39.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.488 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' THR . . . . . 0.52 ' H ' ' HG1' ' A' ' 167' ' ' THR . 0.2 OUTLIER -85.34 158.08 58.19 Favored Pre-proline 0 CA--C 1.538 0.508 0 CA-C-O 121.055 0.455 . . . . 0.0 110.888 -179.572 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.495 ' O ' ' CB ' ' B' ' 702' ' ' LEU . 28.2 Cg_endo -64.69 -17.58 59.96 Favored 'Trans proline' 0 N--CA 1.499 1.803 0 C-N-CA 123.227 2.618 . . . . 0.0 113.038 -179.256 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 48.9 p-10 -90.88 -2.73 57.72 Favored 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 120.148 -0.621 . . . . 0.0 110.958 179.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -73.88 76.97 1.64 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.441 0.639 . . . . 0.0 111.388 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' TRP . . . . . 0.676 ' HE1' ' CE ' ' A' ' 111' ' ' LYS . 5.7 t90 -69.81 -15.74 63.16 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.334 179.506 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -63.38 -32.16 73.51 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.81 -179.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 14.6 m -62.3 -14.57 12.8 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 120.599 -0.441 . . . . 0.0 111.76 -179.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 1.8 t -103.95 -9.71 9.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -179.124 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -72.35 162.72 29.09 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.117 0.484 . . . . 0.0 110.78 -179.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . 0.418 ' N ' ' OD1' ' A' ' 176' ' ' ASP . 35.5 p-10 -65.03 141.31 58.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.897 179.55 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' HIS . . . . . 0.554 ' ND1' ' ND2' ' A' ' 120' ' ' ASN . 66.2 m80 -113.26 10.41 18.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.321 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 66.18 39.28 94.47 Favored Glycine 0 CA--C 1.53 1.008 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 179.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -165.46 171.01 13.81 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.868 0.366 . . . . 0.0 110.914 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -86.94 102.96 14.86 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 177.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -137.02 161.68 35.39 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.347 0.594 . . . . 0.0 111.512 -178.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 20.3 tt -129.93 139.01 52.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.471 178.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 86.4 m -129.24 125.02 35.97 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.188 0.518 . . . . 0.0 112.02 -178.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 84.9 mt -109.3 131.91 54.62 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 88.9 mt -116.15 125.2 73.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 CA-C-O 121.376 0.608 . . . . 0.0 111.276 -179.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' THR . . . . . 0.593 ' OG1' ' ND2' ' A' ' 127' ' ' ASN . 1.7 t -142.03 163.87 31.72 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 115.263 -0.881 . . . . 0.0 110.851 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' CYS . . . . . 0.423 ' N ' ' SG ' ' B' ' 705' ' ' B27 . 1.9 m -95.86 143.51 27.0 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 120.967 0.413 . . . . 0.0 110.847 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 44.2 t -61.4 -48.45 88.79 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 CA-C-O 121.069 0.462 . . . . 0.0 111.206 -179.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 8.5 t -169.38 158.79 8.27 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.226 0.536 . . . . 0.0 110.878 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 29.2 m -71.96 -17.65 19.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.347 179.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -99.19 -4.59 31.73 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.146 179.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 53.8 t0 -139.68 97.15 3.2 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 120.991 0.424 . . . . 0.0 110.972 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 43.3 p-10 -107.88 10.19 28.61 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.357 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 69.7 m -61.2 -41.7 97.28 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 120.811 0.339 . . . . 0.0 111.414 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -144.68 155.72 43.72 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.327 0.584 . . . . 0.0 111.57 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . 0.474 ' O ' ' O ' ' A' ' 166' ' ' VAL . 99.9 mtt180 -132.56 142.2 49.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.004 -179.407 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . 0.486 ' CZ ' ' CG2' ' A' ' 186' ' ' THR . 47.8 p90 -99.08 151.67 20.69 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.315 0.578 . . . . 0.0 111.203 179.674 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 45.8 t -123.88 134.05 67.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.462 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 69.9 t -96.79 134.83 32.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.964 0.412 . . . . 0.0 110.036 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -116.3 138.29 51.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.358 0.599 . . . . 0.0 111.174 -179.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -134.83 138.0 9.69 Favored Glycine 0 CA--C 1.529 0.917 0 N-CA-C 110.179 -1.168 . . . . 0.0 110.179 179.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . 0.598 ' OD1' ' N ' ' A' ' 203' ' ' LEU . 42.5 t0 -108.89 140.53 42.24 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.15 0.5 . . . . 0.0 111.669 -179.185 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . 0.598 ' N ' ' OD1' ' A' ' 202' ' ' ASP . 54.6 tp -63.34 133.61 54.39 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.073 179.514 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -116.09 -18.88 6.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.074 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -178.36 172.94 45.43 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 120.645 -0.788 . . . . 0.0 111.824 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 31.7 m -142.94 138.91 30.47 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -145.37 122.27 11.3 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.462 -0.495 . . . . 0.0 111.629 178.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -61.98 138.77 58.41 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.391 0.615 . . . . 0.0 110.854 -179.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 13.6 ttmt -79.14 109.47 13.48 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.95 178.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 99.8 mttt . . . . . 0 C--O 1.219 -0.532 0 CA-C-O 117.953 -1.022 . . . . 0.0 110.383 -179.846 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 701' ' ' BOC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 702' ' ' LEU . . . . . 0.495 ' CB ' ' O ' ' A' ' 168' ' ' PRO . 0.9 OUTLIER -44.96 108.34 0.74 Allowed Pre-proline 0 CA--C 1.545 0.751 0 CA-C-O 120.492 0.187 . . . . 20.0 111.159 . . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 703' ' ' PRO . . . . . 0.537 ' O ' ' O ' ' B' ' 704' ' ' ALA . 3.0 Cg_exo -65.65 -168.58 0.13 Allowed 'Trans proline' 0 N--CA 1.492 1.398 0 C-N-CA 122.377 2.052 . . . . 20.0 113.484 -179.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 704' ' ' ALA . . . . . 0.537 ' O ' ' O ' ' B' ' 703' ' ' PRO . . . -40.17 -175.91 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 114.501 -1.227 . . . . 20.0 113.058 -179.241 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 705' ' ' B27 . . . . . 0.43 ' OG1' ' O ' ' B' ' 704' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.376 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 76.9 p -59.5 -36.31 75.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.131 0.491 . . . . 0.0 110.375 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -67.59 -37.63 82.85 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.509 179.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 65.6 mtt -87.26 135.05 33.46 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.249 0.547 . . . . 0.0 110.868 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -145.31 85.28 1.72 Allowed 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.01 -0.676 . . . . 0.0 111.633 179.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -94.54 1.03 55.68 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.679 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 23.6 p -82.99 18.74 1.55 Allowed 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.735 -0.666 . . . . 0.0 112.718 -178.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -105.15 17.38 24.15 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.661 -0.416 . . . . 0.0 111.638 -179.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.6 mt -55.41 135.31 18.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 122.124 0.964 . . . . 0.0 112.479 -177.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -76.75 131.92 39.0 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 113.885 -1.507 . . . . 0.0 108.961 178.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.587 ' NE2' ' O ' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -79.23 149.82 73.28 Favored Pre-proline 0 C--N 1.326 -0.449 0 C-N-CA 120.383 -0.527 . . . . 0.0 110.634 -179.074 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -71.0 165.19 33.18 Favored 'Trans proline' 0 N--CA 1.496 1.654 0 C-N-CA 122.888 2.392 . . . . 0.0 113.338 -179.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -53.02 164.94 0.35 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.684 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 89.1 mt -63.81 -45.37 89.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.285 -179.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.17 -36.84 84.95 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.473 -0.491 . . . . 0.0 111.071 -178.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -63.04 -29.91 71.18 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.498 0.666 . . . . 0.0 109.478 178.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 38.7 t -76.71 -46.27 30.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.108 179.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -73.08 -9.01 58.27 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.811 -1.086 . . . . 0.0 111.438 -179.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 96.8 m-20 -106.43 -12.89 15.51 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.525 0.678 . . . . 0.0 109.655 178.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.4 139.71 55.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.044 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 35.5 t -59.06 103.17 0.15 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.013 179.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.433 ' CD2' ' C ' ' A' ' 74' ' ' LEU . 6.9 tt -70.16 123.79 22.49 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.266 0.555 . . . . 0.0 111.068 -179.281 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -96.35 80.11 3.16 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.044 -179.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.409 ' O ' ' CG1' ' A' ' 79' ' ' VAL . 64.5 pttt -79.49 -15.67 57.36 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.742 0.782 . . . . 0.0 109.539 178.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 21.2 mtmt -65.82 -36.28 83.04 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.764 -1.107 . . . . 0.0 111.41 -178.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -87.04 0.07 55.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.941 0.4 . . . . 0.0 111.333 -179.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.412 ' O ' ' CG1' ' A' ' 79' ' ' VAL . 2.3 p -68.36 132.43 32.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.534 0.683 . . . . 0.0 110.683 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 8.6 pt -111.4 -5.81 11.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.427 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -171.74 176.9 44.78 Favored Glycine 0 CA--C 1.531 1.036 0 N-CA-C 111.162 -0.775 . . . . 0.0 111.162 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 51.1 ttt85 -135.92 154.42 51.13 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 20.1 tt -119.07 137.02 54.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 CA-C-O 121.6 0.714 . . . . 0.0 110.124 179.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 8.6 t -135.15 125.35 26.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.771 -178.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.422 HG21 HD11 ' A' ' 85' ' ' ILE . 81.0 mt -135.56 90.23 20.5 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.203 179.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -56.38 -32.04 87.35 Favored 'Trans proline' 0 N--CA 1.494 1.535 0 C-N-CA 123.069 2.513 . . . . 0.0 112.637 -179.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 10.7 t -54.77 -42.44 71.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.294 -179.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.2 m -113.81 11.28 8.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.328 0.585 . . . . 0.0 110.351 179.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 50.19 48.08 22.68 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.265 179.611 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 47.8 tp -109.75 132.1 54.46 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.472 0.653 . . . . 0.0 110.802 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -144.13 113.78 7.13 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.083 -178.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 93.7 mt -147.36 147.44 28.34 Favored Pre-proline 0 CA--C 1.537 0.465 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.656 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -74.4 146.92 36.0 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.593 2.195 . . . . 0.0 112.411 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 78.8 t -94.44 120.14 43.42 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-O 121.002 0.429 . . . . 0.0 110.929 179.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.47 ' N ' ' CD1' ' A' ' 95' ' ' LEU . 10.6 mp -101.02 126.46 47.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.488 0.661 . . . . 0.0 110.962 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.54 ' O ' ' OG1' ' A' ' 109' ' ' THR . 87.2 tttt -64.07 -44.32 92.77 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.267 -0.879 . . . . 0.0 112.316 -178.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 4.2 m -85.59 130.83 34.48 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 121.039 0.447 . . . . 0.0 111.997 -179.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 3.5 p -90.64 59.04 4.1 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.547 179.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 3.3 m -92.72 164.74 13.26 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 179.077 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -58.21 -43.15 87.49 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 120.568 -0.453 . . . . 0.0 111.143 -179.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -64.96 -36.94 86.02 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.542 0.687 . . . . 0.0 110.009 178.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -64.4 -38.61 91.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.565 -179.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 96.9 mt -63.9 -11.97 32.72 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.913 -178.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 88.9 mt -73.95 -20.74 60.27 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.477 -0.489 . . . . 0.0 110.463 179.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 76.2 p -74.41 -4.77 38.5 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.169 -179.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 85.79 -19.25 26.15 Favored Glycine 0 CA--C 1.529 0.931 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.894 178.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -146.65 123.69 11.42 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.588 0.709 . . . . 0.0 111.804 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -146.21 137.15 24.38 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.159 178.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.54 ' OG1' ' O ' ' A' ' 96' ' ' LYS . 68.1 p -64.14 133.93 53.89 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.043 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 37.7 t -81.43 -56.92 5.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.29 0.567 . . . . 0.0 110.568 -179.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -93.07 128.44 38.97 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.988 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -67.01 -31.25 71.67 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 -177.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 72.4 m-80 -82.98 11.61 5.96 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 114.238 1.199 . . . . 0.0 114.238 -176.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . 0.461 ' OE1' ' N ' ' A' ' 122' ' ' ALA . 32.8 mt-30 -81.49 143.52 32.0 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.207 -0.597 . . . . 0.0 111.528 178.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 54.7 t -123.64 125.21 71.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.575 179.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' MET . . . . . 0.437 ' CG ' ' CZ ' ' A' ' 121' ' ' TYR . 97.3 mtp -57.58 130.43 46.31 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.99 0.424 . . . . 0.0 111.602 -179.313 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 80.64 -2.97 76.68 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 120.935 -0.65 . . . . 0.0 111.839 178.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 55.6 tttm -139.22 126.87 21.86 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.12 0.486 . . . . 0.0 110.655 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 74.86 -164.01 54.43 Favored Glycine 0 CA--C 1.529 0.962 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 -179.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 64.4 t-20 -92.7 106.79 18.71 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.978 0.418 . . . . 0.0 110.562 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.437 ' CZ ' ' CG ' ' A' ' 116' ' ' MET . 4.0 t80 -83.98 144.58 29.05 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.474 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.461 ' N ' ' OE1' ' A' ' 114' ' ' GLN . . . -146.83 140.3 25.66 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 119.777 -0.769 . . . . 0.0 112.575 -177.526 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 7.2 mp -139.09 144.74 38.86 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.509 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -108.51 139.9 42.6 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . 0.42 ' N ' HG2B ' B' ' 705' ' ' B27 . . . -144.6 159.36 27.77 Favored Glycine 0 CA--C 1.53 0.977 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 -179.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 60.5 m-70 -99.08 137.14 38.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.35 0.595 . . . . 0.0 111.932 -179.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 64.8 t-20 -131.69 120.2 22.43 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.941 179.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' MET . . . . . 0.529 ' CE ' HE21 ' A' ' 63' ' ' GLN . 64.1 mtt -92.88 -4.48 52.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.189 0.518 . . . . 0.0 111.021 -179.182 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.476 ' CB ' ' O ' ' A' ' 128' ' ' MET . 0.9 OUTLIER 79.25 11.75 1.35 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.846 -0.615 . . . . 0.0 112.149 179.03 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.527 ' O ' ' CG1' ' A' ' 133' ' ' VAL . 58.8 pttt -126.67 128.31 46.52 Favored 'General case' 0 C--O 1.222 -0.346 0 CA-C-O 122.1 0.952 . . . . 0.0 112.801 -179.574 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.482 ' O ' ' O ' ' A' ' 130' ' ' LYS . 29.5 tptt -37.54 162.64 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.833 -1.076 . . . . 0.0 110.289 178.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.47 ' H ' ' HG3' ' A' ' 131' ' ' LYS . . . 73.78 -24.18 1.02 Allowed Glycine 0 CA--C 1.529 0.911 0 N-CA-C 111.837 -0.505 . . . . 0.0 111.837 178.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.527 ' CG1' ' O ' ' A' ' 130' ' ' LYS . 2.9 p -91.16 175.86 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 O-C-N 122.325 -0.515 . . . . 0.0 111.535 -178.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.79 ' O ' ' N ' ' A' ' 136' ' ' SER . 3.9 mm? -60.11 167.09 2.49 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 121.209 0.528 . . . . 0.0 112.349 -177.61 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.7 m-30 22.4 21.01 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 113.947 -1.478 . . . . 0.0 113.868 178.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' SER . . . . . 0.79 ' N ' ' O ' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -64.37 -44.88 90.01 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 113.69 0.996 . . . . 0.0 113.69 -178.318 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.406 ' O ' ' OG ' ' A' ' 140' ' ' SER . 81.1 m-20 -89.25 -3.88 58.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.98 0.419 . . . . 0.0 111.516 -178.178 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.462 HD11 HG21 ' A' ' 138' ' ' ILE . 0.2 OUTLIER -61.47 -40.69 87.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.569 179.697 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -65.26 -10.67 34.06 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 120.284 -0.567 . . . . 0.0 110.144 179.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.406 ' OG ' ' O ' ' A' ' 137' ' ' ASP . 5.9 p -85.34 -2.6 58.26 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.432 179.309 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 73.0 mt -63.39 143.44 57.81 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-O 121.203 0.525 . . . . 0.0 110.262 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.44 ' N ' ' OD2' ' A' ' 145' ' ' ASP . 89.0 tttt -119.41 155.0 32.81 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.44 0.638 . . . . 0.0 111.873 -178.442 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -50.75 133.74 25.71 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.424 179.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.56 ' N ' ' O ' ' A' ' 160' ' ' VAL . . . 79.33 7.95 88.13 Favored Glycine 0 CA--C 1.528 0.88 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.603 179.438 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.44 ' OD2' ' N ' ' A' ' 142' ' ' LYS . 77.2 m-20 -75.35 137.63 41.22 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 119.31 -0.956 . . . . 0.0 110.568 -179.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -79.12 139.99 37.92 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.526 -0.761 . . . . 0.0 112.799 -178.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.425 HG22 HD12 ' A' ' 147' ' ' ILE . 97.2 mt -139.12 137.52 41.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 114.762 -1.108 . . . . 0.0 108.346 178.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -123.65 137.58 54.7 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.022 -0.671 . . . . 0.0 112.556 -178.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -115.7 136.61 52.89 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 177.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -112.94 113.27 25.26 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 119.98 -0.688 . . . . 0.0 111.561 179.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . 0.589 ' OD1' ' N ' ' A' ' 152' ' ' ASN . 66.2 t0 -87.53 162.03 17.44 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 177.247 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . 0.589 ' N ' ' OD1' ' A' ' 151' ' ' ASP . 65.2 m-20 -55.37 -24.19 28.27 Favored 'General case' 0 C--N 1.315 -0.893 0 C-N-CA 119.337 -0.945 . . . . 0.0 110.047 -178.172 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -108.3 -30.16 8.49 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 113.699 1.0 . . . . 0.0 113.699 -177.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . 0.446 ' O ' ' N ' ' A' ' 151' ' ' ASP . 0.3 OUTLIER -148.93 -178.13 6.19 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 119.089 -1.044 . . . . 0.0 113.736 -177.328 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.43 144.33 51.33 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 114.478 -1.237 . . . . 0.0 110.05 178.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -120.97 139.89 52.63 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 120.972 0.415 . . . . 0.0 111.573 -178.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -96.43 115.65 27.77 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.564 179.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 50.1 m-85 -116.97 151.57 36.43 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.001 0.429 . . . . 0.0 111.416 179.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -124.45 124.82 43.14 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.132 179.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.56 ' O ' ' N ' ' A' ' 144' ' ' GLY . 96.4 t -60.08 136.62 23.51 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 178.103 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 7.6 p -105.1 -23.19 12.97 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.666 178.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 159.37 -168.13 35.22 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 120.488 -0.863 . . . . 0.0 111.969 179.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 15.0 p -137.73 146.72 26.98 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 179.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 28.3 m -142.3 172.03 13.24 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 120.955 0.407 . . . . 0.0 111.174 -179.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -111.26 125.74 54.15 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.477 0.656 . . . . 0.0 111.534 -179.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 30.6 m -137.36 164.74 28.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.559 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -82.69 158.73 65.08 Favored Pre-proline 0 CA--C 1.536 0.408 0 CA-C-O 121.047 0.451 . . . . 0.0 110.996 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.486 ' O ' ' CB ' ' B' ' 702' ' ' LEU . 44.3 Cg_endo -67.05 -15.98 48.11 Favored 'Trans proline' 0 N--CA 1.497 1.679 0 C-N-CA 122.85 2.367 . . . . 0.0 111.6 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . 0.409 ' OD1' ' C ' ' A' ' 169' ' ' ASP . 40.9 p-10 -93.17 -6.43 47.83 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.911 179.652 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 16.7 mttm -74.64 82.65 2.05 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.46 0.648 . . . . 0.0 111.397 -179.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 21.9 t90 -73.12 -14.14 61.32 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.803 179.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.487 ' OE1' ' OE1' ' A' ' 175' ' ' GLU . 52.1 tp10 -58.58 -31.25 67.84 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 115.052 -0.976 . . . . 0.0 111.831 -179.386 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 28.2 m -64.2 -20.78 27.56 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 120.618 -0.433 . . . . 0.0 112.04 -178.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . 0.402 ' O ' ' CG1' ' A' ' 174' ' ' VAL . 49.5 t -98.74 -9.11 9.0 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -178.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.487 ' OE1' ' OE1' ' A' ' 172' ' ' GLU . 98.1 mt-10 -74.86 148.28 40.34 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 121.394 0.616 . . . . 0.0 111.585 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 46.6 p-10 -60.2 141.6 55.74 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.363 -179.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' HIS . . . . . 0.482 ' CE1' ' O ' ' A' ' 175' ' ' GLU . 80.5 m80 -117.67 16.85 14.49 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.537 -179.656 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 66.51 39.08 93.9 Favored Glycine 0 CA--C 1.532 1.102 0 N-CA-C 111.361 -0.696 . . . . 0.0 111.361 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 15.7 ptmt -163.26 167.1 22.4 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.997 -0.372 . . . . 0.0 109.997 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -87.05 92.31 9.0 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 178.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . 0.421 ' HG2' ' N ' ' A' ' 182' ' ' ILE . 82.9 tt0 -124.62 164.62 19.47 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.404 0.621 . . . . 0.0 111.441 -179.24 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.421 ' N ' ' HG2' ' A' ' 181' ' ' GLU . 18.1 tt -130.7 138.61 53.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.286 178.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 85.9 m -129.5 125.98 37.59 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 121.145 0.498 . . . . 0.0 111.877 -179.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 93.7 mt -109.53 130.59 55.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.874 178.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 83.0 mt -113.94 124.07 70.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.205 0.526 . . . . 0.0 111.287 -179.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' THR . . . . . 0.63 ' OG1' ' CZ ' ' A' ' 197' ' ' TYR . 0.1 OUTLIER -139.51 167.48 21.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.558 -0.747 . . . . 0.0 110.142 179.448 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' CYS . . . . . . . . . . . . . 8.9 m -95.49 142.2 28.12 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 45.2 t -60.66 -44.39 96.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 120.641 -0.424 . . . . 0.0 110.74 -179.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' SER . . . . . 0.4 ' HG ' ' H ' ' A' ' 191' ' ' LYS . 47.5 t -166.64 148.69 6.46 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.163 -0.615 . . . . 0.0 111.613 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 10.9 p -65.2 -22.35 31.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.403 179.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.4 ' H ' ' HG ' ' A' ' 189' ' ' SER . 98.9 mttt -92.93 -13.28 29.06 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.598 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . 0.412 ' OD1' ' OG ' ' A' ' 194' ' ' SER . 66.8 t0 -143.67 98.32 3.22 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 121.179 0.514 . . . . 0.0 110.938 179.403 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -103.83 9.16 37.03 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.592 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' SER . . . . . 0.412 ' OG ' ' OD1' ' A' ' 192' ' ' ASP . 89.3 p -59.67 -33.82 72.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.018 -179.438 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -130.77 146.48 52.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.258 0.551 . . . . 0.0 110.925 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -125.36 135.42 52.42 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.28 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . 0.63 ' CZ ' ' OG1' ' A' ' 186' ' ' THR . 35.6 p90 -98.22 151.06 20.85 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.402 -0.519 . . . . 0.0 110.309 179.393 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 53.0 t -127.05 133.32 68.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.287 0.565 . . . . 0.0 111.549 -179.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 42.1 t -107.48 130.29 59.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.211 178.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -119.55 152.25 37.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.463 0.649 . . . . 0.0 111.976 -178.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . 0.41 ' H ' HG22 ' A' ' 182' ' ' ILE . . . -138.98 151.58 21.81 Favored Glycine 0 CA--C 1.533 1.175 0 N-CA-C 110.593 -1.003 . . . . 0.0 110.593 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . 0.552 ' OD1' ' N ' ' A' ' 203' ' ' LEU . 67.1 t0 -113.77 137.39 51.71 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 120.877 0.37 . . . . 0.0 111.182 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . 0.552 ' N ' ' OD1' ' A' ' 202' ' ' ASP . 53.6 tp -59.96 131.57 51.26 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 86.0 t -112.85 -19.78 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.969 -179.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -178.6 174.49 46.68 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 120.92 -0.657 . . . . 0.0 111.801 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 26.9 m -138.81 132.31 30.39 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -142.71 116.4 9.22 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.526 0.679 . . . . 0.0 112.239 -179.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -63.55 144.88 56.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.328 -0.851 . . . . 0.0 112.139 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 23.6 ttpt -78.68 109.6 13.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.528 178.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 59.2 pttt . . . . . 0 C--O 1.218 -0.565 0 CA-C-O 118.207 -0.901 . . . . 0.0 110.082 178.998 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 701' ' ' BOC . . . . . 0.438 ' O1 ' ' O ' ' B' ' 702' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 702' ' ' LEU . . . . . 0.486 ' CB ' ' O ' ' A' ' 168' ' ' PRO . 1.3 mt 45.3 102.89 0.03 OUTLIER Pre-proline 0 CA--C 1.542 0.663 0 CA-C-O 120.67 0.272 . . . . 20.0 111.416 . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 703' ' ' PRO . . . . . 0.579 ' O ' ' O ' ' B' ' 704' ' ' ALA . 4.0 Cg_exo -64.8 -170.04 0.13 Allowed 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 121.97 1.78 . . . . 20.0 113.562 -179.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 704' ' ' ALA . . . . . 0.579 ' O ' ' O ' ' B' ' 703' ' ' PRO . . . -36.58 -178.81 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 114.256 -1.338 . . . . 20.0 113.458 -179.099 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 705' ' ' B27 . . . . . 0.518 ' OG1' ' O ' ' B' ' 704' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.308 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 20.5 t -62.29 -43.29 99.17 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 120.86 0.362 . . . . 0.0 111.12 -179.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 99.6 m-70 -113.02 146.08 39.73 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 121.077 0.465 . . . . 0.0 110.95 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 67.4 mtt -75.41 139.07 42.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.398 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.536 ' O ' ' OD1' ' A' ' 57' ' ' ASP . 38.1 p30 -166.43 96.56 0.57 Allowed 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 121.335 0.588 . . . . 0.0 111.322 -179.435 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -96.12 -11.11 26.74 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 121.026 0.441 . . . . 0.0 111.359 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.48 ' CB ' ' O ' ' B' ' 702' ' ' LEU . 3.9 p -82.01 21.07 0.91 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.123 -0.489 . . . . 0.0 112.073 -179.145 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 58.4 mtpt -106.73 23.67 13.93 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.137 0.494 . . . . 0.0 111.449 -179.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.6 mt -55.62 136.67 17.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 122.227 1.013 . . . . 0.0 112.189 -177.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -76.88 131.68 38.72 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 113.783 -1.553 . . . . 0.0 108.266 178.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.712 ' N ' HE21 ' A' ' 63' ' ' GLN . 0.0 OUTLIER -77.11 148.7 78.67 Favored Pre-proline 0 C--N 1.325 -0.469 0 C-N-CA 120.363 -0.535 . . . . 0.0 110.622 -178.679 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.541 ' CB ' ' OE1' ' A' ' 68' ' ' GLU . 65.2 Cg_endo -70.79 163.29 39.62 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 123.291 2.661 . . . . 0.0 113.878 -178.705 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -58.58 168.63 1.11 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.001 -1.0 . . . . 0.0 111.434 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 96.0 mt -70.36 -15.04 62.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.291 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -69.72 -40.3 76.32 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.346 0.593 . . . . 0.0 110.658 178.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.569 ' O ' ' N ' ' A' ' 72' ' ' ALA . 82.2 tt0 -66.42 -28.84 68.93 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.464 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 59.8 t -69.73 -45.29 77.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.288 179.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.42 -10.78 59.74 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.658 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -116.12 -2.81 12.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.299 0.571 . . . . 0.0 110.429 179.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.569 ' N ' ' O ' ' A' ' 68' ' ' GLU . . . -68.9 -172.34 0.38 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.712 0.767 . . . . 0.0 112.085 -178.598 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.6 p -101.4 104.38 15.35 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.016 178.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 42.8 tp -70.22 129.62 39.85 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.273 0.559 . . . . 0.0 111.503 -178.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -118.99 77.39 1.18 Allowed 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 177.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -84.46 -35.8 22.74 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.297 -0.865 . . . . 0.0 112.542 -179.368 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.404 ' H ' ' HG2' ' A' ' 77' ' ' LYS . 50.1 mmtt -75.03 -11.45 60.1 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.0 0.429 . . . . 0.0 111.132 -177.438 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -91.93 -0.51 57.5 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.09 0.471 . . . . 0.0 110.459 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 9.5 p -76.86 128.5 37.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.147 0.498 . . . . 0.0 110.941 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 18.2 pt -106.55 -8.33 10.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.307 0.575 . . . . 0.0 110.066 179.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -171.19 169.38 42.43 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 109.894 -1.283 . . . . 0.0 109.894 179.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 33.7 ptt-85 -146.71 154.58 41.59 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.364 0.602 . . . . 0.0 112.01 -179.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 19.0 tt -103.69 141.63 19.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.645 -179.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 47.9 t -136.7 129.87 31.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.671 -179.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.4 HD13 HG21 ' A' ' 85' ' ' ILE . 93.7 mt -138.07 87.25 16.53 Favored Pre-proline 0 CA--C 1.535 0.381 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.839 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_exo -56.64 -30.76 84.86 Favored 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 122.801 2.334 . . . . 0.0 112.034 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 44.2 m -53.27 -42.09 66.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.75 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.447 HG12 ' HG ' ' A' ' 140' ' ' SER . 17.6 m -114.25 11.23 7.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.719 179.675 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.511 ' O ' ' OG ' ' A' ' 89' ' ' SER . 1.6 p 51.31 51.29 17.18 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.128 179.686 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 59.0 tp -119.14 133.67 55.65 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 121.375 0.607 . . . . 0.0 111.183 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -147.09 124.94 11.91 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.102 179.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 78.0 mt -149.55 146.73 21.33 Favored Pre-proline 0 CA--C 1.539 0.524 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.341 -179.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -74.17 145.11 34.44 Favored 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 122.555 2.17 . . . . 0.0 111.389 178.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 18.3 t -96.41 120.18 45.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-O 121.137 0.494 . . . . 0.0 112.091 -179.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.474 ' N ' ' CD1' ' A' ' 95' ' ' LEU . 10.2 mp -102.67 138.71 39.21 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.735 179.376 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.518 ' O ' ' OG1' ' A' ' 109' ' ' THR . 98.2 mttt -62.12 -82.22 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.372 0.606 . . . . 0.0 112.104 -179.163 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 31.3 m -56.89 134.55 55.52 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.587 -178.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 74.0 p -92.27 70.23 5.21 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.791 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.714 ' HG1' ' H ' ' A' ' 102' ' ' ASN . 63.2 p -92.73 170.44 9.71 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.537 178.8 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -60.75 -43.07 98.42 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 178.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -65.75 -41.68 91.84 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.496 179.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.714 ' H ' ' HG1' ' A' ' 99' ' ' THR . 8.9 m120 -64.49 -37.47 87.64 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.989 -179.324 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 74.4 mt -64.71 -14.37 58.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.042 -0.526 . . . . 0.0 112.062 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 94.8 mt -72.42 -28.43 62.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.986 0.422 . . . . 0.0 111.317 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 86.8 p -73.42 -3.98 30.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.393 0.616 . . . . 0.0 109.813 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 92.29 -18.52 54.1 Favored Glycine 0 CA--C 1.533 1.209 0 CA-C-N 115.432 -0.804 . . . . 0.0 113.946 177.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -145.47 128.16 16.21 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 118.294 1.047 . . . . 0.0 113.147 -178.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -145.67 140.95 27.66 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 114.924 -1.034 . . . . 0.0 110.087 178.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.518 ' OG1' ' O ' ' A' ' 96' ' ' LYS . 30.2 p -68.6 140.25 55.55 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.311 0.577 . . . . 0.0 111.443 -179.17 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 71.6 t -79.88 -58.17 4.22 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 CA-C-N 115.723 -0.672 . . . . 0.0 111.539 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.57 ' H ' ' NE2' ' A' ' 114' ' ' GLN . 68.5 mmtt -105.06 138.69 40.87 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 121.862 0.839 . . . . 0.0 111.838 179.488 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -65.74 -30.36 71.01 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 114.848 -1.069 . . . . 0.0 113.071 -178.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -79.83 13.93 1.96 Allowed 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.373 -0.531 . . . . 0.0 112.283 -178.129 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . 0.57 ' NE2' ' H ' ' A' ' 111' ' ' LYS . 33.6 mt-30 -81.02 134.04 35.6 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 120.928 0.394 . . . . 0.0 111.599 179.336 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.408 ' O ' ' O ' ' A' ' 118' ' ' LYS . 72.4 t -125.73 126.11 69.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 178.351 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 96.1 mtp -57.15 131.18 49.18 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 121.092 0.472 . . . . 0.0 111.903 -179.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 78.75 -3.55 63.87 Favored Glycine 0 CA--C 1.531 1.033 0 N-CA-C 111.685 -0.566 . . . . 0.0 111.685 179.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.408 ' O ' ' O ' ' A' ' 115' ' ' VAL . 64.6 tttm -139.18 126.43 21.4 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.221 0.534 . . . . 0.0 110.924 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 77.16 -170.45 55.1 Favored Glycine 0 CA--C 1.531 1.039 0 N-CA-C 111.181 -0.767 . . . . 0.0 111.181 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 60.9 t-20 -87.82 104.94 17.06 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.953 0.406 . . . . 0.0 110.296 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -88.43 99.14 12.04 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 120.955 0.407 . . . . 0.0 110.574 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.433 ' N ' ' OE1' ' A' ' 114' ' ' GLN . . . -91.83 137.68 32.16 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.101 0.477 . . . . 0.0 111.314 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 78.9 mt -134.99 139.7 45.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.816 179.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -115.52 144.91 43.16 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-O 121.324 0.583 . . . . 0.0 110.757 -179.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -142.08 -162.17 9.09 Favored Glycine 0 CA--C 1.532 1.094 0 N-CA-C 110.154 -1.178 . . . . 0.0 110.154 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.526 ' O ' ' O ' ' A' ' 134' ' ' LEU . 91.5 m-70 -134.6 160.24 38.71 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.411 0.624 . . . . 0.0 111.981 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.44 ' OD1' ' N ' ' A' ' 129' ' ' SER . 28.7 t30 -142.12 120.23 12.16 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.275 179.219 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' MET . . . . . 0.476 ' O ' ' CB ' ' A' ' 129' ' ' SER . 61.8 mtt -96.23 -5.31 40.69 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.446 0.641 . . . . 0.0 109.757 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.476 ' CB ' ' O ' ' A' ' 128' ' ' MET . 1.1 p 78.72 17.07 1.04 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.206 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.507 ' O ' ' CG1' ' A' ' 133' ' ' VAL . 7.6 ptpt -125.76 116.87 22.29 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 121.833 0.825 . . . . 0.0 112.827 -179.01 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -45.71 130.39 9.16 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.212 179.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 109.08 -16.92 32.48 Favored Glycine 0 N--CA 1.444 -0.826 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 -179.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.507 ' CG1' ' O ' ' A' ' 130' ' ' LYS . 7.2 p -90.88 160.27 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.178 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.544 ' H ' ' CD1' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -70.69 141.95 51.56 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 115.016 1.487 . . . . 0.0 115.016 -177.122 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 59.67 9.37 1.58 Allowed 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 112.922 -1.944 . . . . 0.0 115.008 177.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 12.9 p -70.42 -30.29 67.12 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 120.041 -0.664 . . . . 0.0 112.125 179.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.485 ' O ' ' OG ' ' A' ' 140' ' ' SER . 77.2 m-20 -90.59 -0.54 57.72 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 113.296 0.851 . . . . 0.0 113.296 -177.726 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 2.4 pp -58.67 -33.6 49.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 120.362 -0.535 . . . . 0.0 111.106 -179.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -66.44 -13.22 60.45 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.066 0.46 . . . . 0.0 110.954 -179.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.485 ' OG ' ' O ' ' A' ' 137' ' ' ASP . 67.0 p -83.55 -4.54 58.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.099 -179.644 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 88.9 mt -63.98 141.06 58.91 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 121.067 0.461 . . . . 0.0 110.047 179.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -117.03 154.79 30.33 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.462 0.648 . . . . 0.0 111.325 -179.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -47.42 133.7 12.46 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.849 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 160' ' ' VAL . . . 76.8 7.99 86.34 Favored Glycine 0 CA--C 1.53 0.979 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.81 178.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -70.9 135.2 47.85 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 119.832 -0.747 . . . . 0.0 110.587 -179.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -79.98 139.8 36.86 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.895 0.855 . . . . 0.0 112.354 -178.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 98.4 mt -136.48 137.51 47.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 177.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -124.29 138.13 54.42 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 119.708 -0.797 . . . . 0.0 113.061 -177.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 18.6 mt -110.72 133.13 53.6 Favored 'General case' 0 C--O 1.223 -0.3 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 177.368 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.547 ' CZ ' ' OE2' ' A' ' 155' ' ' GLU . 64.5 m-85 -109.77 107.63 17.69 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 119.957 -0.697 . . . . 0.0 111.06 179.462 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -89.19 164.43 14.98 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 178.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 69.6 m-20 -57.68 -22.72 47.65 Favored 'General case' 0 C--N 1.312 -1.034 0 C-N-CA 119.823 -0.751 . . . . 0.0 110.657 -178.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -113.21 -28.26 7.69 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 113.804 1.039 . . . . 0.0 113.804 -178.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -147.97 179.15 7.94 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 119.147 -1.021 . . . . 0.0 113.47 -176.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.547 ' OE2' ' CZ ' ' A' ' 150' ' ' TYR . 85.7 tt0 -126.58 135.69 51.57 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 114.35 -1.296 . . . . 0.0 110.002 178.466 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -109.67 132.83 53.78 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 121.157 0.503 . . . . 0.0 111.687 -179.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -94.0 112.04 23.83 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.789 -0.642 . . . . 0.0 111.943 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -114.13 148.71 36.75 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.013 0.435 . . . . 0.0 111.249 179.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -125.11 122.04 36.01 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 121.24 0.543 . . . . 0.0 110.752 179.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.544 ' O ' ' N ' ' A' ' 144' ' ' GLY . 59.9 t -60.44 137.33 22.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.7 178.3 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 81.0 p -108.8 -25.05 11.0 Favored 'General case' 0 N--CA 1.463 0.182 0 O-C-N 123.415 0.447 . . . . 0.0 111.534 179.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 159.31 -167.12 34.94 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 120.532 -0.842 . . . . 0.0 111.285 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 35.5 m -131.45 160.69 42.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.956 0.408 . . . . 0.0 110.145 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 22.8 p -141.41 162.6 35.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.439 0.637 . . . . 0.0 111.77 -178.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -103.17 115.17 30.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.577 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 17.1 m -136.77 161.78 35.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.316 0.579 . . . . 0.0 111.218 -179.027 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -86.98 157.99 53.64 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.817 -179.758 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.455 ' O ' ' CB ' ' B' ' 702' ' ' LEU . 33.1 Cg_endo -64.81 -15.89 52.57 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 C-N-CA 122.996 2.464 . . . . 0.0 111.565 178.65 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . 0.46 ' O ' ' CD1' ' A' ' 171' ' ' TRP . 38.4 p-10 -96.62 -2.85 43.96 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.724 179.029 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 7.0 mttp -74.03 87.5 1.86 Allowed 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 121.433 0.635 . . . . 0.0 110.994 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' TRP . . . . . 0.514 ' CD1' ' N ' ' A' ' 171' ' ' TRP . 22.3 m0 -73.14 -14.42 61.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.1 -179.521 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -61.26 -27.04 68.17 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.825 -179.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 22.9 m -61.99 -23.85 32.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -178.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 23.3 m -107.96 -5.29 10.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -178.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -72.11 148.75 45.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.0 0.428 . . . . 0.0 110.317 179.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . 0.425 ' OD1' ' O ' ' A' ' 176' ' ' ASP . 44.1 p-10 -76.08 129.97 37.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.145 0.497 . . . . 0.0 110.957 -179.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 74.6 m80 -100.94 -17.1 16.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.781 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 104.05 36.68 3.1 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 110.109 -1.196 . . . . 0.0 110.109 -179.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -153.48 164.36 38.33 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.926 -0.637 . . . . 0.0 110.311 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -87.51 105.66 17.46 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 177.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . 0.403 ' HG2' ' N ' ' A' ' 182' ' ' ILE . 76.0 tt0 -138.79 161.69 36.61 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.507 0.67 . . . . 0.0 111.944 -177.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.403 ' N ' ' HG2' ' A' ' 181' ' ' GLU . 17.8 tt -128.99 136.92 58.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.142 178.454 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 70.9 m -129.25 123.69 32.58 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.109 0.481 . . . . 0.0 110.915 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 85.2 mt -109.47 131.71 54.81 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.349 0.595 . . . . 0.0 109.524 178.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 82.6 mt -112.46 124.38 69.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.134 -179.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' THR . . . . . 0.413 HG23 ' H ' ' A' ' 187' ' ' CYS . 90.8 m -138.11 156.87 47.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.152 -179.566 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' CYS . . . . . 0.413 ' H ' HG23 ' A' ' 186' ' ' THR . 17.4 m -87.66 139.52 30.45 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.594 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.407 HG23 ' CE2' ' A' ' 197' ' ' TYR . 62.3 t -62.59 -46.86 95.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.731 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' SER . . . . . 0.715 ' HG ' ' H ' ' A' ' 191' ' ' LYS . 18.1 t -172.59 155.06 3.24 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.696 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 55.3 t -68.85 -17.07 21.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.395 179.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.715 ' H ' ' HG ' ' A' ' 189' ' ' SER . 74.1 mmtt -98.88 -9.07 24.71 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.104 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 65.5 t0 -134.73 95.1 3.28 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.769 -0.373 . . . . 0.0 111.009 -179.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -105.98 5.89 30.81 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.135 0.493 . . . . 0.0 110.755 179.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 57.1 m -60.51 -40.9 93.09 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.484 -179.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -131.67 153.2 50.23 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.797 -0.361 . . . . 0.0 110.527 -179.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . 0.714 ' NH1' HOG1 ' B' ' 705' ' ' B27 . 59.2 ttp180 -131.27 125.92 34.07 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 120.806 -0.358 . . . . 0.0 110.175 179.442 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . 0.407 ' CE2' HG23 ' A' ' 188' ' ' VAL . 29.2 m-85 -87.76 142.7 27.62 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.166 0.508 . . . . 0.0 110.759 -179.336 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 43.2 t -122.04 130.16 74.8 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.648 179.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 50.4 t -99.57 132.98 44.0 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.516 -179.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -118.9 149.21 41.96 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 121.166 0.508 . . . . 0.0 111.39 -179.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -145.34 146.09 15.99 Favored Glycine 0 CA--C 1.534 1.256 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -105.57 143.55 33.58 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 121.062 0.458 . . . . 0.0 111.954 -179.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 38.5 tp -65.97 132.04 47.65 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 178.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 2.1 p -112.38 -19.49 6.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 120.471 -0.492 . . . . 0.0 111.598 -179.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -179.82 173.98 45.57 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 120.497 -0.858 . . . . 0.0 112.038 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 90.8 m -142.31 139.19 31.75 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 179.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -144.03 118.36 9.61 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 120.152 -0.619 . . . . 0.0 111.233 179.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -64.19 143.28 58.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.824 -179.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 48.9 mtpt -81.64 107.7 14.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.57 178.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 20.0 pttp . . . . . 0 C--N 1.326 -0.426 0 CA-C-O 117.942 -1.027 . . . . 0.0 110.399 179.814 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 701' ' ' BOC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 702' ' ' LEU . . . . . 0.48 ' O ' ' CB ' ' A' ' 59' ' ' SER . 2.1 mt -101.79 109.32 59.24 Favored Pre-proline 0 CA--C 1.538 0.512 0 N-CA-C 110.577 -0.157 . . . . 20.0 110.577 . . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 703' ' ' PRO . . . . . 0.53 ' O ' ' O ' ' B' ' 704' ' ' ALA . 3.7 Cg_exo -62.93 -160.92 0.03 OUTLIER 'Trans proline' 0 N--CA 1.488 1.199 0 C-N-CA 122.303 2.002 . . . . 20.0 113.836 -179.372 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 704' ' ' ALA . . . . . 0.53 ' O ' ' O ' ' B' ' 703' ' ' PRO . . . -44.79 -153.99 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.04 -1.436 . . . . 20.0 114.708 -178.037 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 705' ' ' B27 . . . . . 0.714 HOG1 ' NH1' ' A' ' 196' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.364 0 N-CA-C 109.161 -1.576 . . . . 0.0 109.161 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 86.7 p -77.2 164.76 25.33 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.24 0.543 . . . . 0.0 110.431 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 48.4 t-80 -130.4 146.94 52.04 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.473 -179.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 78.5 mtm -87.43 134.49 33.58 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 121.383 0.611 . . . . 0.0 111.692 -179.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.476 ' OD1' ' N ' ' A' ' 58' ' ' ALA . 62.2 t0 -63.45 136.29 57.5 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.544 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.476 ' N ' ' OD1' ' A' ' 57' ' ' ASP . . . -95.25 8.13 44.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.919 -179.273 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.517 ' CB ' ' O ' ' B' ' 702' ' ' LEU . 93.0 p -80.35 20.07 0.72 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.955 0.407 . . . . 0.0 111.56 -179.407 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -102.69 12.72 35.93 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.633 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.1 mt -56.17 142.31 11.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 122.197 0.999 . . . . 0.0 113.078 -177.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 51.1 t0 -78.27 125.91 30.03 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 113.983 -1.462 . . . . 0.0 109.438 179.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.433 HE22 ' HB2' ' A' ' 103' ' ' LEU . 0.1 OUTLIER -79.23 128.65 75.1 Favored Pre-proline 0 C--N 1.325 -0.469 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 -179.875 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -52.37 149.87 21.88 Favored 'Trans proline' 0 N--CA 1.486 1.043 0 C-N-CA 121.307 1.338 . . . . 0.0 112.097 -179.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -51.94 175.62 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.624 0.726 . . . . 0.0 111.923 -178.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.456 ' N ' ' CD1' ' A' ' 66' ' ' LEU . 10.9 mp -70.17 -10.08 57.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.695 -178.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -67.19 -34.39 77.41 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.547 0.689 . . . . 0.0 110.007 178.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.491 ' O ' ' CB ' ' A' ' 72' ' ' ALA . 78.9 mm-40 -77.53 -20.95 53.4 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.26 -179.58 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 96.7 t -71.31 -46.58 64.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.316 0.579 . . . . 0.0 110.69 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -89.11 -10.58 46.8 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.876 -179.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -105.42 -26.16 12.06 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 120.465 -0.494 . . . . 0.0 112.132 -179.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.491 ' CB ' ' O ' ' A' ' 68' ' ' GLU . . . -68.28 136.59 53.72 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.728 0.775 . . . . 0.0 112.31 -179.02 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 7.8 m -59.82 102.8 0.17 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.133 179.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -68.62 129.15 39.1 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.104 0.478 . . . . 0.0 110.777 -179.685 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -98.02 80.48 2.72 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.171 0.51 . . . . 0.0 110.443 179.16 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -62.56 -36.57 83.07 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.311 0.577 . . . . 0.0 111.314 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.508 ' CD ' ' H ' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -70.2 -18.39 63.18 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.415 -177.062 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -90.61 0.61 57.31 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 121.239 0.542 . . . . 0.0 110.029 179.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 75.4 t -87.76 128.37 40.26 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.981 179.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 39.6 pt -111.4 -5.13 11.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.846 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -166.03 168.35 39.73 Favored Glycine 0 CA--C 1.535 1.31 0 C-N-CA 120.56 -0.829 . . . . 0.0 112.061 -179.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 61.7 ttp180 -137.85 154.91 49.45 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 121.127 0.489 . . . . 0.0 111.272 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 14.6 tt -119.52 140.65 42.78 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.955 178.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 47.5 t -136.26 130.45 33.06 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.378 0.609 . . . . 0.0 111.813 -178.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 57.2 mt -136.91 86.07 21.87 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.839 179.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -56.34 -31.97 86.8 Favored 'Trans proline' 0 N--CA 1.497 1.706 0 C-N-CA 123.076 2.517 . . . . 0.0 112.666 -179.057 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 70.9 m -53.83 -41.24 67.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.275 0.559 . . . . 0.0 110.76 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.2 m -113.78 12.83 8.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.032 178.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.7 m 48.26 48.8 18.47 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.421 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 64.5 tp -114.04 133.27 55.63 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.949 -179.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -148.07 127.51 13.15 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.862 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 90.2 mt -151.55 151.09 28.12 Favored Pre-proline 0 N--CA 1.471 0.61 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.563 -179.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -75.62 147.42 31.65 Favored 'Trans proline' 0 N--CA 1.495 1.601 0 C-N-CA 122.713 2.275 . . . . 0.0 111.712 178.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 49.6 t -97.15 119.17 44.85 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-O 121.19 0.519 . . . . 0.0 111.896 -179.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.475 ' N ' ' CD1' ' A' ' 95' ' ' LEU . 10.0 mp -104.69 141.08 37.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.527 179.182 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.51 ' O ' ' OG1' ' A' ' 109' ' ' THR . 98.5 mttt -64.37 -84.88 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -178.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.498 ' HG ' ' ND2' ' A' ' 102' ' ' ASN . 82.5 p -62.75 142.27 58.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.177 0.513 . . . . 0.0 111.502 -178.466 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 46.8 m -97.13 76.14 2.64 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.244 -179.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.443 ' CG2' ' N ' ' A' ' 100' ' ' GLU . 52.2 m -92.53 168.27 11.37 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 178.485 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.443 ' N ' ' CG2' ' A' ' 99' ' ' THR . 78.2 tt0 -57.53 -44.73 85.32 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 119.686 -0.806 . . . . 0.0 110.118 -179.532 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -62.93 -41.89 99.63 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.497 179.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.498 ' ND2' ' HG ' ' A' ' 97' ' ' SER . 98.4 m-20 -63.41 -36.66 84.46 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.681 -178.638 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.433 ' HB2' HE22 ' A' ' 63' ' ' GLN . 89.8 mt -63.26 -21.97 66.58 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.302 -0.408 . . . . 0.0 112.097 -179.224 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 96.6 mt -70.17 -23.0 62.91 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.899 0.38 . . . . 0.0 110.309 179.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 6.1 m -72.5 -10.28 59.6 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 121.271 0.558 . . . . 0.0 110.036 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 90.99 -18.23 51.98 Favored Glycine 0 CA--C 1.531 1.075 0 CA-C-N 115.642 -0.708 . . . . 0.0 113.43 177.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -145.03 124.9 13.42 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 119.418 -0.913 . . . . 0.0 112.688 -179.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -147.45 141.49 25.99 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.043 -0.98 . . . . 0.0 109.883 178.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.51 ' OG1' ' O ' ' A' ' 96' ' ' LYS . 19.0 p -69.33 136.51 51.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.243 0.544 . . . . 0.0 111.568 -179.161 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 69.4 t -75.76 -45.8 37.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.394 179.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -111.98 144.71 40.87 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 122.312 1.054 . . . . 0.0 113.11 179.273 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -66.69 -32.41 73.71 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.276 -1.329 . . . . 0.0 112.374 -178.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -85.34 18.82 2.51 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 -177.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . 0.497 ' OE1' ' O ' ' A' ' 120' ' ' ASN . 98.0 mm-40 -76.43 137.84 39.97 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 121.73 -0.606 . . . . 0.0 111.678 179.698 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 25.3 t -128.47 120.38 52.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.443 179.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' MET . . . . . 0.563 ' SD ' ' OD1' ' A' ' 151' ' ' ASP . 47.1 mtt -57.67 135.81 56.77 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.708 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.427 ' O ' ' OD2' ' A' ' 180' ' ' ASP . . . 75.15 -6.01 30.75 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 121.152 -0.546 . . . . 0.0 112.606 178.37 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -137.35 126.99 25.28 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.496 0.665 . . . . 0.0 111.436 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 77.18 -169.45 54.93 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 110.768 -0.933 . . . . 0.0 110.768 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.497 ' O ' ' OE1' ' A' ' 114' ' ' GLN . 59.1 t-20 -87.97 106.34 18.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.997 0.427 . . . . 0.0 110.27 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -85.13 145.77 27.46 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 179.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -147.6 140.05 24.58 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.719 0.771 . . . . 0.0 111.587 -179.023 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 71.3 mt -137.62 144.14 41.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.475 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -106.88 136.85 46.02 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.051 0.453 . . . . 0.0 109.826 179.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -144.77 131.99 4.54 Favored Glycine 0 CA--C 1.532 1.143 0 N-CA-C 110.233 -1.147 . . . . 0.0 110.233 -179.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.522 ' O ' ' O ' ' A' ' 134' ' ' LEU . 0.5 OUTLIER -78.71 151.76 31.96 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -178.651 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 46.3 t30 -141.63 121.14 13.27 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 115.415 -0.812 . . . . 0.0 110.173 178.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' MET . . . . . 0.484 ' O ' ' CB ' ' A' ' 129' ' ' SER . 61.5 mtt -97.03 -3.25 41.78 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.104 0.478 . . . . 0.0 110.66 -179.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.484 ' CB ' ' O ' ' A' ' 128' ' ' MET . 1.2 p 78.76 19.57 0.85 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.377 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.406 ' O ' ' C ' ' A' ' 131' ' ' LYS . 8.7 ptpt -123.29 104.94 9.44 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.964 0.888 . . . . 0.0 112.706 -178.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.406 ' C ' ' O ' ' A' ' 130' ' ' LYS . 29.4 tptp -34.58 125.23 0.52 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.269 -1.332 . . . . 0.0 111.067 179.451 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 109.5 -10.03 32.92 Favored Glycine 0 N--CA 1.449 -0.475 0 N-CA-C 108.973 -1.651 . . . . 0.0 108.973 -178.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 9.0 p -93.09 161.68 2.51 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.64 ' CD2' ' H ' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -69.76 139.46 53.3 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.78 0.8 . . . . 0.0 113.038 -177.686 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 63.17 9.1 3.69 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 114.434 -1.257 . . . . 0.0 113.297 178.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.18 -35.26 80.0 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -92.62 0.73 57.47 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 121.108 0.48 . . . . 0.0 111.623 -178.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.46 ' CG2' ' N ' ' A' ' 139' ' ' ALA . 3.4 tt -60.27 -37.72 74.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.069 -179.463 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.46 ' N ' ' CG2' ' A' ' 138' ' ' ILE . . . -65.99 -10.56 40.64 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.929 0.395 . . . . 0.0 111.148 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 5.8 m -82.53 -4.38 57.48 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.975 0.417 . . . . 0.0 111.126 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 76.6 mt -64.53 145.07 56.69 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 121.284 0.564 . . . . 0.0 111.258 -179.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -123.88 157.66 33.71 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.895 -179.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -50.14 134.59 22.07 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.519 -0.764 . . . . 0.0 112.085 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.604 ' N ' ' O ' ' A' ' 160' ' ' VAL . . . 77.02 7.39 86.65 Favored Glycine 0 CA--C 1.532 1.096 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.307 178.549 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -73.54 137.47 44.39 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 119.631 -0.828 . . . . 0.0 110.605 -179.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -81.16 140.48 34.97 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.667 0.746 . . . . 0.0 111.973 -178.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.412 HD11 HG23 ' A' ' 147' ' ' ILE . 88.3 mt -137.15 138.03 45.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 114.751 -1.113 . . . . 0.0 108.221 178.232 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -123.5 137.94 54.68 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 113.464 0.913 . . . . 0.0 113.464 -177.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -112.49 133.24 54.66 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 177.467 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.443 ' CZ ' ' OE2' ' A' ' 155' ' ' GLU . 58.7 m-85 -109.5 109.36 20.15 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.172 -0.611 . . . . 0.0 111.618 179.742 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . 0.563 ' OD1' ' SD ' ' A' ' 116' ' ' MET . 7.8 m-20 -89.53 166.61 13.55 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 177.439 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -58.6 -23.67 59.29 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 120.246 -0.581 . . . . 0.0 111.143 -178.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -109.78 -28.76 8.63 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -178.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -150.5 -174.95 4.91 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 -177.135 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.443 ' OE2' ' CZ ' ' A' ' 150' ' ' TYR . 86.8 tt0 -131.88 139.25 48.72 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 114.122 -1.399 . . . . 0.0 110.083 178.612 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -113.57 137.84 51.0 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 121.073 0.463 . . . . 0.0 111.648 -179.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -94.24 112.89 24.73 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.392 179.248 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -114.51 148.39 37.99 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 120.975 0.417 . . . . 0.0 111.436 179.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -121.5 121.37 37.35 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.446 179.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.604 ' O ' ' N ' ' A' ' 144' ' ' GLY . 97.4 t -59.97 137.2 22.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.942 177.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 24.1 p -105.68 -23.94 12.64 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 120.749 -0.38 . . . . 0.0 111.343 179.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 154.55 -161.67 30.3 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 120.649 -0.786 . . . . 0.0 111.355 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 25.3 m -132.58 162.41 39.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-O 120.832 0.348 . . . . 0.0 110.349 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 83.1 p -146.87 163.96 34.42 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.404 0.621 . . . . 0.0 111.518 -179.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -100.88 117.65 35.37 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.704 -179.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 16.4 m -137.8 158.79 33.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.235 0.54 . . . . 0.0 111.372 179.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -94.0 158.41 36.26 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.592 179.327 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.458 ' O ' ' CB ' ' B' ' 702' ' ' LEU . 29.0 Cg_endo -61.9 -17.15 53.95 Favored 'Trans proline' 0 C--N 1.301 -1.949 0 C-N-CA 122.619 2.213 . . . . 0.0 113.555 -179.619 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 51.1 p-10 -93.02 -6.03 49.2 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 119.501 -0.879 . . . . 0.0 112.511 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -75.47 96.17 3.42 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 119.878 -0.729 . . . . 0.0 111.421 179.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' TRP . . . . . 0.432 ' CD1' ' N ' ' A' ' 171' ' ' TRP . 23.1 m0 -78.7 -15.46 58.44 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.817 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -58.28 -28.88 65.36 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.917 -179.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 10.5 p -62.39 -25.1 36.93 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 CA-C-O 121.031 0.444 . . . . 0.0 111.192 -179.237 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 59.6 t -105.56 -8.11 10.03 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -178.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.44 ' O ' ' CE1' ' A' ' 177' ' ' HIS . 96.7 mt-10 -73.49 144.2 46.3 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 122.08 -0.387 . . . . 0.0 110.663 179.72 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 34.0 p-10 -62.74 144.5 56.36 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.329 0.585 . . . . 0.0 111.661 -179.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' HIS . . . . . 0.44 ' CE1' ' O ' ' A' ' 175' ' ' GLU . 68.8 m80 -122.14 19.73 10.7 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.922 -179.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 64.7 39.06 96.4 Favored Glycine 0 CA--C 1.532 1.095 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 179.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 13.1 ptmt -161.67 166.93 26.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.858 0.361 . . . . 0.0 110.15 179.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . 0.427 ' OD2' ' O ' ' A' ' 117' ' ' GLY . 48.1 t0 -90.19 100.23 13.09 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.18 0.514 . . . . 0.0 110.195 178.625 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . 0.409 ' HG2' ' N ' ' A' ' 182' ' ' ILE . 84.1 tt0 -131.33 164.59 25.31 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.448 -179.062 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.409 ' N ' ' HG2' ' A' ' 181' ' ' GLU . 21.2 tt -128.18 137.26 57.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.928 179.251 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 94.3 m -124.64 122.44 37.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.061 -179.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 69.5 mt -111.35 128.99 56.14 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 178.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . 0.427 HG22 HD12 ' A' ' 185' ' ' ILE . 93.3 mt -110.09 123.67 66.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.397 0.618 . . . . 0.0 111.068 -179.267 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 3.6 t -138.95 158.82 43.51 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.825 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' CYS . . . . . . . . . . . . . 1.3 m -101.63 143.8 31.15 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.164 0.507 . . . . 0.0 111.247 -179.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 95.5 t -62.71 -47.6 92.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.691 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' SER . . . . . 0.686 ' HG ' ' H ' ' A' ' 191' ' ' LYS . 20.4 t -168.4 144.55 3.75 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.309 179.239 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 10.8 p -60.99 -6.28 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.138 0.494 . . . . 0.0 110.69 -179.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.686 ' H ' ' HG ' ' A' ' 189' ' ' SER . 88.6 tttt -101.66 -35.43 9.11 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.848 179.527 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -99.11 110.14 22.76 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.476 -179.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -110.73 7.71 22.24 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.646 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 6.1 t -61.53 -47.18 86.75 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.995 0.426 . . . . 0.0 111.864 -178.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -146.82 158.78 44.0 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.919 -179.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 83.9 mtt85 -128.14 141.45 51.48 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.159 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -90.91 144.45 25.67 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 120.948 0.404 . . . . 0.0 110.844 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 39.4 t -127.42 133.94 66.82 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-O 121.361 0.601 . . . . 0.0 111.032 179.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 39.1 t -105.25 131.38 54.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.502 179.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -119.66 148.27 43.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.466 0.65 . . . . 0.0 111.588 -179.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -142.63 152.32 23.75 Favored Glycine 0 CA--C 1.533 1.16 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 179.296 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . 0.432 ' O ' ' OD1' ' A' ' 202' ' ' ASP . 52.7 p-10 -113.11 155.35 25.08 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.377 -0.529 . . . . 0.0 110.988 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 60.3 tp -74.3 130.22 39.28 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.314 -0.554 . . . . 0.0 109.562 179.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 16.9 m -116.6 -18.24 7.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 C-N-CA 120.371 -0.532 . . . . 0.0 111.357 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -179.98 174.65 46.05 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 120.419 -0.896 . . . . 0.0 112.304 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 40.4 m -140.61 136.59 32.91 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.486 -0.357 . . . . 0.0 110.219 179.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 51.6 mttp -141.25 114.62 8.78 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.29 -0.564 . . . . 0.0 111.996 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -64.43 145.81 55.5 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.335 0.588 . . . . 0.0 111.076 179.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 21.2 ttpt -81.07 112.44 18.45 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.616 178.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 98.7 mttt . . . . . 0 C--O 1.22 -0.457 0 CA-C-O 118.027 -0.987 . . . . 0.0 110.675 -179.879 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 701' ' ' BOC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 702' ' ' LEU . . . . . 0.517 ' O ' ' CB ' ' A' ' 59' ' ' SER . 1.0 OUTLIER -108.13 105.48 56.57 Favored Pre-proline 0 CA--C 1.541 0.611 0 N-CA-C 110.193 -0.299 . . . . 20.0 110.193 . . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 703' ' ' PRO . . . . . 0.527 ' O ' ' O ' ' B' ' 704' ' ' ALA . 4.0 Cg_exo -63.0 -174.4 0.18 Allowed 'Trans proline' 0 N--CA 1.492 1.441 0 C-N-CA 122.125 1.884 . . . . 20.0 113.896 -178.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 704' ' ' ALA . . . . . 0.527 ' O ' ' O ' ' B' ' 703' ' ' PRO . . . -39.49 -176.01 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.084 -1.416 . . . . 20.0 113.26 -178.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 705' ' ' B27 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.501 0 N-CA-C 110.183 -1.167 . . . . 0.0 110.183 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 77.7 p -69.27 -35.41 76.03 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 121.16 0.505 . . . . 0.0 110.517 179.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 72.9 m80 -118.19 138.54 52.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.39 179.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 68.3 mtt -81.16 137.89 35.89 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.949 -179.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -64.67 144.48 57.2 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.475 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -99.06 1.25 45.09 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.237 0.541 . . . . 0.0 110.991 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.489 ' CB ' ' O ' ' B' ' 702' ' ' LEU . 52.1 p -80.65 17.64 1.1 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.532 -179.146 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 59.1 pttt -105.68 21.11 17.81 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.162 0.505 . . . . 0.0 111.334 -179.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.0 mt -56.59 139.47 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-O 122.366 1.079 . . . . 0.0 113.141 -177.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.448 ' OD1' ' N ' ' A' ' 62' ' ' ASP . 24.6 p-10 -76.84 130.08 37.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 113.576 -1.647 . . . . 0.0 109.819 179.028 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.508 ' NE2' ' O ' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -77.19 151.56 81.42 Favored Pre-proline 0 C--N 1.325 -0.472 0 C-N-CA 120.148 -0.621 . . . . 0.0 110.437 -179.393 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -72.78 168.98 23.13 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.669 2.246 . . . . 0.0 111.729 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 -52.18 166.58 0.16 Allowed 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.102 0.477 . . . . 0.0 111.685 -178.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 56.8 tp -64.9 -46.88 79.88 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.459 -178.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.22 -39.33 94.33 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.502 -0.479 . . . . 0.0 111.618 -178.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -57.13 -25.38 58.74 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.02 -0.672 . . . . 0.0 109.745 179.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.467 ' CG1' ' O ' ' A' ' 104' ' ' LEU . 20.0 t -79.42 -45.64 23.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.463 179.542 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -77.06 -9.43 58.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 114.837 -1.074 . . . . 0.0 111.796 -179.153 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 24.5 m120 -103.56 -14.24 16.25 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.371 0.605 . . . . 0.0 110.097 179.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -69.06 145.32 53.58 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.374 -0.83 . . . . 0.0 112.027 -179.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 25.9 p -59.5 104.04 0.24 Allowed 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 121.701 0.762 . . . . 0.0 111.033 -179.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.66 130.52 42.6 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.008 -0.996 . . . . 0.0 111.315 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.518 ' OD2' ' NE2' ' A' ' 78' ' ' GLN . 59.8 t0 -104.38 77.46 1.4 Allowed 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 121.168 0.509 . . . . 0.0 110.64 178.411 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -69.3 -31.11 69.38 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.898 -0.592 . . . . 0.0 112.31 179.049 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 41.0 mmtt -67.6 -29.16 68.43 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -175.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.518 ' NE2' ' OD2' ' A' ' 75' ' ' ASP . 76.7 mt-30 -88.63 -1.66 58.19 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 120.324 -0.551 . . . . 0.0 111.258 -179.703 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 53.3 t -72.72 128.91 35.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.038 178.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 36.0 pt -113.94 -4.4 11.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 C-N-CA 120.671 -0.411 . . . . 0.0 112.045 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -164.74 169.96 39.65 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 120.214 -0.993 . . . . 0.0 111.629 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 62.6 ttp180 -142.84 141.59 31.63 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.36 0.6 . . . . 0.0 111.573 -179.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 19.5 tt -103.2 140.33 21.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.263 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.408 ' HB3' ' HH ' ' A' ' 150' ' ' TYR . 47.3 t -135.6 129.95 33.68 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.274 -0.875 . . . . 0.0 111.156 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 96.7 mt -140.49 93.93 8.6 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 114.702 -1.135 . . . . 0.0 109.608 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -66.46 -22.95 51.23 Favored 'Trans proline' 0 N--CA 1.493 1.457 0 C-N-CA 121.574 1.516 . . . . 0.0 113.027 -178.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' SER . . . . . 0.628 ' HG ' ' N ' ' A' ' 88' ' ' VAL . 94.4 p -55.23 -42.26 73.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.186 0.517 . . . . 0.0 110.215 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.628 ' N ' ' HG ' ' A' ' 87' ' ' SER . 31.7 m -114.03 5.4 7.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.416 0.627 . . . . 0.0 110.294 179.046 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 2.4 m 56.12 52.57 10.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.779 179.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 54.6 tp -114.5 131.93 56.47 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.155 179.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -144.75 118.68 9.33 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.618 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 91.1 mt -148.71 151.36 35.38 Favored Pre-proline 0 CA--C 1.538 0.495 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.628 -178.042 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -79.39 146.0 19.21 Favored 'Trans proline' 0 N--CA 1.492 1.399 0 C-N-CA 122.597 2.198 . . . . 0.0 111.31 178.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.455 ' O ' ' CG2' ' A' ' 94' ' ' VAL . 3.1 m -94.4 121.08 44.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-O 121.239 0.543 . . . . 0.0 111.269 179.614 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.476 ' N ' ' CD1' ' A' ' 95' ' ' LEU . 10.7 mp -100.24 139.65 35.6 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.604 -179.604 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.537 ' O ' ' OG1' ' A' ' 109' ' ' THR . 99.0 mttt -60.54 -91.1 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 121.427 0.632 . . . . 0.0 112.01 -179.263 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.462 ' HG ' ' ND2' ' A' ' 102' ' ' ASN . 6.5 p -58.87 143.39 47.77 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 121.617 0.722 . . . . 0.0 112.742 -178.258 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 87.5 p -92.39 69.94 5.08 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.037 -0.983 . . . . 0.0 111.284 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 62.8 p -91.39 168.34 11.63 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 178.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -62.58 -43.46 98.75 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 119.797 -0.761 . . . . 0.0 109.529 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -65.84 -40.79 92.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.872 179.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.462 ' ND2' ' HG ' ' A' ' 97' ' ' SER . 93.4 m-20 -64.2 -37.38 87.25 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.984 -179.455 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 54.7 mt -68.47 -8.4 40.57 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.951 -179.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.467 ' O ' ' CG1' ' A' ' 69' ' ' VAL . 96.1 mt -72.84 -23.19 60.73 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.814 0.34 . . . . 0.0 110.444 179.07 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 95.2 p -75.32 -2.94 30.66 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.143 0.497 . . . . 0.0 110.199 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 83.76 -13.01 50.43 Favored Glycine 0 CA--C 1.531 1.036 0 CA-C-N 115.632 -0.713 . . . . 0.0 113.384 178.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -145.02 126.1 14.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 117.467 0.634 . . . . 0.0 111.81 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -148.13 141.43 25.18 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.356 178.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.537 ' OG1' ' O ' ' A' ' 96' ' ' LYS . 36.3 p -64.67 138.1 58.2 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.432 0.634 . . . . 0.0 110.888 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 42.1 t -75.76 -24.74 17.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.624 -179.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -141.23 149.51 41.45 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 122.394 1.092 . . . . 0.0 112.43 178.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 77.8 mt-10 -65.35 -32.39 74.01 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.008 -1.451 . . . . 0.0 112.296 -178.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 21.9 m120 -82.06 10.98 5.64 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 113.083 0.772 . . . . 0.0 113.083 -177.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . 0.429 ' OE1' ' O ' ' A' ' 120' ' ' ASN . 86.5 mm-40 -77.08 132.5 38.93 Favored 'General case' 0 C--N 1.329 -0.285 0 O-C-N 121.955 -0.466 . . . . 0.0 110.667 179.174 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 56.4 t -123.94 124.68 69.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.519 0 CA-C-O 121.245 0.545 . . . . 0.0 110.78 179.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' MET . . . . . 0.671 ' SD ' ' CZ ' ' A' ' 121' ' ' TYR . 94.7 mmm -54.12 126.15 21.71 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -179.389 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 72.53 6.76 67.01 Favored Glycine 0 CA--C 1.531 1.092 0 CA-C-N 115.941 -0.572 . . . . 0.0 112.751 177.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -136.93 127.99 27.74 Favored 'General case' 0 C--N 1.328 -0.341 0 O-C-N 122.389 -0.477 . . . . 0.0 111.419 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 71.76 -164.19 54.18 Favored Glycine 0 CA--C 1.531 1.069 0 N-CA-C 110.388 -1.085 . . . . 0.0 110.388 -179.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.429 ' O ' ' OE1' ' A' ' 114' ' ' GLN . 64.8 t-20 -87.59 103.4 15.52 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.48 -0.488 . . . . 0.0 109.794 179.266 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.671 ' CZ ' ' SD ' ' A' ' 116' ' ' MET . 17.4 t80 -86.79 145.95 26.42 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.76 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -147.49 143.39 27.82 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.735 0.779 . . . . 0.0 111.473 -179.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 42.9 mt -139.38 145.99 39.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.765 -179.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -110.66 139.64 45.75 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -136.27 144.92 16.79 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.314 -1.114 . . . . 0.0 110.314 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.463 ' O ' ' O ' ' A' ' 134' ' ' LEU . 21.7 m-70 -88.49 150.69 22.99 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.881 0.372 . . . . 0.0 111.253 -179.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.634 HD22 ' N ' ' A' ' 187' ' ' CYS . 41.5 p30 -146.71 152.57 39.04 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.226 0.536 . . . . 0.0 110.43 179.183 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' MET . . . . . 0.5 ' O ' ' CB ' ' A' ' 129' ' ' SER . 58.4 mtt -116.42 -2.29 12.08 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.166 -179.764 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.5 ' CB ' ' O ' ' A' ' 128' ' ' MET . 0.7 OUTLIER 80.18 5.75 1.76 Allowed 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.201 179.83 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.506 ' O ' ' CG1' ' A' ' 133' ' ' VAL . 8.5 ptpt -114.5 122.76 47.56 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.613 0.72 . . . . 0.0 112.479 -179.61 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 14.6 tmtt? -44.3 127.51 5.74 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.202 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 106.29 -11.08 43.6 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.506 ' CG1' ' O ' ' A' ' 130' ' ' LYS . 9.0 p -94.02 172.85 0.96 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.135 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.506 ' N ' ' CD2' ' A' ' 134' ' ' LEU . 3.8 mm? -68.76 133.09 47.86 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 116.165 1.913 . . . . 0.0 116.165 -176.48 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 53.69 16.19 0.94 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 113.524 -1.671 . . . . 0.0 114.291 176.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 5.3 t -68.94 -39.07 79.77 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -91.33 2.01 56.7 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 -176.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 28.4 pt -65.86 -22.88 31.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 119.073 -1.051 . . . . 0.0 109.922 -179.326 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -70.31 -8.64 51.97 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.194 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 33.6 t -83.04 -5.29 59.05 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.589 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 86.2 mt -63.26 147.79 50.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.808 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 99.9 mttt -124.25 158.89 31.43 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.438 0.637 . . . . 0.0 111.551 -178.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -49.9 131.3 22.5 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.048 179.044 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.569 ' N ' ' O ' ' A' ' 160' ' ' VAL . . . 80.43 9.01 86.99 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 120.408 -0.901 . . . . 0.0 112.273 178.379 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.492 ' OD1' ' N ' ' A' ' 146' ' ' LYS . 62.8 t0 -75.04 131.53 40.65 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 120.219 -0.592 . . . . 0.0 110.584 -179.302 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.492 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 74.8 mmtt -77.08 137.03 38.69 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 121.84 0.828 . . . . 0.0 112.232 -178.588 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.401 HD13 HG22 ' A' ' 147' ' ' ILE . 94.7 mt -138.61 140.17 39.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 114.529 -1.214 . . . . 0.0 108.574 178.345 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 -127.3 140.99 51.83 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 119.583 -0.847 . . . . 0.0 113.196 -177.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 1.4 mt -114.54 131.72 56.56 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 177.462 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.408 ' HH ' ' HB3' ' A' ' 84' ' ' SER . 7.7 m-85 -107.67 112.68 25.5 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 120.007 -0.677 . . . . 0.0 111.007 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . 0.557 ' OD1' ' N ' ' A' ' 152' ' ' ASN . 58.4 t0 -90.21 163.1 14.93 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 177.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . 0.557 ' N ' ' OD1' ' A' ' 151' ' ' ASP . 8.6 t30 -56.32 -22.58 31.6 Favored 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 119.629 -0.828 . . . . 0.0 110.966 -178.812 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -110.36 -29.2 8.22 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -178.012 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -148.73 -176.97 5.53 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 119.359 -0.936 . . . . 0.0 113.32 -176.293 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 65.4 mt-10 -131.44 136.36 47.9 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 114.758 -1.11 . . . . 0.0 109.538 179.147 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -111.3 135.84 51.26 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.149 0.499 . . . . 0.0 111.741 -179.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -92.65 112.59 24.6 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.4 179.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -114.96 147.05 40.55 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.007 0.432 . . . . 0.0 110.523 179.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -122.85 123.46 41.05 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.063 0.459 . . . . 0.0 110.776 179.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.569 ' O ' ' N ' ' A' ' 144' ' ' GLY . 84.5 t -58.24 134.43 23.01 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.036 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 78.0 p -118.08 11.38 13.29 Favored 'General case' 0 CA--C 1.534 0.357 0 O-C-N 123.658 0.599 . . . . 0.0 111.415 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 124.78 -175.26 17.18 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 120.747 -0.739 . . . . 0.0 111.895 179.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 28.5 m -128.15 160.88 37.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 179.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 68.2 m -135.98 159.67 40.98 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.571 0.7 . . . . 0.0 111.601 -179.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -105.31 116.09 31.35 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.596 -179.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 35.5 m -133.89 162.99 38.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.148 -179.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' THR . . . . . 0.458 ' H ' ' HD2' ' A' ' 170' ' ' LYS . 0.1 OUTLIER -91.99 163.99 25.31 Favored Pre-proline 0 CA--C 1.538 0.511 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.222 179.379 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.459 ' O ' ' CB ' ' B' ' 702' ' ' LEU . 36.3 Cg_exo -61.09 -19.02 61.47 Favored 'Trans proline' 0 N--CA 1.502 1.982 0 C-N-CA 122.548 2.165 . . . . 0.0 113.479 179.447 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . 0.403 ' OD1' ' C ' ' A' ' 169' ' ' ASP . 41.0 p-10 -95.68 -6.33 40.21 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -178.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.458 ' HD2' ' H ' ' A' ' 167' ' ' THR . 96.6 mttt -76.46 82.92 3.17 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 119.392 -0.923 . . . . 0.0 111.396 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 67.0 p-90 -70.72 -10.2 58.91 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.949 0.881 . . . . 0.0 109.521 179.259 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -62.69 -31.85 72.83 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.771 -1.104 . . . . 0.0 111.158 -179.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 34.6 m -62.58 -17.35 18.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-N 116.047 -0.524 . . . . 0.0 112.397 -179.081 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 30.3 m -112.87 -2.56 10.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -178.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -74.98 165.82 24.66 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 121.103 0.477 . . . . 0.0 110.949 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . 0.494 ' OD1' ' O ' ' A' ' 176' ' ' ASP . 36.5 p30 -67.33 137.49 56.07 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.075 179.582 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' HIS . . . . . 0.428 ' ND1' ' ND2' ' A' ' 120' ' ' ASN . 40.7 m80 -119.01 13.53 13.02 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.559 -179.71 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 62.39 41.61 99.75 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 121.003 -0.618 . . . . 0.0 111.627 179.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 12.9 ptmt -163.35 168.11 20.87 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.998 0.428 . . . . 0.0 110.832 179.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -88.15 93.48 9.51 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 178.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . 0.423 ' HG2' ' N ' ' A' ' 182' ' ' ILE . 84.6 tt0 -131.88 163.66 27.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.43 0.633 . . . . 0.0 112.106 -178.511 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.423 ' N ' ' HG2' ' A' ' 181' ' ' GLU . 18.0 tt -130.78 138.09 54.44 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.036 178.805 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 80.4 m -130.72 124.63 31.94 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.135 -179.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 87.6 mt -109.21 135.51 50.19 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.65 178.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 92.1 mt -113.21 127.69 70.36 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 CA-C-O 121.129 0.49 . . . . 0.0 110.983 -179.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' THR . . . . . 0.511 ' OG1' ' ND2' ' A' ' 127' ' ' ASN . 13.6 t -139.77 156.81 46.56 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.623 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' CYS . . . . . 0.634 ' N ' HD22 ' A' ' 127' ' ' ASN . 2.3 m -93.19 143.68 26.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.388 0.613 . . . . 0.0 110.257 179.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 40.5 t -61.97 -46.99 95.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.429 -179.11 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 41.3 p -164.97 161.34 19.9 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.335 0.588 . . . . 0.0 110.903 -179.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 71.4 t -71.96 -13.08 16.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.321 179.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -97.71 -13.74 21.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.338 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -142.14 99.92 3.61 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.306 -0.558 . . . . 0.0 112.085 -179.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -103.78 11.35 35.91 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.577 178.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 41.1 m -63.64 -42.0 98.19 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.684 -179.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 43.3 mtmt -123.28 149.71 44.44 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.271 0.558 . . . . 0.0 111.183 -179.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . 0.519 ' HE ' ' CX ' ' B' ' 705' ' ' B27 . 85.0 mtt85 -133.23 139.98 47.27 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.431 -179.085 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -91.41 155.24 18.61 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.153 0.502 . . . . 0.0 111.021 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 3.0 m -131.46 129.25 61.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.603 178.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 58.9 t -97.12 130.43 45.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 178.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -107.81 131.71 54.19 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.217 0.532 . . . . 0.0 111.205 -178.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -132.23 131.9 6.44 Favored Glycine 0 CA--C 1.53 1.008 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -103.07 143.17 32.94 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 121.238 0.542 . . . . 0.0 111.247 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 35.8 tp -69.5 133.52 47.8 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.897 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 4.1 p -116.52 -17.53 7.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.69 -179.103 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 179.19 174.45 45.32 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 120.588 -0.815 . . . . 0.0 111.775 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 72.6 m -145.54 140.81 27.72 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.111 -0.545 . . . . 0.0 110.009 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -145.52 119.59 9.43 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 119.943 -0.703 . . . . 0.0 111.511 179.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -63.72 145.05 56.49 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.318 -0.855 . . . . 0.0 112.442 -179.191 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 8.6 ttpt -79.38 106.67 11.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.47 178.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 98.5 mttt . . . . . 0 C--O 1.22 -0.451 0 CA-C-O 117.93 -1.033 . . . . 0.0 110.287 -179.752 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 701' ' ' BOC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 702' ' ' LEU . . . . . 0.489 ' O ' ' CB ' ' A' ' 59' ' ' SER . 0.0 OUTLIER 57.66 94.56 0.05 OUTLIER Pre-proline 0 CA--C 1.542 0.671 0 N-CA-C 110.222 -0.288 . . . . 20.0 110.222 . . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 703' ' ' PRO . . . . . 0.507 ' O ' ' O ' ' B' ' 704' ' ' ALA . 3.8 Cg_exo -69.43 -173.39 0.66 Allowed 'Trans proline' 0 C--N 1.316 -1.158 0 C-N-CA 122.155 1.903 . . . . 20.0 112.202 179.76 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 704' ' ' ALA . . . . . 0.52 ' O ' ' OG1' ' B' ' 705' ' ' B27 . . . -41.22 -179.52 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.962 -1.017 . . . . 20.0 113.506 -178.645 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 705' ' ' B27 . . . . . 0.52 ' OG1' ' O ' ' B' ' 704' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.233 0 N-CA-C 109.038 -1.625 . . . . 0.0 109.038 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 42.4 t -70.31 144.96 51.56 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -68.3 -42.56 79.27 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.204 -0.598 . . . . 0.0 110.231 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 97.4 mtp -91.15 143.25 26.88 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.231 179.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 83.6 m-20 -64.91 144.23 57.42 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.399 0.619 . . . . 0.0 111.133 -179.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -95.73 0.59 52.65 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.815 179.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 85.2 p -85.72 4.92 34.53 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.65 -179.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -104.49 16.21 26.56 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 -178.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.0 mt -56.05 144.78 7.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 122.337 1.065 . . . . 0.0 112.931 -177.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 59.8 t0 -79.04 125.17 29.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 113.614 -1.63 . . . . 0.0 109.578 178.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.428 ' HB2' ' CG ' ' A' ' 126' ' ' HIS . 7.2 tp60 -78.7 136.17 59.35 Favored Pre-proline 0 C--N 1.322 -0.616 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -61.42 159.29 32.11 Favored 'Trans proline' 0 C--N 1.311 -1.399 0 C-N-CA 121.725 1.616 . . . . 0.0 113.083 -179.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -52.0 162.25 0.48 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.473 -178.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.435 ' N ' ' CD1' ' A' ' 66' ' ' LEU . 9.9 mp -62.75 -44.34 96.46 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.964 -178.436 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.58 -36.72 84.72 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 119.768 -0.773 . . . . 0.0 110.18 -179.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -62.91 -33.71 75.91 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.889 0.852 . . . . 0.0 108.812 177.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 60.6 t -76.09 -45.65 35.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 114.607 -1.179 . . . . 0.0 110.923 179.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -72.31 -8.88 57.26 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.749 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -105.06 -10.54 17.11 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.631 0.729 . . . . 0.0 109.363 178.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.92 138.11 57.04 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.778 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 9.0 t -57.25 99.0 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.517 ' CD1' ' C ' ' A' ' 74' ' ' LEU . 3.2 tm? -65.16 120.21 12.27 Favored 'General case' 0 C--N 1.334 -0.087 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.368 -178.692 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.454 ' OD2' ' CD ' ' A' ' 78' ' ' GLN . 34.1 t0 -99.08 82.5 2.74 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.551 0.691 . . . . 0.0 111.616 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 47.8 tttp -65.31 -32.22 73.76 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.258 -0.883 . . . . 0.0 112.429 179.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 31.4 mmtt -68.19 -16.53 64.02 Favored 'General case' 0 C--N 1.314 -0.943 0 C-N-CA 119.997 -0.681 . . . . 0.0 110.972 -175.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.454 ' CD ' ' OD2' ' A' ' 75' ' ' ASP . 94.8 mt-30 -92.02 -5.91 52.07 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 121.087 0.47 . . . . 0.0 111.388 178.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 86.0 t -78.6 129.0 38.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.19 0.519 . . . . 0.0 110.192 179.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 5.3 pt -112.02 -4.47 11.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.107 -179.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -172.68 174.96 45.82 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 120.249 -0.977 . . . . 0.0 111.717 -179.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.583 ' NH2' ' OE1' ' A' ' 91' ' ' GLU . 75.1 ttt180 -136.4 154.9 50.67 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.362 0.601 . . . . 0.0 110.836 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 19.4 tt -123.8 141.4 44.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.167 -179.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 14.6 t -136.69 130.45 32.14 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 121.43 0.634 . . . . 0.0 111.798 -178.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 89.3 mt -137.94 86.19 18.38 Favored Pre-proline 0 CA--C 1.536 0.44 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.94 -179.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -56.47 -30.15 80.91 Favored 'Trans proline' 0 N--CA 1.497 1.69 0 C-N-CA 123.221 2.614 . . . . 0.0 113.207 -178.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 18.0 m -52.8 -42.14 64.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.213 0.53 . . . . 0.0 110.704 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 23.4 m -115.53 10.91 7.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.713 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.45 ' O ' ' OG ' ' A' ' 89' ' ' SER . 5.3 p 52.04 50.49 18.41 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.047 0.451 . . . . 0.0 110.93 179.569 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 56.2 tp -116.02 133.33 56.14 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.285 0.564 . . . . 0.0 110.146 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.583 ' OE1' ' NH2' ' A' ' 82' ' ' ARG . 98.0 mt-10 -147.27 124.2 11.32 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.763 -179.186 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 71.0 mt -151.25 152.61 31.39 Favored Pre-proline 0 N--CA 1.471 0.62 0 C-N-CA 120.154 -0.618 . . . . 0.0 111.681 -179.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_endo -75.0 150.26 37.88 Favored 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 122.771 2.314 . . . . 0.0 111.244 178.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 91.1 t -98.01 123.5 50.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -178.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 9.7 mp -109.61 136.22 49.32 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-O 120.901 0.381 . . . . 0.0 111.083 178.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 85.7 mttt -67.33 -78.88 0.05 Allowed 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.439 0.638 . . . . 0.0 112.234 -179.229 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 30.6 t -61.95 139.25 58.41 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.952 -178.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 7.5 t -95.44 72.93 3.24 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.364 0.602 . . . . 0.0 110.547 -179.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 39.7 p -90.25 166.85 13.11 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 178.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -60.42 -42.21 95.53 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.68 0.752 . . . . 0.0 109.273 179.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -64.88 -41.82 95.32 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.988 179.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -65.13 -38.23 89.95 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.151 -179.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 84.2 mt -64.01 -12.92 42.54 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.784 -179.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 89.6 mt -72.41 -23.22 61.06 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.279 0.561 . . . . 0.0 109.852 179.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 96.5 p -74.46 -6.11 46.46 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 121.442 0.639 . . . . 0.0 110.893 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 87.4 -19.79 30.07 Favored Glycine 0 CA--C 1.533 1.203 0 CA-C-N 115.642 -0.708 . . . . 0.0 112.85 178.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -145.28 123.71 12.37 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 119.65 -0.82 . . . . 0.0 111.956 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -144.53 135.33 24.88 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.512 179.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 2.3 m -62.44 135.41 57.42 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 121.034 0.445 . . . . 0.0 110.765 -179.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 79.8 t -77.37 -48.84 23.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.765 179.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.464 ' CB ' ' NE2' ' A' ' 114' ' ' GLN . 69.3 mmtt -96.18 132.2 41.86 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.577 0.703 . . . . 0.0 110.854 179.59 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -65.56 -32.77 74.54 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 114.974 -1.012 . . . . 0.0 112.195 -178.315 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 69.0 m-80 -84.55 12.4 7.08 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 -178.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . 0.777 ' N ' HE21 ' A' ' 114' ' ' GLN . 0.0 OUTLIER -81.28 143.72 32.06 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.905 0.383 . . . . 0.0 111.494 179.853 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.459 ' O ' ' O ' ' A' ' 118' ' ' LYS . 41.4 t -126.38 123.79 64.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.982 179.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 98.3 mtp -57.11 137.51 55.73 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 121.241 0.543 . . . . 0.0 111.387 179.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 77.95 -5.01 55.71 Favored Glycine 0 CA--C 1.531 1.058 0 N-CA-C 111.522 -0.631 . . . . 0.0 111.522 179.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.459 ' O ' ' O ' ' A' ' 115' ' ' VAL . 98.5 mttt -141.85 132.28 25.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.208 0.528 . . . . 0.0 111.471 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 72.42 -173.23 46.78 Favored Glycine 0 CA--C 1.528 0.904 0 N-CA-C 110.524 -1.031 . . . . 0.0 110.524 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.51 HD21 ' CE1' ' A' ' 177' ' ' HIS . 56.0 t-20 -84.12 101.92 12.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.165 0.507 . . . . 0.0 109.802 179.492 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 27.0 t80 -88.92 99.53 12.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.362 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -92.4 143.0 26.82 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.172 0.51 . . . . 0.0 111.634 -179.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 62.2 mt -136.7 141.42 43.1 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.835 179.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -109.66 130.83 55.48 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.373 0.606 . . . . 0.0 110.201 179.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -136.79 141.29 12.26 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.518 ' O ' ' O ' ' A' ' 134' ' ' LEU . 0.3 OUTLIER -80.04 146.31 32.03 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.067 -0.653 . . . . 0.0 112.23 -178.849 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 61.8 t-20 -136.07 121.3 19.07 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.305 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' MET . . . . . 0.429 ' O ' ' CB ' ' A' ' 129' ' ' SER . 58.5 mtt -97.69 -4.51 37.15 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.04 -179.443 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.429 ' CB ' ' O ' ' A' ' 128' ' ' MET . 0.9 OUTLIER 78.09 6.59 2.63 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.419 179.527 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.509 ' O ' ' CG1' ' A' ' 133' ' ' VAL . 6.9 ptpt -113.08 116.03 29.26 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 121.468 0.651 . . . . 0.0 111.714 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -40.69 127.66 2.52 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.851 -179.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 105.44 -11.5 47.09 Favored Glycine 0 N--CA 1.444 -0.813 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.509 ' CG1' ' O ' ' A' ' 130' ' ' LYS . 7.7 p -92.43 173.84 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.058 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.518 ' O ' ' O ' ' A' ' 126' ' ' HIS . 3.8 mm? -67.26 131.57 46.02 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 115.773 1.768 . . . . 0.0 115.773 -175.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.9 m-30 50.55 21.33 0.85 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 113.266 -1.788 . . . . 0.0 113.956 176.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 4.5 t -72.18 -34.06 68.14 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 119.764 -0.774 . . . . 0.0 112.523 179.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 -88.91 -1.53 58.14 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.433 0.635 . . . . 0.0 111.388 -179.063 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 4.7 tt -62.7 -34.97 68.39 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.286 -179.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -66.43 -7.31 18.58 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 121.532 0.682 . . . . 0.0 110.234 179.432 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 4.8 m -84.67 -6.1 59.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.175 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 72.8 mt -63.39 142.17 58.49 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.014 -179.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -117.16 159.91 21.86 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 121.817 0.818 . . . . 0.0 112.243 -178.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 65.2 tttm -52.65 133.56 36.33 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.515 178.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.553 ' N ' ' O ' ' A' ' 160' ' ' VAL . . . 77.67 8.53 87.19 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 120.167 -1.016 . . . . 0.0 110.892 179.233 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -81.96 125.8 31.19 Favored 'General case' 0 C--O 1.222 -0.374 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -79.91 151.0 30.38 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 115.107 1.521 . . . . 0.0 115.107 -176.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 97.6 mt -138.37 137.96 43.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 112.518 -2.128 . . . . 0.0 108.204 179.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -121.73 135.85 54.94 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 120.094 -0.642 . . . . 0.0 111.903 -178.039 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 4.0 mt -114.59 134.29 55.16 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 177.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.56 ' CE2' ' CD ' ' A' ' 155' ' ' GLU . 94.4 m-85 -110.16 110.96 22.01 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 120.192 -0.603 . . . . 0.0 111.529 179.644 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . 0.477 ' N ' ' O ' ' A' ' 154' ' ' ASN . 9.6 m-20 -87.59 166.94 14.35 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 177.39 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -56.89 -24.2 50.24 Favored 'General case' 0 C--N 1.312 -1.031 0 C-N-CA 120.088 -0.645 . . . . 0.0 111.058 -178.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -112.69 -25.8 8.92 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 113.758 1.021 . . . . 0.0 113.758 -179.128 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . 0.477 ' O ' ' N ' ' A' ' 151' ' ' ASP . 0.3 OUTLIER -148.73 -176.3 5.27 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 118.904 -1.119 . . . . 0.0 113.533 -176.303 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.56 ' CD ' ' CE2' ' A' ' 150' ' ' TYR . 84.4 tt0 -131.94 137.39 47.92 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 114.812 -1.086 . . . . 0.0 110.197 179.038 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -110.37 136.03 50.17 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.267 0.556 . . . . 0.0 112.311 -179.038 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -94.67 110.6 22.42 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.287 179.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -113.16 146.22 39.62 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 120.918 0.389 . . . . 0.0 110.823 179.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -120.75 120.79 36.65 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.068 179.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.553 ' O ' ' N ' ' A' ' 144' ' ' GLY . 69.0 t -59.32 134.28 24.46 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.331 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 178.273 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 10.2 p -106.91 -25.03 11.83 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 123.507 0.505 . . . . 0.0 111.041 179.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 159.64 -168.08 35.37 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 120.323 -0.942 . . . . 0.0 112.111 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 35.6 m -129.47 159.41 41.54 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 179.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 47.0 t -141.16 162.32 35.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.413 0.625 . . . . 0.0 111.704 -178.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -102.31 119.09 38.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.991 -178.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 22.3 m -136.47 161.17 37.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.509 -179.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' THR . . . . . 0.482 ' OG1' ' OD1' ' A' ' 169' ' ' ASP . 0.2 OUTLIER -98.56 168.33 9.99 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.148 -179.432 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.452 ' O ' ' CB ' ' B' ' 702' ' ' LEU . 31.3 Cg_exo -59.96 -22.21 68.0 Favored 'Trans proline' 0 N--CA 1.499 1.813 0 C-N-CA 122.614 2.209 . . . . 0.0 113.496 179.367 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . 0.482 ' OD1' ' OG1' ' A' ' 167' ' ' THR . 44.9 p-10 -94.16 -1.44 54.19 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -179.041 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.428 ' HD2' ' H ' ' A' ' 167' ' ' THR . 17.7 mttm -76.65 85.49 3.3 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.432 0.634 . . . . 0.0 111.613 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 59.9 p-90 -78.39 -12.11 59.99 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.479 179.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -65.54 -27.12 68.22 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.117 -179.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 33.4 m -63.01 -21.28 27.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 120.74 -0.384 . . . . 0.0 111.766 -179.132 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 26.9 m -107.49 -2.97 10.07 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 -178.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -74.84 162.98 28.16 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.2 0.524 . . . . 0.0 110.835 179.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . 0.447 ' N ' ' OD1' ' A' ' 176' ' ' ASP . 33.6 p-10 -62.88 141.69 58.58 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.82 179.762 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' HIS . . . . . 0.51 ' CE1' HD21 ' A' ' 120' ' ' ASN . 49.1 m80 -118.63 10.5 12.52 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.801 -179.494 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 62.68 41.62 99.8 Favored Glycine 0 CA--C 1.531 1.031 0 C-N-CA 121.323 -0.465 . . . . 0.0 112.195 179.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -167.94 174.49 7.39 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.771 0.319 . . . . 0.0 110.37 178.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 -86.72 97.62 10.69 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 177.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . 0.414 ' HG2' ' N ' ' A' ' 182' ' ' ILE . 83.5 tt0 -134.16 161.07 35.9 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.591 0.71 . . . . 0.0 111.877 -178.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.414 ' N ' ' HG2' ' A' ' 181' ' ' GLU . 19.5 tt -129.25 136.05 60.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 114.936 -1.029 . . . . 0.0 108.701 178.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 90.6 m -130.61 125.21 33.52 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.968 0.413 . . . . 0.0 110.717 -179.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 70.1 mt -109.36 135.36 50.55 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 179.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 99.0 mt -112.72 123.86 68.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.461 0.648 . . . . 0.0 110.84 -179.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 1.2 t -137.62 155.17 49.47 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.47 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' CYS . . . . . . . . . . . . . 19.9 m -88.07 140.14 29.79 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.299 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.411 HG21 ' CE2' ' A' ' 197' ' ' TYR . 55.9 t -62.74 -49.0 85.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 C-N-CA 120.444 -0.502 . . . . 0.0 110.864 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 57.2 p -160.99 166.67 27.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.57 0.7 . . . . 0.0 111.245 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 27.2 t -82.67 -16.94 11.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.699 179.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.48 ' O ' ' OD1' ' A' ' 192' ' ' ASP . 99.6 mttt -95.25 -13.62 24.73 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 121.055 0.455 . . . . 0.0 111.206 -179.288 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . 0.48 ' OD1' ' O ' ' A' ' 191' ' ' LYS . 91.5 m-20 -139.97 101.22 4.12 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.316 -179.683 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -97.26 7.88 45.67 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 121.552 0.691 . . . . 0.0 110.438 179.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 58.4 m -61.64 -37.1 82.76 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.462 179.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -127.1 150.33 49.53 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 121.338 0.589 . . . . 0.0 111.836 -178.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . 0.537 ' NE ' ' SG ' ' B' ' 705' ' ' B27 . 99.8 mtt180 -132.89 140.53 47.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.004 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . 0.411 ' CE2' HG21 ' A' ' 188' ' ' VAL . 25.6 m-85 -93.91 139.62 30.68 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.144 0.497 . . . . 0.0 110.623 178.742 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 40.9 t -129.72 131.09 66.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.178 179.253 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 56.0 t -103.11 134.88 43.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-O 121.07 0.462 . . . . 0.0 110.736 -179.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -115.87 141.61 47.87 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.324 0.583 . . . . 0.0 110.901 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -138.58 142.55 13.17 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 110.836 -0.906 . . . . 0.0 110.836 -179.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 81.4 m-20 -105.83 142.94 34.69 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.962 0.411 . . . . 0.0 110.671 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 46.9 tp -68.29 132.64 47.45 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 64.0 t -115.14 -21.55 5.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -178.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -176.04 173.59 46.36 Favored Glycine 0 CA--C 1.523 0.58 0 C-N-CA 120.155 -1.021 . . . . 0.0 111.76 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 9.2 m -143.16 139.53 30.38 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.238 -0.481 . . . . 0.0 109.802 179.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -141.69 115.42 9.11 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 121.58 0.705 . . . . 0.0 112.335 -179.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -64.12 142.26 58.47 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.286 -0.87 . . . . 0.0 112.325 -179.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.436 ' NZ ' ' O ' ' A' ' 151' ' ' ASP . 54.7 mtmt -76.57 159.23 30.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.977 178.352 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 98.9 mttt . . . . . 0 C--O 1.222 -0.351 0 CA-C-O 117.965 -1.016 . . . . 0.0 111.154 -179.827 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 701' ' ' BOC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 702' ' ' LEU . . . . . 0.452 ' CB ' ' O ' ' A' ' 168' ' ' PRO . 1.0 OUTLIER -47.54 104.65 0.42 Allowed Pre-proline 0 CA--C 1.542 0.647 0 CA-C-O 120.552 0.215 . . . . 20.0 110.735 . . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 703' ' ' PRO . . . . . 0.56 ' O ' ' O ' ' B' ' 704' ' ' ALA . 3.9 Cg_exo -64.8 -178.46 0.74 Allowed 'Trans proline' 0 N--CA 1.491 1.338 0 C-N-CA 122.132 1.888 . . . . 20.0 113.848 -178.756 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 704' ' ' ALA . . . . . 0.56 ' O ' ' O ' ' B' ' 703' ' ' PRO . . . -26.64 162.39 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 114.238 -1.347 . . . . 20.0 114.103 -178.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 705' ' ' B27 . . . . . 0.537 ' SG ' ' NE ' ' A' ' 196' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.215 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 20.0 m -58.79 -38.38 78.43 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.088 0.47 . . . . 0.0 110.636 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 15.7 m80 -126.34 147.27 49.77 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.317 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 97.1 mmm -88.93 7.14 36.07 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.198 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -70.3 88.39 0.63 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.259 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.41 ' C ' ' H ' ' A' ' 60' ' ' LYS . . . -110.79 11.63 22.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.569 -0.742 . . . . 0.0 111.191 -179.385 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.543 ' HG ' ' H11' ' B' ' 701' ' ' BOC . 44.3 p -80.77 23.28 0.54 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 121.313 0.578 . . . . 0.0 110.814 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.41 ' H ' ' C ' ' A' ' 58' ' ' ALA . 53.4 mtmt -109.49 25.07 12.22 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.665 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 94.6 mt -56.09 136.28 18.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 122.36 1.076 . . . . 0.0 113.003 -177.05 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -79.53 128.01 32.84 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 113.552 -1.658 . . . . 0.0 108.39 177.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -79.22 149.81 73.3 Favored Pre-proline 0 C--N 1.325 -0.489 0 C-N-CA 120.546 -0.462 . . . . 0.0 110.211 -179.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -69.66 158.64 56.38 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 122.399 2.066 . . . . 0.0 112.385 -179.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -53.35 174.76 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.883 -178.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 89.8 mt -63.78 -46.78 83.67 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 -177.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.26 -37.8 86.83 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 119.819 -0.752 . . . . 0.0 111.238 -177.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.575 ' N ' ' OE1' ' A' ' 68' ' ' GLU . 35.3 mp0 -60.81 -27.54 68.11 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.416 0.627 . . . . 0.0 109.709 178.664 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 26.2 t -78.98 -46.01 24.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.476 179.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -73.3 -9.21 58.46 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.879 -1.055 . . . . 0.0 111.365 -179.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -110.14 -8.67 14.75 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.526 0.679 . . . . 0.0 109.412 178.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -71.74 144.91 49.1 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 115.137 -0.938 . . . . 0.0 112.042 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 24.1 m -56.92 109.67 0.68 Allowed 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.744 -179.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 37.9 tp -70.12 131.25 43.99 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.773 -179.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -116.4 77.75 1.13 Allowed 'General case' 0 C--O 1.232 0.157 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 176.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -82.45 -33.39 28.54 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.989 -1.005 . . . . 0.0 113.176 -178.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 48.6 mmtt -73.2 -10.61 59.95 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 119.954 -0.699 . . . . 0.0 110.905 -176.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -92.52 -1.17 57.14 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.659 179.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 13.5 t -81.64 127.84 39.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.377 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 21.6 pt -107.84 -2.65 10.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.943 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -161.9 171.23 37.79 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 120.188 -1.006 . . . . 0.0 111.632 -179.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 58.4 ttp180 -140.65 142.0 35.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.219 0.533 . . . . 0.0 111.155 -179.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 7.5 tp -105.2 136.59 38.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.976 179.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 10.0 t -137.05 127.94 27.42 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-O 121.431 0.634 . . . . 0.0 111.231 -179.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 56.1 mt -138.8 86.44 15.57 Favored Pre-proline 0 CA--C 1.537 0.47 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.291 -179.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -54.74 -30.38 66.67 Favored 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 123.044 2.496 . . . . 0.0 112.739 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 67.3 m -54.12 -41.96 68.94 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 121.118 0.485 . . . . 0.0 111.133 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.2 m -116.1 12.3 7.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.808 179.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.406 ' O ' ' OG ' ' A' ' 89' ' ' SER . 13.2 t 50.77 51.54 16.77 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.856 179.742 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 63.3 tp -115.62 132.24 56.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.27 0.557 . . . . 0.0 111.066 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -147.08 123.28 10.86 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.38 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 84.4 mt -150.97 150.67 28.17 Favored Pre-proline 0 N--CA 1.47 0.575 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.428 -179.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -72.38 146.01 44.16 Favored 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 122.511 2.141 . . . . 0.0 111.699 178.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 54.2 t -96.42 120.68 46.1 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-O 121.194 0.521 . . . . 0.0 110.86 179.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.422 ' N ' ' CD1' ' A' ' 95' ' ' LEU . 11.2 mp -99.81 138.61 36.66 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.337 -179.74 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.528 ' O ' ' OG1' ' A' ' 109' ' ' THR . 34.0 tttm -67.08 -77.86 0.07 Allowed 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.526 -179.522 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 38.2 m -61.83 136.82 58.14 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.144 0.497 . . . . 0.0 111.303 -178.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -92.79 65.6 4.22 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 121.664 0.745 . . . . 0.0 110.103 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.464 ' HG1' ' CG ' ' A' ' 102' ' ' ASN . 73.4 p -91.51 165.55 13.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.775 178.442 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 57.1 mp0 -60.39 -42.08 95.15 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.294 -0.562 . . . . 0.0 110.362 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -64.55 -40.45 95.6 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.473 0.654 . . . . 0.0 110.288 179.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.464 ' CG ' ' HG1' ' A' ' 99' ' ' THR . 8.6 m120 -65.0 -34.09 77.62 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.734 -179.353 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 65.2 mt -70.02 -10.14 57.65 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.636 -179.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 96.0 mt -74.42 -22.42 59.16 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.015 0.436 . . . . 0.0 110.352 178.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 82.8 p -77.58 -1.96 33.33 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 121.321 0.581 . . . . 0.0 110.391 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 87.53 -19.16 33.89 Favored Glycine 0 CA--C 1.534 1.226 0 CA-C-N 115.732 -0.667 . . . . 0.0 113.706 177.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -146.2 126.12 13.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 117.975 0.888 . . . . 0.0 112.729 -179.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -147.34 143.52 28.09 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.484 178.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.528 ' OG1' ' O ' ' A' ' 96' ' ' LYS . 18.9 p -68.35 138.63 55.55 Favored 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 120.338 -0.545 . . . . 0.0 109.879 179.747 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 70.2 t -76.55 -49.62 23.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.906 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.604 ' CE ' ' HE1' ' A' ' 171' ' ' TRP . 96.4 mttt -104.22 143.1 33.4 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 122.345 1.069 . . . . 0.0 113.254 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -66.47 -31.63 72.49 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 114.465 -1.243 . . . . 0.0 111.679 -178.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 21.8 m120 -84.99 14.94 4.38 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 -177.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . 0.457 ' OE1' ' O ' ' A' ' 120' ' ' ASN . 89.6 mm-40 -75.16 136.43 41.06 Favored 'General case' 0 N--CA 1.467 0.404 0 O-C-N 121.672 -0.643 . . . . 0.0 111.332 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 46.8 t -127.36 120.72 55.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.533 178.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 51.0 mtt -57.57 132.43 53.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.899 179.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 77.79 -4.48 56.93 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 121.152 -0.547 . . . . 0.0 112.211 178.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -136.91 125.21 23.23 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.308 0.575 . . . . 0.0 110.857 -179.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 76.61 -165.96 53.96 Favored Glycine 0 CA--C 1.527 0.842 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 -179.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.457 ' O ' ' OE1' ' A' ' 114' ' ' GLN . 50.9 t-20 -91.81 106.47 18.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.17 0.51 . . . . 0.0 110.27 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 14.5 t80 -83.75 145.53 28.67 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.91 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -146.01 138.99 25.8 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.645 0.736 . . . . 0.0 112.465 -178.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 74.2 mt -135.11 141.57 46.03 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.319 179.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -110.68 132.52 54.12 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -134.32 146.39 18.38 Favored Glycine 0 CA--C 1.529 0.962 0 N-CA-C 111.031 -0.828 . . . . 0.0 111.031 -178.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.409 ' O ' ' CB ' ' A' ' 134' ' ' LEU . 29.3 m-70 -87.24 150.37 23.95 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.443 0.64 . . . . 0.0 111.725 -179.633 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.712 ' ND2' ' H ' ' A' ' 187' ' ' CYS . 2.9 p30 -147.82 159.29 44.0 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.764 178.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 65.1 mtt -124.95 4.57 8.01 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.162 0.506 . . . . 0.0 110.772 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 76.63 9.24 3.01 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.819 179.156 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.554 ' O ' ' CG1' ' A' ' 133' ' ' VAL . 62.5 pttt -123.6 131.05 53.52 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 122.01 0.909 . . . . 0.0 112.927 -178.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.501 ' O ' ' O ' ' A' ' 130' ' ' LYS . 74.4 mmtt -40.57 165.05 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.184 -0.917 . . . . 0.0 109.171 178.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 70.19 -21.04 0.53 Allowed Glycine 0 CA--C 1.532 1.103 0 C-N-CA 120.673 -0.775 . . . . 0.0 111.748 179.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.554 ' CG1' ' O ' ' A' ' 130' ' ' LYS . 3.9 p -88.65 173.57 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 C-N-CA 119.651 -0.819 . . . . 0.0 110.058 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.499 ' N ' ' CD2' ' A' ' 134' ' ' LEU . 4.0 mm? -67.49 130.44 43.04 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 115.37 1.618 . . . . 0.0 115.37 -176.361 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.4 m-30 58.08 21.94 8.45 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 113.97 -1.468 . . . . 0.0 113.21 177.017 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.28 -39.38 92.49 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -179.645 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -91.47 -1.22 57.62 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 113.904 1.075 . . . . 0.0 113.904 -177.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 1.6 pp -61.2 -30.19 47.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 119.316 -0.954 . . . . 0.0 110.911 -179.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -66.6 -10.35 44.69 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.318 0.58 . . . . 0.0 110.356 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 3.1 m -83.89 -3.01 57.59 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.849 -179.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 91.4 mt -63.65 141.85 58.61 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 121.118 0.485 . . . . 0.0 111.241 -179.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 56.7 mttp -120.42 156.8 30.67 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-O 121.556 0.693 . . . . 0.0 111.74 -179.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -50.77 133.64 25.93 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.33 179.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 160' ' ' VAL . . . 79.88 8.29 87.8 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 120.352 -0.928 . . . . 0.0 111.564 179.066 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.442 ' OD1' ' N ' ' A' ' 146' ' ' LYS . 61.8 t0 -74.38 128.3 35.19 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 120.106 -0.638 . . . . 0.0 110.394 -179.43 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.442 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 75.6 mmtt -77.89 140.18 39.29 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.817 0.818 . . . . 0.0 112.197 -178.291 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 89.7 mt -139.62 139.95 37.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 114.615 -1.175 . . . . 0.0 108.832 179.023 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -124.95 136.91 54.19 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 119.459 -0.896 . . . . 0.0 112.955 -178.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -112.11 134.34 53.72 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 177.296 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.604 ' CZ ' ' OE2' ' A' ' 155' ' ' GLU . 79.7 m-85 -110.66 112.94 25.17 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 119.966 -0.694 . . . . 0.0 111.278 -179.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . 0.445 ' N ' ' O ' ' A' ' 154' ' ' ASN . 38.1 t70 -89.03 165.42 14.55 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 177.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 66.1 m-20 -57.06 -23.98 50.59 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 119.836 -0.746 . . . . 0.0 110.568 -178.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -114.35 -25.51 8.39 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 113.534 0.939 . . . . 0.0 113.534 -178.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . 0.445 ' O ' ' N ' ' A' ' 151' ' ' ASP . 0.1 OUTLIER -146.65 -178.94 6.44 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 118.572 -1.251 . . . . 0.0 113.455 -176.859 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.604 ' OE2' ' CZ ' ' A' ' 150' ' ' TYR . 83.9 tt0 -131.27 133.79 45.76 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 114.674 -1.148 . . . . 0.0 109.988 179.082 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -110.01 136.24 49.58 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 121.109 0.481 . . . . 0.0 111.695 -179.282 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 77.1 tt0 -94.79 113.62 25.4 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.776 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 39.8 m-85 -114.86 149.03 37.75 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.172 0.51 . . . . 0.0 111.581 179.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -123.81 122.74 38.84 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.97 179.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.454 ' O ' ' N ' ' A' ' 144' ' ' GLY . 60.8 t -60.65 137.81 22.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 177.752 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 18.1 p -106.78 -24.69 12.0 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 120.801 -0.359 . . . . 0.0 111.649 179.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 160.37 -166.39 35.27 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 120.531 -0.843 . . . . 0.0 111.756 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 35.0 m -131.98 159.06 43.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-O 120.888 0.375 . . . . 0.0 110.856 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 82.2 p -147.31 162.0 39.85 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 121.095 0.474 . . . . 0.0 110.991 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . 0.456 ' OE1' ' NZ ' ' A' ' 195' ' ' LYS . 98.2 mt-10 -110.47 121.16 44.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.37 0.605 . . . . 0.0 110.843 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 28.1 m -138.43 159.75 31.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.821 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' THR . . . . . 0.508 ' H ' ' HG1' ' A' ' 167' ' ' THR . 0.2 OUTLIER -83.32 158.63 63.42 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.702 179.653 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.503 ' O ' ' CB ' ' B' ' 702' ' ' LEU . 35.9 Cg_endo -64.48 -17.71 60.51 Favored 'Trans proline' 0 N--CA 1.499 1.809 0 C-N-CA 123.103 2.536 . . . . 0.0 113.035 -178.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 43.7 p-10 -91.19 -3.57 56.87 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 120.094 -0.642 . . . . 0.0 111.211 179.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -74.36 78.03 1.87 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.526 0.679 . . . . 0.0 110.804 179.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' TRP . . . . . 0.604 ' HE1' ' CE ' ' A' ' 111' ' ' LYS . 29.4 t90 -70.3 -15.25 62.87 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.046 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -64.26 -29.29 70.39 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.612 -0.722 . . . . 0.0 112.244 -179.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 14.8 m -63.24 -21.2 27.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -179.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 27.2 m -105.6 -3.48 9.83 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 C-N-CA 120.372 -0.531 . . . . 0.0 112.162 -179.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.579 ' OE2' ' CE3' ' A' ' 171' ' ' TRP . 95.7 mt-10 -71.97 150.29 44.22 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.164 0.507 . . . . 0.0 110.634 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . 0.488 ' OD1' ' O ' ' A' ' 176' ' ' ASP . 54.3 p-10 -56.74 142.27 41.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.908 -179.595 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 61.7 m80 -120.46 12.91 11.7 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.863 -179.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 62.54 42.38 99.7 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 120.666 -0.778 . . . . 0.0 111.175 179.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -164.4 168.76 18.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.89 0.376 . . . . 0.0 110.631 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -87.1 99.38 11.88 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 177.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . 0.428 ' HG2' ' N ' ' A' ' 182' ' ' ILE . 84.1 tt0 -135.3 161.91 34.07 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.259 0.552 . . . . 0.0 111.521 -178.275 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.428 ' N ' ' HG2' ' A' ' 181' ' ' GLU . 18.7 tt -129.7 139.19 52.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.741 178.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 94.0 m -130.41 125.44 34.52 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.412 0.625 . . . . 0.0 111.72 -179.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 82.7 mt -109.32 131.14 55.35 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.416 178.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 77.5 mt -111.55 122.05 65.22 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 CA-C-O 121.571 0.7 . . . . 0.0 111.384 -179.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' THR . . . . . 0.479 ' CG2' ' HH ' ' A' ' 197' ' ' TYR . 12.1 m -135.08 157.13 47.71 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.032 179.301 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' CYS . . . . . 0.712 ' H ' ' ND2' ' A' ' 127' ' ' ASN . 1.7 m -97.08 144.84 26.56 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 120.913 0.387 . . . . 0.0 110.945 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 7.6 p -62.71 -46.83 95.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-O 121.057 0.456 . . . . 0.0 110.852 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 36.3 p -159.62 162.36 35.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.113 0.483 . . . . 0.0 110.867 179.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 7.9 p -80.9 -7.67 10.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.533 179.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -96.71 -13.46 22.71 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 121.07 0.462 . . . . 0.0 110.621 179.208 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . 0.529 ' OD1' ' OG ' ' A' ' 194' ' ' SER . 67.8 t0 -148.59 103.39 3.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.315 0.579 . . . . 0.0 111.389 179.634 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -102.64 3.83 37.61 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.372 179.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' SER . . . . . 0.529 ' OG ' ' OD1' ' A' ' 192' ' ' ASP . 78.6 p -64.49 -24.36 67.59 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.653 -179.743 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . 0.456 ' NZ ' ' OE1' ' A' ' 165' ' ' GLU . 88.0 tttt -130.71 133.31 45.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.165 0.507 . . . . 0.0 110.575 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -129.01 139.65 51.98 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.515 -179.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . 0.479 ' HH ' ' CG2' ' A' ' 186' ' ' THR . 37.5 p90 -100.94 135.43 42.41 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.2 0.524 . . . . 0.0 110.021 178.59 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 25.6 t -114.18 135.49 53.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -178.1 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 57.4 t -104.3 132.63 50.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.698 179.066 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -121.28 150.03 42.0 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 121.483 0.658 . . . . 0.0 112.269 -179.028 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -149.98 159.7 28.21 Favored Glycine 0 CA--C 1.532 1.105 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 179.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 55.4 p-10 -116.37 158.7 23.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.203 0.525 . . . . 0.0 111.201 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 60.1 tp -76.01 131.17 39.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.746 179.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 15.0 t -111.98 -21.04 5.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -178.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . 0.401 ' C ' ' HG1' ' A' ' 206' ' ' THR . . . -178.55 174.64 46.83 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 120.514 -0.85 . . . . 0.0 111.988 -179.472 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 206' ' ' THR . . . . . 0.401 ' HG1' ' C ' ' A' ' 205' ' ' GLY . 23.6 m -144.55 139.86 28.45 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.38 -0.41 . . . . 0.0 110.142 179.668 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -143.24 118.2 10.01 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.155 -0.618 . . . . 0.0 111.339 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -63.88 141.96 58.58 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.408 -178.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 53.8 mtpt -77.35 159.79 29.26 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.046 178.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 53.4 mtpt . . . . . 0 C--O 1.219 -0.533 0 CA-C-O 118.037 -0.983 . . . . 0.0 110.736 179.381 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 701' ' ' BOC . . . . . 0.543 ' H11' ' HG ' ' A' ' 59' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 702' ' ' LEU . . . . . 0.503 ' CB ' ' O ' ' A' ' 168' ' ' PRO . 2.3 mt 44.36 100.44 0.03 OUTLIER Pre-proline 0 CA--C 1.542 0.662 0 CA-C-O 120.795 0.331 . . . . 20.0 111.737 . . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 703' ' ' PRO . . . . . 0.508 ' O ' ' O ' ' B' ' 704' ' ' ALA . 4.8 Cg_exo -64.92 -164.91 0.07 OUTLIER 'Trans proline' 0 N--CA 1.491 1.355 0 C-N-CA 122.627 2.218 . . . . 20.0 113.606 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 704' ' ' ALA . . . . . 0.508 ' O ' ' O ' ' B' ' 703' ' ' PRO . . . -42.31 -176.76 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 114.269 -1.332 . . . . 20.0 112.678 -179.26 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 705' ' ' B27 . . . . . 0.473 ' OG1' ' O ' ' B' ' 704' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.336 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 34.6 t -66.15 145.23 56.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.781 0.324 . . . . 0.0 110.581 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 43.0 t-80 -125.4 126.82 45.6 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 121.219 0.533 . . . . 0.0 111.565 179.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 66.9 mtt -83.78 138.75 33.1 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.132 179.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -69.25 146.6 52.18 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 121.619 0.724 . . . . 0.0 111.236 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.421 ' C ' ' H ' ' A' ' 60' ' ' LYS . . . -89.35 -2.94 58.62 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.48 179.779 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.595 ' C ' HH22 ' A' ' 196' ' ' ARG . 2.8 p -78.15 19.44 0.44 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.25 -179.146 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.421 ' H ' ' C ' ' A' ' 58' ' ' ALA . 99.6 mttt -95.75 13.38 26.73 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.927 179.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 94.0 mt -55.43 141.71 11.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 122.035 0.921 . . . . 0.0 112.949 -177.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.403 ' O ' ' OD1' ' A' ' 62' ' ' ASP . 35.1 p-10 -78.53 129.78 35.23 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 114.034 -1.439 . . . . 0.0 109.198 178.435 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.623 ' NE2' ' H ' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -79.98 146.87 64.55 Favored Pre-proline 0 CA--C 1.539 0.527 0 CA-C-O 120.99 0.424 . . . . 0.0 111.222 -179.071 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.23 157.97 59.4 Favored 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 123.079 2.519 . . . . 0.0 113.113 -179.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -55.45 168.67 0.36 Allowed 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.685 -179.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.4 HD12 ' HZ3' ' A' ' 130' ' ' LYS . 92.1 mt -64.18 -45.06 90.03 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.047 -178.535 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.52 -39.41 94.36 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 119.81 -0.756 . . . . 0.0 110.893 -178.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -60.75 -29.39 69.36 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 178.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 50.9 t -75.57 -45.11 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.981 179.101 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -72.6 -9.1 58.18 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.683 -1.144 . . . . 0.0 111.037 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 27.1 m120 -105.84 -10.35 16.72 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.524 0.678 . . . . 0.0 110.226 178.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.09 137.04 54.66 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.634 -179.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -60.35 98.71 0.06 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.236 0.541 . . . . 0.0 109.94 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -68.52 131.1 44.68 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.389 -179.493 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -97.88 80.65 2.77 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.395 178.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -63.95 -42.39 97.32 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -179.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.488 ' H ' ' CE ' ' A' ' 77' ' ' LYS . 1.1 mtmt -69.66 -8.21 45.67 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.446 0.641 . . . . 0.0 111.104 -176.666 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.524 ' CD ' ' N ' ' A' ' 78' ' ' GLN . 18.6 mp0 -94.56 3.85 54.59 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.784 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 14.9 p -86.91 122.71 39.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 120.434 -0.506 . . . . 0.0 111.258 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.615 ' O ' ' ND2' ' A' ' 152' ' ' ASN . 24.0 pt -108.14 -6.11 10.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.1 179.125 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -167.61 166.18 39.16 Favored Glycine 0 CA--C 1.53 1.012 0 N-CA-C 110.813 -0.915 . . . . 0.0 110.813 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 62.6 ttp180 -140.19 142.57 35.88 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 121.207 0.527 . . . . 0.0 111.646 -179.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 19.5 tt -103.9 141.71 19.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.48 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 5.0 t -136.91 129.72 30.59 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 121.335 0.588 . . . . 0.0 111.539 -179.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 89.3 mt -140.29 89.37 10.86 Favored Pre-proline 0 CA--C 1.542 0.657 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.329 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -57.86 -27.67 79.4 Favored 'Trans proline' 0 N--CA 1.502 2.016 0 C-N-CA 123.279 2.653 . . . . 0.0 113.106 -179.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 9.7 t -53.83 -43.0 69.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.262 0.553 . . . . 0.0 110.378 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.8 m -112.89 8.88 8.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.816 179.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 40.7 p 52.74 53.86 11.47 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.524 -179.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 54.8 tp -116.83 134.42 54.8 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 121.461 0.648 . . . . 0.0 111.732 -179.127 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -147.46 117.8 7.39 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.239 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 84.2 mt -149.14 149.63 30.09 Favored Pre-proline 0 CA--C 1.542 0.641 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.447 -179.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -75.18 149.6 36.2 Favored 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 123.026 2.484 . . . . 0.0 112.825 179.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.519 ' O ' ' CG2' ' A' ' 94' ' ' VAL . 3.1 m -96.75 116.56 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-O 121.029 0.442 . . . . 0.0 111.214 179.752 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.457 ' N ' ' CD1' ' A' ' 95' ' ' LEU . 10.9 mp -100.09 136.37 40.09 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 120.955 0.407 . . . . 0.0 111.294 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.497 ' O ' ' OG1' ' A' ' 109' ' ' THR . 98.4 mttt -61.72 -80.42 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.346 0.593 . . . . 0.0 111.438 -179.536 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.59 ' OG ' ' ND2' ' A' ' 102' ' ' ASN . 6.4 p -60.86 132.74 54.84 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.172 -178.81 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.452 ' OG ' ' O ' ' A' ' 109' ' ' THR . 58.1 m -93.46 73.56 4.45 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.335 0.588 . . . . 0.0 110.391 179.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.733 ' HG1' ' H ' ' A' ' 102' ' ' ASN . 44.0 p -87.38 169.68 12.05 Favored 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.585 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -58.31 -45.57 87.75 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 119.335 -0.946 . . . . 0.0 108.94 179.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -65.8 -40.31 91.78 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.979 179.19 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.733 ' H ' ' HG1' ' A' ' 99' ' ' THR . 97.9 m-20 -62.61 -39.42 93.72 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.123 0.487 . . . . 0.0 111.531 -178.749 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 62.4 mt -63.43 -19.39 64.66 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.994 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 45.3 mt -73.1 -14.16 61.33 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.629 -179.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 74.4 p -75.33 -6.98 52.69 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 178.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.49 ' O ' ' CE1' ' A' ' 135' ' ' PHE . . . 90.21 -19.44 42.99 Favored Glycine 0 CA--C 1.533 1.216 0 CA-C-N 115.116 -0.947 . . . . 0.0 112.147 179.244 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -146.27 125.64 13.12 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.264 0.554 . . . . 0.0 111.762 179.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -145.5 140.53 27.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.344 178.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.497 ' OG1' ' O ' ' A' ' 96' ' ' LYS . 21.0 p -72.0 133.0 45.06 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 119.996 -0.682 . . . . 0.0 110.684 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 39.0 t -80.57 -48.47 19.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.155 179.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.607 ' O ' ' NE2' ' A' ' 114' ' ' GLN . 87.6 tttt -89.41 128.44 35.93 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.503 0.668 . . . . 0.0 111.213 -178.69 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -66.64 -36.58 82.91 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.058 -0.974 . . . . 0.0 111.731 -178.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 68.8 m-80 -89.27 31.21 0.91 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.72 -179.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . 0.607 ' NE2' ' O ' ' A' ' 111' ' ' LYS . 0.0 OUTLIER -75.3 138.11 41.61 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 120.954 0.407 . . . . 0.0 111.719 -179.501 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 42.9 t -120.7 105.79 17.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-O 120.893 0.378 . . . . 0.0 110.714 179.434 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 85.4 mtp -55.18 130.32 41.62 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.141 0.496 . . . . 0.0 111.664 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 88.21 -4.72 85.37 Favored Glycine 0 CA--C 1.53 1.013 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.819 179.106 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -142.7 136.32 28.88 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 121.254 0.55 . . . . 0.0 111.95 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 75.11 -166.17 54.8 Favored Glycine 0 CA--C 1.534 1.243 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 -179.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 59.3 t-20 -92.0 108.34 19.86 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 121.001 0.429 . . . . 0.0 110.295 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -85.57 102.47 13.56 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 121.02 0.438 . . . . 0.0 111.009 -179.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -91.9 130.82 37.58 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.911 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 84.5 mt -132.45 137.67 47.34 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.62 179.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -113.33 144.43 42.76 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.003 0.43 . . . . 0.0 110.129 179.23 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . 0.43 ' O ' ' CG2' ' B' ' 705' ' ' B27 . . . -152.34 155.04 25.9 Favored Glycine 0 CA--C 1.531 1.057 0 N-CA-C 110.279 -1.128 . . . . 0.0 110.279 -179.849 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 47.6 m-70 -100.75 145.49 28.42 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.654 0.74 . . . . 0.0 111.959 -179.19 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.494 ' O ' ' OD1' ' A' ' 127' ' ' ASN . 38.0 p-10 -149.64 124.26 9.76 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.788 178.517 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' MET . . . . . 0.523 ' CG ' ' OE1' ' A' ' 63' ' ' GLN . 70.7 mtm -84.58 0.38 50.25 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.306 -0.558 . . . . 0.0 110.26 179.731 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.482 ' CB ' ' O ' ' A' ' 128' ' ' MET . 1.1 m 80.17 12.54 1.0 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.254 179.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.479 ' O ' ' CG1' ' A' ' 133' ' ' VAL . 21.3 ptmt -104.91 124.71 49.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.996 0.903 . . . . 0.0 111.91 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -46.14 120.37 2.73 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.78 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 116.29 -18.72 13.64 Favored Glycine 0 N--CA 1.445 -0.748 0 N-CA-C 109.979 -1.249 . . . . 0.0 109.979 -179.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.479 ' CG1' ' O ' ' A' ' 130' ' ' LYS . 11.4 p -88.6 159.68 2.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.654 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.663 ' CD2' ' H ' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -71.22 144.04 50.23 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 122.156 0.979 . . . . 0.0 113.639 -177.314 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.49 ' CE1' ' O ' ' A' ' 106' ' ' GLY . 4.0 m-85 59.69 9.56 1.66 Allowed 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 113.902 -1.499 . . . . 0.0 114.726 177.763 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 5.7 t -69.77 -40.46 76.07 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 179.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.428 ' O ' ' OG ' ' A' ' 140' ' ' SER . 77.2 m-20 -89.17 7.36 35.67 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 -176.611 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.509 ' CG1' ' OH ' ' A' ' 197' ' ' TYR . 35.0 pt -61.78 -26.45 39.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 C-N-CA 119.185 -1.006 . . . . 0.0 109.102 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -65.92 -14.56 61.77 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.551 179.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.428 ' OG ' ' O ' ' A' ' 137' ' ' ASP . 64.3 p -83.0 -4.51 58.39 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.328 -179.391 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 81.2 mt -63.78 142.2 58.49 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 120.94 0.4 . . . . 0.0 110.977 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 63.9 mttm -118.05 153.3 33.95 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.639 0.733 . . . . 0.0 111.807 -178.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -50.21 130.74 23.24 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.955 178.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.444 ' N ' ' O ' ' A' ' 160' ' ' VAL . . . 81.42 8.7 86.77 Favored Glycine 0 CA--C 1.526 0.746 0 C-N-CA 120.219 -0.991 . . . . 0.0 110.985 179.467 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 146' ' ' LYS . 58.8 t0 -76.95 129.04 35.62 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.295 0.569 . . . . 0.0 110.229 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.504 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 72.8 mmtt -79.26 143.11 35.59 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 121.826 0.822 . . . . 0.0 112.754 -177.624 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 94.7 mt -138.1 139.31 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-N 114.608 -1.178 . . . . 0.0 108.322 178.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -121.11 136.99 54.87 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -177.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -114.0 132.74 55.88 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 177.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.573 ' CZ ' ' OE2' ' A' ' 155' ' ' GLU . 96.3 m-85 -112.02 107.94 17.08 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.006 -0.678 . . . . 0.0 111.783 -179.63 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . 0.523 ' OD1' ' N ' ' A' ' 152' ' ' ASN . 54.2 t0 -88.16 164.0 15.89 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 177.75 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . 0.651 ' N ' HD21 ' A' ' 152' ' ' ASN . 1.4 m120 -58.49 -23.66 58.47 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 119.556 -0.858 . . . . 0.0 110.993 -178.364 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -109.36 -29.75 8.31 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 -177.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . 0.459 ' O ' ' N ' ' A' ' 151' ' ' ASP . 0.2 OUTLIER -149.77 -179.26 6.98 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 119.181 -1.008 . . . . 0.0 113.503 -176.712 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.573 ' OE2' ' CZ ' ' A' ' 150' ' ' TYR . 79.1 tt0 -126.26 133.09 51.55 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 114.48 -1.236 . . . . 0.0 110.159 178.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -107.11 132.33 53.12 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 121.376 0.608 . . . . 0.0 111.323 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -93.54 112.76 24.73 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.81 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -113.05 145.29 41.14 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.01 0.434 . . . . 0.0 111.404 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -120.1 121.43 38.82 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.868 179.107 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.444 ' O ' ' N ' ' A' ' 144' ' ' GLY . 98.1 t -60.58 135.68 25.02 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 177.542 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.444 ' H ' ' HG1' ' A' ' 161' ' ' THR . 6.8 p -108.48 -24.76 11.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.174 0.511 . . . . 0.0 110.716 179.046 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 160.6 -170.43 36.55 Favored Glycine 0 CA--C 1.532 1.126 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 -179.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 35.0 m -133.49 158.79 42.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 179.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' SER . . . . . 0.553 ' HG ' ' N ' ' A' ' 165' ' ' GLU . 39.6 t -142.9 162.5 35.3 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 121.348 0.594 . . . . 0.0 111.784 -179.216 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . 0.553 ' N ' ' HG ' ' A' ' 164' ' ' SER . 95.6 mt-10 -109.31 121.24 44.75 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.79 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 31.3 m -136.12 161.08 38.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.605 -179.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.41 158.75 65.8 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.918 -179.537 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.479 ' O ' ' CB ' ' B' ' 702' ' ' LEU . 36.4 Cg_endo -64.86 -16.73 56.82 Favored 'Trans proline' 0 N--CA 1.496 1.673 0 C-N-CA 123.198 2.599 . . . . 0.0 113.054 -179.155 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 32.6 p-10 -94.79 -7.22 41.03 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.185 -0.606 . . . . 0.0 112.571 -179.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -77.29 92.21 3.87 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 119.832 -0.747 . . . . 0.0 112.004 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' TRP . . . . . 0.405 ' CD1' ' N ' ' A' ' 171' ' ' TRP . 6.3 m0 -75.19 -1.87 25.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.657 0.741 . . . . 0.0 109.677 178.844 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -61.72 -37.3 83.69 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.719 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 26.9 m -63.23 -12.84 11.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.127 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 77.3 t -105.62 -23.56 4.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 N-CA-C 112.665 0.616 . . . . 0.0 112.665 -178.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -74.53 135.1 42.17 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.15 0.5 . . . . 0.0 111.148 -179.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . 0.505 ' OD1' ' O ' ' A' ' 176' ' ' ASP . 43.4 p30 -70.16 135.0 48.69 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 121.123 0.487 . . . . 0.0 110.498 179.712 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 66.8 m80 -97.89 -8.93 27.22 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.622 -0.431 . . . . 0.0 112.158 -178.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 105.11 39.9 2.21 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 109.864 -1.295 . . . . 0.0 109.864 -179.337 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 13.6 ptmt -156.42 166.01 34.68 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.919 -0.64 . . . . 0.0 110.485 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -88.6 97.18 10.96 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 178.079 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . 0.454 ' HG2' ' N ' ' A' ' 182' ' ' ILE . 73.6 tt0 -131.52 162.21 30.79 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 121.519 0.676 . . . . 0.0 111.891 -178.612 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.454 ' N ' ' HG2' ' A' ' 181' ' ' GLU . 18.6 tt -129.24 137.82 56.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.67 179.337 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 89.7 m -134.5 125.69 27.87 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 121.417 0.627 . . . . 0.0 111.778 -179.229 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 73.2 mt -106.61 132.06 53.04 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.075 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 77.0 mt -113.02 119.4 60.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.325 0.583 . . . . 0.0 110.694 -179.024 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' THR . . . . . 0.504 ' C ' ' SG ' ' B' ' 705' ' ' B27 . 48.7 m -141.36 167.81 21.27 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.708 179.634 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' CYS . . . . . 0.612 ' N ' ' SG ' ' B' ' 705' ' ' B27 . 92.7 m -92.7 140.76 29.19 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.944 179.328 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 54.6 t -60.78 -47.74 91.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.14 -179.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 17.4 t -167.56 152.95 7.23 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.287 0.565 . . . . 0.0 110.507 179.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 78.2 t -67.51 -20.13 26.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.503 -179.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -96.53 -8.32 32.27 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.021 -179.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -136.92 98.8 3.85 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 121.141 0.495 . . . . 0.0 110.442 179.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 49.4 p-10 -106.61 13.92 27.63 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.6 -179.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 84.1 p -59.1 -45.14 91.64 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.91 0.386 . . . . 0.0 111.522 -178.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 26.3 pttm -142.41 149.92 39.96 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 121.269 0.557 . . . . 0.0 111.522 -179.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . 0.595 HH22 ' C ' ' A' ' 59' ' ' SER . 99.7 mtt180 -105.34 135.9 45.87 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.24 179.431 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . 0.509 ' OH ' ' CG1' ' A' ' 138' ' ' ILE . 21.0 p90 -96.11 150.3 20.66 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.491 -0.484 . . . . 0.0 110.102 179.599 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 4.4 m -130.52 138.51 53.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.11 0.481 . . . . 0.0 111.976 -178.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 49.4 t -98.79 130.69 47.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 178.188 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -116.45 140.52 49.27 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 121.261 0.553 . . . . 0.0 111.294 -179.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -136.18 151.57 20.82 Favored Glycine 0 CA--C 1.532 1.138 0 N-CA-C 110.421 -1.071 . . . . 0.0 110.421 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . 0.438 ' OD1' ' N ' ' A' ' 203' ' ' LEU . 65.0 t0 -116.99 130.43 56.69 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.152 0.501 . . . . 0.0 110.571 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . 0.438 ' N ' ' OD1' ' A' ' 202' ' ' ASP . 50.4 tp -58.33 131.09 49.63 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.217 -179.741 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 14.0 m -116.27 -16.65 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.919 -179.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -178.89 173.92 46.11 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 119.965 -1.112 . . . . 0.0 112.477 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 31.4 m -144.81 138.87 27.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.616 -0.792 . . . . 0.0 109.377 179.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -144.95 121.52 11.08 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.112 -0.635 . . . . 0.0 111.737 179.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -63.0 140.88 58.92 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.638 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 18.4 ttpt -81.0 110.96 17.04 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.308 179.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt . . . . . 0 C--O 1.219 -0.524 0 CA-C-O 118.139 -0.934 . . . . 0.0 110.717 179.997 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 701' ' ' BOC . . . . . 0.407 ' O1 ' ' O ' ' B' ' 702' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 702' ' ' LEU . . . . . 0.479 ' CB ' ' O ' ' A' ' 168' ' ' PRO . 1.2 mt 51.8 102.15 0.03 OUTLIER Pre-proline 0 CA--C 1.544 0.732 0 CA-C-O 120.55 0.214 . . . . 20.0 110.61 . . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 703' ' ' PRO . . . . . 0.535 ' O ' ' O ' ' B' ' 704' ' ' ALA . 2.9 Cg_endo -65.97 -176.91 0.67 Allowed 'Trans proline' 0 N--CA 1.491 1.361 0 C-N-CA 122.397 2.065 . . . . 20.0 113.84 -178.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 704' ' ' ALA . . . . . 0.535 ' O ' ' O ' ' B' ' 703' ' ' PRO . . . -33.62 175.03 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 114.223 -1.353 . . . . 20.0 113.975 -179.136 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 705' ' ' B27 . . . . . 0.612 ' SG ' ' N ' ' A' ' 187' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.498 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 47.2 t -153.17 154.51 34.89 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 121.253 0.549 . . . . 0.0 111.536 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 78.6 t60 -129.76 127.27 40.04 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.263 -179.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 99.0 mtp -82.98 146.38 28.81 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.089 179.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -62.2 145.62 53.01 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 121.179 0.514 . . . . 0.0 110.726 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.421 ' C ' ' H ' ' A' ' 60' ' ' LYS . . . -79.77 -3.97 49.95 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.28 0.562 . . . . 0.0 110.76 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 10.8 p -79.53 25.66 0.32 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.017 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.421 ' H ' ' C ' ' A' ' 58' ' ' ALA . 72.2 mmtt -96.21 3.74 52.92 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.436 -179.467 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.0 mt -55.98 137.8 17.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 122.199 1.0 . . . . 0.0 113.351 -176.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -77.46 133.02 38.71 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 113.692 -1.595 . . . . 0.0 109.37 178.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.717 ' NE2' ' CE1' ' A' ' 126' ' ' HIS . 0.0 OUTLIER -79.8 150.85 73.13 Favored Pre-proline 0 CA--C 1.537 0.451 0 C-N-CA 119.901 -0.72 . . . . 0.0 109.798 -179.989 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -73.37 163.02 38.86 Favored 'Trans proline' 0 N--CA 1.499 1.826 0 C-N-CA 123.427 2.751 . . . . 0.0 114.086 -178.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -54.51 164.0 0.8 Allowed 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.753 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 53.4 tp -64.28 -47.37 79.79 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 121.102 0.477 . . . . 0.0 111.118 -178.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.43 -36.51 82.63 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.079 -0.648 . . . . 0.0 110.865 -178.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -61.21 -29.27 69.72 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.033 -0.667 . . . . 0.0 109.652 179.144 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 50.8 t -74.05 -43.71 51.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 121.825 0.821 . . . . 0.0 109.729 179.145 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -76.42 -8.23 56.71 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.745 -1.116 . . . . 0.0 111.434 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -105.41 -8.15 18.32 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.038 0.447 . . . . 0.0 110.38 179.008 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.22 137.5 54.84 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 121.369 0.604 . . . . 0.0 111.109 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 32.2 t -60.29 102.19 0.16 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.486 179.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.92 128.45 36.71 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.372 -179.4 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 -96.43 84.33 3.69 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 177.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -62.98 -41.49 99.56 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.272 0.558 . . . . 0.0 111.899 -179.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.446 ' CD ' ' H ' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -71.16 -8.5 53.96 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.869 -176.27 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -94.68 -13.34 25.9 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 121.211 0.529 . . . . 0.0 110.093 178.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 86.9 t -76.2 128.59 37.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.966 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 39.3 pt -113.54 -7.9 12.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.428 179.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -174.21 -175.12 41.57 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 110.431 -1.067 . . . . 0.0 110.431 179.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 39.9 ptt180 -152.1 166.71 30.81 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.472 0.653 . . . . 0.0 111.168 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 19.5 tt -114.5 142.87 25.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.223 178.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 66.1 m -135.64 126.89 28.26 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.47 0.653 . . . . 0.0 111.174 -179.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 43.3 mt -137.45 89.39 15.93 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.481 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_exo -56.5 -30.18 81.37 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.589 2.192 . . . . 0.0 112.831 -179.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 47.0 m -51.86 -40.94 61.42 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 121.185 0.516 . . . . 0.0 110.593 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 18.6 m -114.0 8.46 7.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.888 179.057 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.483 ' O ' ' OG ' ' A' ' 89' ' ' SER . 3.7 t 54.08 54.13 10.09 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 -179.498 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 66.5 tp -118.43 133.52 55.81 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 121.543 0.687 . . . . 0.0 111.166 -179.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -148.03 120.03 8.23 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.329 -0.851 . . . . 0.0 110.452 -179.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 74.6 mt -149.64 152.95 35.96 Favored Pre-proline 0 CA--C 1.537 0.479 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.644 -179.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -75.38 150.72 36.95 Favored 'Trans proline' 0 N--CA 1.497 1.735 0 C-N-CA 123.127 2.551 . . . . 0.0 112.471 179.142 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 53.0 t -99.17 120.91 49.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-O 121.173 0.511 . . . . 0.0 112.058 -179.261 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.459 ' N ' ' CD1' ' A' ' 95' ' ' LEU . 10.4 mp -104.38 134.5 47.48 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.324 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.503 ' O ' ' OG1' ' A' ' 109' ' ' THR . 98.7 mttt -61.7 -80.29 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.217 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 12.0 t -56.45 133.02 52.85 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.952 -178.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.465 ' OG ' ' O ' ' A' ' 109' ' ' THR . 1.8 m -92.53 70.5 5.0 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.756 179.35 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 41.2 m -92.37 169.98 10.14 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 178.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.446 ' O ' ' CD2' ' A' ' 104' ' ' LEU . 96.7 mt-10 -64.3 -42.46 96.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.264 0.554 . . . . 0.0 110.018 179.503 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 61.6 mttm -65.59 -38.67 90.14 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.887 179.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -64.75 -33.6 76.35 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.378 -0.828 . . . . 0.0 112.18 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 83.5 mt -68.83 -6.79 29.01 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -178.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.526 ' CD2' ' N ' ' A' ' 104' ' ' LEU . 3.9 mm? -74.77 -16.36 60.73 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 121.187 0.517 . . . . 0.0 109.635 178.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 79.2 p -81.18 -10.04 59.69 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.751 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.605 ' O ' ' CE1' ' A' ' 135' ' ' PHE . . . 92.87 -19.42 51.85 Favored Glycine 0 CA--C 1.532 1.151 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.636 178.7 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -145.72 127.35 15.18 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 119.605 -0.838 . . . . 0.0 112.661 -179.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -147.69 138.56 23.38 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.272 -0.877 . . . . 0.0 110.11 178.255 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.503 ' OG1' ' O ' ' A' ' 96' ' ' LYS . 12.3 p -69.06 135.49 50.89 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 121.316 0.579 . . . . 0.0 110.928 -179.751 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 78.7 t -78.0 -48.86 22.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.226 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.608 ' HZ3' ' CD ' ' A' ' 175' ' ' GLU . 98.5 mttt -99.06 140.14 33.67 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.801 0.81 . . . . 0.0 112.52 -179.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -65.86 -36.21 82.82 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.625 -1.17 . . . . 0.0 111.47 -179.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 73.7 m-80 -84.6 11.0 9.63 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -177.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . 0.667 ' N ' HE21 ' A' ' 114' ' ' GLN . 0.0 OUTLIER -78.92 139.19 38.32 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 120.799 0.333 . . . . 0.0 111.296 179.569 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 38.8 t -125.8 125.85 69.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 CA-C-O 121.069 0.461 . . . . 0.0 111.227 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' MET . . . . . 0.431 ' CG ' ' CZ ' ' A' ' 121' ' ' TYR . 93.1 mtp -57.11 133.56 55.11 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.126 0.489 . . . . 0.0 111.657 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 78.14 -2.7 64.58 Favored Glycine 0 CA--C 1.529 0.922 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.643 179.162 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -138.49 132.37 31.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.615 0.722 . . . . 0.0 111.784 179.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 71.14 -167.06 52.05 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 110.18 -1.168 . . . . 0.0 110.18 -179.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 64.7 t-20 -87.83 104.69 16.82 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.196 0.522 . . . . 0.0 109.714 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.431 ' CZ ' ' CG ' ' A' ' 116' ' ' MET . 5.3 t80 -87.06 99.37 11.86 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.115 -179.479 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.3 135.12 33.88 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.829 -179.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 68.3 mt -135.37 139.78 44.5 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.735 -179.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -111.37 140.87 45.59 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 178.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -141.16 129.66 4.15 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 110.482 -1.047 . . . . 0.0 110.482 -179.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.717 ' CE1' ' NE2' ' A' ' 63' ' ' GLN . 1.8 m-70 -82.11 131.52 35.24 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.336 0.589 . . . . 0.0 112.098 -179.208 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.588 ' ND2' ' OG1' ' A' ' 186' ' ' THR . 7.2 p30 -138.79 152.21 47.71 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.634 179.322 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' MET . . . . . 0.611 ' O ' ' N ' ' A' ' 130' ' ' LYS . 79.4 mtm -119.28 42.04 2.94 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.598 0.713 . . . . 0.0 110.161 179.179 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 38.64 15.84 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 114.919 -1.037 . . . . 0.0 112.304 178.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.611 ' N ' ' O ' ' A' ' 128' ' ' MET . 19.2 ptmt -110.61 127.32 55.19 Favored 'General case' 0 C--O 1.226 -0.176 0 CA-C-O 122.025 0.917 . . . . 0.0 112.323 -179.723 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.458 ' C ' ' O ' ' A' ' 130' ' ' LYS . 55.8 tptt -38.37 150.71 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.915 179.413 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 79.58 -17.56 8.32 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 121.045 -0.598 . . . . 0.0 112.127 179.224 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.561 ' CG1' ' O ' ' A' ' 130' ' ' LYS . 9.9 p -87.87 153.08 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-N 117.753 0.777 . . . . 0.0 110.342 -179.561 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.619 ' CD2' ' H ' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -69.45 143.53 53.54 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.594 0.711 . . . . 0.0 112.832 -177.889 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.605 ' CE1' ' O ' ' A' ' 106' ' ' GLY . 3.5 m-85 66.39 8.34 5.63 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 114.139 -1.391 . . . . 0.0 114.493 177.712 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 5.2 t -76.88 -42.68 38.9 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 179.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.489 ' O ' ' OG ' ' A' ' 140' ' ' SER . 78.1 m-20 -91.82 1.31 57.26 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 114.055 1.132 . . . . 0.0 114.055 -176.682 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 48.6 pt -66.92 -23.73 31.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 C-N-CA 119.43 -0.908 . . . . 0.0 110.877 -179.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -66.53 -10.68 47.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.551 0.691 . . . . 0.0 109.856 179.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.489 ' OG ' ' O ' ' A' ' 137' ' ' ASP . 94.0 p -81.34 -2.77 50.47 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.625 -179.811 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 67.8 mt -62.73 143.54 57.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.47 0.652 . . . . 0.0 111.059 -179.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -121.57 156.83 32.05 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.216 -179.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -50.86 133.08 26.9 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.061 -0.972 . . . . 0.0 112.116 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 160' ' ' VAL . . . 79.96 8.69 87.44 Favored Glycine 0 CA--C 1.53 0.979 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.239 178.518 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.463 ' OD1' ' N ' ' A' ' 146' ' ' LYS . 60.5 t0 -74.12 133.47 42.82 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 120.277 -0.569 . . . . 0.0 110.277 -179.62 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.463 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 71.1 mmtt -79.06 140.44 37.89 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 121.84 0.829 . . . . 0.0 111.908 -179.033 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.429 HD13 HG22 ' A' ' 147' ' ' ILE . 92.6 mt -140.13 140.12 35.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 114.899 -1.046 . . . . 0.0 108.587 179.511 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -128.64 140.95 51.51 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 119.384 -0.927 . . . . 0.0 113.226 -177.08 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 19.1 mt -112.51 131.98 55.32 Favored 'General case' 0 CA--C 1.519 -0.233 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 176.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.608 ' CZ ' ' OE2' ' A' ' 155' ' ' GLU . 49.2 m-85 -108.18 107.87 18.68 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.028 -0.669 . . . . 0.0 112.468 -178.814 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -88.19 158.74 18.43 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 106.641 -1.615 . . . . 0.0 106.641 176.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 33.7 p-10 -57.45 -16.11 8.63 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 119.137 -1.025 . . . . 0.0 111.365 -177.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -114.22 -29.13 7.04 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -179.098 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -146.47 178.97 7.87 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 -176.616 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.608 ' OE2' ' CZ ' ' A' ' 150' ' ' TYR . 84.3 tt0 -130.65 136.03 48.43 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 114.681 -1.145 . . . . 0.0 109.597 178.537 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -108.94 133.62 52.69 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.779 0.288 . . . . 0.0 111.779 -178.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -93.2 112.51 24.47 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 121.262 0.553 . . . . 0.0 111.983 179.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -112.9 146.06 39.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.176 179.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -121.18 120.72 36.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.207 179.128 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.527 ' O ' ' N ' ' A' ' 144' ' ' GLY . 90.8 t -59.78 136.66 23.16 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.301 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 178.399 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 7.9 p -105.63 -25.39 12.28 Favored 'General case' 0 C--N 1.328 -0.356 0 O-C-N 123.581 0.551 . . . . 0.0 110.86 179.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 158.61 -166.09 34.22 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 120.622 -0.799 . . . . 0.0 111.405 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 32.7 m -134.08 163.1 38.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.036 -0.582 . . . . 0.0 109.722 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 11.8 p -148.87 161.1 42.52 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.315 0.578 . . . . 0.0 111.477 -179.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -103.39 117.18 33.89 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.759 179.151 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 22.7 m -135.18 156.16 38.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.802 -179.226 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -85.14 157.59 59.32 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.508 179.438 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.502 ' O ' ' CB ' ' B' ' 702' ' ' LEU . 19.5 Cg_endo -62.71 -15.66 48.01 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 C-N-CA 122.78 2.32 . . . . 0.0 113.665 -179.685 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . 0.626 ' O ' ' NE1' ' A' ' 171' ' ' TRP . 39.3 p-10 -92.84 -6.72 48.17 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 119.48 -0.888 . . . . 0.0 111.917 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -78.1 85.07 4.32 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.357 -0.537 . . . . 0.0 111.824 179.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' TRP . . . . . 0.626 ' NE1' ' O ' ' A' ' 169' ' ' ASP . 0.0 OUTLIER -75.02 -8.51 56.72 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.428 0.632 . . . . 0.0 110.185 179.159 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 53.3 tp10 -64.77 -29.1 70.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.537 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 35.1 m -62.88 -22.21 29.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.37 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 31.5 m -105.2 -3.46 9.76 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.608 ' CD ' ' HZ3' ' A' ' 111' ' ' LYS . 63.3 mm-40 -71.96 150.68 43.88 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.31 0.576 . . . . 0.0 111.202 179.586 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 38.7 p-10 -67.97 141.8 56.17 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.051 -179.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 78.7 m80 -117.43 23.26 11.9 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.914 0.388 . . . . 0.0 111.411 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 62.06 43.2 99.47 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 110.759 -0.937 . . . . 0.0 110.759 -179.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 12.5 ptmt -164.87 168.44 17.69 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.064 0.459 . . . . 0.0 110.301 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -86.99 100.9 12.94 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 177.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 77.5 tt0 -132.55 160.95 35.09 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.335 0.588 . . . . 0.0 111.32 -178.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 18.7 tt -128.65 138.17 55.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.619 179.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 60.6 m -132.52 126.18 32.29 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.883 -179.178 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 70.7 mt -111.97 134.44 53.52 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.633 179.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 92.9 mt -115.9 123.42 71.19 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 CA-C-O 121.482 0.658 . . . . 0.0 110.732 -179.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' THR . . . . . 0.588 ' OG1' ' ND2' ' A' ' 127' ' ' ASN . 13.2 t -138.69 158.65 43.84 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.97 -179.774 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' CYS . . . . . 0.674 ' N ' ' SG ' ' B' ' 705' ' ' B27 . 91.7 m -89.57 139.2 30.78 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.886 0.374 . . . . 0.0 110.591 -179.331 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.499 ' CG1' ' O ' ' A' ' 192' ' ' ASP . 11.9 p -62.33 -44.56 99.31 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-O 120.968 0.414 . . . . 0.0 110.806 -179.259 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' SER . . . . . 0.466 ' N ' ' CG1' ' A' ' 188' ' ' VAL . 23.9 m -167.52 153.43 7.61 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.252 0.548 . . . . 0.0 111.286 -179.626 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 70.1 t -72.43 -17.69 18.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.256 178.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -96.04 -11.86 25.78 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.251 179.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . 0.499 ' O ' ' CG1' ' A' ' 188' ' ' VAL . 49.5 t0 -141.15 98.62 3.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.171 0.51 . . . . 0.0 111.307 -179.409 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -98.81 9.83 42.58 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.542 0.687 . . . . 0.0 109.75 179.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 25.3 m -60.13 -42.68 95.33 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.785 -178.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt -133.89 150.19 51.34 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 120.979 0.419 . . . . 0.0 111.346 -179.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . 0.444 ' NH1' ' CX ' ' B' ' 705' ' ' B27 . 42.7 mtm180 -128.26 141.45 51.45 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 121.122 0.487 . . . . 0.0 110.48 179.548 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -98.04 137.6 36.59 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.331 0.586 . . . . 0.0 111.708 -179.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 35.1 t -118.27 134.93 60.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.428 178.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 68.6 t -103.45 134.51 44.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.013 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -117.0 138.21 51.72 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 121.449 0.642 . . . . 0.0 111.666 -179.124 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -139.81 130.98 4.93 Favored Glycine 0 CA--C 1.529 0.95 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 179.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -95.89 142.07 28.57 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.253 0.549 . . . . 0.0 111.049 -179.411 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 52.0 tp -67.03 133.22 49.49 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 121.527 0.679 . . . . 0.0 110.186 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 74.9 t -105.6 -51.6 7.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.233 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -152.36 174.94 31.2 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 120.193 -1.003 . . . . 0.0 112.576 -178.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 18.0 m -142.4 138.33 31.06 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 114.892 -0.654 . . . . 0.0 110.711 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 54.6 mtmt -146.35 128.0 15.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.262 0.554 . . . . 0.0 111.885 178.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -62.04 142.07 57.73 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.61 -179.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -79.24 108.23 12.59 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.429 178.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 99.2 mttt . . . . . 0 C--O 1.218 -0.588 0 CA-C-O 117.921 -1.038 . . . . 0.0 110.537 -179.98 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 701' ' ' BOC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 702' ' ' LEU . . . . . 0.502 ' CB ' ' O ' ' A' ' 168' ' ' PRO . 0.6 OUTLIER -46.5 113.39 2.21 Favored Pre-proline 0 CA--C 1.543 0.675 0 CA-C-O 120.378 0.132 . . . . 20.0 110.81 . . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 703' ' ' PRO . . . . . 0.41 ' O ' ' O ' ' B' ' 704' ' ' ALA . 2.4 Cg_endo -64.55 -172.64 0.2 Allowed 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 122.053 1.835 . . . . 20.0 113.482 -178.497 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 704' ' ' ALA . . . . . 0.41 ' O ' ' O ' ' B' ' 703' ' ' PRO . . . -48.69 -172.55 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.098 -1.41 . . . . 20.0 112.424 -179.657 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 705' ' ' B27 . . . . . 0.674 ' SG ' ' N ' ' A' ' 187' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.205 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 59.4 p -72.14 159.5 34.04 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.059 0.457 . . . . 0.0 110.392 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 -67.07 -40.79 87.1 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.232 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 98.5 mmm -97.07 65.39 2.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.277 -179.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 67.2 t0 -61.9 121.97 14.26 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.307 -179.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -98.21 16.26 21.91 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 121.049 0.452 . . . . 0.0 111.383 -179.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 3.9 p -83.18 21.3 1.12 Allowed 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.124 0.488 . . . . 0.0 111.347 -179.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -106.04 15.8 25.94 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.877 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.407 HG21 HD12 ' A' ' 61' ' ' ILE . 96.3 mt -55.37 137.0 17.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 122.315 1.055 . . . . 0.0 112.527 -177.05 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -77.84 133.38 38.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 113.687 -1.597 . . . . 0.0 109.097 179.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.539 ' H ' ' CD ' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -77.57 152.16 80.69 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-O 121.109 0.48 . . . . 0.0 110.813 -178.476 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -74.01 156.42 47.53 Favored 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 123.249 2.632 . . . . 0.0 113.151 -179.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.442 ' O ' ' OE1' ' A' ' 68' ' ' GLU . 39.0 t70 -54.0 172.83 0.07 Allowed 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.073 179.724 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.406 ' H ' ' CG ' ' A' ' 65' ' ' ASP . 86.1 mt -69.55 -13.36 62.29 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.199 -178.509 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -68.11 -37.62 81.35 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.5 0.667 . . . . 0.0 110.455 179.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.553 ' O ' ' CB ' ' A' ' 72' ' ' ALA . 58.9 mp0 -68.16 -31.33 70.81 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.841 -1.072 . . . . 0.0 110.546 179.364 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 8.3 t -71.27 -44.85 72.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.575 -179.457 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -81.92 -13.14 57.93 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.031 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -114.88 1.45 14.06 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 121.252 0.549 . . . . 0.0 110.345 178.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.553 ' CB ' ' O ' ' A' ' 68' ' ' GLU . . . -67.77 -173.5 0.35 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.517 0.675 . . . . 0.0 112.161 -179.019 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.6 t -102.3 95.38 6.25 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 114.887 -1.051 . . . . 0.0 109.786 179.073 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.472 ' CD1' ' C ' ' A' ' 74' ' ' LEU . 0.5 OUTLIER -68.79 103.39 1.76 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.899 -179.376 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.454 ' OD2' ' CD ' ' A' ' 78' ' ' GLN . 46.0 t0 -93.2 82.62 4.54 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.623 0.725 . . . . 0.0 109.751 178.483 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -80.15 -30.32 38.91 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.068 -0.969 . . . . 0.0 112.011 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 35.7 mmtt -68.16 -30.92 70.16 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.13 -176.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.454 ' CD ' ' OD2' ' A' ' 75' ' ' ASP . 86.0 mt-30 -87.47 2.32 50.94 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.441 -0.504 . . . . 0.0 111.688 -179.101 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 67.8 t -75.65 130.51 36.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.323 0.582 . . . . 0.0 109.927 179.291 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 16.2 pt -107.29 -7.35 10.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.994 -179.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -175.27 179.27 46.62 Favored Glycine 0 CA--C 1.527 0.793 0 C-N-CA 120.693 -0.765 . . . . 0.0 111.26 179.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 38.7 ptt180 -152.69 155.35 37.09 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.474 0.654 . . . . 0.0 111.569 179.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 20.4 tt -105.05 147.83 10.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.793 -179.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 9.2 t -136.03 131.4 34.9 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.473 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 96.3 mt -137.19 88.71 17.13 Favored Pre-proline 0 CA--C 1.54 0.584 0 CA-C-N 115.41 -0.813 . . . . 0.0 110.846 -179.173 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -56.31 -31.03 83.18 Favored 'Trans proline' 0 N--CA 1.499 1.804 0 C-N-CA 123.043 2.495 . . . . 0.0 112.683 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 99.1 p -53.6 -44.18 69.23 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 121.333 0.587 . . . . 0.0 110.738 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 12.5 m -113.72 11.61 8.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.891 178.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.4 t 44.74 57.0 4.81 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.651 -179.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 57.7 tp -117.78 136.64 53.26 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.296 179.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -146.13 124.79 12.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.68 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 77.4 mt -148.72 150.13 32.45 Favored Pre-proline 0 CA--C 1.535 0.38 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.53 -178.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.07 148.11 34.57 Favored 'Trans proline' 0 N--CA 1.491 1.351 0 C-N-CA 122.526 2.151 . . . . 0.0 111.707 178.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 88.9 t -96.81 116.73 39.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 CA-C-O 121.006 0.432 . . . . 0.0 111.587 -179.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.518 ' N ' ' CD1' ' A' ' 95' ' ' LEU . 8.7 mp -100.37 138.79 36.95 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.151 0.5 . . . . 0.0 110.7 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.486 ' O ' ' OG1' ' A' ' 109' ' ' THR . 98.3 mttt -66.13 -79.28 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.425 0.631 . . . . 0.0 112.181 -179.005 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 40.7 t -57.54 133.66 55.44 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.935 -178.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 43.4 p -88.41 66.05 8.17 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.549 179.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.441 ' OG1' ' CG ' ' A' ' 102' ' ' ASN . 31.6 p -86.7 167.45 14.46 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 178.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -63.78 -41.39 97.96 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.233 0.539 . . . . 0.0 110.239 179.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -66.28 -39.83 89.66 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.589 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.441 ' CG ' ' OG1' ' A' ' 99' ' ' THR . 8.9 m120 -63.72 -34.79 78.66 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -178.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 70.4 mt -62.71 -17.16 60.23 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -178.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 10.8 mp -73.21 -16.29 61.42 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 120.286 -0.565 . . . . 0.0 110.403 179.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 1.5 m -78.43 -7.28 57.2 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 178.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.449 ' O ' ' CE1' ' A' ' 135' ' ' PHE . . . 91.54 -18.8 51.14 Favored Glycine 0 CA--C 1.534 1.262 0 CA-C-N 114.926 -1.034 . . . . 0.0 113.233 177.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -146.72 127.07 13.96 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 119.563 -0.855 . . . . 0.0 113.08 -179.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -144.73 137.06 26.26 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.922 178.323 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.486 ' OG1' ' O ' ' A' ' 96' ' ' LYS . 69.2 p -69.95 138.43 52.33 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.364 0.602 . . . . 0.0 111.189 -179.493 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 74.1 t -79.16 -53.05 14.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.71 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.67 ' H ' ' NE2' ' A' ' 114' ' ' GLN . 53.6 mtmt -100.69 134.71 43.26 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 121.831 0.824 . . . . 0.0 112.645 -179.002 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -66.63 -30.63 70.94 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 114.51 -1.223 . . . . 0.0 112.477 -179.194 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 75.1 m-80 -84.37 11.21 8.85 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 -177.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . 0.67 ' NE2' ' H ' ' A' ' 111' ' ' LYS . 22.2 mt-30 -81.16 143.3 32.48 Favored 'General case' 0 C--N 1.328 -0.326 0 O-C-N 121.904 -0.497 . . . . 0.0 111.347 178.762 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.424 ' O ' ' O ' ' A' ' 118' ' ' LYS . 51.4 t -122.54 124.28 70.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.246 -0.434 . . . . 0.0 109.92 178.638 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 99.3 mtp -58.25 127.0 29.92 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 121.324 0.583 . . . . 0.0 111.471 -179.281 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 91.62 -4.75 79.73 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 110.606 -0.997 . . . . 0.0 110.606 179.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.424 ' O ' ' O ' ' A' ' 115' ' ' VAL . 87.5 tttt -142.48 130.96 22.4 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.113 0.482 . . . . 0.0 110.614 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 80.39 -174.28 54.94 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 -179.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 63.9 t-20 -90.75 107.1 18.96 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 179.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -85.41 99.31 11.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.242 0.544 . . . . 0.0 110.23 -179.384 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.84 136.16 33.25 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.479 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 67.4 mt -134.07 139.14 45.77 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.491 -0.484 . . . . 0.0 111.469 -179.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -112.77 143.72 43.53 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 178.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . 0.48 ' O ' ' CG2' ' B' ' 705' ' ' B27 . . . -142.42 151.82 23.28 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.164 -1.174 . . . . 0.0 110.164 -178.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 4.7 m-70 -89.24 126.03 35.33 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.592 0.711 . . . . 0.0 111.874 -179.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.424 ' ND2' ' HA ' ' A' ' 136' ' ' SER . 35.1 t30 -129.12 125.18 36.56 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 114.931 -1.031 . . . . 0.0 110.681 179.504 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' MET . . . . . 0.55 ' O ' ' OG ' ' A' ' 129' ' ' SER . 78.1 mtm -102.53 -1.72 29.94 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.351 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.55 ' OG ' ' O ' ' A' ' 128' ' ' MET . 6.2 p 77.78 10.23 2.24 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.473 179.77 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.521 ' O ' ' CG1' ' A' ' 133' ' ' VAL . 5.9 ptmt -110.42 118.15 35.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.474 0.654 . . . . 0.0 112.427 -179.274 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.496 ' C ' ' O ' ' A' ' 130' ' ' LYS . 29.1 tptt -32.98 149.89 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 114.926 -1.034 . . . . 0.0 109.554 178.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.428 ' N ' ' HG3' ' A' ' 131' ' ' LYS . . . 82.82 -15.49 31.43 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 111.064 -0.814 . . . . 0.0 111.064 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.521 ' CG1' ' O ' ' A' ' 130' ' ' LYS . 8.0 p -94.22 151.68 3.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.04 -0.664 . . . . 0.0 111.174 -179.041 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.553 ' CD2' ' H ' ' A' ' 134' ' ' LEU . 0.1 OUTLIER -68.04 147.16 52.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.88 0.848 . . . . 0.0 112.96 -177.774 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.449 ' CE1' ' O ' ' A' ' 106' ' ' GLY . 3.0 m-85 65.2 4.85 2.76 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 113.943 -1.481 . . . . 0.0 114.266 177.528 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' SER . . . . . 0.424 ' HA ' ' ND2' ' A' ' 127' ' ' ASN . 28.1 p -76.51 -35.22 58.46 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 120.147 -0.621 . . . . 0.0 111.908 178.79 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.421 ' N ' ' OD1' ' A' ' 137' ' ' ASP . 36.6 p-10 -94.75 2.09 55.5 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 114.543 1.312 . . . . 0.0 114.543 -177.533 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 45.6 pt -69.22 -20.38 24.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 C-N-CA 119.06 -1.056 . . . . 0.0 110.466 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -68.38 -9.91 51.46 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.191 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 49.7 m -82.96 -5.01 58.9 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.554 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 89.0 mt -64.56 143.77 57.68 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 121.276 0.56 . . . . 0.0 110.764 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.402 ' HG2' ' N ' ' A' ' 143' ' ' LYS . 88.2 tttt -119.79 157.46 28.57 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.569 -179.003 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . 0.402 ' N ' ' HG2' ' A' ' 142' ' ' LYS . 87.8 tttt -50.02 129.52 20.78 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.381 179.366 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.541 ' N ' ' O ' ' A' ' 160' ' ' VAL . . . 83.13 8.96 84.78 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 120.358 -0.925 . . . . 0.0 112.371 178.531 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 47.5 t0 -73.66 130.25 39.63 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 120.076 -0.65 . . . . 0.0 110.679 -179.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -76.61 141.05 41.21 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 121.602 0.715 . . . . 0.0 111.485 -179.001 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.415 HD13 HG21 ' A' ' 147' ' ' ILE . 95.5 mt -137.67 138.66 44.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.063 -0.971 . . . . 0.0 108.815 178.711 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -119.89 133.94 55.41 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 -177.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -111.38 132.29 54.54 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 114.594 -1.184 . . . . 0.0 108.022 177.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -112.18 108.26 17.44 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.205 -0.598 . . . . 0.0 112.119 -178.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . 0.577 ' OD1' ' N ' ' A' ' 152' ' ' ASN . 57.1 t0 -89.42 158.35 17.78 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 177.54 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . 0.577 ' N ' ' OD1' ' A' ' 151' ' ' ASP . 36.8 p-10 -54.85 -20.07 7.9 Favored 'General case' 0 C--N 1.312 -1.042 0 C-N-CA 120.118 -0.633 . . . . 0.0 110.897 -177.817 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -112.49 -29.69 7.4 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 -178.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . 0.425 ' O ' ' N ' ' A' ' 151' ' ' ASP . 0.2 OUTLIER -148.86 -178.42 6.35 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.957 0.885 . . . . 0.0 113.244 -177.205 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -128.52 137.85 51.96 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 114.483 -1.235 . . . . 0.0 109.813 179.193 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -113.61 138.28 50.39 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 121.155 0.503 . . . . 0.0 111.296 -179.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -98.99 114.95 27.85 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 121.296 0.57 . . . . 0.0 111.917 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 45.8 m-85 -113.49 147.11 38.5 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.238 0.542 . . . . 0.0 111.033 179.108 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -120.22 120.27 35.65 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.576 179.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.541 ' O ' ' N ' ' A' ' 144' ' ' GLY . 73.1 t -58.37 136.28 21.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 178.075 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 34.0 p -105.07 -26.79 11.97 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 123.425 0.453 . . . . 0.0 111.803 -179.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 167.1 -175.95 42.16 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 120.143 -1.027 . . . . 0.0 111.882 -179.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 47.7 t -129.22 138.12 55.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 114.8 -0.7 . . . . 0.0 109.465 179.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 20.9 t -137.28 167.51 21.44 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.554 0.692 . . . . 0.0 111.91 -178.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . 0.421 ' CG ' ' CE2' ' A' ' 197' ' ' TYR . 95.5 mt-10 -107.95 122.84 47.65 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.06 -179.619 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 32.6 m -136.93 160.97 36.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.882 179.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -84.76 158.72 59.1 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.357 179.322 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.99 -13.43 39.81 Favored 'Trans proline' 0 C--N 1.303 -1.826 0 C-N-CA 123.169 2.579 . . . . 0.0 113.363 -179.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 35.7 p30 -96.54 -6.89 35.93 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 -179.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -75.55 113.22 12.73 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 -177.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' TRP . . . . . 0.405 ' N ' ' CD1' ' A' ' 171' ' ' TRP . 35.4 m0 -83.24 -22.06 33.2 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.862 179.075 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -54.53 -38.79 66.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.534 -177.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 31.0 m -64.51 -13.41 14.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.022 0.439 . . . . 0.0 111.338 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 76.4 t -111.58 -20.23 6.38 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -178.162 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.411 ' HA ' ' HZ1' ' A' ' 111' ' ' LYS . 94.1 mt-10 -70.35 142.4 52.15 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.386 0.613 . . . . 0.0 111.773 -179.384 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . 0.434 ' OD1' ' O ' ' A' ' 176' ' ' ASP . 46.0 p-10 -66.44 138.34 57.48 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 115.641 -0.708 . . . . 0.0 111.175 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 79.7 m80 -111.68 25.42 11.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.357 179.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 65.28 42.82 96.01 Favored Glycine 0 CA--C 1.532 1.102 0 N-CA-C 111.099 -0.801 . . . . 0.0 111.099 179.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 11.8 ptmt -161.4 166.93 26.61 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 120.94 0.4 . . . . 0.0 110.585 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -85.57 104.83 15.68 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 177.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . 0.43 ' HG2' ' N ' ' A' ' 182' ' ' ILE . 82.9 tt0 -136.15 162.0 34.16 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.395 0.617 . . . . 0.0 111.667 -178.411 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.43 ' N ' ' HG2' ' A' ' 181' ' ' GLU . 18.4 tt -129.32 137.79 56.07 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.038 178.078 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 52.4 m -133.94 127.4 32.35 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 120.979 0.419 . . . . 0.0 111.232 -179.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 71.2 mt -108.65 130.87 55.33 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.13 179.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 91.2 mt -113.68 125.93 71.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.136 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 2.2 t -142.08 163.22 33.46 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.884 179.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' CYS . . . . . . . . . . . . . 4.8 m -86.12 140.83 29.86 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.558 ' CG1' ' O ' ' A' ' 192' ' ' ASP . 9.9 p -62.48 -48.55 87.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.093 0.473 . . . . 0.0 111.129 -179.198 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' SER . . . . . 0.439 ' N ' ' CG1' ' A' ' 188' ' ' VAL . 79.0 p -167.71 156.08 9.24 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.092 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 13.8 p -70.6 -18.81 21.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.21 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -96.84 -15.12 21.42 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . 0.558 ' O ' ' CG1' ' A' ' 188' ' ' VAL . 63.5 t0 -130.73 105.68 7.96 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 120.638 -0.425 . . . . 0.0 111.456 -179.728 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 48.8 p-10 -107.33 12.79 27.74 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 120.78 0.324 . . . . 0.0 111.345 179.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 9.6 t -60.83 -46.66 89.67 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 120.951 0.405 . . . . 0.0 111.906 -179.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 63.3 pttt -144.51 155.64 43.79 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 179.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . 0.708 ' NE ' ' SG ' ' B' ' 705' ' ' B27 . 84.9 mtt85 -127.38 149.51 50.04 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.363 0.601 . . . . 0.0 111.914 -179.046 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . 0.421 ' CE2' ' CG ' ' A' ' 165' ' ' GLU . 53.3 m-85 -92.93 142.58 27.15 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.741 -178.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 25.0 t -129.21 133.52 65.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.696 179.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 53.0 t -101.84 132.67 47.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.236 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -118.15 147.86 42.91 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.125 0.488 . . . . 0.0 110.462 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -148.61 143.07 10.55 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 -179.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 50.9 p30 -107.1 156.3 18.93 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.282 0.563 . . . . 0.0 111.48 -179.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 46.7 tp -77.59 130.87 37.45 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.266 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 15.7 m -114.91 -15.91 9.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.376 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -178.39 173.19 45.64 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 119.522 -1.323 . . . . 0.0 113.097 179.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 57.4 m -142.26 137.95 31.04 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.238 -0.981 . . . . 0.0 109.864 179.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 52.6 mtmt -144.03 114.83 7.74 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.184 0.516 . . . . 0.0 111.529 -179.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -65.77 148.59 51.52 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.551 0.691 . . . . 0.0 111.986 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -79.63 109.1 13.7 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.848 178.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 98.0 mttt . . . . . 0 C--O 1.221 -0.422 0 CA-C-O 117.883 -1.056 . . . . 0.0 110.682 179.712 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 701' ' ' BOC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 702' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 52.08 81.53 0.26 Allowed Pre-proline 0 CA--C 1.535 0.399 0 CA-C-O 121.34 0.591 . . . . 20.0 111.101 . . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 703' ' ' PRO . . . . . 0.516 ' O ' ' O ' ' B' ' 704' ' ' ALA . 3.6 Cg_exo -77.01 -161.66 0.14 Allowed 'Trans proline' 0 C--N 1.305 -1.739 0 C-N-CA 123.305 2.67 . . . . 20.0 113.831 -179.612 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 704' ' ' ALA . . . . . 0.541 ' O ' ' OG1' ' B' ' 705' ' ' B27 . . . -42.54 -175.73 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 113.863 -1.517 . . . . 20.0 112.744 -179.388 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 705' ' ' B27 . . . . . 0.708 ' SG ' ' NE ' ' A' ' 196' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.429 ' H1 ' ' H ' ' A' ' 54' ' ' SER . . . . . . . . 0 N--CA 1.489 2.232 0 N-CA-C 108.852 -1.699 . . . . 0.0 108.852 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.429 ' H ' ' H1 ' ' A' ' 53' ' ' GLY . 10.2 p -154.75 166.24 34.06 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.265 0.555 . . . . 0.0 110.455 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 80.4 m-70 -66.93 -40.79 87.7 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.57 -179.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 66.5 mtt -94.61 135.08 36.48 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.32 179.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -65.96 146.07 55.15 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.293 0.568 . . . . 0.0 110.191 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.473 ' C ' ' H ' ' A' ' 60' ' ' LYS . . . -90.66 1.86 56.43 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.637 -179.741 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.468 ' O ' ' NH2' ' A' ' 196' ' ' ARG . 3.7 p -79.02 22.59 0.39 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.266 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.473 ' H ' ' C ' ' A' ' 58' ' ' ALA . 98.9 mttt -102.15 9.72 39.95 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.128 -179.365 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.8 mt -55.23 139.8 13.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 122.416 1.103 . . . . 0.0 111.869 -177.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.536 ' OD1' ' N ' ' A' ' 62' ' ' ASP . 20.0 p-10 -76.45 128.69 35.29 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 113.528 -1.669 . . . . 0.0 109.551 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.475 ' CD ' ' H ' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -78.86 129.02 74.85 Favored Pre-proline 0 CA--C 1.542 0.654 0 C-N-CA 120.449 -0.5 . . . . 0.0 110.536 -179.025 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -53.41 147.86 35.79 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 C-N-CA 122.129 1.886 . . . . 0.0 112.855 178.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.452 ' CG ' ' H ' ' A' ' 66' ' ' LEU . 27.4 t70 -53.2 177.84 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.77 -179.489 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.452 ' H ' ' CG ' ' A' ' 65' ' ' ASP . 92.1 mt -63.6 -43.8 95.85 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.196 -178.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.09 -36.68 82.43 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 119.761 -0.776 . . . . 0.0 110.336 -179.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -61.31 -35.21 76.73 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.751 0.786 . . . . 0.0 109.042 178.22 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 62.0 t -73.87 -43.26 53.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.917 179.003 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -70.53 -9.71 57.38 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.624 -179.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -118.33 -1.82 11.23 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 121.526 0.679 . . . . 0.0 109.837 179.189 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -70.05 -175.51 0.96 Allowed 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.648 -179.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 6.6 t -94.9 105.42 17.34 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.119 179.15 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 42.0 tp -69.95 135.02 48.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.691 -179.016 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.417 ' OD2' ' OD1' ' A' ' 102' ' ' ASN . 91.3 m-20 -116.06 77.57 1.11 Allowed 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 121.845 0.831 . . . . 0.0 109.36 177.82 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.483 ' O ' ' CG1' ' A' ' 79' ' ' VAL . 86.5 tttt -84.89 -40.32 17.19 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.678 -1.146 . . . . 0.0 112.148 -179.753 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 52.1 mmtt -73.14 -12.89 61.05 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.707 -176.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -94.92 2.1 55.36 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.224 0.535 . . . . 0.0 110.194 179.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.487 ' O ' ' CG1' ' A' ' 79' ' ' VAL . 11.6 p -72.06 115.1 11.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 121.371 0.605 . . . . 0.0 110.833 -179.576 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 32.8 pt -102.84 -7.78 9.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.807 179.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -163.31 158.53 30.94 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 120.637 -0.792 . . . . 0.0 111.339 179.16 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 33.6 ttm180 -133.43 140.01 47.06 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 121.309 0.576 . . . . 0.0 111.334 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 5.1 tt -111.31 142.52 23.44 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.615 179.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 73.8 m -137.45 133.7 34.98 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 115.138 -0.937 . . . . 0.0 112.946 -178.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 66.6 mt -135.61 87.62 25.89 Favored Pre-proline 0 CA--C 1.54 0.558 0 CA-C-O 121.444 0.64 . . . . 0.0 111.034 179.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -55.87 -33.17 87.77 Favored 'Trans proline' 0 N--CA 1.498 1.757 0 C-N-CA 123.309 2.672 . . . . 0.0 112.431 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 28.2 m -52.78 -41.11 63.79 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 121.143 0.497 . . . . 0.0 110.415 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 30.6 m -115.51 13.0 7.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.754 179.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 2.5 p 47.37 52.24 12.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.269 0.557 . . . . 0.0 111.101 -179.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 60.0 tp -119.93 135.25 54.97 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.379 0.609 . . . . 0.0 110.834 179.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -148.92 127.46 12.35 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.866 179.338 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 83.5 mt -149.84 147.85 23.72 Favored Pre-proline 0 CA--C 1.541 0.629 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.458 -178.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -74.12 150.25 42.45 Favored 'Trans proline' 0 N--CA 1.501 1.949 0 C-N-CA 122.881 2.387 . . . . 0.0 112.117 179.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 89.4 t -95.0 125.36 47.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-O 121.26 0.553 . . . . 0.0 111.279 179.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.468 ' N ' ' CD1' ' A' ' 95' ' ' LEU . 10.1 mp -109.34 142.1 40.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.838 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.536 ' O ' ' OG1' ' A' ' 109' ' ' THR . 19.1 ttmt -74.5 -76.19 0.14 Allowed 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 116.103 -0.499 . . . . 0.0 112.148 -178.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 33.4 t -59.62 129.59 42.66 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.185 0.517 . . . . 0.0 111.982 -178.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.407 ' OG ' ' O ' ' A' ' 109' ' ' THR . 23.0 m -87.19 69.48 10.08 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.947 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.415 ' H ' ' HB2' ' A' ' 102' ' ' ASN . 44.4 m -90.27 165.1 14.11 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 178.721 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -58.2 -45.57 87.35 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 119.972 -0.691 . . . . 0.0 110.185 -179.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -65.06 -41.59 95.0 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.217 178.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.417 ' OD1' ' OD2' ' A' ' 75' ' ' ASP . 94.9 m-20 -62.98 -39.71 95.55 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.103 -179.646 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 65.3 mt -61.59 -28.39 69.31 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.695 179.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 98.6 mt -73.98 -15.73 61.1 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.194 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.434 ' HG ' ' CD2' ' A' ' 95' ' ' LEU . 0.7 OUTLIER -71.59 -7.64 48.99 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.466 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.482 ' O ' ' CE1' ' A' ' 135' ' ' PHE . . . 98.84 -22.11 42.61 Favored Glycine 0 CA--C 1.531 1.057 0 CA-C-N 114.701 -1.136 . . . . 0.0 113.447 177.039 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -147.2 125.86 12.56 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 119.643 -0.823 . . . . 0.0 112.211 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -142.03 135.99 29.79 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.698 179.235 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.536 ' OG1' ' O ' ' A' ' 96' ' ' LYS . 71.6 p -69.59 132.16 45.79 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 121.224 0.535 . . . . 0.0 110.515 -179.554 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.438 ' CG1' ' H33' ' B' ' 701' ' ' BOC . 53.6 t -79.07 -50.7 18.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.174 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.755 ' H ' ' NE2' ' A' ' 114' ' ' GLN . 82.5 mttt -102.91 138.19 40.11 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.57 0.7 . . . . 0.0 112.349 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -66.17 -32.58 74.11 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.016 -0.993 . . . . 0.0 112.862 -178.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -82.42 13.51 3.58 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -178.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . 0.755 ' NE2' ' H ' ' A' ' 111' ' ' LYS . 31.4 mt-30 -80.22 136.06 36.39 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.238 0.542 . . . . 0.0 111.341 179.709 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 71.3 t -123.59 127.91 74.28 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.759 179.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' MET . . . . . 0.659 ' SD ' ' CE2' ' A' ' 121' ' ' TYR . 85.3 mmm -55.1 126.02 22.98 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -179.178 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 82.86 -3.27 84.31 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.456 178.098 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -137.21 131.85 33.03 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.063 -0.655 . . . . 0.0 110.867 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 75.03 -174.33 51.81 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 110.226 -1.15 . . . . 0.0 110.226 -179.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.593 ' ND2' ' ND1' ' A' ' 177' ' ' HIS . 62.4 m-20 -84.53 105.04 15.05 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.363 -0.535 . . . . 0.0 109.739 179.548 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.659 ' CE2' ' SD ' ' A' ' 116' ' ' MET . 2.2 t80 -86.34 98.71 11.13 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 120.539 -0.465 . . . . 0.0 110.209 -179.797 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.59 138.05 31.87 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.275 0.56 . . . . 0.0 111.288 -179.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 67.7 mt -135.14 138.59 43.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.435 -179.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -106.82 134.95 49.19 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 178.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -134.6 148.43 19.51 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 -179.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 8.0 m-70 -91.83 136.11 33.4 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.53 0.681 . . . . 0.0 111.805 -179.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 39.2 t30 -132.6 124.96 29.36 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 114.966 -1.016 . . . . 0.0 111.341 -179.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' MET . . . . . 0.443 ' O ' ' CB ' ' A' ' 129' ' ' SER . 65.1 mtt -100.78 -5.81 25.8 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.517 0.675 . . . . 0.0 110.322 179.49 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.443 ' CB ' ' O ' ' A' ' 128' ' ' MET . 0.9 OUTLIER 77.62 12.23 2.01 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.747 178.886 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.468 ' H ' HG13 ' A' ' 133' ' ' VAL . 64.1 pttt -109.85 122.78 48.31 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 122.274 1.035 . . . . 0.0 112.303 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -44.29 119.05 1.69 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.898 179.228 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 117.42 -15.33 13.05 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 -179.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.468 HG13 ' H ' ' A' ' 130' ' ' LYS . 10.6 p -92.73 153.34 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 CA-C-O 120.991 0.424 . . . . 0.0 109.941 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.692 ' CD2' ' H ' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -71.43 146.47 48.65 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.816 0.817 . . . . 0.0 113.088 -177.936 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.482 ' CE1' ' O ' ' A' ' 106' ' ' GLY . 3.6 m-85 66.4 5.34 3.69 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 113.984 -1.462 . . . . 0.0 114.452 178.225 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 23.6 p -75.71 -29.37 58.94 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 119.936 -0.705 . . . . 0.0 112.509 179.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.447 ' N ' ' OD1' ' A' ' 137' ' ' ASP . 31.6 p-10 -92.05 4.79 52.32 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 -176.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 39.2 pt -67.43 -25.73 34.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 C-N-CA 119.016 -1.073 . . . . 0.0 110.493 -179.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -68.02 -13.79 62.47 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.451 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 54.6 p -83.53 -5.63 59.22 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.164 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 88.6 mt -63.43 145.66 55.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.37 0.605 . . . . 0.0 111.275 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -119.32 151.67 38.06 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.574 -179.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -48.98 130.59 18.51 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.114 179.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.609 ' N ' ' O ' ' A' ' 160' ' ' VAL . . . 79.85 8.34 87.76 Favored Glycine 0 CA--C 1.524 0.651 0 C-N-CA 120.847 -0.692 . . . . 0.0 111.453 179.061 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.541 ' OD1' ' N ' ' A' ' 146' ' ' LYS . 53.0 t0 -71.37 130.68 41.95 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 119.519 -0.872 . . . . 0.0 109.866 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.541 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 74.8 mmtt -78.61 142.12 37.5 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 122.044 0.925 . . . . 0.0 111.958 -178.269 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 95.6 mt -136.65 138.49 46.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 114.168 -1.378 . . . . 0.0 108.538 178.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -130.54 143.13 50.56 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 119.981 -0.688 . . . . 0.0 112.537 -178.24 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.524 ' CD1' ' N ' ' A' ' 149' ' ' LEU . 0.0 OUTLIER -143.96 157.77 44.13 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.097 176.788 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.498 ' CD1' ' N ' ' A' ' 150' ' ' TYR . 0.5 OUTLIER -123.53 133.14 54.04 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -177.775 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . 0.521 ' O ' ' NZ ' ' A' ' 209' ' ' LYS . 0.7 OUTLIER -91.04 168.4 11.67 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 105.991 -1.855 . . . . 0.0 105.991 175.804 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 -58.5 -25.76 62.71 Favored 'General case' 0 C--N 1.307 -1.274 0 C-N-CA 119.183 -1.007 . . . . 0.0 110.798 -179.448 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 -110.03 -27.16 9.34 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -178.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -145.31 -172.72 3.93 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 114.608 1.336 . . . . 0.0 114.608 -176.268 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 77.5 tt0 -133.75 134.56 43.12 Favored 'General case' 0 C--N 1.339 0.145 0 CA-C-N 114.508 -1.223 . . . . 0.0 110.045 179.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -114.68 136.37 53.13 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-O 121.34 0.59 . . . . 0.0 110.92 -179.574 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -96.63 114.83 26.52 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.392 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 -114.62 147.95 38.8 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 120.755 0.312 . . . . 0.0 110.868 179.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -126.57 126.66 44.01 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.269 0.557 . . . . 0.0 110.622 178.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.609 ' O ' ' N ' ' A' ' 144' ' ' GLY . 42.8 t -59.79 134.99 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.624 178.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 68.4 p -107.49 -28.75 9.62 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.253 0.549 . . . . 0.0 110.483 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 165.97 -172.34 41.33 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 111.352 -0.699 . . . . 0.0 111.352 179.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 2.3 p -134.39 148.91 29.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 179.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' SER . . . . . 0.557 ' HG ' ' N ' ' A' ' 165' ' ' GLU . 22.9 t -138.29 167.71 21.29 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.465 0.65 . . . . 0.0 111.43 -179.358 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . 0.557 ' N ' ' HG ' ' A' ' 164' ' ' SER . 75.0 tt0 -111.35 119.43 38.83 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.796 -179.191 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . 0.444 ' O ' ' O ' ' A' ' 196' ' ' ARG . 32.3 m -136.2 157.54 37.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.01 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -80.65 160.72 66.3 Favored Pre-proline 0 C--N 1.32 -0.676 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.147 -179.418 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.469 ' O ' ' CB ' ' B' ' 702' ' ' LEU . 33.8 Cg_endo -65.51 -18.11 58.81 Favored 'Trans proline' 0 N--CA 1.502 1.983 0 C-N-CA 122.977 2.451 . . . . 0.0 113.461 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 42.6 p-10 -91.23 -1.6 57.65 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 120.21 -0.596 . . . . 0.0 111.866 179.473 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -75.96 87.15 2.9 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.951 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' TRP . . . . . 0.504 ' CD1' ' N ' ' A' ' 171' ' ' TRP . 31.3 m0 -76.69 -12.12 59.95 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.43 0.633 . . . . 0.0 109.943 179.589 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -62.87 -32.59 73.87 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.365 -179.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 33.3 m -62.48 -18.32 20.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.911 -178.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 35.5 m -110.23 -4.78 10.95 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -179.162 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -73.26 139.69 46.34 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.911 0.386 . . . . 0.0 110.611 179.227 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . 0.516 ' OD1' ' O ' ' A' ' 176' ' ' ASP . 53.1 p-10 -70.83 136.22 48.59 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 121.257 0.551 . . . . 0.0 110.91 -179.649 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' HIS . . . . . 0.593 ' ND1' ' ND2' ' A' ' 120' ' ' ASN . 78.5 m80 -102.34 -15.37 16.58 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.131 0.491 . . . . 0.0 111.219 -179.543 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 105.09 39.74 2.24 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 -179.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -152.96 167.61 28.59 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 114.795 -0.702 . . . . 0.0 111.232 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -88.65 98.99 11.98 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 177.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . 0.411 ' HG2' ' N ' ' A' ' 182' ' ' ILE . 81.8 tt0 -137.24 164.03 29.49 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.694 0.759 . . . . 0.0 111.423 -178.629 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.411 ' N ' ' HG2' ' A' ' 181' ' ' GLU . 16.8 tt -130.74 140.61 48.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 114.689 -1.141 . . . . 0.0 109.258 178.686 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 51.7 m -132.96 126.57 32.32 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.203 0.525 . . . . 0.0 111.249 -179.136 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 91.4 mt -107.53 130.86 54.82 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.068 179.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 81.1 mt -109.56 121.32 62.36 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-O 121.234 0.54 . . . . 0.0 110.637 -179.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' THR . . . . . 0.511 ' C ' ' SG ' ' B' ' 705' ' ' B27 . 43.7 m -139.44 168.17 20.42 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.281 179.814 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' CYS . . . . . 0.545 ' N ' ' SG ' ' B' ' 705' ' ' B27 . 1.6 m -101.91 148.46 25.31 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.288 179.701 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 71.4 t -60.85 -46.89 95.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-O 120.981 0.419 . . . . 0.0 111.44 -178.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' SER . . . . . 0.72 ' HG ' ' H ' ' A' ' 192' ' ' ASP . 86.0 p -170.08 159.5 7.59 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.205 179.317 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 57.7 t -65.75 -18.82 24.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.489 0.661 . . . . 0.0 109.687 179.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -96.74 -13.32 22.77 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.939 -179.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . 0.72 ' H ' ' HG ' ' A' ' 189' ' ' SER . 65.9 t0 -131.67 96.05 3.87 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.421 179.362 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 43.2 p-10 -110.29 5.01 21.35 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 112.23 0.456 . . . . 0.0 112.23 -179.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 11.5 t -63.93 -40.95 97.63 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.954 0.407 . . . . 0.0 111.326 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -126.73 151.74 47.77 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 121.158 0.504 . . . . 0.0 110.749 -179.24 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . 0.468 ' NH2' ' O ' ' A' ' 59' ' ' SER . 99.8 mtt180 -126.19 137.76 53.58 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.386 -179.503 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 43.9 p90 -98.34 144.29 27.89 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.698 178.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 50.2 t -121.27 133.39 67.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.439 0.638 . . . . 0.0 111.573 -178.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 51.0 t -103.67 132.1 50.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.638 179.233 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -118.92 147.76 43.66 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.469 0.652 . . . . 0.0 112.141 -178.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -134.82 140.27 11.58 Favored Glycine 0 CA--C 1.532 1.113 0 N-CA-C 110.422 -1.071 . . . . 0.0 110.422 179.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 54.8 t0 -100.93 136.61 40.51 Favored 'General case' 0 C--N 1.329 -0.304 0 O-C-N 122.626 -0.337 . . . . 0.0 110.804 -179.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 51.7 tp -65.29 127.25 30.96 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 28.6 m -110.52 -18.8 7.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 C-N-CA 120.6 -0.44 . . . . 0.0 112.181 -178.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -179.21 174.34 46.3 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 120.002 -1.095 . . . . 0.0 112.602 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 97.3 m -143.59 138.74 29.27 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 114.991 -0.605 . . . . 0.0 110.439 179.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -142.37 115.8 9.03 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 120.644 -0.423 . . . . 0.0 111.512 178.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -63.36 147.48 51.03 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.498 0.666 . . . . 0.0 111.467 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.521 ' NZ ' ' O ' ' A' ' 151' ' ' ASP . 52.9 mtmt -79.27 106.72 11.51 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.556 179.327 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 97.9 mttt . . . . . 0 C--O 1.219 -0.538 0 CA-C-O 117.827 -1.082 . . . . 0.0 110.613 179.794 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 701' ' ' BOC . . . . . 0.438 ' H33' ' CG1' ' A' ' 110' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 702' ' ' LEU . . . . . 0.469 ' CB ' ' O ' ' A' ' 168' ' ' PRO . 0.5 OUTLIER -86.5 118.16 69.82 Favored Pre-proline 0 CA--C 1.546 0.819 0 N-CA-C 110.806 -0.072 . . . . 20.0 110.806 . . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 703' ' ' PRO . . . . . 0.507 ' O ' ' O ' ' B' ' 704' ' ' ALA . 3.2 Cg_exo -66.15 -177.31 0.79 Allowed 'Trans proline' 0 N--CA 1.496 1.652 0 C-N-CA 122.042 1.828 . . . . 20.0 113.96 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 704' ' ' ALA . . . . . 0.507 ' O ' ' O ' ' B' ' 703' ' ' PRO . . . -39.3 -174.9 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 114.531 1.308 . . . . 20.0 114.531 -178.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 705' ' ' B27 . . . . . 0.545 ' SG ' ' N ' ' A' ' 187' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.423 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 23.0 t -131.12 142.16 50.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.214 0.53 . . . . 0.0 110.554 179.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -64.42 -44.15 92.14 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.082 -179.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 99.4 mmm -88.38 112.29 22.73 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.19 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -64.98 143.52 57.9 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.097 179.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -100.66 -3.11 31.0 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.308 0.575 . . . . 0.0 110.609 179.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 2.0 p -77.54 7.96 4.9 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.544 -178.31 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.417 ' HA ' HH21 ' A' ' 196' ' ' ARG . 59.3 pttt -85.59 26.94 0.88 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.35 0.595 . . . . 0.0 110.926 179.42 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 45.1 mm -55.89 139.76 14.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 122.345 1.069 . . . . 0.0 113.357 -176.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -81.12 124.33 29.14 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 113.584 -1.644 . . . . 0.0 108.128 178.051 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.568 ' H ' ' CD ' ' A' ' 63' ' ' GLN . 1.1 pm0 -77.52 151.71 80.54 Favored Pre-proline 0 C--N 1.324 -0.517 0 C-N-CA 120.064 -0.654 . . . . 0.0 110.855 -178.663 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -68.31 154.75 71.4 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 122.616 2.211 . . . . 0.0 112.084 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -57.98 171.4 0.52 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 121.38 0.61 . . . . 0.0 111.906 -179.027 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 89.3 mt -64.64 -45.58 86.2 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.946 -178.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.09 -37.9 89.13 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 119.924 -0.71 . . . . 0.0 110.323 -178.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -62.9 -32.81 74.16 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 178.037 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.1 t -75.85 -45.33 37.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-N 114.137 -1.392 . . . . 0.0 110.675 179.031 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -75.99 -8.98 58.21 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.819 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -106.18 -13.0 15.55 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 121.436 0.636 . . . . 0.0 109.931 179.158 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -70.22 145.73 51.19 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.41 -0.814 . . . . 0.0 112.189 -179.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.434 ' H ' ' HG ' ' A' ' 73' ' ' SER . 3.5 m -56.67 109.95 0.71 Allowed 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 115.641 -0.708 . . . . 0.0 109.991 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 32.2 tp -69.28 131.97 45.72 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.804 -178.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -109.01 76.63 1.02 Allowed 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 177.471 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -84.11 -36.53 22.89 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.524 -0.762 . . . . 0.0 112.453 -179.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 42.3 mmtt -74.64 -13.37 60.63 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.035 0.445 . . . . 0.0 111.417 -176.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -92.01 -0.1 57.47 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.377 0.608 . . . . 0.0 109.792 179.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 21.9 t -79.58 129.45 37.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.44 -179.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 11.6 pt -110.83 -10.33 11.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.805 179.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -157.81 163.64 32.78 Favored Glycine 0 CA--C 1.523 0.555 0 C-N-CA 120.225 -0.988 . . . . 0.0 111.81 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 61.8 ttp180 -133.71 156.42 47.97 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.756 -0.722 . . . . 0.0 109.91 179.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 18.6 tt -126.07 143.08 40.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.6 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 13.2 t -137.51 133.26 34.37 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 121.504 0.669 . . . . 0.0 112.305 -178.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 65.0 mt -139.33 84.37 16.48 Favored Pre-proline 0 CA--C 1.538 0.498 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.31 -179.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -57.37 -29.7 85.19 Favored 'Trans proline' 0 N--CA 1.499 1.818 0 C-N-CA 123.081 2.52 . . . . 0.0 112.919 -179.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 96.1 p -52.16 -41.66 62.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.32 0.581 . . . . 0.0 111.088 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 22.5 m -115.83 10.33 7.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.043 179.068 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.479 ' O ' ' OG ' ' A' ' 89' ' ' SER . 3.5 t 53.48 53.49 11.54 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.68 179.553 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 62.7 tp -121.98 133.73 54.82 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.656 0.741 . . . . 0.0 111.024 -179.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -148.76 130.85 15.39 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.926 179.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 84.1 mt -152.2 151.28 27.32 Favored Pre-proline 0 N--CA 1.471 0.621 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.368 -178.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -76.02 147.99 30.9 Favored 'Trans proline' 0 N--CA 1.494 1.554 0 C-N-CA 122.584 2.189 . . . . 0.0 111.516 178.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 98.5 t -96.45 118.12 42.17 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-O 120.975 0.417 . . . . 0.0 111.563 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.45 ' N ' ' CD1' ' A' ' 95' ' ' LEU . 10.6 mp -101.74 136.91 40.78 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.394 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -61.7 -81.36 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 121.253 0.549 . . . . 0.0 112.263 -179.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.75 ' HG ' HD21 ' A' ' 102' ' ' ASN . 91.1 p -62.39 135.12 57.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.488 0.661 . . . . 0.0 112.134 -178.238 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.419 ' OG ' ' O ' ' A' ' 109' ' ' THR . 1.3 m -90.83 68.66 6.39 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.219 178.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.701 ' HG1' ' H ' ' A' ' 102' ' ' ASN . 33.8 p -88.57 168.41 12.59 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.069 179.283 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.429 ' O ' ' CD1' ' A' ' 104' ' ' LEU . 52.6 tp10 -62.9 -45.5 92.24 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.169 -0.612 . . . . 0.0 110.435 179.783 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -65.12 -40.67 94.82 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 121.339 0.59 . . . . 0.0 111.487 179.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.75 HD21 ' HG ' ' A' ' 97' ' ' SER . 99.1 m-20 -65.23 -30.35 71.23 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.134 -0.485 . . . . 0.0 112.226 -179.301 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 56.7 mt -67.03 -14.02 62.49 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 120.773 -0.371 . . . . 0.0 111.673 -179.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.429 ' CD1' ' O ' ' A' ' 100' ' ' GLU . 10.5 mp -75.69 -12.17 60.14 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 121.008 -0.277 . . . . 0.0 111.44 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 92.5 p -81.17 -6.24 58.62 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 121.352 0.596 . . . . 0.0 110.356 179.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 89.76 -20.02 37.89 Favored Glycine 0 CA--C 1.533 1.196 0 CA-C-N 115.51 -0.768 . . . . 0.0 113.254 177.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -145.72 125.49 13.43 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 117.814 0.807 . . . . 0.0 112.136 -179.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -145.71 141.64 28.23 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.703 179.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.419 ' O ' ' OG ' ' A' ' 98' ' ' SER . 8.7 p -71.93 132.34 44.22 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.238 0.542 . . . . 0.0 110.667 179.631 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.3 p -81.7 -33.95 12.52 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 -179.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.506 ' O ' ' NE2' ' A' ' 114' ' ' GLN . 88.2 tttt -90.36 153.34 20.51 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 121.357 0.598 . . . . 0.0 111.939 -177.243 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -66.0 -35.06 79.54 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -178.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -141.27 53.36 1.55 Allowed 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 -176.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . 0.716 ' NE2' ' H ' ' A' ' 114' ' ' GLN . 1.6 pm0 -74.34 157.71 35.26 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 120.891 0.377 . . . . 0.0 111.192 179.151 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 61.4 t -128.64 120.89 53.65 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-O 121.149 0.499 . . . . 0.0 111.694 -179.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 66.3 mtt -60.57 134.45 57.08 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.992 -0.549 . . . . 0.0 112.226 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 77.72 -0.91 69.3 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.698 -0.561 . . . . 0.0 111.698 178.206 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -142.0 127.94 19.48 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.358 0.599 . . . . 0.0 110.851 179.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 75.28 -168.99 54.78 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 110.482 -1.047 . . . . 0.0 110.482 -179.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 42.9 t-20 -90.21 103.5 16.17 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.78 0.324 . . . . 0.0 110.2 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.467 ' CE1' ' CG ' ' A' ' 114' ' ' GLN . 11.8 t80 -89.69 99.02 12.1 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -179.696 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -91.65 137.41 32.39 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 112.462 0.541 . . . . 0.0 112.462 -178.404 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 71.6 mt -134.76 138.92 44.74 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.584 179.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -108.72 131.7 54.67 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 121.142 0.496 . . . . 0.0 110.02 179.324 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -137.22 151.08 20.93 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 110.045 -1.222 . . . . 0.0 110.045 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.564 ' ND1' ' OE1' ' A' ' 63' ' ' GLN . 37.5 m-70 -88.73 144.78 26.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.61 0.719 . . . . 0.0 112.522 -178.706 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.797 ' ND2' ' H ' ' A' ' 129' ' ' SER . 1.5 t-20 -137.8 121.24 17.14 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.982 178.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' MET . . . . . 0.509 ' O ' ' CB ' ' A' ' 129' ' ' SER . 57.7 mtt -95.51 -1.42 50.71 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.069 -178.578 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.797 ' H ' ' ND2' ' A' ' 127' ' ' ASN . 1.4 p 78.17 5.52 2.7 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.974 -0.29 . . . . 0.0 111.339 179.247 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.561 ' O ' ' CG1' ' A' ' 133' ' ' VAL . 62.5 pttt -120.58 130.7 54.3 Favored 'General case' 0 C--O 1.222 -0.377 0 CA-C-O 121.885 0.85 . . . . 0.0 113.105 -178.55 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.462 ' O ' ' O ' ' A' ' 130' ' ' LYS . 74.6 mmtt -41.13 162.6 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 178.232 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 76.49 -24.73 1.76 Allowed Glycine 0 CA--C 1.535 1.337 0 C-N-CA 120.396 -0.907 . . . . 0.0 111.379 179.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.561 ' CG1' ' O ' ' A' ' 130' ' ' LYS . 3.7 p -90.18 158.13 2.94 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 O-C-N 122.217 -0.578 . . . . 0.0 111.215 -178.702 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.646 ' H ' ' CD1' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -70.71 145.36 50.57 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 114.903 1.446 . . . . 0.0 114.903 -177.283 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 61.0 7.04 1.37 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 112.866 -1.97 . . . . 0.0 113.854 177.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 5.1 t -72.8 -34.07 66.66 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.143 -0.623 . . . . 0.0 112.385 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.426 ' N ' ' OD1' ' A' ' 137' ' ' ASP . 44.0 p-10 -92.43 4.6 53.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.433 0.635 . . . . 0.0 110.381 -179.329 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.419 ' CG2' ' N ' ' A' ' 139' ' ' ALA . 5.2 tt -64.49 -35.83 75.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.896 -179.506 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.419 ' N ' ' CG2' ' A' ' 138' ' ' ILE . . . -70.33 -9.88 57.41 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 121.091 0.472 . . . . 0.0 111.072 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 19.1 m -81.99 -3.21 53.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.225 0.535 . . . . 0.0 110.223 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 78.5 mt -63.69 145.08 56.41 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.564 179.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -120.97 155.49 34.16 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 121.389 0.614 . . . . 0.0 112.021 -178.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 40.5 tttp -49.85 132.76 22.45 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.978 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.554 ' N ' ' O ' ' A' ' 160' ' ' VAL . . . 80.21 7.33 88.63 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.314 178.691 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -73.41 136.87 44.34 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 118.921 -1.112 . . . . 0.0 109.553 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -80.26 141.33 35.65 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.838 0.828 . . . . 0.0 112.28 -178.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 87.6 mt -137.39 137.74 45.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 114.735 -1.121 . . . . 0.0 108.679 178.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 43.0 m-85 -123.1 136.25 54.72 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.028 -0.669 . . . . 0.0 112.508 -177.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 11.7 mt -110.97 133.5 53.34 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 177.072 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . 0.526 ' CE1' ' CD ' ' A' ' 155' ' ' GLU . 82.1 m-85 -111.87 109.39 19.18 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 119.836 -0.746 . . . . 0.0 111.845 -179.638 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . 0.614 ' OD1' ' N ' ' A' ' 152' ' ' ASN . 66.3 t0 -89.59 163.87 15.0 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 177.7 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . 0.614 ' N ' ' OD1' ' A' ' 151' ' ' ASP . 34.5 p-10 -57.36 -19.61 24.02 Favored 'General case' 0 C--N 1.318 -0.785 0 C-N-CA 119.962 -0.695 . . . . 0.0 111.159 -177.706 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -114.27 -27.83 7.48 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 -178.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -148.18 179.87 7.45 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 -176.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.526 ' CD ' ' CE1' ' A' ' 150' ' ' TYR . 83.0 tt0 -127.79 132.96 49.44 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 114.366 -1.288 . . . . 0.0 109.745 179.122 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -108.44 133.87 52.02 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.027 0.442 . . . . 0.0 111.225 -179.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -93.85 113.15 25.12 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.121 179.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -115.44 150.16 36.88 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 120.828 0.347 . . . . 0.0 110.585 179.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -124.45 124.62 42.7 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.048 0.451 . . . . 0.0 111.215 179.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.554 ' O ' ' N ' ' A' ' 144' ' ' GLY . 71.4 t -60.93 135.47 25.65 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.215 177.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 22.0 p -105.36 -24.95 12.57 Favored 'General case' 0 CA--C 1.533 0.315 0 O-C-N 123.308 0.38 . . . . 0.0 110.202 178.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 157.46 -165.17 33.33 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 120.842 -0.694 . . . . 0.0 111.718 179.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 3.0 p -134.97 155.26 37.87 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 179.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 87.8 p -138.75 167.17 22.57 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.633 0.73 . . . . 0.0 112.212 -178.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -100.19 118.87 37.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 114.99 -1.004 . . . . 0.0 110.204 179.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 27.6 m -137.05 161.7 35.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.225 0.536 . . . . 0.0 111.009 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -96.73 157.07 35.83 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.32 178.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.503 ' O ' ' CB ' ' B' ' 702' ' ' LEU . 20.7 Cg_endo -60.83 -18.02 54.0 Favored 'Trans proline' 0 C--N 1.3 -1.995 0 C-N-CA 122.605 2.204 . . . . 0.0 113.552 -179.627 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 45.5 p-10 -92.27 -5.26 52.71 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 119.45 -0.9 . . . . 0.0 112.313 179.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -76.1 85.56 2.97 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 121.655 0.741 . . . . 0.0 111.373 179.438 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' TRP . . . . . 0.591 ' CZ3' ' OE2' ' A' ' 175' ' ' GLU . 1.2 p-90 -73.97 -7.44 52.41 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.034 -0.984 . . . . 0.0 110.041 179.42 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -61.77 -35.83 79.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.75 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 19.8 m -63.03 -17.77 20.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.781 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 37.0 t -101.47 -17.77 6.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.922 -179.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.591 ' OE2' ' CZ3' ' A' ' 171' ' ' TRP . 76.3 mm-40 -76.26 153.94 35.58 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.246 0.546 . . . . 0.0 111.779 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . 0.491 ' OD1' ' O ' ' A' ' 176' ' ' ASP . 47.0 p-10 -60.27 142.86 53.98 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.719 0.771 . . . . 0.0 111.802 -179.345 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 73.6 m80 -115.36 12.71 16.42 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.707 179.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 64.13 41.66 98.34 Favored Glycine 0 CA--C 1.528 0.856 0 N-CA-C 111.105 -0.798 . . . . 0.0 111.105 179.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -165.2 172.47 12.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.1 0.476 . . . . 0.0 110.882 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -88.28 93.99 9.69 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 177.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . 0.426 ' HG2' ' N ' ' A' ' 182' ' ' ILE . 79.9 tt0 -130.45 161.64 30.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.85 0.833 . . . . 0.0 112.052 -178.078 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.426 ' N ' ' HG2' ' A' ' 181' ' ' GLU . 1.1 mm -125.97 134.5 66.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 114.598 -1.183 . . . . 0.0 110.55 179.608 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 86.3 m -126.3 124.41 40.26 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 121.291 0.567 . . . . 0.0 111.23 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 83.4 mt -113.32 133.41 55.14 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.7 179.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 77.0 mt -113.53 124.77 70.5 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 CA-C-O 121.36 0.6 . . . . 0.0 111.028 -179.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 5.1 t -135.56 156.34 49.03 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 115.254 -0.884 . . . . 0.0 110.492 179.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' CYS . . . . . . . . . . . . . 4.5 m -87.11 141.45 28.65 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.234 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . 0.412 HG22 ' CE2' ' A' ' 197' ' ' TYR . 41.9 t -61.97 -47.32 93.74 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 CA-C-O 120.945 0.402 . . . . 0.0 111.005 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 94.6 p -162.23 164.42 27.71 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 121.038 0.447 . . . . 0.0 110.977 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . 0.501 ' CG1' ' O ' ' A' ' 128' ' ' MET . 18.0 m -69.16 -17.58 21.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.244 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -101.8 -34.69 9.33 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.519 -0.472 . . . . 0.0 111.049 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 49.6 t0 -99.63 103.13 14.81 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 120.984 0.421 . . . . 0.0 111.465 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' ASN . . . . . 0.577 ' O ' ' NH1' ' A' ' 196' ' ' ARG . 27.2 m120 -110.45 -7.22 14.79 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 121.298 0.57 . . . . 0.0 110.639 179.058 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 76.3 p -68.4 -16.68 64.01 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.953 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -136.73 143.03 43.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.468 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . 0.577 ' NH1' ' O ' ' A' ' 193' ' ' ASN . 76.9 mtt85 -136.05 145.15 45.69 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 121.108 0.48 . . . . 0.0 111.959 -179.494 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . 0.412 ' CE2' HG22 ' A' ' 188' ' ' VAL . 35.8 m-85 -96.41 144.57 26.42 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 115.949 -0.568 . . . . 0.0 111.471 179.034 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 39.2 t -128.97 130.69 68.45 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-O 121.083 0.468 . . . . 0.0 110.645 178.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 21.6 t -102.66 134.62 43.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.866 179.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -122.32 147.66 45.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.316 0.579 . . . . 0.0 111.387 -178.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -145.01 152.6 24.63 Favored Glycine 0 CA--C 1.53 1.024 0 N-CA-C 110.079 -1.208 . . . . 0.0 110.079 179.24 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . 0.422 ' O ' ' OD1' ' A' ' 202' ' ' ASP . 51.7 p-10 -111.92 151.39 29.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.994 0.426 . . . . 0.0 110.092 179.673 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 52.7 tp -71.52 131.47 43.32 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 5.2 p -113.88 -19.5 6.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 120.333 -0.547 . . . . 0.0 111.589 -178.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -176.97 172.03 44.96 Favored Glycine 0 CA--C 1.527 0.799 0 C-N-CA 120.088 -1.053 . . . . 0.0 112.055 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 10.4 m -144.19 137.68 27.57 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.963 -0.618 . . . . 0.0 109.503 179.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -145.37 122.17 11.24 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.115 0.483 . . . . 0.0 111.276 179.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -62.39 139.83 58.55 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.491 0.662 . . . . 0.0 111.448 -179.289 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 9.5 tttt -79.2 109.32 13.42 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.552 179.563 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 98.5 mttt . . . . . 0 C--O 1.218 -0.558 0 CA-C-O 118.107 -0.949 . . . . 0.0 110.339 179.205 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 701' ' ' BOC . . . . . 0.5 ' H22' ' N ' ' B' ' 702' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 702' ' ' LEU . . . . . 0.503 ' CB ' ' O ' ' A' ' 168' ' ' PRO . 1.0 OUTLIER -154.12 103.95 2.44 Favored Pre-proline 0 CA--C 1.546 0.805 0 C-N-CA 120.681 -0.408 . . . . 20.0 111.323 . . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 703' ' ' PRO . . . . . 0.544 ' O ' ' O ' ' B' ' 704' ' ' ALA . 4.9 Cg_exo -69.41 -168.06 0.24 Allowed 'Trans proline' 0 N--CA 1.489 1.21 0 C-N-CA 122.906 2.404 . . . . 20.0 114.15 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 704' ' ' ALA . . . . . 0.544 ' O ' ' O ' ' B' ' 703' ' ' PRO . . . -36.79 -179.68 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 113.902 -1.499 . . . . 20.0 113.659 -179.078 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 705' ' ' B27 . . . . . 0.518 ' OG1' ' O ' ' B' ' 704' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.19 0 CA-C-O 121.254 0.549 . . . . 0.0 111.04 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 2.9 p -79.93 17.01 1.03 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.924 -179.131 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -99.64 9.76 42.55 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 120.901 0.382 . . . . 0.0 111.858 -179.45 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.8 mt -55.6 139.98 14.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 122.034 0.921 . . . . 0.0 112.988 -177.107 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.408 ' OD1' ' N ' ' A' ' 63' ' ' GLN . 60.4 t0 -77.59 129.15 35.26 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 114.169 -1.378 . . . . 0.0 109.567 179.166 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.533 ' NE2' ' O ' ' A' ' 64' ' ' PRO . 1.4 tt0 -76.81 119.71 78.62 Favored Pre-proline 0 CA--C 1.541 0.609 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.504 -179.137 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.533 ' O ' ' NE2' ' A' ' 63' ' ' GLN . 73.5 Cg_exo -47.86 162.31 0.28 Allowed 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 122.491 2.127 . . . . 0.0 112.811 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -52.6 168.96 0.09 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.873 0.844 . . . . 0.0 112.308 -178.441 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 97.4 mt -71.13 -12.08 61.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 114.516 -1.22 . . . . 0.0 111.979 -179.277 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.592 ' O ' ' ND2' ' A' ' 71' ' ' ASN . . . -68.21 -41.89 80.63 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.306 0.574 . . . . 0.0 110.492 179.204 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.767 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 98.2 mt-10 -70.7 -23.05 62.4 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.203 179.321 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 76.6 t -71.31 -43.88 73.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.814 -178.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -92.76 -8.82 42.68 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.411 -179.582 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.592 ' ND2' ' O ' ' A' ' 67' ' ' ALA . 84.9 m-20 -106.94 -10.17 16.06 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 121.15 0.5 . . . . 0.0 110.893 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.767 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -69.65 135.54 50.04 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.425 0.631 . . . . 0.0 112.272 -179.134 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 43.7 t -59.71 93.65 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.573 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.672 HD23 ' N ' ' A' ' 75' ' ' ASP . 6.9 tt -66.79 126.29 28.56 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.297 0.57 . . . . 0.0 111.449 -178.147 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.672 ' N ' HD23 ' A' ' 74' ' ' LEU . 88.2 m-20 -93.74 79.51 4.23 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.564 -0.743 . . . . 0.0 110.379 179.61 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.403 ' N ' HD23 ' A' ' 74' ' ' LEU . 86.8 tttt -64.75 -34.12 77.58 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.747 -0.661 . . . . 0.0 112.095 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.45 ' N ' ' HD3' ' A' ' 77' ' ' LYS . 8.0 mmtt -70.01 -13.12 62.08 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 121.428 0.633 . . . . 0.0 109.901 -176.497 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -93.9 -5.24 48.37 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.734 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 72.4 t -73.69 128.63 36.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.068 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 12.6 pt -110.57 -6.59 11.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 120.592 -0.443 . . . . 0.0 111.723 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -174.79 174.8 46.84 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 120.398 -0.906 . . . . 0.0 111.725 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.41 HH12 ' HB2' ' A' ' 84' ' ' SER . 73.2 ttp85 -135.3 156.89 48.19 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 121.158 0.504 . . . . 0.0 111.157 -179.77 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.428 HG22 ' O ' ' A' ' 92' ' ' LEU . 20.9 tt -125.6 139.32 51.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 179.363 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.41 ' HB2' HH12 ' A' ' 82' ' ' ARG . 32.5 t -137.59 134.55 35.69 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 -178.386 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.568 ' CG2' HG22 ' A' ' 88' ' ' VAL . 3.2 mp -137.26 87.58 18.16 Favored Pre-proline 0 CA--C 1.538 0.498 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.415 179.134 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -55.98 -32.56 86.33 Favored 'Trans proline' 0 N--CA 1.5 1.873 0 C-N-CA 123.205 2.604 . . . . 0.0 112.68 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 8.9 t -54.63 -41.63 70.26 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.244 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.568 HG22 ' CG2' ' A' ' 85' ' ' ILE . 11.2 m -113.93 14.44 8.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 CA-C-O 121.261 0.553 . . . . 0.0 110.635 179.456 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.8 p 46.58 52.0 11.46 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.128 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 55.7 tp -117.78 133.29 56.08 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.321 0.581 . . . . 0.0 110.604 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.859 ' O ' HD23 ' A' ' 92' ' ' LEU . 93.7 mt-10 -147.94 125.32 11.6 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.925 -179.292 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.859 HD23 ' O ' ' A' ' 91' ' ' GLU . 7.8 mt -148.89 148.48 27.59 Favored Pre-proline 0 CA--C 1.537 0.457 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.421 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -75.36 147.75 33.03 Favored 'Trans proline' 0 N--CA 1.493 1.465 0 C-N-CA 122.68 2.253 . . . . 0.0 110.878 178.1 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.484 ' C ' HD12 ' A' ' 95' ' ' LEU . 92.3 t -93.51 119.86 41.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.189 0.519 . . . . 0.0 110.649 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.567 HD12 ' N ' ' A' ' 95' ' ' LEU . 10.6 mp -97.82 126.09 43.01 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.72 0.772 . . . . 0.0 110.842 -179.685 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.527 ' O ' ' OG1' ' A' ' 109' ' ' THR . 86.7 tttt -63.64 -38.41 91.0 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.827 -1.078 . . . . 0.0 112.043 -178.581 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.497 ' CB ' ' ND2' ' A' ' 102' ' ' ASN . 2.7 m -79.76 126.43 30.94 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 121.636 0.731 . . . . 0.0 112.463 -178.582 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.462 ' OG ' ' O ' ' A' ' 109' ' ' THR . 0.9 OUTLIER -89.13 44.5 1.22 Allowed 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.714 179.687 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.578 ' OG1' ' ND2' ' A' ' 102' ' ' ASN . 71.4 p -89.48 171.78 9.47 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.03 179.121 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.439 ' HA ' HD12 ' A' ' 103' ' ' LEU . 94.8 mt-10 -66.06 -39.62 90.25 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.161 0.505 . . . . 0.0 110.143 179.247 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -64.43 -41.75 96.41 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.147 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.578 ' ND2' ' OG1' ' A' ' 99' ' ' THR . 54.0 m-80 -65.15 -34.83 79.33 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.6 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.537 HD13 ' HB3' ' B' ' 704' ' ' ALA . 42.0 mt -65.13 -16.54 63.6 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.634 -179.595 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.419 HD23 ' HA ' ' A' ' 104' ' ' LEU . 91.5 mt -73.76 -15.47 61.2 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.381 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.462 ' OG ' HD22 ' A' ' 95' ' ' LEU . 93.9 p -82.11 -2.84 53.3 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.198 0.523 . . . . 0.0 110.431 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.592 ' O ' ' CE1' ' A' ' 135' ' ' PHE . . . 93.31 -19.53 51.87 Favored Glycine 0 CA--C 1.527 0.799 0 CA-C-N 115.854 -0.612 . . . . 0.0 113.08 178.105 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -146.56 125.53 12.8 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 119.483 -0.887 . . . . 0.0 112.382 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -143.24 142.38 31.37 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.833 178.345 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.527 ' OG1' ' O ' ' A' ' 96' ' ' LYS . 58.5 p -65.37 132.44 49.0 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.46 0.648 . . . . 0.0 111.288 -178.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.658 HG13 ' CD ' ' B' ' 703' ' ' PRO . 78.9 t -78.38 -55.2 10.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.655 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.449 ' H ' ' CD ' ' A' ' 114' ' ' GLN . 83.5 mttt -107.04 139.74 40.96 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 122.048 0.928 . . . . 0.0 112.162 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -66.25 -34.48 78.11 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.444 -1.253 . . . . 0.0 112.165 -178.808 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -85.7 20.77 2.04 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 113.075 0.769 . . . . 0.0 113.075 -178.448 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLN . . . . . 0.496 ' NE2' ' H ' ' A' ' 122' ' ' ALA . 80.8 mt-30 -77.9 140.58 39.31 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.048 0.451 . . . . 0.0 111.034 179.635 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.2 t -125.91 108.54 19.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.965 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 73.3 mtp -56.25 126.61 26.94 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 121.121 0.486 . . . . 0.0 111.039 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 97.01 -11.76 65.79 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 121.133 -0.556 . . . . 0.0 111.825 179.255 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -143.72 137.29 28.04 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 121.055 0.455 . . . . 0.0 111.53 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 76.27 -170.7 54.83 Favored Glycine 0 CA--C 1.531 1.069 0 N-CA-C 111.675 -0.57 . . . . 0.0 111.675 179.149 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 54.5 t-20 -88.52 104.56 16.93 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 121.304 0.573 . . . . 0.0 110.576 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.416 ' HE2' HD21 ' A' ' 123' ' ' LEU . 6.6 t80 -86.99 145.97 26.31 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.4 179.417 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.496 ' H ' ' NE2' ' A' ' 114' ' ' GLN . . . -147.58 143.76 27.98 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 119.493 -0.883 . . . . 0.0 111.841 -179.095 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.487 HD23 ' HA ' ' A' ' 109' ' ' THR . 63.8 mt -138.29 143.75 40.16 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 114.823 -1.081 . . . . 0.0 110.181 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -111.71 138.35 48.4 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.128 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -132.03 145.34 17.11 Favored Glycine 0 CA--C 1.531 1.046 0 N-CA-C 110.386 -1.086 . . . . 0.0 110.386 -179.287 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' HIS . . . . . 0.405 ' CG ' ' HB2' ' A' ' 63' ' ' GLN . 7.6 m170 -88.63 124.1 33.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.449 0.642 . . . . 0.0 112.258 -179.231 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -122.83 121.82 37.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.251 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.433 ' H ' HG21 ' A' ' 133' ' ' VAL . 75.9 mtm -95.85 2.22 53.58 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 121.263 0.554 . . . . 0.0 110.748 179.405 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 76.04 10.5 3.14 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.543 179.114 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.81 ' O ' HG12 ' A' ' 133' ' ' VAL . 5.6 ptmt -110.51 114.16 27.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.878 0.847 . . . . 0.0 112.395 -179.352 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 6.1 tmtt? -37.72 120.28 0.81 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.661 -1.154 . . . . 0.0 111.7 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 113.13 -11.94 24.34 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.329 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.81 HG12 ' O ' ' A' ' 130' ' ' LYS . 11.8 p -91.71 164.31 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 CA-C-N 115.048 -0.576 . . . . 0.0 110.267 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.547 ' N ' HG22 ' A' ' 133' ' ' VAL . 0.7 OUTLIER -70.75 140.16 51.27 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.872 0.844 . . . . 0.0 112.645 -177.355 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.649 ' CG ' HD12 ' A' ' 138' ' ' ILE . 3.2 m-85 66.43 5.3 3.68 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 113.977 -1.465 . . . . 0.0 113.796 177.856 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' SER . . . . . 0.542 ' OG ' ' CG1' ' A' ' 133' ' ' VAL . 0.4 OUTLIER -68.14 -40.48 82.4 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 112.373 0.509 . . . . 0.0 112.373 179.131 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.6 p-10 -88.95 -1.34 58.06 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 121.251 0.548 . . . . 0.0 111.439 -178.215 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.649 HD12 ' CG ' ' A' ' 135' ' ' PHE . 0.3 OUTLIER -65.24 -35.71 76.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-O 121.158 0.504 . . . . 0.0 110.254 178.957 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.83 ' HB2' ' OH ' ' A' ' 197' ' ' TYR . . . -66.83 -11.44 55.44 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.052 0.453 . . . . 0.0 110.926 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 59.6 p -84.35 -1.91 56.23 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 121.199 0.524 . . . . 0.0 110.756 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.44 HD21 HG21 ' A' ' 85' ' ' ILE . 66.1 mt -63.54 138.72 58.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.237 -179.547 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -113.48 154.46 27.0 Favored 'General case' 0 CA--C 1.535 0.365 0 CA-C-O 121.425 0.631 . . . . 0.0 111.351 -179.341 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -51.3 133.71 28.62 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.751 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.561 ' N ' ' O ' ' A' ' 160' ' ' VAL . . . 79.32 7.95 88.13 Favored Glycine 0 CA--C 1.527 0.84 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.554 179.14 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -70.12 132.8 46.38 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 119.88 -0.728 . . . . 0.0 109.852 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -78.59 138.32 38.3 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.76 0.79 . . . . 0.0 111.773 -178.704 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.517 HD11 ' CG2' ' A' ' 160' ' ' VAL . 95.9 mt -135.8 136.41 50.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 114.817 -1.083 . . . . 0.0 108.382 178.774 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' TYR . . . . . 0.496 ' C ' HD22 ' A' ' 149' ' ' LEU . 89.9 m-85 -117.81 135.0 54.36 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.906 0.86 . . . . 0.0 112.842 -178.779 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.496 HD22 ' C ' ' A' ' 148' ' ' TYR . 4.5 mm? -110.84 133.57 53.24 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 114.528 -1.215 . . . . 0.0 108.445 178.234 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.601 ' CZ ' ' OE2' ' A' ' 155' ' ' GLU . 79.8 m-85 -116.93 110.52 18.41 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 120.202 -0.599 . . . . 0.0 111.581 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' ASP . . . . . 0.466 ' OD1' ' N ' ' A' ' 152' ' ' ASN . 52.4 t0 -89.25 164.94 14.74 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 177.176 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' ASN . . . . . 0.466 ' N ' ' OD1' ' A' ' 151' ' ' ASP . 34.5 p30 -58.85 -19.12 38.76 Favored 'General case' 0 C--N 1.314 -0.967 0 C-N-CA 119.286 -0.965 . . . . 0.0 111.031 -178.119 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -112.28 -28.08 8.07 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -178.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' ASN . . . . . 0.414 ' O ' ' N ' ' A' ' 151' ' ' ASP . 0.6 OUTLIER -148.67 -175.64 5.01 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 -176.333 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.601 ' OE2' ' CZ ' ' A' ' 150' ' ' TYR . 87.7 tt0 -132.46 133.77 44.25 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 114.072 -1.422 . . . . 0.0 110.237 178.8 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 156' ' ' TYR . . . . . 0.425 ' CD1' HG23 ' A' ' 206' ' ' THR . 80.2 m-85 -112.59 140.22 47.53 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 120.846 0.355 . . . . 0.0 110.315 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' GLU . . . . . 0.44 ' O ' HD12 ' A' ' 203' ' ' LEU . 82.5 tt0 -99.87 117.98 35.34 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 121.047 0.451 . . . . 0.0 112.051 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -114.75 148.82 37.83 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 121.178 0.513 . . . . 0.0 111.416 179.329 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -121.03 120.85 36.58 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.713 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.561 ' O ' ' N ' ' A' ' 144' ' ' GLY . 91.0 t -59.59 136.77 22.86 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.292 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.743 178.199 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 15.1 p -105.63 -24.05 12.63 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.786 178.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 154.86 -163.43 31.32 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 120.682 -0.771 . . . . 0.0 111.62 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.61 HG12 HG22 ' A' ' 199' ' ' VAL . 35.5 m -135.76 158.07 39.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-N 115.343 -0.428 . . . . 0.0 110.004 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 81.6 p -145.95 165.78 27.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.118 0.485 . . . . 0.0 110.924 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -101.85 115.2 30.02 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.898 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.542 ' O ' ' O ' ' A' ' 196' ' ' ARG . 23.8 m -137.98 162.76 30.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.989 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -86.48 157.01 56.22 Favored Pre-proline 0 CA--C 1.54 0.575 0 CA-C-O 121.16 0.505 . . . . 0.0 111.431 -179.443 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 168' ' ' PRO . . . . . 0.517 ' O ' HD12 ' B' ' 702' ' ' LEU . 36.5 Cg_endo -67.86 -9.98 27.34 Favored 'Trans proline' 0 N--CA 1.5 1.862 0 C-N-CA 123.398 2.732 . . . . 0.0 112.861 -179.626 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 169' ' ' ASP . . . . . 0.424 ' OD1' ' C ' ' A' ' 169' ' ' ASP . 40.2 p-10 -95.01 -4.0 47.35 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.236 0.541 . . . . 0.0 110.924 179.018 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.777 ' O ' HD23 ' B' ' 702' ' ' LEU . 70.3 mmtt -75.69 82.83 2.68 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.533 -178.8 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 40.4 p-90 -76.72 -12.08 59.94 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 121.356 0.598 . . . . 0.0 110.594 178.872 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 76.4 tt0 -61.0 -36.58 79.86 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.988 -179.392 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' VAL . . . . . 0.637 HG22 HG21 ' A' ' 183' ' ' THR . 11.6 p -62.44 -25.97 39.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 CA-C-O 121.107 0.479 . . . . 0.0 110.77 -179.556 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.468 HG11 HG11 ' A' ' 110' ' ' VAL . 20.1 t -93.1 -8.49 10.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.945 -179.161 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.525 ' OE1' ' O ' ' A' ' 176' ' ' ASP . 0.6 OUTLIER -73.5 146.77 44.64 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 120.935 0.398 . . . . 0.0 111.076 -179.766 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 176' ' ' ASP . . . . . 0.525 ' O ' ' OE1' ' A' ' 175' ' ' GLU . 48.1 p-10 -66.27 128.29 35.54 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.281 0.563 . . . . 0.0 111.857 -179.169 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 21.4 m80 -111.49 24.66 12.52 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.965 -0.561 . . . . 0.0 112.119 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 60.21 35.79 88.94 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 120.724 -0.75 . . . . 0.0 111.247 179.342 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -154.15 161.41 41.88 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 110.208 -0.293 . . . . 0.0 110.208 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -89.35 105.25 17.67 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.897 179.153 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 -139.21 167.02 23.0 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.569 0.699 . . . . 0.0 112.154 179.365 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.468 HG22 ' O ' ' A' ' 201' ' ' GLY . 18.9 tt -130.08 138.02 55.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 114.827 -1.079 . . . . 0.0 109.917 179.121 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 183' ' ' THR . . . . . 0.637 HG21 HG22 ' A' ' 173' ' ' VAL . 39.8 m -130.98 122.64 27.22 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.176 0.512 . . . . 0.0 111.079 -179.216 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 93.9 mt -109.43 136.29 49.08 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.631 178.721 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 70.0 mt -105.68 115.71 47.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 C-N-CA 120.206 -0.598 . . . . 0.0 110.179 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 186' ' ' THR . . . . . 0.425 HG21 ' OH ' ' A' ' 197' ' ' TYR . 77.1 m -126.79 132.63 51.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.275 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 187' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -84.03 140.8 31.62 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.498 HG23 ' HA ' ' A' ' 196' ' ' ARG . 73.7 t -61.19 -49.05 86.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.161 0.505 . . . . 0.0 111.257 -178.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 34.7 p -168.52 163.84 12.47 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.282 0.563 . . . . 0.0 111.009 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 31.3 m -76.85 -9.89 12.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.349 179.509 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -101.37 -23.49 14.36 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.852 178.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 60.4 t0 -96.68 105.77 17.93 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.04 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -109.77 5.92 23.12 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.177 0.513 . . . . 0.0 110.632 179.63 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 85.9 p -68.43 -59.76 2.94 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.677 -179.317 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -147.49 155.77 42.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.17 0.51 . . . . 0.0 111.25 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 196' ' ' ARG . . . . . 0.542 ' O ' ' O ' ' A' ' 166' ' ' VAL . 99.8 mtt180 -129.58 143.78 50.98 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.533 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 197' ' ' TYR . . . . . 0.83 ' OH ' ' HB2' ' A' ' 139' ' ' ALA . 36.4 p90 -93.16 152.07 19.46 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.425 0.631 . . . . 0.0 111.314 -179.335 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.413 HG11 HG21 ' A' ' 173' ' ' VAL . 48.4 t -123.7 132.93 70.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.378 179.309 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.61 HG22 HG12 ' A' ' 163' ' ' VAL . 40.7 t -94.0 132.32 38.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.989 -179.243 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -119.3 145.0 46.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.465 0.65 . . . . 0.0 111.393 -179.124 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 201' ' ' GLY . . . . . 0.468 ' O ' HG22 ' A' ' 182' ' ' ILE . . . -142.8 146.08 16.62 Favored Glycine 0 CA--C 1.529 0.945 0 N-CA-C 110.451 -1.06 . . . . 0.0 110.451 179.587 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 48.9 p-10 -109.04 151.66 26.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.175 0.512 . . . . 0.0 111.427 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 203' ' ' LEU . . . . . 0.44 HD12 ' O ' ' A' ' 157' ' ' GLU . 51.0 tp -72.48 132.36 43.76 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 178.838 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 2.6 p -115.25 -19.19 6.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 120.74 -0.384 . . . . 0.0 111.493 -179.303 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 205' ' ' GLY . . . . . 0.422 ' O ' HD11 ' A' ' 203' ' ' LEU . . . -178.3 174.64 46.89 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 120.804 -0.712 . . . . 0.0 111.66 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 206' ' ' THR . . . . . 0.425 HG23 ' CD1' ' A' ' 156' ' ' TYR . 60.3 m -141.04 136.3 31.91 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-O 120.662 0.268 . . . . 0.0 110.652 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -143.96 115.62 8.18 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 120.153 -0.619 . . . . 0.0 112.309 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -64.3 147.57 52.2 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.256 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 8.4 ttpt -80.34 109.53 14.92 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.365 178.749 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 98.0 mttt . . . . . 0 C--O 1.221 -0.428 0 CA-C-O 117.837 -1.078 . . . . 0.0 110.536 179.142 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 702' ' ' LEU . . . . . 0.777 HD23 ' O ' ' A' ' 170' ' ' LYS . 0.2 OUTLIER . . . . . 0 CA--C 1.539 0.539 0 CA-C-O 121.628 0.728 . . . . 20.0 110.892 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 703' ' ' PRO . . . . . 0.658 ' CD ' HG13 ' A' ' 110' ' ' VAL . 3.7 Cg_exo -72.18 -171.04 0.63 Allowed 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 123.84 3.027 . . . . 20.0 112.982 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 704' ' ' ALA . . . . . 0.547 ' O ' ' O ' ' B' ' 703' ' ' PRO . . . . . . . . 0 CA--C 1.534 0.34 0 CA-C-N 115.079 -0.964 . . . . 20.0 113.129 -178.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.256 0 CA-C-O 121.42 0.628 . . . . 0.0 110.17 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 5.4 p -82.6 10.08 8.14 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.546 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -96.74 8.56 44.0 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.238 0.542 . . . . 0.0 110.869 -179.46 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 59.0 mt -55.19 142.72 9.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.953 0.882 . . . . 0.0 111.68 -177.75 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -75.48 126.95 32.05 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 114.142 -1.39 . . . . 0.0 108.775 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.682 ' CD ' ' H ' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -78.72 130.87 69.32 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.708 -178.867 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.627 ' HD2' HD21 ' A' ' 104' ' ' LEU . 56.8 Cg_exo -51.14 150.52 13.85 Favored 'Trans proline' 0 N--CA 1.493 1.471 0 C-N-CA 121.695 1.597 . . . . 0.0 111.767 178.705 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.444 ' CG ' ' H ' ' A' ' 66' ' ' LEU . 45.0 t0 -52.41 177.51 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 121.198 0.523 . . . . 0.0 111.506 -178.804 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.742 HD21 HG23 ' A' ' 133' ' ' VAL . 94.5 mt -65.95 -45.25 82.5 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.672 -178.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.63 -30.59 70.81 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.229 -0.588 . . . . 0.0 110.704 -178.528 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -62.82 -30.36 71.42 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.431 178.778 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.611 HG22 HD22 ' A' ' 104' ' ' LEU . 37.3 t -77.84 -46.27 27.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.131 -0.94 . . . . 0.0 110.685 179.403 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.08 -9.58 58.29 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.144 -0.935 . . . . 0.0 111.244 -179.084 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -109.35 -13.61 14.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.318 0.58 . . . . 0.0 110.095 178.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.37 135.44 51.8 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.712 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 33.0 t -59.47 103.01 0.16 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.647 -179.458 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.85 125.95 28.25 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.591 -179.546 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -98.49 83.77 3.07 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 121.382 0.611 . . . . 0.0 109.95 178.704 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -62.82 -38.28 90.11 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.376 -179.529 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.577 ' CD ' ' H ' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -71.51 -12.03 61.17 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 120.471 -0.492 . . . . 0.0 110.999 -177.347 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -93.05 0.71 57.4 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.423 0.63 . . . . 0.0 110.203 178.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 88.3 t -86.11 128.31 39.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.132 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 16.5 pt -107.35 -7.9 10.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.239 -179.198 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -170.95 179.33 42.91 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 120.454 -0.879 . . . . 0.0 111.808 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 56.4 ttp180 -140.24 156.26 46.56 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 121.378 0.609 . . . . 0.0 111.315 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.475 HG22 ' O ' ' A' ' 92' ' ' LEU . 16.8 tt -125.29 141.98 43.56 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 CA-C-O 121.437 0.637 . . . . 0.0 110.464 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 66.5 m -135.31 130.31 34.86 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.093 -0.958 . . . . 0.0 111.258 -178.541 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.429 ' CG2' HG22 ' A' ' 88' ' ' VAL . 22.6 mt -133.79 88.73 32.12 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.121 -178.847 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -54.9 -35.36 89.03 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 123.278 2.652 . . . . 0.0 112.644 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 44.4 t -55.88 -43.41 77.15 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.192 -0.458 . . . . 0.0 112.212 -179.13 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.429 HG22 ' CG2' ' A' ' 85' ' ' ILE . 21.7 m -112.21 6.36 8.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.285 0.564 . . . . 0.0 110.731 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.7 m 56.05 53.01 9.61 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.196 179.223 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 58.1 tp -116.7 135.52 53.71 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.309 0.576 . . . . 0.0 110.779 179.413 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -146.44 117.06 7.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.115 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.475 ' O ' HG22 ' A' ' 83' ' ' ILE . 75.5 mt -150.27 151.45 31.49 Favored Pre-proline 0 CA--C 1.539 0.538 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.481 -179.293 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -74.2 147.0 37.02 Favored 'Trans proline' 0 N--CA 1.493 1.475 0 C-N-CA 122.833 2.355 . . . . 0.0 111.827 179.155 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.549 ' C ' HD12 ' A' ' 95' ' ' LEU . 74.2 t -92.46 122.22 43.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.083 0.468 . . . . 0.0 110.228 179.488 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.581 HD12 ' N ' ' A' ' 95' ' ' LEU . 10.2 mp -100.67 126.66 47.2 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.806 0.812 . . . . 0.0 110.672 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -63.02 -46.45 87.56 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.34 -1.3 . . . . 0.0 112.835 -178.166 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 4.3 m -86.25 132.09 34.07 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 121.123 0.487 . . . . 0.0 111.75 -179.203 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -87.17 60.41 6.14 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.352 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.552 HG22 ' N ' ' A' ' 100' ' ' GLU . 54.1 m -88.11 163.31 16.28 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 178.887 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.552 ' N ' HG22 ' A' ' 99' ' ' THR . 94.5 mt-10 -58.56 -44.56 89.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.284 0.564 . . . . 0.0 110.232 -179.424 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.406 ' H ' HG22 ' A' ' 99' ' ' THR . 66.3 mttm -64.8 -40.33 95.05 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.717 0.77 . . . . 0.0 110.077 178.197 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -63.25 -36.42 83.62 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.054 -0.975 . . . . 0.0 111.711 -179.336 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.644 HD13 ' HB3' ' B' ' 704' ' ' ALA . 74.6 mt -61.89 -25.53 67.61 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 120.809 -0.357 . . . . 0.0 111.223 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.627 HD21 ' HD2' ' A' ' 64' ' ' PRO . 84.6 mt -73.15 -13.32 61.15 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.908 0.385 . . . . 0.0 111.029 -179.483 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 94.4 p -73.98 -9.01 58.21 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.392 0.615 . . . . 0.0 110.158 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.524 ' O ' ' CE1' ' A' ' 135' ' ' PHE . . . 95.31 -20.86 47.36 Favored Glycine 0 CA--C 1.526 0.779 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.884 178.729 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -146.92 125.48 12.47 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.215 -0.594 . . . . 0.0 111.376 179.418 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -144.15 129.11 18.5 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.116 179.005 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.657 ' HA ' HD23 ' A' ' 123' ' ' LEU . 27.7 m -66.96 131.55 46.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.897 -179.483 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.625 HG22 ' HG2' ' B' ' 703' ' ' PRO . 92.7 t -79.07 -53.31 13.74 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.91 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.822 ' H ' ' NE2' ' A' ' 114' ' ' GLN . 73.3 mmtt -100.73 131.68 46.5 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 122.134 0.969 . . . . 0.0 111.949 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -66.09 -27.94 68.44 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 114.627 -1.17 . . . . 0.0 113.076 -178.249 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -84.14 12.97 5.6 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 113.863 1.06 . . . . 0.0 113.863 -177.602 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLN . . . . . 0.822 ' NE2' ' H ' ' A' ' 111' ' ' LYS . 45.5 mt-30 -77.96 143.28 37.75 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.348 0.595 . . . . 0.0 112.502 -179.622 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 53.0 t -123.56 124.64 69.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.046 178.264 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 63.6 mtt -58.42 130.5 47.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.417 179.581 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 84.19 -1.13 89.13 Favored Glycine 0 CA--C 1.529 0.933 0 N-CA-C 111.551 -0.619 . . . . 0.0 111.551 179.093 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -143.85 128.18 17.82 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 121.048 0.451 . . . . 0.0 110.787 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 78.76 -177.68 53.83 Favored Glycine 0 CA--C 1.532 1.117 0 N-CA-C 111.82 -0.512 . . . . 0.0 111.82 179.529 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 61.7 t-20 -84.97 105.4 15.7 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 120.943 0.402 . . . . 0.0 110.131 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.502 ' HE2' HD21 ' A' ' 123' ' ' LEU . 3.7 t80 -86.6 99.69 11.89 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.012 0.434 . . . . 0.0 110.386 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.58 ' HB3' HG13 ' A' ' 174' ' ' VAL . . . -93.09 137.11 32.74 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 121.08 0.467 . . . . 0.0 111.628 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.657 HD23 ' HA ' ' A' ' 109' ' ' THR . 61.1 mt -136.26 142.56 43.99 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.59 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -107.38 139.59 41.63 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 178.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -137.52 148.07 19.6 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 109.254 -1.538 . . . . 0.0 109.254 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 12.6 m-70 -92.26 123.68 35.77 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.744 0.783 . . . . 0.0 112.411 -178.758 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ASN . . . . . 0.401 ' OD1' ' N ' ' A' ' 129' ' ' SER . 52.0 t-20 -116.27 119.71 36.6 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.086 179.282 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.44 ' HB2' HG21 ' A' ' 133' ' ' VAL . 68.6 mtt -94.92 -2.75 49.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.351 0.596 . . . . 0.0 109.923 179.605 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.401 ' N ' ' OD1' ' A' ' 127' ' ' ASN . 0.2 OUTLIER 74.55 6.56 4.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.07 179.585 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.788 ' O ' HG12 ' A' ' 133' ' ' VAL . 11.4 ptpt -113.43 120.71 41.98 Favored 'General case' 0 C--O 1.225 -0.235 0 CA-C-O 121.33 0.586 . . . . 0.0 112.224 -179.379 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.51 ' O ' ' O ' ' A' ' 130' ' ' LYS . 18.2 tptt -31.93 155.13 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.616 179.316 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 77.39 -17.01 5.51 Favored Glycine 0 CA--C 1.529 0.913 0 N-CA-C 110.819 -0.912 . . . . 0.0 110.819 179.462 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.788 HG12 ' O ' ' A' ' 130' ' ' LYS . 7.8 p -91.62 150.88 3.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 120.057 -0.657 . . . . 0.0 109.732 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.795 HD23 ' N ' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -68.27 146.18 53.57 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 122.035 0.922 . . . . 0.0 113.245 -177.112 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.524 ' CE1' ' O ' ' A' ' 106' ' ' GLY . 3.2 m-85 65.12 5.38 2.97 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 113.787 -1.551 . . . . 0.0 113.865 178.143 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' SER . . . . . 0.519 ' OG ' ' CG1' ' A' ' 133' ' ' VAL . 0.5 OUTLIER -71.65 -38.94 70.64 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 121.692 -0.63 . . . . 0.0 112.593 179.465 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 79.0 m-20 -93.46 0.73 56.86 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 114.9 1.444 . . . . 0.0 114.9 -177.025 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.554 HD11 ' HB ' ' A' ' 186' ' ' THR . 38.4 pt -63.87 -22.83 31.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 119.038 -1.065 . . . . 0.0 110.471 -178.908 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -69.49 -10.86 59.85 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.268 0.556 . . . . 0.0 110.086 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 1.4 m -84.45 -5.21 59.26 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.572 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 82.1 mt -64.75 145.55 56.07 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.409 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -120.71 157.59 29.32 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 121.455 0.645 . . . . 0.0 112.148 -178.376 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -50.67 131.97 25.79 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.6 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.452 ' N ' ' O ' ' A' ' 160' ' ' VAL . . . 80.17 7.37 88.59 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 120.648 -0.787 . . . . 0.0 111.149 179.05 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.489 ' OD1' ' N ' ' A' ' 146' ' ' LYS . 64.9 t0 -73.73 131.56 41.73 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 119.89 -0.724 . . . . 0.0 110.007 -179.705 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.489 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 73.6 mmtt -76.95 140.06 40.34 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.616 0.722 . . . . 0.0 112.124 -178.272 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 48.9 mm -131.51 134.42 60.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 177.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' TYR . . . . . 0.431 ' C ' HD22 ' A' ' 149' ' ' LEU . 78.9 m-85 -112.49 127.49 56.07 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 119.747 -0.781 . . . . 0.0 112.424 -178.315 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.431 HD22 ' C ' ' A' ' 148' ' ' TYR . 4.4 mm? -110.79 132.43 54.2 Favored 'General case' 0 C--O 1.224 -0.279 0 CA-C-N 114.943 -1.026 . . . . 0.0 108.658 178.374 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.594 ' CE2' ' OE1' ' A' ' 155' ' ' GLU . 61.2 m-85 -117.21 112.14 20.41 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.204 -0.598 . . . . 0.0 112.569 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' ASP . . . . . 0.563 ' OD1' ' N ' ' A' ' 152' ' ' ASN . 54.6 t0 -91.2 164.81 13.77 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 176.56 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' ASN . . . . . 0.563 ' N ' ' OD1' ' A' ' 151' ' ' ASP . 15.6 m120 -57.61 -23.93 53.66 Favored 'General case' 0 C--N 1.311 -1.074 0 C-N-CA 120.106 -0.637 . . . . 0.0 111.112 -178.023 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -108.3 -29.68 8.74 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 119.762 -0.775 . . . . 0.0 112.839 -178.664 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' ASN . . . . . 0.471 ' O ' ' N ' ' A' ' 151' ' ' ASP . 0.5 OUTLIER -149.51 -177.51 5.9 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 113.723 1.008 . . . . 0.0 113.723 -177.779 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.594 ' OE1' ' CE2' ' A' ' 150' ' ' TYR . 80.0 tt0 -128.76 138.09 51.91 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 114.209 -1.36 . . . . 0.0 110.066 179.143 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -111.56 134.0 53.44 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 121.354 0.597 . . . . 0.0 111.383 -179.608 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -89.65 108.25 19.56 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.453 178.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -112.02 147.22 36.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.026 0.441 . . . . 0.0 111.187 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.525 ' HB2' HG21 ' A' ' 204' ' ' VAL . . . -124.32 123.39 40.1 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 121.047 0.451 . . . . 0.0 110.917 179.238 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.452 ' O ' ' N ' ' A' ' 144' ' ' GLY . 81.2 t -59.45 135.09 24.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 178.07 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 42.6 p -105.29 -26.04 12.17 Favored 'General case' 0 C--N 1.33 -0.263 0 O-C-N 123.325 0.39 . . . . 0.0 110.674 179.047 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 162.69 -169.72 38.02 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 120.452 -0.88 . . . . 0.0 111.992 179.63 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 3.0 p -135.11 149.92 29.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.068 -0.566 . . . . 0.0 110.15 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 50.7 m -139.54 163.58 32.17 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.427 0.632 . . . . 0.0 111.187 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -100.22 121.57 41.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.266 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.436 HG11 HG11 ' A' ' 173' ' ' VAL . 27.1 m -136.72 161.3 36.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.386 -179.517 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -92.68 165.03 20.03 Favored Pre-proline 0 CA--C 1.538 0.501 0 C-N-CA 120.662 -0.415 . . . . 0.0 111.054 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 168' ' ' PRO . . . . . 0.431 ' O ' ' CB ' ' B' ' 702' ' ' LEU . 25.0 Cg_exo -62.52 -19.72 68.52 Favored 'Trans proline' 0 N--CA 1.499 1.852 0 C-N-CA 122.489 2.126 . . . . 0.0 112.998 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 46.7 p-10 -94.76 -5.85 44.36 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.549 ' O ' HG22 ' A' ' 173' ' ' VAL . 96.5 mttt -75.95 88.82 2.93 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 119.655 -0.818 . . . . 0.0 111.657 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 4.9 p90 -76.89 -14.49 59.87 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.467 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -57.59 -35.53 70.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.47 -179.099 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' VAL . . . . . 0.549 HG22 ' O ' ' A' ' 170' ' ' LYS . 27.6 m -64.16 -15.56 17.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 C-N-CA 120.771 -0.372 . . . . 0.0 111.253 -179.602 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.58 HG13 ' HB3' ' A' ' 122' ' ' ALA . 78.6 t -103.96 -16.1 7.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -179.361 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -74.57 144.33 44.04 Favored 'General case' 0 CA--C 1.533 0.319 0 O-C-N 121.816 -0.552 . . . . 0.0 110.956 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 176' ' ' ASP . . . . . 0.501 ' OD1' ' O ' ' A' ' 176' ' ' ASP . 55.7 p-10 -64.95 145.16 56.69 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.456 179.726 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 68.9 m80 -120.7 31.73 6.3 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 121.035 0.445 . . . . 0.0 111.759 -179.421 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 59.93 39.79 96.02 Favored Glycine 0 CA--C 1.534 1.228 0 N-CA-C 111.257 -0.737 . . . . 0.0 111.257 179.447 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -155.89 165.72 35.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.028 0.442 . . . . 0.0 110.781 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -88.56 102.03 14.53 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 177.783 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 181' ' ' GLU . . . . . 0.454 ' HG2' ' N ' ' A' ' 182' ' ' ILE . 84.4 tt0 -138.27 163.54 31.51 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.663 0.744 . . . . 0.0 111.909 -178.335 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.454 ' N ' ' HG2' ' A' ' 181' ' ' GLU . 18.6 tt -130.65 138.93 52.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.13 178.839 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 86.0 m -130.3 125.49 34.87 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.477 0.656 . . . . 0.0 111.639 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 93.2 mt -109.54 131.58 54.93 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.111 178.675 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.794 HD13 HD21 ' B' ' 702' ' ' LEU . 82.6 mt -113.91 125.39 71.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.465 0.65 . . . . 0.0 111.889 -177.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 186' ' ' THR . . . . . 0.554 ' HB ' HD11 ' A' ' 138' ' ' ILE . 3.4 t -140.98 161.95 36.62 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.547 179.563 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 187' ' ' CYS . . . . . . . . . . . . . 1.9 m -96.94 146.43 24.97 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.379 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.565 HG13 ' N ' ' A' ' 189' ' ' SER . 8.0 p -63.8 -43.51 97.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.196 0.522 . . . . 0.0 111.353 -179.322 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 189' ' ' SER . . . . . 0.565 ' N ' HG13 ' A' ' 188' ' ' VAL . 13.6 p -162.76 160.88 25.88 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.483 -179.306 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 190' ' ' VAL . . . . . 0.454 HG22 ' O ' ' A' ' 190' ' ' VAL . 9.5 p -79.18 -11.75 13.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.83 179.277 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -97.97 -19.85 17.79 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.052 0.453 . . . . 0.0 111.083 179.229 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 67.2 t0 -132.64 103.67 6.25 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.103 0.478 . . . . 0.0 111.403 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -104.29 10.84 35.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.875 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 44.2 t -60.72 -43.7 97.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.078 0.466 . . . . 0.0 111.109 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -125.03 144.33 50.45 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.05 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -124.47 143.54 50.59 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.852 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -98.67 133.51 42.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.023 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.404 ' CG2' HG21 ' A' ' 166' ' ' VAL . 30.0 t -120.3 131.17 73.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 CA-C-O 121.426 0.631 . . . . 0.0 110.936 179.271 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 31.7 t -104.28 132.07 51.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.194 179.668 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -113.78 144.38 43.07 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.368 0.604 . . . . 0.0 111.556 -179.344 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -136.46 139.32 10.55 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 110.356 -1.098 . . . . 0.0 110.356 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -103.47 138.65 39.9 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.145 0.497 . . . . 0.0 110.816 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 66.0 tp -62.83 131.52 49.08 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.466 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.525 HG21 ' HB2' ' A' ' 159' ' ' ALA . 2.8 t -115.37 -19.81 6.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 C-N-CA 120.762 -0.375 . . . . 0.0 111.503 -178.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -178.13 173.53 46.01 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 120.649 -0.786 . . . . 0.0 111.716 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 24.7 m -140.87 137.02 32.91 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.584 -0.525 . . . . 0.0 109.584 179.308 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -143.92 117.27 9.05 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.335 0.588 . . . . 0.0 112.075 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -62.43 141.71 58.23 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.991 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 8.9 ttpt -78.52 109.52 12.77 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.224 178.512 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 99.8 mttt . . . . . 0 C--N 1.322 -0.606 0 CA-C-O 117.914 -1.041 . . . . 0.0 110.828 -179.293 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 702' ' ' LEU . . . . . 0.794 HD21 HD13 ' A' ' 185' ' ' ILE . 0.4 OUTLIER . . . . . 0 CA--C 1.543 0.681 0 N-CA-C 110.125 -0.324 . . . . 20.0 110.125 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 703' ' ' PRO . . . . . 0.633 ' HD2' HD23 ' B' ' 702' ' ' LEU . 2.8 Cg_endo -65.68 -176.83 0.61 Allowed 'Trans proline' 0 N--CA 1.489 1.249 0 C-N-CA 121.663 1.575 . . . . 20.0 113.047 -179.131 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 704' ' ' ALA . . . . . 0.644 ' HB3' HD13 ' A' ' 103' ' ' LEU . . . . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 114.319 -1.31 . . . . 20.0 113.527 -179.114 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.172 0 CA-C-O 121.058 0.456 . . . . 0.0 111.524 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 98.4 p -87.72 1.59 53.39 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.587 0.708 . . . . 0.0 110.077 178.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -100.26 10.27 41.49 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.038 -178.402 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 95.7 mt -56.04 135.22 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-O 122.159 0.981 . . . . 0.0 112.948 -176.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 85.0 m-20 -75.94 130.61 38.73 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 113.881 -1.509 . . . . 0.0 108.913 178.326 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.625 ' CD ' ' H ' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -82.25 152.49 67.88 Favored Pre-proline 0 C--N 1.328 -0.348 0 C-N-CA 120.15 -0.62 . . . . 0.0 110.49 -179.66 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -72.43 169.92 20.54 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 123.135 2.557 . . . . 0.0 112.76 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -54.65 169.61 0.2 Allowed 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.416 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 57.2 tp -64.3 -45.4 88.14 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.688 -179.018 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.73 -36.14 75.99 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.09 -0.644 . . . . 0.0 111.157 -177.737 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.604 ' OE1' ' N ' ' A' ' 68' ' ' GLU . 4.9 mp0 -55.88 -28.84 58.53 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.444 0.64 . . . . 0.0 109.511 178.862 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 38.3 t -76.59 -44.41 34.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-N 115.342 -0.844 . . . . 0.0 110.823 179.427 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -79.7 -8.08 59.0 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.974 -179.396 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -105.89 -13.14 15.59 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.337 0.589 . . . . 0.0 109.926 178.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -70.03 138.22 51.97 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.516 -0.766 . . . . 0.0 111.31 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 37.4 t -59.54 100.31 0.08 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.447 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.688 HD13 ' C ' ' A' ' 74' ' ' LEU . 2.8 tm? -71.12 122.87 20.92 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.137 -179.115 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.677 ' N ' HD13 ' A' ' 74' ' ' LEU . 91.4 m-20 -92.66 80.59 4.77 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 121.299 0.571 . . . . 0.0 110.501 178.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 51.8 tptt -65.83 -32.88 74.65 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.052 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.512 ' HE3' ' H ' ' A' ' 77' ' ' LYS . 3.0 mtmt -72.63 -18.31 61.59 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.414 -177.704 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -90.54 -9.51 46.92 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.033 0.444 . . . . 0.0 110.836 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 96.5 t -70.25 130.27 34.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.404 0.621 . . . . 0.0 111.263 -179.273 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.413 HG21 ' HE3' ' A' ' 96' ' ' LYS . 42.9 pt -118.13 -11.86 11.19 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.579 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -159.83 170.02 35.92 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 111.154 -0.779 . . . . 0.0 111.154 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 61.9 ttp180 -143.61 151.35 40.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.542 0.686 . . . . 0.0 112.154 -179.106 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.455 HG22 ' O ' ' A' ' 92' ' ' LEU . 21.0 tt -112.79 138.01 43.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.546 178.612 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 33.3 t -135.64 128.7 31.58 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 121.518 0.675 . . . . 0.0 111.903 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.508 HG22 HG22 ' A' ' 88' ' ' VAL . 85.1 mt -138.16 86.07 17.89 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.182 179.461 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -55.96 -29.85 75.27 Favored 'Trans proline' 0 N--CA 1.497 1.703 0 C-N-CA 123.091 2.527 . . . . 0.0 113.16 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 95.9 p -53.45 -38.43 63.55 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 120.537 -0.465 . . . . 0.0 111.005 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.508 HG22 HG22 ' A' ' 85' ' ' ILE . 23.7 m -117.47 12.2 7.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.387 0.613 . . . . 0.0 110.001 178.574 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 48.21 53.55 11.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.762 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.546 HD11 HD11 ' A' ' 92' ' ' LEU . 58.0 tp -114.93 132.47 56.54 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.318 179.68 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.739 ' O ' HD23 ' A' ' 92' ' ' LEU . 96.2 mt-10 -145.78 122.36 11.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.649 -179.254 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.739 HD23 ' O ' ' A' ' 91' ' ' GLU . 8.6 mt -146.81 147.74 30.79 Favored Pre-proline 0 CA--C 1.54 0.56 0 C-N-CA 120.198 -0.601 . . . . 0.0 111.95 -179.099 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -77.15 151.57 30.38 Favored 'Trans proline' 0 N--CA 1.497 1.688 0 C-N-CA 123.059 2.506 . . . . 0.0 112.478 178.795 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.462 ' C ' HD12 ' A' ' 95' ' ' LEU . 87.7 t -95.52 113.24 29.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-O 121.065 0.46 . . . . 0.0 111.613 179.311 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.562 HD12 ' N ' ' A' ' 95' ' ' LEU . 11.1 mp -98.87 139.82 33.96 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.96 179.6 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.485 ' O ' ' OG1' ' A' ' 109' ' ' THR . 98.8 mttt -63.79 -80.97 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -178.731 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 33.6 t -60.86 131.14 49.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.186 0.517 . . . . 0.0 111.838 -178.576 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 35.3 p -89.72 71.68 7.73 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.99 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.534 HG22 ' N ' ' A' ' 100' ' ' GLU . 26.1 m -92.21 169.53 10.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.505 -0.771 . . . . 0.0 109.251 178.9 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.534 ' N ' HG22 ' A' ' 99' ' ' THR . 99.1 mt-10 -61.65 -44.43 96.98 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 119.776 -0.77 . . . . 0.0 110.059 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -65.7 -40.99 92.86 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 121.33 0.586 . . . . 0.0 110.955 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -63.92 -38.7 92.05 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.149 -179.513 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 64.9 mt -62.63 -18.86 63.08 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.608 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 75.2 mt -70.74 -18.37 62.78 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.998 0.428 . . . . 0.0 110.39 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 88.9 p -74.45 -8.77 57.38 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.555 0.693 . . . . 0.0 109.286 179.17 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.608 ' O ' ' CE1' ' A' ' 135' ' ' PHE . . . 93.01 -19.15 53.98 Favored Glycine 0 CA--C 1.53 0.974 0 CA-C-N 115.123 -0.944 . . . . 0.0 112.337 178.616 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -146.25 126.76 14.13 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 119.659 -0.816 . . . . 0.0 112.745 -179.409 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -143.54 138.85 29.43 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.042 178.443 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.485 ' OG1' ' O ' ' A' ' 96' ' ' LYS . 30.0 p -65.67 133.03 50.25 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 121.271 0.558 . . . . 0.0 110.718 -179.556 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.576 HG22 ' HG2' ' B' ' 703' ' ' PRO . 44.4 t -80.52 -50.4 17.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.385 -179.168 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.753 ' H ' ' NE2' ' A' ' 114' ' ' GLN . 76.8 mttt -105.65 141.22 37.47 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.835 0.826 . . . . 0.0 112.631 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -66.8 -36.26 81.97 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.174 -0.921 . . . . 0.0 112.917 -178.789 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 17.0 p30 -82.13 15.88 2.19 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -178.328 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLN . . . . . 0.753 ' NE2' ' H ' ' A' ' 111' ' ' LYS . 32.9 mt-30 -78.2 137.42 38.13 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 122.031 -0.418 . . . . 0.0 110.482 179.487 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 69.0 t -124.24 125.87 71.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.269 -0.423 . . . . 0.0 109.994 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' MET . . . . . 0.598 ' SD ' ' CZ ' ' A' ' 121' ' ' TYR . 91.7 mmm -56.53 125.75 23.48 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.097 0.475 . . . . 0.0 111.467 -179.605 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 82.59 -0.66 89.11 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-N 115.905 -0.589 . . . . 0.0 112.294 178.771 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -138.07 130.56 29.29 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 119.998 -0.681 . . . . 0.0 110.637 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 74.2 -169.47 53.91 Favored Glycine 0 CA--C 1.53 1.006 0 N-CA-C 110.518 -1.033 . . . . 0.0 110.518 -179.376 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 58.8 t-20 -89.39 105.62 17.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.992 0.425 . . . . 0.0 110.04 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.598 ' CZ ' ' SD ' ' A' ' 116' ' ' MET . 11.4 t80 -88.45 100.44 13.05 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.015 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.14 137.71 32.12 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 121.276 0.56 . . . . 0.0 111.745 -178.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.508 HD21 ' CE2' ' A' ' 121' ' ' TYR . 62.7 mt -135.21 137.33 42.53 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.923 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -112.07 135.69 52.4 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.389 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -130.75 134.22 7.67 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 110.601 -1.0 . . . . 0.0 110.601 -179.218 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -82.14 138.46 34.74 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.504 0.669 . . . . 0.0 111.627 -179.394 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ASN . . . . . 0.924 ' C ' HD21 ' A' ' 127' ' ' ASN . 0.2 OUTLIER -141.47 161.0 38.98 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.14 -0.937 . . . . 0.0 110.388 179.568 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.445 ' O ' ' CB ' ' A' ' 129' ' ' SER . 70.7 mtm -124.28 1.19 8.43 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.575 178.846 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.445 ' CB ' ' O ' ' A' ' 128' ' ' MET . 0.2 OUTLIER 76.93 12.37 2.31 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.764 179.361 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.775 ' O ' HG12 ' A' ' 133' ' ' VAL . 9.3 ptpt -115.21 119.54 36.71 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.465 0.65 . . . . 0.0 112.295 -179.254 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.536 ' O ' ' O ' ' A' ' 130' ' ' LYS . 74.7 mmtt -29.07 154.73 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.893 -1.048 . . . . 0.0 111.611 179.453 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 75.34 -15.09 4.64 Favored Glycine 0 CA--C 1.529 0.94 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.964 179.088 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.775 HG12 ' O ' ' A' ' 130' ' ' LYS . 9.8 p -91.27 153.8 3.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 C-N-CA 120.371 -0.532 . . . . 0.0 109.785 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.782 HD23 ' N ' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -70.69 144.47 51.02 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 113.97 1.1 . . . . 0.0 113.97 -177.396 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.659 ' CG ' HD12 ' A' ' 138' ' ' ILE . 3.9 m-85 68.7 -0.94 2.14 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 113.67 -1.605 . . . . 0.0 113.598 178.579 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 6.7 t -69.4 -39.43 77.94 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 179.349 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -89.36 -6.99 56.16 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.355 0.598 . . . . 0.0 111.252 -178.617 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.659 HD12 ' CG ' ' A' ' 135' ' ' PHE . 8.0 mt -62.86 -42.32 95.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.433 179.329 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -63.38 -12.02 27.33 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 120.238 -0.585 . . . . 0.0 110.337 179.228 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 1.9 m -82.36 -6.19 59.1 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.325 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.406 HD12 HG23 ' A' ' 138' ' ' ILE . 81.4 mt -63.27 142.02 58.54 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.212 179.795 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -116.76 163.62 15.87 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.701 0.762 . . . . 0.0 111.81 -179.013 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -52.08 134.97 32.15 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.868 -1.06 . . . . 0.0 112.158 179.297 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.545 ' N ' ' O ' ' A' ' 160' ' ' VAL . . . 77.14 7.97 86.85 Favored Glycine 0 CA--C 1.527 0.818 0 CA-C-N 115.541 -0.754 . . . . 0.0 112.313 178.011 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 50.6 t0 -72.62 132.93 44.37 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 119.541 -0.864 . . . . 0.0 109.804 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -77.45 138.1 39.05 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 121.663 0.744 . . . . 0.0 111.716 -178.447 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.489 HD11 ' CG2' ' A' ' 160' ' ' VAL . 87.2 mt -133.42 135.4 56.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 114.958 -1.019 . . . . 0.0 108.342 178.637 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' TYR . . . . . 0.404 ' C ' HD22 ' A' ' 149' ' ' LEU . 69.9 m-85 -115.64 133.52 55.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.535 0.683 . . . . 0.0 112.689 -178.243 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.433 HD13 ' HA ' ' A' ' 149' ' ' LEU . 4.5 mm? -115.64 133.02 56.44 Favored 'General case' 0 C--O 1.225 -0.229 0 CA-C-N 115.158 -0.928 . . . . 0.0 108.872 177.891 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.592 ' CZ ' ' OE2' ' A' ' 155' ' ' GLU . 93.4 m-85 -116.39 114.0 23.68 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.315 -0.554 . . . . 0.0 111.138 179.504 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' ASP . . . . . 0.467 ' OD1' ' N ' ' A' ' 152' ' ' ASN . 54.1 t0 -93.29 172.3 8.38 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 177.751 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' ASN . . . . . 0.467 ' N ' ' OD1' ' A' ' 151' ' ' ASP . 68.6 m-20 -58.04 -26.85 63.0 Favored 'General case' 0 C--N 1.318 -0.764 0 C-N-CA 120.483 -0.487 . . . . 0.0 111.477 -177.844 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -115.08 -24.19 8.67 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 -178.22 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -146.86 177.73 8.89 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -176.159 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.592 ' OE2' ' CZ ' ' A' ' 150' ' ' TYR . 83.8 tt0 -126.99 138.0 53.19 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 114.644 -1.162 . . . . 0.0 110.323 178.886 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 156' ' ' TYR . . . . . 0.426 ' CD1' HG23 ' A' ' 206' ' ' THR . 92.0 m-85 -115.12 133.97 55.58 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 121.089 0.471 . . . . 0.0 111.676 -179.094 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -92.95 109.55 21.0 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.482 179.491 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -112.82 148.64 34.43 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.091 0.472 . . . . 0.0 111.168 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -125.23 124.46 41.74 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 121.331 0.586 . . . . 0.0 111.226 179.61 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.545 ' O ' ' N ' ' A' ' 144' ' ' GLY . 77.5 t -59.06 136.47 22.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.918 178.152 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 66.8 p -104.43 -24.81 13.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.09 0.472 . . . . 0.0 110.918 179.4 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 157.97 -167.7 34.35 Favored Glycine 0 CA--C 1.529 0.939 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.672 HG12 HG22 ' A' ' 199' ' ' VAL . 2.8 m -133.55 158.55 42.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.165 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 69.8 m -142.62 164.27 30.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.479 0.657 . . . . 0.0 111.731 -179.611 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -99.59 114.43 27.46 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.682 179.667 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 20.5 m -136.79 158.12 36.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.42 0.629 . . . . 0.0 111.582 -179.051 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -87.65 159.01 50.38 Favored Pre-proline 0 CA--C 1.536 0.423 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.996 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 168' ' ' PRO . . . . . 0.443 ' O ' HD12 ' B' ' 702' ' ' LEU . 37.2 Cg_endo -64.81 -10.54 25.41 Favored 'Trans proline' 0 N--CA 1.498 1.739 0 C-N-CA 122.861 2.374 . . . . 0.0 112.98 -179.416 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 45.5 p-10 -95.44 -8.24 35.99 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.723 ' O ' HD23 ' B' ' 702' ' ' LEU . 98.0 mttt -77.13 86.73 3.6 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 121.75 0.786 . . . . 0.0 112.256 -179.194 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 171' ' ' TRP . . . . . 0.606 ' O ' HG22 ' A' ' 174' ' ' VAL . 1.2 p-90 -80.47 -9.25 59.77 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.798 -1.092 . . . . 0.0 110.883 179.583 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -63.89 -32.11 73.52 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.818 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 173' ' ' VAL . . . . . 0.656 HG22 ' O ' ' A' ' 170' ' ' LYS . 35.0 m -63.13 -18.71 22.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-N 116.112 -0.495 . . . . 0.0 112.137 -179.152 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.613 HG13 HG23 ' A' ' 173' ' ' VAL . 34.8 m -106.47 -0.36 9.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -179.11 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.51 ' OE2' ' CE2' ' A' ' 171' ' ' TRP . 96.7 mt-10 -74.0 149.21 41.4 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 121.138 0.494 . . . . 0.0 111.51 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 176' ' ' ASP . . . . . 0.464 ' OD1' ' O ' ' A' ' 176' ' ' ASP . 46.8 p-10 -68.4 135.0 51.08 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.531 179.23 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 41.9 m80 -117.32 28.68 8.33 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 120.704 -0.398 . . . . 0.0 111.255 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 62.82 34.35 89.53 Favored Glycine 0 CA--C 1.531 1.031 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 179.563 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -152.69 163.63 39.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.842 0.353 . . . . 0.0 110.422 179.601 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -88.14 106.41 18.16 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 177.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 181' ' ' GLU . . . . . 0.435 ' HG2' ' N ' ' A' ' 182' ' ' ILE . 82.7 tt0 -136.18 161.32 36.06 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.421 0.629 . . . . 0.0 111.275 -178.511 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.435 ' N ' ' HG2' ' A' ' 181' ' ' GLU . 17.3 tt -130.11 137.18 57.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.463 -0.789 . . . . 0.0 108.947 178.747 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 85.0 m -131.03 128.02 39.45 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.076 0.465 . . . . 0.0 111.493 -179.089 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 68.4 mt -112.95 133.39 54.94 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.742 178.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 82.0 mt -109.48 120.11 60.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.23 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 8.8 t -133.28 147.74 51.92 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.709 179.601 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 187' ' ' CYS . . . . . 0.601 ' HB2' HD22 ' A' ' 127' ' ' ASN . 2.1 m -87.65 142.31 27.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.863 -179.718 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.569 HG13 ' N ' ' A' ' 189' ' ' SER . 14.3 p -62.35 -44.7 99.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.888 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 189' ' ' SER . . . . . 0.569 ' N ' HG13 ' A' ' 188' ' ' VAL . 24.9 t -170.69 148.72 3.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.122 0.487 . . . . 0.0 111.104 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 190' ' ' VAL . . . . . 0.408 HG22 ' O ' ' A' ' 190' ' ' VAL . 8.7 p -68.77 -14.86 19.02 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 CA-C-O 121.187 0.518 . . . . 0.0 110.493 179.47 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -95.61 -11.74 26.77 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.574 179.641 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -135.67 102.2 5.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.223 0.535 . . . . 0.0 110.87 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -102.99 11.25 37.57 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.845 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 12.3 t -60.8 -45.0 96.13 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.639 -178.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 64.7 pttt -142.59 159.82 41.49 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 120.946 0.403 . . . . 0.0 110.635 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 196' ' ' ARG . . . . . 0.48 ' NH1' ' SG ' ' A' ' 187' ' ' CYS . 94.5 mtt-85 -132.32 147.59 52.4 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 121.053 0.454 . . . . 0.0 111.451 -178.439 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -97.19 135.47 39.09 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 121.164 0.507 . . . . 0.0 111.413 179.521 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 38.9 t -120.53 129.46 75.56 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.914 179.228 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.672 HG22 HG12 ' A' ' 163' ' ' VAL . 54.1 t -100.12 133.27 43.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.527 -179.57 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -122.64 152.52 40.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.522 0.677 . . . . 0.0 111.584 -179.387 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -147.41 149.85 22.03 Favored Glycine 0 CA--C 1.532 1.107 0 N-CA-C 110.33 -1.108 . . . . 0.0 110.33 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -106.28 148.89 27.45 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.927 0.394 . . . . 0.0 111.007 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 62.4 tp -66.23 130.39 43.05 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 178.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 46.9 t -110.32 -24.19 4.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 C-N-CA 120.8 -0.36 . . . . 0.0 111.609 -178.815 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -178.47 173.74 46.08 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 111.164 -0.775 . . . . 0.0 111.164 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 206' ' ' THR . . . . . 0.426 HG23 ' CD1' ' A' ' 156' ' ' TYR . 19.6 m -142.89 141.76 31.59 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.135 0.493 . . . . 0.0 110.254 179.478 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -141.43 114.55 8.66 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.262 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -64.74 148.1 51.81 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.829 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 55.8 mtmt -77.06 154.99 32.82 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.543 178.737 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 53.9 mtmt . . . . . 0 C--O 1.22 -0.479 0 CA-C-O 117.919 -1.039 . . . . 0.0 110.832 179.573 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 702' ' ' LEU . . . . . 0.723 HD23 ' O ' ' A' ' 170' ' ' LYS . 0.2 OUTLIER . . . . . 0 CA--C 1.537 0.476 0 CA-C-O 121.505 0.669 . . . . 20.0 111.046 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 703' ' ' PRO . . . . . 0.576 ' HG2' HG22 ' A' ' 110' ' ' VAL . 3.1 Cg_exo -73.72 -165.43 0.25 Allowed 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 123.576 2.851 . . . . 20.0 112.898 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 704' ' ' ALA . . . . . 0.55 ' O ' ' O ' ' B' ' 703' ' ' PRO . . . . . . . . 0 CA--C 1.537 0.47 0 CA-C-N 115.008 -0.996 . . . . 20.0 113.081 -179.501 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.239 0 CA-C-O 121.145 0.497 . . . . 0.0 110.828 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 92.4 p -85.25 1.49 48.03 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.242 -178.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.437 ' HG2' HH21 ' A' ' 196' ' ' ARG . 99.5 mttt -99.05 17.54 19.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.069 0.462 . . . . 0.0 111.602 -179.361 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 14.7 mm -55.74 136.62 18.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 122.449 1.119 . . . . 0.0 112.231 -177.874 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -80.12 126.23 30.81 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 113.346 -1.752 . . . . 0.0 109.894 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.402 ' HB2' ' CG ' ' A' ' 126' ' ' HIS . 13.2 tt0 -78.17 123.17 86.03 Favored Pre-proline 0 CA--C 1.533 0.322 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -44.0 170.38 0.02 OUTLIER 'Trans proline' 0 C--N 1.313 -1.341 0 C-N-CA 121.886 1.724 . . . . 0.0 112.318 -179.55 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.463 ' O ' HG23 ' A' ' 69' ' ' VAL . 91.7 m-20 -52.18 163.16 0.4 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.15 -179.321 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 55.0 tp -62.58 -44.84 95.32 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.786 -177.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -60.43 -38.51 84.31 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.226 -0.589 . . . . 0.0 111.603 -178.152 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 66.3 tt0 -60.85 -25.17 66.45 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.14 -0.624 . . . . 0.0 110.027 179.606 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.634 HG13 ' HB3' ' A' ' 104' ' ' LEU . 36.1 t -77.83 -47.15 25.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.633 0.73 . . . . 0.0 109.774 178.878 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -73.43 -8.53 56.26 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 114.86 -1.064 . . . . 0.0 110.811 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -103.62 -16.95 15.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.502 0.668 . . . . 0.0 110.255 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -69.4 142.7 53.85 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.898 -179.467 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 33.6 t -58.56 97.52 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.564 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -67.79 136.15 53.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.109 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.446 ' OD2' ' CD ' ' A' ' 78' ' ' GLN . 37.6 t0 -103.55 79.11 1.65 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.334 178.772 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -71.76 -35.37 70.05 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.471 0.653 . . . . 0.0 111.962 179.345 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 43.8 mmtt -67.95 -31.12 70.63 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.058 -0.973 . . . . 0.0 112.781 -174.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.446 ' CD ' ' OD2' ' A' ' 75' ' ' ASP . 86.4 mt-30 -87.34 6.3 34.29 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.219 -0.593 . . . . 0.0 111.621 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 59.3 t -78.42 130.13 36.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 120.434 -0.506 . . . . 0.0 109.661 179.115 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.649 HD13 ' HE3' ' A' ' 96' ' ' LYS . 43.4 pt -110.3 -4.71 10.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.778 -179.271 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -163.56 166.0 37.07 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 120.499 -0.858 . . . . 0.0 111.605 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 72.0 ttp85 -137.66 141.29 41.15 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 121.095 0.474 . . . . 0.0 111.191 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.55 HG22 ' O ' ' A' ' 92' ' ' LEU . 19.9 tt -105.08 141.43 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.984 179.23 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 7.9 t -137.63 131.79 32.05 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 121.4 0.619 . . . . 0.0 112.219 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.624 ' CG2' HG22 ' A' ' 88' ' ' VAL . 87.2 mt -136.71 88.05 19.65 Favored Pre-proline 0 CA--C 1.537 0.465 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.805 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -55.4 -32.01 80.01 Favored 'Trans proline' 0 N--CA 1.5 1.881 0 C-N-CA 123.155 2.57 . . . . 0.0 112.571 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 67.3 m -54.3 -42.71 70.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.26 0.552 . . . . 0.0 110.678 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.624 HG22 ' CG2' ' A' ' 85' ' ' ILE . 19.7 m -112.43 6.84 8.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.371 179.592 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 50.65 52.25 15.27 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.879 0.847 . . . . 0.0 110.187 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 52.8 tp -118.32 133.85 55.54 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.185 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -145.05 126.96 15.43 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.734 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.55 ' O ' HG22 ' A' ' 83' ' ' ILE . 80.1 mt -149.06 151.01 33.55 Favored Pre-proline 0 CA--C 1.538 0.497 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.493 -178.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -76.53 148.82 29.95 Favored 'Trans proline' 0 N--CA 1.496 1.66 0 C-N-CA 122.839 2.359 . . . . 0.0 111.804 178.808 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.55 ' C ' HD12 ' A' ' 95' ' ' LEU . 73.8 t -97.3 117.97 42.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-O 121.047 0.451 . . . . 0.0 111.579 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.563 HD12 ' N ' ' A' ' 95' ' ' LEU . 9.4 mp -102.74 134.1 46.68 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.889 179.437 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.649 ' HE3' HD13 ' A' ' 80' ' ' ILE . 98.1 mttt -58.55 -83.4 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 121.26 0.552 . . . . 0.0 111.934 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 18.7 m -61.33 138.31 58.25 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.527 0.679 . . . . 0.0 111.666 -178.375 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 3.1 m -95.4 70.62 3.15 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.17 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 8.7 p -88.54 166.65 14.02 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 177.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -59.13 -40.61 85.99 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 119.931 -0.707 . . . . 0.0 109.994 179.691 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -65.49 -42.18 92.45 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 121.321 0.581 . . . . 0.0 110.709 178.826 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -64.36 -37.05 86.13 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.477 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.493 HD13 ' CB ' ' B' ' 704' ' ' ALA . 84.7 mt -62.93 -18.02 62.57 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.857 -179.488 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.634 ' HB3' HG13 ' A' ' 69' ' ' VAL . 98.0 mt -74.73 -18.0 60.56 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.846 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 50.5 m -74.36 -4.9 39.19 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-O 121.728 0.775 . . . . 0.0 109.366 179.236 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 86.48 -19.78 26.26 Favored Glycine 0 CA--C 1.532 1.134 0 CA-C-N 114.826 -1.079 . . . . 0.0 112.803 178.38 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -145.91 123.98 12.12 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 119.585 -0.846 . . . . 0.0 112.472 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -145.9 141.55 27.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.362 -0.836 . . . . 0.0 109.968 178.553 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.435 ' OG1' ' O ' ' A' ' 96' ' ' LYS . 20.5 p -65.9 136.39 56.05 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.135 -0.626 . . . . 0.0 109.583 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.538 HG13 ' CG ' ' B' ' 703' ' ' PRO . 76.1 t -76.78 -46.12 30.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.928 -179.573 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.406 ' O ' ' HG2' ' A' ' 114' ' ' GLN . 43.3 mtpt -99.09 142.82 30.08 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 122.013 0.911 . . . . 0.0 112.036 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -67.42 -36.09 80.57 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.594 -1.184 . . . . 0.0 111.956 -179.178 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 72.8 m-80 -86.76 22.18 2.02 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 114.203 1.186 . . . . 0.0 114.203 -177.831 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLN . . . . . 0.438 ' OE1' ' O ' ' A' ' 120' ' ' ASN . 94.5 mm-40 -78.37 137.28 37.94 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 121.797 -0.564 . . . . 0.0 112.312 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 61.5 t -128.18 123.96 61.4 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.868 179.003 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 55.6 mtt -58.55 130.91 49.07 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 121.133 0.492 . . . . 0.0 111.924 179.459 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 78.23 -0.51 73.87 Favored Glycine 0 CA--C 1.531 1.051 0 CA-C-N 116.04 -0.527 . . . . 0.0 112.789 178.266 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -138.38 124.99 20.79 Favored 'General case' 0 C--N 1.329 -0.317 0 O-C-N 122.047 -0.678 . . . . 0.0 111.1 -179.484 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 76.12 -165.31 54.01 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 110.337 -1.105 . . . . 0.0 110.337 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.438 ' O ' ' OE1' ' A' ' 114' ' ' GLN . 59.0 t-20 -91.73 105.34 17.65 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.041 0.448 . . . . 0.0 109.864 179.414 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.775 ' CE2' HD11 ' A' ' 123' ' ' LEU . 7.4 t80 -85.43 144.91 27.71 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 179.637 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.905 ' C ' HD12 ' A' ' 123' ' ' LEU . . . -146.8 145.61 29.97 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 119.842 -0.743 . . . . 0.0 111.944 -178.835 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.905 HD12 ' C ' ' A' ' 122' ' ' ALA . 7.4 mp -139.61 145.25 38.3 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.918 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -110.23 135.73 50.53 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 178.779 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -136.72 148.99 20.02 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 110.294 -1.122 . . . . 0.0 110.294 -179.352 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' HIS . . . . . 0.759 ' O ' HD23 ' A' ' 134' ' ' LEU . 21.6 m-70 -86.79 142.52 28.05 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.616 0.722 . . . . 0.0 111.935 -179.157 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 49.5 t-20 -131.51 120.79 23.44 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.142 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.606 ' HB2' HG21 ' A' ' 133' ' ' VAL . 62.9 mtt -94.4 -2.77 51.42 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.227 0.537 . . . . 0.0 110.662 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.466 ' CB ' ' O ' ' A' ' 128' ' ' MET . 0.7 OUTLIER 77.43 3.97 3.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.318 179.123 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.862 ' O ' HG12 ' A' ' 133' ' ' VAL . 61.8 pttt -118.16 130.72 56.27 Favored 'General case' 0 C--O 1.222 -0.357 0 CA-C-O 121.623 0.725 . . . . 0.0 112.817 -178.578 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.473 ' O ' ' O ' ' A' ' 130' ' ' LYS . 74.9 mmtt -41.12 163.66 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.354 0.597 . . . . 0.0 109.616 179.026 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 74.93 -22.51 1.47 Allowed Glycine 0 CA--C 1.53 1.007 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.862 HG12 ' O ' ' A' ' 130' ' ' LYS . 3.7 p -90.25 156.84 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 119.776 -0.77 . . . . 0.0 110.746 -179.36 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.88 HD13 ' H ' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -70.79 146.25 49.87 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 115.023 1.49 . . . . 0.0 115.023 -176.803 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 59.68 7.77 1.14 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 112.504 -2.135 . . . . 0.0 114.153 177.465 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 5.4 t -69.9 -33.27 71.97 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 119.99 -0.684 . . . . 0.0 112.371 179.66 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -89.52 0.65 56.75 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 -178.083 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 2.1 pp -58.2 -31.52 42.29 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 C-N-CA 119.874 -0.73 . . . . 0.0 110.965 -179.268 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -65.1 -13.89 59.16 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.962 0.411 . . . . 0.0 110.876 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 49.3 m -81.52 -4.0 54.74 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.152 -179.104 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 92.9 mt -64.57 142.12 58.54 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.119 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -120.52 156.01 32.44 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.223 0.535 . . . . 0.0 110.185 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -49.63 130.34 20.58 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.848 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 160' ' ' VAL . . . 80.76 8.46 87.47 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 120.837 -0.697 . . . . 0.0 111.914 178.773 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.498 ' OD1' ' N ' ' A' ' 146' ' ' LYS . 63.8 t0 -71.77 133.95 45.88 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 119.737 -0.785 . . . . 0.0 109.928 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.498 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 73.2 mmtt -78.97 140.52 38.0 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.764 0.792 . . . . 0.0 112.749 -178.235 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.434 HD11 ' CG2' ' A' ' 160' ' ' VAL . 96.3 mt -134.35 134.32 54.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 114.718 -1.128 . . . . 0.0 108.014 178.762 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' TYR . . . . . 0.585 ' C ' HD22 ' A' ' 149' ' ' LEU . 88.1 m-85 -115.45 133.7 55.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.648 0.737 . . . . 0.0 112.706 -178.217 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.585 HD22 ' C ' ' A' ' 148' ' ' TYR . 4.5 mm? -114.7 132.64 56.35 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.97 -1.014 . . . . 0.0 108.397 177.704 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.494 ' CZ ' ' OE2' ' A' ' 155' ' ' GLU . 94.1 m-85 -115.51 110.13 18.82 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 119.985 -0.686 . . . . 0.0 111.673 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' ASP . . . . . 0.57 ' OD1' ' N ' ' A' ' 152' ' ' ASN . 62.3 t0 -88.3 165.67 14.84 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 177.015 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' ASN . . . . . 0.57 ' N ' ' OD1' ' A' ' 151' ' ' ASP . 36.5 p-10 -58.18 -20.35 40.49 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 119.466 -0.894 . . . . 0.0 111.219 -178.21 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -115.03 -27.88 7.19 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 -178.495 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -147.52 176.33 10.14 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 118.963 -1.095 . . . . 0.0 113.455 -176.579 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.494 ' OE2' ' CZ ' ' A' ' 150' ' ' TYR . 83.8 tt0 -125.02 133.48 52.95 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 114.604 -1.18 . . . . 0.0 110.141 178.845 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 156' ' ' TYR . . . . . 0.47 ' CD1' HG23 ' A' ' 206' ' ' THR . 86.1 m-85 -107.94 133.55 52.12 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 120.967 0.413 . . . . 0.0 111.271 -179.557 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -91.7 110.11 21.44 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.352 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -113.36 146.47 39.41 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.015 0.436 . . . . 0.0 111.137 179.726 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -126.12 125.68 42.92 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 121.133 0.492 . . . . 0.0 111.132 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.537 ' O ' ' N ' ' A' ' 144' ' ' GLY . 83.0 t -58.27 133.63 23.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.667 178.425 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 70.5 p -115.49 11.3 15.91 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 139.6 171.6 12.36 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 119.972 -1.109 . . . . 0.0 112.923 178.527 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.63 HG22 HG22 ' A' ' 199' ' ' VAL . 42.1 t -125.63 135.43 63.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 114.305 -0.948 . . . . 0.0 108.874 178.728 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 30.8 m -131.98 162.32 30.99 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.504 0.668 . . . . 0.0 111.85 -179.09 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' GLU . . . . . 0.427 ' HG2' ' CE2' ' A' ' 197' ' ' TYR . 99.1 mt-10 -108.22 121.19 44.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.606 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 29.1 m -136.38 157.45 37.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.431 0.634 . . . . 0.0 111.349 -179.312 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.26 159.39 70.34 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.755 179.169 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 168' ' ' PRO . . . . . 0.51 ' O ' ' CB ' ' B' ' 702' ' ' LEU . 37.8 Cg_endo -65.66 -15.55 49.79 Favored 'Trans proline' 0 C--N 1.302 -1.891 0 C-N-CA 123.114 2.543 . . . . 0.0 113.227 -179.652 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 50.8 p-10 -92.26 -3.78 54.99 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 119.808 -0.757 . . . . 0.0 111.842 179.627 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.801 ' O ' HG22 ' A' ' 173' ' ' VAL . 74.7 mmtt -74.43 80.45 1.91 Allowed 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.261 -0.575 . . . . 0.0 110.634 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 171' ' ' TRP . . . . . 0.466 ' CD1' ' N ' ' A' ' 171' ' ' TRP . 33.8 m0 -69.17 -17.63 63.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.87 179.675 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -61.18 -30.52 70.46 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.73 -178.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' VAL . . . . . 0.801 HG22 ' O ' ' A' ' 170' ' ' LYS . 30.8 m -63.27 -15.88 16.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.188 0.518 . . . . 0.0 111.008 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.701 HG23 HG23 ' A' ' 173' ' ' VAL . 78.3 t -111.16 -11.05 11.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.131 -179.123 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -73.46 152.53 40.7 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.201 0.524 . . . . 0.0 111.224 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 176' ' ' ASP . . . . . 0.523 ' OD1' ' O ' ' A' ' 176' ' ' ASP . 49.5 p30 -70.19 136.74 50.33 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 121.347 0.594 . . . . 0.0 111.41 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 77.9 m80 -107.4 -18.89 13.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.469 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 102.49 37.55 3.24 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -178.842 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 11.6 ptmt -157.38 170.21 22.97 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.089 -0.556 . . . . 0.0 111.063 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -87.79 100.28 12.73 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 177.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 181' ' ' GLU . . . . . 0.446 ' HG2' ' N ' ' A' ' 182' ' ' ILE . 79.4 tt0 -136.32 161.22 36.4 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.403 0.62 . . . . 0.0 111.272 -179.119 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.446 ' N ' ' HG2' ' A' ' 181' ' ' GLU . 20.7 tt -129.6 138.35 54.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.249 -0.887 . . . . 0.0 108.782 178.404 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 183' ' ' THR . . . . . 0.542 ' C ' HD12 ' A' ' 184' ' ' LEU . 97.8 m -128.04 126.02 40.47 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.199 0.523 . . . . 0.0 112.17 -178.732 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.585 HD12 ' N ' ' A' ' 184' ' ' LEU . 10.2 mp -107.94 127.41 53.73 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.119 178.341 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.58 HD13 HD21 ' B' ' 702' ' ' LEU . 93.3 mt -114.29 123.98 70.49 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-O 121.362 0.601 . . . . 0.0 111.545 -178.634 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -142.54 161.55 37.77 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.597 179.425 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 187' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -98.63 139.98 33.54 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 178.172 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.602 HG13 ' N ' ' A' ' 189' ' ' SER . 7.4 p -59.76 -47.26 91.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.807 -178.501 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 189' ' ' SER . . . . . 0.602 ' N ' HG13 ' A' ' 188' ' ' VAL . 23.1 p -160.52 157.85 28.2 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.1 0.476 . . . . 0.0 110.761 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 27.8 m -76.87 -9.21 12.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.212 0.53 . . . . 0.0 110.24 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -96.95 -18.95 19.14 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.978 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -136.8 98.79 3.87 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.09 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -101.44 11.35 39.27 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 121.131 0.491 . . . . 0.0 110.902 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 47.1 t -59.92 -43.25 95.01 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.476 -179.569 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 51.6 mtmt -132.06 146.3 51.97 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 121.185 0.517 . . . . 0.0 111.211 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 196' ' ' ARG . . . . . 0.437 HH21 ' HG2' ' A' ' 60' ' ' LYS . 99.9 mtt180 -121.32 145.41 47.91 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.926 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 197' ' ' TYR . . . . . 0.427 ' CE2' ' HG2' ' A' ' 165' ' ' GLU . 36.4 m-85 -94.87 140.79 29.43 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.727 179.704 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 55.8 t -130.85 132.35 64.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.298 0.57 . . . . 0.0 111.041 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.63 HG22 HG22 ' A' ' 163' ' ' VAL . 47.8 t -100.19 133.93 41.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.07 179.635 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -108.07 132.84 53.14 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.266 0.555 . . . . 0.0 110.93 -179.311 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -132.2 140.59 11.95 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 202' ' ' ASP . . . . . 0.558 ' OD1' ' N ' ' A' ' 203' ' ' LEU . 67.9 t0 -111.5 138.49 47.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.123 0.487 . . . . 0.0 111.151 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 203' ' ' LEU . . . . . 0.558 ' N ' ' OD1' ' A' ' 202' ' ' ASP . 53.8 tp -62.69 128.9 38.1 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.863 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 1.3 p -114.38 -19.94 6.39 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 120.848 -0.341 . . . . 0.0 111.548 -178.643 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -175.87 170.94 44.0 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 120.768 -0.729 . . . . 0.0 111.858 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 206' ' ' THR . . . . . 0.47 HG23 ' CD1' ' A' ' 156' ' ' TYR . 18.2 m -143.71 139.68 29.62 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 179.314 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -144.81 120.23 10.31 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.43 0.633 . . . . 0.0 111.991 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -64.28 142.91 58.25 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.388 -179.624 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -80.75 110.48 16.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.68 179.595 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 99.4 mttt . . . . . 0 C--O 1.221 -0.42 0 CA-C-O 117.88 -1.057 . . . . 0.0 110.994 -179.757 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 702' ' ' LEU . . . . . 0.58 HD21 HD13 ' A' ' 185' ' ' ILE . 2.0 mt . . . . . 0 CA--C 1.54 0.573 0 CA-C-O 120.672 0.272 . . . . 20.0 110.726 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 703' ' ' PRO . . . . . 0.581 ' O ' ' O ' ' B' ' 704' ' ' ALA . 4.2 Cg_exo -67.17 -169.02 0.18 Allowed 'Trans proline' 0 N--CA 1.489 1.25 0 C-N-CA 122.527 2.151 . . . . 20.0 114.006 -179.287 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 704' ' ' ALA . . . . . 0.581 ' O ' ' O ' ' B' ' 703' ' ' PRO . . . . . . . . 0 N--CA 1.464 0.271 0 CA-C-N 113.798 -1.546 . . . . 20.0 113.792 -179.459 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.249 0 CA-C-O 121.097 0.475 . . . . 0.0 111.356 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.51 ' CB ' ' O ' ' B' ' 702' ' ' LEU . 5.5 p -81.28 20.06 0.89 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.356 0.598 . . . . 0.0 111.158 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -102.64 18.48 21.22 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.205 -179.225 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.9 mt -56.26 139.5 15.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 122.415 1.103 . . . . 0.0 113.405 -176.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -77.42 130.69 37.39 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 113.525 -1.671 . . . . 0.0 108.865 178.452 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.617 ' CD ' ' H ' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -81.28 154.9 72.14 Favored Pre-proline 0 C--N 1.32 -0.688 0 C-N-CA 120.364 -0.534 . . . . 0.0 110.513 -179.139 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -72.2 166.48 29.56 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 123.249 2.632 . . . . 0.0 113.34 -178.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.806 ' O ' HG23 ' A' ' 69' ' ' VAL . 87.5 m-20 -52.62 164.45 0.35 Allowed 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 120.975 0.417 . . . . 0.0 110.491 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 56.5 tp -64.27 -47.05 81.05 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.321 -179.0 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.412 ' O ' ' N ' ' A' ' 71' ' ' ASN . . . -62.65 -36.46 82.92 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 119.863 -0.735 . . . . 0.0 110.773 -178.83 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -62.46 -28.81 70.07 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.526 0.679 . . . . 0.0 109.223 178.557 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.806 HG23 ' O ' ' A' ' 65' ' ' ASP . 46.7 t -76.7 -44.38 33.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.862 178.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -79.38 -8.88 59.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.0 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.412 ' N ' ' O ' ' A' ' 67' ' ' ALA . 95.8 m-20 -102.82 -13.28 17.06 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.397 0.618 . . . . 0.0 110.177 179.34 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.402 ' CB ' HD13 ' A' ' 104' ' ' LEU . . . -68.91 145.44 53.66 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.172 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 32.9 m -57.85 110.17 0.86 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.784 -179.33 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.719 HD13 ' C ' ' A' ' 74' ' ' LEU . 3.0 tm? -70.88 119.34 14.86 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.338 0.59 . . . . 0.0 110.535 -179.611 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.608 ' N ' HD13 ' A' ' 74' ' ' LEU . 83.1 m-20 -94.92 78.76 3.62 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.481 -0.782 . . . . 0.0 109.812 179.574 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.577 ' O ' HG12 ' A' ' 79' ' ' VAL . 82.0 tttt -65.07 -32.85 74.76 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.267 -0.879 . . . . 0.0 112.055 -179.615 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 36.9 mmtt -70.15 -10.16 57.93 Favored 'General case' 0 C--N 1.314 -0.955 0 C-N-CA 120.401 -0.52 . . . . 0.0 110.509 -177.045 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -96.65 -3.8 42.11 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.474 178.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.577 HG12 ' O ' ' A' ' 76' ' ' LYS . 3.1 p -81.39 130.14 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-O 121.315 0.579 . . . . 0.0 111.386 -179.368 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 10.0 pt -108.66 -6.75 10.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.982 179.373 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -174.15 -180.0 45.13 Favored Glycine 0 CA--C 1.53 1.012 0 N-CA-C 111.326 -0.71 . . . . 0.0 111.326 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.411 ' HG2' ' N ' ' A' ' 83' ' ' ILE . 61.4 ttp180 -136.74 156.88 47.93 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.415 HG22 ' O ' ' A' ' 92' ' ' LEU . 19.5 tt -124.2 141.96 42.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.113 0.482 . . . . 0.0 110.362 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 74.5 m -135.5 131.05 35.58 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 121.66 0.743 . . . . 0.0 112.332 -178.839 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.546 ' CG2' HG22 ' A' ' 88' ' ' VAL . 92.5 mt -137.33 86.06 20.4 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.082 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -57.48 -30.12 87.11 Favored 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 122.769 2.312 . . . . 0.0 113.063 -179.183 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 70.6 m -52.9 -40.67 63.72 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 121.22 0.533 . . . . 0.0 110.457 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.546 HG22 ' CG2' ' A' ' 85' ' ' ILE . 26.7 m -113.58 8.09 7.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.346 179.011 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 52.59 54.45 10.59 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.501 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 60.1 tp -119.99 135.29 54.97 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.629 0.728 . . . . 0.0 111.337 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -146.31 124.21 12.0 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.186 -0.915 . . . . 0.0 109.224 179.484 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.415 ' O ' HG22 ' A' ' 83' ' ' ILE . 82.3 mt -149.36 148.07 25.26 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.716 -178.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -73.04 146.24 41.08 Favored 'Trans proline' 0 C--N 1.313 -1.313 0 C-N-CA 122.176 1.918 . . . . 0.0 111.318 179.245 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.503 ' C ' HD12 ' A' ' 95' ' ' LEU . 43.8 t -96.55 122.11 47.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.28 0.562 . . . . 0.0 111.081 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.549 HD12 ' N ' ' A' ' 95' ' ' LEU . 11.1 mp -99.68 134.73 42.14 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.199 179.723 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -62.63 -79.03 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.499 -177.823 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 7.5 m -66.98 145.01 55.86 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 121.041 0.448 . . . . 0.0 111.611 -179.173 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 7.2 t -95.43 68.14 2.97 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-O 121.186 0.517 . . . . 0.0 111.51 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.445 HG22 ' N ' ' A' ' 100' ' ' GLU . 12.9 m -88.54 166.99 13.79 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 178.009 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.445 ' N ' HG22 ' A' ' 99' ' ' THR . 72.0 mm-40 -60.99 -43.9 98.19 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.022 -0.671 . . . . 0.0 109.881 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -65.14 -38.38 90.43 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.483 0.659 . . . . 0.0 110.253 178.26 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.421 ' HB2' ' H ' ' A' ' 99' ' ' THR . 92.3 m-20 -63.82 -39.27 93.83 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.057 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.409 HD13 ' CB ' ' B' ' 704' ' ' ALA . 78.2 mt -62.92 -12.01 22.41 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.015 -0.539 . . . . 0.0 112.001 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.432 ' O ' ' CG1' ' A' ' 69' ' ' VAL . 96.9 mt -73.28 -22.6 60.33 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 121.052 0.454 . . . . 0.0 111.15 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 95.7 p -73.84 -3.69 30.3 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.349 0.595 . . . . 0.0 110.498 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 86.85 -18.87 32.67 Favored Glycine 0 CA--C 1.531 1.06 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.509 178.365 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -145.62 127.07 15.0 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 119.941 -0.704 . . . . 0.0 112.103 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -147.74 142.8 27.05 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.551 178.683 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.572 ' HA ' HD23 ' A' ' 123' ' ' LEU . 3.4 p -73.6 140.79 46.45 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.271 0.557 . . . . 0.0 111.65 -179.27 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.746 HG22 ' HG2' ' B' ' 703' ' ' PRO . 58.1 t -78.64 -52.37 15.64 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.973 -179.672 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.778 ' H ' ' NE2' ' A' ' 114' ' ' GLN . 49.0 mtmt -100.32 136.67 39.85 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 122.221 1.01 . . . . 0.0 112.526 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -66.16 -31.98 73.15 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 113.978 -1.465 . . . . 0.0 112.627 -178.607 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 71.5 m-80 -85.33 13.7 6.24 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 -177.656 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLN . . . . . 0.778 ' NE2' ' H ' ' A' ' 111' ' ' LYS . 32.7 mt-30 -79.87 143.5 34.26 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.383 0.611 . . . . 0.0 112.363 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 65.1 t -123.69 123.42 67.12 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.183 178.629 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' MET . . . . . 0.445 ' CG ' ' CZ ' ' A' ' 121' ' ' TYR . 98.9 mtp -57.65 133.82 55.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.195 0.521 . . . . 0.0 111.509 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.496 ' O ' ' OD2' ' A' ' 180' ' ' ASP . . . 81.69 -2.45 82.92 Favored Glycine 0 CA--C 1.53 0.969 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.55 179.557 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -142.87 135.81 28.06 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.213 0.53 . . . . 0.0 111.263 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 72.47 -166.77 53.82 Favored Glycine 0 CA--C 1.529 0.925 0 N-CA-C 110.495 -1.042 . . . . 0.0 110.495 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 64.8 t-20 -92.24 103.49 15.95 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.075 0.464 . . . . 0.0 110.676 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.445 ' CZ ' ' CG ' ' A' ' 116' ' ' MET . 2.5 t80 -88.64 99.04 12.02 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 121.118 0.485 . . . . 0.0 110.1 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.741 ' CB ' HG13 ' A' ' 174' ' ' VAL . . . -91.51 138.43 31.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.091 0.472 . . . . 0.0 111.536 -179.495 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.572 HD23 ' HA ' ' A' ' 109' ' ' THR . 46.0 mt -134.33 139.59 45.78 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.415 -0.514 . . . . 0.0 110.913 179.491 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -107.89 133.24 52.53 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.655 179.252 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -134.3 142.98 14.53 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' HIS . . . . . 0.517 ' O ' ' O ' ' A' ' 134' ' ' LEU . 23.2 m-70 -78.4 142.01 37.92 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.321 0.581 . . . . 0.0 112.39 -178.863 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ASN . . . . . 0.596 ' ND2' ' O ' ' A' ' 187' ' ' CYS . 14.4 t30 -138.76 121.34 16.23 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.816 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.551 ' HB2' HG21 ' A' ' 133' ' ' VAL . 63.4 mtt -97.81 -4.43 36.87 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.744 -179.671 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.462 ' CB ' ' O ' ' A' ' 128' ' ' MET . 0.9 OUTLIER 79.14 4.16 2.32 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.967 179.281 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.861 ' O ' HG12 ' A' ' 133' ' ' VAL . 62.8 pttt -111.99 133.62 54.05 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 122.041 0.924 . . . . 0.0 113.206 -178.825 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.426 ' C ' ' O ' ' A' ' 130' ' ' LYS . 28.6 tptt -40.26 152.69 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.742 178.492 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 75.08 -14.75 4.57 Favored Glycine 0 CA--C 1.535 1.337 0 C-N-CA 121.077 -0.583 . . . . 0.0 112.71 178.818 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.861 HG12 ' O ' ' A' ' 130' ' ' LYS . 6.3 p -88.55 172.47 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 119.331 -0.947 . . . . 0.0 111.044 -179.258 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.671 ' H ' HG22 ' A' ' 133' ' ' VAL . 3.8 mm? -68.64 133.69 48.83 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 115.495 1.665 . . . . 0.0 115.495 -176.363 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 56.84 12.49 1.18 Allowed 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 113.859 -1.519 . . . . 0.0 114.718 176.617 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 2.8 p -69.21 -32.35 71.54 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 121.64 -0.663 . . . . 0.0 112.784 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -89.21 2.15 54.66 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 -178.174 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.582 HD11 HG21 ' A' ' 186' ' ' THR . 1.8 pp -63.45 -30.21 49.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 C-N-CA 120.206 -0.597 . . . . 0.0 111.046 -179.431 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -67.4 -11.06 56.82 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.94 0.4 . . . . 0.0 110.64 -179.572 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 56.8 m -82.45 -6.15 59.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.147 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 97.8 mt -65.33 143.83 57.5 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 121.165 0.507 . . . . 0.0 111.411 -179.709 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.417 ' HG2' ' N ' ' A' ' 143' ' ' LYS . 88.8 tttt -119.82 157.13 29.29 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 121.249 0.547 . . . . 0.0 111.091 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' LYS . . . . . 0.417 ' N ' ' HG2' ' A' ' 142' ' ' LYS . 88.7 tttt -49.76 136.08 18.24 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.178 179.515 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.498 ' N ' ' O ' ' A' ' 160' ' ' VAL . . . 77.24 8.05 86.93 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 120.823 -0.703 . . . . 0.0 111.953 178.51 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -70.79 131.19 43.44 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 119.68 -0.808 . . . . 0.0 110.072 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -77.87 140.32 39.33 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 121.551 0.691 . . . . 0.0 111.926 -178.666 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.457 HD11 ' CG2' ' A' ' 160' ' ' VAL . 98.4 mt -139.08 140.58 38.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-N 114.851 -1.068 . . . . 0.0 108.711 178.853 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' TYR . . . . . 0.715 ' C ' HD23 ' A' ' 149' ' ' LEU . 18.1 m-85 -126.07 139.52 53.33 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 119.748 -0.781 . . . . 0.0 112.794 -178.419 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.715 HD23 ' C ' ' A' ' 148' ' ' TYR . 0.4 OUTLIER -117.97 134.9 54.52 Favored 'General case' 0 C--O 1.226 -0.164 0 CA-C-N 114.983 -1.008 . . . . 0.0 108.633 178.245 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.558 ' CE2' ' CD ' ' A' ' 155' ' ' GLU . 92.4 m-85 -110.53 113.73 26.59 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.319 -0.552 . . . . 0.0 110.938 179.288 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' ASP . . . . . 0.503 ' OD1' ' N ' ' A' ' 152' ' ' ASN . 54.7 t0 -90.5 167.88 12.26 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 177.354 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' ASN . . . . . 0.503 ' N ' ' OD1' ' A' ' 151' ' ' ASP . 71.8 m-20 -55.53 -24.47 32.16 Favored 'General case' 0 C--N 1.317 -0.805 0 C-N-CA 119.971 -0.691 . . . . 0.0 111.28 -177.577 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -112.23 -26.99 8.51 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 114.243 1.201 . . . . 0.0 114.243 -178.225 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -149.82 -177.02 5.65 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 118.764 -1.174 . . . . 0.0 114.018 -176.592 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.558 ' CD ' ' CE2' ' A' ' 150' ' ' TYR . 84.6 tt0 -129.51 141.66 50.94 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 114.582 -1.19 . . . . 0.0 110.467 179.242 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -117.68 138.07 52.24 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 120.829 0.347 . . . . 0.0 111.75 -179.192 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' GLU . . . . . 0.473 ' O ' HG12 ' A' ' 204' ' ' VAL . 96.6 mt-10 -94.44 111.93 23.69 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.279 179.319 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -112.56 148.23 34.98 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.053 0.454 . . . . 0.0 111.696 179.489 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -123.64 122.65 38.68 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 121.145 0.498 . . . . 0.0 111.456 179.421 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.498 ' O ' ' N ' ' A' ' 144' ' ' GLY . 95.4 t -58.84 135.24 23.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 177.901 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 80.9 p -106.32 -26.51 11.47 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 120.525 -0.47 . . . . 0.0 111.413 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 161.39 -169.65 36.97 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 120.481 -0.866 . . . . 0.0 111.89 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.863 HG12 HG22 ' A' ' 199' ' ' VAL . 28.5 m -135.39 162.6 37.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.017 0.437 . . . . 0.0 110.177 179.575 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 81.7 p -148.95 164.96 33.02 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.345 0.593 . . . . 0.0 111.324 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -104.79 115.76 30.86 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.062 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.44 HG21 HG21 ' A' ' 198' ' ' VAL . 24.4 m -137.09 160.95 36.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.48 0.657 . . . . 0.0 111.204 -179.265 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 167' ' ' THR . . . . . 0.502 ' OG1' ' OD1' ' A' ' 169' ' ' ASP . 0.1 OUTLIER -88.95 160.82 42.74 Favored Pre-proline 0 CA--C 1.539 0.533 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.933 179.364 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 168' ' ' PRO . . . . . 0.551 ' O ' ' CB ' ' B' ' 702' ' ' LEU . 55.4 Cg_endo -67.69 -15.81 45.23 Favored 'Trans proline' 0 N--CA 1.5 1.909 0 C-N-CA 123.074 2.516 . . . . 0.0 114.031 -178.346 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 169' ' ' ASP . . . . . 0.502 ' OD1' ' OG1' ' A' ' 167' ' ' THR . 38.4 p-10 -91.06 -2.55 57.62 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 119.58 -0.848 . . . . 0.0 110.803 179.483 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.907 ' O ' HG22 ' A' ' 173' ' ' VAL . 73.0 mmtt -73.53 69.6 1.24 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.445 0.641 . . . . 0.0 110.208 179.41 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 171' ' ' TRP . . . . . 0.575 ' CZ3' ' OE2' ' A' ' 175' ' ' GLU . 57.3 t90 -60.13 -17.72 42.35 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.303 179.604 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -63.72 -28.78 70.12 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.602 -0.727 . . . . 0.0 111.936 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 173' ' ' VAL . . . . . 0.907 HG22 ' O ' ' A' ' 170' ' ' LYS . 34.6 m -62.33 -20.79 25.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 120.692 -0.403 . . . . 0.0 111.05 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.741 HG13 ' CB ' ' A' ' 122' ' ' ALA . 7.8 t -99.81 -6.02 9.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.648 -179.32 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.575 ' OE2' ' CZ3' ' A' ' 171' ' ' TRP . 93.0 mt-10 -73.71 143.91 45.96 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 121.199 0.523 . . . . 0.0 111.419 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 44.8 p-10 -70.94 144.0 50.72 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.776 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 50.4 m80 -119.31 28.02 8.46 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 62.34 37.71 95.05 Favored Glycine 0 CA--C 1.528 0.88 0 N-CA-C 111.272 -0.731 . . . . 0.0 111.272 179.159 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -153.69 161.68 41.92 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 180' ' ' ASP . . . . . 0.741 ' OD2' HD22 ' A' ' 203' ' ' LEU . 56.8 t0 -87.37 101.6 13.72 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 178.225 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 181' ' ' GLU . . . . . 0.462 ' HG2' ' N ' ' A' ' 182' ' ' ILE . 72.5 tt0 -130.78 163.43 27.36 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.469 0.652 . . . . 0.0 111.524 -178.618 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.462 ' N ' ' HG2' ' A' ' 181' ' ' GLU . 20.2 tt -130.07 138.5 53.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.629 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 57.0 m -130.83 125.44 33.68 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.504 -0.478 . . . . 0.0 111.29 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 85.5 mt -109.28 130.87 55.48 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.413 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.56 HD13 HD11 ' B' ' 702' ' ' LEU . 96.7 mt -115.7 128.87 72.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.533 0.682 . . . . 0.0 111.527 -179.112 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 186' ' ' THR . . . . . 0.582 HG21 HD11 ' A' ' 138' ' ' ILE . 3.7 t -141.83 162.16 36.16 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.297 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 187' ' ' CYS . . . . . 0.596 ' O ' ' ND2' ' A' ' 127' ' ' ASN . 33.1 m -87.15 135.27 33.36 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.952 0.406 . . . . 0.0 110.086 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.587 HG13 ' N ' ' A' ' 189' ' ' SER . 11.9 p -61.54 -45.24 99.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-O 121.411 0.624 . . . . 0.0 110.308 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 189' ' ' SER . . . . . 0.587 ' N ' HG13 ' A' ' 188' ' ' VAL . 35.5 t -172.18 144.95 1.68 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.869 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 33.9 m -70.89 -13.01 16.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.124 0.488 . . . . 0.0 110.627 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 63.1 mttm -94.03 -12.8 27.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.121 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 192' ' ' ASP . . . . . 0.412 ' OD1' ' C ' ' A' ' 192' ' ' ASP . 64.2 t0 -140.19 109.03 5.98 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.517 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 46.9 p-10 -107.5 11.72 28.52 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.303 179.308 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 35.0 t -59.89 -43.78 94.59 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.144 -178.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -145.83 155.61 43.02 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 121.28 0.562 . . . . 0.0 111.714 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 196' ' ' ARG . . . . . 0.407 HH12 ' HG3' ' A' ' 168' ' ' PRO . 85.1 mtt85 -128.03 146.91 50.52 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 121.383 0.611 . . . . 0.0 111.603 -179.668 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -91.15 146.51 23.78 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.873 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.44 HG21 HG21 ' A' ' 166' ' ' VAL . 47.8 t -130.28 134.21 62.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.639 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.863 HG22 HG12 ' A' ' 163' ' ' VAL . 54.1 t -105.87 132.14 53.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.348 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -116.05 139.03 50.69 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.246 0.546 . . . . 0.0 110.084 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 201' ' ' GLY . . . . . 0.434 ' O ' HG22 ' A' ' 182' ' ' ILE . . . -140.74 142.65 12.5 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.739 -0.945 . . . . 0.0 110.739 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 35.5 p30 -109.03 155.5 20.84 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.318 0.58 . . . . 0.0 111.544 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 203' ' ' LEU . . . . . 0.741 HD22 ' OD2' ' A' ' 180' ' ' ASP . 49.3 tp -74.13 131.3 41.16 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.478 179.195 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.473 HG12 ' O ' ' A' ' 157' ' ' GLU . 3.9 p -113.83 -20.25 6.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 120.319 -0.553 . . . . 0.0 111.181 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -174.2 169.22 42.21 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 120.486 -0.864 . . . . 0.0 111.779 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 63.6 m -142.65 137.16 29.77 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 179.478 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 54.4 pttt -149.19 123.48 9.58 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.592 0.71 . . . . 0.0 112.31 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -62.97 143.59 57.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.554 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 14.7 ptpt -79.26 111.04 15.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.527 178.492 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 64.8 mttp . . . . . 0 C--O 1.22 -0.493 0 CA-C-O 118.216 -0.897 . . . . 0.0 110.322 -179.966 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 702' ' ' LEU . . . . . 0.56 HD11 HD13 ' A' ' 185' ' ' ILE . 0.0 OUTLIER . . . . . 0 CA--C 1.544 0.737 0 N-CA-C 109.635 -0.506 . . . . 20.0 109.635 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 703' ' ' PRO . . . . . 0.746 ' HG2' HG22 ' A' ' 110' ' ' VAL . 3.1 Cg_exo -65.81 -165.81 0.09 OUTLIER 'Trans proline' 0 N--CA 1.492 1.414 0 C-N-CA 121.921 1.748 . . . . 20.0 113.219 -179.667 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 704' ' ' ALA . . . . . 0.498 ' O ' ' O ' ' B' ' 703' ' ' PRO . . . . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 114.89 -1.05 . . . . 20.0 112.729 -178.785 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.307 0 CA-C-O 120.993 0.425 . . . . 0.0 110.855 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.476 ' CB ' ' O ' ' B' ' 702' ' ' LEU . 61.0 p -80.4 22.8 0.53 Allowed 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -179.389 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -109.2 19.15 19.77 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.069 0.461 . . . . 0.0 111.719 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 98.0 mt -55.83 135.64 18.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-O 122.115 0.96 . . . . 0.0 112.668 -177.205 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -77.72 129.95 36.16 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.148 -1.387 . . . . 0.0 109.336 178.376 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.615 ' O ' ' NE2' ' A' ' 63' ' ' GLN . 1.0 OUTLIER -79.21 147.66 69.56 Favored Pre-proline 0 N--CA 1.446 -0.628 0 C-N-CA 120.087 -0.645 . . . . 0.0 109.977 -179.215 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -69.76 167.63 23.88 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 122.353 2.036 . . . . 0.0 112.477 -179.058 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -51.17 169.77 0.05 OUTLIER 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.568 -178.711 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 55.9 tp -63.4 -46.21 87.49 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.607 -1.178 . . . . 0.0 111.409 -178.134 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.65 -22.96 48.75 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.159 0.505 . . . . 0.0 110.448 -178.737 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.556 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 49.3 tp10 -68.29 -31.56 71.09 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 119.284 -0.966 . . . . 0.0 108.509 178.186 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.464 HG22 ' HB3' ' A' ' 104' ' ' LEU . 36.6 t -74.45 -44.57 47.76 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.466 179.513 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -73.24 -9.82 59.12 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.709 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 38.6 t30 -118.58 -1.31 11.19 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 121.052 0.454 . . . . 0.0 110.179 178.52 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.556 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -69.04 -172.55 0.41 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.425 -179.127 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.3 m -94.87 99.8 11.79 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.287 0.565 . . . . 0.0 110.033 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 49.3 tp -67.83 135.34 52.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.845 -179.389 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -124.89 77.21 1.59 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.461 0.648 . . . . 0.0 109.49 178.59 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.736 ' O ' HG12 ' A' ' 79' ' ' VAL . 86.6 tttt -74.96 -41.14 60.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.37 -0.832 . . . . 0.0 112.162 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.464 ' H ' ' HD2' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -70.94 -6.0 35.18 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.72 -177.062 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -96.49 -10.03 28.32 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.284 0.564 . . . . 0.0 110.506 179.03 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.736 HG12 ' O ' ' A' ' 76' ' ' LYS . 9.9 p -65.31 127.75 26.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.855 179.593 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 12.1 pt -104.61 -8.03 9.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.327 0.584 . . . . 0.0 109.975 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -173.35 178.55 45.25 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 120.742 -0.742 . . . . 0.0 111.291 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.406 ' HG2' ' N ' ' A' ' 83' ' ' ILE . 58.5 ttp180 -136.45 160.92 37.29 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.336 -0.432 . . . . 0.0 110.357 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.566 HG22 ' O ' ' A' ' 92' ' ' LEU . 18.6 tt -124.99 140.94 46.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 CA-C-O 121.203 0.525 . . . . 0.0 109.983 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 47.6 t -137.18 130.39 31.0 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.378 0.608 . . . . 0.0 111.471 -178.861 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.543 ' CG2' HG22 ' A' ' 88' ' ' VAL . 37.3 mt -137.08 85.55 22.21 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.572 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -56.25 -33.05 89.93 Favored 'Trans proline' 0 N--CA 1.496 1.621 0 C-N-CA 123.25 2.633 . . . . 0.0 112.798 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' SER . . . . . 0.439 ' CB ' ' OD1' ' A' ' 145' ' ' ASP . 39.5 t -55.53 -43.44 75.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.097 0.475 . . . . 0.0 111.358 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.543 HG22 ' CG2' ' A' ' 85' ' ' ILE . 35.5 m -110.77 7.75 8.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.522 0.677 . . . . 0.0 109.879 179.173 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.5 m 53.03 51.58 15.5 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.043 179.528 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 69.1 tp -116.11 131.12 57.03 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.294 0.568 . . . . 0.0 110.462 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -148.52 125.67 11.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.817 0.818 . . . . 0.0 110.939 -179.616 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.623 ' CD1' ' HB2' ' A' ' 107' ' ' ALA . 0.3 OUTLIER -156.83 152.69 22.78 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 114.741 -1.118 . . . . 0.0 111.01 179.873 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -74.44 147.82 37.12 Favored 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 122.548 2.165 . . . . 0.0 112.132 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.489 ' C ' HD12 ' A' ' 95' ' ' LEU . 90.1 t -94.89 121.36 45.4 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-O 120.901 0.381 . . . . 0.0 111.159 179.392 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.544 HD12 ' N ' ' A' ' 95' ' ' LEU . 10.9 mp -98.49 127.88 44.61 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 121.654 0.74 . . . . 0.0 111.568 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.509 ' O ' ' OG1' ' A' ' 109' ' ' THR . 88.1 tttt -62.33 -47.0 86.16 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 114.846 -1.07 . . . . 0.0 112.077 -178.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.406 ' HB3' ' ND2' ' A' ' 102' ' ' ASN . 17.4 t -77.98 128.87 34.56 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.509 0.671 . . . . 0.0 112.354 -178.862 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.469 ' OG ' ' O ' ' A' ' 109' ' ' THR . 0.8 OUTLIER -86.62 51.8 2.33 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.523 -179.673 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.535 HG22 ' N ' ' A' ' 100' ' ' GLU . 62.1 m -88.37 162.59 16.46 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.187 -0.46 . . . . 0.0 109.998 178.744 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.535 ' N ' HG22 ' A' ' 99' ' ' THR . 57.6 mp0 -61.92 -43.18 99.37 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 121.133 0.492 . . . . 0.0 110.62 179.747 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -63.01 -40.66 98.43 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.228 -179.621 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.406 ' ND2' ' HB3' ' A' ' 97' ' ' SER . 97.8 m-20 -64.67 -37.75 88.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.616 0.722 . . . . 0.0 110.671 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.527 HD13 ' HB3' ' B' ' 704' ' ' ALA . 16.5 mt -59.62 -24.03 63.48 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.327 -0.852 . . . . 0.0 111.188 -179.056 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.464 ' HB3' HG22 ' A' ' 69' ' ' VAL . 90.0 mt -76.03 -12.22 60.09 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.966 0.412 . . . . 0.0 110.831 179.69 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 90.7 p -78.8 -5.45 53.42 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-O 121.474 0.654 . . . . 0.0 110.011 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 98.96 -19.7 53.23 Favored Glycine 0 CA--C 1.532 1.152 0 CA-C-N 115.326 -0.852 . . . . 0.0 112.758 178.669 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.623 ' HB2' ' CD1' ' A' ' 92' ' ' LEU . . . -146.96 129.63 16.07 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 119.382 -0.927 . . . . 0.0 113.039 -179.587 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -147.39 135.18 21.14 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.489 178.447 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.637 ' HA ' HD23 ' A' ' 123' ' ' LEU . 54.9 p -70.15 135.99 49.67 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.085 0.469 . . . . 0.0 111.118 -179.47 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.969 HG11 HG11 ' A' ' 174' ' ' VAL . 54.0 t -79.74 -56.04 7.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-O 121.074 0.464 . . . . 0.0 110.76 -179.696 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.491 ' N ' ' OE1' ' A' ' 114' ' ' GLN . 43.7 mtpt -102.87 137.97 40.38 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 121.901 0.857 . . . . 0.0 111.717 179.229 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -63.64 -29.47 70.7 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 114.735 -1.121 . . . . 0.0 111.619 -178.287 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 65.1 m-80 -83.06 14.73 3.18 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -177.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLN . . . . . 0.875 ' NE2' ' H ' ' A' ' 122' ' ' ALA . 65.1 mt-30 -77.83 138.24 38.84 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 121.128 0.49 . . . . 0.0 112.285 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 72.9 t -126.26 119.75 54.88 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.531 178.437 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 97.4 mtp -58.31 128.42 37.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.566 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 85.3 -2.88 87.94 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 120.956 -0.64 . . . . 0.0 111.871 178.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -142.95 133.24 24.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.052 0.453 . . . . 0.0 111.153 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 72.24 -171.0 49.43 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 -179.601 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 63.2 t-20 -86.33 102.48 14.04 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.285 -0.566 . . . . 0.0 110.131 179.491 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.547 ' CE2' HD21 ' A' ' 123' ' ' LEU . 12.3 t80 -85.83 98.66 10.88 Favored 'General case' 0 N--CA 1.457 -0.097 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 179.598 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.875 ' H ' ' NE2' ' A' ' 114' ' ' GLN . . . -91.96 139.14 30.94 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.223 -179.372 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.637 HD23 ' HA ' ' A' ' 109' ' ' THR . 81.2 mt -137.94 143.63 40.85 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 120.98 0.419 . . . . 0.0 110.684 179.523 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -115.26 138.86 50.49 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.187 0.518 . . . . 0.0 110.488 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -144.14 134.05 5.57 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -79.43 137.83 37.39 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.004 -0.678 . . . . 0.0 110.51 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -130.55 121.47 25.76 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.562 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.498 ' O ' ' CB ' ' A' ' 129' ' ' SER . 67.0 mtt -87.73 -5.83 58.48 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.133 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.498 ' CB ' ' O ' ' A' ' 128' ' ' MET . 0.9 OUTLIER 79.78 8.77 1.57 Allowed 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 179.123 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.874 ' O ' HG12 ' A' ' 133' ' ' VAL . 65.0 pttt -105.93 128.06 53.55 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 122.111 0.957 . . . . 0.0 112.371 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 38.8 tptt -46.05 119.78 2.43 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.977 -1.011 . . . . 0.0 109.988 178.859 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 115.23 -18.12 16.21 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.197 -1.161 . . . . 0.0 110.197 -179.377 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.874 HG12 ' O ' ' A' ' 130' ' ' LYS . 9.5 p -90.3 160.9 2.7 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 CA-C-O 121.256 0.55 . . . . 0.0 109.974 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.718 HD23 ' N ' ' A' ' 134' ' ' LEU . 0.1 OUTLIER -69.22 138.45 54.01 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -177.338 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.594 ' CD2' HD12 ' A' ' 138' ' ' ILE . 3.2 m-30 65.74 9.39 5.95 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 114.094 -1.412 . . . . 0.0 114.303 177.389 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' SER . . . . . 0.485 ' OG ' ' CG1' ' A' ' 133' ' ' VAL . 0.4 OUTLIER -67.31 -36.27 81.13 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 120.453 -0.499 . . . . 0.0 112.185 179.315 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 22.7 p-10 -93.97 8.93 39.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.594 0.712 . . . . 0.0 110.796 -178.764 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.594 HD12 ' CD2' ' A' ' 135' ' ' PHE . 5.5 tt -64.96 -36.35 77.57 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.534 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -70.02 -10.81 59.92 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 121.958 -0.463 . . . . 0.0 111.399 179.443 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 67.3 m -81.24 -2.85 50.41 Favored 'General case' 0 C--O 1.231 0.088 0 CA-C-O 121.054 0.455 . . . . 0.0 110.303 179.623 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 70.9 mt -63.69 142.33 58.44 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.926 179.429 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -123.24 157.08 33.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.734 0.778 . . . . 0.0 111.85 -178.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -48.72 129.09 16.4 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.41 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 160' ' ' VAL . . . 82.24 8.52 86.28 Favored Glycine 0 CA--C 1.534 1.256 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.574 179.053 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.439 ' OD1' ' CB ' ' A' ' 87' ' ' SER . 23.1 t70 -71.76 130.49 41.23 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 119.908 -0.717 . . . . 0.0 110.838 -179.268 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -77.98 139.9 39.18 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 121.619 0.724 . . . . 0.0 111.628 -179.184 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.524 HG23 HG12 ' A' ' 85' ' ' ILE . 96.4 mt -136.59 137.68 47.36 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 178.885 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' TYR . . . . . 0.55 ' C ' HD23 ' A' ' 149' ' ' LEU . 63.3 m-85 -118.46 135.95 54.07 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 119.966 -0.694 . . . . 0.0 111.938 -178.247 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.55 HD23 ' C ' ' A' ' 148' ' ' TYR . 0.9 OUTLIER -114.16 134.28 55.01 Favored 'General case' 0 C--O 1.222 -0.357 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 177.263 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.427 ' CE2' ' OE1' ' A' ' 155' ' ' GLU . 81.2 m-85 -114.48 110.07 19.27 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.136 -0.626 . . . . 0.0 111.853 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' ASP . . . . . 0.474 ' N ' ' O ' ' A' ' 154' ' ' ASN . 22.4 t0 -88.4 167.92 13.08 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 177.521 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 65.2 m-20 -60.29 -23.77 64.43 Favored 'General case' 0 C--N 1.316 -0.872 0 C-N-CA 119.793 -0.763 . . . . 0.0 111.449 -178.037 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -113.02 -26.3 8.55 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -178.235 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' ASN . . . . . 0.474 ' O ' ' N ' ' A' ' 151' ' ' ASP . 0.3 OUTLIER -148.1 -177.0 5.5 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 119.115 -1.034 . . . . 0.0 112.639 -177.197 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.427 ' OE1' ' CE2' ' A' ' 150' ' ' TYR . 15.2 pt-20 -137.98 145.52 42.04 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 114.403 -1.271 . . . . 0.0 109.891 178.574 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' TYR . . . . . 0.431 ' CD1' HG23 ' A' ' 206' ' ' THR . 84.0 m-85 -118.5 138.41 52.53 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 121.255 0.55 . . . . 0.0 112.312 -178.212 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 157' ' ' GLU . . . . . 0.529 ' O ' HG22 ' A' ' 204' ' ' VAL . 93.5 mt-10 -95.56 114.91 26.72 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.455 179.444 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -118.24 151.73 37.09 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.792 0.329 . . . . 0.0 111.633 179.694 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -124.59 125.15 43.7 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.334 178.724 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.487 ' O ' ' N ' ' A' ' 144' ' ' GLY . 92.3 t -59.95 137.25 22.62 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 177.557 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 77.7 p -106.6 -24.81 12.05 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 123.436 0.46 . . . . 0.0 110.792 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 158.83 -167.93 34.85 Favored Glycine 0 CA--C 1.533 1.218 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.875 HG22 HG22 ' A' ' 199' ' ' VAL . 44.4 t -129.99 128.27 64.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.452 -0.374 . . . . 0.0 109.998 178.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 18.2 m -107.74 157.34 18.2 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.479 0.657 . . . . 0.0 112.06 -179.46 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -101.67 113.44 26.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.253 179.01 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.57 HG21 HG21 ' A' ' 198' ' ' VAL . 22.9 m -135.48 163.3 35.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.682 0.754 . . . . 0.0 112.187 -178.468 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -90.06 155.86 46.93 Favored Pre-proline 0 CA--C 1.538 0.505 0 CA-C-N 114.944 -1.026 . . . . 0.0 110.335 179.133 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 168' ' ' PRO . . . . . 0.581 ' O ' ' CB ' ' B' ' 702' ' ' LEU . 37.0 Cg_endo -65.91 -16.49 52.96 Favored 'Trans proline' 0 N--CA 1.502 1.984 0 C-N-CA 123.273 2.648 . . . . 0.0 113.995 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 169' ' ' ASP . . . . . 0.418 ' O ' ' CD1' ' A' ' 171' ' ' TRP . 51.4 p-10 -91.82 -6.14 52.2 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 119.733 -0.787 . . . . 0.0 111.848 -179.809 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.505 ' O ' HG12 ' A' ' 173' ' ' VAL . 96.7 mttt -75.24 80.84 2.35 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 119.92 -0.712 . . . . 0.0 110.234 178.739 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 171' ' ' TRP . . . . . 0.574 ' O ' HG22 ' A' ' 174' ' ' VAL . 26.8 m0 -67.28 -11.56 57.84 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.003 -179.204 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.489 ' OE1' ' OE1' ' A' ' 175' ' ' GLU . 79.2 mm-40 -58.56 -29.9 66.74 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.456 -179.354 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 173' ' ' VAL . . . . . 0.768 HG13 HG13 ' A' ' 174' ' ' VAL . 10.6 p -60.73 -24.32 31.78 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -178.667 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.969 HG11 HG11 ' A' ' 110' ' ' VAL . 35.1 m -104.49 -8.55 9.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 120.086 -0.646 . . . . 0.0 112.04 -178.876 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.489 ' OE1' ' OE1' ' A' ' 172' ' ' GLU . 98.0 mt-10 -74.36 134.86 42.48 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 178.849 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 176' ' ' ASP . . . . . 0.489 ' OD1' ' O ' ' A' ' 176' ' ' ASP . 43.3 p-10 -66.17 130.9 44.83 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 121.098 0.475 . . . . 0.0 111.024 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 76.7 m80 -98.3 -13.63 20.64 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -179.018 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 100.11 34.78 4.72 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 -178.405 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -148.81 161.84 41.0 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.83 -0.685 . . . . 0.0 110.225 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -87.64 90.76 8.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.885 0.374 . . . . 0.0 110.087 178.202 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 181' ' ' GLU . . . . . 0.455 ' HG2' ' N ' ' A' ' 182' ' ' ILE . 79.1 tt0 -126.81 163.35 23.78 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.817 0.818 . . . . 0.0 111.811 -178.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.476 HG22 ' O ' ' A' ' 201' ' ' GLY . 17.9 tt -131.11 137.66 55.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.135 178.85 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 183' ' ' THR . . . . . 0.745 HG21 ' CG2' ' A' ' 173' ' ' VAL . 88.8 m -131.74 126.32 34.17 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.329 0.585 . . . . 0.0 111.353 179.753 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 84.0 mt -111.17 132.38 54.36 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.463 178.58 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.462 HD13 HD11 ' B' ' 702' ' ' LEU . 77.6 mt -110.14 126.85 67.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.429 0.633 . . . . 0.0 110.725 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 4.7 t -140.15 155.76 46.82 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.981 -1.009 . . . . 0.0 109.835 179.367 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 187' ' ' CYS . . . . . . . . . . . . . 4.0 m -91.9 148.89 21.87 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.546 -0.462 . . . . 0.0 110.652 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 195' ' ' LYS . 77.8 t -61.32 -47.57 92.86 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 CA-C-O 121.058 0.456 . . . . 0.0 110.874 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 92.4 p -163.68 162.22 24.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.313 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 190' ' ' VAL . . . . . 0.502 HG13 ' HG3' ' A' ' 191' ' ' LYS . 9.8 p -69.8 -12.94 16.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.12 0.486 . . . . 0.0 110.469 179.425 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 191' ' ' LYS . . . . . 0.502 ' HG3' HG13 ' A' ' 190' ' ' VAL . 98.3 mttt -108.06 -31.39 7.97 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.132 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -98.94 107.37 19.79 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.393 0.616 . . . . 0.0 111.244 -179.552 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -110.63 12.11 22.72 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.364 179.156 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 20.4 t -59.53 -47.07 86.97 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.359 -0.382 . . . . 0.0 112.028 -178.658 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 195' ' ' LYS . . . . . 0.423 ' O ' HG23 ' A' ' 188' ' ' VAL . 25.4 pttm -147.39 159.19 43.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.178 0.513 . . . . 0.0 111.332 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 83.6 mtt85 -123.53 143.97 49.85 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.407 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 -90.95 152.24 20.78 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.56 179.371 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.57 HG21 HG21 ' A' ' 166' ' ' VAL . 13.6 t -129.11 129.24 67.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.436 178.704 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.875 HG22 HG22 ' A' ' 163' ' ' VAL . 76.4 t -104.47 132.34 51.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.383 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -118.79 140.55 49.77 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.369 0.604 . . . . 0.0 111.207 -179.47 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 201' ' ' GLY . . . . . 0.476 ' O ' HG22 ' A' ' 182' ' ' ILE . . . -133.5 141.8 13.21 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 179.595 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 202' ' ' ASP . . . . . 0.532 ' OD1' ' N ' ' A' ' 203' ' ' LEU . 65.3 t0 -106.92 139.5 41.22 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.851 0.358 . . . . 0.0 110.164 -179.692 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 203' ' ' LEU . . . . . 0.532 ' N ' ' OD1' ' A' ' 202' ' ' ASP . 45.7 tp -64.98 131.34 46.35 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.529 HG22 ' O ' ' A' ' 157' ' ' GLU . 15.4 m -113.05 -20.39 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 C-N-CA 120.665 -0.414 . . . . 0.0 111.043 -178.864 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -175.57 171.59 44.66 Favored Glycine 0 CA--C 1.535 1.298 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.115 179.513 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 206' ' ' THR . . . . . 0.431 HG23 ' CD1' ' A' ' 156' ' ' TYR . 11.4 m -142.98 136.33 28.37 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.596 -0.302 . . . . 0.0 110.328 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -143.44 121.29 11.97 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.452 0.644 . . . . 0.0 112.183 179.269 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -64.99 140.73 58.9 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.259 -0.882 . . . . 0.0 112.106 -179.55 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt -77.47 156.68 30.91 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.953 -1.021 . . . . 0.0 110.484 178.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 98.1 mttt . . . . . 0 C--O 1.22 -0.474 0 CA-C-O 117.934 -1.032 . . . . 0.0 110.682 179.786 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 702' ' ' LEU . . . . . 0.581 ' CB ' ' O ' ' A' ' 168' ' ' PRO . 0.0 OUTLIER . . . . . 0 CA--C 1.545 0.778 0 CA-C-O 120.607 0.242 . . . . 20.0 110.824 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 703' ' ' PRO . . . . . 0.641 ' HG2' HG22 ' A' ' 110' ' ' VAL . 3.3 Cg_exo -66.2 -173.74 0.36 Allowed 'Trans proline' 0 N--CA 1.493 1.5 0 C-N-CA 122.346 2.031 . . . . 20.0 112.603 179.392 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 704' ' ' ALA . . . . . 0.527 ' HB3' HD13 ' A' ' 103' ' ' LEU . . . . . . . . 0 N--CA 1.468 0.473 0 N-CA-C 113.601 0.963 . . . . 20.0 113.601 -178.77 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.246 0 CA-C-O 121.095 0.474 . . . . 0.0 110.868 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 86.6 p -86.21 10.33 14.92 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.315 0.579 . . . . 0.0 111.176 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -104.4 13.39 32.04 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.372 -179.146 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.2 mt -56.73 137.76 18.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 CA-C-O 122.157 0.98 . . . . 0.0 112.864 -177.35 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.477 ' O ' ' OD1' ' A' ' 62' ' ' ASP . 46.7 p-10 -79.49 129.87 34.87 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 113.975 -1.466 . . . . 0.0 109.162 178.107 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.61 ' CD ' ' H ' ' A' ' 63' ' ' GLN . 1.7 pm0 -76.09 154.87 84.63 Favored Pre-proline 0 CA--C 1.535 0.38 0 CA-C-O 121.171 0.51 . . . . 0.0 110.302 -179.033 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -71.5 170.6 18.11 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.783 2.322 . . . . 0.0 112.975 -179.008 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.597 ' O ' HG23 ' A' ' 69' ' ' VAL . 28.1 t70 -52.81 159.35 1.14 Allowed 'General case' 0 C--N 1.334 -0.087 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.595 179.679 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 58.6 tp -63.31 -46.45 86.63 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 120.627 -0.429 . . . . 0.0 111.322 -178.618 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.94 -36.72 84.36 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 119.844 -0.742 . . . . 0.0 111.153 -178.508 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -58.29 -26.54 63.12 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 119.871 -0.732 . . . . 0.0 109.033 178.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.617 HG13 ' HB3' ' A' ' 104' ' ' LEU . 25.2 t -78.98 -44.94 24.64 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.529 178.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -73.07 -9.1 58.36 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.918 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -106.76 -14.62 14.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.276 0.56 . . . . 0.0 110.475 179.129 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -69.44 143.19 53.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.387 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 13.7 t -62.09 99.83 0.14 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.489 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.2 tt -69.7 134.74 48.99 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.274 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.454 ' OD2' ' OE1' ' A' ' 78' ' ' GLN . 84.8 m-20 -94.98 84.28 4.11 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 121.497 0.665 . . . . 0.0 110.244 178.862 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 48.7 tttp -63.19 -43.08 99.21 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.27 -0.877 . . . . 0.0 112.321 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.734 ' H ' ' CE ' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -70.34 -11.36 60.86 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.792 -0.64 . . . . 0.0 112.06 -177.068 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.454 ' OE1' ' OD2' ' A' ' 75' ' ' ASP . 33.5 mt-30 -92.06 -1.6 57.12 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.047 0.451 . . . . 0.0 110.324 179.088 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 58.1 t -76.64 127.14 37.81 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.244 179.6 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 29.2 pt -111.05 -1.79 10.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.65 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -175.99 179.47 47.09 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 120.502 -0.856 . . . . 0.0 111.48 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.566 ' NH1' ' OE2' ' A' ' 91' ' ' GLU . 73.1 ttp85 -141.19 153.76 45.49 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 120.919 0.39 . . . . 0.0 110.971 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.61 HG22 ' O ' ' A' ' 92' ' ' LEU . 18.1 tt -122.3 138.96 50.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-O 121.245 0.545 . . . . 0.0 110.317 179.54 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 10.3 t -137.75 130.85 30.41 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.199 0.524 . . . . 0.0 111.435 -179.416 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.548 HG12 HG23 ' A' ' 147' ' ' ILE . 54.3 mt -137.23 88.77 16.99 Favored Pre-proline 0 CA--C 1.541 0.604 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.987 -179.656 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -56.73 -31.11 86.9 Favored 'Trans proline' 0 N--CA 1.503 2.05 0 C-N-CA 123.086 2.524 . . . . 0.0 113.41 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 22.4 m -53.23 -42.27 66.22 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 121.207 0.527 . . . . 0.0 111.162 -179.511 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 12.7 m -115.77 8.28 7.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.44 0.638 . . . . 0.0 110.412 179.079 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.5 m 54.18 49.03 19.58 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.698 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 60.0 tp -112.15 131.49 55.43 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.384 0.611 . . . . 0.0 110.844 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.566 ' OE2' ' NH1' ' A' ' 82' ' ' ARG . 80.4 tt0 -149.16 126.22 11.32 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.944 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.61 ' O ' HG22 ' A' ' 83' ' ' ILE . 71.8 mt -152.24 151.98 28.54 Favored Pre-proline 0 CA--C 1.533 0.322 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.056 -179.514 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -74.73 147.02 34.58 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.361 2.041 . . . . 0.0 110.519 178.451 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 71.4 t -96.95 125.39 49.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 C-N-CA 120.434 -0.506 . . . . 0.0 110.855 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 9.5 mp -99.53 127.6 45.61 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.56 0.695 . . . . 0.0 111.472 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.514 ' O ' ' OG1' ' A' ' 109' ' ' THR . 87.5 tttt -63.71 -45.54 89.5 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 115.03 -0.986 . . . . 0.0 112.518 -178.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.447 ' HB3' HG23 ' A' ' 99' ' ' THR . 3.3 m -81.38 130.99 35.26 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.267 0.556 . . . . 0.0 111.267 -179.273 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 9.8 p -91.3 53.41 2.31 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.576 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.447 HG23 ' HB3' ' A' ' 97' ' ' SER . 81.2 p -88.44 166.77 14.0 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 178.576 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -64.13 -40.84 97.03 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.39 0.614 . . . . 0.0 110.453 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -63.95 -42.68 97.24 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.617 -179.458 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -65.7 -36.08 82.59 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.121 179.572 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.619 HD13 ' HB3' ' B' ' 704' ' ' ALA . 33.3 mt -61.52 -15.94 42.89 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.799 -179.61 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.617 ' HB3' HG13 ' A' ' 69' ' ' VAL . 88.7 mt -71.94 -20.03 61.82 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.271 0.558 . . . . 0.0 109.871 179.195 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 83.6 p -73.29 -0.98 16.11 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.876 -179.409 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.558 ' HA3' HD12 ' A' ' 134' ' ' LEU . . . 82.84 -18.59 15.03 Favored Glycine 0 CA--C 1.526 0.776 0 CA-C-N 116.069 -0.514 . . . . 0.0 112.387 178.52 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -145.26 123.91 12.53 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.527 0.68 . . . . 0.0 111.349 179.496 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -147.47 149.66 33.09 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.093 179.251 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.568 ' HA ' HD23 ' A' ' 123' ' ' LEU . 68.2 p -66.84 133.73 50.67 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.176 0.512 . . . . 0.0 110.561 -179.798 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.629 HG13 ' CD ' ' B' ' 703' ' ' PRO . 38.2 t -81.8 -62.0 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 C-N-CA 120.356 -0.538 . . . . 0.0 109.699 179.101 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.415 ' O ' ' OE1' ' A' ' 114' ' ' GLN . 85.5 tttt -94.17 133.95 37.14 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.818 179.38 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -66.37 -37.05 84.4 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -177.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -85.27 17.99 2.83 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 -178.484 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLN . . . . . 0.568 ' NE2' ' CZ ' ' A' ' 121' ' ' TYR . 20.1 pt20 -76.87 139.77 40.37 Favored 'General case' 0 CA--C 1.534 0.332 0 O-C-N 121.958 -0.464 . . . . 0.0 110.76 179.27 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 94.3 t -129.27 121.53 53.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.925 0.393 . . . . 0.0 110.162 178.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' MET . . . . . 0.588 ' SD ' ' OD1' ' A' ' 151' ' ' ASP . 56.1 mtt -58.06 134.34 56.34 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.173 0.511 . . . . 0.0 111.105 -179.71 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 78.52 -3.68 62.51 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 121.012 -0.613 . . . . 0.0 111.953 178.736 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -140.3 124.1 17.32 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.239 0.542 . . . . 0.0 110.759 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 76.04 -161.26 51.98 Favored Glycine 0 CA--C 1.531 1.081 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.368 179.313 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 63.2 t-20 -93.24 107.24 19.09 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.069 0.461 . . . . 0.0 110.977 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.568 ' CZ ' ' NE2' ' A' ' 114' ' ' GLN . 20.2 t80 -85.56 145.34 27.41 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.084 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.666 ' CB ' HG13 ' A' ' 174' ' ' VAL . . . -146.73 139.03 24.85 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 119.986 -0.686 . . . . 0.0 112.042 -178.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.568 HD23 ' HA ' ' A' ' 109' ' ' THR . 72.4 mt -135.69 141.66 44.99 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.947 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -111.96 132.94 54.46 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 121.374 0.607 . . . . 0.0 109.852 178.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -134.74 152.13 20.61 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.543 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' HIS . . . . . 0.525 ' ND1' ' OE1' ' A' ' 63' ' ' GLN . 40.9 m-70 -89.47 136.08 33.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.727 0.775 . . . . 0.0 112.339 -178.606 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -130.09 121.05 25.63 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.62 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.566 ' HB2' HG21 ' A' ' 133' ' ' VAL . 53.2 mtt -94.86 -1.46 52.67 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 121.407 0.623 . . . . 0.0 110.212 179.589 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.439 ' CB ' ' O ' ' A' ' 128' ' ' MET . 0.9 OUTLIER 77.78 4.57 2.95 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 115.421 -0.809 . . . . 0.0 112.071 178.665 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.873 ' O ' HG12 ' A' ' 133' ' ' VAL . 62.4 pttt -119.65 125.7 49.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.994 0.902 . . . . 0.0 113.118 -178.616 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.528 ' O ' ' O ' ' A' ' 130' ' ' LYS . 0.0 OUTLIER -35.23 159.73 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.455 179.062 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 74.0 -19.66 1.65 Allowed Glycine 0 CA--C 1.534 1.264 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.873 HG12 ' O ' ' A' ' 130' ' ' LYS . 4.7 p -90.09 173.42 0.88 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 119.587 -0.845 . . . . 0.0 111.094 -179.394 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.661 ' H ' HG22 ' A' ' 133' ' ' VAL . 4.3 mm? -66.81 130.05 41.89 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 -175.531 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.534 ' CD2' HD12 ' A' ' 138' ' ' ILE . 3.8 m-30 60.98 18.28 8.74 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 114.164 -1.38 . . . . 0.0 112.545 178.488 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.37 -37.23 84.92 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 113.005 0.742 . . . . 0.0 113.005 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 31.7 p-10 -94.6 6.25 49.42 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.974 0.416 . . . . 0.0 111.88 -178.442 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.534 HD12 ' CD2' ' A' ' 135' ' ' PHE . 3.6 tt -63.97 -37.9 80.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 C-N-CA 120.553 -0.459 . . . . 0.0 111.786 -179.443 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -67.8 -10.67 54.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.803 0.335 . . . . 0.0 111.352 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 33.1 m -80.93 -4.98 56.85 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.036 0.446 . . . . 0.0 110.505 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 80.1 mt -63.91 139.52 58.78 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.037 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.402 ' HG2' ' N ' ' A' ' 143' ' ' LYS . 88.6 tttt -115.9 156.76 25.59 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 121.478 0.656 . . . . 0.0 112.097 -178.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' LYS . . . . . 0.402 ' N ' ' HG2' ' A' ' 142' ' ' LYS . 88.0 tttt -48.87 130.57 18.17 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.341 -0.845 . . . . 0.0 112.647 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.603 ' N ' ' O ' ' A' ' 160' ' ' VAL . . . 78.37 7.67 87.8 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.972 178.383 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -71.97 137.93 47.66 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 119.567 -0.853 . . . . 0.0 110.268 -179.585 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -80.76 142.06 34.16 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 122.016 0.912 . . . . 0.0 113.021 -177.615 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.548 HG23 HG12 ' A' ' 85' ' ' ILE . 91.6 mt -138.66 139.11 41.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 114.361 -1.291 . . . . 0.0 108.791 178.233 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' TYR . . . . . 0.596 ' C ' HD22 ' A' ' 149' ' ' LEU . 94.0 m-85 -116.68 138.36 51.51 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 122.033 0.92 . . . . 0.0 112.821 -178.857 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.596 HD22 ' C ' ' A' ' 148' ' ' TYR . 4.5 mm? -117.03 137.73 52.05 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.112 -1.404 . . . . 0.0 108.484 178.347 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -126.56 112.06 15.09 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 119.978 -0.689 . . . . 0.0 112.418 -178.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' ASP . . . . . 0.588 ' OD1' ' SD ' ' A' ' 116' ' ' MET . 20.7 m-20 -89.63 164.72 14.62 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 176.465 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 53.4 t30 -56.66 -23.5 42.12 Favored 'General case' 0 C--N 1.31 -1.118 0 C-N-CA 119.893 -0.723 . . . . 0.0 111.124 -178.113 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -111.0 -29.44 7.9 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 113.38 0.882 . . . . 0.0 113.38 -178.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' ASN . . . . . 0.455 ' O ' ' N ' ' A' ' 151' ' ' ASP . 0.4 OUTLIER -145.98 177.77 8.7 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 119.644 -0.822 . . . . 0.0 112.74 -176.949 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -134.32 145.8 49.38 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.099 178.672 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' TYR . . . . . 0.492 ' CD2' HG23 ' A' ' 206' ' ' THR . 48.3 m-85 -120.12 139.29 52.81 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 121.201 0.524 . . . . 0.0 111.486 -178.267 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -93.75 114.69 27.02 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.158 179.391 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -115.07 149.48 37.44 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.226 0.536 . . . . 0.0 111.934 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.454 ' HB2' HG21 ' A' ' 204' ' ' VAL . . . -122.86 122.17 38.0 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.617 179.159 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.603 ' O ' ' N ' ' A' ' 144' ' ' GLY . 86.2 t -60.37 138.62 21.04 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.218 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 177.848 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 20.3 p -107.22 -23.28 12.31 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.671 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 159.84 -167.63 35.37 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 120.28 -0.962 . . . . 0.0 112.033 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.934 HG22 HG22 ' A' ' 199' ' ' VAL . 42.3 t -127.4 137.57 57.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-N 115.124 -0.538 . . . . 0.0 109.74 179.453 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 57.9 m -123.78 157.38 34.18 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 121.317 0.58 . . . . 0.0 111.474 -178.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 28.2 mp0 -104.63 113.43 27.01 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 121.553 0.692 . . . . 0.0 110.705 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 27.6 m -139.49 163.93 24.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.234 -179.556 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' THR . . . . . 0.44 ' H ' ' HD2' ' A' ' 170' ' ' LYS . 0.2 OUTLIER -91.56 159.91 37.74 Favored Pre-proline 0 CA--C 1.538 0.484 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.694 178.513 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 168' ' ' PRO . . . . . 0.488 ' O ' ' CB ' ' B' ' 702' ' ' LEU . 35.6 Cg_endo -65.52 -15.76 50.97 Favored 'Trans proline' 0 N--CA 1.5 1.883 0 C-N-CA 122.874 2.383 . . . . 0.0 113.885 -179.727 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 44.1 p-10 -91.86 -7.21 50.0 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 119.466 -0.893 . . . . 0.0 111.544 179.441 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.722 ' O ' HG22 ' A' ' 173' ' ' VAL . 96.7 mttt -75.64 83.11 2.65 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.808 0.813 . . . . 0.0 111.723 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 33.2 t90 -71.13 -11.31 60.87 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.636 -1.165 . . . . 0.0 110.47 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -61.57 -35.08 76.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.674 -179.745 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 173' ' ' VAL . . . . . 0.722 HG22 ' O ' ' A' ' 170' ' ' LYS . 32.7 m -63.51 -14.03 13.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.427 -179.183 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.666 HG13 ' CB ' ' A' ' 122' ' ' ALA . 12.2 t -110.58 -5.85 11.25 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -179.104 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.499 ' O ' ' CE1' ' A' ' 177' ' ' HIS . 94.9 mt-10 -72.36 149.12 44.64 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.345 0.593 . . . . 0.0 110.88 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 176' ' ' ASP . . . . . 0.52 ' OD1' ' O ' ' A' ' 176' ' ' ASP . 51.9 p-10 -67.61 128.42 36.38 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.611 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 177' ' ' HIS . . . . . 0.499 ' CE1' ' O ' ' A' ' 175' ' ' GLU . 76.6 m80 -110.23 22.02 16.04 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.509 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 59.94 37.45 92.65 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 110.771 -0.932 . . . . 0.0 110.771 179.641 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 18.3 ptmt -146.22 158.7 43.9 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -88.74 91.67 8.91 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.292 177.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -129.56 172.47 11.54 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.478 0.656 . . . . 0.0 111.259 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 18.6 tt -134.44 144.29 35.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.436 178.799 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 84.7 m -131.48 126.55 35.28 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.522 0.677 . . . . 0.0 111.572 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 86.1 mt -109.4 131.47 55.03 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.769 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.488 HD13 ' CD2' ' B' ' 702' ' ' LEU . 85.0 mt -112.87 124.19 69.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.498 0.666 . . . . 0.0 111.31 -178.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 3.9 t -137.81 153.04 49.69 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.831 179.154 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 187' ' ' CYS . . . . . . . . . . . . . 3.3 m -88.5 139.36 30.56 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.039 0.447 . . . . 0.0 110.945 -179.288 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.525 HG13 ' N ' ' A' ' 189' ' ' SER . 10.9 p -65.13 -44.54 95.51 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.099 -179.426 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 189' ' ' SER . . . . . 0.525 ' N ' HG13 ' A' ' 188' ' ' VAL . 80.9 p -164.54 157.57 17.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.076 0.465 . . . . 0.0 110.795 179.525 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 190' ' ' VAL . . . . . 0.428 HG22 ' O ' ' A' ' 190' ' ' VAL . 11.4 p -81.93 -9.96 11.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.034 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -96.4 -9.97 28.71 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.284 0.564 . . . . 0.0 110.688 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -142.89 101.43 3.84 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.633 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 53.3 p-10 -102.21 10.39 39.36 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.247 0.546 . . . . 0.0 110.439 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 39.1 t -61.4 -46.16 91.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.277 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 64.4 pttt -144.86 150.95 37.97 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.453 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 196' ' ' ARG . . . . . 0.847 ' NH2' HD22 ' B' ' 702' ' ' LEU . 21.8 ptt180 -137.96 158.16 44.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.219 0.533 . . . . 0.0 111.165 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -91.75 141.35 28.78 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.839 -0.618 . . . . 0.0 111.561 -179.556 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 42.0 t -118.94 132.08 69.86 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.01 178.807 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.934 HG22 HG22 ' A' ' 163' ' ' VAL . 84.9 t -100.0 132.32 45.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.503 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -118.01 144.27 45.69 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.399 0.618 . . . . 0.0 110.996 -178.806 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -140.22 163.43 26.36 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 110.284 -1.127 . . . . 0.0 110.284 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 202' ' ' ASP . . . . . 0.57 ' OD1' ' N ' ' A' ' 203' ' ' LEU . 67.6 t0 -122.22 139.4 53.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.017 0.437 . . . . 0.0 111.888 -178.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 203' ' ' LEU . . . . . 0.57 ' N ' ' OD1' ' A' ' 202' ' ' ASP . 46.5 tp -62.78 131.54 49.2 Favored 'General case' 0 CA--C 1.52 -0.207 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.454 HG21 ' HB2' ' A' ' 159' ' ' ALA . 57.4 t -110.51 -20.72 6.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 C-N-CA 120.355 -0.538 . . . . 0.0 111.648 -178.699 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -178.03 174.21 46.6 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 120.546 -0.835 . . . . 0.0 111.486 -179.568 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 206' ' ' THR . . . . . 0.492 HG23 ' CD2' ' A' ' 156' ' ' TYR . 24.5 m -146.24 138.2 24.99 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.319 -0.441 . . . . 0.0 110.296 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -145.81 124.19 12.34 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.2 0.524 . . . . 0.0 110.943 178.689 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -65.86 147.98 52.51 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.78 0.8 . . . . 0.0 112.08 -179.684 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 10.1 ttmt -77.43 159.13 29.65 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.704 -1.135 . . . . 0.0 110.495 179.072 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 98.2 mttt . . . . . 0 C--O 1.219 -0.551 0 CA-C-O 118.089 -0.958 . . . . 0.0 110.562 179.429 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 702' ' ' LEU . . . . . 0.847 HD22 ' NH2' ' A' ' 196' ' ' ARG . 2.3 mt . . . . . 0 CA--C 1.541 0.599 0 CA-C-O 120.55 0.214 . . . . 20.0 110.449 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 703' ' ' PRO . . . . . 0.629 ' CD ' HG13 ' A' ' 110' ' ' VAL . 2.5 Cg_endo -62.1 -173.09 0.12 Allowed 'Trans proline' 0 N--CA 1.489 1.232 0 C-N-CA 121.978 1.786 . . . . 20.0 113.061 -178.573 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 704' ' ' ALA . . . . . 0.619 ' HB3' HD13 ' A' ' 103' ' ' LEU . . . . . . . . 0 CA--C 1.532 0.259 0 CA-C-N 114.249 -1.342 . . . . 20.0 113.119 -179.364 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.377 0 CA-C-O 121.118 0.485 . . . . 0.0 111.896 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 29.5 p -84.73 11.15 9.57 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.346 0.498 . . . . 0.0 112.346 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -94.14 8.01 43.15 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.832 -0.347 . . . . 0.0 111.217 -179.023 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.5 mt -56.36 132.8 20.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 122.254 1.026 . . . . 0.0 113.689 -176.726 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -76.47 133.96 39.67 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 113.637 -1.62 . . . . 0.0 109.261 178.428 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.524 ' CD ' ' CG ' ' A' ' 126' ' ' HIS . 0.5 OUTLIER -79.03 149.19 73.05 Favored Pre-proline 0 CA--C 1.537 0.47 0 CA-C-O 121.086 0.469 . . . . 0.0 111.895 -178.369 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -73.6 168.04 25.76 Favored 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 123.177 2.585 . . . . 0.0 112.173 179.72 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -55.1 167.36 0.43 Allowed 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 121.179 0.514 . . . . 0.0 111.481 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.483 HD22 ' N ' ' A' ' 66' ' ' LEU . 4.3 mm? -64.29 -42.67 96.3 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.296 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.78 -35.37 74.5 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.65 -0.42 . . . . 0.0 111.517 -177.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -61.37 -29.76 70.11 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.763 0.792 . . . . 0.0 109.655 179.067 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.679 HG13 ' HB3' ' A' ' 104' ' ' LEU . 23.0 t -75.01 -43.77 44.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.001 -0.999 . . . . 0.0 109.952 179.482 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -76.73 -9.44 58.67 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 114.948 -1.023 . . . . 0.0 111.228 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -113.17 -1.31 14.39 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.296 0.57 . . . . 0.0 110.233 178.855 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.43 -165.77 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.097 -179.112 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 69.6 p -103.72 106.51 17.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.712 178.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.594 HD13 ' C ' ' A' ' 74' ' ' LEU . 2.1 tm? -71.94 118.04 14.3 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.838 0.351 . . . . 0.0 110.836 -179.385 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.555 ' N ' HD13 ' A' ' 74' ' ' LEU . 96.4 m-20 -104.21 77.22 1.4 Allowed 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 121.459 0.647 . . . . 0.0 109.984 179.138 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -69.19 -39.22 78.81 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.261 -0.881 . . . . 0.0 113.019 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.43 ' HG2' ' H ' ' A' ' 77' ' ' LYS . 42.4 mmtt -70.3 -15.24 62.86 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.193 -175.207 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -91.18 -4.47 56.07 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.062 0.458 . . . . 0.0 110.931 179.309 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 78.0 t -80.43 128.04 38.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.068 0.461 . . . . 0.0 110.161 179.389 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.657 HD13 ' CE ' ' A' ' 96' ' ' LYS . 18.4 pt -111.66 -6.21 11.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.862 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -175.3 179.16 46.71 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 110.799 -0.92 . . . . 0.0 110.799 179.535 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -152.8 154.94 36.18 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.44 0.638 . . . . 0.0 111.3 179.673 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 17.0 tt -104.61 144.37 14.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.608 -179.167 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 33.1 t -135.71 127.72 29.65 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.61 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.716 HG12 HG23 ' A' ' 147' ' ' ILE . 53.0 mt -135.44 89.68 22.1 Favored Pre-proline 0 CA--C 1.537 0.456 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.403 -179.547 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -55.18 -33.38 84.04 Favored 'Trans proline' 0 N--CA 1.501 1.936 0 C-N-CA 123.165 2.577 . . . . 0.0 113.699 -179.33 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 74.1 m -52.9 -38.73 62.07 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 120.962 0.411 . . . . 0.0 111.08 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.471 HG22 ' CG2' ' A' ' 85' ' ' ILE . 33.1 m -117.78 13.37 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.292 179.387 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.8 m 49.17 49.52 19.47 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.476 -0.49 . . . . 0.0 110.457 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 62.9 tp -112.94 132.46 55.33 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.325 0.583 . . . . 0.0 110.822 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -146.19 122.03 10.61 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.743 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.661 HD13 ' HA3' ' A' ' 106' ' ' GLY . 94.4 mt -149.17 150.68 32.5 Favored Pre-proline 0 CA--C 1.54 0.588 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.065 -179.171 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -76.25 151.95 34.57 Favored 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 122.695 2.263 . . . . 0.0 112.295 179.21 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.49 ' C ' HD12 ' A' ' 95' ' ' LEU . 98.6 t -96.83 114.65 34.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.855 0.359 . . . . 0.0 110.502 179.255 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.569 HD12 ' N ' ' A' ' 95' ' ' LEU . 10.3 mp -100.64 139.03 36.9 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.1 0.476 . . . . 0.0 111.472 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.657 ' CE ' HD13 ' A' ' 80' ' ' ILE . 98.9 mttt -66.44 -83.44 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 121.284 0.564 . . . . 0.0 112.019 -179.483 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 17.7 m -60.79 132.52 54.13 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.664 -179.297 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 43.6 t -88.28 74.43 8.71 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.371 0.605 . . . . 0.0 109.874 179.388 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.404 ' OG1' ' CG ' ' A' ' 102' ' ' ASN . 57.1 p -88.79 169.86 11.26 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.802 179.029 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -62.68 -44.34 96.51 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 120.23 -0.588 . . . . 0.0 109.952 179.512 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -66.61 -40.97 89.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.395 179.584 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.404 ' CG ' ' OG1' ' A' ' 99' ' ' THR . 95.0 m-20 -64.34 -35.71 81.76 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.816 -179.523 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 34.2 mt -60.49 -26.06 66.52 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.192 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.679 ' HB3' HG13 ' A' ' 69' ' ' VAL . 92.6 mt -72.74 -18.7 61.49 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.297 -179.102 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.478 ' O ' HD22 ' A' ' 92' ' ' LEU . 99.5 p -74.07 -8.25 55.48 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 121.33 0.586 . . . . 0.0 110.085 179.612 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.661 ' HA3' HD13 ' A' ' 92' ' ' LEU . . . 92.74 -19.57 50.5 Favored Glycine 0 CA--C 1.53 1.016 0 CA-C-N 115.721 -0.672 . . . . 0.0 114.003 177.699 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -145.03 127.01 15.5 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 119.556 -0.858 . . . . 0.0 111.701 -179.34 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -144.04 138.81 28.6 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.658 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.62 ' HA ' HD23 ' A' ' 123' ' ' LEU . 64.5 p -73.84 135.01 43.4 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.138 0.494 . . . . 0.0 110.336 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.591 HG13 ' CG ' ' B' ' 703' ' ' PRO . 77.8 t -78.97 -54.89 10.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.066 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.46 ' N ' ' OE1' ' A' ' 114' ' ' GLN . 97.5 mttt -102.15 137.43 40.43 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 122.36 1.076 . . . . 0.0 112.573 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -64.34 -29.54 70.61 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.396 -1.274 . . . . 0.0 112.491 -177.608 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 73.4 m-80 -84.07 17.15 2.56 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 113.669 0.988 . . . . 0.0 113.669 -178.007 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLN . . . . . 0.764 HE21 ' H ' ' A' ' 122' ' ' ALA . 51.2 mt-30 -78.48 134.77 37.29 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 121.966 -0.459 . . . . 0.0 111.672 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 96.3 t -124.85 119.95 57.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-O 120.993 0.425 . . . . 0.0 110.387 178.312 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 64.8 mtt -55.6 131.62 46.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.273 0.558 . . . . 0.0 111.488 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 84.77 -6.18 79.2 Favored Glycine 0 CA--C 1.533 1.199 0 CA-C-N 115.597 -0.728 . . . . 0.0 112.231 179.034 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -143.6 136.75 27.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.333 0.587 . . . . 0.0 112.068 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 75.03 -172.94 53.09 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.672 -0.971 . . . . 0.0 110.672 179.707 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.47 HD22 ' CE1' ' A' ' 177' ' ' HIS . 52.3 t-20 -89.04 103.24 15.87 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.455 -0.498 . . . . 0.0 110.081 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.569 ' HE2' HD21 ' A' ' 123' ' ' LEU . 7.4 t80 -85.63 99.07 11.04 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-O 121.065 0.46 . . . . 0.0 109.773 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.764 ' H ' HE21 ' A' ' 114' ' ' GLN . . . -91.54 136.12 33.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.982 -179.202 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.62 HD23 ' HA ' ' A' ' 109' ' ' THR . 74.6 mt -137.55 140.17 40.88 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 120.914 0.388 . . . . 0.0 111.099 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -108.43 146.23 33.41 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 178.318 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -148.09 156.75 27.06 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 -179.524 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' HIS . . . . . 0.535 ' O ' ' O ' ' A' ' 134' ' ' LEU . 77.9 m-70 -110.56 130.31 55.59 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 113.453 0.908 . . . . 0.0 113.453 -178.239 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ASN . . . . . 0.591 ' ND2' ' O ' ' A' ' 127' ' ' ASN . 0.0 OUTLIER -134.65 121.93 21.55 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.78 177.712 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.545 ' H ' HG21 ' A' ' 133' ' ' VAL . 65.0 mtt -83.83 8.19 15.61 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.057 0.456 . . . . 0.0 110.791 -179.404 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.488 ' CB ' ' O ' ' A' ' 128' ' ' MET . 0.7 OUTLIER 79.0 12.92 1.27 Allowed 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.452 179.118 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.877 ' O ' HG12 ' A' ' 133' ' ' VAL . 23.1 pttp -116.91 126.3 52.76 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 122.241 1.02 . . . . 0.0 112.68 -179.328 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 27.6 tptt -46.24 121.61 3.45 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.538 -1.21 . . . . 0.0 110.082 179.306 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 113.88 -15.14 21.56 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.563 -1.015 . . . . 0.0 110.563 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.877 HG12 ' O ' ' A' ' 130' ' ' LYS . 11.1 p -91.44 166.04 1.85 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.732 HD23 ' N ' ' A' ' 134' ' ' LEU . 0.3 OUTLIER -72.75 138.2 46.36 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 122.384 1.087 . . . . 0.0 113.821 -176.239 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 62.14 9.69 3.31 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 113.67 -1.604 . . . . 0.0 114.643 177.584 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 4.3 p -70.4 -31.96 69.39 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 121.486 -0.759 . . . . 0.0 113.028 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -88.82 8.57 28.39 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 -177.64 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.454 ' CD1' ' OG1' ' A' ' 186' ' ' THR . 18.2 pt -68.7 -31.46 50.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 121.602 0.715 . . . . 0.0 110.476 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -61.98 -20.81 64.26 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.639 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 57.7 m -79.78 -3.41 47.52 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.172 -179.225 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 99.5 mt -65.78 145.6 55.78 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 121.071 0.462 . . . . 0.0 110.198 179.515 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 53.6 mttp -120.67 154.5 35.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.515 0.674 . . . . 0.0 111.254 -179.356 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -49.97 131.86 22.84 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.41 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.483 ' N ' ' O ' ' A' ' 160' ' ' VAL . . . 80.71 8.23 87.72 Favored Glycine 0 CA--C 1.533 1.217 0 C-N-CA 120.682 -0.77 . . . . 0.0 111.72 179.297 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.458 ' OD1' ' N ' ' A' ' 146' ' ' LYS . 56.6 t0 -71.17 130.04 40.45 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 120.042 -0.663 . . . . 0.0 110.304 -179.513 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.458 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 74.5 mmtt -77.81 142.85 38.33 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.8 0.809 . . . . 0.0 112.263 -178.803 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.716 HG23 HG12 ' A' ' 85' ' ' ILE . 80.5 mt -142.64 143.44 25.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 114.562 -1.199 . . . . 0.0 108.656 178.305 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -126.04 139.96 52.98 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 119.599 -0.84 . . . . 0.0 112.563 -178.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 2.9 mt -110.5 134.12 52.66 Favored 'General case' 0 C--O 1.223 -0.334 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 177.759 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.553 ' CZ ' ' CD ' ' A' ' 155' ' ' GLU . 33.3 m-85 -110.25 107.68 17.53 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.303 -0.559 . . . . 0.0 112.078 -179.207 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' ASP . . . . . 0.477 ' OD1' ' N ' ' A' ' 152' ' ' ASN . 54.5 t0 -88.94 162.37 16.13 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 177.449 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' ASN . . . . . 0.477 ' N ' ' OD1' ' A' ' 151' ' ' ASP . 44.9 p-10 -58.27 -18.55 27.53 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 119.422 -0.911 . . . . 0.0 111.358 -178.215 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -113.77 -28.14 7.54 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -178.484 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' ASN . . . . . 0.411 ' O ' ' N ' ' A' ' 151' ' ' ASP . 0.9 OUTLIER -148.58 -175.12 4.8 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 122.134 0.969 . . . . 0.0 113.477 -176.779 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.553 ' CD ' ' CZ ' ' A' ' 150' ' ' TYR . 82.5 tt0 -134.79 140.88 46.22 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 114.153 -1.385 . . . . 0.0 109.939 178.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 156' ' ' TYR . . . . . 0.469 ' CD1' HG23 ' A' ' 206' ' ' THR . 89.9 m-85 -115.45 137.95 51.52 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -179.05 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 157' ' ' GLU . . . . . 0.543 ' O ' HG12 ' A' ' 204' ' ' VAL . 91.2 mt-10 -93.42 109.27 20.85 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.854 179.571 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.404 ' CE2' ' HB2' ' A' ' 203' ' ' LEU . 38.1 m-85 -113.27 147.51 37.42 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.08 0.467 . . . . 0.0 111.349 178.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -122.02 121.55 37.27 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.262 0.553 . . . . 0.0 111.567 179.707 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.483 ' O ' ' N ' ' A' ' 144' ' ' GLY . 52.1 t -59.86 136.31 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.258 178.206 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 22.5 p -105.68 -24.83 12.45 Favored 'General case' 0 CA--C 1.533 0.316 0 O-C-N 123.535 0.522 . . . . 0.0 111.623 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 159.3 -169.08 35.39 Favored Glycine 0 CA--C 1.529 0.949 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.428 HG22 ' N ' ' A' ' 164' ' ' SER . 3.6 p -136.35 155.92 35.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 164' ' ' SER . . . . . 0.428 ' N ' HG22 ' A' ' 163' ' ' VAL . 68.3 m -146.1 167.51 23.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.353 0.597 . . . . 0.0 111.764 -179.216 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -103.14 119.1 38.24 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.119 179.6 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.447 HG21 HG21 ' A' ' 198' ' ' VAL . 21.0 m -136.3 158.45 38.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.452 0.644 . . . . 0.0 111.859 -178.884 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 167' ' ' THR . . . . . 0.425 ' H ' ' HD2' ' A' ' 170' ' ' LYS . 0.3 OUTLIER -86.52 158.61 54.21 Favored Pre-proline 0 CA--C 1.537 0.48 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.111 -179.634 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 168' ' ' PRO . . . . . 0.538 ' O ' ' CB ' ' B' ' 702' ' ' LEU . 32.6 Cg_endo -66.31 -18.7 55.8 Favored 'Trans proline' 0 N--CA 1.498 1.792 0 C-N-CA 123.471 2.781 . . . . 0.0 113.425 -179.78 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 44.0 p-10 -92.88 -3.14 55.13 Favored 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 119.878 -0.729 . . . . 0.0 112.187 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.595 ' O ' HG22 ' A' ' 173' ' ' VAL . 93.6 mttt -76.74 97.29 4.44 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.466 0.65 . . . . 0.0 112.175 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 171' ' ' TRP . . . . . 0.439 ' O ' HG22 ' A' ' 174' ' ' VAL . 95.9 m95 -66.84 -33.62 76.01 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.254 -0.884 . . . . 0.0 110.277 178.841 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -44.27 -36.28 2.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.071 -0.968 . . . . 0.0 112.885 -178.381 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 173' ' ' VAL . . . . . 0.732 HG23 HG13 ' A' ' 174' ' ' VAL . 16.1 m -63.37 -26.04 39.87 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 120.376 -0.53 . . . . 0.0 112.064 -179.104 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.732 HG13 HG23 ' A' ' 173' ' ' VAL . 25.6 m -108.79 -7.8 11.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 120.306 -0.558 . . . . 0.0 112.466 -179.364 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -75.02 153.64 38.38 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.143 0.497 . . . . 0.0 111.502 179.381 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 176' ' ' ASP . . . . . 0.412 ' O ' ' OD1' ' A' ' 176' ' ' ASP . 48.8 p-10 -64.61 138.07 58.19 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.123 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 177' ' ' HIS . . . . . 0.47 ' CE1' HD22 ' A' ' 120' ' ' ASN . 70.1 m80 -112.83 14.9 19.93 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.416 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 72.12 34.37 61.52 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 120.851 -0.69 . . . . 0.0 111.547 179.03 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 42.8 pttt -166.33 178.84 5.95 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.629 0.728 . . . . 0.0 111.722 179.26 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 180' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' A' ' 180' ' ' ASP . 18.3 p30 -89.77 92.99 9.27 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.835 179.201 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 181' ' ' GLU . . . . . 0.426 ' HG2' ' N ' ' A' ' 182' ' ' ILE . 84.3 tt0 -124.85 161.32 26.78 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.411 0.624 . . . . 0.0 111.566 -179.485 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.49 HG22 ' O ' ' A' ' 201' ' ' GLY . 20.5 tt -129.09 135.95 60.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 178.548 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 183' ' ' THR . . . . . 0.614 ' C ' HD12 ' A' ' 184' ' ' LEU . 80.4 m -130.26 126.07 36.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.707 0.765 . . . . 0.0 112.203 -178.928 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.614 HD12 ' C ' ' A' ' 183' ' ' THR . 10.5 mp -109.66 131.87 54.67 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.817 -1.083 . . . . 0.0 109.164 178.824 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.732 HD13 HD21 ' B' ' 702' ' ' LEU . 96.8 mt -113.67 122.63 68.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 121.454 0.645 . . . . 0.0 111.288 -179.185 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 186' ' ' THR . . . . . 0.454 ' OG1' ' CD1' ' A' ' 138' ' ' ILE . 4.7 m -140.86 153.16 45.62 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.827 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 187' ' ' CYS . . . . . . . . . . . . . 86.4 m -87.03 153.92 21.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.269 179.229 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.716 HG23 ' O ' ' A' ' 195' ' ' LYS . 65.8 t -61.04 -48.87 87.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.278 0.561 . . . . 0.0 110.842 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 16.5 t -168.06 151.25 5.79 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.791 179.081 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 190' ' ' VAL . . . . . 0.445 HG13 ' HG3' ' A' ' 191' ' ' LYS . 7.5 p -62.01 -20.69 24.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.38 0.609 . . . . 0.0 109.919 179.462 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 191' ' ' LYS . . . . . 0.445 ' HG3' HG13 ' A' ' 190' ' ' VAL . 60.4 mttp -94.65 -12.13 27.94 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.047 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -138.09 103.11 4.86 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.767 179.561 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -104.68 11.94 33.47 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.549 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 21.3 m -63.57 -36.81 85.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.946 -179.463 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 195' ' ' LYS . . . . . 0.716 ' O ' HG23 ' A' ' 188' ' ' VAL . 57.1 mtmt -135.13 156.95 48.13 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.075 0.464 . . . . 0.0 111.709 -178.796 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -128.63 139.28 52.34 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.433 -179.417 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 197' ' ' TYR . . . . . 0.463 ' CE2' HG22 ' A' ' 188' ' ' VAL . 45.6 m-85 -94.62 144.5 25.55 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.246 0.546 . . . . 0.0 112.086 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.447 HG21 HG21 ' A' ' 166' ' ' VAL . 41.6 t -131.79 131.16 62.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.041 178.12 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 53.5 t -105.29 132.83 51.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.432 179.065 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -116.44 141.82 47.68 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.307 0.575 . . . . 0.0 110.836 -179.055 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 201' ' ' GLY . . . . . 0.49 ' O ' HG22 ' A' ' 182' ' ' ILE . . . -143.57 145.8 15.89 Favored Glycine 0 CA--C 1.528 0.903 0 N-CA-C 110.64 -0.984 . . . . 0.0 110.64 179.479 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -107.03 149.36 27.65 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.027 0.441 . . . . 0.0 110.594 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 203' ' ' LEU . . . . . 0.436 HD12 ' O ' ' A' ' 157' ' ' GLU . 49.2 tp -70.29 131.61 44.44 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 179.245 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.543 HG12 ' O ' ' A' ' 157' ' ' GLU . 7.6 p -114.05 -20.27 6.19 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 C-N-CA 120.442 -0.503 . . . . 0.0 111.767 -179.399 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -174.49 172.36 45.32 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 120.711 -0.757 . . . . 0.0 111.722 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 206' ' ' THR . . . . . 0.469 HG23 ' CD1' ' A' ' 156' ' ' TYR . 17.5 m -142.96 136.13 28.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.44 -0.38 . . . . 0.0 110.21 -179.733 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -144.52 120.62 10.77 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.284 0.564 . . . . 0.0 111.745 179.216 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -62.06 137.35 58.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.465 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -81.22 160.95 24.17 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.099 178.704 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 25.3 pttm . . . . . 0 C--O 1.22 -0.464 0 CA-C-O 118.188 -0.911 . . . . 0.0 110.869 -179.693 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 702' ' ' LEU . . . . . 0.732 HD21 HD13 ' A' ' 185' ' ' ILE . 0.4 OUTLIER . . . . . 0 CA--C 1.536 0.439 0 N-CA-C 109.483 -0.562 . . . . 20.0 109.483 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 703' ' ' PRO . . . . . 0.591 ' CG ' HG13 ' A' ' 110' ' ' VAL . 3.4 Cg_exo -64.01 179.5 1.08 Allowed 'Trans proline' 0 N--CA 1.491 1.378 0 C-N-CA 122.243 1.962 . . . . 20.0 113.903 -178.589 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 704' ' ' ALA . . . . . 0.559 ' O ' ' O ' ' B' ' 703' ' ' PRO . . . . . . . . 0 CA--C 1.533 0.311 0 CA-C-N 114.175 -1.375 . . . . 20.0 113.496 -179.651 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.461 0.077 0 CA-C-O 121.245 0.545 . . . . 0.0 110.542 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 89.8 p -84.26 13.16 5.54 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.914 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 50.9 mtmt -107.29 18.09 22.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.635 -179.036 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 76.8 mt -56.17 138.97 16.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 122.244 1.021 . . . . 0.0 113.142 -177.693 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -76.51 132.74 39.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 113.614 -1.63 . . . . 0.0 109.199 178.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.643 ' H ' HE21 ' A' ' 63' ' ' GLN . 0.0 OUTLIER -77.09 147.5 76.86 Favored Pre-proline 0 C--N 1.324 -0.506 0 C-N-CA 120.513 -0.475 . . . . 0.0 110.14 -179.439 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.451 ' CB ' ' OE1' ' A' ' 68' ' ' GLU . 66.9 Cg_endo -70.4 160.33 49.88 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 122.861 2.374 . . . . 0.0 112.273 -179.262 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 -52.99 172.18 0.05 Allowed 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 121.311 0.577 . . . . 0.0 111.06 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 98.8 mt -71.25 -10.59 60.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.725 -179.156 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -69.17 -40.55 78.07 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.408 0.623 . . . . 0.0 111.024 179.116 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.781 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 90.1 mt-10 -71.44 -26.83 62.9 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.023 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 6.0 t -72.16 -44.25 65.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.67 -179.004 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -89.91 -9.88 47.25 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.925 -0.31 . . . . 0.0 111.581 -179.44 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -110.52 -8.0 14.68 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.647 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.781 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -68.44 138.9 55.66 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.35 0.595 . . . . 0.0 111.731 -179.296 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 5.9 m -57.8 102.85 0.11 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.718 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.669 HD13 ' N ' ' A' ' 75' ' ' ASP . 2.0 tm? -68.34 119.28 12.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.39 -178.557 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.669 ' N ' HD13 ' A' ' 74' ' ' LEU . 89.6 m-20 -97.3 78.47 2.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.393 0.616 . . . . 0.0 109.44 178.058 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -63.77 -36.66 84.6 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.955 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.417 ' H ' ' HE2' ' A' ' 77' ' ' LYS . 0.1 OUTLIER -70.38 -14.5 62.59 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.405 -177.427 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 -90.9 -1.15 57.86 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.301 0.572 . . . . 0.0 110.634 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 74.9 t -84.67 127.21 40.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.389 179.612 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.656 HD13 ' HE3' ' A' ' 96' ' ' LYS . 18.3 pt -110.97 -11.66 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 C-N-CA 120.803 -0.359 . . . . 0.0 111.798 -179.755 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.405 ' O ' HG22 ' A' ' 94' ' ' VAL . . . -160.52 163.77 34.19 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 120.556 -0.83 . . . . 0.0 111.384 -179.722 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.432 HH21 ' HB3' ' A' ' 91' ' ' GLU . 78.8 ttt180 -134.95 138.34 43.96 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.196 0.522 . . . . 0.0 111.35 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.55 HG22 ' O ' ' A' ' 92' ' ' LEU . 20.0 tt -104.12 141.3 20.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.243 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 70.1 m -135.78 128.84 31.56 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.645 -178.742 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.485 HG22 HG22 ' A' ' 88' ' ' VAL . 79.5 mt -139.23 86.41 14.65 Favored Pre-proline 0 CA--C 1.538 0.501 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.09 -179.405 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -56.66 -29.69 80.77 Favored 'Trans proline' 0 N--CA 1.499 1.827 0 C-N-CA 123.286 2.657 . . . . 0.0 113.523 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 91.7 p -53.23 -42.01 65.98 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 121.291 0.567 . . . . 0.0 110.55 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.493 ' O ' ' OG ' ' A' ' 89' ' ' SER . 34.4 m -114.07 11.23 8.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.596 179.502 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.493 ' OG ' ' O ' ' A' ' 88' ' ' VAL . 14.9 p 51.37 52.38 14.9 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.915 -179.768 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 54.5 tp -118.33 134.36 55.11 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 121.535 0.683 . . . . 0.0 111.958 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.432 ' HB3' HH21 ' A' ' 82' ' ' ARG . 97.6 mt-10 -146.1 122.89 11.25 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.823 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.55 ' O ' HG22 ' A' ' 83' ' ' ILE . 76.8 mt -149.81 148.88 26.59 Favored Pre-proline 0 CA--C 1.539 0.529 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.316 -179.105 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.18 145.86 27.99 Favored 'Trans proline' 0 N--CA 1.493 1.49 0 C-N-CA 122.436 2.091 . . . . 0.0 111.867 178.813 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.581 HG23 ' O ' ' A' ' 94' ' ' VAL . 2.0 m -94.02 118.01 38.97 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 CA-C-O 121.53 0.681 . . . . 0.0 110.996 179.428 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.511 HD12 ' N ' ' A' ' 95' ' ' LEU . 11.0 mp -102.6 136.23 42.8 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.098 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.656 ' HE3' HD13 ' A' ' 80' ' ' ILE . 97.1 mttt -64.75 -88.14 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 119.992 -0.683 . . . . 0.0 112.123 -179.065 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 74.0 m -51.79 134.17 30.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.898 -178.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 8.1 m -91.15 74.03 6.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.929 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 55.7 p -88.59 168.48 12.53 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 178.163 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -61.69 -42.53 99.05 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 119.856 -0.738 . . . . 0.0 109.903 179.316 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -65.86 -40.38 91.62 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.527 -0.761 . . . . 0.0 111.372 179.212 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -63.59 -38.93 93.01 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.168 0.508 . . . . 0.0 111.291 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 76.6 mt -61.67 -21.92 64.85 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.763 -179.551 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 63.1 mt -69.84 -21.43 63.36 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.944 0.402 . . . . 0.0 110.429 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.497 ' O ' HD22 ' A' ' 92' ' ' LEU . 95.9 p -72.98 -7.71 52.39 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 179.172 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.526 ' HA3' HD13 ' A' ' 92' ' ' LEU . . . 91.24 -18.65 50.9 Favored Glycine 0 CA--C 1.53 0.991 0 CA-C-N 115.205 -0.907 . . . . 0.0 112.41 178.462 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -145.95 124.75 12.63 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 119.723 -0.791 . . . . 0.0 112.354 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -143.4 132.77 23.36 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.482 178.813 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.649 ' HA ' HD23 ' A' ' 123' ' ' LEU . 11.7 m -62.45 131.44 49.2 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 121.01 0.433 . . . . 0.0 110.836 -179.475 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.506 HG13 ' CG ' ' B' ' 703' ' ' PRO . 75.6 t -78.92 -54.56 11.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 C-N-CA 120.576 -0.449 . . . . 0.0 110.673 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.865 ' H ' ' NE2' ' A' ' 114' ' ' GLN . 97.5 mttt -98.39 135.94 39.26 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 122.258 1.027 . . . . 0.0 112.646 179.483 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -66.53 -30.16 70.41 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 113.71 -1.586 . . . . 0.0 113.558 -178.308 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -83.06 8.57 12.52 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 -177.482 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLN . . . . . 0.865 ' NE2' ' H ' ' A' ' 111' ' ' LYS . 46.0 mt-30 -80.02 139.56 36.91 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 121.913 -0.492 . . . . 0.0 112.104 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.41 ' O ' ' O ' ' A' ' 118' ' ' LYS . 55.4 t -123.62 125.65 71.71 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.971 178.307 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 97.9 mtp -59.66 129.83 43.83 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.753 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 88.52 -10.74 70.62 Favored Glycine 0 CA--C 1.531 1.062 0 N-CA-C 111.796 -0.522 . . . . 0.0 111.796 178.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.41 ' O ' ' O ' ' A' ' 115' ' ' VAL . 67.4 mttm -141.5 138.25 32.66 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.364 0.602 . . . . 0.0 111.549 179.617 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 75.03 -163.83 54.32 Favored Glycine 0 CA--C 1.53 0.979 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.554 ' ND2' ' ND1' ' A' ' 177' ' ' HIS . 54.0 t-20 -93.97 104.59 16.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.932 0.396 . . . . 0.0 110.69 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.558 ' CE2' HD21 ' A' ' 123' ' ' LEU . 9.6 t80 -86.49 144.7 27.13 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 178.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.585 ' N ' ' OE1' ' A' ' 114' ' ' GLN . . . -147.66 140.27 24.68 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.043 -0.663 . . . . 0.0 111.248 -179.12 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.649 HD23 ' HA ' ' A' ' 109' ' ' THR . 48.1 mt -137.72 142.53 41.02 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.064 -179.16 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -110.82 138.55 47.07 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 178.745 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -139.36 151.35 21.84 Favored Glycine 0 CA--C 1.53 0.983 0 N-CA-C 110.441 -1.064 . . . . 0.0 110.441 -179.464 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' HIS . . . . . 0.431 ' CG ' ' HB3' ' A' ' 63' ' ' GLN . 19.5 m-70 -96.92 140.44 31.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.435 0.636 . . . . 0.0 111.928 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ASN . . . . . 0.593 ' ND2' ' OG1' ' A' ' 186' ' ' THR . 52.2 p-10 -145.55 121.42 10.61 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.537 179.019 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.497 ' O ' ' CB ' ' A' ' 129' ' ' SER . 74.9 mtm -87.3 4.61 42.11 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.174 0.511 . . . . 0.0 110.296 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.497 ' CB ' ' O ' ' A' ' 128' ' ' MET . 1.0 OUTLIER 78.93 13.64 1.23 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.129 179.878 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.829 ' O ' HG12 ' A' ' 133' ' ' VAL . 21.2 ptmt -109.72 124.42 51.21 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 122.168 0.985 . . . . 0.0 113.19 -178.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -43.99 119.49 1.77 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.628 -1.169 . . . . 0.0 110.668 179.45 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 115.42 -18.69 15.32 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.829 HG12 ' O ' ' A' ' 130' ' ' LYS . 7.6 p -88.93 154.33 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.854 HD23 ' N ' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -69.19 145.06 53.54 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -177.211 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.504 ' CE1' ' O ' ' A' ' 106' ' ' GLY . 3.3 m-85 65.82 6.37 3.92 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 114.017 -1.447 . . . . 0.0 114.15 178.027 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' SER . . . . . 0.54 ' OG ' ' CG1' ' A' ' 133' ' ' VAL . 2.7 m -75.24 -36.3 61.32 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 179.578 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 51.9 p-10 -94.48 7.1 46.73 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 114.277 1.214 . . . . 0.0 114.277 -176.742 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.504 HD11 ' HB ' ' A' ' 186' ' ' THR . 38.6 pt -72.5 -23.79 21.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 C-N-CA 119.344 -0.943 . . . . 0.0 110.663 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.679 ' HB2' ' OH ' ' A' ' 197' ' ' TYR . . . -71.14 -10.34 59.58 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 121.017 0.436 . . . . 0.0 110.614 179.679 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 66.6 m -81.0 -7.34 59.53 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.286 0.565 . . . . 0.0 110.271 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 88.6 mt -67.47 146.36 54.06 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.041 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -123.8 166.46 15.57 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.392 178.677 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -52.15 140.61 20.59 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.518 0.675 . . . . 0.0 112.359 179.67 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 77.99 7.13 87.6 Favored Glycine 0 CA--C 1.529 0.915 0 CA-C-N 115.139 -0.937 . . . . 0.0 112.283 178.683 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -71.97 133.9 45.62 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 118.925 -1.11 . . . . 0.0 110.165 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -79.72 136.2 36.71 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.759 0.79 . . . . 0.0 111.836 -178.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 97.8 mt -134.82 135.06 53.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 178.236 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' TYR . . . . . 0.69 ' C ' HD23 ' A' ' 149' ' ' LEU . 79.5 m-85 -121.98 135.57 54.86 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 119.858 -0.737 . . . . 0.0 112.632 -177.24 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.69 HD23 ' C ' ' A' ' 148' ' ' TYR . 0.3 OUTLIER -112.43 135.13 53.51 Favored 'General case' 0 C--O 1.224 -0.24 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 178.062 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.503 ' CE1' ' CD ' ' A' ' 155' ' ' GLU . 75.3 m-85 -109.71 108.95 19.51 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 120.247 -0.581 . . . . 0.0 111.712 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' ASP . . . . . 0.509 ' OD1' ' N ' ' A' ' 152' ' ' ASN . 53.8 t0 -87.74 165.23 15.51 Favored 'General case' 0 N--CA 1.447 -0.625 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 177.034 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' ASN . . . . . 0.509 ' N ' ' OD1' ' A' ' 151' ' ' ASP . 50.8 p-10 -59.28 -21.17 59.25 Favored 'General case' 0 C--N 1.312 -1.027 0 C-N-CA 119.522 -0.871 . . . . 0.0 110.978 -178.442 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.468 ' N ' ' OD1' ' A' ' 152' ' ' ASN . 95.4 mt-10 -115.92 -26.83 7.18 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 113.691 0.997 . . . . 0.0 113.691 -178.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -146.38 175.89 10.2 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 119.0 -1.08 . . . . 0.0 113.154 -176.631 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.503 ' CD ' ' CE1' ' A' ' 150' ' ' TYR . 82.5 tt0 -127.19 134.66 50.11 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 114.839 -1.073 . . . . 0.0 109.915 179.268 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -109.25 135.18 50.76 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 121.301 0.572 . . . . 0.0 112.094 -179.187 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' GLU . . . . . 0.475 ' O ' HD12 ' A' ' 203' ' ' LEU . 98.0 mt-10 -93.21 110.08 21.59 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.557 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 43.9 m-85 -113.92 148.81 36.16 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 120.91 0.386 . . . . 0.0 111.386 179.095 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -125.0 125.98 44.73 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.35 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 80.0 t -57.71 131.24 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 178.696 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 16.5 p -113.59 7.32 17.32 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 123.673 0.608 . . . . 0.0 112.529 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 135.79 177.37 14.93 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 120.108 -1.044 . . . . 0.0 112.515 178.472 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.412 HG22 ' N ' ' A' ' 164' ' ' SER . 5.8 p -135.3 154.26 35.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.165 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 164' ' ' SER . . . . . 0.412 ' N ' HG22 ' A' ' 163' ' ' VAL . 25.8 p -144.66 166.89 23.91 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.042 -0.663 . . . . 0.0 111.722 -179.165 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -104.12 117.97 35.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.479 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.474 ' O ' ' O ' ' A' ' 196' ' ' ARG . 27.9 m -135.84 160.1 39.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.488 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 167' ' ' THR . . . . . 0.423 ' H ' ' HG3' ' A' ' 170' ' ' LYS . 0.2 OUTLIER -85.34 158.08 58.19 Favored Pre-proline 0 CA--C 1.538 0.508 0 CA-C-O 121.055 0.455 . . . . 0.0 110.888 -179.572 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 168' ' ' PRO . . . . . 0.495 ' O ' ' CB ' ' B' ' 702' ' ' LEU . 28.2 Cg_endo -64.69 -17.58 59.96 Favored 'Trans proline' 0 N--CA 1.499 1.803 0 C-N-CA 123.227 2.618 . . . . 0.0 113.038 -179.256 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 48.9 p-10 -90.88 -2.73 57.72 Favored 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 120.148 -0.621 . . . . 0.0 110.958 179.351 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.644 ' O ' HG22 ' A' ' 173' ' ' VAL . 71.1 mmtt -73.88 76.97 1.64 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.441 0.639 . . . . 0.0 111.388 -179.68 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 171' ' ' TRP . . . . . 0.71 ' HE1' ' CE ' ' A' ' 111' ' ' LYS . 5.7 t90 -69.81 -15.74 63.16 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.334 179.506 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -63.38 -32.16 73.51 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.81 -179.659 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' VAL . . . . . 0.644 HG22 ' O ' ' A' ' 170' ' ' LYS . 14.6 m -62.3 -14.57 12.8 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 120.599 -0.441 . . . . 0.0 111.76 -179.059 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 1.8 t -103.95 -9.71 9.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -179.124 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -72.35 162.72 29.09 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.117 0.484 . . . . 0.0 110.78 -179.714 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 176' ' ' ASP . . . . . 0.418 ' N ' ' OD1' ' A' ' 176' ' ' ASP . 35.5 p-10 -65.03 141.31 58.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.897 179.55 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 177' ' ' HIS . . . . . 0.554 ' ND1' ' ND2' ' A' ' 120' ' ' ASN . 66.2 m80 -113.26 10.41 18.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.321 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 66.18 39.28 94.47 Favored Glycine 0 CA--C 1.53 1.008 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 179.622 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -165.46 171.01 13.81 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.868 0.366 . . . . 0.0 110.914 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -86.94 102.96 14.86 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 177.157 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -137.02 161.68 35.39 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.347 0.594 . . . . 0.0 111.512 -178.39 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 20.3 tt -129.93 139.01 52.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.471 178.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 86.4 m -129.24 125.02 35.97 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.188 0.518 . . . . 0.0 112.02 -178.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 84.9 mt -109.3 131.91 54.62 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.289 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.769 HD13 HD21 ' B' ' 702' ' ' LEU . 88.9 mt -116.15 125.2 73.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 CA-C-O 121.376 0.608 . . . . 0.0 111.276 -179.064 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 186' ' ' THR . . . . . 0.593 ' OG1' ' ND2' ' A' ' 127' ' ' ASN . 1.7 t -142.03 163.87 31.72 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 115.263 -0.881 . . . . 0.0 110.851 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 187' ' ' CYS . . . . . . . . . . . . . 1.9 m -95.86 143.51 27.0 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 120.967 0.413 . . . . 0.0 110.847 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 44.2 t -61.4 -48.45 88.79 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 CA-C-O 121.069 0.462 . . . . 0.0 111.206 -179.678 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 8.5 t -169.38 158.79 8.27 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.226 0.536 . . . . 0.0 110.878 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 190' ' ' VAL . . . . . 0.516 HG23 ' HG2' ' A' ' 191' ' ' LYS . 29.2 m -71.96 -17.65 19.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.347 179.304 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 191' ' ' LYS . . . . . 0.516 ' HG2' HG23 ' A' ' 190' ' ' VAL . 74.7 mmtt -99.19 -4.59 31.73 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.146 179.631 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 53.8 t0 -139.68 97.15 3.2 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 120.991 0.424 . . . . 0.0 110.972 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 43.3 p-10 -107.88 10.19 28.61 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.357 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 69.7 m -61.2 -41.7 97.28 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 120.811 0.339 . . . . 0.0 111.414 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -144.68 155.72 43.72 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.327 0.584 . . . . 0.0 111.57 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 196' ' ' ARG . . . . . 0.474 ' O ' ' O ' ' A' ' 166' ' ' VAL . 99.9 mtt180 -132.56 142.2 49.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.004 -179.407 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 197' ' ' TYR . . . . . 0.679 ' OH ' ' HB2' ' A' ' 139' ' ' ALA . 47.8 p90 -99.08 151.67 20.69 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.315 0.578 . . . . 0.0 111.203 179.674 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 45.8 t -123.88 134.05 67.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.462 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 69.9 t -96.79 134.83 32.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.964 0.412 . . . . 0.0 110.036 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -116.3 138.29 51.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.358 0.599 . . . . 0.0 111.174 -179.077 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -134.83 138.0 9.69 Favored Glycine 0 CA--C 1.529 0.917 0 N-CA-C 110.179 -1.168 . . . . 0.0 110.179 179.415 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 202' ' ' ASP . . . . . 0.598 ' OD1' ' N ' ' A' ' 203' ' ' LEU . 42.5 t0 -108.89 140.53 42.24 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.15 0.5 . . . . 0.0 111.669 -179.185 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 203' ' ' LEU . . . . . 0.598 ' N ' ' OD1' ' A' ' 202' ' ' ASP . 54.6 tp -63.34 133.61 54.39 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.073 179.514 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -116.09 -18.88 6.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.074 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 205' ' ' GLY . . . . . 0.454 ' O ' HD11 ' A' ' 203' ' ' LEU . . . -178.36 172.94 45.43 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 120.645 -0.788 . . . . 0.0 111.824 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 31.7 m -142.94 138.91 30.47 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -145.37 122.27 11.3 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.462 -0.495 . . . . 0.0 111.629 178.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -61.98 138.77 58.41 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.391 0.615 . . . . 0.0 110.854 -179.479 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 13.6 ttmt -79.14 109.47 13.48 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.95 178.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 99.8 mttt . . . . . 0 C--O 1.219 -0.532 0 CA-C-O 117.953 -1.022 . . . . 0.0 110.383 -179.846 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 702' ' ' LEU . . . . . 0.769 HD21 HD13 ' A' ' 185' ' ' ILE . 0.9 OUTLIER . . . . . 0 CA--C 1.545 0.751 0 CA-C-O 120.492 0.187 . . . . 20.0 111.159 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 703' ' ' PRO . . . . . 0.537 ' O ' ' O ' ' B' ' 704' ' ' ALA . 3.0 Cg_exo -65.65 -168.58 0.13 Allowed 'Trans proline' 0 N--CA 1.492 1.398 0 C-N-CA 122.377 2.052 . . . . 20.0 113.484 -179.688 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 704' ' ' ALA . . . . . 0.537 ' O ' ' O ' ' B' ' 703' ' ' PRO . . . . . . . . 0 C--N 1.332 -0.191 0 CA-C-N 114.501 -1.227 . . . . 20.0 113.058 -179.241 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.321 0 CA-C-O 121.265 0.555 . . . . 0.0 110.679 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 23.6 p -82.99 18.74 1.55 Allowed 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.735 -0.666 . . . . 0.0 112.718 -178.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -105.15 17.38 24.15 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.661 -0.416 . . . . 0.0 111.638 -179.427 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.6 mt -55.41 135.31 18.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 122.124 0.964 . . . . 0.0 112.479 -177.471 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -76.75 131.92 39.0 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 113.885 -1.507 . . . . 0.0 108.961 178.748 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.666 ' NE2' ' H ' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -79.23 149.82 73.28 Favored Pre-proline 0 C--N 1.326 -0.449 0 C-N-CA 120.383 -0.527 . . . . 0.0 110.634 -179.074 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -71.0 165.19 33.18 Favored 'Trans proline' 0 N--CA 1.496 1.654 0 C-N-CA 122.888 2.392 . . . . 0.0 113.338 -179.357 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.815 ' O ' HG23 ' A' ' 69' ' ' VAL . 94.0 m-20 -53.02 164.94 0.35 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.684 179.761 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 1.033 HD21 HG23 ' A' ' 133' ' ' VAL . 89.1 mt -63.81 -45.37 89.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.285 -179.307 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.17 -36.84 84.95 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.473 -0.491 . . . . 0.0 111.071 -178.714 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -63.04 -29.91 71.18 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.498 0.666 . . . . 0.0 109.478 178.817 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.815 HG23 ' O ' ' A' ' 65' ' ' ASP . 38.7 t -76.71 -46.27 30.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.108 179.245 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -73.08 -9.01 58.27 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.811 -1.086 . . . . 0.0 111.438 -179.27 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 96.8 m-20 -106.43 -12.89 15.51 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.525 0.678 . . . . 0.0 109.655 178.708 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.4 139.71 55.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.044 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 35.5 t -59.06 103.17 0.15 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.013 179.674 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.663 ' C ' HD23 ' A' ' 74' ' ' LEU . 6.9 tt -70.16 123.79 22.49 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.266 0.555 . . . . 0.0 111.068 -179.281 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.613 ' N ' HD23 ' A' ' 74' ' ' LEU . 84.9 m-20 -96.35 80.11 3.16 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.044 -179.656 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.655 ' O ' HG12 ' A' ' 79' ' ' VAL . 64.5 pttt -79.49 -15.67 57.36 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.742 0.782 . . . . 0.0 109.539 178.773 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 21.2 mtmt -65.82 -36.28 83.04 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.764 -1.107 . . . . 0.0 111.41 -178.452 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -87.04 0.07 55.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.941 0.4 . . . . 0.0 111.333 -179.603 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.655 HG12 ' O ' ' A' ' 76' ' ' LYS . 2.3 p -68.36 132.43 32.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.534 0.683 . . . . 0.0 110.683 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 8.6 pt -111.4 -5.81 11.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.427 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -171.74 176.9 44.78 Favored Glycine 0 CA--C 1.531 1.036 0 N-CA-C 111.162 -0.775 . . . . 0.0 111.162 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.408 ' NH2' ' HB3' ' A' ' 91' ' ' GLU . 51.1 ttt85 -135.92 154.42 51.13 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.715 HG22 ' O ' ' A' ' 92' ' ' LEU . 20.1 tt -119.07 137.02 54.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 CA-C-O 121.6 0.714 . . . . 0.0 110.124 179.108 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 8.6 t -135.15 125.35 26.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.771 -178.446 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.54 ' CG2' HG22 ' A' ' 88' ' ' VAL . 81.0 mt -135.56 90.23 20.5 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.203 179.63 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -56.38 -32.04 87.35 Favored 'Trans proline' 0 N--CA 1.494 1.535 0 C-N-CA 123.069 2.513 . . . . 0.0 112.637 -179.589 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 10.7 t -54.77 -42.44 71.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.294 -179.306 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.54 HG22 ' CG2' ' A' ' 85' ' ' ILE . 27.2 m -113.81 11.28 8.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.328 0.585 . . . . 0.0 110.351 179.135 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 50.19 48.08 22.68 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.265 179.611 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 47.8 tp -109.75 132.1 54.46 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.472 0.653 . . . . 0.0 110.802 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.408 ' HB3' ' NH2' ' A' ' 82' ' ' ARG . 97.6 mt-10 -144.13 113.78 7.13 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.083 -178.715 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.715 ' O ' HG22 ' A' ' 83' ' ' ILE . 93.7 mt -147.36 147.44 28.34 Favored Pre-proline 0 CA--C 1.537 0.465 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.656 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -74.4 146.92 36.0 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.593 2.195 . . . . 0.0 112.411 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.539 ' C ' HD12 ' A' ' 95' ' ' LEU . 78.8 t -94.44 120.14 43.42 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-O 121.002 0.429 . . . . 0.0 110.929 179.351 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.588 HD12 ' N ' ' A' ' 95' ' ' LEU . 10.6 mp -101.02 126.46 47.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.488 0.661 . . . . 0.0 110.962 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.54 ' O ' ' OG1' ' A' ' 109' ' ' THR . 87.2 tttt -64.07 -44.32 92.77 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.267 -0.879 . . . . 0.0 112.316 -178.775 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 4.2 m -85.59 130.83 34.48 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 121.039 0.447 . . . . 0.0 111.997 -179.326 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 3.5 p -90.64 59.04 4.1 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.547 179.279 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 3.3 m -92.72 164.74 13.26 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 179.077 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -58.21 -43.15 87.49 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 120.568 -0.453 . . . . 0.0 111.143 -179.137 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -64.96 -36.94 86.02 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.542 0.687 . . . . 0.0 110.009 178.771 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -64.4 -38.61 91.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.565 -179.329 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.405 ' HA ' HD23 ' A' ' 103' ' ' LEU . 96.9 mt -63.9 -11.97 32.72 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.913 -178.774 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 88.9 mt -73.95 -20.74 60.27 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.477 -0.489 . . . . 0.0 110.463 179.516 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 76.2 p -74.41 -4.77 38.5 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.169 -179.192 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 85.79 -19.25 26.15 Favored Glycine 0 CA--C 1.529 0.931 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.894 178.589 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -146.65 123.69 11.42 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.588 0.709 . . . . 0.0 111.804 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -146.21 137.15 24.38 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.159 178.73 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.54 ' OG1' ' O ' ' A' ' 96' ' ' LYS . 68.1 p -64.14 133.93 53.89 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.043 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.564 HG13 ' CG ' ' B' ' 703' ' ' PRO . 37.7 t -81.43 -56.92 5.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.29 0.567 . . . . 0.0 110.568 -179.503 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.415 ' HB3' ' NE2' ' A' ' 114' ' ' GLN . 85.5 tttt -93.07 128.44 38.97 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.988 -179.782 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -67.01 -31.25 71.67 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 -177.298 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 72.4 m-80 -82.98 11.61 5.96 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 114.238 1.199 . . . . 0.0 114.238 -176.714 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLN . . . . . 0.461 ' OE1' ' N ' ' A' ' 122' ' ' ALA . 32.8 mt-30 -81.49 143.52 32.0 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.207 -0.597 . . . . 0.0 111.528 178.559 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 54.7 t -123.64 125.21 71.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.575 179.094 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' MET . . . . . 0.437 ' CG ' ' CZ ' ' A' ' 121' ' ' TYR . 97.3 mtp -57.58 130.43 46.31 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.99 0.424 . . . . 0.0 111.602 -179.313 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.426 ' HA3' ' CE2' ' A' ' 156' ' ' TYR . . . 80.64 -2.97 76.68 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 120.935 -0.65 . . . . 0.0 111.839 178.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 55.6 tttm -139.22 126.87 21.86 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.12 0.486 . . . . 0.0 110.655 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 74.86 -164.01 54.43 Favored Glycine 0 CA--C 1.529 0.962 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 -179.37 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 64.4 t-20 -92.7 106.79 18.71 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.978 0.418 . . . . 0.0 110.562 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.668 ' CE2' HD11 ' A' ' 123' ' ' LEU . 4.0 t80 -83.98 144.58 29.05 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.474 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.82 ' C ' HD12 ' A' ' 123' ' ' LEU . . . -146.83 140.3 25.66 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 119.777 -0.769 . . . . 0.0 112.575 -177.526 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.82 HD12 ' C ' ' A' ' 122' ' ' ALA . 7.2 mp -139.09 144.74 38.86 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.509 -179.525 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -108.51 139.9 42.6 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.462 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -144.6 159.36 27.77 Favored Glycine 0 CA--C 1.53 0.977 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 -179.694 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 60.5 m-70 -99.08 137.14 38.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.35 0.595 . . . . 0.0 111.932 -179.236 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 64.8 t-20 -131.69 120.2 22.43 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.941 179.428 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.495 ' SD ' HG21 ' A' ' 133' ' ' VAL . 64.1 mtt -92.88 -4.48 52.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.189 0.518 . . . . 0.0 111.021 -179.182 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.476 ' CB ' ' O ' ' A' ' 128' ' ' MET . 0.9 OUTLIER 79.25 11.75 1.35 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.846 -0.615 . . . . 0.0 112.149 179.03 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.881 ' O ' HG12 ' A' ' 133' ' ' VAL . 58.8 pttt -126.67 128.31 46.52 Favored 'General case' 0 C--O 1.222 -0.346 0 CA-C-O 122.1 0.952 . . . . 0.0 112.801 -179.574 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.482 ' O ' ' O ' ' A' ' 130' ' ' LYS . 29.5 tptt -37.54 162.64 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.833 -1.076 . . . . 0.0 110.289 178.835 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.431 ' H ' ' HG3' ' A' ' 131' ' ' LYS . . . 73.78 -24.18 1.02 Allowed Glycine 0 CA--C 1.529 0.911 0 N-CA-C 111.837 -0.505 . . . . 0.0 111.837 178.798 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 1.033 HG23 HD21 ' A' ' 66' ' ' LEU . 2.9 p -91.16 175.86 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 O-C-N 122.325 -0.515 . . . . 0.0 111.535 -178.776 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.79 ' O ' ' N ' ' A' ' 136' ' ' SER . 3.9 mm? -60.11 167.09 2.49 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 121.209 0.528 . . . . 0.0 112.349 -177.61 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.592 ' CG ' HD12 ' A' ' 138' ' ' ILE . 3.7 m-30 22.4 21.01 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 113.947 -1.478 . . . . 0.0 113.868 178.642 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' SER . . . . . 0.79 ' N ' ' O ' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -64.37 -44.88 90.01 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 113.69 0.996 . . . . 0.0 113.69 -178.318 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -89.25 -3.88 58.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.98 0.419 . . . . 0.0 111.516 -178.178 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.592 HD12 ' CG ' ' A' ' 135' ' ' PHE . 0.2 OUTLIER -61.47 -40.69 87.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.569 179.697 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -65.26 -10.67 34.06 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 120.284 -0.567 . . . . 0.0 110.144 179.094 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 5.9 p -85.34 -2.6 58.26 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.432 179.309 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 73.0 mt -63.39 143.44 57.81 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-O 121.203 0.525 . . . . 0.0 110.262 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.439 ' N ' ' OD2' ' A' ' 145' ' ' ASP . 89.0 tttt -119.41 155.0 32.81 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.44 0.638 . . . . 0.0 111.873 -178.442 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -50.75 133.74 25.71 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.424 179.292 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.56 ' N ' ' O ' ' A' ' 160' ' ' VAL . . . 79.33 7.95 88.13 Favored Glycine 0 CA--C 1.528 0.88 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.603 179.438 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.439 ' OD2' ' N ' ' A' ' 142' ' ' LYS . 77.2 m-20 -75.35 137.63 41.22 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 119.31 -0.956 . . . . 0.0 110.568 -179.583 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -79.12 139.99 37.92 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.526 -0.761 . . . . 0.0 112.799 -178.236 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.457 HG23 HG12 ' A' ' 85' ' ' ILE . 97.2 mt -139.12 137.52 41.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 114.762 -1.108 . . . . 0.0 108.346 178.695 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 148' ' ' TYR . . . . . 0.641 ' C ' HD23 ' A' ' 149' ' ' LEU . 93.2 m-85 -123.65 137.58 54.7 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.022 -0.671 . . . . 0.0 112.556 -178.564 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.641 HD23 ' C ' ' A' ' 148' ' ' TYR . 0.8 OUTLIER -115.7 136.61 52.89 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 177.704 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.418 ' CD2' ' HB2' ' A' ' 155' ' ' GLU . 77.6 m-85 -112.94 113.27 25.26 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 119.98 -0.688 . . . . 0.0 111.561 179.431 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' ASP . . . . . 0.589 ' OD1' ' N ' ' A' ' 152' ' ' ASN . 66.2 t0 -87.53 162.03 17.44 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 177.247 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' ASN . . . . . 0.589 ' N ' ' OD1' ' A' ' 151' ' ' ASP . 65.2 m-20 -55.37 -24.19 28.27 Favored 'General case' 0 C--N 1.315 -0.893 0 C-N-CA 119.337 -0.945 . . . . 0.0 110.047 -178.172 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -108.3 -30.16 8.49 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 113.699 1.0 . . . . 0.0 113.699 -177.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' ASN . . . . . 0.446 ' O ' ' N ' ' A' ' 151' ' ' ASP . 0.6 OUTLIER -148.93 -178.13 6.19 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 119.089 -1.044 . . . . 0.0 113.736 -177.328 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.418 ' HB2' ' CD2' ' A' ' 150' ' ' TYR . 0.0 OUTLIER -130.43 144.33 51.33 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 114.478 -1.237 . . . . 0.0 110.05 178.921 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 156' ' ' TYR . . . . . 0.426 ' CE2' ' HA3' ' A' ' 117' ' ' GLY . 82.5 m-85 -120.97 139.89 52.63 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 120.972 0.415 . . . . 0.0 111.573 -178.541 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -96.43 115.65 27.77 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.564 179.351 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 50.1 m-85 -116.97 151.57 36.43 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.001 0.429 . . . . 0.0 111.416 179.224 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.405 ' HB2' HG21 ' A' ' 204' ' ' VAL . . . -124.45 124.82 43.14 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.132 179.076 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.56 ' O ' ' N ' ' A' ' 144' ' ' GLY . 96.4 t -60.08 136.62 23.51 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 178.103 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 7.6 p -105.1 -23.19 12.97 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.666 178.752 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 159.37 -168.13 35.22 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 120.488 -0.863 . . . . 0.0 111.969 179.646 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 15.0 p -137.73 146.72 26.98 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 179.326 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 28.3 m -142.3 172.03 13.24 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 120.955 0.407 . . . . 0.0 111.174 -179.414 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -111.26 125.74 54.15 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.477 0.656 . . . . 0.0 111.534 -179.161 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 30.6 m -137.36 164.74 28.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.559 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -82.69 158.73 65.08 Favored Pre-proline 0 CA--C 1.536 0.408 0 CA-C-O 121.047 0.451 . . . . 0.0 110.996 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 168' ' ' PRO . . . . . 0.486 ' O ' ' CB ' ' B' ' 702' ' ' LEU . 44.3 Cg_endo -67.05 -15.98 48.11 Favored 'Trans proline' 0 N--CA 1.497 1.679 0 C-N-CA 122.85 2.367 . . . . 0.0 111.6 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 169' ' ' ASP . . . . . 0.409 ' OD1' ' C ' ' A' ' 169' ' ' ASP . 40.9 p-10 -93.17 -6.43 47.83 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.911 179.652 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.654 ' O ' HG22 ' A' ' 173' ' ' VAL . 16.7 mttm -74.64 82.65 2.05 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.46 0.648 . . . . 0.0 111.397 -179.573 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 21.9 t90 -73.12 -14.14 61.32 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.803 179.116 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.487 ' OE1' ' OE1' ' A' ' 175' ' ' GLU . 52.1 tp10 -58.58 -31.25 67.84 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 115.052 -0.976 . . . . 0.0 111.831 -179.386 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 173' ' ' VAL . . . . . 0.654 HG22 ' O ' ' A' ' 170' ' ' LYS . 28.2 m -64.2 -20.78 27.56 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 120.618 -0.433 . . . . 0.0 112.04 -178.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.468 ' O ' HG12 ' A' ' 174' ' ' VAL . 49.5 t -98.74 -9.11 9.0 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -178.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.487 ' OE1' ' OE1' ' A' ' 172' ' ' GLU . 98.1 mt-10 -74.86 148.28 40.34 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 121.394 0.616 . . . . 0.0 111.585 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 46.6 p-10 -60.2 141.6 55.74 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.363 -179.63 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 177' ' ' HIS . . . . . 0.482 ' CE1' ' O ' ' A' ' 175' ' ' GLU . 80.5 m80 -117.67 16.85 14.49 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.537 -179.656 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 66.51 39.08 93.9 Favored Glycine 0 CA--C 1.532 1.102 0 N-CA-C 111.361 -0.696 . . . . 0.0 111.361 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 15.7 ptmt -163.26 167.1 22.4 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.997 -0.372 . . . . 0.0 109.997 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -87.05 92.31 9.0 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 178.482 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 181' ' ' GLU . . . . . 0.447 ' HG2' ' N ' ' A' ' 182' ' ' ILE . 82.9 tt0 -124.62 164.62 19.47 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.404 0.621 . . . . 0.0 111.441 -179.24 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.511 HG22 ' O ' ' A' ' 201' ' ' GLY . 18.1 tt -130.7 138.61 53.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.286 178.887 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 85.9 m -129.5 125.98 37.59 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 121.145 0.498 . . . . 0.0 111.877 -179.133 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 93.7 mt -109.53 130.59 55.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.874 178.774 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.717 HD13 HD21 ' B' ' 702' ' ' LEU . 83.0 mt -113.94 124.07 70.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.205 0.526 . . . . 0.0 111.287 -179.114 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 186' ' ' THR . . . . . 0.625 ' OG1' ' CZ ' ' A' ' 197' ' ' TYR . 0.1 OUTLIER -139.51 167.48 21.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.558 -0.747 . . . . 0.0 110.142 179.448 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 187' ' ' CYS . . . . . . . . . . . . . 8.9 m -95.49 142.2 28.12 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.084 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 45.2 t -60.66 -44.39 96.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 120.641 -0.424 . . . . 0.0 110.74 -179.376 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 47.5 t -166.64 148.69 6.46 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.163 -0.615 . . . . 0.0 111.613 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 10.9 p -65.2 -22.35 31.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.403 179.37 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -92.93 -13.28 29.06 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.598 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -143.67 98.32 3.22 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 121.179 0.514 . . . . 0.0 110.938 179.403 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -103.83 9.16 37.03 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.592 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 89.3 p -59.67 -33.82 72.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.018 -179.438 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -130.77 146.48 52.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.258 0.551 . . . . 0.0 110.925 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -125.36 135.42 52.42 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.28 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 197' ' ' TYR . . . . . 0.625 ' CZ ' ' OG1' ' A' ' 186' ' ' THR . 35.6 p90 -98.22 151.06 20.85 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.402 -0.519 . . . . 0.0 110.309 179.393 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 53.0 t -127.05 133.32 68.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.287 0.565 . . . . 0.0 111.549 -179.183 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 42.1 t -107.48 130.29 59.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.211 178.831 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -119.55 152.25 37.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.463 0.649 . . . . 0.0 111.976 -178.586 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 201' ' ' GLY . . . . . 0.511 ' O ' HG22 ' A' ' 182' ' ' ILE . . . -138.98 151.58 21.81 Favored Glycine 0 CA--C 1.533 1.175 0 N-CA-C 110.593 -1.003 . . . . 0.0 110.593 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 202' ' ' ASP . . . . . 0.552 ' OD1' ' N ' ' A' ' 203' ' ' LEU . 67.1 t0 -113.77 137.39 51.71 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 120.877 0.37 . . . . 0.0 111.182 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 203' ' ' LEU . . . . . 0.552 ' N ' ' OD1' ' A' ' 202' ' ' ASP . 53.6 tp -59.96 131.57 51.26 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.405 HG21 ' HB2' ' A' ' 159' ' ' ALA . 86.0 t -112.85 -19.78 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.969 -179.575 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 205' ' ' GLY . . . . . 0.482 ' O ' HD11 ' A' ' 203' ' ' LEU . . . -178.6 174.49 46.68 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 120.92 -0.657 . . . . 0.0 111.801 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 26.9 m -138.81 132.31 30.39 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -142.71 116.4 9.22 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.526 0.679 . . . . 0.0 112.239 -179.717 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -63.55 144.88 56.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.328 -0.851 . . . . 0.0 112.139 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 23.6 ttpt -78.68 109.6 13.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.528 178.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 59.2 pttt . . . . . 0 C--O 1.218 -0.565 0 CA-C-O 118.207 -0.901 . . . . 0.0 110.082 178.998 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 702' ' ' LEU . . . . . 0.717 HD21 HD13 ' A' ' 185' ' ' ILE . 1.3 mt . . . . . 0 CA--C 1.542 0.663 0 CA-C-O 120.67 0.272 . . . . 20.0 111.416 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 703' ' ' PRO . . . . . 0.579 ' O ' ' O ' ' B' ' 704' ' ' ALA . 4.0 Cg_exo -64.8 -170.04 0.13 Allowed 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 121.97 1.78 . . . . 20.0 113.562 -179.782 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 704' ' ' ALA . . . . . 0.579 ' O ' ' O ' ' B' ' 703' ' ' PRO . . . . . . . . 0 CA--C 1.531 0.224 0 CA-C-N 114.256 -1.338 . . . . 20.0 113.458 -179.099 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.35 0 CA-C-O 121.026 0.441 . . . . 0.0 111.359 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.48 ' CB ' ' O ' ' B' ' 702' ' ' LEU . 3.9 p -82.01 21.07 0.91 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.123 -0.489 . . . . 0.0 112.073 -179.145 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 58.4 mtpt -106.73 23.67 13.93 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.137 0.494 . . . . 0.0 111.449 -179.598 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.6 mt -55.62 136.67 17.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 122.227 1.013 . . . . 0.0 112.189 -177.324 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -76.88 131.68 38.72 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 113.783 -1.553 . . . . 0.0 108.266 178.49 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.424 ' H ' ' CD ' ' A' ' 63' ' ' GLN . 8.5 pm0 -77.11 148.7 78.67 Favored Pre-proline 0 C--N 1.325 -0.469 0 C-N-CA 120.363 -0.535 . . . . 0.0 110.622 -178.679 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.541 ' CB ' ' OE1' ' A' ' 68' ' ' GLU . 65.2 Cg_endo -70.79 163.29 39.62 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 123.291 2.661 . . . . 0.0 113.878 -178.705 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -58.58 168.63 1.11 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.001 -1.0 . . . . 0.0 111.434 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 96.0 mt -70.36 -15.04 62.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.291 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -69.72 -40.3 76.32 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.346 0.593 . . . . 0.0 110.658 178.831 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.815 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 82.2 tt0 -66.42 -28.84 68.93 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.464 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 59.8 t -69.73 -45.29 77.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.288 179.786 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.42 -10.78 59.74 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.658 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -116.12 -2.81 12.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.299 0.571 . . . . 0.0 110.429 179.476 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.815 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -68.9 -172.34 0.38 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.712 0.767 . . . . 0.0 112.085 -178.598 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.6 p -101.4 104.38 15.35 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.016 178.31 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 42.8 tp -70.22 129.62 39.85 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.273 0.559 . . . . 0.0 111.503 -178.635 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -118.99 77.39 1.18 Allowed 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 177.75 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.692 ' O ' HG12 ' A' ' 79' ' ' VAL . 82.6 tttt -84.46 -35.8 22.74 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.297 -0.865 . . . . 0.0 112.542 -179.368 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 50.1 mmtt -75.03 -11.45 60.1 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.0 0.429 . . . . 0.0 111.132 -177.438 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -91.93 -0.51 57.5 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.09 0.471 . . . . 0.0 110.459 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.692 HG12 ' O ' ' A' ' 76' ' ' LYS . 9.5 p -76.86 128.5 37.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.147 0.498 . . . . 0.0 110.941 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.507 HD13 ' CE ' ' A' ' 96' ' ' LYS . 18.2 pt -106.55 -8.33 10.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.307 0.575 . . . . 0.0 110.066 179.354 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -171.19 169.38 42.43 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 109.894 -1.283 . . . . 0.0 109.894 179.718 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.722 ' HA ' HG23 ' A' ' 94' ' ' VAL . 33.7 ptt-85 -146.71 154.58 41.59 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.364 0.602 . . . . 0.0 112.01 -179.605 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 19.0 tt -103.69 141.63 19.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.645 -179.429 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 47.9 t -136.7 129.87 31.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.671 -179.091 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.61 ' CG2' HG22 ' A' ' 88' ' ' VAL . 93.7 mt -138.07 87.25 16.53 Favored Pre-proline 0 CA--C 1.535 0.381 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.839 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_exo -56.64 -30.76 84.86 Favored 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 122.801 2.334 . . . . 0.0 112.034 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 44.2 m -53.27 -42.09 66.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.75 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.61 HG22 ' CG2' ' A' ' 85' ' ' ILE . 17.6 m -114.25 11.23 7.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.719 179.675 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.511 ' O ' ' OG ' ' A' ' 89' ' ' SER . 1.6 p 51.31 51.29 17.18 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.128 179.686 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 59.0 tp -119.14 133.67 55.65 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 121.375 0.607 . . . . 0.0 111.183 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -147.09 124.94 11.91 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.102 179.655 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.504 HD13 ' HA3' ' A' ' 106' ' ' GLY . 78.0 mt -149.55 146.73 21.33 Favored Pre-proline 0 CA--C 1.539 0.524 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.341 -179.442 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -74.17 145.11 34.44 Favored 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 122.555 2.17 . . . . 0.0 111.389 178.416 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.722 HG23 ' HA ' ' A' ' 82' ' ' ARG . 18.3 t -96.41 120.18 45.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-O 121.137 0.494 . . . . 0.0 112.091 -179.332 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.56 HD12 ' C ' ' A' ' 94' ' ' VAL . 10.2 mp -102.67 138.71 39.21 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.735 179.376 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.507 ' CE ' HD13 ' A' ' 80' ' ' ILE . 98.2 mttt -62.12 -82.22 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.372 0.606 . . . . 0.0 112.104 -179.163 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.47 ' O ' ' ND2' ' A' ' 102' ' ' ASN . 31.3 m -56.89 134.55 55.52 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.587 -178.593 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 74.0 p -92.27 70.23 5.21 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.791 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 63.2 p -92.73 170.44 9.71 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.537 178.8 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -60.75 -43.07 98.42 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 178.881 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -65.75 -41.68 91.84 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.496 179.451 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.47 ' ND2' ' O ' ' A' ' 97' ' ' SER . 98.2 m-20 -64.49 -37.47 87.64 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.989 -179.324 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 74.4 mt -64.71 -14.37 58.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.042 -0.526 . . . . 0.0 112.062 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 94.8 mt -72.42 -28.43 62.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.986 0.422 . . . . 0.0 111.317 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.401 ' O ' HD22 ' A' ' 92' ' ' LEU . 86.8 p -73.42 -3.98 30.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.393 0.616 . . . . 0.0 109.813 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.504 ' HA3' HD13 ' A' ' 92' ' ' LEU . . . 92.29 -18.52 54.1 Favored Glycine 0 CA--C 1.533 1.209 0 CA-C-N 115.432 -0.804 . . . . 0.0 113.946 177.324 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -145.47 128.16 16.21 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 118.294 1.047 . . . . 0.0 113.147 -178.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -145.67 140.95 27.66 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 114.924 -1.034 . . . . 0.0 110.087 178.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.514 ' HA ' HD23 ' A' ' 123' ' ' LEU . 30.2 p -68.6 140.25 55.55 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.311 0.577 . . . . 0.0 111.443 -179.17 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.733 HG11 HG11 ' A' ' 174' ' ' VAL . 71.6 t -79.88 -58.17 4.22 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 CA-C-N 115.723 -0.672 . . . . 0.0 111.539 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.598 ' H ' ' NE2' ' A' ' 114' ' ' GLN . 68.5 mmtt -105.06 138.69 40.87 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 121.862 0.839 . . . . 0.0 111.838 179.488 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -65.74 -30.36 71.01 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 114.848 -1.069 . . . . 0.0 113.071 -178.115 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -79.83 13.93 1.96 Allowed 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.373 -0.531 . . . . 0.0 112.283 -178.129 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' GLN . . . . . 0.598 ' NE2' ' H ' ' A' ' 111' ' ' LYS . 33.6 mt-30 -81.02 134.04 35.6 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 120.928 0.394 . . . . 0.0 111.599 179.336 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.408 ' O ' ' O ' ' A' ' 118' ' ' LYS . 72.4 t -125.73 126.11 69.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 178.351 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 96.1 mtp -57.15 131.18 49.18 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 121.092 0.472 . . . . 0.0 111.903 -179.334 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 78.75 -3.55 63.87 Favored Glycine 0 CA--C 1.531 1.033 0 N-CA-C 111.685 -0.566 . . . . 0.0 111.685 179.219 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.408 ' O ' ' O ' ' A' ' 115' ' ' VAL . 64.6 tttm -139.18 126.43 21.4 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.221 0.534 . . . . 0.0 110.924 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 77.16 -170.45 55.1 Favored Glycine 0 CA--C 1.531 1.039 0 N-CA-C 111.181 -0.767 . . . . 0.0 111.181 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 60.9 t-20 -87.82 104.94 17.06 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.953 0.406 . . . . 0.0 110.296 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -88.43 99.14 12.04 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 120.955 0.407 . . . . 0.0 110.574 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.763 ' CB ' HG12 ' A' ' 174' ' ' VAL . . . -91.83 137.68 32.16 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.101 0.477 . . . . 0.0 111.314 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.514 HD23 ' HA ' ' A' ' 109' ' ' THR . 78.9 mt -134.99 139.7 45.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.816 179.521 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -115.52 144.91 43.16 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-O 121.324 0.583 . . . . 0.0 110.757 -179.701 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -142.08 -162.17 9.09 Favored Glycine 0 CA--C 1.532 1.094 0 N-CA-C 110.154 -1.178 . . . . 0.0 110.154 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' HIS . . . . . 0.526 ' O ' ' O ' ' A' ' 134' ' ' LEU . 91.5 m-70 -134.6 160.24 38.71 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.411 0.624 . . . . 0.0 111.981 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 28.7 t30 -142.12 120.23 12.16 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.275 179.219 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.476 ' O ' ' CB ' ' A' ' 129' ' ' SER . 61.8 mtt -96.23 -5.31 40.69 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.446 0.641 . . . . 0.0 109.757 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.476 ' CB ' ' O ' ' A' ' 128' ' ' MET . 1.1 p 78.72 17.07 1.04 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.206 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.819 ' O ' HG12 ' A' ' 133' ' ' VAL . 7.6 ptpt -125.76 116.87 22.29 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 121.833 0.825 . . . . 0.0 112.827 -179.01 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -45.71 130.39 9.16 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.212 179.466 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 109.08 -16.92 32.48 Favored Glycine 0 N--CA 1.444 -0.826 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 -179.243 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.819 HG12 ' O ' ' A' ' 130' ' ' LYS . 7.2 p -90.88 160.27 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.178 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.878 HD13 ' H ' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -70.69 141.95 51.56 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 115.016 1.487 . . . . 0.0 115.016 -177.122 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 59.67 9.37 1.58 Allowed 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 112.922 -1.944 . . . . 0.0 115.008 177.682 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 12.9 p -70.42 -30.29 67.12 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 120.041 -0.664 . . . . 0.0 112.125 179.359 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -90.59 -0.54 57.72 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 113.296 0.851 . . . . 0.0 113.296 -177.726 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 2.4 pp -58.67 -33.6 49.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 120.362 -0.535 . . . . 0.0 111.106 -179.548 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -66.44 -13.22 60.45 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.066 0.46 . . . . 0.0 110.954 -179.675 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 67.0 p -83.55 -4.54 58.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.099 -179.644 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 88.9 mt -63.98 141.06 58.91 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 121.067 0.461 . . . . 0.0 110.047 179.628 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -117.03 154.79 30.33 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.462 0.648 . . . . 0.0 111.325 -179.454 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -47.42 133.7 12.46 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.849 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 160' ' ' VAL . . . 76.8 7.99 86.34 Favored Glycine 0 CA--C 1.53 0.979 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.81 178.887 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -70.9 135.2 47.85 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 119.832 -0.747 . . . . 0.0 110.587 -179.561 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -79.98 139.8 36.86 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.895 0.855 . . . . 0.0 112.354 -178.792 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 98.4 mt -136.48 137.51 47.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 177.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -124.29 138.13 54.42 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 119.708 -0.797 . . . . 0.0 113.061 -177.122 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 18.6 mt -110.72 133.13 53.6 Favored 'General case' 0 C--O 1.223 -0.3 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 177.368 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.547 ' CZ ' ' OE2' ' A' ' 155' ' ' GLU . 64.5 m-85 -109.77 107.63 17.69 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 119.957 -0.697 . . . . 0.0 111.06 179.462 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -89.19 164.43 14.98 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 178.232 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 69.6 m-20 -57.68 -22.72 47.65 Favored 'General case' 0 C--N 1.312 -1.034 0 C-N-CA 119.823 -0.751 . . . . 0.0 110.657 -178.509 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -113.21 -28.26 7.69 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 113.804 1.039 . . . . 0.0 113.804 -178.456 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -147.97 179.15 7.94 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 119.147 -1.021 . . . . 0.0 113.47 -176.885 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.547 ' OE2' ' CZ ' ' A' ' 150' ' ' TYR . 85.7 tt0 -126.58 135.69 51.57 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 114.35 -1.296 . . . . 0.0 110.002 178.466 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -109.67 132.83 53.78 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 121.157 0.503 . . . . 0.0 111.687 -179.445 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -94.0 112.04 23.83 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.789 -0.642 . . . . 0.0 111.943 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -114.13 148.71 36.75 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.013 0.435 . . . . 0.0 111.249 179.323 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -125.11 122.04 36.01 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 121.24 0.543 . . . . 0.0 110.752 179.44 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.544 ' O ' ' N ' ' A' ' 144' ' ' GLY . 59.9 t -60.44 137.33 22.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.7 178.3 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 81.0 p -108.8 -25.05 11.0 Favored 'General case' 0 N--CA 1.463 0.182 0 O-C-N 123.415 0.447 . . . . 0.0 111.534 179.415 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 159.31 -167.12 34.94 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 120.532 -0.842 . . . . 0.0 111.285 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.925 HG12 HG22 ' A' ' 199' ' ' VAL . 35.5 m -131.45 160.69 42.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.956 0.408 . . . . 0.0 110.145 179.778 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 22.8 p -141.41 162.6 35.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.439 0.637 . . . . 0.0 111.77 -178.897 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -103.17 115.17 30.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.577 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 17.1 m -136.77 161.78 35.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.316 0.579 . . . . 0.0 111.218 -179.027 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -86.98 157.99 53.64 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.817 -179.758 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 168' ' ' PRO . . . . . 0.455 ' O ' ' CB ' ' B' ' 702' ' ' LEU . 33.1 Cg_endo -64.81 -15.89 52.57 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 C-N-CA 122.996 2.464 . . . . 0.0 111.565 178.65 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 169' ' ' ASP . . . . . 0.46 ' O ' ' CD1' ' A' ' 171' ' ' TRP . 38.4 p-10 -96.62 -2.85 43.96 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.724 179.029 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.478 ' O ' HG22 ' A' ' 173' ' ' VAL . 7.0 mttp -74.03 87.5 1.86 Allowed 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 121.433 0.635 . . . . 0.0 110.994 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 171' ' ' TRP . . . . . 0.514 ' CD1' ' N ' ' A' ' 171' ' ' TRP . 22.3 m0 -73.14 -14.42 61.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.1 -179.521 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -61.26 -27.04 68.17 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.825 -179.553 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 173' ' ' VAL . . . . . 0.791 HG23 HG13 ' A' ' 174' ' ' VAL . 22.9 m -61.99 -23.85 32.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -178.498 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.791 HG13 HG23 ' A' ' 173' ' ' VAL . 23.3 m -107.96 -5.29 10.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -178.594 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -72.11 148.75 45.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.0 0.428 . . . . 0.0 110.317 179.519 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 176' ' ' ASP . . . . . 0.425 ' OD1' ' O ' ' A' ' 176' ' ' ASP . 44.1 p-10 -76.08 129.97 37.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.145 0.497 . . . . 0.0 110.957 -179.833 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 74.6 m80 -100.94 -17.1 16.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.781 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 104.05 36.68 3.1 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 110.109 -1.196 . . . . 0.0 110.109 -179.377 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -153.48 164.36 38.33 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.926 -0.637 . . . . 0.0 110.311 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -87.51 105.66 17.46 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 177.9 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 181' ' ' GLU . . . . . 0.423 ' HG2' ' N ' ' A' ' 182' ' ' ILE . 76.0 tt0 -138.79 161.69 36.61 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.507 0.67 . . . . 0.0 111.944 -177.955 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.423 ' N ' ' HG2' ' A' ' 181' ' ' GLU . 17.8 tt -128.99 136.92 58.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.142 178.454 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 70.9 m -129.25 123.69 32.58 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.109 0.481 . . . . 0.0 110.915 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 85.2 mt -109.47 131.71 54.81 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.349 0.595 . . . . 0.0 109.524 178.616 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.459 HD13 ' CD2' ' B' ' 702' ' ' LEU . 82.6 mt -112.46 124.38 69.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.134 -179.484 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 186' ' ' THR . . . . . 0.485 HG22 ' N ' ' A' ' 187' ' ' CYS . 90.8 m -138.11 156.87 47.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.152 -179.566 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 187' ' ' CYS . . . . . 0.485 ' N ' HG22 ' A' ' 186' ' ' THR . 17.4 m -87.66 139.52 30.45 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.594 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.721 HG22 ' CD2' ' A' ' 197' ' ' TYR . 62.3 t -62.59 -46.86 95.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.731 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 18.1 t -172.59 155.06 3.24 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.696 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 55.3 t -68.85 -17.07 21.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.395 179.623 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -98.88 -9.07 24.71 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.104 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 65.5 t0 -134.73 95.1 3.28 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.769 -0.373 . . . . 0.0 111.009 -179.731 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -105.98 5.89 30.81 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.135 0.493 . . . . 0.0 110.755 179.667 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 57.1 m -60.51 -40.9 93.09 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.484 -179.434 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -131.67 153.2 50.23 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.797 -0.361 . . . . 0.0 110.527 -179.647 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 196' ' ' ARG . . . . . 0.831 ' NH2' HD22 ' B' ' 702' ' ' LEU . 59.2 ttp180 -131.27 125.92 34.07 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 120.806 -0.358 . . . . 0.0 110.175 179.442 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 197' ' ' TYR . . . . . 0.721 ' CD2' HG22 ' A' ' 188' ' ' VAL . 29.2 m-85 -87.76 142.7 27.62 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.166 0.508 . . . . 0.0 110.759 -179.336 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 43.2 t -122.04 130.16 74.8 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.648 179.585 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.925 HG22 HG12 ' A' ' 163' ' ' VAL . 50.4 t -99.57 132.98 44.0 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.516 -179.439 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -118.9 149.21 41.96 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 121.166 0.508 . . . . 0.0 111.39 -179.584 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -145.34 146.09 15.99 Favored Glycine 0 CA--C 1.534 1.256 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -105.57 143.55 33.58 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 121.062 0.458 . . . . 0.0 111.954 -179.509 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 38.5 tp -65.97 132.04 47.65 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 178.586 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 2.1 p -112.38 -19.49 6.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 120.471 -0.492 . . . . 0.0 111.598 -179.194 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -179.82 173.98 45.57 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 120.497 -0.858 . . . . 0.0 112.038 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 90.8 m -142.31 139.19 31.75 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 179.0 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -144.03 118.36 9.61 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 120.152 -0.619 . . . . 0.0 111.233 179.231 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -64.19 143.28 58.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.824 -179.336 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 48.9 mtpt -81.64 107.7 14.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.57 178.706 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 20.0 pttp . . . . . 0 C--N 1.326 -0.426 0 CA-C-O 117.942 -1.027 . . . . 0.0 110.399 179.814 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 702' ' ' LEU . . . . . 0.831 HD22 ' NH2' ' A' ' 196' ' ' ARG . 2.1 mt . . . . . 0 CA--C 1.538 0.512 0 N-CA-C 110.577 -0.157 . . . . 20.0 110.577 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 703' ' ' PRO . . . . . 0.634 ' CD ' HG13 ' A' ' 110' ' ' VAL . 3.7 Cg_exo -62.93 -160.92 0.03 OUTLIER 'Trans proline' 0 N--CA 1.488 1.199 0 C-N-CA 122.303 2.002 . . . . 20.0 113.836 -179.372 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 704' ' ' ALA . . . . . 0.53 ' O ' ' O ' ' B' ' 703' ' ' PRO . . . . . . . . 0 C--N 1.327 -0.373 0 CA-C-N 114.04 -1.436 . . . . 20.0 114.708 -178.037 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.217 0 CA-C-O 120.894 0.378 . . . . 0.0 111.919 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.517 ' CB ' ' O ' ' B' ' 702' ' ' LEU . 93.0 p -80.35 20.07 0.72 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.955 0.407 . . . . 0.0 111.56 -179.407 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -102.69 12.72 35.93 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.633 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.1 mt -56.17 142.31 11.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 122.197 0.999 . . . . 0.0 113.078 -177.168 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 51.1 t0 -78.27 125.91 30.03 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 113.983 -1.462 . . . . 0.0 109.438 179.134 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.499 HE22 ' HB2' ' A' ' 103' ' ' LEU . 0.1 OUTLIER -79.23 128.65 75.1 Favored Pre-proline 0 C--N 1.325 -0.469 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 -179.875 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -52.37 149.87 21.88 Favored 'Trans proline' 0 N--CA 1.486 1.043 0 C-N-CA 121.307 1.338 . . . . 0.0 112.097 -179.505 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -51.94 175.62 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.624 0.726 . . . . 0.0 111.923 -178.549 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.565 ' N ' HD12 ' A' ' 66' ' ' LEU . 10.9 mp -70.17 -10.08 57.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.695 -178.938 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -67.19 -34.39 77.41 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.547 0.689 . . . . 0.0 110.007 178.857 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.491 ' O ' ' CB ' ' A' ' 72' ' ' ALA . 78.9 mm-40 -77.53 -20.95 53.4 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.26 -179.58 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 96.7 t -71.31 -46.58 64.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.316 0.579 . . . . 0.0 110.69 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -89.11 -10.58 46.8 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.876 -179.598 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -105.42 -26.16 12.06 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 120.465 -0.494 . . . . 0.0 112.132 -179.291 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.491 ' CB ' ' O ' ' A' ' 68' ' ' GLU . . . -68.28 136.59 53.72 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.728 0.775 . . . . 0.0 112.31 -179.02 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 7.8 m -59.82 102.8 0.17 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.133 179.552 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -68.62 129.15 39.1 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.104 0.478 . . . . 0.0 110.777 -179.685 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -98.02 80.48 2.72 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.171 0.51 . . . . 0.0 110.443 179.16 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -62.56 -36.57 83.07 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.311 0.577 . . . . 0.0 111.314 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.584 ' CD ' ' H ' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -70.2 -18.39 63.18 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.415 -177.062 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -90.61 0.61 57.31 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 121.239 0.542 . . . . 0.0 110.029 179.086 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 75.4 t -87.76 128.37 40.26 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.981 179.104 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.642 HD13 ' HE3' ' A' ' 96' ' ' LYS . 39.6 pt -111.4 -5.13 11.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.846 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -166.03 168.35 39.73 Favored Glycine 0 CA--C 1.535 1.31 0 C-N-CA 120.56 -0.829 . . . . 0.0 112.061 -179.491 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 61.7 ttp180 -137.85 154.91 49.45 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 121.127 0.489 . . . . 0.0 111.272 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.535 HG22 ' O ' ' A' ' 92' ' ' LEU . 14.6 tt -119.52 140.65 42.78 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.955 178.638 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 47.5 t -136.26 130.45 33.06 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.378 0.609 . . . . 0.0 111.813 -178.77 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.51 ' CG2' HG22 ' A' ' 88' ' ' VAL . 57.2 mt -136.91 86.07 21.87 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.839 179.429 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -56.34 -31.97 86.8 Favored 'Trans proline' 0 N--CA 1.497 1.706 0 C-N-CA 123.076 2.517 . . . . 0.0 112.666 -179.057 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 70.9 m -53.83 -41.24 67.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.275 0.559 . . . . 0.0 110.76 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.51 HG22 ' CG2' ' A' ' 85' ' ' ILE . 27.2 m -113.78 12.83 8.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.032 178.886 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.7 m 48.26 48.8 18.47 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.421 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 64.5 tp -114.04 133.27 55.63 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.949 -179.577 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -148.07 127.51 13.15 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.862 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.545 HD13 ' HA3' ' A' ' 106' ' ' GLY . 90.2 mt -151.55 151.09 28.12 Favored Pre-proline 0 N--CA 1.471 0.61 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.563 -179.128 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -75.62 147.42 31.65 Favored 'Trans proline' 0 N--CA 1.495 1.601 0 C-N-CA 122.713 2.275 . . . . 0.0 111.712 178.326 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.599 ' C ' HD12 ' A' ' 95' ' ' LEU . 49.6 t -97.15 119.17 44.85 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-O 121.19 0.519 . . . . 0.0 111.896 -179.598 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.6 HD12 ' N ' ' A' ' 95' ' ' LEU . 10.0 mp -104.69 141.08 37.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.527 179.182 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.642 ' HE3' HD13 ' A' ' 80' ' ' ILE . 98.5 mttt -64.37 -84.88 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -178.785 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 82.5 p -62.75 142.27 58.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.177 0.513 . . . . 0.0 111.502 -178.466 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 46.8 m -97.13 76.14 2.64 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.244 -179.705 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.594 HG22 ' N ' ' A' ' 100' ' ' GLU . 52.2 m -92.53 168.27 11.37 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 178.485 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.594 ' N ' HG22 ' A' ' 99' ' ' THR . 78.2 tt0 -57.53 -44.73 85.32 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 119.686 -0.806 . . . . 0.0 110.118 -179.532 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -62.93 -41.89 99.63 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.497 179.114 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -63.41 -36.66 84.46 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.681 -178.638 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.499 ' HB2' HE22 ' A' ' 63' ' ' GLN . 89.8 mt -63.26 -21.97 66.58 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.302 -0.408 . . . . 0.0 112.097 -179.224 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 96.6 mt -70.17 -23.0 62.91 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.899 0.38 . . . . 0.0 110.309 179.652 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 6.1 m -72.5 -10.28 59.6 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 121.271 0.558 . . . . 0.0 110.036 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.545 ' HA3' HD13 ' A' ' 92' ' ' LEU . . . 90.99 -18.23 51.98 Favored Glycine 0 CA--C 1.531 1.075 0 CA-C-N 115.642 -0.708 . . . . 0.0 113.43 177.872 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -145.03 124.9 13.42 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 119.418 -0.913 . . . . 0.0 112.688 -179.683 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -147.45 141.49 25.99 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.043 -0.98 . . . . 0.0 109.883 178.017 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.647 ' HA ' HD23 ' A' ' 123' ' ' LEU . 19.0 p -69.33 136.51 51.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.243 0.544 . . . . 0.0 111.568 -179.161 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.607 HG13 ' CD ' ' B' ' 703' ' ' PRO . 69.4 t -75.76 -45.8 37.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.394 179.626 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.421 ' O ' ' HG2' ' A' ' 114' ' ' GLN . 97.4 mttt -111.98 144.71 40.87 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 122.312 1.054 . . . . 0.0 113.11 179.273 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -66.69 -32.41 73.71 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.276 -1.329 . . . . 0.0 112.374 -178.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -85.34 18.82 2.51 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 -177.12 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' GLN . . . . . 0.497 ' OE1' ' O ' ' A' ' 120' ' ' ASN . 98.0 mm-40 -76.43 137.84 39.97 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 121.73 -0.606 . . . . 0.0 111.678 179.698 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 25.3 t -128.47 120.38 52.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.443 179.214 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' MET . . . . . 0.563 ' SD ' ' OD1' ' A' ' 151' ' ' ASP . 47.1 mtt -57.67 135.81 56.77 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.708 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.427 ' O ' ' OD2' ' A' ' 180' ' ' ASP . . . 75.15 -6.01 30.75 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 121.152 -0.546 . . . . 0.0 112.606 178.37 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -137.35 126.99 25.28 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.496 0.665 . . . . 0.0 111.436 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 77.18 -169.45 54.93 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 110.768 -0.933 . . . . 0.0 110.768 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.497 ' O ' ' OE1' ' A' ' 114' ' ' GLN . 59.1 t-20 -87.97 106.34 18.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.997 0.427 . . . . 0.0 110.27 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.462 ' CE2' HD21 ' A' ' 123' ' ' LEU . 9.5 t80 -85.13 145.77 27.46 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 179.493 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -147.6 140.05 24.58 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.719 0.771 . . . . 0.0 111.587 -179.023 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.647 HD23 ' HA ' ' A' ' 109' ' ' THR . 71.3 mt -137.62 144.14 41.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.475 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -106.88 136.85 46.02 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.051 0.453 . . . . 0.0 109.826 179.537 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -144.77 131.99 4.54 Favored Glycine 0 CA--C 1.532 1.143 0 N-CA-C 110.233 -1.147 . . . . 0.0 110.233 -179.197 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' HIS . . . . . 0.522 ' O ' ' O ' ' A' ' 134' ' ' LEU . 0.5 OUTLIER -78.71 151.76 31.96 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -178.651 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 46.3 t30 -141.63 121.14 13.27 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 115.415 -0.812 . . . . 0.0 110.173 178.788 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.484 ' O ' ' CB ' ' A' ' 129' ' ' SER . 61.5 mtt -97.03 -3.25 41.78 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.104 0.478 . . . . 0.0 110.66 -179.706 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.484 ' CB ' ' O ' ' A' ' 128' ' ' MET . 1.2 p 78.76 19.57 0.85 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.377 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.664 ' O ' HG12 ' A' ' 133' ' ' VAL . 8.7 ptpt -123.29 104.94 9.44 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.964 0.888 . . . . 0.0 112.706 -178.887 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.406 ' C ' ' O ' ' A' ' 130' ' ' LYS . 29.4 tptp -34.58 125.23 0.52 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.269 -1.332 . . . . 0.0 111.067 179.451 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 109.5 -10.03 32.92 Favored Glycine 0 N--CA 1.449 -0.475 0 N-CA-C 108.973 -1.651 . . . . 0.0 108.973 -178.769 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.664 HG12 ' O ' ' A' ' 130' ' ' LYS . 9.0 p -93.09 161.68 2.51 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.887 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.796 HD23 ' N ' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -69.76 139.46 53.3 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.78 0.8 . . . . 0.0 113.038 -177.686 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.495 ' CD2' HD12 ' A' ' 138' ' ' ILE . 3.6 m-85 63.17 9.1 3.69 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 114.434 -1.257 . . . . 0.0 113.297 178.46 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' SER . . . . . 0.403 ' HB3' HG13 ' A' ' 133' ' ' VAL . 0.0 OUTLIER -66.18 -35.26 80.0 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -179.806 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -92.62 0.73 57.47 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 121.108 0.48 . . . . 0.0 111.623 -178.25 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.495 HD12 ' CD2' ' A' ' 135' ' ' PHE . 3.4 tt -60.27 -37.72 74.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.069 -179.463 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.46 ' N ' ' CG2' ' A' ' 138' ' ' ILE . . . -65.99 -10.56 40.64 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.929 0.395 . . . . 0.0 111.148 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 5.8 m -82.53 -4.38 57.48 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.975 0.417 . . . . 0.0 111.126 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.479 HD21 HG21 ' A' ' 85' ' ' ILE . 76.6 mt -64.53 145.07 56.69 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 121.284 0.564 . . . . 0.0 111.258 -179.415 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -123.88 157.66 33.71 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.895 -179.137 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -50.14 134.59 22.07 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.519 -0.764 . . . . 0.0 112.085 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.601 ' N ' ' O ' ' A' ' 160' ' ' VAL . . . 77.02 7.39 86.65 Favored Glycine 0 CA--C 1.532 1.096 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.307 178.549 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -73.54 137.47 44.39 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 119.631 -0.828 . . . . 0.0 110.605 -179.548 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -81.16 140.48 34.97 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.667 0.746 . . . . 0.0 111.973 -178.729 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.461 HG23 HG12 ' A' ' 85' ' ' ILE . 88.3 mt -137.15 138.03 45.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 114.751 -1.113 . . . . 0.0 108.221 178.232 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 148' ' ' TYR . . . . . 0.557 ' C ' HD23 ' A' ' 149' ' ' LEU . 96.2 m-85 -123.5 137.94 54.68 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 113.464 0.913 . . . . 0.0 113.464 -177.457 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.557 HD23 ' C ' ' A' ' 148' ' ' TYR . 0.9 OUTLIER -112.49 133.24 54.66 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 177.467 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.443 ' CZ ' ' OE2' ' A' ' 155' ' ' GLU . 58.7 m-85 -109.5 109.36 20.15 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.172 -0.611 . . . . 0.0 111.618 179.742 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 151' ' ' ASP . . . . . 0.563 ' OD1' ' SD ' ' A' ' 116' ' ' MET . 7.8 m-20 -89.53 166.61 13.55 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 177.439 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -58.6 -23.67 59.29 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 120.246 -0.581 . . . . 0.0 111.143 -178.496 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -109.78 -28.76 8.63 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -178.475 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -150.5 -174.95 4.91 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 -177.135 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.443 ' OE2' ' CZ ' ' A' ' 150' ' ' TYR . 86.8 tt0 -131.88 139.25 48.72 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 114.122 -1.399 . . . . 0.0 110.083 178.612 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -113.57 137.84 51.0 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 121.073 0.463 . . . . 0.0 111.648 -179.649 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -94.24 112.89 24.73 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.392 179.248 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -114.51 148.39 37.99 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 120.975 0.417 . . . . 0.0 111.436 179.411 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -121.5 121.37 37.35 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.446 179.546 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.601 ' O ' ' N ' ' A' ' 144' ' ' GLY . 97.4 t -59.97 137.2 22.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.942 177.728 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 24.1 p -105.68 -23.94 12.64 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 120.749 -0.38 . . . . 0.0 111.343 179.548 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 154.55 -161.67 30.3 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 120.649 -0.786 . . . . 0.0 111.355 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.931 HG12 HG22 ' A' ' 199' ' ' VAL . 25.3 m -132.58 162.41 39.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-O 120.832 0.348 . . . . 0.0 110.349 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 83.1 p -146.87 163.96 34.42 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.404 0.621 . . . . 0.0 111.518 -179.758 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -100.88 117.65 35.37 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.704 -179.371 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 16.4 m -137.8 158.79 33.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.235 0.54 . . . . 0.0 111.372 179.696 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -94.0 158.41 36.26 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.592 179.327 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 168' ' ' PRO . . . . . 0.458 ' O ' ' CB ' ' B' ' 702' ' ' LEU . 29.0 Cg_endo -61.9 -17.15 53.95 Favored 'Trans proline' 0 C--N 1.301 -1.949 0 C-N-CA 122.619 2.213 . . . . 0.0 113.555 -179.619 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 51.1 p-10 -93.02 -6.03 49.2 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 119.501 -0.879 . . . . 0.0 112.511 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -75.47 96.17 3.42 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 119.878 -0.729 . . . . 0.0 111.421 179.553 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 171' ' ' TRP . . . . . 0.432 ' CD1' ' N ' ' A' ' 171' ' ' TRP . 23.1 m0 -78.7 -15.46 58.44 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.817 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -58.28 -28.88 65.36 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.917 -179.314 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 173' ' ' VAL . . . . . 0.854 HG13 HG23 ' A' ' 174' ' ' VAL . 10.5 p -62.39 -25.1 36.93 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 CA-C-O 121.031 0.444 . . . . 0.0 111.192 -179.237 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.854 HG23 HG13 ' A' ' 173' ' ' VAL . 59.6 t -105.56 -8.11 10.03 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -178.628 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.44 ' O ' ' CE1' ' A' ' 177' ' ' HIS . 96.7 mt-10 -73.49 144.2 46.3 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 122.08 -0.387 . . . . 0.0 110.663 179.72 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 34.0 p-10 -62.74 144.5 56.36 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.329 0.585 . . . . 0.0 111.661 -179.484 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 177' ' ' HIS . . . . . 0.44 ' CE1' ' O ' ' A' ' 175' ' ' GLU . 68.8 m80 -122.14 19.73 10.7 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.922 -179.706 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 64.7 39.06 96.4 Favored Glycine 0 CA--C 1.532 1.095 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 179.461 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 13.1 ptmt -161.67 166.93 26.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.858 0.361 . . . . 0.0 110.15 179.586 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 180' ' ' ASP . . . . . 0.854 ' OD2' HD22 ' A' ' 203' ' ' LEU . 48.1 t0 -90.19 100.23 13.09 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.18 0.514 . . . . 0.0 110.195 178.625 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 181' ' ' GLU . . . . . 0.433 ' HG2' ' N ' ' A' ' 182' ' ' ILE . 84.1 tt0 -131.33 164.59 25.31 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.448 -179.062 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.523 HG22 ' O ' ' A' ' 201' ' ' GLY . 21.2 tt -128.18 137.26 57.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.928 179.251 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 183' ' ' THR . . . . . 0.761 HG21 HG22 ' A' ' 173' ' ' VAL . 94.3 m -124.64 122.44 37.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.061 -179.265 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.443 ' HB3' HD11 ' A' ' 138' ' ' ILE . 69.5 mt -111.35 128.99 56.14 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 178.498 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.554 HD13 HD21 ' B' ' 702' ' ' LEU . 93.3 mt -110.09 123.67 66.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.397 0.618 . . . . 0.0 111.068 -179.267 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 3.6 t -138.95 158.82 43.51 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.825 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 187' ' ' CYS . . . . . . . . . . . . . 1.3 m -101.63 143.8 31.15 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.164 0.507 . . . . 0.0 111.247 -179.364 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.685 HG22 ' CD2' ' A' ' 197' ' ' TYR . 95.5 t -62.71 -47.6 92.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.691 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 20.4 t -168.4 144.55 3.75 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.309 179.239 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 190' ' ' VAL . . . . . 0.544 HG22 ' O ' ' A' ' 190' ' ' VAL . 10.8 p -60.99 -6.28 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.138 0.494 . . . . 0.0 110.69 -179.6 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -101.66 -35.43 9.11 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.848 179.527 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -99.11 110.14 22.76 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.476 -179.66 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -110.73 7.71 22.24 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.646 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 6.1 t -61.53 -47.18 86.75 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.995 0.426 . . . . 0.0 111.864 -178.718 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -146.82 158.78 44.0 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.919 -179.585 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 83.9 mtt85 -128.14 141.45 51.48 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.159 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 197' ' ' TYR . . . . . 0.685 ' CD2' HG22 ' A' ' 188' ' ' VAL . 43.1 m-85 -90.91 144.45 25.67 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 120.948 0.404 . . . . 0.0 110.844 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 39.4 t -127.42 133.94 66.82 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-O 121.361 0.601 . . . . 0.0 111.032 179.175 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.931 HG22 HG12 ' A' ' 163' ' ' VAL . 39.1 t -105.25 131.38 54.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.502 179.489 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -119.66 148.27 43.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.466 0.65 . . . . 0.0 111.588 -179.38 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 201' ' ' GLY . . . . . 0.523 ' O ' HG22 ' A' ' 182' ' ' ILE . . . -142.63 152.32 23.75 Favored Glycine 0 CA--C 1.533 1.16 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 179.296 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 202' ' ' ASP . . . . . 0.432 ' OD1' ' O ' ' A' ' 202' ' ' ASP . 52.7 p-10 -113.11 155.35 25.08 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.377 -0.529 . . . . 0.0 110.988 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 203' ' ' LEU . . . . . 0.854 HD22 ' OD2' ' A' ' 180' ' ' ASP . 60.3 tp -74.3 130.22 39.28 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.314 -0.554 . . . . 0.0 109.562 179.281 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 16.9 m -116.6 -18.24 7.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 C-N-CA 120.371 -0.532 . . . . 0.0 111.357 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -179.98 174.65 46.05 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 120.419 -0.896 . . . . 0.0 112.304 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 40.4 m -140.61 136.59 32.91 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.486 -0.357 . . . . 0.0 110.219 179.367 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 51.6 mttp -141.25 114.62 8.78 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.29 -0.564 . . . . 0.0 111.996 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -64.43 145.81 55.5 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.335 0.588 . . . . 0.0 111.076 179.212 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 21.2 ttpt -81.07 112.44 18.45 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.616 178.34 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 98.7 mttt . . . . . 0 C--O 1.22 -0.457 0 CA-C-O 118.027 -0.987 . . . . 0.0 110.675 -179.879 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 702' ' ' LEU . . . . . 0.554 HD21 HD13 ' A' ' 185' ' ' ILE . 1.0 OUTLIER . . . . . 0 CA--C 1.541 0.611 0 N-CA-C 110.193 -0.299 . . . . 20.0 110.193 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 703' ' ' PRO . . . . . 0.607 ' CD ' HG13 ' A' ' 110' ' ' VAL . 4.0 Cg_exo -63.0 -174.4 0.18 Allowed 'Trans proline' 0 N--CA 1.492 1.441 0 C-N-CA 122.125 1.884 . . . . 20.0 113.896 -178.75 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 704' ' ' ALA . . . . . 0.527 ' O ' ' O ' ' B' ' 703' ' ' PRO . . . . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 114.084 -1.416 . . . . 20.0 113.26 -178.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.144 0 CA-C-O 121.237 0.541 . . . . 0.0 110.991 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.489 ' CB ' ' O ' ' B' ' 702' ' ' LEU . 52.1 p -80.65 17.64 1.1 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.532 -179.146 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 59.1 pttt -105.68 21.11 17.81 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.162 0.505 . . . . 0.0 111.334 -179.662 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.0 mt -56.59 139.47 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-O 122.366 1.079 . . . . 0.0 113.141 -177.339 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.448 ' N ' ' OD1' ' A' ' 62' ' ' ASP . 24.6 p-10 -76.84 130.08 37.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 113.576 -1.647 . . . . 0.0 109.819 179.028 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.755 ' NE2' ' H ' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -77.19 151.56 81.42 Favored Pre-proline 0 C--N 1.325 -0.472 0 C-N-CA 120.148 -0.621 . . . . 0.0 110.437 -179.393 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -72.78 168.98 23.13 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.669 2.246 . . . . 0.0 111.729 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.674 ' O ' HG23 ' A' ' 69' ' ' VAL . 85.5 m-20 -52.18 166.58 0.16 Allowed 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.102 0.477 . . . . 0.0 111.685 -178.578 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 56.8 tp -64.9 -46.88 79.88 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.459 -178.492 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.22 -39.33 94.33 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.502 -0.479 . . . . 0.0 111.618 -178.137 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -57.13 -25.38 58.74 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.02 -0.672 . . . . 0.0 109.745 179.349 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.674 HG23 ' O ' ' A' ' 65' ' ' ASP . 20.0 t -79.42 -45.64 23.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.463 179.542 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -77.06 -9.43 58.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 114.837 -1.074 . . . . 0.0 111.796 -179.153 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 24.5 m120 -103.56 -14.24 16.25 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.371 0.605 . . . . 0.0 110.097 179.119 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -69.06 145.32 53.58 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.374 -0.83 . . . . 0.0 112.027 -179.566 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 25.9 p -59.5 104.04 0.24 Allowed 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 121.701 0.762 . . . . 0.0 111.033 -179.577 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.66 130.52 42.6 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.008 -0.996 . . . . 0.0 111.315 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.518 ' OD2' ' NE2' ' A' ' 78' ' ' GLN . 59.8 t0 -104.38 77.46 1.4 Allowed 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 121.168 0.509 . . . . 0.0 110.64 178.411 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -69.3 -31.11 69.38 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.898 -0.592 . . . . 0.0 112.31 179.049 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 41.0 mmtt -67.6 -29.16 68.43 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -175.396 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.518 ' NE2' ' OD2' ' A' ' 75' ' ' ASP . 76.7 mt-30 -88.63 -1.66 58.19 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 120.324 -0.551 . . . . 0.0 111.258 -179.703 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 53.3 t -72.72 128.91 35.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.038 178.364 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.442 HD13 ' HE2' ' A' ' 96' ' ' LYS . 36.0 pt -113.94 -4.4 11.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 C-N-CA 120.671 -0.411 . . . . 0.0 112.045 179.769 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.415 ' O ' HG22 ' A' ' 94' ' ' VAL . . . -164.74 169.96 39.65 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 120.214 -0.993 . . . . 0.0 111.629 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 62.6 ttp180 -142.84 141.59 31.63 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.36 0.6 . . . . 0.0 111.573 -179.69 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.464 HG22 ' O ' ' A' ' 92' ' ' LEU . 19.5 tt -103.2 140.33 21.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.263 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 47.3 t -135.6 129.95 33.68 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.274 -0.875 . . . . 0.0 111.156 -179.77 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.419 HG12 HG23 ' A' ' 147' ' ' ILE . 96.7 mt -140.49 93.93 8.6 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 114.702 -1.135 . . . . 0.0 109.608 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -66.46 -22.95 51.23 Favored 'Trans proline' 0 N--CA 1.493 1.457 0 C-N-CA 121.574 1.516 . . . . 0.0 113.027 -178.561 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 94.4 p -55.23 -42.26 73.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.186 0.517 . . . . 0.0 110.215 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.434 HG11 ' O ' ' A' ' 137' ' ' ASP . 31.7 m -114.03 5.4 7.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.416 0.627 . . . . 0.0 110.294 179.046 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 2.4 m 56.12 52.57 10.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.779 179.266 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.403 HD11 ' CD1' ' A' ' 92' ' ' LEU . 54.6 tp -114.5 131.93 56.47 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.155 179.286 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -144.75 118.68 9.33 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.618 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.464 ' O ' HG22 ' A' ' 83' ' ' ILE . 91.1 mt -148.71 151.36 35.38 Favored Pre-proline 0 CA--C 1.538 0.495 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.628 -178.042 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -79.39 146.0 19.21 Favored 'Trans proline' 0 N--CA 1.492 1.399 0 C-N-CA 122.597 2.198 . . . . 0.0 111.31 178.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.579 HG23 ' O ' ' A' ' 94' ' ' VAL . 3.1 m -94.4 121.08 44.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-O 121.239 0.543 . . . . 0.0 111.269 179.614 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.559 HD12 ' N ' ' A' ' 95' ' ' LEU . 10.7 mp -100.24 139.65 35.6 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.604 -179.604 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.532 ' O ' ' OG1' ' A' ' 109' ' ' THR . 99.0 mttt -60.54 -91.1 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 121.427 0.632 . . . . 0.0 112.01 -179.263 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.435 ' OG ' ' ND2' ' A' ' 102' ' ' ASN . 6.5 p -58.87 143.39 47.77 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 121.617 0.722 . . . . 0.0 112.742 -178.258 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 87.5 p -92.39 69.94 5.08 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.037 -0.983 . . . . 0.0 111.284 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.427 HG23 ' OG ' ' A' ' 97' ' ' SER . 62.8 p -91.39 168.34 11.63 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 178.305 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -62.58 -43.46 98.75 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 119.797 -0.761 . . . . 0.0 109.529 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -65.84 -40.79 92.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.872 179.214 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.435 ' ND2' ' OG ' ' A' ' 97' ' ' SER . 93.4 m-20 -64.2 -37.38 87.25 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.984 -179.455 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 54.7 mt -68.47 -8.4 40.57 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.951 -179.456 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.507 ' HB3' HG13 ' A' ' 69' ' ' VAL . 96.1 mt -72.84 -23.19 60.73 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.814 0.34 . . . . 0.0 110.444 179.07 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 95.2 p -75.32 -2.94 30.66 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.143 0.497 . . . . 0.0 110.199 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.473 ' HA3' HD12 ' A' ' 134' ' ' LEU . . . 83.76 -13.01 50.43 Favored Glycine 0 CA--C 1.531 1.036 0 CA-C-N 115.632 -0.713 . . . . 0.0 113.384 178.185 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -145.02 126.1 14.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 117.467 0.634 . . . . 0.0 111.81 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -148.13 141.43 25.18 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.356 178.932 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.611 ' HA ' HD23 ' A' ' 123' ' ' LEU . 36.3 p -64.67 138.1 58.2 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.432 0.634 . . . . 0.0 110.888 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.578 HG13 ' CD ' ' B' ' 703' ' ' PRO . 42.1 t -75.76 -24.74 17.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.624 -179.524 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.463 ' HG3' HG12 ' A' ' 110' ' ' VAL . 97.3 mttt -141.23 149.51 41.45 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 122.394 1.092 . . . . 0.0 112.43 178.824 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 77.8 mt-10 -65.35 -32.39 74.01 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.008 -1.451 . . . . 0.0 112.296 -178.333 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -82.06 10.98 5.64 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 113.083 0.772 . . . . 0.0 113.083 -177.894 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' GLN . . . . . 0.429 ' OE1' ' O ' ' A' ' 120' ' ' ASN . 86.5 mm-40 -77.08 132.5 38.93 Favored 'General case' 0 C--N 1.329 -0.285 0 O-C-N 121.955 -0.466 . . . . 0.0 110.667 179.174 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 56.4 t -123.94 124.68 69.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.519 0 CA-C-O 121.245 0.545 . . . . 0.0 110.78 179.163 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' MET . . . . . 0.671 ' SD ' ' CZ ' ' A' ' 121' ' ' TYR . 94.7 mmm -54.12 126.15 21.71 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -179.389 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 72.53 6.76 67.01 Favored Glycine 0 CA--C 1.531 1.092 0 CA-C-N 115.941 -0.572 . . . . 0.0 112.751 177.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -136.93 127.99 27.74 Favored 'General case' 0 C--N 1.328 -0.341 0 O-C-N 122.389 -0.477 . . . . 0.0 111.419 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 71.76 -164.19 54.18 Favored Glycine 0 CA--C 1.531 1.069 0 N-CA-C 110.388 -1.085 . . . . 0.0 110.388 -179.693 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.429 ' O ' ' OE1' ' A' ' 114' ' ' GLN . 64.8 t-20 -87.59 103.4 15.52 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.48 -0.488 . . . . 0.0 109.794 179.266 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.671 ' CZ ' ' SD ' ' A' ' 116' ' ' MET . 17.4 t80 -86.79 145.95 26.42 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.76 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -147.49 143.39 27.82 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.735 0.779 . . . . 0.0 111.473 -179.183 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.611 HD23 ' HA ' ' A' ' 109' ' ' THR . 42.9 mt -139.38 145.99 39.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.765 -179.488 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -110.66 139.64 45.75 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.775 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -136.27 144.92 16.79 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.314 -1.114 . . . . 0.0 110.314 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' HIS . . . . . 0.463 ' O ' ' O ' ' A' ' 134' ' ' LEU . 21.7 m-70 -88.49 150.69 22.99 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.881 0.372 . . . . 0.0 111.253 -179.813 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' ASN . . . . . 0.828 ' C ' HD21 ' A' ' 127' ' ' ASN . 0.2 OUTLIER -146.71 152.57 39.04 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.226 0.536 . . . . 0.0 110.43 179.183 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.544 ' CG ' HG21 ' A' ' 133' ' ' VAL . 58.4 mtt -116.42 -2.29 12.08 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.166 -179.764 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.5 ' CB ' ' O ' ' A' ' 128' ' ' MET . 0.7 OUTLIER 80.18 5.75 1.76 Allowed 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.201 179.83 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.834 ' O ' HG12 ' A' ' 133' ' ' VAL . 8.5 ptpt -114.5 122.76 47.56 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.613 0.72 . . . . 0.0 112.479 -179.61 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 14.6 tmtt? -44.3 127.51 5.74 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.202 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 106.29 -11.08 43.6 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.511 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.834 HG12 ' O ' ' A' ' 130' ' ' LYS . 9.0 p -94.02 172.85 0.96 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.135 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.595 ' H ' HG22 ' A' ' 133' ' ' VAL . 3.8 mm? -68.76 133.09 47.86 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 116.165 1.913 . . . . 0.0 116.165 -176.48 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.428 ' CD2' HD13 ' A' ' 138' ' ' ILE . 2.7 m-85 53.69 16.19 0.94 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 113.524 -1.671 . . . . 0.0 114.291 176.496 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 5.3 t -68.94 -39.07 79.77 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' ASP . . . . . 0.434 ' O ' HG11 ' A' ' 88' ' ' VAL . 68.0 m-20 -91.33 2.01 56.7 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 -176.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.56 HD11 ' HB ' ' A' ' 186' ' ' THR . 28.4 pt -65.86 -22.88 31.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 119.073 -1.051 . . . . 0.0 109.922 -179.326 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -70.31 -8.64 51.97 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.194 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 33.6 t -83.04 -5.29 59.05 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.589 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 86.2 mt -63.26 147.79 50.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.808 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 99.9 mttt -124.25 158.89 31.43 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.438 0.637 . . . . 0.0 111.551 -178.761 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -49.9 131.3 22.5 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.048 179.044 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 160' ' ' VAL . . . 80.43 9.01 86.99 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 120.408 -0.901 . . . . 0.0 112.273 178.379 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.492 ' OD1' ' N ' ' A' ' 146' ' ' LYS . 62.8 t0 -75.04 131.53 40.65 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 120.219 -0.592 . . . . 0.0 110.584 -179.302 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.492 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 74.8 mmtt -77.08 137.03 38.69 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 121.84 0.828 . . . . 0.0 112.232 -178.588 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.419 HG23 HG12 ' A' ' 85' ' ' ILE . 94.7 mt -138.61 140.17 39.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 114.529 -1.214 . . . . 0.0 108.574 178.345 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 148' ' ' TYR . . . . . 0.547 ' C ' HD23 ' A' ' 149' ' ' LEU . 12.8 m-85 -127.3 140.99 51.83 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 119.583 -0.847 . . . . 0.0 113.196 -177.726 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.547 HD23 ' C ' ' A' ' 148' ' ' TYR . 1.4 mt -114.54 131.72 56.56 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 177.462 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -107.67 112.68 25.5 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 120.007 -0.677 . . . . 0.0 111.007 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' ASP . . . . . 0.557 ' OD1' ' N ' ' A' ' 152' ' ' ASN . 58.4 t0 -90.21 163.1 14.93 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 177.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 152' ' ' ASN . . . . . 0.557 ' N ' ' OD1' ' A' ' 151' ' ' ASP . 15.3 t-20 -56.32 -22.58 31.6 Favored 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 119.629 -0.828 . . . . 0.0 110.966 -178.812 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -110.36 -29.2 8.22 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -178.012 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -148.73 -176.97 5.53 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 119.359 -0.936 . . . . 0.0 113.32 -176.293 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 65.4 mt-10 -131.44 136.36 47.9 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 114.758 -1.11 . . . . 0.0 109.538 179.147 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -111.3 135.84 51.26 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.149 0.499 . . . . 0.0 111.741 -179.367 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' GLU . . . . . 0.41 ' O ' HD12 ' A' ' 203' ' ' LEU . 98.7 mt-10 -92.65 112.59 24.6 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.4 179.138 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -114.96 147.05 40.55 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.007 0.432 . . . . 0.0 110.523 179.053 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -122.85 123.46 41.05 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.063 0.459 . . . . 0.0 110.776 179.346 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.51 ' O ' ' N ' ' A' ' 144' ' ' GLY . 84.5 t -58.24 134.43 23.01 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.036 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 78.0 p -118.08 11.38 13.29 Favored 'General case' 0 CA--C 1.534 0.357 0 O-C-N 123.658 0.599 . . . . 0.0 111.415 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.433 ' H ' HG12 ' A' ' 160' ' ' VAL . . . 124.78 -175.26 17.18 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 120.747 -0.739 . . . . 0.0 111.895 179.073 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.461 HG12 HG22 ' A' ' 199' ' ' VAL . 28.5 m -128.15 160.88 37.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 179.52 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 68.2 m -135.98 159.67 40.98 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.571 0.7 . . . . 0.0 111.601 -179.543 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -105.31 116.09 31.35 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.596 -179.594 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.59 HG11 ' CG1' ' A' ' 173' ' ' VAL . 35.5 m -133.89 162.99 38.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.148 -179.696 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 167' ' ' THR . . . . . 0.429 ' H ' ' HD2' ' A' ' 170' ' ' LYS . 0.1 OUTLIER -91.99 163.99 25.31 Favored Pre-proline 0 CA--C 1.538 0.511 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.222 179.379 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 168' ' ' PRO . . . . . 0.459 ' O ' ' CB ' ' B' ' 702' ' ' LEU . 36.3 Cg_exo -61.09 -19.02 61.47 Favored 'Trans proline' 0 N--CA 1.502 1.982 0 C-N-CA 122.548 2.165 . . . . 0.0 113.479 179.447 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 169' ' ' ASP . . . . . 0.403 ' OD1' ' C ' ' A' ' 169' ' ' ASP . 41.0 p-10 -95.68 -6.33 40.21 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -178.884 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.734 ' O ' HG22 ' A' ' 173' ' ' VAL . 96.6 mttt -76.46 82.92 3.17 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 119.392 -0.923 . . . . 0.0 111.396 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 171' ' ' TRP . . . . . 0.51 ' O ' HG22 ' A' ' 174' ' ' VAL . 67.0 p-90 -70.72 -10.2 58.91 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.949 0.881 . . . . 0.0 109.521 179.259 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -62.69 -31.85 72.83 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.771 -1.104 . . . . 0.0 111.158 -179.727 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 173' ' ' VAL . . . . . 0.734 HG22 ' O ' ' A' ' 170' ' ' LYS . 34.6 m -62.58 -17.35 18.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-N 116.047 -0.524 . . . . 0.0 112.397 -179.081 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.684 HG13 HG23 ' A' ' 173' ' ' VAL . 30.3 m -112.87 -2.56 10.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -178.765 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -74.98 165.82 24.66 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 121.103 0.477 . . . . 0.0 110.949 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 176' ' ' ASP . . . . . 0.494 ' OD1' ' O ' ' A' ' 176' ' ' ASP . 36.5 p30 -67.33 137.49 56.07 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.075 179.582 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 177' ' ' HIS . . . . . 0.428 ' ND1' ' ND2' ' A' ' 120' ' ' ASN . 40.7 m80 -119.01 13.53 13.02 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.559 -179.71 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 62.39 41.61 99.75 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 121.003 -0.618 . . . . 0.0 111.627 179.527 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 12.9 ptmt -163.35 168.11 20.87 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.998 0.428 . . . . 0.0 110.832 179.672 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -88.15 93.48 9.51 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 178.314 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 181' ' ' GLU . . . . . 0.446 ' HG2' ' N ' ' A' ' 182' ' ' ILE . 84.6 tt0 -131.88 163.66 27.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.43 0.633 . . . . 0.0 112.106 -178.511 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.488 HG22 ' O ' ' A' ' 201' ' ' GLY . 18.0 tt -130.78 138.09 54.44 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.036 178.805 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 80.4 m -130.72 124.63 31.94 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.135 -179.642 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 87.6 mt -109.21 135.51 50.19 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.65 178.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 92.1 mt -113.21 127.69 70.36 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 CA-C-O 121.129 0.49 . . . . 0.0 110.983 -179.423 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 186' ' ' THR . . . . . 0.56 ' HB ' HD11 ' A' ' 138' ' ' ILE . 13.6 t -139.77 156.81 46.56 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.623 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 187' ' ' CYS . . . . . 0.705 ' HB2' HD22 ' A' ' 127' ' ' ASN . 2.3 m -93.19 143.68 26.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.388 0.613 . . . . 0.0 110.257 179.808 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.87 HG22 ' CE2' ' A' ' 197' ' ' TYR . 40.5 t -61.97 -46.99 95.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.429 -179.11 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 41.3 p -164.97 161.34 19.9 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.335 0.588 . . . . 0.0 110.903 -179.505 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 190' ' ' VAL . . . . . 0.456 ' O ' HG12 ' A' ' 190' ' ' VAL . 71.4 t -71.96 -13.08 16.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.321 179.347 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -97.71 -13.74 21.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.338 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -142.14 99.92 3.61 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.306 -0.558 . . . . 0.0 112.085 -179.321 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -103.78 11.35 35.91 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.577 178.85 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 41.1 m -63.64 -42.0 98.19 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.684 -179.301 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 43.3 mtmt -123.28 149.71 44.44 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.271 0.558 . . . . 0.0 111.183 -179.558 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 85.0 mtt85 -133.23 139.98 47.27 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.431 -179.085 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 197' ' ' TYR . . . . . 0.87 ' CE2' HG22 ' A' ' 188' ' ' VAL . 42.8 m-85 -91.41 155.24 18.61 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.153 0.502 . . . . 0.0 111.021 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 3.0 m -131.46 129.25 61.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.603 178.792 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.461 HG22 HG12 ' A' ' 163' ' ' VAL . 58.9 t -97.12 130.43 45.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 178.937 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -107.81 131.71 54.19 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.217 0.532 . . . . 0.0 111.205 -178.239 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 201' ' ' GLY . . . . . 0.488 ' O ' HG22 ' A' ' 182' ' ' ILE . . . -132.23 131.9 6.44 Favored Glycine 0 CA--C 1.53 1.008 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -103.07 143.17 32.94 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 121.238 0.542 . . . . 0.0 111.247 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 203' ' ' LEU . . . . . 0.41 HD12 ' O ' ' A' ' 157' ' ' GLU . 35.8 tp -69.5 133.52 47.8 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.897 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 4.1 p -116.52 -17.53 7.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.69 -179.103 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 179.19 174.45 45.32 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 120.588 -0.815 . . . . 0.0 111.775 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 72.6 m -145.54 140.81 27.72 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.111 -0.545 . . . . 0.0 110.009 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -145.52 119.59 9.43 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 119.943 -0.703 . . . . 0.0 111.511 179.242 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -63.72 145.05 56.49 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.318 -0.855 . . . . 0.0 112.442 -179.191 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 8.6 ttpt -79.38 106.67 11.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.47 178.377 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 98.5 mttt . . . . . 0 C--O 1.22 -0.451 0 CA-C-O 117.93 -1.033 . . . . 0.0 110.287 -179.752 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 702' ' ' LEU . . . . . 0.489 ' O ' ' CB ' ' A' ' 59' ' ' SER . 0.0 OUTLIER . . . . . 0 CA--C 1.542 0.671 0 N-CA-C 110.222 -0.288 . . . . 20.0 110.222 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 703' ' ' PRO . . . . . 0.578 ' CD ' HG13 ' A' ' 110' ' ' VAL . 3.8 Cg_exo -69.43 -173.39 0.66 Allowed 'Trans proline' 0 C--N 1.316 -1.158 0 C-N-CA 122.155 1.903 . . . . 20.0 112.202 179.76 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 704' ' ' ALA . . . . . 0.507 ' O ' ' O ' ' B' ' 703' ' ' PRO . . . . . . . . 0 C--N 1.321 -0.641 0 CA-C-N 114.962 -1.017 . . . . 20.0 113.506 -178.645 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.242 0 CA-C-O 121.479 0.656 . . . . 0.0 109.815 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 85.2 p -85.72 4.92 34.53 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.65 -179.731 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -104.49 16.21 26.56 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 -178.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.0 mt -56.05 144.78 7.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 122.337 1.065 . . . . 0.0 112.931 -177.579 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 59.8 t0 -79.04 125.17 29.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 113.614 -1.63 . . . . 0.0 109.578 178.586 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.454 ' HB2' ' CG ' ' A' ' 126' ' ' HIS . 7.2 tp60 -78.7 136.17 59.35 Favored Pre-proline 0 C--N 1.322 -0.616 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -61.42 159.29 32.11 Favored 'Trans proline' 0 C--N 1.311 -1.399 0 C-N-CA 121.725 1.616 . . . . 0.0 113.083 -179.53 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.777 ' O ' HG23 ' A' ' 69' ' ' VAL . 97.6 m-20 -52.0 162.25 0.48 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.473 -178.554 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.493 ' N ' HD12 ' A' ' 66' ' ' LEU . 9.9 mp -62.75 -44.34 96.46 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.964 -178.436 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.58 -36.72 84.72 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 119.768 -0.773 . . . . 0.0 110.18 -179.561 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -62.91 -33.71 75.91 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.889 0.852 . . . . 0.0 108.812 177.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.777 HG23 ' O ' ' A' ' 65' ' ' ASP . 60.6 t -76.09 -45.65 35.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 114.607 -1.179 . . . . 0.0 110.923 179.288 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -72.31 -8.88 57.26 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.749 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -105.06 -10.54 17.11 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.631 0.729 . . . . 0.0 109.363 178.389 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.92 138.11 57.04 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.778 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 9.0 t -57.25 99.0 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.76 HD13 ' C ' ' A' ' 74' ' ' LEU . 3.2 tm? -65.16 120.21 12.27 Favored 'General case' 0 C--N 1.334 -0.087 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.368 -178.692 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.552 ' N ' HD13 ' A' ' 74' ' ' LEU . 34.1 t0 -99.08 82.5 2.74 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.551 0.691 . . . . 0.0 111.616 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.406 ' N ' HD13 ' A' ' 74' ' ' LEU . 47.8 tttp -65.31 -32.22 73.76 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.258 -0.883 . . . . 0.0 112.429 179.218 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 31.4 mmtt -68.19 -16.53 64.02 Favored 'General case' 0 C--N 1.314 -0.943 0 C-N-CA 119.997 -0.681 . . . . 0.0 110.972 -175.294 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.454 ' CD ' ' OD2' ' A' ' 75' ' ' ASP . 94.8 mt-30 -92.02 -5.91 52.07 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 121.087 0.47 . . . . 0.0 111.388 178.831 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 86.0 t -78.6 129.0 38.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.19 0.519 . . . . 0.0 110.192 179.722 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 5.3 pt -112.02 -4.47 11.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.107 -179.474 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -172.68 174.96 45.82 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 120.249 -0.977 . . . . 0.0 111.717 -179.073 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.583 ' NH2' ' OE1' ' A' ' 91' ' ' GLU . 75.1 ttt180 -136.4 154.9 50.67 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.362 0.601 . . . . 0.0 110.836 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.718 HG22 ' O ' ' A' ' 92' ' ' LEU . 19.4 tt -123.8 141.4 44.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.167 -179.501 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 14.6 t -136.69 130.45 32.14 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 121.43 0.634 . . . . 0.0 111.798 -178.39 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.527 HG22 HG22 ' A' ' 88' ' ' VAL . 89.3 mt -137.94 86.19 18.38 Favored Pre-proline 0 CA--C 1.536 0.44 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.94 -179.554 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -56.47 -30.15 80.91 Favored 'Trans proline' 0 N--CA 1.497 1.69 0 C-N-CA 123.221 2.614 . . . . 0.0 113.207 -178.661 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 18.0 m -52.8 -42.14 64.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.213 0.53 . . . . 0.0 110.704 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.527 HG22 HG22 ' A' ' 85' ' ' ILE . 23.4 m -115.53 10.91 7.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.713 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.45 ' O ' ' OG ' ' A' ' 89' ' ' SER . 5.3 p 52.04 50.49 18.41 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.047 0.451 . . . . 0.0 110.93 179.569 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 56.2 tp -116.02 133.33 56.14 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.285 0.564 . . . . 0.0 110.146 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.583 ' OE1' ' NH2' ' A' ' 82' ' ' ARG . 98.0 mt-10 -147.27 124.2 11.32 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.763 -179.186 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.718 ' O ' HG22 ' A' ' 83' ' ' ILE . 71.0 mt -151.25 152.61 31.39 Favored Pre-proline 0 N--CA 1.471 0.62 0 C-N-CA 120.154 -0.618 . . . . 0.0 111.681 -179.307 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_endo -75.0 150.26 37.88 Favored 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 122.771 2.314 . . . . 0.0 111.244 178.405 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.551 ' C ' HD12 ' A' ' 95' ' ' LEU . 91.1 t -98.01 123.5 50.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -178.751 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.551 HD12 ' C ' ' A' ' 94' ' ' VAL . 9.7 mp -109.61 136.22 49.32 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-O 120.901 0.381 . . . . 0.0 111.083 178.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 85.7 mttt -67.33 -78.88 0.05 Allowed 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.439 0.638 . . . . 0.0 112.234 -179.229 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 30.6 t -61.95 139.25 58.41 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.952 -178.709 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 7.5 t -95.44 72.93 3.24 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.364 0.602 . . . . 0.0 110.547 -179.69 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 39.7 p -90.25 166.85 13.11 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 178.183 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -60.42 -42.21 95.53 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.68 0.752 . . . . 0.0 109.273 179.059 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -64.88 -41.82 95.32 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.988 179.143 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -65.13 -38.23 89.95 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.151 -179.707 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 84.2 mt -64.01 -12.92 42.54 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.784 -179.36 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 89.6 mt -72.41 -23.22 61.06 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.279 0.561 . . . . 0.0 109.852 179.352 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 96.5 p -74.46 -6.11 46.46 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 121.442 0.639 . . . . 0.0 110.893 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.473 ' HA3' HD12 ' A' ' 134' ' ' LEU . . . 87.4 -19.79 30.07 Favored Glycine 0 CA--C 1.533 1.203 0 CA-C-N 115.642 -0.708 . . . . 0.0 112.85 178.469 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -145.28 123.71 12.37 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 119.65 -0.82 . . . . 0.0 111.956 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -144.53 135.33 24.88 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.512 179.489 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.627 ' HA ' HD23 ' A' ' 123' ' ' LEU . 2.3 m -62.44 135.41 57.42 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 121.034 0.445 . . . . 0.0 110.765 -179.074 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.547 HG13 ' CG ' ' B' ' 703' ' ' PRO . 79.8 t -77.37 -48.84 23.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.765 179.642 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 69.3 mmtt -96.18 132.2 41.86 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.577 0.703 . . . . 0.0 110.854 179.59 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -65.56 -32.77 74.54 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 114.974 -1.012 . . . . 0.0 112.195 -178.315 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 69.0 m-80 -84.55 12.4 7.08 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 -178.233 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' GLN . . . . . 0.4 ' N ' ' OE1' ' A' ' 114' ' ' GLN . 0.6 OUTLIER -81.28 143.72 32.06 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.905 0.383 . . . . 0.0 111.494 179.853 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.459 ' O ' ' O ' ' A' ' 118' ' ' LYS . 41.4 t -126.38 123.79 64.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.982 179.796 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 98.3 mtp -57.11 137.51 55.73 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 121.241 0.543 . . . . 0.0 111.387 179.557 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 77.95 -5.01 55.71 Favored Glycine 0 CA--C 1.531 1.058 0 N-CA-C 111.522 -0.631 . . . . 0.0 111.522 179.532 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.459 ' O ' ' O ' ' A' ' 115' ' ' VAL . 98.5 mttt -141.85 132.28 25.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.208 0.528 . . . . 0.0 111.471 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 72.42 -173.23 46.78 Favored Glycine 0 CA--C 1.528 0.904 0 N-CA-C 110.524 -1.031 . . . . 0.0 110.524 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.541 HD22 ' CE1' ' A' ' 177' ' ' HIS . 56.0 t-20 -84.12 101.92 12.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.165 0.507 . . . . 0.0 109.802 179.492 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.683 ' CE2' HD21 ' A' ' 123' ' ' LEU . 27.0 t80 -88.92 99.53 12.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.362 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.715 ' HB1' HG12 ' A' ' 174' ' ' VAL . . . -92.4 143.0 26.82 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.172 0.51 . . . . 0.0 111.634 -179.653 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.683 HD21 ' CE2' ' A' ' 121' ' ' TYR . 62.2 mt -136.7 141.42 43.1 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.835 179.733 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -109.66 130.83 55.48 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.373 0.606 . . . . 0.0 110.201 179.281 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -136.79 141.29 12.26 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' HIS . . . . . 0.518 ' O ' ' O ' ' A' ' 134' ' ' LEU . 0.3 OUTLIER -80.04 146.31 32.03 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.067 -0.653 . . . . 0.0 112.23 -178.849 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 61.8 t-20 -136.07 121.3 19.07 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.305 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.61 ' HB2' HG21 ' A' ' 133' ' ' VAL . 58.5 mtt -97.69 -4.51 37.15 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.04 -179.443 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.429 ' CB ' ' O ' ' A' ' 128' ' ' MET . 0.9 OUTLIER 78.09 6.59 2.63 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.419 179.527 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.781 ' O ' HG12 ' A' ' 133' ' ' VAL . 6.9 ptpt -113.08 116.03 29.26 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 121.468 0.651 . . . . 0.0 111.714 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -40.69 127.66 2.52 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.851 -179.644 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 105.44 -11.5 47.09 Favored Glycine 0 N--CA 1.444 -0.813 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.781 HG12 ' O ' ' A' ' 130' ' ' LYS . 7.7 p -92.43 173.84 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.058 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.598 ' H ' HG22 ' A' ' 133' ' ' VAL . 3.8 mm? -67.26 131.57 46.02 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 115.773 1.768 . . . . 0.0 115.773 -175.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.9 m-30 50.55 21.33 0.85 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 113.266 -1.788 . . . . 0.0 113.956 176.874 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 4.5 t -72.18 -34.06 68.14 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 119.764 -0.774 . . . . 0.0 112.523 179.791 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' ASP . . . . . 0.484 ' O ' HG11 ' A' ' 88' ' ' VAL . 83.9 m-20 -88.91 -1.53 58.14 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.433 0.635 . . . . 0.0 111.388 -179.063 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.876 HD11 HD13 ' A' ' 184' ' ' LEU . 4.7 tt -62.7 -34.97 68.39 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.286 -179.538 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -66.43 -7.31 18.58 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 121.532 0.682 . . . . 0.0 110.234 179.432 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 4.8 m -84.67 -6.1 59.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.175 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 72.8 mt -63.39 142.17 58.49 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.014 -179.639 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -117.16 159.91 21.86 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 121.817 0.818 . . . . 0.0 112.243 -178.894 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 65.2 tttm -52.65 133.56 36.33 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.515 178.883 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.482 ' N ' ' O ' ' A' ' 160' ' ' VAL . . . 77.67 8.53 87.19 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 120.167 -1.016 . . . . 0.0 110.892 179.233 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.413 ' O ' HG23 ' A' ' 160' ' ' VAL . 55.5 t0 -81.96 125.8 31.19 Favored 'General case' 0 C--O 1.222 -0.374 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -79.91 151.0 30.38 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 115.107 1.521 . . . . 0.0 115.107 -176.446 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 97.6 mt -138.37 137.96 43.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 112.518 -2.128 . . . . 0.0 108.204 179.49 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' TYR . . . . . 0.457 ' C ' HD23 ' A' ' 149' ' ' LEU . 68.2 m-85 -121.73 135.85 54.94 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 120.094 -0.642 . . . . 0.0 111.903 -178.039 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.515 HD11 HD12 ' A' ' 182' ' ' ILE . 4.0 mt -114.59 134.29 55.16 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 177.78 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.56 ' CE2' ' CD ' ' A' ' 155' ' ' GLU . 94.4 m-85 -110.16 110.96 22.01 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 120.192 -0.603 . . . . 0.0 111.529 179.644 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 151' ' ' ASP . . . . . 0.477 ' N ' ' O ' ' A' ' 154' ' ' ASN . 9.6 m-20 -87.59 166.94 14.35 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 177.39 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -56.89 -24.2 50.24 Favored 'General case' 0 C--N 1.312 -1.031 0 C-N-CA 120.088 -0.645 . . . . 0.0 111.058 -178.183 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -112.69 -25.8 8.92 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 113.758 1.021 . . . . 0.0 113.758 -179.128 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' ASN . . . . . 0.477 ' O ' ' N ' ' A' ' 151' ' ' ASP . 0.6 OUTLIER -148.73 -176.3 5.27 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 118.904 -1.119 . . . . 0.0 113.533 -176.303 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.56 ' CD ' ' CE2' ' A' ' 150' ' ' TYR . 84.4 tt0 -131.94 137.39 47.92 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 114.812 -1.086 . . . . 0.0 110.197 179.038 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 156' ' ' TYR . . . . . 0.425 ' CD1' HG23 ' A' ' 206' ' ' THR . 94.1 m-85 -110.37 136.03 50.17 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.267 0.556 . . . . 0.0 112.311 -179.038 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -94.67 110.6 22.42 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.287 179.484 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -113.16 146.22 39.62 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 120.918 0.389 . . . . 0.0 110.823 179.442 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.511 ' HB2' HG21 ' A' ' 204' ' ' VAL . . . -120.75 120.79 36.65 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.068 179.611 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.482 ' O ' ' N ' ' A' ' 144' ' ' GLY . 69.0 t -59.32 134.28 24.46 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.331 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 178.273 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 10.2 p -106.91 -25.03 11.83 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 123.507 0.505 . . . . 0.0 111.041 179.124 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 159.64 -168.08 35.37 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 120.323 -0.942 . . . . 0.0 112.111 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.915 HG12 HG22 ' A' ' 199' ' ' VAL . 35.6 m -129.47 159.41 41.54 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 179.323 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 47.0 t -141.16 162.32 35.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.413 0.625 . . . . 0.0 111.704 -178.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -102.31 119.09 38.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.991 -178.757 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.481 HG21 HG21 ' A' ' 198' ' ' VAL . 22.3 m -136.47 161.17 37.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.509 -179.661 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 167' ' ' THR . . . . . 0.442 ' H ' ' HD2' ' A' ' 170' ' ' LYS . 0.2 OUTLIER -98.56 168.33 9.99 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.148 -179.432 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 168' ' ' PRO . . . . . 0.452 ' O ' ' CB ' ' B' ' 702' ' ' LEU . 31.3 Cg_exo -59.96 -22.21 68.0 Favored 'Trans proline' 0 N--CA 1.499 1.813 0 C-N-CA 122.614 2.209 . . . . 0.0 113.496 179.367 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 169' ' ' ASP . . . . . 0.424 ' OD1' ' OG1' ' A' ' 167' ' ' THR . 44.9 p-10 -94.16 -1.44 54.19 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -179.041 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.536 ' O ' HG22 ' A' ' 173' ' ' VAL . 17.7 mttm -76.65 85.49 3.3 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.432 0.634 . . . . 0.0 111.613 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 171' ' ' TRP . . . . . 0.475 ' O ' HG22 ' A' ' 174' ' ' VAL . 59.9 p-90 -78.39 -12.11 59.99 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.479 179.471 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -65.54 -27.12 68.22 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.117 -179.124 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 173' ' ' VAL . . . . . 0.74 HG23 HG13 ' A' ' 174' ' ' VAL . 33.4 m -63.01 -21.28 27.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 120.74 -0.384 . . . . 0.0 111.766 -179.132 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.74 HG13 HG23 ' A' ' 173' ' ' VAL . 26.9 m -107.49 -2.97 10.07 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 -178.699 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -74.84 162.98 28.16 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.2 0.524 . . . . 0.0 110.835 179.735 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 176' ' ' ASP . . . . . 0.447 ' N ' ' OD1' ' A' ' 176' ' ' ASP . 33.6 p-10 -62.88 141.69 58.58 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.82 179.762 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 177' ' ' HIS . . . . . 0.541 ' CE1' HD22 ' A' ' 120' ' ' ASN . 49.1 m80 -118.63 10.5 12.52 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.801 -179.494 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 62.68 41.62 99.8 Favored Glycine 0 CA--C 1.531 1.031 0 C-N-CA 121.323 -0.465 . . . . 0.0 112.195 179.025 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -167.94 174.49 7.39 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.771 0.319 . . . . 0.0 110.37 178.688 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 -86.72 97.62 10.69 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 177.043 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 181' ' ' GLU . . . . . 0.437 ' HG2' ' N ' ' A' ' 182' ' ' ILE . 83.5 tt0 -134.16 161.07 35.9 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.591 0.71 . . . . 0.0 111.877 -178.754 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.515 HD12 HD11 ' A' ' 149' ' ' LEU . 19.5 tt -129.25 136.05 60.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 114.936 -1.029 . . . . 0.0 108.701 178.738 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 90.6 m -130.61 125.21 33.52 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.968 0.413 . . . . 0.0 110.717 -179.428 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.876 HD13 HD11 ' A' ' 138' ' ' ILE . 70.1 mt -109.36 135.36 50.55 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 179.573 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.585 HD13 HD21 ' B' ' 702' ' ' LEU . 99.0 mt -112.72 123.86 68.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.461 0.648 . . . . 0.0 110.84 -179.336 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 1.2 t -137.62 155.17 49.47 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.47 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 187' ' ' CYS . . . . . . . . . . . . . 19.9 m -88.07 140.14 29.79 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.299 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.81 HG22 ' CD2' ' A' ' 197' ' ' TYR . 55.9 t -62.74 -49.0 85.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 C-N-CA 120.444 -0.502 . . . . 0.0 110.864 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 57.2 p -160.99 166.67 27.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.57 0.7 . . . . 0.0 111.245 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 27.2 t -82.67 -16.94 11.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.699 179.709 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 191' ' ' LYS . . . . . 0.48 ' O ' ' OD1' ' A' ' 192' ' ' ASP . 99.6 mttt -95.25 -13.62 24.73 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 121.055 0.455 . . . . 0.0 111.206 -179.288 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 192' ' ' ASP . . . . . 0.48 ' OD1' ' O ' ' A' ' 191' ' ' LYS . 91.5 m-20 -139.97 101.22 4.12 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.316 -179.683 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -97.26 7.88 45.67 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 121.552 0.691 . . . . 0.0 110.438 179.18 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 58.4 m -61.64 -37.1 82.76 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.462 179.676 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -127.1 150.33 49.53 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 121.338 0.589 . . . . 0.0 111.836 -178.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 196' ' ' ARG . . . . . 0.477 ' HA ' HG23 ' A' ' 188' ' ' VAL . 99.8 mtt180 -132.89 140.53 47.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.004 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 197' ' ' TYR . . . . . 0.81 ' CD2' HG22 ' A' ' 188' ' ' VAL . 25.6 m-85 -93.91 139.62 30.68 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.144 0.497 . . . . 0.0 110.623 178.742 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.481 HG21 HG21 ' A' ' 166' ' ' VAL . 40.9 t -129.72 131.09 66.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.178 179.253 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.915 HG22 HG12 ' A' ' 163' ' ' VAL . 56.0 t -103.11 134.88 43.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-O 121.07 0.462 . . . . 0.0 110.736 -179.478 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -115.87 141.61 47.87 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.324 0.583 . . . . 0.0 110.901 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -138.58 142.55 13.17 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 110.836 -0.906 . . . . 0.0 110.836 -179.732 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 81.4 m-20 -105.83 142.94 34.69 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.962 0.411 . . . . 0.0 110.671 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 46.9 tp -68.29 132.64 47.45 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.511 HG21 ' HB2' ' A' ' 159' ' ' ALA . 64.0 t -115.14 -21.55 5.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -178.782 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -176.04 173.59 46.36 Favored Glycine 0 CA--C 1.523 0.58 0 C-N-CA 120.155 -1.021 . . . . 0.0 111.76 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 206' ' ' THR . . . . . 0.425 HG23 ' CD1' ' A' ' 156' ' ' TYR . 9.2 m -143.16 139.53 30.38 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.238 -0.481 . . . . 0.0 109.802 179.686 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -141.69 115.42 9.11 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 121.58 0.705 . . . . 0.0 112.335 -179.397 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -64.12 142.26 58.47 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.286 -0.87 . . . . 0.0 112.325 -179.736 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -76.57 159.23 30.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.977 178.352 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 98.9 mttt . . . . . 0 C--O 1.222 -0.351 0 CA-C-O 117.965 -1.016 . . . . 0.0 111.154 -179.827 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 702' ' ' LEU . . . . . 0.585 HD21 HD13 ' A' ' 185' ' ' ILE . 1.0 OUTLIER . . . . . 0 CA--C 1.542 0.647 0 CA-C-O 120.552 0.215 . . . . 20.0 110.735 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 703' ' ' PRO . . . . . 0.56 ' O ' ' O ' ' B' ' 704' ' ' ALA . 3.9 Cg_exo -64.8 -178.46 0.74 Allowed 'Trans proline' 0 N--CA 1.491 1.338 0 C-N-CA 122.132 1.888 . . . . 20.0 113.848 -178.756 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 704' ' ' ALA . . . . . 0.56 ' O ' ' O ' ' B' ' 703' ' ' PRO . . . . . . . . 0 N--CA 1.467 0.422 0 CA-C-N 114.238 -1.347 . . . . 20.0 114.103 -178.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.271 0 CA-C-O 120.936 0.398 . . . . 0.0 111.191 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 44.3 p -80.77 23.28 0.54 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 121.313 0.578 . . . . 0.0 110.814 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -109.49 25.07 12.22 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.665 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 94.6 mt -56.09 136.28 18.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 122.36 1.076 . . . . 0.0 113.003 -177.05 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -79.53 128.01 32.84 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 113.552 -1.658 . . . . 0.0 108.39 177.768 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.432 HE21 ' HB2' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -79.22 149.81 73.3 Favored Pre-proline 0 C--N 1.325 -0.489 0 C-N-CA 120.546 -0.462 . . . . 0.0 110.211 -179.016 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -69.66 158.64 56.38 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 122.399 2.066 . . . . 0.0 112.385 -179.044 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.706 ' O ' HG23 ' A' ' 69' ' ' VAL . 92.5 m-20 -53.35 174.76 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.883 -178.847 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 89.8 mt -63.78 -46.78 83.67 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 -177.169 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.26 -37.8 86.83 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 119.819 -0.752 . . . . 0.0 111.238 -177.523 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.575 ' OE1' ' N ' ' A' ' 68' ' ' GLU . 35.3 mp0 -60.81 -27.54 68.11 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.416 0.627 . . . . 0.0 109.709 178.664 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.706 HG23 ' O ' ' A' ' 65' ' ' ASP . 26.2 t -78.98 -46.01 24.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.476 179.216 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -73.3 -9.21 58.46 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.879 -1.055 . . . . 0.0 111.365 -179.284 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -110.14 -8.67 14.75 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.526 0.679 . . . . 0.0 109.412 178.537 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.413 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -71.74 144.91 49.1 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 115.137 -0.938 . . . . 0.0 112.042 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 24.1 m -56.92 109.67 0.68 Allowed 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.744 -179.55 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 37.9 tp -70.12 131.25 43.99 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.773 -179.443 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -116.4 77.75 1.13 Allowed 'General case' 0 C--O 1.232 0.157 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 176.754 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -82.45 -33.39 28.54 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.989 -1.005 . . . . 0.0 113.176 -178.778 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 48.6 mmtt -73.2 -10.61 59.95 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 119.954 -0.699 . . . . 0.0 110.905 -176.739 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -92.52 -1.17 57.14 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.659 179.525 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 13.5 t -81.64 127.84 39.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.377 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 21.6 pt -107.84 -2.65 10.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.943 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -161.9 171.23 37.79 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 120.188 -1.006 . . . . 0.0 111.632 -179.386 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 58.4 ttp180 -140.65 142.0 35.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.219 0.533 . . . . 0.0 111.155 -179.72 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.582 HG22 ' O ' ' A' ' 92' ' ' LEU . 7.5 tp -105.2 136.59 38.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.976 179.43 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 10.0 t -137.05 127.94 27.42 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-O 121.431 0.634 . . . . 0.0 111.231 -179.65 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.497 ' CG2' HG22 ' A' ' 88' ' ' VAL . 56.1 mt -138.8 86.44 15.57 Favored Pre-proline 0 CA--C 1.537 0.47 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.291 -179.451 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -54.74 -30.38 66.67 Favored 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 123.044 2.496 . . . . 0.0 112.739 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 67.3 m -54.12 -41.96 68.94 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 121.118 0.485 . . . . 0.0 111.133 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.497 HG22 ' CG2' ' A' ' 85' ' ' ILE . 27.2 m -116.1 12.3 7.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.808 179.52 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 13.2 t 50.77 51.54 16.77 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.856 179.742 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 63.3 tp -115.62 132.24 56.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.27 0.557 . . . . 0.0 111.066 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -147.08 123.28 10.86 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.38 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.582 ' O ' HG22 ' A' ' 83' ' ' ILE . 84.4 mt -150.97 150.67 28.17 Favored Pre-proline 0 N--CA 1.47 0.575 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.428 -179.54 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -72.38 146.01 44.16 Favored 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 122.511 2.141 . . . . 0.0 111.699 178.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.463 ' C ' HD12 ' A' ' 95' ' ' LEU . 54.2 t -96.42 120.68 46.1 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-O 121.194 0.521 . . . . 0.0 110.86 179.736 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.531 HD12 ' N ' ' A' ' 95' ' ' LEU . 11.2 mp -99.81 138.61 36.66 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.337 -179.74 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.485 ' O ' ' OG1' ' A' ' 109' ' ' THR . 34.0 tttm -67.08 -77.86 0.07 Allowed 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.526 -179.522 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 38.2 m -61.83 136.82 58.14 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.144 0.497 . . . . 0.0 111.303 -178.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -92.79 65.6 4.22 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 121.664 0.745 . . . . 0.0 110.103 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 73.4 p -91.51 165.55 13.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.775 178.442 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 57.1 mp0 -60.39 -42.08 95.15 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.294 -0.562 . . . . 0.0 110.362 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -64.55 -40.45 95.6 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.473 0.654 . . . . 0.0 110.288 179.081 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -65.0 -34.09 77.62 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.734 -179.353 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 65.2 mt -70.02 -10.14 57.65 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.636 -179.13 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 96.0 mt -74.42 -22.42 59.16 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.015 0.436 . . . . 0.0 110.352 178.553 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 82.8 p -77.58 -1.96 33.33 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 121.321 0.581 . . . . 0.0 110.391 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 87.53 -19.16 33.89 Favored Glycine 0 CA--C 1.534 1.226 0 CA-C-N 115.732 -0.667 . . . . 0.0 113.706 177.554 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -146.2 126.12 13.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 117.975 0.888 . . . . 0.0 112.729 -179.356 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -147.34 143.52 28.09 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.484 178.492 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.664 ' HA ' HD23 ' A' ' 123' ' ' LEU . 18.9 p -68.35 138.63 55.55 Favored 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 120.338 -0.545 . . . . 0.0 109.879 179.747 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.646 HG13 ' CG ' ' B' ' 703' ' ' PRO . 70.2 t -76.55 -49.62 23.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.906 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.631 ' CE ' ' HE1' ' A' ' 171' ' ' TRP . 96.4 mttt -104.22 143.1 33.4 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 122.345 1.069 . . . . 0.0 113.254 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -66.47 -31.63 72.49 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 114.465 -1.243 . . . . 0.0 111.679 -178.955 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -84.99 14.94 4.38 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 -177.848 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' GLN . . . . . 0.457 ' OE1' ' O ' ' A' ' 120' ' ' ASN . 89.6 mm-40 -75.16 136.43 41.06 Favored 'General case' 0 N--CA 1.467 0.404 0 O-C-N 121.672 -0.643 . . . . 0.0 111.332 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 46.8 t -127.36 120.72 55.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.533 178.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 51.0 mtt -57.57 132.43 53.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.899 179.751 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 77.79 -4.48 56.93 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 121.152 -0.547 . . . . 0.0 112.211 178.298 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -136.91 125.21 23.23 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.308 0.575 . . . . 0.0 110.857 -179.747 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 76.61 -165.96 53.96 Favored Glycine 0 CA--C 1.527 0.842 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 -179.65 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.457 ' O ' ' OE1' ' A' ' 114' ' ' GLN . 50.9 t-20 -91.81 106.47 18.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.17 0.51 . . . . 0.0 110.27 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.445 ' HE2' HD21 ' A' ' 123' ' ' LEU . 14.5 t80 -83.75 145.53 28.67 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.91 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -146.01 138.99 25.8 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.645 0.736 . . . . 0.0 112.465 -178.739 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.664 HD23 ' HA ' ' A' ' 109' ' ' THR . 74.2 mt -135.11 141.57 46.03 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.319 179.313 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -110.68 132.52 54.12 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.03 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -134.32 146.39 18.38 Favored Glycine 0 CA--C 1.529 0.962 0 N-CA-C 111.031 -0.828 . . . . 0.0 111.031 -178.73 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' HIS . . . . . 0.409 ' O ' ' CB ' ' A' ' 134' ' ' LEU . 10.4 m80 -87.24 150.37 23.95 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.443 0.64 . . . . 0.0 111.725 -179.633 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' ASN . . . . . 0.6 ' C ' ' ND2' ' A' ' 127' ' ' ASN . 0.1 OUTLIER -147.82 159.29 44.0 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.764 178.782 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.489 ' N ' HD21 ' A' ' 127' ' ' ASN . 65.1 mtt -124.95 4.57 8.01 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.162 0.506 . . . . 0.0 110.772 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 76.63 9.24 3.01 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.819 179.156 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.887 ' O ' HG12 ' A' ' 133' ' ' VAL . 62.5 pttt -123.6 131.05 53.52 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 122.01 0.909 . . . . 0.0 112.927 -178.948 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.501 ' O ' ' O ' ' A' ' 130' ' ' LYS . 74.4 mmtt -40.57 165.05 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.184 -0.917 . . . . 0.0 109.171 178.943 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 70.19 -21.04 0.53 Allowed Glycine 0 CA--C 1.532 1.103 0 C-N-CA 120.673 -0.775 . . . . 0.0 111.748 179.29 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.887 HG12 ' O ' ' A' ' 130' ' ' LYS . 3.9 p -88.65 173.57 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 C-N-CA 119.651 -0.819 . . . . 0.0 110.058 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.655 ' H ' HG22 ' A' ' 133' ' ' VAL . 4.0 mm? -67.49 130.44 43.04 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 115.37 1.618 . . . . 0.0 115.37 -176.361 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.4 m-30 58.08 21.94 8.45 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 113.97 -1.468 . . . . 0.0 113.21 177.017 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.28 -39.38 92.49 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -179.645 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -91.47 -1.22 57.62 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 113.904 1.075 . . . . 0.0 113.904 -177.508 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 1.6 pp -61.2 -30.19 47.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 119.316 -0.954 . . . . 0.0 110.911 -179.524 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -66.6 -10.35 44.69 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.318 0.58 . . . . 0.0 110.356 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 3.1 m -83.89 -3.01 57.59 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.849 -179.715 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.41 HD23 ' HA ' ' A' ' 141' ' ' LEU . 91.4 mt -63.65 141.85 58.61 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 121.118 0.485 . . . . 0.0 111.241 -179.257 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 56.7 mttp -120.42 156.8 30.67 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-O 121.556 0.693 . . . . 0.0 111.74 -179.259 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -50.77 133.64 25.93 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.33 179.593 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 160' ' ' VAL . . . 79.88 8.29 87.8 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 120.352 -0.928 . . . . 0.0 111.564 179.066 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.442 ' OD1' ' N ' ' A' ' 146' ' ' LYS . 61.8 t0 -74.38 128.3 35.19 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 120.106 -0.638 . . . . 0.0 110.394 -179.43 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.442 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 75.6 mmtt -77.89 140.18 39.29 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.817 0.818 . . . . 0.0 112.197 -178.291 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.441 HG23 HG12 ' A' ' 85' ' ' ILE . 89.7 mt -139.62 139.95 37.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 114.615 -1.175 . . . . 0.0 108.832 179.023 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 148' ' ' TYR . . . . . 0.653 ' C ' HD23 ' A' ' 149' ' ' LEU . 97.6 m-85 -124.95 136.91 54.19 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 119.459 -0.896 . . . . 0.0 112.955 -178.402 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.653 HD23 ' C ' ' A' ' 148' ' ' TYR . 0.3 OUTLIER -112.11 134.34 53.72 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 177.296 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.604 ' CZ ' ' OE2' ' A' ' 155' ' ' GLU . 79.7 m-85 -110.66 112.94 25.17 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 119.966 -0.694 . . . . 0.0 111.278 -179.822 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 151' ' ' ASP . . . . . 0.445 ' N ' ' O ' ' A' ' 154' ' ' ASN . 38.1 t70 -89.03 165.42 14.55 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 177.979 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 66.1 m-20 -57.06 -23.98 50.59 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 119.836 -0.746 . . . . 0.0 110.568 -178.279 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -114.35 -25.51 8.39 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 113.534 0.939 . . . . 0.0 113.534 -178.813 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' ASN . . . . . 0.445 ' O ' ' N ' ' A' ' 151' ' ' ASP . 0.3 OUTLIER -146.65 -178.94 6.44 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 118.572 -1.251 . . . . 0.0 113.455 -176.859 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.604 ' OE2' ' CZ ' ' A' ' 150' ' ' TYR . 83.9 tt0 -131.27 133.79 45.76 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 114.674 -1.148 . . . . 0.0 109.988 179.082 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -110.01 136.24 49.58 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 121.109 0.481 . . . . 0.0 111.695 -179.282 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 157' ' ' GLU . . . . . 0.401 ' O ' HD12 ' A' ' 203' ' ' LEU . 77.1 tt0 -94.79 113.62 25.4 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.776 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 39.8 m-85 -114.86 149.03 37.75 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.172 0.51 . . . . 0.0 111.581 179.426 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.542 ' HB2' HG21 ' A' ' 204' ' ' VAL . . . -123.81 122.74 38.84 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.97 179.343 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.454 ' O ' ' N ' ' A' ' 144' ' ' GLY . 60.8 t -60.65 137.81 22.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 177.752 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 18.1 p -106.78 -24.69 12.0 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 120.801 -0.359 . . . . 0.0 111.649 179.364 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 160.37 -166.39 35.27 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 120.531 -0.843 . . . . 0.0 111.756 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.952 HG12 HG22 ' A' ' 199' ' ' VAL . 35.0 m -131.98 159.06 43.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-O 120.888 0.375 . . . . 0.0 110.856 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 82.2 p -147.31 162.0 39.85 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 121.095 0.474 . . . . 0.0 110.991 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -110.47 121.16 44.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.37 0.605 . . . . 0.0 110.843 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 28.1 m -138.43 159.75 31.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.821 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.32 158.63 63.42 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.702 179.653 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 168' ' ' PRO . . . . . 0.503 ' O ' ' CB ' ' B' ' 702' ' ' LEU . 35.9 Cg_endo -64.48 -17.71 60.51 Favored 'Trans proline' 0 N--CA 1.499 1.809 0 C-N-CA 123.103 2.536 . . . . 0.0 113.035 -178.755 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 43.7 p-10 -91.19 -3.57 56.87 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 120.094 -0.642 . . . . 0.0 111.211 179.495 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.575 ' O ' HG22 ' A' ' 173' ' ' VAL . 73.1 mmtt -74.36 78.03 1.87 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.526 0.679 . . . . 0.0 110.804 179.798 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 171' ' ' TRP . . . . . 0.631 ' HE1' ' CE ' ' A' ' 111' ' ' LYS . 29.4 t90 -70.3 -15.25 62.87 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.046 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -64.26 -29.29 70.39 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.612 -0.722 . . . . 0.0 112.244 -179.395 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 173' ' ' VAL . . . . . 0.623 HG23 HG13 ' A' ' 174' ' ' VAL . 14.8 m -63.24 -21.2 27.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -179.0 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.623 HG13 HG23 ' A' ' 173' ' ' VAL . 27.2 m -105.6 -3.48 9.83 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 C-N-CA 120.372 -0.531 . . . . 0.0 112.162 -179.176 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.579 ' OE2' ' CE3' ' A' ' 171' ' ' TRP . 95.7 mt-10 -71.97 150.29 44.22 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.164 0.507 . . . . 0.0 110.634 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 176' ' ' ASP . . . . . 0.488 ' OD1' ' O ' ' A' ' 176' ' ' ASP . 54.3 p-10 -56.74 142.27 41.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.908 -179.595 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 61.7 m80 -120.46 12.91 11.7 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.863 -179.623 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 62.54 42.38 99.7 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 120.666 -0.778 . . . . 0.0 111.175 179.422 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -164.4 168.76 18.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.89 0.376 . . . . 0.0 110.631 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -87.1 99.38 11.88 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 177.805 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 181' ' ' GLU . . . . . 0.45 ' HG2' ' N ' ' A' ' 182' ' ' ILE . 84.1 tt0 -135.3 161.91 34.07 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.259 0.552 . . . . 0.0 111.521 -178.275 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.459 HG22 ' O ' ' A' ' 201' ' ' GLY . 18.7 tt -129.7 139.19 52.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.741 178.939 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 94.0 m -130.41 125.44 34.52 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.412 0.625 . . . . 0.0 111.72 -179.336 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 82.7 mt -109.32 131.14 55.35 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.416 178.535 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.447 HD13 ' CD2' ' B' ' 702' ' ' LEU . 77.5 mt -111.55 122.05 65.22 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 CA-C-O 121.571 0.7 . . . . 0.0 111.384 -179.534 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 12.1 m -135.08 157.13 47.71 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.032 179.301 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 187' ' ' CYS . . . . . 0.412 ' N ' ' OD1' ' A' ' 127' ' ' ASN . 1.7 m -97.08 144.84 26.56 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 120.913 0.387 . . . . 0.0 110.945 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.571 HG13 ' N ' ' A' ' 189' ' ' SER . 7.6 p -62.71 -46.83 95.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-O 121.057 0.456 . . . . 0.0 110.852 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 189' ' ' SER . . . . . 0.571 ' N ' HG13 ' A' ' 188' ' ' VAL . 36.3 p -159.62 162.36 35.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.113 0.483 . . . . 0.0 110.867 179.656 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 190' ' ' VAL . . . . . 0.492 HG22 ' O ' ' A' ' 190' ' ' VAL . 7.9 p -80.9 -7.67 10.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.533 179.522 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -96.71 -13.46 22.71 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 121.07 0.462 . . . . 0.0 110.621 179.208 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 192' ' ' ASP . . . . . 0.529 ' OD1' ' OG ' ' A' ' 194' ' ' SER . 67.8 t0 -148.59 103.39 3.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.315 0.579 . . . . 0.0 111.389 179.634 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -102.64 3.83 37.61 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.372 179.238 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 194' ' ' SER . . . . . 0.529 ' OG ' ' OD1' ' A' ' 192' ' ' ASP . 78.6 p -64.49 -24.36 67.59 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.653 -179.743 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -130.71 133.31 45.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.165 0.507 . . . . 0.0 110.575 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -129.01 139.65 51.98 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.515 -179.319 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 37.5 p90 -100.94 135.43 42.41 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.2 0.524 . . . . 0.0 110.021 178.59 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 25.6 t -114.18 135.49 53.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -178.1 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.952 HG22 HG12 ' A' ' 163' ' ' VAL . 57.4 t -104.3 132.63 50.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.698 179.066 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -121.28 150.03 42.0 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 121.483 0.658 . . . . 0.0 112.269 -179.028 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 201' ' ' GLY . . . . . 0.459 ' O ' HG22 ' A' ' 182' ' ' ILE . . . -149.98 159.7 28.21 Favored Glycine 0 CA--C 1.532 1.105 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 179.503 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 55.4 p-10 -116.37 158.7 23.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.203 0.525 . . . . 0.0 111.201 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 203' ' ' LEU . . . . . 0.401 HD12 ' O ' ' A' ' 157' ' ' GLU . 60.1 tp -76.01 131.17 39.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.746 179.413 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.542 HG21 ' HB2' ' A' ' 159' ' ' ALA . 15.0 t -111.98 -21.04 5.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -178.583 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -178.55 174.64 46.83 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 120.514 -0.85 . . . . 0.0 111.988 -179.472 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 23.6 m -144.55 139.86 28.45 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.38 -0.41 . . . . 0.0 110.142 179.668 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -143.24 118.2 10.01 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.155 -0.618 . . . . 0.0 111.339 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -63.88 141.96 58.58 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.408 -178.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 53.8 mtpt -77.35 159.79 29.26 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.046 178.465 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 53.4 mtpt . . . . . 0 C--O 1.219 -0.533 0 CA-C-O 118.037 -0.983 . . . . 0.0 110.736 179.381 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 702' ' ' LEU . . . . . 0.503 ' CB ' ' O ' ' A' ' 168' ' ' PRO . 2.3 mt . . . . . 0 CA--C 1.542 0.662 0 CA-C-O 120.795 0.331 . . . . 20.0 111.737 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 703' ' ' PRO . . . . . 0.646 ' CG ' HG13 ' A' ' 110' ' ' VAL . 4.8 Cg_exo -64.92 -164.91 0.07 OUTLIER 'Trans proline' 0 N--CA 1.491 1.355 0 C-N-CA 122.627 2.218 . . . . 20.0 113.606 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 704' ' ' ALA . . . . . 0.508 ' O ' ' O ' ' B' ' 703' ' ' PRO . . . . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 114.269 -1.332 . . . . 20.0 112.678 -179.26 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.409 ' C ' ' H ' ' A' ' 60' ' ' LYS . . . . . . . . 0 CA--C 1.529 0.143 0 CA-C-O 121.219 0.533 . . . . 0.0 110.48 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.605 ' C ' HH22 ' A' ' 196' ' ' ARG . 2.8 p -78.15 19.44 0.44 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.25 -179.146 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.409 ' H ' ' C ' ' A' ' 58' ' ' ALA . 99.6 mttt -95.75 13.38 26.73 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.927 179.804 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 94.0 mt -55.43 141.71 11.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 122.035 0.921 . . . . 0.0 112.949 -177.7 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.403 ' O ' ' OD1' ' A' ' 62' ' ' ASP . 35.1 p-10 -78.53 129.78 35.23 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 114.034 -1.439 . . . . 0.0 109.198 178.435 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.661 ' NE2' ' H ' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -79.98 146.87 64.55 Favored Pre-proline 0 CA--C 1.539 0.527 0 CA-C-O 120.99 0.424 . . . . 0.0 111.222 -179.071 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.23 157.97 59.4 Favored 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 123.079 2.519 . . . . 0.0 113.113 -179.642 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.816 ' O ' HG23 ' A' ' 69' ' ' VAL . 90.4 m-20 -55.45 168.67 0.36 Allowed 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.685 -179.481 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.404 HD23 ' HA ' ' A' ' 66' ' ' LEU . 92.1 mt -64.18 -45.06 90.03 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.047 -178.535 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.52 -39.41 94.36 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 119.81 -0.756 . . . . 0.0 110.893 -178.611 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -60.75 -29.39 69.36 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 178.52 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.816 HG23 ' O ' ' A' ' 65' ' ' ASP . 50.9 t -75.57 -45.11 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.981 179.101 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -72.6 -9.1 58.18 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.683 -1.144 . . . . 0.0 111.037 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 27.1 m120 -105.84 -10.35 16.72 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.524 0.678 . . . . 0.0 110.226 178.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.09 137.04 54.66 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.634 -179.409 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -60.35 98.71 0.06 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.236 0.541 . . . . 0.0 109.94 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -68.52 131.1 44.68 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.389 -179.493 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -97.88 80.65 2.77 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.395 178.78 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.832 ' O ' HG12 ' A' ' 79' ' ' VAL . 87.5 tttt -63.95 -42.39 97.32 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -179.379 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.537 ' H ' ' CE ' ' A' ' 77' ' ' LYS . 1.1 mtmt -69.66 -8.21 45.67 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.446 0.641 . . . . 0.0 111.104 -176.666 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.524 ' N ' ' CD ' ' A' ' 78' ' ' GLN . 18.6 mp0 -94.56 3.85 54.59 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.784 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.832 HG12 ' O ' ' A' ' 76' ' ' LYS . 14.9 p -86.91 122.71 39.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 120.434 -0.506 . . . . 0.0 111.258 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.535 HG21 ' HE3' ' A' ' 96' ' ' LYS . 24.0 pt -108.14 -6.11 10.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.1 179.125 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.44 ' O ' HG22 ' A' ' 94' ' ' VAL . . . -167.61 166.18 39.16 Favored Glycine 0 CA--C 1.53 1.012 0 N-CA-C 110.813 -0.915 . . . . 0.0 110.813 -179.773 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 62.6 ttp180 -140.19 142.57 35.88 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 121.207 0.527 . . . . 0.0 111.646 -179.623 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.466 HG22 ' O ' ' A' ' 92' ' ' LEU . 19.5 tt -103.9 141.71 19.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.48 -179.811 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 5.0 t -136.91 129.72 30.59 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 121.335 0.588 . . . . 0.0 111.539 -179.403 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.48 HG22 HG22 ' A' ' 88' ' ' VAL . 89.3 mt -140.29 89.37 10.86 Favored Pre-proline 0 CA--C 1.542 0.657 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.329 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -57.86 -27.67 79.4 Favored 'Trans proline' 0 N--CA 1.502 2.016 0 C-N-CA 123.279 2.653 . . . . 0.0 113.106 -179.468 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 9.7 t -53.83 -43.0 69.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.262 0.553 . . . . 0.0 110.378 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.48 HG22 HG22 ' A' ' 85' ' ' ILE . 27.8 m -112.89 8.88 8.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.816 179.065 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 40.7 p 52.74 53.86 11.47 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.524 -179.745 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 54.8 tp -116.83 134.42 54.8 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 121.461 0.648 . . . . 0.0 111.732 -179.127 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -147.46 117.8 7.39 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.239 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.474 HD13 ' HA3' ' A' ' 106' ' ' GLY . 84.2 mt -149.14 149.63 30.09 Favored Pre-proline 0 CA--C 1.542 0.641 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.447 -179.048 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -75.18 149.6 36.2 Favored 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 123.026 2.484 . . . . 0.0 112.825 179.392 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.662 HG23 ' O ' ' A' ' 94' ' ' VAL . 3.1 m -96.75 116.56 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-O 121.029 0.442 . . . . 0.0 111.214 179.752 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.561 HD12 ' N ' ' A' ' 95' ' ' LEU . 10.9 mp -100.09 136.37 40.09 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 120.955 0.407 . . . . 0.0 111.294 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.535 ' HE3' HG21 ' A' ' 80' ' ' ILE . 98.4 mttt -61.72 -80.42 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.346 0.593 . . . . 0.0 111.438 -179.536 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.44 ' OG ' ' OD1' ' A' ' 102' ' ' ASN . 6.4 p -60.86 132.74 54.84 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.172 -178.81 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.419 ' OG ' ' O ' ' A' ' 109' ' ' THR . 58.1 m -93.46 73.56 4.45 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.335 0.588 . . . . 0.0 110.391 179.815 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.472 ' H ' ' HB2' ' A' ' 102' ' ' ASN . 44.0 p -87.38 169.68 12.05 Favored 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.585 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -58.31 -45.57 87.75 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 119.335 -0.946 . . . . 0.0 108.94 179.466 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -65.8 -40.31 91.78 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.979 179.19 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.472 ' HB2' ' H ' ' A' ' 99' ' ' THR . 9.7 m120 -62.61 -39.42 93.72 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.123 0.487 . . . . 0.0 111.531 -178.749 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 62.4 mt -63.43 -19.39 64.66 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.994 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.68 ' HB3' HG13 ' A' ' 69' ' ' VAL . 45.3 mt -73.1 -14.16 61.33 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.629 -179.447 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 74.4 p -75.33 -6.98 52.69 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 178.843 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.49 ' O ' ' CE1' ' A' ' 135' ' ' PHE . . . 90.21 -19.44 42.99 Favored Glycine 0 CA--C 1.533 1.216 0 CA-C-N 115.116 -0.947 . . . . 0.0 112.147 179.244 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -146.27 125.64 13.12 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.264 0.554 . . . . 0.0 111.762 179.767 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -145.5 140.53 27.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.344 178.758 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.596 ' HA ' HD23 ' A' ' 123' ' ' LEU . 21.0 p -72.0 133.0 45.06 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 119.996 -0.682 . . . . 0.0 110.684 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.689 HG22 ' HG2' ' B' ' 703' ' ' PRO . 39.0 t -80.57 -48.47 19.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.155 179.591 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.47 ' O ' ' OE1' ' A' ' 114' ' ' GLN . 87.6 tttt -89.41 128.44 35.93 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.503 0.668 . . . . 0.0 111.213 -178.69 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.489 ' O ' ' NE2' ' A' ' 114' ' ' GLN . 96.8 mt-10 -66.64 -36.58 82.91 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.058 -0.974 . . . . 0.0 111.731 -178.88 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 68.8 m-80 -89.27 31.21 0.91 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.72 -179.704 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' GLN . . . . . 0.667 ' NE2' ' N ' ' A' ' 114' ' ' GLN . 0.0 OUTLIER -75.3 138.11 41.61 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 120.954 0.407 . . . . 0.0 111.719 -179.501 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 42.9 t -120.7 105.79 17.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-O 120.893 0.378 . . . . 0.0 110.714 179.434 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' MET . . . . . 0.417 ' HG2' ' CZ ' ' A' ' 121' ' ' TYR . 85.4 mtp -55.18 130.32 41.62 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.141 0.496 . . . . 0.0 111.664 -179.844 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 88.21 -4.72 85.37 Favored Glycine 0 CA--C 1.53 1.013 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.819 179.106 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -142.7 136.32 28.88 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 121.254 0.55 . . . . 0.0 111.95 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 75.11 -166.17 54.8 Favored Glycine 0 CA--C 1.534 1.243 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 -179.577 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 59.3 t-20 -92.0 108.34 19.86 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 121.001 0.429 . . . . 0.0 110.295 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.417 ' CZ ' ' HG2' ' A' ' 116' ' ' MET . 2.5 t80 -85.57 102.47 13.56 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 121.02 0.438 . . . . 0.0 111.009 -179.399 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -91.9 130.82 37.58 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.911 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.596 HD23 ' HA ' ' A' ' 109' ' ' THR . 84.5 mt -132.45 137.67 47.34 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.62 179.715 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -113.33 144.43 42.76 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.003 0.43 . . . . 0.0 110.129 179.23 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -152.34 155.04 25.9 Favored Glycine 0 CA--C 1.531 1.057 0 N-CA-C 110.279 -1.128 . . . . 0.0 110.279 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' HIS . . . . . 0.411 ' CG ' ' HB3' ' A' ' 63' ' ' GLN . 47.6 m-70 -100.75 145.49 28.42 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.654 0.74 . . . . 0.0 111.959 -179.19 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' ASN . . . . . 0.494 ' O ' ' OD1' ' A' ' 127' ' ' ASN . 38.0 p-10 -149.64 124.26 9.76 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.788 178.517 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.523 ' CG ' ' OE1' ' A' ' 63' ' ' GLN . 70.7 mtm -84.58 0.38 50.25 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.306 -0.558 . . . . 0.0 110.26 179.731 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.482 ' CB ' ' O ' ' A' ' 128' ' ' MET . 1.1 m 80.17 12.54 1.0 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.254 179.703 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.897 ' O ' HG12 ' A' ' 133' ' ' VAL . 21.3 ptmt -104.91 124.71 49.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.996 0.903 . . . . 0.0 111.91 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -46.14 120.37 2.73 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.78 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 116.29 -18.72 13.64 Favored Glycine 0 N--CA 1.445 -0.748 0 N-CA-C 109.979 -1.249 . . . . 0.0 109.979 -179.58 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.897 HG12 ' O ' ' A' ' 130' ' ' LYS . 11.4 p -88.6 159.68 2.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.654 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.821 HD23 ' N ' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -71.22 144.04 50.23 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 122.156 0.979 . . . . 0.0 113.639 -177.314 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.49 ' CE1' ' O ' ' A' ' 106' ' ' GLY . 4.0 m-85 59.69 9.56 1.66 Allowed 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 113.902 -1.499 . . . . 0.0 114.726 177.763 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 5.7 t -69.77 -40.46 76.07 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 179.556 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -89.17 7.36 35.67 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 -176.611 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.7 HD11 ' OH ' ' A' ' 197' ' ' TYR . 35.0 pt -61.78 -26.45 39.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 C-N-CA 119.185 -1.006 . . . . 0.0 109.102 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -65.92 -14.56 61.77 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.551 179.408 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 64.3 p -83.0 -4.51 58.39 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.328 -179.391 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 81.2 mt -63.78 142.2 58.49 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 120.94 0.4 . . . . 0.0 110.977 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 63.9 mttm -118.05 153.3 33.95 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.639 0.733 . . . . 0.0 111.807 -178.868 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -50.21 130.74 23.24 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.955 178.95 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.444 ' N ' ' O ' ' A' ' 160' ' ' VAL . . . 81.42 8.7 86.77 Favored Glycine 0 CA--C 1.526 0.746 0 C-N-CA 120.219 -0.991 . . . . 0.0 110.985 179.467 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 146' ' ' LYS . 58.8 t0 -76.95 129.04 35.62 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.295 0.569 . . . . 0.0 110.229 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.504 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 72.8 mmtt -79.26 143.11 35.59 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 121.826 0.822 . . . . 0.0 112.754 -177.624 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.441 HD11 ' CG2' ' A' ' 160' ' ' VAL . 94.7 mt -138.1 139.31 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-N 114.608 -1.178 . . . . 0.0 108.322 178.565 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 148' ' ' TYR . . . . . 0.535 ' C ' HD22 ' A' ' 149' ' ' LEU . 90.9 m-85 -121.11 136.99 54.87 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -177.883 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.535 HD22 ' C ' ' A' ' 148' ' ' TYR . 4.6 mm? -114.0 132.74 55.88 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 177.629 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.573 ' CZ ' ' OE2' ' A' ' 155' ' ' GLU . 96.3 m-85 -112.02 107.94 17.08 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.006 -0.678 . . . . 0.0 111.783 -179.63 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 151' ' ' ASP . . . . . 0.523 ' OD1' ' N ' ' A' ' 152' ' ' ASN . 54.2 t0 -88.16 164.0 15.89 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 177.75 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 152' ' ' ASN . . . . . 0.523 ' N ' ' OD1' ' A' ' 151' ' ' ASP . 7.6 m-20 -58.49 -23.66 58.47 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 119.556 -0.858 . . . . 0.0 110.993 -178.364 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -109.36 -29.75 8.31 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 -177.839 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' ASN . . . . . 0.459 ' O ' ' N ' ' A' ' 151' ' ' ASP . 0.4 OUTLIER -149.77 -179.26 6.98 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 119.181 -1.008 . . . . 0.0 113.503 -176.712 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.573 ' OE2' ' CZ ' ' A' ' 150' ' ' TYR . 79.1 tt0 -126.26 133.09 51.55 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 114.48 -1.236 . . . . 0.0 110.159 178.896 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 156' ' ' TYR . . . . . 0.41 ' CD1' HG23 ' A' ' 206' ' ' THR . 83.2 m-85 -107.11 132.33 53.12 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 121.376 0.608 . . . . 0.0 111.323 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -93.54 112.76 24.73 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.81 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -113.05 145.29 41.14 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.01 0.434 . . . . 0.0 111.404 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -120.1 121.43 38.82 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.868 179.107 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.444 ' O ' ' N ' ' A' ' 144' ' ' GLY . 98.1 t -60.58 135.68 25.02 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 177.542 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 6.8 p -108.48 -24.76 11.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.174 0.511 . . . . 0.0 110.716 179.046 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 160.6 -170.43 36.55 Favored Glycine 0 CA--C 1.532 1.126 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 -179.425 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 35.0 m -133.49 158.79 42.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 179.52 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 39.6 t -142.9 162.5 35.3 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 121.348 0.594 . . . . 0.0 111.784 -179.216 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -109.31 121.24 44.75 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.79 179.805 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.546 HG21 HG11 ' A' ' 173' ' ' VAL . 31.3 m -136.12 161.08 38.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.605 -179.41 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.41 158.75 65.8 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.918 -179.537 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 168' ' ' PRO . . . . . 0.479 ' O ' ' CB ' ' B' ' 702' ' ' LEU . 36.4 Cg_endo -64.86 -16.73 56.82 Favored 'Trans proline' 0 N--CA 1.496 1.673 0 C-N-CA 123.198 2.599 . . . . 0.0 113.054 -179.155 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 32.6 p-10 -94.79 -7.22 41.03 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.185 -0.606 . . . . 0.0 112.571 -179.675 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.443 ' O ' HG22 ' A' ' 173' ' ' VAL . 97.4 mttt -77.29 92.21 3.87 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 119.832 -0.747 . . . . 0.0 112.004 -179.785 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 171' ' ' TRP . . . . . 0.405 ' CD1' ' N ' ' A' ' 171' ' ' TRP . 6.3 m0 -75.19 -1.87 25.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.657 0.741 . . . . 0.0 109.677 178.844 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -61.72 -37.3 83.69 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.719 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 173' ' ' VAL . . . . . 0.546 HG11 HG21 ' A' ' 166' ' ' VAL . 26.9 m -63.23 -12.84 11.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.127 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.458 HG23 HG23 ' A' ' 173' ' ' VAL . 77.3 t -105.62 -23.56 4.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 N-CA-C 112.665 0.616 . . . . 0.0 112.665 -178.969 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -74.53 135.1 42.17 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.15 0.5 . . . . 0.0 111.148 -179.581 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 176' ' ' ASP . . . . . 0.505 ' OD1' ' O ' ' A' ' 176' ' ' ASP . 43.4 p30 -70.16 135.0 48.69 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 121.123 0.487 . . . . 0.0 110.498 179.712 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 66.8 m80 -97.89 -8.93 27.22 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.622 -0.431 . . . . 0.0 112.158 -178.911 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 105.11 39.9 2.21 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 109.864 -1.295 . . . . 0.0 109.864 -179.337 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 13.6 ptmt -156.42 166.01 34.68 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.919 -0.64 . . . . 0.0 110.485 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -88.6 97.18 10.96 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 178.079 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 181' ' ' GLU . . . . . 0.478 ' HG2' ' N ' ' A' ' 182' ' ' ILE . 73.6 tt0 -131.52 162.21 30.79 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 121.519 0.676 . . . . 0.0 111.891 -178.612 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.478 ' N ' ' HG2' ' A' ' 181' ' ' GLU . 18.6 tt -129.24 137.82 56.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.67 179.337 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 89.7 m -134.5 125.69 27.87 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 121.417 0.627 . . . . 0.0 111.778 -179.229 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 73.2 mt -106.61 132.06 53.04 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.075 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.701 HD13 HD21 ' B' ' 702' ' ' LEU . 77.0 mt -113.02 119.4 60.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.325 0.583 . . . . 0.0 110.694 -179.024 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 186' ' ' THR . . . . . 0.671 HG22 ' N ' ' A' ' 187' ' ' CYS . 48.7 m -141.36 167.81 21.27 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.708 179.634 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 187' ' ' CYS . . . . . 0.671 ' N ' HG22 ' A' ' 186' ' ' THR . 92.7 m -92.7 140.76 29.19 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.944 179.328 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 54.6 t -60.78 -47.74 91.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.14 -179.517 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 17.4 t -167.56 152.95 7.23 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.287 0.565 . . . . 0.0 110.507 179.445 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 78.2 t -67.51 -20.13 26.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.503 -179.732 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -96.53 -8.32 32.27 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.021 -179.509 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -136.92 98.8 3.85 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 121.141 0.495 . . . . 0.0 110.442 179.671 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 49.4 p-10 -106.61 13.92 27.63 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.6 -179.216 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 84.1 p -59.1 -45.14 91.64 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.91 0.386 . . . . 0.0 111.522 -178.924 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 26.3 pttm -142.41 149.92 39.96 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 121.269 0.557 . . . . 0.0 111.522 -179.645 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 196' ' ' ARG . . . . . 0.605 HH22 ' C ' ' A' ' 59' ' ' SER . 99.7 mtt180 -105.34 135.9 45.87 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.24 179.431 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 197' ' ' TYR . . . . . 0.7 ' OH ' HD11 ' A' ' 138' ' ' ILE . 21.0 p90 -96.11 150.3 20.66 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.491 -0.484 . . . . 0.0 110.102 179.599 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 4.4 m -130.52 138.51 53.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.11 0.481 . . . . 0.0 111.976 -178.475 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 49.4 t -98.79 130.69 47.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 178.188 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -116.45 140.52 49.27 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 121.261 0.553 . . . . 0.0 111.294 -179.354 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -136.18 151.57 20.82 Favored Glycine 0 CA--C 1.532 1.138 0 N-CA-C 110.421 -1.071 . . . . 0.0 110.421 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 202' ' ' ASP . . . . . 0.438 ' OD1' ' N ' ' A' ' 203' ' ' LEU . 65.0 t0 -116.99 130.43 56.69 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.152 0.501 . . . . 0.0 110.571 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 203' ' ' LEU . . . . . 0.438 ' N ' ' OD1' ' A' ' 202' ' ' ASP . 50.4 tp -58.33 131.09 49.63 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.217 -179.741 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 14.0 m -116.27 -16.65 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.919 -179.525 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -178.89 173.92 46.11 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 119.965 -1.112 . . . . 0.0 112.477 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 206' ' ' THR . . . . . 0.41 HG23 ' CD1' ' A' ' 156' ' ' TYR . 31.4 m -144.81 138.87 27.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.616 -0.792 . . . . 0.0 109.377 179.235 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -144.95 121.52 11.08 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.112 -0.635 . . . . 0.0 111.737 179.324 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -63.0 140.88 58.92 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.638 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 18.4 ttpt -81.0 110.96 17.04 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.308 179.13 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt . . . . . 0 C--O 1.219 -0.524 0 CA-C-O 118.139 -0.934 . . . . 0.0 110.717 179.997 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 702' ' ' LEU . . . . . 0.701 HD21 HD13 ' A' ' 185' ' ' ILE . 1.2 mt . . . . . 0 CA--C 1.544 0.732 0 CA-C-O 120.55 0.214 . . . . 20.0 110.61 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 703' ' ' PRO . . . . . 0.689 ' HG2' HG22 ' A' ' 110' ' ' VAL . 2.9 Cg_endo -65.97 -176.91 0.67 Allowed 'Trans proline' 0 N--CA 1.491 1.361 0 C-N-CA 122.397 2.065 . . . . 20.0 113.84 -178.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 704' ' ' ALA . . . . . 0.535 ' O ' ' O ' ' B' ' 703' ' ' PRO . . . . . . . . 0 CA--C 1.536 0.436 0 CA-C-N 114.223 -1.353 . . . . 20.0 113.975 -179.136 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.258 0 CA-C-O 121.28 0.562 . . . . 0.0 110.76 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 10.8 p -79.53 25.66 0.32 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.017 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -96.21 3.74 52.92 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.436 -179.467 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.0 mt -55.98 137.8 17.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 122.199 1.0 . . . . 0.0 113.351 -176.554 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -77.46 133.02 38.71 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 113.692 -1.595 . . . . 0.0 109.37 178.674 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.562 ' OE1' ' CE1' ' A' ' 126' ' ' HIS . 0.0 OUTLIER -79.8 150.85 73.13 Favored Pre-proline 0 CA--C 1.537 0.451 0 C-N-CA 119.901 -0.72 . . . . 0.0 109.798 -179.989 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.64 ' CG ' HD11 ' A' ' 104' ' ' LEU . 83.0 Cg_endo -73.37 163.02 38.86 Favored 'Trans proline' 0 N--CA 1.499 1.826 0 C-N-CA 123.427 2.751 . . . . 0.0 114.086 -178.05 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.7 ' O ' HG23 ' A' ' 69' ' ' VAL . 88.0 m-20 -54.51 164.0 0.8 Allowed 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.753 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 53.4 tp -64.28 -47.37 79.79 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 121.102 0.477 . . . . 0.0 111.118 -178.749 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.43 -36.51 82.63 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.079 -0.648 . . . . 0.0 110.865 -178.803 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -61.21 -29.27 69.72 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.033 -0.667 . . . . 0.0 109.652 179.144 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.7 HG23 ' O ' ' A' ' 65' ' ' ASP . 50.8 t -74.05 -43.71 51.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 121.825 0.821 . . . . 0.0 109.729 179.145 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -76.42 -8.23 56.71 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.745 -1.116 . . . . 0.0 111.434 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -105.41 -8.15 18.32 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.038 0.447 . . . . 0.0 110.38 179.008 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.22 137.5 54.84 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 121.369 0.604 . . . . 0.0 111.109 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 32.2 t -60.29 102.19 0.16 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.486 179.482 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.92 128.45 36.71 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.372 -179.4 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 -96.43 84.33 3.69 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 177.723 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -62.98 -41.49 99.56 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.272 0.558 . . . . 0.0 111.899 -179.528 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.511 ' CD ' ' H ' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -71.16 -8.5 53.96 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.869 -176.27 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -94.68 -13.34 25.9 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 121.211 0.529 . . . . 0.0 110.093 178.349 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 86.9 t -76.2 128.59 37.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.966 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.669 HD13 ' CE ' ' A' ' 96' ' ' LYS . 39.3 pt -113.54 -7.9 12.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.428 179.565 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -174.21 -175.12 41.57 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 110.431 -1.067 . . . . 0.0 110.431 179.53 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 39.9 ptt180 -152.1 166.71 30.81 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.472 0.653 . . . . 0.0 111.168 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 19.5 tt -114.5 142.87 25.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.223 178.88 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 66.1 m -135.64 126.89 28.26 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.47 0.653 . . . . 0.0 111.174 -179.342 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.492 ' CG2' HG22 ' A' ' 88' ' ' VAL . 43.3 mt -137.45 89.39 15.93 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.481 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_exo -56.5 -30.18 81.37 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.589 2.192 . . . . 0.0 112.831 -179.771 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 47.0 m -51.86 -40.94 61.42 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 121.185 0.516 . . . . 0.0 110.593 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.492 HG22 ' CG2' ' A' ' 85' ' ' ILE . 18.6 m -114.0 8.46 7.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.888 179.057 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.483 ' O ' ' OG ' ' A' ' 89' ' ' SER . 3.7 t 54.08 54.13 10.09 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 -179.498 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 66.5 tp -118.43 133.52 55.81 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 121.543 0.687 . . . . 0.0 111.166 -179.152 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -148.03 120.03 8.23 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.329 -0.851 . . . . 0.0 110.452 -179.306 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.615 HD13 ' O ' ' A' ' 105' ' ' SER . 74.6 mt -149.64 152.95 35.96 Favored Pre-proline 0 CA--C 1.537 0.479 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.644 -179.539 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -75.38 150.72 36.95 Favored 'Trans proline' 0 N--CA 1.497 1.735 0 C-N-CA 123.127 2.551 . . . . 0.0 112.471 179.142 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.567 ' C ' HD12 ' A' ' 95' ' ' LEU . 53.0 t -99.17 120.91 49.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-O 121.173 0.511 . . . . 0.0 112.058 -179.261 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.567 HD12 ' C ' ' A' ' 94' ' ' VAL . 10.4 mp -104.38 134.5 47.48 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.324 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.669 ' CE ' HD13 ' A' ' 80' ' ' ILE . 98.7 mttt -61.7 -80.29 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.217 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 12.0 t -56.45 133.02 52.85 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.952 -178.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.8 m -92.53 70.5 5.0 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.756 179.35 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.59 HG22 ' N ' ' A' ' 100' ' ' GLU . 41.2 m -92.37 169.98 10.14 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 178.769 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.59 ' N ' HG22 ' A' ' 99' ' ' THR . 96.7 mt-10 -64.3 -42.46 96.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.264 0.554 . . . . 0.0 110.018 179.503 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 61.6 mttm -65.59 -38.67 90.14 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.887 179.51 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -64.75 -33.6 76.35 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.378 -0.828 . . . . 0.0 112.18 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 83.5 mt -68.83 -6.79 29.01 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -178.813 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.64 HD11 ' CG ' ' A' ' 64' ' ' PRO . 3.9 mm? -74.77 -16.36 60.73 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 121.187 0.517 . . . . 0.0 109.635 178.857 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.615 ' O ' HD13 ' A' ' 92' ' ' LEU . 79.2 p -81.18 -10.04 59.69 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.751 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.605 ' O ' ' CE1' ' A' ' 135' ' ' PHE . . . 92.87 -19.42 51.85 Favored Glycine 0 CA--C 1.532 1.151 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.636 178.7 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -145.72 127.35 15.18 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 119.605 -0.838 . . . . 0.0 112.661 -179.463 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -147.69 138.56 23.38 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.272 -0.877 . . . . 0.0 110.11 178.255 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.671 ' HA ' HD23 ' A' ' 123' ' ' LEU . 12.3 p -69.06 135.49 50.89 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 121.316 0.579 . . . . 0.0 110.928 -179.751 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.588 HG22 ' HG2' ' B' ' 703' ' ' PRO . 78.7 t -78.0 -48.86 22.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.226 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.535 ' NZ ' ' CD ' ' A' ' 175' ' ' GLU . 98.5 mttt -99.06 140.14 33.67 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.801 0.81 . . . . 0.0 112.52 -179.843 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -65.86 -36.21 82.82 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.625 -1.17 . . . . 0.0 111.47 -179.739 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 73.7 m-80 -84.6 11.0 9.63 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -177.768 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' GLN . . . . . 0.495 ' NE2' ' O ' ' A' ' 120' ' ' ASN . 0.6 OUTLIER -78.92 139.19 38.32 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 120.799 0.333 . . . . 0.0 111.296 179.569 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 38.8 t -125.8 125.85 69.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 CA-C-O 121.069 0.461 . . . . 0.0 111.227 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' MET . . . . . 0.431 ' CG ' ' CZ ' ' A' ' 121' ' ' TYR . 93.1 mtp -57.11 133.56 55.11 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.126 0.489 . . . . 0.0 111.657 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 78.14 -2.7 64.58 Favored Glycine 0 CA--C 1.529 0.922 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.643 179.162 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -138.49 132.37 31.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.615 0.722 . . . . 0.0 111.784 179.687 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 71.14 -167.06 52.05 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 110.18 -1.168 . . . . 0.0 110.18 -179.487 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.495 ' O ' ' NE2' ' A' ' 114' ' ' GLN . 64.7 t-20 -87.83 104.69 16.82 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.196 0.522 . . . . 0.0 109.714 179.726 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.64 ' CE2' HD21 ' A' ' 123' ' ' LEU . 5.3 t80 -87.06 99.37 11.86 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.115 -179.479 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.3 135.12 33.88 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.829 -179.718 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.671 HD23 ' HA ' ' A' ' 109' ' ' THR . 68.3 mt -135.37 139.78 44.5 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.735 -179.771 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -111.37 140.87 45.59 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 178.702 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -141.16 129.66 4.15 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 110.482 -1.047 . . . . 0.0 110.482 -179.474 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' HIS . . . . . 0.562 ' CE1' ' OE1' ' A' ' 63' ' ' GLN . 1.8 m-70 -82.11 131.52 35.24 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.336 0.589 . . . . 0.0 112.098 -179.208 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' ASN . . . . . 0.588 ' ND2' ' OG1' ' A' ' 186' ' ' THR . 7.2 p30 -138.79 152.21 47.71 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.634 179.322 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.611 ' O ' ' N ' ' A' ' 130' ' ' LYS . 79.4 mtm -119.28 42.04 2.94 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.598 0.713 . . . . 0.0 110.161 179.179 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 38.64 15.84 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 114.919 -1.037 . . . . 0.0 112.304 178.983 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.877 ' O ' HG12 ' A' ' 133' ' ' VAL . 19.2 ptmt -110.61 127.32 55.19 Favored 'General case' 0 C--O 1.226 -0.176 0 CA-C-O 122.025 0.917 . . . . 0.0 112.323 -179.723 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.458 ' C ' ' O ' ' A' ' 130' ' ' LYS . 55.8 tptt -38.37 150.71 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.915 179.413 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 79.58 -17.56 8.32 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 121.045 -0.598 . . . . 0.0 112.127 179.224 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.877 HG12 ' O ' ' A' ' 130' ' ' LYS . 9.9 p -87.87 153.08 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-N 117.753 0.777 . . . . 0.0 110.342 -179.561 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.773 HD23 ' N ' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -69.45 143.53 53.54 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.594 0.711 . . . . 0.0 112.832 -177.889 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.605 ' CE1' ' O ' ' A' ' 106' ' ' GLY . 3.5 m-85 66.39 8.34 5.63 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 114.139 -1.391 . . . . 0.0 114.493 177.712 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 5.2 t -76.88 -42.68 38.9 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 179.573 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -91.82 1.31 57.26 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 114.055 1.132 . . . . 0.0 114.055 -176.682 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.607 HD11 ' HB ' ' A' ' 186' ' ' THR . 48.6 pt -66.92 -23.73 31.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 C-N-CA 119.43 -0.908 . . . . 0.0 110.877 -179.431 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -66.53 -10.68 47.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.551 0.691 . . . . 0.0 109.856 179.561 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 94.0 p -81.34 -2.77 50.47 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.625 -179.811 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 67.8 mt -62.73 143.54 57.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.47 0.652 . . . . 0.0 111.059 -179.632 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -121.57 156.83 32.05 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.216 -179.469 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -50.86 133.08 26.9 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.061 -0.972 . . . . 0.0 112.116 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 160' ' ' VAL . . . 79.96 8.69 87.44 Favored Glycine 0 CA--C 1.53 0.979 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.239 178.518 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.463 ' OD1' ' N ' ' A' ' 146' ' ' LYS . 60.5 t0 -74.12 133.47 42.82 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 120.277 -0.569 . . . . 0.0 110.277 -179.62 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.463 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 71.1 mmtt -79.06 140.44 37.89 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 121.84 0.829 . . . . 0.0 111.908 -179.033 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.453 HD11 ' CG2' ' A' ' 160' ' ' VAL . 92.6 mt -140.13 140.12 35.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 114.899 -1.046 . . . . 0.0 108.587 179.511 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -128.64 140.95 51.51 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 119.384 -0.927 . . . . 0.0 113.226 -177.08 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.537 HD11 HD12 ' A' ' 182' ' ' ILE . 19.1 mt -112.51 131.98 55.32 Favored 'General case' 0 CA--C 1.519 -0.233 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 176.966 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.608 ' CZ ' ' OE2' ' A' ' 155' ' ' GLU . 49.2 m-85 -108.18 107.87 18.68 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.028 -0.669 . . . . 0.0 112.468 -178.814 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -88.19 158.74 18.43 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 106.641 -1.615 . . . . 0.0 106.641 176.858 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 33.7 p-10 -57.45 -16.11 8.63 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 119.137 -1.025 . . . . 0.0 111.365 -177.625 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -114.22 -29.13 7.04 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -179.098 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -146.47 178.97 7.87 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 -176.616 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.608 ' OE2' ' CZ ' ' A' ' 150' ' ' TYR . 84.3 tt0 -130.65 136.03 48.43 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 114.681 -1.145 . . . . 0.0 109.597 178.537 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 156' ' ' TYR . . . . . 0.406 ' CD1' HG23 ' A' ' 206' ' ' THR . 80.6 m-85 -108.94 133.62 52.69 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.779 0.288 . . . . 0.0 111.779 -178.852 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -93.2 112.51 24.47 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 121.262 0.553 . . . . 0.0 111.983 179.423 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -112.9 146.06 39.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.176 179.551 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -121.18 120.72 36.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.207 179.128 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.527 ' O ' ' N ' ' A' ' 144' ' ' GLY . 90.8 t -59.78 136.66 23.16 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.301 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 178.399 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 7.9 p -105.63 -25.39 12.28 Favored 'General case' 0 C--N 1.328 -0.356 0 O-C-N 123.581 0.551 . . . . 0.0 110.86 179.325 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 158.61 -166.09 34.22 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 120.622 -0.799 . . . . 0.0 111.405 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.757 HG12 HG22 ' A' ' 199' ' ' VAL . 32.7 m -134.08 163.1 38.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.036 -0.582 . . . . 0.0 109.722 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 11.8 p -148.87 161.1 42.52 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.315 0.578 . . . . 0.0 111.477 -179.428 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 165' ' ' GLU . . . . . 0.403 ' HG2' ' CE2' ' A' ' 197' ' ' TYR . 95.5 mt-10 -103.39 117.18 33.89 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.759 179.151 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 22.7 m -135.18 156.16 38.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.802 -179.226 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -85.14 157.59 59.32 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.508 179.438 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 168' ' ' PRO . . . . . 0.502 ' O ' ' CB ' ' B' ' 702' ' ' LEU . 19.5 Cg_endo -62.71 -15.66 48.01 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 C-N-CA 122.78 2.32 . . . . 0.0 113.665 -179.685 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 169' ' ' ASP . . . . . 0.626 ' O ' ' NE1' ' A' ' 171' ' ' TRP . 39.3 p-10 -92.84 -6.72 48.17 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 119.48 -0.888 . . . . 0.0 111.917 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.749 ' O ' HG22 ' A' ' 173' ' ' VAL . 96.5 mttt -78.1 85.07 4.32 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.357 -0.537 . . . . 0.0 111.824 179.429 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 171' ' ' TRP . . . . . 0.626 ' NE1' ' O ' ' A' ' 169' ' ' ASP . 0.0 OUTLIER -75.02 -8.51 56.72 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.428 0.632 . . . . 0.0 110.185 179.159 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 53.3 tp10 -64.77 -29.1 70.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.537 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 173' ' ' VAL . . . . . 0.749 HG22 ' O ' ' A' ' 170' ' ' LYS . 35.1 m -62.88 -22.21 29.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.37 -179.855 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.628 HG13 HG23 ' A' ' 173' ' ' VAL . 31.5 m -105.2 -3.46 9.76 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.535 ' CD ' ' NZ ' ' A' ' 111' ' ' LYS . 63.3 mm-40 -71.96 150.68 43.88 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.31 0.576 . . . . 0.0 111.202 179.586 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 38.7 p-10 -67.97 141.8 56.17 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.051 -179.687 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 78.7 m80 -117.43 23.26 11.9 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.914 0.388 . . . . 0.0 111.411 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 62.06 43.2 99.47 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 110.759 -0.937 . . . . 0.0 110.759 -179.824 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 12.5 ptmt -164.87 168.44 17.69 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.064 0.459 . . . . 0.0 110.301 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -86.99 100.9 12.94 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 177.416 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 77.5 tt0 -132.55 160.95 35.09 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.335 0.588 . . . . 0.0 111.32 -178.205 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.682 HG22 ' O ' ' A' ' 201' ' ' GLY . 18.7 tt -128.65 138.17 55.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.619 179.244 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 60.6 m -132.52 126.18 32.29 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.883 -179.178 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 70.7 mt -111.97 134.44 53.52 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.633 179.617 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.649 HD13 HD21 ' B' ' 702' ' ' LEU . 92.9 mt -115.9 123.42 71.19 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 CA-C-O 121.482 0.658 . . . . 0.0 110.732 -179.462 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 186' ' ' THR . . . . . 0.607 ' HB ' HD11 ' A' ' 138' ' ' ILE . 13.2 t -138.69 158.65 43.84 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.97 -179.774 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 187' ' ' CYS . . . . . . . . . . . . . 91.7 m -89.57 139.2 30.78 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.886 0.374 . . . . 0.0 110.591 -179.331 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.592 HG13 ' N ' ' A' ' 189' ' ' SER . 11.9 p -62.33 -44.56 99.31 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-O 120.968 0.414 . . . . 0.0 110.806 -179.259 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 189' ' ' SER . . . . . 0.592 ' N ' HG13 ' A' ' 188' ' ' VAL . 23.9 m -167.52 153.43 7.61 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.252 0.548 . . . . 0.0 111.286 -179.626 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 70.1 t -72.43 -17.69 18.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.256 178.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -96.04 -11.86 25.78 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.251 179.698 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 192' ' ' ASP . . . . . 0.499 ' O ' ' CG1' ' A' ' 188' ' ' VAL . 49.5 t0 -141.15 98.62 3.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.171 0.51 . . . . 0.0 111.307 -179.409 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -98.81 9.83 42.58 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.542 0.687 . . . . 0.0 109.75 179.279 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 25.3 m -60.13 -42.68 95.33 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.785 -178.868 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt -133.89 150.19 51.34 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 120.979 0.419 . . . . 0.0 111.346 -179.36 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 196' ' ' ARG . . . . . 0.74 HH22 HD22 ' B' ' 702' ' ' LEU . 42.7 mtm180 -128.26 141.45 51.45 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 121.122 0.487 . . . . 0.0 110.48 179.548 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 197' ' ' TYR . . . . . 0.403 ' CE2' ' HG2' ' A' ' 165' ' ' GLU . 48.4 m-85 -98.04 137.6 36.59 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.331 0.586 . . . . 0.0 111.708 -179.708 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 35.1 t -118.27 134.93 60.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.428 178.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.757 HG22 HG12 ' A' ' 163' ' ' VAL . 68.6 t -103.45 134.51 44.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.013 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -117.0 138.21 51.72 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 121.449 0.642 . . . . 0.0 111.666 -179.124 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 201' ' ' GLY . . . . . 0.682 ' O ' HG22 ' A' ' 182' ' ' ILE . . . -139.81 130.98 4.93 Favored Glycine 0 CA--C 1.529 0.95 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 179.609 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -95.89 142.07 28.57 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.253 0.549 . . . . 0.0 111.049 -179.411 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 52.0 tp -67.03 133.22 49.49 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 121.527 0.679 . . . . 0.0 110.186 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 74.9 t -105.6 -51.6 7.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.233 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -152.36 174.94 31.2 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 120.193 -1.003 . . . . 0.0 112.576 -178.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 206' ' ' THR . . . . . 0.406 HG23 ' CD1' ' A' ' 156' ' ' TYR . 18.0 m -142.4 138.33 31.06 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 114.892 -0.654 . . . . 0.0 110.711 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 54.6 mtmt -146.35 128.0 15.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.262 0.554 . . . . 0.0 111.885 178.557 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -62.04 142.07 57.73 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.61 -179.679 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -79.24 108.23 12.59 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.429 178.613 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 99.2 mttt . . . . . 0 C--O 1.218 -0.588 0 CA-C-O 117.921 -1.038 . . . . 0.0 110.537 -179.98 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 702' ' ' LEU . . . . . 0.74 HD22 HH22 ' A' ' 196' ' ' ARG . 0.6 OUTLIER . . . . . 0 CA--C 1.543 0.675 0 CA-C-O 120.378 0.132 . . . . 20.0 110.81 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 703' ' ' PRO . . . . . 0.621 ' HD2' HD23 ' B' ' 702' ' ' LEU . 2.4 Cg_endo -64.55 -172.64 0.2 Allowed 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 122.053 1.835 . . . . 20.0 113.482 -178.497 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 704' ' ' ALA . . . . . 0.41 ' O ' ' O ' ' B' ' 703' ' ' PRO . . . . . . . . 0 C--N 1.326 -0.44 0 CA-C-N 114.098 -1.41 . . . . 20.0 112.424 -179.657 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.265 0 CA-C-O 121.049 0.452 . . . . 0.0 111.383 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 3.9 p -83.18 21.3 1.12 Allowed 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.124 0.488 . . . . 0.0 111.347 -179.815 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -106.04 15.8 25.94 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.877 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.3 mt -55.37 137.0 17.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 122.315 1.055 . . . . 0.0 112.527 -177.05 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -77.84 133.38 38.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 113.687 -1.597 . . . . 0.0 109.097 179.057 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.627 ' CD ' ' H ' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -77.57 152.16 80.69 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-O 121.109 0.48 . . . . 0.0 110.813 -178.476 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -74.01 156.42 47.53 Favored 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 123.249 2.632 . . . . 0.0 113.151 -179.67 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.442 ' O ' ' OE1' ' A' ' 68' ' ' GLU . 39.0 t70 -54.0 172.83 0.07 Allowed 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.073 179.724 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.411 HD11 ' HE2' ' A' ' 130' ' ' LYS . 86.1 mt -69.55 -13.36 62.29 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.199 -178.509 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -68.11 -37.62 81.35 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.5 0.667 . . . . 0.0 110.455 179.414 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.869 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 58.9 mp0 -68.16 -31.33 70.81 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.841 -1.072 . . . . 0.0 110.546 179.364 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 8.3 t -71.27 -44.85 72.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.575 -179.457 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -81.92 -13.14 57.93 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.031 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -114.88 1.45 14.06 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 121.252 0.549 . . . . 0.0 110.345 178.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.869 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -67.77 -173.5 0.35 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.517 0.675 . . . . 0.0 112.161 -179.019 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.6 t -102.3 95.38 6.25 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 114.887 -1.051 . . . . 0.0 109.786 179.073 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.552 HD13 ' C ' ' A' ' 74' ' ' LEU . 0.5 OUTLIER -68.79 103.39 1.76 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.899 -179.376 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.454 ' OD2' ' CD ' ' A' ' 78' ' ' GLN . 46.0 t0 -93.2 82.62 4.54 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.623 0.725 . . . . 0.0 109.751 178.483 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -80.15 -30.32 38.91 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.068 -0.969 . . . . 0.0 112.011 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 35.7 mmtt -68.16 -30.92 70.16 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.13 -176.159 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.454 ' CD ' ' OD2' ' A' ' 75' ' ' ASP . 86.0 mt-30 -87.47 2.32 50.94 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.441 -0.504 . . . . 0.0 111.688 -179.101 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 67.8 t -75.65 130.51 36.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.323 0.582 . . . . 0.0 109.927 179.291 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.492 HD13 ' CE ' ' A' ' 96' ' ' LYS . 16.2 pt -107.29 -7.35 10.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.994 -179.235 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -175.27 179.27 46.62 Favored Glycine 0 CA--C 1.527 0.793 0 C-N-CA 120.693 -0.765 . . . . 0.0 111.26 179.795 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.459 ' HA ' HG23 ' A' ' 94' ' ' VAL . 38.7 ptt180 -152.69 155.35 37.09 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.474 0.654 . . . . 0.0 111.569 179.381 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 20.4 tt -105.05 147.83 10.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.793 -179.662 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 9.2 t -136.03 131.4 34.9 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.473 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.547 ' CG2' HG22 ' A' ' 88' ' ' VAL . 96.3 mt -137.19 88.71 17.13 Favored Pre-proline 0 CA--C 1.54 0.584 0 CA-C-N 115.41 -0.813 . . . . 0.0 110.846 -179.173 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -56.31 -31.03 83.18 Favored 'Trans proline' 0 N--CA 1.499 1.804 0 C-N-CA 123.043 2.495 . . . . 0.0 112.683 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 99.1 p -53.6 -44.18 69.23 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 121.333 0.587 . . . . 0.0 110.738 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.547 HG22 ' CG2' ' A' ' 85' ' ' ILE . 12.5 m -113.72 11.61 8.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.891 178.861 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.4 t 44.74 57.0 4.81 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.651 -179.516 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 57.7 tp -117.78 136.64 53.26 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.296 179.749 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -146.13 124.79 12.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.68 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.526 HD13 ' HA3' ' A' ' 106' ' ' GLY . 77.4 mt -148.72 150.13 32.45 Favored Pre-proline 0 CA--C 1.535 0.38 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.53 -178.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.07 148.11 34.57 Favored 'Trans proline' 0 N--CA 1.491 1.351 0 C-N-CA 122.526 2.151 . . . . 0.0 111.707 178.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.564 ' C ' HD12 ' A' ' 95' ' ' LEU . 88.9 t -96.81 116.73 39.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 CA-C-O 121.006 0.432 . . . . 0.0 111.587 -179.674 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.58 HD12 ' N ' ' A' ' 95' ' ' LEU . 8.7 mp -100.37 138.79 36.95 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.151 0.5 . . . . 0.0 110.7 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.492 ' CE ' HD13 ' A' ' 80' ' ' ILE . 98.3 mttt -66.13 -79.28 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.425 0.631 . . . . 0.0 112.181 -179.005 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 40.7 t -57.54 133.66 55.44 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.935 -178.16 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 43.4 p -88.41 66.05 8.17 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.549 179.46 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.441 ' OG1' ' CG ' ' A' ' 102' ' ' ASN . 31.6 p -86.7 167.45 14.46 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 178.95 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -63.78 -41.39 97.96 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.233 0.539 . . . . 0.0 110.239 179.57 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -66.28 -39.83 89.66 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.589 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.441 ' CG ' ' OG1' ' A' ' 99' ' ' THR . 8.9 m120 -63.72 -34.79 78.66 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -178.948 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.403 ' HB3' ' CD2' ' A' ' 126' ' ' HIS . 70.4 mt -62.71 -17.16 60.23 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -178.512 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.533 HD12 ' N ' ' A' ' 104' ' ' LEU . 10.8 mp -73.21 -16.29 61.42 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 120.286 -0.565 . . . . 0.0 110.403 179.505 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.447 ' O ' HD13 ' A' ' 92' ' ' LEU . 1.5 m -78.43 -7.28 57.2 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 178.718 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.526 ' HA3' HD13 ' A' ' 92' ' ' LEU . . . 91.54 -18.8 51.14 Favored Glycine 0 CA--C 1.534 1.262 0 CA-C-N 114.926 -1.034 . . . . 0.0 113.233 177.952 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -146.72 127.07 13.96 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 119.563 -0.855 . . . . 0.0 113.08 -179.674 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -144.73 137.06 26.26 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.922 178.323 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.511 ' HA ' HD23 ' A' ' 123' ' ' LEU . 69.2 p -69.95 138.43 52.33 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.364 0.602 . . . . 0.0 111.189 -179.493 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.594 HG22 ' HG2' ' B' ' 703' ' ' PRO . 74.1 t -79.16 -53.05 14.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.71 -179.77 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.741 ' H ' ' NE2' ' A' ' 114' ' ' GLN . 53.6 mtmt -100.69 134.71 43.26 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 121.831 0.824 . . . . 0.0 112.645 -179.002 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -66.63 -30.63 70.94 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 114.51 -1.223 . . . . 0.0 112.477 -179.194 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 75.1 m-80 -84.37 11.21 8.85 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 -177.637 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' GLN . . . . . 0.741 ' NE2' ' H ' ' A' ' 111' ' ' LYS . 22.2 mt-30 -81.16 143.3 32.48 Favored 'General case' 0 C--N 1.328 -0.326 0 O-C-N 121.904 -0.497 . . . . 0.0 111.347 178.762 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.424 ' O ' ' O ' ' A' ' 118' ' ' LYS . 51.4 t -122.54 124.28 70.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.246 -0.434 . . . . 0.0 109.92 178.638 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 99.3 mtp -58.25 127.0 29.92 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 121.324 0.583 . . . . 0.0 111.471 -179.281 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 91.62 -4.75 79.73 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 110.606 -0.997 . . . . 0.0 110.606 179.699 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.424 ' O ' ' O ' ' A' ' 115' ' ' VAL . 87.5 tttt -142.48 130.96 22.4 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.113 0.482 . . . . 0.0 110.614 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 80.39 -174.28 54.94 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 -179.688 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 63.9 t-20 -90.75 107.1 18.96 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 179.649 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -85.41 99.31 11.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.242 0.544 . . . . 0.0 110.23 -179.384 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.84 136.16 33.25 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.479 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.511 HD23 ' HA ' ' A' ' 109' ' ' THR . 67.4 mt -134.07 139.14 45.77 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.491 -0.484 . . . . 0.0 111.469 -179.417 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -112.77 143.72 43.53 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 178.501 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -142.42 151.82 23.28 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.164 -1.174 . . . . 0.0 110.164 -178.885 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' HIS . . . . . 0.403 ' CD2' ' HB3' ' A' ' 103' ' ' LEU . 4.7 m-70 -89.24 126.03 35.33 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.592 0.711 . . . . 0.0 111.874 -179.468 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' ASN . . . . . 0.433 ' ND2' ' HA ' ' A' ' 136' ' ' SER . 35.1 t30 -129.12 125.18 36.56 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 114.931 -1.031 . . . . 0.0 110.681 179.504 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.513 ' O ' ' OG ' ' A' ' 129' ' ' SER . 78.1 mtm -102.53 -1.72 29.94 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.351 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.513 ' OG ' ' O ' ' A' ' 128' ' ' MET . 6.2 p 77.78 10.23 2.24 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.473 179.77 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.76 ' O ' HG12 ' A' ' 133' ' ' VAL . 5.9 ptmt -110.42 118.15 35.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.474 0.654 . . . . 0.0 112.427 -179.274 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.496 ' C ' ' O ' ' A' ' 130' ' ' LYS . 29.1 tptt -32.98 149.89 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 114.926 -1.034 . . . . 0.0 109.554 178.828 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.436 ' N ' ' HG3' ' A' ' 131' ' ' LYS . . . 82.82 -15.49 31.43 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 111.064 -0.814 . . . . 0.0 111.064 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.76 HG12 ' O ' ' A' ' 130' ' ' LYS . 8.0 p -94.22 151.68 3.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.04 -0.664 . . . . 0.0 111.174 -179.041 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.593 HD23 ' N ' ' A' ' 134' ' ' LEU . 0.1 OUTLIER -68.04 147.16 52.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.88 0.848 . . . . 0.0 112.96 -177.774 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.449 ' CE1' ' O ' ' A' ' 106' ' ' GLY . 3.0 m-85 65.2 4.85 2.76 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 113.943 -1.481 . . . . 0.0 114.266 177.528 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 136' ' ' SER . . . . . 0.433 ' HA ' ' ND2' ' A' ' 127' ' ' ASN . 28.1 p -76.51 -35.22 58.46 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 120.147 -0.621 . . . . 0.0 111.908 178.79 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 137' ' ' ASP . . . . . 0.421 ' N ' ' OD1' ' A' ' 137' ' ' ASP . 36.6 p-10 -94.75 2.09 55.5 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 114.543 1.312 . . . . 0.0 114.543 -177.533 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 45.6 pt -69.22 -20.38 24.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 C-N-CA 119.06 -1.056 . . . . 0.0 110.466 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -68.38 -9.91 51.46 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.191 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 49.7 m -82.96 -5.01 58.9 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.554 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 89.0 mt -64.56 143.77 57.68 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 121.276 0.56 . . . . 0.0 110.764 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.419 ' HG2' ' N ' ' A' ' 143' ' ' LYS . 88.2 tttt -119.79 157.46 28.57 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.569 -179.003 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 143' ' ' LYS . . . . . 0.419 ' N ' ' HG2' ' A' ' 142' ' ' LYS . 87.8 tttt -50.02 129.52 20.78 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.381 179.366 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.464 ' N ' ' O ' ' A' ' 160' ' ' VAL . . . 83.13 8.96 84.78 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 120.358 -0.925 . . . . 0.0 112.371 178.531 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 47.5 t0 -73.66 130.25 39.63 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 120.076 -0.65 . . . . 0.0 110.679 -179.372 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -76.61 141.05 41.21 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 121.602 0.715 . . . . 0.0 111.485 -179.001 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 95.5 mt -137.67 138.66 44.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.063 -0.971 . . . . 0.0 108.815 178.711 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' TYR . . . . . 0.517 ' C ' HD22 ' A' ' 149' ' ' LEU . 95.2 m-85 -119.89 133.94 55.41 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 -177.768 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.517 HD22 ' C ' ' A' ' 148' ' ' TYR . 4.4 mm? -111.38 132.29 54.54 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 114.594 -1.184 . . . . 0.0 108.022 177.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -112.18 108.26 17.44 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.205 -0.598 . . . . 0.0 112.119 -178.917 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 151' ' ' ASP . . . . . 0.577 ' OD1' ' N ' ' A' ' 152' ' ' ASN . 57.1 t0 -89.42 158.35 17.78 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 177.54 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 152' ' ' ASN . . . . . 0.577 ' N ' ' OD1' ' A' ' 151' ' ' ASP . 36.8 p-10 -54.85 -20.07 7.9 Favored 'General case' 0 C--N 1.312 -1.042 0 C-N-CA 120.118 -0.633 . . . . 0.0 110.897 -177.817 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -112.49 -29.69 7.4 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 -178.718 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 154' ' ' ASN . . . . . 0.425 ' O ' ' N ' ' A' ' 151' ' ' ASP . 0.4 OUTLIER -148.86 -178.42 6.35 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.957 0.885 . . . . 0.0 113.244 -177.205 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -128.52 137.85 51.96 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 114.483 -1.235 . . . . 0.0 109.813 179.193 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -113.61 138.28 50.39 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 121.155 0.503 . . . . 0.0 111.296 -179.729 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 157' ' ' GLU . . . . . 0.465 ' O ' HD12 ' A' ' 203' ' ' LEU . 84.1 tt0 -98.99 114.95 27.85 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 121.296 0.57 . . . . 0.0 111.917 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 45.8 m-85 -113.49 147.11 38.5 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.238 0.542 . . . . 0.0 111.033 179.108 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -120.22 120.27 35.65 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.576 179.347 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.464 ' O ' ' N ' ' A' ' 144' ' ' GLY . 73.1 t -58.37 136.28 21.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 178.075 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 34.0 p -105.07 -26.79 11.97 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 123.425 0.453 . . . . 0.0 111.803 -179.532 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 167.1 -175.95 42.16 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 120.143 -1.027 . . . . 0.0 111.882 -179.816 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.975 HG22 HG22 ' A' ' 199' ' ' VAL . 47.7 t -129.22 138.12 55.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 114.8 -0.7 . . . . 0.0 109.465 179.311 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 20.9 t -137.28 167.51 21.44 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.554 0.692 . . . . 0.0 111.91 -178.414 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 165' ' ' GLU . . . . . 0.421 ' CG ' ' CE2' ' A' ' 197' ' ' TYR . 95.5 mt-10 -107.95 122.84 47.65 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.06 -179.619 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 32.6 m -136.93 160.97 36.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.882 179.756 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -84.76 158.72 59.1 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.357 179.322 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 168' ' ' PRO . . . . . 0.434 ' O ' HD12 ' B' ' 702' ' ' LEU . 37.0 Cg_endo -65.99 -13.43 39.81 Favored 'Trans proline' 0 C--N 1.303 -1.826 0 C-N-CA 123.169 2.579 . . . . 0.0 113.363 -179.638 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 35.7 p30 -96.54 -6.89 35.93 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 -179.531 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.841 ' O ' HD23 ' B' ' 702' ' ' LEU . 96.8 mttt -75.55 113.22 12.73 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 -177.605 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 171' ' ' TRP . . . . . 0.405 ' N ' ' CD1' ' A' ' 171' ' ' TRP . 35.4 m0 -83.24 -22.06 33.2 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.862 179.075 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -54.53 -38.79 66.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.534 -177.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 173' ' ' VAL . . . . . 0.647 HG23 HG23 ' A' ' 174' ' ' VAL . 31.0 m -64.51 -13.41 14.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.022 0.439 . . . . 0.0 111.338 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.647 HG23 HG23 ' A' ' 173' ' ' VAL . 76.4 t -111.58 -20.23 6.38 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -178.162 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -70.35 142.4 52.15 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.386 0.613 . . . . 0.0 111.773 -179.384 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 176' ' ' ASP . . . . . 0.434 ' OD1' ' O ' ' A' ' 176' ' ' ASP . 46.0 p-10 -66.44 138.34 57.48 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 115.641 -0.708 . . . . 0.0 111.175 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 79.7 m80 -111.68 25.42 11.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.357 179.661 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 65.28 42.82 96.01 Favored Glycine 0 CA--C 1.532 1.102 0 N-CA-C 111.099 -0.801 . . . . 0.0 111.099 179.597 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 11.8 ptmt -161.4 166.93 26.61 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 120.94 0.4 . . . . 0.0 110.585 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -85.57 104.83 15.68 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 177.332 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 181' ' ' GLU . . . . . 0.451 ' HG2' ' N ' ' A' ' 182' ' ' ILE . 82.9 tt0 -136.15 162.0 34.16 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.395 0.617 . . . . 0.0 111.667 -178.411 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.451 ' N ' ' HG2' ' A' ' 181' ' ' GLU . 18.4 tt -129.32 137.79 56.07 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.038 178.078 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 52.4 m -133.94 127.4 32.35 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 120.979 0.419 . . . . 0.0 111.232 -179.704 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 71.2 mt -108.65 130.87 55.33 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.13 179.388 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 91.2 mt -113.68 125.93 71.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.136 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 2.2 t -142.08 163.22 33.46 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.884 179.534 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 187' ' ' CYS . . . . . . . . . . . . . 4.8 m -86.12 140.83 29.86 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.744 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.61 HG13 ' N ' ' A' ' 189' ' ' SER . 9.9 p -62.48 -48.55 87.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.093 0.473 . . . . 0.0 111.129 -179.198 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 189' ' ' SER . . . . . 0.61 ' N ' HG13 ' A' ' 188' ' ' VAL . 79.0 p -167.71 156.08 9.24 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.092 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 13.8 p -70.6 -18.81 21.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.21 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -96.84 -15.12 21.42 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 192' ' ' ASP . . . . . 0.558 ' O ' ' CG1' ' A' ' 188' ' ' VAL . 63.5 t0 -130.73 105.68 7.96 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 120.638 -0.425 . . . . 0.0 111.456 -179.728 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 48.8 p-10 -107.33 12.79 27.74 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 120.78 0.324 . . . . 0.0 111.345 179.747 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 9.6 t -60.83 -46.66 89.67 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 120.951 0.405 . . . . 0.0 111.906 -179.225 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 63.3 pttt -144.51 155.64 43.79 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 179.721 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 84.9 mtt85 -127.38 149.51 50.04 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.363 0.601 . . . . 0.0 111.914 -179.046 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 197' ' ' TYR . . . . . 0.421 ' CE2' ' CG ' ' A' ' 165' ' ' GLU . 53.3 m-85 -92.93 142.58 27.15 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.741 -178.886 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 25.0 t -129.21 133.52 65.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.696 179.318 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.975 HG22 HG22 ' A' ' 163' ' ' VAL . 53.0 t -101.84 132.67 47.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.236 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -118.15 147.86 42.91 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.125 0.488 . . . . 0.0 110.462 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -148.61 143.07 10.55 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 -179.596 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 50.9 p30 -107.1 156.3 18.93 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.282 0.563 . . . . 0.0 111.48 -179.367 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 203' ' ' LEU . . . . . 0.465 HD12 ' O ' ' A' ' 157' ' ' GLU . 46.7 tp -77.59 130.87 37.45 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.266 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 15.7 m -114.91 -15.91 9.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.376 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -178.39 173.19 45.64 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 119.522 -1.323 . . . . 0.0 113.097 179.729 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 57.4 m -142.26 137.95 31.04 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.238 -0.981 . . . . 0.0 109.864 179.733 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 52.6 mtmt -144.03 114.83 7.74 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.184 0.516 . . . . 0.0 111.529 -179.648 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -65.77 148.59 51.52 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.551 0.691 . . . . 0.0 111.986 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -79.63 109.1 13.7 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.848 178.601 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 98.0 mttt . . . . . 0 C--O 1.221 -0.422 0 CA-C-O 117.883 -1.056 . . . . 0.0 110.682 179.712 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 702' ' ' LEU . . . . . 0.841 HD23 ' O ' ' A' ' 170' ' ' LYS . 0.1 OUTLIER . . . . . 0 CA--C 1.535 0.399 0 CA-C-O 121.34 0.591 . . . . 20.0 111.101 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 703' ' ' PRO . . . . . 0.594 ' HG2' HG22 ' A' ' 110' ' ' VAL . 3.6 Cg_exo -77.01 -161.66 0.14 Allowed 'Trans proline' 0 C--N 1.305 -1.739 0 C-N-CA 123.305 2.67 . . . . 20.0 113.831 -179.612 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 704' ' ' ALA . . . . . 0.516 ' O ' ' O ' ' B' ' 703' ' ' PRO . . . . . . . . 0 C--N 1.325 -0.475 0 CA-C-N 113.863 -1.517 . . . . 20.0 112.744 -179.388 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.435 ' C ' ' H ' ' A' ' 60' ' ' LYS . . . . . . . . 0 N--CA 1.454 -0.237 0 CA-C-O 121.212 0.53 . . . . 0.0 110.637 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.468 ' O ' ' NH2' ' A' ' 196' ' ' ARG . 3.7 p -79.02 22.59 0.39 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.266 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.435 ' H ' ' C ' ' A' ' 58' ' ' ALA . 98.9 mttt -102.15 9.72 39.95 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.128 -179.365 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.8 mt -55.23 139.8 13.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 122.416 1.103 . . . . 0.0 111.869 -177.404 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.536 ' N ' ' OD1' ' A' ' 62' ' ' ASP . 20.0 p-10 -76.45 128.69 35.29 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 113.528 -1.669 . . . . 0.0 109.551 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.547 ' CD ' ' H ' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -78.86 129.02 74.85 Favored Pre-proline 0 CA--C 1.542 0.654 0 C-N-CA 120.449 -0.5 . . . . 0.0 110.536 -179.025 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -53.41 147.86 35.79 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 C-N-CA 122.129 1.886 . . . . 0.0 112.855 178.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.655 ' O ' HG23 ' A' ' 69' ' ' VAL . 27.4 t70 -53.2 177.84 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.77 -179.489 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.414 ' H ' ' CG ' ' A' ' 65' ' ' ASP . 92.1 mt -63.6 -43.8 95.85 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.196 -178.966 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.09 -36.68 82.43 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 119.761 -0.776 . . . . 0.0 110.336 -179.296 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -61.31 -35.21 76.73 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.751 0.786 . . . . 0.0 109.042 178.22 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.655 HG23 ' O ' ' A' ' 65' ' ' ASP . 62.0 t -73.87 -43.26 53.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.917 179.003 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -70.53 -9.71 57.38 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.624 -179.774 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -118.33 -1.82 11.23 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 121.526 0.679 . . . . 0.0 109.837 179.189 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -70.05 -175.51 0.96 Allowed 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.648 -179.651 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 6.6 t -94.9 105.42 17.34 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.119 179.15 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 42.0 tp -69.95 135.02 48.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.691 -179.016 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.417 ' OD2' ' OD1' ' A' ' 102' ' ' ASN . 91.3 m-20 -116.06 77.57 1.11 Allowed 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 121.845 0.831 . . . . 0.0 109.36 177.82 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.78 ' O ' HG12 ' A' ' 79' ' ' VAL . 86.5 tttt -84.89 -40.32 17.19 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.678 -1.146 . . . . 0.0 112.148 -179.753 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.423 ' HG2' ' H ' ' A' ' 77' ' ' LYS . 52.1 mmtt -73.14 -12.89 61.05 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.707 -176.444 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -94.92 2.1 55.36 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.224 0.535 . . . . 0.0 110.194 179.51 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.78 HG12 ' O ' ' A' ' 76' ' ' LYS . 11.6 p -72.06 115.1 11.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 121.371 0.605 . . . . 0.0 110.833 -179.576 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 32.8 pt -102.84 -7.78 9.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.807 179.751 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -163.31 158.53 30.94 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 120.637 -0.792 . . . . 0.0 111.339 179.16 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 33.6 ttm180 -133.43 140.01 47.06 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 121.309 0.576 . . . . 0.0 111.334 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 5.1 tt -111.31 142.52 23.44 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.615 179.791 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 73.8 m -137.45 133.7 34.98 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 115.138 -0.937 . . . . 0.0 112.946 -178.746 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.575 ' CG2' HG22 ' A' ' 88' ' ' VAL . 66.6 mt -135.61 87.62 25.89 Favored Pre-proline 0 CA--C 1.54 0.558 0 CA-C-O 121.444 0.64 . . . . 0.0 111.034 179.834 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -55.87 -33.17 87.77 Favored 'Trans proline' 0 N--CA 1.498 1.757 0 C-N-CA 123.309 2.672 . . . . 0.0 112.431 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 28.2 m -52.78 -41.11 63.79 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 121.143 0.497 . . . . 0.0 110.415 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.575 HG22 ' CG2' ' A' ' 85' ' ' ILE . 30.6 m -115.51 13.0 7.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.754 179.267 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 2.5 p 47.37 52.24 12.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.269 0.557 . . . . 0.0 111.101 -179.686 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 60.0 tp -119.93 135.25 54.97 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.379 0.609 . . . . 0.0 110.834 179.48 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -148.92 127.46 12.35 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.866 179.338 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.654 HD13 ' HA3' ' A' ' 106' ' ' GLY . 83.5 mt -149.84 147.85 23.72 Favored Pre-proline 0 CA--C 1.541 0.629 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.458 -178.516 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -74.12 150.25 42.45 Favored 'Trans proline' 0 N--CA 1.501 1.949 0 C-N-CA 122.881 2.387 . . . . 0.0 112.117 179.067 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.666 ' C ' HD12 ' A' ' 95' ' ' LEU . 89.4 t -95.0 125.36 47.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-O 121.26 0.553 . . . . 0.0 111.279 179.613 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.666 HD12 ' C ' ' A' ' 94' ' ' VAL . 10.1 mp -109.34 142.1 40.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.838 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.536 ' O ' ' OG1' ' A' ' 109' ' ' THR . 19.1 ttmt -74.5 -76.19 0.14 Allowed 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 116.103 -0.499 . . . . 0.0 112.148 -178.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 33.4 t -59.62 129.59 42.66 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.185 0.517 . . . . 0.0 111.982 -178.829 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.407 ' OG ' ' O ' ' A' ' 109' ' ' THR . 23.0 m -87.19 69.48 10.08 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.947 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.545 HG22 ' N ' ' A' ' 100' ' ' GLU . 44.4 m -90.27 165.1 14.11 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 178.721 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.545 ' N ' HG22 ' A' ' 99' ' ' THR . 83.3 tt0 -58.2 -45.57 87.35 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 119.972 -0.691 . . . . 0.0 110.185 -179.477 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -65.06 -41.59 95.0 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.217 178.647 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.446 ' HB2' ' H ' ' A' ' 99' ' ' THR . 94.9 m-20 -62.98 -39.71 95.55 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.103 -179.646 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.475 HD13 ' HB3' ' B' ' 704' ' ' ALA . 65.3 mt -61.59 -28.39 69.31 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.695 179.825 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.573 HD13 HG22 ' A' ' 69' ' ' VAL . 98.6 mt -73.98 -15.73 61.1 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.194 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.59 -7.64 48.99 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.466 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.654 ' HA3' HD13 ' A' ' 92' ' ' LEU . . . 98.84 -22.11 42.61 Favored Glycine 0 CA--C 1.531 1.057 0 CA-C-N 114.701 -1.136 . . . . 0.0 113.447 177.039 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -147.2 125.86 12.56 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 119.643 -0.823 . . . . 0.0 112.211 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -142.03 135.99 29.79 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.698 179.235 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.575 ' HA ' HD23 ' A' ' 123' ' ' LEU . 71.6 p -69.59 132.16 45.79 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 121.224 0.535 . . . . 0.0 110.515 -179.554 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.575 HG22 ' HG2' ' B' ' 703' ' ' PRO . 53.6 t -79.07 -50.7 18.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.174 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.798 ' H ' ' NE2' ' A' ' 114' ' ' GLN . 82.5 mttt -102.91 138.19 40.11 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.57 0.7 . . . . 0.0 112.349 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -66.17 -32.58 74.11 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.016 -0.993 . . . . 0.0 112.862 -178.544 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -82.42 13.51 3.58 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -178.217 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' GLN . . . . . 0.798 ' NE2' ' H ' ' A' ' 111' ' ' LYS . 31.4 mt-30 -80.22 136.06 36.39 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.238 0.542 . . . . 0.0 111.341 179.709 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 71.3 t -123.59 127.91 74.28 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.759 179.649 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' MET . . . . . 0.659 ' SD ' ' CE2' ' A' ' 121' ' ' TYR . 85.3 mmm -55.1 126.02 22.98 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -179.178 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 82.86 -3.27 84.31 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.456 178.098 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -137.21 131.85 33.03 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.063 -0.655 . . . . 0.0 110.867 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 75.03 -174.33 51.81 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 110.226 -1.15 . . . . 0.0 110.226 -179.506 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.49 ' ND2' ' HB3' ' A' ' 181' ' ' GLU . 3.9 m120 -84.53 105.04 15.05 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.363 -0.535 . . . . 0.0 109.739 179.548 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.659 ' CE2' ' SD ' ' A' ' 116' ' ' MET . 2.2 t80 -86.34 98.71 11.13 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 120.539 -0.465 . . . . 0.0 110.209 -179.797 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.59 138.05 31.87 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.275 0.56 . . . . 0.0 111.288 -179.778 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.575 HD23 ' HA ' ' A' ' 109' ' ' THR . 67.7 mt -135.14 138.59 43.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.435 -179.49 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -106.82 134.95 49.19 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 178.553 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -134.6 148.43 19.51 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 -179.728 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 8.0 m-70 -91.83 136.11 33.4 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.53 0.681 . . . . 0.0 111.805 -179.176 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 39.2 t30 -132.6 124.96 29.36 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 114.966 -1.016 . . . . 0.0 111.341 -179.616 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.443 ' O ' ' CB ' ' A' ' 129' ' ' SER . 65.1 mtt -100.78 -5.81 25.8 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.517 0.675 . . . . 0.0 110.322 179.49 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.443 ' CB ' ' O ' ' A' ' 128' ' ' MET . 0.9 OUTLIER 77.62 12.23 2.01 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.747 178.886 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.794 ' O ' HG12 ' A' ' 133' ' ' VAL . 64.1 pttt -109.85 122.78 48.31 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 122.274 1.035 . . . . 0.0 112.303 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -44.29 119.05 1.69 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.898 179.228 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 117.42 -15.33 13.05 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 -179.191 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.794 HG12 ' O ' ' A' ' 130' ' ' LYS . 10.6 p -92.73 153.34 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 CA-C-O 120.991 0.424 . . . . 0.0 109.941 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.825 HD23 ' N ' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -71.43 146.47 48.65 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.816 0.817 . . . . 0.0 113.088 -177.936 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.482 ' CE1' ' O ' ' A' ' 106' ' ' GLY . 3.6 m-85 66.4 5.34 3.69 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 113.984 -1.462 . . . . 0.0 114.452 178.225 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 23.6 p -75.71 -29.37 58.94 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 119.936 -0.705 . . . . 0.0 112.509 179.525 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 31.6 p-10 -92.05 4.79 52.32 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 -176.904 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.421 HD11 ' OG1' ' A' ' 186' ' ' THR . 39.2 pt -67.43 -25.73 34.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 C-N-CA 119.016 -1.073 . . . . 0.0 110.493 -179.578 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -68.02 -13.79 62.47 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.451 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 54.6 p -83.53 -5.63 59.22 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.164 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 88.6 mt -63.43 145.66 55.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.37 0.605 . . . . 0.0 111.275 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -119.32 151.67 38.06 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.574 -179.253 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -48.98 130.59 18.51 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.114 179.388 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.609 ' N ' ' O ' ' A' ' 160' ' ' VAL . . . 79.85 8.34 87.76 Favored Glycine 0 CA--C 1.524 0.651 0 C-N-CA 120.847 -0.692 . . . . 0.0 111.453 179.061 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.541 ' OD1' ' N ' ' A' ' 146' ' ' LYS . 53.0 t0 -71.37 130.68 41.95 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 119.519 -0.872 . . . . 0.0 109.866 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.541 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 74.8 mmtt -78.61 142.12 37.5 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 122.044 0.925 . . . . 0.0 111.958 -178.269 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 95.6 mt -136.65 138.49 46.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 114.168 -1.378 . . . . 0.0 108.538 178.863 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -130.54 143.13 50.56 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 119.981 -0.688 . . . . 0.0 112.537 -178.24 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.789 HD22 ' C ' ' A' ' 149' ' ' LEU . 0.0 OUTLIER -143.96 157.77 44.13 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.097 176.788 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.498 ' CD1' ' N ' ' A' ' 150' ' ' TYR . 0.5 OUTLIER -123.53 133.14 54.04 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -177.775 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -91.04 168.4 11.67 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 105.991 -1.855 . . . . 0.0 105.991 175.804 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 -58.5 -25.76 62.71 Favored 'General case' 0 C--N 1.307 -1.274 0 C-N-CA 119.183 -1.007 . . . . 0.0 110.798 -179.448 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 -110.03 -27.16 9.34 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -178.749 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -145.31 -172.72 3.93 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 114.608 1.336 . . . . 0.0 114.608 -176.268 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 77.5 tt0 -133.75 134.56 43.12 Favored 'General case' 0 C--N 1.339 0.145 0 CA-C-N 114.508 -1.223 . . . . 0.0 110.045 179.722 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 156' ' ' TYR . . . . . 0.433 ' HB2' HD11 ' A' ' 149' ' ' LEU . 58.9 m-85 -114.68 136.37 53.13 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-O 121.34 0.59 . . . . 0.0 110.92 -179.574 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 157' ' ' GLU . . . . . 0.589 ' O ' HG22 ' A' ' 204' ' ' VAL . 97.7 mt-10 -96.63 114.83 26.52 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.392 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 -114.62 147.95 38.8 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 120.755 0.312 . . . . 0.0 110.868 179.345 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -126.57 126.66 44.01 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.269 0.557 . . . . 0.0 110.622 178.675 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.609 ' O ' ' N ' ' A' ' 144' ' ' GLY . 42.8 t -59.79 134.99 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.624 178.964 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 68.4 p -107.49 -28.75 9.62 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.253 0.549 . . . . 0.0 110.483 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 165.97 -172.34 41.33 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 111.352 -0.699 . . . . 0.0 111.352 179.788 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 2.3 p -134.39 148.91 29.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 179.385 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 22.9 t -138.29 167.71 21.29 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.465 0.65 . . . . 0.0 111.43 -179.358 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 75.0 tt0 -111.35 119.43 38.83 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.796 -179.191 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.479 HG21 HG11 ' A' ' 173' ' ' VAL . 32.3 m -136.2 157.54 37.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.01 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -80.65 160.72 66.3 Favored Pre-proline 0 C--N 1.32 -0.676 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.147 -179.418 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 168' ' ' PRO . . . . . 0.469 ' O ' ' CB ' ' B' ' 702' ' ' LEU . 33.8 Cg_endo -65.51 -18.11 58.81 Favored 'Trans proline' 0 N--CA 1.502 1.983 0 C-N-CA 122.977 2.451 . . . . 0.0 113.461 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 42.6 p-10 -91.23 -1.6 57.65 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 120.21 -0.596 . . . . 0.0 111.866 179.473 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.754 ' O ' HG22 ' A' ' 173' ' ' VAL . 71.6 mmtt -75.96 87.15 2.9 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.951 -179.772 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 171' ' ' TRP . . . . . 0.587 ' O ' HG22 ' A' ' 174' ' ' VAL . 31.3 m0 -76.69 -12.12 59.95 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.43 0.633 . . . . 0.0 109.943 179.589 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -62.87 -32.59 73.87 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.365 -179.668 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 173' ' ' VAL . . . . . 0.754 HG22 ' O ' ' A' ' 170' ' ' LYS . 33.3 m -62.48 -18.32 20.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.911 -178.465 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.742 HG13 HG23 ' A' ' 173' ' ' VAL . 35.5 m -110.23 -4.78 10.95 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -179.162 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -73.26 139.69 46.34 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.911 0.386 . . . . 0.0 110.611 179.227 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 176' ' ' ASP . . . . . 0.516 ' OD1' ' O ' ' A' ' 176' ' ' ASP . 53.1 p-10 -70.83 136.22 48.59 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 121.257 0.551 . . . . 0.0 110.91 -179.649 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 78.5 m80 -102.34 -15.37 16.58 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.131 0.491 . . . . 0.0 111.219 -179.543 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 105.09 39.74 2.24 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 -179.365 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -152.96 167.61 28.59 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 114.795 -0.702 . . . . 0.0 111.232 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -88.65 98.99 11.98 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 177.758 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 181' ' ' GLU . . . . . 0.49 ' HB3' ' ND2' ' A' ' 120' ' ' ASN . 81.8 tt0 -137.24 164.03 29.49 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.694 0.759 . . . . 0.0 111.423 -178.629 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.442 ' N ' ' HG2' ' A' ' 181' ' ' GLU . 16.8 tt -130.74 140.61 48.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 114.689 -1.141 . . . . 0.0 109.258 178.686 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 183' ' ' THR . . . . . 0.401 HG23 ' CG1' ' A' ' 198' ' ' VAL . 51.7 m -132.96 126.57 32.32 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.203 0.525 . . . . 0.0 111.249 -179.136 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 91.4 mt -107.53 130.86 54.82 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.068 179.81 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.747 HD13 HD21 ' B' ' 702' ' ' LEU . 81.1 mt -109.56 121.32 62.36 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-O 121.234 0.54 . . . . 0.0 110.637 -179.647 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 186' ' ' THR . . . . . 0.625 HG22 ' N ' ' A' ' 187' ' ' CYS . 43.7 m -139.44 168.17 20.42 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.281 179.814 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 187' ' ' CYS . . . . . 0.625 ' N ' HG22 ' A' ' 186' ' ' THR . 1.6 m -101.91 148.46 25.31 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.288 179.701 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 71.4 t -60.85 -46.89 95.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-O 120.981 0.419 . . . . 0.0 111.44 -178.887 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 86.0 p -170.08 159.5 7.59 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.205 179.317 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 57.7 t -65.75 -18.82 24.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.489 0.661 . . . . 0.0 109.687 179.324 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -96.74 -13.32 22.77 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.939 -179.597 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -131.67 96.05 3.87 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.421 179.362 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 43.2 p-10 -110.29 5.01 21.35 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 112.23 0.456 . . . . 0.0 112.23 -179.547 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 11.5 t -63.93 -40.95 97.63 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.954 0.407 . . . . 0.0 111.326 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -126.73 151.74 47.77 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 121.158 0.504 . . . . 0.0 110.749 -179.24 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 196' ' ' ARG . . . . . 0.468 ' NH2' ' O ' ' A' ' 59' ' ' SER . 99.8 mtt180 -126.19 137.76 53.58 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.386 -179.503 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 43.9 p90 -98.34 144.29 27.89 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.698 178.771 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.401 ' CG1' HG23 ' A' ' 183' ' ' THR . 50.2 t -121.27 133.39 67.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.439 0.638 . . . . 0.0 111.573 -178.548 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 51.0 t -103.67 132.1 50.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.638 179.233 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -118.92 147.76 43.66 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.469 0.652 . . . . 0.0 112.141 -178.487 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -134.82 140.27 11.58 Favored Glycine 0 CA--C 1.532 1.113 0 N-CA-C 110.422 -1.071 . . . . 0.0 110.422 179.27 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 54.8 t0 -100.93 136.61 40.51 Favored 'General case' 0 C--N 1.329 -0.304 0 O-C-N 122.626 -0.337 . . . . 0.0 110.804 -179.61 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 51.7 tp -65.29 127.25 30.96 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.649 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.589 HG22 ' O ' ' A' ' 157' ' ' GLU . 28.6 m -110.52 -18.8 7.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 C-N-CA 120.6 -0.44 . . . . 0.0 112.181 -178.65 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -179.21 174.34 46.3 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 120.002 -1.095 . . . . 0.0 112.602 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 97.3 m -143.59 138.74 29.27 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 114.991 -0.605 . . . . 0.0 110.439 179.723 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -142.37 115.8 9.03 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 120.644 -0.423 . . . . 0.0 111.512 178.637 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -63.36 147.48 51.03 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.498 0.666 . . . . 0.0 111.467 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 52.9 mtmt -79.27 106.72 11.51 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.556 179.327 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 97.9 mttt . . . . . 0 C--O 1.219 -0.538 0 CA-C-O 117.827 -1.082 . . . . 0.0 110.613 179.794 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 702' ' ' LEU . . . . . 0.747 HD21 HD13 ' A' ' 185' ' ' ILE . 0.5 OUTLIER . . . . . 0 CA--C 1.546 0.819 0 N-CA-C 110.806 -0.072 . . . . 20.0 110.806 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 703' ' ' PRO . . . . . 0.695 ' HD2' HD23 ' B' ' 702' ' ' LEU . 3.2 Cg_exo -66.15 -177.31 0.79 Allowed 'Trans proline' 0 N--CA 1.496 1.652 0 C-N-CA 122.042 1.828 . . . . 20.0 113.96 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 704' ' ' ALA . . . . . 0.507 ' O ' ' O ' ' B' ' 703' ' ' PRO . . . . . . . . 0 N--CA 1.473 0.715 0 N-CA-C 114.531 1.308 . . . . 20.0 114.531 -178.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.258 0 CA-C-O 121.308 0.575 . . . . 0.0 110.609 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 2.0 p -77.54 7.96 4.9 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.544 -178.31 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.416 ' HA ' HH21 ' A' ' 196' ' ' ARG . 59.3 pttt -85.59 26.94 0.88 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.35 0.595 . . . . 0.0 110.926 179.42 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 45.1 mm -55.89 139.76 14.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 122.345 1.069 . . . . 0.0 113.357 -176.93 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -81.12 124.33 29.14 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 113.584 -1.644 . . . . 0.0 108.128 178.051 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.631 ' CD ' ' H ' ' A' ' 63' ' ' GLN . 1.1 pm0 -77.52 151.71 80.54 Favored Pre-proline 0 C--N 1.324 -0.517 0 C-N-CA 120.064 -0.654 . . . . 0.0 110.855 -178.663 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -68.31 154.75 71.4 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 122.616 2.211 . . . . 0.0 112.084 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -57.98 171.4 0.52 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 121.38 0.61 . . . . 0.0 111.906 -179.027 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 89.3 mt -64.64 -45.58 86.2 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.946 -178.43 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.09 -37.9 89.13 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 119.924 -0.71 . . . . 0.0 110.323 -178.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -62.9 -32.81 74.16 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 178.037 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.1 t -75.85 -45.33 37.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-N 114.137 -1.392 . . . . 0.0 110.675 179.031 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -75.99 -8.98 58.21 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.819 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -106.18 -13.0 15.55 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 121.436 0.636 . . . . 0.0 109.931 179.158 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -70.22 145.73 51.19 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.41 -0.814 . . . . 0.0 112.189 -179.555 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.5 m -56.67 109.95 0.71 Allowed 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 115.641 -0.708 . . . . 0.0 109.991 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 32.2 tp -69.28 131.97 45.72 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.804 -178.914 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -109.01 76.63 1.02 Allowed 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 177.471 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -84.11 -36.53 22.89 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.524 -0.762 . . . . 0.0 112.453 -179.603 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 42.3 mmtt -74.64 -13.37 60.63 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.035 0.445 . . . . 0.0 111.417 -176.651 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -92.01 -0.1 57.47 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.377 0.608 . . . . 0.0 109.792 179.632 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 21.9 t -79.58 129.45 37.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.44 -179.643 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 11.6 pt -110.83 -10.33 11.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.805 179.347 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -157.81 163.64 32.78 Favored Glycine 0 CA--C 1.523 0.555 0 C-N-CA 120.225 -0.988 . . . . 0.0 111.81 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 61.8 ttp180 -133.71 156.42 47.97 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.756 -0.722 . . . . 0.0 109.91 179.648 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.582 HG22 ' O ' ' A' ' 92' ' ' LEU . 18.6 tt -126.07 143.08 40.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.6 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 13.2 t -137.51 133.26 34.37 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 121.504 0.669 . . . . 0.0 112.305 -178.51 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.461 HG22 HG22 ' A' ' 88' ' ' VAL . 65.0 mt -139.33 84.37 16.48 Favored Pre-proline 0 CA--C 1.538 0.498 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.31 -179.772 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -57.37 -29.7 85.19 Favored 'Trans proline' 0 N--CA 1.499 1.818 0 C-N-CA 123.081 2.52 . . . . 0.0 112.919 -179.21 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 96.1 p -52.16 -41.66 62.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.32 0.581 . . . . 0.0 111.088 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.461 HG22 HG22 ' A' ' 85' ' ' ILE . 22.5 m -115.83 10.33 7.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.043 179.068 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.479 ' O ' ' OG ' ' A' ' 89' ' ' SER . 3.5 t 53.48 53.49 11.54 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.68 179.553 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 62.7 tp -121.98 133.73 54.82 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.656 0.741 . . . . 0.0 111.024 -179.712 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -148.76 130.85 15.39 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.926 179.368 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.582 ' O ' HG22 ' A' ' 83' ' ' ILE . 84.1 mt -152.2 151.28 27.32 Favored Pre-proline 0 N--CA 1.471 0.621 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.368 -178.517 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -76.02 147.99 30.9 Favored 'Trans proline' 0 N--CA 1.494 1.554 0 C-N-CA 122.584 2.189 . . . . 0.0 111.516 178.214 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.518 ' C ' HD12 ' A' ' 95' ' ' LEU . 98.5 t -96.45 118.12 42.17 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-O 120.975 0.417 . . . . 0.0 111.563 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.544 HD12 ' N ' ' A' ' 95' ' ' LEU . 10.6 mp -101.74 136.91 40.78 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.394 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -61.7 -81.36 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 121.253 0.549 . . . . 0.0 112.263 -179.335 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 91.1 p -62.39 135.12 57.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.488 0.661 . . . . 0.0 112.134 -178.238 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.419 ' OG ' ' O ' ' A' ' 109' ' ' THR . 1.3 m -90.83 68.66 6.39 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.219 178.834 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 33.8 p -88.57 168.41 12.59 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.069 179.283 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.429 ' O ' ' CD1' ' A' ' 104' ' ' LEU . 52.6 tp10 -62.9 -45.5 92.24 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.169 -0.612 . . . . 0.0 110.435 179.783 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -65.12 -40.67 94.82 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 121.339 0.59 . . . . 0.0 111.487 179.535 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.414 HD21 ' HA ' ' A' ' 102' ' ' ASN . 9.6 m120 -65.23 -30.35 71.23 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.134 -0.485 . . . . 0.0 112.226 -179.301 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.417 HD23 ' HA ' ' A' ' 103' ' ' LEU . 56.7 mt -67.03 -14.02 62.49 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 120.773 -0.371 . . . . 0.0 111.673 -179.321 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.534 HD12 ' N ' ' A' ' 104' ' ' LEU . 10.5 mp -75.69 -12.17 60.14 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 121.008 -0.277 . . . . 0.0 111.44 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.415 ' O ' HD22 ' A' ' 92' ' ' LEU . 92.5 p -81.17 -6.24 58.62 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 121.352 0.596 . . . . 0.0 110.356 179.677 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.547 ' HA3' HD13 ' A' ' 92' ' ' LEU . . . 89.76 -20.02 37.89 Favored Glycine 0 CA--C 1.533 1.196 0 CA-C-N 115.51 -0.768 . . . . 0.0 113.254 177.884 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -145.72 125.49 13.43 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 117.814 0.807 . . . . 0.0 112.136 -179.797 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -145.71 141.64 28.23 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.703 179.236 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.706 ' HA ' HD23 ' A' ' 123' ' ' LEU . 8.7 p -71.93 132.34 44.22 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.238 0.542 . . . . 0.0 110.667 179.631 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.655 HG23 ' CG ' ' B' ' 703' ' ' PRO . 7.3 p -81.7 -33.95 12.52 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 -179.533 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.506 ' O ' ' NE2' ' A' ' 114' ' ' GLN . 88.2 tttt -90.36 153.34 20.51 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 121.357 0.598 . . . . 0.0 111.939 -177.243 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -66.0 -35.06 79.54 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -178.036 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -141.27 53.36 1.55 Allowed 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 -176.84 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' GLN . . . . . 0.752 ' NE2' ' H ' ' A' ' 114' ' ' GLN . 1.6 pm0 -74.34 157.71 35.26 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 120.891 0.377 . . . . 0.0 111.192 179.151 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 61.4 t -128.64 120.89 53.65 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-O 121.149 0.499 . . . . 0.0 111.694 -179.45 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 66.3 mtt -60.57 134.45 57.08 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.992 -0.549 . . . . 0.0 112.226 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 77.72 -0.91 69.3 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.698 -0.561 . . . . 0.0 111.698 178.206 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -142.0 127.94 19.48 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.358 0.599 . . . . 0.0 110.851 179.67 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 75.28 -168.99 54.78 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 110.482 -1.047 . . . . 0.0 110.482 -179.721 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 42.9 t-20 -90.21 103.5 16.17 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.78 0.324 . . . . 0.0 110.2 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.513 ' HE2' HD21 ' A' ' 123' ' ' LEU . 11.8 t80 -89.69 99.02 12.1 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -179.696 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.463 ' HB3' ' CG1' ' A' ' 110' ' ' VAL . . . -91.65 137.41 32.39 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 112.462 0.541 . . . . 0.0 112.462 -178.404 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.706 HD23 ' HA ' ' A' ' 109' ' ' THR . 71.6 mt -134.76 138.92 44.74 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.584 179.779 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -108.72 131.7 54.67 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 121.142 0.496 . . . . 0.0 110.02 179.324 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -137.22 151.08 20.93 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 110.045 -1.222 . . . . 0.0 110.045 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' HIS . . . . . 0.752 ' O ' HD23 ' A' ' 134' ' ' LEU . 37.5 m-70 -88.73 144.78 26.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.61 0.719 . . . . 0.0 112.522 -178.706 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -137.8 121.24 17.14 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.982 178.838 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.518 ' HB2' HG21 ' A' ' 133' ' ' VAL . 57.7 mtt -95.51 -1.42 50.71 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.069 -178.578 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.509 ' CB ' ' O ' ' A' ' 128' ' ' MET . 1.4 p 78.17 5.52 2.7 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.974 -0.29 . . . . 0.0 111.339 179.247 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.876 ' O ' HG12 ' A' ' 133' ' ' VAL . 62.5 pttt -120.58 130.7 54.3 Favored 'General case' 0 C--O 1.222 -0.377 0 CA-C-O 121.885 0.85 . . . . 0.0 113.105 -178.55 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.462 ' O ' ' O ' ' A' ' 130' ' ' LYS . 74.6 mmtt -41.13 162.6 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 178.232 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 76.49 -24.73 1.76 Allowed Glycine 0 CA--C 1.535 1.337 0 C-N-CA 120.396 -0.907 . . . . 0.0 111.379 179.594 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.876 HG12 ' O ' ' A' ' 130' ' ' LYS . 3.7 p -90.18 158.13 2.94 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 O-C-N 122.217 -0.578 . . . . 0.0 111.215 -178.702 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.852 HD13 ' H ' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -70.71 145.36 50.57 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 114.903 1.446 . . . . 0.0 114.903 -177.283 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 61.0 7.04 1.37 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 112.866 -1.97 . . . . 0.0 113.854 177.754 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 5.1 t -72.8 -34.07 66.66 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.143 -0.623 . . . . 0.0 112.385 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' ASP . . . . . 0.418 ' OD1' ' N ' ' A' ' 137' ' ' ASP . 44.0 p-10 -92.43 4.6 53.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.433 0.635 . . . . 0.0 110.381 -179.329 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.46 HD11 HD13 ' A' ' 184' ' ' LEU . 5.2 tt -64.49 -35.83 75.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.896 -179.506 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.419 ' N ' ' CG2' ' A' ' 138' ' ' ILE . . . -70.33 -9.88 57.41 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 121.091 0.472 . . . . 0.0 111.072 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 19.1 m -81.99 -3.21 53.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.225 0.535 . . . . 0.0 110.223 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.401 HD21 HG21 ' A' ' 85' ' ' ILE . 78.5 mt -63.69 145.08 56.41 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.564 179.739 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -120.97 155.49 34.16 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 121.389 0.614 . . . . 0.0 112.021 -178.3 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 40.5 tttp -49.85 132.76 22.45 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.978 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.554 ' N ' ' O ' ' A' ' 160' ' ' VAL . . . 80.21 7.33 88.63 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.314 178.691 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -73.41 136.87 44.34 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 118.921 -1.112 . . . . 0.0 109.553 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -80.26 141.33 35.65 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.838 0.828 . . . . 0.0 112.28 -178.36 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.449 HD11 ' CG2' ' A' ' 160' ' ' VAL . 87.6 mt -137.39 137.74 45.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 114.735 -1.121 . . . . 0.0 108.679 178.841 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 43.0 m-85 -123.1 136.25 54.72 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.028 -0.669 . . . . 0.0 112.508 -177.763 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.544 HD11 HD11 ' A' ' 182' ' ' ILE . 11.7 mt -110.97 133.5 53.34 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 177.072 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 150' ' ' TYR . . . . . 0.526 ' CE1' ' CD ' ' A' ' 155' ' ' GLU . 82.1 m-85 -111.87 109.39 19.18 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 119.836 -0.746 . . . . 0.0 111.845 -179.638 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 151' ' ' ASP . . . . . 0.614 ' OD1' ' N ' ' A' ' 152' ' ' ASN . 66.3 t0 -89.59 163.87 15.0 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 177.7 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 152' ' ' ASN . . . . . 0.614 ' N ' ' OD1' ' A' ' 151' ' ' ASP . 34.5 p-10 -57.36 -19.61 24.02 Favored 'General case' 0 C--N 1.318 -0.785 0 C-N-CA 119.962 -0.695 . . . . 0.0 111.159 -177.706 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -114.27 -27.83 7.48 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 -178.463 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -148.18 179.87 7.45 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 -176.858 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.526 ' CD ' ' CE1' ' A' ' 150' ' ' TYR . 83.0 tt0 -127.79 132.96 49.44 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 114.366 -1.288 . . . . 0.0 109.745 179.122 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 156' ' ' TYR . . . . . 0.501 ' CD1' HG23 ' A' ' 206' ' ' THR . 95.5 m-85 -108.44 133.87 52.02 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.027 0.442 . . . . 0.0 111.225 -179.395 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 157' ' ' GLU . . . . . 0.644 ' O ' HG12 ' A' ' 204' ' ' VAL . 92.4 mt-10 -93.85 113.15 25.12 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.121 179.54 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -115.44 150.16 36.88 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 120.828 0.347 . . . . 0.0 110.585 179.487 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -124.45 124.62 42.7 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.048 0.451 . . . . 0.0 111.215 179.22 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.554 ' O ' ' N ' ' A' ' 144' ' ' GLY . 71.4 t -60.93 135.47 25.65 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.215 177.918 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 22.0 p -105.36 -24.95 12.57 Favored 'General case' 0 CA--C 1.533 0.315 0 O-C-N 123.308 0.38 . . . . 0.0 110.202 178.689 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 157.46 -165.17 33.33 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 120.842 -0.694 . . . . 0.0 111.718 179.791 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 3.0 p -134.97 155.26 37.87 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 179.776 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 87.8 p -138.75 167.17 22.57 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.633 0.73 . . . . 0.0 112.212 -178.489 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -100.19 118.87 37.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 114.99 -1.004 . . . . 0.0 110.204 179.694 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.475 HG21 ' CG2' ' A' ' 198' ' ' VAL . 27.6 m -137.05 161.7 35.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.225 0.536 . . . . 0.0 111.009 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -96.73 157.07 35.83 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.32 178.98 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 168' ' ' PRO . . . . . 0.503 ' O ' ' CB ' ' B' ' 702' ' ' LEU . 20.7 Cg_endo -60.83 -18.02 54.0 Favored 'Trans proline' 0 C--N 1.3 -1.995 0 C-N-CA 122.605 2.204 . . . . 0.0 113.552 -179.627 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 45.5 p-10 -92.27 -5.26 52.71 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 119.45 -0.9 . . . . 0.0 112.313 179.711 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.561 ' O ' HG22 ' A' ' 173' ' ' VAL . 97.0 mttt -76.1 85.56 2.97 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 121.655 0.741 . . . . 0.0 111.373 179.438 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 171' ' ' TRP . . . . . 0.591 ' CZ3' ' OE2' ' A' ' 175' ' ' GLU . 1.2 p-90 -73.97 -7.44 52.41 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.034 -0.984 . . . . 0.0 110.041 179.42 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -61.77 -35.83 79.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.75 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 173' ' ' VAL . . . . . 0.561 HG22 ' O ' ' A' ' 170' ' ' LYS . 19.8 m -63.03 -17.77 20.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.781 -179.702 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 37.0 t -101.47 -17.77 6.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.922 -179.615 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.591 ' OE2' ' CZ3' ' A' ' 171' ' ' TRP . 76.3 mm-40 -76.26 153.94 35.58 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.246 0.546 . . . . 0.0 111.779 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 176' ' ' ASP . . . . . 0.491 ' OD1' ' O ' ' A' ' 176' ' ' ASP . 47.0 p-10 -60.27 142.86 53.98 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.719 0.771 . . . . 0.0 111.802 -179.345 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 73.6 m80 -115.36 12.71 16.42 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.707 179.523 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 64.13 41.66 98.34 Favored Glycine 0 CA--C 1.528 0.856 0 N-CA-C 111.105 -0.798 . . . . 0.0 111.105 179.646 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -165.2 172.47 12.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.1 0.476 . . . . 0.0 110.882 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -88.28 93.99 9.69 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 177.583 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 181' ' ' GLU . . . . . 0.447 ' HG2' ' N ' ' A' ' 182' ' ' ILE . 79.9 tt0 -130.45 161.64 30.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.85 0.833 . . . . 0.0 112.052 -178.078 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.544 HD11 HD11 ' A' ' 149' ' ' LEU . 1.1 mm -125.97 134.5 66.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 114.598 -1.183 . . . . 0.0 110.55 179.608 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 86.3 m -126.3 124.41 40.26 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 121.291 0.567 . . . . 0.0 111.23 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.46 HD13 HD11 ' A' ' 138' ' ' ILE . 83.4 mt -113.32 133.41 55.14 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.7 179.143 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.668 HD13 HD21 ' B' ' 702' ' ' LEU . 77.0 mt -113.53 124.77 70.5 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 CA-C-O 121.36 0.6 . . . . 0.0 111.028 -179.581 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 5.1 t -135.56 156.34 49.03 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 115.254 -0.884 . . . . 0.0 110.492 179.337 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 187' ' ' CYS . . . . . . . . . . . . . 4.5 m -87.11 141.45 28.65 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.234 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 188' ' ' VAL . . . . . 0.758 HG22 ' CD2' ' A' ' 197' ' ' TYR . 41.9 t -61.97 -47.32 93.74 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 CA-C-O 120.945 0.402 . . . . 0.0 111.005 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 94.6 p -162.23 164.42 27.71 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 121.038 0.447 . . . . 0.0 110.977 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 190' ' ' VAL . . . . . 0.501 ' CG1' ' O ' ' A' ' 128' ' ' MET . 18.0 m -69.16 -17.58 21.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.244 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -101.8 -34.69 9.33 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.519 -0.472 . . . . 0.0 111.049 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 49.6 t0 -99.63 103.13 14.81 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 120.984 0.421 . . . . 0.0 111.465 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 193' ' ' ASN . . . . . 0.577 ' O ' ' NH1' ' A' ' 196' ' ' ARG . 27.2 m120 -110.45 -7.22 14.79 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 121.298 0.57 . . . . 0.0 110.639 179.058 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 76.3 p -68.4 -16.68 64.01 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.953 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -136.73 143.03 43.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.468 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 196' ' ' ARG . . . . . 0.577 ' NH1' ' O ' ' A' ' 193' ' ' ASN . 76.9 mtt85 -136.05 145.15 45.69 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 121.108 0.48 . . . . 0.0 111.959 -179.494 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 197' ' ' TYR . . . . . 0.758 ' CD2' HG22 ' A' ' 188' ' ' VAL . 35.8 m-85 -96.41 144.57 26.42 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 115.949 -0.568 . . . . 0.0 111.471 179.034 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.475 ' CG2' HG21 ' A' ' 166' ' ' VAL . 39.2 t -128.97 130.69 68.45 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-O 121.083 0.468 . . . . 0.0 110.645 178.365 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 21.6 t -102.66 134.62 43.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.866 179.308 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -122.32 147.66 45.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.316 0.579 . . . . 0.0 111.387 -178.924 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -145.01 152.6 24.63 Favored Glycine 0 CA--C 1.53 1.024 0 N-CA-C 110.079 -1.208 . . . . 0.0 110.079 179.24 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 202' ' ' ASP . . . . . 0.422 ' OD1' ' O ' ' A' ' 202' ' ' ASP . 51.7 p-10 -111.92 151.39 29.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.994 0.426 . . . . 0.0 110.092 179.673 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 52.7 tp -71.52 131.47 43.32 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.678 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.644 HG12 ' O ' ' A' ' 157' ' ' GLU . 5.2 p -113.88 -19.5 6.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 120.333 -0.547 . . . . 0.0 111.589 -178.753 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -176.97 172.03 44.96 Favored Glycine 0 CA--C 1.527 0.799 0 C-N-CA 120.088 -1.053 . . . . 0.0 112.055 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 206' ' ' THR . . . . . 0.501 HG23 ' CD1' ' A' ' 156' ' ' TYR . 10.4 m -144.19 137.68 27.57 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.963 -0.618 . . . . 0.0 109.503 179.019 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -145.37 122.17 11.24 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.115 0.483 . . . . 0.0 111.276 179.621 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -62.39 139.83 58.55 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.491 0.662 . . . . 0.0 111.448 -179.289 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 9.5 tttt -79.2 109.32 13.42 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.552 179.563 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 98.5 mttt . . . . . 0 C--O 1.218 -0.558 0 CA-C-O 118.107 -0.949 . . . . 0.0 110.339 179.205 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 702' ' ' LEU . . . . . 0.668 HD21 HD13 ' A' ' 185' ' ' ILE . 1.0 OUTLIER . . . . . 0 CA--C 1.546 0.805 0 CA-C-O 120.554 0.216 . . . . 20.0 111.323 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 703' ' ' PRO . . . . . 0.655 ' CG ' HG23 ' A' ' 110' ' ' VAL . 4.9 Cg_exo -69.41 -168.06 0.24 Allowed 'Trans proline' 0 N--CA 1.489 1.21 0 C-N-CA 122.906 2.404 . . . . 20.0 114.15 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 704' ' ' ALA . . . . . 0.544 ' O ' ' O ' ' B' ' 703' ' ' PRO . . . . . . . . 0 N--CA 1.466 0.367 0 CA-C-N 113.902 -1.499 . . . . 20.0 113.659 -179.078 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.414 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 38.9 t -63.1 -42.82 99.66 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.129 0.49 . . . . 0.0 111.299 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 85.1 t60 -115.05 125.65 53.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.918 -179.419 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 77.6 mtm -93.87 138.08 32.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.592 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.484 ' OD1' ' O ' ' A' ' 57' ' ' ASP . 34.6 p30 -68.25 150.98 47.6 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.624 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -90.02 11.41 20.71 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.254 0.549 . . . . 0.0 111.04 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 2.9 p -79.93 17.01 1.03 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.924 -179.131 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -99.64 9.76 42.55 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 120.901 0.382 . . . . 0.0 111.858 -179.45 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.8 mt -55.6 139.98 14.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 122.034 0.921 . . . . 0.0 112.988 -177.107 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.408 ' OD1' ' N ' ' A' ' 63' ' ' GLN . 60.4 t0 -77.59 129.15 35.26 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 114.169 -1.378 . . . . 0.0 109.567 179.166 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.533 ' NE2' ' O ' ' A' ' 64' ' ' PRO . 1.4 tt0 -76.81 119.71 78.62 Favored Pre-proline 0 CA--C 1.541 0.609 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.504 -179.137 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.533 ' O ' ' NE2' ' A' ' 63' ' ' GLN . 73.5 Cg_exo -47.86 162.31 0.28 Allowed 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 122.491 2.127 . . . . 0.0 112.811 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -52.6 168.96 0.09 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.873 0.844 . . . . 0.0 112.308 -178.441 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 97.4 mt -71.13 -12.08 61.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 114.516 -1.22 . . . . 0.0 111.979 -179.277 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.592 ' O ' ' ND2' ' A' ' 71' ' ' ASN . . . -68.21 -41.89 80.63 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.306 0.574 . . . . 0.0 110.492 179.204 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.767 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 98.2 mt-10 -70.7 -23.05 62.4 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.203 179.321 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 76.6 t -71.31 -43.88 73.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.814 -178.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -92.76 -8.82 42.68 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.411 -179.582 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.592 ' ND2' ' O ' ' A' ' 67' ' ' ALA . 84.9 m-20 -106.94 -10.17 16.06 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 121.15 0.5 . . . . 0.0 110.893 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.767 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -69.65 135.54 50.04 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.425 0.631 . . . . 0.0 112.272 -179.134 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 43.7 t -59.71 93.65 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.573 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.672 HD23 ' N ' ' A' ' 75' ' ' ASP . 6.9 tt -66.79 126.29 28.56 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.297 0.57 . . . . 0.0 111.449 -178.147 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.672 ' N ' HD23 ' A' ' 74' ' ' LEU . 88.2 m-20 -93.74 79.51 4.23 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.564 -0.743 . . . . 0.0 110.379 179.61 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.403 ' N ' HD23 ' A' ' 74' ' ' LEU . 86.8 tttt -64.75 -34.12 77.58 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.747 -0.661 . . . . 0.0 112.095 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.45 ' N ' ' HD3' ' A' ' 77' ' ' LYS . 8.0 mmtt -70.01 -13.12 62.08 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 121.428 0.633 . . . . 0.0 109.901 -176.497 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -93.9 -5.24 48.37 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.734 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 72.4 t -73.69 128.63 36.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.068 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 12.6 pt -110.57 -6.59 11.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 120.592 -0.443 . . . . 0.0 111.723 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -174.79 174.8 46.84 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 120.398 -0.906 . . . . 0.0 111.725 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.41 HH12 ' HB2' ' A' ' 84' ' ' SER . 73.2 ttp85 -135.3 156.89 48.19 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 121.158 0.504 . . . . 0.0 111.157 -179.77 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.428 HG22 ' O ' ' A' ' 92' ' ' LEU . 20.9 tt -125.6 139.32 51.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 179.363 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.41 ' HB2' HH12 ' A' ' 82' ' ' ARG . 32.5 t -137.59 134.55 35.69 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 -178.386 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.568 ' CG2' HG22 ' A' ' 88' ' ' VAL . 3.2 mp -137.26 87.58 18.16 Favored Pre-proline 0 CA--C 1.538 0.498 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.415 179.134 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -55.98 -32.56 86.33 Favored 'Trans proline' 0 N--CA 1.5 1.873 0 C-N-CA 123.205 2.604 . . . . 0.0 112.68 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 8.9 t -54.63 -41.63 70.26 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.244 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.568 HG22 ' CG2' ' A' ' 85' ' ' ILE . 11.2 m -113.93 14.44 8.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 CA-C-O 121.261 0.553 . . . . 0.0 110.635 179.456 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.8 p 46.58 52.0 11.46 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.128 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 55.7 tp -117.78 133.29 56.08 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.321 0.581 . . . . 0.0 110.604 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.859 ' O ' HD23 ' A' ' 92' ' ' LEU . 93.7 mt-10 -147.94 125.32 11.6 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.925 -179.292 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.859 HD23 ' O ' ' A' ' 91' ' ' GLU . 7.8 mt -148.89 148.48 27.59 Favored Pre-proline 0 CA--C 1.537 0.457 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.421 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -75.36 147.75 33.03 Favored 'Trans proline' 0 N--CA 1.493 1.465 0 C-N-CA 122.68 2.253 . . . . 0.0 110.878 178.1 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.484 ' C ' HD12 ' A' ' 95' ' ' LEU . 92.3 t -93.51 119.86 41.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.189 0.519 . . . . 0.0 110.649 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.567 HD12 ' N ' ' A' ' 95' ' ' LEU . 10.6 mp -97.82 126.09 43.01 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.72 0.772 . . . . 0.0 110.842 -179.685 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.527 ' O ' ' OG1' ' A' ' 109' ' ' THR . 86.7 tttt -63.64 -38.41 91.0 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.827 -1.078 . . . . 0.0 112.043 -178.581 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.497 ' CB ' ' ND2' ' A' ' 102' ' ' ASN . 2.7 m -79.76 126.43 30.94 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 121.636 0.731 . . . . 0.0 112.463 -178.582 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.462 ' OG ' ' O ' ' A' ' 109' ' ' THR . 0.9 OUTLIER -89.13 44.5 1.22 Allowed 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.714 179.687 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.578 ' OG1' ' ND2' ' A' ' 102' ' ' ASN . 71.4 p -89.48 171.78 9.47 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.03 179.121 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.439 ' HA ' HD12 ' A' ' 103' ' ' LEU . 94.8 mt-10 -66.06 -39.62 90.25 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.161 0.505 . . . . 0.0 110.143 179.247 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -64.43 -41.75 96.41 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.147 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.578 ' ND2' ' OG1' ' A' ' 99' ' ' THR . 54.0 m-80 -65.15 -34.83 79.33 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.6 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.537 HD13 ' HB3' ' B' ' 704' ' ' ALA . 42.0 mt -65.13 -16.54 63.6 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.634 -179.595 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.419 HD23 ' HA ' ' A' ' 104' ' ' LEU . 91.5 mt -73.76 -15.47 61.2 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.381 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.462 ' OG ' HD22 ' A' ' 95' ' ' LEU . 93.9 p -82.11 -2.84 53.3 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.198 0.523 . . . . 0.0 110.431 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.592 ' O ' ' CE1' ' A' ' 135' ' ' PHE . . . 93.31 -19.53 51.87 Favored Glycine 0 CA--C 1.527 0.799 0 CA-C-N 115.854 -0.612 . . . . 0.0 113.08 178.105 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -146.56 125.53 12.8 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 119.483 -0.887 . . . . 0.0 112.382 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -143.24 142.38 31.37 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.833 178.345 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.527 ' OG1' ' O ' ' A' ' 96' ' ' LYS . 58.5 p -65.37 132.44 49.0 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.46 0.648 . . . . 0.0 111.288 -178.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.658 HG13 ' CD ' ' B' ' 703' ' ' PRO . 78.9 t -78.38 -55.2 10.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.655 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.449 ' H ' ' CD ' ' A' ' 114' ' ' GLN . 83.5 mttt -107.04 139.74 40.96 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 122.048 0.928 . . . . 0.0 112.162 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -66.25 -34.48 78.11 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.444 -1.253 . . . . 0.0 112.165 -178.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -85.7 20.77 2.04 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 113.075 0.769 . . . . 0.0 113.075 -178.448 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.496 ' NE2' ' H ' ' A' ' 122' ' ' ALA . 80.8 mt-30 -77.9 140.58 39.31 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.048 0.451 . . . . 0.0 111.034 179.635 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.2 t -125.91 108.54 19.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.965 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 73.3 mtp -56.25 126.61 26.94 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 121.121 0.486 . . . . 0.0 111.039 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 97.01 -11.76 65.79 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 121.133 -0.556 . . . . 0.0 111.825 179.255 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -143.72 137.29 28.04 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 121.055 0.455 . . . . 0.0 111.53 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 76.27 -170.7 54.83 Favored Glycine 0 CA--C 1.531 1.069 0 N-CA-C 111.675 -0.57 . . . . 0.0 111.675 179.149 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 54.5 t-20 -88.52 104.56 16.93 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 121.304 0.573 . . . . 0.0 110.576 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.416 ' HE2' HD21 ' A' ' 123' ' ' LEU . 6.6 t80 -86.99 145.97 26.31 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.4 179.417 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.496 ' H ' ' NE2' ' A' ' 114' ' ' GLN . . . -147.58 143.76 27.98 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 119.493 -0.883 . . . . 0.0 111.841 -179.095 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.487 HD23 ' HA ' ' A' ' 109' ' ' THR . 63.8 mt -138.29 143.75 40.16 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 114.823 -1.081 . . . . 0.0 110.181 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -111.71 138.35 48.4 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.128 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -132.03 145.34 17.11 Favored Glycine 0 CA--C 1.531 1.046 0 N-CA-C 110.386 -1.086 . . . . 0.0 110.386 -179.287 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.437 ' ND1' HG2B ' B' ' 705' ' ' B27 . 10.1 m-70 -88.63 124.1 33.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.449 0.642 . . . . 0.0 112.258 -179.231 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -122.83 121.82 37.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.251 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.433 ' H ' HG21 ' A' ' 133' ' ' VAL . 75.9 mtm -95.85 2.22 53.58 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 121.263 0.554 . . . . 0.0 110.748 179.405 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 76.04 10.5 3.14 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.543 179.114 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.81 ' O ' HG12 ' A' ' 133' ' ' VAL . 5.6 ptmt -110.51 114.16 27.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.878 0.847 . . . . 0.0 112.395 -179.352 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 6.1 tmtt? -37.72 120.28 0.81 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.661 -1.154 . . . . 0.0 111.7 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 113.13 -11.94 24.34 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.329 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.81 HG12 ' O ' ' A' ' 130' ' ' LYS . 11.8 p -91.71 164.31 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 CA-C-N 115.048 -0.576 . . . . 0.0 110.267 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.547 ' N ' HG22 ' A' ' 133' ' ' VAL . 0.7 OUTLIER -70.75 140.16 51.27 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.872 0.844 . . . . 0.0 112.645 -177.355 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.649 ' CG ' HD12 ' A' ' 138' ' ' ILE . 3.2 m-85 66.43 5.3 3.68 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 113.977 -1.465 . . . . 0.0 113.796 177.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' SER . . . . . 0.542 ' OG ' ' CG1' ' A' ' 133' ' ' VAL . 0.4 OUTLIER -68.14 -40.48 82.4 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 112.373 0.509 . . . . 0.0 112.373 179.131 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.6 p-10 -88.95 -1.34 58.06 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 121.251 0.548 . . . . 0.0 111.439 -178.215 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.649 HD12 ' CG ' ' A' ' 135' ' ' PHE . 0.3 OUTLIER -65.24 -35.71 76.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-O 121.158 0.504 . . . . 0.0 110.254 178.957 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.83 ' HB2' ' OH ' ' A' ' 197' ' ' TYR . . . -66.83 -11.44 55.44 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.052 0.453 . . . . 0.0 110.926 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 59.6 p -84.35 -1.91 56.23 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 121.199 0.524 . . . . 0.0 110.756 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.44 HD21 HG21 ' A' ' 85' ' ' ILE . 66.1 mt -63.54 138.72 58.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.237 -179.547 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -113.48 154.46 27.0 Favored 'General case' 0 CA--C 1.535 0.365 0 CA-C-O 121.425 0.631 . . . . 0.0 111.351 -179.341 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -51.3 133.71 28.62 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.751 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.561 ' N ' ' O ' ' A' ' 160' ' ' VAL . . . 79.32 7.95 88.13 Favored Glycine 0 CA--C 1.527 0.84 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.554 179.14 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -70.12 132.8 46.38 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 119.88 -0.728 . . . . 0.0 109.852 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -78.59 138.32 38.3 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.76 0.79 . . . . 0.0 111.773 -178.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.517 HD11 ' CG2' ' A' ' 160' ' ' VAL . 95.9 mt -135.8 136.41 50.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 114.817 -1.083 . . . . 0.0 108.382 178.774 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' TYR . . . . . 0.496 ' C ' HD22 ' A' ' 149' ' ' LEU . 89.9 m-85 -117.81 135.0 54.36 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.906 0.86 . . . . 0.0 112.842 -178.779 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.496 HD22 ' C ' ' A' ' 148' ' ' TYR . 4.5 mm? -110.84 133.57 53.24 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 114.528 -1.215 . . . . 0.0 108.445 178.234 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.601 ' CZ ' ' OE2' ' A' ' 155' ' ' GLU . 79.8 m-85 -116.93 110.52 18.41 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 120.202 -0.599 . . . . 0.0 111.581 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ASP . . . . . 0.466 ' OD1' ' N ' ' A' ' 152' ' ' ASN . 52.4 t0 -89.25 164.94 14.74 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 177.176 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ASN . . . . . 0.466 ' N ' ' OD1' ' A' ' 151' ' ' ASP . 34.5 p30 -58.85 -19.12 38.76 Favored 'General case' 0 C--N 1.314 -0.967 0 C-N-CA 119.286 -0.965 . . . . 0.0 111.031 -178.119 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -112.28 -28.08 8.07 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -178.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' ASN . . . . . 0.414 ' O ' ' N ' ' A' ' 151' ' ' ASP . 0.6 OUTLIER -148.67 -175.64 5.01 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 -176.333 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.601 ' OE2' ' CZ ' ' A' ' 150' ' ' TYR . 87.7 tt0 -132.46 133.77 44.25 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 114.072 -1.422 . . . . 0.0 110.237 178.8 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' TYR . . . . . 0.425 ' CD1' HG23 ' A' ' 206' ' ' THR . 80.2 m-85 -112.59 140.22 47.53 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 120.846 0.355 . . . . 0.0 110.315 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' GLU . . . . . 0.44 ' O ' HD12 ' A' ' 203' ' ' LEU . 82.5 tt0 -99.87 117.98 35.34 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 121.047 0.451 . . . . 0.0 112.051 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -114.75 148.82 37.83 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 121.178 0.513 . . . . 0.0 111.416 179.329 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -121.03 120.85 36.58 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.713 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.561 ' O ' ' N ' ' A' ' 144' ' ' GLY . 91.0 t -59.59 136.77 22.86 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.292 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.743 178.199 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 15.1 p -105.63 -24.05 12.63 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.786 178.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 154.86 -163.43 31.32 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 120.682 -0.771 . . . . 0.0 111.62 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.61 HG12 HG22 ' A' ' 199' ' ' VAL . 35.5 m -135.76 158.07 39.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-N 115.343 -0.428 . . . . 0.0 110.004 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 81.6 p -145.95 165.78 27.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.118 0.485 . . . . 0.0 110.924 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -101.85 115.2 30.02 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.898 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.542 ' O ' ' O ' ' A' ' 196' ' ' ARG . 23.8 m -137.98 162.76 30.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.989 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -86.48 157.01 56.22 Favored Pre-proline 0 CA--C 1.54 0.575 0 CA-C-O 121.16 0.505 . . . . 0.0 111.431 -179.443 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.517 ' O ' HD12 ' B' ' 702' ' ' LEU . 36.5 Cg_endo -67.86 -9.98 27.34 Favored 'Trans proline' 0 N--CA 1.5 1.862 0 C-N-CA 123.398 2.732 . . . . 0.0 112.861 -179.626 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' ASP . . . . . 0.424 ' OD1' ' C ' ' A' ' 169' ' ' ASP . 40.2 p-10 -95.01 -4.0 47.35 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.236 0.541 . . . . 0.0 110.924 179.018 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.777 ' O ' HD23 ' B' ' 702' ' ' LEU . 70.3 mmtt -75.69 82.83 2.68 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.533 -178.8 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 40.4 p-90 -76.72 -12.08 59.94 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 121.356 0.598 . . . . 0.0 110.594 178.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 76.4 tt0 -61.0 -36.58 79.86 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.988 -179.392 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' VAL . . . . . 0.637 HG22 HG21 ' A' ' 183' ' ' THR . 11.6 p -62.44 -25.97 39.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 CA-C-O 121.107 0.479 . . . . 0.0 110.77 -179.556 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.468 HG11 HG11 ' A' ' 110' ' ' VAL . 20.1 t -93.1 -8.49 10.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.945 -179.161 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.525 ' OE1' ' O ' ' A' ' 176' ' ' ASP . 0.6 OUTLIER -73.5 146.77 44.64 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 120.935 0.398 . . . . 0.0 111.076 -179.766 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 176' ' ' ASP . . . . . 0.525 ' O ' ' OE1' ' A' ' 175' ' ' GLU . 48.1 p-10 -66.27 128.29 35.54 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.281 0.563 . . . . 0.0 111.857 -179.169 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 21.4 m80 -111.49 24.66 12.52 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.965 -0.561 . . . . 0.0 112.119 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 60.21 35.79 88.94 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 120.724 -0.75 . . . . 0.0 111.247 179.342 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -154.15 161.41 41.88 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 110.208 -0.293 . . . . 0.0 110.208 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -89.35 105.25 17.67 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.897 179.153 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 -139.21 167.02 23.0 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.569 0.699 . . . . 0.0 112.154 179.365 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.468 HG22 ' O ' ' A' ' 201' ' ' GLY . 18.9 tt -130.08 138.02 55.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 114.827 -1.079 . . . . 0.0 109.917 179.121 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 183' ' ' THR . . . . . 0.637 HG21 HG22 ' A' ' 173' ' ' VAL . 39.8 m -130.98 122.64 27.22 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.176 0.512 . . . . 0.0 111.079 -179.216 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 93.9 mt -109.43 136.29 49.08 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.631 178.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 70.0 mt -105.68 115.71 47.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 C-N-CA 120.206 -0.598 . . . . 0.0 110.179 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' THR . . . . . 0.425 HG21 ' OH ' ' A' ' 197' ' ' TYR . 77.1 m -126.79 132.63 51.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.275 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 187' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -84.03 140.8 31.62 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.498 HG23 ' HA ' ' A' ' 196' ' ' ARG . 73.7 t -61.19 -49.05 86.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.161 0.505 . . . . 0.0 111.257 -178.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 34.7 p -168.52 163.84 12.47 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.282 0.563 . . . . 0.0 111.009 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 31.3 m -76.85 -9.89 12.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.349 179.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -101.37 -23.49 14.36 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.852 178.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 60.4 t0 -96.68 105.77 17.93 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.04 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -109.77 5.92 23.12 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.177 0.513 . . . . 0.0 110.632 179.63 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 85.9 p -68.43 -59.76 2.94 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.677 -179.317 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -147.49 155.77 42.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.17 0.51 . . . . 0.0 111.25 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 196' ' ' ARG . . . . . 0.542 ' O ' ' O ' ' A' ' 166' ' ' VAL . 99.8 mtt180 -129.58 143.78 50.98 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.533 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 197' ' ' TYR . . . . . 0.83 ' OH ' ' HB2' ' A' ' 139' ' ' ALA . 36.4 p90 -93.16 152.07 19.46 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.425 0.631 . . . . 0.0 111.314 -179.335 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.413 HG11 HG21 ' A' ' 173' ' ' VAL . 48.4 t -123.7 132.93 70.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.378 179.309 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.61 HG22 HG12 ' A' ' 163' ' ' VAL . 40.7 t -94.0 132.32 38.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.989 -179.243 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -119.3 145.0 46.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.465 0.65 . . . . 0.0 111.393 -179.124 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 201' ' ' GLY . . . . . 0.468 ' O ' HG22 ' A' ' 182' ' ' ILE . . . -142.8 146.08 16.62 Favored Glycine 0 CA--C 1.529 0.945 0 N-CA-C 110.451 -1.06 . . . . 0.0 110.451 179.587 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 48.9 p-10 -109.04 151.66 26.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.175 0.512 . . . . 0.0 111.427 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 203' ' ' LEU . . . . . 0.44 HD12 ' O ' ' A' ' 157' ' ' GLU . 51.0 tp -72.48 132.36 43.76 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 178.838 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 2.6 p -115.25 -19.19 6.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 120.74 -0.384 . . . . 0.0 111.493 -179.303 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 205' ' ' GLY . . . . . 0.422 ' O ' HD11 ' A' ' 203' ' ' LEU . . . -178.3 174.64 46.89 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 120.804 -0.712 . . . . 0.0 111.66 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 206' ' ' THR . . . . . 0.425 HG23 ' CD1' ' A' ' 156' ' ' TYR . 60.3 m -141.04 136.3 31.91 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-O 120.662 0.268 . . . . 0.0 110.652 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -143.96 115.62 8.18 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 120.153 -0.619 . . . . 0.0 112.309 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -64.3 147.57 52.2 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.256 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 8.4 ttpt -80.34 109.53 14.92 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.365 178.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 98.0 mttt . . . . . 0 C--O 1.221 -0.428 0 CA-C-O 117.837 -1.078 . . . . 0.0 110.536 179.142 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 701' ' ' BOC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 702' ' ' LEU . . . . . 0.777 HD23 ' O ' ' A' ' 170' ' ' LYS . 0.2 OUTLIER 56.32 77.58 0.42 Allowed Pre-proline 0 CA--C 1.539 0.539 0 CA-C-O 121.628 0.728 . . . . 20.0 110.892 . . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 703' ' ' PRO . . . . . 0.658 ' CD ' HG13 ' A' ' 110' ' ' VAL . 3.7 Cg_exo -72.18 -171.04 0.63 Allowed 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 123.84 3.027 . . . . 20.0 112.982 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 704' ' ' ALA . . . . . 0.547 ' O ' ' O ' ' B' ' 703' ' ' PRO . . . -39.04 178.34 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.079 -0.964 . . . . 20.0 113.129 -178.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 705' ' ' B27 . . . . . 0.468 ' OG1' ' O ' ' B' ' 704' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.259 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 58.8 m -60.81 -41.05 94.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.896 0.379 . . . . 0.0 111.717 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 44.0 m80 -69.21 -13.95 62.7 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.32 0.581 . . . . 0.0 110.391 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 11.0 ttm -104.13 121.46 43.29 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.165 179.514 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -66.53 143.29 57.15 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-O 121.202 0.525 . . . . 0.0 110.474 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -88.9 9.17 25.84 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.42 0.628 . . . . 0.0 110.17 179.651 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 5.4 p -82.6 10.08 8.14 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.546 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -96.74 8.56 44.0 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.238 0.542 . . . . 0.0 110.869 -179.46 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 59.0 mt -55.19 142.72 9.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.953 0.882 . . . . 0.0 111.68 -177.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -75.48 126.95 32.05 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 114.142 -1.39 . . . . 0.0 108.775 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.682 ' CD ' ' H ' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -78.72 130.87 69.32 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.708 -178.867 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.627 ' HD2' HD21 ' A' ' 104' ' ' LEU . 56.8 Cg_exo -51.14 150.52 13.85 Favored 'Trans proline' 0 N--CA 1.493 1.471 0 C-N-CA 121.695 1.597 . . . . 0.0 111.767 178.705 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.444 ' CG ' ' H ' ' A' ' 66' ' ' LEU . 45.0 t0 -52.41 177.51 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 121.198 0.523 . . . . 0.0 111.506 -178.804 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.742 HD21 HG23 ' A' ' 133' ' ' VAL . 94.5 mt -65.95 -45.25 82.5 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.672 -178.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.63 -30.59 70.81 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.229 -0.588 . . . . 0.0 110.704 -178.528 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -62.82 -30.36 71.42 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.431 178.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.611 HG22 HD22 ' A' ' 104' ' ' LEU . 37.3 t -77.84 -46.27 27.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.131 -0.94 . . . . 0.0 110.685 179.403 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.08 -9.58 58.29 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.144 -0.935 . . . . 0.0 111.244 -179.084 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -109.35 -13.61 14.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.318 0.58 . . . . 0.0 110.095 178.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.37 135.44 51.8 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.712 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 33.0 t -59.47 103.01 0.16 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.647 -179.458 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.85 125.95 28.25 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.591 -179.546 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -98.49 83.77 3.07 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 121.382 0.611 . . . . 0.0 109.95 178.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -62.82 -38.28 90.11 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.376 -179.529 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.577 ' CD ' ' H ' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -71.51 -12.03 61.17 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 120.471 -0.492 . . . . 0.0 110.999 -177.347 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -93.05 0.71 57.4 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.423 0.63 . . . . 0.0 110.203 178.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 88.3 t -86.11 128.31 39.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.132 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 16.5 pt -107.35 -7.9 10.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.239 -179.198 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -170.95 179.33 42.91 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 120.454 -0.879 . . . . 0.0 111.808 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 56.4 ttp180 -140.24 156.26 46.56 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 121.378 0.609 . . . . 0.0 111.315 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.475 HG22 ' O ' ' A' ' 92' ' ' LEU . 16.8 tt -125.29 141.98 43.56 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 CA-C-O 121.437 0.637 . . . . 0.0 110.464 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 66.5 m -135.31 130.31 34.86 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.093 -0.958 . . . . 0.0 111.258 -178.541 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.429 ' CG2' HG22 ' A' ' 88' ' ' VAL . 22.6 mt -133.79 88.73 32.12 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.121 -178.847 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -54.9 -35.36 89.03 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 123.278 2.652 . . . . 0.0 112.644 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 44.4 t -55.88 -43.41 77.15 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.192 -0.458 . . . . 0.0 112.212 -179.13 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.429 HG22 ' CG2' ' A' ' 85' ' ' ILE . 21.7 m -112.21 6.36 8.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.285 0.564 . . . . 0.0 110.731 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.7 m 56.05 53.01 9.61 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.196 179.223 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 58.1 tp -116.7 135.52 53.71 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.309 0.576 . . . . 0.0 110.779 179.413 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -146.44 117.06 7.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.115 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.475 ' O ' HG22 ' A' ' 83' ' ' ILE . 75.5 mt -150.27 151.45 31.49 Favored Pre-proline 0 CA--C 1.539 0.538 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.481 -179.293 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -74.2 147.0 37.02 Favored 'Trans proline' 0 N--CA 1.493 1.475 0 C-N-CA 122.833 2.355 . . . . 0.0 111.827 179.155 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.549 ' C ' HD12 ' A' ' 95' ' ' LEU . 74.2 t -92.46 122.22 43.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.083 0.468 . . . . 0.0 110.228 179.488 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.581 HD12 ' N ' ' A' ' 95' ' ' LEU . 10.2 mp -100.67 126.66 47.2 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.806 0.812 . . . . 0.0 110.672 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -63.02 -46.45 87.56 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.34 -1.3 . . . . 0.0 112.835 -178.166 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 4.3 m -86.25 132.09 34.07 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 121.123 0.487 . . . . 0.0 111.75 -179.203 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -87.17 60.41 6.14 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.352 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.552 HG22 ' N ' ' A' ' 100' ' ' GLU . 54.1 m -88.11 163.31 16.28 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 178.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.552 ' N ' HG22 ' A' ' 99' ' ' THR . 94.5 mt-10 -58.56 -44.56 89.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.284 0.564 . . . . 0.0 110.232 -179.424 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.406 ' H ' HG22 ' A' ' 99' ' ' THR . 66.3 mttm -64.8 -40.33 95.05 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.717 0.77 . . . . 0.0 110.077 178.197 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -63.25 -36.42 83.62 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.054 -0.975 . . . . 0.0 111.711 -179.336 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.644 HD13 ' HB3' ' B' ' 704' ' ' ALA . 74.6 mt -61.89 -25.53 67.61 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 120.809 -0.357 . . . . 0.0 111.223 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.627 HD21 ' HD2' ' A' ' 64' ' ' PRO . 84.6 mt -73.15 -13.32 61.15 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.908 0.385 . . . . 0.0 111.029 -179.483 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 94.4 p -73.98 -9.01 58.21 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.392 0.615 . . . . 0.0 110.158 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.524 ' O ' ' CE1' ' A' ' 135' ' ' PHE . . . 95.31 -20.86 47.36 Favored Glycine 0 CA--C 1.526 0.779 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.884 178.729 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -146.92 125.48 12.47 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.215 -0.594 . . . . 0.0 111.376 179.418 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -144.15 129.11 18.5 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.116 179.005 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.657 ' HA ' HD23 ' A' ' 123' ' ' LEU . 27.7 m -66.96 131.55 46.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.897 -179.483 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.625 HG22 ' HG2' ' B' ' 703' ' ' PRO . 92.7 t -79.07 -53.31 13.74 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.91 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.822 ' H ' ' NE2' ' A' ' 114' ' ' GLN . 73.3 mmtt -100.73 131.68 46.5 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 122.134 0.969 . . . . 0.0 111.949 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -66.09 -27.94 68.44 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 114.627 -1.17 . . . . 0.0 113.076 -178.249 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -84.14 12.97 5.6 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 113.863 1.06 . . . . 0.0 113.863 -177.602 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.822 ' NE2' ' H ' ' A' ' 111' ' ' LYS . 45.5 mt-30 -77.96 143.28 37.75 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.348 0.595 . . . . 0.0 112.502 -179.622 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 53.0 t -123.56 124.64 69.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.046 178.264 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 63.6 mtt -58.42 130.5 47.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.417 179.581 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 84.19 -1.13 89.13 Favored Glycine 0 CA--C 1.529 0.933 0 N-CA-C 111.551 -0.619 . . . . 0.0 111.551 179.093 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -143.85 128.18 17.82 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 121.048 0.451 . . . . 0.0 110.787 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 78.76 -177.68 53.83 Favored Glycine 0 CA--C 1.532 1.117 0 N-CA-C 111.82 -0.512 . . . . 0.0 111.82 179.529 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 61.7 t-20 -84.97 105.4 15.7 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 120.943 0.402 . . . . 0.0 110.131 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.502 ' HE2' HD21 ' A' ' 123' ' ' LEU . 3.7 t80 -86.6 99.69 11.89 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.012 0.434 . . . . 0.0 110.386 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.58 ' HB3' HG13 ' A' ' 174' ' ' VAL . . . -93.09 137.11 32.74 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 121.08 0.467 . . . . 0.0 111.628 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.657 HD23 ' HA ' ' A' ' 109' ' ' THR . 61.1 mt -136.26 142.56 43.99 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.59 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -107.38 139.59 41.63 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 178.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -137.52 148.07 19.6 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 109.254 -1.538 . . . . 0.0 109.254 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 12.6 m-70 -92.26 123.68 35.77 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.744 0.783 . . . . 0.0 112.411 -178.758 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ASN . . . . . 0.401 ' OD1' ' N ' ' A' ' 129' ' ' SER . 52.0 t-20 -116.27 119.71 36.6 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.086 179.282 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.44 ' HB2' HG21 ' A' ' 133' ' ' VAL . 68.6 mtt -94.92 -2.75 49.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.351 0.596 . . . . 0.0 109.923 179.605 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.401 ' N ' ' OD1' ' A' ' 127' ' ' ASN . 0.2 OUTLIER 74.55 6.56 4.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.07 179.585 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.788 ' O ' HG12 ' A' ' 133' ' ' VAL . 11.4 ptpt -113.43 120.71 41.98 Favored 'General case' 0 C--O 1.225 -0.235 0 CA-C-O 121.33 0.586 . . . . 0.0 112.224 -179.379 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.51 ' O ' ' O ' ' A' ' 130' ' ' LYS . 18.2 tptt -31.93 155.13 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.616 179.316 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 77.39 -17.01 5.51 Favored Glycine 0 CA--C 1.529 0.913 0 N-CA-C 110.819 -0.912 . . . . 0.0 110.819 179.462 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.788 HG12 ' O ' ' A' ' 130' ' ' LYS . 7.8 p -91.62 150.88 3.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 120.057 -0.657 . . . . 0.0 109.732 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.795 HD23 ' N ' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -68.27 146.18 53.57 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 122.035 0.922 . . . . 0.0 113.245 -177.112 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.524 ' CE1' ' O ' ' A' ' 106' ' ' GLY . 3.2 m-85 65.12 5.38 2.97 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 113.787 -1.551 . . . . 0.0 113.865 178.143 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' SER . . . . . 0.519 ' OG ' ' CG1' ' A' ' 133' ' ' VAL . 0.5 OUTLIER -71.65 -38.94 70.64 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 121.692 -0.63 . . . . 0.0 112.593 179.465 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 79.0 m-20 -93.46 0.73 56.86 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 114.9 1.444 . . . . 0.0 114.9 -177.025 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.554 HD11 ' HB ' ' A' ' 186' ' ' THR . 38.4 pt -63.87 -22.83 31.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 119.038 -1.065 . . . . 0.0 110.471 -178.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -69.49 -10.86 59.85 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.268 0.556 . . . . 0.0 110.086 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 1.4 m -84.45 -5.21 59.26 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.572 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 82.1 mt -64.75 145.55 56.07 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.409 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -120.71 157.59 29.32 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 121.455 0.645 . . . . 0.0 112.148 -178.376 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -50.67 131.97 25.79 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.6 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.452 ' N ' ' O ' ' A' ' 160' ' ' VAL . . . 80.17 7.37 88.59 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 120.648 -0.787 . . . . 0.0 111.149 179.05 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.489 ' OD1' ' N ' ' A' ' 146' ' ' LYS . 64.9 t0 -73.73 131.56 41.73 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 119.89 -0.724 . . . . 0.0 110.007 -179.705 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.489 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 73.6 mmtt -76.95 140.06 40.34 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.616 0.722 . . . . 0.0 112.124 -178.272 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 48.9 mm -131.51 134.42 60.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 177.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' TYR . . . . . 0.431 ' C ' HD22 ' A' ' 149' ' ' LEU . 78.9 m-85 -112.49 127.49 56.07 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 119.747 -0.781 . . . . 0.0 112.424 -178.315 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.431 HD22 ' C ' ' A' ' 148' ' ' TYR . 4.4 mm? -110.79 132.43 54.2 Favored 'General case' 0 C--O 1.224 -0.279 0 CA-C-N 114.943 -1.026 . . . . 0.0 108.658 178.374 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.594 ' CE2' ' OE1' ' A' ' 155' ' ' GLU . 61.2 m-85 -117.21 112.14 20.41 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.204 -0.598 . . . . 0.0 112.569 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' ASP . . . . . 0.563 ' OD1' ' N ' ' A' ' 152' ' ' ASN . 54.6 t0 -91.2 164.81 13.77 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 176.56 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' ASN . . . . . 0.563 ' N ' ' OD1' ' A' ' 151' ' ' ASP . 15.6 m120 -57.61 -23.93 53.66 Favored 'General case' 0 C--N 1.311 -1.074 0 C-N-CA 120.106 -0.637 . . . . 0.0 111.112 -178.023 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -108.3 -29.68 8.74 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 119.762 -0.775 . . . . 0.0 112.839 -178.664 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' ASN . . . . . 0.471 ' O ' ' N ' ' A' ' 151' ' ' ASP . 0.5 OUTLIER -149.51 -177.51 5.9 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 113.723 1.008 . . . . 0.0 113.723 -177.779 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.594 ' OE1' ' CE2' ' A' ' 150' ' ' TYR . 80.0 tt0 -128.76 138.09 51.91 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 114.209 -1.36 . . . . 0.0 110.066 179.143 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -111.56 134.0 53.44 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 121.354 0.597 . . . . 0.0 111.383 -179.608 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -89.65 108.25 19.56 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.453 178.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -112.02 147.22 36.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.026 0.441 . . . . 0.0 111.187 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.525 ' HB2' HG21 ' A' ' 204' ' ' VAL . . . -124.32 123.39 40.1 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 121.047 0.451 . . . . 0.0 110.917 179.238 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.452 ' O ' ' N ' ' A' ' 144' ' ' GLY . 81.2 t -59.45 135.09 24.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 178.07 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 42.6 p -105.29 -26.04 12.17 Favored 'General case' 0 C--N 1.33 -0.263 0 O-C-N 123.325 0.39 . . . . 0.0 110.674 179.047 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 162.69 -169.72 38.02 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 120.452 -0.88 . . . . 0.0 111.992 179.63 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 3.0 p -135.11 149.92 29.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.068 -0.566 . . . . 0.0 110.15 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 50.7 m -139.54 163.58 32.17 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.427 0.632 . . . . 0.0 111.187 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -100.22 121.57 41.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.266 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.436 HG11 HG11 ' A' ' 173' ' ' VAL . 27.1 m -136.72 161.3 36.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.386 -179.517 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -92.68 165.03 20.03 Favored Pre-proline 0 CA--C 1.538 0.501 0 C-N-CA 120.662 -0.415 . . . . 0.0 111.054 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.431 ' O ' ' CB ' ' B' ' 702' ' ' LEU . 25.0 Cg_exo -62.52 -19.72 68.52 Favored 'Trans proline' 0 N--CA 1.499 1.852 0 C-N-CA 122.489 2.126 . . . . 0.0 112.998 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 46.7 p-10 -94.76 -5.85 44.36 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.549 ' O ' HG22 ' A' ' 173' ' ' VAL . 96.5 mttt -75.95 88.82 2.93 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 119.655 -0.818 . . . . 0.0 111.657 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 4.9 p90 -76.89 -14.49 59.87 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.467 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -57.59 -35.53 70.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.47 -179.099 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' VAL . . . . . 0.549 HG22 ' O ' ' A' ' 170' ' ' LYS . 27.6 m -64.16 -15.56 17.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 C-N-CA 120.771 -0.372 . . . . 0.0 111.253 -179.602 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.58 HG13 ' HB3' ' A' ' 122' ' ' ALA . 78.6 t -103.96 -16.1 7.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -179.361 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -74.57 144.33 44.04 Favored 'General case' 0 CA--C 1.533 0.319 0 O-C-N 121.816 -0.552 . . . . 0.0 110.956 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' ASP . . . . . 0.501 ' OD1' ' O ' ' A' ' 176' ' ' ASP . 55.7 p-10 -64.95 145.16 56.69 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.456 179.726 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 68.9 m80 -120.7 31.73 6.3 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 121.035 0.445 . . . . 0.0 111.759 -179.421 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 59.93 39.79 96.02 Favored Glycine 0 CA--C 1.534 1.228 0 N-CA-C 111.257 -0.737 . . . . 0.0 111.257 179.447 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -155.89 165.72 35.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.028 0.442 . . . . 0.0 110.781 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -88.56 102.03 14.53 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 177.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' GLU . . . . . 0.454 ' HG2' ' N ' ' A' ' 182' ' ' ILE . 84.4 tt0 -138.27 163.54 31.51 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.663 0.744 . . . . 0.0 111.909 -178.335 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.454 ' N ' ' HG2' ' A' ' 181' ' ' GLU . 18.6 tt -130.65 138.93 52.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.13 178.839 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 86.0 m -130.3 125.49 34.87 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.477 0.656 . . . . 0.0 111.639 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 93.2 mt -109.54 131.58 54.93 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.111 178.675 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.794 HD13 HD21 ' B' ' 702' ' ' LEU . 82.6 mt -113.91 125.39 71.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.465 0.65 . . . . 0.0 111.889 -177.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 186' ' ' THR . . . . . 0.554 ' HB ' HD11 ' A' ' 138' ' ' ILE . 3.4 t -140.98 161.95 36.62 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.547 179.563 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 187' ' ' CYS . . . . . 0.531 ' N ' ' SG ' ' B' ' 705' ' ' B27 . 1.9 m -96.94 146.43 24.97 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.379 179.634 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.565 HG13 ' N ' ' A' ' 189' ' ' SER . 8.0 p -63.8 -43.51 97.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.196 0.522 . . . . 0.0 111.353 -179.322 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 189' ' ' SER . . . . . 0.565 ' N ' HG13 ' A' ' 188' ' ' VAL . 13.6 p -162.76 160.88 25.88 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.483 -179.306 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 190' ' ' VAL . . . . . 0.454 HG22 ' O ' ' A' ' 190' ' ' VAL . 9.5 p -79.18 -11.75 13.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.83 179.277 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -97.97 -19.85 17.79 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.052 0.453 . . . . 0.0 111.083 179.229 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 67.2 t0 -132.64 103.67 6.25 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.103 0.478 . . . . 0.0 111.403 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -104.29 10.84 35.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.875 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 44.2 t -60.72 -43.7 97.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.078 0.466 . . . . 0.0 111.109 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -125.03 144.33 50.45 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.05 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -124.47 143.54 50.59 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.852 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -98.67 133.51 42.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.023 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.404 ' CG2' HG21 ' A' ' 166' ' ' VAL . 30.0 t -120.3 131.17 73.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 CA-C-O 121.426 0.631 . . . . 0.0 110.936 179.271 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 31.7 t -104.28 132.07 51.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.194 179.668 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -113.78 144.38 43.07 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.368 0.604 . . . . 0.0 111.556 -179.344 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -136.46 139.32 10.55 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 110.356 -1.098 . . . . 0.0 110.356 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -103.47 138.65 39.9 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.145 0.497 . . . . 0.0 110.816 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 66.0 tp -62.83 131.52 49.08 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.466 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.525 HG21 ' HB2' ' A' ' 159' ' ' ALA . 2.8 t -115.37 -19.81 6.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 C-N-CA 120.762 -0.375 . . . . 0.0 111.503 -178.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -178.13 173.53 46.01 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 120.649 -0.786 . . . . 0.0 111.716 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 24.7 m -140.87 137.02 32.91 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.584 -0.525 . . . . 0.0 109.584 179.308 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -143.92 117.27 9.05 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.335 0.588 . . . . 0.0 112.075 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -62.43 141.71 58.23 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.991 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 8.9 ttpt -78.52 109.52 12.77 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.224 178.512 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 99.8 mttt . . . . . 0 C--N 1.322 -0.606 0 CA-C-O 117.914 -1.041 . . . . 0.0 110.828 -179.293 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 701' ' ' BOC . . . . . 0.559 ' H32' HG11 ' A' ' 110' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 702' ' ' LEU . . . . . 0.794 HD21 HD13 ' A' ' 185' ' ' ILE . 0.4 OUTLIER -77.93 119.59 77.98 Favored Pre-proline 0 CA--C 1.543 0.681 0 N-CA-C 110.125 -0.324 . . . . 20.0 110.125 . . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 703' ' ' PRO . . . . . 0.633 ' HD2' HD23 ' B' ' 702' ' ' LEU . 2.8 Cg_endo -65.68 -176.83 0.61 Allowed 'Trans proline' 0 N--CA 1.489 1.249 0 C-N-CA 121.663 1.575 . . . . 20.0 113.047 -179.131 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 704' ' ' ALA . . . . . 0.644 ' HB3' HD13 ' A' ' 103' ' ' LEU . . . -41.21 -177.53 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.319 -1.31 . . . . 20.0 113.527 -179.114 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 705' ' ' B27 . . . . . 0.531 ' SG ' ' N ' ' A' ' 187' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.297 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 81.1 p -62.02 -35.54 78.88 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 120.903 0.382 . . . . 0.0 111.184 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 81.5 t60 -115.24 118.02 32.13 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.008 0.432 . . . . 0.0 110.572 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 78.1 mtm -82.59 137.13 34.64 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.731 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -61.49 118.28 6.81 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 120.543 -0.463 . . . . 0.0 110.138 -179.667 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -101.96 14.89 30.69 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.524 -179.252 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 98.4 p -87.72 1.59 53.39 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.587 0.708 . . . . 0.0 110.077 178.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -100.26 10.27 41.49 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.038 -178.402 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 95.7 mt -56.04 135.22 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-O 122.159 0.981 . . . . 0.0 112.948 -176.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 85.0 m-20 -75.94 130.61 38.73 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 113.881 -1.509 . . . . 0.0 108.913 178.326 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.625 ' CD ' ' H ' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -82.25 152.49 67.88 Favored Pre-proline 0 C--N 1.328 -0.348 0 C-N-CA 120.15 -0.62 . . . . 0.0 110.49 -179.66 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -72.43 169.92 20.54 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 123.135 2.557 . . . . 0.0 112.76 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -54.65 169.61 0.2 Allowed 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.416 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 57.2 tp -64.3 -45.4 88.14 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.688 -179.018 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.73 -36.14 75.99 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.09 -0.644 . . . . 0.0 111.157 -177.737 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.604 ' OE1' ' N ' ' A' ' 68' ' ' GLU . 4.9 mp0 -55.88 -28.84 58.53 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.444 0.64 . . . . 0.0 109.511 178.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 38.3 t -76.59 -44.41 34.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-N 115.342 -0.844 . . . . 0.0 110.823 179.427 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -79.7 -8.08 59.0 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.974 -179.396 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -105.89 -13.14 15.59 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.337 0.589 . . . . 0.0 109.926 178.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -70.03 138.22 51.97 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.516 -0.766 . . . . 0.0 111.31 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 37.4 t -59.54 100.31 0.08 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.447 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.688 HD13 ' C ' ' A' ' 74' ' ' LEU . 2.8 tm? -71.12 122.87 20.92 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.137 -179.115 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.677 ' N ' HD13 ' A' ' 74' ' ' LEU . 91.4 m-20 -92.66 80.59 4.77 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 121.299 0.571 . . . . 0.0 110.501 178.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 51.8 tptt -65.83 -32.88 74.65 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.052 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.512 ' HE3' ' H ' ' A' ' 77' ' ' LYS . 3.0 mtmt -72.63 -18.31 61.59 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.414 -177.704 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -90.54 -9.51 46.92 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.033 0.444 . . . . 0.0 110.836 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 96.5 t -70.25 130.27 34.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.404 0.621 . . . . 0.0 111.263 -179.273 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.413 HG21 ' HE3' ' A' ' 96' ' ' LYS . 42.9 pt -118.13 -11.86 11.19 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.579 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -159.83 170.02 35.92 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 111.154 -0.779 . . . . 0.0 111.154 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 61.9 ttp180 -143.61 151.35 40.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.542 0.686 . . . . 0.0 112.154 -179.106 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.455 HG22 ' O ' ' A' ' 92' ' ' LEU . 21.0 tt -112.79 138.01 43.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.546 178.612 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 33.3 t -135.64 128.7 31.58 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 121.518 0.675 . . . . 0.0 111.903 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.508 HG22 HG22 ' A' ' 88' ' ' VAL . 85.1 mt -138.16 86.07 17.89 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.182 179.461 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -55.96 -29.85 75.27 Favored 'Trans proline' 0 N--CA 1.497 1.703 0 C-N-CA 123.091 2.527 . . . . 0.0 113.16 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 95.9 p -53.45 -38.43 63.55 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 120.537 -0.465 . . . . 0.0 111.005 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.508 HG22 HG22 ' A' ' 85' ' ' ILE . 23.7 m -117.47 12.2 7.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.387 0.613 . . . . 0.0 110.001 178.574 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 48.21 53.55 11.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.762 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.546 HD11 HD11 ' A' ' 92' ' ' LEU . 58.0 tp -114.93 132.47 56.54 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.318 179.68 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.739 ' O ' HD23 ' A' ' 92' ' ' LEU . 96.2 mt-10 -145.78 122.36 11.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.649 -179.254 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.739 HD23 ' O ' ' A' ' 91' ' ' GLU . 8.6 mt -146.81 147.74 30.79 Favored Pre-proline 0 CA--C 1.54 0.56 0 C-N-CA 120.198 -0.601 . . . . 0.0 111.95 -179.099 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -77.15 151.57 30.38 Favored 'Trans proline' 0 N--CA 1.497 1.688 0 C-N-CA 123.059 2.506 . . . . 0.0 112.478 178.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.462 ' C ' HD12 ' A' ' 95' ' ' LEU . 87.7 t -95.52 113.24 29.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-O 121.065 0.46 . . . . 0.0 111.613 179.311 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.562 HD12 ' N ' ' A' ' 95' ' ' LEU . 11.1 mp -98.87 139.82 33.96 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.96 179.6 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.485 ' O ' ' OG1' ' A' ' 109' ' ' THR . 98.8 mttt -63.79 -80.97 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -178.731 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 33.6 t -60.86 131.14 49.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.186 0.517 . . . . 0.0 111.838 -178.576 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 35.3 p -89.72 71.68 7.73 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.99 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.534 HG22 ' N ' ' A' ' 100' ' ' GLU . 26.1 m -92.21 169.53 10.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.505 -0.771 . . . . 0.0 109.251 178.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.534 ' N ' HG22 ' A' ' 99' ' ' THR . 99.1 mt-10 -61.65 -44.43 96.98 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 119.776 -0.77 . . . . 0.0 110.059 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -65.7 -40.99 92.86 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 121.33 0.586 . . . . 0.0 110.955 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -63.92 -38.7 92.05 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.149 -179.513 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 64.9 mt -62.63 -18.86 63.08 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.608 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 75.2 mt -70.74 -18.37 62.78 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.998 0.428 . . . . 0.0 110.39 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 88.9 p -74.45 -8.77 57.38 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.555 0.693 . . . . 0.0 109.286 179.17 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.608 ' O ' ' CE1' ' A' ' 135' ' ' PHE . . . 93.01 -19.15 53.98 Favored Glycine 0 CA--C 1.53 0.974 0 CA-C-N 115.123 -0.944 . . . . 0.0 112.337 178.616 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -146.25 126.76 14.13 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 119.659 -0.816 . . . . 0.0 112.745 -179.409 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -143.54 138.85 29.43 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.042 178.443 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.485 ' OG1' ' O ' ' A' ' 96' ' ' LYS . 30.0 p -65.67 133.03 50.25 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 121.271 0.558 . . . . 0.0 110.718 -179.556 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.576 HG22 ' HG2' ' B' ' 703' ' ' PRO . 44.4 t -80.52 -50.4 17.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.385 -179.168 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.753 ' H ' ' NE2' ' A' ' 114' ' ' GLN . 76.8 mttt -105.65 141.22 37.47 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.835 0.826 . . . . 0.0 112.631 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -66.8 -36.26 81.97 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.174 -0.921 . . . . 0.0 112.917 -178.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 17.0 p30 -82.13 15.88 2.19 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -178.328 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.753 ' NE2' ' H ' ' A' ' 111' ' ' LYS . 32.9 mt-30 -78.2 137.42 38.13 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 122.031 -0.418 . . . . 0.0 110.482 179.487 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 69.0 t -124.24 125.87 71.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.269 -0.423 . . . . 0.0 109.994 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' MET . . . . . 0.598 ' SD ' ' CZ ' ' A' ' 121' ' ' TYR . 91.7 mmm -56.53 125.75 23.48 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.097 0.475 . . . . 0.0 111.467 -179.605 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 82.59 -0.66 89.11 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-N 115.905 -0.589 . . . . 0.0 112.294 178.771 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -138.07 130.56 29.29 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 119.998 -0.681 . . . . 0.0 110.637 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 74.2 -169.47 53.91 Favored Glycine 0 CA--C 1.53 1.006 0 N-CA-C 110.518 -1.033 . . . . 0.0 110.518 -179.376 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 58.8 t-20 -89.39 105.62 17.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.992 0.425 . . . . 0.0 110.04 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.598 ' CZ ' ' SD ' ' A' ' 116' ' ' MET . 11.4 t80 -88.45 100.44 13.05 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.015 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.14 137.71 32.12 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 121.276 0.56 . . . . 0.0 111.745 -178.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.508 HD21 ' CE2' ' A' ' 121' ' ' TYR . 62.7 mt -135.21 137.33 42.53 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.923 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -112.07 135.69 52.4 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.389 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -130.75 134.22 7.67 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 110.601 -1.0 . . . . 0.0 110.601 -179.218 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -82.14 138.46 34.74 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.504 0.669 . . . . 0.0 111.627 -179.394 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ASN . . . . . 0.924 ' C ' HD21 ' A' ' 127' ' ' ASN . 0.2 OUTLIER -141.47 161.0 38.98 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.14 -0.937 . . . . 0.0 110.388 179.568 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.445 ' O ' ' CB ' ' A' ' 129' ' ' SER . 70.7 mtm -124.28 1.19 8.43 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.575 178.846 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.445 ' CB ' ' O ' ' A' ' 128' ' ' MET . 0.2 OUTLIER 76.93 12.37 2.31 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.764 179.361 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.775 ' O ' HG12 ' A' ' 133' ' ' VAL . 9.3 ptpt -115.21 119.54 36.71 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.465 0.65 . . . . 0.0 112.295 -179.254 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.536 ' O ' ' O ' ' A' ' 130' ' ' LYS . 74.7 mmtt -29.07 154.73 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.893 -1.048 . . . . 0.0 111.611 179.453 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 75.34 -15.09 4.64 Favored Glycine 0 CA--C 1.529 0.94 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.964 179.088 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.775 HG12 ' O ' ' A' ' 130' ' ' LYS . 9.8 p -91.27 153.8 3.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 C-N-CA 120.371 -0.532 . . . . 0.0 109.785 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.782 HD23 ' N ' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -70.69 144.47 51.02 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 113.97 1.1 . . . . 0.0 113.97 -177.396 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.659 ' CG ' HD12 ' A' ' 138' ' ' ILE . 3.9 m-85 68.7 -0.94 2.14 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 113.67 -1.605 . . . . 0.0 113.598 178.579 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 6.7 t -69.4 -39.43 77.94 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 179.349 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -89.36 -6.99 56.16 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.355 0.598 . . . . 0.0 111.252 -178.617 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.659 HD12 ' CG ' ' A' ' 135' ' ' PHE . 8.0 mt -62.86 -42.32 95.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.433 179.329 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -63.38 -12.02 27.33 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 120.238 -0.585 . . . . 0.0 110.337 179.228 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 1.9 m -82.36 -6.19 59.1 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.325 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.406 HD12 HG23 ' A' ' 138' ' ' ILE . 81.4 mt -63.27 142.02 58.54 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.212 179.795 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -116.76 163.62 15.87 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.701 0.762 . . . . 0.0 111.81 -179.013 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -52.08 134.97 32.15 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.868 -1.06 . . . . 0.0 112.158 179.297 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.545 ' N ' ' O ' ' A' ' 160' ' ' VAL . . . 77.14 7.97 86.85 Favored Glycine 0 CA--C 1.527 0.818 0 CA-C-N 115.541 -0.754 . . . . 0.0 112.313 178.011 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 50.6 t0 -72.62 132.93 44.37 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 119.541 -0.864 . . . . 0.0 109.804 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -77.45 138.1 39.05 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 121.663 0.744 . . . . 0.0 111.716 -178.447 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.489 HD11 ' CG2' ' A' ' 160' ' ' VAL . 87.2 mt -133.42 135.4 56.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 114.958 -1.019 . . . . 0.0 108.342 178.637 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' TYR . . . . . 0.404 ' C ' HD22 ' A' ' 149' ' ' LEU . 69.9 m-85 -115.64 133.52 55.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.535 0.683 . . . . 0.0 112.689 -178.243 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.433 HD13 ' HA ' ' A' ' 149' ' ' LEU . 4.5 mm? -115.64 133.02 56.44 Favored 'General case' 0 C--O 1.225 -0.229 0 CA-C-N 115.158 -0.928 . . . . 0.0 108.872 177.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.592 ' CZ ' ' OE2' ' A' ' 155' ' ' GLU . 93.4 m-85 -116.39 114.0 23.68 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.315 -0.554 . . . . 0.0 111.138 179.504 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' ASP . . . . . 0.467 ' OD1' ' N ' ' A' ' 152' ' ' ASN . 54.1 t0 -93.29 172.3 8.38 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 177.751 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' ASN . . . . . 0.467 ' N ' ' OD1' ' A' ' 151' ' ' ASP . 68.6 m-20 -58.04 -26.85 63.0 Favored 'General case' 0 C--N 1.318 -0.764 0 C-N-CA 120.483 -0.487 . . . . 0.0 111.477 -177.844 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -115.08 -24.19 8.67 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 -178.22 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -146.86 177.73 8.89 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -176.159 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.592 ' OE2' ' CZ ' ' A' ' 150' ' ' TYR . 83.8 tt0 -126.99 138.0 53.19 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 114.644 -1.162 . . . . 0.0 110.323 178.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' TYR . . . . . 0.426 ' CD1' HG23 ' A' ' 206' ' ' THR . 92.0 m-85 -115.12 133.97 55.58 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 121.089 0.471 . . . . 0.0 111.676 -179.094 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -92.95 109.55 21.0 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.482 179.491 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -112.82 148.64 34.43 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.091 0.472 . . . . 0.0 111.168 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -125.23 124.46 41.74 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 121.331 0.586 . . . . 0.0 111.226 179.61 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.545 ' O ' ' N ' ' A' ' 144' ' ' GLY . 77.5 t -59.06 136.47 22.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.918 178.152 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 66.8 p -104.43 -24.81 13.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.09 0.472 . . . . 0.0 110.918 179.4 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 157.97 -167.7 34.35 Favored Glycine 0 CA--C 1.529 0.939 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.672 HG12 HG22 ' A' ' 199' ' ' VAL . 2.8 m -133.55 158.55 42.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.165 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 69.8 m -142.62 164.27 30.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.479 0.657 . . . . 0.0 111.731 -179.611 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -99.59 114.43 27.46 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.682 179.667 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 20.5 m -136.79 158.12 36.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.42 0.629 . . . . 0.0 111.582 -179.051 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -87.65 159.01 50.38 Favored Pre-proline 0 CA--C 1.536 0.423 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.996 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.443 ' O ' HD12 ' B' ' 702' ' ' LEU . 37.2 Cg_endo -64.81 -10.54 25.41 Favored 'Trans proline' 0 N--CA 1.498 1.739 0 C-N-CA 122.861 2.374 . . . . 0.0 112.98 -179.416 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 45.5 p-10 -95.44 -8.24 35.99 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.723 ' O ' HD23 ' B' ' 702' ' ' LEU . 98.0 mttt -77.13 86.73 3.6 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 121.75 0.786 . . . . 0.0 112.256 -179.194 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' TRP . . . . . 0.606 ' O ' HG22 ' A' ' 174' ' ' VAL . 1.2 p-90 -80.47 -9.25 59.77 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.798 -1.092 . . . . 0.0 110.883 179.583 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -63.89 -32.11 73.52 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.818 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' VAL . . . . . 0.656 HG22 ' O ' ' A' ' 170' ' ' LYS . 35.0 m -63.13 -18.71 22.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-N 116.112 -0.495 . . . . 0.0 112.137 -179.152 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.613 HG13 HG23 ' A' ' 173' ' ' VAL . 34.8 m -106.47 -0.36 9.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -179.11 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.51 ' OE2' ' CE2' ' A' ' 171' ' ' TRP . 96.7 mt-10 -74.0 149.21 41.4 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 121.138 0.494 . . . . 0.0 111.51 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 176' ' ' ASP . . . . . 0.464 ' OD1' ' O ' ' A' ' 176' ' ' ASP . 46.8 p-10 -68.4 135.0 51.08 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.531 179.23 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 41.9 m80 -117.32 28.68 8.33 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 120.704 -0.398 . . . . 0.0 111.255 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 62.82 34.35 89.53 Favored Glycine 0 CA--C 1.531 1.031 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 179.563 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -152.69 163.63 39.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.842 0.353 . . . . 0.0 110.422 179.601 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -88.14 106.41 18.16 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 177.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' GLU . . . . . 0.435 ' HG2' ' N ' ' A' ' 182' ' ' ILE . 82.7 tt0 -136.18 161.32 36.06 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.421 0.629 . . . . 0.0 111.275 -178.511 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.435 ' N ' ' HG2' ' A' ' 181' ' ' GLU . 17.3 tt -130.11 137.18 57.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.463 -0.789 . . . . 0.0 108.947 178.747 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 85.0 m -131.03 128.02 39.45 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.076 0.465 . . . . 0.0 111.493 -179.089 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 68.4 mt -112.95 133.39 54.94 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.742 178.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 82.0 mt -109.48 120.11 60.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.23 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 8.8 t -133.28 147.74 51.92 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.709 179.601 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 187' ' ' CYS . . . . . 0.601 ' HB2' HD22 ' A' ' 127' ' ' ASN . 2.1 m -87.65 142.31 27.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.863 -179.718 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.569 HG13 ' N ' ' A' ' 189' ' ' SER . 14.3 p -62.35 -44.7 99.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.888 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 189' ' ' SER . . . . . 0.569 ' N ' HG13 ' A' ' 188' ' ' VAL . 24.9 t -170.69 148.72 3.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.122 0.487 . . . . 0.0 111.104 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 190' ' ' VAL . . . . . 0.408 HG22 ' O ' ' A' ' 190' ' ' VAL . 8.7 p -68.77 -14.86 19.02 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 CA-C-O 121.187 0.518 . . . . 0.0 110.493 179.47 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -95.61 -11.74 26.77 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.574 179.641 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -135.67 102.2 5.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.223 0.535 . . . . 0.0 110.87 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -102.99 11.25 37.57 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.845 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 12.3 t -60.8 -45.0 96.13 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.639 -178.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 64.7 pttt -142.59 159.82 41.49 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 120.946 0.403 . . . . 0.0 110.635 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 196' ' ' ARG . . . . . 0.502 ' NH1' ' SG ' ' B' ' 705' ' ' B27 . 94.5 mtt-85 -132.32 147.59 52.4 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 121.053 0.454 . . . . 0.0 111.451 -178.439 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -97.19 135.47 39.09 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 121.164 0.507 . . . . 0.0 111.413 179.521 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 38.9 t -120.53 129.46 75.56 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.914 179.228 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.672 HG22 HG12 ' A' ' 163' ' ' VAL . 54.1 t -100.12 133.27 43.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.527 -179.57 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -122.64 152.52 40.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.522 0.677 . . . . 0.0 111.584 -179.387 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -147.41 149.85 22.03 Favored Glycine 0 CA--C 1.532 1.107 0 N-CA-C 110.33 -1.108 . . . . 0.0 110.33 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -106.28 148.89 27.45 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.927 0.394 . . . . 0.0 111.007 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 62.4 tp -66.23 130.39 43.05 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 178.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 46.9 t -110.32 -24.19 4.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 C-N-CA 120.8 -0.36 . . . . 0.0 111.609 -178.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -178.47 173.74 46.08 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 111.164 -0.775 . . . . 0.0 111.164 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 206' ' ' THR . . . . . 0.426 HG23 ' CD1' ' A' ' 156' ' ' TYR . 19.6 m -142.89 141.76 31.59 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.135 0.493 . . . . 0.0 110.254 179.478 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -141.43 114.55 8.66 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.262 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -64.74 148.1 51.81 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.829 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 55.8 mtmt -77.06 154.99 32.82 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.543 178.737 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 53.9 mtmt . . . . . 0 C--O 1.22 -0.479 0 CA-C-O 117.919 -1.039 . . . . 0.0 110.832 179.573 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 701' ' ' BOC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 702' ' ' LEU . . . . . 0.723 HD23 ' O ' ' A' ' 170' ' ' LYS . 0.2 OUTLIER 57.5 78.34 0.37 Allowed Pre-proline 0 CA--C 1.537 0.476 0 CA-C-O 121.505 0.669 . . . . 20.0 111.046 . . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 703' ' ' PRO . . . . . 0.576 ' HG2' HG22 ' A' ' 110' ' ' VAL . 3.1 Cg_exo -73.72 -165.43 0.25 Allowed 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 123.576 2.851 . . . . 20.0 112.898 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 704' ' ' ALA . . . . . 0.55 ' O ' ' O ' ' B' ' 703' ' ' PRO . . . -39.64 -176.21 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 115.008 -0.996 . . . . 20.0 113.081 -179.501 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 705' ' ' B27 . . . . . 0.558 ' SG ' ' N ' ' A' ' 187' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.378 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 30.8 t -136.93 136.34 38.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.971 0.415 . . . . 0.0 110.581 179.47 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -112.27 132.21 55.07 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.107 0.479 . . . . 0.0 110.813 179.381 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 78.2 mtm -101.87 140.57 35.97 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.492 179.22 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.45 ' OD1' ' OG ' ' A' ' 59' ' ' SER . 47.2 t0 -165.04 122.53 1.58 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.619 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -97.55 -1.58 43.65 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.145 0.497 . . . . 0.0 110.828 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.45 ' OG ' ' OD1' ' A' ' 57' ' ' ASP . 92.4 p -85.25 1.49 48.03 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.242 -178.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.437 ' HG2' HH21 ' A' ' 196' ' ' ARG . 99.5 mttt -99.05 17.54 19.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.069 0.462 . . . . 0.0 111.602 -179.361 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 14.7 mm -55.74 136.62 18.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 122.449 1.119 . . . . 0.0 112.231 -177.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -80.12 126.23 30.81 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 113.346 -1.752 . . . . 0.0 109.894 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.402 ' HB2' ' CG ' ' A' ' 126' ' ' HIS . 13.2 tt0 -78.17 123.17 86.03 Favored Pre-proline 0 CA--C 1.533 0.322 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -44.0 170.38 0.02 OUTLIER 'Trans proline' 0 C--N 1.313 -1.341 0 C-N-CA 121.886 1.724 . . . . 0.0 112.318 -179.55 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.463 ' O ' HG23 ' A' ' 69' ' ' VAL . 91.7 m-20 -52.18 163.16 0.4 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.15 -179.321 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 55.0 tp -62.58 -44.84 95.32 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.786 -177.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -60.43 -38.51 84.31 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.226 -0.589 . . . . 0.0 111.603 -178.152 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 66.3 tt0 -60.85 -25.17 66.45 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.14 -0.624 . . . . 0.0 110.027 179.606 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.634 HG13 ' HB3' ' A' ' 104' ' ' LEU . 36.1 t -77.83 -47.15 25.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.633 0.73 . . . . 0.0 109.774 178.878 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -73.43 -8.53 56.26 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 114.86 -1.064 . . . . 0.0 110.811 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -103.62 -16.95 15.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.502 0.668 . . . . 0.0 110.255 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -69.4 142.7 53.85 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.898 -179.467 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 33.6 t -58.56 97.52 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.564 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -67.79 136.15 53.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.109 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.446 ' OD2' ' CD ' ' A' ' 78' ' ' GLN . 37.6 t0 -103.55 79.11 1.65 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.334 178.772 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -71.76 -35.37 70.05 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.471 0.653 . . . . 0.0 111.962 179.345 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 43.8 mmtt -67.95 -31.12 70.63 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.058 -0.973 . . . . 0.0 112.781 -174.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.446 ' CD ' ' OD2' ' A' ' 75' ' ' ASP . 86.4 mt-30 -87.34 6.3 34.29 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.219 -0.593 . . . . 0.0 111.621 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 59.3 t -78.42 130.13 36.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 120.434 -0.506 . . . . 0.0 109.661 179.115 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.649 HD13 ' HE3' ' A' ' 96' ' ' LYS . 43.4 pt -110.3 -4.71 10.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.778 -179.271 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -163.56 166.0 37.07 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 120.499 -0.858 . . . . 0.0 111.605 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 72.0 ttp85 -137.66 141.29 41.15 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 121.095 0.474 . . . . 0.0 111.191 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.55 HG22 ' O ' ' A' ' 92' ' ' LEU . 19.9 tt -105.08 141.43 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.984 179.23 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 7.9 t -137.63 131.79 32.05 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 121.4 0.619 . . . . 0.0 112.219 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.624 ' CG2' HG22 ' A' ' 88' ' ' VAL . 87.2 mt -136.71 88.05 19.65 Favored Pre-proline 0 CA--C 1.537 0.465 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.805 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -55.4 -32.01 80.01 Favored 'Trans proline' 0 N--CA 1.5 1.881 0 C-N-CA 123.155 2.57 . . . . 0.0 112.571 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 67.3 m -54.3 -42.71 70.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.26 0.552 . . . . 0.0 110.678 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.624 HG22 ' CG2' ' A' ' 85' ' ' ILE . 19.7 m -112.43 6.84 8.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.371 179.592 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 50.65 52.25 15.27 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.879 0.847 . . . . 0.0 110.187 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 52.8 tp -118.32 133.85 55.54 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.185 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -145.05 126.96 15.43 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.734 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.55 ' O ' HG22 ' A' ' 83' ' ' ILE . 80.1 mt -149.06 151.01 33.55 Favored Pre-proline 0 CA--C 1.538 0.497 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.493 -178.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -76.53 148.82 29.95 Favored 'Trans proline' 0 N--CA 1.496 1.66 0 C-N-CA 122.839 2.359 . . . . 0.0 111.804 178.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.55 ' C ' HD12 ' A' ' 95' ' ' LEU . 73.8 t -97.3 117.97 42.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-O 121.047 0.451 . . . . 0.0 111.579 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.563 HD12 ' N ' ' A' ' 95' ' ' LEU . 9.4 mp -102.74 134.1 46.68 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.889 179.437 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.649 ' HE3' HD13 ' A' ' 80' ' ' ILE . 98.1 mttt -58.55 -83.4 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 121.26 0.552 . . . . 0.0 111.934 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 18.7 m -61.33 138.31 58.25 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.527 0.679 . . . . 0.0 111.666 -178.375 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 3.1 m -95.4 70.62 3.15 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.17 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 8.7 p -88.54 166.65 14.02 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 177.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -59.13 -40.61 85.99 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 119.931 -0.707 . . . . 0.0 109.994 179.691 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -65.49 -42.18 92.45 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 121.321 0.581 . . . . 0.0 110.709 178.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -64.36 -37.05 86.13 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.477 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.493 HD13 ' CB ' ' B' ' 704' ' ' ALA . 84.7 mt -62.93 -18.02 62.57 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.857 -179.488 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.634 ' HB3' HG13 ' A' ' 69' ' ' VAL . 98.0 mt -74.73 -18.0 60.56 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.846 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 50.5 m -74.36 -4.9 39.19 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-O 121.728 0.775 . . . . 0.0 109.366 179.236 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 86.48 -19.78 26.26 Favored Glycine 0 CA--C 1.532 1.134 0 CA-C-N 114.826 -1.079 . . . . 0.0 112.803 178.38 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -145.91 123.98 12.12 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 119.585 -0.846 . . . . 0.0 112.472 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -145.9 141.55 27.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.362 -0.836 . . . . 0.0 109.968 178.553 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.435 ' OG1' ' O ' ' A' ' 96' ' ' LYS . 20.5 p -65.9 136.39 56.05 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.135 -0.626 . . . . 0.0 109.583 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.538 HG13 ' CG ' ' B' ' 703' ' ' PRO . 76.1 t -76.78 -46.12 30.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.928 -179.573 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.406 ' O ' ' HG2' ' A' ' 114' ' ' GLN . 43.3 mtpt -99.09 142.82 30.08 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 122.013 0.911 . . . . 0.0 112.036 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -67.42 -36.09 80.57 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.594 -1.184 . . . . 0.0 111.956 -179.178 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 72.8 m-80 -86.76 22.18 2.02 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 114.203 1.186 . . . . 0.0 114.203 -177.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.438 ' OE1' ' O ' ' A' ' 120' ' ' ASN . 94.5 mm-40 -78.37 137.28 37.94 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 121.797 -0.564 . . . . 0.0 112.312 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 61.5 t -128.18 123.96 61.4 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.868 179.003 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 55.6 mtt -58.55 130.91 49.07 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 121.133 0.492 . . . . 0.0 111.924 179.459 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 78.23 -0.51 73.87 Favored Glycine 0 CA--C 1.531 1.051 0 CA-C-N 116.04 -0.527 . . . . 0.0 112.789 178.266 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -138.38 124.99 20.79 Favored 'General case' 0 C--N 1.329 -0.317 0 O-C-N 122.047 -0.678 . . . . 0.0 111.1 -179.484 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 76.12 -165.31 54.01 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 110.337 -1.105 . . . . 0.0 110.337 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.438 ' O ' ' OE1' ' A' ' 114' ' ' GLN . 59.0 t-20 -91.73 105.34 17.65 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.041 0.448 . . . . 0.0 109.864 179.414 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.775 ' CE2' HD11 ' A' ' 123' ' ' LEU . 7.4 t80 -85.43 144.91 27.71 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 179.637 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.905 ' C ' HD12 ' A' ' 123' ' ' LEU . . . -146.8 145.61 29.97 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 119.842 -0.743 . . . . 0.0 111.944 -178.835 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.905 HD12 ' C ' ' A' ' 122' ' ' ALA . 7.4 mp -139.61 145.25 38.3 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.918 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.426 ' HB1' ' HG2' ' B' ' 705' ' ' B27 . . . -110.23 135.73 50.53 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 178.779 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -136.72 148.99 20.02 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 110.294 -1.122 . . . . 0.0 110.294 -179.352 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.759 ' O ' HD23 ' A' ' 134' ' ' LEU . 21.6 m-70 -86.79 142.52 28.05 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.616 0.722 . . . . 0.0 111.935 -179.157 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 49.5 t-20 -131.51 120.79 23.44 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.142 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.606 ' HB2' HG21 ' A' ' 133' ' ' VAL . 62.9 mtt -94.4 -2.77 51.42 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.227 0.537 . . . . 0.0 110.662 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.466 ' CB ' ' O ' ' A' ' 128' ' ' MET . 0.7 OUTLIER 77.43 3.97 3.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.318 179.123 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.862 ' O ' HG12 ' A' ' 133' ' ' VAL . 61.8 pttt -118.16 130.72 56.27 Favored 'General case' 0 C--O 1.222 -0.357 0 CA-C-O 121.623 0.725 . . . . 0.0 112.817 -178.578 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.473 ' O ' ' O ' ' A' ' 130' ' ' LYS . 74.9 mmtt -41.12 163.66 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.354 0.597 . . . . 0.0 109.616 179.026 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 74.93 -22.51 1.47 Allowed Glycine 0 CA--C 1.53 1.007 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.862 HG12 ' O ' ' A' ' 130' ' ' LYS . 3.7 p -90.25 156.84 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 119.776 -0.77 . . . . 0.0 110.746 -179.36 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.88 HD13 ' H ' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -70.79 146.25 49.87 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 115.023 1.49 . . . . 0.0 115.023 -176.803 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 59.68 7.77 1.14 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 112.504 -2.135 . . . . 0.0 114.153 177.465 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 5.4 t -69.9 -33.27 71.97 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 119.99 -0.684 . . . . 0.0 112.371 179.66 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -89.52 0.65 56.75 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 -178.083 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 2.1 pp -58.2 -31.52 42.29 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 C-N-CA 119.874 -0.73 . . . . 0.0 110.965 -179.268 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -65.1 -13.89 59.16 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.962 0.411 . . . . 0.0 110.876 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 49.3 m -81.52 -4.0 54.74 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.152 -179.104 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 92.9 mt -64.57 142.12 58.54 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.119 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -120.52 156.01 32.44 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.223 0.535 . . . . 0.0 110.185 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -49.63 130.34 20.58 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.848 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 160' ' ' VAL . . . 80.76 8.46 87.47 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 120.837 -0.697 . . . . 0.0 111.914 178.773 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.498 ' OD1' ' N ' ' A' ' 146' ' ' LYS . 63.8 t0 -71.77 133.95 45.88 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 119.737 -0.785 . . . . 0.0 109.928 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.498 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 73.2 mmtt -78.97 140.52 38.0 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.764 0.792 . . . . 0.0 112.749 -178.235 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.434 HD11 ' CG2' ' A' ' 160' ' ' VAL . 96.3 mt -134.35 134.32 54.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 114.718 -1.128 . . . . 0.0 108.014 178.762 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' TYR . . . . . 0.585 ' C ' HD22 ' A' ' 149' ' ' LEU . 88.1 m-85 -115.45 133.7 55.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.648 0.737 . . . . 0.0 112.706 -178.217 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.585 HD22 ' C ' ' A' ' 148' ' ' TYR . 4.5 mm? -114.7 132.64 56.35 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.97 -1.014 . . . . 0.0 108.397 177.704 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.494 ' CZ ' ' OE2' ' A' ' 155' ' ' GLU . 94.1 m-85 -115.51 110.13 18.82 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 119.985 -0.686 . . . . 0.0 111.673 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' ASP . . . . . 0.57 ' OD1' ' N ' ' A' ' 152' ' ' ASN . 62.3 t0 -88.3 165.67 14.84 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 177.015 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' ASN . . . . . 0.57 ' N ' ' OD1' ' A' ' 151' ' ' ASP . 36.5 p-10 -58.18 -20.35 40.49 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 119.466 -0.894 . . . . 0.0 111.219 -178.21 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -115.03 -27.88 7.19 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 -178.495 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -147.52 176.33 10.14 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 118.963 -1.095 . . . . 0.0 113.455 -176.579 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.494 ' OE2' ' CZ ' ' A' ' 150' ' ' TYR . 83.8 tt0 -125.02 133.48 52.95 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 114.604 -1.18 . . . . 0.0 110.141 178.845 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' TYR . . . . . 0.47 ' CD1' HG23 ' A' ' 206' ' ' THR . 86.1 m-85 -107.94 133.55 52.12 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 120.967 0.413 . . . . 0.0 111.271 -179.557 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -91.7 110.11 21.44 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.352 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -113.36 146.47 39.41 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.015 0.436 . . . . 0.0 111.137 179.726 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -126.12 125.68 42.92 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 121.133 0.492 . . . . 0.0 111.132 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.537 ' O ' ' N ' ' A' ' 144' ' ' GLY . 83.0 t -58.27 133.63 23.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.667 178.425 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 70.5 p -115.49 11.3 15.91 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 139.6 171.6 12.36 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 119.972 -1.109 . . . . 0.0 112.923 178.527 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.63 HG22 HG22 ' A' ' 199' ' ' VAL . 42.1 t -125.63 135.43 63.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 114.305 -0.948 . . . . 0.0 108.874 178.728 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 30.8 m -131.98 162.32 30.99 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.504 0.668 . . . . 0.0 111.85 -179.09 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.427 ' HG2' ' CE2' ' A' ' 197' ' ' TYR . 99.1 mt-10 -108.22 121.19 44.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.606 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 29.1 m -136.38 157.45 37.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.431 0.634 . . . . 0.0 111.349 -179.312 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.26 159.39 70.34 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.755 179.169 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.51 ' O ' ' CB ' ' B' ' 702' ' ' LEU . 37.8 Cg_endo -65.66 -15.55 49.79 Favored 'Trans proline' 0 C--N 1.302 -1.891 0 C-N-CA 123.114 2.543 . . . . 0.0 113.227 -179.652 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 50.8 p-10 -92.26 -3.78 54.99 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 119.808 -0.757 . . . . 0.0 111.842 179.627 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.801 ' O ' HG22 ' A' ' 173' ' ' VAL . 74.7 mmtt -74.43 80.45 1.91 Allowed 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.261 -0.575 . . . . 0.0 110.634 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' TRP . . . . . 0.701 ' CZ3' ' H22' ' B' ' 701' ' ' BOC . 33.8 m0 -69.17 -17.63 63.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.87 179.675 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -61.18 -30.52 70.46 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.73 -178.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' VAL . . . . . 0.801 HG22 ' O ' ' A' ' 170' ' ' LYS . 30.8 m -63.27 -15.88 16.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.188 0.518 . . . . 0.0 111.008 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.701 HG23 HG23 ' A' ' 173' ' ' VAL . 78.3 t -111.16 -11.05 11.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.131 -179.123 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -73.46 152.53 40.7 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.201 0.524 . . . . 0.0 111.224 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' ASP . . . . . 0.523 ' OD1' ' O ' ' A' ' 176' ' ' ASP . 49.5 p30 -70.19 136.74 50.33 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 121.347 0.594 . . . . 0.0 111.41 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 77.9 m80 -107.4 -18.89 13.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.469 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 102.49 37.55 3.24 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -178.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 11.6 ptmt -157.38 170.21 22.97 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.089 -0.556 . . . . 0.0 111.063 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -87.79 100.28 12.73 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 177.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' GLU . . . . . 0.446 ' HG2' ' N ' ' A' ' 182' ' ' ILE . 79.4 tt0 -136.32 161.22 36.4 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.403 0.62 . . . . 0.0 111.272 -179.119 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.446 ' N ' ' HG2' ' A' ' 181' ' ' GLU . 20.7 tt -129.6 138.35 54.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.249 -0.887 . . . . 0.0 108.782 178.404 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 183' ' ' THR . . . . . 0.542 ' C ' HD12 ' A' ' 184' ' ' LEU . 97.8 m -128.04 126.02 40.47 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.199 0.523 . . . . 0.0 112.17 -178.732 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.585 HD12 ' N ' ' A' ' 184' ' ' LEU . 10.2 mp -107.94 127.41 53.73 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.119 178.341 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.58 HD13 HD21 ' B' ' 702' ' ' LEU . 93.3 mt -114.29 123.98 70.49 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-O 121.362 0.601 . . . . 0.0 111.545 -178.634 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -142.54 161.55 37.77 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.597 179.425 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 187' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -98.63 139.98 33.54 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 178.172 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.602 HG13 ' N ' ' A' ' 189' ' ' SER . 7.4 p -59.76 -47.26 91.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.807 -178.501 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 189' ' ' SER . . . . . 0.602 ' N ' HG13 ' A' ' 188' ' ' VAL . 23.1 p -160.52 157.85 28.2 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.1 0.476 . . . . 0.0 110.761 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 27.8 m -76.87 -9.21 12.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.212 0.53 . . . . 0.0 110.24 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -96.95 -18.95 19.14 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.978 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -136.8 98.79 3.87 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.09 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -101.44 11.35 39.27 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 121.131 0.491 . . . . 0.0 110.902 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 47.1 t -59.92 -43.25 95.01 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.476 -179.569 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 51.6 mtmt -132.06 146.3 51.97 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 121.185 0.517 . . . . 0.0 111.211 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 196' ' ' ARG . . . . . 0.47 ' CZ ' ' HX ' ' B' ' 705' ' ' B27 . 99.9 mtt180 -121.32 145.41 47.91 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.926 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 197' ' ' TYR . . . . . 0.427 ' CE2' ' HG2' ' A' ' 165' ' ' GLU . 36.4 m-85 -94.87 140.79 29.43 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.727 179.704 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 55.8 t -130.85 132.35 64.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.298 0.57 . . . . 0.0 111.041 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.63 HG22 HG22 ' A' ' 163' ' ' VAL . 47.8 t -100.19 133.93 41.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.07 179.635 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -108.07 132.84 53.14 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.266 0.555 . . . . 0.0 110.93 -179.311 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -132.2 140.59 11.95 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 202' ' ' ASP . . . . . 0.558 ' OD1' ' N ' ' A' ' 203' ' ' LEU . 67.9 t0 -111.5 138.49 47.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.123 0.487 . . . . 0.0 111.151 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 203' ' ' LEU . . . . . 0.558 ' N ' ' OD1' ' A' ' 202' ' ' ASP . 53.8 tp -62.69 128.9 38.1 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.863 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 1.3 p -114.38 -19.94 6.39 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 120.848 -0.341 . . . . 0.0 111.548 -178.643 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -175.87 170.94 44.0 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 120.768 -0.729 . . . . 0.0 111.858 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 206' ' ' THR . . . . . 0.47 HG23 ' CD1' ' A' ' 156' ' ' TYR . 18.2 m -143.71 139.68 29.62 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 179.314 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -144.81 120.23 10.31 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.43 0.633 . . . . 0.0 111.991 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -64.28 142.91 58.25 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.388 -179.624 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -80.75 110.48 16.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.68 179.595 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 99.4 mttt . . . . . 0 C--O 1.221 -0.42 0 CA-C-O 117.88 -1.057 . . . . 0.0 110.994 -179.757 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 701' ' ' BOC . . . . . 0.701 ' H22' ' CZ3' ' A' ' 171' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 702' ' ' LEU . . . . . 0.58 HD21 HD13 ' A' ' 185' ' ' ILE . 2.0 mt -112.88 98.81 46.45 Favored Pre-proline 0 CA--C 1.54 0.573 0 CA-C-O 120.672 0.272 . . . . 20.0 110.726 . . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 703' ' ' PRO . . . . . 0.581 ' O ' ' O ' ' B' ' 704' ' ' ALA . 4.2 Cg_exo -67.17 -169.02 0.18 Allowed 'Trans proline' 0 N--CA 1.489 1.25 0 C-N-CA 122.527 2.151 . . . . 20.0 114.006 -179.287 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 704' ' ' ALA . . . . . 0.716 ' C ' HG2A ' B' ' 705' ' ' B27 . . . -33.01 176.73 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 113.798 -1.546 . . . . 20.0 113.792 -179.459 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 705' ' ' B27 . . . . . 0.716 HG2A ' C ' ' B' ' 704' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.169 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 17.7 p -149.75 161.0 43.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.238 0.542 . . . . 0.0 110.788 -179.725 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 -115.99 131.54 56.91 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.018 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 78.4 mtm -100.54 119.14 38.07 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.268 0.556 . . . . 0.0 110.846 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -56.13 114.02 1.78 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.709 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -103.56 14.07 32.0 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.356 -179.511 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.51 ' CB ' ' O ' ' B' ' 702' ' ' LEU . 5.5 p -81.28 20.06 0.89 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.356 0.598 . . . . 0.0 111.158 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -102.64 18.48 21.22 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.205 -179.225 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.9 mt -56.26 139.5 15.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 122.415 1.103 . . . . 0.0 113.405 -176.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -77.42 130.69 37.39 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 113.525 -1.671 . . . . 0.0 108.865 178.452 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.617 ' CD ' ' H ' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -81.28 154.9 72.14 Favored Pre-proline 0 C--N 1.32 -0.688 0 C-N-CA 120.364 -0.534 . . . . 0.0 110.513 -179.139 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -72.2 166.48 29.56 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 123.249 2.632 . . . . 0.0 113.34 -178.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.806 ' O ' HG23 ' A' ' 69' ' ' VAL . 87.5 m-20 -52.62 164.45 0.35 Allowed 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 120.975 0.417 . . . . 0.0 110.491 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 56.5 tp -64.27 -47.05 81.05 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.321 -179.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.412 ' O ' ' N ' ' A' ' 71' ' ' ASN . . . -62.65 -36.46 82.92 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 119.863 -0.735 . . . . 0.0 110.773 -178.83 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -62.46 -28.81 70.07 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.526 0.679 . . . . 0.0 109.223 178.557 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.806 HG23 ' O ' ' A' ' 65' ' ' ASP . 46.7 t -76.7 -44.38 33.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.862 178.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -79.38 -8.88 59.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.0 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.412 ' N ' ' O ' ' A' ' 67' ' ' ALA . 95.8 m-20 -102.82 -13.28 17.06 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.397 0.618 . . . . 0.0 110.177 179.34 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.402 ' CB ' HD13 ' A' ' 104' ' ' LEU . . . -68.91 145.44 53.66 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.172 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 32.9 m -57.85 110.17 0.86 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.784 -179.33 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.719 HD13 ' C ' ' A' ' 74' ' ' LEU . 3.0 tm? -70.88 119.34 14.86 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.338 0.59 . . . . 0.0 110.535 -179.611 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.608 ' N ' HD13 ' A' ' 74' ' ' LEU . 83.1 m-20 -94.92 78.76 3.62 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.481 -0.782 . . . . 0.0 109.812 179.574 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.577 ' O ' HG12 ' A' ' 79' ' ' VAL . 82.0 tttt -65.07 -32.85 74.76 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.267 -0.879 . . . . 0.0 112.055 -179.615 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 36.9 mmtt -70.15 -10.16 57.93 Favored 'General case' 0 C--N 1.314 -0.955 0 C-N-CA 120.401 -0.52 . . . . 0.0 110.509 -177.045 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -96.65 -3.8 42.11 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.474 178.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.577 HG12 ' O ' ' A' ' 76' ' ' LYS . 3.1 p -81.39 130.14 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-O 121.315 0.579 . . . . 0.0 111.386 -179.368 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 10.0 pt -108.66 -6.75 10.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.982 179.373 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -174.15 -180.0 45.13 Favored Glycine 0 CA--C 1.53 1.012 0 N-CA-C 111.326 -0.71 . . . . 0.0 111.326 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.411 ' HG2' ' N ' ' A' ' 83' ' ' ILE . 61.4 ttp180 -136.74 156.88 47.93 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.415 HG22 ' O ' ' A' ' 92' ' ' LEU . 19.5 tt -124.2 141.96 42.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.113 0.482 . . . . 0.0 110.362 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 74.5 m -135.5 131.05 35.58 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 121.66 0.743 . . . . 0.0 112.332 -178.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.546 ' CG2' HG22 ' A' ' 88' ' ' VAL . 92.5 mt -137.33 86.06 20.4 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.082 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -57.48 -30.12 87.11 Favored 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 122.769 2.312 . . . . 0.0 113.063 -179.183 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 70.6 m -52.9 -40.67 63.72 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 121.22 0.533 . . . . 0.0 110.457 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.546 HG22 ' CG2' ' A' ' 85' ' ' ILE . 26.7 m -113.58 8.09 7.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.346 179.011 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 52.59 54.45 10.59 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.501 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 60.1 tp -119.99 135.29 54.97 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.629 0.728 . . . . 0.0 111.337 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -146.31 124.21 12.0 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.186 -0.915 . . . . 0.0 109.224 179.484 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.415 ' O ' HG22 ' A' ' 83' ' ' ILE . 82.3 mt -149.36 148.07 25.26 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.716 -178.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -73.04 146.24 41.08 Favored 'Trans proline' 0 C--N 1.313 -1.313 0 C-N-CA 122.176 1.918 . . . . 0.0 111.318 179.245 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.503 ' C ' HD12 ' A' ' 95' ' ' LEU . 43.8 t -96.55 122.11 47.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.28 0.562 . . . . 0.0 111.081 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.549 HD12 ' N ' ' A' ' 95' ' ' LEU . 11.1 mp -99.68 134.73 42.14 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.199 179.723 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -62.63 -79.03 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.499 -177.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 7.5 m -66.98 145.01 55.86 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 121.041 0.448 . . . . 0.0 111.611 -179.173 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 7.2 t -95.43 68.14 2.97 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-O 121.186 0.517 . . . . 0.0 111.51 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.445 HG22 ' N ' ' A' ' 100' ' ' GLU . 12.9 m -88.54 166.99 13.79 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 178.009 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.445 ' N ' HG22 ' A' ' 99' ' ' THR . 72.0 mm-40 -60.99 -43.9 98.19 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.022 -0.671 . . . . 0.0 109.881 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -65.14 -38.38 90.43 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.483 0.659 . . . . 0.0 110.253 178.26 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.421 ' HB2' ' H ' ' A' ' 99' ' ' THR . 92.3 m-20 -63.82 -39.27 93.83 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.057 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.409 HD13 ' CB ' ' B' ' 704' ' ' ALA . 78.2 mt -62.92 -12.01 22.41 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.015 -0.539 . . . . 0.0 112.001 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.432 ' O ' ' CG1' ' A' ' 69' ' ' VAL . 96.9 mt -73.28 -22.6 60.33 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 121.052 0.454 . . . . 0.0 111.15 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 95.7 p -73.84 -3.69 30.3 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.349 0.595 . . . . 0.0 110.498 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 86.85 -18.87 32.67 Favored Glycine 0 CA--C 1.531 1.06 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.509 178.365 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -145.62 127.07 15.0 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 119.941 -0.704 . . . . 0.0 112.103 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -147.74 142.8 27.05 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.551 178.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.572 ' HA ' HD23 ' A' ' 123' ' ' LEU . 3.4 p -73.6 140.79 46.45 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.271 0.557 . . . . 0.0 111.65 -179.27 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.746 HG22 ' HG2' ' B' ' 703' ' ' PRO . 58.1 t -78.64 -52.37 15.64 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.973 -179.672 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.778 ' H ' ' NE2' ' A' ' 114' ' ' GLN . 49.0 mtmt -100.32 136.67 39.85 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 122.221 1.01 . . . . 0.0 112.526 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -66.16 -31.98 73.15 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 113.978 -1.465 . . . . 0.0 112.627 -178.607 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 71.5 m-80 -85.33 13.7 6.24 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 -177.656 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.778 ' NE2' ' H ' ' A' ' 111' ' ' LYS . 32.7 mt-30 -79.87 143.5 34.26 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.383 0.611 . . . . 0.0 112.363 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 65.1 t -123.69 123.42 67.12 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.183 178.629 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' MET . . . . . 0.445 ' CG ' ' CZ ' ' A' ' 121' ' ' TYR . 98.9 mtp -57.65 133.82 55.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.195 0.521 . . . . 0.0 111.509 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.496 ' O ' ' OD2' ' A' ' 180' ' ' ASP . . . 81.69 -2.45 82.92 Favored Glycine 0 CA--C 1.53 0.969 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.55 179.557 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -142.87 135.81 28.06 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.213 0.53 . . . . 0.0 111.263 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 72.47 -166.77 53.82 Favored Glycine 0 CA--C 1.529 0.925 0 N-CA-C 110.495 -1.042 . . . . 0.0 110.495 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 64.8 t-20 -92.24 103.49 15.95 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.075 0.464 . . . . 0.0 110.676 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.445 ' CZ ' ' CG ' ' A' ' 116' ' ' MET . 2.5 t80 -88.64 99.04 12.02 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 121.118 0.485 . . . . 0.0 110.1 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.741 ' CB ' HG13 ' A' ' 174' ' ' VAL . . . -91.51 138.43 31.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.091 0.472 . . . . 0.0 111.536 -179.495 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.572 HD23 ' HA ' ' A' ' 109' ' ' THR . 46.0 mt -134.33 139.59 45.78 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.415 -0.514 . . . . 0.0 110.913 179.491 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -107.89 133.24 52.53 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.655 179.252 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -134.3 142.98 14.53 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.517 ' O ' ' O ' ' A' ' 134' ' ' LEU . 23.2 m-70 -78.4 142.01 37.92 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.321 0.581 . . . . 0.0 112.39 -178.863 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ASN . . . . . 0.596 ' ND2' ' O ' ' A' ' 187' ' ' CYS . 14.4 t30 -138.76 121.34 16.23 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.816 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.551 ' HB2' HG21 ' A' ' 133' ' ' VAL . 63.4 mtt -97.81 -4.43 36.87 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.744 -179.671 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.462 ' CB ' ' O ' ' A' ' 128' ' ' MET . 0.9 OUTLIER 79.14 4.16 2.32 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.967 179.281 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.861 ' O ' HG12 ' A' ' 133' ' ' VAL . 62.8 pttt -111.99 133.62 54.05 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 122.041 0.924 . . . . 0.0 113.206 -178.825 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.426 ' C ' ' O ' ' A' ' 130' ' ' LYS . 28.6 tptt -40.26 152.69 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.742 178.492 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 75.08 -14.75 4.57 Favored Glycine 0 CA--C 1.535 1.337 0 C-N-CA 121.077 -0.583 . . . . 0.0 112.71 178.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.861 HG12 ' O ' ' A' ' 130' ' ' LYS . 6.3 p -88.55 172.47 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 119.331 -0.947 . . . . 0.0 111.044 -179.258 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.671 ' H ' HG22 ' A' ' 133' ' ' VAL . 3.8 mm? -68.64 133.69 48.83 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 115.495 1.665 . . . . 0.0 115.495 -176.363 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 56.84 12.49 1.18 Allowed 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 113.859 -1.519 . . . . 0.0 114.718 176.617 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 2.8 p -69.21 -32.35 71.54 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 121.64 -0.663 . . . . 0.0 112.784 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -89.21 2.15 54.66 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 -178.174 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.582 HD11 HG21 ' A' ' 186' ' ' THR . 1.8 pp -63.45 -30.21 49.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 C-N-CA 120.206 -0.597 . . . . 0.0 111.046 -179.431 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -67.4 -11.06 56.82 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.94 0.4 . . . . 0.0 110.64 -179.572 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 56.8 m -82.45 -6.15 59.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.147 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 97.8 mt -65.33 143.83 57.5 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 121.165 0.507 . . . . 0.0 111.411 -179.709 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.417 ' HG2' ' N ' ' A' ' 143' ' ' LYS . 88.8 tttt -119.82 157.13 29.29 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 121.249 0.547 . . . . 0.0 111.091 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' LYS . . . . . 0.417 ' N ' ' HG2' ' A' ' 142' ' ' LYS . 88.7 tttt -49.76 136.08 18.24 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.178 179.515 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.498 ' N ' ' O ' ' A' ' 160' ' ' VAL . . . 77.24 8.05 86.93 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 120.823 -0.703 . . . . 0.0 111.953 178.51 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -70.79 131.19 43.44 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 119.68 -0.808 . . . . 0.0 110.072 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -77.87 140.32 39.33 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 121.551 0.691 . . . . 0.0 111.926 -178.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.457 HD11 ' CG2' ' A' ' 160' ' ' VAL . 98.4 mt -139.08 140.58 38.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-N 114.851 -1.068 . . . . 0.0 108.711 178.853 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' TYR . . . . . 0.715 ' C ' HD23 ' A' ' 149' ' ' LEU . 18.1 m-85 -126.07 139.52 53.33 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 119.748 -0.781 . . . . 0.0 112.794 -178.419 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.715 HD23 ' C ' ' A' ' 148' ' ' TYR . 0.4 OUTLIER -117.97 134.9 54.52 Favored 'General case' 0 C--O 1.226 -0.164 0 CA-C-N 114.983 -1.008 . . . . 0.0 108.633 178.245 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.558 ' CE2' ' CD ' ' A' ' 155' ' ' GLU . 92.4 m-85 -110.53 113.73 26.59 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.319 -0.552 . . . . 0.0 110.938 179.288 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' ASP . . . . . 0.503 ' OD1' ' N ' ' A' ' 152' ' ' ASN . 54.7 t0 -90.5 167.88 12.26 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 177.354 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' ASN . . . . . 0.503 ' N ' ' OD1' ' A' ' 151' ' ' ASP . 71.8 m-20 -55.53 -24.47 32.16 Favored 'General case' 0 C--N 1.317 -0.805 0 C-N-CA 119.971 -0.691 . . . . 0.0 111.28 -177.577 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -112.23 -26.99 8.51 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 114.243 1.201 . . . . 0.0 114.243 -178.225 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -149.82 -177.02 5.65 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 118.764 -1.174 . . . . 0.0 114.018 -176.592 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.558 ' CD ' ' CE2' ' A' ' 150' ' ' TYR . 84.6 tt0 -129.51 141.66 50.94 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 114.582 -1.19 . . . . 0.0 110.467 179.242 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -117.68 138.07 52.24 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 120.829 0.347 . . . . 0.0 111.75 -179.192 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' GLU . . . . . 0.473 ' O ' HG12 ' A' ' 204' ' ' VAL . 96.6 mt-10 -94.44 111.93 23.69 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.279 179.319 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -112.56 148.23 34.98 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.053 0.454 . . . . 0.0 111.696 179.489 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -123.64 122.65 38.68 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 121.145 0.498 . . . . 0.0 111.456 179.421 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.498 ' O ' ' N ' ' A' ' 144' ' ' GLY . 95.4 t -58.84 135.24 23.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 177.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 80.9 p -106.32 -26.51 11.47 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 120.525 -0.47 . . . . 0.0 111.413 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 161.39 -169.65 36.97 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 120.481 -0.866 . . . . 0.0 111.89 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.863 HG12 HG22 ' A' ' 199' ' ' VAL . 28.5 m -135.39 162.6 37.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.017 0.437 . . . . 0.0 110.177 179.575 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 81.7 p -148.95 164.96 33.02 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.345 0.593 . . . . 0.0 111.324 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -104.79 115.76 30.86 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.062 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.44 HG21 HG21 ' A' ' 198' ' ' VAL . 24.4 m -137.09 160.95 36.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.48 0.657 . . . . 0.0 111.204 -179.265 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 167' ' ' THR . . . . . 0.502 ' OG1' ' OD1' ' A' ' 169' ' ' ASP . 0.1 OUTLIER -88.95 160.82 42.74 Favored Pre-proline 0 CA--C 1.539 0.533 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.933 179.364 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.551 ' O ' ' CB ' ' B' ' 702' ' ' LEU . 55.4 Cg_endo -67.69 -15.81 45.23 Favored 'Trans proline' 0 N--CA 1.5 1.909 0 C-N-CA 123.074 2.516 . . . . 0.0 114.031 -178.346 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 169' ' ' ASP . . . . . 0.502 ' OD1' ' OG1' ' A' ' 167' ' ' THR . 38.4 p-10 -91.06 -2.55 57.62 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 119.58 -0.848 . . . . 0.0 110.803 179.483 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.907 ' O ' HG22 ' A' ' 173' ' ' VAL . 73.0 mmtt -73.53 69.6 1.24 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.445 0.641 . . . . 0.0 110.208 179.41 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' TRP . . . . . 0.575 ' CZ3' ' OE2' ' A' ' 175' ' ' GLU . 57.3 t90 -60.13 -17.72 42.35 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.303 179.604 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -63.72 -28.78 70.12 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.602 -0.727 . . . . 0.0 111.936 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' VAL . . . . . 0.907 HG22 ' O ' ' A' ' 170' ' ' LYS . 34.6 m -62.33 -20.79 25.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 120.692 -0.403 . . . . 0.0 111.05 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.741 HG13 ' CB ' ' A' ' 122' ' ' ALA . 7.8 t -99.81 -6.02 9.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.648 -179.32 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.575 ' OE2' ' CZ3' ' A' ' 171' ' ' TRP . 93.0 mt-10 -73.71 143.91 45.96 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 121.199 0.523 . . . . 0.0 111.419 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 44.8 p-10 -70.94 144.0 50.72 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.776 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 50.4 m80 -119.31 28.02 8.46 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 62.34 37.71 95.05 Favored Glycine 0 CA--C 1.528 0.88 0 N-CA-C 111.272 -0.731 . . . . 0.0 111.272 179.159 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -153.69 161.68 41.92 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.741 ' OD2' HD22 ' A' ' 203' ' ' LEU . 56.8 t0 -87.37 101.6 13.72 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 178.225 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 181' ' ' GLU . . . . . 0.462 ' HG2' ' N ' ' A' ' 182' ' ' ILE . 72.5 tt0 -130.78 163.43 27.36 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.469 0.652 . . . . 0.0 111.524 -178.618 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.462 ' N ' ' HG2' ' A' ' 181' ' ' GLU . 20.2 tt -130.07 138.5 53.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.629 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 57.0 m -130.83 125.44 33.68 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.504 -0.478 . . . . 0.0 111.29 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 85.5 mt -109.28 130.87 55.48 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.413 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.56 HD13 HD11 ' B' ' 702' ' ' LEU . 96.7 mt -115.7 128.87 72.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.533 0.682 . . . . 0.0 111.527 -179.112 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 186' ' ' THR . . . . . 0.582 HG21 HD11 ' A' ' 138' ' ' ILE . 3.7 t -141.83 162.16 36.16 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.297 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 187' ' ' CYS . . . . . 0.596 ' O ' ' ND2' ' A' ' 127' ' ' ASN . 33.1 m -87.15 135.27 33.36 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.952 0.406 . . . . 0.0 110.086 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.587 HG13 ' N ' ' A' ' 189' ' ' SER . 11.9 p -61.54 -45.24 99.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-O 121.411 0.624 . . . . 0.0 110.308 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 189' ' ' SER . . . . . 0.587 ' N ' HG13 ' A' ' 188' ' ' VAL . 35.5 t -172.18 144.95 1.68 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.869 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 33.9 m -70.89 -13.01 16.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.124 0.488 . . . . 0.0 110.627 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 63.1 mttm -94.03 -12.8 27.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.121 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 192' ' ' ASP . . . . . 0.412 ' OD1' ' C ' ' A' ' 192' ' ' ASP . 64.2 t0 -140.19 109.03 5.98 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.517 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 46.9 p-10 -107.5 11.72 28.52 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.303 179.308 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 35.0 t -59.89 -43.78 94.59 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.144 -178.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -145.83 155.61 43.02 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 121.28 0.562 . . . . 0.0 111.714 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 196' ' ' ARG . . . . . 0.51 ' NE ' ' SG ' ' B' ' 705' ' ' B27 . 85.1 mtt85 -128.03 146.91 50.52 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 121.383 0.611 . . . . 0.0 111.603 -179.668 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -91.15 146.51 23.78 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.873 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.44 HG21 HG21 ' A' ' 166' ' ' VAL . 47.8 t -130.28 134.21 62.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.639 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.863 HG22 HG12 ' A' ' 163' ' ' VAL . 54.1 t -105.87 132.14 53.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.348 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -116.05 139.03 50.69 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.246 0.546 . . . . 0.0 110.084 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 201' ' ' GLY . . . . . 0.434 ' O ' HG22 ' A' ' 182' ' ' ILE . . . -140.74 142.65 12.5 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.739 -0.945 . . . . 0.0 110.739 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 35.5 p30 -109.03 155.5 20.84 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.318 0.58 . . . . 0.0 111.544 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 203' ' ' LEU . . . . . 0.741 HD22 ' OD2' ' A' ' 180' ' ' ASP . 49.3 tp -74.13 131.3 41.16 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.478 179.195 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.473 HG12 ' O ' ' A' ' 157' ' ' GLU . 3.9 p -113.83 -20.25 6.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 120.319 -0.553 . . . . 0.0 111.181 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -174.2 169.22 42.21 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 120.486 -0.864 . . . . 0.0 111.779 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 63.6 m -142.65 137.16 29.77 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 179.478 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 54.4 pttt -149.19 123.48 9.58 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.592 0.71 . . . . 0.0 112.31 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -62.97 143.59 57.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.554 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 14.7 ptpt -79.26 111.04 15.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.527 178.492 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 64.8 mttp . . . . . 0 C--O 1.22 -0.493 0 CA-C-O 118.216 -0.897 . . . . 0.0 110.322 -179.966 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 701' ' ' BOC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 702' ' ' LEU . . . . . 0.56 HD11 HD13 ' A' ' 185' ' ' ILE . 0.0 OUTLIER 56.94 102.09 0.04 OUTLIER Pre-proline 0 CA--C 1.544 0.737 0 N-CA-C 109.635 -0.506 . . . . 20.0 109.635 . . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 703' ' ' PRO . . . . . 0.746 ' HG2' HG22 ' A' ' 110' ' ' VAL . 3.1 Cg_exo -65.81 -165.81 0.09 OUTLIER 'Trans proline' 0 N--CA 1.492 1.414 0 C-N-CA 121.921 1.748 . . . . 20.0 113.219 -179.667 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 704' ' ' ALA . . . . . 0.523 ' C ' HG2A ' B' ' 705' ' ' B27 . . . -44.5 -174.73 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.89 -1.05 . . . . 20.0 112.729 -178.785 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 705' ' ' B27 . . . . . 0.523 HG2A ' C ' ' B' ' 704' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.204 0 N-CA-C 109.889 -1.284 . . . . 0.0 109.889 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 44.0 t -65.33 145.68 55.88 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.103 0.478 . . . . 0.0 110.655 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 76.7 t60 -119.22 124.15 46.05 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.965 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 89.4 mmm -79.67 145.59 32.91 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.832 179.545 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.434 ' OD1' ' OG ' ' A' ' 59' ' ' SER . 46.0 t0 -159.57 114.38 2.38 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.246 -179.298 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -92.82 -5.94 49.94 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.993 0.425 . . . . 0.0 110.855 179.543 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.476 ' CB ' ' O ' ' B' ' 702' ' ' LEU . 61.0 p -80.4 22.8 0.53 Allowed 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -179.389 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -109.2 19.15 19.77 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.069 0.461 . . . . 0.0 111.719 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 98.0 mt -55.83 135.64 18.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-O 122.115 0.96 . . . . 0.0 112.668 -177.205 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -77.72 129.95 36.16 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.148 -1.387 . . . . 0.0 109.336 178.376 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.615 ' O ' ' NE2' ' A' ' 63' ' ' GLN . 1.0 OUTLIER -79.21 147.66 69.56 Favored Pre-proline 0 N--CA 1.446 -0.628 0 C-N-CA 120.087 -0.645 . . . . 0.0 109.977 -179.215 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -69.76 167.63 23.88 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 122.353 2.036 . . . . 0.0 112.477 -179.058 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -51.17 169.77 0.05 OUTLIER 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.568 -178.711 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 55.9 tp -63.4 -46.21 87.49 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.607 -1.178 . . . . 0.0 111.409 -178.134 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.65 -22.96 48.75 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.159 0.505 . . . . 0.0 110.448 -178.737 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.556 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 49.3 tp10 -68.29 -31.56 71.09 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 119.284 -0.966 . . . . 0.0 108.509 178.186 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.464 HG22 ' HB3' ' A' ' 104' ' ' LEU . 36.6 t -74.45 -44.57 47.76 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.466 179.513 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -73.24 -9.82 59.12 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.709 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 38.6 t30 -118.58 -1.31 11.19 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 121.052 0.454 . . . . 0.0 110.179 178.52 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.556 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -69.04 -172.55 0.41 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.425 -179.127 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.3 m -94.87 99.8 11.79 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.287 0.565 . . . . 0.0 110.033 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 49.3 tp -67.83 135.34 52.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.845 -179.389 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -124.89 77.21 1.59 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.461 0.648 . . . . 0.0 109.49 178.59 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.736 ' O ' HG12 ' A' ' 79' ' ' VAL . 86.6 tttt -74.96 -41.14 60.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.37 -0.832 . . . . 0.0 112.162 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.464 ' H ' ' HD2' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -70.94 -6.0 35.18 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.72 -177.062 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -96.49 -10.03 28.32 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.284 0.564 . . . . 0.0 110.506 179.03 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.736 HG12 ' O ' ' A' ' 76' ' ' LYS . 9.9 p -65.31 127.75 26.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.855 179.593 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 12.1 pt -104.61 -8.03 9.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.327 0.584 . . . . 0.0 109.975 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -173.35 178.55 45.25 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 120.742 -0.742 . . . . 0.0 111.291 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.406 ' HG2' ' N ' ' A' ' 83' ' ' ILE . 58.5 ttp180 -136.45 160.92 37.29 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.336 -0.432 . . . . 0.0 110.357 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.566 HG22 ' O ' ' A' ' 92' ' ' LEU . 18.6 tt -124.99 140.94 46.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 CA-C-O 121.203 0.525 . . . . 0.0 109.983 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 47.6 t -137.18 130.39 31.0 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.378 0.608 . . . . 0.0 111.471 -178.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.543 ' CG2' HG22 ' A' ' 88' ' ' VAL . 37.3 mt -137.08 85.55 22.21 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.572 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -56.25 -33.05 89.93 Favored 'Trans proline' 0 N--CA 1.496 1.621 0 C-N-CA 123.25 2.633 . . . . 0.0 112.798 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.439 ' CB ' ' OD1' ' A' ' 145' ' ' ASP . 39.5 t -55.53 -43.44 75.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.097 0.475 . . . . 0.0 111.358 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.543 HG22 ' CG2' ' A' ' 85' ' ' ILE . 35.5 m -110.77 7.75 8.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.522 0.677 . . . . 0.0 109.879 179.173 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.5 m 53.03 51.58 15.5 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.043 179.528 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 69.1 tp -116.11 131.12 57.03 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.294 0.568 . . . . 0.0 110.462 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -148.52 125.67 11.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.817 0.818 . . . . 0.0 110.939 -179.616 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.623 ' CD1' ' HB2' ' A' ' 107' ' ' ALA . 0.3 OUTLIER -156.83 152.69 22.78 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 114.741 -1.118 . . . . 0.0 111.01 179.873 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -74.44 147.82 37.12 Favored 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 122.548 2.165 . . . . 0.0 112.132 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.489 ' C ' HD12 ' A' ' 95' ' ' LEU . 90.1 t -94.89 121.36 45.4 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-O 120.901 0.381 . . . . 0.0 111.159 179.392 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.544 HD12 ' N ' ' A' ' 95' ' ' LEU . 10.9 mp -98.49 127.88 44.61 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 121.654 0.74 . . . . 0.0 111.568 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.509 ' O ' ' OG1' ' A' ' 109' ' ' THR . 88.1 tttt -62.33 -47.0 86.16 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 114.846 -1.07 . . . . 0.0 112.077 -178.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.406 ' HB3' ' ND2' ' A' ' 102' ' ' ASN . 17.4 t -77.98 128.87 34.56 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.509 0.671 . . . . 0.0 112.354 -178.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.469 ' OG ' ' O ' ' A' ' 109' ' ' THR . 0.8 OUTLIER -86.62 51.8 2.33 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.523 -179.673 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.535 HG22 ' N ' ' A' ' 100' ' ' GLU . 62.1 m -88.37 162.59 16.46 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.187 -0.46 . . . . 0.0 109.998 178.744 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.535 ' N ' HG22 ' A' ' 99' ' ' THR . 57.6 mp0 -61.92 -43.18 99.37 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 121.133 0.492 . . . . 0.0 110.62 179.747 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -63.01 -40.66 98.43 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.228 -179.621 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.406 ' ND2' ' HB3' ' A' ' 97' ' ' SER . 97.8 m-20 -64.67 -37.75 88.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.616 0.722 . . . . 0.0 110.671 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.527 HD13 ' HB3' ' B' ' 704' ' ' ALA . 16.5 mt -59.62 -24.03 63.48 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.327 -0.852 . . . . 0.0 111.188 -179.056 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.464 ' HB3' HG22 ' A' ' 69' ' ' VAL . 90.0 mt -76.03 -12.22 60.09 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.966 0.412 . . . . 0.0 110.831 179.69 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 90.7 p -78.8 -5.45 53.42 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-O 121.474 0.654 . . . . 0.0 110.011 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 98.96 -19.7 53.23 Favored Glycine 0 CA--C 1.532 1.152 0 CA-C-N 115.326 -0.852 . . . . 0.0 112.758 178.669 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.623 ' HB2' ' CD1' ' A' ' 92' ' ' LEU . . . -146.96 129.63 16.07 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 119.382 -0.927 . . . . 0.0 113.039 -179.587 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -147.39 135.18 21.14 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.489 178.447 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.637 ' HA ' HD23 ' A' ' 123' ' ' LEU . 54.9 p -70.15 135.99 49.67 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.085 0.469 . . . . 0.0 111.118 -179.47 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.969 HG11 HG11 ' A' ' 174' ' ' VAL . 54.0 t -79.74 -56.04 7.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-O 121.074 0.464 . . . . 0.0 110.76 -179.696 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.491 ' N ' ' OE1' ' A' ' 114' ' ' GLN . 43.7 mtpt -102.87 137.97 40.38 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 121.901 0.857 . . . . 0.0 111.717 179.229 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -63.64 -29.47 70.7 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 114.735 -1.121 . . . . 0.0 111.619 -178.287 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 65.1 m-80 -83.06 14.73 3.18 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -177.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.875 ' NE2' ' H ' ' A' ' 122' ' ' ALA . 65.1 mt-30 -77.83 138.24 38.84 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 121.128 0.49 . . . . 0.0 112.285 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 72.9 t -126.26 119.75 54.88 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.531 178.437 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 97.4 mtp -58.31 128.42 37.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.566 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 85.3 -2.88 87.94 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 120.956 -0.64 . . . . 0.0 111.871 178.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -142.95 133.24 24.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.052 0.453 . . . . 0.0 111.153 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 72.24 -171.0 49.43 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 -179.601 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 63.2 t-20 -86.33 102.48 14.04 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.285 -0.566 . . . . 0.0 110.131 179.491 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.547 ' CE2' HD21 ' A' ' 123' ' ' LEU . 12.3 t80 -85.83 98.66 10.88 Favored 'General case' 0 N--CA 1.457 -0.097 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 179.598 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.875 ' H ' ' NE2' ' A' ' 114' ' ' GLN . . . -91.96 139.14 30.94 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.223 -179.372 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.637 HD23 ' HA ' ' A' ' 109' ' ' THR . 81.2 mt -137.94 143.63 40.85 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 120.98 0.419 . . . . 0.0 110.684 179.523 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -115.26 138.86 50.49 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.187 0.518 . . . . 0.0 110.488 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -144.14 134.05 5.57 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.414 ' CD2' ' OE1' ' A' ' 63' ' ' GLN . 0.2 OUTLIER -79.43 137.83 37.39 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.004 -0.678 . . . . 0.0 110.51 -179.828 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -130.55 121.47 25.76 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.562 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.498 ' O ' ' CB ' ' A' ' 129' ' ' SER . 67.0 mtt -87.73 -5.83 58.48 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.133 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.498 ' CB ' ' O ' ' A' ' 128' ' ' MET . 0.9 OUTLIER 79.78 8.77 1.57 Allowed 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 179.123 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.874 ' O ' HG12 ' A' ' 133' ' ' VAL . 65.0 pttt -105.93 128.06 53.55 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 122.111 0.957 . . . . 0.0 112.371 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 38.8 tptt -46.05 119.78 2.43 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.977 -1.011 . . . . 0.0 109.988 178.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 115.23 -18.12 16.21 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.197 -1.161 . . . . 0.0 110.197 -179.377 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.874 HG12 ' O ' ' A' ' 130' ' ' LYS . 9.5 p -90.3 160.9 2.7 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 CA-C-O 121.256 0.55 . . . . 0.0 109.974 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.718 HD23 ' N ' ' A' ' 134' ' ' LEU . 0.1 OUTLIER -69.22 138.45 54.01 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -177.338 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.594 ' CD2' HD12 ' A' ' 138' ' ' ILE . 3.2 m-30 65.74 9.39 5.95 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 114.094 -1.412 . . . . 0.0 114.303 177.389 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' SER . . . . . 0.485 ' OG ' ' CG1' ' A' ' 133' ' ' VAL . 0.4 OUTLIER -67.31 -36.27 81.13 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 120.453 -0.499 . . . . 0.0 112.185 179.315 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 22.7 p-10 -93.97 8.93 39.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.594 0.712 . . . . 0.0 110.796 -178.764 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.594 HD12 ' CD2' ' A' ' 135' ' ' PHE . 5.5 tt -64.96 -36.35 77.57 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.534 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -70.02 -10.81 59.92 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 121.958 -0.463 . . . . 0.0 111.399 179.443 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 67.3 m -81.24 -2.85 50.41 Favored 'General case' 0 C--O 1.231 0.088 0 CA-C-O 121.054 0.455 . . . . 0.0 110.303 179.623 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 70.9 mt -63.69 142.33 58.44 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.926 179.429 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -123.24 157.08 33.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.734 0.778 . . . . 0.0 111.85 -178.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -48.72 129.09 16.4 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.41 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 160' ' ' VAL . . . 82.24 8.52 86.28 Favored Glycine 0 CA--C 1.534 1.256 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.574 179.053 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.439 ' OD1' ' CB ' ' A' ' 87' ' ' SER . 23.1 t70 -71.76 130.49 41.23 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 119.908 -0.717 . . . . 0.0 110.838 -179.268 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -77.98 139.9 39.18 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 121.619 0.724 . . . . 0.0 111.628 -179.184 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.524 HG23 HG12 ' A' ' 85' ' ' ILE . 96.4 mt -136.59 137.68 47.36 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 178.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' TYR . . . . . 0.55 ' C ' HD23 ' A' ' 149' ' ' LEU . 63.3 m-85 -118.46 135.95 54.07 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 119.966 -0.694 . . . . 0.0 111.938 -178.247 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.55 HD23 ' C ' ' A' ' 148' ' ' TYR . 0.9 OUTLIER -114.16 134.28 55.01 Favored 'General case' 0 C--O 1.222 -0.357 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 177.263 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.427 ' CE2' ' OE1' ' A' ' 155' ' ' GLU . 81.2 m-85 -114.48 110.07 19.27 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.136 -0.626 . . . . 0.0 111.853 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' ASP . . . . . 0.474 ' N ' ' O ' ' A' ' 154' ' ' ASN . 22.4 t0 -88.4 167.92 13.08 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 177.521 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 65.2 m-20 -60.29 -23.77 64.43 Favored 'General case' 0 C--N 1.316 -0.872 0 C-N-CA 119.793 -0.763 . . . . 0.0 111.449 -178.037 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -113.02 -26.3 8.55 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -178.235 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' ASN . . . . . 0.474 ' O ' ' N ' ' A' ' 151' ' ' ASP . 0.3 OUTLIER -148.1 -177.0 5.5 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 119.115 -1.034 . . . . 0.0 112.639 -177.197 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.427 ' OE1' ' CE2' ' A' ' 150' ' ' TYR . 15.2 pt-20 -137.98 145.52 42.04 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 114.403 -1.271 . . . . 0.0 109.891 178.574 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' TYR . . . . . 0.431 ' CD1' HG23 ' A' ' 206' ' ' THR . 84.0 m-85 -118.5 138.41 52.53 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 121.255 0.55 . . . . 0.0 112.312 -178.212 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' GLU . . . . . 0.529 ' O ' HG22 ' A' ' 204' ' ' VAL . 93.5 mt-10 -95.56 114.91 26.72 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.455 179.444 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -118.24 151.73 37.09 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.792 0.329 . . . . 0.0 111.633 179.694 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -124.59 125.15 43.7 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.334 178.724 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.487 ' O ' ' N ' ' A' ' 144' ' ' GLY . 92.3 t -59.95 137.25 22.62 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 177.557 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 77.7 p -106.6 -24.81 12.05 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 123.436 0.46 . . . . 0.0 110.792 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 158.83 -167.93 34.85 Favored Glycine 0 CA--C 1.533 1.218 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.875 HG22 HG22 ' A' ' 199' ' ' VAL . 44.4 t -129.99 128.27 64.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.452 -0.374 . . . . 0.0 109.998 178.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 18.2 m -107.74 157.34 18.2 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.479 0.657 . . . . 0.0 112.06 -179.46 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -101.67 113.44 26.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.253 179.01 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.57 HG21 HG21 ' A' ' 198' ' ' VAL . 22.9 m -135.48 163.3 35.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.682 0.754 . . . . 0.0 112.187 -178.468 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -90.06 155.86 46.93 Favored Pre-proline 0 CA--C 1.538 0.505 0 CA-C-N 114.944 -1.026 . . . . 0.0 110.335 179.133 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.581 ' O ' ' CB ' ' B' ' 702' ' ' LEU . 37.0 Cg_endo -65.91 -16.49 52.96 Favored 'Trans proline' 0 N--CA 1.502 1.984 0 C-N-CA 123.273 2.648 . . . . 0.0 113.995 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 169' ' ' ASP . . . . . 0.418 ' O ' ' CD1' ' A' ' 171' ' ' TRP . 51.4 p-10 -91.82 -6.14 52.2 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 119.733 -0.787 . . . . 0.0 111.848 -179.809 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.505 ' O ' HG12 ' A' ' 173' ' ' VAL . 96.7 mttt -75.24 80.84 2.35 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 119.92 -0.712 . . . . 0.0 110.234 178.739 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 171' ' ' TRP . . . . . 0.98 ' CZ3' ' H12' ' B' ' 701' ' ' BOC . 26.8 m0 -67.28 -11.56 57.84 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.003 -179.204 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.489 ' OE1' ' OE1' ' A' ' 175' ' ' GLU . 79.2 mm-40 -58.56 -29.9 66.74 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.456 -179.354 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 173' ' ' VAL . . . . . 0.768 HG13 HG13 ' A' ' 174' ' ' VAL . 10.6 p -60.73 -24.32 31.78 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -178.667 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.969 HG11 HG11 ' A' ' 110' ' ' VAL . 35.1 m -104.49 -8.55 9.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 120.086 -0.646 . . . . 0.0 112.04 -178.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.489 ' OE1' ' OE1' ' A' ' 172' ' ' GLU . 98.0 mt-10 -74.36 134.86 42.48 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 178.849 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 176' ' ' ASP . . . . . 0.489 ' OD1' ' O ' ' A' ' 176' ' ' ASP . 43.3 p-10 -66.17 130.9 44.83 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 121.098 0.475 . . . . 0.0 111.024 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 76.7 m80 -98.3 -13.63 20.64 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -179.018 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 100.11 34.78 4.72 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 -178.405 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -148.81 161.84 41.0 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.83 -0.685 . . . . 0.0 110.225 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -87.64 90.76 8.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.885 0.374 . . . . 0.0 110.087 178.202 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' GLU . . . . . 0.455 ' HG2' ' N ' ' A' ' 182' ' ' ILE . 79.1 tt0 -126.81 163.35 23.78 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.817 0.818 . . . . 0.0 111.811 -178.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.476 HG22 ' O ' ' A' ' 201' ' ' GLY . 17.9 tt -131.11 137.66 55.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.135 178.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 183' ' ' THR . . . . . 0.745 HG21 ' CG2' ' A' ' 173' ' ' VAL . 88.8 m -131.74 126.32 34.17 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.329 0.585 . . . . 0.0 111.353 179.753 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 84.0 mt -111.17 132.38 54.36 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.463 178.58 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.462 HD13 HD11 ' B' ' 702' ' ' LEU . 77.6 mt -110.14 126.85 67.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.429 0.633 . . . . 0.0 110.725 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 4.7 t -140.15 155.76 46.82 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.981 -1.009 . . . . 0.0 109.835 179.367 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' CYS . . . . . . . . . . . . . 4.0 m -91.9 148.89 21.87 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.546 -0.462 . . . . 0.0 110.652 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 195' ' ' LYS . 77.8 t -61.32 -47.57 92.86 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 CA-C-O 121.058 0.456 . . . . 0.0 110.874 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 92.4 p -163.68 162.22 24.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.313 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 190' ' ' VAL . . . . . 0.502 HG13 ' HG3' ' A' ' 191' ' ' LYS . 9.8 p -69.8 -12.94 16.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.12 0.486 . . . . 0.0 110.469 179.425 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.502 ' HG3' HG13 ' A' ' 190' ' ' VAL . 98.3 mttt -108.06 -31.39 7.97 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.132 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -98.94 107.37 19.79 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.393 0.616 . . . . 0.0 111.244 -179.552 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -110.63 12.11 22.72 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.364 179.156 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 20.4 t -59.53 -47.07 86.97 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.359 -0.382 . . . . 0.0 112.028 -178.658 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 195' ' ' LYS . . . . . 0.423 ' O ' HG23 ' A' ' 188' ' ' VAL . 25.4 pttm -147.39 159.19 43.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.178 0.513 . . . . 0.0 111.332 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 196' ' ' ARG . . . . . 0.491 ' NE ' ' SG ' ' B' ' 705' ' ' B27 . 83.6 mtt85 -123.53 143.97 49.85 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.407 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 -90.95 152.24 20.78 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.56 179.371 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.57 HG21 HG21 ' A' ' 166' ' ' VAL . 13.6 t -129.11 129.24 67.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.436 178.704 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.875 HG22 HG22 ' A' ' 163' ' ' VAL . 76.4 t -104.47 132.34 51.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.383 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -118.79 140.55 49.77 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.369 0.604 . . . . 0.0 111.207 -179.47 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 201' ' ' GLY . . . . . 0.476 ' O ' HG22 ' A' ' 182' ' ' ILE . . . -133.5 141.8 13.21 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 179.595 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 202' ' ' ASP . . . . . 0.532 ' OD1' ' N ' ' A' ' 203' ' ' LEU . 65.3 t0 -106.92 139.5 41.22 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.851 0.358 . . . . 0.0 110.164 -179.692 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 203' ' ' LEU . . . . . 0.532 ' N ' ' OD1' ' A' ' 202' ' ' ASP . 45.7 tp -64.98 131.34 46.35 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.529 HG22 ' O ' ' A' ' 157' ' ' GLU . 15.4 m -113.05 -20.39 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 C-N-CA 120.665 -0.414 . . . . 0.0 111.043 -178.864 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -175.57 171.59 44.66 Favored Glycine 0 CA--C 1.535 1.298 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.115 179.513 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 206' ' ' THR . . . . . 0.431 HG23 ' CD1' ' A' ' 156' ' ' TYR . 11.4 m -142.98 136.33 28.37 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.596 -0.302 . . . . 0.0 110.328 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -143.44 121.29 11.97 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.452 0.644 . . . . 0.0 112.183 179.269 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -64.99 140.73 58.9 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.259 -0.882 . . . . 0.0 112.106 -179.55 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt -77.47 156.68 30.91 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.953 -1.021 . . . . 0.0 110.484 178.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 98.1 mttt . . . . . 0 C--O 1.22 -0.474 0 CA-C-O 117.934 -1.032 . . . . 0.0 110.682 179.786 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 701' ' ' BOC . . . . . 0.98 ' H12' ' CZ3' ' A' ' 171' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 702' ' ' LEU . . . . . 0.581 ' CB ' ' O ' ' A' ' 168' ' ' PRO . 0.0 OUTLIER -138.34 99.03 8.93 Favored Pre-proline 0 CA--C 1.545 0.778 0 C-N-CA 121.036 -0.266 . . . . 20.0 110.824 . . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 703' ' ' PRO . . . . . 0.641 ' HG2' HG22 ' A' ' 110' ' ' VAL . 3.3 Cg_exo -66.2 -173.74 0.36 Allowed 'Trans proline' 0 N--CA 1.493 1.5 0 C-N-CA 122.346 2.031 . . . . 20.0 112.603 179.392 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 704' ' ' ALA . . . . . 0.557 ' O ' ' OG1' ' B' ' 705' ' ' B27 . . . -40.04 -179.41 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 113.601 0.963 . . . . 20.0 113.601 -178.77 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 705' ' ' B27 . . . . . 0.557 ' OG1' ' O ' ' B' ' 704' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.316 0 N-CA-C 109.089 -1.605 . . . . 0.0 109.089 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 46.8 t -59.89 -43.88 94.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.228 0.537 . . . . 0.0 110.553 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -70.32 -39.02 75.01 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.12 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 97.1 mtp -81.42 146.02 30.49 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 121.196 0.522 . . . . 0.0 111.511 -179.592 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 85.3 m-20 -64.78 144.38 57.29 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.319 -179.21 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -97.44 5.96 48.92 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.868 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 86.6 p -86.21 10.33 14.92 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.315 0.579 . . . . 0.0 111.176 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -104.4 13.39 32.04 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.372 -179.146 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.2 mt -56.73 137.76 18.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 CA-C-O 122.157 0.98 . . . . 0.0 112.864 -177.35 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.477 ' O ' ' OD1' ' A' ' 62' ' ' ASP . 46.7 p-10 -79.49 129.87 34.87 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 113.975 -1.466 . . . . 0.0 109.162 178.107 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.61 ' CD ' ' H ' ' A' ' 63' ' ' GLN . 1.7 pm0 -76.09 154.87 84.63 Favored Pre-proline 0 CA--C 1.535 0.38 0 CA-C-O 121.171 0.51 . . . . 0.0 110.302 -179.033 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -71.5 170.6 18.11 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.783 2.322 . . . . 0.0 112.975 -179.008 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.597 ' O ' HG23 ' A' ' 69' ' ' VAL . 28.1 t70 -52.81 159.35 1.14 Allowed 'General case' 0 C--N 1.334 -0.087 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.595 179.679 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 58.6 tp -63.31 -46.45 86.63 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 120.627 -0.429 . . . . 0.0 111.322 -178.618 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.94 -36.72 84.36 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 119.844 -0.742 . . . . 0.0 111.153 -178.508 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -58.29 -26.54 63.12 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 119.871 -0.732 . . . . 0.0 109.033 178.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.617 HG13 ' HB3' ' A' ' 104' ' ' LEU . 25.2 t -78.98 -44.94 24.64 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.529 178.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -73.07 -9.1 58.36 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.918 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -106.76 -14.62 14.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.276 0.56 . . . . 0.0 110.475 179.129 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -69.44 143.19 53.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.387 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 13.7 t -62.09 99.83 0.14 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.489 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.2 tt -69.7 134.74 48.99 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.274 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.454 ' OD2' ' OE1' ' A' ' 78' ' ' GLN . 84.8 m-20 -94.98 84.28 4.11 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 121.497 0.665 . . . . 0.0 110.244 178.862 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 48.7 tttp -63.19 -43.08 99.21 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.27 -0.877 . . . . 0.0 112.321 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.734 ' H ' ' CE ' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -70.34 -11.36 60.86 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.792 -0.64 . . . . 0.0 112.06 -177.068 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.454 ' OE1' ' OD2' ' A' ' 75' ' ' ASP . 33.5 mt-30 -92.06 -1.6 57.12 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.047 0.451 . . . . 0.0 110.324 179.088 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 58.1 t -76.64 127.14 37.81 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.244 179.6 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 29.2 pt -111.05 -1.79 10.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.65 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -175.99 179.47 47.09 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 120.502 -0.856 . . . . 0.0 111.48 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.566 ' NH1' ' OE2' ' A' ' 91' ' ' GLU . 73.1 ttp85 -141.19 153.76 45.49 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 120.919 0.39 . . . . 0.0 110.971 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.61 HG22 ' O ' ' A' ' 92' ' ' LEU . 18.1 tt -122.3 138.96 50.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-O 121.245 0.545 . . . . 0.0 110.317 179.54 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 10.3 t -137.75 130.85 30.41 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.199 0.524 . . . . 0.0 111.435 -179.416 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.548 HG12 HG23 ' A' ' 147' ' ' ILE . 54.3 mt -137.23 88.77 16.99 Favored Pre-proline 0 CA--C 1.541 0.604 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.987 -179.656 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -56.73 -31.11 86.9 Favored 'Trans proline' 0 N--CA 1.503 2.05 0 C-N-CA 123.086 2.524 . . . . 0.0 113.41 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 22.4 m -53.23 -42.27 66.22 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 121.207 0.527 . . . . 0.0 111.162 -179.511 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 12.7 m -115.77 8.28 7.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.44 0.638 . . . . 0.0 110.412 179.079 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.5 m 54.18 49.03 19.58 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.698 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 60.0 tp -112.15 131.49 55.43 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.384 0.611 . . . . 0.0 110.844 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.566 ' OE2' ' NH1' ' A' ' 82' ' ' ARG . 80.4 tt0 -149.16 126.22 11.32 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.944 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.61 ' O ' HG22 ' A' ' 83' ' ' ILE . 71.8 mt -152.24 151.98 28.54 Favored Pre-proline 0 CA--C 1.533 0.322 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.056 -179.514 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -74.73 147.02 34.58 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.361 2.041 . . . . 0.0 110.519 178.451 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 71.4 t -96.95 125.39 49.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 C-N-CA 120.434 -0.506 . . . . 0.0 110.855 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 9.5 mp -99.53 127.6 45.61 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.56 0.695 . . . . 0.0 111.472 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.514 ' O ' ' OG1' ' A' ' 109' ' ' THR . 87.5 tttt -63.71 -45.54 89.5 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 115.03 -0.986 . . . . 0.0 112.518 -178.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.447 ' HB3' HG23 ' A' ' 99' ' ' THR . 3.3 m -81.38 130.99 35.26 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.267 0.556 . . . . 0.0 111.267 -179.273 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 9.8 p -91.3 53.41 2.31 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.576 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.447 HG23 ' HB3' ' A' ' 97' ' ' SER . 81.2 p -88.44 166.77 14.0 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 178.576 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -64.13 -40.84 97.03 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.39 0.614 . . . . 0.0 110.453 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -63.95 -42.68 97.24 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.617 -179.458 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -65.7 -36.08 82.59 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.121 179.572 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.619 HD13 ' HB3' ' B' ' 704' ' ' ALA . 33.3 mt -61.52 -15.94 42.89 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.799 -179.61 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.617 ' HB3' HG13 ' A' ' 69' ' ' VAL . 88.7 mt -71.94 -20.03 61.82 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.271 0.558 . . . . 0.0 109.871 179.195 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 83.6 p -73.29 -0.98 16.11 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.876 -179.409 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.558 ' HA3' HD12 ' A' ' 134' ' ' LEU . . . 82.84 -18.59 15.03 Favored Glycine 0 CA--C 1.526 0.776 0 CA-C-N 116.069 -0.514 . . . . 0.0 112.387 178.52 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -145.26 123.91 12.53 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.527 0.68 . . . . 0.0 111.349 179.496 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -147.47 149.66 33.09 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.093 179.251 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.568 ' HA ' HD23 ' A' ' 123' ' ' LEU . 68.2 p -66.84 133.73 50.67 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.176 0.512 . . . . 0.0 110.561 -179.798 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.629 HG13 ' CD ' ' B' ' 703' ' ' PRO . 38.2 t -81.8 -62.0 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 C-N-CA 120.356 -0.538 . . . . 0.0 109.699 179.101 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.415 ' O ' ' OE1' ' A' ' 114' ' ' GLN . 85.5 tttt -94.17 133.95 37.14 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.818 179.38 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -66.37 -37.05 84.4 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -177.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -85.27 17.99 2.83 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 -178.484 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.568 ' NE2' ' CZ ' ' A' ' 121' ' ' TYR . 20.1 pt20 -76.87 139.77 40.37 Favored 'General case' 0 CA--C 1.534 0.332 0 O-C-N 121.958 -0.464 . . . . 0.0 110.76 179.27 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 94.3 t -129.27 121.53 53.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.925 0.393 . . . . 0.0 110.162 178.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' MET . . . . . 0.588 ' SD ' ' OD1' ' A' ' 151' ' ' ASP . 56.1 mtt -58.06 134.34 56.34 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.173 0.511 . . . . 0.0 111.105 -179.71 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 78.52 -3.68 62.51 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 121.012 -0.613 . . . . 0.0 111.953 178.736 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -140.3 124.1 17.32 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.239 0.542 . . . . 0.0 110.759 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 76.04 -161.26 51.98 Favored Glycine 0 CA--C 1.531 1.081 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.368 179.313 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 63.2 t-20 -93.24 107.24 19.09 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.069 0.461 . . . . 0.0 110.977 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.568 ' CZ ' ' NE2' ' A' ' 114' ' ' GLN . 20.2 t80 -85.56 145.34 27.41 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.084 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.666 ' CB ' HG13 ' A' ' 174' ' ' VAL . . . -146.73 139.03 24.85 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 119.986 -0.686 . . . . 0.0 112.042 -178.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.568 HD23 ' HA ' ' A' ' 109' ' ' THR . 72.4 mt -135.69 141.66 44.99 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.947 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -111.96 132.94 54.46 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 121.374 0.607 . . . . 0.0 109.852 178.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -134.74 152.13 20.61 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.543 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.525 ' ND1' ' OE1' ' A' ' 63' ' ' GLN . 40.9 m-70 -89.47 136.08 33.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.727 0.775 . . . . 0.0 112.339 -178.606 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -130.09 121.05 25.63 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.62 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.566 ' HB2' HG21 ' A' ' 133' ' ' VAL . 53.2 mtt -94.86 -1.46 52.67 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 121.407 0.623 . . . . 0.0 110.212 179.589 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.439 ' CB ' ' O ' ' A' ' 128' ' ' MET . 0.9 OUTLIER 77.78 4.57 2.95 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 115.421 -0.809 . . . . 0.0 112.071 178.665 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.873 ' O ' HG12 ' A' ' 133' ' ' VAL . 62.4 pttt -119.65 125.7 49.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.994 0.902 . . . . 0.0 113.118 -178.616 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.528 ' O ' ' O ' ' A' ' 130' ' ' LYS . 0.0 OUTLIER -35.23 159.73 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.455 179.062 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 74.0 -19.66 1.65 Allowed Glycine 0 CA--C 1.534 1.264 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.873 HG12 ' O ' ' A' ' 130' ' ' LYS . 4.7 p -90.09 173.42 0.88 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 119.587 -0.845 . . . . 0.0 111.094 -179.394 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.661 ' H ' HG22 ' A' ' 133' ' ' VAL . 4.3 mm? -66.81 130.05 41.89 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 -175.531 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.534 ' CD2' HD12 ' A' ' 138' ' ' ILE . 3.8 m-30 60.98 18.28 8.74 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 114.164 -1.38 . . . . 0.0 112.545 178.488 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.37 -37.23 84.92 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 113.005 0.742 . . . . 0.0 113.005 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 31.7 p-10 -94.6 6.25 49.42 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.974 0.416 . . . . 0.0 111.88 -178.442 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.534 HD12 ' CD2' ' A' ' 135' ' ' PHE . 3.6 tt -63.97 -37.9 80.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 C-N-CA 120.553 -0.459 . . . . 0.0 111.786 -179.443 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -67.8 -10.67 54.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.803 0.335 . . . . 0.0 111.352 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 33.1 m -80.93 -4.98 56.85 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.036 0.446 . . . . 0.0 110.505 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 80.1 mt -63.91 139.52 58.78 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.037 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.402 ' HG2' ' N ' ' A' ' 143' ' ' LYS . 88.6 tttt -115.9 156.76 25.59 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 121.478 0.656 . . . . 0.0 112.097 -178.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' LYS . . . . . 0.402 ' N ' ' HG2' ' A' ' 142' ' ' LYS . 88.0 tttt -48.87 130.57 18.17 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.341 -0.845 . . . . 0.0 112.647 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.603 ' N ' ' O ' ' A' ' 160' ' ' VAL . . . 78.37 7.67 87.8 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.972 178.383 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -71.97 137.93 47.66 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 119.567 -0.853 . . . . 0.0 110.268 -179.585 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -80.76 142.06 34.16 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 122.016 0.912 . . . . 0.0 113.021 -177.615 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.548 HG23 HG12 ' A' ' 85' ' ' ILE . 91.6 mt -138.66 139.11 41.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 114.361 -1.291 . . . . 0.0 108.791 178.233 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' TYR . . . . . 0.596 ' C ' HD22 ' A' ' 149' ' ' LEU . 94.0 m-85 -116.68 138.36 51.51 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 122.033 0.92 . . . . 0.0 112.821 -178.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.596 HD22 ' C ' ' A' ' 148' ' ' TYR . 4.5 mm? -117.03 137.73 52.05 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.112 -1.404 . . . . 0.0 108.484 178.347 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -126.56 112.06 15.09 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 119.978 -0.689 . . . . 0.0 112.418 -178.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' ASP . . . . . 0.588 ' OD1' ' SD ' ' A' ' 116' ' ' MET . 20.7 m-20 -89.63 164.72 14.62 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 176.465 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 53.4 t30 -56.66 -23.5 42.12 Favored 'General case' 0 C--N 1.31 -1.118 0 C-N-CA 119.893 -0.723 . . . . 0.0 111.124 -178.113 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -111.0 -29.44 7.9 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 113.38 0.882 . . . . 0.0 113.38 -178.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' ASN . . . . . 0.455 ' O ' ' N ' ' A' ' 151' ' ' ASP . 0.4 OUTLIER -145.98 177.77 8.7 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 119.644 -0.822 . . . . 0.0 112.74 -176.949 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -134.32 145.8 49.38 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.099 178.672 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' TYR . . . . . 0.492 ' CD2' HG23 ' A' ' 206' ' ' THR . 48.3 m-85 -120.12 139.29 52.81 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 121.201 0.524 . . . . 0.0 111.486 -178.267 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -93.75 114.69 27.02 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.158 179.391 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -115.07 149.48 37.44 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.226 0.536 . . . . 0.0 111.934 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.454 ' HB2' HG21 ' A' ' 204' ' ' VAL . . . -122.86 122.17 38.0 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.617 179.159 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.603 ' O ' ' N ' ' A' ' 144' ' ' GLY . 86.2 t -60.37 138.62 21.04 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.218 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 177.848 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 20.3 p -107.22 -23.28 12.31 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.671 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 159.84 -167.63 35.37 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 120.28 -0.962 . . . . 0.0 112.033 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.934 HG22 HG22 ' A' ' 199' ' ' VAL . 42.3 t -127.4 137.57 57.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-N 115.124 -0.538 . . . . 0.0 109.74 179.453 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 57.9 m -123.78 157.38 34.18 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 121.317 0.58 . . . . 0.0 111.474 -178.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 28.2 mp0 -104.63 113.43 27.01 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 121.553 0.692 . . . . 0.0 110.705 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 27.6 m -139.49 163.93 24.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.234 -179.556 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' THR . . . . . 0.44 ' H ' ' HD2' ' A' ' 170' ' ' LYS . 0.2 OUTLIER -91.56 159.91 37.74 Favored Pre-proline 0 CA--C 1.538 0.484 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.694 178.513 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.488 ' O ' ' CB ' ' B' ' 702' ' ' LEU . 35.6 Cg_endo -65.52 -15.76 50.97 Favored 'Trans proline' 0 N--CA 1.5 1.883 0 C-N-CA 122.874 2.383 . . . . 0.0 113.885 -179.727 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 44.1 p-10 -91.86 -7.21 50.0 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 119.466 -0.893 . . . . 0.0 111.544 179.441 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.722 ' O ' HG22 ' A' ' 173' ' ' VAL . 96.7 mttt -75.64 83.11 2.65 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.808 0.813 . . . . 0.0 111.723 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 33.2 t90 -71.13 -11.31 60.87 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.636 -1.165 . . . . 0.0 110.47 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -61.57 -35.08 76.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.674 -179.745 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' VAL . . . . . 0.722 HG22 ' O ' ' A' ' 170' ' ' LYS . 32.7 m -63.51 -14.03 13.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.427 -179.183 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.666 HG13 ' CB ' ' A' ' 122' ' ' ALA . 12.2 t -110.58 -5.85 11.25 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -179.104 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.499 ' O ' ' CE1' ' A' ' 177' ' ' HIS . 94.9 mt-10 -72.36 149.12 44.64 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.345 0.593 . . . . 0.0 110.88 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 176' ' ' ASP . . . . . 0.52 ' OD1' ' O ' ' A' ' 176' ' ' ASP . 51.9 p-10 -67.61 128.42 36.38 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.611 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 177' ' ' HIS . . . . . 0.499 ' CE1' ' O ' ' A' ' 175' ' ' GLU . 76.6 m80 -110.23 22.02 16.04 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.509 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 59.94 37.45 92.65 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 110.771 -0.932 . . . . 0.0 110.771 179.641 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 18.3 ptmt -146.22 158.7 43.9 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -88.74 91.67 8.91 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.292 177.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -129.56 172.47 11.54 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.478 0.656 . . . . 0.0 111.259 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 18.6 tt -134.44 144.29 35.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.436 178.799 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 84.7 m -131.48 126.55 35.28 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.522 0.677 . . . . 0.0 111.572 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 86.1 mt -109.4 131.47 55.03 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.769 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.488 HD13 ' CD2' ' B' ' 702' ' ' LEU . 85.0 mt -112.87 124.19 69.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.498 0.666 . . . . 0.0 111.31 -178.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 3.9 t -137.81 153.04 49.69 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.831 179.154 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' CYS . . . . . . . . . . . . . 3.3 m -88.5 139.36 30.56 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.039 0.447 . . . . 0.0 110.945 -179.288 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.525 HG13 ' N ' ' A' ' 189' ' ' SER . 10.9 p -65.13 -44.54 95.51 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.099 -179.426 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 189' ' ' SER . . . . . 0.525 ' N ' HG13 ' A' ' 188' ' ' VAL . 80.9 p -164.54 157.57 17.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.076 0.465 . . . . 0.0 110.795 179.525 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 190' ' ' VAL . . . . . 0.428 HG22 ' O ' ' A' ' 190' ' ' VAL . 11.4 p -81.93 -9.96 11.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.034 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -96.4 -9.97 28.71 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.284 0.564 . . . . 0.0 110.688 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -142.89 101.43 3.84 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.633 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 53.3 p-10 -102.21 10.39 39.36 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.247 0.546 . . . . 0.0 110.439 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 39.1 t -61.4 -46.16 91.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.277 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 64.4 pttt -144.86 150.95 37.97 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.453 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 196' ' ' ARG . . . . . 0.847 ' NH2' HD22 ' B' ' 702' ' ' LEU . 21.8 ptt180 -137.96 158.16 44.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.219 0.533 . . . . 0.0 111.165 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -91.75 141.35 28.78 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.839 -0.618 . . . . 0.0 111.561 -179.556 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 42.0 t -118.94 132.08 69.86 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.01 178.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.934 HG22 HG22 ' A' ' 163' ' ' VAL . 84.9 t -100.0 132.32 45.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.503 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -118.01 144.27 45.69 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.399 0.618 . . . . 0.0 110.996 -178.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -140.22 163.43 26.36 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 110.284 -1.127 . . . . 0.0 110.284 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 202' ' ' ASP . . . . . 0.57 ' OD1' ' N ' ' A' ' 203' ' ' LEU . 67.6 t0 -122.22 139.4 53.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.017 0.437 . . . . 0.0 111.888 -178.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 203' ' ' LEU . . . . . 0.57 ' N ' ' OD1' ' A' ' 202' ' ' ASP . 46.5 tp -62.78 131.54 49.2 Favored 'General case' 0 CA--C 1.52 -0.207 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.454 HG21 ' HB2' ' A' ' 159' ' ' ALA . 57.4 t -110.51 -20.72 6.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 C-N-CA 120.355 -0.538 . . . . 0.0 111.648 -178.699 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -178.03 174.21 46.6 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 120.546 -0.835 . . . . 0.0 111.486 -179.568 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 206' ' ' THR . . . . . 0.492 HG23 ' CD2' ' A' ' 156' ' ' TYR . 24.5 m -146.24 138.2 24.99 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.319 -0.441 . . . . 0.0 110.296 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -145.81 124.19 12.34 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.2 0.524 . . . . 0.0 110.943 178.689 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -65.86 147.98 52.51 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.78 0.8 . . . . 0.0 112.08 -179.684 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 10.1 ttmt -77.43 159.13 29.65 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.704 -1.135 . . . . 0.0 110.495 179.072 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 98.2 mttt . . . . . 0 C--O 1.219 -0.551 0 CA-C-O 118.089 -0.958 . . . . 0.0 110.562 179.429 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 701' ' ' BOC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 702' ' ' LEU . . . . . 0.847 HD22 ' NH2' ' A' ' 196' ' ' ARG . 2.3 mt -42.93 108.85 0.69 Allowed Pre-proline 0 CA--C 1.541 0.599 0 C-N-CA 120.618 -0.433 . . . . 20.0 110.449 . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 703' ' ' PRO . . . . . 0.629 ' CD ' HG13 ' A' ' 110' ' ' VAL . 2.5 Cg_endo -62.1 -173.09 0.12 Allowed 'Trans proline' 0 N--CA 1.489 1.232 0 C-N-CA 121.978 1.786 . . . . 20.0 113.061 -178.573 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 704' ' ' ALA . . . . . 0.619 ' HB3' HD13 ' A' ' 103' ' ' LEU . . . -41.7 -172.17 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 114.249 -1.342 . . . . 20.0 113.119 -179.364 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 705' ' ' B27 . . . . . 0.493 ' OG1' ' O ' ' B' ' 704' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.158 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 35.5 p -161.31 155.62 22.8 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.207 0.527 . . . . 0.0 110.325 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -122.16 150.69 41.87 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.797 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 61.4 mtt -91.81 130.76 37.52 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.656 -179.264 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.418 ' OD1' ' N ' ' A' ' 58' ' ' ALA . 61.6 t0 -62.46 131.67 49.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.894 179.308 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.418 ' N ' ' OD1' ' A' ' 57' ' ' ASP . . . -89.02 13.19 13.51 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.896 -178.742 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.408 ' OG ' ' CG ' ' A' ' 57' ' ' ASP . 29.5 p -84.73 11.15 9.57 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.346 0.498 . . . . 0.0 112.346 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -94.14 8.01 43.15 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.832 -0.347 . . . . 0.0 111.217 -179.023 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.5 mt -56.36 132.8 20.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 122.254 1.026 . . . . 0.0 113.689 -176.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -76.47 133.96 39.67 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 113.637 -1.62 . . . . 0.0 109.261 178.428 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.524 ' CD ' ' CG ' ' A' ' 126' ' ' HIS . 0.5 OUTLIER -79.03 149.19 73.05 Favored Pre-proline 0 CA--C 1.537 0.47 0 CA-C-O 121.086 0.469 . . . . 0.0 111.895 -178.369 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -73.6 168.04 25.76 Favored 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 123.177 2.585 . . . . 0.0 112.173 179.72 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -55.1 167.36 0.43 Allowed 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 121.179 0.514 . . . . 0.0 111.481 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.483 HD22 ' N ' ' A' ' 66' ' ' LEU . 4.3 mm? -64.29 -42.67 96.3 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.296 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.78 -35.37 74.5 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.65 -0.42 . . . . 0.0 111.517 -177.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -61.37 -29.76 70.11 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.763 0.792 . . . . 0.0 109.655 179.067 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.679 HG13 ' HB3' ' A' ' 104' ' ' LEU . 23.0 t -75.01 -43.77 44.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.001 -0.999 . . . . 0.0 109.952 179.482 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -76.73 -9.44 58.67 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 114.948 -1.023 . . . . 0.0 111.228 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -113.17 -1.31 14.39 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.296 0.57 . . . . 0.0 110.233 178.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.43 -165.77 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.097 -179.112 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 69.6 p -103.72 106.51 17.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.712 178.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.594 HD13 ' C ' ' A' ' 74' ' ' LEU . 2.1 tm? -71.94 118.04 14.3 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.838 0.351 . . . . 0.0 110.836 -179.385 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.555 ' N ' HD13 ' A' ' 74' ' ' LEU . 96.4 m-20 -104.21 77.22 1.4 Allowed 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 121.459 0.647 . . . . 0.0 109.984 179.138 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -69.19 -39.22 78.81 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.261 -0.881 . . . . 0.0 113.019 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.43 ' HG2' ' H ' ' A' ' 77' ' ' LYS . 42.4 mmtt -70.3 -15.24 62.86 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.193 -175.207 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -91.18 -4.47 56.07 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.062 0.458 . . . . 0.0 110.931 179.309 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 78.0 t -80.43 128.04 38.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.068 0.461 . . . . 0.0 110.161 179.389 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.657 HD13 ' CE ' ' A' ' 96' ' ' LYS . 18.4 pt -111.66 -6.21 11.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.862 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -175.3 179.16 46.71 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 110.799 -0.92 . . . . 0.0 110.799 179.535 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -152.8 154.94 36.18 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.44 0.638 . . . . 0.0 111.3 179.673 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 17.0 tt -104.61 144.37 14.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.608 -179.167 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 33.1 t -135.71 127.72 29.65 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.61 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.716 HG12 HG23 ' A' ' 147' ' ' ILE . 53.0 mt -135.44 89.68 22.1 Favored Pre-proline 0 CA--C 1.537 0.456 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.403 -179.547 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -55.18 -33.38 84.04 Favored 'Trans proline' 0 N--CA 1.501 1.936 0 C-N-CA 123.165 2.577 . . . . 0.0 113.699 -179.33 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 74.1 m -52.9 -38.73 62.07 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 120.962 0.411 . . . . 0.0 111.08 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.471 HG22 ' CG2' ' A' ' 85' ' ' ILE . 33.1 m -117.78 13.37 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.292 179.387 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.8 m 49.17 49.52 19.47 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.476 -0.49 . . . . 0.0 110.457 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 62.9 tp -112.94 132.46 55.33 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.325 0.583 . . . . 0.0 110.822 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -146.19 122.03 10.61 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.743 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.661 HD13 ' HA3' ' A' ' 106' ' ' GLY . 94.4 mt -149.17 150.68 32.5 Favored Pre-proline 0 CA--C 1.54 0.588 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.065 -179.171 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -76.25 151.95 34.57 Favored 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 122.695 2.263 . . . . 0.0 112.295 179.21 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.49 ' C ' HD12 ' A' ' 95' ' ' LEU . 98.6 t -96.83 114.65 34.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.855 0.359 . . . . 0.0 110.502 179.255 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.569 HD12 ' N ' ' A' ' 95' ' ' LEU . 10.3 mp -100.64 139.03 36.9 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.1 0.476 . . . . 0.0 111.472 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.657 ' CE ' HD13 ' A' ' 80' ' ' ILE . 98.9 mttt -66.44 -83.44 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 121.284 0.564 . . . . 0.0 112.019 -179.483 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 17.7 m -60.79 132.52 54.13 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.664 -179.297 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 43.6 t -88.28 74.43 8.71 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.371 0.605 . . . . 0.0 109.874 179.388 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.404 ' OG1' ' CG ' ' A' ' 102' ' ' ASN . 57.1 p -88.79 169.86 11.26 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.802 179.029 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -62.68 -44.34 96.51 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 120.23 -0.588 . . . . 0.0 109.952 179.512 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -66.61 -40.97 89.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.395 179.584 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.404 ' CG ' ' OG1' ' A' ' 99' ' ' THR . 95.0 m-20 -64.34 -35.71 81.76 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.816 -179.523 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 34.2 mt -60.49 -26.06 66.52 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.192 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.679 ' HB3' HG13 ' A' ' 69' ' ' VAL . 92.6 mt -72.74 -18.7 61.49 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.297 -179.102 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.478 ' O ' HD22 ' A' ' 92' ' ' LEU . 99.5 p -74.07 -8.25 55.48 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 121.33 0.586 . . . . 0.0 110.085 179.612 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.661 ' HA3' HD13 ' A' ' 92' ' ' LEU . . . 92.74 -19.57 50.5 Favored Glycine 0 CA--C 1.53 1.016 0 CA-C-N 115.721 -0.672 . . . . 0.0 114.003 177.699 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -145.03 127.01 15.5 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 119.556 -0.858 . . . . 0.0 111.701 -179.34 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -144.04 138.81 28.6 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.658 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.62 ' HA ' HD23 ' A' ' 123' ' ' LEU . 64.5 p -73.84 135.01 43.4 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.138 0.494 . . . . 0.0 110.336 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.591 HG13 ' CG ' ' B' ' 703' ' ' PRO . 77.8 t -78.97 -54.89 10.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.066 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.46 ' N ' ' OE1' ' A' ' 114' ' ' GLN . 97.5 mttt -102.15 137.43 40.43 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 122.36 1.076 . . . . 0.0 112.573 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -64.34 -29.54 70.61 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.396 -1.274 . . . . 0.0 112.491 -177.608 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 73.4 m-80 -84.07 17.15 2.56 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 113.669 0.988 . . . . 0.0 113.669 -178.007 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.764 HE21 ' H ' ' A' ' 122' ' ' ALA . 51.2 mt-30 -78.48 134.77 37.29 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 121.966 -0.459 . . . . 0.0 111.672 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 96.3 t -124.85 119.95 57.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-O 120.993 0.425 . . . . 0.0 110.387 178.312 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 64.8 mtt -55.6 131.62 46.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.273 0.558 . . . . 0.0 111.488 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 84.77 -6.18 79.2 Favored Glycine 0 CA--C 1.533 1.199 0 CA-C-N 115.597 -0.728 . . . . 0.0 112.231 179.034 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -143.6 136.75 27.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.333 0.587 . . . . 0.0 112.068 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 75.03 -172.94 53.09 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.672 -0.971 . . . . 0.0 110.672 179.707 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.47 HD22 ' CE1' ' A' ' 177' ' ' HIS . 52.3 t-20 -89.04 103.24 15.87 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.455 -0.498 . . . . 0.0 110.081 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.569 ' HE2' HD21 ' A' ' 123' ' ' LEU . 7.4 t80 -85.63 99.07 11.04 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-O 121.065 0.46 . . . . 0.0 109.773 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.764 ' H ' HE21 ' A' ' 114' ' ' GLN . . . -91.54 136.12 33.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.982 -179.202 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.62 HD23 ' HA ' ' A' ' 109' ' ' THR . 74.6 mt -137.55 140.17 40.88 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 120.914 0.388 . . . . 0.0 111.099 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -108.43 146.23 33.41 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 178.318 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' GLY . . . . . 0.456 ' O ' ' CG2' ' B' ' 705' ' ' B27 . . . -148.09 156.75 27.06 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 -179.524 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.535 ' O ' ' O ' ' A' ' 134' ' ' LEU . 77.9 m-70 -110.56 130.31 55.59 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 113.453 0.908 . . . . 0.0 113.453 -178.239 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ASN . . . . . 0.591 ' ND2' ' O ' ' A' ' 127' ' ' ASN . 0.0 OUTLIER -134.65 121.93 21.55 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.78 177.712 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.545 ' H ' HG21 ' A' ' 133' ' ' VAL . 65.0 mtt -83.83 8.19 15.61 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.057 0.456 . . . . 0.0 110.791 -179.404 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.488 ' CB ' ' O ' ' A' ' 128' ' ' MET . 0.7 OUTLIER 79.0 12.92 1.27 Allowed 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.452 179.118 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.877 ' O ' HG12 ' A' ' 133' ' ' VAL . 23.1 pttp -116.91 126.3 52.76 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 122.241 1.02 . . . . 0.0 112.68 -179.328 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 27.6 tptt -46.24 121.61 3.45 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.538 -1.21 . . . . 0.0 110.082 179.306 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 113.88 -15.14 21.56 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.563 -1.015 . . . . 0.0 110.563 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.877 HG12 ' O ' ' A' ' 130' ' ' LYS . 11.1 p -91.44 166.04 1.85 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.732 HD23 ' N ' ' A' ' 134' ' ' LEU . 0.3 OUTLIER -72.75 138.2 46.36 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 122.384 1.087 . . . . 0.0 113.821 -176.239 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 62.14 9.69 3.31 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 113.67 -1.604 . . . . 0.0 114.643 177.584 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 4.3 p -70.4 -31.96 69.39 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 121.486 -0.759 . . . . 0.0 113.028 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -88.82 8.57 28.39 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 -177.64 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.454 ' CD1' ' OG1' ' A' ' 186' ' ' THR . 18.2 pt -68.7 -31.46 50.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 121.602 0.715 . . . . 0.0 110.476 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -61.98 -20.81 64.26 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.639 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 57.7 m -79.78 -3.41 47.52 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.172 -179.225 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 99.5 mt -65.78 145.6 55.78 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 121.071 0.462 . . . . 0.0 110.198 179.515 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 53.6 mttp -120.67 154.5 35.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.515 0.674 . . . . 0.0 111.254 -179.356 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -49.97 131.86 22.84 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.41 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.483 ' N ' ' O ' ' A' ' 160' ' ' VAL . . . 80.71 8.23 87.72 Favored Glycine 0 CA--C 1.533 1.217 0 C-N-CA 120.682 -0.77 . . . . 0.0 111.72 179.297 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.458 ' OD1' ' N ' ' A' ' 146' ' ' LYS . 56.6 t0 -71.17 130.04 40.45 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 120.042 -0.663 . . . . 0.0 110.304 -179.513 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.458 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 74.5 mmtt -77.81 142.85 38.33 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.8 0.809 . . . . 0.0 112.263 -178.803 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.716 HG23 HG12 ' A' ' 85' ' ' ILE . 80.5 mt -142.64 143.44 25.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 114.562 -1.199 . . . . 0.0 108.656 178.305 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -126.04 139.96 52.98 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 119.599 -0.84 . . . . 0.0 112.563 -178.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 2.9 mt -110.5 134.12 52.66 Favored 'General case' 0 C--O 1.223 -0.334 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 177.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.553 ' CZ ' ' CD ' ' A' ' 155' ' ' GLU . 33.3 m-85 -110.25 107.68 17.53 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.303 -0.559 . . . . 0.0 112.078 -179.207 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' ASP . . . . . 0.477 ' OD1' ' N ' ' A' ' 152' ' ' ASN . 54.5 t0 -88.94 162.37 16.13 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 177.449 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' ASN . . . . . 0.477 ' N ' ' OD1' ' A' ' 151' ' ' ASP . 44.9 p-10 -58.27 -18.55 27.53 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 119.422 -0.911 . . . . 0.0 111.358 -178.215 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -113.77 -28.14 7.54 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -178.484 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' ASN . . . . . 0.411 ' O ' ' N ' ' A' ' 151' ' ' ASP . 0.9 OUTLIER -148.58 -175.12 4.8 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 122.134 0.969 . . . . 0.0 113.477 -176.779 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.553 ' CD ' ' CZ ' ' A' ' 150' ' ' TYR . 82.5 tt0 -134.79 140.88 46.22 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 114.153 -1.385 . . . . 0.0 109.939 178.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' TYR . . . . . 0.469 ' CD1' HG23 ' A' ' 206' ' ' THR . 89.9 m-85 -115.45 137.95 51.52 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -179.05 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' GLU . . . . . 0.543 ' O ' HG12 ' A' ' 204' ' ' VAL . 91.2 mt-10 -93.42 109.27 20.85 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.854 179.571 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.404 ' CE2' ' HB2' ' A' ' 203' ' ' LEU . 38.1 m-85 -113.27 147.51 37.42 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.08 0.467 . . . . 0.0 111.349 178.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -122.02 121.55 37.27 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.262 0.553 . . . . 0.0 111.567 179.707 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.483 ' O ' ' N ' ' A' ' 144' ' ' GLY . 52.1 t -59.86 136.31 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.258 178.206 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 22.5 p -105.68 -24.83 12.45 Favored 'General case' 0 CA--C 1.533 0.316 0 O-C-N 123.535 0.522 . . . . 0.0 111.623 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 159.3 -169.08 35.39 Favored Glycine 0 CA--C 1.529 0.949 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.428 HG22 ' N ' ' A' ' 164' ' ' SER . 3.6 p -136.35 155.92 35.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' SER . . . . . 0.428 ' N ' HG22 ' A' ' 163' ' ' VAL . 68.3 m -146.1 167.51 23.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.353 0.597 . . . . 0.0 111.764 -179.216 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -103.14 119.1 38.24 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.119 179.6 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.447 HG21 HG21 ' A' ' 198' ' ' VAL . 21.0 m -136.3 158.45 38.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.452 0.644 . . . . 0.0 111.859 -178.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 167' ' ' THR . . . . . 0.425 ' H ' ' HD2' ' A' ' 170' ' ' LYS . 0.3 OUTLIER -86.52 158.61 54.21 Favored Pre-proline 0 CA--C 1.537 0.48 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.111 -179.634 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.538 ' O ' ' CB ' ' B' ' 702' ' ' LEU . 32.6 Cg_endo -66.31 -18.7 55.8 Favored 'Trans proline' 0 N--CA 1.498 1.792 0 C-N-CA 123.471 2.781 . . . . 0.0 113.425 -179.78 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 44.0 p-10 -92.88 -3.14 55.13 Favored 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 119.878 -0.729 . . . . 0.0 112.187 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.595 ' O ' HG22 ' A' ' 173' ' ' VAL . 93.6 mttt -76.74 97.29 4.44 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.466 0.65 . . . . 0.0 112.175 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' TRP . . . . . 0.458 ' CH2' ' C ' ' B' ' 701' ' ' BOC . 95.9 m95 -66.84 -33.62 76.01 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.254 -0.884 . . . . 0.0 110.277 178.841 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -44.27 -36.28 2.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.071 -0.968 . . . . 0.0 112.885 -178.381 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' VAL . . . . . 0.732 HG23 HG13 ' A' ' 174' ' ' VAL . 16.1 m -63.37 -26.04 39.87 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 120.376 -0.53 . . . . 0.0 112.064 -179.104 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.732 HG13 HG23 ' A' ' 173' ' ' VAL . 25.6 m -108.79 -7.8 11.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 120.306 -0.558 . . . . 0.0 112.466 -179.364 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -75.02 153.64 38.38 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.143 0.497 . . . . 0.0 111.502 179.381 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' ASP . . . . . 0.412 ' O ' ' OD1' ' A' ' 176' ' ' ASP . 48.8 p-10 -64.61 138.07 58.19 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.123 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 177' ' ' HIS . . . . . 0.47 ' CE1' HD22 ' A' ' 120' ' ' ASN . 70.1 m80 -112.83 14.9 19.93 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.416 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 72.12 34.37 61.52 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 120.851 -0.69 . . . . 0.0 111.547 179.03 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 42.8 pttt -166.33 178.84 5.95 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.629 0.728 . . . . 0.0 111.722 179.26 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' A' ' 180' ' ' ASP . 18.3 p30 -89.77 92.99 9.27 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.835 179.201 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 181' ' ' GLU . . . . . 0.426 ' HG2' ' N ' ' A' ' 182' ' ' ILE . 84.3 tt0 -124.85 161.32 26.78 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.411 0.624 . . . . 0.0 111.566 -179.485 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.49 HG22 ' O ' ' A' ' 201' ' ' GLY . 20.5 tt -129.09 135.95 60.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 178.548 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 183' ' ' THR . . . . . 0.614 ' C ' HD12 ' A' ' 184' ' ' LEU . 80.4 m -130.26 126.07 36.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.707 0.765 . . . . 0.0 112.203 -178.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.614 HD12 ' C ' ' A' ' 183' ' ' THR . 10.5 mp -109.66 131.87 54.67 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.817 -1.083 . . . . 0.0 109.164 178.824 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.732 HD13 HD21 ' B' ' 702' ' ' LEU . 96.8 mt -113.67 122.63 68.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 121.454 0.645 . . . . 0.0 111.288 -179.185 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 186' ' ' THR . . . . . 0.454 ' OG1' ' CD1' ' A' ' 138' ' ' ILE . 4.7 m -140.86 153.16 45.62 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.827 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 187' ' ' CYS . . . . . 0.678 ' N ' ' SG ' ' B' ' 705' ' ' B27 . 86.4 m -87.03 153.92 21.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.269 179.229 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.716 HG23 ' O ' ' A' ' 195' ' ' LYS . 65.8 t -61.04 -48.87 87.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.278 0.561 . . . . 0.0 110.842 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 16.5 t -168.06 151.25 5.79 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.791 179.081 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' VAL . . . . . 0.445 HG13 ' HG3' ' A' ' 191' ' ' LYS . 7.5 p -62.01 -20.69 24.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.38 0.609 . . . . 0.0 109.919 179.462 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.445 ' HG3' HG13 ' A' ' 190' ' ' VAL . 60.4 mttp -94.65 -12.13 27.94 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.047 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -138.09 103.11 4.86 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.767 179.561 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -104.68 11.94 33.47 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.549 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 21.3 m -63.57 -36.81 85.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.946 -179.463 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 195' ' ' LYS . . . . . 0.716 ' O ' HG23 ' A' ' 188' ' ' VAL . 57.1 mtmt -135.13 156.95 48.13 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.075 0.464 . . . . 0.0 111.709 -178.796 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 196' ' ' ARG . . . . . 0.466 ' NH1' ' HX ' ' B' ' 705' ' ' B27 . 96.7 mtt180 -128.63 139.28 52.34 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.433 -179.417 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 197' ' ' TYR . . . . . 0.463 ' CE2' HG22 ' A' ' 188' ' ' VAL . 45.6 m-85 -94.62 144.5 25.55 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.246 0.546 . . . . 0.0 112.086 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.447 HG21 HG21 ' A' ' 166' ' ' VAL . 41.6 t -131.79 131.16 62.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.041 178.12 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 53.5 t -105.29 132.83 51.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.432 179.065 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -116.44 141.82 47.68 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.307 0.575 . . . . 0.0 110.836 -179.055 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 201' ' ' GLY . . . . . 0.49 ' O ' HG22 ' A' ' 182' ' ' ILE . . . -143.57 145.8 15.89 Favored Glycine 0 CA--C 1.528 0.903 0 N-CA-C 110.64 -0.984 . . . . 0.0 110.64 179.479 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -107.03 149.36 27.65 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.027 0.441 . . . . 0.0 110.594 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 203' ' ' LEU . . . . . 0.436 HD12 ' O ' ' A' ' 157' ' ' GLU . 49.2 tp -70.29 131.61 44.44 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 179.245 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.543 HG12 ' O ' ' A' ' 157' ' ' GLU . 7.6 p -114.05 -20.27 6.19 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 C-N-CA 120.442 -0.503 . . . . 0.0 111.767 -179.399 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -174.49 172.36 45.32 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 120.711 -0.757 . . . . 0.0 111.722 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 206' ' ' THR . . . . . 0.469 HG23 ' CD1' ' A' ' 156' ' ' TYR . 17.5 m -142.96 136.13 28.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.44 -0.38 . . . . 0.0 110.21 -179.733 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -144.52 120.62 10.77 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.284 0.564 . . . . 0.0 111.745 179.216 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -62.06 137.35 58.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.465 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -81.22 160.95 24.17 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.099 178.704 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 25.3 pttm . . . . . 0 C--O 1.22 -0.464 0 CA-C-O 118.188 -0.911 . . . . 0.0 110.869 -179.693 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 701' ' ' BOC . . . . . 0.458 ' C ' ' CH2' ' A' ' 171' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 702' ' ' LEU . . . . . 0.732 HD21 HD13 ' A' ' 185' ' ' ILE . 0.4 OUTLIER -36.33 110.56 0.46 Allowed Pre-proline 0 CA--C 1.536 0.439 0 N-CA-C 109.483 -0.562 . . . . 20.0 109.483 . . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 703' ' ' PRO . . . . . 0.591 ' CG ' HG13 ' A' ' 110' ' ' VAL . 3.4 Cg_exo -64.01 179.5 1.08 Allowed 'Trans proline' 0 N--CA 1.491 1.378 0 C-N-CA 122.243 1.962 . . . . 20.0 113.903 -178.589 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 704' ' ' ALA . . . . . 0.559 ' O ' ' O ' ' B' ' 703' ' ' PRO . . . -37.57 -178.23 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 114.175 -1.375 . . . . 20.0 113.496 -179.651 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 705' ' ' B27 . . . . . 0.678 ' SG ' ' N ' ' A' ' 187' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.359 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 78.0 p -65.17 -21.19 66.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.965 0.412 . . . . 0.0 111.063 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 75.6 m80 -66.92 -36.04 81.36 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.05 0.452 . . . . 0.0 110.575 179.699 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 62.5 ttp -89.92 133.99 34.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.583 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -66.14 142.19 57.84 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.439 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -101.88 11.76 38.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.245 0.545 . . . . 0.0 110.542 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 89.8 p -84.26 13.16 5.54 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.914 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 50.9 mtmt -107.29 18.09 22.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.635 -179.036 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 76.8 mt -56.17 138.97 16.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 122.244 1.021 . . . . 0.0 113.142 -177.693 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -76.51 132.74 39.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 113.614 -1.63 . . . . 0.0 109.199 178.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.643 ' H ' HE21 ' A' ' 63' ' ' GLN . 0.0 OUTLIER -77.09 147.5 76.86 Favored Pre-proline 0 C--N 1.324 -0.506 0 C-N-CA 120.513 -0.475 . . . . 0.0 110.14 -179.439 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.451 ' CB ' ' OE1' ' A' ' 68' ' ' GLU . 66.9 Cg_endo -70.4 160.33 49.88 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 122.861 2.374 . . . . 0.0 112.273 -179.262 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 -52.99 172.18 0.05 Allowed 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 121.311 0.577 . . . . 0.0 111.06 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 98.8 mt -71.25 -10.59 60.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.725 -179.156 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -69.17 -40.55 78.07 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.408 0.623 . . . . 0.0 111.024 179.116 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.781 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 90.1 mt-10 -71.44 -26.83 62.9 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.023 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 6.0 t -72.16 -44.25 65.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.67 -179.004 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -89.91 -9.88 47.25 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.925 -0.31 . . . . 0.0 111.581 -179.44 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -110.52 -8.0 14.68 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.647 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.781 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -68.44 138.9 55.66 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.35 0.595 . . . . 0.0 111.731 -179.296 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 5.9 m -57.8 102.85 0.11 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.718 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.669 HD13 ' N ' ' A' ' 75' ' ' ASP . 2.0 tm? -68.34 119.28 12.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.39 -178.557 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.669 ' N ' HD13 ' A' ' 74' ' ' LEU . 89.6 m-20 -97.3 78.47 2.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.393 0.616 . . . . 0.0 109.44 178.058 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -63.77 -36.66 84.6 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.955 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.417 ' H ' ' HE2' ' A' ' 77' ' ' LYS . 0.1 OUTLIER -70.38 -14.5 62.59 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.405 -177.427 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 -90.9 -1.15 57.86 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.301 0.572 . . . . 0.0 110.634 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 74.9 t -84.67 127.21 40.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.389 179.612 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.656 HD13 ' HE3' ' A' ' 96' ' ' LYS . 18.3 pt -110.97 -11.66 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 C-N-CA 120.803 -0.359 . . . . 0.0 111.798 -179.755 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.405 ' O ' HG22 ' A' ' 94' ' ' VAL . . . -160.52 163.77 34.19 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 120.556 -0.83 . . . . 0.0 111.384 -179.722 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.432 HH21 ' HB3' ' A' ' 91' ' ' GLU . 78.8 ttt180 -134.95 138.34 43.96 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.196 0.522 . . . . 0.0 111.35 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.55 HG22 ' O ' ' A' ' 92' ' ' LEU . 20.0 tt -104.12 141.3 20.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.243 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 70.1 m -135.78 128.84 31.56 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.645 -178.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.485 HG22 HG22 ' A' ' 88' ' ' VAL . 79.5 mt -139.23 86.41 14.65 Favored Pre-proline 0 CA--C 1.538 0.501 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.09 -179.405 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -56.66 -29.69 80.77 Favored 'Trans proline' 0 N--CA 1.499 1.827 0 C-N-CA 123.286 2.657 . . . . 0.0 113.523 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 91.7 p -53.23 -42.01 65.98 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 121.291 0.567 . . . . 0.0 110.55 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.493 ' O ' ' OG ' ' A' ' 89' ' ' SER . 34.4 m -114.07 11.23 8.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.596 179.502 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.493 ' OG ' ' O ' ' A' ' 88' ' ' VAL . 14.9 p 51.37 52.38 14.9 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.915 -179.768 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 54.5 tp -118.33 134.36 55.11 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 121.535 0.683 . . . . 0.0 111.958 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.432 ' HB3' HH21 ' A' ' 82' ' ' ARG . 97.6 mt-10 -146.1 122.89 11.25 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.823 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.55 ' O ' HG22 ' A' ' 83' ' ' ILE . 76.8 mt -149.81 148.88 26.59 Favored Pre-proline 0 CA--C 1.539 0.529 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.316 -179.105 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.18 145.86 27.99 Favored 'Trans proline' 0 N--CA 1.493 1.49 0 C-N-CA 122.436 2.091 . . . . 0.0 111.867 178.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.581 HG23 ' O ' ' A' ' 94' ' ' VAL . 2.0 m -94.02 118.01 38.97 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 CA-C-O 121.53 0.681 . . . . 0.0 110.996 179.428 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.511 HD12 ' N ' ' A' ' 95' ' ' LEU . 11.0 mp -102.6 136.23 42.8 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.098 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.656 ' HE3' HD13 ' A' ' 80' ' ' ILE . 97.1 mttt -64.75 -88.14 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 119.992 -0.683 . . . . 0.0 112.123 -179.065 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 74.0 m -51.79 134.17 30.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.898 -178.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 8.1 m -91.15 74.03 6.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.929 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 55.7 p -88.59 168.48 12.53 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 178.163 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -61.69 -42.53 99.05 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 119.856 -0.738 . . . . 0.0 109.903 179.316 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -65.86 -40.38 91.62 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.527 -0.761 . . . . 0.0 111.372 179.212 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -63.59 -38.93 93.01 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.168 0.508 . . . . 0.0 111.291 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 76.6 mt -61.67 -21.92 64.85 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.763 -179.551 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 63.1 mt -69.84 -21.43 63.36 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.944 0.402 . . . . 0.0 110.429 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.497 ' O ' HD22 ' A' ' 92' ' ' LEU . 95.9 p -72.98 -7.71 52.39 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 179.172 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.526 ' HA3' HD13 ' A' ' 92' ' ' LEU . . . 91.24 -18.65 50.9 Favored Glycine 0 CA--C 1.53 0.991 0 CA-C-N 115.205 -0.907 . . . . 0.0 112.41 178.462 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -145.95 124.75 12.63 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 119.723 -0.791 . . . . 0.0 112.354 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -143.4 132.77 23.36 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.482 178.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.649 ' HA ' HD23 ' A' ' 123' ' ' LEU . 11.7 m -62.45 131.44 49.2 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 121.01 0.433 . . . . 0.0 110.836 -179.475 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.506 HG13 ' CG ' ' B' ' 703' ' ' PRO . 75.6 t -78.92 -54.56 11.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 C-N-CA 120.576 -0.449 . . . . 0.0 110.673 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.865 ' H ' ' NE2' ' A' ' 114' ' ' GLN . 97.5 mttt -98.39 135.94 39.26 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 122.258 1.027 . . . . 0.0 112.646 179.483 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -66.53 -30.16 70.41 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 113.71 -1.586 . . . . 0.0 113.558 -178.308 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -83.06 8.57 12.52 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 -177.482 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.865 ' NE2' ' H ' ' A' ' 111' ' ' LYS . 46.0 mt-30 -80.02 139.56 36.91 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 121.913 -0.492 . . . . 0.0 112.104 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.41 ' O ' ' O ' ' A' ' 118' ' ' LYS . 55.4 t -123.62 125.65 71.71 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.971 178.307 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 97.9 mtp -59.66 129.83 43.83 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.753 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 88.52 -10.74 70.62 Favored Glycine 0 CA--C 1.531 1.062 0 N-CA-C 111.796 -0.522 . . . . 0.0 111.796 178.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.41 ' O ' ' O ' ' A' ' 115' ' ' VAL . 67.4 mttm -141.5 138.25 32.66 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.364 0.602 . . . . 0.0 111.549 179.617 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 75.03 -163.83 54.32 Favored Glycine 0 CA--C 1.53 0.979 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.554 ' ND2' ' ND1' ' A' ' 177' ' ' HIS . 54.0 t-20 -93.97 104.59 16.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.932 0.396 . . . . 0.0 110.69 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.558 ' CE2' HD21 ' A' ' 123' ' ' LEU . 9.6 t80 -86.49 144.7 27.13 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 178.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.585 ' N ' ' OE1' ' A' ' 114' ' ' GLN . . . -147.66 140.27 24.68 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.043 -0.663 . . . . 0.0 111.248 -179.12 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.649 HD23 ' HA ' ' A' ' 109' ' ' THR . 48.1 mt -137.72 142.53 41.02 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.064 -179.16 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -110.82 138.55 47.07 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 178.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -139.36 151.35 21.84 Favored Glycine 0 CA--C 1.53 0.983 0 N-CA-C 110.441 -1.064 . . . . 0.0 110.441 -179.464 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.431 ' CG ' ' HB3' ' A' ' 63' ' ' GLN . 19.5 m-70 -96.92 140.44 31.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.435 0.636 . . . . 0.0 111.928 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ASN . . . . . 0.593 ' ND2' ' OG1' ' A' ' 186' ' ' THR . 52.2 p-10 -145.55 121.42 10.61 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.537 179.019 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.497 ' O ' ' CB ' ' A' ' 129' ' ' SER . 74.9 mtm -87.3 4.61 42.11 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.174 0.511 . . . . 0.0 110.296 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.497 ' CB ' ' O ' ' A' ' 128' ' ' MET . 1.0 OUTLIER 78.93 13.64 1.23 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.129 179.878 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.829 ' O ' HG12 ' A' ' 133' ' ' VAL . 21.2 ptmt -109.72 124.42 51.21 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 122.168 0.985 . . . . 0.0 113.19 -178.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -43.99 119.49 1.77 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.628 -1.169 . . . . 0.0 110.668 179.45 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 115.42 -18.69 15.32 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.829 HG12 ' O ' ' A' ' 130' ' ' LYS . 7.6 p -88.93 154.33 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.854 HD23 ' N ' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -69.19 145.06 53.54 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -177.211 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.504 ' CE1' ' O ' ' A' ' 106' ' ' GLY . 3.3 m-85 65.82 6.37 3.92 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 114.017 -1.447 . . . . 0.0 114.15 178.027 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' SER . . . . . 0.54 ' OG ' ' CG1' ' A' ' 133' ' ' VAL . 2.7 m -75.24 -36.3 61.32 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 179.578 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 51.9 p-10 -94.48 7.1 46.73 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 114.277 1.214 . . . . 0.0 114.277 -176.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.504 HD11 ' HB ' ' A' ' 186' ' ' THR . 38.6 pt -72.5 -23.79 21.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 C-N-CA 119.344 -0.943 . . . . 0.0 110.663 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.679 ' HB2' ' OH ' ' A' ' 197' ' ' TYR . . . -71.14 -10.34 59.58 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 121.017 0.436 . . . . 0.0 110.614 179.679 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 66.6 m -81.0 -7.34 59.53 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.286 0.565 . . . . 0.0 110.271 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 88.6 mt -67.47 146.36 54.06 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.041 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -123.8 166.46 15.57 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.392 178.677 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -52.15 140.61 20.59 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.518 0.675 . . . . 0.0 112.359 179.67 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 77.99 7.13 87.6 Favored Glycine 0 CA--C 1.529 0.915 0 CA-C-N 115.139 -0.937 . . . . 0.0 112.283 178.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -71.97 133.9 45.62 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 118.925 -1.11 . . . . 0.0 110.165 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -79.72 136.2 36.71 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.759 0.79 . . . . 0.0 111.836 -178.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 97.8 mt -134.82 135.06 53.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 178.236 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' TYR . . . . . 0.69 ' C ' HD23 ' A' ' 149' ' ' LEU . 79.5 m-85 -121.98 135.57 54.86 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 119.858 -0.737 . . . . 0.0 112.632 -177.24 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.69 HD23 ' C ' ' A' ' 148' ' ' TYR . 0.3 OUTLIER -112.43 135.13 53.51 Favored 'General case' 0 C--O 1.224 -0.24 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 178.062 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.503 ' CE1' ' CD ' ' A' ' 155' ' ' GLU . 75.3 m-85 -109.71 108.95 19.51 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 120.247 -0.581 . . . . 0.0 111.712 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' ASP . . . . . 0.509 ' OD1' ' N ' ' A' ' 152' ' ' ASN . 53.8 t0 -87.74 165.23 15.51 Favored 'General case' 0 N--CA 1.447 -0.625 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 177.034 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' ASN . . . . . 0.509 ' N ' ' OD1' ' A' ' 151' ' ' ASP . 50.8 p-10 -59.28 -21.17 59.25 Favored 'General case' 0 C--N 1.312 -1.027 0 C-N-CA 119.522 -0.871 . . . . 0.0 110.978 -178.442 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.468 ' N ' ' OD1' ' A' ' 152' ' ' ASN . 95.4 mt-10 -115.92 -26.83 7.18 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 113.691 0.997 . . . . 0.0 113.691 -178.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -146.38 175.89 10.2 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 119.0 -1.08 . . . . 0.0 113.154 -176.631 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.503 ' CD ' ' CE1' ' A' ' 150' ' ' TYR . 82.5 tt0 -127.19 134.66 50.11 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 114.839 -1.073 . . . . 0.0 109.915 179.268 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -109.25 135.18 50.76 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 121.301 0.572 . . . . 0.0 112.094 -179.187 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' GLU . . . . . 0.475 ' O ' HD12 ' A' ' 203' ' ' LEU . 98.0 mt-10 -93.21 110.08 21.59 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.557 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 43.9 m-85 -113.92 148.81 36.16 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 120.91 0.386 . . . . 0.0 111.386 179.095 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -125.0 125.98 44.73 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.35 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 80.0 t -57.71 131.24 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 178.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 16.5 p -113.59 7.32 17.32 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 123.673 0.608 . . . . 0.0 112.529 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 135.79 177.37 14.93 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 120.108 -1.044 . . . . 0.0 112.515 178.472 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.412 HG22 ' N ' ' A' ' 164' ' ' SER . 5.8 p -135.3 154.26 35.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.165 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 164' ' ' SER . . . . . 0.412 ' N ' HG22 ' A' ' 163' ' ' VAL . 25.8 p -144.66 166.89 23.91 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.042 -0.663 . . . . 0.0 111.722 -179.165 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -104.12 117.97 35.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.479 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.474 ' O ' ' O ' ' A' ' 196' ' ' ARG . 27.9 m -135.84 160.1 39.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.488 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' THR . . . . . 0.423 ' H ' ' HG3' ' A' ' 170' ' ' LYS . 0.2 OUTLIER -85.34 158.08 58.19 Favored Pre-proline 0 CA--C 1.538 0.508 0 CA-C-O 121.055 0.455 . . . . 0.0 110.888 -179.572 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.495 ' O ' ' CB ' ' B' ' 702' ' ' LEU . 28.2 Cg_endo -64.69 -17.58 59.96 Favored 'Trans proline' 0 N--CA 1.499 1.803 0 C-N-CA 123.227 2.618 . . . . 0.0 113.038 -179.256 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 48.9 p-10 -90.88 -2.73 57.72 Favored 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 120.148 -0.621 . . . . 0.0 110.958 179.351 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.644 ' O ' HG22 ' A' ' 173' ' ' VAL . 71.1 mmtt -73.88 76.97 1.64 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.441 0.639 . . . . 0.0 111.388 -179.68 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' TRP . . . . . 0.71 ' HE1' ' CE ' ' A' ' 111' ' ' LYS . 5.7 t90 -69.81 -15.74 63.16 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.334 179.506 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -63.38 -32.16 73.51 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.81 -179.659 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' VAL . . . . . 0.644 HG22 ' O ' ' A' ' 170' ' ' LYS . 14.6 m -62.3 -14.57 12.8 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 120.599 -0.441 . . . . 0.0 111.76 -179.059 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 1.8 t -103.95 -9.71 9.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -179.124 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -72.35 162.72 29.09 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.117 0.484 . . . . 0.0 110.78 -179.714 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' ASP . . . . . 0.418 ' N ' ' OD1' ' A' ' 176' ' ' ASP . 35.5 p-10 -65.03 141.31 58.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.897 179.55 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 177' ' ' HIS . . . . . 0.554 ' ND1' ' ND2' ' A' ' 120' ' ' ASN . 66.2 m80 -113.26 10.41 18.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.321 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 66.18 39.28 94.47 Favored Glycine 0 CA--C 1.53 1.008 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 179.622 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -165.46 171.01 13.81 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.868 0.366 . . . . 0.0 110.914 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -86.94 102.96 14.86 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 177.157 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -137.02 161.68 35.39 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.347 0.594 . . . . 0.0 111.512 -178.39 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 20.3 tt -129.93 139.01 52.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.471 178.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 86.4 m -129.24 125.02 35.97 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.188 0.518 . . . . 0.0 112.02 -178.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 84.9 mt -109.3 131.91 54.62 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.289 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.769 HD13 HD21 ' B' ' 702' ' ' LEU . 88.9 mt -116.15 125.2 73.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 CA-C-O 121.376 0.608 . . . . 0.0 111.276 -179.064 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 186' ' ' THR . . . . . 0.593 ' OG1' ' ND2' ' A' ' 127' ' ' ASN . 1.7 t -142.03 163.87 31.72 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 115.263 -0.881 . . . . 0.0 110.851 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 187' ' ' CYS . . . . . 0.423 ' N ' ' SG ' ' B' ' 705' ' ' B27 . 1.9 m -95.86 143.51 27.0 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 120.967 0.413 . . . . 0.0 110.847 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 44.2 t -61.4 -48.45 88.79 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 CA-C-O 121.069 0.462 . . . . 0.0 111.206 -179.678 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 8.5 t -169.38 158.79 8.27 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.226 0.536 . . . . 0.0 110.878 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 190' ' ' VAL . . . . . 0.516 HG23 ' HG2' ' A' ' 191' ' ' LYS . 29.2 m -71.96 -17.65 19.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.347 179.304 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.516 ' HG2' HG23 ' A' ' 190' ' ' VAL . 74.7 mmtt -99.19 -4.59 31.73 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.146 179.631 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 53.8 t0 -139.68 97.15 3.2 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 120.991 0.424 . . . . 0.0 110.972 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 43.3 p-10 -107.88 10.19 28.61 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.357 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 69.7 m -61.2 -41.7 97.28 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 120.811 0.339 . . . . 0.0 111.414 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -144.68 155.72 43.72 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.327 0.584 . . . . 0.0 111.57 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 196' ' ' ARG . . . . . 0.474 ' O ' ' O ' ' A' ' 166' ' ' VAL . 99.9 mtt180 -132.56 142.2 49.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.004 -179.407 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 197' ' ' TYR . . . . . 0.679 ' OH ' ' HB2' ' A' ' 139' ' ' ALA . 47.8 p90 -99.08 151.67 20.69 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.315 0.578 . . . . 0.0 111.203 179.674 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 45.8 t -123.88 134.05 67.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.462 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 69.9 t -96.79 134.83 32.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.964 0.412 . . . . 0.0 110.036 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -116.3 138.29 51.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.358 0.599 . . . . 0.0 111.174 -179.077 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -134.83 138.0 9.69 Favored Glycine 0 CA--C 1.529 0.917 0 N-CA-C 110.179 -1.168 . . . . 0.0 110.179 179.415 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 202' ' ' ASP . . . . . 0.598 ' OD1' ' N ' ' A' ' 203' ' ' LEU . 42.5 t0 -108.89 140.53 42.24 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.15 0.5 . . . . 0.0 111.669 -179.185 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 203' ' ' LEU . . . . . 0.598 ' N ' ' OD1' ' A' ' 202' ' ' ASP . 54.6 tp -63.34 133.61 54.39 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.073 179.514 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -116.09 -18.88 6.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.074 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 205' ' ' GLY . . . . . 0.454 ' O ' HD11 ' A' ' 203' ' ' LEU . . . -178.36 172.94 45.43 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 120.645 -0.788 . . . . 0.0 111.824 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 31.7 m -142.94 138.91 30.47 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -145.37 122.27 11.3 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.462 -0.495 . . . . 0.0 111.629 178.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -61.98 138.77 58.41 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.391 0.615 . . . . 0.0 110.854 -179.479 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 13.6 ttmt -79.14 109.47 13.48 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.95 178.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 99.8 mttt . . . . . 0 C--O 1.219 -0.532 0 CA-C-O 117.953 -1.022 . . . . 0.0 110.383 -179.846 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 701' ' ' BOC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 702' ' ' LEU . . . . . 0.769 HD21 HD13 ' A' ' 185' ' ' ILE . 0.9 OUTLIER -44.96 108.34 0.74 Allowed Pre-proline 0 CA--C 1.545 0.751 0 CA-C-O 120.492 0.187 . . . . 20.0 111.159 . . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 703' ' ' PRO . . . . . 0.537 ' O ' ' O ' ' B' ' 704' ' ' ALA . 3.0 Cg_exo -65.65 -168.58 0.13 Allowed 'Trans proline' 0 N--CA 1.492 1.398 0 C-N-CA 122.377 2.052 . . . . 20.0 113.484 -179.688 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 704' ' ' ALA . . . . . 0.537 ' O ' ' O ' ' B' ' 703' ' ' PRO . . . -40.17 -175.91 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 114.501 -1.227 . . . . 20.0 113.058 -179.241 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 705' ' ' B27 . . . . . 0.445 HG2A ' C ' ' B' ' 704' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.376 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 76.9 p -59.5 -36.31 75.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.131 0.491 . . . . 0.0 110.375 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -67.59 -37.63 82.85 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.509 179.271 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 65.6 mtt -87.26 135.05 33.46 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.249 0.547 . . . . 0.0 110.868 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -145.31 85.28 1.72 Allowed 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.01 -0.676 . . . . 0.0 111.633 179.294 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -94.54 1.03 55.68 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.679 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 23.6 p -82.99 18.74 1.55 Allowed 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.735 -0.666 . . . . 0.0 112.718 -178.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -105.15 17.38 24.15 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.661 -0.416 . . . . 0.0 111.638 -179.427 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.6 mt -55.41 135.31 18.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 122.124 0.964 . . . . 0.0 112.479 -177.471 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -76.75 131.92 39.0 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 113.885 -1.507 . . . . 0.0 108.961 178.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.666 ' NE2' ' H ' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -79.23 149.82 73.28 Favored Pre-proline 0 C--N 1.326 -0.449 0 C-N-CA 120.383 -0.527 . . . . 0.0 110.634 -179.074 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -71.0 165.19 33.18 Favored 'Trans proline' 0 N--CA 1.496 1.654 0 C-N-CA 122.888 2.392 . . . . 0.0 113.338 -179.357 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.815 ' O ' HG23 ' A' ' 69' ' ' VAL . 94.0 m-20 -53.02 164.94 0.35 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.684 179.761 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 1.033 HD21 HG23 ' A' ' 133' ' ' VAL . 89.1 mt -63.81 -45.37 89.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.285 -179.307 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.17 -36.84 84.95 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.473 -0.491 . . . . 0.0 111.071 -178.714 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -63.04 -29.91 71.18 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.498 0.666 . . . . 0.0 109.478 178.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.815 HG23 ' O ' ' A' ' 65' ' ' ASP . 38.7 t -76.71 -46.27 30.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.108 179.245 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -73.08 -9.01 58.27 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.811 -1.086 . . . . 0.0 111.438 -179.27 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 96.8 m-20 -106.43 -12.89 15.51 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.525 0.678 . . . . 0.0 109.655 178.708 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.4 139.71 55.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.044 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 35.5 t -59.06 103.17 0.15 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.013 179.674 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.663 ' C ' HD23 ' A' ' 74' ' ' LEU . 6.9 tt -70.16 123.79 22.49 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.266 0.555 . . . . 0.0 111.068 -179.281 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.613 ' N ' HD23 ' A' ' 74' ' ' LEU . 84.9 m-20 -96.35 80.11 3.16 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.044 -179.656 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.655 ' O ' HG12 ' A' ' 79' ' ' VAL . 64.5 pttt -79.49 -15.67 57.36 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.742 0.782 . . . . 0.0 109.539 178.773 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 21.2 mtmt -65.82 -36.28 83.04 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.764 -1.107 . . . . 0.0 111.41 -178.452 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -87.04 0.07 55.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.941 0.4 . . . . 0.0 111.333 -179.603 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.655 HG12 ' O ' ' A' ' 76' ' ' LYS . 2.3 p -68.36 132.43 32.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.534 0.683 . . . . 0.0 110.683 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 8.6 pt -111.4 -5.81 11.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.427 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -171.74 176.9 44.78 Favored Glycine 0 CA--C 1.531 1.036 0 N-CA-C 111.162 -0.775 . . . . 0.0 111.162 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.408 ' NH2' ' HB3' ' A' ' 91' ' ' GLU . 51.1 ttt85 -135.92 154.42 51.13 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.715 HG22 ' O ' ' A' ' 92' ' ' LEU . 20.1 tt -119.07 137.02 54.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 CA-C-O 121.6 0.714 . . . . 0.0 110.124 179.108 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 8.6 t -135.15 125.35 26.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.771 -178.446 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.54 ' CG2' HG22 ' A' ' 88' ' ' VAL . 81.0 mt -135.56 90.23 20.5 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.203 179.63 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -56.38 -32.04 87.35 Favored 'Trans proline' 0 N--CA 1.494 1.535 0 C-N-CA 123.069 2.513 . . . . 0.0 112.637 -179.589 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 10.7 t -54.77 -42.44 71.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.294 -179.306 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.54 HG22 ' CG2' ' A' ' 85' ' ' ILE . 27.2 m -113.81 11.28 8.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.328 0.585 . . . . 0.0 110.351 179.135 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 50.19 48.08 22.68 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.265 179.611 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 47.8 tp -109.75 132.1 54.46 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.472 0.653 . . . . 0.0 110.802 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.408 ' HB3' ' NH2' ' A' ' 82' ' ' ARG . 97.6 mt-10 -144.13 113.78 7.13 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.083 -178.715 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.715 ' O ' HG22 ' A' ' 83' ' ' ILE . 93.7 mt -147.36 147.44 28.34 Favored Pre-proline 0 CA--C 1.537 0.465 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.656 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -74.4 146.92 36.0 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.593 2.195 . . . . 0.0 112.411 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.539 ' C ' HD12 ' A' ' 95' ' ' LEU . 78.8 t -94.44 120.14 43.42 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-O 121.002 0.429 . . . . 0.0 110.929 179.351 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.588 HD12 ' N ' ' A' ' 95' ' ' LEU . 10.6 mp -101.02 126.46 47.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.488 0.661 . . . . 0.0 110.962 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.54 ' O ' ' OG1' ' A' ' 109' ' ' THR . 87.2 tttt -64.07 -44.32 92.77 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.267 -0.879 . . . . 0.0 112.316 -178.775 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 4.2 m -85.59 130.83 34.48 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 121.039 0.447 . . . . 0.0 111.997 -179.326 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 3.5 p -90.64 59.04 4.1 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.547 179.279 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 3.3 m -92.72 164.74 13.26 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 179.077 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -58.21 -43.15 87.49 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 120.568 -0.453 . . . . 0.0 111.143 -179.137 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -64.96 -36.94 86.02 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.542 0.687 . . . . 0.0 110.009 178.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -64.4 -38.61 91.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.565 -179.329 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.405 ' HA ' HD23 ' A' ' 103' ' ' LEU . 96.9 mt -63.9 -11.97 32.72 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.913 -178.774 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 88.9 mt -73.95 -20.74 60.27 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.477 -0.489 . . . . 0.0 110.463 179.516 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 76.2 p -74.41 -4.77 38.5 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.169 -179.192 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 85.79 -19.25 26.15 Favored Glycine 0 CA--C 1.529 0.931 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.894 178.589 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -146.65 123.69 11.42 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.588 0.709 . . . . 0.0 111.804 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -146.21 137.15 24.38 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.159 178.73 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.54 ' OG1' ' O ' ' A' ' 96' ' ' LYS . 68.1 p -64.14 133.93 53.89 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.043 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.564 HG13 ' CG ' ' B' ' 703' ' ' PRO . 37.7 t -81.43 -56.92 5.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.29 0.567 . . . . 0.0 110.568 -179.503 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.415 ' HB3' ' NE2' ' A' ' 114' ' ' GLN . 85.5 tttt -93.07 128.44 38.97 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.988 -179.782 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -67.01 -31.25 71.67 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 -177.298 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 72.4 m-80 -82.98 11.61 5.96 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 114.238 1.199 . . . . 0.0 114.238 -176.714 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.461 ' OE1' ' N ' ' A' ' 122' ' ' ALA . 32.8 mt-30 -81.49 143.52 32.0 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.207 -0.597 . . . . 0.0 111.528 178.559 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 54.7 t -123.64 125.21 71.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.575 179.094 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' MET . . . . . 0.437 ' CG ' ' CZ ' ' A' ' 121' ' ' TYR . 97.3 mtp -57.58 130.43 46.31 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.99 0.424 . . . . 0.0 111.602 -179.313 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.426 ' HA3' ' CE2' ' A' ' 156' ' ' TYR . . . 80.64 -2.97 76.68 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 120.935 -0.65 . . . . 0.0 111.839 178.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 55.6 tttm -139.22 126.87 21.86 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.12 0.486 . . . . 0.0 110.655 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 74.86 -164.01 54.43 Favored Glycine 0 CA--C 1.529 0.962 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 -179.37 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 64.4 t-20 -92.7 106.79 18.71 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.978 0.418 . . . . 0.0 110.562 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.668 ' CE2' HD11 ' A' ' 123' ' ' LEU . 4.0 t80 -83.98 144.58 29.05 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.474 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.82 ' C ' HD12 ' A' ' 123' ' ' LEU . . . -146.83 140.3 25.66 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 119.777 -0.769 . . . . 0.0 112.575 -177.526 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.82 HD12 ' C ' ' A' ' 122' ' ' ALA . 7.2 mp -139.09 144.74 38.86 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.509 -179.525 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -108.51 139.9 42.6 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.462 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' GLY . . . . . 0.408 ' N ' ' HG2' ' B' ' 705' ' ' B27 . . . -144.6 159.36 27.77 Favored Glycine 0 CA--C 1.53 0.977 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 -179.694 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 60.5 m-70 -99.08 137.14 38.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.35 0.595 . . . . 0.0 111.932 -179.236 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 64.8 t-20 -131.69 120.2 22.43 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.941 179.428 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.495 ' SD ' HG21 ' A' ' 133' ' ' VAL . 64.1 mtt -92.88 -4.48 52.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.189 0.518 . . . . 0.0 111.021 -179.182 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.476 ' CB ' ' O ' ' A' ' 128' ' ' MET . 0.9 OUTLIER 79.25 11.75 1.35 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.846 -0.615 . . . . 0.0 112.149 179.03 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.881 ' O ' HG12 ' A' ' 133' ' ' VAL . 58.8 pttt -126.67 128.31 46.52 Favored 'General case' 0 C--O 1.222 -0.346 0 CA-C-O 122.1 0.952 . . . . 0.0 112.801 -179.574 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.482 ' O ' ' O ' ' A' ' 130' ' ' LYS . 29.5 tptt -37.54 162.64 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.833 -1.076 . . . . 0.0 110.289 178.835 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.431 ' H ' ' HG3' ' A' ' 131' ' ' LYS . . . 73.78 -24.18 1.02 Allowed Glycine 0 CA--C 1.529 0.911 0 N-CA-C 111.837 -0.505 . . . . 0.0 111.837 178.798 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 1.033 HG23 HD21 ' A' ' 66' ' ' LEU . 2.9 p -91.16 175.86 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 O-C-N 122.325 -0.515 . . . . 0.0 111.535 -178.776 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.79 ' O ' ' N ' ' A' ' 136' ' ' SER . 3.9 mm? -60.11 167.09 2.49 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 121.209 0.528 . . . . 0.0 112.349 -177.61 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.592 ' CG ' HD12 ' A' ' 138' ' ' ILE . 3.7 m-30 22.4 21.01 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 113.947 -1.478 . . . . 0.0 113.868 178.642 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' SER . . . . . 0.79 ' N ' ' O ' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -64.37 -44.88 90.01 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 113.69 0.996 . . . . 0.0 113.69 -178.318 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -89.25 -3.88 58.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.98 0.419 . . . . 0.0 111.516 -178.178 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.592 HD12 ' CG ' ' A' ' 135' ' ' PHE . 0.2 OUTLIER -61.47 -40.69 87.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.569 179.697 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -65.26 -10.67 34.06 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 120.284 -0.567 . . . . 0.0 110.144 179.094 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 5.9 p -85.34 -2.6 58.26 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.432 179.309 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 73.0 mt -63.39 143.44 57.81 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-O 121.203 0.525 . . . . 0.0 110.262 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.439 ' N ' ' OD2' ' A' ' 145' ' ' ASP . 89.0 tttt -119.41 155.0 32.81 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.44 0.638 . . . . 0.0 111.873 -178.442 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -50.75 133.74 25.71 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.424 179.292 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.56 ' N ' ' O ' ' A' ' 160' ' ' VAL . . . 79.33 7.95 88.13 Favored Glycine 0 CA--C 1.528 0.88 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.603 179.438 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.439 ' OD2' ' N ' ' A' ' 142' ' ' LYS . 77.2 m-20 -75.35 137.63 41.22 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 119.31 -0.956 . . . . 0.0 110.568 -179.583 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -79.12 139.99 37.92 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.526 -0.761 . . . . 0.0 112.799 -178.236 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.457 HG23 HG12 ' A' ' 85' ' ' ILE . 97.2 mt -139.12 137.52 41.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 114.762 -1.108 . . . . 0.0 108.346 178.695 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' TYR . . . . . 0.641 ' C ' HD23 ' A' ' 149' ' ' LEU . 93.2 m-85 -123.65 137.58 54.7 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.022 -0.671 . . . . 0.0 112.556 -178.564 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.641 HD23 ' C ' ' A' ' 148' ' ' TYR . 0.8 OUTLIER -115.7 136.61 52.89 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 177.704 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.418 ' CD2' ' HB2' ' A' ' 155' ' ' GLU . 77.6 m-85 -112.94 113.27 25.26 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 119.98 -0.688 . . . . 0.0 111.561 179.431 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' ASP . . . . . 0.589 ' OD1' ' N ' ' A' ' 152' ' ' ASN . 66.2 t0 -87.53 162.03 17.44 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 177.247 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' ASN . . . . . 0.589 ' N ' ' OD1' ' A' ' 151' ' ' ASP . 65.2 m-20 -55.37 -24.19 28.27 Favored 'General case' 0 C--N 1.315 -0.893 0 C-N-CA 119.337 -0.945 . . . . 0.0 110.047 -178.172 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -108.3 -30.16 8.49 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 113.699 1.0 . . . . 0.0 113.699 -177.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' ASN . . . . . 0.446 ' O ' ' N ' ' A' ' 151' ' ' ASP . 0.6 OUTLIER -148.93 -178.13 6.19 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 119.089 -1.044 . . . . 0.0 113.736 -177.328 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.418 ' HB2' ' CD2' ' A' ' 150' ' ' TYR . 0.0 OUTLIER -130.43 144.33 51.33 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 114.478 -1.237 . . . . 0.0 110.05 178.921 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 156' ' ' TYR . . . . . 0.426 ' CE2' ' HA3' ' A' ' 117' ' ' GLY . 82.5 m-85 -120.97 139.89 52.63 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 120.972 0.415 . . . . 0.0 111.573 -178.541 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -96.43 115.65 27.77 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.564 179.351 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 50.1 m-85 -116.97 151.57 36.43 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.001 0.429 . . . . 0.0 111.416 179.224 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.405 ' HB2' HG21 ' A' ' 204' ' ' VAL . . . -124.45 124.82 43.14 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.132 179.076 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.56 ' O ' ' N ' ' A' ' 144' ' ' GLY . 96.4 t -60.08 136.62 23.51 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 178.103 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 7.6 p -105.1 -23.19 12.97 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.666 178.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 159.37 -168.13 35.22 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 120.488 -0.863 . . . . 0.0 111.969 179.646 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 15.0 p -137.73 146.72 26.98 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 179.326 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 28.3 m -142.3 172.03 13.24 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 120.955 0.407 . . . . 0.0 111.174 -179.414 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -111.26 125.74 54.15 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.477 0.656 . . . . 0.0 111.534 -179.161 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 30.6 m -137.36 164.74 28.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.559 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -82.69 158.73 65.08 Favored Pre-proline 0 CA--C 1.536 0.408 0 CA-C-O 121.047 0.451 . . . . 0.0 110.996 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.486 ' O ' ' CB ' ' B' ' 702' ' ' LEU . 44.3 Cg_endo -67.05 -15.98 48.11 Favored 'Trans proline' 0 N--CA 1.497 1.679 0 C-N-CA 122.85 2.367 . . . . 0.0 111.6 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 169' ' ' ASP . . . . . 0.409 ' OD1' ' C ' ' A' ' 169' ' ' ASP . 40.9 p-10 -93.17 -6.43 47.83 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.911 179.652 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.654 ' O ' HG22 ' A' ' 173' ' ' VAL . 16.7 mttm -74.64 82.65 2.05 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.46 0.648 . . . . 0.0 111.397 -179.573 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 21.9 t90 -73.12 -14.14 61.32 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.803 179.116 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.487 ' OE1' ' OE1' ' A' ' 175' ' ' GLU . 52.1 tp10 -58.58 -31.25 67.84 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 115.052 -0.976 . . . . 0.0 111.831 -179.386 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 173' ' ' VAL . . . . . 0.654 HG22 ' O ' ' A' ' 170' ' ' LYS . 28.2 m -64.2 -20.78 27.56 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 120.618 -0.433 . . . . 0.0 112.04 -178.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.468 ' O ' HG12 ' A' ' 174' ' ' VAL . 49.5 t -98.74 -9.11 9.0 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -178.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.487 ' OE1' ' OE1' ' A' ' 172' ' ' GLU . 98.1 mt-10 -74.86 148.28 40.34 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 121.394 0.616 . . . . 0.0 111.585 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 46.6 p-10 -60.2 141.6 55.74 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.363 -179.63 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' HIS . . . . . 0.482 ' CE1' ' O ' ' A' ' 175' ' ' GLU . 80.5 m80 -117.67 16.85 14.49 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.537 -179.656 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 66.51 39.08 93.9 Favored Glycine 0 CA--C 1.532 1.102 0 N-CA-C 111.361 -0.696 . . . . 0.0 111.361 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 15.7 ptmt -163.26 167.1 22.4 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.997 -0.372 . . . . 0.0 109.997 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -87.05 92.31 9.0 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 178.482 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' GLU . . . . . 0.447 ' HG2' ' N ' ' A' ' 182' ' ' ILE . 82.9 tt0 -124.62 164.62 19.47 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.404 0.621 . . . . 0.0 111.441 -179.24 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.511 HG22 ' O ' ' A' ' 201' ' ' GLY . 18.1 tt -130.7 138.61 53.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.286 178.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 85.9 m -129.5 125.98 37.59 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 121.145 0.498 . . . . 0.0 111.877 -179.133 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 93.7 mt -109.53 130.59 55.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.874 178.774 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.717 HD13 HD21 ' B' ' 702' ' ' LEU . 83.0 mt -113.94 124.07 70.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.205 0.526 . . . . 0.0 111.287 -179.114 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 186' ' ' THR . . . . . 0.625 ' OG1' ' CZ ' ' A' ' 197' ' ' TYR . 0.1 OUTLIER -139.51 167.48 21.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.558 -0.747 . . . . 0.0 110.142 179.448 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 187' ' ' CYS . . . . . . . . . . . . . 8.9 m -95.49 142.2 28.12 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.084 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 45.2 t -60.66 -44.39 96.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 120.641 -0.424 . . . . 0.0 110.74 -179.376 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 47.5 t -166.64 148.69 6.46 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.163 -0.615 . . . . 0.0 111.613 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 10.9 p -65.2 -22.35 31.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.403 179.37 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -92.93 -13.28 29.06 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.598 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -143.67 98.32 3.22 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 121.179 0.514 . . . . 0.0 110.938 179.403 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -103.83 9.16 37.03 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.592 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 89.3 p -59.67 -33.82 72.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.018 -179.438 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -130.77 146.48 52.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.258 0.551 . . . . 0.0 110.925 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -125.36 135.42 52.42 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.28 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 197' ' ' TYR . . . . . 0.625 ' CZ ' ' OG1' ' A' ' 186' ' ' THR . 35.6 p90 -98.22 151.06 20.85 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.402 -0.519 . . . . 0.0 110.309 179.393 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 53.0 t -127.05 133.32 68.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.287 0.565 . . . . 0.0 111.549 -179.183 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 42.1 t -107.48 130.29 59.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.211 178.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -119.55 152.25 37.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.463 0.649 . . . . 0.0 111.976 -178.586 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 201' ' ' GLY . . . . . 0.511 ' O ' HG22 ' A' ' 182' ' ' ILE . . . -138.98 151.58 21.81 Favored Glycine 0 CA--C 1.533 1.175 0 N-CA-C 110.593 -1.003 . . . . 0.0 110.593 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 202' ' ' ASP . . . . . 0.552 ' OD1' ' N ' ' A' ' 203' ' ' LEU . 67.1 t0 -113.77 137.39 51.71 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 120.877 0.37 . . . . 0.0 111.182 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 203' ' ' LEU . . . . . 0.552 ' N ' ' OD1' ' A' ' 202' ' ' ASP . 53.6 tp -59.96 131.57 51.26 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.405 HG21 ' HB2' ' A' ' 159' ' ' ALA . 86.0 t -112.85 -19.78 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.969 -179.575 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 205' ' ' GLY . . . . . 0.482 ' O ' HD11 ' A' ' 203' ' ' LEU . . . -178.6 174.49 46.68 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 120.92 -0.657 . . . . 0.0 111.801 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 26.9 m -138.81 132.31 30.39 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -142.71 116.4 9.22 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.526 0.679 . . . . 0.0 112.239 -179.717 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -63.55 144.88 56.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.328 -0.851 . . . . 0.0 112.139 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 23.6 ttpt -78.68 109.6 13.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.528 178.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 59.2 pttt . . . . . 0 C--O 1.218 -0.565 0 CA-C-O 118.207 -0.901 . . . . 0.0 110.082 178.998 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 701' ' ' BOC . . . . . 0.438 ' O1 ' ' O ' ' B' ' 702' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 702' ' ' LEU . . . . . 0.717 HD21 HD13 ' A' ' 185' ' ' ILE . 1.3 mt 45.3 102.89 0.03 OUTLIER Pre-proline 0 CA--C 1.542 0.663 0 CA-C-O 120.67 0.272 . . . . 20.0 111.416 . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 703' ' ' PRO . . . . . 0.579 ' O ' ' O ' ' B' ' 704' ' ' ALA . 4.0 Cg_exo -64.8 -170.04 0.13 Allowed 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 121.97 1.78 . . . . 20.0 113.562 -179.782 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 704' ' ' ALA . . . . . 0.579 ' O ' ' O ' ' B' ' 703' ' ' PRO . . . -36.58 -178.81 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 114.256 -1.338 . . . . 20.0 113.458 -179.099 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 705' ' ' B27 . . . . . 0.408 ' HG2' ' N ' ' A' ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.308 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 20.5 t -62.29 -43.29 99.17 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 120.86 0.362 . . . . 0.0 111.12 -179.723 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 99.6 m-70 -113.02 146.08 39.73 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 121.077 0.465 . . . . 0.0 110.95 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 67.4 mtt -75.41 139.07 42.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.398 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.536 ' OD1' ' O ' ' A' ' 57' ' ' ASP . 38.1 p30 -166.43 96.56 0.57 Allowed 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 121.335 0.588 . . . . 0.0 111.322 -179.435 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -96.12 -11.11 26.74 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 121.026 0.441 . . . . 0.0 111.359 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.48 ' CB ' ' O ' ' B' ' 702' ' ' LEU . 3.9 p -82.01 21.07 0.91 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.123 -0.489 . . . . 0.0 112.073 -179.145 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 58.4 mtpt -106.73 23.67 13.93 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.137 0.494 . . . . 0.0 111.449 -179.598 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.6 mt -55.62 136.67 17.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 122.227 1.013 . . . . 0.0 112.189 -177.324 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -76.88 131.68 38.72 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 113.783 -1.553 . . . . 0.0 108.266 178.49 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.424 ' H ' ' CD ' ' A' ' 63' ' ' GLN . 8.5 pm0 -77.11 148.7 78.67 Favored Pre-proline 0 C--N 1.325 -0.469 0 C-N-CA 120.363 -0.535 . . . . 0.0 110.622 -178.679 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.541 ' CB ' ' OE1' ' A' ' 68' ' ' GLU . 65.2 Cg_endo -70.79 163.29 39.62 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 123.291 2.661 . . . . 0.0 113.878 -178.705 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -58.58 168.63 1.11 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.001 -1.0 . . . . 0.0 111.434 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 96.0 mt -70.36 -15.04 62.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.291 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -69.72 -40.3 76.32 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.346 0.593 . . . . 0.0 110.658 178.831 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.815 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 82.2 tt0 -66.42 -28.84 68.93 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.464 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 59.8 t -69.73 -45.29 77.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.288 179.786 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.42 -10.78 59.74 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.658 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -116.12 -2.81 12.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.299 0.571 . . . . 0.0 110.429 179.476 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.815 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -68.9 -172.34 0.38 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.712 0.767 . . . . 0.0 112.085 -178.598 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.6 p -101.4 104.38 15.35 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.016 178.31 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 42.8 tp -70.22 129.62 39.85 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.273 0.559 . . . . 0.0 111.503 -178.635 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -118.99 77.39 1.18 Allowed 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 177.75 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.692 ' O ' HG12 ' A' ' 79' ' ' VAL . 82.6 tttt -84.46 -35.8 22.74 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.297 -0.865 . . . . 0.0 112.542 -179.368 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 50.1 mmtt -75.03 -11.45 60.1 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.0 0.429 . . . . 0.0 111.132 -177.438 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -91.93 -0.51 57.5 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.09 0.471 . . . . 0.0 110.459 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.692 HG12 ' O ' ' A' ' 76' ' ' LYS . 9.5 p -76.86 128.5 37.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.147 0.498 . . . . 0.0 110.941 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.507 HD13 ' CE ' ' A' ' 96' ' ' LYS . 18.2 pt -106.55 -8.33 10.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.307 0.575 . . . . 0.0 110.066 179.354 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -171.19 169.38 42.43 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 109.894 -1.283 . . . . 0.0 109.894 179.718 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.722 ' HA ' HG23 ' A' ' 94' ' ' VAL . 33.7 ptt-85 -146.71 154.58 41.59 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.364 0.602 . . . . 0.0 112.01 -179.605 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 19.0 tt -103.69 141.63 19.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.645 -179.429 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 47.9 t -136.7 129.87 31.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.671 -179.091 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.61 ' CG2' HG22 ' A' ' 88' ' ' VAL . 93.7 mt -138.07 87.25 16.53 Favored Pre-proline 0 CA--C 1.535 0.381 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.839 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_exo -56.64 -30.76 84.86 Favored 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 122.801 2.334 . . . . 0.0 112.034 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 44.2 m -53.27 -42.09 66.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.75 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.61 HG22 ' CG2' ' A' ' 85' ' ' ILE . 17.6 m -114.25 11.23 7.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.719 179.675 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.511 ' O ' ' OG ' ' A' ' 89' ' ' SER . 1.6 p 51.31 51.29 17.18 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.128 179.686 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 59.0 tp -119.14 133.67 55.65 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 121.375 0.607 . . . . 0.0 111.183 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -147.09 124.94 11.91 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.102 179.655 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.504 HD13 ' HA3' ' A' ' 106' ' ' GLY . 78.0 mt -149.55 146.73 21.33 Favored Pre-proline 0 CA--C 1.539 0.524 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.341 -179.442 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -74.17 145.11 34.44 Favored 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 122.555 2.17 . . . . 0.0 111.389 178.416 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.722 HG23 ' HA ' ' A' ' 82' ' ' ARG . 18.3 t -96.41 120.18 45.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-O 121.137 0.494 . . . . 0.0 112.091 -179.332 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.56 HD12 ' C ' ' A' ' 94' ' ' VAL . 10.2 mp -102.67 138.71 39.21 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.735 179.376 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.507 ' CE ' HD13 ' A' ' 80' ' ' ILE . 98.2 mttt -62.12 -82.22 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.372 0.606 . . . . 0.0 112.104 -179.163 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.47 ' O ' ' ND2' ' A' ' 102' ' ' ASN . 31.3 m -56.89 134.55 55.52 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.587 -178.593 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 74.0 p -92.27 70.23 5.21 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.791 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 63.2 p -92.73 170.44 9.71 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.537 178.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -60.75 -43.07 98.42 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 178.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -65.75 -41.68 91.84 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.496 179.451 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.47 ' ND2' ' O ' ' A' ' 97' ' ' SER . 98.2 m-20 -64.49 -37.47 87.64 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.989 -179.324 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 74.4 mt -64.71 -14.37 58.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.042 -0.526 . . . . 0.0 112.062 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 94.8 mt -72.42 -28.43 62.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.986 0.422 . . . . 0.0 111.317 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.401 ' O ' HD22 ' A' ' 92' ' ' LEU . 86.8 p -73.42 -3.98 30.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.393 0.616 . . . . 0.0 109.813 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.504 ' HA3' HD13 ' A' ' 92' ' ' LEU . . . 92.29 -18.52 54.1 Favored Glycine 0 CA--C 1.533 1.209 0 CA-C-N 115.432 -0.804 . . . . 0.0 113.946 177.324 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -145.47 128.16 16.21 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 118.294 1.047 . . . . 0.0 113.147 -178.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -145.67 140.95 27.66 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 114.924 -1.034 . . . . 0.0 110.087 178.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.514 ' HA ' HD23 ' A' ' 123' ' ' LEU . 30.2 p -68.6 140.25 55.55 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.311 0.577 . . . . 0.0 111.443 -179.17 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.733 HG11 HG11 ' A' ' 174' ' ' VAL . 71.6 t -79.88 -58.17 4.22 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 CA-C-N 115.723 -0.672 . . . . 0.0 111.539 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.598 ' H ' ' NE2' ' A' ' 114' ' ' GLN . 68.5 mmtt -105.06 138.69 40.87 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 121.862 0.839 . . . . 0.0 111.838 179.488 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -65.74 -30.36 71.01 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 114.848 -1.069 . . . . 0.0 113.071 -178.115 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -79.83 13.93 1.96 Allowed 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.373 -0.531 . . . . 0.0 112.283 -178.129 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.598 ' NE2' ' H ' ' A' ' 111' ' ' LYS . 33.6 mt-30 -81.02 134.04 35.6 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 120.928 0.394 . . . . 0.0 111.599 179.336 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.408 ' O ' ' O ' ' A' ' 118' ' ' LYS . 72.4 t -125.73 126.11 69.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 178.351 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 96.1 mtp -57.15 131.18 49.18 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 121.092 0.472 . . . . 0.0 111.903 -179.334 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 78.75 -3.55 63.87 Favored Glycine 0 CA--C 1.531 1.033 0 N-CA-C 111.685 -0.566 . . . . 0.0 111.685 179.219 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.408 ' O ' ' O ' ' A' ' 115' ' ' VAL . 64.6 tttm -139.18 126.43 21.4 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.221 0.534 . . . . 0.0 110.924 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 77.16 -170.45 55.1 Favored Glycine 0 CA--C 1.531 1.039 0 N-CA-C 111.181 -0.767 . . . . 0.0 111.181 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 60.9 t-20 -87.82 104.94 17.06 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.953 0.406 . . . . 0.0 110.296 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -88.43 99.14 12.04 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 120.955 0.407 . . . . 0.0 110.574 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.763 ' CB ' HG12 ' A' ' 174' ' ' VAL . . . -91.83 137.68 32.16 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.101 0.477 . . . . 0.0 111.314 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.514 HD23 ' HA ' ' A' ' 109' ' ' THR . 78.9 mt -134.99 139.7 45.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.816 179.521 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.638 ' HB1' ' HG2' ' B' ' 705' ' ' B27 . . . -115.52 144.91 43.16 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-O 121.324 0.583 . . . . 0.0 110.757 -179.701 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' GLY . . . . . 0.459 ' O ' HG2B ' B' ' 705' ' ' B27 . . . -142.08 -162.17 9.09 Favored Glycine 0 CA--C 1.532 1.094 0 N-CA-C 110.154 -1.178 . . . . 0.0 110.154 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.526 ' O ' ' O ' ' A' ' 134' ' ' LEU . 91.5 m-70 -134.6 160.24 38.71 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.411 0.624 . . . . 0.0 111.981 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 28.7 t30 -142.12 120.23 12.16 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.275 179.219 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.476 ' O ' ' CB ' ' A' ' 129' ' ' SER . 61.8 mtt -96.23 -5.31 40.69 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.446 0.641 . . . . 0.0 109.757 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.476 ' CB ' ' O ' ' A' ' 128' ' ' MET . 1.1 p 78.72 17.07 1.04 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.206 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.819 ' O ' HG12 ' A' ' 133' ' ' VAL . 7.6 ptpt -125.76 116.87 22.29 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 121.833 0.825 . . . . 0.0 112.827 -179.01 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -45.71 130.39 9.16 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.212 179.466 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 109.08 -16.92 32.48 Favored Glycine 0 N--CA 1.444 -0.826 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 -179.243 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.819 HG12 ' O ' ' A' ' 130' ' ' LYS . 7.2 p -90.88 160.27 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.178 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.878 HD13 ' H ' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -70.69 141.95 51.56 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 115.016 1.487 . . . . 0.0 115.016 -177.122 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 59.67 9.37 1.58 Allowed 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 112.922 -1.944 . . . . 0.0 115.008 177.682 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 12.9 p -70.42 -30.29 67.12 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 120.041 -0.664 . . . . 0.0 112.125 179.359 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -90.59 -0.54 57.72 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 113.296 0.851 . . . . 0.0 113.296 -177.726 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 2.4 pp -58.67 -33.6 49.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 120.362 -0.535 . . . . 0.0 111.106 -179.548 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -66.44 -13.22 60.45 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.066 0.46 . . . . 0.0 110.954 -179.675 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 67.0 p -83.55 -4.54 58.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.099 -179.644 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 88.9 mt -63.98 141.06 58.91 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 121.067 0.461 . . . . 0.0 110.047 179.628 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -117.03 154.79 30.33 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.462 0.648 . . . . 0.0 111.325 -179.454 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -47.42 133.7 12.46 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.849 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 160' ' ' VAL . . . 76.8 7.99 86.34 Favored Glycine 0 CA--C 1.53 0.979 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.81 178.887 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -70.9 135.2 47.85 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 119.832 -0.747 . . . . 0.0 110.587 -179.561 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -79.98 139.8 36.86 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.895 0.855 . . . . 0.0 112.354 -178.792 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 98.4 mt -136.48 137.51 47.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 177.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -124.29 138.13 54.42 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 119.708 -0.797 . . . . 0.0 113.061 -177.122 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 18.6 mt -110.72 133.13 53.6 Favored 'General case' 0 C--O 1.223 -0.3 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 177.368 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.547 ' CZ ' ' OE2' ' A' ' 155' ' ' GLU . 64.5 m-85 -109.77 107.63 17.69 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 119.957 -0.697 . . . . 0.0 111.06 179.462 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -89.19 164.43 14.98 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 178.232 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 69.6 m-20 -57.68 -22.72 47.65 Favored 'General case' 0 C--N 1.312 -1.034 0 C-N-CA 119.823 -0.751 . . . . 0.0 110.657 -178.509 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -113.21 -28.26 7.69 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 113.804 1.039 . . . . 0.0 113.804 -178.456 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -147.97 179.15 7.94 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 119.147 -1.021 . . . . 0.0 113.47 -176.885 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.547 ' OE2' ' CZ ' ' A' ' 150' ' ' TYR . 85.7 tt0 -126.58 135.69 51.57 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 114.35 -1.296 . . . . 0.0 110.002 178.466 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -109.67 132.83 53.78 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 121.157 0.503 . . . . 0.0 111.687 -179.445 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -94.0 112.04 23.83 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.789 -0.642 . . . . 0.0 111.943 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -114.13 148.71 36.75 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.013 0.435 . . . . 0.0 111.249 179.323 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -125.11 122.04 36.01 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 121.24 0.543 . . . . 0.0 110.752 179.44 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.544 ' O ' ' N ' ' A' ' 144' ' ' GLY . 59.9 t -60.44 137.33 22.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.7 178.3 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 81.0 p -108.8 -25.05 11.0 Favored 'General case' 0 N--CA 1.463 0.182 0 O-C-N 123.415 0.447 . . . . 0.0 111.534 179.415 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 159.31 -167.12 34.94 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 120.532 -0.842 . . . . 0.0 111.285 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.925 HG12 HG22 ' A' ' 199' ' ' VAL . 35.5 m -131.45 160.69 42.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.956 0.408 . . . . 0.0 110.145 179.778 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 22.8 p -141.41 162.6 35.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.439 0.637 . . . . 0.0 111.77 -178.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -103.17 115.17 30.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.577 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 17.1 m -136.77 161.78 35.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.316 0.579 . . . . 0.0 111.218 -179.027 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -86.98 157.99 53.64 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.817 -179.758 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.455 ' O ' ' CB ' ' B' ' 702' ' ' LEU . 33.1 Cg_endo -64.81 -15.89 52.57 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 C-N-CA 122.996 2.464 . . . . 0.0 111.565 178.65 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 169' ' ' ASP . . . . . 0.46 ' O ' ' CD1' ' A' ' 171' ' ' TRP . 38.4 p-10 -96.62 -2.85 43.96 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.724 179.029 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.478 ' O ' HG22 ' A' ' 173' ' ' VAL . 7.0 mttp -74.03 87.5 1.86 Allowed 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 121.433 0.635 . . . . 0.0 110.994 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 171' ' ' TRP . . . . . 0.514 ' CD1' ' N ' ' A' ' 171' ' ' TRP . 22.3 m0 -73.14 -14.42 61.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.1 -179.521 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -61.26 -27.04 68.17 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.825 -179.553 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 173' ' ' VAL . . . . . 0.791 HG23 HG13 ' A' ' 174' ' ' VAL . 22.9 m -61.99 -23.85 32.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -178.498 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.791 HG13 HG23 ' A' ' 173' ' ' VAL . 23.3 m -107.96 -5.29 10.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -178.594 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -72.11 148.75 45.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.0 0.428 . . . . 0.0 110.317 179.519 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 176' ' ' ASP . . . . . 0.425 ' OD1' ' O ' ' A' ' 176' ' ' ASP . 44.1 p-10 -76.08 129.97 37.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.145 0.497 . . . . 0.0 110.957 -179.833 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 74.6 m80 -100.94 -17.1 16.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.781 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 104.05 36.68 3.1 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 110.109 -1.196 . . . . 0.0 110.109 -179.377 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -153.48 164.36 38.33 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.926 -0.637 . . . . 0.0 110.311 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -87.51 105.66 17.46 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 177.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 181' ' ' GLU . . . . . 0.423 ' HG2' ' N ' ' A' ' 182' ' ' ILE . 76.0 tt0 -138.79 161.69 36.61 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.507 0.67 . . . . 0.0 111.944 -177.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.423 ' N ' ' HG2' ' A' ' 181' ' ' GLU . 17.8 tt -128.99 136.92 58.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.142 178.454 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 70.9 m -129.25 123.69 32.58 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.109 0.481 . . . . 0.0 110.915 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 85.2 mt -109.47 131.71 54.81 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.349 0.595 . . . . 0.0 109.524 178.616 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.459 HD13 ' CD2' ' B' ' 702' ' ' LEU . 82.6 mt -112.46 124.38 69.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.134 -179.484 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 186' ' ' THR . . . . . 0.485 HG22 ' N ' ' A' ' 187' ' ' CYS . 90.8 m -138.11 156.87 47.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.152 -179.566 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 187' ' ' CYS . . . . . 0.485 ' N ' HG22 ' A' ' 186' ' ' THR . 17.4 m -87.66 139.52 30.45 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.594 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.721 HG22 ' CD2' ' A' ' 197' ' ' TYR . 62.3 t -62.59 -46.86 95.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.731 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 18.1 t -172.59 155.06 3.24 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.696 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 55.3 t -68.85 -17.07 21.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.395 179.623 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -98.88 -9.07 24.71 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.104 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 65.5 t0 -134.73 95.1 3.28 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.769 -0.373 . . . . 0.0 111.009 -179.731 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -105.98 5.89 30.81 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.135 0.493 . . . . 0.0 110.755 179.667 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 57.1 m -60.51 -40.9 93.09 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.484 -179.434 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -131.67 153.2 50.23 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.797 -0.361 . . . . 0.0 110.527 -179.647 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 196' ' ' ARG . . . . . 0.831 ' NH2' HD22 ' B' ' 702' ' ' LEU . 59.2 ttp180 -131.27 125.92 34.07 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 120.806 -0.358 . . . . 0.0 110.175 179.442 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 197' ' ' TYR . . . . . 0.721 ' CD2' HG22 ' A' ' 188' ' ' VAL . 29.2 m-85 -87.76 142.7 27.62 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.166 0.508 . . . . 0.0 110.759 -179.336 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 43.2 t -122.04 130.16 74.8 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.648 179.585 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.925 HG22 HG12 ' A' ' 163' ' ' VAL . 50.4 t -99.57 132.98 44.0 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.516 -179.439 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -118.9 149.21 41.96 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 121.166 0.508 . . . . 0.0 111.39 -179.584 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -145.34 146.09 15.99 Favored Glycine 0 CA--C 1.534 1.256 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -105.57 143.55 33.58 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 121.062 0.458 . . . . 0.0 111.954 -179.509 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 38.5 tp -65.97 132.04 47.65 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 178.586 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 2.1 p -112.38 -19.49 6.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 120.471 -0.492 . . . . 0.0 111.598 -179.194 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -179.82 173.98 45.57 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 120.497 -0.858 . . . . 0.0 112.038 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 90.8 m -142.31 139.19 31.75 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 179.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -144.03 118.36 9.61 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 120.152 -0.619 . . . . 0.0 111.233 179.231 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -64.19 143.28 58.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.824 -179.336 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 48.9 mtpt -81.64 107.7 14.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.57 178.706 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 20.0 pttp . . . . . 0 C--N 1.326 -0.426 0 CA-C-O 117.942 -1.027 . . . . 0.0 110.399 179.814 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 701' ' ' BOC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 702' ' ' LEU . . . . . 0.831 HD22 ' NH2' ' A' ' 196' ' ' ARG . 2.1 mt -101.79 109.32 59.24 Favored Pre-proline 0 CA--C 1.538 0.512 0 N-CA-C 110.577 -0.157 . . . . 20.0 110.577 . . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 703' ' ' PRO . . . . . 0.634 ' CD ' HG13 ' A' ' 110' ' ' VAL . 3.7 Cg_exo -62.93 -160.92 0.03 OUTLIER 'Trans proline' 0 N--CA 1.488 1.199 0 C-N-CA 122.303 2.002 . . . . 20.0 113.836 -179.372 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 704' ' ' ALA . . . . . 0.606 ' C ' HG2A ' B' ' 705' ' ' B27 . . . -44.79 -153.99 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.04 -1.436 . . . . 20.0 114.708 -178.037 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 705' ' ' B27 . . . . . 0.688 ' HXA' HH11 ' A' ' 196' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.364 0 N-CA-C 109.161 -1.576 . . . . 0.0 109.161 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 86.7 p -77.2 164.76 25.33 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.24 0.543 . . . . 0.0 110.431 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 48.4 t-80 -130.4 146.94 52.04 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.473 -179.692 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 78.5 mtm -87.43 134.49 33.58 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 121.383 0.611 . . . . 0.0 111.692 -179.437 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.476 ' OD1' ' N ' ' A' ' 58' ' ' ALA . 62.2 t0 -63.45 136.29 57.5 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.544 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.476 ' N ' ' OD1' ' A' ' 57' ' ' ASP . . . -95.25 8.13 44.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.919 -179.273 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.517 ' CB ' ' O ' ' B' ' 702' ' ' LEU . 93.0 p -80.35 20.07 0.72 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.955 0.407 . . . . 0.0 111.56 -179.407 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -102.69 12.72 35.93 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.633 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.1 mt -56.17 142.31 11.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 122.197 0.999 . . . . 0.0 113.078 -177.168 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 51.1 t0 -78.27 125.91 30.03 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 113.983 -1.462 . . . . 0.0 109.438 179.134 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.499 HE22 ' HB2' ' A' ' 103' ' ' LEU . 0.1 OUTLIER -79.23 128.65 75.1 Favored Pre-proline 0 C--N 1.325 -0.469 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 -179.875 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -52.37 149.87 21.88 Favored 'Trans proline' 0 N--CA 1.486 1.043 0 C-N-CA 121.307 1.338 . . . . 0.0 112.097 -179.505 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -51.94 175.62 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.624 0.726 . . . . 0.0 111.923 -178.549 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.565 ' N ' HD12 ' A' ' 66' ' ' LEU . 10.9 mp -70.17 -10.08 57.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.695 -178.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -67.19 -34.39 77.41 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.547 0.689 . . . . 0.0 110.007 178.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.491 ' O ' ' CB ' ' A' ' 72' ' ' ALA . 78.9 mm-40 -77.53 -20.95 53.4 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.26 -179.58 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 96.7 t -71.31 -46.58 64.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.316 0.579 . . . . 0.0 110.69 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -89.11 -10.58 46.8 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.876 -179.598 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -105.42 -26.16 12.06 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 120.465 -0.494 . . . . 0.0 112.132 -179.291 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.491 ' CB ' ' O ' ' A' ' 68' ' ' GLU . . . -68.28 136.59 53.72 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.728 0.775 . . . . 0.0 112.31 -179.02 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 7.8 m -59.82 102.8 0.17 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.133 179.552 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -68.62 129.15 39.1 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.104 0.478 . . . . 0.0 110.777 -179.685 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -98.02 80.48 2.72 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.171 0.51 . . . . 0.0 110.443 179.16 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -62.56 -36.57 83.07 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.311 0.577 . . . . 0.0 111.314 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.584 ' CD ' ' H ' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -70.2 -18.39 63.18 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.415 -177.062 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -90.61 0.61 57.31 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 121.239 0.542 . . . . 0.0 110.029 179.086 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 75.4 t -87.76 128.37 40.26 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.981 179.104 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.642 HD13 ' HE3' ' A' ' 96' ' ' LYS . 39.6 pt -111.4 -5.13 11.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.846 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -166.03 168.35 39.73 Favored Glycine 0 CA--C 1.535 1.31 0 C-N-CA 120.56 -0.829 . . . . 0.0 112.061 -179.491 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 61.7 ttp180 -137.85 154.91 49.45 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 121.127 0.489 . . . . 0.0 111.272 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.535 HG22 ' O ' ' A' ' 92' ' ' LEU . 14.6 tt -119.52 140.65 42.78 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.955 178.638 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 47.5 t -136.26 130.45 33.06 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.378 0.609 . . . . 0.0 111.813 -178.77 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.51 ' CG2' HG22 ' A' ' 88' ' ' VAL . 57.2 mt -136.91 86.07 21.87 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.839 179.429 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -56.34 -31.97 86.8 Favored 'Trans proline' 0 N--CA 1.497 1.706 0 C-N-CA 123.076 2.517 . . . . 0.0 112.666 -179.057 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 70.9 m -53.83 -41.24 67.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.275 0.559 . . . . 0.0 110.76 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.51 HG22 ' CG2' ' A' ' 85' ' ' ILE . 27.2 m -113.78 12.83 8.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.032 178.886 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.7 m 48.26 48.8 18.47 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.421 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 64.5 tp -114.04 133.27 55.63 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.949 -179.577 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -148.07 127.51 13.15 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.862 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.545 HD13 ' HA3' ' A' ' 106' ' ' GLY . 90.2 mt -151.55 151.09 28.12 Favored Pre-proline 0 N--CA 1.471 0.61 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.563 -179.128 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -75.62 147.42 31.65 Favored 'Trans proline' 0 N--CA 1.495 1.601 0 C-N-CA 122.713 2.275 . . . . 0.0 111.712 178.326 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.599 ' C ' HD12 ' A' ' 95' ' ' LEU . 49.6 t -97.15 119.17 44.85 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-O 121.19 0.519 . . . . 0.0 111.896 -179.598 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.6 HD12 ' N ' ' A' ' 95' ' ' LEU . 10.0 mp -104.69 141.08 37.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.527 179.182 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.642 ' HE3' HD13 ' A' ' 80' ' ' ILE . 98.5 mttt -64.37 -84.88 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -178.785 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 82.5 p -62.75 142.27 58.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.177 0.513 . . . . 0.0 111.502 -178.466 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 46.8 m -97.13 76.14 2.64 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.244 -179.705 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.594 HG22 ' N ' ' A' ' 100' ' ' GLU . 52.2 m -92.53 168.27 11.37 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 178.485 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.594 ' N ' HG22 ' A' ' 99' ' ' THR . 78.2 tt0 -57.53 -44.73 85.32 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 119.686 -0.806 . . . . 0.0 110.118 -179.532 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -62.93 -41.89 99.63 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.497 179.114 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -63.41 -36.66 84.46 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.681 -178.638 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.499 ' HB2' HE22 ' A' ' 63' ' ' GLN . 89.8 mt -63.26 -21.97 66.58 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.302 -0.408 . . . . 0.0 112.097 -179.224 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 96.6 mt -70.17 -23.0 62.91 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.899 0.38 . . . . 0.0 110.309 179.652 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 6.1 m -72.5 -10.28 59.6 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 121.271 0.558 . . . . 0.0 110.036 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.545 ' HA3' HD13 ' A' ' 92' ' ' LEU . . . 90.99 -18.23 51.98 Favored Glycine 0 CA--C 1.531 1.075 0 CA-C-N 115.642 -0.708 . . . . 0.0 113.43 177.872 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -145.03 124.9 13.42 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 119.418 -0.913 . . . . 0.0 112.688 -179.683 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -147.45 141.49 25.99 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.043 -0.98 . . . . 0.0 109.883 178.017 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.647 ' HA ' HD23 ' A' ' 123' ' ' LEU . 19.0 p -69.33 136.51 51.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.243 0.544 . . . . 0.0 111.568 -179.161 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.607 HG13 ' CD ' ' B' ' 703' ' ' PRO . 69.4 t -75.76 -45.8 37.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.394 179.626 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.421 ' O ' ' HG2' ' A' ' 114' ' ' GLN . 97.4 mttt -111.98 144.71 40.87 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 122.312 1.054 . . . . 0.0 113.11 179.273 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -66.69 -32.41 73.71 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.276 -1.329 . . . . 0.0 112.374 -178.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -85.34 18.82 2.51 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 -177.12 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.497 ' OE1' ' O ' ' A' ' 120' ' ' ASN . 98.0 mm-40 -76.43 137.84 39.97 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 121.73 -0.606 . . . . 0.0 111.678 179.698 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 25.3 t -128.47 120.38 52.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.443 179.214 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' MET . . . . . 0.563 ' SD ' ' OD1' ' A' ' 151' ' ' ASP . 47.1 mtt -57.67 135.81 56.77 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.708 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.427 ' O ' ' OD2' ' A' ' 180' ' ' ASP . . . 75.15 -6.01 30.75 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 121.152 -0.546 . . . . 0.0 112.606 178.37 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -137.35 126.99 25.28 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.496 0.665 . . . . 0.0 111.436 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 77.18 -169.45 54.93 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 110.768 -0.933 . . . . 0.0 110.768 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.497 ' O ' ' OE1' ' A' ' 114' ' ' GLN . 59.1 t-20 -87.97 106.34 18.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.997 0.427 . . . . 0.0 110.27 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.462 ' CE2' HD21 ' A' ' 123' ' ' LEU . 9.5 t80 -85.13 145.77 27.46 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 179.493 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -147.6 140.05 24.58 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.719 0.771 . . . . 0.0 111.587 -179.023 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.647 HD23 ' HA ' ' A' ' 109' ' ' THR . 71.3 mt -137.62 144.14 41.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.475 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -106.88 136.85 46.02 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.051 0.453 . . . . 0.0 109.826 179.537 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -144.77 131.99 4.54 Favored Glycine 0 CA--C 1.532 1.143 0 N-CA-C 110.233 -1.147 . . . . 0.0 110.233 -179.197 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.522 ' O ' ' O ' ' A' ' 134' ' ' LEU . 0.5 OUTLIER -78.71 151.76 31.96 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -178.651 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 46.3 t30 -141.63 121.14 13.27 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 115.415 -0.812 . . . . 0.0 110.173 178.788 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.484 ' O ' ' CB ' ' A' ' 129' ' ' SER . 61.5 mtt -97.03 -3.25 41.78 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.104 0.478 . . . . 0.0 110.66 -179.706 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.484 ' CB ' ' O ' ' A' ' 128' ' ' MET . 1.2 p 78.76 19.57 0.85 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.377 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.664 ' O ' HG12 ' A' ' 133' ' ' VAL . 8.7 ptpt -123.29 104.94 9.44 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.964 0.888 . . . . 0.0 112.706 -178.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.406 ' C ' ' O ' ' A' ' 130' ' ' LYS . 29.4 tptp -34.58 125.23 0.52 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.269 -1.332 . . . . 0.0 111.067 179.451 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 109.5 -10.03 32.92 Favored Glycine 0 N--CA 1.449 -0.475 0 N-CA-C 108.973 -1.651 . . . . 0.0 108.973 -178.769 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.664 HG12 ' O ' ' A' ' 130' ' ' LYS . 9.0 p -93.09 161.68 2.51 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.796 HD23 ' N ' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -69.76 139.46 53.3 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.78 0.8 . . . . 0.0 113.038 -177.686 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.495 ' CD2' HD12 ' A' ' 138' ' ' ILE . 3.6 m-85 63.17 9.1 3.69 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 114.434 -1.257 . . . . 0.0 113.297 178.46 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' SER . . . . . 0.403 ' HB3' HG13 ' A' ' 133' ' ' VAL . 0.0 OUTLIER -66.18 -35.26 80.0 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -179.806 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -92.62 0.73 57.47 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 121.108 0.48 . . . . 0.0 111.623 -178.25 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.495 HD12 ' CD2' ' A' ' 135' ' ' PHE . 3.4 tt -60.27 -37.72 74.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.069 -179.463 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.46 ' N ' ' CG2' ' A' ' 138' ' ' ILE . . . -65.99 -10.56 40.64 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.929 0.395 . . . . 0.0 111.148 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 5.8 m -82.53 -4.38 57.48 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.975 0.417 . . . . 0.0 111.126 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.479 HD21 HG21 ' A' ' 85' ' ' ILE . 76.6 mt -64.53 145.07 56.69 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 121.284 0.564 . . . . 0.0 111.258 -179.415 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -123.88 157.66 33.71 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.895 -179.137 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -50.14 134.59 22.07 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.519 -0.764 . . . . 0.0 112.085 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.601 ' N ' ' O ' ' A' ' 160' ' ' VAL . . . 77.02 7.39 86.65 Favored Glycine 0 CA--C 1.532 1.096 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.307 178.549 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -73.54 137.47 44.39 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 119.631 -0.828 . . . . 0.0 110.605 -179.548 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -81.16 140.48 34.97 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.667 0.746 . . . . 0.0 111.973 -178.729 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.461 HG23 HG12 ' A' ' 85' ' ' ILE . 88.3 mt -137.15 138.03 45.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 114.751 -1.113 . . . . 0.0 108.221 178.232 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' TYR . . . . . 0.557 ' C ' HD23 ' A' ' 149' ' ' LEU . 96.2 m-85 -123.5 137.94 54.68 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 113.464 0.913 . . . . 0.0 113.464 -177.457 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.557 HD23 ' C ' ' A' ' 148' ' ' TYR . 0.9 OUTLIER -112.49 133.24 54.66 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 177.467 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.443 ' CZ ' ' OE2' ' A' ' 155' ' ' GLU . 58.7 m-85 -109.5 109.36 20.15 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.172 -0.611 . . . . 0.0 111.618 179.742 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' ASP . . . . . 0.563 ' OD1' ' SD ' ' A' ' 116' ' ' MET . 7.8 m-20 -89.53 166.61 13.55 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 177.439 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -58.6 -23.67 59.29 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 120.246 -0.581 . . . . 0.0 111.143 -178.496 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -109.78 -28.76 8.63 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -178.475 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -150.5 -174.95 4.91 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 -177.135 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.443 ' OE2' ' CZ ' ' A' ' 150' ' ' TYR . 86.8 tt0 -131.88 139.25 48.72 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 114.122 -1.399 . . . . 0.0 110.083 178.612 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -113.57 137.84 51.0 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 121.073 0.463 . . . . 0.0 111.648 -179.649 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -94.24 112.89 24.73 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.392 179.248 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -114.51 148.39 37.99 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 120.975 0.417 . . . . 0.0 111.436 179.411 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -121.5 121.37 37.35 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.446 179.546 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.601 ' O ' ' N ' ' A' ' 144' ' ' GLY . 97.4 t -59.97 137.2 22.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.942 177.728 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 24.1 p -105.68 -23.94 12.64 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 120.749 -0.38 . . . . 0.0 111.343 179.548 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 154.55 -161.67 30.3 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 120.649 -0.786 . . . . 0.0 111.355 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.931 HG12 HG22 ' A' ' 199' ' ' VAL . 25.3 m -132.58 162.41 39.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-O 120.832 0.348 . . . . 0.0 110.349 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 83.1 p -146.87 163.96 34.42 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.404 0.621 . . . . 0.0 111.518 -179.758 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -100.88 117.65 35.37 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.704 -179.371 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 16.4 m -137.8 158.79 33.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.235 0.54 . . . . 0.0 111.372 179.696 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -94.0 158.41 36.26 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.592 179.327 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.458 ' O ' ' CB ' ' B' ' 702' ' ' LEU . 29.0 Cg_endo -61.9 -17.15 53.95 Favored 'Trans proline' 0 C--N 1.301 -1.949 0 C-N-CA 122.619 2.213 . . . . 0.0 113.555 -179.619 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 51.1 p-10 -93.02 -6.03 49.2 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 119.501 -0.879 . . . . 0.0 112.511 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -75.47 96.17 3.42 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 119.878 -0.729 . . . . 0.0 111.421 179.553 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 171' ' ' TRP . . . . . 0.432 ' CD1' ' N ' ' A' ' 171' ' ' TRP . 23.1 m0 -78.7 -15.46 58.44 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.817 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -58.28 -28.88 65.36 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.917 -179.314 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' VAL . . . . . 0.854 HG13 HG23 ' A' ' 174' ' ' VAL . 10.5 p -62.39 -25.1 36.93 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 CA-C-O 121.031 0.444 . . . . 0.0 111.192 -179.237 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.854 HG23 HG13 ' A' ' 173' ' ' VAL . 59.6 t -105.56 -8.11 10.03 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -178.628 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.44 ' O ' ' CE1' ' A' ' 177' ' ' HIS . 96.7 mt-10 -73.49 144.2 46.3 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 122.08 -0.387 . . . . 0.0 110.663 179.72 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 34.0 p-10 -62.74 144.5 56.36 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.329 0.585 . . . . 0.0 111.661 -179.484 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 177' ' ' HIS . . . . . 0.44 ' CE1' ' O ' ' A' ' 175' ' ' GLU . 68.8 m80 -122.14 19.73 10.7 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.922 -179.706 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 64.7 39.06 96.4 Favored Glycine 0 CA--C 1.532 1.095 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 179.461 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 13.1 ptmt -161.67 166.93 26.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.858 0.361 . . . . 0.0 110.15 179.586 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.854 ' OD2' HD22 ' A' ' 203' ' ' LEU . 48.1 t0 -90.19 100.23 13.09 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.18 0.514 . . . . 0.0 110.195 178.625 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 181' ' ' GLU . . . . . 0.433 ' HG2' ' N ' ' A' ' 182' ' ' ILE . 84.1 tt0 -131.33 164.59 25.31 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.448 -179.062 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.523 HG22 ' O ' ' A' ' 201' ' ' GLY . 21.2 tt -128.18 137.26 57.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.928 179.251 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 183' ' ' THR . . . . . 0.761 HG21 HG22 ' A' ' 173' ' ' VAL . 94.3 m -124.64 122.44 37.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.061 -179.265 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.443 ' HB3' HD11 ' A' ' 138' ' ' ILE . 69.5 mt -111.35 128.99 56.14 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 178.498 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.554 HD13 HD21 ' B' ' 702' ' ' LEU . 93.3 mt -110.09 123.67 66.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.397 0.618 . . . . 0.0 111.068 -179.267 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 3.6 t -138.95 158.82 43.51 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.825 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 187' ' ' CYS . . . . . . . . . . . . . 1.3 m -101.63 143.8 31.15 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.164 0.507 . . . . 0.0 111.247 -179.364 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.685 HG22 ' CD2' ' A' ' 197' ' ' TYR . 95.5 t -62.71 -47.6 92.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.691 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 20.4 t -168.4 144.55 3.75 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.309 179.239 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 190' ' ' VAL . . . . . 0.544 HG22 ' O ' ' A' ' 190' ' ' VAL . 10.8 p -60.99 -6.28 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.138 0.494 . . . . 0.0 110.69 -179.6 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -101.66 -35.43 9.11 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.848 179.527 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -99.11 110.14 22.76 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.476 -179.66 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -110.73 7.71 22.24 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.646 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 6.1 t -61.53 -47.18 86.75 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.995 0.426 . . . . 0.0 111.864 -178.718 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -146.82 158.78 44.0 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.919 -179.585 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 83.9 mtt85 -128.14 141.45 51.48 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.159 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 197' ' ' TYR . . . . . 0.685 ' CD2' HG22 ' A' ' 188' ' ' VAL . 43.1 m-85 -90.91 144.45 25.67 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 120.948 0.404 . . . . 0.0 110.844 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 39.4 t -127.42 133.94 66.82 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-O 121.361 0.601 . . . . 0.0 111.032 179.175 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.931 HG22 HG12 ' A' ' 163' ' ' VAL . 39.1 t -105.25 131.38 54.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.502 179.489 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -119.66 148.27 43.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.466 0.65 . . . . 0.0 111.588 -179.38 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 201' ' ' GLY . . . . . 0.523 ' O ' HG22 ' A' ' 182' ' ' ILE . . . -142.63 152.32 23.75 Favored Glycine 0 CA--C 1.533 1.16 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 179.296 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 202' ' ' ASP . . . . . 0.432 ' OD1' ' O ' ' A' ' 202' ' ' ASP . 52.7 p-10 -113.11 155.35 25.08 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.377 -0.529 . . . . 0.0 110.988 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 203' ' ' LEU . . . . . 0.854 HD22 ' OD2' ' A' ' 180' ' ' ASP . 60.3 tp -74.3 130.22 39.28 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.314 -0.554 . . . . 0.0 109.562 179.281 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 16.9 m -116.6 -18.24 7.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 C-N-CA 120.371 -0.532 . . . . 0.0 111.357 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -179.98 174.65 46.05 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 120.419 -0.896 . . . . 0.0 112.304 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 40.4 m -140.61 136.59 32.91 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.486 -0.357 . . . . 0.0 110.219 179.367 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 51.6 mttp -141.25 114.62 8.78 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.29 -0.564 . . . . 0.0 111.996 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -64.43 145.81 55.5 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.335 0.588 . . . . 0.0 111.076 179.212 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 21.2 ttpt -81.07 112.44 18.45 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.616 178.34 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 98.7 mttt . . . . . 0 C--O 1.22 -0.457 0 CA-C-O 118.027 -0.987 . . . . 0.0 110.675 -179.879 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 701' ' ' BOC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 702' ' ' LEU . . . . . 0.554 HD21 HD13 ' A' ' 185' ' ' ILE . 1.0 OUTLIER -108.13 105.48 56.57 Favored Pre-proline 0 CA--C 1.541 0.611 0 N-CA-C 110.193 -0.299 . . . . 20.0 110.193 . . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 703' ' ' PRO . . . . . 0.607 ' CD ' HG13 ' A' ' 110' ' ' VAL . 4.0 Cg_exo -63.0 -174.4 0.18 Allowed 'Trans proline' 0 N--CA 1.492 1.441 0 C-N-CA 122.125 1.884 . . . . 20.0 113.896 -178.75 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 704' ' ' ALA . . . . . 0.531 ' C ' HG2A ' B' ' 705' ' ' B27 . . . -39.49 -176.01 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.084 -1.416 . . . . 20.0 113.26 -178.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 705' ' ' B27 . . . . . 0.531 HG2A ' C ' ' B' ' 704' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.501 0 N-CA-C 110.183 -1.167 . . . . 0.0 110.183 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 77.7 p -69.27 -35.41 76.03 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 121.16 0.505 . . . . 0.0 110.517 179.5 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 72.9 m80 -118.19 138.54 52.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.39 179.456 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 68.3 mtt -81.16 137.89 35.89 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.949 -179.527 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -64.67 144.48 57.2 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.475 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -99.06 1.25 45.09 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.237 0.541 . . . . 0.0 110.991 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.489 ' CB ' ' O ' ' B' ' 702' ' ' LEU . 52.1 p -80.65 17.64 1.1 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.532 -179.146 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 59.1 pttt -105.68 21.11 17.81 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.162 0.505 . . . . 0.0 111.334 -179.662 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.0 mt -56.59 139.47 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-O 122.366 1.079 . . . . 0.0 113.141 -177.339 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.448 ' N ' ' OD1' ' A' ' 62' ' ' ASP . 24.6 p-10 -76.84 130.08 37.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 113.576 -1.647 . . . . 0.0 109.819 179.028 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.755 ' NE2' ' H ' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -77.19 151.56 81.42 Favored Pre-proline 0 C--N 1.325 -0.472 0 C-N-CA 120.148 -0.621 . . . . 0.0 110.437 -179.393 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -72.78 168.98 23.13 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.669 2.246 . . . . 0.0 111.729 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.674 ' O ' HG23 ' A' ' 69' ' ' VAL . 85.5 m-20 -52.18 166.58 0.16 Allowed 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.102 0.477 . . . . 0.0 111.685 -178.578 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 56.8 tp -64.9 -46.88 79.88 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.459 -178.492 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.22 -39.33 94.33 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.502 -0.479 . . . . 0.0 111.618 -178.137 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -57.13 -25.38 58.74 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.02 -0.672 . . . . 0.0 109.745 179.349 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.674 HG23 ' O ' ' A' ' 65' ' ' ASP . 20.0 t -79.42 -45.64 23.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.463 179.542 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -77.06 -9.43 58.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 114.837 -1.074 . . . . 0.0 111.796 -179.153 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 24.5 m120 -103.56 -14.24 16.25 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.371 0.605 . . . . 0.0 110.097 179.119 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -69.06 145.32 53.58 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.374 -0.83 . . . . 0.0 112.027 -179.566 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 25.9 p -59.5 104.04 0.24 Allowed 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 121.701 0.762 . . . . 0.0 111.033 -179.577 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.66 130.52 42.6 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.008 -0.996 . . . . 0.0 111.315 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.518 ' OD2' ' NE2' ' A' ' 78' ' ' GLN . 59.8 t0 -104.38 77.46 1.4 Allowed 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 121.168 0.509 . . . . 0.0 110.64 178.411 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -69.3 -31.11 69.38 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.898 -0.592 . . . . 0.0 112.31 179.049 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 41.0 mmtt -67.6 -29.16 68.43 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -175.396 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.518 ' NE2' ' OD2' ' A' ' 75' ' ' ASP . 76.7 mt-30 -88.63 -1.66 58.19 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 120.324 -0.551 . . . . 0.0 111.258 -179.703 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 53.3 t -72.72 128.91 35.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.038 178.364 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.442 HD13 ' HE2' ' A' ' 96' ' ' LYS . 36.0 pt -113.94 -4.4 11.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 C-N-CA 120.671 -0.411 . . . . 0.0 112.045 179.769 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.415 ' O ' HG22 ' A' ' 94' ' ' VAL . . . -164.74 169.96 39.65 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 120.214 -0.993 . . . . 0.0 111.629 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 62.6 ttp180 -142.84 141.59 31.63 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.36 0.6 . . . . 0.0 111.573 -179.69 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.464 HG22 ' O ' ' A' ' 92' ' ' LEU . 19.5 tt -103.2 140.33 21.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.263 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 47.3 t -135.6 129.95 33.68 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.274 -0.875 . . . . 0.0 111.156 -179.77 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.419 HG12 HG23 ' A' ' 147' ' ' ILE . 96.7 mt -140.49 93.93 8.6 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 114.702 -1.135 . . . . 0.0 109.608 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -66.46 -22.95 51.23 Favored 'Trans proline' 0 N--CA 1.493 1.457 0 C-N-CA 121.574 1.516 . . . . 0.0 113.027 -178.561 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 94.4 p -55.23 -42.26 73.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.186 0.517 . . . . 0.0 110.215 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.434 HG11 ' O ' ' A' ' 137' ' ' ASP . 31.7 m -114.03 5.4 7.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.416 0.627 . . . . 0.0 110.294 179.046 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 2.4 m 56.12 52.57 10.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.779 179.266 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.403 HD11 ' CD1' ' A' ' 92' ' ' LEU . 54.6 tp -114.5 131.93 56.47 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.155 179.286 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -144.75 118.68 9.33 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.618 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.464 ' O ' HG22 ' A' ' 83' ' ' ILE . 91.1 mt -148.71 151.36 35.38 Favored Pre-proline 0 CA--C 1.538 0.495 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.628 -178.042 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -79.39 146.0 19.21 Favored 'Trans proline' 0 N--CA 1.492 1.399 0 C-N-CA 122.597 2.198 . . . . 0.0 111.31 178.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.579 HG23 ' O ' ' A' ' 94' ' ' VAL . 3.1 m -94.4 121.08 44.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-O 121.239 0.543 . . . . 0.0 111.269 179.614 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.559 HD12 ' N ' ' A' ' 95' ' ' LEU . 10.7 mp -100.24 139.65 35.6 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.604 -179.604 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.532 ' O ' ' OG1' ' A' ' 109' ' ' THR . 99.0 mttt -60.54 -91.1 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 121.427 0.632 . . . . 0.0 112.01 -179.263 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.435 ' OG ' ' ND2' ' A' ' 102' ' ' ASN . 6.5 p -58.87 143.39 47.77 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 121.617 0.722 . . . . 0.0 112.742 -178.258 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 87.5 p -92.39 69.94 5.08 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.037 -0.983 . . . . 0.0 111.284 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.427 HG23 ' OG ' ' A' ' 97' ' ' SER . 62.8 p -91.39 168.34 11.63 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 178.305 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -62.58 -43.46 98.75 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 119.797 -0.761 . . . . 0.0 109.529 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -65.84 -40.79 92.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.872 179.214 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.435 ' ND2' ' OG ' ' A' ' 97' ' ' SER . 93.4 m-20 -64.2 -37.38 87.25 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.984 -179.455 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 54.7 mt -68.47 -8.4 40.57 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.951 -179.456 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.507 ' HB3' HG13 ' A' ' 69' ' ' VAL . 96.1 mt -72.84 -23.19 60.73 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.814 0.34 . . . . 0.0 110.444 179.07 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 95.2 p -75.32 -2.94 30.66 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.143 0.497 . . . . 0.0 110.199 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.473 ' HA3' HD12 ' A' ' 134' ' ' LEU . . . 83.76 -13.01 50.43 Favored Glycine 0 CA--C 1.531 1.036 0 CA-C-N 115.632 -0.713 . . . . 0.0 113.384 178.185 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -145.02 126.1 14.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 117.467 0.634 . . . . 0.0 111.81 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -148.13 141.43 25.18 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.356 178.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.611 ' HA ' HD23 ' A' ' 123' ' ' LEU . 36.3 p -64.67 138.1 58.2 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.432 0.634 . . . . 0.0 110.888 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.578 HG13 ' CD ' ' B' ' 703' ' ' PRO . 42.1 t -75.76 -24.74 17.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.624 -179.524 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.463 ' HG3' HG12 ' A' ' 110' ' ' VAL . 97.3 mttt -141.23 149.51 41.45 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 122.394 1.092 . . . . 0.0 112.43 178.824 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 77.8 mt-10 -65.35 -32.39 74.01 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.008 -1.451 . . . . 0.0 112.296 -178.333 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -82.06 10.98 5.64 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 113.083 0.772 . . . . 0.0 113.083 -177.894 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.429 ' OE1' ' O ' ' A' ' 120' ' ' ASN . 86.5 mm-40 -77.08 132.5 38.93 Favored 'General case' 0 C--N 1.329 -0.285 0 O-C-N 121.955 -0.466 . . . . 0.0 110.667 179.174 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 56.4 t -123.94 124.68 69.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.519 0 CA-C-O 121.245 0.545 . . . . 0.0 110.78 179.163 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' MET . . . . . 0.671 ' SD ' ' CZ ' ' A' ' 121' ' ' TYR . 94.7 mmm -54.12 126.15 21.71 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -179.389 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 72.53 6.76 67.01 Favored Glycine 0 CA--C 1.531 1.092 0 CA-C-N 115.941 -0.572 . . . . 0.0 112.751 177.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -136.93 127.99 27.74 Favored 'General case' 0 C--N 1.328 -0.341 0 O-C-N 122.389 -0.477 . . . . 0.0 111.419 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 71.76 -164.19 54.18 Favored Glycine 0 CA--C 1.531 1.069 0 N-CA-C 110.388 -1.085 . . . . 0.0 110.388 -179.693 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.429 ' O ' ' OE1' ' A' ' 114' ' ' GLN . 64.8 t-20 -87.59 103.4 15.52 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.48 -0.488 . . . . 0.0 109.794 179.266 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.671 ' CZ ' ' SD ' ' A' ' 116' ' ' MET . 17.4 t80 -86.79 145.95 26.42 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.76 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -147.49 143.39 27.82 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.735 0.779 . . . . 0.0 111.473 -179.183 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.611 HD23 ' HA ' ' A' ' 109' ' ' THR . 42.9 mt -139.38 145.99 39.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.765 -179.488 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -110.66 139.64 45.75 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.775 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -136.27 144.92 16.79 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.314 -1.114 . . . . 0.0 110.314 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.463 ' O ' ' O ' ' A' ' 134' ' ' LEU . 21.7 m-70 -88.49 150.69 22.99 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.881 0.372 . . . . 0.0 111.253 -179.813 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ASN . . . . . 0.828 ' C ' HD21 ' A' ' 127' ' ' ASN . 0.2 OUTLIER -146.71 152.57 39.04 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.226 0.536 . . . . 0.0 110.43 179.183 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.544 ' CG ' HG21 ' A' ' 133' ' ' VAL . 58.4 mtt -116.42 -2.29 12.08 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.166 -179.764 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.5 ' CB ' ' O ' ' A' ' 128' ' ' MET . 0.7 OUTLIER 80.18 5.75 1.76 Allowed 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.201 179.83 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.834 ' O ' HG12 ' A' ' 133' ' ' VAL . 8.5 ptpt -114.5 122.76 47.56 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.613 0.72 . . . . 0.0 112.479 -179.61 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 14.6 tmtt? -44.3 127.51 5.74 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.202 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 106.29 -11.08 43.6 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.511 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.834 HG12 ' O ' ' A' ' 130' ' ' LYS . 9.0 p -94.02 172.85 0.96 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.135 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.595 ' H ' HG22 ' A' ' 133' ' ' VAL . 3.8 mm? -68.76 133.09 47.86 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 116.165 1.913 . . . . 0.0 116.165 -176.48 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.428 ' CD2' HD13 ' A' ' 138' ' ' ILE . 2.7 m-85 53.69 16.19 0.94 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 113.524 -1.671 . . . . 0.0 114.291 176.496 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 5.3 t -68.94 -39.07 79.77 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.434 ' O ' HG11 ' A' ' 88' ' ' VAL . 68.0 m-20 -91.33 2.01 56.7 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 -176.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.56 HD11 ' HB ' ' A' ' 186' ' ' THR . 28.4 pt -65.86 -22.88 31.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 119.073 -1.051 . . . . 0.0 109.922 -179.326 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -70.31 -8.64 51.97 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.194 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 33.6 t -83.04 -5.29 59.05 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.589 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 86.2 mt -63.26 147.79 50.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.808 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 99.9 mttt -124.25 158.89 31.43 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.438 0.637 . . . . 0.0 111.551 -178.761 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -49.9 131.3 22.5 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.048 179.044 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 160' ' ' VAL . . . 80.43 9.01 86.99 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 120.408 -0.901 . . . . 0.0 112.273 178.379 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.492 ' OD1' ' N ' ' A' ' 146' ' ' LYS . 62.8 t0 -75.04 131.53 40.65 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 120.219 -0.592 . . . . 0.0 110.584 -179.302 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.492 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 74.8 mmtt -77.08 137.03 38.69 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 121.84 0.828 . . . . 0.0 112.232 -178.588 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.419 HG23 HG12 ' A' ' 85' ' ' ILE . 94.7 mt -138.61 140.17 39.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 114.529 -1.214 . . . . 0.0 108.574 178.345 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' TYR . . . . . 0.547 ' C ' HD23 ' A' ' 149' ' ' LEU . 12.8 m-85 -127.3 140.99 51.83 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 119.583 -0.847 . . . . 0.0 113.196 -177.726 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.547 HD23 ' C ' ' A' ' 148' ' ' TYR . 1.4 mt -114.54 131.72 56.56 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 177.462 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -107.67 112.68 25.5 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 120.007 -0.677 . . . . 0.0 111.007 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' ASP . . . . . 0.557 ' OD1' ' N ' ' A' ' 152' ' ' ASN . 58.4 t0 -90.21 163.1 14.93 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 177.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' ASN . . . . . 0.557 ' N ' ' OD1' ' A' ' 151' ' ' ASP . 15.3 t-20 -56.32 -22.58 31.6 Favored 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 119.629 -0.828 . . . . 0.0 110.966 -178.812 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -110.36 -29.2 8.22 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -178.012 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -148.73 -176.97 5.53 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 119.359 -0.936 . . . . 0.0 113.32 -176.293 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 65.4 mt-10 -131.44 136.36 47.9 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 114.758 -1.11 . . . . 0.0 109.538 179.147 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -111.3 135.84 51.26 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.149 0.499 . . . . 0.0 111.741 -179.367 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' GLU . . . . . 0.41 ' O ' HD12 ' A' ' 203' ' ' LEU . 98.7 mt-10 -92.65 112.59 24.6 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.4 179.138 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -114.96 147.05 40.55 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.007 0.432 . . . . 0.0 110.523 179.053 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -122.85 123.46 41.05 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.063 0.459 . . . . 0.0 110.776 179.346 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.51 ' O ' ' N ' ' A' ' 144' ' ' GLY . 84.5 t -58.24 134.43 23.01 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.036 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 78.0 p -118.08 11.38 13.29 Favored 'General case' 0 CA--C 1.534 0.357 0 O-C-N 123.658 0.599 . . . . 0.0 111.415 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.433 ' H ' HG12 ' A' ' 160' ' ' VAL . . . 124.78 -175.26 17.18 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 120.747 -0.739 . . . . 0.0 111.895 179.073 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.461 HG12 HG22 ' A' ' 199' ' ' VAL . 28.5 m -128.15 160.88 37.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 179.52 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 68.2 m -135.98 159.67 40.98 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.571 0.7 . . . . 0.0 111.601 -179.543 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -105.31 116.09 31.35 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.596 -179.594 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.59 HG11 ' CG1' ' A' ' 173' ' ' VAL . 35.5 m -133.89 162.99 38.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.148 -179.696 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 167' ' ' THR . . . . . 0.429 ' H ' ' HD2' ' A' ' 170' ' ' LYS . 0.1 OUTLIER -91.99 163.99 25.31 Favored Pre-proline 0 CA--C 1.538 0.511 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.222 179.379 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.459 ' O ' ' CB ' ' B' ' 702' ' ' LEU . 36.3 Cg_exo -61.09 -19.02 61.47 Favored 'Trans proline' 0 N--CA 1.502 1.982 0 C-N-CA 122.548 2.165 . . . . 0.0 113.479 179.447 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 169' ' ' ASP . . . . . 0.403 ' OD1' ' C ' ' A' ' 169' ' ' ASP . 41.0 p-10 -95.68 -6.33 40.21 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -178.884 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.734 ' O ' HG22 ' A' ' 173' ' ' VAL . 96.6 mttt -76.46 82.92 3.17 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 119.392 -0.923 . . . . 0.0 111.396 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 171' ' ' TRP . . . . . 0.51 ' O ' HG22 ' A' ' 174' ' ' VAL . 67.0 p-90 -70.72 -10.2 58.91 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.949 0.881 . . . . 0.0 109.521 179.259 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -62.69 -31.85 72.83 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.771 -1.104 . . . . 0.0 111.158 -179.727 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 173' ' ' VAL . . . . . 0.734 HG22 ' O ' ' A' ' 170' ' ' LYS . 34.6 m -62.58 -17.35 18.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-N 116.047 -0.524 . . . . 0.0 112.397 -179.081 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.684 HG13 HG23 ' A' ' 173' ' ' VAL . 30.3 m -112.87 -2.56 10.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -178.765 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -74.98 165.82 24.66 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 121.103 0.477 . . . . 0.0 110.949 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 176' ' ' ASP . . . . . 0.494 ' OD1' ' O ' ' A' ' 176' ' ' ASP . 36.5 p30 -67.33 137.49 56.07 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.075 179.582 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 177' ' ' HIS . . . . . 0.428 ' ND1' ' ND2' ' A' ' 120' ' ' ASN . 40.7 m80 -119.01 13.53 13.02 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.559 -179.71 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 62.39 41.61 99.75 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 121.003 -0.618 . . . . 0.0 111.627 179.527 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 12.9 ptmt -163.35 168.11 20.87 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.998 0.428 . . . . 0.0 110.832 179.672 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -88.15 93.48 9.51 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 178.314 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 181' ' ' GLU . . . . . 0.446 ' HG2' ' N ' ' A' ' 182' ' ' ILE . 84.6 tt0 -131.88 163.66 27.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.43 0.633 . . . . 0.0 112.106 -178.511 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.488 HG22 ' O ' ' A' ' 201' ' ' GLY . 18.0 tt -130.78 138.09 54.44 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.036 178.805 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 80.4 m -130.72 124.63 31.94 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.135 -179.642 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 87.6 mt -109.21 135.51 50.19 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.65 178.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 92.1 mt -113.21 127.69 70.36 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 CA-C-O 121.129 0.49 . . . . 0.0 110.983 -179.423 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 186' ' ' THR . . . . . 0.56 ' HB ' HD11 ' A' ' 138' ' ' ILE . 13.6 t -139.77 156.81 46.56 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.623 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 187' ' ' CYS . . . . . 0.705 ' HB2' HD22 ' A' ' 127' ' ' ASN . 2.3 m -93.19 143.68 26.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.388 0.613 . . . . 0.0 110.257 179.808 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.87 HG22 ' CE2' ' A' ' 197' ' ' TYR . 40.5 t -61.97 -46.99 95.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.429 -179.11 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 41.3 p -164.97 161.34 19.9 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.335 0.588 . . . . 0.0 110.903 -179.505 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 190' ' ' VAL . . . . . 0.456 ' O ' HG12 ' A' ' 190' ' ' VAL . 71.4 t -71.96 -13.08 16.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.321 179.347 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -97.71 -13.74 21.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.338 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -142.14 99.92 3.61 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.306 -0.558 . . . . 0.0 112.085 -179.321 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -103.78 11.35 35.91 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.577 178.85 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 41.1 m -63.64 -42.0 98.19 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.684 -179.301 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 43.3 mtmt -123.28 149.71 44.44 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.271 0.558 . . . . 0.0 111.183 -179.558 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 196' ' ' ARG . . . . . 0.546 ' HE ' ' CX ' ' B' ' 705' ' ' B27 . 85.0 mtt85 -133.23 139.98 47.27 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.431 -179.085 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 197' ' ' TYR . . . . . 0.87 ' CE2' HG22 ' A' ' 188' ' ' VAL . 42.8 m-85 -91.41 155.24 18.61 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.153 0.502 . . . . 0.0 111.021 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 3.0 m -131.46 129.25 61.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.603 178.792 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.461 HG22 HG12 ' A' ' 163' ' ' VAL . 58.9 t -97.12 130.43 45.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 178.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -107.81 131.71 54.19 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.217 0.532 . . . . 0.0 111.205 -178.239 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 201' ' ' GLY . . . . . 0.488 ' O ' HG22 ' A' ' 182' ' ' ILE . . . -132.23 131.9 6.44 Favored Glycine 0 CA--C 1.53 1.008 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -103.07 143.17 32.94 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 121.238 0.542 . . . . 0.0 111.247 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 203' ' ' LEU . . . . . 0.41 HD12 ' O ' ' A' ' 157' ' ' GLU . 35.8 tp -69.5 133.52 47.8 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.897 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 4.1 p -116.52 -17.53 7.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.69 -179.103 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 179.19 174.45 45.32 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 120.588 -0.815 . . . . 0.0 111.775 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 72.6 m -145.54 140.81 27.72 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.111 -0.545 . . . . 0.0 110.009 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -145.52 119.59 9.43 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 119.943 -0.703 . . . . 0.0 111.511 179.242 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -63.72 145.05 56.49 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.318 -0.855 . . . . 0.0 112.442 -179.191 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 8.6 ttpt -79.38 106.67 11.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.47 178.377 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 98.5 mttt . . . . . 0 C--O 1.22 -0.451 0 CA-C-O 117.93 -1.033 . . . . 0.0 110.287 -179.752 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 701' ' ' BOC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 702' ' ' LEU . . . . . 0.489 ' O ' ' CB ' ' A' ' 59' ' ' SER . 0.0 OUTLIER 57.66 94.56 0.05 OUTLIER Pre-proline 0 CA--C 1.542 0.671 0 N-CA-C 110.222 -0.288 . . . . 20.0 110.222 . . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 703' ' ' PRO . . . . . 0.578 ' CD ' HG13 ' A' ' 110' ' ' VAL . 3.8 Cg_exo -69.43 -173.39 0.66 Allowed 'Trans proline' 0 C--N 1.316 -1.158 0 C-N-CA 122.155 1.903 . . . . 20.0 112.202 179.76 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 704' ' ' ALA . . . . . 0.507 ' O ' ' O ' ' B' ' 703' ' ' PRO . . . -41.22 -179.52 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.962 -1.017 . . . . 20.0 113.506 -178.645 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 705' ' ' B27 . . . . . 0.546 ' CX ' ' HE ' ' A' ' 196' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.233 0 N-CA-C 109.038 -1.625 . . . . 0.0 109.038 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 42.4 t -70.31 144.96 51.56 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.309 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -68.3 -42.56 79.27 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.204 -0.598 . . . . 0.0 110.231 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 97.4 mtp -91.15 143.25 26.88 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.231 179.011 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 83.6 m-20 -64.91 144.23 57.42 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.399 0.619 . . . . 0.0 111.133 -179.385 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -95.73 0.59 52.65 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.815 179.089 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 85.2 p -85.72 4.92 34.53 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.65 -179.731 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -104.49 16.21 26.56 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 -178.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.0 mt -56.05 144.78 7.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 122.337 1.065 . . . . 0.0 112.931 -177.579 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 59.8 t0 -79.04 125.17 29.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 113.614 -1.63 . . . . 0.0 109.578 178.586 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.454 ' HB2' ' CG ' ' A' ' 126' ' ' HIS . 7.2 tp60 -78.7 136.17 59.35 Favored Pre-proline 0 C--N 1.322 -0.616 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -61.42 159.29 32.11 Favored 'Trans proline' 0 C--N 1.311 -1.399 0 C-N-CA 121.725 1.616 . . . . 0.0 113.083 -179.53 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.777 ' O ' HG23 ' A' ' 69' ' ' VAL . 97.6 m-20 -52.0 162.25 0.48 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.473 -178.554 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.493 ' N ' HD12 ' A' ' 66' ' ' LEU . 9.9 mp -62.75 -44.34 96.46 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.964 -178.436 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.58 -36.72 84.72 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 119.768 -0.773 . . . . 0.0 110.18 -179.561 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -62.91 -33.71 75.91 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.889 0.852 . . . . 0.0 108.812 177.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.777 HG23 ' O ' ' A' ' 65' ' ' ASP . 60.6 t -76.09 -45.65 35.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 114.607 -1.179 . . . . 0.0 110.923 179.288 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -72.31 -8.88 57.26 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.749 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -105.06 -10.54 17.11 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.631 0.729 . . . . 0.0 109.363 178.389 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.92 138.11 57.04 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.778 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 9.0 t -57.25 99.0 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.76 HD13 ' C ' ' A' ' 74' ' ' LEU . 3.2 tm? -65.16 120.21 12.27 Favored 'General case' 0 C--N 1.334 -0.087 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.368 -178.692 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.552 ' N ' HD13 ' A' ' 74' ' ' LEU . 34.1 t0 -99.08 82.5 2.74 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.551 0.691 . . . . 0.0 111.616 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.406 ' N ' HD13 ' A' ' 74' ' ' LEU . 47.8 tttp -65.31 -32.22 73.76 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.258 -0.883 . . . . 0.0 112.429 179.218 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 31.4 mmtt -68.19 -16.53 64.02 Favored 'General case' 0 C--N 1.314 -0.943 0 C-N-CA 119.997 -0.681 . . . . 0.0 110.972 -175.294 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.454 ' CD ' ' OD2' ' A' ' 75' ' ' ASP . 94.8 mt-30 -92.02 -5.91 52.07 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 121.087 0.47 . . . . 0.0 111.388 178.831 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 86.0 t -78.6 129.0 38.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.19 0.519 . . . . 0.0 110.192 179.722 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 5.3 pt -112.02 -4.47 11.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.107 -179.474 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -172.68 174.96 45.82 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 120.249 -0.977 . . . . 0.0 111.717 -179.073 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.583 ' NH2' ' OE1' ' A' ' 91' ' ' GLU . 75.1 ttt180 -136.4 154.9 50.67 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.362 0.601 . . . . 0.0 110.836 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.718 HG22 ' O ' ' A' ' 92' ' ' LEU . 19.4 tt -123.8 141.4 44.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.167 -179.501 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 14.6 t -136.69 130.45 32.14 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 121.43 0.634 . . . . 0.0 111.798 -178.39 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.527 HG22 HG22 ' A' ' 88' ' ' VAL . 89.3 mt -137.94 86.19 18.38 Favored Pre-proline 0 CA--C 1.536 0.44 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.94 -179.554 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -56.47 -30.15 80.91 Favored 'Trans proline' 0 N--CA 1.497 1.69 0 C-N-CA 123.221 2.614 . . . . 0.0 113.207 -178.661 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 18.0 m -52.8 -42.14 64.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.213 0.53 . . . . 0.0 110.704 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.527 HG22 HG22 ' A' ' 85' ' ' ILE . 23.4 m -115.53 10.91 7.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.713 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.45 ' O ' ' OG ' ' A' ' 89' ' ' SER . 5.3 p 52.04 50.49 18.41 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.047 0.451 . . . . 0.0 110.93 179.569 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 56.2 tp -116.02 133.33 56.14 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.285 0.564 . . . . 0.0 110.146 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.583 ' OE1' ' NH2' ' A' ' 82' ' ' ARG . 98.0 mt-10 -147.27 124.2 11.32 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.763 -179.186 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.718 ' O ' HG22 ' A' ' 83' ' ' ILE . 71.0 mt -151.25 152.61 31.39 Favored Pre-proline 0 N--CA 1.471 0.62 0 C-N-CA 120.154 -0.618 . . . . 0.0 111.681 -179.307 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_endo -75.0 150.26 37.88 Favored 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 122.771 2.314 . . . . 0.0 111.244 178.405 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.551 ' C ' HD12 ' A' ' 95' ' ' LEU . 91.1 t -98.01 123.5 50.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -178.751 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.551 HD12 ' C ' ' A' ' 94' ' ' VAL . 9.7 mp -109.61 136.22 49.32 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-O 120.901 0.381 . . . . 0.0 111.083 178.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 85.7 mttt -67.33 -78.88 0.05 Allowed 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.439 0.638 . . . . 0.0 112.234 -179.229 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 30.6 t -61.95 139.25 58.41 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.952 -178.709 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 7.5 t -95.44 72.93 3.24 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.364 0.602 . . . . 0.0 110.547 -179.69 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 39.7 p -90.25 166.85 13.11 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 178.183 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -60.42 -42.21 95.53 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.68 0.752 . . . . 0.0 109.273 179.059 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -64.88 -41.82 95.32 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.988 179.143 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -65.13 -38.23 89.95 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.151 -179.707 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 84.2 mt -64.01 -12.92 42.54 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.784 -179.36 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 89.6 mt -72.41 -23.22 61.06 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.279 0.561 . . . . 0.0 109.852 179.352 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 96.5 p -74.46 -6.11 46.46 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 121.442 0.639 . . . . 0.0 110.893 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.473 ' HA3' HD12 ' A' ' 134' ' ' LEU . . . 87.4 -19.79 30.07 Favored Glycine 0 CA--C 1.533 1.203 0 CA-C-N 115.642 -0.708 . . . . 0.0 112.85 178.469 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -145.28 123.71 12.37 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 119.65 -0.82 . . . . 0.0 111.956 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -144.53 135.33 24.88 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.512 179.489 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.627 ' HA ' HD23 ' A' ' 123' ' ' LEU . 2.3 m -62.44 135.41 57.42 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 121.034 0.445 . . . . 0.0 110.765 -179.074 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.547 HG13 ' CG ' ' B' ' 703' ' ' PRO . 79.8 t -77.37 -48.84 23.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.765 179.642 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 69.3 mmtt -96.18 132.2 41.86 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.577 0.703 . . . . 0.0 110.854 179.59 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -65.56 -32.77 74.54 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 114.974 -1.012 . . . . 0.0 112.195 -178.315 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 69.0 m-80 -84.55 12.4 7.08 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 -178.233 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.4 ' N ' ' OE1' ' A' ' 114' ' ' GLN . 0.6 OUTLIER -81.28 143.72 32.06 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.905 0.383 . . . . 0.0 111.494 179.853 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.459 ' O ' ' O ' ' A' ' 118' ' ' LYS . 41.4 t -126.38 123.79 64.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.982 179.796 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 98.3 mtp -57.11 137.51 55.73 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 121.241 0.543 . . . . 0.0 111.387 179.557 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 77.95 -5.01 55.71 Favored Glycine 0 CA--C 1.531 1.058 0 N-CA-C 111.522 -0.631 . . . . 0.0 111.522 179.532 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.459 ' O ' ' O ' ' A' ' 115' ' ' VAL . 98.5 mttt -141.85 132.28 25.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.208 0.528 . . . . 0.0 111.471 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 72.42 -173.23 46.78 Favored Glycine 0 CA--C 1.528 0.904 0 N-CA-C 110.524 -1.031 . . . . 0.0 110.524 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.541 HD22 ' CE1' ' A' ' 177' ' ' HIS . 56.0 t-20 -84.12 101.92 12.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.165 0.507 . . . . 0.0 109.802 179.492 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.683 ' CE2' HD21 ' A' ' 123' ' ' LEU . 27.0 t80 -88.92 99.53 12.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.362 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.715 ' HB1' HG12 ' A' ' 174' ' ' VAL . . . -92.4 143.0 26.82 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.172 0.51 . . . . 0.0 111.634 -179.653 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.683 HD21 ' CE2' ' A' ' 121' ' ' TYR . 62.2 mt -136.7 141.42 43.1 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.835 179.733 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -109.66 130.83 55.48 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.373 0.606 . . . . 0.0 110.201 179.281 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -136.79 141.29 12.26 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.518 ' O ' ' O ' ' A' ' 134' ' ' LEU . 0.3 OUTLIER -80.04 146.31 32.03 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.067 -0.653 . . . . 0.0 112.23 -178.849 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 61.8 t-20 -136.07 121.3 19.07 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.305 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.61 ' HB2' HG21 ' A' ' 133' ' ' VAL . 58.5 mtt -97.69 -4.51 37.15 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.04 -179.443 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.429 ' CB ' ' O ' ' A' ' 128' ' ' MET . 0.9 OUTLIER 78.09 6.59 2.63 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.419 179.527 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.781 ' O ' HG12 ' A' ' 133' ' ' VAL . 6.9 ptpt -113.08 116.03 29.26 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 121.468 0.651 . . . . 0.0 111.714 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -40.69 127.66 2.52 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.851 -179.644 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 105.44 -11.5 47.09 Favored Glycine 0 N--CA 1.444 -0.813 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.781 HG12 ' O ' ' A' ' 130' ' ' LYS . 7.7 p -92.43 173.84 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.058 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.598 ' H ' HG22 ' A' ' 133' ' ' VAL . 3.8 mm? -67.26 131.57 46.02 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 115.773 1.768 . . . . 0.0 115.773 -175.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.9 m-30 50.55 21.33 0.85 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 113.266 -1.788 . . . . 0.0 113.956 176.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 4.5 t -72.18 -34.06 68.14 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 119.764 -0.774 . . . . 0.0 112.523 179.791 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.484 ' O ' HG11 ' A' ' 88' ' ' VAL . 83.9 m-20 -88.91 -1.53 58.14 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.433 0.635 . . . . 0.0 111.388 -179.063 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.876 HD11 HD13 ' A' ' 184' ' ' LEU . 4.7 tt -62.7 -34.97 68.39 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.286 -179.538 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -66.43 -7.31 18.58 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 121.532 0.682 . . . . 0.0 110.234 179.432 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 4.8 m -84.67 -6.1 59.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.175 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 72.8 mt -63.39 142.17 58.49 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.014 -179.639 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -117.16 159.91 21.86 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 121.817 0.818 . . . . 0.0 112.243 -178.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 65.2 tttm -52.65 133.56 36.33 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.515 178.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.482 ' N ' ' O ' ' A' ' 160' ' ' VAL . . . 77.67 8.53 87.19 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 120.167 -1.016 . . . . 0.0 110.892 179.233 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.413 ' O ' HG23 ' A' ' 160' ' ' VAL . 55.5 t0 -81.96 125.8 31.19 Favored 'General case' 0 C--O 1.222 -0.374 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -79.91 151.0 30.38 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 115.107 1.521 . . . . 0.0 115.107 -176.446 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 97.6 mt -138.37 137.96 43.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 112.518 -2.128 . . . . 0.0 108.204 179.49 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' TYR . . . . . 0.457 ' C ' HD23 ' A' ' 149' ' ' LEU . 68.2 m-85 -121.73 135.85 54.94 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 120.094 -0.642 . . . . 0.0 111.903 -178.039 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.515 HD11 HD12 ' A' ' 182' ' ' ILE . 4.0 mt -114.59 134.29 55.16 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 177.78 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.56 ' CE2' ' CD ' ' A' ' 155' ' ' GLU . 94.4 m-85 -110.16 110.96 22.01 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 120.192 -0.603 . . . . 0.0 111.529 179.644 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' ASP . . . . . 0.477 ' N ' ' O ' ' A' ' 154' ' ' ASN . 9.6 m-20 -87.59 166.94 14.35 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 177.39 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -56.89 -24.2 50.24 Favored 'General case' 0 C--N 1.312 -1.031 0 C-N-CA 120.088 -0.645 . . . . 0.0 111.058 -178.183 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -112.69 -25.8 8.92 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 113.758 1.021 . . . . 0.0 113.758 -179.128 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' ASN . . . . . 0.477 ' O ' ' N ' ' A' ' 151' ' ' ASP . 0.6 OUTLIER -148.73 -176.3 5.27 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 118.904 -1.119 . . . . 0.0 113.533 -176.303 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.56 ' CD ' ' CE2' ' A' ' 150' ' ' TYR . 84.4 tt0 -131.94 137.39 47.92 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 114.812 -1.086 . . . . 0.0 110.197 179.038 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 156' ' ' TYR . . . . . 0.425 ' CD1' HG23 ' A' ' 206' ' ' THR . 94.1 m-85 -110.37 136.03 50.17 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.267 0.556 . . . . 0.0 112.311 -179.038 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -94.67 110.6 22.42 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.287 179.484 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -113.16 146.22 39.62 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 120.918 0.389 . . . . 0.0 110.823 179.442 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.511 ' HB2' HG21 ' A' ' 204' ' ' VAL . . . -120.75 120.79 36.65 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.068 179.611 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.482 ' O ' ' N ' ' A' ' 144' ' ' GLY . 69.0 t -59.32 134.28 24.46 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.331 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 178.273 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 10.2 p -106.91 -25.03 11.83 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 123.507 0.505 . . . . 0.0 111.041 179.124 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 159.64 -168.08 35.37 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 120.323 -0.942 . . . . 0.0 112.111 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.915 HG12 HG22 ' A' ' 199' ' ' VAL . 35.6 m -129.47 159.41 41.54 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 179.323 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 47.0 t -141.16 162.32 35.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.413 0.625 . . . . 0.0 111.704 -178.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -102.31 119.09 38.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.991 -178.757 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.481 HG21 HG21 ' A' ' 198' ' ' VAL . 22.3 m -136.47 161.17 37.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.509 -179.661 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 167' ' ' THR . . . . . 0.442 ' H ' ' HD2' ' A' ' 170' ' ' LYS . 0.2 OUTLIER -98.56 168.33 9.99 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.148 -179.432 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.452 ' O ' ' CB ' ' B' ' 702' ' ' LEU . 31.3 Cg_exo -59.96 -22.21 68.0 Favored 'Trans proline' 0 N--CA 1.499 1.813 0 C-N-CA 122.614 2.209 . . . . 0.0 113.496 179.367 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 169' ' ' ASP . . . . . 0.424 ' OD1' ' OG1' ' A' ' 167' ' ' THR . 44.9 p-10 -94.16 -1.44 54.19 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -179.041 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.536 ' O ' HG22 ' A' ' 173' ' ' VAL . 17.7 mttm -76.65 85.49 3.3 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.432 0.634 . . . . 0.0 111.613 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 171' ' ' TRP . . . . . 0.475 ' O ' HG22 ' A' ' 174' ' ' VAL . 59.9 p-90 -78.39 -12.11 59.99 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.479 179.471 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -65.54 -27.12 68.22 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.117 -179.124 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' VAL . . . . . 0.74 HG23 HG13 ' A' ' 174' ' ' VAL . 33.4 m -63.01 -21.28 27.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 120.74 -0.384 . . . . 0.0 111.766 -179.132 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.74 HG13 HG23 ' A' ' 173' ' ' VAL . 26.9 m -107.49 -2.97 10.07 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 -178.699 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -74.84 162.98 28.16 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.2 0.524 . . . . 0.0 110.835 179.735 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 176' ' ' ASP . . . . . 0.447 ' N ' ' OD1' ' A' ' 176' ' ' ASP . 33.6 p-10 -62.88 141.69 58.58 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.82 179.762 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 177' ' ' HIS . . . . . 0.541 ' CE1' HD22 ' A' ' 120' ' ' ASN . 49.1 m80 -118.63 10.5 12.52 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.801 -179.494 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 62.68 41.62 99.8 Favored Glycine 0 CA--C 1.531 1.031 0 C-N-CA 121.323 -0.465 . . . . 0.0 112.195 179.025 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -167.94 174.49 7.39 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.771 0.319 . . . . 0.0 110.37 178.688 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 -86.72 97.62 10.69 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 177.043 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 181' ' ' GLU . . . . . 0.437 ' HG2' ' N ' ' A' ' 182' ' ' ILE . 83.5 tt0 -134.16 161.07 35.9 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.591 0.71 . . . . 0.0 111.877 -178.754 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.515 HD12 HD11 ' A' ' 149' ' ' LEU . 19.5 tt -129.25 136.05 60.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 114.936 -1.029 . . . . 0.0 108.701 178.738 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 90.6 m -130.61 125.21 33.52 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.968 0.413 . . . . 0.0 110.717 -179.428 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.876 HD13 HD11 ' A' ' 138' ' ' ILE . 70.1 mt -109.36 135.36 50.55 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 179.573 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.585 HD13 HD21 ' B' ' 702' ' ' LEU . 99.0 mt -112.72 123.86 68.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.461 0.648 . . . . 0.0 110.84 -179.336 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 1.2 t -137.62 155.17 49.47 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.47 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 187' ' ' CYS . . . . . . . . . . . . . 19.9 m -88.07 140.14 29.79 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.299 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.81 HG22 ' CD2' ' A' ' 197' ' ' TYR . 55.9 t -62.74 -49.0 85.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 C-N-CA 120.444 -0.502 . . . . 0.0 110.864 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 57.2 p -160.99 166.67 27.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.57 0.7 . . . . 0.0 111.245 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 27.2 t -82.67 -16.94 11.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.699 179.709 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.48 ' O ' ' OD1' ' A' ' 192' ' ' ASP . 99.6 mttt -95.25 -13.62 24.73 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 121.055 0.455 . . . . 0.0 111.206 -179.288 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 192' ' ' ASP . . . . . 0.48 ' OD1' ' O ' ' A' ' 191' ' ' LYS . 91.5 m-20 -139.97 101.22 4.12 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.316 -179.683 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -97.26 7.88 45.67 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 121.552 0.691 . . . . 0.0 110.438 179.18 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 58.4 m -61.64 -37.1 82.76 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.462 179.676 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -127.1 150.33 49.53 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 121.338 0.589 . . . . 0.0 111.836 -178.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 196' ' ' ARG . . . . . 0.537 ' NE ' ' SG ' ' B' ' 705' ' ' B27 . 99.8 mtt180 -132.89 140.53 47.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.004 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 197' ' ' TYR . . . . . 0.81 ' CD2' HG22 ' A' ' 188' ' ' VAL . 25.6 m-85 -93.91 139.62 30.68 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.144 0.497 . . . . 0.0 110.623 178.742 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.481 HG21 HG21 ' A' ' 166' ' ' VAL . 40.9 t -129.72 131.09 66.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.178 179.253 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.915 HG22 HG12 ' A' ' 163' ' ' VAL . 56.0 t -103.11 134.88 43.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-O 121.07 0.462 . . . . 0.0 110.736 -179.478 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -115.87 141.61 47.87 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.324 0.583 . . . . 0.0 110.901 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -138.58 142.55 13.17 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 110.836 -0.906 . . . . 0.0 110.836 -179.732 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 81.4 m-20 -105.83 142.94 34.69 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.962 0.411 . . . . 0.0 110.671 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 46.9 tp -68.29 132.64 47.45 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.511 HG21 ' HB2' ' A' ' 159' ' ' ALA . 64.0 t -115.14 -21.55 5.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -178.782 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -176.04 173.59 46.36 Favored Glycine 0 CA--C 1.523 0.58 0 C-N-CA 120.155 -1.021 . . . . 0.0 111.76 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 206' ' ' THR . . . . . 0.425 HG23 ' CD1' ' A' ' 156' ' ' TYR . 9.2 m -143.16 139.53 30.38 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.238 -0.481 . . . . 0.0 109.802 179.686 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -141.69 115.42 9.11 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 121.58 0.705 . . . . 0.0 112.335 -179.397 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -64.12 142.26 58.47 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.286 -0.87 . . . . 0.0 112.325 -179.736 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -76.57 159.23 30.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.977 178.352 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 98.9 mttt . . . . . 0 C--O 1.222 -0.351 0 CA-C-O 117.965 -1.016 . . . . 0.0 111.154 -179.827 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 701' ' ' BOC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 702' ' ' LEU . . . . . 0.585 HD21 HD13 ' A' ' 185' ' ' ILE . 1.0 OUTLIER -47.54 104.65 0.42 Allowed Pre-proline 0 CA--C 1.542 0.647 0 CA-C-O 120.552 0.215 . . . . 20.0 110.735 . . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 703' ' ' PRO . . . . . 0.56 ' O ' ' O ' ' B' ' 704' ' ' ALA . 3.9 Cg_exo -64.8 -178.46 0.74 Allowed 'Trans proline' 0 N--CA 1.491 1.338 0 C-N-CA 122.132 1.888 . . . . 20.0 113.848 -178.756 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 704' ' ' ALA . . . . . 0.624 ' C ' HG2A ' B' ' 705' ' ' B27 . . . -26.64 162.39 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 114.238 -1.347 . . . . 20.0 114.103 -178.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 705' ' ' B27 . . . . . 0.624 HG2A ' C ' ' B' ' 704' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.215 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 20.0 m -58.79 -38.38 78.43 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.088 0.47 . . . . 0.0 110.636 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 15.7 m80 -126.34 147.27 49.77 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.317 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 97.1 mmm -88.93 7.14 36.07 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.198 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -70.3 88.39 0.63 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.259 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -110.79 11.63 22.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.569 -0.742 . . . . 0.0 111.191 -179.385 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.655 ' OG ' ' H13' ' B' ' 701' ' ' BOC . 44.3 p -80.77 23.28 0.54 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 121.313 0.578 . . . . 0.0 110.814 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -109.49 25.07 12.22 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.665 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 94.6 mt -56.09 136.28 18.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 122.36 1.076 . . . . 0.0 113.003 -177.05 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -79.53 128.01 32.84 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 113.552 -1.658 . . . . 0.0 108.39 177.768 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.432 HE21 ' HB2' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -79.22 149.81 73.3 Favored Pre-proline 0 C--N 1.325 -0.489 0 C-N-CA 120.546 -0.462 . . . . 0.0 110.211 -179.016 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -69.66 158.64 56.38 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 122.399 2.066 . . . . 0.0 112.385 -179.044 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.706 ' O ' HG23 ' A' ' 69' ' ' VAL . 92.5 m-20 -53.35 174.76 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.883 -178.847 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 89.8 mt -63.78 -46.78 83.67 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 -177.169 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.26 -37.8 86.83 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 119.819 -0.752 . . . . 0.0 111.238 -177.523 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.575 ' OE1' ' N ' ' A' ' 68' ' ' GLU . 35.3 mp0 -60.81 -27.54 68.11 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.416 0.627 . . . . 0.0 109.709 178.664 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.706 HG23 ' O ' ' A' ' 65' ' ' ASP . 26.2 t -78.98 -46.01 24.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.476 179.216 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -73.3 -9.21 58.46 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.879 -1.055 . . . . 0.0 111.365 -179.284 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -110.14 -8.67 14.75 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.526 0.679 . . . . 0.0 109.412 178.537 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.413 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -71.74 144.91 49.1 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 115.137 -0.938 . . . . 0.0 112.042 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 24.1 m -56.92 109.67 0.68 Allowed 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.744 -179.55 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 37.9 tp -70.12 131.25 43.99 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.773 -179.443 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -116.4 77.75 1.13 Allowed 'General case' 0 C--O 1.232 0.157 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 176.754 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -82.45 -33.39 28.54 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.989 -1.005 . . . . 0.0 113.176 -178.778 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 48.6 mmtt -73.2 -10.61 59.95 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 119.954 -0.699 . . . . 0.0 110.905 -176.739 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -92.52 -1.17 57.14 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.659 179.525 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 13.5 t -81.64 127.84 39.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.377 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 21.6 pt -107.84 -2.65 10.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.943 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -161.9 171.23 37.79 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 120.188 -1.006 . . . . 0.0 111.632 -179.386 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 58.4 ttp180 -140.65 142.0 35.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.219 0.533 . . . . 0.0 111.155 -179.72 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.582 HG22 ' O ' ' A' ' 92' ' ' LEU . 7.5 tp -105.2 136.59 38.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.976 179.43 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 10.0 t -137.05 127.94 27.42 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-O 121.431 0.634 . . . . 0.0 111.231 -179.65 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.497 ' CG2' HG22 ' A' ' 88' ' ' VAL . 56.1 mt -138.8 86.44 15.57 Favored Pre-proline 0 CA--C 1.537 0.47 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.291 -179.451 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -54.74 -30.38 66.67 Favored 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 123.044 2.496 . . . . 0.0 112.739 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 67.3 m -54.12 -41.96 68.94 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 121.118 0.485 . . . . 0.0 111.133 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.497 HG22 ' CG2' ' A' ' 85' ' ' ILE . 27.2 m -116.1 12.3 7.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.808 179.52 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 13.2 t 50.77 51.54 16.77 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.856 179.742 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 63.3 tp -115.62 132.24 56.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.27 0.557 . . . . 0.0 111.066 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -147.08 123.28 10.86 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.38 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.582 ' O ' HG22 ' A' ' 83' ' ' ILE . 84.4 mt -150.97 150.67 28.17 Favored Pre-proline 0 N--CA 1.47 0.575 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.428 -179.54 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -72.38 146.01 44.16 Favored 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 122.511 2.141 . . . . 0.0 111.699 178.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.463 ' C ' HD12 ' A' ' 95' ' ' LEU . 54.2 t -96.42 120.68 46.1 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-O 121.194 0.521 . . . . 0.0 110.86 179.736 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.531 HD12 ' N ' ' A' ' 95' ' ' LEU . 11.2 mp -99.81 138.61 36.66 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.337 -179.74 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.485 ' O ' ' OG1' ' A' ' 109' ' ' THR . 34.0 tttm -67.08 -77.86 0.07 Allowed 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.526 -179.522 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 38.2 m -61.83 136.82 58.14 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.144 0.497 . . . . 0.0 111.303 -178.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -92.79 65.6 4.22 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 121.664 0.745 . . . . 0.0 110.103 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 73.4 p -91.51 165.55 13.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.775 178.442 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 57.1 mp0 -60.39 -42.08 95.15 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.294 -0.562 . . . . 0.0 110.362 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -64.55 -40.45 95.6 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.473 0.654 . . . . 0.0 110.288 179.081 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -65.0 -34.09 77.62 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.734 -179.353 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 65.2 mt -70.02 -10.14 57.65 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.636 -179.13 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 96.0 mt -74.42 -22.42 59.16 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.015 0.436 . . . . 0.0 110.352 178.553 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 82.8 p -77.58 -1.96 33.33 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 121.321 0.581 . . . . 0.0 110.391 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 87.53 -19.16 33.89 Favored Glycine 0 CA--C 1.534 1.226 0 CA-C-N 115.732 -0.667 . . . . 0.0 113.706 177.554 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -146.2 126.12 13.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 117.975 0.888 . . . . 0.0 112.729 -179.356 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -147.34 143.52 28.09 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.484 178.492 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.664 ' HA ' HD23 ' A' ' 123' ' ' LEU . 18.9 p -68.35 138.63 55.55 Favored 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 120.338 -0.545 . . . . 0.0 109.879 179.747 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.646 HG13 ' CG ' ' B' ' 703' ' ' PRO . 70.2 t -76.55 -49.62 23.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.906 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.631 ' CE ' ' HE1' ' A' ' 171' ' ' TRP . 96.4 mttt -104.22 143.1 33.4 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 122.345 1.069 . . . . 0.0 113.254 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -66.47 -31.63 72.49 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 114.465 -1.243 . . . . 0.0 111.679 -178.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -84.99 14.94 4.38 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 -177.848 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.457 ' OE1' ' O ' ' A' ' 120' ' ' ASN . 89.6 mm-40 -75.16 136.43 41.06 Favored 'General case' 0 N--CA 1.467 0.404 0 O-C-N 121.672 -0.643 . . . . 0.0 111.332 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 46.8 t -127.36 120.72 55.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.533 178.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 51.0 mtt -57.57 132.43 53.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.899 179.751 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 77.79 -4.48 56.93 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 121.152 -0.547 . . . . 0.0 112.211 178.298 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -136.91 125.21 23.23 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.308 0.575 . . . . 0.0 110.857 -179.747 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 76.61 -165.96 53.96 Favored Glycine 0 CA--C 1.527 0.842 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 -179.65 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.457 ' O ' ' OE1' ' A' ' 114' ' ' GLN . 50.9 t-20 -91.81 106.47 18.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.17 0.51 . . . . 0.0 110.27 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.445 ' HE2' HD21 ' A' ' 123' ' ' LEU . 14.5 t80 -83.75 145.53 28.67 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.91 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -146.01 138.99 25.8 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.645 0.736 . . . . 0.0 112.465 -178.739 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.664 HD23 ' HA ' ' A' ' 109' ' ' THR . 74.2 mt -135.11 141.57 46.03 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.319 179.313 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -110.68 132.52 54.12 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.03 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -134.32 146.39 18.38 Favored Glycine 0 CA--C 1.529 0.962 0 N-CA-C 111.031 -0.828 . . . . 0.0 111.031 -178.73 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.409 ' O ' ' CB ' ' A' ' 134' ' ' LEU . 29.3 m-70 -87.24 150.37 23.95 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.443 0.64 . . . . 0.0 111.725 -179.633 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ASN . . . . . 0.6 ' C ' ' ND2' ' A' ' 127' ' ' ASN . 0.1 OUTLIER -147.82 159.29 44.0 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.764 178.782 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.489 ' N ' HD21 ' A' ' 127' ' ' ASN . 65.1 mtt -124.95 4.57 8.01 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.162 0.506 . . . . 0.0 110.772 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 76.63 9.24 3.01 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.819 179.156 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.887 ' O ' HG12 ' A' ' 133' ' ' VAL . 62.5 pttt -123.6 131.05 53.52 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 122.01 0.909 . . . . 0.0 112.927 -178.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.501 ' O ' ' O ' ' A' ' 130' ' ' LYS . 74.4 mmtt -40.57 165.05 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.184 -0.917 . . . . 0.0 109.171 178.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 70.19 -21.04 0.53 Allowed Glycine 0 CA--C 1.532 1.103 0 C-N-CA 120.673 -0.775 . . . . 0.0 111.748 179.29 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.887 HG12 ' O ' ' A' ' 130' ' ' LYS . 3.9 p -88.65 173.57 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 C-N-CA 119.651 -0.819 . . . . 0.0 110.058 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.655 ' H ' HG22 ' A' ' 133' ' ' VAL . 4.0 mm? -67.49 130.44 43.04 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 115.37 1.618 . . . . 0.0 115.37 -176.361 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.4 m-30 58.08 21.94 8.45 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 113.97 -1.468 . . . . 0.0 113.21 177.017 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.28 -39.38 92.49 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -179.645 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -91.47 -1.22 57.62 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 113.904 1.075 . . . . 0.0 113.904 -177.508 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 1.6 pp -61.2 -30.19 47.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 119.316 -0.954 . . . . 0.0 110.911 -179.524 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -66.6 -10.35 44.69 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.318 0.58 . . . . 0.0 110.356 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 3.1 m -83.89 -3.01 57.59 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.849 -179.715 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.41 HD23 ' HA ' ' A' ' 141' ' ' LEU . 91.4 mt -63.65 141.85 58.61 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 121.118 0.485 . . . . 0.0 111.241 -179.257 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 56.7 mttp -120.42 156.8 30.67 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-O 121.556 0.693 . . . . 0.0 111.74 -179.259 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -50.77 133.64 25.93 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.33 179.593 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 160' ' ' VAL . . . 79.88 8.29 87.8 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 120.352 -0.928 . . . . 0.0 111.564 179.066 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.442 ' OD1' ' N ' ' A' ' 146' ' ' LYS . 61.8 t0 -74.38 128.3 35.19 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 120.106 -0.638 . . . . 0.0 110.394 -179.43 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.442 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 75.6 mmtt -77.89 140.18 39.29 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.817 0.818 . . . . 0.0 112.197 -178.291 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.441 HG23 HG12 ' A' ' 85' ' ' ILE . 89.7 mt -139.62 139.95 37.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 114.615 -1.175 . . . . 0.0 108.832 179.023 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' TYR . . . . . 0.653 ' C ' HD23 ' A' ' 149' ' ' LEU . 97.6 m-85 -124.95 136.91 54.19 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 119.459 -0.896 . . . . 0.0 112.955 -178.402 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.653 HD23 ' C ' ' A' ' 148' ' ' TYR . 0.3 OUTLIER -112.11 134.34 53.72 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 177.296 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.604 ' CZ ' ' OE2' ' A' ' 155' ' ' GLU . 79.7 m-85 -110.66 112.94 25.17 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 119.966 -0.694 . . . . 0.0 111.278 -179.822 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 151' ' ' ASP . . . . . 0.445 ' N ' ' O ' ' A' ' 154' ' ' ASN . 38.1 t70 -89.03 165.42 14.55 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 177.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 66.1 m-20 -57.06 -23.98 50.59 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 119.836 -0.746 . . . . 0.0 110.568 -178.279 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -114.35 -25.51 8.39 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 113.534 0.939 . . . . 0.0 113.534 -178.813 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' ASN . . . . . 0.445 ' O ' ' N ' ' A' ' 151' ' ' ASP . 0.3 OUTLIER -146.65 -178.94 6.44 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 118.572 -1.251 . . . . 0.0 113.455 -176.859 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.604 ' OE2' ' CZ ' ' A' ' 150' ' ' TYR . 83.9 tt0 -131.27 133.79 45.76 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 114.674 -1.148 . . . . 0.0 109.988 179.082 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -110.01 136.24 49.58 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 121.109 0.481 . . . . 0.0 111.695 -179.282 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' GLU . . . . . 0.401 ' O ' HD12 ' A' ' 203' ' ' LEU . 77.1 tt0 -94.79 113.62 25.4 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.776 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 39.8 m-85 -114.86 149.03 37.75 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.172 0.51 . . . . 0.0 111.581 179.426 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.542 ' HB2' HG21 ' A' ' 204' ' ' VAL . . . -123.81 122.74 38.84 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.97 179.343 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.454 ' O ' ' N ' ' A' ' 144' ' ' GLY . 60.8 t -60.65 137.81 22.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 177.752 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 18.1 p -106.78 -24.69 12.0 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 120.801 -0.359 . . . . 0.0 111.649 179.364 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 160.37 -166.39 35.27 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 120.531 -0.843 . . . . 0.0 111.756 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.952 HG12 HG22 ' A' ' 199' ' ' VAL . 35.0 m -131.98 159.06 43.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-O 120.888 0.375 . . . . 0.0 110.856 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 82.2 p -147.31 162.0 39.85 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 121.095 0.474 . . . . 0.0 110.991 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -110.47 121.16 44.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.37 0.605 . . . . 0.0 110.843 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 28.1 m -138.43 159.75 31.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.821 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.32 158.63 63.42 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.702 179.653 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.503 ' O ' ' CB ' ' B' ' 702' ' ' LEU . 35.9 Cg_endo -64.48 -17.71 60.51 Favored 'Trans proline' 0 N--CA 1.499 1.809 0 C-N-CA 123.103 2.536 . . . . 0.0 113.035 -178.755 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 43.7 p-10 -91.19 -3.57 56.87 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 120.094 -0.642 . . . . 0.0 111.211 179.495 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.575 ' O ' HG22 ' A' ' 173' ' ' VAL . 73.1 mmtt -74.36 78.03 1.87 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.526 0.679 . . . . 0.0 110.804 179.798 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 171' ' ' TRP . . . . . 0.631 ' HE1' ' CE ' ' A' ' 111' ' ' LYS . 29.4 t90 -70.3 -15.25 62.87 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.046 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -64.26 -29.29 70.39 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.612 -0.722 . . . . 0.0 112.244 -179.395 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' VAL . . . . . 0.623 HG23 HG13 ' A' ' 174' ' ' VAL . 14.8 m -63.24 -21.2 27.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -179.0 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.623 HG13 HG23 ' A' ' 173' ' ' VAL . 27.2 m -105.6 -3.48 9.83 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 C-N-CA 120.372 -0.531 . . . . 0.0 112.162 -179.176 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.579 ' OE2' ' CE3' ' A' ' 171' ' ' TRP . 95.7 mt-10 -71.97 150.29 44.22 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.164 0.507 . . . . 0.0 110.634 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 176' ' ' ASP . . . . . 0.488 ' OD1' ' O ' ' A' ' 176' ' ' ASP . 54.3 p-10 -56.74 142.27 41.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.908 -179.595 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 61.7 m80 -120.46 12.91 11.7 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.863 -179.623 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 62.54 42.38 99.7 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 120.666 -0.778 . . . . 0.0 111.175 179.422 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -164.4 168.76 18.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.89 0.376 . . . . 0.0 110.631 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -87.1 99.38 11.88 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 177.805 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 181' ' ' GLU . . . . . 0.45 ' HG2' ' N ' ' A' ' 182' ' ' ILE . 84.1 tt0 -135.3 161.91 34.07 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.259 0.552 . . . . 0.0 111.521 -178.275 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.459 HG22 ' O ' ' A' ' 201' ' ' GLY . 18.7 tt -129.7 139.19 52.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.741 178.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 94.0 m -130.41 125.44 34.52 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.412 0.625 . . . . 0.0 111.72 -179.336 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 82.7 mt -109.32 131.14 55.35 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.416 178.535 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.447 HD13 ' CD2' ' B' ' 702' ' ' LEU . 77.5 mt -111.55 122.05 65.22 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 CA-C-O 121.571 0.7 . . . . 0.0 111.384 -179.534 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 12.1 m -135.08 157.13 47.71 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.032 179.301 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 187' ' ' CYS . . . . . 0.412 ' N ' ' OD1' ' A' ' 127' ' ' ASN . 1.7 m -97.08 144.84 26.56 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 120.913 0.387 . . . . 0.0 110.945 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.571 HG13 ' N ' ' A' ' 189' ' ' SER . 7.6 p -62.71 -46.83 95.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-O 121.057 0.456 . . . . 0.0 110.852 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 189' ' ' SER . . . . . 0.571 ' N ' HG13 ' A' ' 188' ' ' VAL . 36.3 p -159.62 162.36 35.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.113 0.483 . . . . 0.0 110.867 179.656 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 190' ' ' VAL . . . . . 0.492 HG22 ' O ' ' A' ' 190' ' ' VAL . 7.9 p -80.9 -7.67 10.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.533 179.522 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -96.71 -13.46 22.71 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 121.07 0.462 . . . . 0.0 110.621 179.208 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 192' ' ' ASP . . . . . 0.529 ' OD1' ' OG ' ' A' ' 194' ' ' SER . 67.8 t0 -148.59 103.39 3.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.315 0.579 . . . . 0.0 111.389 179.634 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -102.64 3.83 37.61 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.372 179.238 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 194' ' ' SER . . . . . 0.529 ' OG ' ' OD1' ' A' ' 192' ' ' ASP . 78.6 p -64.49 -24.36 67.59 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.653 -179.743 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -130.71 133.31 45.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.165 0.507 . . . . 0.0 110.575 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 196' ' ' ARG . . . . . 0.49 ' CZ ' ' HX ' ' B' ' 705' ' ' B27 . 99.6 mtt180 -129.01 139.65 51.98 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.515 -179.319 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 37.5 p90 -100.94 135.43 42.41 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.2 0.524 . . . . 0.0 110.021 178.59 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 25.6 t -114.18 135.49 53.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -178.1 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.952 HG22 HG12 ' A' ' 163' ' ' VAL . 57.4 t -104.3 132.63 50.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.698 179.066 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -121.28 150.03 42.0 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 121.483 0.658 . . . . 0.0 112.269 -179.028 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 201' ' ' GLY . . . . . 0.459 ' O ' HG22 ' A' ' 182' ' ' ILE . . . -149.98 159.7 28.21 Favored Glycine 0 CA--C 1.532 1.105 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 179.503 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 55.4 p-10 -116.37 158.7 23.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.203 0.525 . . . . 0.0 111.201 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 203' ' ' LEU . . . . . 0.401 HD12 ' O ' ' A' ' 157' ' ' GLU . 60.1 tp -76.01 131.17 39.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.746 179.413 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.542 HG21 ' HB2' ' A' ' 159' ' ' ALA . 15.0 t -111.98 -21.04 5.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -178.583 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -178.55 174.64 46.83 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 120.514 -0.85 . . . . 0.0 111.988 -179.472 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 23.6 m -144.55 139.86 28.45 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.38 -0.41 . . . . 0.0 110.142 179.668 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -143.24 118.2 10.01 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.155 -0.618 . . . . 0.0 111.339 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -63.88 141.96 58.58 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.408 -178.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 53.8 mtpt -77.35 159.79 29.26 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.046 178.465 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 53.4 mtpt . . . . . 0 C--O 1.219 -0.533 0 CA-C-O 118.037 -0.983 . . . . 0.0 110.736 179.381 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 701' ' ' BOC . . . . . 0.655 ' H13' ' OG ' ' A' ' 59' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 702' ' ' LEU . . . . . 0.503 ' CB ' ' O ' ' A' ' 168' ' ' PRO . 2.3 mt 44.36 100.44 0.03 OUTLIER Pre-proline 0 CA--C 1.542 0.662 0 CA-C-O 120.795 0.331 . . . . 20.0 111.737 . . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 703' ' ' PRO . . . . . 0.646 ' CG ' HG13 ' A' ' 110' ' ' VAL . 4.8 Cg_exo -64.92 -164.91 0.07 OUTLIER 'Trans proline' 0 N--CA 1.491 1.355 0 C-N-CA 122.627 2.218 . . . . 20.0 113.606 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 704' ' ' ALA . . . . . 0.508 ' O ' ' O ' ' B' ' 703' ' ' PRO . . . -42.31 -176.76 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 114.269 -1.332 . . . . 20.0 112.678 -179.26 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 705' ' ' B27 . . . . . 0.49 ' HX ' ' CZ ' ' A' ' 196' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.336 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 34.6 t -66.15 145.23 56.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.781 0.324 . . . . 0.0 110.581 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 43.0 t-80 -125.4 126.82 45.6 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 121.219 0.533 . . . . 0.0 111.565 179.773 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 66.9 mtt -83.78 138.75 33.1 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.132 179.762 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -69.25 146.6 52.18 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 121.619 0.724 . . . . 0.0 111.236 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.409 ' C ' ' H ' ' A' ' 60' ' ' LYS . . . -89.35 -2.94 58.62 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.48 179.779 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.605 ' C ' HH22 ' A' ' 196' ' ' ARG . 2.8 p -78.15 19.44 0.44 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.25 -179.146 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.409 ' H ' ' C ' ' A' ' 58' ' ' ALA . 99.6 mttt -95.75 13.38 26.73 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.927 179.804 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 94.0 mt -55.43 141.71 11.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 122.035 0.921 . . . . 0.0 112.949 -177.7 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.403 ' O ' ' OD1' ' A' ' 62' ' ' ASP . 35.1 p-10 -78.53 129.78 35.23 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 114.034 -1.439 . . . . 0.0 109.198 178.435 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.661 ' NE2' ' H ' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -79.98 146.87 64.55 Favored Pre-proline 0 CA--C 1.539 0.527 0 CA-C-O 120.99 0.424 . . . . 0.0 111.222 -179.071 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.23 157.97 59.4 Favored 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 123.079 2.519 . . . . 0.0 113.113 -179.642 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.816 ' O ' HG23 ' A' ' 69' ' ' VAL . 90.4 m-20 -55.45 168.67 0.36 Allowed 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.685 -179.481 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.404 HD23 ' HA ' ' A' ' 66' ' ' LEU . 92.1 mt -64.18 -45.06 90.03 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.047 -178.535 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.52 -39.41 94.36 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 119.81 -0.756 . . . . 0.0 110.893 -178.611 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -60.75 -29.39 69.36 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 178.52 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.816 HG23 ' O ' ' A' ' 65' ' ' ASP . 50.9 t -75.57 -45.11 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.981 179.101 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -72.6 -9.1 58.18 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.683 -1.144 . . . . 0.0 111.037 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 27.1 m120 -105.84 -10.35 16.72 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.524 0.678 . . . . 0.0 110.226 178.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.09 137.04 54.66 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.634 -179.409 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -60.35 98.71 0.06 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.236 0.541 . . . . 0.0 109.94 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -68.52 131.1 44.68 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.389 -179.493 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -97.88 80.65 2.77 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.395 178.78 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.832 ' O ' HG12 ' A' ' 79' ' ' VAL . 87.5 tttt -63.95 -42.39 97.32 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -179.379 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.537 ' H ' ' CE ' ' A' ' 77' ' ' LYS . 1.1 mtmt -69.66 -8.21 45.67 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.446 0.641 . . . . 0.0 111.104 -176.666 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.524 ' N ' ' CD ' ' A' ' 78' ' ' GLN . 18.6 mp0 -94.56 3.85 54.59 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.784 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.832 HG12 ' O ' ' A' ' 76' ' ' LYS . 14.9 p -86.91 122.71 39.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 120.434 -0.506 . . . . 0.0 111.258 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.535 HG21 ' HE3' ' A' ' 96' ' ' LYS . 24.0 pt -108.14 -6.11 10.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.1 179.125 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.44 ' O ' HG22 ' A' ' 94' ' ' VAL . . . -167.61 166.18 39.16 Favored Glycine 0 CA--C 1.53 1.012 0 N-CA-C 110.813 -0.915 . . . . 0.0 110.813 -179.773 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 62.6 ttp180 -140.19 142.57 35.88 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 121.207 0.527 . . . . 0.0 111.646 -179.623 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.466 HG22 ' O ' ' A' ' 92' ' ' LEU . 19.5 tt -103.9 141.71 19.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.48 -179.811 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 5.0 t -136.91 129.72 30.59 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 121.335 0.588 . . . . 0.0 111.539 -179.403 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.48 HG22 HG22 ' A' ' 88' ' ' VAL . 89.3 mt -140.29 89.37 10.86 Favored Pre-proline 0 CA--C 1.542 0.657 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.329 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -57.86 -27.67 79.4 Favored 'Trans proline' 0 N--CA 1.502 2.016 0 C-N-CA 123.279 2.653 . . . . 0.0 113.106 -179.468 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 9.7 t -53.83 -43.0 69.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.262 0.553 . . . . 0.0 110.378 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.48 HG22 HG22 ' A' ' 85' ' ' ILE . 27.8 m -112.89 8.88 8.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.816 179.065 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 40.7 p 52.74 53.86 11.47 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.524 -179.745 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 54.8 tp -116.83 134.42 54.8 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 121.461 0.648 . . . . 0.0 111.732 -179.127 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -147.46 117.8 7.39 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.239 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.474 HD13 ' HA3' ' A' ' 106' ' ' GLY . 84.2 mt -149.14 149.63 30.09 Favored Pre-proline 0 CA--C 1.542 0.641 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.447 -179.048 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -75.18 149.6 36.2 Favored 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 123.026 2.484 . . . . 0.0 112.825 179.392 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.662 HG23 ' O ' ' A' ' 94' ' ' VAL . 3.1 m -96.75 116.56 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-O 121.029 0.442 . . . . 0.0 111.214 179.752 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.561 HD12 ' N ' ' A' ' 95' ' ' LEU . 10.9 mp -100.09 136.37 40.09 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 120.955 0.407 . . . . 0.0 111.294 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.535 ' HE3' HG21 ' A' ' 80' ' ' ILE . 98.4 mttt -61.72 -80.42 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.346 0.593 . . . . 0.0 111.438 -179.536 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.44 ' OG ' ' OD1' ' A' ' 102' ' ' ASN . 6.4 p -60.86 132.74 54.84 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.172 -178.81 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.419 ' OG ' ' O ' ' A' ' 109' ' ' THR . 58.1 m -93.46 73.56 4.45 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.335 0.588 . . . . 0.0 110.391 179.815 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.472 ' H ' ' HB2' ' A' ' 102' ' ' ASN . 44.0 p -87.38 169.68 12.05 Favored 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.585 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -58.31 -45.57 87.75 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 119.335 -0.946 . . . . 0.0 108.94 179.466 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -65.8 -40.31 91.78 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.979 179.19 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.472 ' HB2' ' H ' ' A' ' 99' ' ' THR . 9.7 m120 -62.61 -39.42 93.72 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.123 0.487 . . . . 0.0 111.531 -178.749 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 62.4 mt -63.43 -19.39 64.66 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.994 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.68 ' HB3' HG13 ' A' ' 69' ' ' VAL . 45.3 mt -73.1 -14.16 61.33 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.629 -179.447 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 74.4 p -75.33 -6.98 52.69 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 178.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.49 ' O ' ' CE1' ' A' ' 135' ' ' PHE . . . 90.21 -19.44 42.99 Favored Glycine 0 CA--C 1.533 1.216 0 CA-C-N 115.116 -0.947 . . . . 0.0 112.147 179.244 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -146.27 125.64 13.12 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.264 0.554 . . . . 0.0 111.762 179.767 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -145.5 140.53 27.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.344 178.758 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.596 ' HA ' HD23 ' A' ' 123' ' ' LEU . 21.0 p -72.0 133.0 45.06 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 119.996 -0.682 . . . . 0.0 110.684 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.689 HG22 ' HG2' ' B' ' 703' ' ' PRO . 39.0 t -80.57 -48.47 19.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.155 179.591 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.47 ' O ' ' OE1' ' A' ' 114' ' ' GLN . 87.6 tttt -89.41 128.44 35.93 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.503 0.668 . . . . 0.0 111.213 -178.69 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.489 ' O ' ' NE2' ' A' ' 114' ' ' GLN . 96.8 mt-10 -66.64 -36.58 82.91 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.058 -0.974 . . . . 0.0 111.731 -178.88 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 68.8 m-80 -89.27 31.21 0.91 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.72 -179.704 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.667 ' NE2' ' N ' ' A' ' 114' ' ' GLN . 0.0 OUTLIER -75.3 138.11 41.61 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 120.954 0.407 . . . . 0.0 111.719 -179.501 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 42.9 t -120.7 105.79 17.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-O 120.893 0.378 . . . . 0.0 110.714 179.434 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' MET . . . . . 0.417 ' HG2' ' CZ ' ' A' ' 121' ' ' TYR . 85.4 mtp -55.18 130.32 41.62 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.141 0.496 . . . . 0.0 111.664 -179.844 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 88.21 -4.72 85.37 Favored Glycine 0 CA--C 1.53 1.013 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.819 179.106 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -142.7 136.32 28.88 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 121.254 0.55 . . . . 0.0 111.95 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 75.11 -166.17 54.8 Favored Glycine 0 CA--C 1.534 1.243 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 -179.577 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 59.3 t-20 -92.0 108.34 19.86 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 121.001 0.429 . . . . 0.0 110.295 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.417 ' CZ ' ' HG2' ' A' ' 116' ' ' MET . 2.5 t80 -85.57 102.47 13.56 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 121.02 0.438 . . . . 0.0 111.009 -179.399 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -91.9 130.82 37.58 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.911 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.596 HD23 ' HA ' ' A' ' 109' ' ' THR . 84.5 mt -132.45 137.67 47.34 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.62 179.715 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -113.33 144.43 42.76 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.003 0.43 . . . . 0.0 110.129 179.23 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' GLY . . . . . 0.48 ' C ' ' HG2' ' B' ' 705' ' ' B27 . . . -152.34 155.04 25.9 Favored Glycine 0 CA--C 1.531 1.057 0 N-CA-C 110.279 -1.128 . . . . 0.0 110.279 -179.849 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.432 ' ND1' HG2B ' B' ' 705' ' ' B27 . 47.6 m-70 -100.75 145.49 28.42 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.654 0.74 . . . . 0.0 111.959 -179.19 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' ASN . . . . . 0.494 ' O ' ' OD1' ' A' ' 127' ' ' ASN . 38.0 p-10 -149.64 124.26 9.76 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.788 178.517 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.523 ' CG ' ' OE1' ' A' ' 63' ' ' GLN . 70.7 mtm -84.58 0.38 50.25 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.306 -0.558 . . . . 0.0 110.26 179.731 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.482 ' CB ' ' O ' ' A' ' 128' ' ' MET . 1.1 m 80.17 12.54 1.0 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.254 179.703 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.897 ' O ' HG12 ' A' ' 133' ' ' VAL . 21.3 ptmt -104.91 124.71 49.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.996 0.903 . . . . 0.0 111.91 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -46.14 120.37 2.73 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.78 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 116.29 -18.72 13.64 Favored Glycine 0 N--CA 1.445 -0.748 0 N-CA-C 109.979 -1.249 . . . . 0.0 109.979 -179.58 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.897 HG12 ' O ' ' A' ' 130' ' ' LYS . 11.4 p -88.6 159.68 2.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.654 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.821 HD23 ' N ' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -71.22 144.04 50.23 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 122.156 0.979 . . . . 0.0 113.639 -177.314 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.49 ' CE1' ' O ' ' A' ' 106' ' ' GLY . 4.0 m-85 59.69 9.56 1.66 Allowed 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 113.902 -1.499 . . . . 0.0 114.726 177.763 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 5.7 t -69.77 -40.46 76.07 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 179.556 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -89.17 7.36 35.67 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 -176.611 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.7 HD11 ' OH ' ' A' ' 197' ' ' TYR . 35.0 pt -61.78 -26.45 39.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 C-N-CA 119.185 -1.006 . . . . 0.0 109.102 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -65.92 -14.56 61.77 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.551 179.408 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 64.3 p -83.0 -4.51 58.39 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.328 -179.391 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 81.2 mt -63.78 142.2 58.49 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 120.94 0.4 . . . . 0.0 110.977 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 63.9 mttm -118.05 153.3 33.95 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.639 0.733 . . . . 0.0 111.807 -178.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -50.21 130.74 23.24 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.955 178.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.444 ' N ' ' O ' ' A' ' 160' ' ' VAL . . . 81.42 8.7 86.77 Favored Glycine 0 CA--C 1.526 0.746 0 C-N-CA 120.219 -0.991 . . . . 0.0 110.985 179.467 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 146' ' ' LYS . 58.8 t0 -76.95 129.04 35.62 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.295 0.569 . . . . 0.0 110.229 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.504 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 72.8 mmtt -79.26 143.11 35.59 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 121.826 0.822 . . . . 0.0 112.754 -177.624 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.441 HD11 ' CG2' ' A' ' 160' ' ' VAL . 94.7 mt -138.1 139.31 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-N 114.608 -1.178 . . . . 0.0 108.322 178.565 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' TYR . . . . . 0.535 ' C ' HD22 ' A' ' 149' ' ' LEU . 90.9 m-85 -121.11 136.99 54.87 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -177.883 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.535 HD22 ' C ' ' A' ' 148' ' ' TYR . 4.6 mm? -114.0 132.74 55.88 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 177.629 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.573 ' CZ ' ' OE2' ' A' ' 155' ' ' GLU . 96.3 m-85 -112.02 107.94 17.08 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.006 -0.678 . . . . 0.0 111.783 -179.63 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 151' ' ' ASP . . . . . 0.523 ' OD1' ' N ' ' A' ' 152' ' ' ASN . 54.2 t0 -88.16 164.0 15.89 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 177.75 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 152' ' ' ASN . . . . . 0.523 ' N ' ' OD1' ' A' ' 151' ' ' ASP . 7.6 m-20 -58.49 -23.66 58.47 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 119.556 -0.858 . . . . 0.0 110.993 -178.364 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -109.36 -29.75 8.31 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 -177.839 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' ASN . . . . . 0.459 ' O ' ' N ' ' A' ' 151' ' ' ASP . 0.4 OUTLIER -149.77 -179.26 6.98 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 119.181 -1.008 . . . . 0.0 113.503 -176.712 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.573 ' OE2' ' CZ ' ' A' ' 150' ' ' TYR . 79.1 tt0 -126.26 133.09 51.55 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 114.48 -1.236 . . . . 0.0 110.159 178.896 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 156' ' ' TYR . . . . . 0.41 ' CD1' HG23 ' A' ' 206' ' ' THR . 83.2 m-85 -107.11 132.33 53.12 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 121.376 0.608 . . . . 0.0 111.323 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -93.54 112.76 24.73 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.81 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -113.05 145.29 41.14 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.01 0.434 . . . . 0.0 111.404 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -120.1 121.43 38.82 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.868 179.107 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.444 ' O ' ' N ' ' A' ' 144' ' ' GLY . 98.1 t -60.58 135.68 25.02 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 177.542 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 6.8 p -108.48 -24.76 11.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.174 0.511 . . . . 0.0 110.716 179.046 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 160.6 -170.43 36.55 Favored Glycine 0 CA--C 1.532 1.126 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 -179.425 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 35.0 m -133.49 158.79 42.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 179.52 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 39.6 t -142.9 162.5 35.3 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 121.348 0.594 . . . . 0.0 111.784 -179.216 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -109.31 121.24 44.75 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.79 179.805 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.546 HG21 HG11 ' A' ' 173' ' ' VAL . 31.3 m -136.12 161.08 38.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.605 -179.41 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.41 158.75 65.8 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.918 -179.537 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.479 ' O ' ' CB ' ' B' ' 702' ' ' LEU . 36.4 Cg_endo -64.86 -16.73 56.82 Favored 'Trans proline' 0 N--CA 1.496 1.673 0 C-N-CA 123.198 2.599 . . . . 0.0 113.054 -179.155 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 32.6 p-10 -94.79 -7.22 41.03 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.185 -0.606 . . . . 0.0 112.571 -179.675 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.443 ' O ' HG22 ' A' ' 173' ' ' VAL . 97.4 mttt -77.29 92.21 3.87 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 119.832 -0.747 . . . . 0.0 112.004 -179.785 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 171' ' ' TRP . . . . . 0.405 ' CD1' ' N ' ' A' ' 171' ' ' TRP . 6.3 m0 -75.19 -1.87 25.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.657 0.741 . . . . 0.0 109.677 178.844 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -61.72 -37.3 83.69 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.719 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 173' ' ' VAL . . . . . 0.546 HG11 HG21 ' A' ' 166' ' ' VAL . 26.9 m -63.23 -12.84 11.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.127 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.458 HG23 HG23 ' A' ' 173' ' ' VAL . 77.3 t -105.62 -23.56 4.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 N-CA-C 112.665 0.616 . . . . 0.0 112.665 -178.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -74.53 135.1 42.17 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.15 0.5 . . . . 0.0 111.148 -179.581 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 176' ' ' ASP . . . . . 0.505 ' OD1' ' O ' ' A' ' 176' ' ' ASP . 43.4 p30 -70.16 135.0 48.69 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 121.123 0.487 . . . . 0.0 110.498 179.712 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 66.8 m80 -97.89 -8.93 27.22 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.622 -0.431 . . . . 0.0 112.158 -178.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 105.11 39.9 2.21 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 109.864 -1.295 . . . . 0.0 109.864 -179.337 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 13.6 ptmt -156.42 166.01 34.68 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.919 -0.64 . . . . 0.0 110.485 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -88.6 97.18 10.96 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 178.079 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 181' ' ' GLU . . . . . 0.478 ' HG2' ' N ' ' A' ' 182' ' ' ILE . 73.6 tt0 -131.52 162.21 30.79 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 121.519 0.676 . . . . 0.0 111.891 -178.612 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.478 ' N ' ' HG2' ' A' ' 181' ' ' GLU . 18.6 tt -129.24 137.82 56.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.67 179.337 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 89.7 m -134.5 125.69 27.87 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 121.417 0.627 . . . . 0.0 111.778 -179.229 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 73.2 mt -106.61 132.06 53.04 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.075 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.701 HD13 HD21 ' B' ' 702' ' ' LEU . 77.0 mt -113.02 119.4 60.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.325 0.583 . . . . 0.0 110.694 -179.024 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 186' ' ' THR . . . . . 0.671 HG22 ' N ' ' A' ' 187' ' ' CYS . 48.7 m -141.36 167.81 21.27 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.708 179.634 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 187' ' ' CYS . . . . . 0.671 ' N ' HG22 ' A' ' 186' ' ' THR . 92.7 m -92.7 140.76 29.19 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.944 179.328 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 54.6 t -60.78 -47.74 91.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.14 -179.517 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 17.4 t -167.56 152.95 7.23 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.287 0.565 . . . . 0.0 110.507 179.445 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 78.2 t -67.51 -20.13 26.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.503 -179.732 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -96.53 -8.32 32.27 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.021 -179.509 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -136.92 98.8 3.85 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 121.141 0.495 . . . . 0.0 110.442 179.671 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 49.4 p-10 -106.61 13.92 27.63 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.6 -179.216 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 84.1 p -59.1 -45.14 91.64 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.91 0.386 . . . . 0.0 111.522 -178.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 26.3 pttm -142.41 149.92 39.96 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 121.269 0.557 . . . . 0.0 111.522 -179.645 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 196' ' ' ARG . . . . . 0.605 HH22 ' C ' ' A' ' 59' ' ' SER . 99.7 mtt180 -105.34 135.9 45.87 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.24 179.431 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 197' ' ' TYR . . . . . 0.7 ' OH ' HD11 ' A' ' 138' ' ' ILE . 21.0 p90 -96.11 150.3 20.66 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.491 -0.484 . . . . 0.0 110.102 179.599 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 4.4 m -130.52 138.51 53.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.11 0.481 . . . . 0.0 111.976 -178.475 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 49.4 t -98.79 130.69 47.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 178.188 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -116.45 140.52 49.27 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 121.261 0.553 . . . . 0.0 111.294 -179.354 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -136.18 151.57 20.82 Favored Glycine 0 CA--C 1.532 1.138 0 N-CA-C 110.421 -1.071 . . . . 0.0 110.421 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 202' ' ' ASP . . . . . 0.438 ' OD1' ' N ' ' A' ' 203' ' ' LEU . 65.0 t0 -116.99 130.43 56.69 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.152 0.501 . . . . 0.0 110.571 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 203' ' ' LEU . . . . . 0.438 ' N ' ' OD1' ' A' ' 202' ' ' ASP . 50.4 tp -58.33 131.09 49.63 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.217 -179.741 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 14.0 m -116.27 -16.65 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.919 -179.525 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -178.89 173.92 46.11 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 119.965 -1.112 . . . . 0.0 112.477 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 206' ' ' THR . . . . . 0.41 HG23 ' CD1' ' A' ' 156' ' ' TYR . 31.4 m -144.81 138.87 27.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.616 -0.792 . . . . 0.0 109.377 179.235 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -144.95 121.52 11.08 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.112 -0.635 . . . . 0.0 111.737 179.324 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -63.0 140.88 58.92 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.638 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 18.4 ttpt -81.0 110.96 17.04 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.308 179.13 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt . . . . . 0 C--O 1.219 -0.524 0 CA-C-O 118.139 -0.934 . . . . 0.0 110.717 179.997 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 701' ' ' BOC . . . . . 0.407 ' O1 ' ' O ' ' B' ' 702' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 702' ' ' LEU . . . . . 0.701 HD21 HD13 ' A' ' 185' ' ' ILE . 1.2 mt 51.8 102.15 0.03 OUTLIER Pre-proline 0 CA--C 1.544 0.732 0 CA-C-O 120.55 0.214 . . . . 20.0 110.61 . . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 703' ' ' PRO . . . . . 0.689 ' HG2' HG22 ' A' ' 110' ' ' VAL . 2.9 Cg_endo -65.97 -176.91 0.67 Allowed 'Trans proline' 0 N--CA 1.491 1.361 0 C-N-CA 122.397 2.065 . . . . 20.0 113.84 -178.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 704' ' ' ALA . . . . . 0.535 ' O ' ' O ' ' B' ' 703' ' ' PRO . . . -33.62 175.03 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 114.223 -1.353 . . . . 20.0 113.975 -179.136 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 705' ' ' B27 . . . . . 0.612 ' SG ' ' N ' ' A' ' 187' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.498 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 47.2 t -153.17 154.51 34.89 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 121.253 0.549 . . . . 0.0 111.536 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 78.6 t60 -129.76 127.27 40.04 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.263 -179.604 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 99.0 mtp -82.98 146.38 28.81 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.089 179.36 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -62.2 145.62 53.01 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 121.179 0.514 . . . . 0.0 110.726 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -79.77 -3.97 49.95 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.28 0.562 . . . . 0.0 110.76 -179.781 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 10.8 p -79.53 25.66 0.32 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.017 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -96.21 3.74 52.92 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.436 -179.467 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.0 mt -55.98 137.8 17.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 122.199 1.0 . . . . 0.0 113.351 -176.554 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -77.46 133.02 38.71 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 113.692 -1.595 . . . . 0.0 109.37 178.674 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.562 ' OE1' ' CE1' ' A' ' 126' ' ' HIS . 0.0 OUTLIER -79.8 150.85 73.13 Favored Pre-proline 0 CA--C 1.537 0.451 0 C-N-CA 119.901 -0.72 . . . . 0.0 109.798 -179.989 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.64 ' CG ' HD11 ' A' ' 104' ' ' LEU . 83.0 Cg_endo -73.37 163.02 38.86 Favored 'Trans proline' 0 N--CA 1.499 1.826 0 C-N-CA 123.427 2.751 . . . . 0.0 114.086 -178.05 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.7 ' O ' HG23 ' A' ' 69' ' ' VAL . 88.0 m-20 -54.51 164.0 0.8 Allowed 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.753 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 53.4 tp -64.28 -47.37 79.79 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 121.102 0.477 . . . . 0.0 111.118 -178.749 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.43 -36.51 82.63 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.079 -0.648 . . . . 0.0 110.865 -178.803 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -61.21 -29.27 69.72 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.033 -0.667 . . . . 0.0 109.652 179.144 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.7 HG23 ' O ' ' A' ' 65' ' ' ASP . 50.8 t -74.05 -43.71 51.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 121.825 0.821 . . . . 0.0 109.729 179.145 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -76.42 -8.23 56.71 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.745 -1.116 . . . . 0.0 111.434 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -105.41 -8.15 18.32 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.038 0.447 . . . . 0.0 110.38 179.008 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.22 137.5 54.84 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 121.369 0.604 . . . . 0.0 111.109 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 32.2 t -60.29 102.19 0.16 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.486 179.482 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.92 128.45 36.71 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.372 -179.4 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 -96.43 84.33 3.69 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 177.723 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -62.98 -41.49 99.56 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.272 0.558 . . . . 0.0 111.899 -179.528 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.511 ' CD ' ' H ' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -71.16 -8.5 53.96 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.869 -176.27 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -94.68 -13.34 25.9 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 121.211 0.529 . . . . 0.0 110.093 178.349 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 86.9 t -76.2 128.59 37.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.966 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.669 HD13 ' CE ' ' A' ' 96' ' ' LYS . 39.3 pt -113.54 -7.9 12.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.428 179.565 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -174.21 -175.12 41.57 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 110.431 -1.067 . . . . 0.0 110.431 179.53 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 39.9 ptt180 -152.1 166.71 30.81 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.472 0.653 . . . . 0.0 111.168 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 19.5 tt -114.5 142.87 25.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.223 178.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 66.1 m -135.64 126.89 28.26 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.47 0.653 . . . . 0.0 111.174 -179.342 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.492 ' CG2' HG22 ' A' ' 88' ' ' VAL . 43.3 mt -137.45 89.39 15.93 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.481 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_exo -56.5 -30.18 81.37 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.589 2.192 . . . . 0.0 112.831 -179.771 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 47.0 m -51.86 -40.94 61.42 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 121.185 0.516 . . . . 0.0 110.593 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.492 HG22 ' CG2' ' A' ' 85' ' ' ILE . 18.6 m -114.0 8.46 7.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.888 179.057 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.483 ' O ' ' OG ' ' A' ' 89' ' ' SER . 3.7 t 54.08 54.13 10.09 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 -179.498 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 66.5 tp -118.43 133.52 55.81 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 121.543 0.687 . . . . 0.0 111.166 -179.152 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -148.03 120.03 8.23 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.329 -0.851 . . . . 0.0 110.452 -179.306 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.615 HD13 ' O ' ' A' ' 105' ' ' SER . 74.6 mt -149.64 152.95 35.96 Favored Pre-proline 0 CA--C 1.537 0.479 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.644 -179.539 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -75.38 150.72 36.95 Favored 'Trans proline' 0 N--CA 1.497 1.735 0 C-N-CA 123.127 2.551 . . . . 0.0 112.471 179.142 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.567 ' C ' HD12 ' A' ' 95' ' ' LEU . 53.0 t -99.17 120.91 49.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-O 121.173 0.511 . . . . 0.0 112.058 -179.261 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.567 HD12 ' C ' ' A' ' 94' ' ' VAL . 10.4 mp -104.38 134.5 47.48 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.324 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.669 ' CE ' HD13 ' A' ' 80' ' ' ILE . 98.7 mttt -61.7 -80.29 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.217 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 12.0 t -56.45 133.02 52.85 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.952 -178.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.8 m -92.53 70.5 5.0 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.756 179.35 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.59 HG22 ' N ' ' A' ' 100' ' ' GLU . 41.2 m -92.37 169.98 10.14 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 178.769 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.59 ' N ' HG22 ' A' ' 99' ' ' THR . 96.7 mt-10 -64.3 -42.46 96.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.264 0.554 . . . . 0.0 110.018 179.503 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 61.6 mttm -65.59 -38.67 90.14 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.887 179.51 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -64.75 -33.6 76.35 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.378 -0.828 . . . . 0.0 112.18 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 83.5 mt -68.83 -6.79 29.01 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -178.813 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.64 HD11 ' CG ' ' A' ' 64' ' ' PRO . 3.9 mm? -74.77 -16.36 60.73 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 121.187 0.517 . . . . 0.0 109.635 178.857 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.615 ' O ' HD13 ' A' ' 92' ' ' LEU . 79.2 p -81.18 -10.04 59.69 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.751 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.605 ' O ' ' CE1' ' A' ' 135' ' ' PHE . . . 92.87 -19.42 51.85 Favored Glycine 0 CA--C 1.532 1.151 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.636 178.7 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -145.72 127.35 15.18 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 119.605 -0.838 . . . . 0.0 112.661 -179.463 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -147.69 138.56 23.38 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.272 -0.877 . . . . 0.0 110.11 178.255 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.671 ' HA ' HD23 ' A' ' 123' ' ' LEU . 12.3 p -69.06 135.49 50.89 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 121.316 0.579 . . . . 0.0 110.928 -179.751 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.588 HG22 ' HG2' ' B' ' 703' ' ' PRO . 78.7 t -78.0 -48.86 22.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.226 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.535 ' NZ ' ' CD ' ' A' ' 175' ' ' GLU . 98.5 mttt -99.06 140.14 33.67 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.801 0.81 . . . . 0.0 112.52 -179.843 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -65.86 -36.21 82.82 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.625 -1.17 . . . . 0.0 111.47 -179.739 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 73.7 m-80 -84.6 11.0 9.63 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -177.768 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.495 ' NE2' ' O ' ' A' ' 120' ' ' ASN . 0.6 OUTLIER -78.92 139.19 38.32 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 120.799 0.333 . . . . 0.0 111.296 179.569 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 38.8 t -125.8 125.85 69.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 CA-C-O 121.069 0.461 . . . . 0.0 111.227 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' MET . . . . . 0.431 ' CG ' ' CZ ' ' A' ' 121' ' ' TYR . 93.1 mtp -57.11 133.56 55.11 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.126 0.489 . . . . 0.0 111.657 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 78.14 -2.7 64.58 Favored Glycine 0 CA--C 1.529 0.922 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.643 179.162 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -138.49 132.37 31.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.615 0.722 . . . . 0.0 111.784 179.687 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 71.14 -167.06 52.05 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 110.18 -1.168 . . . . 0.0 110.18 -179.487 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.495 ' O ' ' NE2' ' A' ' 114' ' ' GLN . 64.7 t-20 -87.83 104.69 16.82 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.196 0.522 . . . . 0.0 109.714 179.726 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.64 ' CE2' HD21 ' A' ' 123' ' ' LEU . 5.3 t80 -87.06 99.37 11.86 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.115 -179.479 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.3 135.12 33.88 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.829 -179.718 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.671 HD23 ' HA ' ' A' ' 109' ' ' THR . 68.3 mt -135.37 139.78 44.5 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.735 -179.771 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -111.37 140.87 45.59 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 178.702 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -141.16 129.66 4.15 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 110.482 -1.047 . . . . 0.0 110.482 -179.474 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.562 ' CE1' ' OE1' ' A' ' 63' ' ' GLN . 1.8 m-70 -82.11 131.52 35.24 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.336 0.589 . . . . 0.0 112.098 -179.208 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' ASN . . . . . 0.588 ' ND2' ' OG1' ' A' ' 186' ' ' THR . 7.2 p30 -138.79 152.21 47.71 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.634 179.322 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.611 ' O ' ' N ' ' A' ' 130' ' ' LYS . 79.4 mtm -119.28 42.04 2.94 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.598 0.713 . . . . 0.0 110.161 179.179 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 38.64 15.84 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 114.919 -1.037 . . . . 0.0 112.304 178.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.877 ' O ' HG12 ' A' ' 133' ' ' VAL . 19.2 ptmt -110.61 127.32 55.19 Favored 'General case' 0 C--O 1.226 -0.176 0 CA-C-O 122.025 0.917 . . . . 0.0 112.323 -179.723 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.458 ' C ' ' O ' ' A' ' 130' ' ' LYS . 55.8 tptt -38.37 150.71 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.915 179.413 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 79.58 -17.56 8.32 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 121.045 -0.598 . . . . 0.0 112.127 179.224 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.877 HG12 ' O ' ' A' ' 130' ' ' LYS . 9.9 p -87.87 153.08 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-N 117.753 0.777 . . . . 0.0 110.342 -179.561 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.773 HD23 ' N ' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -69.45 143.53 53.54 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.594 0.711 . . . . 0.0 112.832 -177.889 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.605 ' CE1' ' O ' ' A' ' 106' ' ' GLY . 3.5 m-85 66.39 8.34 5.63 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 114.139 -1.391 . . . . 0.0 114.493 177.712 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 5.2 t -76.88 -42.68 38.9 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 179.573 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -91.82 1.31 57.26 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 114.055 1.132 . . . . 0.0 114.055 -176.682 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.607 HD11 ' HB ' ' A' ' 186' ' ' THR . 48.6 pt -66.92 -23.73 31.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 C-N-CA 119.43 -0.908 . . . . 0.0 110.877 -179.431 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -66.53 -10.68 47.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.551 0.691 . . . . 0.0 109.856 179.561 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 94.0 p -81.34 -2.77 50.47 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.625 -179.811 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 67.8 mt -62.73 143.54 57.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.47 0.652 . . . . 0.0 111.059 -179.632 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -121.57 156.83 32.05 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.216 -179.469 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -50.86 133.08 26.9 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.061 -0.972 . . . . 0.0 112.116 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 160' ' ' VAL . . . 79.96 8.69 87.44 Favored Glycine 0 CA--C 1.53 0.979 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.239 178.518 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.463 ' OD1' ' N ' ' A' ' 146' ' ' LYS . 60.5 t0 -74.12 133.47 42.82 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 120.277 -0.569 . . . . 0.0 110.277 -179.62 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.463 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 71.1 mmtt -79.06 140.44 37.89 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 121.84 0.829 . . . . 0.0 111.908 -179.033 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.453 HD11 ' CG2' ' A' ' 160' ' ' VAL . 92.6 mt -140.13 140.12 35.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 114.899 -1.046 . . . . 0.0 108.587 179.511 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -128.64 140.95 51.51 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 119.384 -0.927 . . . . 0.0 113.226 -177.08 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.537 HD11 HD12 ' A' ' 182' ' ' ILE . 19.1 mt -112.51 131.98 55.32 Favored 'General case' 0 CA--C 1.519 -0.233 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 176.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.608 ' CZ ' ' OE2' ' A' ' 155' ' ' GLU . 49.2 m-85 -108.18 107.87 18.68 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.028 -0.669 . . . . 0.0 112.468 -178.814 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -88.19 158.74 18.43 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 106.641 -1.615 . . . . 0.0 106.641 176.858 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 33.7 p-10 -57.45 -16.11 8.63 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 119.137 -1.025 . . . . 0.0 111.365 -177.625 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -114.22 -29.13 7.04 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -179.098 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -146.47 178.97 7.87 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 -176.616 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.608 ' OE2' ' CZ ' ' A' ' 150' ' ' TYR . 84.3 tt0 -130.65 136.03 48.43 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 114.681 -1.145 . . . . 0.0 109.597 178.537 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 156' ' ' TYR . . . . . 0.406 ' CD1' HG23 ' A' ' 206' ' ' THR . 80.6 m-85 -108.94 133.62 52.69 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.779 0.288 . . . . 0.0 111.779 -178.852 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -93.2 112.51 24.47 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 121.262 0.553 . . . . 0.0 111.983 179.423 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -112.9 146.06 39.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.176 179.551 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -121.18 120.72 36.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.207 179.128 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.527 ' O ' ' N ' ' A' ' 144' ' ' GLY . 90.8 t -59.78 136.66 23.16 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.301 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 178.399 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 7.9 p -105.63 -25.39 12.28 Favored 'General case' 0 C--N 1.328 -0.356 0 O-C-N 123.581 0.551 . . . . 0.0 110.86 179.325 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 158.61 -166.09 34.22 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 120.622 -0.799 . . . . 0.0 111.405 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.757 HG12 HG22 ' A' ' 199' ' ' VAL . 32.7 m -134.08 163.1 38.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.036 -0.582 . . . . 0.0 109.722 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 11.8 p -148.87 161.1 42.52 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.315 0.578 . . . . 0.0 111.477 -179.428 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.403 ' HG2' ' CE2' ' A' ' 197' ' ' TYR . 95.5 mt-10 -103.39 117.18 33.89 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.759 179.151 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 22.7 m -135.18 156.16 38.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.802 -179.226 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -85.14 157.59 59.32 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.508 179.438 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.502 ' O ' ' CB ' ' B' ' 702' ' ' LEU . 19.5 Cg_endo -62.71 -15.66 48.01 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 C-N-CA 122.78 2.32 . . . . 0.0 113.665 -179.685 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 169' ' ' ASP . . . . . 0.626 ' O ' ' NE1' ' A' ' 171' ' ' TRP . 39.3 p-10 -92.84 -6.72 48.17 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 119.48 -0.888 . . . . 0.0 111.917 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.749 ' O ' HG22 ' A' ' 173' ' ' VAL . 96.5 mttt -78.1 85.07 4.32 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.357 -0.537 . . . . 0.0 111.824 179.429 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 171' ' ' TRP . . . . . 0.626 ' NE1' ' O ' ' A' ' 169' ' ' ASP . 0.0 OUTLIER -75.02 -8.51 56.72 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.428 0.632 . . . . 0.0 110.185 179.159 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 53.3 tp10 -64.77 -29.1 70.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.537 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 173' ' ' VAL . . . . . 0.749 HG22 ' O ' ' A' ' 170' ' ' LYS . 35.1 m -62.88 -22.21 29.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.37 -179.855 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.628 HG13 HG23 ' A' ' 173' ' ' VAL . 31.5 m -105.2 -3.46 9.76 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.535 ' CD ' ' NZ ' ' A' ' 111' ' ' LYS . 63.3 mm-40 -71.96 150.68 43.88 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.31 0.576 . . . . 0.0 111.202 179.586 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 38.7 p-10 -67.97 141.8 56.17 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.051 -179.687 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 78.7 m80 -117.43 23.26 11.9 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.914 0.388 . . . . 0.0 111.411 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 62.06 43.2 99.47 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 110.759 -0.937 . . . . 0.0 110.759 -179.824 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 12.5 ptmt -164.87 168.44 17.69 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.064 0.459 . . . . 0.0 110.301 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -86.99 100.9 12.94 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 177.416 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 77.5 tt0 -132.55 160.95 35.09 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.335 0.588 . . . . 0.0 111.32 -178.205 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.682 HG22 ' O ' ' A' ' 201' ' ' GLY . 18.7 tt -128.65 138.17 55.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.619 179.244 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 60.6 m -132.52 126.18 32.29 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.883 -179.178 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 70.7 mt -111.97 134.44 53.52 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.633 179.617 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.649 HD13 HD21 ' B' ' 702' ' ' LEU . 92.9 mt -115.9 123.42 71.19 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 CA-C-O 121.482 0.658 . . . . 0.0 110.732 -179.462 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 186' ' ' THR . . . . . 0.607 ' HB ' HD11 ' A' ' 138' ' ' ILE . 13.2 t -138.69 158.65 43.84 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.97 -179.774 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 187' ' ' CYS . . . . . 0.674 ' N ' ' SG ' ' B' ' 705' ' ' B27 . 91.7 m -89.57 139.2 30.78 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.886 0.374 . . . . 0.0 110.591 -179.331 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.592 HG13 ' N ' ' A' ' 189' ' ' SER . 11.9 p -62.33 -44.56 99.31 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-O 120.968 0.414 . . . . 0.0 110.806 -179.259 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 189' ' ' SER . . . . . 0.592 ' N ' HG13 ' A' ' 188' ' ' VAL . 23.9 m -167.52 153.43 7.61 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.252 0.548 . . . . 0.0 111.286 -179.626 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 70.1 t -72.43 -17.69 18.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.256 178.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -96.04 -11.86 25.78 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.251 179.698 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 192' ' ' ASP . . . . . 0.499 ' O ' ' CG1' ' A' ' 188' ' ' VAL . 49.5 t0 -141.15 98.62 3.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.171 0.51 . . . . 0.0 111.307 -179.409 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -98.81 9.83 42.58 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.542 0.687 . . . . 0.0 109.75 179.279 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 25.3 m -60.13 -42.68 95.33 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.785 -178.868 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt -133.89 150.19 51.34 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 120.979 0.419 . . . . 0.0 111.346 -179.36 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 196' ' ' ARG . . . . . 0.74 HH22 HD22 ' B' ' 702' ' ' LEU . 42.7 mtm180 -128.26 141.45 51.45 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 121.122 0.487 . . . . 0.0 110.48 179.548 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 197' ' ' TYR . . . . . 0.403 ' CE2' ' HG2' ' A' ' 165' ' ' GLU . 48.4 m-85 -98.04 137.6 36.59 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.331 0.586 . . . . 0.0 111.708 -179.708 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 35.1 t -118.27 134.93 60.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.428 178.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.757 HG22 HG12 ' A' ' 163' ' ' VAL . 68.6 t -103.45 134.51 44.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.013 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -117.0 138.21 51.72 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 121.449 0.642 . . . . 0.0 111.666 -179.124 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 201' ' ' GLY . . . . . 0.682 ' O ' HG22 ' A' ' 182' ' ' ILE . . . -139.81 130.98 4.93 Favored Glycine 0 CA--C 1.529 0.95 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 179.609 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -95.89 142.07 28.57 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.253 0.549 . . . . 0.0 111.049 -179.411 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 52.0 tp -67.03 133.22 49.49 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 121.527 0.679 . . . . 0.0 110.186 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 74.9 t -105.6 -51.6 7.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.233 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -152.36 174.94 31.2 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 120.193 -1.003 . . . . 0.0 112.576 -178.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 206' ' ' THR . . . . . 0.406 HG23 ' CD1' ' A' ' 156' ' ' TYR . 18.0 m -142.4 138.33 31.06 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 114.892 -0.654 . . . . 0.0 110.711 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 54.6 mtmt -146.35 128.0 15.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.262 0.554 . . . . 0.0 111.885 178.557 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -62.04 142.07 57.73 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.61 -179.679 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -79.24 108.23 12.59 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.429 178.613 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 99.2 mttt . . . . . 0 C--O 1.218 -0.588 0 CA-C-O 117.921 -1.038 . . . . 0.0 110.537 -179.98 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 701' ' ' BOC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 702' ' ' LEU . . . . . 0.74 HD22 HH22 ' A' ' 196' ' ' ARG . 0.6 OUTLIER -46.5 113.39 2.21 Favored Pre-proline 0 CA--C 1.543 0.675 0 CA-C-O 120.378 0.132 . . . . 20.0 110.81 . . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 703' ' ' PRO . . . . . 0.621 ' HD2' HD23 ' B' ' 702' ' ' LEU . 2.4 Cg_endo -64.55 -172.64 0.2 Allowed 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 122.053 1.835 . . . . 20.0 113.482 -178.497 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 704' ' ' ALA . . . . . 0.41 ' O ' ' O ' ' B' ' 703' ' ' PRO . . . -48.69 -172.55 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.098 -1.41 . . . . 20.0 112.424 -179.657 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 705' ' ' B27 . . . . . 0.674 ' SG ' ' N ' ' A' ' 187' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.205 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 59.4 p -72.14 159.5 34.04 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.059 0.457 . . . . 0.0 110.392 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 -67.07 -40.79 87.1 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.232 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 98.5 mmm -97.07 65.39 2.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.277 -179.624 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 67.2 t0 -61.9 121.97 14.26 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.307 -179.644 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -98.21 16.26 21.91 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 121.049 0.452 . . . . 0.0 111.383 -179.706 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 3.9 p -83.18 21.3 1.12 Allowed 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.124 0.488 . . . . 0.0 111.347 -179.815 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -106.04 15.8 25.94 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.877 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.3 mt -55.37 137.0 17.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 122.315 1.055 . . . . 0.0 112.527 -177.05 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -77.84 133.38 38.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 113.687 -1.597 . . . . 0.0 109.097 179.057 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.627 ' CD ' ' H ' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -77.57 152.16 80.69 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-O 121.109 0.48 . . . . 0.0 110.813 -178.476 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -74.01 156.42 47.53 Favored 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 123.249 2.632 . . . . 0.0 113.151 -179.67 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.442 ' O ' ' OE1' ' A' ' 68' ' ' GLU . 39.0 t70 -54.0 172.83 0.07 Allowed 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.073 179.724 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.411 HD11 ' HE2' ' A' ' 130' ' ' LYS . 86.1 mt -69.55 -13.36 62.29 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.199 -178.509 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -68.11 -37.62 81.35 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.5 0.667 . . . . 0.0 110.455 179.414 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.869 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 58.9 mp0 -68.16 -31.33 70.81 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.841 -1.072 . . . . 0.0 110.546 179.364 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 8.3 t -71.27 -44.85 72.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.575 -179.457 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -81.92 -13.14 57.93 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.031 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -114.88 1.45 14.06 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 121.252 0.549 . . . . 0.0 110.345 178.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.869 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -67.77 -173.5 0.35 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.517 0.675 . . . . 0.0 112.161 -179.019 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.6 t -102.3 95.38 6.25 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 114.887 -1.051 . . . . 0.0 109.786 179.073 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.552 HD13 ' C ' ' A' ' 74' ' ' LEU . 0.5 OUTLIER -68.79 103.39 1.76 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.899 -179.376 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.454 ' OD2' ' CD ' ' A' ' 78' ' ' GLN . 46.0 t0 -93.2 82.62 4.54 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.623 0.725 . . . . 0.0 109.751 178.483 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -80.15 -30.32 38.91 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.068 -0.969 . . . . 0.0 112.011 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 35.7 mmtt -68.16 -30.92 70.16 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.13 -176.159 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.454 ' CD ' ' OD2' ' A' ' 75' ' ' ASP . 86.0 mt-30 -87.47 2.32 50.94 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.441 -0.504 . . . . 0.0 111.688 -179.101 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 67.8 t -75.65 130.51 36.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.323 0.582 . . . . 0.0 109.927 179.291 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.492 HD13 ' CE ' ' A' ' 96' ' ' LYS . 16.2 pt -107.29 -7.35 10.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.994 -179.235 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -175.27 179.27 46.62 Favored Glycine 0 CA--C 1.527 0.793 0 C-N-CA 120.693 -0.765 . . . . 0.0 111.26 179.795 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.459 ' HA ' HG23 ' A' ' 94' ' ' VAL . 38.7 ptt180 -152.69 155.35 37.09 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.474 0.654 . . . . 0.0 111.569 179.381 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 20.4 tt -105.05 147.83 10.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.793 -179.662 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 9.2 t -136.03 131.4 34.9 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.473 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.547 ' CG2' HG22 ' A' ' 88' ' ' VAL . 96.3 mt -137.19 88.71 17.13 Favored Pre-proline 0 CA--C 1.54 0.584 0 CA-C-N 115.41 -0.813 . . . . 0.0 110.846 -179.173 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -56.31 -31.03 83.18 Favored 'Trans proline' 0 N--CA 1.499 1.804 0 C-N-CA 123.043 2.495 . . . . 0.0 112.683 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 99.1 p -53.6 -44.18 69.23 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 121.333 0.587 . . . . 0.0 110.738 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.547 HG22 ' CG2' ' A' ' 85' ' ' ILE . 12.5 m -113.72 11.61 8.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.891 178.861 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.4 t 44.74 57.0 4.81 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.651 -179.516 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 57.7 tp -117.78 136.64 53.26 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.296 179.749 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -146.13 124.79 12.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.68 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.526 HD13 ' HA3' ' A' ' 106' ' ' GLY . 77.4 mt -148.72 150.13 32.45 Favored Pre-proline 0 CA--C 1.535 0.38 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.53 -178.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.07 148.11 34.57 Favored 'Trans proline' 0 N--CA 1.491 1.351 0 C-N-CA 122.526 2.151 . . . . 0.0 111.707 178.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.564 ' C ' HD12 ' A' ' 95' ' ' LEU . 88.9 t -96.81 116.73 39.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 CA-C-O 121.006 0.432 . . . . 0.0 111.587 -179.674 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.58 HD12 ' N ' ' A' ' 95' ' ' LEU . 8.7 mp -100.37 138.79 36.95 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.151 0.5 . . . . 0.0 110.7 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.492 ' CE ' HD13 ' A' ' 80' ' ' ILE . 98.3 mttt -66.13 -79.28 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.425 0.631 . . . . 0.0 112.181 -179.005 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 40.7 t -57.54 133.66 55.44 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.935 -178.16 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 43.4 p -88.41 66.05 8.17 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.549 179.46 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.441 ' OG1' ' CG ' ' A' ' 102' ' ' ASN . 31.6 p -86.7 167.45 14.46 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 178.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -63.78 -41.39 97.96 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.233 0.539 . . . . 0.0 110.239 179.57 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -66.28 -39.83 89.66 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.589 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.441 ' CG ' ' OG1' ' A' ' 99' ' ' THR . 8.9 m120 -63.72 -34.79 78.66 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -178.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.403 ' HB3' ' CD2' ' A' ' 126' ' ' HIS . 70.4 mt -62.71 -17.16 60.23 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -178.512 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.533 HD12 ' N ' ' A' ' 104' ' ' LEU . 10.8 mp -73.21 -16.29 61.42 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 120.286 -0.565 . . . . 0.0 110.403 179.505 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.447 ' O ' HD13 ' A' ' 92' ' ' LEU . 1.5 m -78.43 -7.28 57.2 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 178.718 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.526 ' HA3' HD13 ' A' ' 92' ' ' LEU . . . 91.54 -18.8 51.14 Favored Glycine 0 CA--C 1.534 1.262 0 CA-C-N 114.926 -1.034 . . . . 0.0 113.233 177.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -146.72 127.07 13.96 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 119.563 -0.855 . . . . 0.0 113.08 -179.674 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -144.73 137.06 26.26 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.922 178.323 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.511 ' HA ' HD23 ' A' ' 123' ' ' LEU . 69.2 p -69.95 138.43 52.33 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.364 0.602 . . . . 0.0 111.189 -179.493 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.594 HG22 ' HG2' ' B' ' 703' ' ' PRO . 74.1 t -79.16 -53.05 14.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.71 -179.77 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.741 ' H ' ' NE2' ' A' ' 114' ' ' GLN . 53.6 mtmt -100.69 134.71 43.26 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 121.831 0.824 . . . . 0.0 112.645 -179.002 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -66.63 -30.63 70.94 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 114.51 -1.223 . . . . 0.0 112.477 -179.194 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 75.1 m-80 -84.37 11.21 8.85 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 -177.637 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.741 ' NE2' ' H ' ' A' ' 111' ' ' LYS . 22.2 mt-30 -81.16 143.3 32.48 Favored 'General case' 0 C--N 1.328 -0.326 0 O-C-N 121.904 -0.497 . . . . 0.0 111.347 178.762 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.424 ' O ' ' O ' ' A' ' 118' ' ' LYS . 51.4 t -122.54 124.28 70.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.246 -0.434 . . . . 0.0 109.92 178.638 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 99.3 mtp -58.25 127.0 29.92 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 121.324 0.583 . . . . 0.0 111.471 -179.281 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 91.62 -4.75 79.73 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 110.606 -0.997 . . . . 0.0 110.606 179.699 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.424 ' O ' ' O ' ' A' ' 115' ' ' VAL . 87.5 tttt -142.48 130.96 22.4 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.113 0.482 . . . . 0.0 110.614 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 80.39 -174.28 54.94 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 -179.688 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 63.9 t-20 -90.75 107.1 18.96 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 179.649 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -85.41 99.31 11.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.242 0.544 . . . . 0.0 110.23 -179.384 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.84 136.16 33.25 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.479 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.511 HD23 ' HA ' ' A' ' 109' ' ' THR . 67.4 mt -134.07 139.14 45.77 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.491 -0.484 . . . . 0.0 111.469 -179.417 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -112.77 143.72 43.53 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 178.501 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' GLY . . . . . 0.48 ' O ' ' CG2' ' B' ' 705' ' ' B27 . . . -142.42 151.82 23.28 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.164 -1.174 . . . . 0.0 110.164 -178.885 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.403 ' CD2' ' HB3' ' A' ' 103' ' ' LEU . 4.7 m-70 -89.24 126.03 35.33 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.592 0.711 . . . . 0.0 111.874 -179.468 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' ASN . . . . . 0.433 ' ND2' ' HA ' ' A' ' 136' ' ' SER . 35.1 t30 -129.12 125.18 36.56 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 114.931 -1.031 . . . . 0.0 110.681 179.504 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.513 ' O ' ' OG ' ' A' ' 129' ' ' SER . 78.1 mtm -102.53 -1.72 29.94 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.351 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.513 ' OG ' ' O ' ' A' ' 128' ' ' MET . 6.2 p 77.78 10.23 2.24 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.473 179.77 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.76 ' O ' HG12 ' A' ' 133' ' ' VAL . 5.9 ptmt -110.42 118.15 35.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.474 0.654 . . . . 0.0 112.427 -179.274 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.496 ' C ' ' O ' ' A' ' 130' ' ' LYS . 29.1 tptt -32.98 149.89 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 114.926 -1.034 . . . . 0.0 109.554 178.828 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.436 ' N ' ' HG3' ' A' ' 131' ' ' LYS . . . 82.82 -15.49 31.43 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 111.064 -0.814 . . . . 0.0 111.064 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.76 HG12 ' O ' ' A' ' 130' ' ' LYS . 8.0 p -94.22 151.68 3.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.04 -0.664 . . . . 0.0 111.174 -179.041 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.593 HD23 ' N ' ' A' ' 134' ' ' LEU . 0.1 OUTLIER -68.04 147.16 52.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.88 0.848 . . . . 0.0 112.96 -177.774 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.449 ' CE1' ' O ' ' A' ' 106' ' ' GLY . 3.0 m-85 65.2 4.85 2.76 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 113.943 -1.481 . . . . 0.0 114.266 177.528 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' SER . . . . . 0.433 ' HA ' ' ND2' ' A' ' 127' ' ' ASN . 28.1 p -76.51 -35.22 58.46 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 120.147 -0.621 . . . . 0.0 111.908 178.79 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.421 ' N ' ' OD1' ' A' ' 137' ' ' ASP . 36.6 p-10 -94.75 2.09 55.5 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 114.543 1.312 . . . . 0.0 114.543 -177.533 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 45.6 pt -69.22 -20.38 24.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 C-N-CA 119.06 -1.056 . . . . 0.0 110.466 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -68.38 -9.91 51.46 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.191 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 49.7 m -82.96 -5.01 58.9 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.554 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 89.0 mt -64.56 143.77 57.68 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 121.276 0.56 . . . . 0.0 110.764 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.419 ' HG2' ' N ' ' A' ' 143' ' ' LYS . 88.2 tttt -119.79 157.46 28.57 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.569 -179.003 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 143' ' ' LYS . . . . . 0.419 ' N ' ' HG2' ' A' ' 142' ' ' LYS . 87.8 tttt -50.02 129.52 20.78 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.381 179.366 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.464 ' N ' ' O ' ' A' ' 160' ' ' VAL . . . 83.13 8.96 84.78 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 120.358 -0.925 . . . . 0.0 112.371 178.531 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 47.5 t0 -73.66 130.25 39.63 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 120.076 -0.65 . . . . 0.0 110.679 -179.372 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -76.61 141.05 41.21 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 121.602 0.715 . . . . 0.0 111.485 -179.001 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 95.5 mt -137.67 138.66 44.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.063 -0.971 . . . . 0.0 108.815 178.711 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' TYR . . . . . 0.517 ' C ' HD22 ' A' ' 149' ' ' LEU . 95.2 m-85 -119.89 133.94 55.41 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 -177.768 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.517 HD22 ' C ' ' A' ' 148' ' ' TYR . 4.4 mm? -111.38 132.29 54.54 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 114.594 -1.184 . . . . 0.0 108.022 177.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -112.18 108.26 17.44 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.205 -0.598 . . . . 0.0 112.119 -178.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' ASP . . . . . 0.577 ' OD1' ' N ' ' A' ' 152' ' ' ASN . 57.1 t0 -89.42 158.35 17.78 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 177.54 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' ASN . . . . . 0.577 ' N ' ' OD1' ' A' ' 151' ' ' ASP . 36.8 p-10 -54.85 -20.07 7.9 Favored 'General case' 0 C--N 1.312 -1.042 0 C-N-CA 120.118 -0.633 . . . . 0.0 110.897 -177.817 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -112.49 -29.69 7.4 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 -178.718 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' ASN . . . . . 0.425 ' O ' ' N ' ' A' ' 151' ' ' ASP . 0.4 OUTLIER -148.86 -178.42 6.35 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.957 0.885 . . . . 0.0 113.244 -177.205 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -128.52 137.85 51.96 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 114.483 -1.235 . . . . 0.0 109.813 179.193 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -113.61 138.28 50.39 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 121.155 0.503 . . . . 0.0 111.296 -179.729 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' GLU . . . . . 0.465 ' O ' HD12 ' A' ' 203' ' ' LEU . 84.1 tt0 -98.99 114.95 27.85 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 121.296 0.57 . . . . 0.0 111.917 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 45.8 m-85 -113.49 147.11 38.5 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.238 0.542 . . . . 0.0 111.033 179.108 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -120.22 120.27 35.65 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.576 179.347 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.464 ' O ' ' N ' ' A' ' 144' ' ' GLY . 73.1 t -58.37 136.28 21.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 178.075 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 34.0 p -105.07 -26.79 11.97 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 123.425 0.453 . . . . 0.0 111.803 -179.532 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 167.1 -175.95 42.16 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 120.143 -1.027 . . . . 0.0 111.882 -179.816 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.975 HG22 HG22 ' A' ' 199' ' ' VAL . 47.7 t -129.22 138.12 55.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 114.8 -0.7 . . . . 0.0 109.465 179.311 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 20.9 t -137.28 167.51 21.44 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.554 0.692 . . . . 0.0 111.91 -178.414 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.421 ' CG ' ' CE2' ' A' ' 197' ' ' TYR . 95.5 mt-10 -107.95 122.84 47.65 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.06 -179.619 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 32.6 m -136.93 160.97 36.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.882 179.756 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -84.76 158.72 59.1 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.357 179.322 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.434 ' O ' HD12 ' B' ' 702' ' ' LEU . 37.0 Cg_endo -65.99 -13.43 39.81 Favored 'Trans proline' 0 C--N 1.303 -1.826 0 C-N-CA 123.169 2.579 . . . . 0.0 113.363 -179.638 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 35.7 p30 -96.54 -6.89 35.93 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 -179.531 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.841 ' O ' HD23 ' B' ' 702' ' ' LEU . 96.8 mttt -75.55 113.22 12.73 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 -177.605 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 171' ' ' TRP . . . . . 0.405 ' N ' ' CD1' ' A' ' 171' ' ' TRP . 35.4 m0 -83.24 -22.06 33.2 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.862 179.075 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -54.53 -38.79 66.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.534 -177.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 173' ' ' VAL . . . . . 0.647 HG23 HG23 ' A' ' 174' ' ' VAL . 31.0 m -64.51 -13.41 14.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.022 0.439 . . . . 0.0 111.338 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.647 HG23 HG23 ' A' ' 173' ' ' VAL . 76.4 t -111.58 -20.23 6.38 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -178.162 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -70.35 142.4 52.15 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.386 0.613 . . . . 0.0 111.773 -179.384 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 176' ' ' ASP . . . . . 0.434 ' OD1' ' O ' ' A' ' 176' ' ' ASP . 46.0 p-10 -66.44 138.34 57.48 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 115.641 -0.708 . . . . 0.0 111.175 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 79.7 m80 -111.68 25.42 11.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.357 179.661 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 65.28 42.82 96.01 Favored Glycine 0 CA--C 1.532 1.102 0 N-CA-C 111.099 -0.801 . . . . 0.0 111.099 179.597 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 11.8 ptmt -161.4 166.93 26.61 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 120.94 0.4 . . . . 0.0 110.585 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -85.57 104.83 15.68 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 177.332 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 181' ' ' GLU . . . . . 0.451 ' HG2' ' N ' ' A' ' 182' ' ' ILE . 82.9 tt0 -136.15 162.0 34.16 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.395 0.617 . . . . 0.0 111.667 -178.411 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.451 ' N ' ' HG2' ' A' ' 181' ' ' GLU . 18.4 tt -129.32 137.79 56.07 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.038 178.078 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 52.4 m -133.94 127.4 32.35 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 120.979 0.419 . . . . 0.0 111.232 -179.704 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 71.2 mt -108.65 130.87 55.33 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.13 179.388 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 91.2 mt -113.68 125.93 71.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.136 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 2.2 t -142.08 163.22 33.46 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.884 179.534 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 187' ' ' CYS . . . . . . . . . . . . . 4.8 m -86.12 140.83 29.86 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.744 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.61 HG13 ' N ' ' A' ' 189' ' ' SER . 9.9 p -62.48 -48.55 87.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.093 0.473 . . . . 0.0 111.129 -179.198 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 189' ' ' SER . . . . . 0.61 ' N ' HG13 ' A' ' 188' ' ' VAL . 79.0 p -167.71 156.08 9.24 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.092 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 13.8 p -70.6 -18.81 21.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.21 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -96.84 -15.12 21.42 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 192' ' ' ASP . . . . . 0.558 ' O ' ' CG1' ' A' ' 188' ' ' VAL . 63.5 t0 -130.73 105.68 7.96 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 120.638 -0.425 . . . . 0.0 111.456 -179.728 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 48.8 p-10 -107.33 12.79 27.74 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 120.78 0.324 . . . . 0.0 111.345 179.747 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 9.6 t -60.83 -46.66 89.67 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 120.951 0.405 . . . . 0.0 111.906 -179.225 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 63.3 pttt -144.51 155.64 43.79 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 179.721 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 196' ' ' ARG . . . . . 0.708 ' NE ' ' SG ' ' B' ' 705' ' ' B27 . 84.9 mtt85 -127.38 149.51 50.04 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.363 0.601 . . . . 0.0 111.914 -179.046 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 197' ' ' TYR . . . . . 0.421 ' CE2' ' CG ' ' A' ' 165' ' ' GLU . 53.3 m-85 -92.93 142.58 27.15 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.741 -178.886 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 25.0 t -129.21 133.52 65.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.696 179.318 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.975 HG22 HG22 ' A' ' 163' ' ' VAL . 53.0 t -101.84 132.67 47.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.236 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -118.15 147.86 42.91 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.125 0.488 . . . . 0.0 110.462 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -148.61 143.07 10.55 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 -179.596 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 50.9 p30 -107.1 156.3 18.93 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.282 0.563 . . . . 0.0 111.48 -179.367 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 203' ' ' LEU . . . . . 0.465 HD12 ' O ' ' A' ' 157' ' ' GLU . 46.7 tp -77.59 130.87 37.45 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.266 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 15.7 m -114.91 -15.91 9.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.376 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -178.39 173.19 45.64 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 119.522 -1.323 . . . . 0.0 113.097 179.729 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 57.4 m -142.26 137.95 31.04 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.238 -0.981 . . . . 0.0 109.864 179.733 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 52.6 mtmt -144.03 114.83 7.74 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.184 0.516 . . . . 0.0 111.529 -179.648 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -65.77 148.59 51.52 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.551 0.691 . . . . 0.0 111.986 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -79.63 109.1 13.7 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.848 178.601 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 98.0 mttt . . . . . 0 C--O 1.221 -0.422 0 CA-C-O 117.883 -1.056 . . . . 0.0 110.682 179.712 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 701' ' ' BOC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 702' ' ' LEU . . . . . 0.841 HD23 ' O ' ' A' ' 170' ' ' LYS . 0.1 OUTLIER 52.08 81.53 0.26 Allowed Pre-proline 0 CA--C 1.535 0.399 0 CA-C-O 121.34 0.591 . . . . 20.0 111.101 . . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 703' ' ' PRO . . . . . 0.594 ' HG2' HG22 ' A' ' 110' ' ' VAL . 3.6 Cg_exo -77.01 -161.66 0.14 Allowed 'Trans proline' 0 C--N 1.305 -1.739 0 C-N-CA 123.305 2.67 . . . . 20.0 113.831 -179.612 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 704' ' ' ALA . . . . . 0.541 ' O ' ' OG1' ' B' ' 705' ' ' B27 . . . -42.54 -175.73 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 113.863 -1.517 . . . . 20.0 112.744 -179.388 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 705' ' ' B27 . . . . . 0.708 ' SG ' ' NE ' ' A' ' 196' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.232 0 N-CA-C 108.852 -1.699 . . . . 0.0 108.852 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 10.2 p -154.75 166.24 34.06 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.265 0.555 . . . . 0.0 110.455 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 80.4 m-70 -66.93 -40.79 87.7 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.57 -179.587 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 66.5 mtt -94.61 135.08 36.48 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.32 179.72 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -65.96 146.07 55.15 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.293 0.568 . . . . 0.0 110.191 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.435 ' C ' ' H ' ' A' ' 60' ' ' LYS . . . -90.66 1.86 56.43 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.637 -179.741 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.468 ' O ' ' NH2' ' A' ' 196' ' ' ARG . 3.7 p -79.02 22.59 0.39 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.266 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.435 ' H ' ' C ' ' A' ' 58' ' ' ALA . 98.9 mttt -102.15 9.72 39.95 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.128 -179.365 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.8 mt -55.23 139.8 13.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 122.416 1.103 . . . . 0.0 111.869 -177.404 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.536 ' N ' ' OD1' ' A' ' 62' ' ' ASP . 20.0 p-10 -76.45 128.69 35.29 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 113.528 -1.669 . . . . 0.0 109.551 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.547 ' CD ' ' H ' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -78.86 129.02 74.85 Favored Pre-proline 0 CA--C 1.542 0.654 0 C-N-CA 120.449 -0.5 . . . . 0.0 110.536 -179.025 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -53.41 147.86 35.79 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 C-N-CA 122.129 1.886 . . . . 0.0 112.855 178.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.655 ' O ' HG23 ' A' ' 69' ' ' VAL . 27.4 t70 -53.2 177.84 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.77 -179.489 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.414 ' H ' ' CG ' ' A' ' 65' ' ' ASP . 92.1 mt -63.6 -43.8 95.85 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.196 -178.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.09 -36.68 82.43 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 119.761 -0.776 . . . . 0.0 110.336 -179.296 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -61.31 -35.21 76.73 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.751 0.786 . . . . 0.0 109.042 178.22 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.655 HG23 ' O ' ' A' ' 65' ' ' ASP . 62.0 t -73.87 -43.26 53.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.917 179.003 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -70.53 -9.71 57.38 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.624 -179.774 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -118.33 -1.82 11.23 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 121.526 0.679 . . . . 0.0 109.837 179.189 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -70.05 -175.51 0.96 Allowed 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.648 -179.651 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 6.6 t -94.9 105.42 17.34 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.119 179.15 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 42.0 tp -69.95 135.02 48.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.691 -179.016 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.417 ' OD2' ' OD1' ' A' ' 102' ' ' ASN . 91.3 m-20 -116.06 77.57 1.11 Allowed 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 121.845 0.831 . . . . 0.0 109.36 177.82 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.78 ' O ' HG12 ' A' ' 79' ' ' VAL . 86.5 tttt -84.89 -40.32 17.19 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.678 -1.146 . . . . 0.0 112.148 -179.753 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.423 ' HG2' ' H ' ' A' ' 77' ' ' LYS . 52.1 mmtt -73.14 -12.89 61.05 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.707 -176.444 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -94.92 2.1 55.36 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.224 0.535 . . . . 0.0 110.194 179.51 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.78 HG12 ' O ' ' A' ' 76' ' ' LYS . 11.6 p -72.06 115.1 11.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 121.371 0.605 . . . . 0.0 110.833 -179.576 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 32.8 pt -102.84 -7.78 9.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.807 179.751 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -163.31 158.53 30.94 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 120.637 -0.792 . . . . 0.0 111.339 179.16 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 33.6 ttm180 -133.43 140.01 47.06 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 121.309 0.576 . . . . 0.0 111.334 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 5.1 tt -111.31 142.52 23.44 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.615 179.791 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 73.8 m -137.45 133.7 34.98 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 115.138 -0.937 . . . . 0.0 112.946 -178.746 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.575 ' CG2' HG22 ' A' ' 88' ' ' VAL . 66.6 mt -135.61 87.62 25.89 Favored Pre-proline 0 CA--C 1.54 0.558 0 CA-C-O 121.444 0.64 . . . . 0.0 111.034 179.834 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -55.87 -33.17 87.77 Favored 'Trans proline' 0 N--CA 1.498 1.757 0 C-N-CA 123.309 2.672 . . . . 0.0 112.431 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 28.2 m -52.78 -41.11 63.79 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 121.143 0.497 . . . . 0.0 110.415 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.575 HG22 ' CG2' ' A' ' 85' ' ' ILE . 30.6 m -115.51 13.0 7.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.754 179.267 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 2.5 p 47.37 52.24 12.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.269 0.557 . . . . 0.0 111.101 -179.686 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 60.0 tp -119.93 135.25 54.97 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.379 0.609 . . . . 0.0 110.834 179.48 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -148.92 127.46 12.35 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.866 179.338 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.654 HD13 ' HA3' ' A' ' 106' ' ' GLY . 83.5 mt -149.84 147.85 23.72 Favored Pre-proline 0 CA--C 1.541 0.629 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.458 -178.516 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -74.12 150.25 42.45 Favored 'Trans proline' 0 N--CA 1.501 1.949 0 C-N-CA 122.881 2.387 . . . . 0.0 112.117 179.067 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.666 ' C ' HD12 ' A' ' 95' ' ' LEU . 89.4 t -95.0 125.36 47.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-O 121.26 0.553 . . . . 0.0 111.279 179.613 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.666 HD12 ' C ' ' A' ' 94' ' ' VAL . 10.1 mp -109.34 142.1 40.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.838 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.536 ' O ' ' OG1' ' A' ' 109' ' ' THR . 19.1 ttmt -74.5 -76.19 0.14 Allowed 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 116.103 -0.499 . . . . 0.0 112.148 -178.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 33.4 t -59.62 129.59 42.66 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.185 0.517 . . . . 0.0 111.982 -178.829 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.407 ' OG ' ' O ' ' A' ' 109' ' ' THR . 23.0 m -87.19 69.48 10.08 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.947 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.545 HG22 ' N ' ' A' ' 100' ' ' GLU . 44.4 m -90.27 165.1 14.11 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 178.721 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.545 ' N ' HG22 ' A' ' 99' ' ' THR . 83.3 tt0 -58.2 -45.57 87.35 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 119.972 -0.691 . . . . 0.0 110.185 -179.477 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -65.06 -41.59 95.0 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.217 178.647 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.446 ' HB2' ' H ' ' A' ' 99' ' ' THR . 94.9 m-20 -62.98 -39.71 95.55 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.103 -179.646 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.475 HD13 ' HB3' ' B' ' 704' ' ' ALA . 65.3 mt -61.59 -28.39 69.31 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.695 179.825 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.573 HD13 HG22 ' A' ' 69' ' ' VAL . 98.6 mt -73.98 -15.73 61.1 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.194 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.59 -7.64 48.99 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.466 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.654 ' HA3' HD13 ' A' ' 92' ' ' LEU . . . 98.84 -22.11 42.61 Favored Glycine 0 CA--C 1.531 1.057 0 CA-C-N 114.701 -1.136 . . . . 0.0 113.447 177.039 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -147.2 125.86 12.56 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 119.643 -0.823 . . . . 0.0 112.211 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -142.03 135.99 29.79 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.698 179.235 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.575 ' HA ' HD23 ' A' ' 123' ' ' LEU . 71.6 p -69.59 132.16 45.79 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 121.224 0.535 . . . . 0.0 110.515 -179.554 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.575 HG22 ' HG2' ' B' ' 703' ' ' PRO . 53.6 t -79.07 -50.7 18.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.174 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.798 ' H ' ' NE2' ' A' ' 114' ' ' GLN . 82.5 mttt -102.91 138.19 40.11 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.57 0.7 . . . . 0.0 112.349 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -66.17 -32.58 74.11 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.016 -0.993 . . . . 0.0 112.862 -178.544 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -82.42 13.51 3.58 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -178.217 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.798 ' NE2' ' H ' ' A' ' 111' ' ' LYS . 31.4 mt-30 -80.22 136.06 36.39 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.238 0.542 . . . . 0.0 111.341 179.709 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 71.3 t -123.59 127.91 74.28 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.759 179.649 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' MET . . . . . 0.659 ' SD ' ' CE2' ' A' ' 121' ' ' TYR . 85.3 mmm -55.1 126.02 22.98 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -179.178 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 82.86 -3.27 84.31 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.456 178.098 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -137.21 131.85 33.03 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.063 -0.655 . . . . 0.0 110.867 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 75.03 -174.33 51.81 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 110.226 -1.15 . . . . 0.0 110.226 -179.506 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.49 ' ND2' ' HB3' ' A' ' 181' ' ' GLU . 3.9 m120 -84.53 105.04 15.05 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.363 -0.535 . . . . 0.0 109.739 179.548 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.659 ' CE2' ' SD ' ' A' ' 116' ' ' MET . 2.2 t80 -86.34 98.71 11.13 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 120.539 -0.465 . . . . 0.0 110.209 -179.797 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.59 138.05 31.87 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.275 0.56 . . . . 0.0 111.288 -179.778 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.575 HD23 ' HA ' ' A' ' 109' ' ' THR . 67.7 mt -135.14 138.59 43.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.435 -179.49 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -106.82 134.95 49.19 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 178.553 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -134.6 148.43 19.51 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 -179.728 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 8.0 m-70 -91.83 136.11 33.4 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.53 0.681 . . . . 0.0 111.805 -179.176 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 39.2 t30 -132.6 124.96 29.36 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 114.966 -1.016 . . . . 0.0 111.341 -179.616 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.443 ' O ' ' CB ' ' A' ' 129' ' ' SER . 65.1 mtt -100.78 -5.81 25.8 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.517 0.675 . . . . 0.0 110.322 179.49 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.443 ' CB ' ' O ' ' A' ' 128' ' ' MET . 0.9 OUTLIER 77.62 12.23 2.01 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.747 178.886 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.794 ' O ' HG12 ' A' ' 133' ' ' VAL . 64.1 pttt -109.85 122.78 48.31 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 122.274 1.035 . . . . 0.0 112.303 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -44.29 119.05 1.69 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.898 179.228 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 117.42 -15.33 13.05 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 -179.191 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.794 HG12 ' O ' ' A' ' 130' ' ' LYS . 10.6 p -92.73 153.34 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 CA-C-O 120.991 0.424 . . . . 0.0 109.941 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.825 HD23 ' N ' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -71.43 146.47 48.65 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.816 0.817 . . . . 0.0 113.088 -177.936 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.482 ' CE1' ' O ' ' A' ' 106' ' ' GLY . 3.6 m-85 66.4 5.34 3.69 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 113.984 -1.462 . . . . 0.0 114.452 178.225 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 23.6 p -75.71 -29.37 58.94 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 119.936 -0.705 . . . . 0.0 112.509 179.525 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 31.6 p-10 -92.05 4.79 52.32 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 -176.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.421 HD11 ' OG1' ' A' ' 186' ' ' THR . 39.2 pt -67.43 -25.73 34.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 C-N-CA 119.016 -1.073 . . . . 0.0 110.493 -179.578 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -68.02 -13.79 62.47 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.451 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 54.6 p -83.53 -5.63 59.22 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.164 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 88.6 mt -63.43 145.66 55.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.37 0.605 . . . . 0.0 111.275 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -119.32 151.67 38.06 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.574 -179.253 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -48.98 130.59 18.51 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.114 179.388 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.609 ' N ' ' O ' ' A' ' 160' ' ' VAL . . . 79.85 8.34 87.76 Favored Glycine 0 CA--C 1.524 0.651 0 C-N-CA 120.847 -0.692 . . . . 0.0 111.453 179.061 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.541 ' OD1' ' N ' ' A' ' 146' ' ' LYS . 53.0 t0 -71.37 130.68 41.95 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 119.519 -0.872 . . . . 0.0 109.866 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.541 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 74.8 mmtt -78.61 142.12 37.5 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 122.044 0.925 . . . . 0.0 111.958 -178.269 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 95.6 mt -136.65 138.49 46.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 114.168 -1.378 . . . . 0.0 108.538 178.863 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -130.54 143.13 50.56 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 119.981 -0.688 . . . . 0.0 112.537 -178.24 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.789 HD22 ' C ' ' A' ' 149' ' ' LEU . 0.0 OUTLIER -143.96 157.77 44.13 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.097 176.788 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.498 ' CD1' ' N ' ' A' ' 150' ' ' TYR . 0.5 OUTLIER -123.53 133.14 54.04 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -177.775 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -91.04 168.4 11.67 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 105.991 -1.855 . . . . 0.0 105.991 175.804 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 -58.5 -25.76 62.71 Favored 'General case' 0 C--N 1.307 -1.274 0 C-N-CA 119.183 -1.007 . . . . 0.0 110.798 -179.448 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 -110.03 -27.16 9.34 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -178.749 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -145.31 -172.72 3.93 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 114.608 1.336 . . . . 0.0 114.608 -176.268 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 77.5 tt0 -133.75 134.56 43.12 Favored 'General case' 0 C--N 1.339 0.145 0 CA-C-N 114.508 -1.223 . . . . 0.0 110.045 179.722 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' TYR . . . . . 0.433 ' HB2' HD11 ' A' ' 149' ' ' LEU . 58.9 m-85 -114.68 136.37 53.13 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-O 121.34 0.59 . . . . 0.0 110.92 -179.574 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 157' ' ' GLU . . . . . 0.589 ' O ' HG22 ' A' ' 204' ' ' VAL . 97.7 mt-10 -96.63 114.83 26.52 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.392 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 -114.62 147.95 38.8 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 120.755 0.312 . . . . 0.0 110.868 179.345 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -126.57 126.66 44.01 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.269 0.557 . . . . 0.0 110.622 178.675 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.609 ' O ' ' N ' ' A' ' 144' ' ' GLY . 42.8 t -59.79 134.99 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.624 178.964 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 68.4 p -107.49 -28.75 9.62 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.253 0.549 . . . . 0.0 110.483 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 165.97 -172.34 41.33 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 111.352 -0.699 . . . . 0.0 111.352 179.788 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 2.3 p -134.39 148.91 29.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 179.385 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 22.9 t -138.29 167.71 21.29 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.465 0.65 . . . . 0.0 111.43 -179.358 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 75.0 tt0 -111.35 119.43 38.83 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.796 -179.191 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.479 HG21 HG11 ' A' ' 173' ' ' VAL . 32.3 m -136.2 157.54 37.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.01 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -80.65 160.72 66.3 Favored Pre-proline 0 C--N 1.32 -0.676 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.147 -179.418 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.469 ' O ' ' CB ' ' B' ' 702' ' ' LEU . 33.8 Cg_endo -65.51 -18.11 58.81 Favored 'Trans proline' 0 N--CA 1.502 1.983 0 C-N-CA 122.977 2.451 . . . . 0.0 113.461 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 42.6 p-10 -91.23 -1.6 57.65 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 120.21 -0.596 . . . . 0.0 111.866 179.473 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.754 ' O ' HG22 ' A' ' 173' ' ' VAL . 71.6 mmtt -75.96 87.15 2.9 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.951 -179.772 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 171' ' ' TRP . . . . . 0.587 ' O ' HG22 ' A' ' 174' ' ' VAL . 31.3 m0 -76.69 -12.12 59.95 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.43 0.633 . . . . 0.0 109.943 179.589 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -62.87 -32.59 73.87 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.365 -179.668 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 173' ' ' VAL . . . . . 0.754 HG22 ' O ' ' A' ' 170' ' ' LYS . 33.3 m -62.48 -18.32 20.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.911 -178.465 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.742 HG13 HG23 ' A' ' 173' ' ' VAL . 35.5 m -110.23 -4.78 10.95 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -179.162 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -73.26 139.69 46.34 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.911 0.386 . . . . 0.0 110.611 179.227 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 176' ' ' ASP . . . . . 0.516 ' OD1' ' O ' ' A' ' 176' ' ' ASP . 53.1 p-10 -70.83 136.22 48.59 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 121.257 0.551 . . . . 0.0 110.91 -179.649 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 78.5 m80 -102.34 -15.37 16.58 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.131 0.491 . . . . 0.0 111.219 -179.543 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 105.09 39.74 2.24 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 -179.365 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -152.96 167.61 28.59 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 114.795 -0.702 . . . . 0.0 111.232 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -88.65 98.99 11.98 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 177.758 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 181' ' ' GLU . . . . . 0.49 ' HB3' ' ND2' ' A' ' 120' ' ' ASN . 81.8 tt0 -137.24 164.03 29.49 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.694 0.759 . . . . 0.0 111.423 -178.629 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.442 ' N ' ' HG2' ' A' ' 181' ' ' GLU . 16.8 tt -130.74 140.61 48.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 114.689 -1.141 . . . . 0.0 109.258 178.686 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 183' ' ' THR . . . . . 0.401 HG23 ' CG1' ' A' ' 198' ' ' VAL . 51.7 m -132.96 126.57 32.32 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.203 0.525 . . . . 0.0 111.249 -179.136 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 91.4 mt -107.53 130.86 54.82 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.068 179.81 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.747 HD13 HD21 ' B' ' 702' ' ' LEU . 81.1 mt -109.56 121.32 62.36 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-O 121.234 0.54 . . . . 0.0 110.637 -179.647 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 186' ' ' THR . . . . . 0.625 HG22 ' N ' ' A' ' 187' ' ' CYS . 43.7 m -139.44 168.17 20.42 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.281 179.814 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 187' ' ' CYS . . . . . 0.625 ' N ' HG22 ' A' ' 186' ' ' THR . 1.6 m -101.91 148.46 25.31 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.288 179.701 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 71.4 t -60.85 -46.89 95.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-O 120.981 0.419 . . . . 0.0 111.44 -178.887 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 86.0 p -170.08 159.5 7.59 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.205 179.317 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 57.7 t -65.75 -18.82 24.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.489 0.661 . . . . 0.0 109.687 179.324 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -96.74 -13.32 22.77 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.939 -179.597 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -131.67 96.05 3.87 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.421 179.362 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 43.2 p-10 -110.29 5.01 21.35 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 112.23 0.456 . . . . 0.0 112.23 -179.547 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 11.5 t -63.93 -40.95 97.63 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.954 0.407 . . . . 0.0 111.326 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -126.73 151.74 47.77 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 121.158 0.504 . . . . 0.0 110.749 -179.24 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 196' ' ' ARG . . . . . 0.468 ' NH2' ' O ' ' A' ' 59' ' ' SER . 99.8 mtt180 -126.19 137.76 53.58 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.386 -179.503 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 43.9 p90 -98.34 144.29 27.89 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.698 178.771 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.401 ' CG1' HG23 ' A' ' 183' ' ' THR . 50.2 t -121.27 133.39 67.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.439 0.638 . . . . 0.0 111.573 -178.548 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 51.0 t -103.67 132.1 50.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.638 179.233 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -118.92 147.76 43.66 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.469 0.652 . . . . 0.0 112.141 -178.487 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -134.82 140.27 11.58 Favored Glycine 0 CA--C 1.532 1.113 0 N-CA-C 110.422 -1.071 . . . . 0.0 110.422 179.27 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 54.8 t0 -100.93 136.61 40.51 Favored 'General case' 0 C--N 1.329 -0.304 0 O-C-N 122.626 -0.337 . . . . 0.0 110.804 -179.61 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 51.7 tp -65.29 127.25 30.96 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.649 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.589 HG22 ' O ' ' A' ' 157' ' ' GLU . 28.6 m -110.52 -18.8 7.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 C-N-CA 120.6 -0.44 . . . . 0.0 112.181 -178.65 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -179.21 174.34 46.3 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 120.002 -1.095 . . . . 0.0 112.602 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 97.3 m -143.59 138.74 29.27 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 114.991 -0.605 . . . . 0.0 110.439 179.723 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -142.37 115.8 9.03 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 120.644 -0.423 . . . . 0.0 111.512 178.637 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -63.36 147.48 51.03 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.498 0.666 . . . . 0.0 111.467 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 52.9 mtmt -79.27 106.72 11.51 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.556 179.327 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 97.9 mttt . . . . . 0 C--O 1.219 -0.538 0 CA-C-O 117.827 -1.082 . . . . 0.0 110.613 179.794 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 701' ' ' BOC . . . . . 0.423 ' O1 ' ' H12' ' B' ' 701' ' ' BOC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 702' ' ' LEU . . . . . 0.747 HD21 HD13 ' A' ' 185' ' ' ILE . 0.5 OUTLIER -86.5 118.16 69.82 Favored Pre-proline 0 CA--C 1.546 0.819 0 N-CA-C 110.806 -0.072 . . . . 20.0 110.806 . . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 703' ' ' PRO . . . . . 0.695 ' HD2' HD23 ' B' ' 702' ' ' LEU . 3.2 Cg_exo -66.15 -177.31 0.79 Allowed 'Trans proline' 0 N--CA 1.496 1.652 0 C-N-CA 122.042 1.828 . . . . 20.0 113.96 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 704' ' ' ALA . . . . . 0.507 ' O ' ' O ' ' B' ' 703' ' ' PRO . . . -39.3 -174.9 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 114.531 1.308 . . . . 20.0 114.531 -178.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 705' ' ' B27 . . . . . 0.545 ' SG ' ' N ' ' A' ' 187' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.423 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 23.0 t -131.12 142.16 50.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.214 0.53 . . . . 0.0 110.554 179.735 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -64.42 -44.15 92.14 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.082 -179.371 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 99.4 mmm -88.38 112.29 22.73 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.19 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -64.98 143.52 57.9 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.097 179.737 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -100.66 -3.11 31.0 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.308 0.575 . . . . 0.0 110.609 179.628 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 2.0 p -77.54 7.96 4.9 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.544 -178.31 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.416 ' HA ' HH21 ' A' ' 196' ' ' ARG . 59.3 pttt -85.59 26.94 0.88 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.35 0.595 . . . . 0.0 110.926 179.42 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 45.1 mm -55.89 139.76 14.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 122.345 1.069 . . . . 0.0 113.357 -176.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -81.12 124.33 29.14 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 113.584 -1.644 . . . . 0.0 108.128 178.051 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.631 ' CD ' ' H ' ' A' ' 63' ' ' GLN . 1.1 pm0 -77.52 151.71 80.54 Favored Pre-proline 0 C--N 1.324 -0.517 0 C-N-CA 120.064 -0.654 . . . . 0.0 110.855 -178.663 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -68.31 154.75 71.4 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 122.616 2.211 . . . . 0.0 112.084 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -57.98 171.4 0.52 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 121.38 0.61 . . . . 0.0 111.906 -179.027 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 89.3 mt -64.64 -45.58 86.2 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.946 -178.43 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.09 -37.9 89.13 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 119.924 -0.71 . . . . 0.0 110.323 -178.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -62.9 -32.81 74.16 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 178.037 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.1 t -75.85 -45.33 37.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-N 114.137 -1.392 . . . . 0.0 110.675 179.031 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -75.99 -8.98 58.21 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.819 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -106.18 -13.0 15.55 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 121.436 0.636 . . . . 0.0 109.931 179.158 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -70.22 145.73 51.19 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.41 -0.814 . . . . 0.0 112.189 -179.555 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.5 m -56.67 109.95 0.71 Allowed 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 115.641 -0.708 . . . . 0.0 109.991 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 32.2 tp -69.28 131.97 45.72 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.804 -178.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -109.01 76.63 1.02 Allowed 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 177.471 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -84.11 -36.53 22.89 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.524 -0.762 . . . . 0.0 112.453 -179.603 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 42.3 mmtt -74.64 -13.37 60.63 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.035 0.445 . . . . 0.0 111.417 -176.651 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -92.01 -0.1 57.47 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.377 0.608 . . . . 0.0 109.792 179.632 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 21.9 t -79.58 129.45 37.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.44 -179.643 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 11.6 pt -110.83 -10.33 11.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.805 179.347 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -157.81 163.64 32.78 Favored Glycine 0 CA--C 1.523 0.555 0 C-N-CA 120.225 -0.988 . . . . 0.0 111.81 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 61.8 ttp180 -133.71 156.42 47.97 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.756 -0.722 . . . . 0.0 109.91 179.648 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.582 HG22 ' O ' ' A' ' 92' ' ' LEU . 18.6 tt -126.07 143.08 40.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.6 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 13.2 t -137.51 133.26 34.37 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 121.504 0.669 . . . . 0.0 112.305 -178.51 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.461 HG22 HG22 ' A' ' 88' ' ' VAL . 65.0 mt -139.33 84.37 16.48 Favored Pre-proline 0 CA--C 1.538 0.498 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.31 -179.772 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -57.37 -29.7 85.19 Favored 'Trans proline' 0 N--CA 1.499 1.818 0 C-N-CA 123.081 2.52 . . . . 0.0 112.919 -179.21 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 96.1 p -52.16 -41.66 62.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.32 0.581 . . . . 0.0 111.088 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.461 HG22 HG22 ' A' ' 85' ' ' ILE . 22.5 m -115.83 10.33 7.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.043 179.068 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.479 ' O ' ' OG ' ' A' ' 89' ' ' SER . 3.5 t 53.48 53.49 11.54 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.68 179.553 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 62.7 tp -121.98 133.73 54.82 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.656 0.741 . . . . 0.0 111.024 -179.712 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -148.76 130.85 15.39 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.926 179.368 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.582 ' O ' HG22 ' A' ' 83' ' ' ILE . 84.1 mt -152.2 151.28 27.32 Favored Pre-proline 0 N--CA 1.471 0.621 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.368 -178.517 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -76.02 147.99 30.9 Favored 'Trans proline' 0 N--CA 1.494 1.554 0 C-N-CA 122.584 2.189 . . . . 0.0 111.516 178.214 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.518 ' C ' HD12 ' A' ' 95' ' ' LEU . 98.5 t -96.45 118.12 42.17 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-O 120.975 0.417 . . . . 0.0 111.563 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.544 HD12 ' N ' ' A' ' 95' ' ' LEU . 10.6 mp -101.74 136.91 40.78 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.394 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -61.7 -81.36 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 121.253 0.549 . . . . 0.0 112.263 -179.335 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 91.1 p -62.39 135.12 57.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.488 0.661 . . . . 0.0 112.134 -178.238 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.419 ' OG ' ' O ' ' A' ' 109' ' ' THR . 1.3 m -90.83 68.66 6.39 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.219 178.834 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 33.8 p -88.57 168.41 12.59 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.069 179.283 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.429 ' O ' ' CD1' ' A' ' 104' ' ' LEU . 52.6 tp10 -62.9 -45.5 92.24 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.169 -0.612 . . . . 0.0 110.435 179.783 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -65.12 -40.67 94.82 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 121.339 0.59 . . . . 0.0 111.487 179.535 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.414 HD21 ' HA ' ' A' ' 102' ' ' ASN . 9.6 m120 -65.23 -30.35 71.23 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.134 -0.485 . . . . 0.0 112.226 -179.301 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.417 HD23 ' HA ' ' A' ' 103' ' ' LEU . 56.7 mt -67.03 -14.02 62.49 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 120.773 -0.371 . . . . 0.0 111.673 -179.321 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.534 HD12 ' N ' ' A' ' 104' ' ' LEU . 10.5 mp -75.69 -12.17 60.14 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 121.008 -0.277 . . . . 0.0 111.44 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.415 ' O ' HD22 ' A' ' 92' ' ' LEU . 92.5 p -81.17 -6.24 58.62 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 121.352 0.596 . . . . 0.0 110.356 179.677 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.547 ' HA3' HD13 ' A' ' 92' ' ' LEU . . . 89.76 -20.02 37.89 Favored Glycine 0 CA--C 1.533 1.196 0 CA-C-N 115.51 -0.768 . . . . 0.0 113.254 177.884 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -145.72 125.49 13.43 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 117.814 0.807 . . . . 0.0 112.136 -179.797 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -145.71 141.64 28.23 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.703 179.236 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.706 ' HA ' HD23 ' A' ' 123' ' ' LEU . 8.7 p -71.93 132.34 44.22 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.238 0.542 . . . . 0.0 110.667 179.631 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.655 HG23 ' CG ' ' B' ' 703' ' ' PRO . 7.3 p -81.7 -33.95 12.52 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 -179.533 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.506 ' O ' ' NE2' ' A' ' 114' ' ' GLN . 88.2 tttt -90.36 153.34 20.51 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 121.357 0.598 . . . . 0.0 111.939 -177.243 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -66.0 -35.06 79.54 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -178.036 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -141.27 53.36 1.55 Allowed 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 -176.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.752 ' NE2' ' H ' ' A' ' 114' ' ' GLN . 1.6 pm0 -74.34 157.71 35.26 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 120.891 0.377 . . . . 0.0 111.192 179.151 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 61.4 t -128.64 120.89 53.65 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-O 121.149 0.499 . . . . 0.0 111.694 -179.45 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 66.3 mtt -60.57 134.45 57.08 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.992 -0.549 . . . . 0.0 112.226 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 77.72 -0.91 69.3 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.698 -0.561 . . . . 0.0 111.698 178.206 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -142.0 127.94 19.48 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.358 0.599 . . . . 0.0 110.851 179.67 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 75.28 -168.99 54.78 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 110.482 -1.047 . . . . 0.0 110.482 -179.721 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 42.9 t-20 -90.21 103.5 16.17 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.78 0.324 . . . . 0.0 110.2 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.513 ' HE2' HD21 ' A' ' 123' ' ' LEU . 11.8 t80 -89.69 99.02 12.1 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -179.696 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.463 ' HB3' ' CG1' ' A' ' 110' ' ' VAL . . . -91.65 137.41 32.39 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 112.462 0.541 . . . . 0.0 112.462 -178.404 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.706 HD23 ' HA ' ' A' ' 109' ' ' THR . 71.6 mt -134.76 138.92 44.74 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.584 179.779 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -108.72 131.7 54.67 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 121.142 0.496 . . . . 0.0 110.02 179.324 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -137.22 151.08 20.93 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 110.045 -1.222 . . . . 0.0 110.045 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.752 ' O ' HD23 ' A' ' 134' ' ' LEU . 37.5 m-70 -88.73 144.78 26.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.61 0.719 . . . . 0.0 112.522 -178.706 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -137.8 121.24 17.14 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.982 178.838 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.518 ' HB2' HG21 ' A' ' 133' ' ' VAL . 57.7 mtt -95.51 -1.42 50.71 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.069 -178.578 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.509 ' CB ' ' O ' ' A' ' 128' ' ' MET . 1.4 p 78.17 5.52 2.7 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.974 -0.29 . . . . 0.0 111.339 179.247 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.876 ' O ' HG12 ' A' ' 133' ' ' VAL . 62.5 pttt -120.58 130.7 54.3 Favored 'General case' 0 C--O 1.222 -0.377 0 CA-C-O 121.885 0.85 . . . . 0.0 113.105 -178.55 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.462 ' O ' ' O ' ' A' ' 130' ' ' LYS . 74.6 mmtt -41.13 162.6 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 178.232 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 76.49 -24.73 1.76 Allowed Glycine 0 CA--C 1.535 1.337 0 C-N-CA 120.396 -0.907 . . . . 0.0 111.379 179.594 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.876 HG12 ' O ' ' A' ' 130' ' ' LYS . 3.7 p -90.18 158.13 2.94 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 O-C-N 122.217 -0.578 . . . . 0.0 111.215 -178.702 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.852 HD13 ' H ' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -70.71 145.36 50.57 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 114.903 1.446 . . . . 0.0 114.903 -177.283 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 61.0 7.04 1.37 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 112.866 -1.97 . . . . 0.0 113.854 177.754 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 5.1 t -72.8 -34.07 66.66 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.143 -0.623 . . . . 0.0 112.385 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.418 ' OD1' ' N ' ' A' ' 137' ' ' ASP . 44.0 p-10 -92.43 4.6 53.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.433 0.635 . . . . 0.0 110.381 -179.329 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.46 HD11 HD13 ' A' ' 184' ' ' LEU . 5.2 tt -64.49 -35.83 75.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.896 -179.506 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.419 ' N ' ' CG2' ' A' ' 138' ' ' ILE . . . -70.33 -9.88 57.41 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 121.091 0.472 . . . . 0.0 111.072 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 19.1 m -81.99 -3.21 53.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.225 0.535 . . . . 0.0 110.223 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.401 HD21 HG21 ' A' ' 85' ' ' ILE . 78.5 mt -63.69 145.08 56.41 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.564 179.739 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -120.97 155.49 34.16 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 121.389 0.614 . . . . 0.0 112.021 -178.3 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 40.5 tttp -49.85 132.76 22.45 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.978 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.554 ' N ' ' O ' ' A' ' 160' ' ' VAL . . . 80.21 7.33 88.63 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.314 178.691 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -73.41 136.87 44.34 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 118.921 -1.112 . . . . 0.0 109.553 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -80.26 141.33 35.65 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.838 0.828 . . . . 0.0 112.28 -178.36 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.449 HD11 ' CG2' ' A' ' 160' ' ' VAL . 87.6 mt -137.39 137.74 45.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 114.735 -1.121 . . . . 0.0 108.679 178.841 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 43.0 m-85 -123.1 136.25 54.72 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.028 -0.669 . . . . 0.0 112.508 -177.763 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.544 HD11 HD11 ' A' ' 182' ' ' ILE . 11.7 mt -110.97 133.5 53.34 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 177.072 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 150' ' ' TYR . . . . . 0.526 ' CE1' ' CD ' ' A' ' 155' ' ' GLU . 82.1 m-85 -111.87 109.39 19.18 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 119.836 -0.746 . . . . 0.0 111.845 -179.638 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 151' ' ' ASP . . . . . 0.614 ' OD1' ' N ' ' A' ' 152' ' ' ASN . 66.3 t0 -89.59 163.87 15.0 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 177.7 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 152' ' ' ASN . . . . . 0.614 ' N ' ' OD1' ' A' ' 151' ' ' ASP . 34.5 p-10 -57.36 -19.61 24.02 Favored 'General case' 0 C--N 1.318 -0.785 0 C-N-CA 119.962 -0.695 . . . . 0.0 111.159 -177.706 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -114.27 -27.83 7.48 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 -178.463 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -148.18 179.87 7.45 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 -176.858 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.526 ' CD ' ' CE1' ' A' ' 150' ' ' TYR . 83.0 tt0 -127.79 132.96 49.44 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 114.366 -1.288 . . . . 0.0 109.745 179.122 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 156' ' ' TYR . . . . . 0.501 ' CD1' HG23 ' A' ' 206' ' ' THR . 95.5 m-85 -108.44 133.87 52.02 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.027 0.442 . . . . 0.0 111.225 -179.395 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 157' ' ' GLU . . . . . 0.644 ' O ' HG12 ' A' ' 204' ' ' VAL . 92.4 mt-10 -93.85 113.15 25.12 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.121 179.54 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -115.44 150.16 36.88 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 120.828 0.347 . . . . 0.0 110.585 179.487 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -124.45 124.62 42.7 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.048 0.451 . . . . 0.0 111.215 179.22 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.554 ' O ' ' N ' ' A' ' 144' ' ' GLY . 71.4 t -60.93 135.47 25.65 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.215 177.918 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 22.0 p -105.36 -24.95 12.57 Favored 'General case' 0 CA--C 1.533 0.315 0 O-C-N 123.308 0.38 . . . . 0.0 110.202 178.689 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 157.46 -165.17 33.33 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 120.842 -0.694 . . . . 0.0 111.718 179.791 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 3.0 p -134.97 155.26 37.87 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 179.776 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 87.8 p -138.75 167.17 22.57 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.633 0.73 . . . . 0.0 112.212 -178.489 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -100.19 118.87 37.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 114.99 -1.004 . . . . 0.0 110.204 179.694 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.475 HG21 ' CG2' ' A' ' 198' ' ' VAL . 27.6 m -137.05 161.7 35.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.225 0.536 . . . . 0.0 111.009 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -96.73 157.07 35.83 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.32 178.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.503 ' O ' ' CB ' ' B' ' 702' ' ' LEU . 20.7 Cg_endo -60.83 -18.02 54.0 Favored 'Trans proline' 0 C--N 1.3 -1.995 0 C-N-CA 122.605 2.204 . . . . 0.0 113.552 -179.627 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 45.5 p-10 -92.27 -5.26 52.71 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 119.45 -0.9 . . . . 0.0 112.313 179.711 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.561 ' O ' HG22 ' A' ' 173' ' ' VAL . 97.0 mttt -76.1 85.56 2.97 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 121.655 0.741 . . . . 0.0 111.373 179.438 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 171' ' ' TRP . . . . . 0.591 ' CZ3' ' OE2' ' A' ' 175' ' ' GLU . 1.2 p-90 -73.97 -7.44 52.41 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.034 -0.984 . . . . 0.0 110.041 179.42 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -61.77 -35.83 79.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.75 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 173' ' ' VAL . . . . . 0.561 HG22 ' O ' ' A' ' 170' ' ' LYS . 19.8 m -63.03 -17.77 20.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.781 -179.702 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 37.0 t -101.47 -17.77 6.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.922 -179.615 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.591 ' OE2' ' CZ3' ' A' ' 171' ' ' TRP . 76.3 mm-40 -76.26 153.94 35.58 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.246 0.546 . . . . 0.0 111.779 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 176' ' ' ASP . . . . . 0.491 ' OD1' ' O ' ' A' ' 176' ' ' ASP . 47.0 p-10 -60.27 142.86 53.98 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.719 0.771 . . . . 0.0 111.802 -179.345 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 73.6 m80 -115.36 12.71 16.42 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.707 179.523 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 64.13 41.66 98.34 Favored Glycine 0 CA--C 1.528 0.856 0 N-CA-C 111.105 -0.798 . . . . 0.0 111.105 179.646 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -165.2 172.47 12.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.1 0.476 . . . . 0.0 110.882 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -88.28 93.99 9.69 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 177.583 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 181' ' ' GLU . . . . . 0.447 ' HG2' ' N ' ' A' ' 182' ' ' ILE . 79.9 tt0 -130.45 161.64 30.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.85 0.833 . . . . 0.0 112.052 -178.078 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.544 HD11 HD11 ' A' ' 149' ' ' LEU . 1.1 mm -125.97 134.5 66.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 114.598 -1.183 . . . . 0.0 110.55 179.608 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 86.3 m -126.3 124.41 40.26 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 121.291 0.567 . . . . 0.0 111.23 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.46 HD13 HD11 ' A' ' 138' ' ' ILE . 83.4 mt -113.32 133.41 55.14 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.7 179.143 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.668 HD13 HD21 ' B' ' 702' ' ' LEU . 77.0 mt -113.53 124.77 70.5 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 CA-C-O 121.36 0.6 . . . . 0.0 111.028 -179.581 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 5.1 t -135.56 156.34 49.03 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 115.254 -0.884 . . . . 0.0 110.492 179.337 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 187' ' ' CYS . . . . . . . . . . . . . 4.5 m -87.11 141.45 28.65 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.234 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 188' ' ' VAL . . . . . 0.758 HG22 ' CD2' ' A' ' 197' ' ' TYR . 41.9 t -61.97 -47.32 93.74 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 CA-C-O 120.945 0.402 . . . . 0.0 111.005 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 94.6 p -162.23 164.42 27.71 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 121.038 0.447 . . . . 0.0 110.977 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 190' ' ' VAL . . . . . 0.501 ' CG1' ' O ' ' A' ' 128' ' ' MET . 18.0 m -69.16 -17.58 21.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.244 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -101.8 -34.69 9.33 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.519 -0.472 . . . . 0.0 111.049 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 49.6 t0 -99.63 103.13 14.81 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 120.984 0.421 . . . . 0.0 111.465 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 193' ' ' ASN . . . . . 0.577 ' O ' ' NH1' ' A' ' 196' ' ' ARG . 27.2 m120 -110.45 -7.22 14.79 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 121.298 0.57 . . . . 0.0 110.639 179.058 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 76.3 p -68.4 -16.68 64.01 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.953 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -136.73 143.03 43.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.468 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 196' ' ' ARG . . . . . 0.577 ' NH1' ' O ' ' A' ' 193' ' ' ASN . 76.9 mtt85 -136.05 145.15 45.69 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 121.108 0.48 . . . . 0.0 111.959 -179.494 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 197' ' ' TYR . . . . . 0.758 ' CD2' HG22 ' A' ' 188' ' ' VAL . 35.8 m-85 -96.41 144.57 26.42 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 115.949 -0.568 . . . . 0.0 111.471 179.034 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.475 ' CG2' HG21 ' A' ' 166' ' ' VAL . 39.2 t -128.97 130.69 68.45 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-O 121.083 0.468 . . . . 0.0 110.645 178.365 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 21.6 t -102.66 134.62 43.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.866 179.308 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -122.32 147.66 45.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.316 0.579 . . . . 0.0 111.387 -178.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -145.01 152.6 24.63 Favored Glycine 0 CA--C 1.53 1.024 0 N-CA-C 110.079 -1.208 . . . . 0.0 110.079 179.24 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 202' ' ' ASP . . . . . 0.422 ' OD1' ' O ' ' A' ' 202' ' ' ASP . 51.7 p-10 -111.92 151.39 29.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.994 0.426 . . . . 0.0 110.092 179.673 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 52.7 tp -71.52 131.47 43.32 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.678 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.644 HG12 ' O ' ' A' ' 157' ' ' GLU . 5.2 p -113.88 -19.5 6.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 120.333 -0.547 . . . . 0.0 111.589 -178.753 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -176.97 172.03 44.96 Favored Glycine 0 CA--C 1.527 0.799 0 C-N-CA 120.088 -1.053 . . . . 0.0 112.055 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 206' ' ' THR . . . . . 0.501 HG23 ' CD1' ' A' ' 156' ' ' TYR . 10.4 m -144.19 137.68 27.57 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.963 -0.618 . . . . 0.0 109.503 179.019 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -145.37 122.17 11.24 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.115 0.483 . . . . 0.0 111.276 179.621 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -62.39 139.83 58.55 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.491 0.662 . . . . 0.0 111.448 -179.289 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 9.5 tttt -79.2 109.32 13.42 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.552 179.563 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 98.5 mttt . . . . . 0 C--O 1.218 -0.558 0 CA-C-O 118.107 -0.949 . . . . 0.0 110.339 179.205 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 701' ' ' BOC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 702' ' ' LEU . . . . . 0.668 HD21 HD13 ' A' ' 185' ' ' ILE . 1.0 OUTLIER -154.12 103.95 2.44 Favored Pre-proline 0 CA--C 1.546 0.805 0 C-N-CA 120.681 -0.408 . . . . 20.0 111.323 . . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 703' ' ' PRO . . . . . 0.655 ' CG ' HG23 ' A' ' 110' ' ' VAL . 4.9 Cg_exo -69.41 -168.06 0.24 Allowed 'Trans proline' 0 N--CA 1.489 1.21 0 C-N-CA 122.906 2.404 . . . . 20.0 114.15 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 704' ' ' ALA . . . . . 0.544 ' O ' ' O ' ' B' ' 703' ' ' PRO . . . -36.79 -179.68 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 113.902 -1.499 . . . . 20.0 113.659 -179.078 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 705' ' ' B27 . . . . . 0.498 HG2A ' C ' ' B' ' 704' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.19 0 CA-C-O 121.254 0.549 . . . . 0.0 111.04 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 2.9 p -79.93 17.01 1.03 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.924 -179.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -99.64 9.76 42.55 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 120.901 0.382 . . . . 0.0 111.858 -179.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.8 mt -55.6 139.98 14.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 122.034 0.921 . . . . 0.0 112.988 -177.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.408 ' OD1' ' N ' ' A' ' 63' ' ' GLN . 60.4 t0 -77.59 129.15 35.26 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 114.169 -1.378 . . . . 0.0 109.567 179.166 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.533 ' NE2' ' O ' ' A' ' 64' ' ' PRO . 1.4 tt0 -76.81 119.71 78.62 Favored Pre-proline 0 CA--C 1.541 0.609 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.504 -179.137 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.533 ' O ' ' NE2' ' A' ' 63' ' ' GLN . 73.5 Cg_exo -47.86 162.31 0.28 Allowed 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 122.491 2.127 . . . . 0.0 112.811 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -52.6 168.96 0.09 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.873 0.844 . . . . 0.0 112.308 -178.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 97.4 mt -71.13 -12.08 61.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 114.516 -1.22 . . . . 0.0 111.979 -179.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.592 ' O ' ' ND2' ' A' ' 71' ' ' ASN . . . -68.21 -41.89 80.63 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.306 0.574 . . . . 0.0 110.492 179.204 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.767 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 98.2 mt-10 -70.7 -23.05 62.4 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.203 179.321 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 76.6 t -71.31 -43.88 73.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.814 -178.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -92.76 -8.82 42.68 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.411 -179.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.592 ' ND2' ' O ' ' A' ' 67' ' ' ALA . 84.9 m-20 -106.94 -10.17 16.06 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 121.15 0.5 . . . . 0.0 110.893 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.767 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -69.65 135.54 50.04 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.425 0.631 . . . . 0.0 112.272 -179.134 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 43.7 t -59.71 93.65 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.672 HD23 ' N ' ' A' ' 75' ' ' ASP . 6.9 tt -66.79 126.29 28.56 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.297 0.57 . . . . 0.0 111.449 -178.147 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.672 ' N ' HD23 ' A' ' 74' ' ' LEU . 88.2 m-20 -93.74 79.51 4.23 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.564 -0.743 . . . . 0.0 110.379 179.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.403 ' N ' HD23 ' A' ' 74' ' ' LEU . 86.8 tttt -64.75 -34.12 77.58 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.747 -0.661 . . . . 0.0 112.095 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.45 ' HD3' ' N ' ' A' ' 77' ' ' LYS . 8.0 mmtt -70.01 -13.12 62.08 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 121.428 0.633 . . . . 0.0 109.901 -176.497 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -93.9 -5.24 48.37 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.734 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 72.4 t -73.69 128.63 36.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.068 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 12.6 pt -110.57 -6.59 11.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 120.592 -0.443 . . . . 0.0 111.723 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -174.79 174.8 46.84 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 120.398 -0.906 . . . . 0.0 111.725 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.41 HH12 ' HB2' ' A' ' 84' ' ' SER . 73.2 ttp85 -135.3 156.89 48.19 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 121.158 0.504 . . . . 0.0 111.157 -179.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.428 HG22 ' O ' ' A' ' 92' ' ' LEU . 20.9 tt -125.6 139.32 51.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 179.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.41 ' HB2' HH12 ' A' ' 82' ' ' ARG . 32.5 t -137.59 134.55 35.69 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 -178.386 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.568 ' CG2' HG22 ' A' ' 88' ' ' VAL . 3.2 mp -137.26 87.58 18.16 Favored Pre-proline 0 CA--C 1.538 0.498 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.415 179.134 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -55.98 -32.56 86.33 Favored 'Trans proline' 0 N--CA 1.5 1.873 0 C-N-CA 123.205 2.604 . . . . 0.0 112.68 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 8.9 t -54.63 -41.63 70.26 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.244 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.568 HG22 ' CG2' ' A' ' 85' ' ' ILE . 11.2 m -113.93 14.44 8.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 CA-C-O 121.261 0.553 . . . . 0.0 110.635 179.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.8 p 46.58 52.0 11.46 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.128 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 55.7 tp -117.78 133.29 56.08 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.321 0.581 . . . . 0.0 110.604 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.859 ' O ' HD23 ' A' ' 92' ' ' LEU . 93.7 mt-10 -147.94 125.32 11.6 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.925 -179.292 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.859 HD23 ' O ' ' A' ' 91' ' ' GLU . 7.8 mt -148.89 148.48 27.59 Favored Pre-proline 0 CA--C 1.537 0.457 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.421 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -75.36 147.75 33.03 Favored 'Trans proline' 0 N--CA 1.493 1.465 0 C-N-CA 122.68 2.253 . . . . 0.0 110.878 178.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.484 ' C ' HD12 ' A' ' 95' ' ' LEU . 92.3 t -93.51 119.86 41.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.189 0.519 . . . . 0.0 110.649 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.567 ' N ' HD12 ' A' ' 95' ' ' LEU . 10.6 mp -97.82 126.09 43.01 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.72 0.772 . . . . 0.0 110.842 -179.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.527 ' O ' ' OG1' ' A' ' 109' ' ' THR . 86.7 tttt -63.64 -38.41 91.0 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.827 -1.078 . . . . 0.0 112.043 -178.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.497 ' CB ' ' ND2' ' A' ' 102' ' ' ASN . 2.7 m -79.76 126.43 30.94 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 121.636 0.731 . . . . 0.0 112.463 -178.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.462 ' OG ' ' O ' ' A' ' 109' ' ' THR . 0.9 OUTLIER -89.13 44.5 1.22 Allowed 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.714 179.687 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.578 ' OG1' ' ND2' ' A' ' 102' ' ' ASN . 71.4 p -89.48 171.78 9.47 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.03 179.121 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.439 ' HA ' HD12 ' A' ' 103' ' ' LEU . 94.8 mt-10 -66.06 -39.62 90.25 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.161 0.505 . . . . 0.0 110.143 179.247 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -64.43 -41.75 96.41 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.147 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.578 ' ND2' ' OG1' ' A' ' 99' ' ' THR . 54.0 m-80 -65.15 -34.83 79.33 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.6 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.537 HD13 ' HB3' ' B' ' 704' ' ' ALA . 42.0 mt -65.13 -16.54 63.6 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.634 -179.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.419 HD23 ' HA ' ' A' ' 104' ' ' LEU . 91.5 mt -73.76 -15.47 61.2 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.381 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.462 ' OG ' HD22 ' A' ' 95' ' ' LEU . 93.9 p -82.11 -2.84 53.3 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.198 0.523 . . . . 0.0 110.431 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.592 ' O ' ' CE1' ' A' ' 135' ' ' PHE . . . 93.31 -19.53 51.87 Favored Glycine 0 CA--C 1.527 0.799 0 CA-C-N 115.854 -0.612 . . . . 0.0 113.08 178.105 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -146.56 125.53 12.8 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 119.483 -0.887 . . . . 0.0 112.382 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -143.24 142.38 31.37 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.833 178.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.527 ' OG1' ' O ' ' A' ' 96' ' ' LYS . 58.5 p -65.37 132.44 49.0 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.46 0.648 . . . . 0.0 111.288 -178.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.658 HG13 ' CD ' ' B' ' 703' ' ' PRO . 78.9 t -78.38 -55.2 10.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.655 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.59 ' H ' ' NE2' ' A' ' 114' ' ' GLN . 83.5 mttt -107.04 139.74 40.96 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 122.048 0.928 . . . . 0.0 112.162 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -66.25 -34.48 78.11 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.444 -1.253 . . . . 0.0 112.165 -178.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -85.7 20.77 2.04 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 113.075 0.769 . . . . 0.0 113.075 -178.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . 0.59 ' NE2' ' H ' ' A' ' 111' ' ' LYS . 34.3 mt-30 -77.9 140.58 39.31 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.048 0.451 . . . . 0.0 111.034 179.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.2 t -125.91 108.54 19.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.965 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 73.3 mtp -56.25 126.61 26.94 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 121.121 0.486 . . . . 0.0 111.039 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 97.01 -11.76 65.79 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 121.133 -0.556 . . . . 0.0 111.825 179.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -143.72 137.29 28.04 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 121.055 0.455 . . . . 0.0 111.53 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 76.27 -170.7 54.83 Favored Glycine 0 CA--C 1.531 1.069 0 N-CA-C 111.675 -0.57 . . . . 0.0 111.675 179.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 54.5 t-20 -88.52 104.56 16.93 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 121.304 0.573 . . . . 0.0 110.576 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.416 ' HE2' HD21 ' A' ' 123' ' ' LEU . 6.6 t80 -86.99 145.97 26.31 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.4 179.417 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.425 ' HB3' HG13 ' A' ' 174' ' ' VAL . . . -147.58 143.76 27.98 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 119.493 -0.883 . . . . 0.0 111.841 -179.095 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.487 HD23 ' HA ' ' A' ' 109' ' ' THR . 63.8 mt -138.29 143.75 40.16 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 114.823 -1.081 . . . . 0.0 110.181 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -111.71 138.35 48.4 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -132.03 145.34 17.11 Favored Glycine 0 CA--C 1.531 1.046 0 N-CA-C 110.386 -1.086 . . . . 0.0 110.386 -179.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . 0.405 ' CG ' ' HB2' ' A' ' 63' ' ' GLN . 10.1 m-70 -88.63 124.1 33.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.449 0.642 . . . . 0.0 112.258 -179.231 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . 0.565 ' ND2' ' H ' ' A' ' 129' ' ' SER . 2.6 t-20 -122.83 121.82 37.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.251 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.433 ' H ' HG21 ' A' ' 133' ' ' VAL . 75.9 mtm -95.85 2.22 53.58 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 121.263 0.554 . . . . 0.0 110.748 179.405 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.565 ' H ' ' ND2' ' A' ' 127' ' ' ASN . 0.1 OUTLIER 76.04 10.5 3.14 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.543 179.114 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.81 ' O ' HG12 ' A' ' 133' ' ' VAL . 5.6 ptmt -110.51 114.16 27.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.878 0.847 . . . . 0.0 112.395 -179.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 6.1 tmtt? -37.72 120.28 0.81 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.661 -1.154 . . . . 0.0 111.7 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 113.13 -11.94 24.34 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.81 HG12 ' O ' ' A' ' 130' ' ' LYS . 11.8 p -91.71 164.31 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 CA-C-N 115.048 -0.576 . . . . 0.0 110.267 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.547 ' N ' HG22 ' A' ' 133' ' ' VAL . 0.7 OUTLIER -70.75 140.16 51.27 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.872 0.844 . . . . 0.0 112.645 -177.355 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.649 ' CG ' HD12 ' A' ' 138' ' ' ILE . 3.2 m-85 66.43 5.3 3.68 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 113.977 -1.465 . . . . 0.0 113.796 177.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . 0.542 ' OG ' ' CG1' ' A' ' 133' ' ' VAL . 0.4 OUTLIER -68.14 -40.48 82.4 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 112.373 0.509 . . . . 0.0 112.373 179.131 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.6 p-10 -88.95 -1.34 58.06 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 121.251 0.548 . . . . 0.0 111.439 -178.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.649 HD12 ' CG ' ' A' ' 135' ' ' PHE . 0.3 OUTLIER -65.24 -35.71 76.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-O 121.158 0.504 . . . . 0.0 110.254 178.957 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.83 ' HB2' ' OH ' ' A' ' 197' ' ' TYR . . . -66.83 -11.44 55.44 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.052 0.453 . . . . 0.0 110.926 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 59.6 p -84.35 -1.91 56.23 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 121.199 0.524 . . . . 0.0 110.756 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.44 HD21 HG21 ' A' ' 85' ' ' ILE . 66.1 mt -63.54 138.72 58.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.237 -179.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -113.48 154.46 27.0 Favored 'General case' 0 CA--C 1.535 0.365 0 CA-C-O 121.425 0.631 . . . . 0.0 111.351 -179.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -51.3 133.71 28.62 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.751 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.561 ' N ' ' O ' ' A' ' 160' ' ' VAL . . . 79.32 7.95 88.13 Favored Glycine 0 CA--C 1.527 0.84 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.554 179.14 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -70.12 132.8 46.38 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 119.88 -0.728 . . . . 0.0 109.852 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -78.59 138.32 38.3 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.76 0.79 . . . . 0.0 111.773 -178.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.517 HD11 ' CG2' ' A' ' 160' ' ' VAL . 95.9 mt -135.8 136.41 50.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 114.817 -1.083 . . . . 0.0 108.382 178.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . 0.496 ' C ' HD22 ' A' ' 149' ' ' LEU . 89.9 m-85 -117.81 135.0 54.36 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.906 0.86 . . . . 0.0 112.842 -178.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.496 HD22 ' C ' ' A' ' 148' ' ' TYR . 4.5 mm? -110.84 133.57 53.24 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 114.528 -1.215 . . . . 0.0 108.445 178.234 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.601 ' CZ ' ' OE2' ' A' ' 155' ' ' GLU . 79.8 m-85 -116.93 110.52 18.41 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 120.202 -0.599 . . . . 0.0 111.581 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . 0.466 ' OD1' ' N ' ' A' ' 152' ' ' ASN . 52.4 t0 -89.25 164.94 14.74 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 177.176 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . 0.466 ' N ' ' OD1' ' A' ' 151' ' ' ASP . 34.5 p30 -58.85 -19.12 38.76 Favored 'General case' 0 C--N 1.314 -0.967 0 C-N-CA 119.286 -0.965 . . . . 0.0 111.031 -178.119 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -112.28 -28.08 8.07 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -178.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . 0.414 ' O ' ' N ' ' A' ' 151' ' ' ASP . 0.4 OUTLIER -148.67 -175.64 5.01 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 -176.333 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.601 ' OE2' ' CZ ' ' A' ' 150' ' ' TYR . 87.7 tt0 -132.46 133.77 44.25 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 114.072 -1.422 . . . . 0.0 110.237 178.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . 0.425 ' CD1' HG23 ' A' ' 206' ' ' THR . 80.2 m-85 -112.59 140.22 47.53 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 120.846 0.355 . . . . 0.0 110.315 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . 0.44 ' O ' HD12 ' A' ' 203' ' ' LEU . 82.5 tt0 -99.87 117.98 35.34 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 121.047 0.451 . . . . 0.0 112.051 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -114.75 148.82 37.83 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 121.178 0.513 . . . . 0.0 111.416 179.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -121.03 120.85 36.58 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.713 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.561 ' O ' ' N ' ' A' ' 144' ' ' GLY . 91.0 t -59.59 136.77 22.86 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.292 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.743 178.199 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 15.1 p -105.63 -24.05 12.63 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.786 178.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 154.86 -163.43 31.32 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 120.682 -0.771 . . . . 0.0 111.62 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.61 HG12 HG22 ' A' ' 199' ' ' VAL . 35.5 m -135.76 158.07 39.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-N 115.343 -0.428 . . . . 0.0 110.004 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 81.6 p -145.95 165.78 27.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.118 0.485 . . . . 0.0 110.924 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -101.85 115.2 30.02 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.898 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.542 ' O ' ' O ' ' A' ' 196' ' ' ARG . 23.8 m -137.98 162.76 30.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.989 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -86.48 157.01 56.22 Favored Pre-proline 0 CA--C 1.54 0.575 0 CA-C-O 121.16 0.505 . . . . 0.0 111.431 -179.443 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . 0.517 ' O ' HD12 ' B' ' 702' ' ' LEU . 36.5 Cg_endo -67.86 -9.98 27.34 Favored 'Trans proline' 0 N--CA 1.5 1.862 0 C-N-CA 123.398 2.732 . . . . 0.0 112.861 -179.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . 0.424 ' OD1' ' C ' ' A' ' 169' ' ' ASP . 40.2 p-10 -95.01 -4.0 47.35 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.236 0.541 . . . . 0.0 110.924 179.018 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.777 ' O ' HD23 ' B' ' 702' ' ' LEU . 70.3 mmtt -75.69 82.83 2.68 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.533 -178.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 40.4 p-90 -76.72 -12.08 59.94 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 121.356 0.598 . . . . 0.0 110.594 178.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 76.4 tt0 -61.0 -36.58 79.86 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.988 -179.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . 0.637 HG22 HG21 ' A' ' 183' ' ' THR . 11.6 p -62.44 -25.97 39.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 CA-C-O 121.107 0.479 . . . . 0.0 110.77 -179.556 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.468 HG11 HG11 ' A' ' 110' ' ' VAL . 20.1 t -93.1 -8.49 10.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.945 -179.161 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.525 ' OE1' ' O ' ' A' ' 176' ' ' ASP . 0.6 OUTLIER -73.5 146.77 44.64 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 120.935 0.398 . . . . 0.0 111.076 -179.766 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . 0.525 ' O ' ' OE1' ' A' ' 175' ' ' GLU . 48.1 p-10 -66.27 128.29 35.54 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.281 0.563 . . . . 0.0 111.857 -179.169 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 21.4 m80 -111.49 24.66 12.52 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.965 -0.561 . . . . 0.0 112.119 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 60.21 35.79 88.94 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 120.724 -0.75 . . . . 0.0 111.247 179.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -154.15 161.41 41.88 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 110.208 -0.293 . . . . 0.0 110.208 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -89.35 105.25 17.67 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.897 179.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 -139.21 167.02 23.0 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.569 0.699 . . . . 0.0 112.154 179.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.468 HG22 ' O ' ' A' ' 201' ' ' GLY . 18.9 tt -130.08 138.02 55.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 114.827 -1.079 . . . . 0.0 109.917 179.121 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . 0.637 HG21 HG22 ' A' ' 173' ' ' VAL . 39.8 m -130.98 122.64 27.22 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.176 0.512 . . . . 0.0 111.079 -179.216 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 93.9 mt -109.43 136.29 49.08 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.631 178.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 70.0 mt -105.68 115.71 47.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 C-N-CA 120.206 -0.598 . . . . 0.0 110.179 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' THR . . . . . 0.425 HG21 ' OH ' ' A' ' 197' ' ' TYR . 77.1 m -126.79 132.63 51.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.275 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -84.03 140.8 31.62 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.498 HG23 ' HA ' ' A' ' 196' ' ' ARG . 73.7 t -61.19 -49.05 86.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.161 0.505 . . . . 0.0 111.257 -178.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 34.7 p -168.52 163.84 12.47 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.282 0.563 . . . . 0.0 111.009 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 31.3 m -76.85 -9.89 12.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.349 179.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -101.37 -23.49 14.36 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.852 178.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 60.4 t0 -96.68 105.77 17.93 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.04 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -109.77 5.92 23.12 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.177 0.513 . . . . 0.0 110.632 179.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 85.9 p -68.43 -59.76 2.94 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.677 -179.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -147.49 155.77 42.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.17 0.51 . . . . 0.0 111.25 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . 0.542 ' O ' ' O ' ' A' ' 166' ' ' VAL . 99.8 mtt180 -129.58 143.78 50.98 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.533 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . 0.83 ' OH ' ' HB2' ' A' ' 139' ' ' ALA . 36.4 p90 -93.16 152.07 19.46 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.425 0.631 . . . . 0.0 111.314 -179.335 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.413 HG11 HG21 ' A' ' 173' ' ' VAL . 48.4 t -123.7 132.93 70.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.378 179.309 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.61 HG22 HG12 ' A' ' 163' ' ' VAL . 40.7 t -94.0 132.32 38.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.989 -179.243 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -119.3 145.0 46.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.465 0.65 . . . . 0.0 111.393 -179.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . 0.468 ' O ' HG22 ' A' ' 182' ' ' ILE . . . -142.8 146.08 16.62 Favored Glycine 0 CA--C 1.529 0.945 0 N-CA-C 110.451 -1.06 . . . . 0.0 110.451 179.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 48.9 p-10 -109.04 151.66 26.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.175 0.512 . . . . 0.0 111.427 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . 0.44 HD12 ' O ' ' A' ' 157' ' ' GLU . 51.0 tp -72.48 132.36 43.76 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 178.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 2.6 p -115.25 -19.19 6.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 120.74 -0.384 . . . . 0.0 111.493 -179.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . 0.422 ' O ' HD11 ' A' ' 203' ' ' LEU . . . -178.3 174.64 46.89 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 120.804 -0.712 . . . . 0.0 111.66 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . 0.425 HG23 ' CD1' ' A' ' 156' ' ' TYR . 60.3 m -141.04 136.3 31.91 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-O 120.662 0.268 . . . . 0.0 110.652 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -143.96 115.62 8.18 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 120.153 -0.619 . . . . 0.0 112.309 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -64.3 147.57 52.2 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.256 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 8.4 ttpt -80.34 109.53 14.92 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.365 178.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 98.0 mttt . . . . . 0 C--O 1.221 -0.428 0 CA-C-O 117.837 -1.078 . . . . 0.0 110.536 179.142 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 702' ' ' LEU . . . . . 0.777 HD23 ' O ' ' A' ' 170' ' ' LYS . 0.2 OUTLIER . . . . . 0 CA--C 1.539 0.539 0 CA-C-O 121.628 0.728 . . . . 20.0 110.892 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 703' ' ' PRO . . . . . 0.658 ' CD ' HG13 ' A' ' 110' ' ' VAL . 3.7 Cg_exo -72.18 -171.04 0.63 Allowed 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 123.84 3.027 . . . . 20.0 112.982 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 704' ' ' ALA . . . . . 0.547 ' O ' ' O ' ' B' ' 703' ' ' PRO . . . . . . . . 0 CA--C 1.534 0.34 0 CA-C-N 115.079 -0.964 . . . . 20.0 113.129 -178.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.256 0 CA-C-O 121.42 0.628 . . . . 0.0 110.17 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 5.4 p -82.6 10.08 8.14 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.546 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -96.74 8.56 44.0 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.238 0.542 . . . . 0.0 110.869 -179.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 59.0 mt -55.19 142.72 9.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.953 0.882 . . . . 0.0 111.68 -177.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -75.48 126.95 32.05 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 114.142 -1.39 . . . . 0.0 108.775 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.682 ' H ' ' CD ' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -78.72 130.87 69.32 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.708 -178.867 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.627 ' HD2' HD21 ' A' ' 104' ' ' LEU . 56.8 Cg_exo -51.14 150.52 13.85 Favored 'Trans proline' 0 N--CA 1.493 1.471 0 C-N-CA 121.695 1.597 . . . . 0.0 111.767 178.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.444 ' CG ' ' H ' ' A' ' 66' ' ' LEU . 45.0 t0 -52.41 177.51 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 121.198 0.523 . . . . 0.0 111.506 -178.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.742 HD21 HG23 ' A' ' 133' ' ' VAL . 94.5 mt -65.95 -45.25 82.5 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.672 -178.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.63 -30.59 70.81 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.229 -0.588 . . . . 0.0 110.704 -178.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -62.82 -30.36 71.42 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.431 178.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.611 HG22 HD22 ' A' ' 104' ' ' LEU . 37.3 t -77.84 -46.27 27.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.131 -0.94 . . . . 0.0 110.685 179.403 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.08 -9.58 58.29 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.144 -0.935 . . . . 0.0 111.244 -179.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -109.35 -13.61 14.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.318 0.58 . . . . 0.0 110.095 178.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.37 135.44 51.8 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.712 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 33.0 t -59.47 103.01 0.16 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.647 -179.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.85 125.95 28.25 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.591 -179.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -98.49 83.77 3.07 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 121.382 0.611 . . . . 0.0 109.95 178.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -62.82 -38.28 90.11 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.376 -179.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.577 ' CD ' ' H ' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -71.51 -12.03 61.17 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 120.471 -0.492 . . . . 0.0 110.999 -177.347 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -93.05 0.71 57.4 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.423 0.63 . . . . 0.0 110.203 178.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 88.3 t -86.11 128.31 39.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.132 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.436 ' HA ' HD21 ' A' ' 152' ' ' ASN . 16.5 pt -107.35 -7.9 10.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.239 -179.198 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -170.95 179.33 42.91 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 120.454 -0.879 . . . . 0.0 111.808 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 56.4 ttp180 -140.24 156.26 46.56 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 121.378 0.609 . . . . 0.0 111.315 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.475 HG22 ' O ' ' A' ' 92' ' ' LEU . 16.8 tt -125.29 141.98 43.56 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 CA-C-O 121.437 0.637 . . . . 0.0 110.464 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 66.5 m -135.31 130.31 34.86 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.093 -0.958 . . . . 0.0 111.258 -178.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.429 ' CG2' HG22 ' A' ' 88' ' ' VAL . 22.6 mt -133.79 88.73 32.12 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.121 -178.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -54.9 -35.36 89.03 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 123.278 2.652 . . . . 0.0 112.644 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 44.4 t -55.88 -43.41 77.15 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.192 -0.458 . . . . 0.0 112.212 -179.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.429 HG22 ' CG2' ' A' ' 85' ' ' ILE . 21.7 m -112.21 6.36 8.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.285 0.564 . . . . 0.0 110.731 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.7 m 56.05 53.01 9.61 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.196 179.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 58.1 tp -116.7 135.52 53.71 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.309 0.576 . . . . 0.0 110.779 179.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -146.44 117.06 7.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.115 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.475 ' O ' HG22 ' A' ' 83' ' ' ILE . 75.5 mt -150.27 151.45 31.49 Favored Pre-proline 0 CA--C 1.539 0.538 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.481 -179.293 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -74.2 147.0 37.02 Favored 'Trans proline' 0 N--CA 1.493 1.475 0 C-N-CA 122.833 2.355 . . . . 0.0 111.827 179.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.549 ' C ' HD12 ' A' ' 95' ' ' LEU . 74.2 t -92.46 122.22 43.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.083 0.468 . . . . 0.0 110.228 179.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.581 ' N ' HD12 ' A' ' 95' ' ' LEU . 10.2 mp -100.67 126.66 47.2 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.806 0.812 . . . . 0.0 110.672 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -63.02 -46.45 87.56 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.34 -1.3 . . . . 0.0 112.835 -178.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 4.3 m -86.25 132.09 34.07 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 121.123 0.487 . . . . 0.0 111.75 -179.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -87.17 60.41 6.14 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.352 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.552 HG22 ' N ' ' A' ' 100' ' ' GLU . 54.1 m -88.11 163.31 16.28 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 178.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.552 ' N ' HG22 ' A' ' 99' ' ' THR . 94.5 mt-10 -58.56 -44.56 89.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.284 0.564 . . . . 0.0 110.232 -179.424 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.406 ' H ' HG22 ' A' ' 99' ' ' THR . 66.3 mttm -64.8 -40.33 95.05 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.717 0.77 . . . . 0.0 110.077 178.197 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -63.25 -36.42 83.62 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.054 -0.975 . . . . 0.0 111.711 -179.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.644 HD13 ' HB3' ' B' ' 704' ' ' ALA . 74.6 mt -61.89 -25.53 67.61 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 120.809 -0.357 . . . . 0.0 111.223 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.627 HD21 ' HD2' ' A' ' 64' ' ' PRO . 84.6 mt -73.15 -13.32 61.15 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.908 0.385 . . . . 0.0 111.029 -179.483 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 94.4 p -73.98 -9.01 58.21 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.392 0.615 . . . . 0.0 110.158 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.524 ' O ' ' CE1' ' A' ' 135' ' ' PHE . . . 95.31 -20.86 47.36 Favored Glycine 0 CA--C 1.526 0.779 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.884 178.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -146.92 125.48 12.47 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.215 -0.594 . . . . 0.0 111.376 179.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -144.15 129.11 18.5 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.116 179.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.657 ' HA ' HD23 ' A' ' 123' ' ' LEU . 27.7 m -66.96 131.55 46.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.897 -179.483 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.625 HG22 ' HG2' ' B' ' 703' ' ' PRO . 92.7 t -79.07 -53.31 13.74 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.91 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.822 ' H ' ' NE2' ' A' ' 114' ' ' GLN . 73.3 mmtt -100.73 131.68 46.5 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 122.134 0.969 . . . . 0.0 111.949 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -66.09 -27.94 68.44 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 114.627 -1.17 . . . . 0.0 113.076 -178.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -84.14 12.97 5.6 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 113.863 1.06 . . . . 0.0 113.863 -177.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . 0.822 ' NE2' ' H ' ' A' ' 111' ' ' LYS . 45.5 mt-30 -77.96 143.28 37.75 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.348 0.595 . . . . 0.0 112.502 -179.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 53.0 t -123.56 124.64 69.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.046 178.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 63.6 mtt -58.42 130.5 47.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.417 179.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 84.19 -1.13 89.13 Favored Glycine 0 CA--C 1.529 0.933 0 N-CA-C 111.551 -0.619 . . . . 0.0 111.551 179.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -143.85 128.18 17.82 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 121.048 0.451 . . . . 0.0 110.787 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 78.76 -177.68 53.83 Favored Glycine 0 CA--C 1.532 1.117 0 N-CA-C 111.82 -0.512 . . . . 0.0 111.82 179.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 61.7 t-20 -84.97 105.4 15.7 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 120.943 0.402 . . . . 0.0 110.131 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.502 ' HE2' HD21 ' A' ' 123' ' ' LEU . 3.7 t80 -86.6 99.69 11.89 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.012 0.434 . . . . 0.0 110.386 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.58 ' HB3' HG13 ' A' ' 174' ' ' VAL . . . -93.09 137.11 32.74 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 121.08 0.467 . . . . 0.0 111.628 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.657 HD23 ' HA ' ' A' ' 109' ' ' THR . 61.1 mt -136.26 142.56 43.99 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.59 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -107.38 139.59 41.63 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 178.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -137.52 148.07 19.6 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 109.254 -1.538 . . . . 0.0 109.254 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 12.6 m-70 -92.26 123.68 35.77 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.744 0.783 . . . . 0.0 112.411 -178.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . 0.401 ' OD1' ' N ' ' A' ' 129' ' ' SER . 52.0 t-20 -116.27 119.71 36.6 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.086 179.282 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.44 ' HB2' HG21 ' A' ' 133' ' ' VAL . 68.6 mtt -94.92 -2.75 49.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.351 0.596 . . . . 0.0 109.923 179.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.401 ' N ' ' OD1' ' A' ' 127' ' ' ASN . 0.2 OUTLIER 74.55 6.56 4.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.07 179.585 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.788 ' O ' HG12 ' A' ' 133' ' ' VAL . 11.4 ptpt -113.43 120.71 41.98 Favored 'General case' 0 C--O 1.225 -0.235 0 CA-C-O 121.33 0.586 . . . . 0.0 112.224 -179.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.51 ' O ' ' O ' ' A' ' 130' ' ' LYS . 18.2 tptt -31.93 155.13 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.616 179.316 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 77.39 -17.01 5.51 Favored Glycine 0 CA--C 1.529 0.913 0 N-CA-C 110.819 -0.912 . . . . 0.0 110.819 179.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.788 HG12 ' O ' ' A' ' 130' ' ' LYS . 7.8 p -91.62 150.88 3.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 120.057 -0.657 . . . . 0.0 109.732 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.795 HD23 ' N ' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -68.27 146.18 53.57 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 122.035 0.922 . . . . 0.0 113.245 -177.112 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.524 ' CE1' ' O ' ' A' ' 106' ' ' GLY . 3.2 m-85 65.12 5.38 2.97 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 113.787 -1.551 . . . . 0.0 113.865 178.143 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . 0.519 ' OG ' ' CG1' ' A' ' 133' ' ' VAL . 0.5 OUTLIER -71.65 -38.94 70.64 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 121.692 -0.63 . . . . 0.0 112.593 179.465 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 79.0 m-20 -93.46 0.73 56.86 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 114.9 1.444 . . . . 0.0 114.9 -177.025 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.554 HD11 ' HB ' ' A' ' 186' ' ' THR . 38.4 pt -63.87 -22.83 31.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 119.038 -1.065 . . . . 0.0 110.471 -178.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -69.49 -10.86 59.85 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.268 0.556 . . . . 0.0 110.086 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 1.4 m -84.45 -5.21 59.26 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.572 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 82.1 mt -64.75 145.55 56.07 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.409 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -120.71 157.59 29.32 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 121.455 0.645 . . . . 0.0 112.148 -178.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -50.67 131.97 25.79 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.6 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.452 ' N ' ' O ' ' A' ' 160' ' ' VAL . . . 80.17 7.37 88.59 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 120.648 -0.787 . . . . 0.0 111.149 179.05 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.489 ' OD1' ' N ' ' A' ' 146' ' ' LYS . 64.9 t0 -73.73 131.56 41.73 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 119.89 -0.724 . . . . 0.0 110.007 -179.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.489 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 73.6 mmtt -76.95 140.06 40.34 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.616 0.722 . . . . 0.0 112.124 -178.272 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 48.9 mm -131.51 134.42 60.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 177.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . 0.431 ' C ' HD22 ' A' ' 149' ' ' LEU . 78.9 m-85 -112.49 127.49 56.07 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 119.747 -0.781 . . . . 0.0 112.424 -178.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.431 HD22 ' C ' ' A' ' 148' ' ' TYR . 4.4 mm? -110.79 132.43 54.2 Favored 'General case' 0 C--O 1.224 -0.279 0 CA-C-N 114.943 -1.026 . . . . 0.0 108.658 178.374 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.594 ' CE2' ' OE1' ' A' ' 155' ' ' GLU . 61.2 m-85 -117.21 112.14 20.41 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.204 -0.598 . . . . 0.0 112.569 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . 0.563 ' OD1' ' N ' ' A' ' 152' ' ' ASN . 54.6 t0 -91.2 164.81 13.77 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 176.56 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . 0.563 ' N ' ' OD1' ' A' ' 151' ' ' ASP . 65.8 m-20 -57.61 -23.93 53.66 Favored 'General case' 0 C--N 1.311 -1.074 0 C-N-CA 120.106 -0.637 . . . . 0.0 111.112 -178.023 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -108.3 -29.68 8.74 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 119.762 -0.775 . . . . 0.0 112.839 -178.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . 0.471 ' O ' ' N ' ' A' ' 151' ' ' ASP . 0.3 OUTLIER -149.51 -177.51 5.9 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 113.723 1.008 . . . . 0.0 113.723 -177.779 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.594 ' OE1' ' CE2' ' A' ' 150' ' ' TYR . 80.0 tt0 -128.76 138.09 51.91 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 114.209 -1.36 . . . . 0.0 110.066 179.143 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -111.56 134.0 53.44 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 121.354 0.597 . . . . 0.0 111.383 -179.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -89.65 108.25 19.56 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.453 178.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -112.02 147.22 36.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.026 0.441 . . . . 0.0 111.187 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.525 ' HB2' HG21 ' A' ' 204' ' ' VAL . . . -124.32 123.39 40.1 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 121.047 0.451 . . . . 0.0 110.917 179.238 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.452 ' O ' ' N ' ' A' ' 144' ' ' GLY . 81.2 t -59.45 135.09 24.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 178.07 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 42.6 p -105.29 -26.04 12.17 Favored 'General case' 0 C--N 1.33 -0.263 0 O-C-N 123.325 0.39 . . . . 0.0 110.674 179.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 162.69 -169.72 38.02 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 120.452 -0.88 . . . . 0.0 111.992 179.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 3.0 p -135.11 149.92 29.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.068 -0.566 . . . . 0.0 110.15 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 50.7 m -139.54 163.58 32.17 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.427 0.632 . . . . 0.0 111.187 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -100.22 121.57 41.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.266 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.436 HG11 HG11 ' A' ' 173' ' ' VAL . 27.1 m -136.72 161.3 36.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.386 -179.517 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -92.68 165.03 20.03 Favored Pre-proline 0 CA--C 1.538 0.501 0 C-N-CA 120.662 -0.415 . . . . 0.0 111.054 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . 0.431 ' O ' ' CB ' ' B' ' 702' ' ' LEU . 25.0 Cg_exo -62.52 -19.72 68.52 Favored 'Trans proline' 0 N--CA 1.499 1.852 0 C-N-CA 122.489 2.126 . . . . 0.0 112.998 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 46.7 p-10 -94.76 -5.85 44.36 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.549 ' O ' HG22 ' A' ' 173' ' ' VAL . 96.5 mttt -75.95 88.82 2.93 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 119.655 -0.818 . . . . 0.0 111.657 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 4.9 p90 -76.89 -14.49 59.87 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.467 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -57.59 -35.53 70.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.47 -179.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . 0.549 HG22 ' O ' ' A' ' 170' ' ' LYS . 27.6 m -64.16 -15.56 17.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 C-N-CA 120.771 -0.372 . . . . 0.0 111.253 -179.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.58 HG13 ' HB3' ' A' ' 122' ' ' ALA . 78.6 t -103.96 -16.1 7.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -179.361 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -74.57 144.33 44.04 Favored 'General case' 0 CA--C 1.533 0.319 0 O-C-N 121.816 -0.552 . . . . 0.0 110.956 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . 0.501 ' OD1' ' O ' ' A' ' 176' ' ' ASP . 55.7 p-10 -64.95 145.16 56.69 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.456 179.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 68.9 m80 -120.7 31.73 6.3 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 121.035 0.445 . . . . 0.0 111.759 -179.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 59.93 39.79 96.02 Favored Glycine 0 CA--C 1.534 1.228 0 N-CA-C 111.257 -0.737 . . . . 0.0 111.257 179.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -155.89 165.72 35.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.028 0.442 . . . . 0.0 110.781 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -88.56 102.03 14.53 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 177.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . 0.454 ' HG2' ' N ' ' A' ' 182' ' ' ILE . 84.4 tt0 -138.27 163.54 31.51 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.663 0.744 . . . . 0.0 111.909 -178.335 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.454 ' N ' ' HG2' ' A' ' 181' ' ' GLU . 18.6 tt -130.65 138.93 52.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.13 178.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 86.0 m -130.3 125.49 34.87 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.477 0.656 . . . . 0.0 111.639 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 93.2 mt -109.54 131.58 54.93 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.111 178.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.794 HD13 HD21 ' B' ' 702' ' ' LEU . 82.6 mt -113.91 125.39 71.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.465 0.65 . . . . 0.0 111.889 -177.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' THR . . . . . 0.554 ' HB ' HD11 ' A' ' 138' ' ' ILE . 3.4 t -140.98 161.95 36.62 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.547 179.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' CYS . . . . . . . . . . . . . 1.9 m -96.94 146.43 24.97 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.379 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.565 HG13 ' N ' ' A' ' 189' ' ' SER . 8.0 p -63.8 -43.51 97.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.196 0.522 . . . . 0.0 111.353 -179.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . 0.565 ' N ' HG13 ' A' ' 188' ' ' VAL . 13.6 p -162.76 160.88 25.88 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.483 -179.306 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . 0.454 HG22 ' O ' ' A' ' 190' ' ' VAL . 9.5 p -79.18 -11.75 13.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.83 179.277 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -97.97 -19.85 17.79 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.052 0.453 . . . . 0.0 111.083 179.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 67.2 t0 -132.64 103.67 6.25 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.103 0.478 . . . . 0.0 111.403 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -104.29 10.84 35.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.875 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 44.2 t -60.72 -43.7 97.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.078 0.466 . . . . 0.0 111.109 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -125.03 144.33 50.45 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.05 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -124.47 143.54 50.59 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.852 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -98.67 133.51 42.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.023 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.404 ' CG2' HG21 ' A' ' 166' ' ' VAL . 30.0 t -120.3 131.17 73.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 CA-C-O 121.426 0.631 . . . . 0.0 110.936 179.271 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 31.7 t -104.28 132.07 51.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.194 179.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -113.78 144.38 43.07 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.368 0.604 . . . . 0.0 111.556 -179.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -136.46 139.32 10.55 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 110.356 -1.098 . . . . 0.0 110.356 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -103.47 138.65 39.9 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.145 0.497 . . . . 0.0 110.816 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 66.0 tp -62.83 131.52 49.08 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.525 HG21 ' HB2' ' A' ' 159' ' ' ALA . 2.8 t -115.37 -19.81 6.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 C-N-CA 120.762 -0.375 . . . . 0.0 111.503 -178.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -178.13 173.53 46.01 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 120.649 -0.786 . . . . 0.0 111.716 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 24.7 m -140.87 137.02 32.91 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.584 -0.525 . . . . 0.0 109.584 179.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -143.92 117.27 9.05 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.335 0.588 . . . . 0.0 112.075 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -62.43 141.71 58.23 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.991 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 8.9 ttpt -78.52 109.52 12.77 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.224 178.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 99.8 mttt . . . . . 0 C--N 1.322 -0.606 0 CA-C-O 117.914 -1.041 . . . . 0.0 110.828 -179.293 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 702' ' ' LEU . . . . . 0.794 HD21 HD13 ' A' ' 185' ' ' ILE . 0.4 OUTLIER . . . . . 0 CA--C 1.543 0.681 0 N-CA-C 110.125 -0.324 . . . . 20.0 110.125 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 703' ' ' PRO . . . . . 0.633 ' HD2' HD23 ' B' ' 702' ' ' LEU . 2.8 Cg_endo -65.68 -176.83 0.61 Allowed 'Trans proline' 0 N--CA 1.489 1.249 0 C-N-CA 121.663 1.575 . . . . 20.0 113.047 -179.131 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 704' ' ' ALA . . . . . 0.644 ' HB3' HD13 ' A' ' 103' ' ' LEU . . . . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 114.319 -1.31 . . . . 20.0 113.527 -179.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.172 0 CA-C-O 121.058 0.456 . . . . 0.0 111.524 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 98.4 p -87.72 1.59 53.39 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.587 0.708 . . . . 0.0 110.077 178.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -100.26 10.27 41.49 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.038 -178.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 95.7 mt -56.04 135.22 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-O 122.159 0.981 . . . . 0.0 112.948 -176.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 85.0 m-20 -75.94 130.61 38.73 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 113.881 -1.509 . . . . 0.0 108.913 178.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.625 ' H ' ' CD ' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -82.25 152.49 67.88 Favored Pre-proline 0 C--N 1.328 -0.348 0 C-N-CA 120.15 -0.62 . . . . 0.0 110.49 -179.66 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -72.43 169.92 20.54 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 123.135 2.557 . . . . 0.0 112.76 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -54.65 169.61 0.2 Allowed 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.416 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 57.2 tp -64.3 -45.4 88.14 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.688 -179.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.73 -36.14 75.99 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.09 -0.644 . . . . 0.0 111.157 -177.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.604 ' N ' ' OE1' ' A' ' 68' ' ' GLU . 4.9 mp0 -55.88 -28.84 58.53 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.444 0.64 . . . . 0.0 109.511 178.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 38.3 t -76.59 -44.41 34.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-N 115.342 -0.844 . . . . 0.0 110.823 179.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -79.7 -8.08 59.0 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.974 -179.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -105.89 -13.14 15.59 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.337 0.589 . . . . 0.0 109.926 178.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -70.03 138.22 51.97 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.516 -0.766 . . . . 0.0 111.31 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 37.4 t -59.54 100.31 0.08 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.447 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.688 HD13 ' C ' ' A' ' 74' ' ' LEU . 2.8 tm? -71.12 122.87 20.92 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.137 -179.115 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.677 ' N ' HD13 ' A' ' 74' ' ' LEU . 91.4 m-20 -92.66 80.59 4.77 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 121.299 0.571 . . . . 0.0 110.501 178.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 51.8 tptt -65.83 -32.88 74.65 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.052 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.512 ' H ' ' HE3' ' A' ' 77' ' ' LYS . 3.0 mtmt -72.63 -18.31 61.59 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.414 -177.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -90.54 -9.51 46.92 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.033 0.444 . . . . 0.0 110.836 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 96.5 t -70.25 130.27 34.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.404 0.621 . . . . 0.0 111.263 -179.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.413 HG21 ' HE3' ' A' ' 96' ' ' LYS . 42.9 pt -118.13 -11.86 11.19 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.579 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -159.83 170.02 35.92 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 111.154 -0.779 . . . . 0.0 111.154 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 61.9 ttp180 -143.61 151.35 40.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.542 0.686 . . . . 0.0 112.154 -179.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.455 HG22 ' O ' ' A' ' 92' ' ' LEU . 21.0 tt -112.79 138.01 43.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.546 178.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 33.3 t -135.64 128.7 31.58 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 121.518 0.675 . . . . 0.0 111.903 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.508 HG22 HG22 ' A' ' 88' ' ' VAL . 85.1 mt -138.16 86.07 17.89 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.182 179.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -55.96 -29.85 75.27 Favored 'Trans proline' 0 N--CA 1.497 1.703 0 C-N-CA 123.091 2.527 . . . . 0.0 113.16 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 95.9 p -53.45 -38.43 63.55 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 120.537 -0.465 . . . . 0.0 111.005 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.508 HG22 HG22 ' A' ' 85' ' ' ILE . 23.7 m -117.47 12.2 7.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.387 0.613 . . . . 0.0 110.001 178.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 48.21 53.55 11.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.762 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.546 HD11 HD11 ' A' ' 92' ' ' LEU . 58.0 tp -114.93 132.47 56.54 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.318 179.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.739 ' O ' HD23 ' A' ' 92' ' ' LEU . 96.2 mt-10 -145.78 122.36 11.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.649 -179.254 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.739 HD23 ' O ' ' A' ' 91' ' ' GLU . 8.6 mt -146.81 147.74 30.79 Favored Pre-proline 0 CA--C 1.54 0.56 0 C-N-CA 120.198 -0.601 . . . . 0.0 111.95 -179.099 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -77.15 151.57 30.38 Favored 'Trans proline' 0 N--CA 1.497 1.688 0 C-N-CA 123.059 2.506 . . . . 0.0 112.478 178.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.462 ' C ' HD12 ' A' ' 95' ' ' LEU . 87.7 t -95.52 113.24 29.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-O 121.065 0.46 . . . . 0.0 111.613 179.311 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.562 ' N ' HD12 ' A' ' 95' ' ' LEU . 11.1 mp -98.87 139.82 33.96 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.96 179.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.485 ' O ' ' OG1' ' A' ' 109' ' ' THR . 98.8 mttt -63.79 -80.97 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -178.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 33.6 t -60.86 131.14 49.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.186 0.517 . . . . 0.0 111.838 -178.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 35.3 p -89.72 71.68 7.73 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.99 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.534 HG22 ' N ' ' A' ' 100' ' ' GLU . 26.1 m -92.21 169.53 10.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.505 -0.771 . . . . 0.0 109.251 178.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.534 ' N ' HG22 ' A' ' 99' ' ' THR . 99.1 mt-10 -61.65 -44.43 96.98 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 119.776 -0.77 . . . . 0.0 110.059 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -65.7 -40.99 92.86 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 121.33 0.586 . . . . 0.0 110.955 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -63.92 -38.7 92.05 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.149 -179.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 64.9 mt -62.63 -18.86 63.08 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.608 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 75.2 mt -70.74 -18.37 62.78 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.998 0.428 . . . . 0.0 110.39 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 88.9 p -74.45 -8.77 57.38 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.555 0.693 . . . . 0.0 109.286 179.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.608 ' O ' ' CE1' ' A' ' 135' ' ' PHE . . . 93.01 -19.15 53.98 Favored Glycine 0 CA--C 1.53 0.974 0 CA-C-N 115.123 -0.944 . . . . 0.0 112.337 178.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -146.25 126.76 14.13 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 119.659 -0.816 . . . . 0.0 112.745 -179.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -143.54 138.85 29.43 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.042 178.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.485 ' OG1' ' O ' ' A' ' 96' ' ' LYS . 30.0 p -65.67 133.03 50.25 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 121.271 0.558 . . . . 0.0 110.718 -179.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.576 HG22 ' HG2' ' B' ' 703' ' ' PRO . 44.4 t -80.52 -50.4 17.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.385 -179.168 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.753 ' H ' ' NE2' ' A' ' 114' ' ' GLN . 76.8 mttt -105.65 141.22 37.47 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.835 0.826 . . . . 0.0 112.631 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -66.8 -36.26 81.97 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.174 -0.921 . . . . 0.0 112.917 -178.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 17.0 p30 -82.13 15.88 2.19 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -178.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . 0.753 ' NE2' ' H ' ' A' ' 111' ' ' LYS . 32.9 mt-30 -78.2 137.42 38.13 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 122.031 -0.418 . . . . 0.0 110.482 179.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 69.0 t -124.24 125.87 71.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.269 -0.423 . . . . 0.0 109.994 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' MET . . . . . 0.598 ' SD ' ' CZ ' ' A' ' 121' ' ' TYR . 91.7 mmm -56.53 125.75 23.48 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.097 0.475 . . . . 0.0 111.467 -179.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 82.59 -0.66 89.11 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-N 115.905 -0.589 . . . . 0.0 112.294 178.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -138.07 130.56 29.29 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 119.998 -0.681 . . . . 0.0 110.637 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 74.2 -169.47 53.91 Favored Glycine 0 CA--C 1.53 1.006 0 N-CA-C 110.518 -1.033 . . . . 0.0 110.518 -179.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 58.8 t-20 -89.39 105.62 17.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.992 0.425 . . . . 0.0 110.04 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.598 ' CZ ' ' SD ' ' A' ' 116' ' ' MET . 11.4 t80 -88.45 100.44 13.05 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.015 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.14 137.71 32.12 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 121.276 0.56 . . . . 0.0 111.745 -178.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.508 HD21 ' CE2' ' A' ' 121' ' ' TYR . 62.7 mt -135.21 137.33 42.53 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.923 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -112.07 135.69 52.4 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -130.75 134.22 7.67 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 110.601 -1.0 . . . . 0.0 110.601 -179.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -82.14 138.46 34.74 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.504 0.669 . . . . 0.0 111.627 -179.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . 0.683 HD21 ' H ' ' A' ' 187' ' ' CYS . 32.1 p30 -141.47 161.0 38.98 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.14 -0.937 . . . . 0.0 110.388 179.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.445 ' O ' ' CB ' ' A' ' 129' ' ' SER . 70.7 mtm -124.28 1.19 8.43 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.575 178.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.445 ' CB ' ' O ' ' A' ' 128' ' ' MET . 0.2 OUTLIER 76.93 12.37 2.31 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.764 179.361 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.775 ' O ' HG12 ' A' ' 133' ' ' VAL . 9.3 ptpt -115.21 119.54 36.71 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.465 0.65 . . . . 0.0 112.295 -179.254 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.536 ' O ' ' O ' ' A' ' 130' ' ' LYS . 74.7 mmtt -29.07 154.73 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.893 -1.048 . . . . 0.0 111.611 179.453 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 75.34 -15.09 4.64 Favored Glycine 0 CA--C 1.529 0.94 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.964 179.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.775 HG12 ' O ' ' A' ' 130' ' ' LYS . 9.8 p -91.27 153.8 3.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 C-N-CA 120.371 -0.532 . . . . 0.0 109.785 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.782 HD23 ' N ' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -70.69 144.47 51.02 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 113.97 1.1 . . . . 0.0 113.97 -177.396 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.659 ' CG ' HD12 ' A' ' 138' ' ' ILE . 3.9 m-85 68.7 -0.94 2.14 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 113.67 -1.605 . . . . 0.0 113.598 178.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 6.7 t -69.4 -39.43 77.94 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 179.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -89.36 -6.99 56.16 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.355 0.598 . . . . 0.0 111.252 -178.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.659 HD12 ' CG ' ' A' ' 135' ' ' PHE . 8.0 mt -62.86 -42.32 95.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.433 179.329 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -63.38 -12.02 27.33 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 120.238 -0.585 . . . . 0.0 110.337 179.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 1.9 m -82.36 -6.19 59.1 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.325 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.406 HD12 HG23 ' A' ' 138' ' ' ILE . 81.4 mt -63.27 142.02 58.54 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.212 179.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -116.76 163.62 15.87 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.701 0.762 . . . . 0.0 111.81 -179.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -52.08 134.97 32.15 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.868 -1.06 . . . . 0.0 112.158 179.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.545 ' N ' ' O ' ' A' ' 160' ' ' VAL . . . 77.14 7.97 86.85 Favored Glycine 0 CA--C 1.527 0.818 0 CA-C-N 115.541 -0.754 . . . . 0.0 112.313 178.011 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 50.6 t0 -72.62 132.93 44.37 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 119.541 -0.864 . . . . 0.0 109.804 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -77.45 138.1 39.05 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 121.663 0.744 . . . . 0.0 111.716 -178.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.489 HD11 ' CG2' ' A' ' 160' ' ' VAL . 87.2 mt -133.42 135.4 56.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 114.958 -1.019 . . . . 0.0 108.342 178.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . 0.404 ' C ' HD22 ' A' ' 149' ' ' LEU . 69.9 m-85 -115.64 133.52 55.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.535 0.683 . . . . 0.0 112.689 -178.243 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.433 HD13 ' HA ' ' A' ' 149' ' ' LEU . 4.5 mm? -115.64 133.02 56.44 Favored 'General case' 0 C--O 1.225 -0.229 0 CA-C-N 115.158 -0.928 . . . . 0.0 108.872 177.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.592 ' CZ ' ' OE2' ' A' ' 155' ' ' GLU . 93.4 m-85 -116.39 114.0 23.68 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.315 -0.554 . . . . 0.0 111.138 179.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . 0.467 ' OD1' ' N ' ' A' ' 152' ' ' ASN . 54.1 t0 -93.29 172.3 8.38 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 177.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . 0.467 ' N ' ' OD1' ' A' ' 151' ' ' ASP . 68.6 m-20 -58.04 -26.85 63.0 Favored 'General case' 0 C--N 1.318 -0.764 0 C-N-CA 120.483 -0.487 . . . . 0.0 111.477 -177.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -115.08 -24.19 8.67 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 -178.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -146.86 177.73 8.89 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -176.159 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.592 ' OE2' ' CZ ' ' A' ' 150' ' ' TYR . 83.8 tt0 -126.99 138.0 53.19 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 114.644 -1.162 . . . . 0.0 110.323 178.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . 0.426 ' CD1' HG23 ' A' ' 206' ' ' THR . 92.0 m-85 -115.12 133.97 55.58 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 121.089 0.471 . . . . 0.0 111.676 -179.094 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -92.95 109.55 21.0 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.482 179.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -112.82 148.64 34.43 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.091 0.472 . . . . 0.0 111.168 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -125.23 124.46 41.74 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 121.331 0.586 . . . . 0.0 111.226 179.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.545 ' O ' ' N ' ' A' ' 144' ' ' GLY . 77.5 t -59.06 136.47 22.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.918 178.152 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 66.8 p -104.43 -24.81 13.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.09 0.472 . . . . 0.0 110.918 179.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 157.97 -167.7 34.35 Favored Glycine 0 CA--C 1.529 0.939 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.672 HG12 HG22 ' A' ' 199' ' ' VAL . 2.8 m -133.55 158.55 42.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.165 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 69.8 m -142.62 164.27 30.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.479 0.657 . . . . 0.0 111.731 -179.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -99.59 114.43 27.46 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.682 179.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 20.5 m -136.79 158.12 36.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.42 0.629 . . . . 0.0 111.582 -179.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -87.65 159.01 50.38 Favored Pre-proline 0 CA--C 1.536 0.423 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.996 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . 0.443 ' O ' HD12 ' B' ' 702' ' ' LEU . 37.2 Cg_endo -64.81 -10.54 25.41 Favored 'Trans proline' 0 N--CA 1.498 1.739 0 C-N-CA 122.861 2.374 . . . . 0.0 112.98 -179.416 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 45.5 p-10 -95.44 -8.24 35.99 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.723 ' O ' HD23 ' B' ' 702' ' ' LEU . 98.0 mttt -77.13 86.73 3.6 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 121.75 0.786 . . . . 0.0 112.256 -179.194 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' TRP . . . . . 0.606 ' O ' HG22 ' A' ' 174' ' ' VAL . 1.2 p-90 -80.47 -9.25 59.77 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.798 -1.092 . . . . 0.0 110.883 179.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -63.89 -32.11 73.52 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.818 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . 0.656 HG22 ' O ' ' A' ' 170' ' ' LYS . 35.0 m -63.13 -18.71 22.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-N 116.112 -0.495 . . . . 0.0 112.137 -179.152 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.613 HG13 HG23 ' A' ' 173' ' ' VAL . 34.8 m -106.47 -0.36 9.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -179.11 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.51 ' OE2' ' CE2' ' A' ' 171' ' ' TRP . 96.7 mt-10 -74.0 149.21 41.4 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 121.138 0.494 . . . . 0.0 111.51 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . 0.464 ' OD1' ' O ' ' A' ' 176' ' ' ASP . 46.8 p-10 -68.4 135.0 51.08 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.531 179.23 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 41.9 m80 -117.32 28.68 8.33 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 120.704 -0.398 . . . . 0.0 111.255 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 62.82 34.35 89.53 Favored Glycine 0 CA--C 1.531 1.031 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 179.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -152.69 163.63 39.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.842 0.353 . . . . 0.0 110.422 179.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -88.14 106.41 18.16 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 177.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . 0.435 ' HG2' ' N ' ' A' ' 182' ' ' ILE . 82.7 tt0 -136.18 161.32 36.06 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.421 0.629 . . . . 0.0 111.275 -178.511 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.435 ' N ' ' HG2' ' A' ' 181' ' ' GLU . 17.3 tt -130.11 137.18 57.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.463 -0.789 . . . . 0.0 108.947 178.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 85.0 m -131.03 128.02 39.45 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.076 0.465 . . . . 0.0 111.493 -179.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 68.4 mt -112.95 133.39 54.94 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.742 178.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 82.0 mt -109.48 120.11 60.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.23 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' THR . . . . . 0.52 ' OG1' ' ND2' ' A' ' 127' ' ' ASN . 8.8 t -133.28 147.74 51.92 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.709 179.601 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' CYS . . . . . 0.683 ' H ' HD21 ' A' ' 127' ' ' ASN . 2.1 m -87.65 142.31 27.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.863 -179.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.569 HG13 ' N ' ' A' ' 189' ' ' SER . 14.3 p -62.35 -44.7 99.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.888 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . 0.569 ' N ' HG13 ' A' ' 188' ' ' VAL . 24.9 t -170.69 148.72 3.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.122 0.487 . . . . 0.0 111.104 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . 0.408 HG22 ' O ' ' A' ' 190' ' ' VAL . 8.7 p -68.77 -14.86 19.02 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 CA-C-O 121.187 0.518 . . . . 0.0 110.493 179.47 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -95.61 -11.74 26.77 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.574 179.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -135.67 102.2 5.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.223 0.535 . . . . 0.0 110.87 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -102.99 11.25 37.57 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.845 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 12.3 t -60.8 -45.0 96.13 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.639 -178.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 64.7 pttt -142.59 159.82 41.49 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 120.946 0.403 . . . . 0.0 110.635 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . 0.48 ' NH1' ' SG ' ' A' ' 187' ' ' CYS . 94.5 mtt-85 -132.32 147.59 52.4 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 121.053 0.454 . . . . 0.0 111.451 -178.439 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -97.19 135.47 39.09 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 121.164 0.507 . . . . 0.0 111.413 179.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 38.9 t -120.53 129.46 75.56 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.914 179.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.672 HG22 HG12 ' A' ' 163' ' ' VAL . 54.1 t -100.12 133.27 43.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.527 -179.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -122.64 152.52 40.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.522 0.677 . . . . 0.0 111.584 -179.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -147.41 149.85 22.03 Favored Glycine 0 CA--C 1.532 1.107 0 N-CA-C 110.33 -1.108 . . . . 0.0 110.33 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -106.28 148.89 27.45 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.927 0.394 . . . . 0.0 111.007 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 62.4 tp -66.23 130.39 43.05 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 178.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 46.9 t -110.32 -24.19 4.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 C-N-CA 120.8 -0.36 . . . . 0.0 111.609 -178.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -178.47 173.74 46.08 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 111.164 -0.775 . . . . 0.0 111.164 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . 0.426 HG23 ' CD1' ' A' ' 156' ' ' TYR . 19.6 m -142.89 141.76 31.59 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.135 0.493 . . . . 0.0 110.254 179.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -141.43 114.55 8.66 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.262 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -64.74 148.1 51.81 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.829 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 55.8 mtmt -77.06 154.99 32.82 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.543 178.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 53.9 mtmt . . . . . 0 C--O 1.22 -0.479 0 CA-C-O 117.919 -1.039 . . . . 0.0 110.832 179.573 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 702' ' ' LEU . . . . . 0.723 HD23 ' O ' ' A' ' 170' ' ' LYS . 0.2 OUTLIER . . . . . 0 CA--C 1.537 0.476 0 CA-C-O 121.505 0.669 . . . . 20.0 111.046 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 703' ' ' PRO . . . . . 0.576 ' HG2' HG22 ' A' ' 110' ' ' VAL . 3.1 Cg_exo -73.72 -165.43 0.25 Allowed 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 123.576 2.851 . . . . 20.0 112.898 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 704' ' ' ALA . . . . . 0.55 ' O ' ' O ' ' B' ' 703' ' ' PRO . . . . . . . . 0 CA--C 1.537 0.47 0 CA-C-N 115.008 -0.996 . . . . 20.0 113.081 -179.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.239 0 CA-C-O 121.145 0.497 . . . . 0.0 110.828 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 92.4 p -85.25 1.49 48.03 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.242 -178.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.437 ' HG2' HH21 ' A' ' 196' ' ' ARG . 99.5 mttt -99.05 17.54 19.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.069 0.462 . . . . 0.0 111.602 -179.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 14.7 mm -55.74 136.62 18.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 122.449 1.119 . . . . 0.0 112.231 -177.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -80.12 126.23 30.81 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 113.346 -1.752 . . . . 0.0 109.894 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.632 HE22 HD21 ' A' ' 134' ' ' LEU . 2.1 tt0 -78.17 123.17 86.03 Favored Pre-proline 0 CA--C 1.533 0.322 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -44.0 170.38 0.02 OUTLIER 'Trans proline' 0 C--N 1.313 -1.341 0 C-N-CA 121.886 1.724 . . . . 0.0 112.318 -179.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.463 ' O ' HG23 ' A' ' 69' ' ' VAL . 91.7 m-20 -52.18 163.16 0.4 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.15 -179.321 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 55.0 tp -62.58 -44.84 95.32 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.786 -177.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -60.43 -38.51 84.31 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.226 -0.589 . . . . 0.0 111.603 -178.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 66.3 tt0 -60.85 -25.17 66.45 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.14 -0.624 . . . . 0.0 110.027 179.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.634 HG13 ' HB3' ' A' ' 104' ' ' LEU . 36.1 t -77.83 -47.15 25.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.633 0.73 . . . . 0.0 109.774 178.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -73.43 -8.53 56.26 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 114.86 -1.064 . . . . 0.0 110.811 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -103.62 -16.95 15.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.502 0.668 . . . . 0.0 110.255 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -69.4 142.7 53.85 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.898 -179.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 33.6 t -58.56 97.52 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.564 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -67.79 136.15 53.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.109 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.446 ' OD2' ' CD ' ' A' ' 78' ' ' GLN . 37.6 t0 -103.55 79.11 1.65 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.334 178.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -71.76 -35.37 70.05 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.471 0.653 . . . . 0.0 111.962 179.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 43.8 mmtt -67.95 -31.12 70.63 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.058 -0.973 . . . . 0.0 112.781 -174.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.446 ' CD ' ' OD2' ' A' ' 75' ' ' ASP . 86.4 mt-30 -87.34 6.3 34.29 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.219 -0.593 . . . . 0.0 111.621 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 59.3 t -78.42 130.13 36.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 120.434 -0.506 . . . . 0.0 109.661 179.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.649 HD13 ' HE3' ' A' ' 96' ' ' LYS . 43.4 pt -110.3 -4.71 10.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.778 -179.271 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -163.56 166.0 37.07 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 120.499 -0.858 . . . . 0.0 111.605 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 72.0 ttp85 -137.66 141.29 41.15 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 121.095 0.474 . . . . 0.0 111.191 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.55 HG22 ' O ' ' A' ' 92' ' ' LEU . 19.9 tt -105.08 141.43 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.984 179.23 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 7.9 t -137.63 131.79 32.05 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 121.4 0.619 . . . . 0.0 112.219 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.624 ' CG2' HG22 ' A' ' 88' ' ' VAL . 87.2 mt -136.71 88.05 19.65 Favored Pre-proline 0 CA--C 1.537 0.465 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.805 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -55.4 -32.01 80.01 Favored 'Trans proline' 0 N--CA 1.5 1.881 0 C-N-CA 123.155 2.57 . . . . 0.0 112.571 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 67.3 m -54.3 -42.71 70.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.26 0.552 . . . . 0.0 110.678 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.624 HG22 ' CG2' ' A' ' 85' ' ' ILE . 19.7 m -112.43 6.84 8.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.371 179.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 50.65 52.25 15.27 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.879 0.847 . . . . 0.0 110.187 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 52.8 tp -118.32 133.85 55.54 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.185 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -145.05 126.96 15.43 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.734 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.55 ' O ' HG22 ' A' ' 83' ' ' ILE . 80.1 mt -149.06 151.01 33.55 Favored Pre-proline 0 CA--C 1.538 0.497 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.493 -178.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -76.53 148.82 29.95 Favored 'Trans proline' 0 N--CA 1.496 1.66 0 C-N-CA 122.839 2.359 . . . . 0.0 111.804 178.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.55 ' C ' HD12 ' A' ' 95' ' ' LEU . 73.8 t -97.3 117.97 42.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-O 121.047 0.451 . . . . 0.0 111.579 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.563 ' N ' HD12 ' A' ' 95' ' ' LEU . 9.4 mp -102.74 134.1 46.68 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.889 179.437 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.649 ' HE3' HD13 ' A' ' 80' ' ' ILE . 98.1 mttt -58.55 -83.4 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 121.26 0.552 . . . . 0.0 111.934 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 18.7 m -61.33 138.31 58.25 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.527 0.679 . . . . 0.0 111.666 -178.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 3.1 m -95.4 70.62 3.15 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.17 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 8.7 p -88.54 166.65 14.02 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 177.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -59.13 -40.61 85.99 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 119.931 -0.707 . . . . 0.0 109.994 179.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -65.49 -42.18 92.45 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 121.321 0.581 . . . . 0.0 110.709 178.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -64.36 -37.05 86.13 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.477 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.493 HD13 ' CB ' ' B' ' 704' ' ' ALA . 84.7 mt -62.93 -18.02 62.57 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.857 -179.488 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.634 ' HB3' HG13 ' A' ' 69' ' ' VAL . 98.0 mt -74.73 -18.0 60.56 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.846 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 50.5 m -74.36 -4.9 39.19 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-O 121.728 0.775 . . . . 0.0 109.366 179.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 86.48 -19.78 26.26 Favored Glycine 0 CA--C 1.532 1.134 0 CA-C-N 114.826 -1.079 . . . . 0.0 112.803 178.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -145.91 123.98 12.12 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 119.585 -0.846 . . . . 0.0 112.472 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -145.9 141.55 27.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.362 -0.836 . . . . 0.0 109.968 178.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.435 ' OG1' ' O ' ' A' ' 96' ' ' LYS . 20.5 p -65.9 136.39 56.05 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.135 -0.626 . . . . 0.0 109.583 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.538 HG13 ' CG ' ' B' ' 703' ' ' PRO . 76.1 t -76.78 -46.12 30.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.928 -179.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.406 ' O ' ' HG2' ' A' ' 114' ' ' GLN . 43.3 mtpt -99.09 142.82 30.08 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 122.013 0.911 . . . . 0.0 112.036 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -67.42 -36.09 80.57 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.594 -1.184 . . . . 0.0 111.956 -179.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 72.8 m-80 -86.76 22.18 2.02 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 114.203 1.186 . . . . 0.0 114.203 -177.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . 0.438 ' OE1' ' O ' ' A' ' 120' ' ' ASN . 94.5 mm-40 -78.37 137.28 37.94 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 121.797 -0.564 . . . . 0.0 112.312 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 61.5 t -128.18 123.96 61.4 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.868 179.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 55.6 mtt -58.55 130.91 49.07 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 121.133 0.492 . . . . 0.0 111.924 179.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 78.23 -0.51 73.87 Favored Glycine 0 CA--C 1.531 1.051 0 CA-C-N 116.04 -0.527 . . . . 0.0 112.789 178.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -138.38 124.99 20.79 Favored 'General case' 0 C--N 1.329 -0.317 0 O-C-N 122.047 -0.678 . . . . 0.0 111.1 -179.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 76.12 -165.31 54.01 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 110.337 -1.105 . . . . 0.0 110.337 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.438 ' O ' ' OE1' ' A' ' 114' ' ' GLN . 59.0 t-20 -91.73 105.34 17.65 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.041 0.448 . . . . 0.0 109.864 179.414 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.775 ' CE2' HD11 ' A' ' 123' ' ' LEU . 7.4 t80 -85.43 144.91 27.71 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 179.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.905 ' C ' HD12 ' A' ' 123' ' ' LEU . . . -146.8 145.61 29.97 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 119.842 -0.743 . . . . 0.0 111.944 -178.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.905 HD12 ' C ' ' A' ' 122' ' ' ALA . 7.4 mp -139.61 145.25 38.3 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.918 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -110.23 135.73 50.53 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 178.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -136.72 148.99 20.02 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 110.294 -1.122 . . . . 0.0 110.294 -179.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . 0.759 ' O ' HD23 ' A' ' 134' ' ' LEU . 21.6 m-70 -86.79 142.52 28.05 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.616 0.722 . . . . 0.0 111.935 -179.157 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 49.5 t-20 -131.51 120.79 23.44 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.142 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.606 ' HB2' HG21 ' A' ' 133' ' ' VAL . 62.9 mtt -94.4 -2.77 51.42 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.227 0.537 . . . . 0.0 110.662 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.466 ' CB ' ' O ' ' A' ' 128' ' ' MET . 0.7 OUTLIER 77.43 3.97 3.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.318 179.123 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.862 ' O ' HG12 ' A' ' 133' ' ' VAL . 61.8 pttt -118.16 130.72 56.27 Favored 'General case' 0 C--O 1.222 -0.357 0 CA-C-O 121.623 0.725 . . . . 0.0 112.817 -178.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.473 ' O ' ' O ' ' A' ' 130' ' ' LYS . 74.9 mmtt -41.12 163.66 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.354 0.597 . . . . 0.0 109.616 179.026 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 74.93 -22.51 1.47 Allowed Glycine 0 CA--C 1.53 1.007 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.862 HG12 ' O ' ' A' ' 130' ' ' LYS . 3.7 p -90.25 156.84 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 119.776 -0.77 . . . . 0.0 110.746 -179.36 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.88 ' H ' HD13 ' A' ' 134' ' ' LEU . 0.0 OUTLIER -70.79 146.25 49.87 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 115.023 1.49 . . . . 0.0 115.023 -176.803 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 59.68 7.77 1.14 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 112.504 -2.135 . . . . 0.0 114.153 177.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 5.4 t -69.9 -33.27 71.97 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 119.99 -0.684 . . . . 0.0 112.371 179.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -89.52 0.65 56.75 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 -178.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 2.1 pp -58.2 -31.52 42.29 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 C-N-CA 119.874 -0.73 . . . . 0.0 110.965 -179.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -65.1 -13.89 59.16 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.962 0.411 . . . . 0.0 110.876 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 49.3 m -81.52 -4.0 54.74 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.152 -179.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 92.9 mt -64.57 142.12 58.54 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -120.52 156.01 32.44 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.223 0.535 . . . . 0.0 110.185 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -49.63 130.34 20.58 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.848 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 160' ' ' VAL . . . 80.76 8.46 87.47 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 120.837 -0.697 . . . . 0.0 111.914 178.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.498 ' OD1' ' N ' ' A' ' 146' ' ' LYS . 63.8 t0 -71.77 133.95 45.88 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 119.737 -0.785 . . . . 0.0 109.928 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.498 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 73.2 mmtt -78.97 140.52 38.0 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.764 0.792 . . . . 0.0 112.749 -178.235 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.434 HD11 ' CG2' ' A' ' 160' ' ' VAL . 96.3 mt -134.35 134.32 54.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 114.718 -1.128 . . . . 0.0 108.014 178.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . 0.585 ' C ' HD22 ' A' ' 149' ' ' LEU . 88.1 m-85 -115.45 133.7 55.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.648 0.737 . . . . 0.0 112.706 -178.217 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.585 HD22 ' C ' ' A' ' 148' ' ' TYR . 4.5 mm? -114.7 132.64 56.35 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.97 -1.014 . . . . 0.0 108.397 177.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.494 ' CZ ' ' OE2' ' A' ' 155' ' ' GLU . 94.1 m-85 -115.51 110.13 18.82 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 119.985 -0.686 . . . . 0.0 111.673 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . 0.57 ' OD1' ' N ' ' A' ' 152' ' ' ASN . 62.3 t0 -88.3 165.67 14.84 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 177.015 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . 0.57 ' N ' ' OD1' ' A' ' 151' ' ' ASP . 36.5 p-10 -58.18 -20.35 40.49 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 119.466 -0.894 . . . . 0.0 111.219 -178.21 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -115.03 -27.88 7.19 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 -178.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -147.52 176.33 10.14 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 118.963 -1.095 . . . . 0.0 113.455 -176.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.494 ' OE2' ' CZ ' ' A' ' 150' ' ' TYR . 83.8 tt0 -125.02 133.48 52.95 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 114.604 -1.18 . . . . 0.0 110.141 178.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . 0.47 ' CD1' HG23 ' A' ' 206' ' ' THR . 86.1 m-85 -107.94 133.55 52.12 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 120.967 0.413 . . . . 0.0 111.271 -179.557 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -91.7 110.11 21.44 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.352 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -113.36 146.47 39.41 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.015 0.436 . . . . 0.0 111.137 179.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -126.12 125.68 42.92 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 121.133 0.492 . . . . 0.0 111.132 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.537 ' O ' ' N ' ' A' ' 144' ' ' GLY . 83.0 t -58.27 133.63 23.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.667 178.425 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 70.5 p -115.49 11.3 15.91 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 139.6 171.6 12.36 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 119.972 -1.109 . . . . 0.0 112.923 178.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.63 HG22 HG22 ' A' ' 199' ' ' VAL . 42.1 t -125.63 135.43 63.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 114.305 -0.948 . . . . 0.0 108.874 178.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 30.8 m -131.98 162.32 30.99 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.504 0.668 . . . . 0.0 111.85 -179.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . 0.427 ' HG2' ' CE2' ' A' ' 197' ' ' TYR . 99.1 mt-10 -108.22 121.19 44.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.606 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 29.1 m -136.38 157.45 37.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.431 0.634 . . . . 0.0 111.349 -179.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.26 159.39 70.34 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.755 179.169 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . 0.51 ' O ' ' CB ' ' B' ' 702' ' ' LEU . 37.8 Cg_endo -65.66 -15.55 49.79 Favored 'Trans proline' 0 C--N 1.302 -1.891 0 C-N-CA 123.114 2.543 . . . . 0.0 113.227 -179.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 50.8 p-10 -92.26 -3.78 54.99 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 119.808 -0.757 . . . . 0.0 111.842 179.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.801 ' O ' HG22 ' A' ' 173' ' ' VAL . 74.7 mmtt -74.43 80.45 1.91 Allowed 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.261 -0.575 . . . . 0.0 110.634 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' TRP . . . . . 0.466 ' CD1' ' N ' ' A' ' 171' ' ' TRP . 33.8 m0 -69.17 -17.63 63.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.87 179.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -61.18 -30.52 70.46 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.73 -178.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . 0.801 HG22 ' O ' ' A' ' 170' ' ' LYS . 30.8 m -63.27 -15.88 16.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.188 0.518 . . . . 0.0 111.008 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.701 HG23 HG23 ' A' ' 173' ' ' VAL . 78.3 t -111.16 -11.05 11.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.131 -179.123 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -73.46 152.53 40.7 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.201 0.524 . . . . 0.0 111.224 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . 0.523 ' OD1' ' O ' ' A' ' 176' ' ' ASP . 49.5 p30 -70.19 136.74 50.33 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 121.347 0.594 . . . . 0.0 111.41 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 77.9 m80 -107.4 -18.89 13.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.469 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 102.49 37.55 3.24 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -178.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 11.6 ptmt -157.38 170.21 22.97 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.089 -0.556 . . . . 0.0 111.063 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -87.79 100.28 12.73 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 177.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . 0.446 ' HG2' ' N ' ' A' ' 182' ' ' ILE . 79.4 tt0 -136.32 161.22 36.4 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.403 0.62 . . . . 0.0 111.272 -179.119 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.446 ' N ' ' HG2' ' A' ' 181' ' ' GLU . 20.7 tt -129.6 138.35 54.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.249 -0.887 . . . . 0.0 108.782 178.404 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . 0.542 ' C ' HD12 ' A' ' 184' ' ' LEU . 97.8 m -128.04 126.02 40.47 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.199 0.523 . . . . 0.0 112.17 -178.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.585 ' N ' HD12 ' A' ' 184' ' ' LEU . 10.2 mp -107.94 127.41 53.73 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.119 178.341 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.58 HD13 HD21 ' B' ' 702' ' ' LEU . 93.3 mt -114.29 123.98 70.49 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-O 121.362 0.601 . . . . 0.0 111.545 -178.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -142.54 161.55 37.77 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.597 179.425 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -98.63 139.98 33.54 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 178.172 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.602 HG13 ' N ' ' A' ' 189' ' ' SER . 7.4 p -59.76 -47.26 91.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.807 -178.501 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . 0.602 ' N ' HG13 ' A' ' 188' ' ' VAL . 23.1 p -160.52 157.85 28.2 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.1 0.476 . . . . 0.0 110.761 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 27.8 m -76.87 -9.21 12.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.212 0.53 . . . . 0.0 110.24 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -96.95 -18.95 19.14 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.978 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -136.8 98.79 3.87 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.09 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -101.44 11.35 39.27 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 121.131 0.491 . . . . 0.0 110.902 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 47.1 t -59.92 -43.25 95.01 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.476 -179.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 51.6 mtmt -132.06 146.3 51.97 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 121.185 0.517 . . . . 0.0 111.211 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . 0.437 HH21 ' HG2' ' A' ' 60' ' ' LYS . 99.9 mtt180 -121.32 145.41 47.91 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.926 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . 0.427 ' CE2' ' HG2' ' A' ' 165' ' ' GLU . 36.4 m-85 -94.87 140.79 29.43 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.727 179.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 55.8 t -130.85 132.35 64.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.298 0.57 . . . . 0.0 111.041 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.63 HG22 HG22 ' A' ' 163' ' ' VAL . 47.8 t -100.19 133.93 41.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.07 179.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -108.07 132.84 53.14 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.266 0.555 . . . . 0.0 110.93 -179.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -132.2 140.59 11.95 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . 0.558 ' OD1' ' N ' ' A' ' 203' ' ' LEU . 67.9 t0 -111.5 138.49 47.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.123 0.487 . . . . 0.0 111.151 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . 0.558 ' N ' ' OD1' ' A' ' 202' ' ' ASP . 53.8 tp -62.69 128.9 38.1 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 1.3 p -114.38 -19.94 6.39 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 120.848 -0.341 . . . . 0.0 111.548 -178.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -175.87 170.94 44.0 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 120.768 -0.729 . . . . 0.0 111.858 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . 0.47 HG23 ' CD1' ' A' ' 156' ' ' TYR . 18.2 m -143.71 139.68 29.62 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 179.314 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -144.81 120.23 10.31 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.43 0.633 . . . . 0.0 111.991 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -64.28 142.91 58.25 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.388 -179.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -80.75 110.48 16.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.68 179.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 99.4 mttt . . . . . 0 C--O 1.221 -0.42 0 CA-C-O 117.88 -1.057 . . . . 0.0 110.994 -179.757 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 702' ' ' LEU . . . . . 0.58 HD21 HD13 ' A' ' 185' ' ' ILE . 2.0 mt . . . . . 0 CA--C 1.54 0.573 0 CA-C-O 120.672 0.272 . . . . 20.0 110.726 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 703' ' ' PRO . . . . . 0.581 ' O ' ' O ' ' B' ' 704' ' ' ALA . 4.2 Cg_exo -67.17 -169.02 0.18 Allowed 'Trans proline' 0 N--CA 1.489 1.25 0 C-N-CA 122.527 2.151 . . . . 20.0 114.006 -179.287 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 704' ' ' ALA . . . . . 0.581 ' O ' ' O ' ' B' ' 703' ' ' PRO . . . . . . . . 0 N--CA 1.464 0.271 0 CA-C-N 113.798 -1.546 . . . . 20.0 113.792 -179.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.249 0 CA-C-O 121.097 0.475 . . . . 0.0 111.356 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.51 ' CB ' ' O ' ' B' ' 702' ' ' LEU . 5.5 p -81.28 20.06 0.89 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.356 0.598 . . . . 0.0 111.158 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -102.64 18.48 21.22 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.205 -179.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.9 mt -56.26 139.5 15.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 122.415 1.103 . . . . 0.0 113.405 -176.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -77.42 130.69 37.39 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 113.525 -1.671 . . . . 0.0 108.865 178.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.617 ' H ' ' CD ' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -81.28 154.9 72.14 Favored Pre-proline 0 C--N 1.32 -0.688 0 C-N-CA 120.364 -0.534 . . . . 0.0 110.513 -179.139 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -72.2 166.48 29.56 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 123.249 2.632 . . . . 0.0 113.34 -178.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.806 ' O ' HG23 ' A' ' 69' ' ' VAL . 87.5 m-20 -52.62 164.45 0.35 Allowed 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 120.975 0.417 . . . . 0.0 110.491 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 56.5 tp -64.27 -47.05 81.05 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.321 -179.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.412 ' O ' ' N ' ' A' ' 71' ' ' ASN . . . -62.65 -36.46 82.92 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 119.863 -0.735 . . . . 0.0 110.773 -178.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -62.46 -28.81 70.07 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.526 0.679 . . . . 0.0 109.223 178.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.806 HG23 ' O ' ' A' ' 65' ' ' ASP . 46.7 t -76.7 -44.38 33.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.862 178.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -79.38 -8.88 59.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.0 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.412 ' N ' ' O ' ' A' ' 67' ' ' ALA . 10.3 m120 -102.82 -13.28 17.06 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.397 0.618 . . . . 0.0 110.177 179.34 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.402 ' CB ' HD13 ' A' ' 104' ' ' LEU . . . -68.91 145.44 53.66 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.172 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 32.9 m -57.85 110.17 0.86 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.784 -179.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.719 HD13 ' C ' ' A' ' 74' ' ' LEU . 3.0 tm? -70.88 119.34 14.86 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.338 0.59 . . . . 0.0 110.535 -179.611 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.608 ' N ' HD13 ' A' ' 74' ' ' LEU . 83.1 m-20 -94.92 78.76 3.62 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.481 -0.782 . . . . 0.0 109.812 179.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.577 ' O ' HG12 ' A' ' 79' ' ' VAL . 82.0 tttt -65.07 -32.85 74.76 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.267 -0.879 . . . . 0.0 112.055 -179.615 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 36.9 mmtt -70.15 -10.16 57.93 Favored 'General case' 0 C--N 1.314 -0.955 0 C-N-CA 120.401 -0.52 . . . . 0.0 110.509 -177.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -96.65 -3.8 42.11 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.474 178.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.577 HG12 ' O ' ' A' ' 76' ' ' LYS . 3.1 p -81.39 130.14 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-O 121.315 0.579 . . . . 0.0 111.386 -179.368 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 10.0 pt -108.66 -6.75 10.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.982 179.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -174.15 -180.0 45.13 Favored Glycine 0 CA--C 1.53 1.012 0 N-CA-C 111.326 -0.71 . . . . 0.0 111.326 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.411 ' HG2' ' N ' ' A' ' 83' ' ' ILE . 61.4 ttp180 -136.74 156.88 47.93 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.415 HG22 ' O ' ' A' ' 92' ' ' LEU . 19.5 tt -124.2 141.96 42.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.113 0.482 . . . . 0.0 110.362 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 74.5 m -135.5 131.05 35.58 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 121.66 0.743 . . . . 0.0 112.332 -178.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.546 ' CG2' HG22 ' A' ' 88' ' ' VAL . 92.5 mt -137.33 86.06 20.4 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.082 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -57.48 -30.12 87.11 Favored 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 122.769 2.312 . . . . 0.0 113.063 -179.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 70.6 m -52.9 -40.67 63.72 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 121.22 0.533 . . . . 0.0 110.457 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.546 HG22 ' CG2' ' A' ' 85' ' ' ILE . 26.7 m -113.58 8.09 7.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.346 179.011 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 52.59 54.45 10.59 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.501 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 60.1 tp -119.99 135.29 54.97 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.629 0.728 . . . . 0.0 111.337 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -146.31 124.21 12.0 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.186 -0.915 . . . . 0.0 109.224 179.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.415 ' O ' HG22 ' A' ' 83' ' ' ILE . 82.3 mt -149.36 148.07 25.26 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.716 -178.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -73.04 146.24 41.08 Favored 'Trans proline' 0 C--N 1.313 -1.313 0 C-N-CA 122.176 1.918 . . . . 0.0 111.318 179.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.503 ' C ' HD12 ' A' ' 95' ' ' LEU . 43.8 t -96.55 122.11 47.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.28 0.562 . . . . 0.0 111.081 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.549 ' N ' HD12 ' A' ' 95' ' ' LEU . 11.1 mp -99.68 134.73 42.14 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.199 179.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -62.63 -79.03 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.499 -177.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 7.5 m -66.98 145.01 55.86 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 121.041 0.448 . . . . 0.0 111.611 -179.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 7.2 t -95.43 68.14 2.97 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-O 121.186 0.517 . . . . 0.0 111.51 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.445 HG22 ' N ' ' A' ' 100' ' ' GLU . 12.9 m -88.54 166.99 13.79 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 178.009 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.445 ' N ' HG22 ' A' ' 99' ' ' THR . 72.0 mm-40 -60.99 -43.9 98.19 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.022 -0.671 . . . . 0.0 109.881 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -65.14 -38.38 90.43 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.483 0.659 . . . . 0.0 110.253 178.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.421 ' HB2' ' H ' ' A' ' 99' ' ' THR . 92.3 m-20 -63.82 -39.27 93.83 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.057 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.409 HD13 ' CB ' ' B' ' 704' ' ' ALA . 78.2 mt -62.92 -12.01 22.41 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.015 -0.539 . . . . 0.0 112.001 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.432 ' O ' ' CG1' ' A' ' 69' ' ' VAL . 96.9 mt -73.28 -22.6 60.33 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 121.052 0.454 . . . . 0.0 111.15 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 95.7 p -73.84 -3.69 30.3 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.349 0.595 . . . . 0.0 110.498 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 86.85 -18.87 32.67 Favored Glycine 0 CA--C 1.531 1.06 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.509 178.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -145.62 127.07 15.0 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 119.941 -0.704 . . . . 0.0 112.103 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -147.74 142.8 27.05 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.551 178.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.572 ' HA ' HD23 ' A' ' 123' ' ' LEU . 3.4 p -73.6 140.79 46.45 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.271 0.557 . . . . 0.0 111.65 -179.27 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.746 HG22 ' HG2' ' B' ' 703' ' ' PRO . 58.1 t -78.64 -52.37 15.64 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.973 -179.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.778 ' H ' ' NE2' ' A' ' 114' ' ' GLN . 49.0 mtmt -100.32 136.67 39.85 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 122.221 1.01 . . . . 0.0 112.526 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -66.16 -31.98 73.15 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 113.978 -1.465 . . . . 0.0 112.627 -178.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 71.5 m-80 -85.33 13.7 6.24 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 -177.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . 0.778 ' NE2' ' H ' ' A' ' 111' ' ' LYS . 32.7 mt-30 -79.87 143.5 34.26 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.383 0.611 . . . . 0.0 112.363 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 65.1 t -123.69 123.42 67.12 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.183 178.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' MET . . . . . 0.445 ' CG ' ' CZ ' ' A' ' 121' ' ' TYR . 98.9 mtp -57.65 133.82 55.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.195 0.521 . . . . 0.0 111.509 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.496 ' O ' ' OD2' ' A' ' 180' ' ' ASP . . . 81.69 -2.45 82.92 Favored Glycine 0 CA--C 1.53 0.969 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.55 179.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -142.87 135.81 28.06 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.213 0.53 . . . . 0.0 111.263 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 72.47 -166.77 53.82 Favored Glycine 0 CA--C 1.529 0.925 0 N-CA-C 110.495 -1.042 . . . . 0.0 110.495 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 64.8 t-20 -92.24 103.49 15.95 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.075 0.464 . . . . 0.0 110.676 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.445 ' CZ ' ' CG ' ' A' ' 116' ' ' MET . 2.5 t80 -88.64 99.04 12.02 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 121.118 0.485 . . . . 0.0 110.1 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.741 ' CB ' HG13 ' A' ' 174' ' ' VAL . . . -91.51 138.43 31.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.091 0.472 . . . . 0.0 111.536 -179.495 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.572 HD23 ' HA ' ' A' ' 109' ' ' THR . 46.0 mt -134.33 139.59 45.78 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.415 -0.514 . . . . 0.0 110.913 179.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -107.89 133.24 52.53 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.655 179.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -134.3 142.98 14.53 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . 0.517 ' O ' ' O ' ' A' ' 134' ' ' LEU . 23.2 m-70 -78.4 142.01 37.92 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.321 0.581 . . . . 0.0 112.39 -178.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . 0.792 ' ND2' ' H ' ' A' ' 129' ' ' SER . 3.0 t-20 -138.76 121.34 16.23 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.816 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.551 ' HB2' HG21 ' A' ' 133' ' ' VAL . 63.4 mtt -97.81 -4.43 36.87 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.744 -179.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.792 ' H ' ' ND2' ' A' ' 127' ' ' ASN . 0.9 OUTLIER 79.14 4.16 2.32 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.967 179.281 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.861 ' O ' HG12 ' A' ' 133' ' ' VAL . 62.8 pttt -111.99 133.62 54.05 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 122.041 0.924 . . . . 0.0 113.206 -178.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.426 ' C ' ' O ' ' A' ' 130' ' ' LYS . 28.6 tptt -40.26 152.69 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.742 178.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 75.08 -14.75 4.57 Favored Glycine 0 CA--C 1.535 1.337 0 C-N-CA 121.077 -0.583 . . . . 0.0 112.71 178.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.861 HG12 ' O ' ' A' ' 130' ' ' LYS . 6.3 p -88.55 172.47 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 119.331 -0.947 . . . . 0.0 111.044 -179.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.671 ' H ' HG22 ' A' ' 133' ' ' VAL . 3.8 mm? -68.64 133.69 48.83 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 115.495 1.665 . . . . 0.0 115.495 -176.363 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 56.84 12.49 1.18 Allowed 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 113.859 -1.519 . . . . 0.0 114.718 176.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 2.8 p -69.21 -32.35 71.54 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 121.64 -0.663 . . . . 0.0 112.784 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -89.21 2.15 54.66 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 -178.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.582 HD11 HG21 ' A' ' 186' ' ' THR . 1.8 pp -63.45 -30.21 49.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 C-N-CA 120.206 -0.597 . . . . 0.0 111.046 -179.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -67.4 -11.06 56.82 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.94 0.4 . . . . 0.0 110.64 -179.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 56.8 m -82.45 -6.15 59.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.147 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 97.8 mt -65.33 143.83 57.5 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 121.165 0.507 . . . . 0.0 111.411 -179.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.417 ' HG2' ' N ' ' A' ' 143' ' ' LYS . 88.8 tttt -119.82 157.13 29.29 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 121.249 0.547 . . . . 0.0 111.091 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . 0.417 ' N ' ' HG2' ' A' ' 142' ' ' LYS . 88.7 tttt -49.76 136.08 18.24 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.178 179.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.498 ' N ' ' O ' ' A' ' 160' ' ' VAL . . . 77.24 8.05 86.93 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 120.823 -0.703 . . . . 0.0 111.953 178.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -70.79 131.19 43.44 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 119.68 -0.808 . . . . 0.0 110.072 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -77.87 140.32 39.33 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 121.551 0.691 . . . . 0.0 111.926 -178.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.457 HD11 ' CG2' ' A' ' 160' ' ' VAL . 98.4 mt -139.08 140.58 38.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-N 114.851 -1.068 . . . . 0.0 108.711 178.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . 0.715 ' C ' HD23 ' A' ' 149' ' ' LEU . 18.1 m-85 -126.07 139.52 53.33 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 119.748 -0.781 . . . . 0.0 112.794 -178.419 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.715 HD23 ' C ' ' A' ' 148' ' ' TYR . 0.4 OUTLIER -117.97 134.9 54.52 Favored 'General case' 0 C--O 1.226 -0.164 0 CA-C-N 114.983 -1.008 . . . . 0.0 108.633 178.245 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.558 ' CE2' ' CD ' ' A' ' 155' ' ' GLU . 92.4 m-85 -110.53 113.73 26.59 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.319 -0.552 . . . . 0.0 110.938 179.288 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . 0.503 ' OD1' ' N ' ' A' ' 152' ' ' ASN . 54.7 t0 -90.5 167.88 12.26 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 177.354 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . 0.503 ' N ' ' OD1' ' A' ' 151' ' ' ASP . 71.8 m-20 -55.53 -24.47 32.16 Favored 'General case' 0 C--N 1.317 -0.805 0 C-N-CA 119.971 -0.691 . . . . 0.0 111.28 -177.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -112.23 -26.99 8.51 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 114.243 1.201 . . . . 0.0 114.243 -178.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -149.82 -177.02 5.65 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 118.764 -1.174 . . . . 0.0 114.018 -176.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.558 ' CD ' ' CE2' ' A' ' 150' ' ' TYR . 84.6 tt0 -129.51 141.66 50.94 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 114.582 -1.19 . . . . 0.0 110.467 179.242 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -117.68 138.07 52.24 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 120.829 0.347 . . . . 0.0 111.75 -179.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . 0.473 ' O ' HG12 ' A' ' 204' ' ' VAL . 96.6 mt-10 -94.44 111.93 23.69 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.279 179.319 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -112.56 148.23 34.98 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.053 0.454 . . . . 0.0 111.696 179.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -123.64 122.65 38.68 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 121.145 0.498 . . . . 0.0 111.456 179.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.498 ' O ' ' N ' ' A' ' 144' ' ' GLY . 95.4 t -58.84 135.24 23.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 177.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 80.9 p -106.32 -26.51 11.47 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 120.525 -0.47 . . . . 0.0 111.413 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 161.39 -169.65 36.97 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 120.481 -0.866 . . . . 0.0 111.89 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.863 HG12 HG22 ' A' ' 199' ' ' VAL . 28.5 m -135.39 162.6 37.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.017 0.437 . . . . 0.0 110.177 179.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 81.7 p -148.95 164.96 33.02 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.345 0.593 . . . . 0.0 111.324 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -104.79 115.76 30.86 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.062 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.44 HG21 HG21 ' A' ' 198' ' ' VAL . 24.4 m -137.09 160.95 36.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.48 0.657 . . . . 0.0 111.204 -179.265 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . 0.502 ' OG1' ' OD1' ' A' ' 169' ' ' ASP . 0.1 OUTLIER -88.95 160.82 42.74 Favored Pre-proline 0 CA--C 1.539 0.533 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.933 179.364 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . 0.551 ' O ' ' CB ' ' B' ' 702' ' ' LEU . 55.4 Cg_endo -67.69 -15.81 45.23 Favored 'Trans proline' 0 N--CA 1.5 1.909 0 C-N-CA 123.074 2.516 . . . . 0.0 114.031 -178.346 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . 0.502 ' OD1' ' OG1' ' A' ' 167' ' ' THR . 38.4 p-10 -91.06 -2.55 57.62 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 119.58 -0.848 . . . . 0.0 110.803 179.483 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.907 ' O ' HG22 ' A' ' 173' ' ' VAL . 73.0 mmtt -73.53 69.6 1.24 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.445 0.641 . . . . 0.0 110.208 179.41 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' TRP . . . . . 0.575 ' CZ3' ' OE2' ' A' ' 175' ' ' GLU . 57.3 t90 -60.13 -17.72 42.35 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.303 179.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -63.72 -28.78 70.12 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.602 -0.727 . . . . 0.0 111.936 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . 0.907 HG22 ' O ' ' A' ' 170' ' ' LYS . 34.6 m -62.33 -20.79 25.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 120.692 -0.403 . . . . 0.0 111.05 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.741 HG13 ' CB ' ' A' ' 122' ' ' ALA . 7.8 t -99.81 -6.02 9.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.648 -179.32 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.575 ' OE2' ' CZ3' ' A' ' 171' ' ' TRP . 93.0 mt-10 -73.71 143.91 45.96 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 121.199 0.523 . . . . 0.0 111.419 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 44.8 p-10 -70.94 144.0 50.72 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.776 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 50.4 m80 -119.31 28.02 8.46 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 62.34 37.71 95.05 Favored Glycine 0 CA--C 1.528 0.88 0 N-CA-C 111.272 -0.731 . . . . 0.0 111.272 179.159 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -153.69 161.68 41.92 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.741 ' OD2' HD22 ' A' ' 203' ' ' LEU . 56.8 t0 -87.37 101.6 13.72 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 178.225 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . 0.462 ' HG2' ' N ' ' A' ' 182' ' ' ILE . 72.5 tt0 -130.78 163.43 27.36 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.469 0.652 . . . . 0.0 111.524 -178.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.462 ' N ' ' HG2' ' A' ' 181' ' ' GLU . 20.2 tt -130.07 138.5 53.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 57.0 m -130.83 125.44 33.68 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.504 -0.478 . . . . 0.0 111.29 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 85.5 mt -109.28 130.87 55.48 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.56 HD13 HD11 ' B' ' 702' ' ' LEU . 96.7 mt -115.7 128.87 72.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.533 0.682 . . . . 0.0 111.527 -179.112 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' THR . . . . . 0.582 HG21 HD11 ' A' ' 138' ' ' ILE . 3.7 t -141.83 162.16 36.16 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.297 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' CYS . . . . . 0.447 ' O ' ' OD1' ' A' ' 127' ' ' ASN . 33.1 m -87.15 135.27 33.36 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.952 0.406 . . . . 0.0 110.086 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.587 HG13 ' N ' ' A' ' 189' ' ' SER . 11.9 p -61.54 -45.24 99.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-O 121.411 0.624 . . . . 0.0 110.308 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . 0.587 ' N ' HG13 ' A' ' 188' ' ' VAL . 35.5 t -172.18 144.95 1.68 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.869 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 33.9 m -70.89 -13.01 16.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.124 0.488 . . . . 0.0 110.627 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 63.1 mttm -94.03 -12.8 27.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.121 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . 0.412 ' C ' ' OD1' ' A' ' 192' ' ' ASP . 64.2 t0 -140.19 109.03 5.98 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.517 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 46.9 p-10 -107.5 11.72 28.52 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.303 179.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 35.0 t -59.89 -43.78 94.59 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.144 -178.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -145.83 155.61 43.02 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 121.28 0.562 . . . . 0.0 111.714 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . 0.407 HH12 ' HG3' ' A' ' 168' ' ' PRO . 85.1 mtt85 -128.03 146.91 50.52 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 121.383 0.611 . . . . 0.0 111.603 -179.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -91.15 146.51 23.78 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.873 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.44 HG21 HG21 ' A' ' 166' ' ' VAL . 47.8 t -130.28 134.21 62.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.639 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.863 HG22 HG12 ' A' ' 163' ' ' VAL . 54.1 t -105.87 132.14 53.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.348 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -116.05 139.03 50.69 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.246 0.546 . . . . 0.0 110.084 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . 0.434 ' O ' HG22 ' A' ' 182' ' ' ILE . . . -140.74 142.65 12.5 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.739 -0.945 . . . . 0.0 110.739 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 35.5 p30 -109.03 155.5 20.84 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.318 0.58 . . . . 0.0 111.544 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . 0.741 HD22 ' OD2' ' A' ' 180' ' ' ASP . 49.3 tp -74.13 131.3 41.16 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.478 179.195 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.473 HG12 ' O ' ' A' ' 157' ' ' GLU . 3.9 p -113.83 -20.25 6.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 120.319 -0.553 . . . . 0.0 111.181 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -174.2 169.22 42.21 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 120.486 -0.864 . . . . 0.0 111.779 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 63.6 m -142.65 137.16 29.77 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 179.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 54.4 pttt -149.19 123.48 9.58 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.592 0.71 . . . . 0.0 112.31 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -62.97 143.59 57.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.554 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 14.7 ptpt -79.26 111.04 15.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.527 178.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 64.8 mttp . . . . . 0 C--O 1.22 -0.493 0 CA-C-O 118.216 -0.897 . . . . 0.0 110.322 -179.966 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 702' ' ' LEU . . . . . 0.56 HD11 HD13 ' A' ' 185' ' ' ILE . 0.0 OUTLIER . . . . . 0 CA--C 1.544 0.737 0 N-CA-C 109.635 -0.506 . . . . 20.0 109.635 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 703' ' ' PRO . . . . . 0.746 ' HG2' HG22 ' A' ' 110' ' ' VAL . 3.1 Cg_exo -65.81 -165.81 0.09 OUTLIER 'Trans proline' 0 N--CA 1.492 1.414 0 C-N-CA 121.921 1.748 . . . . 20.0 113.219 -179.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 704' ' ' ALA . . . . . 0.498 ' O ' ' O ' ' B' ' 703' ' ' PRO . . . . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 114.89 -1.05 . . . . 20.0 112.729 -178.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.307 0 CA-C-O 120.993 0.425 . . . . 0.0 110.855 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.476 ' CB ' ' O ' ' B' ' 702' ' ' LEU . 61.0 p -80.4 22.8 0.53 Allowed 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -179.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -109.2 19.15 19.77 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.069 0.461 . . . . 0.0 111.719 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 98.0 mt -55.83 135.64 18.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-O 122.115 0.96 . . . . 0.0 112.668 -177.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -77.72 129.95 36.16 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.148 -1.387 . . . . 0.0 109.336 178.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.615 ' NE2' ' O ' ' A' ' 63' ' ' GLN . 1.0 OUTLIER -79.21 147.66 69.56 Favored Pre-proline 0 N--CA 1.446 -0.628 0 C-N-CA 120.087 -0.645 . . . . 0.0 109.977 -179.215 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -69.76 167.63 23.88 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 122.353 2.036 . . . . 0.0 112.477 -179.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -51.17 169.77 0.05 OUTLIER 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.568 -178.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 55.9 tp -63.4 -46.21 87.49 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.607 -1.178 . . . . 0.0 111.409 -178.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.65 -22.96 48.75 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.159 0.505 . . . . 0.0 110.448 -178.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.556 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 49.3 tp10 -68.29 -31.56 71.09 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 119.284 -0.966 . . . . 0.0 108.509 178.186 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.464 HG22 ' HB3' ' A' ' 104' ' ' LEU . 36.6 t -74.45 -44.57 47.76 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.466 179.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -73.24 -9.82 59.12 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.709 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 38.6 t30 -118.58 -1.31 11.19 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 121.052 0.454 . . . . 0.0 110.179 178.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.556 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -69.04 -172.55 0.41 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.425 -179.127 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.3 m -94.87 99.8 11.79 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.287 0.565 . . . . 0.0 110.033 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 49.3 tp -67.83 135.34 52.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.845 -179.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -124.89 77.21 1.59 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.461 0.648 . . . . 0.0 109.49 178.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.736 ' O ' HG12 ' A' ' 79' ' ' VAL . 86.6 tttt -74.96 -41.14 60.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.37 -0.832 . . . . 0.0 112.162 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.464 ' H ' ' HD2' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -70.94 -6.0 35.18 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.72 -177.062 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -96.49 -10.03 28.32 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.284 0.564 . . . . 0.0 110.506 179.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.736 HG12 ' O ' ' A' ' 76' ' ' LYS . 9.9 p -65.31 127.75 26.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.855 179.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 12.1 pt -104.61 -8.03 9.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.327 0.584 . . . . 0.0 109.975 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -173.35 178.55 45.25 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 120.742 -0.742 . . . . 0.0 111.291 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.406 ' HG2' ' N ' ' A' ' 83' ' ' ILE . 58.5 ttp180 -136.45 160.92 37.29 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.336 -0.432 . . . . 0.0 110.357 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.566 HG22 ' O ' ' A' ' 92' ' ' LEU . 18.6 tt -124.99 140.94 46.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 CA-C-O 121.203 0.525 . . . . 0.0 109.983 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 47.6 t -137.18 130.39 31.0 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.378 0.608 . . . . 0.0 111.471 -178.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.543 ' CG2' HG22 ' A' ' 88' ' ' VAL . 37.3 mt -137.08 85.55 22.21 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.572 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -56.25 -33.05 89.93 Favored 'Trans proline' 0 N--CA 1.496 1.621 0 C-N-CA 123.25 2.633 . . . . 0.0 112.798 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . 0.439 ' CB ' ' OD1' ' A' ' 145' ' ' ASP . 39.5 t -55.53 -43.44 75.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.097 0.475 . . . . 0.0 111.358 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.543 HG22 ' CG2' ' A' ' 85' ' ' ILE . 35.5 m -110.77 7.75 8.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.522 0.677 . . . . 0.0 109.879 179.173 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.5 m 53.03 51.58 15.5 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.043 179.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 69.1 tp -116.11 131.12 57.03 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.294 0.568 . . . . 0.0 110.462 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -148.52 125.67 11.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.817 0.818 . . . . 0.0 110.939 -179.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.623 ' CD1' ' HB2' ' A' ' 107' ' ' ALA . 0.3 OUTLIER -156.83 152.69 22.78 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 114.741 -1.118 . . . . 0.0 111.01 179.873 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -74.44 147.82 37.12 Favored 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 122.548 2.165 . . . . 0.0 112.132 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.489 ' C ' HD12 ' A' ' 95' ' ' LEU . 90.1 t -94.89 121.36 45.4 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-O 120.901 0.381 . . . . 0.0 111.159 179.392 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.544 ' N ' HD12 ' A' ' 95' ' ' LEU . 10.9 mp -98.49 127.88 44.61 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 121.654 0.74 . . . . 0.0 111.568 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.509 ' O ' ' OG1' ' A' ' 109' ' ' THR . 88.1 tttt -62.33 -47.0 86.16 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 114.846 -1.07 . . . . 0.0 112.077 -178.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.406 ' HB3' ' ND2' ' A' ' 102' ' ' ASN . 17.4 t -77.98 128.87 34.56 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.509 0.671 . . . . 0.0 112.354 -178.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.469 ' OG ' ' O ' ' A' ' 109' ' ' THR . 0.8 OUTLIER -86.62 51.8 2.33 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.523 -179.673 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.535 HG22 ' N ' ' A' ' 100' ' ' GLU . 62.1 m -88.37 162.59 16.46 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.187 -0.46 . . . . 0.0 109.998 178.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.535 ' N ' HG22 ' A' ' 99' ' ' THR . 57.6 mp0 -61.92 -43.18 99.37 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 121.133 0.492 . . . . 0.0 110.62 179.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -63.01 -40.66 98.43 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.228 -179.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.406 ' ND2' ' HB3' ' A' ' 97' ' ' SER . 97.8 m-20 -64.67 -37.75 88.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.616 0.722 . . . . 0.0 110.671 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.527 HD13 ' HB3' ' B' ' 704' ' ' ALA . 16.5 mt -59.62 -24.03 63.48 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.327 -0.852 . . . . 0.0 111.188 -179.056 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.464 ' HB3' HG22 ' A' ' 69' ' ' VAL . 90.0 mt -76.03 -12.22 60.09 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.966 0.412 . . . . 0.0 110.831 179.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 90.7 p -78.8 -5.45 53.42 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-O 121.474 0.654 . . . . 0.0 110.011 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 98.96 -19.7 53.23 Favored Glycine 0 CA--C 1.532 1.152 0 CA-C-N 115.326 -0.852 . . . . 0.0 112.758 178.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.623 ' HB2' ' CD1' ' A' ' 92' ' ' LEU . . . -146.96 129.63 16.07 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 119.382 -0.927 . . . . 0.0 113.039 -179.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -147.39 135.18 21.14 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.489 178.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.637 ' HA ' HD23 ' A' ' 123' ' ' LEU . 54.9 p -70.15 135.99 49.67 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.085 0.469 . . . . 0.0 111.118 -179.47 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.969 HG11 HG11 ' A' ' 174' ' ' VAL . 54.0 t -79.74 -56.04 7.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-O 121.074 0.464 . . . . 0.0 110.76 -179.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.82 ' H ' ' NE2' ' A' ' 114' ' ' GLN . 43.7 mtpt -102.87 137.97 40.38 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 121.901 0.857 . . . . 0.0 111.717 179.229 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -63.64 -29.47 70.7 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 114.735 -1.121 . . . . 0.0 111.619 -178.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 65.1 m-80 -83.06 14.73 3.18 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -177.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . 0.82 ' NE2' ' H ' ' A' ' 111' ' ' LYS . 45.0 mt-30 -77.83 138.24 38.84 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 121.128 0.49 . . . . 0.0 112.285 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 72.9 t -126.26 119.75 54.88 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.531 178.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 97.4 mtp -58.31 128.42 37.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.566 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 85.3 -2.88 87.94 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 120.956 -0.64 . . . . 0.0 111.871 178.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -142.95 133.24 24.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.052 0.453 . . . . 0.0 111.153 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 72.24 -171.0 49.43 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 -179.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 63.2 t-20 -86.33 102.48 14.04 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.285 -0.566 . . . . 0.0 110.131 179.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.547 ' CE2' HD21 ' A' ' 123' ' ' LEU . 12.3 t80 -85.83 98.66 10.88 Favored 'General case' 0 N--CA 1.457 -0.097 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 179.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.573 ' N ' ' OE1' ' A' ' 114' ' ' GLN . . . -91.96 139.14 30.94 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.223 -179.372 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.637 HD23 ' HA ' ' A' ' 109' ' ' THR . 81.2 mt -137.94 143.63 40.85 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 120.98 0.419 . . . . 0.0 110.684 179.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -115.26 138.86 50.49 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.187 0.518 . . . . 0.0 110.488 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -144.14 134.05 5.57 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . 0.414 ' CD2' ' OE1' ' A' ' 63' ' ' GLN . 0.2 OUTLIER -79.43 137.83 37.39 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.004 -0.678 . . . . 0.0 110.51 -179.828 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . 0.803 ' ND2' ' H ' ' A' ' 129' ' ' SER . 3.5 t-20 -130.55 121.47 25.76 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.562 -179.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.498 ' O ' ' CB ' ' A' ' 129' ' ' SER . 67.0 mtt -87.73 -5.83 58.48 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.133 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.803 ' H ' ' ND2' ' A' ' 127' ' ' ASN . 0.9 OUTLIER 79.78 8.77 1.57 Allowed 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 179.123 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.874 ' O ' HG12 ' A' ' 133' ' ' VAL . 65.0 pttt -105.93 128.06 53.55 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 122.111 0.957 . . . . 0.0 112.371 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 38.8 tptt -46.05 119.78 2.43 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.977 -1.011 . . . . 0.0 109.988 178.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 115.23 -18.12 16.21 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.197 -1.161 . . . . 0.0 110.197 -179.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.874 HG12 ' O ' ' A' ' 130' ' ' LYS . 9.5 p -90.3 160.9 2.7 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 CA-C-O 121.256 0.55 . . . . 0.0 109.974 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.718 HD23 ' N ' ' A' ' 134' ' ' LEU . 0.1 OUTLIER -69.22 138.45 54.01 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -177.338 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.594 ' CD2' HD12 ' A' ' 138' ' ' ILE . 3.2 m-30 65.74 9.39 5.95 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 114.094 -1.412 . . . . 0.0 114.303 177.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . 0.552 ' OG ' ' ND2' ' A' ' 127' ' ' ASN . 0.4 OUTLIER -67.31 -36.27 81.13 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 120.453 -0.499 . . . . 0.0 112.185 179.315 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 22.7 p-10 -93.97 8.93 39.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.594 0.712 . . . . 0.0 110.796 -178.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.594 HD12 ' CD2' ' A' ' 135' ' ' PHE . 5.5 tt -64.96 -36.35 77.57 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.534 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -70.02 -10.81 59.92 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 121.958 -0.463 . . . . 0.0 111.399 179.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 67.3 m -81.24 -2.85 50.41 Favored 'General case' 0 C--O 1.231 0.088 0 CA-C-O 121.054 0.455 . . . . 0.0 110.303 179.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 70.9 mt -63.69 142.33 58.44 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.926 179.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -123.24 157.08 33.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.734 0.778 . . . . 0.0 111.85 -178.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -48.72 129.09 16.4 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.41 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 160' ' ' VAL . . . 82.24 8.52 86.28 Favored Glycine 0 CA--C 1.534 1.256 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.574 179.053 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.439 ' OD1' ' CB ' ' A' ' 87' ' ' SER . 23.1 t70 -71.76 130.49 41.23 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 119.908 -0.717 . . . . 0.0 110.838 -179.268 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -77.98 139.9 39.18 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 121.619 0.724 . . . . 0.0 111.628 -179.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.524 HG23 HG12 ' A' ' 85' ' ' ILE . 96.4 mt -136.59 137.68 47.36 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 178.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . 0.55 ' C ' HD23 ' A' ' 149' ' ' LEU . 63.3 m-85 -118.46 135.95 54.07 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 119.966 -0.694 . . . . 0.0 111.938 -178.247 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.55 HD23 ' C ' ' A' ' 148' ' ' TYR . 0.9 OUTLIER -114.16 134.28 55.01 Favored 'General case' 0 C--O 1.222 -0.357 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 177.263 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.427 ' CE2' ' OE1' ' A' ' 155' ' ' GLU . 81.2 m-85 -114.48 110.07 19.27 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.136 -0.626 . . . . 0.0 111.853 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . 0.474 ' N ' ' O ' ' A' ' 154' ' ' ASN . 22.4 t0 -88.4 167.92 13.08 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 177.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 65.2 m-20 -60.29 -23.77 64.43 Favored 'General case' 0 C--N 1.316 -0.872 0 C-N-CA 119.793 -0.763 . . . . 0.0 111.449 -178.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -113.02 -26.3 8.55 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -178.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . 0.474 ' O ' ' N ' ' A' ' 151' ' ' ASP . 0.3 OUTLIER -148.1 -177.0 5.5 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 119.115 -1.034 . . . . 0.0 112.639 -177.197 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.427 ' OE1' ' CE2' ' A' ' 150' ' ' TYR . 15.2 pt-20 -137.98 145.52 42.04 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 114.403 -1.271 . . . . 0.0 109.891 178.574 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . 0.431 ' CD1' HG23 ' A' ' 206' ' ' THR . 84.0 m-85 -118.5 138.41 52.53 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 121.255 0.55 . . . . 0.0 112.312 -178.212 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . 0.529 ' O ' HG22 ' A' ' 204' ' ' VAL . 93.5 mt-10 -95.56 114.91 26.72 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.455 179.444 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -118.24 151.73 37.09 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.792 0.329 . . . . 0.0 111.633 179.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -124.59 125.15 43.7 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.334 178.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.487 ' O ' ' N ' ' A' ' 144' ' ' GLY . 92.3 t -59.95 137.25 22.62 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 177.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 77.7 p -106.6 -24.81 12.05 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 123.436 0.46 . . . . 0.0 110.792 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 158.83 -167.93 34.85 Favored Glycine 0 CA--C 1.533 1.218 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.875 HG22 HG22 ' A' ' 199' ' ' VAL . 44.4 t -129.99 128.27 64.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.452 -0.374 . . . . 0.0 109.998 178.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 18.2 m -107.74 157.34 18.2 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.479 0.657 . . . . 0.0 112.06 -179.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -101.67 113.44 26.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.253 179.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.57 HG21 HG21 ' A' ' 198' ' ' VAL . 22.9 m -135.48 163.3 35.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.682 0.754 . . . . 0.0 112.187 -178.468 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -90.06 155.86 46.93 Favored Pre-proline 0 CA--C 1.538 0.505 0 CA-C-N 114.944 -1.026 . . . . 0.0 110.335 179.133 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . 0.581 ' O ' ' CB ' ' B' ' 702' ' ' LEU . 37.0 Cg_endo -65.91 -16.49 52.96 Favored 'Trans proline' 0 N--CA 1.502 1.984 0 C-N-CA 123.273 2.648 . . . . 0.0 113.995 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . 0.418 ' O ' ' CD1' ' A' ' 171' ' ' TRP . 51.4 p-10 -91.82 -6.14 52.2 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 119.733 -0.787 . . . . 0.0 111.848 -179.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.505 ' O ' HG12 ' A' ' 173' ' ' VAL . 96.7 mttt -75.24 80.84 2.35 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 119.92 -0.712 . . . . 0.0 110.234 178.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' TRP . . . . . 0.574 ' O ' HG22 ' A' ' 174' ' ' VAL . 26.8 m0 -67.28 -11.56 57.84 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.003 -179.204 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.489 ' OE1' ' OE1' ' A' ' 175' ' ' GLU . 79.2 mm-40 -58.56 -29.9 66.74 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.456 -179.354 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . 0.768 HG13 HG13 ' A' ' 174' ' ' VAL . 10.6 p -60.73 -24.32 31.78 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -178.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.969 HG11 HG11 ' A' ' 110' ' ' VAL . 35.1 m -104.49 -8.55 9.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 120.086 -0.646 . . . . 0.0 112.04 -178.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.489 ' OE1' ' OE1' ' A' ' 172' ' ' GLU . 98.0 mt-10 -74.36 134.86 42.48 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 178.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . 0.489 ' OD1' ' O ' ' A' ' 176' ' ' ASP . 43.3 p-10 -66.17 130.9 44.83 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 121.098 0.475 . . . . 0.0 111.024 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 76.7 m80 -98.3 -13.63 20.64 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -179.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 100.11 34.78 4.72 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 -178.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -148.81 161.84 41.0 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.83 -0.685 . . . . 0.0 110.225 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -87.64 90.76 8.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.885 0.374 . . . . 0.0 110.087 178.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . 0.455 ' HG2' ' N ' ' A' ' 182' ' ' ILE . 79.1 tt0 -126.81 163.35 23.78 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.817 0.818 . . . . 0.0 111.811 -178.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.476 HG22 ' O ' ' A' ' 201' ' ' GLY . 17.9 tt -131.11 137.66 55.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.135 178.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . 0.745 HG21 ' CG2' ' A' ' 173' ' ' VAL . 88.8 m -131.74 126.32 34.17 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.329 0.585 . . . . 0.0 111.353 179.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 84.0 mt -111.17 132.38 54.36 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.463 178.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.462 HD13 HD11 ' B' ' 702' ' ' LEU . 77.6 mt -110.14 126.85 67.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.429 0.633 . . . . 0.0 110.725 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 4.7 t -140.15 155.76 46.82 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.981 -1.009 . . . . 0.0 109.835 179.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' CYS . . . . . . . . . . . . . 4.0 m -91.9 148.89 21.87 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.546 -0.462 . . . . 0.0 110.652 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 195' ' ' LYS . 77.8 t -61.32 -47.57 92.86 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 CA-C-O 121.058 0.456 . . . . 0.0 110.874 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 92.4 p -163.68 162.22 24.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.313 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . 0.502 HG13 ' HG3' ' A' ' 191' ' ' LYS . 9.8 p -69.8 -12.94 16.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.12 0.486 . . . . 0.0 110.469 179.425 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . 0.502 ' HG3' HG13 ' A' ' 190' ' ' VAL . 98.3 mttt -108.06 -31.39 7.97 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.132 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -98.94 107.37 19.79 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.393 0.616 . . . . 0.0 111.244 -179.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -110.63 12.11 22.72 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.364 179.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 20.4 t -59.53 -47.07 86.97 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.359 -0.382 . . . . 0.0 112.028 -178.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' LYS . . . . . 0.423 ' O ' HG23 ' A' ' 188' ' ' VAL . 25.4 pttm -147.39 159.19 43.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.178 0.513 . . . . 0.0 111.332 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 83.6 mtt85 -123.53 143.97 49.85 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.407 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 -90.95 152.24 20.78 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.56 179.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.57 HG21 HG21 ' A' ' 166' ' ' VAL . 13.6 t -129.11 129.24 67.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.436 178.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.875 HG22 HG22 ' A' ' 163' ' ' VAL . 76.4 t -104.47 132.34 51.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.383 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -118.79 140.55 49.77 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.369 0.604 . . . . 0.0 111.207 -179.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . 0.476 ' O ' HG22 ' A' ' 182' ' ' ILE . . . -133.5 141.8 13.21 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 179.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . 0.532 ' OD1' ' N ' ' A' ' 203' ' ' LEU . 65.3 t0 -106.92 139.5 41.22 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.851 0.358 . . . . 0.0 110.164 -179.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . 0.532 ' N ' ' OD1' ' A' ' 202' ' ' ASP . 45.7 tp -64.98 131.34 46.35 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.529 HG22 ' O ' ' A' ' 157' ' ' GLU . 15.4 m -113.05 -20.39 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 C-N-CA 120.665 -0.414 . . . . 0.0 111.043 -178.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -175.57 171.59 44.66 Favored Glycine 0 CA--C 1.535 1.298 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.115 179.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . 0.431 HG23 ' CD1' ' A' ' 156' ' ' TYR . 11.4 m -142.98 136.33 28.37 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.596 -0.302 . . . . 0.0 110.328 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -143.44 121.29 11.97 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.452 0.644 . . . . 0.0 112.183 179.269 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -64.99 140.73 58.9 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.259 -0.882 . . . . 0.0 112.106 -179.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt -77.47 156.68 30.91 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.953 -1.021 . . . . 0.0 110.484 178.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 98.1 mttt . . . . . 0 C--O 1.22 -0.474 0 CA-C-O 117.934 -1.032 . . . . 0.0 110.682 179.786 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 702' ' ' LEU . . . . . 0.581 ' CB ' ' O ' ' A' ' 168' ' ' PRO . 0.0 OUTLIER . . . . . 0 CA--C 1.545 0.778 0 CA-C-O 120.607 0.242 . . . . 20.0 110.824 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 703' ' ' PRO . . . . . 0.641 ' HG2' HG22 ' A' ' 110' ' ' VAL . 3.3 Cg_exo -66.2 -173.74 0.36 Allowed 'Trans proline' 0 N--CA 1.493 1.5 0 C-N-CA 122.346 2.031 . . . . 20.0 112.603 179.392 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 704' ' ' ALA . . . . . 0.527 ' HB3' HD13 ' A' ' 103' ' ' LEU . . . . . . . . 0 N--CA 1.468 0.473 0 N-CA-C 113.601 0.963 . . . . 20.0 113.601 -178.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.246 0 CA-C-O 121.095 0.474 . . . . 0.0 110.868 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 86.6 p -86.21 10.33 14.92 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.315 0.579 . . . . 0.0 111.176 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -104.4 13.39 32.04 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.372 -179.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.2 mt -56.73 137.76 18.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 CA-C-O 122.157 0.98 . . . . 0.0 112.864 -177.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.477 ' O ' ' OD1' ' A' ' 62' ' ' ASP . 46.7 p-10 -79.49 129.87 34.87 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 113.975 -1.466 . . . . 0.0 109.162 178.107 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.667 ' NE2' ' ND1' ' A' ' 126' ' ' HIS . 0.0 OUTLIER -76.09 154.87 84.63 Favored Pre-proline 0 CA--C 1.535 0.38 0 CA-C-O 121.171 0.51 . . . . 0.0 110.302 -179.033 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -71.5 170.6 18.11 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.783 2.322 . . . . 0.0 112.975 -179.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.597 ' O ' HG23 ' A' ' 69' ' ' VAL . 28.1 t70 -52.81 159.35 1.14 Allowed 'General case' 0 C--N 1.334 -0.087 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.595 179.679 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 58.6 tp -63.31 -46.45 86.63 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 120.627 -0.429 . . . . 0.0 111.322 -178.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.94 -36.72 84.36 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 119.844 -0.742 . . . . 0.0 111.153 -178.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -58.29 -26.54 63.12 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 119.871 -0.732 . . . . 0.0 109.033 178.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.617 HG13 ' HB3' ' A' ' 104' ' ' LEU . 25.2 t -78.98 -44.94 24.64 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.529 178.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -73.07 -9.1 58.36 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.918 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -106.76 -14.62 14.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.276 0.56 . . . . 0.0 110.475 179.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -69.44 143.19 53.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.387 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 13.7 t -62.09 99.83 0.14 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.489 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.2 tt -69.7 134.74 48.99 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.274 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.596 ' OD2' ' NE2' ' A' ' 78' ' ' GLN . 84.8 m-20 -94.98 84.28 4.11 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 121.497 0.665 . . . . 0.0 110.244 178.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 48.7 tttp -63.19 -43.08 99.21 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.27 -0.877 . . . . 0.0 112.321 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.734 ' H ' ' CE ' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -70.34 -11.36 60.86 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.792 -0.64 . . . . 0.0 112.06 -177.068 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.596 ' NE2' ' OD2' ' A' ' 75' ' ' ASP . 77.8 mt-30 -92.06 -1.6 57.12 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.047 0.451 . . . . 0.0 110.324 179.088 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 58.1 t -76.64 127.14 37.81 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.244 179.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 29.2 pt -111.05 -1.79 10.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.65 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -175.99 179.47 47.09 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 120.502 -0.856 . . . . 0.0 111.48 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.566 ' NH1' ' OE2' ' A' ' 91' ' ' GLU . 73.1 ttp85 -141.19 153.76 45.49 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 120.919 0.39 . . . . 0.0 110.971 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.61 HG22 ' O ' ' A' ' 92' ' ' LEU . 18.1 tt -122.3 138.96 50.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-O 121.245 0.545 . . . . 0.0 110.317 179.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 10.3 t -137.75 130.85 30.41 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.199 0.524 . . . . 0.0 111.435 -179.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.548 HG12 HG23 ' A' ' 147' ' ' ILE . 54.3 mt -137.23 88.77 16.99 Favored Pre-proline 0 CA--C 1.541 0.604 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.987 -179.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -56.73 -31.11 86.9 Favored 'Trans proline' 0 N--CA 1.503 2.05 0 C-N-CA 123.086 2.524 . . . . 0.0 113.41 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 22.4 m -53.23 -42.27 66.22 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 121.207 0.527 . . . . 0.0 111.162 -179.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 12.7 m -115.77 8.28 7.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.44 0.638 . . . . 0.0 110.412 179.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.5 m 54.18 49.03 19.58 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.698 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 60.0 tp -112.15 131.49 55.43 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.384 0.611 . . . . 0.0 110.844 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.566 ' OE2' ' NH1' ' A' ' 82' ' ' ARG . 80.4 tt0 -149.16 126.22 11.32 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.944 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.61 ' O ' HG22 ' A' ' 83' ' ' ILE . 71.8 mt -152.24 151.98 28.54 Favored Pre-proline 0 CA--C 1.533 0.322 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.056 -179.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -74.73 147.02 34.58 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.361 2.041 . . . . 0.0 110.519 178.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 71.4 t -96.95 125.39 49.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 C-N-CA 120.434 -0.506 . . . . 0.0 110.855 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 9.5 mp -99.53 127.6 45.61 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.56 0.695 . . . . 0.0 111.472 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.514 ' O ' ' OG1' ' A' ' 109' ' ' THR . 87.5 tttt -63.71 -45.54 89.5 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 115.03 -0.986 . . . . 0.0 112.518 -178.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.447 ' HB3' HG23 ' A' ' 99' ' ' THR . 3.3 m -81.38 130.99 35.26 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.267 0.556 . . . . 0.0 111.267 -179.273 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 9.8 p -91.3 53.41 2.31 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.576 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.447 HG23 ' HB3' ' A' ' 97' ' ' SER . 81.2 p -88.44 166.77 14.0 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 178.576 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -64.13 -40.84 97.03 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.39 0.614 . . . . 0.0 110.453 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -63.95 -42.68 97.24 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.617 -179.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -65.7 -36.08 82.59 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.121 179.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.619 HD13 ' HB3' ' B' ' 704' ' ' ALA . 33.3 mt -61.52 -15.94 42.89 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.799 -179.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.617 ' HB3' HG13 ' A' ' 69' ' ' VAL . 88.7 mt -71.94 -20.03 61.82 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.271 0.558 . . . . 0.0 109.871 179.195 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 83.6 p -73.29 -0.98 16.11 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.876 -179.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.558 ' HA3' HD12 ' A' ' 134' ' ' LEU . . . 82.84 -18.59 15.03 Favored Glycine 0 CA--C 1.526 0.776 0 CA-C-N 116.069 -0.514 . . . . 0.0 112.387 178.52 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -145.26 123.91 12.53 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.527 0.68 . . . . 0.0 111.349 179.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -147.47 149.66 33.09 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.093 179.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.568 ' HA ' HD23 ' A' ' 123' ' ' LEU . 68.2 p -66.84 133.73 50.67 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.176 0.512 . . . . 0.0 110.561 -179.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.629 HG13 ' CD ' ' B' ' 703' ' ' PRO . 38.2 t -81.8 -62.0 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 C-N-CA 120.356 -0.538 . . . . 0.0 109.699 179.101 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.563 ' O ' ' NE2' ' A' ' 114' ' ' GLN . 85.5 tttt -94.17 133.95 37.14 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.818 179.38 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -66.37 -37.05 84.4 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -177.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -85.27 17.99 2.83 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 -178.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . 0.563 ' NE2' ' O ' ' A' ' 111' ' ' LYS . 5.5 pt20 -76.87 139.77 40.37 Favored 'General case' 0 CA--C 1.534 0.332 0 O-C-N 121.958 -0.464 . . . . 0.0 110.76 179.27 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 94.3 t -129.27 121.53 53.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.925 0.393 . . . . 0.0 110.162 178.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' MET . . . . . 0.588 ' SD ' ' OD1' ' A' ' 151' ' ' ASP . 56.1 mtt -58.06 134.34 56.34 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.173 0.511 . . . . 0.0 111.105 -179.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 78.52 -3.68 62.51 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 121.012 -0.613 . . . . 0.0 111.953 178.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -140.3 124.1 17.32 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.239 0.542 . . . . 0.0 110.759 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 76.04 -161.26 51.98 Favored Glycine 0 CA--C 1.531 1.081 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.368 179.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 63.2 t-20 -93.24 107.24 19.09 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.069 0.461 . . . . 0.0 110.977 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.487 ' CE2' HD21 ' A' ' 123' ' ' LEU . 20.2 t80 -85.56 145.34 27.41 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.084 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.666 ' CB ' HG13 ' A' ' 174' ' ' VAL . . . -146.73 139.03 24.85 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 119.986 -0.686 . . . . 0.0 112.042 -178.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.568 HD23 ' HA ' ' A' ' 109' ' ' THR . 72.4 mt -135.69 141.66 44.99 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.947 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -111.96 132.94 54.46 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 121.374 0.607 . . . . 0.0 109.852 178.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -134.74 152.13 20.61 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . 0.667 ' ND1' ' NE2' ' A' ' 63' ' ' GLN . 40.9 m-70 -89.47 136.08 33.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.727 0.775 . . . . 0.0 112.339 -178.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -130.09 121.05 25.63 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.62 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.566 ' HB2' HG21 ' A' ' 133' ' ' VAL . 53.2 mtt -94.86 -1.46 52.67 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 121.407 0.623 . . . . 0.0 110.212 179.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.439 ' CB ' ' O ' ' A' ' 128' ' ' MET . 0.9 OUTLIER 77.78 4.57 2.95 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 115.421 -0.809 . . . . 0.0 112.071 178.665 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.873 ' O ' HG12 ' A' ' 133' ' ' VAL . 62.4 pttt -119.65 125.7 49.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.994 0.902 . . . . 0.0 113.118 -178.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.528 ' O ' ' O ' ' A' ' 130' ' ' LYS . 0.0 OUTLIER -35.23 159.73 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.455 179.062 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 74.0 -19.66 1.65 Allowed Glycine 0 CA--C 1.534 1.264 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.873 HG12 ' O ' ' A' ' 130' ' ' LYS . 4.7 p -90.09 173.42 0.88 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 119.587 -0.845 . . . . 0.0 111.094 -179.394 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.661 ' H ' HG22 ' A' ' 133' ' ' VAL . 4.3 mm? -66.81 130.05 41.89 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 -175.531 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.534 ' CD2' HD12 ' A' ' 138' ' ' ILE . 3.8 m-30 60.98 18.28 8.74 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 114.164 -1.38 . . . . 0.0 112.545 178.488 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.37 -37.23 84.92 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 113.005 0.742 . . . . 0.0 113.005 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 31.7 p-10 -94.6 6.25 49.42 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.974 0.416 . . . . 0.0 111.88 -178.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.534 HD12 ' CD2' ' A' ' 135' ' ' PHE . 3.6 tt -63.97 -37.9 80.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 C-N-CA 120.553 -0.459 . . . . 0.0 111.786 -179.443 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -67.8 -10.67 54.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.803 0.335 . . . . 0.0 111.352 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 33.1 m -80.93 -4.98 56.85 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.036 0.446 . . . . 0.0 110.505 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 80.1 mt -63.91 139.52 58.78 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.037 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.402 ' HG2' ' N ' ' A' ' 143' ' ' LYS . 88.6 tttt -115.9 156.76 25.59 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 121.478 0.656 . . . . 0.0 112.097 -178.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . 0.402 ' N ' ' HG2' ' A' ' 142' ' ' LYS . 88.0 tttt -48.87 130.57 18.17 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.341 -0.845 . . . . 0.0 112.647 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.603 ' N ' ' O ' ' A' ' 160' ' ' VAL . . . 78.37 7.67 87.8 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.972 178.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -71.97 137.93 47.66 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 119.567 -0.853 . . . . 0.0 110.268 -179.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -80.76 142.06 34.16 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 122.016 0.912 . . . . 0.0 113.021 -177.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.548 HG23 HG12 ' A' ' 85' ' ' ILE . 91.6 mt -138.66 139.11 41.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 114.361 -1.291 . . . . 0.0 108.791 178.233 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . 0.596 ' C ' HD22 ' A' ' 149' ' ' LEU . 94.0 m-85 -116.68 138.36 51.51 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 122.033 0.92 . . . . 0.0 112.821 -178.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.596 HD22 ' C ' ' A' ' 148' ' ' TYR . 4.5 mm? -117.03 137.73 52.05 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.112 -1.404 . . . . 0.0 108.484 178.347 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -126.56 112.06 15.09 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 119.978 -0.689 . . . . 0.0 112.418 -178.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . 0.588 ' OD1' ' SD ' ' A' ' 116' ' ' MET . 20.7 m-20 -89.63 164.72 14.62 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 176.465 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 53.4 t30 -56.66 -23.5 42.12 Favored 'General case' 0 C--N 1.31 -1.118 0 C-N-CA 119.893 -0.723 . . . . 0.0 111.124 -178.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -111.0 -29.44 7.9 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 113.38 0.882 . . . . 0.0 113.38 -178.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . 0.455 ' O ' ' N ' ' A' ' 151' ' ' ASP . 0.4 OUTLIER -145.98 177.77 8.7 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 119.644 -0.822 . . . . 0.0 112.74 -176.949 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -134.32 145.8 49.38 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.099 178.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . 0.492 ' CD2' HG23 ' A' ' 206' ' ' THR . 48.3 m-85 -120.12 139.29 52.81 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 121.201 0.524 . . . . 0.0 111.486 -178.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -93.75 114.69 27.02 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.158 179.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -115.07 149.48 37.44 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.226 0.536 . . . . 0.0 111.934 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.454 ' HB2' HG21 ' A' ' 204' ' ' VAL . . . -122.86 122.17 38.0 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.617 179.159 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.603 ' O ' ' N ' ' A' ' 144' ' ' GLY . 86.2 t -60.37 138.62 21.04 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.218 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 177.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 20.3 p -107.22 -23.28 12.31 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.671 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 159.84 -167.63 35.37 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 120.28 -0.962 . . . . 0.0 112.033 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.934 HG22 HG22 ' A' ' 199' ' ' VAL . 42.3 t -127.4 137.57 57.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-N 115.124 -0.538 . . . . 0.0 109.74 179.453 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 57.9 m -123.78 157.38 34.18 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 121.317 0.58 . . . . 0.0 111.474 -178.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 28.2 mp0 -104.63 113.43 27.01 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 121.553 0.692 . . . . 0.0 110.705 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 27.6 m -139.49 163.93 24.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.234 -179.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . 0.44 ' H ' ' HD2' ' A' ' 170' ' ' LYS . 0.2 OUTLIER -91.56 159.91 37.74 Favored Pre-proline 0 CA--C 1.538 0.484 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.694 178.513 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . 0.488 ' O ' ' CB ' ' B' ' 702' ' ' LEU . 35.6 Cg_endo -65.52 -15.76 50.97 Favored 'Trans proline' 0 N--CA 1.5 1.883 0 C-N-CA 122.874 2.383 . . . . 0.0 113.885 -179.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 44.1 p-10 -91.86 -7.21 50.0 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 119.466 -0.893 . . . . 0.0 111.544 179.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.722 ' O ' HG22 ' A' ' 173' ' ' VAL . 96.7 mttt -75.64 83.11 2.65 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.808 0.813 . . . . 0.0 111.723 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 33.2 t90 -71.13 -11.31 60.87 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.636 -1.165 . . . . 0.0 110.47 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -61.57 -35.08 76.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.674 -179.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . 0.722 HG22 ' O ' ' A' ' 170' ' ' LYS . 32.7 m -63.51 -14.03 13.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.427 -179.183 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.666 HG13 ' CB ' ' A' ' 122' ' ' ALA . 12.2 t -110.58 -5.85 11.25 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -179.104 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.499 ' O ' ' CE1' ' A' ' 177' ' ' HIS . 94.9 mt-10 -72.36 149.12 44.64 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.345 0.593 . . . . 0.0 110.88 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . 0.52 ' OD1' ' O ' ' A' ' 176' ' ' ASP . 51.9 p-10 -67.61 128.42 36.38 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.611 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' HIS . . . . . 0.499 ' CE1' ' O ' ' A' ' 175' ' ' GLU . 76.6 m80 -110.23 22.02 16.04 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.509 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 59.94 37.45 92.65 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 110.771 -0.932 . . . . 0.0 110.771 179.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 18.3 ptmt -146.22 158.7 43.9 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -88.74 91.67 8.91 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.292 177.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -129.56 172.47 11.54 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.478 0.656 . . . . 0.0 111.259 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 18.6 tt -134.44 144.29 35.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.436 178.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 84.7 m -131.48 126.55 35.28 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.522 0.677 . . . . 0.0 111.572 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 86.1 mt -109.4 131.47 55.03 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.488 HD13 ' CD2' ' B' ' 702' ' ' LEU . 85.0 mt -112.87 124.19 69.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.498 0.666 . . . . 0.0 111.31 -178.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 3.9 t -137.81 153.04 49.69 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.831 179.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' CYS . . . . . . . . . . . . . 3.3 m -88.5 139.36 30.56 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.039 0.447 . . . . 0.0 110.945 -179.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.525 HG13 ' N ' ' A' ' 189' ' ' SER . 10.9 p -65.13 -44.54 95.51 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.099 -179.426 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . 0.525 ' N ' HG13 ' A' ' 188' ' ' VAL . 80.9 p -164.54 157.57 17.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.076 0.465 . . . . 0.0 110.795 179.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . 0.428 HG22 ' O ' ' A' ' 190' ' ' VAL . 11.4 p -81.93 -9.96 11.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.034 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -96.4 -9.97 28.71 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.284 0.564 . . . . 0.0 110.688 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -142.89 101.43 3.84 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.633 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 53.3 p-10 -102.21 10.39 39.36 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.247 0.546 . . . . 0.0 110.439 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 39.1 t -61.4 -46.16 91.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.277 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 64.4 pttt -144.86 150.95 37.97 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.453 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . 0.847 ' NH2' HD22 ' B' ' 702' ' ' LEU . 21.8 ptt180 -137.96 158.16 44.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.219 0.533 . . . . 0.0 111.165 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -91.75 141.35 28.78 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.839 -0.618 . . . . 0.0 111.561 -179.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 42.0 t -118.94 132.08 69.86 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.01 178.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.934 HG22 HG22 ' A' ' 163' ' ' VAL . 84.9 t -100.0 132.32 45.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.503 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -118.01 144.27 45.69 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.399 0.618 . . . . 0.0 110.996 -178.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -140.22 163.43 26.36 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 110.284 -1.127 . . . . 0.0 110.284 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . 0.57 ' OD1' ' N ' ' A' ' 203' ' ' LEU . 67.6 t0 -122.22 139.4 53.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.017 0.437 . . . . 0.0 111.888 -178.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . 0.57 ' N ' ' OD1' ' A' ' 202' ' ' ASP . 46.5 tp -62.78 131.54 49.2 Favored 'General case' 0 CA--C 1.52 -0.207 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.454 HG21 ' HB2' ' A' ' 159' ' ' ALA . 57.4 t -110.51 -20.72 6.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 C-N-CA 120.355 -0.538 . . . . 0.0 111.648 -178.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -178.03 174.21 46.6 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 120.546 -0.835 . . . . 0.0 111.486 -179.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . 0.492 HG23 ' CD2' ' A' ' 156' ' ' TYR . 24.5 m -146.24 138.2 24.99 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.319 -0.441 . . . . 0.0 110.296 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -145.81 124.19 12.34 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.2 0.524 . . . . 0.0 110.943 178.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -65.86 147.98 52.51 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.78 0.8 . . . . 0.0 112.08 -179.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 10.1 ttmt -77.43 159.13 29.65 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.704 -1.135 . . . . 0.0 110.495 179.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 98.2 mttt . . . . . 0 C--O 1.219 -0.551 0 CA-C-O 118.089 -0.958 . . . . 0.0 110.562 179.429 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 702' ' ' LEU . . . . . 0.847 HD22 ' NH2' ' A' ' 196' ' ' ARG . 2.3 mt . . . . . 0 CA--C 1.541 0.599 0 CA-C-O 120.55 0.214 . . . . 20.0 110.449 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 703' ' ' PRO . . . . . 0.629 ' CD ' HG13 ' A' ' 110' ' ' VAL . 2.5 Cg_endo -62.1 -173.09 0.12 Allowed 'Trans proline' 0 N--CA 1.489 1.232 0 C-N-CA 121.978 1.786 . . . . 20.0 113.061 -178.573 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 704' ' ' ALA . . . . . 0.619 ' HB3' HD13 ' A' ' 103' ' ' LEU . . . . . . . . 0 CA--C 1.532 0.259 0 CA-C-N 114.249 -1.342 . . . . 20.0 113.119 -179.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.377 0 CA-C-O 121.118 0.485 . . . . 0.0 111.896 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 29.5 p -84.73 11.15 9.57 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.346 0.498 . . . . 0.0 112.346 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -94.14 8.01 43.15 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.832 -0.347 . . . . 0.0 111.217 -179.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.5 mt -56.36 132.8 20.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 122.254 1.026 . . . . 0.0 113.689 -176.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -76.47 133.96 39.67 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 113.637 -1.62 . . . . 0.0 109.261 178.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.524 ' CD ' ' CG ' ' A' ' 126' ' ' HIS . 6.6 mm-40 -79.03 149.19 73.05 Favored Pre-proline 0 CA--C 1.537 0.47 0 CA-C-O 121.086 0.469 . . . . 0.0 111.895 -178.369 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -73.6 168.04 25.76 Favored 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 123.177 2.585 . . . . 0.0 112.173 179.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -55.1 167.36 0.43 Allowed 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 121.179 0.514 . . . . 0.0 111.481 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.483 ' N ' HD22 ' A' ' 66' ' ' LEU . 4.3 mm? -64.29 -42.67 96.3 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.296 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.78 -35.37 74.5 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.65 -0.42 . . . . 0.0 111.517 -177.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -61.37 -29.76 70.11 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.763 0.792 . . . . 0.0 109.655 179.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.679 HG13 ' HB3' ' A' ' 104' ' ' LEU . 23.0 t -75.01 -43.77 44.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.001 -0.999 . . . . 0.0 109.952 179.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -76.73 -9.44 58.67 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 114.948 -1.023 . . . . 0.0 111.228 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -113.17 -1.31 14.39 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.296 0.57 . . . . 0.0 110.233 178.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.43 -165.77 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.097 -179.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 69.6 p -103.72 106.51 17.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.712 178.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.594 HD13 ' C ' ' A' ' 74' ' ' LEU . 2.1 tm? -71.94 118.04 14.3 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.838 0.351 . . . . 0.0 110.836 -179.385 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.555 ' N ' HD13 ' A' ' 74' ' ' LEU . 96.4 m-20 -104.21 77.22 1.4 Allowed 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 121.459 0.647 . . . . 0.0 109.984 179.138 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -69.19 -39.22 78.81 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.261 -0.881 . . . . 0.0 113.019 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.43 ' HG2' ' H ' ' A' ' 77' ' ' LYS . 42.4 mmtt -70.3 -15.24 62.86 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.193 -175.207 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -91.18 -4.47 56.07 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.062 0.458 . . . . 0.0 110.931 179.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 78.0 t -80.43 128.04 38.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.068 0.461 . . . . 0.0 110.161 179.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.657 HD13 ' CE ' ' A' ' 96' ' ' LYS . 18.4 pt -111.66 -6.21 11.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.862 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -175.3 179.16 46.71 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 110.799 -0.92 . . . . 0.0 110.799 179.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -152.8 154.94 36.18 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.44 0.638 . . . . 0.0 111.3 179.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 17.0 tt -104.61 144.37 14.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.608 -179.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 33.1 t -135.71 127.72 29.65 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.61 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.716 HG12 HG23 ' A' ' 147' ' ' ILE . 53.0 mt -135.44 89.68 22.1 Favored Pre-proline 0 CA--C 1.537 0.456 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.403 -179.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -55.18 -33.38 84.04 Favored 'Trans proline' 0 N--CA 1.501 1.936 0 C-N-CA 123.165 2.577 . . . . 0.0 113.699 -179.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 74.1 m -52.9 -38.73 62.07 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 120.962 0.411 . . . . 0.0 111.08 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.471 HG22 ' CG2' ' A' ' 85' ' ' ILE . 33.1 m -117.78 13.37 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.292 179.387 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.8 m 49.17 49.52 19.47 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.476 -0.49 . . . . 0.0 110.457 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 62.9 tp -112.94 132.46 55.33 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.325 0.583 . . . . 0.0 110.822 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -146.19 122.03 10.61 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.743 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.661 HD13 ' HA3' ' A' ' 106' ' ' GLY . 94.4 mt -149.17 150.68 32.5 Favored Pre-proline 0 CA--C 1.54 0.588 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.065 -179.171 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -76.25 151.95 34.57 Favored 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 122.695 2.263 . . . . 0.0 112.295 179.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.49 ' C ' HD12 ' A' ' 95' ' ' LEU . 98.6 t -96.83 114.65 34.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.855 0.359 . . . . 0.0 110.502 179.255 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.569 ' N ' HD12 ' A' ' 95' ' ' LEU . 10.3 mp -100.64 139.03 36.9 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.1 0.476 . . . . 0.0 111.472 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.657 ' CE ' HD13 ' A' ' 80' ' ' ILE . 98.9 mttt -66.44 -83.44 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 121.284 0.564 . . . . 0.0 112.019 -179.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 17.7 m -60.79 132.52 54.13 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.664 -179.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 43.6 t -88.28 74.43 8.71 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.371 0.605 . . . . 0.0 109.874 179.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.404 ' OG1' ' CG ' ' A' ' 102' ' ' ASN . 57.1 p -88.79 169.86 11.26 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.802 179.029 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -62.68 -44.34 96.51 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 120.23 -0.588 . . . . 0.0 109.952 179.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -66.61 -40.97 89.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.395 179.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.404 ' CG ' ' OG1' ' A' ' 99' ' ' THR . 95.0 m-20 -64.34 -35.71 81.76 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.816 -179.523 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 34.2 mt -60.49 -26.06 66.52 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.192 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.679 ' HB3' HG13 ' A' ' 69' ' ' VAL . 92.6 mt -72.74 -18.7 61.49 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.297 -179.102 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.478 ' O ' HD22 ' A' ' 92' ' ' LEU . 99.5 p -74.07 -8.25 55.48 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 121.33 0.586 . . . . 0.0 110.085 179.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.661 ' HA3' HD13 ' A' ' 92' ' ' LEU . . . 92.74 -19.57 50.5 Favored Glycine 0 CA--C 1.53 1.016 0 CA-C-N 115.721 -0.672 . . . . 0.0 114.003 177.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -145.03 127.01 15.5 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 119.556 -0.858 . . . . 0.0 111.701 -179.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -144.04 138.81 28.6 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.658 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.62 ' HA ' HD23 ' A' ' 123' ' ' LEU . 64.5 p -73.84 135.01 43.4 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.138 0.494 . . . . 0.0 110.336 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.592 ' N ' HE22 ' A' ' 114' ' ' GLN . 77.8 t -78.97 -54.89 10.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.066 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.759 ' H ' ' NE2' ' A' ' 114' ' ' GLN . 97.5 mttt -102.15 137.43 40.43 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 122.36 1.076 . . . . 0.0 112.573 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -64.34 -29.54 70.61 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.396 -1.274 . . . . 0.0 112.491 -177.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 73.4 m-80 -84.07 17.15 2.56 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 113.669 0.988 . . . . 0.0 113.669 -178.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . 0.759 ' NE2' ' H ' ' A' ' 111' ' ' LYS . 50.1 mt-30 -78.48 134.77 37.29 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 121.966 -0.459 . . . . 0.0 111.672 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 96.3 t -124.85 119.95 57.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-O 120.993 0.425 . . . . 0.0 110.387 178.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 64.8 mtt -55.6 131.62 46.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.273 0.558 . . . . 0.0 111.488 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 84.77 -6.18 79.2 Favored Glycine 0 CA--C 1.533 1.199 0 CA-C-N 115.597 -0.728 . . . . 0.0 112.231 179.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -143.6 136.75 27.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.333 0.587 . . . . 0.0 112.068 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 75.03 -172.94 53.09 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.672 -0.971 . . . . 0.0 110.672 179.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.47 HD22 ' CE1' ' A' ' 177' ' ' HIS . 52.3 t-20 -89.04 103.24 15.87 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.455 -0.498 . . . . 0.0 110.081 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.569 ' HE2' HD21 ' A' ' 123' ' ' LEU . 7.4 t80 -85.63 99.07 11.04 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-O 121.065 0.46 . . . . 0.0 109.773 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.583 ' HB1' HG12 ' A' ' 174' ' ' VAL . . . -91.54 136.12 33.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.982 -179.202 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.62 HD23 ' HA ' ' A' ' 109' ' ' THR . 74.6 mt -137.55 140.17 40.88 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 120.914 0.388 . . . . 0.0 111.099 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -108.43 146.23 33.41 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 178.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -148.09 156.75 27.06 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 -179.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . 0.535 ' O ' ' O ' ' A' ' 134' ' ' LEU . 77.9 m-70 -110.56 130.31 55.59 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 113.453 0.908 . . . . 0.0 113.453 -178.239 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . 0.591 ' ND2' ' O ' ' A' ' 127' ' ' ASN . 0.0 OUTLIER -134.65 121.93 21.55 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.78 177.712 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.545 ' H ' HG21 ' A' ' 133' ' ' VAL . 65.0 mtt -83.83 8.19 15.61 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.057 0.456 . . . . 0.0 110.791 -179.404 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.488 ' CB ' ' O ' ' A' ' 128' ' ' MET . 0.7 OUTLIER 79.0 12.92 1.27 Allowed 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.452 179.118 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.877 ' O ' HG12 ' A' ' 133' ' ' VAL . 23.1 pttp -116.91 126.3 52.76 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 122.241 1.02 . . . . 0.0 112.68 -179.328 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 27.6 tptt -46.24 121.61 3.45 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.538 -1.21 . . . . 0.0 110.082 179.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 113.88 -15.14 21.56 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.563 -1.015 . . . . 0.0 110.563 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.877 HG12 ' O ' ' A' ' 130' ' ' LYS . 11.1 p -91.44 166.04 1.85 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.732 HD23 ' N ' ' A' ' 134' ' ' LEU . 0.3 OUTLIER -72.75 138.2 46.36 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 122.384 1.087 . . . . 0.0 113.821 -176.239 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 62.14 9.69 3.31 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 113.67 -1.604 . . . . 0.0 114.643 177.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 4.3 p -70.4 -31.96 69.39 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 121.486 -0.759 . . . . 0.0 113.028 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -88.82 8.57 28.39 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 -177.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.454 ' CD1' ' OG1' ' A' ' 186' ' ' THR . 18.2 pt -68.7 -31.46 50.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 121.602 0.715 . . . . 0.0 110.476 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -61.98 -20.81 64.26 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.639 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 57.7 m -79.78 -3.41 47.52 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.172 -179.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 99.5 mt -65.78 145.6 55.78 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 121.071 0.462 . . . . 0.0 110.198 179.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 53.6 mttp -120.67 154.5 35.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.515 0.674 . . . . 0.0 111.254 -179.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -49.97 131.86 22.84 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.41 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.483 ' N ' ' O ' ' A' ' 160' ' ' VAL . . . 80.71 8.23 87.72 Favored Glycine 0 CA--C 1.533 1.217 0 C-N-CA 120.682 -0.77 . . . . 0.0 111.72 179.297 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.458 ' OD1' ' N ' ' A' ' 146' ' ' LYS . 56.6 t0 -71.17 130.04 40.45 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 120.042 -0.663 . . . . 0.0 110.304 -179.513 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.458 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 74.5 mmtt -77.81 142.85 38.33 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.8 0.809 . . . . 0.0 112.263 -178.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.716 HG23 HG12 ' A' ' 85' ' ' ILE . 80.5 mt -142.64 143.44 25.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 114.562 -1.199 . . . . 0.0 108.656 178.305 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -126.04 139.96 52.98 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 119.599 -0.84 . . . . 0.0 112.563 -178.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 2.9 mt -110.5 134.12 52.66 Favored 'General case' 0 C--O 1.223 -0.334 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 177.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.553 ' CZ ' ' CD ' ' A' ' 155' ' ' GLU . 33.3 m-85 -110.25 107.68 17.53 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.303 -0.559 . . . . 0.0 112.078 -179.207 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . 0.477 ' OD1' ' N ' ' A' ' 152' ' ' ASN . 54.5 t0 -88.94 162.37 16.13 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 177.449 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . 0.477 ' N ' ' OD1' ' A' ' 151' ' ' ASP . 44.9 p-10 -58.27 -18.55 27.53 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 119.422 -0.911 . . . . 0.0 111.358 -178.215 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.401 ' HB2' ' ND2' ' A' ' 154' ' ' ASN . 96.1 mt-10 -113.77 -28.14 7.54 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -178.484 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . 0.438 ' ND2' ' N ' ' A' ' 154' ' ' ASN . 0.4 OUTLIER -148.58 -175.12 4.8 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 122.134 0.969 . . . . 0.0 113.477 -176.779 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.553 ' CD ' ' CZ ' ' A' ' 150' ' ' TYR . 82.5 tt0 -134.79 140.88 46.22 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 114.153 -1.385 . . . . 0.0 109.939 178.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . 0.469 ' CD1' HG23 ' A' ' 206' ' ' THR . 89.9 m-85 -115.45 137.95 51.52 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -179.05 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . 0.543 ' O ' HG12 ' A' ' 204' ' ' VAL . 91.2 mt-10 -93.42 109.27 20.85 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.854 179.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.404 ' CE2' ' HB2' ' A' ' 203' ' ' LEU . 38.1 m-85 -113.27 147.51 37.42 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.08 0.467 . . . . 0.0 111.349 178.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -122.02 121.55 37.27 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.262 0.553 . . . . 0.0 111.567 179.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.483 ' O ' ' N ' ' A' ' 144' ' ' GLY . 52.1 t -59.86 136.31 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.258 178.206 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 22.5 p -105.68 -24.83 12.45 Favored 'General case' 0 CA--C 1.533 0.316 0 O-C-N 123.535 0.522 . . . . 0.0 111.623 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 159.3 -169.08 35.39 Favored Glycine 0 CA--C 1.529 0.949 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.428 HG22 ' N ' ' A' ' 164' ' ' SER . 3.6 p -136.35 155.92 35.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . 0.428 ' N ' HG22 ' A' ' 163' ' ' VAL . 68.3 m -146.1 167.51 23.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.353 0.597 . . . . 0.0 111.764 -179.216 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -103.14 119.1 38.24 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.119 179.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.447 HG21 HG21 ' A' ' 198' ' ' VAL . 21.0 m -136.3 158.45 38.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.452 0.644 . . . . 0.0 111.859 -178.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . 0.425 ' H ' ' HD2' ' A' ' 170' ' ' LYS . 0.3 OUTLIER -86.52 158.61 54.21 Favored Pre-proline 0 CA--C 1.537 0.48 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.111 -179.634 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . 0.538 ' O ' ' CB ' ' B' ' 702' ' ' LEU . 32.6 Cg_endo -66.31 -18.7 55.8 Favored 'Trans proline' 0 N--CA 1.498 1.792 0 C-N-CA 123.471 2.781 . . . . 0.0 113.425 -179.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 44.0 p-10 -92.88 -3.14 55.13 Favored 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 119.878 -0.729 . . . . 0.0 112.187 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.595 ' O ' HG22 ' A' ' 173' ' ' VAL . 93.6 mttt -76.74 97.29 4.44 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.466 0.65 . . . . 0.0 112.175 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' TRP . . . . . 0.439 ' O ' HG22 ' A' ' 174' ' ' VAL . 95.9 m95 -66.84 -33.62 76.01 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.254 -0.884 . . . . 0.0 110.277 178.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -44.27 -36.28 2.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.071 -0.968 . . . . 0.0 112.885 -178.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . 0.732 HG23 HG13 ' A' ' 174' ' ' VAL . 16.1 m -63.37 -26.04 39.87 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 120.376 -0.53 . . . . 0.0 112.064 -179.104 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.732 HG13 HG23 ' A' ' 173' ' ' VAL . 25.6 m -108.79 -7.8 11.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 120.306 -0.558 . . . . 0.0 112.466 -179.364 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -75.02 153.64 38.38 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.143 0.497 . . . . 0.0 111.502 179.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . 0.412 ' O ' ' OD1' ' A' ' 176' ' ' ASP . 48.8 p-10 -64.61 138.07 58.19 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.123 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' HIS . . . . . 0.47 ' CE1' HD22 ' A' ' 120' ' ' ASN . 70.1 m80 -112.83 14.9 19.93 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.416 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 72.12 34.37 61.52 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 120.851 -0.69 . . . . 0.0 111.547 179.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 42.8 pttt -166.33 178.84 5.95 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.629 0.728 . . . . 0.0 111.722 179.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' A' ' 180' ' ' ASP . 18.3 p30 -89.77 92.99 9.27 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.835 179.201 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . 0.426 ' HG2' ' N ' ' A' ' 182' ' ' ILE . 84.3 tt0 -124.85 161.32 26.78 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.411 0.624 . . . . 0.0 111.566 -179.485 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.49 HG22 ' O ' ' A' ' 201' ' ' GLY . 20.5 tt -129.09 135.95 60.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 178.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . 0.614 ' C ' HD12 ' A' ' 184' ' ' LEU . 80.4 m -130.26 126.07 36.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.707 0.765 . . . . 0.0 112.203 -178.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.614 HD12 ' C ' ' A' ' 183' ' ' THR . 10.5 mp -109.66 131.87 54.67 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.817 -1.083 . . . . 0.0 109.164 178.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.732 HD13 HD21 ' B' ' 702' ' ' LEU . 96.8 mt -113.67 122.63 68.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 121.454 0.645 . . . . 0.0 111.288 -179.185 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' THR . . . . . 0.454 ' OG1' ' CD1' ' A' ' 138' ' ' ILE . 4.7 m -140.86 153.16 45.62 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.827 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' CYS . . . . . . . . . . . . . 86.4 m -87.03 153.92 21.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.269 179.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.716 HG23 ' O ' ' A' ' 195' ' ' LYS . 65.8 t -61.04 -48.87 87.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.278 0.561 . . . . 0.0 110.842 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 16.5 t -168.06 151.25 5.79 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.791 179.081 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . 0.445 HG13 ' HG3' ' A' ' 191' ' ' LYS . 7.5 p -62.01 -20.69 24.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.38 0.609 . . . . 0.0 109.919 179.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . 0.445 ' HG3' HG13 ' A' ' 190' ' ' VAL . 60.4 mttp -94.65 -12.13 27.94 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.047 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -138.09 103.11 4.86 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.767 179.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -104.68 11.94 33.47 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.549 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 21.3 m -63.57 -36.81 85.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.946 -179.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' LYS . . . . . 0.716 ' O ' HG23 ' A' ' 188' ' ' VAL . 57.1 mtmt -135.13 156.95 48.13 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.075 0.464 . . . . 0.0 111.709 -178.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -128.63 139.28 52.34 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.433 -179.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . 0.463 ' CE2' HG22 ' A' ' 188' ' ' VAL . 45.6 m-85 -94.62 144.5 25.55 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.246 0.546 . . . . 0.0 112.086 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.447 HG21 HG21 ' A' ' 166' ' ' VAL . 41.6 t -131.79 131.16 62.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.041 178.12 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 53.5 t -105.29 132.83 51.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.432 179.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -116.44 141.82 47.68 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.307 0.575 . . . . 0.0 110.836 -179.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . 0.49 ' O ' HG22 ' A' ' 182' ' ' ILE . . . -143.57 145.8 15.89 Favored Glycine 0 CA--C 1.528 0.903 0 N-CA-C 110.64 -0.984 . . . . 0.0 110.64 179.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -107.03 149.36 27.65 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.027 0.441 . . . . 0.0 110.594 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . 0.436 HD12 ' O ' ' A' ' 157' ' ' GLU . 49.2 tp -70.29 131.61 44.44 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 179.245 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.543 HG12 ' O ' ' A' ' 157' ' ' GLU . 7.6 p -114.05 -20.27 6.19 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 C-N-CA 120.442 -0.503 . . . . 0.0 111.767 -179.399 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -174.49 172.36 45.32 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 120.711 -0.757 . . . . 0.0 111.722 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . 0.469 HG23 ' CD1' ' A' ' 156' ' ' TYR . 17.5 m -142.96 136.13 28.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.44 -0.38 . . . . 0.0 110.21 -179.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -144.52 120.62 10.77 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.284 0.564 . . . . 0.0 111.745 179.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -62.06 137.35 58.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.465 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -81.22 160.95 24.17 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.099 178.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 25.3 pttm . . . . . 0 C--O 1.22 -0.464 0 CA-C-O 118.188 -0.911 . . . . 0.0 110.869 -179.693 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 702' ' ' LEU . . . . . 0.732 HD21 HD13 ' A' ' 185' ' ' ILE . 0.4 OUTLIER . . . . . 0 CA--C 1.536 0.439 0 N-CA-C 109.483 -0.562 . . . . 20.0 109.483 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 703' ' ' PRO . . . . . 0.591 ' CG ' HG13 ' A' ' 110' ' ' VAL . 3.4 Cg_exo -64.01 179.5 1.08 Allowed 'Trans proline' 0 N--CA 1.491 1.378 0 C-N-CA 122.243 1.962 . . . . 20.0 113.903 -178.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 704' ' ' ALA . . . . . 0.559 ' O ' ' O ' ' B' ' 703' ' ' PRO . . . . . . . . 0 CA--C 1.533 0.311 0 CA-C-N 114.175 -1.375 . . . . 20.0 113.496 -179.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.461 0.077 0 CA-C-O 121.245 0.545 . . . . 0.0 110.542 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 89.8 p -84.26 13.16 5.54 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.914 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 50.9 mtmt -107.29 18.09 22.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.635 -179.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 76.8 mt -56.17 138.97 16.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 122.244 1.021 . . . . 0.0 113.142 -177.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -76.51 132.74 39.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 113.614 -1.63 . . . . 0.0 109.199 178.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.431 ' HB3' ' CG ' ' A' ' 126' ' ' HIS . 3.2 pm0 -77.09 147.5 76.86 Favored Pre-proline 0 C--N 1.324 -0.506 0 C-N-CA 120.513 -0.475 . . . . 0.0 110.14 -179.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.451 ' CB ' ' OE1' ' A' ' 68' ' ' GLU . 66.9 Cg_endo -70.4 160.33 49.88 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 122.861 2.374 . . . . 0.0 112.273 -179.262 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 -52.99 172.18 0.05 Allowed 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 121.311 0.577 . . . . 0.0 111.06 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 98.8 mt -71.25 -10.59 60.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.725 -179.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -69.17 -40.55 78.07 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.408 0.623 . . . . 0.0 111.024 179.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.781 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 90.1 mt-10 -71.44 -26.83 62.9 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.023 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 6.0 t -72.16 -44.25 65.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.67 -179.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -89.91 -9.88 47.25 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.925 -0.31 . . . . 0.0 111.581 -179.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -110.52 -8.0 14.68 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.647 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.781 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -68.44 138.9 55.66 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.35 0.595 . . . . 0.0 111.731 -179.296 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 5.9 m -57.8 102.85 0.11 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.718 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.669 HD13 ' N ' ' A' ' 75' ' ' ASP . 2.0 tm? -68.34 119.28 12.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.39 -178.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.669 ' N ' HD13 ' A' ' 74' ' ' LEU . 89.6 m-20 -97.3 78.47 2.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.393 0.616 . . . . 0.0 109.44 178.058 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -63.77 -36.66 84.6 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.955 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.417 ' HE2' ' H ' ' A' ' 77' ' ' LYS . 0.1 OUTLIER -70.38 -14.5 62.59 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.405 -177.427 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 -90.9 -1.15 57.86 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.301 0.572 . . . . 0.0 110.634 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 74.9 t -84.67 127.21 40.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.389 179.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.656 HD13 ' HE3' ' A' ' 96' ' ' LYS . 18.3 pt -110.97 -11.66 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 C-N-CA 120.803 -0.359 . . . . 0.0 111.798 -179.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.405 ' O ' HG22 ' A' ' 94' ' ' VAL . . . -160.52 163.77 34.19 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 120.556 -0.83 . . . . 0.0 111.384 -179.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.432 HH21 ' HB3' ' A' ' 91' ' ' GLU . 78.8 ttt180 -134.95 138.34 43.96 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.196 0.522 . . . . 0.0 111.35 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.55 HG22 ' O ' ' A' ' 92' ' ' LEU . 20.0 tt -104.12 141.3 20.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.243 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 70.1 m -135.78 128.84 31.56 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.645 -178.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.485 HG22 HG22 ' A' ' 88' ' ' VAL . 79.5 mt -139.23 86.41 14.65 Favored Pre-proline 0 CA--C 1.538 0.501 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.09 -179.405 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -56.66 -29.69 80.77 Favored 'Trans proline' 0 N--CA 1.499 1.827 0 C-N-CA 123.286 2.657 . . . . 0.0 113.523 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 91.7 p -53.23 -42.01 65.98 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 121.291 0.567 . . . . 0.0 110.55 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.493 ' O ' ' OG ' ' A' ' 89' ' ' SER . 34.4 m -114.07 11.23 8.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.596 179.502 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.493 ' OG ' ' O ' ' A' ' 88' ' ' VAL . 14.9 p 51.37 52.38 14.9 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.915 -179.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 54.5 tp -118.33 134.36 55.11 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 121.535 0.683 . . . . 0.0 111.958 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.432 ' HB3' HH21 ' A' ' 82' ' ' ARG . 97.6 mt-10 -146.1 122.89 11.25 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.823 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.55 ' O ' HG22 ' A' ' 83' ' ' ILE . 76.8 mt -149.81 148.88 26.59 Favored Pre-proline 0 CA--C 1.539 0.529 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.316 -179.105 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.18 145.86 27.99 Favored 'Trans proline' 0 N--CA 1.493 1.49 0 C-N-CA 122.436 2.091 . . . . 0.0 111.867 178.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.581 HG23 ' O ' ' A' ' 94' ' ' VAL . 2.0 m -94.02 118.01 38.97 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 CA-C-O 121.53 0.681 . . . . 0.0 110.996 179.428 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.511 ' N ' HD12 ' A' ' 95' ' ' LEU . 11.0 mp -102.6 136.23 42.8 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.098 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.656 ' HE3' HD13 ' A' ' 80' ' ' ILE . 97.1 mttt -64.75 -88.14 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 119.992 -0.683 . . . . 0.0 112.123 -179.065 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 74.0 m -51.79 134.17 30.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.898 -178.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 8.1 m -91.15 74.03 6.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.929 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 55.7 p -88.59 168.48 12.53 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 178.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -61.69 -42.53 99.05 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 119.856 -0.738 . . . . 0.0 109.903 179.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -65.86 -40.38 91.62 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.527 -0.761 . . . . 0.0 111.372 179.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -63.59 -38.93 93.01 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.168 0.508 . . . . 0.0 111.291 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 76.6 mt -61.67 -21.92 64.85 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.763 -179.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 63.1 mt -69.84 -21.43 63.36 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.944 0.402 . . . . 0.0 110.429 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.497 ' O ' HD22 ' A' ' 92' ' ' LEU . 95.9 p -72.98 -7.71 52.39 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 179.172 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.526 ' HA3' HD13 ' A' ' 92' ' ' LEU . . . 91.24 -18.65 50.9 Favored Glycine 0 CA--C 1.53 0.991 0 CA-C-N 115.205 -0.907 . . . . 0.0 112.41 178.462 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -145.95 124.75 12.63 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 119.723 -0.791 . . . . 0.0 112.354 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -143.4 132.77 23.36 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.482 178.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.649 ' HA ' HD23 ' A' ' 123' ' ' LEU . 11.7 m -62.45 131.44 49.2 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 121.01 0.433 . . . . 0.0 110.836 -179.475 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.506 HG13 ' CG ' ' B' ' 703' ' ' PRO . 75.6 t -78.92 -54.56 11.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 C-N-CA 120.576 -0.449 . . . . 0.0 110.673 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.865 ' H ' ' NE2' ' A' ' 114' ' ' GLN . 97.5 mttt -98.39 135.94 39.26 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 122.258 1.027 . . . . 0.0 112.646 179.483 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -66.53 -30.16 70.41 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 113.71 -1.586 . . . . 0.0 113.558 -178.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -83.06 8.57 12.52 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 -177.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . 0.865 ' NE2' ' H ' ' A' ' 111' ' ' LYS . 46.0 mt-30 -80.02 139.56 36.91 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 121.913 -0.492 . . . . 0.0 112.104 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.41 ' O ' ' O ' ' A' ' 118' ' ' LYS . 55.4 t -123.62 125.65 71.71 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.971 178.307 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 97.9 mtp -59.66 129.83 43.83 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.753 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 88.52 -10.74 70.62 Favored Glycine 0 CA--C 1.531 1.062 0 N-CA-C 111.796 -0.522 . . . . 0.0 111.796 178.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.41 ' O ' ' O ' ' A' ' 115' ' ' VAL . 67.4 mttm -141.5 138.25 32.66 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.364 0.602 . . . . 0.0 111.549 179.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 75.03 -163.83 54.32 Favored Glycine 0 CA--C 1.53 0.979 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.554 ' ND2' ' ND1' ' A' ' 177' ' ' HIS . 54.0 t-20 -93.97 104.59 16.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.932 0.396 . . . . 0.0 110.69 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.558 ' CE2' HD21 ' A' ' 123' ' ' LEU . 9.6 t80 -86.49 144.7 27.13 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 178.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.585 ' N ' ' OE1' ' A' ' 114' ' ' GLN . . . -147.66 140.27 24.68 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.043 -0.663 . . . . 0.0 111.248 -179.12 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.649 HD23 ' HA ' ' A' ' 109' ' ' THR . 48.1 mt -137.72 142.53 41.02 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.064 -179.16 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -110.82 138.55 47.07 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 178.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -139.36 151.35 21.84 Favored Glycine 0 CA--C 1.53 0.983 0 N-CA-C 110.441 -1.064 . . . . 0.0 110.441 -179.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . 0.431 ' CG ' ' HB3' ' A' ' 63' ' ' GLN . 19.5 m-70 -96.92 140.44 31.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.435 0.636 . . . . 0.0 111.928 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . 0.593 ' ND2' ' OG1' ' A' ' 186' ' ' THR . 52.2 p-10 -145.55 121.42 10.61 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.537 179.019 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.497 ' O ' ' CB ' ' A' ' 129' ' ' SER . 74.9 mtm -87.3 4.61 42.11 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.174 0.511 . . . . 0.0 110.296 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.497 ' CB ' ' O ' ' A' ' 128' ' ' MET . 1.0 OUTLIER 78.93 13.64 1.23 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.129 179.878 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.829 ' O ' HG12 ' A' ' 133' ' ' VAL . 21.2 ptmt -109.72 124.42 51.21 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 122.168 0.985 . . . . 0.0 113.19 -178.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -43.99 119.49 1.77 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.628 -1.169 . . . . 0.0 110.668 179.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 115.42 -18.69 15.32 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.829 HG12 ' O ' ' A' ' 130' ' ' LYS . 7.6 p -88.93 154.33 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.854 HD23 ' N ' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -69.19 145.06 53.54 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -177.211 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.504 ' CE1' ' O ' ' A' ' 106' ' ' GLY . 3.3 m-85 65.82 6.37 3.92 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 114.017 -1.447 . . . . 0.0 114.15 178.027 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . 0.54 ' OG ' ' CG1' ' A' ' 133' ' ' VAL . 2.7 m -75.24 -36.3 61.32 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 179.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 51.9 p-10 -94.48 7.1 46.73 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 114.277 1.214 . . . . 0.0 114.277 -176.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.504 HD11 ' HB ' ' A' ' 186' ' ' THR . 38.6 pt -72.5 -23.79 21.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 C-N-CA 119.344 -0.943 . . . . 0.0 110.663 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.679 ' HB2' ' OH ' ' A' ' 197' ' ' TYR . . . -71.14 -10.34 59.58 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 121.017 0.436 . . . . 0.0 110.614 179.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 66.6 m -81.0 -7.34 59.53 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.286 0.565 . . . . 0.0 110.271 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 88.6 mt -67.47 146.36 54.06 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.041 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -123.8 166.46 15.57 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.392 178.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -52.15 140.61 20.59 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.518 0.675 . . . . 0.0 112.359 179.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 77.99 7.13 87.6 Favored Glycine 0 CA--C 1.529 0.915 0 CA-C-N 115.139 -0.937 . . . . 0.0 112.283 178.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -71.97 133.9 45.62 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 118.925 -1.11 . . . . 0.0 110.165 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -79.72 136.2 36.71 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.759 0.79 . . . . 0.0 111.836 -178.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 97.8 mt -134.82 135.06 53.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 178.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . 0.69 ' C ' HD23 ' A' ' 149' ' ' LEU . 79.5 m-85 -121.98 135.57 54.86 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 119.858 -0.737 . . . . 0.0 112.632 -177.24 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.69 HD23 ' C ' ' A' ' 148' ' ' TYR . 0.3 OUTLIER -112.43 135.13 53.51 Favored 'General case' 0 C--O 1.224 -0.24 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 178.062 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.503 ' CE1' ' CD ' ' A' ' 155' ' ' GLU . 75.3 m-85 -109.71 108.95 19.51 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 120.247 -0.581 . . . . 0.0 111.712 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . 0.509 ' OD1' ' N ' ' A' ' 152' ' ' ASN . 53.8 t0 -87.74 165.23 15.51 Favored 'General case' 0 N--CA 1.447 -0.625 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 177.034 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . 0.509 ' N ' ' OD1' ' A' ' 151' ' ' ASP . 50.8 p-10 -59.28 -21.17 59.25 Favored 'General case' 0 C--N 1.312 -1.027 0 C-N-CA 119.522 -0.871 . . . . 0.0 110.978 -178.442 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.468 ' N ' ' OD1' ' A' ' 152' ' ' ASN . 95.4 mt-10 -115.92 -26.83 7.18 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 113.691 0.997 . . . . 0.0 113.691 -178.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -146.38 175.89 10.2 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 119.0 -1.08 . . . . 0.0 113.154 -176.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.503 ' CD ' ' CE1' ' A' ' 150' ' ' TYR . 82.5 tt0 -127.19 134.66 50.11 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 114.839 -1.073 . . . . 0.0 109.915 179.268 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -109.25 135.18 50.76 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 121.301 0.572 . . . . 0.0 112.094 -179.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . 0.475 ' O ' HD12 ' A' ' 203' ' ' LEU . 98.0 mt-10 -93.21 110.08 21.59 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.557 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 43.9 m-85 -113.92 148.81 36.16 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 120.91 0.386 . . . . 0.0 111.386 179.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -125.0 125.98 44.73 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.35 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 80.0 t -57.71 131.24 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 178.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 16.5 p -113.59 7.32 17.32 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 123.673 0.608 . . . . 0.0 112.529 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 135.79 177.37 14.93 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 120.108 -1.044 . . . . 0.0 112.515 178.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.412 HG22 ' N ' ' A' ' 164' ' ' SER . 5.8 p -135.3 154.26 35.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.165 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . 0.412 ' N ' HG22 ' A' ' 163' ' ' VAL . 25.8 p -144.66 166.89 23.91 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.042 -0.663 . . . . 0.0 111.722 -179.165 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -104.12 117.97 35.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.479 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.474 ' O ' ' O ' ' A' ' 196' ' ' ARG . 27.9 m -135.84 160.1 39.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.488 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . 0.423 ' H ' ' HG3' ' A' ' 170' ' ' LYS . 0.2 OUTLIER -85.34 158.08 58.19 Favored Pre-proline 0 CA--C 1.538 0.508 0 CA-C-O 121.055 0.455 . . . . 0.0 110.888 -179.572 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . 0.495 ' O ' ' CB ' ' B' ' 702' ' ' LEU . 28.2 Cg_endo -64.69 -17.58 59.96 Favored 'Trans proline' 0 N--CA 1.499 1.803 0 C-N-CA 123.227 2.618 . . . . 0.0 113.038 -179.256 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 48.9 p-10 -90.88 -2.73 57.72 Favored 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 120.148 -0.621 . . . . 0.0 110.958 179.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.644 ' O ' HG22 ' A' ' 173' ' ' VAL . 71.1 mmtt -73.88 76.97 1.64 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.441 0.639 . . . . 0.0 111.388 -179.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' TRP . . . . . 0.71 ' HE1' ' CE ' ' A' ' 111' ' ' LYS . 5.7 t90 -69.81 -15.74 63.16 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.334 179.506 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -63.38 -32.16 73.51 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.81 -179.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . 0.644 HG22 ' O ' ' A' ' 170' ' ' LYS . 14.6 m -62.3 -14.57 12.8 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 120.599 -0.441 . . . . 0.0 111.76 -179.059 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 1.8 t -103.95 -9.71 9.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -179.124 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -72.35 162.72 29.09 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.117 0.484 . . . . 0.0 110.78 -179.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . 0.418 ' N ' ' OD1' ' A' ' 176' ' ' ASP . 35.5 p-10 -65.03 141.31 58.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.897 179.55 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' HIS . . . . . 0.554 ' ND1' ' ND2' ' A' ' 120' ' ' ASN . 66.2 m80 -113.26 10.41 18.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.321 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 66.18 39.28 94.47 Favored Glycine 0 CA--C 1.53 1.008 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 179.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -165.46 171.01 13.81 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.868 0.366 . . . . 0.0 110.914 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -86.94 102.96 14.86 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 177.157 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -137.02 161.68 35.39 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.347 0.594 . . . . 0.0 111.512 -178.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 20.3 tt -129.93 139.01 52.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.471 178.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 86.4 m -129.24 125.02 35.97 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.188 0.518 . . . . 0.0 112.02 -178.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 84.9 mt -109.3 131.91 54.62 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.769 HD13 HD21 ' B' ' 702' ' ' LEU . 88.9 mt -116.15 125.2 73.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 CA-C-O 121.376 0.608 . . . . 0.0 111.276 -179.064 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' THR . . . . . 0.593 ' OG1' ' ND2' ' A' ' 127' ' ' ASN . 1.7 t -142.03 163.87 31.72 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 115.263 -0.881 . . . . 0.0 110.851 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' CYS . . . . . . . . . . . . . 1.9 m -95.86 143.51 27.0 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 120.967 0.413 . . . . 0.0 110.847 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 44.2 t -61.4 -48.45 88.79 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 CA-C-O 121.069 0.462 . . . . 0.0 111.206 -179.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 8.5 t -169.38 158.79 8.27 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.226 0.536 . . . . 0.0 110.878 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . 0.516 HG23 ' HG2' ' A' ' 191' ' ' LYS . 29.2 m -71.96 -17.65 19.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.347 179.304 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . 0.516 ' HG2' HG23 ' A' ' 190' ' ' VAL . 74.7 mmtt -99.19 -4.59 31.73 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.146 179.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 53.8 t0 -139.68 97.15 3.2 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 120.991 0.424 . . . . 0.0 110.972 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 43.3 p-10 -107.88 10.19 28.61 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.357 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 69.7 m -61.2 -41.7 97.28 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 120.811 0.339 . . . . 0.0 111.414 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -144.68 155.72 43.72 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.327 0.584 . . . . 0.0 111.57 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . 0.474 ' O ' ' O ' ' A' ' 166' ' ' VAL . 99.9 mtt180 -132.56 142.2 49.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.004 -179.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . 0.679 ' OH ' ' HB2' ' A' ' 139' ' ' ALA . 47.8 p90 -99.08 151.67 20.69 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.315 0.578 . . . . 0.0 111.203 179.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 45.8 t -123.88 134.05 67.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.462 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 69.9 t -96.79 134.83 32.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.964 0.412 . . . . 0.0 110.036 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -116.3 138.29 51.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.358 0.599 . . . . 0.0 111.174 -179.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -134.83 138.0 9.69 Favored Glycine 0 CA--C 1.529 0.917 0 N-CA-C 110.179 -1.168 . . . . 0.0 110.179 179.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . 0.598 ' OD1' ' N ' ' A' ' 203' ' ' LEU . 42.5 t0 -108.89 140.53 42.24 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.15 0.5 . . . . 0.0 111.669 -179.185 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . 0.598 ' N ' ' OD1' ' A' ' 202' ' ' ASP . 54.6 tp -63.34 133.61 54.39 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.073 179.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -116.09 -18.88 6.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.074 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . 0.454 ' O ' HD11 ' A' ' 203' ' ' LEU . . . -178.36 172.94 45.43 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 120.645 -0.788 . . . . 0.0 111.824 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 31.7 m -142.94 138.91 30.47 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -145.37 122.27 11.3 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.462 -0.495 . . . . 0.0 111.629 178.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -61.98 138.77 58.41 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.391 0.615 . . . . 0.0 110.854 -179.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 13.6 ttmt -79.14 109.47 13.48 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.95 178.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 99.8 mttt . . . . . 0 C--O 1.219 -0.532 0 CA-C-O 117.953 -1.022 . . . . 0.0 110.383 -179.846 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 702' ' ' LEU . . . . . 0.769 HD21 HD13 ' A' ' 185' ' ' ILE . 0.9 OUTLIER . . . . . 0 CA--C 1.545 0.751 0 CA-C-O 120.492 0.187 . . . . 20.0 111.159 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 703' ' ' PRO . . . . . 0.537 ' O ' ' O ' ' B' ' 704' ' ' ALA . 3.0 Cg_exo -65.65 -168.58 0.13 Allowed 'Trans proline' 0 N--CA 1.492 1.398 0 C-N-CA 122.377 2.052 . . . . 20.0 113.484 -179.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 704' ' ' ALA . . . . . 0.537 ' O ' ' O ' ' B' ' 703' ' ' PRO . . . . . . . . 0 C--N 1.332 -0.191 0 CA-C-N 114.501 -1.227 . . . . 20.0 113.058 -179.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.321 0 CA-C-O 121.265 0.555 . . . . 0.0 110.679 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 23.6 p -82.99 18.74 1.55 Allowed 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.735 -0.666 . . . . 0.0 112.718 -178.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -105.15 17.38 24.15 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.661 -0.416 . . . . 0.0 111.638 -179.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.6 mt -55.41 135.31 18.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 122.124 0.964 . . . . 0.0 112.479 -177.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -76.75 131.92 39.0 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 113.885 -1.507 . . . . 0.0 108.961 178.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.647 ' H ' ' CD ' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -79.23 149.82 73.28 Favored Pre-proline 0 C--N 1.326 -0.449 0 C-N-CA 120.383 -0.527 . . . . 0.0 110.634 -179.074 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -71.0 165.19 33.18 Favored 'Trans proline' 0 N--CA 1.496 1.654 0 C-N-CA 122.888 2.392 . . . . 0.0 113.338 -179.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.815 ' O ' HG23 ' A' ' 69' ' ' VAL . 94.0 m-20 -53.02 164.94 0.35 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.684 179.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 1.033 HD21 HG23 ' A' ' 133' ' ' VAL . 89.1 mt -63.81 -45.37 89.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.285 -179.307 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.17 -36.84 84.95 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.473 -0.491 . . . . 0.0 111.071 -178.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -63.04 -29.91 71.18 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.498 0.666 . . . . 0.0 109.478 178.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.815 HG23 ' O ' ' A' ' 65' ' ' ASP . 38.7 t -76.71 -46.27 30.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.108 179.245 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -73.08 -9.01 58.27 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.811 -1.086 . . . . 0.0 111.438 -179.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 96.8 m-20 -106.43 -12.89 15.51 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.525 0.678 . . . . 0.0 109.655 178.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.4 139.71 55.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.044 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 35.5 t -59.06 103.17 0.15 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.013 179.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.663 ' C ' HD23 ' A' ' 74' ' ' LEU . 6.9 tt -70.16 123.79 22.49 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.266 0.555 . . . . 0.0 111.068 -179.281 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.613 ' N ' HD23 ' A' ' 74' ' ' LEU . 84.9 m-20 -96.35 80.11 3.16 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.044 -179.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.655 ' O ' HG12 ' A' ' 79' ' ' VAL . 64.5 pttt -79.49 -15.67 57.36 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.742 0.782 . . . . 0.0 109.539 178.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 21.2 mtmt -65.82 -36.28 83.04 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.764 -1.107 . . . . 0.0 111.41 -178.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -87.04 0.07 55.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.941 0.4 . . . . 0.0 111.333 -179.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.655 HG12 ' O ' ' A' ' 76' ' ' LYS . 2.3 p -68.36 132.43 32.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.534 0.683 . . . . 0.0 110.683 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 8.6 pt -111.4 -5.81 11.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.427 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -171.74 176.9 44.78 Favored Glycine 0 CA--C 1.531 1.036 0 N-CA-C 111.162 -0.775 . . . . 0.0 111.162 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.408 ' NH2' ' HB3' ' A' ' 91' ' ' GLU . 51.1 ttt85 -135.92 154.42 51.13 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.715 HG22 ' O ' ' A' ' 92' ' ' LEU . 20.1 tt -119.07 137.02 54.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 CA-C-O 121.6 0.714 . . . . 0.0 110.124 179.108 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 8.6 t -135.15 125.35 26.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.771 -178.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.54 ' CG2' HG22 ' A' ' 88' ' ' VAL . 81.0 mt -135.56 90.23 20.5 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.203 179.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -56.38 -32.04 87.35 Favored 'Trans proline' 0 N--CA 1.494 1.535 0 C-N-CA 123.069 2.513 . . . . 0.0 112.637 -179.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 10.7 t -54.77 -42.44 71.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.294 -179.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.54 HG22 ' CG2' ' A' ' 85' ' ' ILE . 27.2 m -113.81 11.28 8.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.328 0.585 . . . . 0.0 110.351 179.135 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 50.19 48.08 22.68 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.265 179.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 47.8 tp -109.75 132.1 54.46 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.472 0.653 . . . . 0.0 110.802 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.408 ' HB3' ' NH2' ' A' ' 82' ' ' ARG . 97.6 mt-10 -144.13 113.78 7.13 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.083 -178.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.715 ' O ' HG22 ' A' ' 83' ' ' ILE . 93.7 mt -147.36 147.44 28.34 Favored Pre-proline 0 CA--C 1.537 0.465 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.656 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -74.4 146.92 36.0 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.593 2.195 . . . . 0.0 112.411 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.539 ' C ' HD12 ' A' ' 95' ' ' LEU . 78.8 t -94.44 120.14 43.42 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-O 121.002 0.429 . . . . 0.0 110.929 179.351 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.588 ' N ' HD12 ' A' ' 95' ' ' LEU . 10.6 mp -101.02 126.46 47.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.488 0.661 . . . . 0.0 110.962 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.54 ' O ' ' OG1' ' A' ' 109' ' ' THR . 87.2 tttt -64.07 -44.32 92.77 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.267 -0.879 . . . . 0.0 112.316 -178.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 4.2 m -85.59 130.83 34.48 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 121.039 0.447 . . . . 0.0 111.997 -179.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 3.5 p -90.64 59.04 4.1 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.547 179.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 3.3 m -92.72 164.74 13.26 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 179.077 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -58.21 -43.15 87.49 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 120.568 -0.453 . . . . 0.0 111.143 -179.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -64.96 -36.94 86.02 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.542 0.687 . . . . 0.0 110.009 178.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -64.4 -38.61 91.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.565 -179.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.405 ' HA ' HD23 ' A' ' 103' ' ' LEU . 96.9 mt -63.9 -11.97 32.72 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.913 -178.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 88.9 mt -73.95 -20.74 60.27 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.477 -0.489 . . . . 0.0 110.463 179.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 76.2 p -74.41 -4.77 38.5 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.169 -179.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 85.79 -19.25 26.15 Favored Glycine 0 CA--C 1.529 0.931 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.894 178.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -146.65 123.69 11.42 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.588 0.709 . . . . 0.0 111.804 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -146.21 137.15 24.38 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.159 178.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.54 ' OG1' ' O ' ' A' ' 96' ' ' LYS . 68.1 p -64.14 133.93 53.89 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.043 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.564 HG13 ' CG ' ' B' ' 703' ' ' PRO . 37.7 t -81.43 -56.92 5.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.29 0.567 . . . . 0.0 110.568 -179.503 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.415 ' HB3' ' NE2' ' A' ' 114' ' ' GLN . 85.5 tttt -93.07 128.44 38.97 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.988 -179.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -67.01 -31.25 71.67 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 -177.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 72.4 m-80 -82.98 11.61 5.96 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 114.238 1.199 . . . . 0.0 114.238 -176.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . 0.461 ' OE1' ' N ' ' A' ' 122' ' ' ALA . 32.8 mt-30 -81.49 143.52 32.0 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.207 -0.597 . . . . 0.0 111.528 178.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 54.7 t -123.64 125.21 71.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.575 179.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' MET . . . . . 0.437 ' CG ' ' CZ ' ' A' ' 121' ' ' TYR . 97.3 mtp -57.58 130.43 46.31 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.99 0.424 . . . . 0.0 111.602 -179.313 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.426 ' HA3' ' CE2' ' A' ' 156' ' ' TYR . . . 80.64 -2.97 76.68 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 120.935 -0.65 . . . . 0.0 111.839 178.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 55.6 tttm -139.22 126.87 21.86 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.12 0.486 . . . . 0.0 110.655 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 74.86 -164.01 54.43 Favored Glycine 0 CA--C 1.529 0.962 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 -179.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 64.4 t-20 -92.7 106.79 18.71 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.978 0.418 . . . . 0.0 110.562 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.668 ' CE2' HD11 ' A' ' 123' ' ' LEU . 4.0 t80 -83.98 144.58 29.05 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.474 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.82 ' C ' HD12 ' A' ' 123' ' ' LEU . . . -146.83 140.3 25.66 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 119.777 -0.769 . . . . 0.0 112.575 -177.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.82 HD12 ' C ' ' A' ' 122' ' ' ALA . 7.2 mp -139.09 144.74 38.86 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.509 -179.525 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -108.51 139.9 42.6 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -144.6 159.36 27.77 Favored Glycine 0 CA--C 1.53 0.977 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 -179.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 60.5 m-70 -99.08 137.14 38.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.35 0.595 . . . . 0.0 111.932 -179.236 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 64.8 t-20 -131.69 120.2 22.43 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.941 179.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.548 ' CE ' HE21 ' A' ' 63' ' ' GLN . 64.1 mtt -92.88 -4.48 52.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.189 0.518 . . . . 0.0 111.021 -179.182 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.476 ' CB ' ' O ' ' A' ' 128' ' ' MET . 0.9 OUTLIER 79.25 11.75 1.35 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.846 -0.615 . . . . 0.0 112.149 179.03 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.881 ' O ' HG12 ' A' ' 133' ' ' VAL . 58.8 pttt -126.67 128.31 46.52 Favored 'General case' 0 C--O 1.222 -0.346 0 CA-C-O 122.1 0.952 . . . . 0.0 112.801 -179.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.482 ' O ' ' O ' ' A' ' 130' ' ' LYS . 29.5 tptt -37.54 162.64 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.833 -1.076 . . . . 0.0 110.289 178.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.431 ' H ' ' HG3' ' A' ' 131' ' ' LYS . . . 73.78 -24.18 1.02 Allowed Glycine 0 CA--C 1.529 0.911 0 N-CA-C 111.837 -0.505 . . . . 0.0 111.837 178.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 1.033 HG23 HD21 ' A' ' 66' ' ' LEU . 2.9 p -91.16 175.86 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 O-C-N 122.325 -0.515 . . . . 0.0 111.535 -178.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.79 ' O ' ' N ' ' A' ' 136' ' ' SER . 3.9 mm? -60.11 167.09 2.49 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 121.209 0.528 . . . . 0.0 112.349 -177.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.592 ' CG ' HD12 ' A' ' 138' ' ' ILE . 3.7 m-30 22.4 21.01 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 113.947 -1.478 . . . . 0.0 113.868 178.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . 0.79 ' N ' ' O ' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -64.37 -44.88 90.01 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 113.69 0.996 . . . . 0.0 113.69 -178.318 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -89.25 -3.88 58.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.98 0.419 . . . . 0.0 111.516 -178.178 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.592 HD12 ' CG ' ' A' ' 135' ' ' PHE . 0.2 OUTLIER -61.47 -40.69 87.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.569 179.697 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -65.26 -10.67 34.06 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 120.284 -0.567 . . . . 0.0 110.144 179.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 5.9 p -85.34 -2.6 58.26 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.432 179.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 73.0 mt -63.39 143.44 57.81 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-O 121.203 0.525 . . . . 0.0 110.262 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.439 ' N ' ' OD2' ' A' ' 145' ' ' ASP . 89.0 tttt -119.41 155.0 32.81 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.44 0.638 . . . . 0.0 111.873 -178.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -50.75 133.74 25.71 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.424 179.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.56 ' N ' ' O ' ' A' ' 160' ' ' VAL . . . 79.33 7.95 88.13 Favored Glycine 0 CA--C 1.528 0.88 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.603 179.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.439 ' OD2' ' N ' ' A' ' 142' ' ' LYS . 77.2 m-20 -75.35 137.63 41.22 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 119.31 -0.956 . . . . 0.0 110.568 -179.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -79.12 139.99 37.92 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.526 -0.761 . . . . 0.0 112.799 -178.236 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.457 HG23 HG12 ' A' ' 85' ' ' ILE . 97.2 mt -139.12 137.52 41.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 114.762 -1.108 . . . . 0.0 108.346 178.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . 0.641 ' C ' HD23 ' A' ' 149' ' ' LEU . 93.2 m-85 -123.65 137.58 54.7 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.022 -0.671 . . . . 0.0 112.556 -178.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.641 HD23 ' C ' ' A' ' 148' ' ' TYR . 0.8 OUTLIER -115.7 136.61 52.89 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 177.704 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.418 ' CD2' ' HB2' ' A' ' 155' ' ' GLU . 77.6 m-85 -112.94 113.27 25.26 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 119.98 -0.688 . . . . 0.0 111.561 179.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . 0.589 ' OD1' ' N ' ' A' ' 152' ' ' ASN . 66.2 t0 -87.53 162.03 17.44 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 177.247 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . 0.589 ' N ' ' OD1' ' A' ' 151' ' ' ASP . 65.2 m-20 -55.37 -24.19 28.27 Favored 'General case' 0 C--N 1.315 -0.893 0 C-N-CA 119.337 -0.945 . . . . 0.0 110.047 -178.172 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -108.3 -30.16 8.49 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 113.699 1.0 . . . . 0.0 113.699 -177.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . 0.446 ' O ' ' N ' ' A' ' 151' ' ' ASP . 0.3 OUTLIER -148.93 -178.13 6.19 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 119.089 -1.044 . . . . 0.0 113.736 -177.328 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.418 ' HB2' ' CD2' ' A' ' 150' ' ' TYR . 0.0 OUTLIER -130.43 144.33 51.33 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 114.478 -1.237 . . . . 0.0 110.05 178.921 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . 0.426 ' CE2' ' HA3' ' A' ' 117' ' ' GLY . 82.5 m-85 -120.97 139.89 52.63 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 120.972 0.415 . . . . 0.0 111.573 -178.541 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -96.43 115.65 27.77 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.564 179.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 50.1 m-85 -116.97 151.57 36.43 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.001 0.429 . . . . 0.0 111.416 179.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.405 ' HB2' HG21 ' A' ' 204' ' ' VAL . . . -124.45 124.82 43.14 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.132 179.076 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.56 ' O ' ' N ' ' A' ' 144' ' ' GLY . 96.4 t -60.08 136.62 23.51 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 178.103 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 7.6 p -105.1 -23.19 12.97 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.666 178.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 159.37 -168.13 35.22 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 120.488 -0.863 . . . . 0.0 111.969 179.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 15.0 p -137.73 146.72 26.98 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 179.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 28.3 m -142.3 172.03 13.24 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 120.955 0.407 . . . . 0.0 111.174 -179.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -111.26 125.74 54.15 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.477 0.656 . . . . 0.0 111.534 -179.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 30.6 m -137.36 164.74 28.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.559 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -82.69 158.73 65.08 Favored Pre-proline 0 CA--C 1.536 0.408 0 CA-C-O 121.047 0.451 . . . . 0.0 110.996 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . 0.486 ' O ' ' CB ' ' B' ' 702' ' ' LEU . 44.3 Cg_endo -67.05 -15.98 48.11 Favored 'Trans proline' 0 N--CA 1.497 1.679 0 C-N-CA 122.85 2.367 . . . . 0.0 111.6 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . 0.409 ' OD1' ' C ' ' A' ' 169' ' ' ASP . 40.9 p-10 -93.17 -6.43 47.83 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.911 179.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.654 ' O ' HG22 ' A' ' 173' ' ' VAL . 16.7 mttm -74.64 82.65 2.05 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.46 0.648 . . . . 0.0 111.397 -179.573 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 21.9 t90 -73.12 -14.14 61.32 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.803 179.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.487 ' OE1' ' OE1' ' A' ' 175' ' ' GLU . 52.1 tp10 -58.58 -31.25 67.84 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 115.052 -0.976 . . . . 0.0 111.831 -179.386 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . 0.654 HG22 ' O ' ' A' ' 170' ' ' LYS . 28.2 m -64.2 -20.78 27.56 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 120.618 -0.433 . . . . 0.0 112.04 -178.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.468 ' O ' HG12 ' A' ' 174' ' ' VAL . 49.5 t -98.74 -9.11 9.0 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -178.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.487 ' OE1' ' OE1' ' A' ' 172' ' ' GLU . 98.1 mt-10 -74.86 148.28 40.34 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 121.394 0.616 . . . . 0.0 111.585 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 46.6 p-10 -60.2 141.6 55.74 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.363 -179.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' HIS . . . . . 0.482 ' CE1' ' O ' ' A' ' 175' ' ' GLU . 80.5 m80 -117.67 16.85 14.49 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.537 -179.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 66.51 39.08 93.9 Favored Glycine 0 CA--C 1.532 1.102 0 N-CA-C 111.361 -0.696 . . . . 0.0 111.361 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 15.7 ptmt -163.26 167.1 22.4 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.997 -0.372 . . . . 0.0 109.997 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -87.05 92.31 9.0 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 178.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . 0.447 ' HG2' ' N ' ' A' ' 182' ' ' ILE . 82.9 tt0 -124.62 164.62 19.47 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.404 0.621 . . . . 0.0 111.441 -179.24 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.511 HG22 ' O ' ' A' ' 201' ' ' GLY . 18.1 tt -130.7 138.61 53.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.286 178.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 85.9 m -129.5 125.98 37.59 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 121.145 0.498 . . . . 0.0 111.877 -179.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 93.7 mt -109.53 130.59 55.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.874 178.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.717 HD13 HD21 ' B' ' 702' ' ' LEU . 83.0 mt -113.94 124.07 70.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.205 0.526 . . . . 0.0 111.287 -179.114 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' THR . . . . . 0.625 ' OG1' ' CZ ' ' A' ' 197' ' ' TYR . 0.1 OUTLIER -139.51 167.48 21.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.558 -0.747 . . . . 0.0 110.142 179.448 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' CYS . . . . . . . . . . . . . 8.9 m -95.49 142.2 28.12 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 45.2 t -60.66 -44.39 96.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 120.641 -0.424 . . . . 0.0 110.74 -179.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 47.5 t -166.64 148.69 6.46 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.163 -0.615 . . . . 0.0 111.613 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 10.9 p -65.2 -22.35 31.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.403 179.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -92.93 -13.28 29.06 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.598 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -143.67 98.32 3.22 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 121.179 0.514 . . . . 0.0 110.938 179.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -103.83 9.16 37.03 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.592 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 89.3 p -59.67 -33.82 72.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.018 -179.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -130.77 146.48 52.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.258 0.551 . . . . 0.0 110.925 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -125.36 135.42 52.42 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.28 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . 0.625 ' CZ ' ' OG1' ' A' ' 186' ' ' THR . 35.6 p90 -98.22 151.06 20.85 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.402 -0.519 . . . . 0.0 110.309 179.393 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 53.0 t -127.05 133.32 68.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.287 0.565 . . . . 0.0 111.549 -179.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 42.1 t -107.48 130.29 59.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.211 178.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -119.55 152.25 37.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.463 0.649 . . . . 0.0 111.976 -178.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . 0.511 ' O ' HG22 ' A' ' 182' ' ' ILE . . . -138.98 151.58 21.81 Favored Glycine 0 CA--C 1.533 1.175 0 N-CA-C 110.593 -1.003 . . . . 0.0 110.593 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . 0.552 ' OD1' ' N ' ' A' ' 203' ' ' LEU . 67.1 t0 -113.77 137.39 51.71 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 120.877 0.37 . . . . 0.0 111.182 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . 0.552 ' N ' ' OD1' ' A' ' 202' ' ' ASP . 53.6 tp -59.96 131.57 51.26 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.405 HG21 ' HB2' ' A' ' 159' ' ' ALA . 86.0 t -112.85 -19.78 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.969 -179.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . 0.482 ' O ' HD11 ' A' ' 203' ' ' LEU . . . -178.6 174.49 46.68 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 120.92 -0.657 . . . . 0.0 111.801 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 26.9 m -138.81 132.31 30.39 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -142.71 116.4 9.22 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.526 0.679 . . . . 0.0 112.239 -179.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -63.55 144.88 56.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.328 -0.851 . . . . 0.0 112.139 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 23.6 ttpt -78.68 109.6 13.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.528 178.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 59.2 pttt . . . . . 0 C--O 1.218 -0.565 0 CA-C-O 118.207 -0.901 . . . . 0.0 110.082 178.998 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 702' ' ' LEU . . . . . 0.717 HD21 HD13 ' A' ' 185' ' ' ILE . 1.3 mt . . . . . 0 CA--C 1.542 0.663 0 CA-C-O 120.67 0.272 . . . . 20.0 111.416 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 703' ' ' PRO . . . . . 0.579 ' O ' ' O ' ' B' ' 704' ' ' ALA . 4.0 Cg_exo -64.8 -170.04 0.13 Allowed 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 121.97 1.78 . . . . 20.0 113.562 -179.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 704' ' ' ALA . . . . . 0.579 ' O ' ' O ' ' B' ' 703' ' ' PRO . . . . . . . . 0 CA--C 1.531 0.224 0 CA-C-N 114.256 -1.338 . . . . 20.0 113.458 -179.099 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.35 0 CA-C-O 121.026 0.441 . . . . 0.0 111.359 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.48 ' CB ' ' O ' ' B' ' 702' ' ' LEU . 3.9 p -82.01 21.07 0.91 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.123 -0.489 . . . . 0.0 112.073 -179.145 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 58.4 mtpt -106.73 23.67 13.93 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.137 0.494 . . . . 0.0 111.449 -179.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.6 mt -55.62 136.67 17.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 122.227 1.013 . . . . 0.0 112.189 -177.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -76.88 131.68 38.72 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 113.783 -1.553 . . . . 0.0 108.266 178.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.737 ' N ' HE21 ' A' ' 63' ' ' GLN . 0.0 OUTLIER -77.11 148.7 78.67 Favored Pre-proline 0 C--N 1.325 -0.469 0 C-N-CA 120.363 -0.535 . . . . 0.0 110.622 -178.679 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.541 ' CB ' ' OE1' ' A' ' 68' ' ' GLU . 65.2 Cg_endo -70.79 163.29 39.62 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 123.291 2.661 . . . . 0.0 113.878 -178.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -58.58 168.63 1.11 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.001 -1.0 . . . . 0.0 111.434 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 96.0 mt -70.36 -15.04 62.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.291 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -69.72 -40.3 76.32 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.346 0.593 . . . . 0.0 110.658 178.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.815 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 82.2 tt0 -66.42 -28.84 68.93 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.464 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 59.8 t -69.73 -45.29 77.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.288 179.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.42 -10.78 59.74 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.658 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -116.12 -2.81 12.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.299 0.571 . . . . 0.0 110.429 179.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.815 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -68.9 -172.34 0.38 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.712 0.767 . . . . 0.0 112.085 -178.598 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.6 p -101.4 104.38 15.35 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.016 178.31 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 42.8 tp -70.22 129.62 39.85 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.273 0.559 . . . . 0.0 111.503 -178.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -118.99 77.39 1.18 Allowed 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 177.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.692 ' O ' HG12 ' A' ' 79' ' ' VAL . 82.6 tttt -84.46 -35.8 22.74 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.297 -0.865 . . . . 0.0 112.542 -179.368 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 50.1 mmtt -75.03 -11.45 60.1 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.0 0.429 . . . . 0.0 111.132 -177.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -91.93 -0.51 57.5 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.09 0.471 . . . . 0.0 110.459 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.692 HG12 ' O ' ' A' ' 76' ' ' LYS . 9.5 p -76.86 128.5 37.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.147 0.498 . . . . 0.0 110.941 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.507 HD13 ' CE ' ' A' ' 96' ' ' LYS . 18.2 pt -106.55 -8.33 10.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.307 0.575 . . . . 0.0 110.066 179.354 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -171.19 169.38 42.43 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 109.894 -1.283 . . . . 0.0 109.894 179.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.722 ' HA ' HG23 ' A' ' 94' ' ' VAL . 33.7 ptt-85 -146.71 154.58 41.59 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.364 0.602 . . . . 0.0 112.01 -179.605 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 19.0 tt -103.69 141.63 19.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.645 -179.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 47.9 t -136.7 129.87 31.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.671 -179.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.61 ' CG2' HG22 ' A' ' 88' ' ' VAL . 93.7 mt -138.07 87.25 16.53 Favored Pre-proline 0 CA--C 1.535 0.381 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.839 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_exo -56.64 -30.76 84.86 Favored 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 122.801 2.334 . . . . 0.0 112.034 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 44.2 m -53.27 -42.09 66.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.75 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.61 HG22 ' CG2' ' A' ' 85' ' ' ILE . 17.6 m -114.25 11.23 7.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.719 179.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.511 ' O ' ' OG ' ' A' ' 89' ' ' SER . 1.6 p 51.31 51.29 17.18 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.128 179.686 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 59.0 tp -119.14 133.67 55.65 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 121.375 0.607 . . . . 0.0 111.183 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -147.09 124.94 11.91 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.102 179.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.504 HD13 ' HA3' ' A' ' 106' ' ' GLY . 78.0 mt -149.55 146.73 21.33 Favored Pre-proline 0 CA--C 1.539 0.524 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.341 -179.442 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -74.17 145.11 34.44 Favored 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 122.555 2.17 . . . . 0.0 111.389 178.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.722 HG23 ' HA ' ' A' ' 82' ' ' ARG . 18.3 t -96.41 120.18 45.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-O 121.137 0.494 . . . . 0.0 112.091 -179.332 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.56 HD12 ' C ' ' A' ' 94' ' ' VAL . 10.2 mp -102.67 138.71 39.21 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.735 179.376 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.507 ' CE ' HD13 ' A' ' 80' ' ' ILE . 98.2 mttt -62.12 -82.22 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.372 0.606 . . . . 0.0 112.104 -179.163 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 31.3 m -56.89 134.55 55.52 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.587 -178.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 74.0 p -92.27 70.23 5.21 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.791 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 63.2 p -92.73 170.44 9.71 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.537 178.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -60.75 -43.07 98.42 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 178.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -65.75 -41.68 91.84 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.496 179.451 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -64.49 -37.47 87.64 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.989 -179.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 74.4 mt -64.71 -14.37 58.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.042 -0.526 . . . . 0.0 112.062 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 94.8 mt -72.42 -28.43 62.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.986 0.422 . . . . 0.0 111.317 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.401 ' O ' HD22 ' A' ' 92' ' ' LEU . 86.8 p -73.42 -3.98 30.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.393 0.616 . . . . 0.0 109.813 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.504 ' HA3' HD13 ' A' ' 92' ' ' LEU . . . 92.29 -18.52 54.1 Favored Glycine 0 CA--C 1.533 1.209 0 CA-C-N 115.432 -0.804 . . . . 0.0 113.946 177.324 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -145.47 128.16 16.21 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 118.294 1.047 . . . . 0.0 113.147 -178.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -145.67 140.95 27.66 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 114.924 -1.034 . . . . 0.0 110.087 178.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.514 ' HA ' HD23 ' A' ' 123' ' ' LEU . 30.2 p -68.6 140.25 55.55 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.311 0.577 . . . . 0.0 111.443 -179.17 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.733 HG11 HG11 ' A' ' 174' ' ' VAL . 71.6 t -79.88 -58.17 4.22 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 CA-C-N 115.723 -0.672 . . . . 0.0 111.539 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.598 ' H ' ' NE2' ' A' ' 114' ' ' GLN . 68.5 mmtt -105.06 138.69 40.87 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 121.862 0.839 . . . . 0.0 111.838 179.488 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -65.74 -30.36 71.01 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 114.848 -1.069 . . . . 0.0 113.071 -178.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -79.83 13.93 1.96 Allowed 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.373 -0.531 . . . . 0.0 112.283 -178.129 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . 0.598 ' NE2' ' H ' ' A' ' 111' ' ' LYS . 33.6 mt-30 -81.02 134.04 35.6 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 120.928 0.394 . . . . 0.0 111.599 179.336 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.408 ' O ' ' O ' ' A' ' 118' ' ' LYS . 72.4 t -125.73 126.11 69.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 178.351 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 96.1 mtp -57.15 131.18 49.18 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 121.092 0.472 . . . . 0.0 111.903 -179.334 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 78.75 -3.55 63.87 Favored Glycine 0 CA--C 1.531 1.033 0 N-CA-C 111.685 -0.566 . . . . 0.0 111.685 179.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.408 ' O ' ' O ' ' A' ' 115' ' ' VAL . 64.6 tttm -139.18 126.43 21.4 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.221 0.534 . . . . 0.0 110.924 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 77.16 -170.45 55.1 Favored Glycine 0 CA--C 1.531 1.039 0 N-CA-C 111.181 -0.767 . . . . 0.0 111.181 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 60.9 t-20 -87.82 104.94 17.06 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.953 0.406 . . . . 0.0 110.296 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -88.43 99.14 12.04 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 120.955 0.407 . . . . 0.0 110.574 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.763 ' CB ' HG12 ' A' ' 174' ' ' VAL . . . -91.83 137.68 32.16 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.101 0.477 . . . . 0.0 111.314 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.514 HD23 ' HA ' ' A' ' 109' ' ' THR . 78.9 mt -134.99 139.7 45.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.816 179.521 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -115.52 144.91 43.16 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-O 121.324 0.583 . . . . 0.0 110.757 -179.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -142.08 -162.17 9.09 Favored Glycine 0 CA--C 1.532 1.094 0 N-CA-C 110.154 -1.178 . . . . 0.0 110.154 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . 0.526 ' O ' ' O ' ' A' ' 134' ' ' LEU . 91.5 m-70 -134.6 160.24 38.71 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.411 0.624 . . . . 0.0 111.981 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 28.7 t30 -142.12 120.23 12.16 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.275 179.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.476 ' O ' ' CB ' ' A' ' 129' ' ' SER . 61.8 mtt -96.23 -5.31 40.69 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.446 0.641 . . . . 0.0 109.757 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.476 ' CB ' ' O ' ' A' ' 128' ' ' MET . 1.1 p 78.72 17.07 1.04 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.206 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.819 ' O ' HG12 ' A' ' 133' ' ' VAL . 7.6 ptpt -125.76 116.87 22.29 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 121.833 0.825 . . . . 0.0 112.827 -179.01 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -45.71 130.39 9.16 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.212 179.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 109.08 -16.92 32.48 Favored Glycine 0 N--CA 1.444 -0.826 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 -179.243 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.819 HG12 ' O ' ' A' ' 130' ' ' LYS . 7.2 p -90.88 160.27 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.178 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.878 ' H ' HD13 ' A' ' 134' ' ' LEU . 0.0 OUTLIER -70.69 141.95 51.56 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 115.016 1.487 . . . . 0.0 115.016 -177.122 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 59.67 9.37 1.58 Allowed 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 112.922 -1.944 . . . . 0.0 115.008 177.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 12.9 p -70.42 -30.29 67.12 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 120.041 -0.664 . . . . 0.0 112.125 179.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -90.59 -0.54 57.72 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 113.296 0.851 . . . . 0.0 113.296 -177.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 2.4 pp -58.67 -33.6 49.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 120.362 -0.535 . . . . 0.0 111.106 -179.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -66.44 -13.22 60.45 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.066 0.46 . . . . 0.0 110.954 -179.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 67.0 p -83.55 -4.54 58.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.099 -179.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 88.9 mt -63.98 141.06 58.91 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 121.067 0.461 . . . . 0.0 110.047 179.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -117.03 154.79 30.33 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.462 0.648 . . . . 0.0 111.325 -179.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -47.42 133.7 12.46 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.849 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 160' ' ' VAL . . . 76.8 7.99 86.34 Favored Glycine 0 CA--C 1.53 0.979 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.81 178.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -70.9 135.2 47.85 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 119.832 -0.747 . . . . 0.0 110.587 -179.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -79.98 139.8 36.86 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.895 0.855 . . . . 0.0 112.354 -178.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 98.4 mt -136.48 137.51 47.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 177.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -124.29 138.13 54.42 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 119.708 -0.797 . . . . 0.0 113.061 -177.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 18.6 mt -110.72 133.13 53.6 Favored 'General case' 0 C--O 1.223 -0.3 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 177.368 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.547 ' CZ ' ' OE2' ' A' ' 155' ' ' GLU . 64.5 m-85 -109.77 107.63 17.69 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 119.957 -0.697 . . . . 0.0 111.06 179.462 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -89.19 164.43 14.98 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 178.232 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 69.6 m-20 -57.68 -22.72 47.65 Favored 'General case' 0 C--N 1.312 -1.034 0 C-N-CA 119.823 -0.751 . . . . 0.0 110.657 -178.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -113.21 -28.26 7.69 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 113.804 1.039 . . . . 0.0 113.804 -178.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -147.97 179.15 7.94 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 119.147 -1.021 . . . . 0.0 113.47 -176.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.547 ' OE2' ' CZ ' ' A' ' 150' ' ' TYR . 85.7 tt0 -126.58 135.69 51.57 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 114.35 -1.296 . . . . 0.0 110.002 178.466 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -109.67 132.83 53.78 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 121.157 0.503 . . . . 0.0 111.687 -179.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -94.0 112.04 23.83 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.789 -0.642 . . . . 0.0 111.943 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -114.13 148.71 36.75 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.013 0.435 . . . . 0.0 111.249 179.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -125.11 122.04 36.01 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 121.24 0.543 . . . . 0.0 110.752 179.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.544 ' O ' ' N ' ' A' ' 144' ' ' GLY . 59.9 t -60.44 137.33 22.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.7 178.3 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 81.0 p -108.8 -25.05 11.0 Favored 'General case' 0 N--CA 1.463 0.182 0 O-C-N 123.415 0.447 . . . . 0.0 111.534 179.415 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 159.31 -167.12 34.94 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 120.532 -0.842 . . . . 0.0 111.285 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.925 HG12 HG22 ' A' ' 199' ' ' VAL . 35.5 m -131.45 160.69 42.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.956 0.408 . . . . 0.0 110.145 179.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 22.8 p -141.41 162.6 35.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.439 0.637 . . . . 0.0 111.77 -178.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -103.17 115.17 30.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.577 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 17.1 m -136.77 161.78 35.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.316 0.579 . . . . 0.0 111.218 -179.027 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -86.98 157.99 53.64 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.817 -179.758 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . 0.455 ' O ' ' CB ' ' B' ' 702' ' ' LEU . 33.1 Cg_endo -64.81 -15.89 52.57 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 C-N-CA 122.996 2.464 . . . . 0.0 111.565 178.65 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . 0.46 ' O ' ' CD1' ' A' ' 171' ' ' TRP . 38.4 p-10 -96.62 -2.85 43.96 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.724 179.029 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.478 ' O ' HG22 ' A' ' 173' ' ' VAL . 7.0 mttp -74.03 87.5 1.86 Allowed 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 121.433 0.635 . . . . 0.0 110.994 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' TRP . . . . . 0.514 ' CD1' ' N ' ' A' ' 171' ' ' TRP . 22.3 m0 -73.14 -14.42 61.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.1 -179.521 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -61.26 -27.04 68.17 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.825 -179.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . 0.791 HG23 HG13 ' A' ' 174' ' ' VAL . 22.9 m -61.99 -23.85 32.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -178.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.791 HG13 HG23 ' A' ' 173' ' ' VAL . 23.3 m -107.96 -5.29 10.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -178.594 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -72.11 148.75 45.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.0 0.428 . . . . 0.0 110.317 179.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . 0.425 ' OD1' ' O ' ' A' ' 176' ' ' ASP . 44.1 p-10 -76.08 129.97 37.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.145 0.497 . . . . 0.0 110.957 -179.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 74.6 m80 -100.94 -17.1 16.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.781 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 104.05 36.68 3.1 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 110.109 -1.196 . . . . 0.0 110.109 -179.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -153.48 164.36 38.33 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.926 -0.637 . . . . 0.0 110.311 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -87.51 105.66 17.46 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 177.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . 0.423 ' HG2' ' N ' ' A' ' 182' ' ' ILE . 76.0 tt0 -138.79 161.69 36.61 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.507 0.67 . . . . 0.0 111.944 -177.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.423 ' N ' ' HG2' ' A' ' 181' ' ' GLU . 17.8 tt -128.99 136.92 58.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.142 178.454 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 70.9 m -129.25 123.69 32.58 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.109 0.481 . . . . 0.0 110.915 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 85.2 mt -109.47 131.71 54.81 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.349 0.595 . . . . 0.0 109.524 178.616 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.459 HD13 ' CD2' ' B' ' 702' ' ' LEU . 82.6 mt -112.46 124.38 69.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.134 -179.484 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 186' ' ' THR . . . . . 0.485 HG22 ' N ' ' A' ' 187' ' ' CYS . 90.8 m -138.11 156.87 47.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.152 -179.566 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 187' ' ' CYS . . . . . 0.485 ' N ' HG22 ' A' ' 186' ' ' THR . 17.4 m -87.66 139.52 30.45 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.594 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.721 HG22 ' CD2' ' A' ' 197' ' ' TYR . 62.3 t -62.59 -46.86 95.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.731 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 18.1 t -172.59 155.06 3.24 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.696 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 55.3 t -68.85 -17.07 21.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.395 179.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -98.88 -9.07 24.71 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.104 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 65.5 t0 -134.73 95.1 3.28 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.769 -0.373 . . . . 0.0 111.009 -179.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -105.98 5.89 30.81 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.135 0.493 . . . . 0.0 110.755 179.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 57.1 m -60.51 -40.9 93.09 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.484 -179.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -131.67 153.2 50.23 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.797 -0.361 . . . . 0.0 110.527 -179.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . 0.831 ' NH2' HD22 ' B' ' 702' ' ' LEU . 59.2 ttp180 -131.27 125.92 34.07 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 120.806 -0.358 . . . . 0.0 110.175 179.442 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . 0.721 ' CD2' HG22 ' A' ' 188' ' ' VAL . 29.2 m-85 -87.76 142.7 27.62 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.166 0.508 . . . . 0.0 110.759 -179.336 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 43.2 t -122.04 130.16 74.8 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.648 179.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.925 HG22 HG12 ' A' ' 163' ' ' VAL . 50.4 t -99.57 132.98 44.0 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.516 -179.439 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -118.9 149.21 41.96 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 121.166 0.508 . . . . 0.0 111.39 -179.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -145.34 146.09 15.99 Favored Glycine 0 CA--C 1.534 1.256 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -105.57 143.55 33.58 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 121.062 0.458 . . . . 0.0 111.954 -179.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 38.5 tp -65.97 132.04 47.65 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 178.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 2.1 p -112.38 -19.49 6.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 120.471 -0.492 . . . . 0.0 111.598 -179.194 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -179.82 173.98 45.57 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 120.497 -0.858 . . . . 0.0 112.038 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 90.8 m -142.31 139.19 31.75 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 179.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -144.03 118.36 9.61 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 120.152 -0.619 . . . . 0.0 111.233 179.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -64.19 143.28 58.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.824 -179.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 48.9 mtpt -81.64 107.7 14.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.57 178.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 20.0 pttp . . . . . 0 C--N 1.326 -0.426 0 CA-C-O 117.942 -1.027 . . . . 0.0 110.399 179.814 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 702' ' ' LEU . . . . . 0.831 HD22 ' NH2' ' A' ' 196' ' ' ARG . 2.1 mt . . . . . 0 CA--C 1.538 0.512 0 N-CA-C 110.577 -0.157 . . . . 20.0 110.577 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 703' ' ' PRO . . . . . 0.634 ' CD ' HG13 ' A' ' 110' ' ' VAL . 3.7 Cg_exo -62.93 -160.92 0.03 OUTLIER 'Trans proline' 0 N--CA 1.488 1.199 0 C-N-CA 122.303 2.002 . . . . 20.0 113.836 -179.372 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 704' ' ' ALA . . . . . 0.53 ' O ' ' O ' ' B' ' 703' ' ' PRO . . . . . . . . 0 C--N 1.327 -0.373 0 CA-C-N 114.04 -1.436 . . . . 20.0 114.708 -178.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.217 0 CA-C-O 120.894 0.378 . . . . 0.0 111.919 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.517 ' CB ' ' O ' ' B' ' 702' ' ' LEU . 93.0 p -80.35 20.07 0.72 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.955 0.407 . . . . 0.0 111.56 -179.407 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -102.69 12.72 35.93 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.633 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.1 mt -56.17 142.31 11.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 122.197 0.999 . . . . 0.0 113.078 -177.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 51.1 t0 -78.27 125.91 30.03 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 113.983 -1.462 . . . . 0.0 109.438 179.134 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.499 HE22 ' HB2' ' A' ' 103' ' ' LEU . 0.1 OUTLIER -79.23 128.65 75.1 Favored Pre-proline 0 C--N 1.325 -0.469 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 -179.875 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -52.37 149.87 21.88 Favored 'Trans proline' 0 N--CA 1.486 1.043 0 C-N-CA 121.307 1.338 . . . . 0.0 112.097 -179.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -51.94 175.62 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.624 0.726 . . . . 0.0 111.923 -178.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.565 ' N ' HD12 ' A' ' 66' ' ' LEU . 10.9 mp -70.17 -10.08 57.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.695 -178.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -67.19 -34.39 77.41 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.547 0.689 . . . . 0.0 110.007 178.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.491 ' O ' ' CB ' ' A' ' 72' ' ' ALA . 78.9 mm-40 -77.53 -20.95 53.4 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.26 -179.58 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 96.7 t -71.31 -46.58 64.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.316 0.579 . . . . 0.0 110.69 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -89.11 -10.58 46.8 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.876 -179.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -105.42 -26.16 12.06 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 120.465 -0.494 . . . . 0.0 112.132 -179.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.491 ' CB ' ' O ' ' A' ' 68' ' ' GLU . . . -68.28 136.59 53.72 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.728 0.775 . . . . 0.0 112.31 -179.02 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 7.8 m -59.82 102.8 0.17 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.133 179.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -68.62 129.15 39.1 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.104 0.478 . . . . 0.0 110.777 -179.685 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -98.02 80.48 2.72 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.171 0.51 . . . . 0.0 110.443 179.16 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -62.56 -36.57 83.07 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.311 0.577 . . . . 0.0 111.314 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.584 ' CD ' ' H ' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -70.2 -18.39 63.18 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.415 -177.062 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -90.61 0.61 57.31 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 121.239 0.542 . . . . 0.0 110.029 179.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 75.4 t -87.76 128.37 40.26 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.981 179.104 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.642 HD13 ' HE3' ' A' ' 96' ' ' LYS . 39.6 pt -111.4 -5.13 11.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.846 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -166.03 168.35 39.73 Favored Glycine 0 CA--C 1.535 1.31 0 C-N-CA 120.56 -0.829 . . . . 0.0 112.061 -179.491 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 61.7 ttp180 -137.85 154.91 49.45 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 121.127 0.489 . . . . 0.0 111.272 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.535 HG22 ' O ' ' A' ' 92' ' ' LEU . 14.6 tt -119.52 140.65 42.78 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.955 178.638 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 47.5 t -136.26 130.45 33.06 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.378 0.609 . . . . 0.0 111.813 -178.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.51 ' CG2' HG22 ' A' ' 88' ' ' VAL . 57.2 mt -136.91 86.07 21.87 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.839 179.429 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -56.34 -31.97 86.8 Favored 'Trans proline' 0 N--CA 1.497 1.706 0 C-N-CA 123.076 2.517 . . . . 0.0 112.666 -179.057 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 70.9 m -53.83 -41.24 67.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.275 0.559 . . . . 0.0 110.76 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.51 HG22 ' CG2' ' A' ' 85' ' ' ILE . 27.2 m -113.78 12.83 8.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.032 178.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.7 m 48.26 48.8 18.47 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.421 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 64.5 tp -114.04 133.27 55.63 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.949 -179.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -148.07 127.51 13.15 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.862 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.545 HD13 ' HA3' ' A' ' 106' ' ' GLY . 90.2 mt -151.55 151.09 28.12 Favored Pre-proline 0 N--CA 1.471 0.61 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.563 -179.128 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -75.62 147.42 31.65 Favored 'Trans proline' 0 N--CA 1.495 1.601 0 C-N-CA 122.713 2.275 . . . . 0.0 111.712 178.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.599 ' C ' HD12 ' A' ' 95' ' ' LEU . 49.6 t -97.15 119.17 44.85 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-O 121.19 0.519 . . . . 0.0 111.896 -179.598 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.6 ' N ' HD12 ' A' ' 95' ' ' LEU . 10.0 mp -104.69 141.08 37.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.527 179.182 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.642 ' HE3' HD13 ' A' ' 80' ' ' ILE . 98.5 mttt -64.37 -84.88 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -178.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 82.5 p -62.75 142.27 58.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.177 0.513 . . . . 0.0 111.502 -178.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 46.8 m -97.13 76.14 2.64 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.244 -179.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.594 HG22 ' N ' ' A' ' 100' ' ' GLU . 52.2 m -92.53 168.27 11.37 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 178.485 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.594 ' N ' HG22 ' A' ' 99' ' ' THR . 78.2 tt0 -57.53 -44.73 85.32 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 119.686 -0.806 . . . . 0.0 110.118 -179.532 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -62.93 -41.89 99.63 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.497 179.114 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -63.41 -36.66 84.46 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.681 -178.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.499 ' HB2' HE22 ' A' ' 63' ' ' GLN . 89.8 mt -63.26 -21.97 66.58 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.302 -0.408 . . . . 0.0 112.097 -179.224 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 96.6 mt -70.17 -23.0 62.91 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.899 0.38 . . . . 0.0 110.309 179.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 6.1 m -72.5 -10.28 59.6 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 121.271 0.558 . . . . 0.0 110.036 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.545 ' HA3' HD13 ' A' ' 92' ' ' LEU . . . 90.99 -18.23 51.98 Favored Glycine 0 CA--C 1.531 1.075 0 CA-C-N 115.642 -0.708 . . . . 0.0 113.43 177.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -145.03 124.9 13.42 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 119.418 -0.913 . . . . 0.0 112.688 -179.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -147.45 141.49 25.99 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.043 -0.98 . . . . 0.0 109.883 178.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.647 ' HA ' HD23 ' A' ' 123' ' ' LEU . 19.0 p -69.33 136.51 51.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.243 0.544 . . . . 0.0 111.568 -179.161 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.607 HG13 ' CD ' ' B' ' 703' ' ' PRO . 69.4 t -75.76 -45.8 37.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.394 179.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.421 ' O ' ' HG2' ' A' ' 114' ' ' GLN . 97.4 mttt -111.98 144.71 40.87 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 122.312 1.054 . . . . 0.0 113.11 179.273 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -66.69 -32.41 73.71 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.276 -1.329 . . . . 0.0 112.374 -178.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -85.34 18.82 2.51 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 -177.12 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . 0.497 ' OE1' ' O ' ' A' ' 120' ' ' ASN . 98.0 mm-40 -76.43 137.84 39.97 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 121.73 -0.606 . . . . 0.0 111.678 179.698 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 25.3 t -128.47 120.38 52.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.443 179.214 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' MET . . . . . 0.563 ' SD ' ' OD1' ' A' ' 151' ' ' ASP . 47.1 mtt -57.67 135.81 56.77 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.708 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.427 ' O ' ' OD2' ' A' ' 180' ' ' ASP . . . 75.15 -6.01 30.75 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 121.152 -0.546 . . . . 0.0 112.606 178.37 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -137.35 126.99 25.28 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.496 0.665 . . . . 0.0 111.436 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 77.18 -169.45 54.93 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 110.768 -0.933 . . . . 0.0 110.768 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.497 ' O ' ' OE1' ' A' ' 114' ' ' GLN . 59.1 t-20 -87.97 106.34 18.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.997 0.427 . . . . 0.0 110.27 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.462 ' CE2' HD21 ' A' ' 123' ' ' LEU . 9.5 t80 -85.13 145.77 27.46 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 179.493 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -147.6 140.05 24.58 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.719 0.771 . . . . 0.0 111.587 -179.023 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.647 HD23 ' HA ' ' A' ' 109' ' ' THR . 71.3 mt -137.62 144.14 41.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.475 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -106.88 136.85 46.02 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.051 0.453 . . . . 0.0 109.826 179.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -144.77 131.99 4.54 Favored Glycine 0 CA--C 1.532 1.143 0 N-CA-C 110.233 -1.147 . . . . 0.0 110.233 -179.197 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . 0.522 ' O ' ' O ' ' A' ' 134' ' ' LEU . 0.5 OUTLIER -78.71 151.76 31.96 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -178.651 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 46.3 t30 -141.63 121.14 13.27 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 115.415 -0.812 . . . . 0.0 110.173 178.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.484 ' O ' ' CB ' ' A' ' 129' ' ' SER . 61.5 mtt -97.03 -3.25 41.78 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.104 0.478 . . . . 0.0 110.66 -179.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.484 ' CB ' ' O ' ' A' ' 128' ' ' MET . 1.2 p 78.76 19.57 0.85 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.377 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.664 ' O ' HG12 ' A' ' 133' ' ' VAL . 8.7 ptpt -123.29 104.94 9.44 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.964 0.888 . . . . 0.0 112.706 -178.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.406 ' C ' ' O ' ' A' ' 130' ' ' LYS . 29.4 tptp -34.58 125.23 0.52 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.269 -1.332 . . . . 0.0 111.067 179.451 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 109.5 -10.03 32.92 Favored Glycine 0 N--CA 1.449 -0.475 0 N-CA-C 108.973 -1.651 . . . . 0.0 108.973 -178.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.664 HG12 ' O ' ' A' ' 130' ' ' LYS . 9.0 p -93.09 161.68 2.51 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.796 HD23 ' N ' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -69.76 139.46 53.3 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.78 0.8 . . . . 0.0 113.038 -177.686 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.495 ' CD2' HD12 ' A' ' 138' ' ' ILE . 3.6 m-85 63.17 9.1 3.69 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 114.434 -1.257 . . . . 0.0 113.297 178.46 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . 0.403 ' HB3' HG13 ' A' ' 133' ' ' VAL . 0.0 OUTLIER -66.18 -35.26 80.0 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -179.806 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -92.62 0.73 57.47 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 121.108 0.48 . . . . 0.0 111.623 -178.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.495 HD12 ' CD2' ' A' ' 135' ' ' PHE . 3.4 tt -60.27 -37.72 74.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.069 -179.463 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.46 ' N ' ' CG2' ' A' ' 138' ' ' ILE . . . -65.99 -10.56 40.64 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.929 0.395 . . . . 0.0 111.148 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 5.8 m -82.53 -4.38 57.48 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.975 0.417 . . . . 0.0 111.126 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.479 HD21 HG21 ' A' ' 85' ' ' ILE . 76.6 mt -64.53 145.07 56.69 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 121.284 0.564 . . . . 0.0 111.258 -179.415 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -123.88 157.66 33.71 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.895 -179.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -50.14 134.59 22.07 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.519 -0.764 . . . . 0.0 112.085 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.601 ' N ' ' O ' ' A' ' 160' ' ' VAL . . . 77.02 7.39 86.65 Favored Glycine 0 CA--C 1.532 1.096 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.307 178.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -73.54 137.47 44.39 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 119.631 -0.828 . . . . 0.0 110.605 -179.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -81.16 140.48 34.97 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.667 0.746 . . . . 0.0 111.973 -178.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.461 HG23 HG12 ' A' ' 85' ' ' ILE . 88.3 mt -137.15 138.03 45.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 114.751 -1.113 . . . . 0.0 108.221 178.232 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . 0.557 ' C ' HD23 ' A' ' 149' ' ' LEU . 96.2 m-85 -123.5 137.94 54.68 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 113.464 0.913 . . . . 0.0 113.464 -177.457 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.557 HD23 ' C ' ' A' ' 148' ' ' TYR . 0.9 OUTLIER -112.49 133.24 54.66 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 177.467 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.443 ' CZ ' ' OE2' ' A' ' 155' ' ' GLU . 58.7 m-85 -109.5 109.36 20.15 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.172 -0.611 . . . . 0.0 111.618 179.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . 0.563 ' OD1' ' SD ' ' A' ' 116' ' ' MET . 7.8 m-20 -89.53 166.61 13.55 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 177.439 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -58.6 -23.67 59.29 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 120.246 -0.581 . . . . 0.0 111.143 -178.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -109.78 -28.76 8.63 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -178.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -150.5 -174.95 4.91 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 -177.135 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.443 ' OE2' ' CZ ' ' A' ' 150' ' ' TYR . 86.8 tt0 -131.88 139.25 48.72 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 114.122 -1.399 . . . . 0.0 110.083 178.612 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -113.57 137.84 51.0 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 121.073 0.463 . . . . 0.0 111.648 -179.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -94.24 112.89 24.73 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.392 179.248 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -114.51 148.39 37.99 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 120.975 0.417 . . . . 0.0 111.436 179.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -121.5 121.37 37.35 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.446 179.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.601 ' O ' ' N ' ' A' ' 144' ' ' GLY . 97.4 t -59.97 137.2 22.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.942 177.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 24.1 p -105.68 -23.94 12.64 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 120.749 -0.38 . . . . 0.0 111.343 179.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 154.55 -161.67 30.3 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 120.649 -0.786 . . . . 0.0 111.355 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.931 HG12 HG22 ' A' ' 199' ' ' VAL . 25.3 m -132.58 162.41 39.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-O 120.832 0.348 . . . . 0.0 110.349 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 83.1 p -146.87 163.96 34.42 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.404 0.621 . . . . 0.0 111.518 -179.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -100.88 117.65 35.37 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.704 -179.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 16.4 m -137.8 158.79 33.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.235 0.54 . . . . 0.0 111.372 179.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -94.0 158.41 36.26 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.592 179.327 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . 0.458 ' O ' ' CB ' ' B' ' 702' ' ' LEU . 29.0 Cg_endo -61.9 -17.15 53.95 Favored 'Trans proline' 0 C--N 1.301 -1.949 0 C-N-CA 122.619 2.213 . . . . 0.0 113.555 -179.619 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 51.1 p-10 -93.02 -6.03 49.2 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 119.501 -0.879 . . . . 0.0 112.511 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -75.47 96.17 3.42 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 119.878 -0.729 . . . . 0.0 111.421 179.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' TRP . . . . . 0.432 ' CD1' ' N ' ' A' ' 171' ' ' TRP . 23.1 m0 -78.7 -15.46 58.44 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.817 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -58.28 -28.88 65.36 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.917 -179.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . 0.854 HG13 HG23 ' A' ' 174' ' ' VAL . 10.5 p -62.39 -25.1 36.93 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 CA-C-O 121.031 0.444 . . . . 0.0 111.192 -179.237 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.854 HG23 HG13 ' A' ' 173' ' ' VAL . 59.6 t -105.56 -8.11 10.03 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -178.628 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.44 ' O ' ' CE1' ' A' ' 177' ' ' HIS . 96.7 mt-10 -73.49 144.2 46.3 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 122.08 -0.387 . . . . 0.0 110.663 179.72 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 34.0 p-10 -62.74 144.5 56.36 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.329 0.585 . . . . 0.0 111.661 -179.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' HIS . . . . . 0.44 ' CE1' ' O ' ' A' ' 175' ' ' GLU . 68.8 m80 -122.14 19.73 10.7 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.922 -179.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 64.7 39.06 96.4 Favored Glycine 0 CA--C 1.532 1.095 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 179.461 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 13.1 ptmt -161.67 166.93 26.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.858 0.361 . . . . 0.0 110.15 179.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.854 ' OD2' HD22 ' A' ' 203' ' ' LEU . 48.1 t0 -90.19 100.23 13.09 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.18 0.514 . . . . 0.0 110.195 178.625 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . 0.433 ' HG2' ' N ' ' A' ' 182' ' ' ILE . 84.1 tt0 -131.33 164.59 25.31 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.448 -179.062 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.523 HG22 ' O ' ' A' ' 201' ' ' GLY . 21.2 tt -128.18 137.26 57.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.928 179.251 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . 0.761 HG21 HG22 ' A' ' 173' ' ' VAL . 94.3 m -124.64 122.44 37.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.061 -179.265 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.443 ' HB3' HD11 ' A' ' 138' ' ' ILE . 69.5 mt -111.35 128.99 56.14 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 178.498 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.554 HD13 HD21 ' B' ' 702' ' ' LEU . 93.3 mt -110.09 123.67 66.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.397 0.618 . . . . 0.0 111.068 -179.267 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 3.6 t -138.95 158.82 43.51 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.825 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 187' ' ' CYS . . . . . . . . . . . . . 1.3 m -101.63 143.8 31.15 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.164 0.507 . . . . 0.0 111.247 -179.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.685 HG22 ' CD2' ' A' ' 197' ' ' TYR . 95.5 t -62.71 -47.6 92.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.691 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 20.4 t -168.4 144.55 3.75 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.309 179.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . 0.544 HG22 ' O ' ' A' ' 190' ' ' VAL . 10.8 p -60.99 -6.28 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.138 0.494 . . . . 0.0 110.69 -179.6 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -101.66 -35.43 9.11 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.848 179.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -99.11 110.14 22.76 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.476 -179.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -110.73 7.71 22.24 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.646 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 6.1 t -61.53 -47.18 86.75 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.995 0.426 . . . . 0.0 111.864 -178.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -146.82 158.78 44.0 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.919 -179.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 83.9 mtt85 -128.14 141.45 51.48 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.159 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . 0.685 ' CD2' HG22 ' A' ' 188' ' ' VAL . 43.1 m-85 -90.91 144.45 25.67 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 120.948 0.404 . . . . 0.0 110.844 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 39.4 t -127.42 133.94 66.82 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-O 121.361 0.601 . . . . 0.0 111.032 179.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.931 HG22 HG12 ' A' ' 163' ' ' VAL . 39.1 t -105.25 131.38 54.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.502 179.489 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -119.66 148.27 43.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.466 0.65 . . . . 0.0 111.588 -179.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . 0.523 ' O ' HG22 ' A' ' 182' ' ' ILE . . . -142.63 152.32 23.75 Favored Glycine 0 CA--C 1.533 1.16 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 179.296 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . 0.432 ' O ' ' OD1' ' A' ' 202' ' ' ASP . 52.7 p-10 -113.11 155.35 25.08 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.377 -0.529 . . . . 0.0 110.988 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . 0.854 HD22 ' OD2' ' A' ' 180' ' ' ASP . 60.3 tp -74.3 130.22 39.28 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.314 -0.554 . . . . 0.0 109.562 179.281 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 16.9 m -116.6 -18.24 7.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 C-N-CA 120.371 -0.532 . . . . 0.0 111.357 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -179.98 174.65 46.05 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 120.419 -0.896 . . . . 0.0 112.304 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 40.4 m -140.61 136.59 32.91 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.486 -0.357 . . . . 0.0 110.219 179.367 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 51.6 mttp -141.25 114.62 8.78 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.29 -0.564 . . . . 0.0 111.996 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -64.43 145.81 55.5 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.335 0.588 . . . . 0.0 111.076 179.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 21.2 ttpt -81.07 112.44 18.45 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.616 178.34 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 98.7 mttt . . . . . 0 C--O 1.22 -0.457 0 CA-C-O 118.027 -0.987 . . . . 0.0 110.675 -179.879 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 702' ' ' LEU . . . . . 0.554 HD21 HD13 ' A' ' 185' ' ' ILE . 1.0 OUTLIER . . . . . 0 CA--C 1.541 0.611 0 N-CA-C 110.193 -0.299 . . . . 20.0 110.193 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 703' ' ' PRO . . . . . 0.607 ' CD ' HG13 ' A' ' 110' ' ' VAL . 4.0 Cg_exo -63.0 -174.4 0.18 Allowed 'Trans proline' 0 N--CA 1.492 1.441 0 C-N-CA 122.125 1.884 . . . . 20.0 113.896 -178.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 704' ' ' ALA . . . . . 0.527 ' O ' ' O ' ' B' ' 703' ' ' PRO . . . . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 114.084 -1.416 . . . . 20.0 113.26 -178.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.144 0 CA-C-O 121.237 0.541 . . . . 0.0 110.991 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.489 ' CB ' ' O ' ' B' ' 702' ' ' LEU . 52.1 p -80.65 17.64 1.1 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.532 -179.146 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 59.1 pttt -105.68 21.11 17.81 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.162 0.505 . . . . 0.0 111.334 -179.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.0 mt -56.59 139.47 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-O 122.366 1.079 . . . . 0.0 113.141 -177.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.448 ' OD1' ' N ' ' A' ' 62' ' ' ASP . 24.6 p-10 -76.84 130.08 37.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 113.576 -1.647 . . . . 0.0 109.819 179.028 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.508 ' NE2' ' O ' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -77.19 151.56 81.42 Favored Pre-proline 0 C--N 1.325 -0.472 0 C-N-CA 120.148 -0.621 . . . . 0.0 110.437 -179.393 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -72.78 168.98 23.13 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.669 2.246 . . . . 0.0 111.729 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.674 ' O ' HG23 ' A' ' 69' ' ' VAL . 85.5 m-20 -52.18 166.58 0.16 Allowed 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.102 0.477 . . . . 0.0 111.685 -178.578 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 56.8 tp -64.9 -46.88 79.88 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.459 -178.492 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.22 -39.33 94.33 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.502 -0.479 . . . . 0.0 111.618 -178.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -57.13 -25.38 58.74 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.02 -0.672 . . . . 0.0 109.745 179.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.674 HG23 ' O ' ' A' ' 65' ' ' ASP . 20.0 t -79.42 -45.64 23.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.463 179.542 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -77.06 -9.43 58.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 114.837 -1.074 . . . . 0.0 111.796 -179.153 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 24.5 m120 -103.56 -14.24 16.25 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.371 0.605 . . . . 0.0 110.097 179.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -69.06 145.32 53.58 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.374 -0.83 . . . . 0.0 112.027 -179.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 25.9 p -59.5 104.04 0.24 Allowed 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 121.701 0.762 . . . . 0.0 111.033 -179.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.66 130.52 42.6 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.008 -0.996 . . . . 0.0 111.315 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.518 ' OD2' ' NE2' ' A' ' 78' ' ' GLN . 59.8 t0 -104.38 77.46 1.4 Allowed 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 121.168 0.509 . . . . 0.0 110.64 178.411 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -69.3 -31.11 69.38 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.898 -0.592 . . . . 0.0 112.31 179.049 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 41.0 mmtt -67.6 -29.16 68.43 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -175.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.518 ' NE2' ' OD2' ' A' ' 75' ' ' ASP . 76.7 mt-30 -88.63 -1.66 58.19 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 120.324 -0.551 . . . . 0.0 111.258 -179.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 53.3 t -72.72 128.91 35.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.038 178.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.442 HD13 ' HE2' ' A' ' 96' ' ' LYS . 36.0 pt -113.94 -4.4 11.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 C-N-CA 120.671 -0.411 . . . . 0.0 112.045 179.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.415 ' O ' HG22 ' A' ' 94' ' ' VAL . . . -164.74 169.96 39.65 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 120.214 -0.993 . . . . 0.0 111.629 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 62.6 ttp180 -142.84 141.59 31.63 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.36 0.6 . . . . 0.0 111.573 -179.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.464 HG22 ' O ' ' A' ' 92' ' ' LEU . 19.5 tt -103.2 140.33 21.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.263 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 47.3 t -135.6 129.95 33.68 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.274 -0.875 . . . . 0.0 111.156 -179.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.419 HG12 HG23 ' A' ' 147' ' ' ILE . 96.7 mt -140.49 93.93 8.6 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 114.702 -1.135 . . . . 0.0 109.608 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -66.46 -22.95 51.23 Favored 'Trans proline' 0 N--CA 1.493 1.457 0 C-N-CA 121.574 1.516 . . . . 0.0 113.027 -178.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 94.4 p -55.23 -42.26 73.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.186 0.517 . . . . 0.0 110.215 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.434 HG11 ' O ' ' A' ' 137' ' ' ASP . 31.7 m -114.03 5.4 7.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.416 0.627 . . . . 0.0 110.294 179.046 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 2.4 m 56.12 52.57 10.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.779 179.266 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.403 HD11 ' CD1' ' A' ' 92' ' ' LEU . 54.6 tp -114.5 131.93 56.47 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.155 179.286 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -144.75 118.68 9.33 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.618 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.464 ' O ' HG22 ' A' ' 83' ' ' ILE . 91.1 mt -148.71 151.36 35.38 Favored Pre-proline 0 CA--C 1.538 0.495 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.628 -178.042 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -79.39 146.0 19.21 Favored 'Trans proline' 0 N--CA 1.492 1.399 0 C-N-CA 122.597 2.198 . . . . 0.0 111.31 178.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.579 HG23 ' O ' ' A' ' 94' ' ' VAL . 3.1 m -94.4 121.08 44.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-O 121.239 0.543 . . . . 0.0 111.269 179.614 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.559 ' N ' HD12 ' A' ' 95' ' ' LEU . 10.7 mp -100.24 139.65 35.6 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.604 -179.604 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.532 ' O ' ' OG1' ' A' ' 109' ' ' THR . 99.0 mttt -60.54 -91.1 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 121.427 0.632 . . . . 0.0 112.01 -179.263 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.435 ' OG ' ' ND2' ' A' ' 102' ' ' ASN . 6.5 p -58.87 143.39 47.77 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 121.617 0.722 . . . . 0.0 112.742 -178.258 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 87.5 p -92.39 69.94 5.08 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.037 -0.983 . . . . 0.0 111.284 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.427 HG23 ' OG ' ' A' ' 97' ' ' SER . 62.8 p -91.39 168.34 11.63 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 178.305 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -62.58 -43.46 98.75 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 119.797 -0.761 . . . . 0.0 109.529 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -65.84 -40.79 92.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.872 179.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.435 ' ND2' ' OG ' ' A' ' 97' ' ' SER . 93.4 m-20 -64.2 -37.38 87.25 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.984 -179.455 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 54.7 mt -68.47 -8.4 40.57 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.951 -179.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.507 ' HB3' HG13 ' A' ' 69' ' ' VAL . 96.1 mt -72.84 -23.19 60.73 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.814 0.34 . . . . 0.0 110.444 179.07 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 95.2 p -75.32 -2.94 30.66 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.143 0.497 . . . . 0.0 110.199 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.473 ' HA3' HD12 ' A' ' 134' ' ' LEU . . . 83.76 -13.01 50.43 Favored Glycine 0 CA--C 1.531 1.036 0 CA-C-N 115.632 -0.713 . . . . 0.0 113.384 178.185 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -145.02 126.1 14.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 117.467 0.634 . . . . 0.0 111.81 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -148.13 141.43 25.18 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.356 178.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.611 ' HA ' HD23 ' A' ' 123' ' ' LEU . 36.3 p -64.67 138.1 58.2 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.432 0.634 . . . . 0.0 110.888 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.578 HG13 ' CD ' ' B' ' 703' ' ' PRO . 42.1 t -75.76 -24.74 17.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.624 -179.524 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.463 ' HG3' HG12 ' A' ' 110' ' ' VAL . 97.3 mttt -141.23 149.51 41.45 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 122.394 1.092 . . . . 0.0 112.43 178.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 77.8 mt-10 -65.35 -32.39 74.01 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.008 -1.451 . . . . 0.0 112.296 -178.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 21.9 m120 -82.06 10.98 5.64 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 113.083 0.772 . . . . 0.0 113.083 -177.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . 0.429 ' OE1' ' O ' ' A' ' 120' ' ' ASN . 86.5 mm-40 -77.08 132.5 38.93 Favored 'General case' 0 C--N 1.329 -0.285 0 O-C-N 121.955 -0.466 . . . . 0.0 110.667 179.174 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 56.4 t -123.94 124.68 69.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.519 0 CA-C-O 121.245 0.545 . . . . 0.0 110.78 179.163 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' MET . . . . . 0.671 ' SD ' ' CZ ' ' A' ' 121' ' ' TYR . 94.7 mmm -54.12 126.15 21.71 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -179.389 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 72.53 6.76 67.01 Favored Glycine 0 CA--C 1.531 1.092 0 CA-C-N 115.941 -0.572 . . . . 0.0 112.751 177.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -136.93 127.99 27.74 Favored 'General case' 0 C--N 1.328 -0.341 0 O-C-N 122.389 -0.477 . . . . 0.0 111.419 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 71.76 -164.19 54.18 Favored Glycine 0 CA--C 1.531 1.069 0 N-CA-C 110.388 -1.085 . . . . 0.0 110.388 -179.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.429 ' O ' ' OE1' ' A' ' 114' ' ' GLN . 64.8 t-20 -87.59 103.4 15.52 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.48 -0.488 . . . . 0.0 109.794 179.266 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.671 ' CZ ' ' SD ' ' A' ' 116' ' ' MET . 17.4 t80 -86.79 145.95 26.42 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.76 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -147.49 143.39 27.82 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.735 0.779 . . . . 0.0 111.473 -179.183 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.611 HD23 ' HA ' ' A' ' 109' ' ' THR . 42.9 mt -139.38 145.99 39.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.765 -179.488 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -110.66 139.64 45.75 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -136.27 144.92 16.79 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.314 -1.114 . . . . 0.0 110.314 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . 0.463 ' O ' ' O ' ' A' ' 134' ' ' LEU . 21.7 m-70 -88.49 150.69 22.99 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.881 0.372 . . . . 0.0 111.253 -179.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . 0.654 HD21 ' N ' ' A' ' 187' ' ' CYS . 41.5 p30 -146.71 152.57 39.04 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.226 0.536 . . . . 0.0 110.43 179.183 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.544 ' CG ' HG21 ' A' ' 133' ' ' VAL . 58.4 mtt -116.42 -2.29 12.08 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.166 -179.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.5 ' CB ' ' O ' ' A' ' 128' ' ' MET . 0.7 OUTLIER 80.18 5.75 1.76 Allowed 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.201 179.83 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.834 ' O ' HG12 ' A' ' 133' ' ' VAL . 8.5 ptpt -114.5 122.76 47.56 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.613 0.72 . . . . 0.0 112.479 -179.61 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 14.6 tmtt? -44.3 127.51 5.74 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.202 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 106.29 -11.08 43.6 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.834 HG12 ' O ' ' A' ' 130' ' ' LYS . 9.0 p -94.02 172.85 0.96 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.135 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.595 ' H ' HG22 ' A' ' 133' ' ' VAL . 3.8 mm? -68.76 133.09 47.86 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 116.165 1.913 . . . . 0.0 116.165 -176.48 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.428 ' CD2' HD13 ' A' ' 138' ' ' ILE . 2.7 m-85 53.69 16.19 0.94 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 113.524 -1.671 . . . . 0.0 114.291 176.496 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 5.3 t -68.94 -39.07 79.77 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . 0.434 ' O ' HG11 ' A' ' 88' ' ' VAL . 68.0 m-20 -91.33 2.01 56.7 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 -176.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.56 HD11 ' HB ' ' A' ' 186' ' ' THR . 28.4 pt -65.86 -22.88 31.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 119.073 -1.051 . . . . 0.0 109.922 -179.326 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -70.31 -8.64 51.97 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.194 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 33.6 t -83.04 -5.29 59.05 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.589 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 86.2 mt -63.26 147.79 50.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.808 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 99.9 mttt -124.25 158.89 31.43 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.438 0.637 . . . . 0.0 111.551 -178.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -49.9 131.3 22.5 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.048 179.044 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 160' ' ' VAL . . . 80.43 9.01 86.99 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 120.408 -0.901 . . . . 0.0 112.273 178.379 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.492 ' OD1' ' N ' ' A' ' 146' ' ' LYS . 62.8 t0 -75.04 131.53 40.65 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 120.219 -0.592 . . . . 0.0 110.584 -179.302 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.492 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 74.8 mmtt -77.08 137.03 38.69 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 121.84 0.828 . . . . 0.0 112.232 -178.588 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.419 HG23 HG12 ' A' ' 85' ' ' ILE . 94.7 mt -138.61 140.17 39.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 114.529 -1.214 . . . . 0.0 108.574 178.345 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . 0.547 ' C ' HD23 ' A' ' 149' ' ' LEU . 12.8 m-85 -127.3 140.99 51.83 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 119.583 -0.847 . . . . 0.0 113.196 -177.726 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.547 HD23 ' C ' ' A' ' 148' ' ' TYR . 1.4 mt -114.54 131.72 56.56 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 177.462 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -107.67 112.68 25.5 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 120.007 -0.677 . . . . 0.0 111.007 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . 0.557 ' OD1' ' N ' ' A' ' 152' ' ' ASN . 58.4 t0 -90.21 163.1 14.93 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 177.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . 0.557 ' N ' ' OD1' ' A' ' 151' ' ' ASP . 8.6 t30 -56.32 -22.58 31.6 Favored 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 119.629 -0.828 . . . . 0.0 110.966 -178.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -110.36 -29.2 8.22 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -178.012 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -148.73 -176.97 5.53 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 119.359 -0.936 . . . . 0.0 113.32 -176.293 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 65.4 mt-10 -131.44 136.36 47.9 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 114.758 -1.11 . . . . 0.0 109.538 179.147 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -111.3 135.84 51.26 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.149 0.499 . . . . 0.0 111.741 -179.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . 0.41 ' O ' HD12 ' A' ' 203' ' ' LEU . 98.7 mt-10 -92.65 112.59 24.6 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.4 179.138 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -114.96 147.05 40.55 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.007 0.432 . . . . 0.0 110.523 179.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -122.85 123.46 41.05 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.063 0.459 . . . . 0.0 110.776 179.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.51 ' O ' ' N ' ' A' ' 144' ' ' GLY . 84.5 t -58.24 134.43 23.01 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.036 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 78.0 p -118.08 11.38 13.29 Favored 'General case' 0 CA--C 1.534 0.357 0 O-C-N 123.658 0.599 . . . . 0.0 111.415 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.433 ' H ' HG12 ' A' ' 160' ' ' VAL . . . 124.78 -175.26 17.18 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 120.747 -0.739 . . . . 0.0 111.895 179.073 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.461 HG12 HG22 ' A' ' 199' ' ' VAL . 28.5 m -128.15 160.88 37.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 179.52 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 68.2 m -135.98 159.67 40.98 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.571 0.7 . . . . 0.0 111.601 -179.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -105.31 116.09 31.35 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.596 -179.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.59 HG11 ' CG1' ' A' ' 173' ' ' VAL . 35.5 m -133.89 162.99 38.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.148 -179.696 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . 0.429 ' H ' ' HD2' ' A' ' 170' ' ' LYS . 0.1 OUTLIER -91.99 163.99 25.31 Favored Pre-proline 0 CA--C 1.538 0.511 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.222 179.379 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . 0.459 ' O ' ' CB ' ' B' ' 702' ' ' LEU . 36.3 Cg_exo -61.09 -19.02 61.47 Favored 'Trans proline' 0 N--CA 1.502 1.982 0 C-N-CA 122.548 2.165 . . . . 0.0 113.479 179.447 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . 0.403 ' OD1' ' C ' ' A' ' 169' ' ' ASP . 41.0 p-10 -95.68 -6.33 40.21 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -178.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.734 ' O ' HG22 ' A' ' 173' ' ' VAL . 96.6 mttt -76.46 82.92 3.17 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 119.392 -0.923 . . . . 0.0 111.396 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' TRP . . . . . 0.51 ' O ' HG22 ' A' ' 174' ' ' VAL . 67.0 p-90 -70.72 -10.2 58.91 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.949 0.881 . . . . 0.0 109.521 179.259 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -62.69 -31.85 72.83 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.771 -1.104 . . . . 0.0 111.158 -179.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . 0.734 HG22 ' O ' ' A' ' 170' ' ' LYS . 34.6 m -62.58 -17.35 18.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-N 116.047 -0.524 . . . . 0.0 112.397 -179.081 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.684 HG13 HG23 ' A' ' 173' ' ' VAL . 30.3 m -112.87 -2.56 10.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -178.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -74.98 165.82 24.66 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 121.103 0.477 . . . . 0.0 110.949 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . 0.494 ' OD1' ' O ' ' A' ' 176' ' ' ASP . 36.5 p30 -67.33 137.49 56.07 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.075 179.582 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' HIS . . . . . 0.428 ' ND1' ' ND2' ' A' ' 120' ' ' ASN . 40.7 m80 -119.01 13.53 13.02 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.559 -179.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 62.39 41.61 99.75 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 121.003 -0.618 . . . . 0.0 111.627 179.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 12.9 ptmt -163.35 168.11 20.87 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.998 0.428 . . . . 0.0 110.832 179.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -88.15 93.48 9.51 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 178.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . 0.446 ' HG2' ' N ' ' A' ' 182' ' ' ILE . 84.6 tt0 -131.88 163.66 27.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.43 0.633 . . . . 0.0 112.106 -178.511 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.488 HG22 ' O ' ' A' ' 201' ' ' GLY . 18.0 tt -130.78 138.09 54.44 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.036 178.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 80.4 m -130.72 124.63 31.94 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.135 -179.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 87.6 mt -109.21 135.51 50.19 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.65 178.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 92.1 mt -113.21 127.69 70.36 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 CA-C-O 121.129 0.49 . . . . 0.0 110.983 -179.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 186' ' ' THR . . . . . 0.56 ' HB ' HD11 ' A' ' 138' ' ' ILE . 13.6 t -139.77 156.81 46.56 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.623 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 187' ' ' CYS . . . . . 0.654 ' N ' HD21 ' A' ' 127' ' ' ASN . 2.3 m -93.19 143.68 26.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.388 0.613 . . . . 0.0 110.257 179.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.87 HG22 ' CE2' ' A' ' 197' ' ' TYR . 40.5 t -61.97 -46.99 95.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.429 -179.11 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 41.3 p -164.97 161.34 19.9 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.335 0.588 . . . . 0.0 110.903 -179.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . 0.456 ' O ' HG12 ' A' ' 190' ' ' VAL . 71.4 t -71.96 -13.08 16.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.321 179.347 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -97.71 -13.74 21.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.338 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -142.14 99.92 3.61 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.306 -0.558 . . . . 0.0 112.085 -179.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -103.78 11.35 35.91 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.577 178.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 41.1 m -63.64 -42.0 98.19 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.684 -179.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 43.3 mtmt -123.28 149.71 44.44 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.271 0.558 . . . . 0.0 111.183 -179.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 85.0 mtt85 -133.23 139.98 47.27 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.431 -179.085 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . 0.87 ' CE2' HG22 ' A' ' 188' ' ' VAL . 42.8 m-85 -91.41 155.24 18.61 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.153 0.502 . . . . 0.0 111.021 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 3.0 m -131.46 129.25 61.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.603 178.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.461 HG22 HG12 ' A' ' 163' ' ' VAL . 58.9 t -97.12 130.43 45.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 178.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -107.81 131.71 54.19 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.217 0.532 . . . . 0.0 111.205 -178.239 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . 0.488 ' O ' HG22 ' A' ' 182' ' ' ILE . . . -132.23 131.9 6.44 Favored Glycine 0 CA--C 1.53 1.008 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -103.07 143.17 32.94 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 121.238 0.542 . . . . 0.0 111.247 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . 0.41 HD12 ' O ' ' A' ' 157' ' ' GLU . 35.8 tp -69.5 133.52 47.8 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.897 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 4.1 p -116.52 -17.53 7.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.69 -179.103 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 179.19 174.45 45.32 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 120.588 -0.815 . . . . 0.0 111.775 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 72.6 m -145.54 140.81 27.72 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.111 -0.545 . . . . 0.0 110.009 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -145.52 119.59 9.43 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 119.943 -0.703 . . . . 0.0 111.511 179.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -63.72 145.05 56.49 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.318 -0.855 . . . . 0.0 112.442 -179.191 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 8.6 ttpt -79.38 106.67 11.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.47 178.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 98.5 mttt . . . . . 0 C--O 1.22 -0.451 0 CA-C-O 117.93 -1.033 . . . . 0.0 110.287 -179.752 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 702' ' ' LEU . . . . . 0.489 ' O ' ' CB ' ' A' ' 59' ' ' SER . 0.0 OUTLIER . . . . . 0 CA--C 1.542 0.671 0 N-CA-C 110.222 -0.288 . . . . 20.0 110.222 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 703' ' ' PRO . . . . . 0.578 ' CD ' HG13 ' A' ' 110' ' ' VAL . 3.8 Cg_exo -69.43 -173.39 0.66 Allowed 'Trans proline' 0 C--N 1.316 -1.158 0 C-N-CA 122.155 1.903 . . . . 20.0 112.202 179.76 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 704' ' ' ALA . . . . . 0.507 ' O ' ' O ' ' B' ' 703' ' ' PRO . . . . . . . . 0 C--N 1.321 -0.641 0 CA-C-N 114.962 -1.017 . . . . 20.0 113.506 -178.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.242 0 CA-C-O 121.479 0.656 . . . . 0.0 109.815 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 85.2 p -85.72 4.92 34.53 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.65 -179.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -104.49 16.21 26.56 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 -178.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.0 mt -56.05 144.78 7.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 122.337 1.065 . . . . 0.0 112.931 -177.579 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 59.8 t0 -79.04 125.17 29.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 113.614 -1.63 . . . . 0.0 109.578 178.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.454 ' HB2' ' CG ' ' A' ' 126' ' ' HIS . 7.2 tp60 -78.7 136.17 59.35 Favored Pre-proline 0 C--N 1.322 -0.616 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -61.42 159.29 32.11 Favored 'Trans proline' 0 C--N 1.311 -1.399 0 C-N-CA 121.725 1.616 . . . . 0.0 113.083 -179.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.777 ' O ' HG23 ' A' ' 69' ' ' VAL . 97.6 m-20 -52.0 162.25 0.48 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.473 -178.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.493 ' N ' HD12 ' A' ' 66' ' ' LEU . 9.9 mp -62.75 -44.34 96.46 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.964 -178.436 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.58 -36.72 84.72 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 119.768 -0.773 . . . . 0.0 110.18 -179.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -62.91 -33.71 75.91 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.889 0.852 . . . . 0.0 108.812 177.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.777 HG23 ' O ' ' A' ' 65' ' ' ASP . 60.6 t -76.09 -45.65 35.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 114.607 -1.179 . . . . 0.0 110.923 179.288 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -72.31 -8.88 57.26 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.749 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -105.06 -10.54 17.11 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.631 0.729 . . . . 0.0 109.363 178.389 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.92 138.11 57.04 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.778 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 9.0 t -57.25 99.0 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.76 HD13 ' C ' ' A' ' 74' ' ' LEU . 3.2 tm? -65.16 120.21 12.27 Favored 'General case' 0 C--N 1.334 -0.087 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.368 -178.692 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.552 ' N ' HD13 ' A' ' 74' ' ' LEU . 34.1 t0 -99.08 82.5 2.74 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.551 0.691 . . . . 0.0 111.616 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.406 ' N ' HD13 ' A' ' 74' ' ' LEU . 47.8 tttp -65.31 -32.22 73.76 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.258 -0.883 . . . . 0.0 112.429 179.218 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 31.4 mmtt -68.19 -16.53 64.02 Favored 'General case' 0 C--N 1.314 -0.943 0 C-N-CA 119.997 -0.681 . . . . 0.0 110.972 -175.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.454 ' CD ' ' OD2' ' A' ' 75' ' ' ASP . 94.8 mt-30 -92.02 -5.91 52.07 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 121.087 0.47 . . . . 0.0 111.388 178.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 86.0 t -78.6 129.0 38.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.19 0.519 . . . . 0.0 110.192 179.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 5.3 pt -112.02 -4.47 11.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.107 -179.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -172.68 174.96 45.82 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 120.249 -0.977 . . . . 0.0 111.717 -179.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.583 ' NH2' ' OE1' ' A' ' 91' ' ' GLU . 75.1 ttt180 -136.4 154.9 50.67 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.362 0.601 . . . . 0.0 110.836 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.718 HG22 ' O ' ' A' ' 92' ' ' LEU . 19.4 tt -123.8 141.4 44.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.167 -179.501 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 14.6 t -136.69 130.45 32.14 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 121.43 0.634 . . . . 0.0 111.798 -178.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.527 HG22 HG22 ' A' ' 88' ' ' VAL . 89.3 mt -137.94 86.19 18.38 Favored Pre-proline 0 CA--C 1.536 0.44 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.94 -179.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -56.47 -30.15 80.91 Favored 'Trans proline' 0 N--CA 1.497 1.69 0 C-N-CA 123.221 2.614 . . . . 0.0 113.207 -178.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 18.0 m -52.8 -42.14 64.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.213 0.53 . . . . 0.0 110.704 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.527 HG22 HG22 ' A' ' 85' ' ' ILE . 23.4 m -115.53 10.91 7.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.713 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.45 ' O ' ' OG ' ' A' ' 89' ' ' SER . 5.3 p 52.04 50.49 18.41 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.047 0.451 . . . . 0.0 110.93 179.569 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 56.2 tp -116.02 133.33 56.14 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.285 0.564 . . . . 0.0 110.146 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.583 ' OE1' ' NH2' ' A' ' 82' ' ' ARG . 98.0 mt-10 -147.27 124.2 11.32 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.763 -179.186 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.718 ' O ' HG22 ' A' ' 83' ' ' ILE . 71.0 mt -151.25 152.61 31.39 Favored Pre-proline 0 N--CA 1.471 0.62 0 C-N-CA 120.154 -0.618 . . . . 0.0 111.681 -179.307 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_endo -75.0 150.26 37.88 Favored 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 122.771 2.314 . . . . 0.0 111.244 178.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.551 ' C ' HD12 ' A' ' 95' ' ' LEU . 91.1 t -98.01 123.5 50.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -178.751 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.551 HD12 ' C ' ' A' ' 94' ' ' VAL . 9.7 mp -109.61 136.22 49.32 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-O 120.901 0.381 . . . . 0.0 111.083 178.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 85.7 mttt -67.33 -78.88 0.05 Allowed 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.439 0.638 . . . . 0.0 112.234 -179.229 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 30.6 t -61.95 139.25 58.41 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.952 -178.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 7.5 t -95.44 72.93 3.24 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.364 0.602 . . . . 0.0 110.547 -179.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 39.7 p -90.25 166.85 13.11 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 178.183 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -60.42 -42.21 95.53 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.68 0.752 . . . . 0.0 109.273 179.059 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -64.88 -41.82 95.32 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.988 179.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -65.13 -38.23 89.95 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.151 -179.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 84.2 mt -64.01 -12.92 42.54 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.784 -179.36 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 89.6 mt -72.41 -23.22 61.06 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.279 0.561 . . . . 0.0 109.852 179.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 96.5 p -74.46 -6.11 46.46 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 121.442 0.639 . . . . 0.0 110.893 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.473 ' HA3' HD12 ' A' ' 134' ' ' LEU . . . 87.4 -19.79 30.07 Favored Glycine 0 CA--C 1.533 1.203 0 CA-C-N 115.642 -0.708 . . . . 0.0 112.85 178.469 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -145.28 123.71 12.37 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 119.65 -0.82 . . . . 0.0 111.956 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -144.53 135.33 24.88 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.512 179.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.627 ' HA ' HD23 ' A' ' 123' ' ' LEU . 2.3 m -62.44 135.41 57.42 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 121.034 0.445 . . . . 0.0 110.765 -179.074 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.547 HG13 ' CG ' ' B' ' 703' ' ' PRO . 79.8 t -77.37 -48.84 23.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.765 179.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.507 ' HB2' ' NE2' ' A' ' 114' ' ' GLN . 69.3 mmtt -96.18 132.2 41.86 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.577 0.703 . . . . 0.0 110.854 179.59 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -65.56 -32.77 74.54 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 114.974 -1.012 . . . . 0.0 112.195 -178.315 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 69.0 m-80 -84.55 12.4 7.08 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 -178.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . 0.811 ' N ' HE21 ' A' ' 114' ' ' GLN . 0.0 OUTLIER -81.28 143.72 32.06 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.905 0.383 . . . . 0.0 111.494 179.853 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.459 ' O ' ' O ' ' A' ' 118' ' ' LYS . 41.4 t -126.38 123.79 64.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.982 179.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 98.3 mtp -57.11 137.51 55.73 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 121.241 0.543 . . . . 0.0 111.387 179.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 77.95 -5.01 55.71 Favored Glycine 0 CA--C 1.531 1.058 0 N-CA-C 111.522 -0.631 . . . . 0.0 111.522 179.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.459 ' O ' ' O ' ' A' ' 115' ' ' VAL . 98.5 mttt -141.85 132.28 25.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.208 0.528 . . . . 0.0 111.471 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 72.42 -173.23 46.78 Favored Glycine 0 CA--C 1.528 0.904 0 N-CA-C 110.524 -1.031 . . . . 0.0 110.524 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.541 HD22 ' CE1' ' A' ' 177' ' ' HIS . 56.0 t-20 -84.12 101.92 12.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.165 0.507 . . . . 0.0 109.802 179.492 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.683 ' CE2' HD21 ' A' ' 123' ' ' LEU . 27.0 t80 -88.92 99.53 12.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.362 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.715 ' HB1' HG12 ' A' ' 174' ' ' VAL . . . -92.4 143.0 26.82 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.172 0.51 . . . . 0.0 111.634 -179.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.683 HD21 ' CE2' ' A' ' 121' ' ' TYR . 62.2 mt -136.7 141.42 43.1 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.835 179.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -109.66 130.83 55.48 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.373 0.606 . . . . 0.0 110.201 179.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -136.79 141.29 12.26 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . 0.518 ' O ' ' O ' ' A' ' 134' ' ' LEU . 0.3 OUTLIER -80.04 146.31 32.03 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.067 -0.653 . . . . 0.0 112.23 -178.849 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 61.8 t-20 -136.07 121.3 19.07 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.305 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.61 ' HB2' HG21 ' A' ' 133' ' ' VAL . 58.5 mtt -97.69 -4.51 37.15 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.04 -179.443 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.429 ' CB ' ' O ' ' A' ' 128' ' ' MET . 0.9 OUTLIER 78.09 6.59 2.63 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.419 179.527 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.781 ' O ' HG12 ' A' ' 133' ' ' VAL . 6.9 ptpt -113.08 116.03 29.26 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 121.468 0.651 . . . . 0.0 111.714 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -40.69 127.66 2.52 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.851 -179.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 105.44 -11.5 47.09 Favored Glycine 0 N--CA 1.444 -0.813 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.781 HG12 ' O ' ' A' ' 130' ' ' LYS . 7.7 p -92.43 173.84 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.058 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.598 ' H ' HG22 ' A' ' 133' ' ' VAL . 3.8 mm? -67.26 131.57 46.02 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 115.773 1.768 . . . . 0.0 115.773 -175.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.9 m-30 50.55 21.33 0.85 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 113.266 -1.788 . . . . 0.0 113.956 176.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 4.5 t -72.18 -34.06 68.14 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 119.764 -0.774 . . . . 0.0 112.523 179.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . 0.484 ' O ' HG11 ' A' ' 88' ' ' VAL . 83.9 m-20 -88.91 -1.53 58.14 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.433 0.635 . . . . 0.0 111.388 -179.063 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.876 HD11 HD13 ' A' ' 184' ' ' LEU . 4.7 tt -62.7 -34.97 68.39 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.286 -179.538 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -66.43 -7.31 18.58 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 121.532 0.682 . . . . 0.0 110.234 179.432 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 4.8 m -84.67 -6.1 59.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.175 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 72.8 mt -63.39 142.17 58.49 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.014 -179.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -117.16 159.91 21.86 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 121.817 0.818 . . . . 0.0 112.243 -178.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 65.2 tttm -52.65 133.56 36.33 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.515 178.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.482 ' N ' ' O ' ' A' ' 160' ' ' VAL . . . 77.67 8.53 87.19 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 120.167 -1.016 . . . . 0.0 110.892 179.233 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.413 ' O ' HG23 ' A' ' 160' ' ' VAL . 55.5 t0 -81.96 125.8 31.19 Favored 'General case' 0 C--O 1.222 -0.374 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -79.91 151.0 30.38 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 115.107 1.521 . . . . 0.0 115.107 -176.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 97.6 mt -138.37 137.96 43.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 112.518 -2.128 . . . . 0.0 108.204 179.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . 0.457 ' C ' HD23 ' A' ' 149' ' ' LEU . 68.2 m-85 -121.73 135.85 54.94 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 120.094 -0.642 . . . . 0.0 111.903 -178.039 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.515 HD11 HD12 ' A' ' 182' ' ' ILE . 4.0 mt -114.59 134.29 55.16 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 177.78 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.56 ' CE2' ' CD ' ' A' ' 155' ' ' GLU . 94.4 m-85 -110.16 110.96 22.01 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 120.192 -0.603 . . . . 0.0 111.529 179.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . 0.477 ' N ' ' O ' ' A' ' 154' ' ' ASN . 9.6 m-20 -87.59 166.94 14.35 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 177.39 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -56.89 -24.2 50.24 Favored 'General case' 0 C--N 1.312 -1.031 0 C-N-CA 120.088 -0.645 . . . . 0.0 111.058 -178.183 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -112.69 -25.8 8.92 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 113.758 1.021 . . . . 0.0 113.758 -179.128 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . 0.477 ' O ' ' N ' ' A' ' 151' ' ' ASP . 0.3 OUTLIER -148.73 -176.3 5.27 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 118.904 -1.119 . . . . 0.0 113.533 -176.303 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.56 ' CD ' ' CE2' ' A' ' 150' ' ' TYR . 84.4 tt0 -131.94 137.39 47.92 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 114.812 -1.086 . . . . 0.0 110.197 179.038 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . 0.425 ' CD1' HG23 ' A' ' 206' ' ' THR . 94.1 m-85 -110.37 136.03 50.17 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.267 0.556 . . . . 0.0 112.311 -179.038 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -94.67 110.6 22.42 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.287 179.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -113.16 146.22 39.62 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 120.918 0.389 . . . . 0.0 110.823 179.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.511 ' HB2' HG21 ' A' ' 204' ' ' VAL . . . -120.75 120.79 36.65 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.068 179.611 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.482 ' O ' ' N ' ' A' ' 144' ' ' GLY . 69.0 t -59.32 134.28 24.46 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.331 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 178.273 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 10.2 p -106.91 -25.03 11.83 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 123.507 0.505 . . . . 0.0 111.041 179.124 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 159.64 -168.08 35.37 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 120.323 -0.942 . . . . 0.0 112.111 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.915 HG12 HG22 ' A' ' 199' ' ' VAL . 35.6 m -129.47 159.41 41.54 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 179.323 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 47.0 t -141.16 162.32 35.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.413 0.625 . . . . 0.0 111.704 -178.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -102.31 119.09 38.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.991 -178.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.481 HG21 HG21 ' A' ' 198' ' ' VAL . 22.3 m -136.47 161.17 37.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.509 -179.661 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . 0.442 ' H ' ' HD2' ' A' ' 170' ' ' LYS . 0.2 OUTLIER -98.56 168.33 9.99 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.148 -179.432 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . 0.452 ' O ' ' CB ' ' B' ' 702' ' ' LEU . 31.3 Cg_exo -59.96 -22.21 68.0 Favored 'Trans proline' 0 N--CA 1.499 1.813 0 C-N-CA 122.614 2.209 . . . . 0.0 113.496 179.367 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . 0.424 ' OD1' ' OG1' ' A' ' 167' ' ' THR . 44.9 p-10 -94.16 -1.44 54.19 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -179.041 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.536 ' O ' HG22 ' A' ' 173' ' ' VAL . 17.7 mttm -76.65 85.49 3.3 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.432 0.634 . . . . 0.0 111.613 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' TRP . . . . . 0.475 ' O ' HG22 ' A' ' 174' ' ' VAL . 59.9 p-90 -78.39 -12.11 59.99 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.479 179.471 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -65.54 -27.12 68.22 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.117 -179.124 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . 0.74 HG23 HG13 ' A' ' 174' ' ' VAL . 33.4 m -63.01 -21.28 27.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 120.74 -0.384 . . . . 0.0 111.766 -179.132 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.74 HG13 HG23 ' A' ' 173' ' ' VAL . 26.9 m -107.49 -2.97 10.07 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 -178.699 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -74.84 162.98 28.16 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.2 0.524 . . . . 0.0 110.835 179.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . 0.447 ' N ' ' OD1' ' A' ' 176' ' ' ASP . 33.6 p-10 -62.88 141.69 58.58 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.82 179.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' HIS . . . . . 0.541 ' CE1' HD22 ' A' ' 120' ' ' ASN . 49.1 m80 -118.63 10.5 12.52 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.801 -179.494 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 62.68 41.62 99.8 Favored Glycine 0 CA--C 1.531 1.031 0 C-N-CA 121.323 -0.465 . . . . 0.0 112.195 179.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -167.94 174.49 7.39 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.771 0.319 . . . . 0.0 110.37 178.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 -86.72 97.62 10.69 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 177.043 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . 0.437 ' HG2' ' N ' ' A' ' 182' ' ' ILE . 83.5 tt0 -134.16 161.07 35.9 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.591 0.71 . . . . 0.0 111.877 -178.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.515 HD12 HD11 ' A' ' 149' ' ' LEU . 19.5 tt -129.25 136.05 60.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 114.936 -1.029 . . . . 0.0 108.701 178.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 90.6 m -130.61 125.21 33.52 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.968 0.413 . . . . 0.0 110.717 -179.428 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.876 HD13 HD11 ' A' ' 138' ' ' ILE . 70.1 mt -109.36 135.36 50.55 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 179.573 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.585 HD13 HD21 ' B' ' 702' ' ' LEU . 99.0 mt -112.72 123.86 68.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.461 0.648 . . . . 0.0 110.84 -179.336 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 1.2 t -137.62 155.17 49.47 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.47 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 187' ' ' CYS . . . . . . . . . . . . . 19.9 m -88.07 140.14 29.79 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.299 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.81 HG22 ' CD2' ' A' ' 197' ' ' TYR . 55.9 t -62.74 -49.0 85.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 C-N-CA 120.444 -0.502 . . . . 0.0 110.864 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 57.2 p -160.99 166.67 27.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.57 0.7 . . . . 0.0 111.245 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 27.2 t -82.67 -16.94 11.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.699 179.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . 0.48 ' O ' ' OD1' ' A' ' 192' ' ' ASP . 99.6 mttt -95.25 -13.62 24.73 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 121.055 0.455 . . . . 0.0 111.206 -179.288 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . 0.48 ' OD1' ' O ' ' A' ' 191' ' ' LYS . 91.5 m-20 -139.97 101.22 4.12 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.316 -179.683 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -97.26 7.88 45.67 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 121.552 0.691 . . . . 0.0 110.438 179.18 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 58.4 m -61.64 -37.1 82.76 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.462 179.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -127.1 150.33 49.53 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 121.338 0.589 . . . . 0.0 111.836 -178.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . 0.477 ' HA ' HG23 ' A' ' 188' ' ' VAL . 99.8 mtt180 -132.89 140.53 47.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.004 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . 0.81 ' CD2' HG22 ' A' ' 188' ' ' VAL . 25.6 m-85 -93.91 139.62 30.68 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.144 0.497 . . . . 0.0 110.623 178.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.481 HG21 HG21 ' A' ' 166' ' ' VAL . 40.9 t -129.72 131.09 66.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.178 179.253 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.915 HG22 HG12 ' A' ' 163' ' ' VAL . 56.0 t -103.11 134.88 43.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-O 121.07 0.462 . . . . 0.0 110.736 -179.478 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -115.87 141.61 47.87 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.324 0.583 . . . . 0.0 110.901 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -138.58 142.55 13.17 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 110.836 -0.906 . . . . 0.0 110.836 -179.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 81.4 m-20 -105.83 142.94 34.69 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.962 0.411 . . . . 0.0 110.671 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 46.9 tp -68.29 132.64 47.45 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.511 HG21 ' HB2' ' A' ' 159' ' ' ALA . 64.0 t -115.14 -21.55 5.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -178.782 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -176.04 173.59 46.36 Favored Glycine 0 CA--C 1.523 0.58 0 C-N-CA 120.155 -1.021 . . . . 0.0 111.76 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . 0.425 HG23 ' CD1' ' A' ' 156' ' ' TYR . 9.2 m -143.16 139.53 30.38 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.238 -0.481 . . . . 0.0 109.802 179.686 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -141.69 115.42 9.11 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 121.58 0.705 . . . . 0.0 112.335 -179.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -64.12 142.26 58.47 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.286 -0.87 . . . . 0.0 112.325 -179.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -76.57 159.23 30.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.977 178.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 98.9 mttt . . . . . 0 C--O 1.222 -0.351 0 CA-C-O 117.965 -1.016 . . . . 0.0 111.154 -179.827 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 702' ' ' LEU . . . . . 0.585 HD21 HD13 ' A' ' 185' ' ' ILE . 1.0 OUTLIER . . . . . 0 CA--C 1.542 0.647 0 CA-C-O 120.552 0.215 . . . . 20.0 110.735 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 703' ' ' PRO . . . . . 0.56 ' O ' ' O ' ' B' ' 704' ' ' ALA . 3.9 Cg_exo -64.8 -178.46 0.74 Allowed 'Trans proline' 0 N--CA 1.491 1.338 0 C-N-CA 122.132 1.888 . . . . 20.0 113.848 -178.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 704' ' ' ALA . . . . . 0.56 ' O ' ' O ' ' B' ' 703' ' ' PRO . . . . . . . . 0 N--CA 1.467 0.422 0 CA-C-N 114.238 -1.347 . . . . 20.0 114.103 -178.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.271 0 CA-C-O 120.936 0.398 . . . . 0.0 111.191 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 44.3 p -80.77 23.28 0.54 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 121.313 0.578 . . . . 0.0 110.814 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -109.49 25.07 12.22 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.665 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 94.6 mt -56.09 136.28 18.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 122.36 1.076 . . . . 0.0 113.003 -177.05 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -79.53 128.01 32.84 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 113.552 -1.658 . . . . 0.0 108.39 177.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -79.22 149.81 73.3 Favored Pre-proline 0 C--N 1.325 -0.489 0 C-N-CA 120.546 -0.462 . . . . 0.0 110.211 -179.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -69.66 158.64 56.38 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 122.399 2.066 . . . . 0.0 112.385 -179.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.706 ' O ' HG23 ' A' ' 69' ' ' VAL . 92.5 m-20 -53.35 174.76 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.883 -178.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 89.8 mt -63.78 -46.78 83.67 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 -177.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.26 -37.8 86.83 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 119.819 -0.752 . . . . 0.0 111.238 -177.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.575 ' N ' ' OE1' ' A' ' 68' ' ' GLU . 35.3 mp0 -60.81 -27.54 68.11 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.416 0.627 . . . . 0.0 109.709 178.664 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.706 HG23 ' O ' ' A' ' 65' ' ' ASP . 26.2 t -78.98 -46.01 24.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.476 179.216 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -73.3 -9.21 58.46 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.879 -1.055 . . . . 0.0 111.365 -179.284 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -110.14 -8.67 14.75 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.526 0.679 . . . . 0.0 109.412 178.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.413 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -71.74 144.91 49.1 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 115.137 -0.938 . . . . 0.0 112.042 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 24.1 m -56.92 109.67 0.68 Allowed 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.744 -179.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 37.9 tp -70.12 131.25 43.99 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.773 -179.443 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -116.4 77.75 1.13 Allowed 'General case' 0 C--O 1.232 0.157 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 176.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -82.45 -33.39 28.54 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.989 -1.005 . . . . 0.0 113.176 -178.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 48.6 mmtt -73.2 -10.61 59.95 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 119.954 -0.699 . . . . 0.0 110.905 -176.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -92.52 -1.17 57.14 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.659 179.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 13.5 t -81.64 127.84 39.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.377 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 21.6 pt -107.84 -2.65 10.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.943 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -161.9 171.23 37.79 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 120.188 -1.006 . . . . 0.0 111.632 -179.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 58.4 ttp180 -140.65 142.0 35.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.219 0.533 . . . . 0.0 111.155 -179.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.582 HG22 ' O ' ' A' ' 92' ' ' LEU . 7.5 tp -105.2 136.59 38.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.976 179.43 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 10.0 t -137.05 127.94 27.42 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-O 121.431 0.634 . . . . 0.0 111.231 -179.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.497 ' CG2' HG22 ' A' ' 88' ' ' VAL . 56.1 mt -138.8 86.44 15.57 Favored Pre-proline 0 CA--C 1.537 0.47 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.291 -179.451 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -54.74 -30.38 66.67 Favored 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 123.044 2.496 . . . . 0.0 112.739 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 67.3 m -54.12 -41.96 68.94 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 121.118 0.485 . . . . 0.0 111.133 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.497 HG22 ' CG2' ' A' ' 85' ' ' ILE . 27.2 m -116.1 12.3 7.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.808 179.52 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 13.2 t 50.77 51.54 16.77 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.856 179.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 63.3 tp -115.62 132.24 56.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.27 0.557 . . . . 0.0 111.066 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -147.08 123.28 10.86 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.38 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.582 ' O ' HG22 ' A' ' 83' ' ' ILE . 84.4 mt -150.97 150.67 28.17 Favored Pre-proline 0 N--CA 1.47 0.575 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.428 -179.54 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -72.38 146.01 44.16 Favored 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 122.511 2.141 . . . . 0.0 111.699 178.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.463 ' C ' HD12 ' A' ' 95' ' ' LEU . 54.2 t -96.42 120.68 46.1 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-O 121.194 0.521 . . . . 0.0 110.86 179.736 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.531 ' N ' HD12 ' A' ' 95' ' ' LEU . 11.2 mp -99.81 138.61 36.66 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.337 -179.74 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.485 ' O ' ' OG1' ' A' ' 109' ' ' THR . 34.0 tttm -67.08 -77.86 0.07 Allowed 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.526 -179.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 38.2 m -61.83 136.82 58.14 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.144 0.497 . . . . 0.0 111.303 -178.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -92.79 65.6 4.22 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 121.664 0.745 . . . . 0.0 110.103 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.437 ' HG1' ' CG ' ' A' ' 102' ' ' ASN . 73.4 p -91.51 165.55 13.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.775 178.442 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 57.1 mp0 -60.39 -42.08 95.15 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.294 -0.562 . . . . 0.0 110.362 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -64.55 -40.45 95.6 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.473 0.654 . . . . 0.0 110.288 179.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.437 ' CG ' ' HG1' ' A' ' 99' ' ' THR . 8.6 m120 -65.0 -34.09 77.62 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.734 -179.353 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 65.2 mt -70.02 -10.14 57.65 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.636 -179.13 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 96.0 mt -74.42 -22.42 59.16 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.015 0.436 . . . . 0.0 110.352 178.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 82.8 p -77.58 -1.96 33.33 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 121.321 0.581 . . . . 0.0 110.391 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 87.53 -19.16 33.89 Favored Glycine 0 CA--C 1.534 1.226 0 CA-C-N 115.732 -0.667 . . . . 0.0 113.706 177.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -146.2 126.12 13.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 117.975 0.888 . . . . 0.0 112.729 -179.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -147.34 143.52 28.09 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.484 178.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.664 ' HA ' HD23 ' A' ' 123' ' ' LEU . 18.9 p -68.35 138.63 55.55 Favored 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 120.338 -0.545 . . . . 0.0 109.879 179.747 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.646 HG13 ' CG ' ' B' ' 703' ' ' PRO . 70.2 t -76.55 -49.62 23.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.906 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.631 ' CE ' ' HE1' ' A' ' 171' ' ' TRP . 96.4 mttt -104.22 143.1 33.4 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 122.345 1.069 . . . . 0.0 113.254 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -66.47 -31.63 72.49 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 114.465 -1.243 . . . . 0.0 111.679 -178.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 21.8 m120 -84.99 14.94 4.38 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 -177.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . 0.457 ' OE1' ' O ' ' A' ' 120' ' ' ASN . 89.6 mm-40 -75.16 136.43 41.06 Favored 'General case' 0 N--CA 1.467 0.404 0 O-C-N 121.672 -0.643 . . . . 0.0 111.332 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 46.8 t -127.36 120.72 55.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.533 178.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 51.0 mtt -57.57 132.43 53.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.899 179.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 77.79 -4.48 56.93 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 121.152 -0.547 . . . . 0.0 112.211 178.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -136.91 125.21 23.23 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.308 0.575 . . . . 0.0 110.857 -179.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 76.61 -165.96 53.96 Favored Glycine 0 CA--C 1.527 0.842 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 -179.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.457 ' O ' ' OE1' ' A' ' 114' ' ' GLN . 50.9 t-20 -91.81 106.47 18.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.17 0.51 . . . . 0.0 110.27 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.445 ' HE2' HD21 ' A' ' 123' ' ' LEU . 14.5 t80 -83.75 145.53 28.67 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.91 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -146.01 138.99 25.8 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.645 0.736 . . . . 0.0 112.465 -178.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.664 HD23 ' HA ' ' A' ' 109' ' ' THR . 74.2 mt -135.11 141.57 46.03 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.319 179.313 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -110.68 132.52 54.12 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.03 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -134.32 146.39 18.38 Favored Glycine 0 CA--C 1.529 0.962 0 N-CA-C 111.031 -0.828 . . . . 0.0 111.031 -178.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . 0.409 ' O ' ' CB ' ' A' ' 134' ' ' LEU . 29.3 m-70 -87.24 150.37 23.95 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.443 0.64 . . . . 0.0 111.725 -179.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . 0.784 ' ND2' ' H ' ' A' ' 187' ' ' CYS . 2.9 p30 -147.82 159.29 44.0 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.764 178.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.419 ' CG ' HG21 ' A' ' 133' ' ' VAL . 65.1 mtt -124.95 4.57 8.01 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.162 0.506 . . . . 0.0 110.772 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 76.63 9.24 3.01 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.819 179.156 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.887 ' O ' HG12 ' A' ' 133' ' ' VAL . 62.5 pttt -123.6 131.05 53.52 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 122.01 0.909 . . . . 0.0 112.927 -178.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.501 ' O ' ' O ' ' A' ' 130' ' ' LYS . 74.4 mmtt -40.57 165.05 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.184 -0.917 . . . . 0.0 109.171 178.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 70.19 -21.04 0.53 Allowed Glycine 0 CA--C 1.532 1.103 0 C-N-CA 120.673 -0.775 . . . . 0.0 111.748 179.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.887 HG12 ' O ' ' A' ' 130' ' ' LYS . 3.9 p -88.65 173.57 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 C-N-CA 119.651 -0.819 . . . . 0.0 110.058 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.655 ' H ' HG22 ' A' ' 133' ' ' VAL . 4.0 mm? -67.49 130.44 43.04 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 115.37 1.618 . . . . 0.0 115.37 -176.361 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.4 m-30 58.08 21.94 8.45 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 113.97 -1.468 . . . . 0.0 113.21 177.017 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.28 -39.38 92.49 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -179.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -91.47 -1.22 57.62 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 113.904 1.075 . . . . 0.0 113.904 -177.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 1.6 pp -61.2 -30.19 47.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 119.316 -0.954 . . . . 0.0 110.911 -179.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -66.6 -10.35 44.69 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.318 0.58 . . . . 0.0 110.356 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 3.1 m -83.89 -3.01 57.59 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.849 -179.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.41 HD23 ' HA ' ' A' ' 141' ' ' LEU . 91.4 mt -63.65 141.85 58.61 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 121.118 0.485 . . . . 0.0 111.241 -179.257 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 56.7 mttp -120.42 156.8 30.67 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-O 121.556 0.693 . . . . 0.0 111.74 -179.259 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -50.77 133.64 25.93 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.33 179.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 160' ' ' VAL . . . 79.88 8.29 87.8 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 120.352 -0.928 . . . . 0.0 111.564 179.066 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.442 ' OD1' ' N ' ' A' ' 146' ' ' LYS . 61.8 t0 -74.38 128.3 35.19 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 120.106 -0.638 . . . . 0.0 110.394 -179.43 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.442 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 75.6 mmtt -77.89 140.18 39.29 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.817 0.818 . . . . 0.0 112.197 -178.291 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.441 HG23 HG12 ' A' ' 85' ' ' ILE . 89.7 mt -139.62 139.95 37.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 114.615 -1.175 . . . . 0.0 108.832 179.023 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . 0.653 ' C ' HD23 ' A' ' 149' ' ' LEU . 97.6 m-85 -124.95 136.91 54.19 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 119.459 -0.896 . . . . 0.0 112.955 -178.402 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.653 HD23 ' C ' ' A' ' 148' ' ' TYR . 0.3 OUTLIER -112.11 134.34 53.72 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 177.296 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.604 ' CZ ' ' OE2' ' A' ' 155' ' ' GLU . 79.7 m-85 -110.66 112.94 25.17 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 119.966 -0.694 . . . . 0.0 111.278 -179.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . 0.445 ' N ' ' O ' ' A' ' 154' ' ' ASN . 38.1 t70 -89.03 165.42 14.55 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 177.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 66.1 m-20 -57.06 -23.98 50.59 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 119.836 -0.746 . . . . 0.0 110.568 -178.279 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -114.35 -25.51 8.39 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 113.534 0.939 . . . . 0.0 113.534 -178.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . 0.445 ' O ' ' N ' ' A' ' 151' ' ' ASP . 0.1 OUTLIER -146.65 -178.94 6.44 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 118.572 -1.251 . . . . 0.0 113.455 -176.859 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.604 ' OE2' ' CZ ' ' A' ' 150' ' ' TYR . 83.9 tt0 -131.27 133.79 45.76 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 114.674 -1.148 . . . . 0.0 109.988 179.082 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -110.01 136.24 49.58 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 121.109 0.481 . . . . 0.0 111.695 -179.282 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . 0.401 ' O ' HD12 ' A' ' 203' ' ' LEU . 77.1 tt0 -94.79 113.62 25.4 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.776 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 39.8 m-85 -114.86 149.03 37.75 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.172 0.51 . . . . 0.0 111.581 179.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.542 ' HB2' HG21 ' A' ' 204' ' ' VAL . . . -123.81 122.74 38.84 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.97 179.343 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.454 ' O ' ' N ' ' A' ' 144' ' ' GLY . 60.8 t -60.65 137.81 22.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 177.752 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 18.1 p -106.78 -24.69 12.0 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 120.801 -0.359 . . . . 0.0 111.649 179.364 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 160.37 -166.39 35.27 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 120.531 -0.843 . . . . 0.0 111.756 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.952 HG12 HG22 ' A' ' 199' ' ' VAL . 35.0 m -131.98 159.06 43.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-O 120.888 0.375 . . . . 0.0 110.856 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 82.2 p -147.31 162.0 39.85 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 121.095 0.474 . . . . 0.0 110.991 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -110.47 121.16 44.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.37 0.605 . . . . 0.0 110.843 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 28.1 m -138.43 159.75 31.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.821 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.32 158.63 63.42 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.702 179.653 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . 0.503 ' O ' ' CB ' ' B' ' 702' ' ' LEU . 35.9 Cg_endo -64.48 -17.71 60.51 Favored 'Trans proline' 0 N--CA 1.499 1.809 0 C-N-CA 123.103 2.536 . . . . 0.0 113.035 -178.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 43.7 p-10 -91.19 -3.57 56.87 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 120.094 -0.642 . . . . 0.0 111.211 179.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.575 ' O ' HG22 ' A' ' 173' ' ' VAL . 73.1 mmtt -74.36 78.03 1.87 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.526 0.679 . . . . 0.0 110.804 179.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' TRP . . . . . 0.631 ' HE1' ' CE ' ' A' ' 111' ' ' LYS . 29.4 t90 -70.3 -15.25 62.87 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.046 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -64.26 -29.29 70.39 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.612 -0.722 . . . . 0.0 112.244 -179.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . 0.623 HG23 HG13 ' A' ' 174' ' ' VAL . 14.8 m -63.24 -21.2 27.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -179.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.623 HG13 HG23 ' A' ' 173' ' ' VAL . 27.2 m -105.6 -3.48 9.83 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 C-N-CA 120.372 -0.531 . . . . 0.0 112.162 -179.176 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.579 ' OE2' ' CE3' ' A' ' 171' ' ' TRP . 95.7 mt-10 -71.97 150.29 44.22 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.164 0.507 . . . . 0.0 110.634 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . 0.488 ' OD1' ' O ' ' A' ' 176' ' ' ASP . 54.3 p-10 -56.74 142.27 41.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.908 -179.595 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 61.7 m80 -120.46 12.91 11.7 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.863 -179.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 62.54 42.38 99.7 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 120.666 -0.778 . . . . 0.0 111.175 179.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -164.4 168.76 18.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.89 0.376 . . . . 0.0 110.631 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -87.1 99.38 11.88 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 177.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . 0.45 ' HG2' ' N ' ' A' ' 182' ' ' ILE . 84.1 tt0 -135.3 161.91 34.07 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.259 0.552 . . . . 0.0 111.521 -178.275 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.459 HG22 ' O ' ' A' ' 201' ' ' GLY . 18.7 tt -129.7 139.19 52.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.741 178.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 94.0 m -130.41 125.44 34.52 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.412 0.625 . . . . 0.0 111.72 -179.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 82.7 mt -109.32 131.14 55.35 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.416 178.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.447 HD13 ' CD2' ' B' ' 702' ' ' LEU . 77.5 mt -111.55 122.05 65.22 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 CA-C-O 121.571 0.7 . . . . 0.0 111.384 -179.534 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 186' ' ' THR . . . . . 0.497 HG22 ' ND2' ' A' ' 127' ' ' ASN . 12.1 m -135.08 157.13 47.71 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.032 179.301 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 187' ' ' CYS . . . . . 0.784 ' H ' ' ND2' ' A' ' 127' ' ' ASN . 1.7 m -97.08 144.84 26.56 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 120.913 0.387 . . . . 0.0 110.945 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.571 HG13 ' N ' ' A' ' 189' ' ' SER . 7.6 p -62.71 -46.83 95.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-O 121.057 0.456 . . . . 0.0 110.852 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . 0.571 ' N ' HG13 ' A' ' 188' ' ' VAL . 36.3 p -159.62 162.36 35.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.113 0.483 . . . . 0.0 110.867 179.656 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . 0.492 HG22 ' O ' ' A' ' 190' ' ' VAL . 7.9 p -80.9 -7.67 10.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.533 179.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -96.71 -13.46 22.71 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 121.07 0.462 . . . . 0.0 110.621 179.208 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . 0.529 ' OD1' ' OG ' ' A' ' 194' ' ' SER . 67.8 t0 -148.59 103.39 3.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.315 0.579 . . . . 0.0 111.389 179.634 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -102.64 3.83 37.61 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.372 179.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 194' ' ' SER . . . . . 0.529 ' OG ' ' OD1' ' A' ' 192' ' ' ASP . 78.6 p -64.49 -24.36 67.59 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.653 -179.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -130.71 133.31 45.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.165 0.507 . . . . 0.0 110.575 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -129.01 139.65 51.98 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.515 -179.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 37.5 p90 -100.94 135.43 42.41 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.2 0.524 . . . . 0.0 110.021 178.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 25.6 t -114.18 135.49 53.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -178.1 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.952 HG22 HG12 ' A' ' 163' ' ' VAL . 57.4 t -104.3 132.63 50.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.698 179.066 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -121.28 150.03 42.0 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 121.483 0.658 . . . . 0.0 112.269 -179.028 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . 0.459 ' O ' HG22 ' A' ' 182' ' ' ILE . . . -149.98 159.7 28.21 Favored Glycine 0 CA--C 1.532 1.105 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 179.503 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 55.4 p-10 -116.37 158.7 23.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.203 0.525 . . . . 0.0 111.201 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . 0.401 HD12 ' O ' ' A' ' 157' ' ' GLU . 60.1 tp -76.01 131.17 39.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.746 179.413 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.542 HG21 ' HB2' ' A' ' 159' ' ' ALA . 15.0 t -111.98 -21.04 5.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -178.583 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -178.55 174.64 46.83 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 120.514 -0.85 . . . . 0.0 111.988 -179.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 23.6 m -144.55 139.86 28.45 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.38 -0.41 . . . . 0.0 110.142 179.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -143.24 118.2 10.01 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.155 -0.618 . . . . 0.0 111.339 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -63.88 141.96 58.58 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.408 -178.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 53.8 mtpt -77.35 159.79 29.26 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.046 178.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 53.4 mtpt . . . . . 0 C--O 1.219 -0.533 0 CA-C-O 118.037 -0.983 . . . . 0.0 110.736 179.381 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 702' ' ' LEU . . . . . 0.503 ' CB ' ' O ' ' A' ' 168' ' ' PRO . 2.3 mt . . . . . 0 CA--C 1.542 0.662 0 CA-C-O 120.795 0.331 . . . . 20.0 111.737 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 703' ' ' PRO . . . . . 0.646 ' CG ' HG13 ' A' ' 110' ' ' VAL . 4.8 Cg_exo -64.92 -164.91 0.07 OUTLIER 'Trans proline' 0 N--CA 1.491 1.355 0 C-N-CA 122.627 2.218 . . . . 20.0 113.606 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 704' ' ' ALA . . . . . 0.508 ' O ' ' O ' ' B' ' 703' ' ' PRO . . . . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 114.269 -1.332 . . . . 20.0 112.678 -179.26 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.409 ' C ' ' H ' ' A' ' 60' ' ' LYS . . . . . . . . 0 CA--C 1.529 0.143 0 CA-C-O 121.219 0.533 . . . . 0.0 110.48 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.605 ' C ' HH22 ' A' ' 196' ' ' ARG . 2.8 p -78.15 19.44 0.44 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.25 -179.146 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.409 ' H ' ' C ' ' A' ' 58' ' ' ALA . 99.6 mttt -95.75 13.38 26.73 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.927 179.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 94.0 mt -55.43 141.71 11.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 122.035 0.921 . . . . 0.0 112.949 -177.7 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.403 ' O ' ' OD1' ' A' ' 62' ' ' ASP . 35.1 p-10 -78.53 129.78 35.23 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 114.034 -1.439 . . . . 0.0 109.198 178.435 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.661 ' NE2' ' H ' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -79.98 146.87 64.55 Favored Pre-proline 0 CA--C 1.539 0.527 0 CA-C-O 120.99 0.424 . . . . 0.0 111.222 -179.071 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.23 157.97 59.4 Favored 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 123.079 2.519 . . . . 0.0 113.113 -179.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.816 ' O ' HG23 ' A' ' 69' ' ' VAL . 90.4 m-20 -55.45 168.67 0.36 Allowed 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.685 -179.481 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.404 HD23 ' HA ' ' A' ' 66' ' ' LEU . 92.1 mt -64.18 -45.06 90.03 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.047 -178.535 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.52 -39.41 94.36 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 119.81 -0.756 . . . . 0.0 110.893 -178.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -60.75 -29.39 69.36 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 178.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.816 HG23 ' O ' ' A' ' 65' ' ' ASP . 50.9 t -75.57 -45.11 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.981 179.101 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -72.6 -9.1 58.18 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.683 -1.144 . . . . 0.0 111.037 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 27.1 m120 -105.84 -10.35 16.72 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.524 0.678 . . . . 0.0 110.226 178.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.09 137.04 54.66 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.634 -179.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -60.35 98.71 0.06 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.236 0.541 . . . . 0.0 109.94 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -68.52 131.1 44.68 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.389 -179.493 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -97.88 80.65 2.77 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.395 178.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.832 ' O ' HG12 ' A' ' 79' ' ' VAL . 87.5 tttt -63.95 -42.39 97.32 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -179.379 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.537 ' H ' ' CE ' ' A' ' 77' ' ' LYS . 1.1 mtmt -69.66 -8.21 45.67 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.446 0.641 . . . . 0.0 111.104 -176.666 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.524 ' CD ' ' N ' ' A' ' 78' ' ' GLN . 18.6 mp0 -94.56 3.85 54.59 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.784 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.832 HG12 ' O ' ' A' ' 76' ' ' LYS . 14.9 p -86.91 122.71 39.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 120.434 -0.506 . . . . 0.0 111.258 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.615 ' O ' ' ND2' ' A' ' 152' ' ' ASN . 24.0 pt -108.14 -6.11 10.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.1 179.125 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.44 ' O ' HG22 ' A' ' 94' ' ' VAL . . . -167.61 166.18 39.16 Favored Glycine 0 CA--C 1.53 1.012 0 N-CA-C 110.813 -0.915 . . . . 0.0 110.813 -179.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 62.6 ttp180 -140.19 142.57 35.88 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 121.207 0.527 . . . . 0.0 111.646 -179.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.466 HG22 ' O ' ' A' ' 92' ' ' LEU . 19.5 tt -103.9 141.71 19.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.48 -179.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 5.0 t -136.91 129.72 30.59 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 121.335 0.588 . . . . 0.0 111.539 -179.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.48 HG22 HG22 ' A' ' 88' ' ' VAL . 89.3 mt -140.29 89.37 10.86 Favored Pre-proline 0 CA--C 1.542 0.657 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.329 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -57.86 -27.67 79.4 Favored 'Trans proline' 0 N--CA 1.502 2.016 0 C-N-CA 123.279 2.653 . . . . 0.0 113.106 -179.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 9.7 t -53.83 -43.0 69.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.262 0.553 . . . . 0.0 110.378 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.48 HG22 HG22 ' A' ' 85' ' ' ILE . 27.8 m -112.89 8.88 8.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.816 179.065 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 40.7 p 52.74 53.86 11.47 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.524 -179.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 54.8 tp -116.83 134.42 54.8 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 121.461 0.648 . . . . 0.0 111.732 -179.127 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -147.46 117.8 7.39 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.239 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.474 HD13 ' HA3' ' A' ' 106' ' ' GLY . 84.2 mt -149.14 149.63 30.09 Favored Pre-proline 0 CA--C 1.542 0.641 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.447 -179.048 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -75.18 149.6 36.2 Favored 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 123.026 2.484 . . . . 0.0 112.825 179.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.662 HG23 ' O ' ' A' ' 94' ' ' VAL . 3.1 m -96.75 116.56 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-O 121.029 0.442 . . . . 0.0 111.214 179.752 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.561 ' N ' HD12 ' A' ' 95' ' ' LEU . 10.9 mp -100.09 136.37 40.09 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 120.955 0.407 . . . . 0.0 111.294 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.535 ' HE3' HG21 ' A' ' 80' ' ' ILE . 98.4 mttt -61.72 -80.42 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.346 0.593 . . . . 0.0 111.438 -179.536 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.59 ' OG ' ' ND2' ' A' ' 102' ' ' ASN . 6.4 p -60.86 132.74 54.84 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.172 -178.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.419 ' OG ' ' O ' ' A' ' 109' ' ' THR . 58.1 m -93.46 73.56 4.45 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.335 0.588 . . . . 0.0 110.391 179.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.484 HG23 HD22 ' A' ' 102' ' ' ASN . 44.0 p -87.38 169.68 12.05 Favored 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.585 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -58.31 -45.57 87.75 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 119.335 -0.946 . . . . 0.0 108.94 179.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -65.8 -40.31 91.78 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.979 179.19 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.59 ' ND2' ' OG ' ' A' ' 97' ' ' SER . 97.9 m-20 -62.61 -39.42 93.72 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.123 0.487 . . . . 0.0 111.531 -178.749 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 62.4 mt -63.43 -19.39 64.66 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.994 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.68 ' HB3' HG13 ' A' ' 69' ' ' VAL . 45.3 mt -73.1 -14.16 61.33 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.629 -179.447 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 74.4 p -75.33 -6.98 52.69 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 178.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.49 ' O ' ' CE1' ' A' ' 135' ' ' PHE . . . 90.21 -19.44 42.99 Favored Glycine 0 CA--C 1.533 1.216 0 CA-C-N 115.116 -0.947 . . . . 0.0 112.147 179.244 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -146.27 125.64 13.12 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.264 0.554 . . . . 0.0 111.762 179.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -145.5 140.53 27.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.344 178.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.596 ' HA ' HD23 ' A' ' 123' ' ' LEU . 21.0 p -72.0 133.0 45.06 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 119.996 -0.682 . . . . 0.0 110.684 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.689 HG22 ' HG2' ' B' ' 703' ' ' PRO . 39.0 t -80.57 -48.47 19.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.155 179.591 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.607 ' O ' ' NE2' ' A' ' 114' ' ' GLN . 87.6 tttt -89.41 128.44 35.93 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.503 0.668 . . . . 0.0 111.213 -178.69 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -66.64 -36.58 82.91 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.058 -0.974 . . . . 0.0 111.731 -178.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 68.8 m-80 -89.27 31.21 0.91 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.72 -179.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . 0.62 ' H ' ' CD ' ' A' ' 114' ' ' GLN . 0.0 OUTLIER -75.3 138.11 41.61 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 120.954 0.407 . . . . 0.0 111.719 -179.501 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 42.9 t -120.7 105.79 17.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-O 120.893 0.378 . . . . 0.0 110.714 179.434 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' MET . . . . . 0.417 ' HG2' ' CZ ' ' A' ' 121' ' ' TYR . 85.4 mtp -55.18 130.32 41.62 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.141 0.496 . . . . 0.0 111.664 -179.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 88.21 -4.72 85.37 Favored Glycine 0 CA--C 1.53 1.013 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.819 179.106 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -142.7 136.32 28.88 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 121.254 0.55 . . . . 0.0 111.95 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 75.11 -166.17 54.8 Favored Glycine 0 CA--C 1.534 1.243 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 -179.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 59.3 t-20 -92.0 108.34 19.86 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 121.001 0.429 . . . . 0.0 110.295 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.417 ' CZ ' ' HG2' ' A' ' 116' ' ' MET . 2.5 t80 -85.57 102.47 13.56 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 121.02 0.438 . . . . 0.0 111.009 -179.399 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -91.9 130.82 37.58 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.911 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.596 HD23 ' HA ' ' A' ' 109' ' ' THR . 84.5 mt -132.45 137.67 47.34 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.62 179.715 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -113.33 144.43 42.76 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.003 0.43 . . . . 0.0 110.129 179.23 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -152.34 155.04 25.9 Favored Glycine 0 CA--C 1.531 1.057 0 N-CA-C 110.279 -1.128 . . . . 0.0 110.279 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . 0.411 ' CG ' ' HB3' ' A' ' 63' ' ' GLN . 47.6 m-70 -100.75 145.49 28.42 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.654 0.74 . . . . 0.0 111.959 -179.19 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . 0.494 ' O ' ' OD1' ' A' ' 127' ' ' ASN . 38.0 p-10 -149.64 124.26 9.76 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.788 178.517 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.523 ' CG ' ' OE1' ' A' ' 63' ' ' GLN . 70.7 mtm -84.58 0.38 50.25 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.306 -0.558 . . . . 0.0 110.26 179.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.482 ' CB ' ' O ' ' A' ' 128' ' ' MET . 1.1 m 80.17 12.54 1.0 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.254 179.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.897 ' O ' HG12 ' A' ' 133' ' ' VAL . 21.3 ptmt -104.91 124.71 49.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.996 0.903 . . . . 0.0 111.91 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -46.14 120.37 2.73 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.78 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 116.29 -18.72 13.64 Favored Glycine 0 N--CA 1.445 -0.748 0 N-CA-C 109.979 -1.249 . . . . 0.0 109.979 -179.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.897 HG12 ' O ' ' A' ' 130' ' ' LYS . 11.4 p -88.6 159.68 2.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.654 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.821 HD23 ' N ' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -71.22 144.04 50.23 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 122.156 0.979 . . . . 0.0 113.639 -177.314 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.49 ' CE1' ' O ' ' A' ' 106' ' ' GLY . 4.0 m-85 59.69 9.56 1.66 Allowed 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 113.902 -1.499 . . . . 0.0 114.726 177.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 5.7 t -69.77 -40.46 76.07 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 179.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -89.17 7.36 35.67 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 -176.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.7 HD11 ' OH ' ' A' ' 197' ' ' TYR . 35.0 pt -61.78 -26.45 39.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 C-N-CA 119.185 -1.006 . . . . 0.0 109.102 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -65.92 -14.56 61.77 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.551 179.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 64.3 p -83.0 -4.51 58.39 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.328 -179.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 81.2 mt -63.78 142.2 58.49 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 120.94 0.4 . . . . 0.0 110.977 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 63.9 mttm -118.05 153.3 33.95 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.639 0.733 . . . . 0.0 111.807 -178.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -50.21 130.74 23.24 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.955 178.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.444 ' N ' ' O ' ' A' ' 160' ' ' VAL . . . 81.42 8.7 86.77 Favored Glycine 0 CA--C 1.526 0.746 0 C-N-CA 120.219 -0.991 . . . . 0.0 110.985 179.467 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 146' ' ' LYS . 58.8 t0 -76.95 129.04 35.62 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.295 0.569 . . . . 0.0 110.229 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.504 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 72.8 mmtt -79.26 143.11 35.59 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 121.826 0.822 . . . . 0.0 112.754 -177.624 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.441 HD11 ' CG2' ' A' ' 160' ' ' VAL . 94.7 mt -138.1 139.31 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-N 114.608 -1.178 . . . . 0.0 108.322 178.565 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . 0.535 ' C ' HD22 ' A' ' 149' ' ' LEU . 90.9 m-85 -121.11 136.99 54.87 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -177.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.535 HD22 ' C ' ' A' ' 148' ' ' TYR . 4.6 mm? -114.0 132.74 55.88 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 177.629 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.573 ' CZ ' ' OE2' ' A' ' 155' ' ' GLU . 96.3 m-85 -112.02 107.94 17.08 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.006 -0.678 . . . . 0.0 111.783 -179.63 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . 0.523 ' OD1' ' N ' ' A' ' 152' ' ' ASN . 54.2 t0 -88.16 164.0 15.89 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 177.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . 0.666 ' N ' HD22 ' A' ' 152' ' ' ASN . 1.4 m120 -58.49 -23.66 58.47 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 119.556 -0.858 . . . . 0.0 110.993 -178.364 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.402 ' HB2' ' ND2' ' A' ' 154' ' ' ASN . 80.2 mm-40 -109.36 -29.75 8.31 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 -177.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . 0.459 ' O ' ' N ' ' A' ' 151' ' ' ASP . 0.2 OUTLIER -149.77 -179.26 6.98 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 119.181 -1.008 . . . . 0.0 113.503 -176.712 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.573 ' OE2' ' CZ ' ' A' ' 150' ' ' TYR . 79.1 tt0 -126.26 133.09 51.55 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 114.48 -1.236 . . . . 0.0 110.159 178.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . 0.41 ' CD1' HG23 ' A' ' 206' ' ' THR . 83.2 m-85 -107.11 132.33 53.12 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 121.376 0.608 . . . . 0.0 111.323 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -93.54 112.76 24.73 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.81 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -113.05 145.29 41.14 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.01 0.434 . . . . 0.0 111.404 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -120.1 121.43 38.82 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.868 179.107 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.444 ' O ' ' N ' ' A' ' 144' ' ' GLY . 98.1 t -60.58 135.68 25.02 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 177.542 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 6.8 p -108.48 -24.76 11.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.174 0.511 . . . . 0.0 110.716 179.046 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 160.6 -170.43 36.55 Favored Glycine 0 CA--C 1.532 1.126 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 -179.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 35.0 m -133.49 158.79 42.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 179.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 39.6 t -142.9 162.5 35.3 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 121.348 0.594 . . . . 0.0 111.784 -179.216 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -109.31 121.24 44.75 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.79 179.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.546 HG21 HG11 ' A' ' 173' ' ' VAL . 31.3 m -136.12 161.08 38.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.605 -179.41 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.41 158.75 65.8 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.918 -179.537 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . 0.479 ' O ' ' CB ' ' B' ' 702' ' ' LEU . 36.4 Cg_endo -64.86 -16.73 56.82 Favored 'Trans proline' 0 N--CA 1.496 1.673 0 C-N-CA 123.198 2.599 . . . . 0.0 113.054 -179.155 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 32.6 p-10 -94.79 -7.22 41.03 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.185 -0.606 . . . . 0.0 112.571 -179.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.443 ' O ' HG22 ' A' ' 173' ' ' VAL . 97.4 mttt -77.29 92.21 3.87 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 119.832 -0.747 . . . . 0.0 112.004 -179.785 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' TRP . . . . . 0.405 ' CD1' ' N ' ' A' ' 171' ' ' TRP . 6.3 m0 -75.19 -1.87 25.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.657 0.741 . . . . 0.0 109.677 178.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -61.72 -37.3 83.69 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.719 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . 0.546 HG11 HG21 ' A' ' 166' ' ' VAL . 26.9 m -63.23 -12.84 11.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.127 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.458 HG23 HG23 ' A' ' 173' ' ' VAL . 77.3 t -105.62 -23.56 4.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 N-CA-C 112.665 0.616 . . . . 0.0 112.665 -178.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -74.53 135.1 42.17 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.15 0.5 . . . . 0.0 111.148 -179.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . 0.505 ' OD1' ' O ' ' A' ' 176' ' ' ASP . 43.4 p30 -70.16 135.0 48.69 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 121.123 0.487 . . . . 0.0 110.498 179.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 66.8 m80 -97.89 -8.93 27.22 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.622 -0.431 . . . . 0.0 112.158 -178.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 105.11 39.9 2.21 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 109.864 -1.295 . . . . 0.0 109.864 -179.337 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 13.6 ptmt -156.42 166.01 34.68 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.919 -0.64 . . . . 0.0 110.485 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -88.6 97.18 10.96 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 178.079 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . 0.478 ' HG2' ' N ' ' A' ' 182' ' ' ILE . 73.6 tt0 -131.52 162.21 30.79 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 121.519 0.676 . . . . 0.0 111.891 -178.612 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.478 ' N ' ' HG2' ' A' ' 181' ' ' GLU . 18.6 tt -129.24 137.82 56.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.67 179.337 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 89.7 m -134.5 125.69 27.87 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 121.417 0.627 . . . . 0.0 111.778 -179.229 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 73.2 mt -106.61 132.06 53.04 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.075 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.701 HD13 HD21 ' B' ' 702' ' ' LEU . 77.0 mt -113.02 119.4 60.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.325 0.583 . . . . 0.0 110.694 -179.024 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 186' ' ' THR . . . . . 0.671 HG22 ' N ' ' A' ' 187' ' ' CYS . 48.7 m -141.36 167.81 21.27 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.708 179.634 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 187' ' ' CYS . . . . . 0.671 ' N ' HG22 ' A' ' 186' ' ' THR . 92.7 m -92.7 140.76 29.19 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.944 179.328 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 54.6 t -60.78 -47.74 91.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.14 -179.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 17.4 t -167.56 152.95 7.23 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.287 0.565 . . . . 0.0 110.507 179.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 78.2 t -67.51 -20.13 26.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.503 -179.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -96.53 -8.32 32.27 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.021 -179.509 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -136.92 98.8 3.85 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 121.141 0.495 . . . . 0.0 110.442 179.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 49.4 p-10 -106.61 13.92 27.63 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.6 -179.216 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 84.1 p -59.1 -45.14 91.64 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.91 0.386 . . . . 0.0 111.522 -178.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 26.3 pttm -142.41 149.92 39.96 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 121.269 0.557 . . . . 0.0 111.522 -179.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . 0.605 HH22 ' C ' ' A' ' 59' ' ' SER . 99.7 mtt180 -105.34 135.9 45.87 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.24 179.431 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . 0.7 ' OH ' HD11 ' A' ' 138' ' ' ILE . 21.0 p90 -96.11 150.3 20.66 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.491 -0.484 . . . . 0.0 110.102 179.599 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 4.4 m -130.52 138.51 53.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.11 0.481 . . . . 0.0 111.976 -178.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 49.4 t -98.79 130.69 47.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 178.188 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -116.45 140.52 49.27 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 121.261 0.553 . . . . 0.0 111.294 -179.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -136.18 151.57 20.82 Favored Glycine 0 CA--C 1.532 1.138 0 N-CA-C 110.421 -1.071 . . . . 0.0 110.421 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . 0.438 ' OD1' ' N ' ' A' ' 203' ' ' LEU . 65.0 t0 -116.99 130.43 56.69 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.152 0.501 . . . . 0.0 110.571 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . 0.438 ' N ' ' OD1' ' A' ' 202' ' ' ASP . 50.4 tp -58.33 131.09 49.63 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.217 -179.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 14.0 m -116.27 -16.65 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.919 -179.525 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -178.89 173.92 46.11 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 119.965 -1.112 . . . . 0.0 112.477 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . 0.41 HG23 ' CD1' ' A' ' 156' ' ' TYR . 31.4 m -144.81 138.87 27.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.616 -0.792 . . . . 0.0 109.377 179.235 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -144.95 121.52 11.08 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.112 -0.635 . . . . 0.0 111.737 179.324 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -63.0 140.88 58.92 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.638 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 18.4 ttpt -81.0 110.96 17.04 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.308 179.13 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt . . . . . 0 C--O 1.219 -0.524 0 CA-C-O 118.139 -0.934 . . . . 0.0 110.717 179.997 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 702' ' ' LEU . . . . . 0.701 HD21 HD13 ' A' ' 185' ' ' ILE . 1.2 mt . . . . . 0 CA--C 1.544 0.732 0 CA-C-O 120.55 0.214 . . . . 20.0 110.61 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 703' ' ' PRO . . . . . 0.689 ' HG2' HG22 ' A' ' 110' ' ' VAL . 2.9 Cg_endo -65.97 -176.91 0.67 Allowed 'Trans proline' 0 N--CA 1.491 1.361 0 C-N-CA 122.397 2.065 . . . . 20.0 113.84 -178.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 704' ' ' ALA . . . . . 0.535 ' O ' ' O ' ' B' ' 703' ' ' PRO . . . . . . . . 0 CA--C 1.536 0.436 0 CA-C-N 114.223 -1.353 . . . . 20.0 113.975 -179.136 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.258 0 CA-C-O 121.28 0.562 . . . . 0.0 110.76 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 10.8 p -79.53 25.66 0.32 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.017 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -96.21 3.74 52.92 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.436 -179.467 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.0 mt -55.98 137.8 17.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 122.199 1.0 . . . . 0.0 113.351 -176.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -77.46 133.02 38.71 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 113.692 -1.595 . . . . 0.0 109.37 178.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.717 ' NE2' ' CE1' ' A' ' 126' ' ' HIS . 0.0 OUTLIER -79.8 150.85 73.13 Favored Pre-proline 0 CA--C 1.537 0.451 0 C-N-CA 119.901 -0.72 . . . . 0.0 109.798 -179.989 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.64 ' CG ' HD11 ' A' ' 104' ' ' LEU . 83.0 Cg_endo -73.37 163.02 38.86 Favored 'Trans proline' 0 N--CA 1.499 1.826 0 C-N-CA 123.427 2.751 . . . . 0.0 114.086 -178.05 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.7 ' O ' HG23 ' A' ' 69' ' ' VAL . 88.0 m-20 -54.51 164.0 0.8 Allowed 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.753 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 53.4 tp -64.28 -47.37 79.79 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 121.102 0.477 . . . . 0.0 111.118 -178.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.43 -36.51 82.63 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.079 -0.648 . . . . 0.0 110.865 -178.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -61.21 -29.27 69.72 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.033 -0.667 . . . . 0.0 109.652 179.144 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.7 HG23 ' O ' ' A' ' 65' ' ' ASP . 50.8 t -74.05 -43.71 51.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 121.825 0.821 . . . . 0.0 109.729 179.145 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -76.42 -8.23 56.71 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.745 -1.116 . . . . 0.0 111.434 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -105.41 -8.15 18.32 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.038 0.447 . . . . 0.0 110.38 179.008 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.22 137.5 54.84 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 121.369 0.604 . . . . 0.0 111.109 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 32.2 t -60.29 102.19 0.16 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.486 179.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.92 128.45 36.71 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.372 -179.4 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 -96.43 84.33 3.69 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 177.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -62.98 -41.49 99.56 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.272 0.558 . . . . 0.0 111.899 -179.528 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.511 ' CD ' ' H ' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -71.16 -8.5 53.96 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.869 -176.27 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -94.68 -13.34 25.9 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 121.211 0.529 . . . . 0.0 110.093 178.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 86.9 t -76.2 128.59 37.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.966 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.669 HD13 ' CE ' ' A' ' 96' ' ' LYS . 39.3 pt -113.54 -7.9 12.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.428 179.565 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -174.21 -175.12 41.57 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 110.431 -1.067 . . . . 0.0 110.431 179.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 39.9 ptt180 -152.1 166.71 30.81 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.472 0.653 . . . . 0.0 111.168 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 19.5 tt -114.5 142.87 25.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.223 178.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 66.1 m -135.64 126.89 28.26 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.47 0.653 . . . . 0.0 111.174 -179.342 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.492 ' CG2' HG22 ' A' ' 88' ' ' VAL . 43.3 mt -137.45 89.39 15.93 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.481 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_exo -56.5 -30.18 81.37 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.589 2.192 . . . . 0.0 112.831 -179.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 47.0 m -51.86 -40.94 61.42 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 121.185 0.516 . . . . 0.0 110.593 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.492 HG22 ' CG2' ' A' ' 85' ' ' ILE . 18.6 m -114.0 8.46 7.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.888 179.057 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.483 ' O ' ' OG ' ' A' ' 89' ' ' SER . 3.7 t 54.08 54.13 10.09 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 -179.498 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 66.5 tp -118.43 133.52 55.81 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 121.543 0.687 . . . . 0.0 111.166 -179.152 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -148.03 120.03 8.23 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.329 -0.851 . . . . 0.0 110.452 -179.306 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.615 HD13 ' O ' ' A' ' 105' ' ' SER . 74.6 mt -149.64 152.95 35.96 Favored Pre-proline 0 CA--C 1.537 0.479 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.644 -179.539 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -75.38 150.72 36.95 Favored 'Trans proline' 0 N--CA 1.497 1.735 0 C-N-CA 123.127 2.551 . . . . 0.0 112.471 179.142 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.567 ' C ' HD12 ' A' ' 95' ' ' LEU . 53.0 t -99.17 120.91 49.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-O 121.173 0.511 . . . . 0.0 112.058 -179.261 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.567 HD12 ' C ' ' A' ' 94' ' ' VAL . 10.4 mp -104.38 134.5 47.48 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.324 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.669 ' CE ' HD13 ' A' ' 80' ' ' ILE . 98.7 mttt -61.7 -80.29 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.217 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 12.0 t -56.45 133.02 52.85 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.952 -178.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.8 m -92.53 70.5 5.0 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.756 179.35 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.59 HG22 ' N ' ' A' ' 100' ' ' GLU . 41.2 m -92.37 169.98 10.14 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 178.769 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.59 ' N ' HG22 ' A' ' 99' ' ' THR . 96.7 mt-10 -64.3 -42.46 96.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.264 0.554 . . . . 0.0 110.018 179.503 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 61.6 mttm -65.59 -38.67 90.14 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.887 179.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -64.75 -33.6 76.35 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.378 -0.828 . . . . 0.0 112.18 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 83.5 mt -68.83 -6.79 29.01 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -178.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.64 HD11 ' CG ' ' A' ' 64' ' ' PRO . 3.9 mm? -74.77 -16.36 60.73 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 121.187 0.517 . . . . 0.0 109.635 178.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.615 ' O ' HD13 ' A' ' 92' ' ' LEU . 79.2 p -81.18 -10.04 59.69 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.751 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.605 ' O ' ' CE1' ' A' ' 135' ' ' PHE . . . 92.87 -19.42 51.85 Favored Glycine 0 CA--C 1.532 1.151 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.636 178.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -145.72 127.35 15.18 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 119.605 -0.838 . . . . 0.0 112.661 -179.463 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -147.69 138.56 23.38 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.272 -0.877 . . . . 0.0 110.11 178.255 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.671 ' HA ' HD23 ' A' ' 123' ' ' LEU . 12.3 p -69.06 135.49 50.89 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 121.316 0.579 . . . . 0.0 110.928 -179.751 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.588 HG22 ' HG2' ' B' ' 703' ' ' PRO . 78.7 t -78.0 -48.86 22.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.226 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.535 ' NZ ' ' CD ' ' A' ' 175' ' ' GLU . 98.5 mttt -99.06 140.14 33.67 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.801 0.81 . . . . 0.0 112.52 -179.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -65.86 -36.21 82.82 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.625 -1.17 . . . . 0.0 111.47 -179.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 73.7 m-80 -84.6 11.0 9.63 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -177.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . 0.705 ' N ' HE21 ' A' ' 114' ' ' GLN . 0.0 OUTLIER -78.92 139.19 38.32 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 120.799 0.333 . . . . 0.0 111.296 179.569 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 38.8 t -125.8 125.85 69.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 CA-C-O 121.069 0.461 . . . . 0.0 111.227 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' MET . . . . . 0.431 ' CG ' ' CZ ' ' A' ' 121' ' ' TYR . 93.1 mtp -57.11 133.56 55.11 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.126 0.489 . . . . 0.0 111.657 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 78.14 -2.7 64.58 Favored Glycine 0 CA--C 1.529 0.922 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.643 179.162 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -138.49 132.37 31.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.615 0.722 . . . . 0.0 111.784 179.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 71.14 -167.06 52.05 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 110.18 -1.168 . . . . 0.0 110.18 -179.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 64.7 t-20 -87.83 104.69 16.82 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.196 0.522 . . . . 0.0 109.714 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.64 ' CE2' HD21 ' A' ' 123' ' ' LEU . 5.3 t80 -87.06 99.37 11.86 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.115 -179.479 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.3 135.12 33.88 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.829 -179.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.671 HD23 ' HA ' ' A' ' 109' ' ' THR . 68.3 mt -135.37 139.78 44.5 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.735 -179.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -111.37 140.87 45.59 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 178.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -141.16 129.66 4.15 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 110.482 -1.047 . . . . 0.0 110.482 -179.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . 0.717 ' CE1' ' NE2' ' A' ' 63' ' ' GLN . 1.8 m-70 -82.11 131.52 35.24 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.336 0.589 . . . . 0.0 112.098 -179.208 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . 0.588 ' ND2' ' OG1' ' A' ' 186' ' ' THR . 7.2 p30 -138.79 152.21 47.71 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.634 179.322 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.611 ' O ' ' N ' ' A' ' 130' ' ' LYS . 79.4 mtm -119.28 42.04 2.94 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.598 0.713 . . . . 0.0 110.161 179.179 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 38.64 15.84 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 114.919 -1.037 . . . . 0.0 112.304 178.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.877 ' O ' HG12 ' A' ' 133' ' ' VAL . 19.2 ptmt -110.61 127.32 55.19 Favored 'General case' 0 C--O 1.226 -0.176 0 CA-C-O 122.025 0.917 . . . . 0.0 112.323 -179.723 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.458 ' C ' ' O ' ' A' ' 130' ' ' LYS . 55.8 tptt -38.37 150.71 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.915 179.413 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 79.58 -17.56 8.32 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 121.045 -0.598 . . . . 0.0 112.127 179.224 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.877 HG12 ' O ' ' A' ' 130' ' ' LYS . 9.9 p -87.87 153.08 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-N 117.753 0.777 . . . . 0.0 110.342 -179.561 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.773 HD23 ' N ' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -69.45 143.53 53.54 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.594 0.711 . . . . 0.0 112.832 -177.889 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.605 ' CE1' ' O ' ' A' ' 106' ' ' GLY . 3.5 m-85 66.39 8.34 5.63 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 114.139 -1.391 . . . . 0.0 114.493 177.712 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 5.2 t -76.88 -42.68 38.9 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 179.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -91.82 1.31 57.26 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 114.055 1.132 . . . . 0.0 114.055 -176.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.607 HD11 ' HB ' ' A' ' 186' ' ' THR . 48.6 pt -66.92 -23.73 31.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 C-N-CA 119.43 -0.908 . . . . 0.0 110.877 -179.431 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -66.53 -10.68 47.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.551 0.691 . . . . 0.0 109.856 179.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 94.0 p -81.34 -2.77 50.47 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.625 -179.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 67.8 mt -62.73 143.54 57.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.47 0.652 . . . . 0.0 111.059 -179.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -121.57 156.83 32.05 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.216 -179.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -50.86 133.08 26.9 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.061 -0.972 . . . . 0.0 112.116 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 160' ' ' VAL . . . 79.96 8.69 87.44 Favored Glycine 0 CA--C 1.53 0.979 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.239 178.518 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.463 ' OD1' ' N ' ' A' ' 146' ' ' LYS . 60.5 t0 -74.12 133.47 42.82 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 120.277 -0.569 . . . . 0.0 110.277 -179.62 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.463 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 71.1 mmtt -79.06 140.44 37.89 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 121.84 0.829 . . . . 0.0 111.908 -179.033 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.453 HD11 ' CG2' ' A' ' 160' ' ' VAL . 92.6 mt -140.13 140.12 35.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 114.899 -1.046 . . . . 0.0 108.587 179.511 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -128.64 140.95 51.51 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 119.384 -0.927 . . . . 0.0 113.226 -177.08 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.537 HD11 HD12 ' A' ' 182' ' ' ILE . 19.1 mt -112.51 131.98 55.32 Favored 'General case' 0 CA--C 1.519 -0.233 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 176.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.608 ' CZ ' ' OE2' ' A' ' 155' ' ' GLU . 49.2 m-85 -108.18 107.87 18.68 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.028 -0.669 . . . . 0.0 112.468 -178.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -88.19 158.74 18.43 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 106.641 -1.615 . . . . 0.0 106.641 176.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 33.7 p-10 -57.45 -16.11 8.63 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 119.137 -1.025 . . . . 0.0 111.365 -177.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -114.22 -29.13 7.04 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -179.098 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -146.47 178.97 7.87 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 -176.616 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.608 ' OE2' ' CZ ' ' A' ' 150' ' ' TYR . 84.3 tt0 -130.65 136.03 48.43 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 114.681 -1.145 . . . . 0.0 109.597 178.537 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . 0.406 ' CD1' HG23 ' A' ' 206' ' ' THR . 80.6 m-85 -108.94 133.62 52.69 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.779 0.288 . . . . 0.0 111.779 -178.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -93.2 112.51 24.47 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 121.262 0.553 . . . . 0.0 111.983 179.423 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -112.9 146.06 39.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.176 179.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -121.18 120.72 36.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.207 179.128 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.527 ' O ' ' N ' ' A' ' 144' ' ' GLY . 90.8 t -59.78 136.66 23.16 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.301 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 178.399 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 7.9 p -105.63 -25.39 12.28 Favored 'General case' 0 C--N 1.328 -0.356 0 O-C-N 123.581 0.551 . . . . 0.0 110.86 179.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 158.61 -166.09 34.22 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 120.622 -0.799 . . . . 0.0 111.405 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.757 HG12 HG22 ' A' ' 199' ' ' VAL . 32.7 m -134.08 163.1 38.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.036 -0.582 . . . . 0.0 109.722 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 11.8 p -148.87 161.1 42.52 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.315 0.578 . . . . 0.0 111.477 -179.428 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . 0.403 ' HG2' ' CE2' ' A' ' 197' ' ' TYR . 95.5 mt-10 -103.39 117.18 33.89 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.759 179.151 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 22.7 m -135.18 156.16 38.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.802 -179.226 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -85.14 157.59 59.32 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.508 179.438 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . 0.502 ' O ' ' CB ' ' B' ' 702' ' ' LEU . 19.5 Cg_endo -62.71 -15.66 48.01 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 C-N-CA 122.78 2.32 . . . . 0.0 113.665 -179.685 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . 0.626 ' O ' ' NE1' ' A' ' 171' ' ' TRP . 39.3 p-10 -92.84 -6.72 48.17 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 119.48 -0.888 . . . . 0.0 111.917 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.749 ' O ' HG22 ' A' ' 173' ' ' VAL . 96.5 mttt -78.1 85.07 4.32 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.357 -0.537 . . . . 0.0 111.824 179.429 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' TRP . . . . . 0.626 ' NE1' ' O ' ' A' ' 169' ' ' ASP . 0.0 OUTLIER -75.02 -8.51 56.72 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.428 0.632 . . . . 0.0 110.185 179.159 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 53.3 tp10 -64.77 -29.1 70.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.537 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . 0.749 HG22 ' O ' ' A' ' 170' ' ' LYS . 35.1 m -62.88 -22.21 29.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.37 -179.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.628 HG13 HG23 ' A' ' 173' ' ' VAL . 31.5 m -105.2 -3.46 9.76 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.535 ' CD ' ' NZ ' ' A' ' 111' ' ' LYS . 63.3 mm-40 -71.96 150.68 43.88 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.31 0.576 . . . . 0.0 111.202 179.586 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 38.7 p-10 -67.97 141.8 56.17 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.051 -179.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 78.7 m80 -117.43 23.26 11.9 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.914 0.388 . . . . 0.0 111.411 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 62.06 43.2 99.47 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 110.759 -0.937 . . . . 0.0 110.759 -179.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 12.5 ptmt -164.87 168.44 17.69 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.064 0.459 . . . . 0.0 110.301 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -86.99 100.9 12.94 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 177.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 77.5 tt0 -132.55 160.95 35.09 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.335 0.588 . . . . 0.0 111.32 -178.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.682 HG22 ' O ' ' A' ' 201' ' ' GLY . 18.7 tt -128.65 138.17 55.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.619 179.244 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 60.6 m -132.52 126.18 32.29 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.883 -179.178 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 70.7 mt -111.97 134.44 53.52 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.633 179.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.649 HD13 HD21 ' B' ' 702' ' ' LEU . 92.9 mt -115.9 123.42 71.19 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 CA-C-O 121.482 0.658 . . . . 0.0 110.732 -179.462 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 186' ' ' THR . . . . . 0.607 ' HB ' HD11 ' A' ' 138' ' ' ILE . 13.2 t -138.69 158.65 43.84 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.97 -179.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 187' ' ' CYS . . . . . . . . . . . . . 91.7 m -89.57 139.2 30.78 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.886 0.374 . . . . 0.0 110.591 -179.331 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.592 HG13 ' N ' ' A' ' 189' ' ' SER . 11.9 p -62.33 -44.56 99.31 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-O 120.968 0.414 . . . . 0.0 110.806 -179.259 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . 0.592 ' N ' HG13 ' A' ' 188' ' ' VAL . 23.9 m -167.52 153.43 7.61 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.252 0.548 . . . . 0.0 111.286 -179.626 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 70.1 t -72.43 -17.69 18.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.256 178.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -96.04 -11.86 25.78 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.251 179.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . 0.499 ' O ' ' CG1' ' A' ' 188' ' ' VAL . 49.5 t0 -141.15 98.62 3.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.171 0.51 . . . . 0.0 111.307 -179.409 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -98.81 9.83 42.58 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.542 0.687 . . . . 0.0 109.75 179.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 25.3 m -60.13 -42.68 95.33 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.785 -178.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt -133.89 150.19 51.34 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 120.979 0.419 . . . . 0.0 111.346 -179.36 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . 0.74 HH22 HD22 ' B' ' 702' ' ' LEU . 42.7 mtm180 -128.26 141.45 51.45 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 121.122 0.487 . . . . 0.0 110.48 179.548 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . 0.403 ' CE2' ' HG2' ' A' ' 165' ' ' GLU . 48.4 m-85 -98.04 137.6 36.59 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.331 0.586 . . . . 0.0 111.708 -179.708 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 35.1 t -118.27 134.93 60.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.428 178.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.757 HG22 HG12 ' A' ' 163' ' ' VAL . 68.6 t -103.45 134.51 44.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.013 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -117.0 138.21 51.72 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 121.449 0.642 . . . . 0.0 111.666 -179.124 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . 0.682 ' O ' HG22 ' A' ' 182' ' ' ILE . . . -139.81 130.98 4.93 Favored Glycine 0 CA--C 1.529 0.95 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 179.609 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -95.89 142.07 28.57 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.253 0.549 . . . . 0.0 111.049 -179.411 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 52.0 tp -67.03 133.22 49.49 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 121.527 0.679 . . . . 0.0 110.186 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 74.9 t -105.6 -51.6 7.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.233 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -152.36 174.94 31.2 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 120.193 -1.003 . . . . 0.0 112.576 -178.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . 0.406 HG23 ' CD1' ' A' ' 156' ' ' TYR . 18.0 m -142.4 138.33 31.06 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 114.892 -0.654 . . . . 0.0 110.711 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 54.6 mtmt -146.35 128.0 15.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.262 0.554 . . . . 0.0 111.885 178.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -62.04 142.07 57.73 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.61 -179.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -79.24 108.23 12.59 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.429 178.613 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 99.2 mttt . . . . . 0 C--O 1.218 -0.588 0 CA-C-O 117.921 -1.038 . . . . 0.0 110.537 -179.98 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 702' ' ' LEU . . . . . 0.74 HD22 HH22 ' A' ' 196' ' ' ARG . 0.6 OUTLIER . . . . . 0 CA--C 1.543 0.675 0 CA-C-O 120.378 0.132 . . . . 20.0 110.81 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 703' ' ' PRO . . . . . 0.621 ' HD2' HD23 ' B' ' 702' ' ' LEU . 2.4 Cg_endo -64.55 -172.64 0.2 Allowed 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 122.053 1.835 . . . . 20.0 113.482 -178.497 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 704' ' ' ALA . . . . . 0.41 ' O ' ' O ' ' B' ' 703' ' ' PRO . . . . . . . . 0 C--N 1.326 -0.44 0 CA-C-N 114.098 -1.41 . . . . 20.0 112.424 -179.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.265 0 CA-C-O 121.049 0.452 . . . . 0.0 111.383 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 3.9 p -83.18 21.3 1.12 Allowed 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.124 0.488 . . . . 0.0 111.347 -179.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -106.04 15.8 25.94 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.877 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.3 mt -55.37 137.0 17.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 122.315 1.055 . . . . 0.0 112.527 -177.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -77.84 133.38 38.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 113.687 -1.597 . . . . 0.0 109.097 179.057 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.627 ' H ' ' CD ' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -77.57 152.16 80.69 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-O 121.109 0.48 . . . . 0.0 110.813 -178.476 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -74.01 156.42 47.53 Favored 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 123.249 2.632 . . . . 0.0 113.151 -179.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.442 ' O ' ' OE1' ' A' ' 68' ' ' GLU . 39.0 t70 -54.0 172.83 0.07 Allowed 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.073 179.724 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.411 HD11 ' HE2' ' A' ' 130' ' ' LYS . 86.1 mt -69.55 -13.36 62.29 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.199 -178.509 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -68.11 -37.62 81.35 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.5 0.667 . . . . 0.0 110.455 179.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.869 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 58.9 mp0 -68.16 -31.33 70.81 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.841 -1.072 . . . . 0.0 110.546 179.364 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 8.3 t -71.27 -44.85 72.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.575 -179.457 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -81.92 -13.14 57.93 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.031 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -114.88 1.45 14.06 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 121.252 0.549 . . . . 0.0 110.345 178.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.869 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -67.77 -173.5 0.35 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.517 0.675 . . . . 0.0 112.161 -179.019 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.6 t -102.3 95.38 6.25 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 114.887 -1.051 . . . . 0.0 109.786 179.073 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.552 HD13 ' C ' ' A' ' 74' ' ' LEU . 0.5 OUTLIER -68.79 103.39 1.76 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.899 -179.376 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.454 ' OD2' ' CD ' ' A' ' 78' ' ' GLN . 46.0 t0 -93.2 82.62 4.54 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.623 0.725 . . . . 0.0 109.751 178.483 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -80.15 -30.32 38.91 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.068 -0.969 . . . . 0.0 112.011 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 35.7 mmtt -68.16 -30.92 70.16 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.13 -176.159 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.454 ' CD ' ' OD2' ' A' ' 75' ' ' ASP . 86.0 mt-30 -87.47 2.32 50.94 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.441 -0.504 . . . . 0.0 111.688 -179.101 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 67.8 t -75.65 130.51 36.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.323 0.582 . . . . 0.0 109.927 179.291 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.492 HD13 ' CE ' ' A' ' 96' ' ' LYS . 16.2 pt -107.29 -7.35 10.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.994 -179.235 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -175.27 179.27 46.62 Favored Glycine 0 CA--C 1.527 0.793 0 C-N-CA 120.693 -0.765 . . . . 0.0 111.26 179.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.459 ' HA ' HG23 ' A' ' 94' ' ' VAL . 38.7 ptt180 -152.69 155.35 37.09 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.474 0.654 . . . . 0.0 111.569 179.381 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 20.4 tt -105.05 147.83 10.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.793 -179.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 9.2 t -136.03 131.4 34.9 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.473 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.547 ' CG2' HG22 ' A' ' 88' ' ' VAL . 96.3 mt -137.19 88.71 17.13 Favored Pre-proline 0 CA--C 1.54 0.584 0 CA-C-N 115.41 -0.813 . . . . 0.0 110.846 -179.173 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -56.31 -31.03 83.18 Favored 'Trans proline' 0 N--CA 1.499 1.804 0 C-N-CA 123.043 2.495 . . . . 0.0 112.683 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 99.1 p -53.6 -44.18 69.23 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 121.333 0.587 . . . . 0.0 110.738 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.547 HG22 ' CG2' ' A' ' 85' ' ' ILE . 12.5 m -113.72 11.61 8.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.891 178.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.4 t 44.74 57.0 4.81 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.651 -179.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 57.7 tp -117.78 136.64 53.26 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.296 179.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -146.13 124.79 12.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.68 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.526 HD13 ' HA3' ' A' ' 106' ' ' GLY . 77.4 mt -148.72 150.13 32.45 Favored Pre-proline 0 CA--C 1.535 0.38 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.53 -178.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.07 148.11 34.57 Favored 'Trans proline' 0 N--CA 1.491 1.351 0 C-N-CA 122.526 2.151 . . . . 0.0 111.707 178.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.564 ' C ' HD12 ' A' ' 95' ' ' LEU . 88.9 t -96.81 116.73 39.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 CA-C-O 121.006 0.432 . . . . 0.0 111.587 -179.674 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.58 ' N ' HD12 ' A' ' 95' ' ' LEU . 8.7 mp -100.37 138.79 36.95 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.151 0.5 . . . . 0.0 110.7 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.492 ' CE ' HD13 ' A' ' 80' ' ' ILE . 98.3 mttt -66.13 -79.28 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.425 0.631 . . . . 0.0 112.181 -179.005 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 40.7 t -57.54 133.66 55.44 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.935 -178.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 43.4 p -88.41 66.05 8.17 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.549 179.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.441 ' OG1' ' CG ' ' A' ' 102' ' ' ASN . 31.6 p -86.7 167.45 14.46 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 178.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -63.78 -41.39 97.96 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.233 0.539 . . . . 0.0 110.239 179.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -66.28 -39.83 89.66 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.589 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.441 ' CG ' ' OG1' ' A' ' 99' ' ' THR . 8.9 m120 -63.72 -34.79 78.66 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -178.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.403 ' HB3' ' CD2' ' A' ' 126' ' ' HIS . 70.4 mt -62.71 -17.16 60.23 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -178.512 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.533 ' N ' HD12 ' A' ' 104' ' ' LEU . 10.8 mp -73.21 -16.29 61.42 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 120.286 -0.565 . . . . 0.0 110.403 179.505 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.447 ' O ' HD13 ' A' ' 92' ' ' LEU . 1.5 m -78.43 -7.28 57.2 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 178.718 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.526 ' HA3' HD13 ' A' ' 92' ' ' LEU . . . 91.54 -18.8 51.14 Favored Glycine 0 CA--C 1.534 1.262 0 CA-C-N 114.926 -1.034 . . . . 0.0 113.233 177.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -146.72 127.07 13.96 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 119.563 -0.855 . . . . 0.0 113.08 -179.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -144.73 137.06 26.26 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.922 178.323 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.511 ' HA ' HD23 ' A' ' 123' ' ' LEU . 69.2 p -69.95 138.43 52.33 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.364 0.602 . . . . 0.0 111.189 -179.493 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.594 HG22 ' HG2' ' B' ' 703' ' ' PRO . 74.1 t -79.16 -53.05 14.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.71 -179.77 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.741 ' H ' ' NE2' ' A' ' 114' ' ' GLN . 53.6 mtmt -100.69 134.71 43.26 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 121.831 0.824 . . . . 0.0 112.645 -179.002 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -66.63 -30.63 70.94 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 114.51 -1.223 . . . . 0.0 112.477 -179.194 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 75.1 m-80 -84.37 11.21 8.85 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 -177.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . 0.741 ' NE2' ' H ' ' A' ' 111' ' ' LYS . 22.2 mt-30 -81.16 143.3 32.48 Favored 'General case' 0 C--N 1.328 -0.326 0 O-C-N 121.904 -0.497 . . . . 0.0 111.347 178.762 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.424 ' O ' ' O ' ' A' ' 118' ' ' LYS . 51.4 t -122.54 124.28 70.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.246 -0.434 . . . . 0.0 109.92 178.638 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 99.3 mtp -58.25 127.0 29.92 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 121.324 0.583 . . . . 0.0 111.471 -179.281 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 91.62 -4.75 79.73 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 110.606 -0.997 . . . . 0.0 110.606 179.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.424 ' O ' ' O ' ' A' ' 115' ' ' VAL . 87.5 tttt -142.48 130.96 22.4 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.113 0.482 . . . . 0.0 110.614 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 80.39 -174.28 54.94 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 -179.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 63.9 t-20 -90.75 107.1 18.96 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 179.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -85.41 99.31 11.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.242 0.544 . . . . 0.0 110.23 -179.384 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.84 136.16 33.25 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.479 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.511 HD23 ' HA ' ' A' ' 109' ' ' THR . 67.4 mt -134.07 139.14 45.77 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.491 -0.484 . . . . 0.0 111.469 -179.417 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -112.77 143.72 43.53 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 178.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -142.42 151.82 23.28 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.164 -1.174 . . . . 0.0 110.164 -178.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . 0.403 ' CD2' ' HB3' ' A' ' 103' ' ' LEU . 4.7 m-70 -89.24 126.03 35.33 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.592 0.711 . . . . 0.0 111.874 -179.468 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . 0.433 ' ND2' ' HA ' ' A' ' 136' ' ' SER . 35.1 t30 -129.12 125.18 36.56 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 114.931 -1.031 . . . . 0.0 110.681 179.504 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.513 ' O ' ' OG ' ' A' ' 129' ' ' SER . 78.1 mtm -102.53 -1.72 29.94 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.351 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.513 ' OG ' ' O ' ' A' ' 128' ' ' MET . 6.2 p 77.78 10.23 2.24 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.473 179.77 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.76 ' O ' HG12 ' A' ' 133' ' ' VAL . 5.9 ptmt -110.42 118.15 35.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.474 0.654 . . . . 0.0 112.427 -179.274 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.496 ' C ' ' O ' ' A' ' 130' ' ' LYS . 29.1 tptt -32.98 149.89 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 114.926 -1.034 . . . . 0.0 109.554 178.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.436 ' N ' ' HG3' ' A' ' 131' ' ' LYS . . . 82.82 -15.49 31.43 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 111.064 -0.814 . . . . 0.0 111.064 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.76 HG12 ' O ' ' A' ' 130' ' ' LYS . 8.0 p -94.22 151.68 3.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.04 -0.664 . . . . 0.0 111.174 -179.041 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.593 HD23 ' N ' ' A' ' 134' ' ' LEU . 0.1 OUTLIER -68.04 147.16 52.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.88 0.848 . . . . 0.0 112.96 -177.774 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.449 ' CE1' ' O ' ' A' ' 106' ' ' GLY . 3.0 m-85 65.2 4.85 2.76 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 113.943 -1.481 . . . . 0.0 114.266 177.528 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . 0.433 ' HA ' ' ND2' ' A' ' 127' ' ' ASN . 28.1 p -76.51 -35.22 58.46 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 120.147 -0.621 . . . . 0.0 111.908 178.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . 0.421 ' N ' ' OD1' ' A' ' 137' ' ' ASP . 36.6 p-10 -94.75 2.09 55.5 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 114.543 1.312 . . . . 0.0 114.543 -177.533 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 45.6 pt -69.22 -20.38 24.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 C-N-CA 119.06 -1.056 . . . . 0.0 110.466 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -68.38 -9.91 51.46 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.191 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 49.7 m -82.96 -5.01 58.9 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.554 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 89.0 mt -64.56 143.77 57.68 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 121.276 0.56 . . . . 0.0 110.764 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.419 ' HG2' ' N ' ' A' ' 143' ' ' LYS . 88.2 tttt -119.79 157.46 28.57 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.569 -179.003 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . 0.419 ' N ' ' HG2' ' A' ' 142' ' ' LYS . 87.8 tttt -50.02 129.52 20.78 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.381 179.366 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.464 ' N ' ' O ' ' A' ' 160' ' ' VAL . . . 83.13 8.96 84.78 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 120.358 -0.925 . . . . 0.0 112.371 178.531 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 47.5 t0 -73.66 130.25 39.63 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 120.076 -0.65 . . . . 0.0 110.679 -179.372 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -76.61 141.05 41.21 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 121.602 0.715 . . . . 0.0 111.485 -179.001 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 95.5 mt -137.67 138.66 44.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.063 -0.971 . . . . 0.0 108.815 178.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . 0.517 ' C ' HD22 ' A' ' 149' ' ' LEU . 95.2 m-85 -119.89 133.94 55.41 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 -177.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.517 HD22 ' C ' ' A' ' 148' ' ' TYR . 4.4 mm? -111.38 132.29 54.54 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 114.594 -1.184 . . . . 0.0 108.022 177.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -112.18 108.26 17.44 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.205 -0.598 . . . . 0.0 112.119 -178.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . 0.577 ' OD1' ' N ' ' A' ' 152' ' ' ASN . 57.1 t0 -89.42 158.35 17.78 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 177.54 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . 0.577 ' N ' ' OD1' ' A' ' 151' ' ' ASP . 36.8 p-10 -54.85 -20.07 7.9 Favored 'General case' 0 C--N 1.312 -1.042 0 C-N-CA 120.118 -0.633 . . . . 0.0 110.897 -177.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -112.49 -29.69 7.4 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 -178.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . 0.425 ' O ' ' N ' ' A' ' 151' ' ' ASP . 0.2 OUTLIER -148.86 -178.42 6.35 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.957 0.885 . . . . 0.0 113.244 -177.205 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -128.52 137.85 51.96 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 114.483 -1.235 . . . . 0.0 109.813 179.193 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -113.61 138.28 50.39 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 121.155 0.503 . . . . 0.0 111.296 -179.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . 0.465 ' O ' HD12 ' A' ' 203' ' ' LEU . 84.1 tt0 -98.99 114.95 27.85 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 121.296 0.57 . . . . 0.0 111.917 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 45.8 m-85 -113.49 147.11 38.5 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.238 0.542 . . . . 0.0 111.033 179.108 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -120.22 120.27 35.65 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.576 179.347 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.464 ' O ' ' N ' ' A' ' 144' ' ' GLY . 73.1 t -58.37 136.28 21.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 178.075 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 34.0 p -105.07 -26.79 11.97 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 123.425 0.453 . . . . 0.0 111.803 -179.532 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 167.1 -175.95 42.16 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 120.143 -1.027 . . . . 0.0 111.882 -179.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.975 HG22 HG22 ' A' ' 199' ' ' VAL . 47.7 t -129.22 138.12 55.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 114.8 -0.7 . . . . 0.0 109.465 179.311 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 20.9 t -137.28 167.51 21.44 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.554 0.692 . . . . 0.0 111.91 -178.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . 0.421 ' CG ' ' CE2' ' A' ' 197' ' ' TYR . 95.5 mt-10 -107.95 122.84 47.65 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.06 -179.619 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 32.6 m -136.93 160.97 36.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.882 179.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -84.76 158.72 59.1 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.357 179.322 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . 0.434 ' O ' HD12 ' B' ' 702' ' ' LEU . 37.0 Cg_endo -65.99 -13.43 39.81 Favored 'Trans proline' 0 C--N 1.303 -1.826 0 C-N-CA 123.169 2.579 . . . . 0.0 113.363 -179.638 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 35.7 p30 -96.54 -6.89 35.93 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 -179.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.841 ' O ' HD23 ' B' ' 702' ' ' LEU . 96.8 mttt -75.55 113.22 12.73 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 -177.605 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' TRP . . . . . 0.405 ' N ' ' CD1' ' A' ' 171' ' ' TRP . 35.4 m0 -83.24 -22.06 33.2 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.862 179.075 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -54.53 -38.79 66.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.534 -177.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . 0.647 HG23 HG23 ' A' ' 174' ' ' VAL . 31.0 m -64.51 -13.41 14.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.022 0.439 . . . . 0.0 111.338 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.647 HG23 HG23 ' A' ' 173' ' ' VAL . 76.4 t -111.58 -20.23 6.38 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -178.162 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -70.35 142.4 52.15 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.386 0.613 . . . . 0.0 111.773 -179.384 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . 0.434 ' OD1' ' O ' ' A' ' 176' ' ' ASP . 46.0 p-10 -66.44 138.34 57.48 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 115.641 -0.708 . . . . 0.0 111.175 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 79.7 m80 -111.68 25.42 11.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.357 179.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 65.28 42.82 96.01 Favored Glycine 0 CA--C 1.532 1.102 0 N-CA-C 111.099 -0.801 . . . . 0.0 111.099 179.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 11.8 ptmt -161.4 166.93 26.61 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 120.94 0.4 . . . . 0.0 110.585 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -85.57 104.83 15.68 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 177.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . 0.451 ' HG2' ' N ' ' A' ' 182' ' ' ILE . 82.9 tt0 -136.15 162.0 34.16 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.395 0.617 . . . . 0.0 111.667 -178.411 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.451 ' N ' ' HG2' ' A' ' 181' ' ' GLU . 18.4 tt -129.32 137.79 56.07 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.038 178.078 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 52.4 m -133.94 127.4 32.35 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 120.979 0.419 . . . . 0.0 111.232 -179.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 71.2 mt -108.65 130.87 55.33 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.13 179.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 91.2 mt -113.68 125.93 71.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.136 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 2.2 t -142.08 163.22 33.46 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.884 179.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 187' ' ' CYS . . . . . . . . . . . . . 4.8 m -86.12 140.83 29.86 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.61 HG13 ' N ' ' A' ' 189' ' ' SER . 9.9 p -62.48 -48.55 87.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.093 0.473 . . . . 0.0 111.129 -179.198 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . 0.61 ' N ' HG13 ' A' ' 188' ' ' VAL . 79.0 p -167.71 156.08 9.24 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.092 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 13.8 p -70.6 -18.81 21.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.21 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -96.84 -15.12 21.42 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . 0.558 ' O ' ' CG1' ' A' ' 188' ' ' VAL . 63.5 t0 -130.73 105.68 7.96 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 120.638 -0.425 . . . . 0.0 111.456 -179.728 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 48.8 p-10 -107.33 12.79 27.74 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 120.78 0.324 . . . . 0.0 111.345 179.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 9.6 t -60.83 -46.66 89.67 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 120.951 0.405 . . . . 0.0 111.906 -179.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 63.3 pttt -144.51 155.64 43.79 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 179.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 84.9 mtt85 -127.38 149.51 50.04 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.363 0.601 . . . . 0.0 111.914 -179.046 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . 0.421 ' CE2' ' CG ' ' A' ' 165' ' ' GLU . 53.3 m-85 -92.93 142.58 27.15 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.741 -178.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 25.0 t -129.21 133.52 65.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.696 179.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.975 HG22 HG22 ' A' ' 163' ' ' VAL . 53.0 t -101.84 132.67 47.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.236 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -118.15 147.86 42.91 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.125 0.488 . . . . 0.0 110.462 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -148.61 143.07 10.55 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 -179.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 50.9 p30 -107.1 156.3 18.93 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.282 0.563 . . . . 0.0 111.48 -179.367 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . 0.465 HD12 ' O ' ' A' ' 157' ' ' GLU . 46.7 tp -77.59 130.87 37.45 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.266 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 15.7 m -114.91 -15.91 9.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.376 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -178.39 173.19 45.64 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 119.522 -1.323 . . . . 0.0 113.097 179.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 57.4 m -142.26 137.95 31.04 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.238 -0.981 . . . . 0.0 109.864 179.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 52.6 mtmt -144.03 114.83 7.74 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.184 0.516 . . . . 0.0 111.529 -179.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -65.77 148.59 51.52 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.551 0.691 . . . . 0.0 111.986 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -79.63 109.1 13.7 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.848 178.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 98.0 mttt . . . . . 0 C--O 1.221 -0.422 0 CA-C-O 117.883 -1.056 . . . . 0.0 110.682 179.712 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 702' ' ' LEU . . . . . 0.841 HD23 ' O ' ' A' ' 170' ' ' LYS . 0.1 OUTLIER . . . . . 0 CA--C 1.535 0.399 0 CA-C-O 121.34 0.591 . . . . 20.0 111.101 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 703' ' ' PRO . . . . . 0.594 ' HG2' HG22 ' A' ' 110' ' ' VAL . 3.6 Cg_exo -77.01 -161.66 0.14 Allowed 'Trans proline' 0 C--N 1.305 -1.739 0 C-N-CA 123.305 2.67 . . . . 20.0 113.831 -179.612 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 704' ' ' ALA . . . . . 0.516 ' O ' ' O ' ' B' ' 703' ' ' PRO . . . . . . . . 0 C--N 1.325 -0.475 0 CA-C-N 113.863 -1.517 . . . . 20.0 112.744 -179.388 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.435 ' C ' ' H ' ' A' ' 60' ' ' LYS . . . . . . . . 0 N--CA 1.454 -0.237 0 CA-C-O 121.212 0.53 . . . . 0.0 110.637 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.468 ' O ' ' NH2' ' A' ' 196' ' ' ARG . 3.7 p -79.02 22.59 0.39 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.266 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.435 ' H ' ' C ' ' A' ' 58' ' ' ALA . 98.9 mttt -102.15 9.72 39.95 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.128 -179.365 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.8 mt -55.23 139.8 13.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 122.416 1.103 . . . . 0.0 111.869 -177.404 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.536 ' OD1' ' N ' ' A' ' 62' ' ' ASP . 20.0 p-10 -76.45 128.69 35.29 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 113.528 -1.669 . . . . 0.0 109.551 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.547 ' H ' ' CD ' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -78.86 129.02 74.85 Favored Pre-proline 0 CA--C 1.542 0.654 0 C-N-CA 120.449 -0.5 . . . . 0.0 110.536 -179.025 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -53.41 147.86 35.79 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 C-N-CA 122.129 1.886 . . . . 0.0 112.855 178.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.655 ' O ' HG23 ' A' ' 69' ' ' VAL . 27.4 t70 -53.2 177.84 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.77 -179.489 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.414 ' H ' ' CG ' ' A' ' 65' ' ' ASP . 92.1 mt -63.6 -43.8 95.85 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.196 -178.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.09 -36.68 82.43 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 119.761 -0.776 . . . . 0.0 110.336 -179.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -61.31 -35.21 76.73 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.751 0.786 . . . . 0.0 109.042 178.22 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.655 HG23 ' O ' ' A' ' 65' ' ' ASP . 62.0 t -73.87 -43.26 53.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.917 179.003 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -70.53 -9.71 57.38 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.624 -179.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -118.33 -1.82 11.23 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 121.526 0.679 . . . . 0.0 109.837 179.189 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -70.05 -175.51 0.96 Allowed 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.648 -179.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 6.6 t -94.9 105.42 17.34 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.119 179.15 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 42.0 tp -69.95 135.02 48.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.691 -179.016 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.417 ' OD2' ' OD1' ' A' ' 102' ' ' ASN . 91.3 m-20 -116.06 77.57 1.11 Allowed 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 121.845 0.831 . . . . 0.0 109.36 177.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.78 ' O ' HG12 ' A' ' 79' ' ' VAL . 86.5 tttt -84.89 -40.32 17.19 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.678 -1.146 . . . . 0.0 112.148 -179.753 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.423 ' H ' ' HG2' ' A' ' 77' ' ' LYS . 52.1 mmtt -73.14 -12.89 61.05 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.707 -176.444 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -94.92 2.1 55.36 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.224 0.535 . . . . 0.0 110.194 179.51 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.78 HG12 ' O ' ' A' ' 76' ' ' LYS . 11.6 p -72.06 115.1 11.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 121.371 0.605 . . . . 0.0 110.833 -179.576 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 32.8 pt -102.84 -7.78 9.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.807 179.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -163.31 158.53 30.94 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 120.637 -0.792 . . . . 0.0 111.339 179.16 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 33.6 ttm180 -133.43 140.01 47.06 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 121.309 0.576 . . . . 0.0 111.334 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 5.1 tt -111.31 142.52 23.44 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.615 179.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 73.8 m -137.45 133.7 34.98 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 115.138 -0.937 . . . . 0.0 112.946 -178.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.575 ' CG2' HG22 ' A' ' 88' ' ' VAL . 66.6 mt -135.61 87.62 25.89 Favored Pre-proline 0 CA--C 1.54 0.558 0 CA-C-O 121.444 0.64 . . . . 0.0 111.034 179.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -55.87 -33.17 87.77 Favored 'Trans proline' 0 N--CA 1.498 1.757 0 C-N-CA 123.309 2.672 . . . . 0.0 112.431 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 28.2 m -52.78 -41.11 63.79 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 121.143 0.497 . . . . 0.0 110.415 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.575 HG22 ' CG2' ' A' ' 85' ' ' ILE . 30.6 m -115.51 13.0 7.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.754 179.267 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 2.5 p 47.37 52.24 12.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.269 0.557 . . . . 0.0 111.101 -179.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 60.0 tp -119.93 135.25 54.97 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.379 0.609 . . . . 0.0 110.834 179.48 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -148.92 127.46 12.35 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.866 179.338 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.654 HD13 ' HA3' ' A' ' 106' ' ' GLY . 83.5 mt -149.84 147.85 23.72 Favored Pre-proline 0 CA--C 1.541 0.629 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.458 -178.516 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -74.12 150.25 42.45 Favored 'Trans proline' 0 N--CA 1.501 1.949 0 C-N-CA 122.881 2.387 . . . . 0.0 112.117 179.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.666 ' C ' HD12 ' A' ' 95' ' ' LEU . 89.4 t -95.0 125.36 47.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-O 121.26 0.553 . . . . 0.0 111.279 179.613 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.666 HD12 ' C ' ' A' ' 94' ' ' VAL . 10.1 mp -109.34 142.1 40.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.838 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.536 ' O ' ' OG1' ' A' ' 109' ' ' THR . 19.1 ttmt -74.5 -76.19 0.14 Allowed 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 116.103 -0.499 . . . . 0.0 112.148 -178.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 33.4 t -59.62 129.59 42.66 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.185 0.517 . . . . 0.0 111.982 -178.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.407 ' OG ' ' O ' ' A' ' 109' ' ' THR . 23.0 m -87.19 69.48 10.08 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.947 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.545 HG22 ' N ' ' A' ' 100' ' ' GLU . 44.4 m -90.27 165.1 14.11 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 178.721 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.545 ' N ' HG22 ' A' ' 99' ' ' THR . 83.3 tt0 -58.2 -45.57 87.35 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 119.972 -0.691 . . . . 0.0 110.185 -179.477 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -65.06 -41.59 95.0 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.217 178.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.446 ' HB2' ' H ' ' A' ' 99' ' ' THR . 94.9 m-20 -62.98 -39.71 95.55 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.103 -179.646 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.475 HD13 ' HB3' ' B' ' 704' ' ' ALA . 65.3 mt -61.59 -28.39 69.31 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.695 179.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.573 HD13 HG22 ' A' ' 69' ' ' VAL . 98.6 mt -73.98 -15.73 61.1 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.194 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.59 -7.64 48.99 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.466 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.654 ' HA3' HD13 ' A' ' 92' ' ' LEU . . . 98.84 -22.11 42.61 Favored Glycine 0 CA--C 1.531 1.057 0 CA-C-N 114.701 -1.136 . . . . 0.0 113.447 177.039 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -147.2 125.86 12.56 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 119.643 -0.823 . . . . 0.0 112.211 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -142.03 135.99 29.79 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.698 179.235 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.575 ' HA ' HD23 ' A' ' 123' ' ' LEU . 71.6 p -69.59 132.16 45.79 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 121.224 0.535 . . . . 0.0 110.515 -179.554 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.575 HG22 ' HG2' ' B' ' 703' ' ' PRO . 53.6 t -79.07 -50.7 18.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.174 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.798 ' H ' ' NE2' ' A' ' 114' ' ' GLN . 82.5 mttt -102.91 138.19 40.11 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.57 0.7 . . . . 0.0 112.349 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -66.17 -32.58 74.11 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.016 -0.993 . . . . 0.0 112.862 -178.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -82.42 13.51 3.58 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -178.217 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . 0.798 ' NE2' ' H ' ' A' ' 111' ' ' LYS . 31.4 mt-30 -80.22 136.06 36.39 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.238 0.542 . . . . 0.0 111.341 179.709 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 71.3 t -123.59 127.91 74.28 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.759 179.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' MET . . . . . 0.659 ' SD ' ' CE2' ' A' ' 121' ' ' TYR . 85.3 mmm -55.1 126.02 22.98 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -179.178 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 82.86 -3.27 84.31 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.456 178.098 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -137.21 131.85 33.03 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.063 -0.655 . . . . 0.0 110.867 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 75.03 -174.33 51.81 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 110.226 -1.15 . . . . 0.0 110.226 -179.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.593 ' ND2' ' ND1' ' A' ' 177' ' ' HIS . 62.4 m-20 -84.53 105.04 15.05 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.363 -0.535 . . . . 0.0 109.739 179.548 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.659 ' CE2' ' SD ' ' A' ' 116' ' ' MET . 2.2 t80 -86.34 98.71 11.13 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 120.539 -0.465 . . . . 0.0 110.209 -179.797 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.59 138.05 31.87 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.275 0.56 . . . . 0.0 111.288 -179.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.575 HD23 ' HA ' ' A' ' 109' ' ' THR . 67.7 mt -135.14 138.59 43.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.435 -179.49 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -106.82 134.95 49.19 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 178.553 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -134.6 148.43 19.51 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 -179.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 8.0 m-70 -91.83 136.11 33.4 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.53 0.681 . . . . 0.0 111.805 -179.176 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 39.2 t30 -132.6 124.96 29.36 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 114.966 -1.016 . . . . 0.0 111.341 -179.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.443 ' O ' ' CB ' ' A' ' 129' ' ' SER . 65.1 mtt -100.78 -5.81 25.8 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.517 0.675 . . . . 0.0 110.322 179.49 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.443 ' CB ' ' O ' ' A' ' 128' ' ' MET . 0.9 OUTLIER 77.62 12.23 2.01 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.747 178.886 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.794 ' O ' HG12 ' A' ' 133' ' ' VAL . 64.1 pttt -109.85 122.78 48.31 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 122.274 1.035 . . . . 0.0 112.303 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -44.29 119.05 1.69 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.898 179.228 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 117.42 -15.33 13.05 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 -179.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.794 HG12 ' O ' ' A' ' 130' ' ' LYS . 10.6 p -92.73 153.34 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 CA-C-O 120.991 0.424 . . . . 0.0 109.941 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.825 HD23 ' N ' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -71.43 146.47 48.65 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.816 0.817 . . . . 0.0 113.088 -177.936 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.482 ' CE1' ' O ' ' A' ' 106' ' ' GLY . 3.6 m-85 66.4 5.34 3.69 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 113.984 -1.462 . . . . 0.0 114.452 178.225 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 23.6 p -75.71 -29.37 58.94 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 119.936 -0.705 . . . . 0.0 112.509 179.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 31.6 p-10 -92.05 4.79 52.32 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 -176.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.421 HD11 ' OG1' ' A' ' 186' ' ' THR . 39.2 pt -67.43 -25.73 34.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 C-N-CA 119.016 -1.073 . . . . 0.0 110.493 -179.578 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -68.02 -13.79 62.47 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.451 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 54.6 p -83.53 -5.63 59.22 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.164 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 88.6 mt -63.43 145.66 55.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.37 0.605 . . . . 0.0 111.275 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -119.32 151.67 38.06 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.574 -179.253 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -48.98 130.59 18.51 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.114 179.388 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.609 ' N ' ' O ' ' A' ' 160' ' ' VAL . . . 79.85 8.34 87.76 Favored Glycine 0 CA--C 1.524 0.651 0 C-N-CA 120.847 -0.692 . . . . 0.0 111.453 179.061 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.541 ' OD1' ' N ' ' A' ' 146' ' ' LYS . 53.0 t0 -71.37 130.68 41.95 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 119.519 -0.872 . . . . 0.0 109.866 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.541 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 74.8 mmtt -78.61 142.12 37.5 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 122.044 0.925 . . . . 0.0 111.958 -178.269 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 95.6 mt -136.65 138.49 46.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 114.168 -1.378 . . . . 0.0 108.538 178.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -130.54 143.13 50.56 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 119.981 -0.688 . . . . 0.0 112.537 -178.24 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.789 ' C ' HD22 ' A' ' 149' ' ' LEU . 0.0 OUTLIER -143.96 157.77 44.13 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.097 176.788 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.498 ' CD1' ' N ' ' A' ' 150' ' ' TYR . 0.5 OUTLIER -123.53 133.14 54.04 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -177.775 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -91.04 168.4 11.67 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 105.991 -1.855 . . . . 0.0 105.991 175.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 -58.5 -25.76 62.71 Favored 'General case' 0 C--N 1.307 -1.274 0 C-N-CA 119.183 -1.007 . . . . 0.0 110.798 -179.448 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 -110.03 -27.16 9.34 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -178.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -145.31 -172.72 3.93 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 114.608 1.336 . . . . 0.0 114.608 -176.268 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 77.5 tt0 -133.75 134.56 43.12 Favored 'General case' 0 C--N 1.339 0.145 0 CA-C-N 114.508 -1.223 . . . . 0.0 110.045 179.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . 0.433 ' HB2' HD11 ' A' ' 149' ' ' LEU . 58.9 m-85 -114.68 136.37 53.13 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-O 121.34 0.59 . . . . 0.0 110.92 -179.574 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . 0.589 ' O ' HG22 ' A' ' 204' ' ' VAL . 97.7 mt-10 -96.63 114.83 26.52 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.392 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 -114.62 147.95 38.8 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 120.755 0.312 . . . . 0.0 110.868 179.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -126.57 126.66 44.01 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.269 0.557 . . . . 0.0 110.622 178.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.609 ' O ' ' N ' ' A' ' 144' ' ' GLY . 42.8 t -59.79 134.99 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.624 178.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 68.4 p -107.49 -28.75 9.62 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.253 0.549 . . . . 0.0 110.483 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 165.97 -172.34 41.33 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 111.352 -0.699 . . . . 0.0 111.352 179.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 2.3 p -134.39 148.91 29.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 179.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 22.9 t -138.29 167.71 21.29 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.465 0.65 . . . . 0.0 111.43 -179.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 75.0 tt0 -111.35 119.43 38.83 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.796 -179.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.479 HG21 HG11 ' A' ' 173' ' ' VAL . 32.3 m -136.2 157.54 37.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.01 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -80.65 160.72 66.3 Favored Pre-proline 0 C--N 1.32 -0.676 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.147 -179.418 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . 0.469 ' O ' ' CB ' ' B' ' 702' ' ' LEU . 33.8 Cg_endo -65.51 -18.11 58.81 Favored 'Trans proline' 0 N--CA 1.502 1.983 0 C-N-CA 122.977 2.451 . . . . 0.0 113.461 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 42.6 p-10 -91.23 -1.6 57.65 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 120.21 -0.596 . . . . 0.0 111.866 179.473 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.754 ' O ' HG22 ' A' ' 173' ' ' VAL . 71.6 mmtt -75.96 87.15 2.9 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.951 -179.772 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' TRP . . . . . 0.587 ' O ' HG22 ' A' ' 174' ' ' VAL . 31.3 m0 -76.69 -12.12 59.95 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.43 0.633 . . . . 0.0 109.943 179.589 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -62.87 -32.59 73.87 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.365 -179.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . 0.754 HG22 ' O ' ' A' ' 170' ' ' LYS . 33.3 m -62.48 -18.32 20.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.911 -178.465 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.742 HG13 HG23 ' A' ' 173' ' ' VAL . 35.5 m -110.23 -4.78 10.95 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -179.162 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -73.26 139.69 46.34 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.911 0.386 . . . . 0.0 110.611 179.227 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . 0.516 ' OD1' ' O ' ' A' ' 176' ' ' ASP . 53.1 p-10 -70.83 136.22 48.59 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 121.257 0.551 . . . . 0.0 110.91 -179.649 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' HIS . . . . . 0.593 ' ND1' ' ND2' ' A' ' 120' ' ' ASN . 78.5 m80 -102.34 -15.37 16.58 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.131 0.491 . . . . 0.0 111.219 -179.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 105.09 39.74 2.24 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 -179.365 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -152.96 167.61 28.59 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 114.795 -0.702 . . . . 0.0 111.232 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -88.65 98.99 11.98 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 177.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . 0.442 ' HG2' ' N ' ' A' ' 182' ' ' ILE . 81.8 tt0 -137.24 164.03 29.49 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.694 0.759 . . . . 0.0 111.423 -178.629 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.442 ' N ' ' HG2' ' A' ' 181' ' ' GLU . 16.8 tt -130.74 140.61 48.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 114.689 -1.141 . . . . 0.0 109.258 178.686 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . 0.401 HG23 ' CG1' ' A' ' 198' ' ' VAL . 51.7 m -132.96 126.57 32.32 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.203 0.525 . . . . 0.0 111.249 -179.136 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 91.4 mt -107.53 130.86 54.82 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.068 179.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.747 HD13 HD21 ' B' ' 702' ' ' LEU . 81.1 mt -109.56 121.32 62.36 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-O 121.234 0.54 . . . . 0.0 110.637 -179.647 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 186' ' ' THR . . . . . 0.625 HG22 ' N ' ' A' ' 187' ' ' CYS . 43.7 m -139.44 168.17 20.42 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.281 179.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 187' ' ' CYS . . . . . 0.625 ' N ' HG22 ' A' ' 186' ' ' THR . 1.6 m -101.91 148.46 25.31 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.288 179.701 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 71.4 t -60.85 -46.89 95.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-O 120.981 0.419 . . . . 0.0 111.44 -178.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 86.0 p -170.08 159.5 7.59 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.205 179.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 57.7 t -65.75 -18.82 24.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.489 0.661 . . . . 0.0 109.687 179.324 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -96.74 -13.32 22.77 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.939 -179.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -131.67 96.05 3.87 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.421 179.362 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 43.2 p-10 -110.29 5.01 21.35 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 112.23 0.456 . . . . 0.0 112.23 -179.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 11.5 t -63.93 -40.95 97.63 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.954 0.407 . . . . 0.0 111.326 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -126.73 151.74 47.77 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 121.158 0.504 . . . . 0.0 110.749 -179.24 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . 0.468 ' NH2' ' O ' ' A' ' 59' ' ' SER . 99.8 mtt180 -126.19 137.76 53.58 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.386 -179.503 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 43.9 p90 -98.34 144.29 27.89 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.698 178.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.401 ' CG1' HG23 ' A' ' 183' ' ' THR . 50.2 t -121.27 133.39 67.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.439 0.638 . . . . 0.0 111.573 -178.548 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 51.0 t -103.67 132.1 50.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.638 179.233 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -118.92 147.76 43.66 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.469 0.652 . . . . 0.0 112.141 -178.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -134.82 140.27 11.58 Favored Glycine 0 CA--C 1.532 1.113 0 N-CA-C 110.422 -1.071 . . . . 0.0 110.422 179.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 54.8 t0 -100.93 136.61 40.51 Favored 'General case' 0 C--N 1.329 -0.304 0 O-C-N 122.626 -0.337 . . . . 0.0 110.804 -179.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 51.7 tp -65.29 127.25 30.96 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.589 HG22 ' O ' ' A' ' 157' ' ' GLU . 28.6 m -110.52 -18.8 7.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 C-N-CA 120.6 -0.44 . . . . 0.0 112.181 -178.65 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -179.21 174.34 46.3 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 120.002 -1.095 . . . . 0.0 112.602 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 97.3 m -143.59 138.74 29.27 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 114.991 -0.605 . . . . 0.0 110.439 179.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -142.37 115.8 9.03 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 120.644 -0.423 . . . . 0.0 111.512 178.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -63.36 147.48 51.03 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.498 0.666 . . . . 0.0 111.467 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 52.9 mtmt -79.27 106.72 11.51 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.556 179.327 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 97.9 mttt . . . . . 0 C--O 1.219 -0.538 0 CA-C-O 117.827 -1.082 . . . . 0.0 110.613 179.794 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 702' ' ' LEU . . . . . 0.747 HD21 HD13 ' A' ' 185' ' ' ILE . 0.5 OUTLIER . . . . . 0 CA--C 1.546 0.819 0 N-CA-C 110.806 -0.072 . . . . 20.0 110.806 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 703' ' ' PRO . . . . . 0.695 ' HD2' HD23 ' B' ' 702' ' ' LEU . 3.2 Cg_exo -66.15 -177.31 0.79 Allowed 'Trans proline' 0 N--CA 1.496 1.652 0 C-N-CA 122.042 1.828 . . . . 20.0 113.96 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 704' ' ' ALA . . . . . 0.507 ' O ' ' O ' ' B' ' 703' ' ' PRO . . . . . . . . 0 N--CA 1.473 0.715 0 N-CA-C 114.531 1.308 . . . . 20.0 114.531 -178.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.258 0 CA-C-O 121.308 0.575 . . . . 0.0 110.609 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 2.0 p -77.54 7.96 4.9 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.544 -178.31 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.416 ' HA ' HH21 ' A' ' 196' ' ' ARG . 59.3 pttt -85.59 26.94 0.88 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.35 0.595 . . . . 0.0 110.926 179.42 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 45.1 mm -55.89 139.76 14.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 122.345 1.069 . . . . 0.0 113.357 -176.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -81.12 124.33 29.14 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 113.584 -1.644 . . . . 0.0 108.128 178.051 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.631 ' H ' ' CD ' ' A' ' 63' ' ' GLN . 1.1 pm0 -77.52 151.71 80.54 Favored Pre-proline 0 C--N 1.324 -0.517 0 C-N-CA 120.064 -0.654 . . . . 0.0 110.855 -178.663 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -68.31 154.75 71.4 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 122.616 2.211 . . . . 0.0 112.084 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -57.98 171.4 0.52 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 121.38 0.61 . . . . 0.0 111.906 -179.027 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 89.3 mt -64.64 -45.58 86.2 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.946 -178.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.09 -37.9 89.13 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 119.924 -0.71 . . . . 0.0 110.323 -178.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -62.9 -32.81 74.16 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 178.037 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.1 t -75.85 -45.33 37.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-N 114.137 -1.392 . . . . 0.0 110.675 179.031 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -75.99 -8.98 58.21 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.819 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -106.18 -13.0 15.55 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 121.436 0.636 . . . . 0.0 109.931 179.158 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -70.22 145.73 51.19 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.41 -0.814 . . . . 0.0 112.189 -179.555 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.5 m -56.67 109.95 0.71 Allowed 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 115.641 -0.708 . . . . 0.0 109.991 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 32.2 tp -69.28 131.97 45.72 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.804 -178.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -109.01 76.63 1.02 Allowed 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 177.471 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -84.11 -36.53 22.89 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.524 -0.762 . . . . 0.0 112.453 -179.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 42.3 mmtt -74.64 -13.37 60.63 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.035 0.445 . . . . 0.0 111.417 -176.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -92.01 -0.1 57.47 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.377 0.608 . . . . 0.0 109.792 179.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 21.9 t -79.58 129.45 37.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.44 -179.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 11.6 pt -110.83 -10.33 11.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.805 179.347 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -157.81 163.64 32.78 Favored Glycine 0 CA--C 1.523 0.555 0 C-N-CA 120.225 -0.988 . . . . 0.0 111.81 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 61.8 ttp180 -133.71 156.42 47.97 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.756 -0.722 . . . . 0.0 109.91 179.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.582 HG22 ' O ' ' A' ' 92' ' ' LEU . 18.6 tt -126.07 143.08 40.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.6 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 13.2 t -137.51 133.26 34.37 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 121.504 0.669 . . . . 0.0 112.305 -178.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.461 HG22 HG22 ' A' ' 88' ' ' VAL . 65.0 mt -139.33 84.37 16.48 Favored Pre-proline 0 CA--C 1.538 0.498 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.31 -179.772 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -57.37 -29.7 85.19 Favored 'Trans proline' 0 N--CA 1.499 1.818 0 C-N-CA 123.081 2.52 . . . . 0.0 112.919 -179.21 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 96.1 p -52.16 -41.66 62.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.32 0.581 . . . . 0.0 111.088 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.461 HG22 HG22 ' A' ' 85' ' ' ILE . 22.5 m -115.83 10.33 7.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.043 179.068 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.479 ' O ' ' OG ' ' A' ' 89' ' ' SER . 3.5 t 53.48 53.49 11.54 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.68 179.553 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 62.7 tp -121.98 133.73 54.82 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.656 0.741 . . . . 0.0 111.024 -179.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -148.76 130.85 15.39 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.926 179.368 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.582 ' O ' HG22 ' A' ' 83' ' ' ILE . 84.1 mt -152.2 151.28 27.32 Favored Pre-proline 0 N--CA 1.471 0.621 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.368 -178.517 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -76.02 147.99 30.9 Favored 'Trans proline' 0 N--CA 1.494 1.554 0 C-N-CA 122.584 2.189 . . . . 0.0 111.516 178.214 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.518 ' C ' HD12 ' A' ' 95' ' ' LEU . 98.5 t -96.45 118.12 42.17 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-O 120.975 0.417 . . . . 0.0 111.563 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.544 ' N ' HD12 ' A' ' 95' ' ' LEU . 10.6 mp -101.74 136.91 40.78 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.394 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -61.7 -81.36 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 121.253 0.549 . . . . 0.0 112.263 -179.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 91.1 p -62.39 135.12 57.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.488 0.661 . . . . 0.0 112.134 -178.238 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.419 ' OG ' ' O ' ' A' ' 109' ' ' THR . 1.3 m -90.83 68.66 6.39 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.219 178.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 33.8 p -88.57 168.41 12.59 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.069 179.283 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.429 ' O ' ' CD1' ' A' ' 104' ' ' LEU . 52.6 tp10 -62.9 -45.5 92.24 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.169 -0.612 . . . . 0.0 110.435 179.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -65.12 -40.67 94.82 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 121.339 0.59 . . . . 0.0 111.487 179.535 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -65.23 -30.35 71.23 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.134 -0.485 . . . . 0.0 112.226 -179.301 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.417 HD23 ' HA ' ' A' ' 103' ' ' LEU . 56.7 mt -67.03 -14.02 62.49 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 120.773 -0.371 . . . . 0.0 111.673 -179.321 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.534 ' N ' HD12 ' A' ' 104' ' ' LEU . 10.5 mp -75.69 -12.17 60.14 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 121.008 -0.277 . . . . 0.0 111.44 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.415 ' O ' HD22 ' A' ' 92' ' ' LEU . 92.5 p -81.17 -6.24 58.62 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 121.352 0.596 . . . . 0.0 110.356 179.677 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.547 ' HA3' HD13 ' A' ' 92' ' ' LEU . . . 89.76 -20.02 37.89 Favored Glycine 0 CA--C 1.533 1.196 0 CA-C-N 115.51 -0.768 . . . . 0.0 113.254 177.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -145.72 125.49 13.43 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 117.814 0.807 . . . . 0.0 112.136 -179.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -145.71 141.64 28.23 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.703 179.236 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.706 ' HA ' HD23 ' A' ' 123' ' ' LEU . 8.7 p -71.93 132.34 44.22 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.238 0.542 . . . . 0.0 110.667 179.631 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.655 HG23 ' CG ' ' B' ' 703' ' ' PRO . 7.3 p -81.7 -33.95 12.52 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 -179.533 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.506 ' O ' ' NE2' ' A' ' 114' ' ' GLN . 88.2 tttt -90.36 153.34 20.51 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 121.357 0.598 . . . . 0.0 111.939 -177.243 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -66.0 -35.06 79.54 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -178.036 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -141.27 53.36 1.55 Allowed 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 -176.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . 0.752 ' NE2' ' H ' ' A' ' 114' ' ' GLN . 1.6 pm0 -74.34 157.71 35.26 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 120.891 0.377 . . . . 0.0 111.192 179.151 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 61.4 t -128.64 120.89 53.65 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-O 121.149 0.499 . . . . 0.0 111.694 -179.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 66.3 mtt -60.57 134.45 57.08 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.992 -0.549 . . . . 0.0 112.226 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 77.72 -0.91 69.3 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.698 -0.561 . . . . 0.0 111.698 178.206 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -142.0 127.94 19.48 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.358 0.599 . . . . 0.0 110.851 179.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 75.28 -168.99 54.78 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 110.482 -1.047 . . . . 0.0 110.482 -179.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 42.9 t-20 -90.21 103.5 16.17 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.78 0.324 . . . . 0.0 110.2 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.513 ' HE2' HD21 ' A' ' 123' ' ' LEU . 11.8 t80 -89.69 99.02 12.1 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -179.696 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.463 ' HB3' ' CG1' ' A' ' 110' ' ' VAL . . . -91.65 137.41 32.39 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 112.462 0.541 . . . . 0.0 112.462 -178.404 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.706 HD23 ' HA ' ' A' ' 109' ' ' THR . 71.6 mt -134.76 138.92 44.74 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.584 179.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -108.72 131.7 54.67 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 121.142 0.496 . . . . 0.0 110.02 179.324 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -137.22 151.08 20.93 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 110.045 -1.222 . . . . 0.0 110.045 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . 0.752 ' O ' HD23 ' A' ' 134' ' ' LEU . 37.5 m-70 -88.73 144.78 26.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.61 0.719 . . . . 0.0 112.522 -178.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . 0.879 ' ND2' ' H ' ' A' ' 129' ' ' SER . 1.5 t-20 -137.8 121.24 17.14 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.982 178.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.518 ' HB2' HG21 ' A' ' 133' ' ' VAL . 57.7 mtt -95.51 -1.42 50.71 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.069 -178.578 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.879 ' H ' ' ND2' ' A' ' 127' ' ' ASN . 1.4 p 78.17 5.52 2.7 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.974 -0.29 . . . . 0.0 111.339 179.247 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.876 ' O ' HG12 ' A' ' 133' ' ' VAL . 62.5 pttt -120.58 130.7 54.3 Favored 'General case' 0 C--O 1.222 -0.377 0 CA-C-O 121.885 0.85 . . . . 0.0 113.105 -178.55 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.462 ' O ' ' O ' ' A' ' 130' ' ' LYS . 74.6 mmtt -41.13 162.6 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 178.232 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 76.49 -24.73 1.76 Allowed Glycine 0 CA--C 1.535 1.337 0 C-N-CA 120.396 -0.907 . . . . 0.0 111.379 179.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.876 HG12 ' O ' ' A' ' 130' ' ' LYS . 3.7 p -90.18 158.13 2.94 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 O-C-N 122.217 -0.578 . . . . 0.0 111.215 -178.702 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.852 ' H ' HD13 ' A' ' 134' ' ' LEU . 0.0 OUTLIER -70.71 145.36 50.57 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 114.903 1.446 . . . . 0.0 114.903 -177.283 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 61.0 7.04 1.37 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 112.866 -1.97 . . . . 0.0 113.854 177.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 5.1 t -72.8 -34.07 66.66 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.143 -0.623 . . . . 0.0 112.385 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . 0.418 ' OD1' ' N ' ' A' ' 137' ' ' ASP . 44.0 p-10 -92.43 4.6 53.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.433 0.635 . . . . 0.0 110.381 -179.329 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.46 HD11 HD13 ' A' ' 184' ' ' LEU . 5.2 tt -64.49 -35.83 75.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.896 -179.506 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.419 ' N ' ' CG2' ' A' ' 138' ' ' ILE . . . -70.33 -9.88 57.41 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 121.091 0.472 . . . . 0.0 111.072 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 19.1 m -81.99 -3.21 53.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.225 0.535 . . . . 0.0 110.223 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.401 HD21 HG21 ' A' ' 85' ' ' ILE . 78.5 mt -63.69 145.08 56.41 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.564 179.739 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -120.97 155.49 34.16 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 121.389 0.614 . . . . 0.0 112.021 -178.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 40.5 tttp -49.85 132.76 22.45 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.978 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.554 ' N ' ' O ' ' A' ' 160' ' ' VAL . . . 80.21 7.33 88.63 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.314 178.691 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -73.41 136.87 44.34 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 118.921 -1.112 . . . . 0.0 109.553 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -80.26 141.33 35.65 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.838 0.828 . . . . 0.0 112.28 -178.36 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.449 HD11 ' CG2' ' A' ' 160' ' ' VAL . 87.6 mt -137.39 137.74 45.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 114.735 -1.121 . . . . 0.0 108.679 178.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 43.0 m-85 -123.1 136.25 54.72 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.028 -0.669 . . . . 0.0 112.508 -177.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.544 HD11 HD11 ' A' ' 182' ' ' ILE . 11.7 mt -110.97 133.5 53.34 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 177.072 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . 0.526 ' CE1' ' CD ' ' A' ' 155' ' ' GLU . 82.1 m-85 -111.87 109.39 19.18 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 119.836 -0.746 . . . . 0.0 111.845 -179.638 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . 0.614 ' OD1' ' N ' ' A' ' 152' ' ' ASN . 66.3 t0 -89.59 163.87 15.0 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 177.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . 0.614 ' N ' ' OD1' ' A' ' 151' ' ' ASP . 34.5 p-10 -57.36 -19.61 24.02 Favored 'General case' 0 C--N 1.318 -0.785 0 C-N-CA 119.962 -0.695 . . . . 0.0 111.159 -177.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -114.27 -27.83 7.48 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 -178.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -148.18 179.87 7.45 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 -176.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.526 ' CD ' ' CE1' ' A' ' 150' ' ' TYR . 83.0 tt0 -127.79 132.96 49.44 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 114.366 -1.288 . . . . 0.0 109.745 179.122 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . 0.501 ' CD1' HG23 ' A' ' 206' ' ' THR . 95.5 m-85 -108.44 133.87 52.02 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.027 0.442 . . . . 0.0 111.225 -179.395 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . 0.644 ' O ' HG12 ' A' ' 204' ' ' VAL . 92.4 mt-10 -93.85 113.15 25.12 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.121 179.54 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -115.44 150.16 36.88 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 120.828 0.347 . . . . 0.0 110.585 179.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -124.45 124.62 42.7 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.048 0.451 . . . . 0.0 111.215 179.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.554 ' O ' ' N ' ' A' ' 144' ' ' GLY . 71.4 t -60.93 135.47 25.65 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.215 177.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 22.0 p -105.36 -24.95 12.57 Favored 'General case' 0 CA--C 1.533 0.315 0 O-C-N 123.308 0.38 . . . . 0.0 110.202 178.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 157.46 -165.17 33.33 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 120.842 -0.694 . . . . 0.0 111.718 179.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 3.0 p -134.97 155.26 37.87 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 179.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 87.8 p -138.75 167.17 22.57 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.633 0.73 . . . . 0.0 112.212 -178.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -100.19 118.87 37.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 114.99 -1.004 . . . . 0.0 110.204 179.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.475 HG21 ' CG2' ' A' ' 198' ' ' VAL . 27.6 m -137.05 161.7 35.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.225 0.536 . . . . 0.0 111.009 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -96.73 157.07 35.83 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.32 178.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . 0.503 ' O ' ' CB ' ' B' ' 702' ' ' LEU . 20.7 Cg_endo -60.83 -18.02 54.0 Favored 'Trans proline' 0 C--N 1.3 -1.995 0 C-N-CA 122.605 2.204 . . . . 0.0 113.552 -179.627 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 45.5 p-10 -92.27 -5.26 52.71 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 119.45 -0.9 . . . . 0.0 112.313 179.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.561 ' O ' HG22 ' A' ' 173' ' ' VAL . 97.0 mttt -76.1 85.56 2.97 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 121.655 0.741 . . . . 0.0 111.373 179.438 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' TRP . . . . . 0.591 ' CZ3' ' OE2' ' A' ' 175' ' ' GLU . 1.2 p-90 -73.97 -7.44 52.41 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.034 -0.984 . . . . 0.0 110.041 179.42 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -61.77 -35.83 79.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.75 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . 0.561 HG22 ' O ' ' A' ' 170' ' ' LYS . 19.8 m -63.03 -17.77 20.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.781 -179.702 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 37.0 t -101.47 -17.77 6.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.922 -179.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.591 ' OE2' ' CZ3' ' A' ' 171' ' ' TRP . 76.3 mm-40 -76.26 153.94 35.58 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.246 0.546 . . . . 0.0 111.779 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . 0.491 ' OD1' ' O ' ' A' ' 176' ' ' ASP . 47.0 p-10 -60.27 142.86 53.98 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.719 0.771 . . . . 0.0 111.802 -179.345 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 73.6 m80 -115.36 12.71 16.42 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.707 179.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 64.13 41.66 98.34 Favored Glycine 0 CA--C 1.528 0.856 0 N-CA-C 111.105 -0.798 . . . . 0.0 111.105 179.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -165.2 172.47 12.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.1 0.476 . . . . 0.0 110.882 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -88.28 93.99 9.69 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 177.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . 0.447 ' HG2' ' N ' ' A' ' 182' ' ' ILE . 79.9 tt0 -130.45 161.64 30.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.85 0.833 . . . . 0.0 112.052 -178.078 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.544 HD11 HD11 ' A' ' 149' ' ' LEU . 1.1 mm -125.97 134.5 66.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 114.598 -1.183 . . . . 0.0 110.55 179.608 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 86.3 m -126.3 124.41 40.26 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 121.291 0.567 . . . . 0.0 111.23 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.46 HD13 HD11 ' A' ' 138' ' ' ILE . 83.4 mt -113.32 133.41 55.14 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.7 179.143 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.668 HD13 HD21 ' B' ' 702' ' ' LEU . 77.0 mt -113.53 124.77 70.5 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 CA-C-O 121.36 0.6 . . . . 0.0 111.028 -179.581 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 5.1 t -135.56 156.34 49.03 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 115.254 -0.884 . . . . 0.0 110.492 179.337 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 187' ' ' CYS . . . . . . . . . . . . . 4.5 m -87.11 141.45 28.65 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.234 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . 0.758 HG22 ' CD2' ' A' ' 197' ' ' TYR . 41.9 t -61.97 -47.32 93.74 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 CA-C-O 120.945 0.402 . . . . 0.0 111.005 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 94.6 p -162.23 164.42 27.71 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 121.038 0.447 . . . . 0.0 110.977 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . 0.501 ' CG1' ' O ' ' A' ' 128' ' ' MET . 18.0 m -69.16 -17.58 21.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.244 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -101.8 -34.69 9.33 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.519 -0.472 . . . . 0.0 111.049 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 49.6 t0 -99.63 103.13 14.81 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 120.984 0.421 . . . . 0.0 111.465 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 193' ' ' ASN . . . . . 0.577 ' O ' ' NH1' ' A' ' 196' ' ' ARG . 27.2 m120 -110.45 -7.22 14.79 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 121.298 0.57 . . . . 0.0 110.639 179.058 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 76.3 p -68.4 -16.68 64.01 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.953 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -136.73 143.03 43.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.468 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . 0.577 ' NH1' ' O ' ' A' ' 193' ' ' ASN . 76.9 mtt85 -136.05 145.15 45.69 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 121.108 0.48 . . . . 0.0 111.959 -179.494 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . 0.758 ' CD2' HG22 ' A' ' 188' ' ' VAL . 35.8 m-85 -96.41 144.57 26.42 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 115.949 -0.568 . . . . 0.0 111.471 179.034 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.475 ' CG2' HG21 ' A' ' 166' ' ' VAL . 39.2 t -128.97 130.69 68.45 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-O 121.083 0.468 . . . . 0.0 110.645 178.365 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 21.6 t -102.66 134.62 43.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.866 179.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -122.32 147.66 45.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.316 0.579 . . . . 0.0 111.387 -178.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -145.01 152.6 24.63 Favored Glycine 0 CA--C 1.53 1.024 0 N-CA-C 110.079 -1.208 . . . . 0.0 110.079 179.24 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . 0.422 ' O ' ' OD1' ' A' ' 202' ' ' ASP . 51.7 p-10 -111.92 151.39 29.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.994 0.426 . . . . 0.0 110.092 179.673 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 52.7 tp -71.52 131.47 43.32 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.644 HG12 ' O ' ' A' ' 157' ' ' GLU . 5.2 p -113.88 -19.5 6.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 120.333 -0.547 . . . . 0.0 111.589 -178.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -176.97 172.03 44.96 Favored Glycine 0 CA--C 1.527 0.799 0 C-N-CA 120.088 -1.053 . . . . 0.0 112.055 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . 0.501 HG23 ' CD1' ' A' ' 156' ' ' TYR . 10.4 m -144.19 137.68 27.57 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.963 -0.618 . . . . 0.0 109.503 179.019 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -145.37 122.17 11.24 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.115 0.483 . . . . 0.0 111.276 179.621 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -62.39 139.83 58.55 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.491 0.662 . . . . 0.0 111.448 -179.289 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 9.5 tttt -79.2 109.32 13.42 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.552 179.563 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 98.5 mttt . . . . . 0 C--O 1.218 -0.558 0 CA-C-O 118.107 -0.949 . . . . 0.0 110.339 179.205 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 702' ' ' LEU . . . . . 0.668 HD21 HD13 ' A' ' 185' ' ' ILE . 1.0 OUTLIER . . . . . 0 CA--C 1.546 0.805 0 CA-C-O 120.554 0.216 . . . . 20.0 111.323 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 703' ' ' PRO . . . . . 0.655 ' CG ' HG23 ' A' ' 110' ' ' VAL . 4.9 Cg_exo -69.41 -168.06 0.24 Allowed 'Trans proline' 0 N--CA 1.489 1.21 0 C-N-CA 122.906 2.404 . . . . 20.0 114.15 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 704' ' ' ALA . . . . . 0.544 ' O ' ' O ' ' B' ' 703' ' ' PRO . . . . . . . . 0 N--CA 1.466 0.367 0 CA-C-N 113.902 -1.499 . . . . 20.0 113.659 -179.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.414 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 38.9 t -63.1 -42.82 99.66 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.129 0.49 . . . . 0.0 111.299 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 85.1 t60 -115.05 125.65 53.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.918 -179.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 77.6 mtm -93.87 138.08 32.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.592 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.484 ' O ' ' OD1' ' A' ' 57' ' ' ASP . 34.6 p30 -68.25 150.98 47.6 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.624 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -90.02 11.41 20.71 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.254 0.549 . . . . 0.0 111.04 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 2.9 p -79.93 17.01 1.03 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.924 -179.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -99.64 9.76 42.55 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 120.901 0.382 . . . . 0.0 111.858 -179.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.8 mt -55.6 139.98 14.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 122.034 0.921 . . . . 0.0 112.988 -177.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.408 ' OD1' ' N ' ' A' ' 63' ' ' GLN . 60.4 t0 -77.59 129.15 35.26 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 114.169 -1.378 . . . . 0.0 109.567 179.166 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.533 ' NE2' ' O ' ' A' ' 64' ' ' PRO . 1.4 tt0 -76.81 119.71 78.62 Favored Pre-proline 0 CA--C 1.541 0.609 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.504 -179.137 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.533 ' O ' ' NE2' ' A' ' 63' ' ' GLN . 73.5 Cg_exo -47.86 162.31 0.28 Allowed 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 122.491 2.127 . . . . 0.0 112.811 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -52.6 168.96 0.09 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.873 0.844 . . . . 0.0 112.308 -178.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 97.4 mt -71.13 -12.08 61.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 114.516 -1.22 . . . . 0.0 111.979 -179.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.592 ' O ' ' ND2' ' A' ' 71' ' ' ASN . . . -68.21 -41.89 80.63 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.306 0.574 . . . . 0.0 110.492 179.204 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.767 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 98.2 mt-10 -70.7 -23.05 62.4 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.203 179.321 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 76.6 t -71.31 -43.88 73.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.814 -178.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -92.76 -8.82 42.68 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.411 -179.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.592 ' ND2' ' O ' ' A' ' 67' ' ' ALA . 84.9 m-20 -106.94 -10.17 16.06 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 121.15 0.5 . . . . 0.0 110.893 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.767 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -69.65 135.54 50.04 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.425 0.631 . . . . 0.0 112.272 -179.134 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 43.7 t -59.71 93.65 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.672 HD23 ' N ' ' A' ' 75' ' ' ASP . 6.9 tt -66.79 126.29 28.56 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.297 0.57 . . . . 0.0 111.449 -178.147 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.672 ' N ' HD23 ' A' ' 74' ' ' LEU . 88.2 m-20 -93.74 79.51 4.23 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.564 -0.743 . . . . 0.0 110.379 179.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.403 ' N ' HD23 ' A' ' 74' ' ' LEU . 86.8 tttt -64.75 -34.12 77.58 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.747 -0.661 . . . . 0.0 112.095 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.45 ' HD3' ' N ' ' A' ' 77' ' ' LYS . 8.0 mmtt -70.01 -13.12 62.08 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 121.428 0.633 . . . . 0.0 109.901 -176.497 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -93.9 -5.24 48.37 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.734 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 72.4 t -73.69 128.63 36.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.068 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 12.6 pt -110.57 -6.59 11.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 120.592 -0.443 . . . . 0.0 111.723 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -174.79 174.8 46.84 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 120.398 -0.906 . . . . 0.0 111.725 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.41 HH12 ' HB2' ' A' ' 84' ' ' SER . 73.2 ttp85 -135.3 156.89 48.19 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 121.158 0.504 . . . . 0.0 111.157 -179.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.428 HG22 ' O ' ' A' ' 92' ' ' LEU . 20.9 tt -125.6 139.32 51.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 179.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.41 ' HB2' HH12 ' A' ' 82' ' ' ARG . 32.5 t -137.59 134.55 35.69 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 -178.386 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.568 ' CG2' HG22 ' A' ' 88' ' ' VAL . 3.2 mp -137.26 87.58 18.16 Favored Pre-proline 0 CA--C 1.538 0.498 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.415 179.134 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -55.98 -32.56 86.33 Favored 'Trans proline' 0 N--CA 1.5 1.873 0 C-N-CA 123.205 2.604 . . . . 0.0 112.68 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 8.9 t -54.63 -41.63 70.26 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.244 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.568 HG22 ' CG2' ' A' ' 85' ' ' ILE . 11.2 m -113.93 14.44 8.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 CA-C-O 121.261 0.553 . . . . 0.0 110.635 179.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.8 p 46.58 52.0 11.46 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.128 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 55.7 tp -117.78 133.29 56.08 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.321 0.581 . . . . 0.0 110.604 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.859 ' O ' HD23 ' A' ' 92' ' ' LEU . 93.7 mt-10 -147.94 125.32 11.6 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.925 -179.292 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.859 HD23 ' O ' ' A' ' 91' ' ' GLU . 7.8 mt -148.89 148.48 27.59 Favored Pre-proline 0 CA--C 1.537 0.457 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.421 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -75.36 147.75 33.03 Favored 'Trans proline' 0 N--CA 1.493 1.465 0 C-N-CA 122.68 2.253 . . . . 0.0 110.878 178.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.484 ' C ' HD12 ' A' ' 95' ' ' LEU . 92.3 t -93.51 119.86 41.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.189 0.519 . . . . 0.0 110.649 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.567 ' N ' HD12 ' A' ' 95' ' ' LEU . 10.6 mp -97.82 126.09 43.01 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.72 0.772 . . . . 0.0 110.842 -179.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.527 ' O ' ' OG1' ' A' ' 109' ' ' THR . 86.7 tttt -63.64 -38.41 91.0 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.827 -1.078 . . . . 0.0 112.043 -178.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.497 ' CB ' ' ND2' ' A' ' 102' ' ' ASN . 2.7 m -79.76 126.43 30.94 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 121.636 0.731 . . . . 0.0 112.463 -178.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.462 ' OG ' ' O ' ' A' ' 109' ' ' THR . 0.9 OUTLIER -89.13 44.5 1.22 Allowed 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.714 179.687 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.578 ' OG1' ' ND2' ' A' ' 102' ' ' ASN . 71.4 p -89.48 171.78 9.47 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.03 179.121 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.439 ' HA ' HD12 ' A' ' 103' ' ' LEU . 94.8 mt-10 -66.06 -39.62 90.25 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.161 0.505 . . . . 0.0 110.143 179.247 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -64.43 -41.75 96.41 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.147 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.578 ' ND2' ' OG1' ' A' ' 99' ' ' THR . 54.0 m-80 -65.15 -34.83 79.33 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.6 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.537 HD13 ' HB3' ' B' ' 704' ' ' ALA . 42.0 mt -65.13 -16.54 63.6 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.634 -179.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.419 HD23 ' HA ' ' A' ' 104' ' ' LEU . 91.5 mt -73.76 -15.47 61.2 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.381 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.462 ' OG ' HD22 ' A' ' 95' ' ' LEU . 93.9 p -82.11 -2.84 53.3 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.198 0.523 . . . . 0.0 110.431 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.592 ' O ' ' CE1' ' A' ' 135' ' ' PHE . . . 93.31 -19.53 51.87 Favored Glycine 0 CA--C 1.527 0.799 0 CA-C-N 115.854 -0.612 . . . . 0.0 113.08 178.105 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -146.56 125.53 12.8 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 119.483 -0.887 . . . . 0.0 112.382 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -143.24 142.38 31.37 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.833 178.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.527 ' OG1' ' O ' ' A' ' 96' ' ' LYS . 58.5 p -65.37 132.44 49.0 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.46 0.648 . . . . 0.0 111.288 -178.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.658 HG13 ' CD ' ' B' ' 703' ' ' PRO . 78.9 t -78.38 -55.2 10.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.655 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.59 ' H ' ' NE2' ' A' ' 114' ' ' GLN . 83.5 mttt -107.04 139.74 40.96 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 122.048 0.928 . . . . 0.0 112.162 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -66.25 -34.48 78.11 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.444 -1.253 . . . . 0.0 112.165 -178.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -85.7 20.77 2.04 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 113.075 0.769 . . . . 0.0 113.075 -178.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.59 ' NE2' ' H ' ' A' ' 111' ' ' LYS . 34.3 mt-30 -77.9 140.58 39.31 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.048 0.451 . . . . 0.0 111.034 179.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.2 t -125.91 108.54 19.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.965 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 73.3 mtp -56.25 126.61 26.94 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 121.121 0.486 . . . . 0.0 111.039 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 97.01 -11.76 65.79 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 121.133 -0.556 . . . . 0.0 111.825 179.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -143.72 137.29 28.04 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 121.055 0.455 . . . . 0.0 111.53 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 76.27 -170.7 54.83 Favored Glycine 0 CA--C 1.531 1.069 0 N-CA-C 111.675 -0.57 . . . . 0.0 111.675 179.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 54.5 t-20 -88.52 104.56 16.93 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 121.304 0.573 . . . . 0.0 110.576 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.416 ' HE2' HD21 ' A' ' 123' ' ' LEU . 6.6 t80 -86.99 145.97 26.31 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.4 179.417 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.425 ' HB3' HG13 ' A' ' 174' ' ' VAL . . . -147.58 143.76 27.98 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 119.493 -0.883 . . . . 0.0 111.841 -179.095 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.487 HD23 ' HA ' ' A' ' 109' ' ' THR . 63.8 mt -138.29 143.75 40.16 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 114.823 -1.081 . . . . 0.0 110.181 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -111.71 138.35 48.4 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -132.03 145.34 17.11 Favored Glycine 0 CA--C 1.531 1.046 0 N-CA-C 110.386 -1.086 . . . . 0.0 110.386 -179.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.437 ' ND1' HG2B ' B' ' 705' ' ' B27 . 10.1 m-70 -88.63 124.1 33.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.449 0.642 . . . . 0.0 112.258 -179.231 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.565 ' ND2' ' H ' ' A' ' 129' ' ' SER . 2.6 t-20 -122.83 121.82 37.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.251 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.433 ' H ' HG21 ' A' ' 133' ' ' VAL . 75.9 mtm -95.85 2.22 53.58 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 121.263 0.554 . . . . 0.0 110.748 179.405 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.565 ' H ' ' ND2' ' A' ' 127' ' ' ASN . 0.1 OUTLIER 76.04 10.5 3.14 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.543 179.114 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.81 ' O ' HG12 ' A' ' 133' ' ' VAL . 5.6 ptmt -110.51 114.16 27.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.878 0.847 . . . . 0.0 112.395 -179.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 6.1 tmtt? -37.72 120.28 0.81 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.661 -1.154 . . . . 0.0 111.7 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 113.13 -11.94 24.34 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.81 HG12 ' O ' ' A' ' 130' ' ' LYS . 11.8 p -91.71 164.31 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 CA-C-N 115.048 -0.576 . . . . 0.0 110.267 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.547 ' N ' HG22 ' A' ' 133' ' ' VAL . 0.7 OUTLIER -70.75 140.16 51.27 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.872 0.844 . . . . 0.0 112.645 -177.355 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.649 ' CG ' HD12 ' A' ' 138' ' ' ILE . 3.2 m-85 66.43 5.3 3.68 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 113.977 -1.465 . . . . 0.0 113.796 177.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . 0.542 ' OG ' ' CG1' ' A' ' 133' ' ' VAL . 0.4 OUTLIER -68.14 -40.48 82.4 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 112.373 0.509 . . . . 0.0 112.373 179.131 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 48.6 p-10 -88.95 -1.34 58.06 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 121.251 0.548 . . . . 0.0 111.439 -178.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.649 HD12 ' CG ' ' A' ' 135' ' ' PHE . 0.3 OUTLIER -65.24 -35.71 76.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-O 121.158 0.504 . . . . 0.0 110.254 178.957 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.83 ' HB2' ' OH ' ' A' ' 197' ' ' TYR . . . -66.83 -11.44 55.44 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.052 0.453 . . . . 0.0 110.926 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 59.6 p -84.35 -1.91 56.23 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 121.199 0.524 . . . . 0.0 110.756 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.44 HD21 HG21 ' A' ' 85' ' ' ILE . 66.1 mt -63.54 138.72 58.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.237 -179.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -113.48 154.46 27.0 Favored 'General case' 0 CA--C 1.535 0.365 0 CA-C-O 121.425 0.631 . . . . 0.0 111.351 -179.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -51.3 133.71 28.62 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.751 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.561 ' N ' ' O ' ' A' ' 160' ' ' VAL . . . 79.32 7.95 88.13 Favored Glycine 0 CA--C 1.527 0.84 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.554 179.14 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -70.12 132.8 46.38 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 119.88 -0.728 . . . . 0.0 109.852 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -78.59 138.32 38.3 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.76 0.79 . . . . 0.0 111.773 -178.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.517 HD11 ' CG2' ' A' ' 160' ' ' VAL . 95.9 mt -135.8 136.41 50.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 114.817 -1.083 . . . . 0.0 108.382 178.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . 0.496 ' C ' HD22 ' A' ' 149' ' ' LEU . 89.9 m-85 -117.81 135.0 54.36 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.906 0.86 . . . . 0.0 112.842 -178.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.496 HD22 ' C ' ' A' ' 148' ' ' TYR . 4.5 mm? -110.84 133.57 53.24 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 114.528 -1.215 . . . . 0.0 108.445 178.234 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.601 ' CZ ' ' OE2' ' A' ' 155' ' ' GLU . 79.8 m-85 -116.93 110.52 18.41 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 120.202 -0.599 . . . . 0.0 111.581 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . 0.466 ' OD1' ' N ' ' A' ' 152' ' ' ASN . 52.4 t0 -89.25 164.94 14.74 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 177.176 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . 0.466 ' N ' ' OD1' ' A' ' 151' ' ' ASP . 34.5 p30 -58.85 -19.12 38.76 Favored 'General case' 0 C--N 1.314 -0.967 0 C-N-CA 119.286 -0.965 . . . . 0.0 111.031 -178.119 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -112.28 -28.08 8.07 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -178.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . 0.414 ' O ' ' N ' ' A' ' 151' ' ' ASP . 0.4 OUTLIER -148.67 -175.64 5.01 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 113.897 1.073 . . . . 0.0 113.897 -176.333 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.601 ' OE2' ' CZ ' ' A' ' 150' ' ' TYR . 87.7 tt0 -132.46 133.77 44.25 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 114.072 -1.422 . . . . 0.0 110.237 178.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . 0.425 ' CD1' HG23 ' A' ' 206' ' ' THR . 80.2 m-85 -112.59 140.22 47.53 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 120.846 0.355 . . . . 0.0 110.315 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . 0.44 ' O ' HD12 ' A' ' 203' ' ' LEU . 82.5 tt0 -99.87 117.98 35.34 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 121.047 0.451 . . . . 0.0 112.051 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -114.75 148.82 37.83 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 121.178 0.513 . . . . 0.0 111.416 179.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -121.03 120.85 36.58 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.713 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.561 ' O ' ' N ' ' A' ' 144' ' ' GLY . 91.0 t -59.59 136.77 22.86 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.292 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.743 178.199 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 15.1 p -105.63 -24.05 12.63 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.786 178.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 154.86 -163.43 31.32 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 120.682 -0.771 . . . . 0.0 111.62 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.61 HG12 HG22 ' A' ' 199' ' ' VAL . 35.5 m -135.76 158.07 39.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-N 115.343 -0.428 . . . . 0.0 110.004 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 81.6 p -145.95 165.78 27.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.118 0.485 . . . . 0.0 110.924 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -101.85 115.2 30.02 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.898 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.542 ' O ' ' O ' ' A' ' 196' ' ' ARG . 23.8 m -137.98 162.76 30.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.989 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -86.48 157.01 56.22 Favored Pre-proline 0 CA--C 1.54 0.575 0 CA-C-O 121.16 0.505 . . . . 0.0 111.431 -179.443 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.517 ' O ' HD12 ' B' ' 702' ' ' LEU . 36.5 Cg_endo -67.86 -9.98 27.34 Favored 'Trans proline' 0 N--CA 1.5 1.862 0 C-N-CA 123.398 2.732 . . . . 0.0 112.861 -179.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . 0.424 ' OD1' ' C ' ' A' ' 169' ' ' ASP . 40.2 p-10 -95.01 -4.0 47.35 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.236 0.541 . . . . 0.0 110.924 179.018 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.777 ' O ' HD23 ' B' ' 702' ' ' LEU . 70.3 mmtt -75.69 82.83 2.68 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.533 -178.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 40.4 p-90 -76.72 -12.08 59.94 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 121.356 0.598 . . . . 0.0 110.594 178.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 76.4 tt0 -61.0 -36.58 79.86 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.988 -179.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . 0.637 HG22 HG21 ' A' ' 183' ' ' THR . 11.6 p -62.44 -25.97 39.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 CA-C-O 121.107 0.479 . . . . 0.0 110.77 -179.556 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.468 HG11 HG11 ' A' ' 110' ' ' VAL . 20.1 t -93.1 -8.49 10.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.945 -179.161 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.525 ' OE1' ' O ' ' A' ' 176' ' ' ASP . 0.6 OUTLIER -73.5 146.77 44.64 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 120.935 0.398 . . . . 0.0 111.076 -179.766 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . 0.525 ' O ' ' OE1' ' A' ' 175' ' ' GLU . 48.1 p-10 -66.27 128.29 35.54 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.281 0.563 . . . . 0.0 111.857 -179.169 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 21.4 m80 -111.49 24.66 12.52 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.965 -0.561 . . . . 0.0 112.119 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 60.21 35.79 88.94 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 120.724 -0.75 . . . . 0.0 111.247 179.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -154.15 161.41 41.88 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 110.208 -0.293 . . . . 0.0 110.208 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -89.35 105.25 17.67 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.897 179.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 -139.21 167.02 23.0 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.569 0.699 . . . . 0.0 112.154 179.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.468 HG22 ' O ' ' A' ' 201' ' ' GLY . 18.9 tt -130.08 138.02 55.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 114.827 -1.079 . . . . 0.0 109.917 179.121 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . 0.637 HG21 HG22 ' A' ' 173' ' ' VAL . 39.8 m -130.98 122.64 27.22 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.176 0.512 . . . . 0.0 111.079 -179.216 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 93.9 mt -109.43 136.29 49.08 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.631 178.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 70.0 mt -105.68 115.71 47.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 C-N-CA 120.206 -0.598 . . . . 0.0 110.179 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . 0.425 HG21 ' OH ' ' A' ' 197' ' ' TYR . 77.1 m -126.79 132.63 51.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.275 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -84.03 140.8 31.62 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.498 HG23 ' HA ' ' A' ' 196' ' ' ARG . 73.7 t -61.19 -49.05 86.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.161 0.505 . . . . 0.0 111.257 -178.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 34.7 p -168.52 163.84 12.47 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.282 0.563 . . . . 0.0 111.009 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 31.3 m -76.85 -9.89 12.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.349 179.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -101.37 -23.49 14.36 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.852 178.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 60.4 t0 -96.68 105.77 17.93 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.04 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -109.77 5.92 23.12 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.177 0.513 . . . . 0.0 110.632 179.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 85.9 p -68.43 -59.76 2.94 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.677 -179.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 63.8 pttt -147.49 155.77 42.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.17 0.51 . . . . 0.0 111.25 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . 0.542 ' O ' ' O ' ' A' ' 166' ' ' VAL . 99.8 mtt180 -129.58 143.78 50.98 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.533 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . 0.83 ' OH ' ' HB2' ' A' ' 139' ' ' ALA . 36.4 p90 -93.16 152.07 19.46 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.425 0.631 . . . . 0.0 111.314 -179.335 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.413 HG11 HG21 ' A' ' 173' ' ' VAL . 48.4 t -123.7 132.93 70.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.378 179.309 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.61 HG22 HG12 ' A' ' 163' ' ' VAL . 40.7 t -94.0 132.32 38.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.989 -179.243 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -119.3 145.0 46.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.465 0.65 . . . . 0.0 111.393 -179.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . 0.468 ' O ' HG22 ' A' ' 182' ' ' ILE . . . -142.8 146.08 16.62 Favored Glycine 0 CA--C 1.529 0.945 0 N-CA-C 110.451 -1.06 . . . . 0.0 110.451 179.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 48.9 p-10 -109.04 151.66 26.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.175 0.512 . . . . 0.0 111.427 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . 0.44 HD12 ' O ' ' A' ' 157' ' ' GLU . 51.0 tp -72.48 132.36 43.76 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 178.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 2.6 p -115.25 -19.19 6.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 120.74 -0.384 . . . . 0.0 111.493 -179.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . 0.422 ' O ' HD11 ' A' ' 203' ' ' LEU . . . -178.3 174.64 46.89 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 120.804 -0.712 . . . . 0.0 111.66 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . 0.425 HG23 ' CD1' ' A' ' 156' ' ' TYR . 60.3 m -141.04 136.3 31.91 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-O 120.662 0.268 . . . . 0.0 110.652 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -143.96 115.62 8.18 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 120.153 -0.619 . . . . 0.0 112.309 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -64.3 147.57 52.2 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.256 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 8.4 ttpt -80.34 109.53 14.92 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.365 178.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 98.0 mttt . . . . . 0 C--O 1.221 -0.428 0 CA-C-O 117.837 -1.078 . . . . 0.0 110.536 179.142 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 701' ' ' BOC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 702' ' ' LEU . . . . . 0.777 HD23 ' O ' ' A' ' 170' ' ' LYS . 0.2 OUTLIER 56.32 77.58 0.42 Allowed Pre-proline 0 CA--C 1.539 0.539 0 CA-C-O 121.628 0.728 . . . . 20.0 110.892 . . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 703' ' ' PRO . . . . . 0.658 ' CD ' HG13 ' A' ' 110' ' ' VAL . 3.7 Cg_exo -72.18 -171.04 0.63 Allowed 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 123.84 3.027 . . . . 20.0 112.982 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 704' ' ' ALA . . . . . 0.547 ' O ' ' O ' ' B' ' 703' ' ' PRO . . . -39.04 178.34 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.079 -0.964 . . . . 20.0 113.129 -178.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 705' ' ' B27 . . . . . 0.468 ' OG1' ' O ' ' B' ' 704' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.259 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 58.8 m -60.81 -41.05 94.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.896 0.379 . . . . 0.0 111.717 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 44.0 m80 -69.21 -13.95 62.7 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.32 0.581 . . . . 0.0 110.391 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 11.0 ttm -104.13 121.46 43.29 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.165 179.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -66.53 143.29 57.15 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-O 121.202 0.525 . . . . 0.0 110.474 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -88.9 9.17 25.84 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.42 0.628 . . . . 0.0 110.17 179.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 5.4 p -82.6 10.08 8.14 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.546 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -96.74 8.56 44.0 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.238 0.542 . . . . 0.0 110.869 -179.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 59.0 mt -55.19 142.72 9.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.953 0.882 . . . . 0.0 111.68 -177.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -75.48 126.95 32.05 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 114.142 -1.39 . . . . 0.0 108.775 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.682 ' H ' ' CD ' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -78.72 130.87 69.32 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.708 -178.867 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.627 ' HD2' HD21 ' A' ' 104' ' ' LEU . 56.8 Cg_exo -51.14 150.52 13.85 Favored 'Trans proline' 0 N--CA 1.493 1.471 0 C-N-CA 121.695 1.597 . . . . 0.0 111.767 178.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.444 ' CG ' ' H ' ' A' ' 66' ' ' LEU . 45.0 t0 -52.41 177.51 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 121.198 0.523 . . . . 0.0 111.506 -178.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.742 HD21 HG23 ' A' ' 133' ' ' VAL . 94.5 mt -65.95 -45.25 82.5 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.672 -178.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.63 -30.59 70.81 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.229 -0.588 . . . . 0.0 110.704 -178.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -62.82 -30.36 71.42 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.431 178.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.611 HG22 HD22 ' A' ' 104' ' ' LEU . 37.3 t -77.84 -46.27 27.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.131 -0.94 . . . . 0.0 110.685 179.403 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.08 -9.58 58.29 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.144 -0.935 . . . . 0.0 111.244 -179.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -109.35 -13.61 14.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.318 0.58 . . . . 0.0 110.095 178.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.37 135.44 51.8 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.712 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 33.0 t -59.47 103.01 0.16 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.647 -179.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.85 125.95 28.25 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.591 -179.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -98.49 83.77 3.07 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 121.382 0.611 . . . . 0.0 109.95 178.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -62.82 -38.28 90.11 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.376 -179.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.577 ' CD ' ' H ' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -71.51 -12.03 61.17 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 120.471 -0.492 . . . . 0.0 110.999 -177.347 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -93.05 0.71 57.4 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.423 0.63 . . . . 0.0 110.203 178.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 88.3 t -86.11 128.31 39.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.132 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.436 ' HA ' HD21 ' A' ' 152' ' ' ASN . 16.5 pt -107.35 -7.9 10.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.239 -179.198 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -170.95 179.33 42.91 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 120.454 -0.879 . . . . 0.0 111.808 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 56.4 ttp180 -140.24 156.26 46.56 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 121.378 0.609 . . . . 0.0 111.315 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.475 HG22 ' O ' ' A' ' 92' ' ' LEU . 16.8 tt -125.29 141.98 43.56 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 CA-C-O 121.437 0.637 . . . . 0.0 110.464 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 66.5 m -135.31 130.31 34.86 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.093 -0.958 . . . . 0.0 111.258 -178.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.429 ' CG2' HG22 ' A' ' 88' ' ' VAL . 22.6 mt -133.79 88.73 32.12 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.121 -178.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -54.9 -35.36 89.03 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 123.278 2.652 . . . . 0.0 112.644 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 44.4 t -55.88 -43.41 77.15 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.192 -0.458 . . . . 0.0 112.212 -179.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.429 HG22 ' CG2' ' A' ' 85' ' ' ILE . 21.7 m -112.21 6.36 8.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.285 0.564 . . . . 0.0 110.731 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.7 m 56.05 53.01 9.61 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.196 179.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 58.1 tp -116.7 135.52 53.71 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.309 0.576 . . . . 0.0 110.779 179.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -146.44 117.06 7.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.115 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.475 ' O ' HG22 ' A' ' 83' ' ' ILE . 75.5 mt -150.27 151.45 31.49 Favored Pre-proline 0 CA--C 1.539 0.538 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.481 -179.293 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -74.2 147.0 37.02 Favored 'Trans proline' 0 N--CA 1.493 1.475 0 C-N-CA 122.833 2.355 . . . . 0.0 111.827 179.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.549 ' C ' HD12 ' A' ' 95' ' ' LEU . 74.2 t -92.46 122.22 43.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.083 0.468 . . . . 0.0 110.228 179.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.581 ' N ' HD12 ' A' ' 95' ' ' LEU . 10.2 mp -100.67 126.66 47.2 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.806 0.812 . . . . 0.0 110.672 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -63.02 -46.45 87.56 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.34 -1.3 . . . . 0.0 112.835 -178.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 4.3 m -86.25 132.09 34.07 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 121.123 0.487 . . . . 0.0 111.75 -179.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -87.17 60.41 6.14 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.352 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.552 HG22 ' N ' ' A' ' 100' ' ' GLU . 54.1 m -88.11 163.31 16.28 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 178.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.552 ' N ' HG22 ' A' ' 99' ' ' THR . 94.5 mt-10 -58.56 -44.56 89.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.284 0.564 . . . . 0.0 110.232 -179.424 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.406 ' H ' HG22 ' A' ' 99' ' ' THR . 66.3 mttm -64.8 -40.33 95.05 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.717 0.77 . . . . 0.0 110.077 178.197 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -63.25 -36.42 83.62 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.054 -0.975 . . . . 0.0 111.711 -179.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.644 HD13 ' HB3' ' B' ' 704' ' ' ALA . 74.6 mt -61.89 -25.53 67.61 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 120.809 -0.357 . . . . 0.0 111.223 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.627 HD21 ' HD2' ' A' ' 64' ' ' PRO . 84.6 mt -73.15 -13.32 61.15 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.908 0.385 . . . . 0.0 111.029 -179.483 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 94.4 p -73.98 -9.01 58.21 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.392 0.615 . . . . 0.0 110.158 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.524 ' O ' ' CE1' ' A' ' 135' ' ' PHE . . . 95.31 -20.86 47.36 Favored Glycine 0 CA--C 1.526 0.779 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.884 178.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -146.92 125.48 12.47 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.215 -0.594 . . . . 0.0 111.376 179.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -144.15 129.11 18.5 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.116 179.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.657 ' HA ' HD23 ' A' ' 123' ' ' LEU . 27.7 m -66.96 131.55 46.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.897 -179.483 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.625 HG22 ' HG2' ' B' ' 703' ' ' PRO . 92.7 t -79.07 -53.31 13.74 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.91 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.822 ' H ' ' NE2' ' A' ' 114' ' ' GLN . 73.3 mmtt -100.73 131.68 46.5 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 122.134 0.969 . . . . 0.0 111.949 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -66.09 -27.94 68.44 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 114.627 -1.17 . . . . 0.0 113.076 -178.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -84.14 12.97 5.6 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 113.863 1.06 . . . . 0.0 113.863 -177.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.822 ' NE2' ' H ' ' A' ' 111' ' ' LYS . 45.5 mt-30 -77.96 143.28 37.75 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.348 0.595 . . . . 0.0 112.502 -179.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 53.0 t -123.56 124.64 69.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.046 178.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 63.6 mtt -58.42 130.5 47.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.417 179.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 84.19 -1.13 89.13 Favored Glycine 0 CA--C 1.529 0.933 0 N-CA-C 111.551 -0.619 . . . . 0.0 111.551 179.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -143.85 128.18 17.82 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 121.048 0.451 . . . . 0.0 110.787 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 78.76 -177.68 53.83 Favored Glycine 0 CA--C 1.532 1.117 0 N-CA-C 111.82 -0.512 . . . . 0.0 111.82 179.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 61.7 t-20 -84.97 105.4 15.7 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 120.943 0.402 . . . . 0.0 110.131 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.502 ' HE2' HD21 ' A' ' 123' ' ' LEU . 3.7 t80 -86.6 99.69 11.89 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.012 0.434 . . . . 0.0 110.386 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.58 ' HB3' HG13 ' A' ' 174' ' ' VAL . . . -93.09 137.11 32.74 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 121.08 0.467 . . . . 0.0 111.628 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.657 HD23 ' HA ' ' A' ' 109' ' ' THR . 61.1 mt -136.26 142.56 43.99 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.59 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -107.38 139.59 41.63 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 178.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -137.52 148.07 19.6 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 109.254 -1.538 . . . . 0.0 109.254 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 12.6 m-70 -92.26 123.68 35.77 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.744 0.783 . . . . 0.0 112.411 -178.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.401 ' OD1' ' N ' ' A' ' 129' ' ' SER . 52.0 t-20 -116.27 119.71 36.6 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.086 179.282 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.44 ' HB2' HG21 ' A' ' 133' ' ' VAL . 68.6 mtt -94.92 -2.75 49.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.351 0.596 . . . . 0.0 109.923 179.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.401 ' N ' ' OD1' ' A' ' 127' ' ' ASN . 0.2 OUTLIER 74.55 6.56 4.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.07 179.585 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.788 ' O ' HG12 ' A' ' 133' ' ' VAL . 11.4 ptpt -113.43 120.71 41.98 Favored 'General case' 0 C--O 1.225 -0.235 0 CA-C-O 121.33 0.586 . . . . 0.0 112.224 -179.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.51 ' O ' ' O ' ' A' ' 130' ' ' LYS . 18.2 tptt -31.93 155.13 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.616 179.316 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 77.39 -17.01 5.51 Favored Glycine 0 CA--C 1.529 0.913 0 N-CA-C 110.819 -0.912 . . . . 0.0 110.819 179.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.788 HG12 ' O ' ' A' ' 130' ' ' LYS . 7.8 p -91.62 150.88 3.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 120.057 -0.657 . . . . 0.0 109.732 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.795 HD23 ' N ' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -68.27 146.18 53.57 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 122.035 0.922 . . . . 0.0 113.245 -177.112 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.524 ' CE1' ' O ' ' A' ' 106' ' ' GLY . 3.2 m-85 65.12 5.38 2.97 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 113.787 -1.551 . . . . 0.0 113.865 178.143 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . 0.519 ' OG ' ' CG1' ' A' ' 133' ' ' VAL . 0.5 OUTLIER -71.65 -38.94 70.64 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 121.692 -0.63 . . . . 0.0 112.593 179.465 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 79.0 m-20 -93.46 0.73 56.86 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 114.9 1.444 . . . . 0.0 114.9 -177.025 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.554 HD11 ' HB ' ' A' ' 186' ' ' THR . 38.4 pt -63.87 -22.83 31.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 119.038 -1.065 . . . . 0.0 110.471 -178.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -69.49 -10.86 59.85 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.268 0.556 . . . . 0.0 110.086 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 1.4 m -84.45 -5.21 59.26 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.572 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 82.1 mt -64.75 145.55 56.07 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.409 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -120.71 157.59 29.32 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 121.455 0.645 . . . . 0.0 112.148 -178.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -50.67 131.97 25.79 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.6 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.452 ' N ' ' O ' ' A' ' 160' ' ' VAL . . . 80.17 7.37 88.59 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 120.648 -0.787 . . . . 0.0 111.149 179.05 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.489 ' OD1' ' N ' ' A' ' 146' ' ' LYS . 64.9 t0 -73.73 131.56 41.73 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 119.89 -0.724 . . . . 0.0 110.007 -179.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.489 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 73.6 mmtt -76.95 140.06 40.34 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.616 0.722 . . . . 0.0 112.124 -178.272 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 48.9 mm -131.51 134.42 60.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 177.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . 0.431 ' C ' HD22 ' A' ' 149' ' ' LEU . 78.9 m-85 -112.49 127.49 56.07 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 119.747 -0.781 . . . . 0.0 112.424 -178.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.431 HD22 ' C ' ' A' ' 148' ' ' TYR . 4.4 mm? -110.79 132.43 54.2 Favored 'General case' 0 C--O 1.224 -0.279 0 CA-C-N 114.943 -1.026 . . . . 0.0 108.658 178.374 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.594 ' CE2' ' OE1' ' A' ' 155' ' ' GLU . 61.2 m-85 -117.21 112.14 20.41 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.204 -0.598 . . . . 0.0 112.569 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . 0.563 ' OD1' ' N ' ' A' ' 152' ' ' ASN . 54.6 t0 -91.2 164.81 13.77 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 176.56 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . 0.563 ' N ' ' OD1' ' A' ' 151' ' ' ASP . 65.8 m-20 -57.61 -23.93 53.66 Favored 'General case' 0 C--N 1.311 -1.074 0 C-N-CA 120.106 -0.637 . . . . 0.0 111.112 -178.023 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -108.3 -29.68 8.74 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 119.762 -0.775 . . . . 0.0 112.839 -178.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . 0.471 ' O ' ' N ' ' A' ' 151' ' ' ASP . 0.3 OUTLIER -149.51 -177.51 5.9 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 113.723 1.008 . . . . 0.0 113.723 -177.779 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.594 ' OE1' ' CE2' ' A' ' 150' ' ' TYR . 80.0 tt0 -128.76 138.09 51.91 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 114.209 -1.36 . . . . 0.0 110.066 179.143 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -111.56 134.0 53.44 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 121.354 0.597 . . . . 0.0 111.383 -179.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -89.65 108.25 19.56 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.453 178.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -112.02 147.22 36.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.026 0.441 . . . . 0.0 111.187 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.525 ' HB2' HG21 ' A' ' 204' ' ' VAL . . . -124.32 123.39 40.1 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 121.047 0.451 . . . . 0.0 110.917 179.238 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.452 ' O ' ' N ' ' A' ' 144' ' ' GLY . 81.2 t -59.45 135.09 24.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 178.07 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 42.6 p -105.29 -26.04 12.17 Favored 'General case' 0 C--N 1.33 -0.263 0 O-C-N 123.325 0.39 . . . . 0.0 110.674 179.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 162.69 -169.72 38.02 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 120.452 -0.88 . . . . 0.0 111.992 179.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 3.0 p -135.11 149.92 29.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.068 -0.566 . . . . 0.0 110.15 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 50.7 m -139.54 163.58 32.17 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.427 0.632 . . . . 0.0 111.187 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -100.22 121.57 41.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.266 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.436 HG11 HG11 ' A' ' 173' ' ' VAL . 27.1 m -136.72 161.3 36.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.386 -179.517 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -92.68 165.03 20.03 Favored Pre-proline 0 CA--C 1.538 0.501 0 C-N-CA 120.662 -0.415 . . . . 0.0 111.054 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.431 ' O ' ' CB ' ' B' ' 702' ' ' LEU . 25.0 Cg_exo -62.52 -19.72 68.52 Favored 'Trans proline' 0 N--CA 1.499 1.852 0 C-N-CA 122.489 2.126 . . . . 0.0 112.998 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 46.7 p-10 -94.76 -5.85 44.36 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.549 ' O ' HG22 ' A' ' 173' ' ' VAL . 96.5 mttt -75.95 88.82 2.93 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 119.655 -0.818 . . . . 0.0 111.657 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 4.9 p90 -76.89 -14.49 59.87 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.467 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -57.59 -35.53 70.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.47 -179.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . 0.549 HG22 ' O ' ' A' ' 170' ' ' LYS . 27.6 m -64.16 -15.56 17.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 C-N-CA 120.771 -0.372 . . . . 0.0 111.253 -179.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.58 HG13 ' HB3' ' A' ' 122' ' ' ALA . 78.6 t -103.96 -16.1 7.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -179.361 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -74.57 144.33 44.04 Favored 'General case' 0 CA--C 1.533 0.319 0 O-C-N 121.816 -0.552 . . . . 0.0 110.956 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . 0.501 ' OD1' ' O ' ' A' ' 176' ' ' ASP . 55.7 p-10 -64.95 145.16 56.69 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.456 179.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 68.9 m80 -120.7 31.73 6.3 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 121.035 0.445 . . . . 0.0 111.759 -179.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 59.93 39.79 96.02 Favored Glycine 0 CA--C 1.534 1.228 0 N-CA-C 111.257 -0.737 . . . . 0.0 111.257 179.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -155.89 165.72 35.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.028 0.442 . . . . 0.0 110.781 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -88.56 102.03 14.53 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 177.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . 0.454 ' HG2' ' N ' ' A' ' 182' ' ' ILE . 84.4 tt0 -138.27 163.54 31.51 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.663 0.744 . . . . 0.0 111.909 -178.335 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.454 ' N ' ' HG2' ' A' ' 181' ' ' GLU . 18.6 tt -130.65 138.93 52.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.13 178.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 86.0 m -130.3 125.49 34.87 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.477 0.656 . . . . 0.0 111.639 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 93.2 mt -109.54 131.58 54.93 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.111 178.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.794 HD13 HD21 ' B' ' 702' ' ' LEU . 82.6 mt -113.91 125.39 71.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.465 0.65 . . . . 0.0 111.889 -177.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . 0.554 ' HB ' HD11 ' A' ' 138' ' ' ILE . 3.4 t -140.98 161.95 36.62 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.547 179.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' CYS . . . . . 0.531 ' N ' ' SG ' ' B' ' 705' ' ' B27 . 1.9 m -96.94 146.43 24.97 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.379 179.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.565 HG13 ' N ' ' A' ' 189' ' ' SER . 8.0 p -63.8 -43.51 97.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.196 0.522 . . . . 0.0 111.353 -179.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . 0.565 ' N ' HG13 ' A' ' 188' ' ' VAL . 13.6 p -162.76 160.88 25.88 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.483 -179.306 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . 0.454 HG22 ' O ' ' A' ' 190' ' ' VAL . 9.5 p -79.18 -11.75 13.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.83 179.277 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -97.97 -19.85 17.79 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.052 0.453 . . . . 0.0 111.083 179.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 67.2 t0 -132.64 103.67 6.25 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.103 0.478 . . . . 0.0 111.403 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -104.29 10.84 35.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.875 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 44.2 t -60.72 -43.7 97.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.078 0.466 . . . . 0.0 111.109 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -125.03 144.33 50.45 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.05 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -124.47 143.54 50.59 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.852 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -98.67 133.51 42.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.023 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.404 ' CG2' HG21 ' A' ' 166' ' ' VAL . 30.0 t -120.3 131.17 73.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 CA-C-O 121.426 0.631 . . . . 0.0 110.936 179.271 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 31.7 t -104.28 132.07 51.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.194 179.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -113.78 144.38 43.07 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.368 0.604 . . . . 0.0 111.556 -179.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -136.46 139.32 10.55 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 110.356 -1.098 . . . . 0.0 110.356 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -103.47 138.65 39.9 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.145 0.497 . . . . 0.0 110.816 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 66.0 tp -62.83 131.52 49.08 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.525 HG21 ' HB2' ' A' ' 159' ' ' ALA . 2.8 t -115.37 -19.81 6.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 C-N-CA 120.762 -0.375 . . . . 0.0 111.503 -178.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -178.13 173.53 46.01 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 120.649 -0.786 . . . . 0.0 111.716 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 24.7 m -140.87 137.02 32.91 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.584 -0.525 . . . . 0.0 109.584 179.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -143.92 117.27 9.05 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.335 0.588 . . . . 0.0 112.075 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -62.43 141.71 58.23 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.991 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 8.9 ttpt -78.52 109.52 12.77 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.224 178.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 99.8 mttt . . . . . 0 C--N 1.322 -0.606 0 CA-C-O 117.914 -1.041 . . . . 0.0 110.828 -179.293 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 701' ' ' BOC . . . . . 0.559 ' H32' HG11 ' A' ' 110' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 702' ' ' LEU . . . . . 0.794 HD21 HD13 ' A' ' 185' ' ' ILE . 0.4 OUTLIER -77.93 119.59 77.98 Favored Pre-proline 0 CA--C 1.543 0.681 0 N-CA-C 110.125 -0.324 . . . . 20.0 110.125 . . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 703' ' ' PRO . . . . . 0.633 ' HD2' HD23 ' B' ' 702' ' ' LEU . 2.8 Cg_endo -65.68 -176.83 0.61 Allowed 'Trans proline' 0 N--CA 1.489 1.249 0 C-N-CA 121.663 1.575 . . . . 20.0 113.047 -179.131 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 704' ' ' ALA . . . . . 0.644 ' HB3' HD13 ' A' ' 103' ' ' LEU . . . -41.21 -177.53 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.319 -1.31 . . . . 20.0 113.527 -179.114 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 705' ' ' B27 . . . . . 0.531 ' SG ' ' N ' ' A' ' 187' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.297 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 81.1 p -62.02 -35.54 78.88 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 120.903 0.382 . . . . 0.0 111.184 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 81.5 t60 -115.24 118.02 32.13 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.008 0.432 . . . . 0.0 110.572 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 78.1 mtm -82.59 137.13 34.64 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.731 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -61.49 118.28 6.81 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 120.543 -0.463 . . . . 0.0 110.138 -179.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -101.96 14.89 30.69 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.524 -179.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 98.4 p -87.72 1.59 53.39 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.587 0.708 . . . . 0.0 110.077 178.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -100.26 10.27 41.49 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.038 -178.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 95.7 mt -56.04 135.22 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-O 122.159 0.981 . . . . 0.0 112.948 -176.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 85.0 m-20 -75.94 130.61 38.73 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 113.881 -1.509 . . . . 0.0 108.913 178.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.625 ' H ' ' CD ' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -82.25 152.49 67.88 Favored Pre-proline 0 C--N 1.328 -0.348 0 C-N-CA 120.15 -0.62 . . . . 0.0 110.49 -179.66 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -72.43 169.92 20.54 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 123.135 2.557 . . . . 0.0 112.76 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -54.65 169.61 0.2 Allowed 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.416 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 57.2 tp -64.3 -45.4 88.14 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.688 -179.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.73 -36.14 75.99 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.09 -0.644 . . . . 0.0 111.157 -177.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.604 ' N ' ' OE1' ' A' ' 68' ' ' GLU . 4.9 mp0 -55.88 -28.84 58.53 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.444 0.64 . . . . 0.0 109.511 178.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 38.3 t -76.59 -44.41 34.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-N 115.342 -0.844 . . . . 0.0 110.823 179.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -79.7 -8.08 59.0 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.974 -179.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -105.89 -13.14 15.59 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.337 0.589 . . . . 0.0 109.926 178.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -70.03 138.22 51.97 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.516 -0.766 . . . . 0.0 111.31 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 37.4 t -59.54 100.31 0.08 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.447 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.688 HD13 ' C ' ' A' ' 74' ' ' LEU . 2.8 tm? -71.12 122.87 20.92 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.137 -179.115 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.677 ' N ' HD13 ' A' ' 74' ' ' LEU . 91.4 m-20 -92.66 80.59 4.77 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 121.299 0.571 . . . . 0.0 110.501 178.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 51.8 tptt -65.83 -32.88 74.65 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.052 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.512 ' H ' ' HE3' ' A' ' 77' ' ' LYS . 3.0 mtmt -72.63 -18.31 61.59 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.414 -177.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -90.54 -9.51 46.92 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.033 0.444 . . . . 0.0 110.836 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 96.5 t -70.25 130.27 34.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.404 0.621 . . . . 0.0 111.263 -179.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.413 HG21 ' HE3' ' A' ' 96' ' ' LYS . 42.9 pt -118.13 -11.86 11.19 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.579 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -159.83 170.02 35.92 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 111.154 -0.779 . . . . 0.0 111.154 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 61.9 ttp180 -143.61 151.35 40.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.542 0.686 . . . . 0.0 112.154 -179.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.455 HG22 ' O ' ' A' ' 92' ' ' LEU . 21.0 tt -112.79 138.01 43.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.546 178.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 33.3 t -135.64 128.7 31.58 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 121.518 0.675 . . . . 0.0 111.903 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.508 HG22 HG22 ' A' ' 88' ' ' VAL . 85.1 mt -138.16 86.07 17.89 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.182 179.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -55.96 -29.85 75.27 Favored 'Trans proline' 0 N--CA 1.497 1.703 0 C-N-CA 123.091 2.527 . . . . 0.0 113.16 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 95.9 p -53.45 -38.43 63.55 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 120.537 -0.465 . . . . 0.0 111.005 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.508 HG22 HG22 ' A' ' 85' ' ' ILE . 23.7 m -117.47 12.2 7.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.387 0.613 . . . . 0.0 110.001 178.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 48.21 53.55 11.62 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.762 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.546 HD11 HD11 ' A' ' 92' ' ' LEU . 58.0 tp -114.93 132.47 56.54 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.318 179.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.739 ' O ' HD23 ' A' ' 92' ' ' LEU . 96.2 mt-10 -145.78 122.36 11.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.649 -179.254 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.739 HD23 ' O ' ' A' ' 91' ' ' GLU . 8.6 mt -146.81 147.74 30.79 Favored Pre-proline 0 CA--C 1.54 0.56 0 C-N-CA 120.198 -0.601 . . . . 0.0 111.95 -179.099 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -77.15 151.57 30.38 Favored 'Trans proline' 0 N--CA 1.497 1.688 0 C-N-CA 123.059 2.506 . . . . 0.0 112.478 178.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.462 ' C ' HD12 ' A' ' 95' ' ' LEU . 87.7 t -95.52 113.24 29.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-O 121.065 0.46 . . . . 0.0 111.613 179.311 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.562 ' N ' HD12 ' A' ' 95' ' ' LEU . 11.1 mp -98.87 139.82 33.96 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.96 179.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.485 ' O ' ' OG1' ' A' ' 109' ' ' THR . 98.8 mttt -63.79 -80.97 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -178.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 33.6 t -60.86 131.14 49.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.186 0.517 . . . . 0.0 111.838 -178.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 35.3 p -89.72 71.68 7.73 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.99 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.534 HG22 ' N ' ' A' ' 100' ' ' GLU . 26.1 m -92.21 169.53 10.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.505 -0.771 . . . . 0.0 109.251 178.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.534 ' N ' HG22 ' A' ' 99' ' ' THR . 99.1 mt-10 -61.65 -44.43 96.98 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 119.776 -0.77 . . . . 0.0 110.059 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -65.7 -40.99 92.86 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 121.33 0.586 . . . . 0.0 110.955 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -63.92 -38.7 92.05 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.149 -179.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 64.9 mt -62.63 -18.86 63.08 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.608 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 75.2 mt -70.74 -18.37 62.78 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.998 0.428 . . . . 0.0 110.39 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 88.9 p -74.45 -8.77 57.38 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.555 0.693 . . . . 0.0 109.286 179.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.608 ' O ' ' CE1' ' A' ' 135' ' ' PHE . . . 93.01 -19.15 53.98 Favored Glycine 0 CA--C 1.53 0.974 0 CA-C-N 115.123 -0.944 . . . . 0.0 112.337 178.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -146.25 126.76 14.13 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 119.659 -0.816 . . . . 0.0 112.745 -179.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -143.54 138.85 29.43 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.042 178.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.485 ' OG1' ' O ' ' A' ' 96' ' ' LYS . 30.0 p -65.67 133.03 50.25 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 121.271 0.558 . . . . 0.0 110.718 -179.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.576 HG22 ' HG2' ' B' ' 703' ' ' PRO . 44.4 t -80.52 -50.4 17.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.385 -179.168 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.753 ' H ' ' NE2' ' A' ' 114' ' ' GLN . 76.8 mttt -105.65 141.22 37.47 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.835 0.826 . . . . 0.0 112.631 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -66.8 -36.26 81.97 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.174 -0.921 . . . . 0.0 112.917 -178.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 17.0 p30 -82.13 15.88 2.19 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -178.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.753 ' NE2' ' H ' ' A' ' 111' ' ' LYS . 32.9 mt-30 -78.2 137.42 38.13 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 122.031 -0.418 . . . . 0.0 110.482 179.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 69.0 t -124.24 125.87 71.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.269 -0.423 . . . . 0.0 109.994 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . 0.598 ' SD ' ' CZ ' ' A' ' 121' ' ' TYR . 91.7 mmm -56.53 125.75 23.48 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.097 0.475 . . . . 0.0 111.467 -179.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 82.59 -0.66 89.11 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-N 115.905 -0.589 . . . . 0.0 112.294 178.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -138.07 130.56 29.29 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 119.998 -0.681 . . . . 0.0 110.637 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 74.2 -169.47 53.91 Favored Glycine 0 CA--C 1.53 1.006 0 N-CA-C 110.518 -1.033 . . . . 0.0 110.518 -179.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 58.8 t-20 -89.39 105.62 17.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.992 0.425 . . . . 0.0 110.04 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.598 ' CZ ' ' SD ' ' A' ' 116' ' ' MET . 11.4 t80 -88.45 100.44 13.05 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.015 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.14 137.71 32.12 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 121.276 0.56 . . . . 0.0 111.745 -178.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.508 HD21 ' CE2' ' A' ' 121' ' ' TYR . 62.7 mt -135.21 137.33 42.53 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.923 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -112.07 135.69 52.4 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -130.75 134.22 7.67 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 110.601 -1.0 . . . . 0.0 110.601 -179.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -82.14 138.46 34.74 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.504 0.669 . . . . 0.0 111.627 -179.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.683 HD21 ' H ' ' A' ' 187' ' ' CYS . 32.1 p30 -141.47 161.0 38.98 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.14 -0.937 . . . . 0.0 110.388 179.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.445 ' O ' ' CB ' ' A' ' 129' ' ' SER . 70.7 mtm -124.28 1.19 8.43 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.575 178.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.445 ' CB ' ' O ' ' A' ' 128' ' ' MET . 0.2 OUTLIER 76.93 12.37 2.31 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.764 179.361 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.775 ' O ' HG12 ' A' ' 133' ' ' VAL . 9.3 ptpt -115.21 119.54 36.71 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.465 0.65 . . . . 0.0 112.295 -179.254 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.536 ' O ' ' O ' ' A' ' 130' ' ' LYS . 74.7 mmtt -29.07 154.73 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.893 -1.048 . . . . 0.0 111.611 179.453 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 75.34 -15.09 4.64 Favored Glycine 0 CA--C 1.529 0.94 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.964 179.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.775 HG12 ' O ' ' A' ' 130' ' ' LYS . 9.8 p -91.27 153.8 3.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 C-N-CA 120.371 -0.532 . . . . 0.0 109.785 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.782 HD23 ' N ' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -70.69 144.47 51.02 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 113.97 1.1 . . . . 0.0 113.97 -177.396 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.659 ' CG ' HD12 ' A' ' 138' ' ' ILE . 3.9 m-85 68.7 -0.94 2.14 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 113.67 -1.605 . . . . 0.0 113.598 178.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 6.7 t -69.4 -39.43 77.94 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 179.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -89.36 -6.99 56.16 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.355 0.598 . . . . 0.0 111.252 -178.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.659 HD12 ' CG ' ' A' ' 135' ' ' PHE . 8.0 mt -62.86 -42.32 95.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.433 179.329 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -63.38 -12.02 27.33 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 120.238 -0.585 . . . . 0.0 110.337 179.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 1.9 m -82.36 -6.19 59.1 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.325 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.406 HD12 HG23 ' A' ' 138' ' ' ILE . 81.4 mt -63.27 142.02 58.54 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.212 179.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -116.76 163.62 15.87 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.701 0.762 . . . . 0.0 111.81 -179.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -52.08 134.97 32.15 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.868 -1.06 . . . . 0.0 112.158 179.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.545 ' N ' ' O ' ' A' ' 160' ' ' VAL . . . 77.14 7.97 86.85 Favored Glycine 0 CA--C 1.527 0.818 0 CA-C-N 115.541 -0.754 . . . . 0.0 112.313 178.011 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 50.6 t0 -72.62 132.93 44.37 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 119.541 -0.864 . . . . 0.0 109.804 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -77.45 138.1 39.05 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 121.663 0.744 . . . . 0.0 111.716 -178.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.489 HD11 ' CG2' ' A' ' 160' ' ' VAL . 87.2 mt -133.42 135.4 56.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 114.958 -1.019 . . . . 0.0 108.342 178.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . 0.404 ' C ' HD22 ' A' ' 149' ' ' LEU . 69.9 m-85 -115.64 133.52 55.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.535 0.683 . . . . 0.0 112.689 -178.243 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.433 HD13 ' HA ' ' A' ' 149' ' ' LEU . 4.5 mm? -115.64 133.02 56.44 Favored 'General case' 0 C--O 1.225 -0.229 0 CA-C-N 115.158 -0.928 . . . . 0.0 108.872 177.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.592 ' CZ ' ' OE2' ' A' ' 155' ' ' GLU . 93.4 m-85 -116.39 114.0 23.68 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.315 -0.554 . . . . 0.0 111.138 179.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . 0.467 ' OD1' ' N ' ' A' ' 152' ' ' ASN . 54.1 t0 -93.29 172.3 8.38 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 177.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . 0.467 ' N ' ' OD1' ' A' ' 151' ' ' ASP . 68.6 m-20 -58.04 -26.85 63.0 Favored 'General case' 0 C--N 1.318 -0.764 0 C-N-CA 120.483 -0.487 . . . . 0.0 111.477 -177.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -115.08 -24.19 8.67 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 -178.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -146.86 177.73 8.89 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -176.159 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.592 ' OE2' ' CZ ' ' A' ' 150' ' ' TYR . 83.8 tt0 -126.99 138.0 53.19 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 114.644 -1.162 . . . . 0.0 110.323 178.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . 0.426 ' CD1' HG23 ' A' ' 206' ' ' THR . 92.0 m-85 -115.12 133.97 55.58 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 121.089 0.471 . . . . 0.0 111.676 -179.094 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -92.95 109.55 21.0 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.482 179.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -112.82 148.64 34.43 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.091 0.472 . . . . 0.0 111.168 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -125.23 124.46 41.74 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 121.331 0.586 . . . . 0.0 111.226 179.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.545 ' O ' ' N ' ' A' ' 144' ' ' GLY . 77.5 t -59.06 136.47 22.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.918 178.152 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 66.8 p -104.43 -24.81 13.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.09 0.472 . . . . 0.0 110.918 179.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 157.97 -167.7 34.35 Favored Glycine 0 CA--C 1.529 0.939 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.672 HG12 HG22 ' A' ' 199' ' ' VAL . 2.8 m -133.55 158.55 42.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.165 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 69.8 m -142.62 164.27 30.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.479 0.657 . . . . 0.0 111.731 -179.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -99.59 114.43 27.46 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.682 179.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 20.5 m -136.79 158.12 36.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.42 0.629 . . . . 0.0 111.582 -179.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -87.65 159.01 50.38 Favored Pre-proline 0 CA--C 1.536 0.423 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.996 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.443 ' O ' HD12 ' B' ' 702' ' ' LEU . 37.2 Cg_endo -64.81 -10.54 25.41 Favored 'Trans proline' 0 N--CA 1.498 1.739 0 C-N-CA 122.861 2.374 . . . . 0.0 112.98 -179.416 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 45.5 p-10 -95.44 -8.24 35.99 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.723 ' O ' HD23 ' B' ' 702' ' ' LEU . 98.0 mttt -77.13 86.73 3.6 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 121.75 0.786 . . . . 0.0 112.256 -179.194 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' TRP . . . . . 0.606 ' O ' HG22 ' A' ' 174' ' ' VAL . 1.2 p-90 -80.47 -9.25 59.77 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.798 -1.092 . . . . 0.0 110.883 179.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -63.89 -32.11 73.52 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.818 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . 0.656 HG22 ' O ' ' A' ' 170' ' ' LYS . 35.0 m -63.13 -18.71 22.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-N 116.112 -0.495 . . . . 0.0 112.137 -179.152 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.613 HG13 HG23 ' A' ' 173' ' ' VAL . 34.8 m -106.47 -0.36 9.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -179.11 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.51 ' OE2' ' CE2' ' A' ' 171' ' ' TRP . 96.7 mt-10 -74.0 149.21 41.4 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 121.138 0.494 . . . . 0.0 111.51 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . 0.464 ' OD1' ' O ' ' A' ' 176' ' ' ASP . 46.8 p-10 -68.4 135.0 51.08 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.531 179.23 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 41.9 m80 -117.32 28.68 8.33 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 120.704 -0.398 . . . . 0.0 111.255 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 62.82 34.35 89.53 Favored Glycine 0 CA--C 1.531 1.031 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 179.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -152.69 163.63 39.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.842 0.353 . . . . 0.0 110.422 179.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -88.14 106.41 18.16 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 177.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . 0.435 ' HG2' ' N ' ' A' ' 182' ' ' ILE . 82.7 tt0 -136.18 161.32 36.06 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.421 0.629 . . . . 0.0 111.275 -178.511 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.435 ' N ' ' HG2' ' A' ' 181' ' ' GLU . 17.3 tt -130.11 137.18 57.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.463 -0.789 . . . . 0.0 108.947 178.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 85.0 m -131.03 128.02 39.45 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.076 0.465 . . . . 0.0 111.493 -179.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 68.4 mt -112.95 133.39 54.94 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.742 178.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 82.0 mt -109.48 120.11 60.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.23 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . 0.52 ' OG1' ' ND2' ' A' ' 127' ' ' ASN . 8.8 t -133.28 147.74 51.92 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.709 179.601 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' CYS . . . . . 0.683 ' H ' HD21 ' A' ' 127' ' ' ASN . 2.1 m -87.65 142.31 27.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.863 -179.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.569 HG13 ' N ' ' A' ' 189' ' ' SER . 14.3 p -62.35 -44.7 99.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.888 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . 0.569 ' N ' HG13 ' A' ' 188' ' ' VAL . 24.9 t -170.69 148.72 3.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.122 0.487 . . . . 0.0 111.104 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . 0.408 HG22 ' O ' ' A' ' 190' ' ' VAL . 8.7 p -68.77 -14.86 19.02 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 CA-C-O 121.187 0.518 . . . . 0.0 110.493 179.47 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -95.61 -11.74 26.77 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.574 179.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -135.67 102.2 5.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.223 0.535 . . . . 0.0 110.87 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -102.99 11.25 37.57 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.845 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 12.3 t -60.8 -45.0 96.13 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.639 -178.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 64.7 pttt -142.59 159.82 41.49 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 120.946 0.403 . . . . 0.0 110.635 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . 0.502 ' NH1' ' SG ' ' B' ' 705' ' ' B27 . 94.5 mtt-85 -132.32 147.59 52.4 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 121.053 0.454 . . . . 0.0 111.451 -178.439 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -97.19 135.47 39.09 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 121.164 0.507 . . . . 0.0 111.413 179.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 38.9 t -120.53 129.46 75.56 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.914 179.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.672 HG22 HG12 ' A' ' 163' ' ' VAL . 54.1 t -100.12 133.27 43.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.527 -179.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -122.64 152.52 40.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.522 0.677 . . . . 0.0 111.584 -179.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -147.41 149.85 22.03 Favored Glycine 0 CA--C 1.532 1.107 0 N-CA-C 110.33 -1.108 . . . . 0.0 110.33 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -106.28 148.89 27.45 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.927 0.394 . . . . 0.0 111.007 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 62.4 tp -66.23 130.39 43.05 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 178.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 46.9 t -110.32 -24.19 4.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 C-N-CA 120.8 -0.36 . . . . 0.0 111.609 -178.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -178.47 173.74 46.08 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 111.164 -0.775 . . . . 0.0 111.164 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . 0.426 HG23 ' CD1' ' A' ' 156' ' ' TYR . 19.6 m -142.89 141.76 31.59 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.135 0.493 . . . . 0.0 110.254 179.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -141.43 114.55 8.66 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.262 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -64.74 148.1 51.81 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.829 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 55.8 mtmt -77.06 154.99 32.82 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.543 178.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 53.9 mtmt . . . . . 0 C--O 1.22 -0.479 0 CA-C-O 117.919 -1.039 . . . . 0.0 110.832 179.573 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 701' ' ' BOC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 702' ' ' LEU . . . . . 0.723 HD23 ' O ' ' A' ' 170' ' ' LYS . 0.2 OUTLIER 57.5 78.34 0.37 Allowed Pre-proline 0 CA--C 1.537 0.476 0 CA-C-O 121.505 0.669 . . . . 20.0 111.046 . . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 703' ' ' PRO . . . . . 0.576 ' HG2' HG22 ' A' ' 110' ' ' VAL . 3.1 Cg_exo -73.72 -165.43 0.25 Allowed 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 123.576 2.851 . . . . 20.0 112.898 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 704' ' ' ALA . . . . . 0.55 ' O ' ' O ' ' B' ' 703' ' ' PRO . . . -39.64 -176.21 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 115.008 -0.996 . . . . 20.0 113.081 -179.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 705' ' ' B27 . . . . . 0.558 ' SG ' ' N ' ' A' ' 187' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.378 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 30.8 t -136.93 136.34 38.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.971 0.415 . . . . 0.0 110.581 179.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -112.27 132.21 55.07 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.107 0.479 . . . . 0.0 110.813 179.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 78.2 mtm -101.87 140.57 35.97 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.492 179.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.45 ' OD1' ' OG ' ' A' ' 59' ' ' SER . 47.2 t0 -165.04 122.53 1.58 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.619 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -97.55 -1.58 43.65 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.145 0.497 . . . . 0.0 110.828 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.45 ' OG ' ' OD1' ' A' ' 57' ' ' ASP . 92.4 p -85.25 1.49 48.03 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.242 -178.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.437 ' HG2' HH21 ' A' ' 196' ' ' ARG . 99.5 mttt -99.05 17.54 19.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.069 0.462 . . . . 0.0 111.602 -179.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 14.7 mm -55.74 136.62 18.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 122.449 1.119 . . . . 0.0 112.231 -177.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -80.12 126.23 30.81 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 113.346 -1.752 . . . . 0.0 109.894 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.632 HE22 HD21 ' A' ' 134' ' ' LEU . 2.1 tt0 -78.17 123.17 86.03 Favored Pre-proline 0 CA--C 1.533 0.322 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -44.0 170.38 0.02 OUTLIER 'Trans proline' 0 C--N 1.313 -1.341 0 C-N-CA 121.886 1.724 . . . . 0.0 112.318 -179.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.463 ' O ' HG23 ' A' ' 69' ' ' VAL . 91.7 m-20 -52.18 163.16 0.4 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.15 -179.321 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 55.0 tp -62.58 -44.84 95.32 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.786 -177.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -60.43 -38.51 84.31 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.226 -0.589 . . . . 0.0 111.603 -178.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 66.3 tt0 -60.85 -25.17 66.45 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.14 -0.624 . . . . 0.0 110.027 179.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.634 HG13 ' HB3' ' A' ' 104' ' ' LEU . 36.1 t -77.83 -47.15 25.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.633 0.73 . . . . 0.0 109.774 178.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -73.43 -8.53 56.26 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 114.86 -1.064 . . . . 0.0 110.811 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -103.62 -16.95 15.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.502 0.668 . . . . 0.0 110.255 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -69.4 142.7 53.85 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.898 -179.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 33.6 t -58.56 97.52 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.564 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -67.79 136.15 53.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.109 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.446 ' OD2' ' CD ' ' A' ' 78' ' ' GLN . 37.6 t0 -103.55 79.11 1.65 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.334 178.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -71.76 -35.37 70.05 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.471 0.653 . . . . 0.0 111.962 179.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 43.8 mmtt -67.95 -31.12 70.63 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.058 -0.973 . . . . 0.0 112.781 -174.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.446 ' CD ' ' OD2' ' A' ' 75' ' ' ASP . 86.4 mt-30 -87.34 6.3 34.29 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.219 -0.593 . . . . 0.0 111.621 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 59.3 t -78.42 130.13 36.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 120.434 -0.506 . . . . 0.0 109.661 179.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.649 HD13 ' HE3' ' A' ' 96' ' ' LYS . 43.4 pt -110.3 -4.71 10.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.778 -179.271 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -163.56 166.0 37.07 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 120.499 -0.858 . . . . 0.0 111.605 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 72.0 ttp85 -137.66 141.29 41.15 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 121.095 0.474 . . . . 0.0 111.191 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.55 HG22 ' O ' ' A' ' 92' ' ' LEU . 19.9 tt -105.08 141.43 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.984 179.23 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 7.9 t -137.63 131.79 32.05 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 121.4 0.619 . . . . 0.0 112.219 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.624 ' CG2' HG22 ' A' ' 88' ' ' VAL . 87.2 mt -136.71 88.05 19.65 Favored Pre-proline 0 CA--C 1.537 0.465 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.805 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -55.4 -32.01 80.01 Favored 'Trans proline' 0 N--CA 1.5 1.881 0 C-N-CA 123.155 2.57 . . . . 0.0 112.571 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 67.3 m -54.3 -42.71 70.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.26 0.552 . . . . 0.0 110.678 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.624 HG22 ' CG2' ' A' ' 85' ' ' ILE . 19.7 m -112.43 6.84 8.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.371 179.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 50.65 52.25 15.27 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.879 0.847 . . . . 0.0 110.187 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 52.8 tp -118.32 133.85 55.54 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.185 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -145.05 126.96 15.43 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.734 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.55 ' O ' HG22 ' A' ' 83' ' ' ILE . 80.1 mt -149.06 151.01 33.55 Favored Pre-proline 0 CA--C 1.538 0.497 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.493 -178.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -76.53 148.82 29.95 Favored 'Trans proline' 0 N--CA 1.496 1.66 0 C-N-CA 122.839 2.359 . . . . 0.0 111.804 178.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.55 ' C ' HD12 ' A' ' 95' ' ' LEU . 73.8 t -97.3 117.97 42.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-O 121.047 0.451 . . . . 0.0 111.579 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.563 ' N ' HD12 ' A' ' 95' ' ' LEU . 9.4 mp -102.74 134.1 46.68 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.889 179.437 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.649 ' HE3' HD13 ' A' ' 80' ' ' ILE . 98.1 mttt -58.55 -83.4 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 121.26 0.552 . . . . 0.0 111.934 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 18.7 m -61.33 138.31 58.25 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.527 0.679 . . . . 0.0 111.666 -178.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 3.1 m -95.4 70.62 3.15 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.17 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 8.7 p -88.54 166.65 14.02 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 177.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -59.13 -40.61 85.99 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 119.931 -0.707 . . . . 0.0 109.994 179.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -65.49 -42.18 92.45 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 121.321 0.581 . . . . 0.0 110.709 178.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -64.36 -37.05 86.13 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.477 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.493 HD13 ' CB ' ' B' ' 704' ' ' ALA . 84.7 mt -62.93 -18.02 62.57 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.857 -179.488 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.634 ' HB3' HG13 ' A' ' 69' ' ' VAL . 98.0 mt -74.73 -18.0 60.56 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.846 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 50.5 m -74.36 -4.9 39.19 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-O 121.728 0.775 . . . . 0.0 109.366 179.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 86.48 -19.78 26.26 Favored Glycine 0 CA--C 1.532 1.134 0 CA-C-N 114.826 -1.079 . . . . 0.0 112.803 178.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -145.91 123.98 12.12 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 119.585 -0.846 . . . . 0.0 112.472 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -145.9 141.55 27.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.362 -0.836 . . . . 0.0 109.968 178.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.435 ' OG1' ' O ' ' A' ' 96' ' ' LYS . 20.5 p -65.9 136.39 56.05 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.135 -0.626 . . . . 0.0 109.583 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.538 HG13 ' CG ' ' B' ' 703' ' ' PRO . 76.1 t -76.78 -46.12 30.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.928 -179.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.406 ' O ' ' HG2' ' A' ' 114' ' ' GLN . 43.3 mtpt -99.09 142.82 30.08 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 122.013 0.911 . . . . 0.0 112.036 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -67.42 -36.09 80.57 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.594 -1.184 . . . . 0.0 111.956 -179.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 72.8 m-80 -86.76 22.18 2.02 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 114.203 1.186 . . . . 0.0 114.203 -177.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.438 ' OE1' ' O ' ' A' ' 120' ' ' ASN . 94.5 mm-40 -78.37 137.28 37.94 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 121.797 -0.564 . . . . 0.0 112.312 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 61.5 t -128.18 123.96 61.4 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.868 179.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 55.6 mtt -58.55 130.91 49.07 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 121.133 0.492 . . . . 0.0 111.924 179.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 78.23 -0.51 73.87 Favored Glycine 0 CA--C 1.531 1.051 0 CA-C-N 116.04 -0.527 . . . . 0.0 112.789 178.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -138.38 124.99 20.79 Favored 'General case' 0 C--N 1.329 -0.317 0 O-C-N 122.047 -0.678 . . . . 0.0 111.1 -179.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 76.12 -165.31 54.01 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 110.337 -1.105 . . . . 0.0 110.337 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.438 ' O ' ' OE1' ' A' ' 114' ' ' GLN . 59.0 t-20 -91.73 105.34 17.65 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.041 0.448 . . . . 0.0 109.864 179.414 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.775 ' CE2' HD11 ' A' ' 123' ' ' LEU . 7.4 t80 -85.43 144.91 27.71 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 179.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.905 ' C ' HD12 ' A' ' 123' ' ' LEU . . . -146.8 145.61 29.97 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 119.842 -0.743 . . . . 0.0 111.944 -178.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.905 HD12 ' C ' ' A' ' 122' ' ' ALA . 7.4 mp -139.61 145.25 38.3 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.918 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.426 ' HB1' ' HG2' ' B' ' 705' ' ' B27 . . . -110.23 135.73 50.53 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 178.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -136.72 148.99 20.02 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 110.294 -1.122 . . . . 0.0 110.294 -179.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.759 ' O ' HD23 ' A' ' 134' ' ' LEU . 21.6 m-70 -86.79 142.52 28.05 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.616 0.722 . . . . 0.0 111.935 -179.157 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 49.5 t-20 -131.51 120.79 23.44 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.142 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.606 ' HB2' HG21 ' A' ' 133' ' ' VAL . 62.9 mtt -94.4 -2.77 51.42 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.227 0.537 . . . . 0.0 110.662 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.466 ' CB ' ' O ' ' A' ' 128' ' ' MET . 0.7 OUTLIER 77.43 3.97 3.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.318 179.123 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.862 ' O ' HG12 ' A' ' 133' ' ' VAL . 61.8 pttt -118.16 130.72 56.27 Favored 'General case' 0 C--O 1.222 -0.357 0 CA-C-O 121.623 0.725 . . . . 0.0 112.817 -178.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.473 ' O ' ' O ' ' A' ' 130' ' ' LYS . 74.9 mmtt -41.12 163.66 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.354 0.597 . . . . 0.0 109.616 179.026 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 74.93 -22.51 1.47 Allowed Glycine 0 CA--C 1.53 1.007 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.862 HG12 ' O ' ' A' ' 130' ' ' LYS . 3.7 p -90.25 156.84 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 119.776 -0.77 . . . . 0.0 110.746 -179.36 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.88 ' H ' HD13 ' A' ' 134' ' ' LEU . 0.0 OUTLIER -70.79 146.25 49.87 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 115.023 1.49 . . . . 0.0 115.023 -176.803 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 59.68 7.77 1.14 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 112.504 -2.135 . . . . 0.0 114.153 177.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 5.4 t -69.9 -33.27 71.97 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 119.99 -0.684 . . . . 0.0 112.371 179.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -89.52 0.65 56.75 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 -178.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 2.1 pp -58.2 -31.52 42.29 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 C-N-CA 119.874 -0.73 . . . . 0.0 110.965 -179.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -65.1 -13.89 59.16 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.962 0.411 . . . . 0.0 110.876 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 49.3 m -81.52 -4.0 54.74 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.152 -179.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 92.9 mt -64.57 142.12 58.54 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -120.52 156.01 32.44 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.223 0.535 . . . . 0.0 110.185 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -49.63 130.34 20.58 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.848 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 160' ' ' VAL . . . 80.76 8.46 87.47 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 120.837 -0.697 . . . . 0.0 111.914 178.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.498 ' OD1' ' N ' ' A' ' 146' ' ' LYS . 63.8 t0 -71.77 133.95 45.88 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 119.737 -0.785 . . . . 0.0 109.928 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.498 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 73.2 mmtt -78.97 140.52 38.0 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.764 0.792 . . . . 0.0 112.749 -178.235 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.434 HD11 ' CG2' ' A' ' 160' ' ' VAL . 96.3 mt -134.35 134.32 54.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 114.718 -1.128 . . . . 0.0 108.014 178.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . 0.585 ' C ' HD22 ' A' ' 149' ' ' LEU . 88.1 m-85 -115.45 133.7 55.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.648 0.737 . . . . 0.0 112.706 -178.217 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.585 HD22 ' C ' ' A' ' 148' ' ' TYR . 4.5 mm? -114.7 132.64 56.35 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.97 -1.014 . . . . 0.0 108.397 177.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.494 ' CZ ' ' OE2' ' A' ' 155' ' ' GLU . 94.1 m-85 -115.51 110.13 18.82 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 119.985 -0.686 . . . . 0.0 111.673 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . 0.57 ' OD1' ' N ' ' A' ' 152' ' ' ASN . 62.3 t0 -88.3 165.67 14.84 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 177.015 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . 0.57 ' N ' ' OD1' ' A' ' 151' ' ' ASP . 36.5 p-10 -58.18 -20.35 40.49 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 119.466 -0.894 . . . . 0.0 111.219 -178.21 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -115.03 -27.88 7.19 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 113.622 0.971 . . . . 0.0 113.622 -178.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -147.52 176.33 10.14 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 118.963 -1.095 . . . . 0.0 113.455 -176.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.494 ' OE2' ' CZ ' ' A' ' 150' ' ' TYR . 83.8 tt0 -125.02 133.48 52.95 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 114.604 -1.18 . . . . 0.0 110.141 178.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . 0.47 ' CD1' HG23 ' A' ' 206' ' ' THR . 86.1 m-85 -107.94 133.55 52.12 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 120.967 0.413 . . . . 0.0 111.271 -179.557 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -91.7 110.11 21.44 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.352 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -113.36 146.47 39.41 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.015 0.436 . . . . 0.0 111.137 179.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -126.12 125.68 42.92 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 121.133 0.492 . . . . 0.0 111.132 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.537 ' O ' ' N ' ' A' ' 144' ' ' GLY . 83.0 t -58.27 133.63 23.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.667 178.425 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 70.5 p -115.49 11.3 15.91 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 139.6 171.6 12.36 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 119.972 -1.109 . . . . 0.0 112.923 178.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.63 HG22 HG22 ' A' ' 199' ' ' VAL . 42.1 t -125.63 135.43 63.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 114.305 -0.948 . . . . 0.0 108.874 178.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 30.8 m -131.98 162.32 30.99 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.504 0.668 . . . . 0.0 111.85 -179.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.427 ' HG2' ' CE2' ' A' ' 197' ' ' TYR . 99.1 mt-10 -108.22 121.19 44.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.606 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 29.1 m -136.38 157.45 37.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.431 0.634 . . . . 0.0 111.349 -179.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.26 159.39 70.34 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.755 179.169 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.51 ' O ' ' CB ' ' B' ' 702' ' ' LEU . 37.8 Cg_endo -65.66 -15.55 49.79 Favored 'Trans proline' 0 C--N 1.302 -1.891 0 C-N-CA 123.114 2.543 . . . . 0.0 113.227 -179.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 50.8 p-10 -92.26 -3.78 54.99 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 119.808 -0.757 . . . . 0.0 111.842 179.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.801 ' O ' HG22 ' A' ' 173' ' ' VAL . 74.7 mmtt -74.43 80.45 1.91 Allowed 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.261 -0.575 . . . . 0.0 110.634 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' TRP . . . . . 0.701 ' CZ3' ' H22' ' B' ' 701' ' ' BOC . 33.8 m0 -69.17 -17.63 63.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.87 179.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -61.18 -30.52 70.46 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.73 -178.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . 0.801 HG22 ' O ' ' A' ' 170' ' ' LYS . 30.8 m -63.27 -15.88 16.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.188 0.518 . . . . 0.0 111.008 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.701 HG23 HG23 ' A' ' 173' ' ' VAL . 78.3 t -111.16 -11.05 11.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.131 -179.123 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -73.46 152.53 40.7 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.201 0.524 . . . . 0.0 111.224 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . 0.523 ' OD1' ' O ' ' A' ' 176' ' ' ASP . 49.5 p30 -70.19 136.74 50.33 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 121.347 0.594 . . . . 0.0 111.41 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 77.9 m80 -107.4 -18.89 13.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.469 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 102.49 37.55 3.24 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -178.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 11.6 ptmt -157.38 170.21 22.97 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.089 -0.556 . . . . 0.0 111.063 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -87.79 100.28 12.73 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 177.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . 0.446 ' HG2' ' N ' ' A' ' 182' ' ' ILE . 79.4 tt0 -136.32 161.22 36.4 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.403 0.62 . . . . 0.0 111.272 -179.119 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.446 ' N ' ' HG2' ' A' ' 181' ' ' GLU . 20.7 tt -129.6 138.35 54.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.249 -0.887 . . . . 0.0 108.782 178.404 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . 0.542 ' C ' HD12 ' A' ' 184' ' ' LEU . 97.8 m -128.04 126.02 40.47 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.199 0.523 . . . . 0.0 112.17 -178.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.585 ' N ' HD12 ' A' ' 184' ' ' LEU . 10.2 mp -107.94 127.41 53.73 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.119 178.341 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.58 HD13 HD21 ' B' ' 702' ' ' LEU . 93.3 mt -114.29 123.98 70.49 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-O 121.362 0.601 . . . . 0.0 111.545 -178.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -142.54 161.55 37.77 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.597 179.425 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -98.63 139.98 33.54 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 178.172 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.602 HG13 ' N ' ' A' ' 189' ' ' SER . 7.4 p -59.76 -47.26 91.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.807 -178.501 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . 0.602 ' N ' HG13 ' A' ' 188' ' ' VAL . 23.1 p -160.52 157.85 28.2 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.1 0.476 . . . . 0.0 110.761 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 27.8 m -76.87 -9.21 12.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.212 0.53 . . . . 0.0 110.24 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -96.95 -18.95 19.14 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.978 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -136.8 98.79 3.87 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.09 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -101.44 11.35 39.27 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 121.131 0.491 . . . . 0.0 110.902 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 47.1 t -59.92 -43.25 95.01 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.476 -179.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 51.6 mtmt -132.06 146.3 51.97 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 121.185 0.517 . . . . 0.0 111.211 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . 0.47 ' CZ ' ' HX ' ' B' ' 705' ' ' B27 . 99.9 mtt180 -121.32 145.41 47.91 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.926 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . 0.427 ' CE2' ' HG2' ' A' ' 165' ' ' GLU . 36.4 m-85 -94.87 140.79 29.43 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.727 179.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 55.8 t -130.85 132.35 64.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.298 0.57 . . . . 0.0 111.041 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.63 HG22 HG22 ' A' ' 163' ' ' VAL . 47.8 t -100.19 133.93 41.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.07 179.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -108.07 132.84 53.14 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.266 0.555 . . . . 0.0 110.93 -179.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -132.2 140.59 11.95 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . 0.558 ' OD1' ' N ' ' A' ' 203' ' ' LEU . 67.9 t0 -111.5 138.49 47.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.123 0.487 . . . . 0.0 111.151 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . 0.558 ' N ' ' OD1' ' A' ' 202' ' ' ASP . 53.8 tp -62.69 128.9 38.1 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 1.3 p -114.38 -19.94 6.39 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 120.848 -0.341 . . . . 0.0 111.548 -178.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -175.87 170.94 44.0 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 120.768 -0.729 . . . . 0.0 111.858 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . 0.47 HG23 ' CD1' ' A' ' 156' ' ' TYR . 18.2 m -143.71 139.68 29.62 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 179.314 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -144.81 120.23 10.31 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.43 0.633 . . . . 0.0 111.991 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -64.28 142.91 58.25 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.388 -179.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -80.75 110.48 16.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.68 179.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 99.4 mttt . . . . . 0 C--O 1.221 -0.42 0 CA-C-O 117.88 -1.057 . . . . 0.0 110.994 -179.757 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 701' ' ' BOC . . . . . 0.701 ' H22' ' CZ3' ' A' ' 171' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 702' ' ' LEU . . . . . 0.58 HD21 HD13 ' A' ' 185' ' ' ILE . 2.0 mt -112.88 98.81 46.45 Favored Pre-proline 0 CA--C 1.54 0.573 0 CA-C-O 120.672 0.272 . . . . 20.0 110.726 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 703' ' ' PRO . . . . . 0.581 ' O ' ' O ' ' B' ' 704' ' ' ALA . 4.2 Cg_exo -67.17 -169.02 0.18 Allowed 'Trans proline' 0 N--CA 1.489 1.25 0 C-N-CA 122.527 2.151 . . . . 20.0 114.006 -179.287 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 704' ' ' ALA . . . . . 0.716 ' C ' HG2A ' B' ' 705' ' ' B27 . . . -33.01 176.73 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 113.798 -1.546 . . . . 20.0 113.792 -179.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 705' ' ' B27 . . . . . 0.716 HG2A ' C ' ' B' ' 704' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.169 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 17.7 p -149.75 161.0 43.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.238 0.542 . . . . 0.0 110.788 -179.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 -115.99 131.54 56.91 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.018 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 78.4 mtm -100.54 119.14 38.07 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.268 0.556 . . . . 0.0 110.846 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -56.13 114.02 1.78 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.709 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -103.56 14.07 32.0 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.356 -179.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.51 ' CB ' ' O ' ' B' ' 702' ' ' LEU . 5.5 p -81.28 20.06 0.89 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.356 0.598 . . . . 0.0 111.158 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -102.64 18.48 21.22 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.205 -179.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.9 mt -56.26 139.5 15.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 122.415 1.103 . . . . 0.0 113.405 -176.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -77.42 130.69 37.39 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 113.525 -1.671 . . . . 0.0 108.865 178.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.617 ' H ' ' CD ' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -81.28 154.9 72.14 Favored Pre-proline 0 C--N 1.32 -0.688 0 C-N-CA 120.364 -0.534 . . . . 0.0 110.513 -179.139 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -72.2 166.48 29.56 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 123.249 2.632 . . . . 0.0 113.34 -178.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.806 ' O ' HG23 ' A' ' 69' ' ' VAL . 87.5 m-20 -52.62 164.45 0.35 Allowed 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 120.975 0.417 . . . . 0.0 110.491 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 56.5 tp -64.27 -47.05 81.05 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.321 -179.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.412 ' O ' ' N ' ' A' ' 71' ' ' ASN . . . -62.65 -36.46 82.92 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 119.863 -0.735 . . . . 0.0 110.773 -178.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -62.46 -28.81 70.07 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.526 0.679 . . . . 0.0 109.223 178.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.806 HG23 ' O ' ' A' ' 65' ' ' ASP . 46.7 t -76.7 -44.38 33.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.862 178.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -79.38 -8.88 59.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.0 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.412 ' N ' ' O ' ' A' ' 67' ' ' ALA . 10.3 m120 -102.82 -13.28 17.06 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.397 0.618 . . . . 0.0 110.177 179.34 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.402 ' CB ' HD13 ' A' ' 104' ' ' LEU . . . -68.91 145.44 53.66 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.172 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 32.9 m -57.85 110.17 0.86 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.784 -179.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.719 HD13 ' C ' ' A' ' 74' ' ' LEU . 3.0 tm? -70.88 119.34 14.86 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.338 0.59 . . . . 0.0 110.535 -179.611 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.608 ' N ' HD13 ' A' ' 74' ' ' LEU . 83.1 m-20 -94.92 78.76 3.62 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.481 -0.782 . . . . 0.0 109.812 179.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.577 ' O ' HG12 ' A' ' 79' ' ' VAL . 82.0 tttt -65.07 -32.85 74.76 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.267 -0.879 . . . . 0.0 112.055 -179.615 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 36.9 mmtt -70.15 -10.16 57.93 Favored 'General case' 0 C--N 1.314 -0.955 0 C-N-CA 120.401 -0.52 . . . . 0.0 110.509 -177.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -96.65 -3.8 42.11 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.474 178.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.577 HG12 ' O ' ' A' ' 76' ' ' LYS . 3.1 p -81.39 130.14 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-O 121.315 0.579 . . . . 0.0 111.386 -179.368 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 10.0 pt -108.66 -6.75 10.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.982 179.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -174.15 -180.0 45.13 Favored Glycine 0 CA--C 1.53 1.012 0 N-CA-C 111.326 -0.71 . . . . 0.0 111.326 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.411 ' HG2' ' N ' ' A' ' 83' ' ' ILE . 61.4 ttp180 -136.74 156.88 47.93 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.415 HG22 ' O ' ' A' ' 92' ' ' LEU . 19.5 tt -124.2 141.96 42.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.113 0.482 . . . . 0.0 110.362 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 74.5 m -135.5 131.05 35.58 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 121.66 0.743 . . . . 0.0 112.332 -178.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.546 ' CG2' HG22 ' A' ' 88' ' ' VAL . 92.5 mt -137.33 86.06 20.4 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.082 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -57.48 -30.12 87.11 Favored 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 122.769 2.312 . . . . 0.0 113.063 -179.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 70.6 m -52.9 -40.67 63.72 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 121.22 0.533 . . . . 0.0 110.457 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.546 HG22 ' CG2' ' A' ' 85' ' ' ILE . 26.7 m -113.58 8.09 7.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.346 179.011 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 52.59 54.45 10.59 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.501 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 60.1 tp -119.99 135.29 54.97 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.629 0.728 . . . . 0.0 111.337 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -146.31 124.21 12.0 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.186 -0.915 . . . . 0.0 109.224 179.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.415 ' O ' HG22 ' A' ' 83' ' ' ILE . 82.3 mt -149.36 148.07 25.26 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.716 -178.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -73.04 146.24 41.08 Favored 'Trans proline' 0 C--N 1.313 -1.313 0 C-N-CA 122.176 1.918 . . . . 0.0 111.318 179.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.503 ' C ' HD12 ' A' ' 95' ' ' LEU . 43.8 t -96.55 122.11 47.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.28 0.562 . . . . 0.0 111.081 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.549 ' N ' HD12 ' A' ' 95' ' ' LEU . 11.1 mp -99.68 134.73 42.14 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.199 179.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -62.63 -79.03 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.499 -177.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 7.5 m -66.98 145.01 55.86 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 121.041 0.448 . . . . 0.0 111.611 -179.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 7.2 t -95.43 68.14 2.97 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-O 121.186 0.517 . . . . 0.0 111.51 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.445 HG22 ' N ' ' A' ' 100' ' ' GLU . 12.9 m -88.54 166.99 13.79 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 178.009 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.445 ' N ' HG22 ' A' ' 99' ' ' THR . 72.0 mm-40 -60.99 -43.9 98.19 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.022 -0.671 . . . . 0.0 109.881 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -65.14 -38.38 90.43 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.483 0.659 . . . . 0.0 110.253 178.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.421 ' HB2' ' H ' ' A' ' 99' ' ' THR . 92.3 m-20 -63.82 -39.27 93.83 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.057 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.409 HD13 ' CB ' ' B' ' 704' ' ' ALA . 78.2 mt -62.92 -12.01 22.41 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.015 -0.539 . . . . 0.0 112.001 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.432 ' O ' ' CG1' ' A' ' 69' ' ' VAL . 96.9 mt -73.28 -22.6 60.33 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 121.052 0.454 . . . . 0.0 111.15 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 95.7 p -73.84 -3.69 30.3 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.349 0.595 . . . . 0.0 110.498 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 86.85 -18.87 32.67 Favored Glycine 0 CA--C 1.531 1.06 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.509 178.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -145.62 127.07 15.0 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 119.941 -0.704 . . . . 0.0 112.103 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -147.74 142.8 27.05 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.551 178.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.572 ' HA ' HD23 ' A' ' 123' ' ' LEU . 3.4 p -73.6 140.79 46.45 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.271 0.557 . . . . 0.0 111.65 -179.27 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.746 HG22 ' HG2' ' B' ' 703' ' ' PRO . 58.1 t -78.64 -52.37 15.64 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.973 -179.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.778 ' H ' ' NE2' ' A' ' 114' ' ' GLN . 49.0 mtmt -100.32 136.67 39.85 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 122.221 1.01 . . . . 0.0 112.526 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -66.16 -31.98 73.15 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 113.978 -1.465 . . . . 0.0 112.627 -178.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 71.5 m-80 -85.33 13.7 6.24 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 -177.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.778 ' NE2' ' H ' ' A' ' 111' ' ' LYS . 32.7 mt-30 -79.87 143.5 34.26 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.383 0.611 . . . . 0.0 112.363 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 65.1 t -123.69 123.42 67.12 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.183 178.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . 0.445 ' CG ' ' CZ ' ' A' ' 121' ' ' TYR . 98.9 mtp -57.65 133.82 55.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.195 0.521 . . . . 0.0 111.509 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.496 ' O ' ' OD2' ' A' ' 180' ' ' ASP . . . 81.69 -2.45 82.92 Favored Glycine 0 CA--C 1.53 0.969 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.55 179.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -142.87 135.81 28.06 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.213 0.53 . . . . 0.0 111.263 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 72.47 -166.77 53.82 Favored Glycine 0 CA--C 1.529 0.925 0 N-CA-C 110.495 -1.042 . . . . 0.0 110.495 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 64.8 t-20 -92.24 103.49 15.95 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.075 0.464 . . . . 0.0 110.676 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.445 ' CZ ' ' CG ' ' A' ' 116' ' ' MET . 2.5 t80 -88.64 99.04 12.02 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 121.118 0.485 . . . . 0.0 110.1 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.741 ' CB ' HG13 ' A' ' 174' ' ' VAL . . . -91.51 138.43 31.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.091 0.472 . . . . 0.0 111.536 -179.495 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.572 HD23 ' HA ' ' A' ' 109' ' ' THR . 46.0 mt -134.33 139.59 45.78 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.415 -0.514 . . . . 0.0 110.913 179.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -107.89 133.24 52.53 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.655 179.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -134.3 142.98 14.53 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.517 ' O ' ' O ' ' A' ' 134' ' ' LEU . 23.2 m-70 -78.4 142.01 37.92 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.321 0.581 . . . . 0.0 112.39 -178.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.792 ' ND2' ' H ' ' A' ' 129' ' ' SER . 3.0 t-20 -138.76 121.34 16.23 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.816 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.551 ' HB2' HG21 ' A' ' 133' ' ' VAL . 63.4 mtt -97.81 -4.43 36.87 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.744 -179.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.792 ' H ' ' ND2' ' A' ' 127' ' ' ASN . 0.9 OUTLIER 79.14 4.16 2.32 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.967 179.281 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.861 ' O ' HG12 ' A' ' 133' ' ' VAL . 62.8 pttt -111.99 133.62 54.05 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 122.041 0.924 . . . . 0.0 113.206 -178.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.426 ' C ' ' O ' ' A' ' 130' ' ' LYS . 28.6 tptt -40.26 152.69 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.742 178.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 75.08 -14.75 4.57 Favored Glycine 0 CA--C 1.535 1.337 0 C-N-CA 121.077 -0.583 . . . . 0.0 112.71 178.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.861 HG12 ' O ' ' A' ' 130' ' ' LYS . 6.3 p -88.55 172.47 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 119.331 -0.947 . . . . 0.0 111.044 -179.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.671 ' H ' HG22 ' A' ' 133' ' ' VAL . 3.8 mm? -68.64 133.69 48.83 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 115.495 1.665 . . . . 0.0 115.495 -176.363 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 56.84 12.49 1.18 Allowed 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 113.859 -1.519 . . . . 0.0 114.718 176.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 2.8 p -69.21 -32.35 71.54 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 121.64 -0.663 . . . . 0.0 112.784 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -89.21 2.15 54.66 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 -178.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.582 HD11 HG21 ' A' ' 186' ' ' THR . 1.8 pp -63.45 -30.21 49.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 C-N-CA 120.206 -0.597 . . . . 0.0 111.046 -179.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -67.4 -11.06 56.82 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.94 0.4 . . . . 0.0 110.64 -179.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 56.8 m -82.45 -6.15 59.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.147 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 97.8 mt -65.33 143.83 57.5 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 121.165 0.507 . . . . 0.0 111.411 -179.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.417 ' HG2' ' N ' ' A' ' 143' ' ' LYS . 88.8 tttt -119.82 157.13 29.29 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 121.249 0.547 . . . . 0.0 111.091 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . 0.417 ' N ' ' HG2' ' A' ' 142' ' ' LYS . 88.7 tttt -49.76 136.08 18.24 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.178 179.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.498 ' N ' ' O ' ' A' ' 160' ' ' VAL . . . 77.24 8.05 86.93 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 120.823 -0.703 . . . . 0.0 111.953 178.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -70.79 131.19 43.44 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 119.68 -0.808 . . . . 0.0 110.072 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -77.87 140.32 39.33 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 121.551 0.691 . . . . 0.0 111.926 -178.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.457 HD11 ' CG2' ' A' ' 160' ' ' VAL . 98.4 mt -139.08 140.58 38.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-N 114.851 -1.068 . . . . 0.0 108.711 178.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . 0.715 ' C ' HD23 ' A' ' 149' ' ' LEU . 18.1 m-85 -126.07 139.52 53.33 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 119.748 -0.781 . . . . 0.0 112.794 -178.419 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.715 HD23 ' C ' ' A' ' 148' ' ' TYR . 0.4 OUTLIER -117.97 134.9 54.52 Favored 'General case' 0 C--O 1.226 -0.164 0 CA-C-N 114.983 -1.008 . . . . 0.0 108.633 178.245 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.558 ' CE2' ' CD ' ' A' ' 155' ' ' GLU . 92.4 m-85 -110.53 113.73 26.59 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.319 -0.552 . . . . 0.0 110.938 179.288 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . 0.503 ' OD1' ' N ' ' A' ' 152' ' ' ASN . 54.7 t0 -90.5 167.88 12.26 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 177.354 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . 0.503 ' N ' ' OD1' ' A' ' 151' ' ' ASP . 71.8 m-20 -55.53 -24.47 32.16 Favored 'General case' 0 C--N 1.317 -0.805 0 C-N-CA 119.971 -0.691 . . . . 0.0 111.28 -177.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -112.23 -26.99 8.51 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 114.243 1.201 . . . . 0.0 114.243 -178.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -149.82 -177.02 5.65 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 118.764 -1.174 . . . . 0.0 114.018 -176.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.558 ' CD ' ' CE2' ' A' ' 150' ' ' TYR . 84.6 tt0 -129.51 141.66 50.94 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 114.582 -1.19 . . . . 0.0 110.467 179.242 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -117.68 138.07 52.24 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 120.829 0.347 . . . . 0.0 111.75 -179.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . 0.473 ' O ' HG12 ' A' ' 204' ' ' VAL . 96.6 mt-10 -94.44 111.93 23.69 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.279 179.319 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -112.56 148.23 34.98 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.053 0.454 . . . . 0.0 111.696 179.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -123.64 122.65 38.68 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 121.145 0.498 . . . . 0.0 111.456 179.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.498 ' O ' ' N ' ' A' ' 144' ' ' GLY . 95.4 t -58.84 135.24 23.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 177.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 80.9 p -106.32 -26.51 11.47 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 120.525 -0.47 . . . . 0.0 111.413 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 161.39 -169.65 36.97 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 120.481 -0.866 . . . . 0.0 111.89 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.863 HG12 HG22 ' A' ' 199' ' ' VAL . 28.5 m -135.39 162.6 37.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.017 0.437 . . . . 0.0 110.177 179.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 81.7 p -148.95 164.96 33.02 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.345 0.593 . . . . 0.0 111.324 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -104.79 115.76 30.86 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.062 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.44 HG21 HG21 ' A' ' 198' ' ' VAL . 24.4 m -137.09 160.95 36.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.48 0.657 . . . . 0.0 111.204 -179.265 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . 0.502 ' OG1' ' OD1' ' A' ' 169' ' ' ASP . 0.1 OUTLIER -88.95 160.82 42.74 Favored Pre-proline 0 CA--C 1.539 0.533 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.933 179.364 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.551 ' O ' ' CB ' ' B' ' 702' ' ' LEU . 55.4 Cg_endo -67.69 -15.81 45.23 Favored 'Trans proline' 0 N--CA 1.5 1.909 0 C-N-CA 123.074 2.516 . . . . 0.0 114.031 -178.346 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . 0.502 ' OD1' ' OG1' ' A' ' 167' ' ' THR . 38.4 p-10 -91.06 -2.55 57.62 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 119.58 -0.848 . . . . 0.0 110.803 179.483 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.907 ' O ' HG22 ' A' ' 173' ' ' VAL . 73.0 mmtt -73.53 69.6 1.24 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.445 0.641 . . . . 0.0 110.208 179.41 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' TRP . . . . . 0.575 ' CZ3' ' OE2' ' A' ' 175' ' ' GLU . 57.3 t90 -60.13 -17.72 42.35 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.303 179.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -63.72 -28.78 70.12 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.602 -0.727 . . . . 0.0 111.936 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . 0.907 HG22 ' O ' ' A' ' 170' ' ' LYS . 34.6 m -62.33 -20.79 25.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 120.692 -0.403 . . . . 0.0 111.05 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.741 HG13 ' CB ' ' A' ' 122' ' ' ALA . 7.8 t -99.81 -6.02 9.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.648 -179.32 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.575 ' OE2' ' CZ3' ' A' ' 171' ' ' TRP . 93.0 mt-10 -73.71 143.91 45.96 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 121.199 0.523 . . . . 0.0 111.419 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 44.8 p-10 -70.94 144.0 50.72 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.776 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 50.4 m80 -119.31 28.02 8.46 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 62.34 37.71 95.05 Favored Glycine 0 CA--C 1.528 0.88 0 N-CA-C 111.272 -0.731 . . . . 0.0 111.272 179.159 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -153.69 161.68 41.92 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.741 ' OD2' HD22 ' A' ' 203' ' ' LEU . 56.8 t0 -87.37 101.6 13.72 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 178.225 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . 0.462 ' HG2' ' N ' ' A' ' 182' ' ' ILE . 72.5 tt0 -130.78 163.43 27.36 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.469 0.652 . . . . 0.0 111.524 -178.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.462 ' N ' ' HG2' ' A' ' 181' ' ' GLU . 20.2 tt -130.07 138.5 53.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 57.0 m -130.83 125.44 33.68 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.504 -0.478 . . . . 0.0 111.29 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 85.5 mt -109.28 130.87 55.48 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.56 HD13 HD11 ' B' ' 702' ' ' LEU . 96.7 mt -115.7 128.87 72.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.533 0.682 . . . . 0.0 111.527 -179.112 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . 0.582 HG21 HD11 ' A' ' 138' ' ' ILE . 3.7 t -141.83 162.16 36.16 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.297 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' CYS . . . . . 0.447 ' O ' ' OD1' ' A' ' 127' ' ' ASN . 33.1 m -87.15 135.27 33.36 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.952 0.406 . . . . 0.0 110.086 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.587 HG13 ' N ' ' A' ' 189' ' ' SER . 11.9 p -61.54 -45.24 99.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-O 121.411 0.624 . . . . 0.0 110.308 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . 0.587 ' N ' HG13 ' A' ' 188' ' ' VAL . 35.5 t -172.18 144.95 1.68 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.869 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 33.9 m -70.89 -13.01 16.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.124 0.488 . . . . 0.0 110.627 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 63.1 mttm -94.03 -12.8 27.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.121 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . 0.412 ' C ' ' OD1' ' A' ' 192' ' ' ASP . 64.2 t0 -140.19 109.03 5.98 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.517 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 46.9 p-10 -107.5 11.72 28.52 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.303 179.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 35.0 t -59.89 -43.78 94.59 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.144 -178.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -145.83 155.61 43.02 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 121.28 0.562 . . . . 0.0 111.714 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . 0.51 ' NE ' ' SG ' ' B' ' 705' ' ' B27 . 85.1 mtt85 -128.03 146.91 50.52 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 121.383 0.611 . . . . 0.0 111.603 -179.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -91.15 146.51 23.78 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.873 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.44 HG21 HG21 ' A' ' 166' ' ' VAL . 47.8 t -130.28 134.21 62.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.639 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.863 HG22 HG12 ' A' ' 163' ' ' VAL . 54.1 t -105.87 132.14 53.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.348 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -116.05 139.03 50.69 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.246 0.546 . . . . 0.0 110.084 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . 0.434 ' O ' HG22 ' A' ' 182' ' ' ILE . . . -140.74 142.65 12.5 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.739 -0.945 . . . . 0.0 110.739 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 35.5 p30 -109.03 155.5 20.84 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.318 0.58 . . . . 0.0 111.544 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . 0.741 HD22 ' OD2' ' A' ' 180' ' ' ASP . 49.3 tp -74.13 131.3 41.16 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.478 179.195 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.473 HG12 ' O ' ' A' ' 157' ' ' GLU . 3.9 p -113.83 -20.25 6.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 120.319 -0.553 . . . . 0.0 111.181 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -174.2 169.22 42.21 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 120.486 -0.864 . . . . 0.0 111.779 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 63.6 m -142.65 137.16 29.77 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 179.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 54.4 pttt -149.19 123.48 9.58 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.592 0.71 . . . . 0.0 112.31 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -62.97 143.59 57.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.554 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 14.7 ptpt -79.26 111.04 15.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.527 178.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 64.8 mttp . . . . . 0 C--O 1.22 -0.493 0 CA-C-O 118.216 -0.897 . . . . 0.0 110.322 -179.966 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 701' ' ' BOC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 702' ' ' LEU . . . . . 0.56 HD11 HD13 ' A' ' 185' ' ' ILE . 0.0 OUTLIER 56.94 102.09 0.04 OUTLIER Pre-proline 0 CA--C 1.544 0.737 0 N-CA-C 109.635 -0.506 . . . . 20.0 109.635 . . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 703' ' ' PRO . . . . . 0.746 ' HG2' HG22 ' A' ' 110' ' ' VAL . 3.1 Cg_exo -65.81 -165.81 0.09 OUTLIER 'Trans proline' 0 N--CA 1.492 1.414 0 C-N-CA 121.921 1.748 . . . . 20.0 113.219 -179.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 704' ' ' ALA . . . . . 0.523 ' C ' HG2A ' B' ' 705' ' ' B27 . . . -44.5 -174.73 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.89 -1.05 . . . . 20.0 112.729 -178.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 705' ' ' B27 . . . . . 0.523 HG2A ' C ' ' B' ' 704' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.204 0 N-CA-C 109.889 -1.284 . . . . 0.0 109.889 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 44.0 t -65.33 145.68 55.88 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.103 0.478 . . . . 0.0 110.655 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 54.1 t-80 -119.22 124.15 46.05 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.965 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 89.4 mmm -79.67 145.59 32.91 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.832 179.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.434 ' OD1' ' OG ' ' A' ' 59' ' ' SER . 46.0 t0 -159.57 114.38 2.38 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.246 -179.298 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -92.82 -5.94 49.94 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.993 0.425 . . . . 0.0 110.855 179.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.476 ' CB ' ' O ' ' B' ' 702' ' ' LEU . 61.0 p -80.4 22.8 0.53 Allowed 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -179.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -109.2 19.15 19.77 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.069 0.461 . . . . 0.0 111.719 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 98.0 mt -55.83 135.64 18.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-O 122.115 0.96 . . . . 0.0 112.668 -177.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -77.72 129.95 36.16 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.148 -1.387 . . . . 0.0 109.336 178.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.615 ' NE2' ' O ' ' A' ' 63' ' ' GLN . 1.0 OUTLIER -79.21 147.66 69.56 Favored Pre-proline 0 N--CA 1.446 -0.628 0 C-N-CA 120.087 -0.645 . . . . 0.0 109.977 -179.215 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -69.76 167.63 23.88 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 122.353 2.036 . . . . 0.0 112.477 -179.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -51.17 169.77 0.05 OUTLIER 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.568 -178.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 55.9 tp -63.4 -46.21 87.49 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.607 -1.178 . . . . 0.0 111.409 -178.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.65 -22.96 48.75 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.159 0.505 . . . . 0.0 110.448 -178.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.556 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 49.3 tp10 -68.29 -31.56 71.09 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 119.284 -0.966 . . . . 0.0 108.509 178.186 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.464 HG22 ' HB3' ' A' ' 104' ' ' LEU . 36.6 t -74.45 -44.57 47.76 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.466 179.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -73.24 -9.82 59.12 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.709 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 38.6 t30 -118.58 -1.31 11.19 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 121.052 0.454 . . . . 0.0 110.179 178.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.556 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -69.04 -172.55 0.41 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.425 -179.127 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.3 m -94.87 99.8 11.79 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.287 0.565 . . . . 0.0 110.033 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 49.3 tp -67.83 135.34 52.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.845 -179.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -124.89 77.21 1.59 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.461 0.648 . . . . 0.0 109.49 178.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.736 ' O ' HG12 ' A' ' 79' ' ' VAL . 86.6 tttt -74.96 -41.14 60.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.37 -0.832 . . . . 0.0 112.162 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.464 ' H ' ' HD2' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -70.94 -6.0 35.18 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.72 -177.062 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -96.49 -10.03 28.32 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.284 0.564 . . . . 0.0 110.506 179.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.736 HG12 ' O ' ' A' ' 76' ' ' LYS . 9.9 p -65.31 127.75 26.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.855 179.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 12.1 pt -104.61 -8.03 9.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.327 0.584 . . . . 0.0 109.975 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -173.35 178.55 45.25 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 120.742 -0.742 . . . . 0.0 111.291 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.406 ' HG2' ' N ' ' A' ' 83' ' ' ILE . 58.5 ttp180 -136.45 160.92 37.29 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.336 -0.432 . . . . 0.0 110.357 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.566 HG22 ' O ' ' A' ' 92' ' ' LEU . 18.6 tt -124.99 140.94 46.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 CA-C-O 121.203 0.525 . . . . 0.0 109.983 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 47.6 t -137.18 130.39 31.0 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.378 0.608 . . . . 0.0 111.471 -178.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.543 ' CG2' HG22 ' A' ' 88' ' ' VAL . 37.3 mt -137.08 85.55 22.21 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.572 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -56.25 -33.05 89.93 Favored 'Trans proline' 0 N--CA 1.496 1.621 0 C-N-CA 123.25 2.633 . . . . 0.0 112.798 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.439 ' CB ' ' OD1' ' A' ' 145' ' ' ASP . 39.5 t -55.53 -43.44 75.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.097 0.475 . . . . 0.0 111.358 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.543 HG22 ' CG2' ' A' ' 85' ' ' ILE . 35.5 m -110.77 7.75 8.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.522 0.677 . . . . 0.0 109.879 179.173 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.5 m 53.03 51.58 15.5 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.043 179.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 69.1 tp -116.11 131.12 57.03 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.294 0.568 . . . . 0.0 110.462 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -148.52 125.67 11.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.817 0.818 . . . . 0.0 110.939 -179.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.623 ' CD1' ' HB2' ' A' ' 107' ' ' ALA . 0.3 OUTLIER -156.83 152.69 22.78 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 114.741 -1.118 . . . . 0.0 111.01 179.873 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -74.44 147.82 37.12 Favored 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 122.548 2.165 . . . . 0.0 112.132 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.489 ' C ' HD12 ' A' ' 95' ' ' LEU . 90.1 t -94.89 121.36 45.4 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-O 120.901 0.381 . . . . 0.0 111.159 179.392 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.544 ' N ' HD12 ' A' ' 95' ' ' LEU . 10.9 mp -98.49 127.88 44.61 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 121.654 0.74 . . . . 0.0 111.568 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.509 ' O ' ' OG1' ' A' ' 109' ' ' THR . 88.1 tttt -62.33 -47.0 86.16 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 114.846 -1.07 . . . . 0.0 112.077 -178.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.406 ' HB3' ' ND2' ' A' ' 102' ' ' ASN . 17.4 t -77.98 128.87 34.56 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.509 0.671 . . . . 0.0 112.354 -178.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.469 ' OG ' ' O ' ' A' ' 109' ' ' THR . 0.8 OUTLIER -86.62 51.8 2.33 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.523 -179.673 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.535 HG22 ' N ' ' A' ' 100' ' ' GLU . 62.1 m -88.37 162.59 16.46 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.187 -0.46 . . . . 0.0 109.998 178.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.535 ' N ' HG22 ' A' ' 99' ' ' THR . 57.6 mp0 -61.92 -43.18 99.37 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 121.133 0.492 . . . . 0.0 110.62 179.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -63.01 -40.66 98.43 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.228 -179.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.406 ' ND2' ' HB3' ' A' ' 97' ' ' SER . 97.8 m-20 -64.67 -37.75 88.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.616 0.722 . . . . 0.0 110.671 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.527 HD13 ' HB3' ' B' ' 704' ' ' ALA . 16.5 mt -59.62 -24.03 63.48 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.327 -0.852 . . . . 0.0 111.188 -179.056 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.464 ' HB3' HG22 ' A' ' 69' ' ' VAL . 90.0 mt -76.03 -12.22 60.09 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.966 0.412 . . . . 0.0 110.831 179.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 90.7 p -78.8 -5.45 53.42 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-O 121.474 0.654 . . . . 0.0 110.011 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 98.96 -19.7 53.23 Favored Glycine 0 CA--C 1.532 1.152 0 CA-C-N 115.326 -0.852 . . . . 0.0 112.758 178.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.623 ' HB2' ' CD1' ' A' ' 92' ' ' LEU . . . -146.96 129.63 16.07 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 119.382 -0.927 . . . . 0.0 113.039 -179.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -147.39 135.18 21.14 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.489 178.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.637 ' HA ' HD23 ' A' ' 123' ' ' LEU . 54.9 p -70.15 135.99 49.67 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.085 0.469 . . . . 0.0 111.118 -179.47 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.969 HG11 HG11 ' A' ' 174' ' ' VAL . 54.0 t -79.74 -56.04 7.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-O 121.074 0.464 . . . . 0.0 110.76 -179.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.82 ' H ' ' NE2' ' A' ' 114' ' ' GLN . 43.7 mtpt -102.87 137.97 40.38 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 121.901 0.857 . . . . 0.0 111.717 179.229 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -63.64 -29.47 70.7 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 114.735 -1.121 . . . . 0.0 111.619 -178.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 65.1 m-80 -83.06 14.73 3.18 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -177.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.82 ' NE2' ' H ' ' A' ' 111' ' ' LYS . 45.0 mt-30 -77.83 138.24 38.84 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 121.128 0.49 . . . . 0.0 112.285 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 72.9 t -126.26 119.75 54.88 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.531 178.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 97.4 mtp -58.31 128.42 37.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.566 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 85.3 -2.88 87.94 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 120.956 -0.64 . . . . 0.0 111.871 178.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -142.95 133.24 24.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.052 0.453 . . . . 0.0 111.153 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 72.24 -171.0 49.43 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 -179.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 63.2 t-20 -86.33 102.48 14.04 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.285 -0.566 . . . . 0.0 110.131 179.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.547 ' CE2' HD21 ' A' ' 123' ' ' LEU . 12.3 t80 -85.83 98.66 10.88 Favored 'General case' 0 N--CA 1.457 -0.097 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 179.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.573 ' N ' ' OE1' ' A' ' 114' ' ' GLN . . . -91.96 139.14 30.94 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.223 -179.372 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.637 HD23 ' HA ' ' A' ' 109' ' ' THR . 81.2 mt -137.94 143.63 40.85 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 120.98 0.419 . . . . 0.0 110.684 179.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -115.26 138.86 50.49 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.187 0.518 . . . . 0.0 110.488 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -144.14 134.05 5.57 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.414 ' CD2' ' OE1' ' A' ' 63' ' ' GLN . 0.2 OUTLIER -79.43 137.83 37.39 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.004 -0.678 . . . . 0.0 110.51 -179.828 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.803 ' ND2' ' H ' ' A' ' 129' ' ' SER . 3.5 t-20 -130.55 121.47 25.76 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.562 -179.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.498 ' O ' ' CB ' ' A' ' 129' ' ' SER . 67.0 mtt -87.73 -5.83 58.48 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.133 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.803 ' H ' ' ND2' ' A' ' 127' ' ' ASN . 0.9 OUTLIER 79.78 8.77 1.57 Allowed 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 179.123 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.874 ' O ' HG12 ' A' ' 133' ' ' VAL . 65.0 pttt -105.93 128.06 53.55 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 122.111 0.957 . . . . 0.0 112.371 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 38.8 tptt -46.05 119.78 2.43 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.977 -1.011 . . . . 0.0 109.988 178.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 115.23 -18.12 16.21 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.197 -1.161 . . . . 0.0 110.197 -179.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.874 HG12 ' O ' ' A' ' 130' ' ' LYS . 9.5 p -90.3 160.9 2.7 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 CA-C-O 121.256 0.55 . . . . 0.0 109.974 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.718 HD23 ' N ' ' A' ' 134' ' ' LEU . 0.1 OUTLIER -69.22 138.45 54.01 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -177.338 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.594 ' CD2' HD12 ' A' ' 138' ' ' ILE . 3.2 m-30 65.74 9.39 5.95 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 114.094 -1.412 . . . . 0.0 114.303 177.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . 0.552 ' OG ' ' ND2' ' A' ' 127' ' ' ASN . 0.4 OUTLIER -67.31 -36.27 81.13 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 120.453 -0.499 . . . . 0.0 112.185 179.315 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 22.7 p-10 -93.97 8.93 39.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.594 0.712 . . . . 0.0 110.796 -178.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.594 HD12 ' CD2' ' A' ' 135' ' ' PHE . 5.5 tt -64.96 -36.35 77.57 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.534 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -70.02 -10.81 59.92 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 121.958 -0.463 . . . . 0.0 111.399 179.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 67.3 m -81.24 -2.85 50.41 Favored 'General case' 0 C--O 1.231 0.088 0 CA-C-O 121.054 0.455 . . . . 0.0 110.303 179.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 70.9 mt -63.69 142.33 58.44 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.926 179.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -123.24 157.08 33.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.734 0.778 . . . . 0.0 111.85 -178.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -48.72 129.09 16.4 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.41 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 160' ' ' VAL . . . 82.24 8.52 86.28 Favored Glycine 0 CA--C 1.534 1.256 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.574 179.053 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.439 ' OD1' ' CB ' ' A' ' 87' ' ' SER . 23.1 t70 -71.76 130.49 41.23 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 119.908 -0.717 . . . . 0.0 110.838 -179.268 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -77.98 139.9 39.18 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 121.619 0.724 . . . . 0.0 111.628 -179.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.524 HG23 HG12 ' A' ' 85' ' ' ILE . 96.4 mt -136.59 137.68 47.36 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 178.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . 0.55 ' C ' HD23 ' A' ' 149' ' ' LEU . 63.3 m-85 -118.46 135.95 54.07 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 119.966 -0.694 . . . . 0.0 111.938 -178.247 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.55 HD23 ' C ' ' A' ' 148' ' ' TYR . 0.9 OUTLIER -114.16 134.28 55.01 Favored 'General case' 0 C--O 1.222 -0.357 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 177.263 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.427 ' CE2' ' OE1' ' A' ' 155' ' ' GLU . 81.2 m-85 -114.48 110.07 19.27 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.136 -0.626 . . . . 0.0 111.853 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . 0.474 ' N ' ' O ' ' A' ' 154' ' ' ASN . 22.4 t0 -88.4 167.92 13.08 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 177.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 65.2 m-20 -60.29 -23.77 64.43 Favored 'General case' 0 C--N 1.316 -0.872 0 C-N-CA 119.793 -0.763 . . . . 0.0 111.449 -178.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -113.02 -26.3 8.55 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -178.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . 0.474 ' O ' ' N ' ' A' ' 151' ' ' ASP . 0.3 OUTLIER -148.1 -177.0 5.5 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 119.115 -1.034 . . . . 0.0 112.639 -177.197 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.427 ' OE1' ' CE2' ' A' ' 150' ' ' TYR . 15.2 pt-20 -137.98 145.52 42.04 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 114.403 -1.271 . . . . 0.0 109.891 178.574 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . 0.431 ' CD1' HG23 ' A' ' 206' ' ' THR . 84.0 m-85 -118.5 138.41 52.53 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 121.255 0.55 . . . . 0.0 112.312 -178.212 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . 0.529 ' O ' HG22 ' A' ' 204' ' ' VAL . 93.5 mt-10 -95.56 114.91 26.72 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.455 179.444 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -118.24 151.73 37.09 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.792 0.329 . . . . 0.0 111.633 179.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -124.59 125.15 43.7 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.334 178.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.487 ' O ' ' N ' ' A' ' 144' ' ' GLY . 92.3 t -59.95 137.25 22.62 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 177.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 77.7 p -106.6 -24.81 12.05 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 123.436 0.46 . . . . 0.0 110.792 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 158.83 -167.93 34.85 Favored Glycine 0 CA--C 1.533 1.218 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.875 HG22 HG22 ' A' ' 199' ' ' VAL . 44.4 t -129.99 128.27 64.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.452 -0.374 . . . . 0.0 109.998 178.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 18.2 m -107.74 157.34 18.2 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.479 0.657 . . . . 0.0 112.06 -179.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -101.67 113.44 26.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.253 179.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.57 HG21 HG21 ' A' ' 198' ' ' VAL . 22.9 m -135.48 163.3 35.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.682 0.754 . . . . 0.0 112.187 -178.468 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -90.06 155.86 46.93 Favored Pre-proline 0 CA--C 1.538 0.505 0 CA-C-N 114.944 -1.026 . . . . 0.0 110.335 179.133 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.581 ' O ' ' CB ' ' B' ' 702' ' ' LEU . 37.0 Cg_endo -65.91 -16.49 52.96 Favored 'Trans proline' 0 N--CA 1.502 1.984 0 C-N-CA 123.273 2.648 . . . . 0.0 113.995 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . 0.418 ' O ' ' CD1' ' A' ' 171' ' ' TRP . 51.4 p-10 -91.82 -6.14 52.2 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 119.733 -0.787 . . . . 0.0 111.848 -179.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.505 ' O ' HG12 ' A' ' 173' ' ' VAL . 96.7 mttt -75.24 80.84 2.35 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 119.92 -0.712 . . . . 0.0 110.234 178.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' TRP . . . . . 0.98 ' CZ3' ' H12' ' B' ' 701' ' ' BOC . 26.8 m0 -67.28 -11.56 57.84 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.003 -179.204 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.489 ' OE1' ' OE1' ' A' ' 175' ' ' GLU . 79.2 mm-40 -58.56 -29.9 66.74 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.456 -179.354 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . 0.768 HG13 HG13 ' A' ' 174' ' ' VAL . 10.6 p -60.73 -24.32 31.78 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -178.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.969 HG11 HG11 ' A' ' 110' ' ' VAL . 35.1 m -104.49 -8.55 9.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 120.086 -0.646 . . . . 0.0 112.04 -178.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.489 ' OE1' ' OE1' ' A' ' 172' ' ' GLU . 98.0 mt-10 -74.36 134.86 42.48 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 178.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . 0.489 ' OD1' ' O ' ' A' ' 176' ' ' ASP . 43.3 p-10 -66.17 130.9 44.83 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 121.098 0.475 . . . . 0.0 111.024 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 76.7 m80 -98.3 -13.63 20.64 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -179.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 100.11 34.78 4.72 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 -178.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -148.81 161.84 41.0 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.83 -0.685 . . . . 0.0 110.225 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -87.64 90.76 8.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.885 0.374 . . . . 0.0 110.087 178.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . 0.455 ' HG2' ' N ' ' A' ' 182' ' ' ILE . 79.1 tt0 -126.81 163.35 23.78 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.817 0.818 . . . . 0.0 111.811 -178.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.476 HG22 ' O ' ' A' ' 201' ' ' GLY . 17.9 tt -131.11 137.66 55.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.135 178.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . 0.745 HG21 ' CG2' ' A' ' 173' ' ' VAL . 88.8 m -131.74 126.32 34.17 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.329 0.585 . . . . 0.0 111.353 179.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 84.0 mt -111.17 132.38 54.36 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.463 178.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.462 HD13 HD11 ' B' ' 702' ' ' LEU . 77.6 mt -110.14 126.85 67.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.429 0.633 . . . . 0.0 110.725 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 4.7 t -140.15 155.76 46.82 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.981 -1.009 . . . . 0.0 109.835 179.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' CYS . . . . . . . . . . . . . 4.0 m -91.9 148.89 21.87 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.546 -0.462 . . . . 0.0 110.652 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 195' ' ' LYS . 77.8 t -61.32 -47.57 92.86 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 CA-C-O 121.058 0.456 . . . . 0.0 110.874 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 92.4 p -163.68 162.22 24.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.313 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . 0.502 HG13 ' HG3' ' A' ' 191' ' ' LYS . 9.8 p -69.8 -12.94 16.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.12 0.486 . . . . 0.0 110.469 179.425 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.502 ' HG3' HG13 ' A' ' 190' ' ' VAL . 98.3 mttt -108.06 -31.39 7.97 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.132 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -98.94 107.37 19.79 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.393 0.616 . . . . 0.0 111.244 -179.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -110.63 12.11 22.72 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.364 179.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 20.4 t -59.53 -47.07 86.97 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.359 -0.382 . . . . 0.0 112.028 -178.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . 0.423 ' O ' HG23 ' A' ' 188' ' ' VAL . 25.4 pttm -147.39 159.19 43.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.178 0.513 . . . . 0.0 111.332 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . 0.491 ' NE ' ' SG ' ' B' ' 705' ' ' B27 . 83.6 mtt85 -123.53 143.97 49.85 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.407 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 56.2 m-85 -90.95 152.24 20.78 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.56 179.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.57 HG21 HG21 ' A' ' 166' ' ' VAL . 13.6 t -129.11 129.24 67.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.436 178.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.875 HG22 HG22 ' A' ' 163' ' ' VAL . 76.4 t -104.47 132.34 51.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.383 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -118.79 140.55 49.77 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.369 0.604 . . . . 0.0 111.207 -179.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . 0.476 ' O ' HG22 ' A' ' 182' ' ' ILE . . . -133.5 141.8 13.21 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 179.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . 0.532 ' OD1' ' N ' ' A' ' 203' ' ' LEU . 65.3 t0 -106.92 139.5 41.22 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.851 0.358 . . . . 0.0 110.164 -179.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . 0.532 ' N ' ' OD1' ' A' ' 202' ' ' ASP . 45.7 tp -64.98 131.34 46.35 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.529 HG22 ' O ' ' A' ' 157' ' ' GLU . 15.4 m -113.05 -20.39 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 C-N-CA 120.665 -0.414 . . . . 0.0 111.043 -178.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -175.57 171.59 44.66 Favored Glycine 0 CA--C 1.535 1.298 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.115 179.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . 0.431 HG23 ' CD1' ' A' ' 156' ' ' TYR . 11.4 m -142.98 136.33 28.37 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.596 -0.302 . . . . 0.0 110.328 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -143.44 121.29 11.97 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.452 0.644 . . . . 0.0 112.183 179.269 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -64.99 140.73 58.9 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.259 -0.882 . . . . 0.0 112.106 -179.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt -77.47 156.68 30.91 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.953 -1.021 . . . . 0.0 110.484 178.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 98.1 mttt . . . . . 0 C--O 1.22 -0.474 0 CA-C-O 117.934 -1.032 . . . . 0.0 110.682 179.786 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 701' ' ' BOC . . . . . 0.98 ' H12' ' CZ3' ' A' ' 171' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 702' ' ' LEU . . . . . 0.581 ' CB ' ' O ' ' A' ' 168' ' ' PRO . 0.0 OUTLIER -138.34 99.03 8.93 Favored Pre-proline 0 CA--C 1.545 0.778 0 C-N-CA 121.036 -0.266 . . . . 20.0 110.824 . . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 703' ' ' PRO . . . . . 0.641 ' HG2' HG22 ' A' ' 110' ' ' VAL . 3.3 Cg_exo -66.2 -173.74 0.36 Allowed 'Trans proline' 0 N--CA 1.493 1.5 0 C-N-CA 122.346 2.031 . . . . 20.0 112.603 179.392 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 704' ' ' ALA . . . . . 0.557 ' O ' ' OG1' ' B' ' 705' ' ' B27 . . . -40.04 -179.41 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 113.601 0.963 . . . . 20.0 113.601 -178.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 705' ' ' B27 . . . . . 0.557 ' OG1' ' O ' ' B' ' 704' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.316 0 N-CA-C 109.089 -1.605 . . . . 0.0 109.089 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 46.8 t -59.89 -43.88 94.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.228 0.537 . . . . 0.0 110.553 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -70.32 -39.02 75.01 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.12 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 97.1 mtp -81.42 146.02 30.49 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 121.196 0.522 . . . . 0.0 111.511 -179.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 85.3 m-20 -64.78 144.38 57.29 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.319 -179.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -97.44 5.96 48.92 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.868 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 86.6 p -86.21 10.33 14.92 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.315 0.579 . . . . 0.0 111.176 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -104.4 13.39 32.04 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.372 -179.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.2 mt -56.73 137.76 18.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 CA-C-O 122.157 0.98 . . . . 0.0 112.864 -177.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.477 ' O ' ' OD1' ' A' ' 62' ' ' ASP . 46.7 p-10 -79.49 129.87 34.87 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 113.975 -1.466 . . . . 0.0 109.162 178.107 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.667 ' NE2' ' ND1' ' A' ' 126' ' ' HIS . 0.0 OUTLIER -76.09 154.87 84.63 Favored Pre-proline 0 CA--C 1.535 0.38 0 CA-C-O 121.171 0.51 . . . . 0.0 110.302 -179.033 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -71.5 170.6 18.11 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.783 2.322 . . . . 0.0 112.975 -179.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.597 ' O ' HG23 ' A' ' 69' ' ' VAL . 28.1 t70 -52.81 159.35 1.14 Allowed 'General case' 0 C--N 1.334 -0.087 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.595 179.679 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 58.6 tp -63.31 -46.45 86.63 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 120.627 -0.429 . . . . 0.0 111.322 -178.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.94 -36.72 84.36 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 119.844 -0.742 . . . . 0.0 111.153 -178.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -58.29 -26.54 63.12 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 119.871 -0.732 . . . . 0.0 109.033 178.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.617 HG13 ' HB3' ' A' ' 104' ' ' LEU . 25.2 t -78.98 -44.94 24.64 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.529 178.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -73.07 -9.1 58.36 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.918 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -106.76 -14.62 14.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.276 0.56 . . . . 0.0 110.475 179.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -69.44 143.19 53.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.387 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 13.7 t -62.09 99.83 0.14 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.489 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.2 tt -69.7 134.74 48.99 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.274 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.596 ' OD2' ' NE2' ' A' ' 78' ' ' GLN . 84.8 m-20 -94.98 84.28 4.11 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 121.497 0.665 . . . . 0.0 110.244 178.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 48.7 tttp -63.19 -43.08 99.21 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.27 -0.877 . . . . 0.0 112.321 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.734 ' H ' ' CE ' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -70.34 -11.36 60.86 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.792 -0.64 . . . . 0.0 112.06 -177.068 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.596 ' NE2' ' OD2' ' A' ' 75' ' ' ASP . 77.8 mt-30 -92.06 -1.6 57.12 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.047 0.451 . . . . 0.0 110.324 179.088 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 58.1 t -76.64 127.14 37.81 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.244 179.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 29.2 pt -111.05 -1.79 10.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.65 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -175.99 179.47 47.09 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 120.502 -0.856 . . . . 0.0 111.48 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.566 ' NH1' ' OE2' ' A' ' 91' ' ' GLU . 73.1 ttp85 -141.19 153.76 45.49 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 120.919 0.39 . . . . 0.0 110.971 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.61 HG22 ' O ' ' A' ' 92' ' ' LEU . 18.1 tt -122.3 138.96 50.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-O 121.245 0.545 . . . . 0.0 110.317 179.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 10.3 t -137.75 130.85 30.41 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.199 0.524 . . . . 0.0 111.435 -179.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.548 HG12 HG23 ' A' ' 147' ' ' ILE . 54.3 mt -137.23 88.77 16.99 Favored Pre-proline 0 CA--C 1.541 0.604 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.987 -179.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -56.73 -31.11 86.9 Favored 'Trans proline' 0 N--CA 1.503 2.05 0 C-N-CA 123.086 2.524 . . . . 0.0 113.41 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 22.4 m -53.23 -42.27 66.22 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 121.207 0.527 . . . . 0.0 111.162 -179.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 12.7 m -115.77 8.28 7.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.44 0.638 . . . . 0.0 110.412 179.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.5 m 54.18 49.03 19.58 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.698 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 60.0 tp -112.15 131.49 55.43 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.384 0.611 . . . . 0.0 110.844 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.566 ' OE2' ' NH1' ' A' ' 82' ' ' ARG . 80.4 tt0 -149.16 126.22 11.32 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.944 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.61 ' O ' HG22 ' A' ' 83' ' ' ILE . 71.8 mt -152.24 151.98 28.54 Favored Pre-proline 0 CA--C 1.533 0.322 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.056 -179.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -74.73 147.02 34.58 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.361 2.041 . . . . 0.0 110.519 178.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 71.4 t -96.95 125.39 49.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 C-N-CA 120.434 -0.506 . . . . 0.0 110.855 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 9.5 mp -99.53 127.6 45.61 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.56 0.695 . . . . 0.0 111.472 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.514 ' O ' ' OG1' ' A' ' 109' ' ' THR . 87.5 tttt -63.71 -45.54 89.5 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 115.03 -0.986 . . . . 0.0 112.518 -178.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.447 ' HB3' HG23 ' A' ' 99' ' ' THR . 3.3 m -81.38 130.99 35.26 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.267 0.556 . . . . 0.0 111.267 -179.273 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 9.8 p -91.3 53.41 2.31 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.576 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.447 HG23 ' HB3' ' A' ' 97' ' ' SER . 81.2 p -88.44 166.77 14.0 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 178.576 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -64.13 -40.84 97.03 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.39 0.614 . . . . 0.0 110.453 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -63.95 -42.68 97.24 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.617 -179.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -65.7 -36.08 82.59 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.121 179.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.619 HD13 ' HB3' ' B' ' 704' ' ' ALA . 33.3 mt -61.52 -15.94 42.89 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.799 -179.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.617 ' HB3' HG13 ' A' ' 69' ' ' VAL . 88.7 mt -71.94 -20.03 61.82 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.271 0.558 . . . . 0.0 109.871 179.195 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 83.6 p -73.29 -0.98 16.11 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.876 -179.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.558 ' HA3' HD12 ' A' ' 134' ' ' LEU . . . 82.84 -18.59 15.03 Favored Glycine 0 CA--C 1.526 0.776 0 CA-C-N 116.069 -0.514 . . . . 0.0 112.387 178.52 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -145.26 123.91 12.53 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.527 0.68 . . . . 0.0 111.349 179.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -147.47 149.66 33.09 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.093 179.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.568 ' HA ' HD23 ' A' ' 123' ' ' LEU . 68.2 p -66.84 133.73 50.67 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.176 0.512 . . . . 0.0 110.561 -179.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.629 HG13 ' CD ' ' B' ' 703' ' ' PRO . 38.2 t -81.8 -62.0 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 C-N-CA 120.356 -0.538 . . . . 0.0 109.699 179.101 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.563 ' O ' ' NE2' ' A' ' 114' ' ' GLN . 85.5 tttt -94.17 133.95 37.14 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.818 179.38 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -66.37 -37.05 84.4 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -177.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -85.27 17.99 2.83 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 -178.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.563 ' NE2' ' O ' ' A' ' 111' ' ' LYS . 5.5 pt20 -76.87 139.77 40.37 Favored 'General case' 0 CA--C 1.534 0.332 0 O-C-N 121.958 -0.464 . . . . 0.0 110.76 179.27 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 94.3 t -129.27 121.53 53.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.925 0.393 . . . . 0.0 110.162 178.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . 0.588 ' SD ' ' OD1' ' A' ' 151' ' ' ASP . 56.1 mtt -58.06 134.34 56.34 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.173 0.511 . . . . 0.0 111.105 -179.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 78.52 -3.68 62.51 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 121.012 -0.613 . . . . 0.0 111.953 178.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -140.3 124.1 17.32 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.239 0.542 . . . . 0.0 110.759 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 76.04 -161.26 51.98 Favored Glycine 0 CA--C 1.531 1.081 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.368 179.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 63.2 t-20 -93.24 107.24 19.09 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.069 0.461 . . . . 0.0 110.977 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.487 ' CE2' HD21 ' A' ' 123' ' ' LEU . 20.2 t80 -85.56 145.34 27.41 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.084 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.666 ' CB ' HG13 ' A' ' 174' ' ' VAL . . . -146.73 139.03 24.85 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 119.986 -0.686 . . . . 0.0 112.042 -178.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.568 HD23 ' HA ' ' A' ' 109' ' ' THR . 72.4 mt -135.69 141.66 44.99 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.947 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -111.96 132.94 54.46 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 121.374 0.607 . . . . 0.0 109.852 178.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -134.74 152.13 20.61 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.667 ' ND1' ' NE2' ' A' ' 63' ' ' GLN . 40.9 m-70 -89.47 136.08 33.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.727 0.775 . . . . 0.0 112.339 -178.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -130.09 121.05 25.63 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.62 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.566 ' HB2' HG21 ' A' ' 133' ' ' VAL . 53.2 mtt -94.86 -1.46 52.67 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 121.407 0.623 . . . . 0.0 110.212 179.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.439 ' CB ' ' O ' ' A' ' 128' ' ' MET . 0.9 OUTLIER 77.78 4.57 2.95 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 115.421 -0.809 . . . . 0.0 112.071 178.665 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.873 ' O ' HG12 ' A' ' 133' ' ' VAL . 62.4 pttt -119.65 125.7 49.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.994 0.902 . . . . 0.0 113.118 -178.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.528 ' O ' ' O ' ' A' ' 130' ' ' LYS . 0.0 OUTLIER -35.23 159.73 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.455 179.062 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 74.0 -19.66 1.65 Allowed Glycine 0 CA--C 1.534 1.264 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.873 HG12 ' O ' ' A' ' 130' ' ' LYS . 4.7 p -90.09 173.42 0.88 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 119.587 -0.845 . . . . 0.0 111.094 -179.394 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.661 ' H ' HG22 ' A' ' 133' ' ' VAL . 4.3 mm? -66.81 130.05 41.89 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 -175.531 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.534 ' CD2' HD12 ' A' ' 138' ' ' ILE . 3.8 m-30 60.98 18.28 8.74 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 114.164 -1.38 . . . . 0.0 112.545 178.488 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.37 -37.23 84.92 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 113.005 0.742 . . . . 0.0 113.005 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 31.7 p-10 -94.6 6.25 49.42 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.974 0.416 . . . . 0.0 111.88 -178.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.534 HD12 ' CD2' ' A' ' 135' ' ' PHE . 3.6 tt -63.97 -37.9 80.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 C-N-CA 120.553 -0.459 . . . . 0.0 111.786 -179.443 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -67.8 -10.67 54.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.803 0.335 . . . . 0.0 111.352 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 33.1 m -80.93 -4.98 56.85 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.036 0.446 . . . . 0.0 110.505 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 80.1 mt -63.91 139.52 58.78 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.037 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.402 ' HG2' ' N ' ' A' ' 143' ' ' LYS . 88.6 tttt -115.9 156.76 25.59 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 121.478 0.656 . . . . 0.0 112.097 -178.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . 0.402 ' N ' ' HG2' ' A' ' 142' ' ' LYS . 88.0 tttt -48.87 130.57 18.17 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.341 -0.845 . . . . 0.0 112.647 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.603 ' N ' ' O ' ' A' ' 160' ' ' VAL . . . 78.37 7.67 87.8 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.972 178.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -71.97 137.93 47.66 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 119.567 -0.853 . . . . 0.0 110.268 -179.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -80.76 142.06 34.16 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 122.016 0.912 . . . . 0.0 113.021 -177.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.548 HG23 HG12 ' A' ' 85' ' ' ILE . 91.6 mt -138.66 139.11 41.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 114.361 -1.291 . . . . 0.0 108.791 178.233 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . 0.596 ' C ' HD22 ' A' ' 149' ' ' LEU . 94.0 m-85 -116.68 138.36 51.51 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 122.033 0.92 . . . . 0.0 112.821 -178.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.596 HD22 ' C ' ' A' ' 148' ' ' TYR . 4.5 mm? -117.03 137.73 52.05 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 114.112 -1.404 . . . . 0.0 108.484 178.347 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -126.56 112.06 15.09 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 119.978 -0.689 . . . . 0.0 112.418 -178.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . 0.588 ' OD1' ' SD ' ' A' ' 116' ' ' MET . 20.7 m-20 -89.63 164.72 14.62 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 176.465 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 53.4 t30 -56.66 -23.5 42.12 Favored 'General case' 0 C--N 1.31 -1.118 0 C-N-CA 119.893 -0.723 . . . . 0.0 111.124 -178.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -111.0 -29.44 7.9 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 113.38 0.882 . . . . 0.0 113.38 -178.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . 0.455 ' O ' ' N ' ' A' ' 151' ' ' ASP . 0.4 OUTLIER -145.98 177.77 8.7 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 119.644 -0.822 . . . . 0.0 112.74 -176.949 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -134.32 145.8 49.38 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.099 178.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . 0.492 ' CD2' HG23 ' A' ' 206' ' ' THR . 48.3 m-85 -120.12 139.29 52.81 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 121.201 0.524 . . . . 0.0 111.486 -178.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -93.75 114.69 27.02 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.158 179.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -115.07 149.48 37.44 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.226 0.536 . . . . 0.0 111.934 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.454 ' HB2' HG21 ' A' ' 204' ' ' VAL . . . -122.86 122.17 38.0 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.617 179.159 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.603 ' O ' ' N ' ' A' ' 144' ' ' GLY . 86.2 t -60.37 138.62 21.04 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.218 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 177.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 20.3 p -107.22 -23.28 12.31 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.671 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 159.84 -167.63 35.37 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 120.28 -0.962 . . . . 0.0 112.033 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.934 HG22 HG22 ' A' ' 199' ' ' VAL . 42.3 t -127.4 137.57 57.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-N 115.124 -0.538 . . . . 0.0 109.74 179.453 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 57.9 m -123.78 157.38 34.18 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 121.317 0.58 . . . . 0.0 111.474 -178.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 28.2 mp0 -104.63 113.43 27.01 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 121.553 0.692 . . . . 0.0 110.705 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 27.6 m -139.49 163.93 24.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.234 -179.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . 0.44 ' H ' ' HD2' ' A' ' 170' ' ' LYS . 0.2 OUTLIER -91.56 159.91 37.74 Favored Pre-proline 0 CA--C 1.538 0.484 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.694 178.513 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.488 ' O ' ' CB ' ' B' ' 702' ' ' LEU . 35.6 Cg_endo -65.52 -15.76 50.97 Favored 'Trans proline' 0 N--CA 1.5 1.883 0 C-N-CA 122.874 2.383 . . . . 0.0 113.885 -179.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 44.1 p-10 -91.86 -7.21 50.0 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 119.466 -0.893 . . . . 0.0 111.544 179.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.722 ' O ' HG22 ' A' ' 173' ' ' VAL . 96.7 mttt -75.64 83.11 2.65 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.808 0.813 . . . . 0.0 111.723 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 33.2 t90 -71.13 -11.31 60.87 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.636 -1.165 . . . . 0.0 110.47 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -61.57 -35.08 76.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.674 -179.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . 0.722 HG22 ' O ' ' A' ' 170' ' ' LYS . 32.7 m -63.51 -14.03 13.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.427 -179.183 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.666 HG13 ' CB ' ' A' ' 122' ' ' ALA . 12.2 t -110.58 -5.85 11.25 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -179.104 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.499 ' O ' ' CE1' ' A' ' 177' ' ' HIS . 94.9 mt-10 -72.36 149.12 44.64 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.345 0.593 . . . . 0.0 110.88 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . 0.52 ' OD1' ' O ' ' A' ' 176' ' ' ASP . 51.9 p-10 -67.61 128.42 36.38 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.611 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' HIS . . . . . 0.499 ' CE1' ' O ' ' A' ' 175' ' ' GLU . 76.6 m80 -110.23 22.02 16.04 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.509 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 59.94 37.45 92.65 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 110.771 -0.932 . . . . 0.0 110.771 179.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 18.3 ptmt -146.22 158.7 43.9 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -88.74 91.67 8.91 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.292 177.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -129.56 172.47 11.54 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.478 0.656 . . . . 0.0 111.259 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 18.6 tt -134.44 144.29 35.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.436 178.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 84.7 m -131.48 126.55 35.28 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.522 0.677 . . . . 0.0 111.572 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 86.1 mt -109.4 131.47 55.03 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.488 HD13 ' CD2' ' B' ' 702' ' ' LEU . 85.0 mt -112.87 124.19 69.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.498 0.666 . . . . 0.0 111.31 -178.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 3.9 t -137.81 153.04 49.69 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.831 179.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' CYS . . . . . . . . . . . . . 3.3 m -88.5 139.36 30.56 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.039 0.447 . . . . 0.0 110.945 -179.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.525 HG13 ' N ' ' A' ' 189' ' ' SER . 10.9 p -65.13 -44.54 95.51 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.099 -179.426 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . 0.525 ' N ' HG13 ' A' ' 188' ' ' VAL . 80.9 p -164.54 157.57 17.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.076 0.465 . . . . 0.0 110.795 179.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . 0.428 HG22 ' O ' ' A' ' 190' ' ' VAL . 11.4 p -81.93 -9.96 11.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.034 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -96.4 -9.97 28.71 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.284 0.564 . . . . 0.0 110.688 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -142.89 101.43 3.84 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.633 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 53.3 p-10 -102.21 10.39 39.36 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.247 0.546 . . . . 0.0 110.439 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 39.1 t -61.4 -46.16 91.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.277 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 64.4 pttt -144.86 150.95 37.97 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.453 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . 0.847 ' NH2' HD22 ' B' ' 702' ' ' LEU . 21.8 ptt180 -137.96 158.16 44.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.219 0.533 . . . . 0.0 111.165 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -91.75 141.35 28.78 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.839 -0.618 . . . . 0.0 111.561 -179.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 42.0 t -118.94 132.08 69.86 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.01 178.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.934 HG22 HG22 ' A' ' 163' ' ' VAL . 84.9 t -100.0 132.32 45.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.503 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -118.01 144.27 45.69 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.399 0.618 . . . . 0.0 110.996 -178.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -140.22 163.43 26.36 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 110.284 -1.127 . . . . 0.0 110.284 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . 0.57 ' OD1' ' N ' ' A' ' 203' ' ' LEU . 67.6 t0 -122.22 139.4 53.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.017 0.437 . . . . 0.0 111.888 -178.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . 0.57 ' N ' ' OD1' ' A' ' 202' ' ' ASP . 46.5 tp -62.78 131.54 49.2 Favored 'General case' 0 CA--C 1.52 -0.207 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.454 HG21 ' HB2' ' A' ' 159' ' ' ALA . 57.4 t -110.51 -20.72 6.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 C-N-CA 120.355 -0.538 . . . . 0.0 111.648 -178.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -178.03 174.21 46.6 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 120.546 -0.835 . . . . 0.0 111.486 -179.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . 0.492 HG23 ' CD2' ' A' ' 156' ' ' TYR . 24.5 m -146.24 138.2 24.99 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.319 -0.441 . . . . 0.0 110.296 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -145.81 124.19 12.34 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.2 0.524 . . . . 0.0 110.943 178.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -65.86 147.98 52.51 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.78 0.8 . . . . 0.0 112.08 -179.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 10.1 ttmt -77.43 159.13 29.65 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.704 -1.135 . . . . 0.0 110.495 179.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 98.2 mttt . . . . . 0 C--O 1.219 -0.551 0 CA-C-O 118.089 -0.958 . . . . 0.0 110.562 179.429 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 701' ' ' BOC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 702' ' ' LEU . . . . . 0.847 HD22 ' NH2' ' A' ' 196' ' ' ARG . 2.3 mt -42.93 108.85 0.69 Allowed Pre-proline 0 CA--C 1.541 0.599 0 C-N-CA 120.618 -0.433 . . . . 20.0 110.449 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 703' ' ' PRO . . . . . 0.629 ' CD ' HG13 ' A' ' 110' ' ' VAL . 2.5 Cg_endo -62.1 -173.09 0.12 Allowed 'Trans proline' 0 N--CA 1.489 1.232 0 C-N-CA 121.978 1.786 . . . . 20.0 113.061 -178.573 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 704' ' ' ALA . . . . . 0.619 ' HB3' HD13 ' A' ' 103' ' ' LEU . . . -41.7 -172.17 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 114.249 -1.342 . . . . 20.0 113.119 -179.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 705' ' ' B27 . . . . . 0.493 ' OG1' ' O ' ' B' ' 704' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.158 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 35.5 p -161.31 155.62 22.8 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.207 0.527 . . . . 0.0 110.325 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -122.16 150.69 41.87 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.797 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 61.4 mtt -91.81 130.76 37.52 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.656 -179.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.418 ' OD1' ' N ' ' A' ' 58' ' ' ALA . 61.6 t0 -62.46 131.67 49.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.894 179.308 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.418 ' N ' ' OD1' ' A' ' 57' ' ' ASP . . . -89.02 13.19 13.51 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.896 -178.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.408 ' OG ' ' CG ' ' A' ' 57' ' ' ASP . 29.5 p -84.73 11.15 9.57 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.346 0.498 . . . . 0.0 112.346 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -94.14 8.01 43.15 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.832 -0.347 . . . . 0.0 111.217 -179.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.5 mt -56.36 132.8 20.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 122.254 1.026 . . . . 0.0 113.689 -176.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -76.47 133.96 39.67 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 113.637 -1.62 . . . . 0.0 109.261 178.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.524 ' CD ' ' CG ' ' A' ' 126' ' ' HIS . 6.6 mm-40 -79.03 149.19 73.05 Favored Pre-proline 0 CA--C 1.537 0.47 0 CA-C-O 121.086 0.469 . . . . 0.0 111.895 -178.369 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -73.6 168.04 25.76 Favored 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 123.177 2.585 . . . . 0.0 112.173 179.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -55.1 167.36 0.43 Allowed 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 121.179 0.514 . . . . 0.0 111.481 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.483 ' N ' HD22 ' A' ' 66' ' ' LEU . 4.3 mm? -64.29 -42.67 96.3 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.296 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.78 -35.37 74.5 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.65 -0.42 . . . . 0.0 111.517 -177.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -61.37 -29.76 70.11 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.763 0.792 . . . . 0.0 109.655 179.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.679 HG13 ' HB3' ' A' ' 104' ' ' LEU . 23.0 t -75.01 -43.77 44.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.001 -0.999 . . . . 0.0 109.952 179.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -76.73 -9.44 58.67 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 114.948 -1.023 . . . . 0.0 111.228 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -113.17 -1.31 14.39 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.296 0.57 . . . . 0.0 110.233 178.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.43 -165.77 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.097 -179.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 69.6 p -103.72 106.51 17.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.712 178.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.594 HD13 ' C ' ' A' ' 74' ' ' LEU . 2.1 tm? -71.94 118.04 14.3 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.838 0.351 . . . . 0.0 110.836 -179.385 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.555 ' N ' HD13 ' A' ' 74' ' ' LEU . 96.4 m-20 -104.21 77.22 1.4 Allowed 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 121.459 0.647 . . . . 0.0 109.984 179.138 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -69.19 -39.22 78.81 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.261 -0.881 . . . . 0.0 113.019 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.43 ' HG2' ' H ' ' A' ' 77' ' ' LYS . 42.4 mmtt -70.3 -15.24 62.86 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.193 -175.207 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -91.18 -4.47 56.07 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.062 0.458 . . . . 0.0 110.931 179.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 78.0 t -80.43 128.04 38.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.068 0.461 . . . . 0.0 110.161 179.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.657 HD13 ' CE ' ' A' ' 96' ' ' LYS . 18.4 pt -111.66 -6.21 11.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.862 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -175.3 179.16 46.71 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 110.799 -0.92 . . . . 0.0 110.799 179.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 39.1 ptt180 -152.8 154.94 36.18 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.44 0.638 . . . . 0.0 111.3 179.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 17.0 tt -104.61 144.37 14.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.608 -179.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 33.1 t -135.71 127.72 29.65 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.61 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.716 HG12 HG23 ' A' ' 147' ' ' ILE . 53.0 mt -135.44 89.68 22.1 Favored Pre-proline 0 CA--C 1.537 0.456 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.403 -179.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -55.18 -33.38 84.04 Favored 'Trans proline' 0 N--CA 1.501 1.936 0 C-N-CA 123.165 2.577 . . . . 0.0 113.699 -179.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 74.1 m -52.9 -38.73 62.07 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 120.962 0.411 . . . . 0.0 111.08 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.471 HG22 ' CG2' ' A' ' 85' ' ' ILE . 33.1 m -117.78 13.37 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.292 179.387 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.8 m 49.17 49.52 19.47 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.476 -0.49 . . . . 0.0 110.457 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 62.9 tp -112.94 132.46 55.33 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.325 0.583 . . . . 0.0 110.822 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -146.19 122.03 10.61 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.743 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.661 HD13 ' HA3' ' A' ' 106' ' ' GLY . 94.4 mt -149.17 150.68 32.5 Favored Pre-proline 0 CA--C 1.54 0.588 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.065 -179.171 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -76.25 151.95 34.57 Favored 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 122.695 2.263 . . . . 0.0 112.295 179.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.49 ' C ' HD12 ' A' ' 95' ' ' LEU . 98.6 t -96.83 114.65 34.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.855 0.359 . . . . 0.0 110.502 179.255 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.569 ' N ' HD12 ' A' ' 95' ' ' LEU . 10.3 mp -100.64 139.03 36.9 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.1 0.476 . . . . 0.0 111.472 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.657 ' CE ' HD13 ' A' ' 80' ' ' ILE . 98.9 mttt -66.44 -83.44 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 121.284 0.564 . . . . 0.0 112.019 -179.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 17.7 m -60.79 132.52 54.13 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.664 -179.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 43.6 t -88.28 74.43 8.71 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.371 0.605 . . . . 0.0 109.874 179.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.404 ' OG1' ' CG ' ' A' ' 102' ' ' ASN . 57.1 p -88.79 169.86 11.26 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.802 179.029 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -62.68 -44.34 96.51 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 120.23 -0.588 . . . . 0.0 109.952 179.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -66.61 -40.97 89.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.395 179.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.404 ' CG ' ' OG1' ' A' ' 99' ' ' THR . 95.0 m-20 -64.34 -35.71 81.76 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.816 -179.523 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 34.2 mt -60.49 -26.06 66.52 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.192 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.679 ' HB3' HG13 ' A' ' 69' ' ' VAL . 92.6 mt -72.74 -18.7 61.49 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.297 -179.102 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.478 ' O ' HD22 ' A' ' 92' ' ' LEU . 99.5 p -74.07 -8.25 55.48 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 121.33 0.586 . . . . 0.0 110.085 179.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.661 ' HA3' HD13 ' A' ' 92' ' ' LEU . . . 92.74 -19.57 50.5 Favored Glycine 0 CA--C 1.53 1.016 0 CA-C-N 115.721 -0.672 . . . . 0.0 114.003 177.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -145.03 127.01 15.5 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 119.556 -0.858 . . . . 0.0 111.701 -179.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -144.04 138.81 28.6 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.658 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.62 ' HA ' HD23 ' A' ' 123' ' ' LEU . 64.5 p -73.84 135.01 43.4 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.138 0.494 . . . . 0.0 110.336 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.592 ' N ' HE22 ' A' ' 114' ' ' GLN . 77.8 t -78.97 -54.89 10.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.066 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.759 ' H ' ' NE2' ' A' ' 114' ' ' GLN . 97.5 mttt -102.15 137.43 40.43 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 122.36 1.076 . . . . 0.0 112.573 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -64.34 -29.54 70.61 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.396 -1.274 . . . . 0.0 112.491 -177.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 73.4 m-80 -84.07 17.15 2.56 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 113.669 0.988 . . . . 0.0 113.669 -178.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.759 ' NE2' ' H ' ' A' ' 111' ' ' LYS . 50.1 mt-30 -78.48 134.77 37.29 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 121.966 -0.459 . . . . 0.0 111.672 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 96.3 t -124.85 119.95 57.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-O 120.993 0.425 . . . . 0.0 110.387 178.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 64.8 mtt -55.6 131.62 46.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.273 0.558 . . . . 0.0 111.488 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 84.77 -6.18 79.2 Favored Glycine 0 CA--C 1.533 1.199 0 CA-C-N 115.597 -0.728 . . . . 0.0 112.231 179.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -143.6 136.75 27.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.333 0.587 . . . . 0.0 112.068 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 75.03 -172.94 53.09 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.672 -0.971 . . . . 0.0 110.672 179.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.47 HD22 ' CE1' ' A' ' 177' ' ' HIS . 52.3 t-20 -89.04 103.24 15.87 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.455 -0.498 . . . . 0.0 110.081 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.569 ' HE2' HD21 ' A' ' 123' ' ' LEU . 7.4 t80 -85.63 99.07 11.04 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-O 121.065 0.46 . . . . 0.0 109.773 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.583 ' HB1' HG12 ' A' ' 174' ' ' VAL . . . -91.54 136.12 33.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.982 -179.202 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.62 HD23 ' HA ' ' A' ' 109' ' ' THR . 74.6 mt -137.55 140.17 40.88 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 120.914 0.388 . . . . 0.0 111.099 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -108.43 146.23 33.41 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 178.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . 0.456 ' O ' ' CG2' ' B' ' 705' ' ' B27 . . . -148.09 156.75 27.06 Favored Glycine 0 CA--C 1.522 0.525 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 -179.524 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.535 ' O ' ' O ' ' A' ' 134' ' ' LEU . 77.9 m-70 -110.56 130.31 55.59 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 113.453 0.908 . . . . 0.0 113.453 -178.239 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.591 ' ND2' ' O ' ' A' ' 127' ' ' ASN . 0.0 OUTLIER -134.65 121.93 21.55 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.78 177.712 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.545 ' H ' HG21 ' A' ' 133' ' ' VAL . 65.0 mtt -83.83 8.19 15.61 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.057 0.456 . . . . 0.0 110.791 -179.404 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.488 ' CB ' ' O ' ' A' ' 128' ' ' MET . 0.7 OUTLIER 79.0 12.92 1.27 Allowed 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.452 179.118 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.877 ' O ' HG12 ' A' ' 133' ' ' VAL . 23.1 pttp -116.91 126.3 52.76 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 122.241 1.02 . . . . 0.0 112.68 -179.328 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 27.6 tptt -46.24 121.61 3.45 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.538 -1.21 . . . . 0.0 110.082 179.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 113.88 -15.14 21.56 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.563 -1.015 . . . . 0.0 110.563 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.877 HG12 ' O ' ' A' ' 130' ' ' LYS . 11.1 p -91.44 166.04 1.85 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.732 HD23 ' N ' ' A' ' 134' ' ' LEU . 0.3 OUTLIER -72.75 138.2 46.36 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 122.384 1.087 . . . . 0.0 113.821 -176.239 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 62.14 9.69 3.31 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 113.67 -1.604 . . . . 0.0 114.643 177.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 4.3 p -70.4 -31.96 69.39 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 121.486 -0.759 . . . . 0.0 113.028 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -88.82 8.57 28.39 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 -177.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.454 ' CD1' ' OG1' ' A' ' 186' ' ' THR . 18.2 pt -68.7 -31.46 50.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 121.602 0.715 . . . . 0.0 110.476 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -61.98 -20.81 64.26 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.639 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 57.7 m -79.78 -3.41 47.52 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.172 -179.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 99.5 mt -65.78 145.6 55.78 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 121.071 0.462 . . . . 0.0 110.198 179.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 53.6 mttp -120.67 154.5 35.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.515 0.674 . . . . 0.0 111.254 -179.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -49.97 131.86 22.84 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.41 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.483 ' N ' ' O ' ' A' ' 160' ' ' VAL . . . 80.71 8.23 87.72 Favored Glycine 0 CA--C 1.533 1.217 0 C-N-CA 120.682 -0.77 . . . . 0.0 111.72 179.297 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.458 ' OD1' ' N ' ' A' ' 146' ' ' LYS . 56.6 t0 -71.17 130.04 40.45 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 120.042 -0.663 . . . . 0.0 110.304 -179.513 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.458 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 74.5 mmtt -77.81 142.85 38.33 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.8 0.809 . . . . 0.0 112.263 -178.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.716 HG23 HG12 ' A' ' 85' ' ' ILE . 80.5 mt -142.64 143.44 25.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 114.562 -1.199 . . . . 0.0 108.656 178.305 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -126.04 139.96 52.98 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 119.599 -0.84 . . . . 0.0 112.563 -178.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 2.9 mt -110.5 134.12 52.66 Favored 'General case' 0 C--O 1.223 -0.334 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 177.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.553 ' CZ ' ' CD ' ' A' ' 155' ' ' GLU . 33.3 m-85 -110.25 107.68 17.53 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.303 -0.559 . . . . 0.0 112.078 -179.207 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . 0.477 ' OD1' ' N ' ' A' ' 152' ' ' ASN . 54.5 t0 -88.94 162.37 16.13 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 177.449 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . 0.477 ' N ' ' OD1' ' A' ' 151' ' ' ASP . 44.9 p-10 -58.27 -18.55 27.53 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 119.422 -0.911 . . . . 0.0 111.358 -178.215 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.401 ' HB2' ' ND2' ' A' ' 154' ' ' ASN . 96.1 mt-10 -113.77 -28.14 7.54 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -178.484 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . 0.438 ' ND2' ' N ' ' A' ' 154' ' ' ASN . 0.4 OUTLIER -148.58 -175.12 4.8 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 122.134 0.969 . . . . 0.0 113.477 -176.779 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.553 ' CD ' ' CZ ' ' A' ' 150' ' ' TYR . 82.5 tt0 -134.79 140.88 46.22 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 114.153 -1.385 . . . . 0.0 109.939 178.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . 0.469 ' CD1' HG23 ' A' ' 206' ' ' THR . 89.9 m-85 -115.45 137.95 51.52 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -179.05 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . 0.543 ' O ' HG12 ' A' ' 204' ' ' VAL . 91.2 mt-10 -93.42 109.27 20.85 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.854 179.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.404 ' CE2' ' HB2' ' A' ' 203' ' ' LEU . 38.1 m-85 -113.27 147.51 37.42 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.08 0.467 . . . . 0.0 111.349 178.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -122.02 121.55 37.27 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.262 0.553 . . . . 0.0 111.567 179.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.483 ' O ' ' N ' ' A' ' 144' ' ' GLY . 52.1 t -59.86 136.31 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.258 178.206 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 22.5 p -105.68 -24.83 12.45 Favored 'General case' 0 CA--C 1.533 0.316 0 O-C-N 123.535 0.522 . . . . 0.0 111.623 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 159.3 -169.08 35.39 Favored Glycine 0 CA--C 1.529 0.949 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.428 HG22 ' N ' ' A' ' 164' ' ' SER . 3.6 p -136.35 155.92 35.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . 0.428 ' N ' HG22 ' A' ' 163' ' ' VAL . 68.3 m -146.1 167.51 23.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.353 0.597 . . . . 0.0 111.764 -179.216 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -103.14 119.1 38.24 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.119 179.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.447 HG21 HG21 ' A' ' 198' ' ' VAL . 21.0 m -136.3 158.45 38.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.452 0.644 . . . . 0.0 111.859 -178.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . 0.425 ' H ' ' HD2' ' A' ' 170' ' ' LYS . 0.3 OUTLIER -86.52 158.61 54.21 Favored Pre-proline 0 CA--C 1.537 0.48 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.111 -179.634 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.538 ' O ' ' CB ' ' B' ' 702' ' ' LEU . 32.6 Cg_endo -66.31 -18.7 55.8 Favored 'Trans proline' 0 N--CA 1.498 1.792 0 C-N-CA 123.471 2.781 . . . . 0.0 113.425 -179.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 44.0 p-10 -92.88 -3.14 55.13 Favored 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 119.878 -0.729 . . . . 0.0 112.187 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.595 ' O ' HG22 ' A' ' 173' ' ' VAL . 93.6 mttt -76.74 97.29 4.44 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.466 0.65 . . . . 0.0 112.175 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' TRP . . . . . 0.458 ' CH2' ' C ' ' B' ' 701' ' ' BOC . 95.9 m95 -66.84 -33.62 76.01 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.254 -0.884 . . . . 0.0 110.277 178.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -44.27 -36.28 2.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.071 -0.968 . . . . 0.0 112.885 -178.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . 0.732 HG23 HG13 ' A' ' 174' ' ' VAL . 16.1 m -63.37 -26.04 39.87 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 120.376 -0.53 . . . . 0.0 112.064 -179.104 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.732 HG13 HG23 ' A' ' 173' ' ' VAL . 25.6 m -108.79 -7.8 11.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 120.306 -0.558 . . . . 0.0 112.466 -179.364 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -75.02 153.64 38.38 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.143 0.497 . . . . 0.0 111.502 179.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . 0.412 ' O ' ' OD1' ' A' ' 176' ' ' ASP . 48.8 p-10 -64.61 138.07 58.19 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.123 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' HIS . . . . . 0.47 ' CE1' HD22 ' A' ' 120' ' ' ASN . 70.1 m80 -112.83 14.9 19.93 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.416 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 72.12 34.37 61.52 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 120.851 -0.69 . . . . 0.0 111.547 179.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 42.8 pttt -166.33 178.84 5.95 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.629 0.728 . . . . 0.0 111.722 179.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' A' ' 180' ' ' ASP . 18.3 p30 -89.77 92.99 9.27 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.835 179.201 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . 0.426 ' HG2' ' N ' ' A' ' 182' ' ' ILE . 84.3 tt0 -124.85 161.32 26.78 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.411 0.624 . . . . 0.0 111.566 -179.485 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.49 HG22 ' O ' ' A' ' 201' ' ' GLY . 20.5 tt -129.09 135.95 60.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 178.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . 0.614 ' C ' HD12 ' A' ' 184' ' ' LEU . 80.4 m -130.26 126.07 36.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.707 0.765 . . . . 0.0 112.203 -178.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.614 HD12 ' C ' ' A' ' 183' ' ' THR . 10.5 mp -109.66 131.87 54.67 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.817 -1.083 . . . . 0.0 109.164 178.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.732 HD13 HD21 ' B' ' 702' ' ' LEU . 96.8 mt -113.67 122.63 68.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 121.454 0.645 . . . . 0.0 111.288 -179.185 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . 0.454 ' OG1' ' CD1' ' A' ' 138' ' ' ILE . 4.7 m -140.86 153.16 45.62 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.827 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' CYS . . . . . 0.678 ' N ' ' SG ' ' B' ' 705' ' ' B27 . 86.4 m -87.03 153.92 21.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.269 179.229 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.716 HG23 ' O ' ' A' ' 195' ' ' LYS . 65.8 t -61.04 -48.87 87.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.278 0.561 . . . . 0.0 110.842 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 16.5 t -168.06 151.25 5.79 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.791 179.081 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . 0.445 HG13 ' HG3' ' A' ' 191' ' ' LYS . 7.5 p -62.01 -20.69 24.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.38 0.609 . . . . 0.0 109.919 179.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.445 ' HG3' HG13 ' A' ' 190' ' ' VAL . 60.4 mttp -94.65 -12.13 27.94 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.047 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -138.09 103.11 4.86 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.767 179.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -104.68 11.94 33.47 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.549 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 21.3 m -63.57 -36.81 85.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.946 -179.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . 0.716 ' O ' HG23 ' A' ' 188' ' ' VAL . 57.1 mtmt -135.13 156.95 48.13 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.075 0.464 . . . . 0.0 111.709 -178.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . 0.466 ' NH1' ' HX ' ' B' ' 705' ' ' B27 . 96.7 mtt180 -128.63 139.28 52.34 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.433 -179.417 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . 0.463 ' CE2' HG22 ' A' ' 188' ' ' VAL . 45.6 m-85 -94.62 144.5 25.55 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.246 0.546 . . . . 0.0 112.086 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.447 HG21 HG21 ' A' ' 166' ' ' VAL . 41.6 t -131.79 131.16 62.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.041 178.12 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 53.5 t -105.29 132.83 51.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.432 179.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -116.44 141.82 47.68 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.307 0.575 . . . . 0.0 110.836 -179.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . 0.49 ' O ' HG22 ' A' ' 182' ' ' ILE . . . -143.57 145.8 15.89 Favored Glycine 0 CA--C 1.528 0.903 0 N-CA-C 110.64 -0.984 . . . . 0.0 110.64 179.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -107.03 149.36 27.65 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.027 0.441 . . . . 0.0 110.594 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . 0.436 HD12 ' O ' ' A' ' 157' ' ' GLU . 49.2 tp -70.29 131.61 44.44 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 179.245 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.543 HG12 ' O ' ' A' ' 157' ' ' GLU . 7.6 p -114.05 -20.27 6.19 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 C-N-CA 120.442 -0.503 . . . . 0.0 111.767 -179.399 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -174.49 172.36 45.32 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 120.711 -0.757 . . . . 0.0 111.722 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . 0.469 HG23 ' CD1' ' A' ' 156' ' ' TYR . 17.5 m -142.96 136.13 28.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.44 -0.38 . . . . 0.0 110.21 -179.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -144.52 120.62 10.77 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.284 0.564 . . . . 0.0 111.745 179.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -62.06 137.35 58.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.465 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -81.22 160.95 24.17 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.099 178.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 25.3 pttm . . . . . 0 C--O 1.22 -0.464 0 CA-C-O 118.188 -0.911 . . . . 0.0 110.869 -179.693 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 701' ' ' BOC . . . . . 0.458 ' C ' ' CH2' ' A' ' 171' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 702' ' ' LEU . . . . . 0.732 HD21 HD13 ' A' ' 185' ' ' ILE . 0.4 OUTLIER -36.33 110.56 0.46 Allowed Pre-proline 0 CA--C 1.536 0.439 0 N-CA-C 109.483 -0.562 . . . . 20.0 109.483 . . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 703' ' ' PRO . . . . . 0.591 ' CG ' HG13 ' A' ' 110' ' ' VAL . 3.4 Cg_exo -64.01 179.5 1.08 Allowed 'Trans proline' 0 N--CA 1.491 1.378 0 C-N-CA 122.243 1.962 . . . . 20.0 113.903 -178.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 704' ' ' ALA . . . . . 0.559 ' O ' ' O ' ' B' ' 703' ' ' PRO . . . -37.57 -178.23 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 114.175 -1.375 . . . . 20.0 113.496 -179.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 705' ' ' B27 . . . . . 0.678 ' SG ' ' N ' ' A' ' 187' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.359 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 78.0 p -65.17 -21.19 66.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.965 0.412 . . . . 0.0 111.063 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 75.6 m80 -66.92 -36.04 81.36 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.05 0.452 . . . . 0.0 110.575 179.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 62.5 ttp -89.92 133.99 34.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.583 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -66.14 142.19 57.84 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.439 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -101.88 11.76 38.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.245 0.545 . . . . 0.0 110.542 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 89.8 p -84.26 13.16 5.54 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.914 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 50.9 mtmt -107.29 18.09 22.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.635 -179.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 76.8 mt -56.17 138.97 16.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 122.244 1.021 . . . . 0.0 113.142 -177.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -76.51 132.74 39.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 113.614 -1.63 . . . . 0.0 109.199 178.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.431 ' HB3' ' CG ' ' A' ' 126' ' ' HIS . 3.2 pm0 -77.09 147.5 76.86 Favored Pre-proline 0 C--N 1.324 -0.506 0 C-N-CA 120.513 -0.475 . . . . 0.0 110.14 -179.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.451 ' CB ' ' OE1' ' A' ' 68' ' ' GLU . 66.9 Cg_endo -70.4 160.33 49.88 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 122.861 2.374 . . . . 0.0 112.273 -179.262 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 -52.99 172.18 0.05 Allowed 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 121.311 0.577 . . . . 0.0 111.06 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 98.8 mt -71.25 -10.59 60.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.725 -179.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -69.17 -40.55 78.07 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.408 0.623 . . . . 0.0 111.024 179.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.781 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 90.1 mt-10 -71.44 -26.83 62.9 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.023 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 6.0 t -72.16 -44.25 65.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.67 -179.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -89.91 -9.88 47.25 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.925 -0.31 . . . . 0.0 111.581 -179.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -110.52 -8.0 14.68 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.647 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.781 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -68.44 138.9 55.66 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.35 0.595 . . . . 0.0 111.731 -179.296 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 5.9 m -57.8 102.85 0.11 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.718 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.669 HD13 ' N ' ' A' ' 75' ' ' ASP . 2.0 tm? -68.34 119.28 12.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.39 -178.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.669 ' N ' HD13 ' A' ' 74' ' ' LEU . 89.6 m-20 -97.3 78.47 2.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.393 0.616 . . . . 0.0 109.44 178.058 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -63.77 -36.66 84.6 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.955 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.417 ' HE2' ' H ' ' A' ' 77' ' ' LYS . 0.1 OUTLIER -70.38 -14.5 62.59 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.405 -177.427 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 -90.9 -1.15 57.86 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.301 0.572 . . . . 0.0 110.634 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 74.9 t -84.67 127.21 40.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.389 179.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.656 HD13 ' HE3' ' A' ' 96' ' ' LYS . 18.3 pt -110.97 -11.66 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 C-N-CA 120.803 -0.359 . . . . 0.0 111.798 -179.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.405 ' O ' HG22 ' A' ' 94' ' ' VAL . . . -160.52 163.77 34.19 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 120.556 -0.83 . . . . 0.0 111.384 -179.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.432 HH21 ' HB3' ' A' ' 91' ' ' GLU . 78.8 ttt180 -134.95 138.34 43.96 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.196 0.522 . . . . 0.0 111.35 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.55 HG22 ' O ' ' A' ' 92' ' ' LEU . 20.0 tt -104.12 141.3 20.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.243 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 70.1 m -135.78 128.84 31.56 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.645 -178.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.485 HG22 HG22 ' A' ' 88' ' ' VAL . 79.5 mt -139.23 86.41 14.65 Favored Pre-proline 0 CA--C 1.538 0.501 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.09 -179.405 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -56.66 -29.69 80.77 Favored 'Trans proline' 0 N--CA 1.499 1.827 0 C-N-CA 123.286 2.657 . . . . 0.0 113.523 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 91.7 p -53.23 -42.01 65.98 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 121.291 0.567 . . . . 0.0 110.55 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.493 ' O ' ' OG ' ' A' ' 89' ' ' SER . 34.4 m -114.07 11.23 8.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.596 179.502 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.493 ' OG ' ' O ' ' A' ' 88' ' ' VAL . 14.9 p 51.37 52.38 14.9 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.915 -179.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 54.5 tp -118.33 134.36 55.11 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 121.535 0.683 . . . . 0.0 111.958 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.432 ' HB3' HH21 ' A' ' 82' ' ' ARG . 97.6 mt-10 -146.1 122.89 11.25 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.823 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.55 ' O ' HG22 ' A' ' 83' ' ' ILE . 76.8 mt -149.81 148.88 26.59 Favored Pre-proline 0 CA--C 1.539 0.529 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.316 -179.105 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.18 145.86 27.99 Favored 'Trans proline' 0 N--CA 1.493 1.49 0 C-N-CA 122.436 2.091 . . . . 0.0 111.867 178.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.581 HG23 ' O ' ' A' ' 94' ' ' VAL . 2.0 m -94.02 118.01 38.97 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 CA-C-O 121.53 0.681 . . . . 0.0 110.996 179.428 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.511 ' N ' HD12 ' A' ' 95' ' ' LEU . 11.0 mp -102.6 136.23 42.8 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.098 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.656 ' HE3' HD13 ' A' ' 80' ' ' ILE . 97.1 mttt -64.75 -88.14 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 119.992 -0.683 . . . . 0.0 112.123 -179.065 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 74.0 m -51.79 134.17 30.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.898 -178.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 8.1 m -91.15 74.03 6.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.929 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 55.7 p -88.59 168.48 12.53 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 178.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -61.69 -42.53 99.05 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 119.856 -0.738 . . . . 0.0 109.903 179.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -65.86 -40.38 91.62 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.527 -0.761 . . . . 0.0 111.372 179.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -63.59 -38.93 93.01 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.168 0.508 . . . . 0.0 111.291 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 76.6 mt -61.67 -21.92 64.85 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.763 -179.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 63.1 mt -69.84 -21.43 63.36 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.944 0.402 . . . . 0.0 110.429 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.497 ' O ' HD22 ' A' ' 92' ' ' LEU . 95.9 p -72.98 -7.71 52.39 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 179.172 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.526 ' HA3' HD13 ' A' ' 92' ' ' LEU . . . 91.24 -18.65 50.9 Favored Glycine 0 CA--C 1.53 0.991 0 CA-C-N 115.205 -0.907 . . . . 0.0 112.41 178.462 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -145.95 124.75 12.63 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 119.723 -0.791 . . . . 0.0 112.354 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -143.4 132.77 23.36 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.482 178.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.649 ' HA ' HD23 ' A' ' 123' ' ' LEU . 11.7 m -62.45 131.44 49.2 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 121.01 0.433 . . . . 0.0 110.836 -179.475 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.506 HG13 ' CG ' ' B' ' 703' ' ' PRO . 75.6 t -78.92 -54.56 11.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 C-N-CA 120.576 -0.449 . . . . 0.0 110.673 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.865 ' H ' ' NE2' ' A' ' 114' ' ' GLN . 97.5 mttt -98.39 135.94 39.26 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 122.258 1.027 . . . . 0.0 112.646 179.483 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -66.53 -30.16 70.41 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 113.71 -1.586 . . . . 0.0 113.558 -178.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -83.06 8.57 12.52 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 113.737 1.014 . . . . 0.0 113.737 -177.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.865 ' NE2' ' H ' ' A' ' 111' ' ' LYS . 46.0 mt-30 -80.02 139.56 36.91 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 121.913 -0.492 . . . . 0.0 112.104 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.41 ' O ' ' O ' ' A' ' 118' ' ' LYS . 55.4 t -123.62 125.65 71.71 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.971 178.307 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 97.9 mtp -59.66 129.83 43.83 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.753 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 88.52 -10.74 70.62 Favored Glycine 0 CA--C 1.531 1.062 0 N-CA-C 111.796 -0.522 . . . . 0.0 111.796 178.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.41 ' O ' ' O ' ' A' ' 115' ' ' VAL . 67.4 mttm -141.5 138.25 32.66 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.364 0.602 . . . . 0.0 111.549 179.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 75.03 -163.83 54.32 Favored Glycine 0 CA--C 1.53 0.979 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.554 ' ND2' ' ND1' ' A' ' 177' ' ' HIS . 54.0 t-20 -93.97 104.59 16.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.932 0.396 . . . . 0.0 110.69 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.558 ' CE2' HD21 ' A' ' 123' ' ' LEU . 9.6 t80 -86.49 144.7 27.13 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 178.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.585 ' N ' ' OE1' ' A' ' 114' ' ' GLN . . . -147.66 140.27 24.68 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.043 -0.663 . . . . 0.0 111.248 -179.12 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.649 HD23 ' HA ' ' A' ' 109' ' ' THR . 48.1 mt -137.72 142.53 41.02 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.064 -179.16 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -110.82 138.55 47.07 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 178.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -139.36 151.35 21.84 Favored Glycine 0 CA--C 1.53 0.983 0 N-CA-C 110.441 -1.064 . . . . 0.0 110.441 -179.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.431 ' CG ' ' HB3' ' A' ' 63' ' ' GLN . 19.5 m-70 -96.92 140.44 31.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.435 0.636 . . . . 0.0 111.928 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.593 ' ND2' ' OG1' ' A' ' 186' ' ' THR . 52.2 p-10 -145.55 121.42 10.61 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.537 179.019 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.497 ' O ' ' CB ' ' A' ' 129' ' ' SER . 74.9 mtm -87.3 4.61 42.11 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.174 0.511 . . . . 0.0 110.296 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.497 ' CB ' ' O ' ' A' ' 128' ' ' MET . 1.0 OUTLIER 78.93 13.64 1.23 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.129 179.878 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.829 ' O ' HG12 ' A' ' 133' ' ' VAL . 21.2 ptmt -109.72 124.42 51.21 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 122.168 0.985 . . . . 0.0 113.19 -178.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -43.99 119.49 1.77 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.628 -1.169 . . . . 0.0 110.668 179.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 115.42 -18.69 15.32 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.829 HG12 ' O ' ' A' ' 130' ' ' LYS . 7.6 p -88.93 154.33 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.854 HD23 ' N ' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -69.19 145.06 53.54 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -177.211 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.504 ' CE1' ' O ' ' A' ' 106' ' ' GLY . 3.3 m-85 65.82 6.37 3.92 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 114.017 -1.447 . . . . 0.0 114.15 178.027 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . 0.54 ' OG ' ' CG1' ' A' ' 133' ' ' VAL . 2.7 m -75.24 -36.3 61.32 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 179.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 51.9 p-10 -94.48 7.1 46.73 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 114.277 1.214 . . . . 0.0 114.277 -176.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.504 HD11 ' HB ' ' A' ' 186' ' ' THR . 38.6 pt -72.5 -23.79 21.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 C-N-CA 119.344 -0.943 . . . . 0.0 110.663 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.679 ' HB2' ' OH ' ' A' ' 197' ' ' TYR . . . -71.14 -10.34 59.58 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 121.017 0.436 . . . . 0.0 110.614 179.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 66.6 m -81.0 -7.34 59.53 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.286 0.565 . . . . 0.0 110.271 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 88.6 mt -67.47 146.36 54.06 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.041 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -123.8 166.46 15.57 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.392 178.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -52.15 140.61 20.59 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.518 0.675 . . . . 0.0 112.359 179.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 77.99 7.13 87.6 Favored Glycine 0 CA--C 1.529 0.915 0 CA-C-N 115.139 -0.937 . . . . 0.0 112.283 178.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -71.97 133.9 45.62 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 118.925 -1.11 . . . . 0.0 110.165 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -79.72 136.2 36.71 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.759 0.79 . . . . 0.0 111.836 -178.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 97.8 mt -134.82 135.06 53.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 178.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . 0.69 ' C ' HD23 ' A' ' 149' ' ' LEU . 79.5 m-85 -121.98 135.57 54.86 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 119.858 -0.737 . . . . 0.0 112.632 -177.24 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.69 HD23 ' C ' ' A' ' 148' ' ' TYR . 0.3 OUTLIER -112.43 135.13 53.51 Favored 'General case' 0 C--O 1.224 -0.24 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 178.062 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.503 ' CE1' ' CD ' ' A' ' 155' ' ' GLU . 75.3 m-85 -109.71 108.95 19.51 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 120.247 -0.581 . . . . 0.0 111.712 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . 0.509 ' OD1' ' N ' ' A' ' 152' ' ' ASN . 53.8 t0 -87.74 165.23 15.51 Favored 'General case' 0 N--CA 1.447 -0.625 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 177.034 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . 0.509 ' N ' ' OD1' ' A' ' 151' ' ' ASP . 50.8 p-10 -59.28 -21.17 59.25 Favored 'General case' 0 C--N 1.312 -1.027 0 C-N-CA 119.522 -0.871 . . . . 0.0 110.978 -178.442 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.468 ' N ' ' OD1' ' A' ' 152' ' ' ASN . 95.4 mt-10 -115.92 -26.83 7.18 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 113.691 0.997 . . . . 0.0 113.691 -178.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -146.38 175.89 10.2 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 119.0 -1.08 . . . . 0.0 113.154 -176.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.503 ' CD ' ' CE1' ' A' ' 150' ' ' TYR . 82.5 tt0 -127.19 134.66 50.11 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 114.839 -1.073 . . . . 0.0 109.915 179.268 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -109.25 135.18 50.76 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 121.301 0.572 . . . . 0.0 112.094 -179.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . 0.475 ' O ' HD12 ' A' ' 203' ' ' LEU . 98.0 mt-10 -93.21 110.08 21.59 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.557 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 43.9 m-85 -113.92 148.81 36.16 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 120.91 0.386 . . . . 0.0 111.386 179.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -125.0 125.98 44.73 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.35 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 80.0 t -57.71 131.24 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 178.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 16.5 p -113.59 7.32 17.32 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 123.673 0.608 . . . . 0.0 112.529 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 135.79 177.37 14.93 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 120.108 -1.044 . . . . 0.0 112.515 178.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.412 HG22 ' N ' ' A' ' 164' ' ' SER . 5.8 p -135.3 154.26 35.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.165 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . 0.412 ' N ' HG22 ' A' ' 163' ' ' VAL . 25.8 p -144.66 166.89 23.91 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.042 -0.663 . . . . 0.0 111.722 -179.165 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -104.12 117.97 35.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.479 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.474 ' O ' ' O ' ' A' ' 196' ' ' ARG . 27.9 m -135.84 160.1 39.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.488 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . 0.423 ' H ' ' HG3' ' A' ' 170' ' ' LYS . 0.2 OUTLIER -85.34 158.08 58.19 Favored Pre-proline 0 CA--C 1.538 0.508 0 CA-C-O 121.055 0.455 . . . . 0.0 110.888 -179.572 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.495 ' O ' ' CB ' ' B' ' 702' ' ' LEU . 28.2 Cg_endo -64.69 -17.58 59.96 Favored 'Trans proline' 0 N--CA 1.499 1.803 0 C-N-CA 123.227 2.618 . . . . 0.0 113.038 -179.256 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 48.9 p-10 -90.88 -2.73 57.72 Favored 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 120.148 -0.621 . . . . 0.0 110.958 179.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.644 ' O ' HG22 ' A' ' 173' ' ' VAL . 71.1 mmtt -73.88 76.97 1.64 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.441 0.639 . . . . 0.0 111.388 -179.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' TRP . . . . . 0.71 ' HE1' ' CE ' ' A' ' 111' ' ' LYS . 5.7 t90 -69.81 -15.74 63.16 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.334 179.506 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -63.38 -32.16 73.51 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.81 -179.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . 0.644 HG22 ' O ' ' A' ' 170' ' ' LYS . 14.6 m -62.3 -14.57 12.8 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 120.599 -0.441 . . . . 0.0 111.76 -179.059 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 1.8 t -103.95 -9.71 9.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -179.124 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -72.35 162.72 29.09 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.117 0.484 . . . . 0.0 110.78 -179.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . 0.418 ' N ' ' OD1' ' A' ' 176' ' ' ASP . 35.5 p-10 -65.03 141.31 58.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.897 179.55 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' HIS . . . . . 0.554 ' ND1' ' ND2' ' A' ' 120' ' ' ASN . 66.2 m80 -113.26 10.41 18.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.321 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 66.18 39.28 94.47 Favored Glycine 0 CA--C 1.53 1.008 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 179.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -165.46 171.01 13.81 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.868 0.366 . . . . 0.0 110.914 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -86.94 102.96 14.86 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 177.157 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -137.02 161.68 35.39 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.347 0.594 . . . . 0.0 111.512 -178.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 20.3 tt -129.93 139.01 52.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.471 178.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 86.4 m -129.24 125.02 35.97 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.188 0.518 . . . . 0.0 112.02 -178.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 84.9 mt -109.3 131.91 54.62 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.769 HD13 HD21 ' B' ' 702' ' ' LEU . 88.9 mt -116.15 125.2 73.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 CA-C-O 121.376 0.608 . . . . 0.0 111.276 -179.064 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . 0.593 ' OG1' ' ND2' ' A' ' 127' ' ' ASN . 1.7 t -142.03 163.87 31.72 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 115.263 -0.881 . . . . 0.0 110.851 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' CYS . . . . . 0.423 ' N ' ' SG ' ' B' ' 705' ' ' B27 . 1.9 m -95.86 143.51 27.0 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 120.967 0.413 . . . . 0.0 110.847 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 44.2 t -61.4 -48.45 88.79 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 CA-C-O 121.069 0.462 . . . . 0.0 111.206 -179.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 8.5 t -169.38 158.79 8.27 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.226 0.536 . . . . 0.0 110.878 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . 0.516 HG23 ' HG2' ' A' ' 191' ' ' LYS . 29.2 m -71.96 -17.65 19.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.347 179.304 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.516 ' HG2' HG23 ' A' ' 190' ' ' VAL . 74.7 mmtt -99.19 -4.59 31.73 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.146 179.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 53.8 t0 -139.68 97.15 3.2 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 120.991 0.424 . . . . 0.0 110.972 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 43.3 p-10 -107.88 10.19 28.61 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.357 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 69.7 m -61.2 -41.7 97.28 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 120.811 0.339 . . . . 0.0 111.414 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -144.68 155.72 43.72 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.327 0.584 . . . . 0.0 111.57 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . 0.474 ' O ' ' O ' ' A' ' 166' ' ' VAL . 99.9 mtt180 -132.56 142.2 49.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.004 -179.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . 0.679 ' OH ' ' HB2' ' A' ' 139' ' ' ALA . 47.8 p90 -99.08 151.67 20.69 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.315 0.578 . . . . 0.0 111.203 179.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 45.8 t -123.88 134.05 67.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.462 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 69.9 t -96.79 134.83 32.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.964 0.412 . . . . 0.0 110.036 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -116.3 138.29 51.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.358 0.599 . . . . 0.0 111.174 -179.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -134.83 138.0 9.69 Favored Glycine 0 CA--C 1.529 0.917 0 N-CA-C 110.179 -1.168 . . . . 0.0 110.179 179.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . 0.598 ' OD1' ' N ' ' A' ' 203' ' ' LEU . 42.5 t0 -108.89 140.53 42.24 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.15 0.5 . . . . 0.0 111.669 -179.185 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . 0.598 ' N ' ' OD1' ' A' ' 202' ' ' ASP . 54.6 tp -63.34 133.61 54.39 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.073 179.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -116.09 -18.88 6.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.074 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . 0.454 ' O ' HD11 ' A' ' 203' ' ' LEU . . . -178.36 172.94 45.43 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 120.645 -0.788 . . . . 0.0 111.824 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 31.7 m -142.94 138.91 30.47 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -145.37 122.27 11.3 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.462 -0.495 . . . . 0.0 111.629 178.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -61.98 138.77 58.41 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.391 0.615 . . . . 0.0 110.854 -179.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 13.6 ttmt -79.14 109.47 13.48 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.95 178.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 99.8 mttt . . . . . 0 C--O 1.219 -0.532 0 CA-C-O 117.953 -1.022 . . . . 0.0 110.383 -179.846 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 701' ' ' BOC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 702' ' ' LEU . . . . . 0.769 HD21 HD13 ' A' ' 185' ' ' ILE . 0.9 OUTLIER -44.96 108.34 0.74 Allowed Pre-proline 0 CA--C 1.545 0.751 0 CA-C-O 120.492 0.187 . . . . 20.0 111.159 . . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 703' ' ' PRO . . . . . 0.537 ' O ' ' O ' ' B' ' 704' ' ' ALA . 3.0 Cg_exo -65.65 -168.58 0.13 Allowed 'Trans proline' 0 N--CA 1.492 1.398 0 C-N-CA 122.377 2.052 . . . . 20.0 113.484 -179.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 704' ' ' ALA . . . . . 0.537 ' O ' ' O ' ' B' ' 703' ' ' PRO . . . -40.17 -175.91 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 114.501 -1.227 . . . . 20.0 113.058 -179.241 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 705' ' ' B27 . . . . . 0.445 HG2A ' C ' ' B' ' 704' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.376 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 76.9 p -59.5 -36.31 75.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.131 0.491 . . . . 0.0 110.375 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -67.59 -37.63 82.85 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.509 179.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 65.6 mtt -87.26 135.05 33.46 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.249 0.547 . . . . 0.0 110.868 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -145.31 85.28 1.72 Allowed 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.01 -0.676 . . . . 0.0 111.633 179.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -94.54 1.03 55.68 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.679 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 23.6 p -82.99 18.74 1.55 Allowed 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.735 -0.666 . . . . 0.0 112.718 -178.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -105.15 17.38 24.15 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.661 -0.416 . . . . 0.0 111.638 -179.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.6 mt -55.41 135.31 18.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 122.124 0.964 . . . . 0.0 112.479 -177.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -76.75 131.92 39.0 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 113.885 -1.507 . . . . 0.0 108.961 178.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.647 ' H ' ' CD ' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -79.23 149.82 73.28 Favored Pre-proline 0 C--N 1.326 -0.449 0 C-N-CA 120.383 -0.527 . . . . 0.0 110.634 -179.074 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -71.0 165.19 33.18 Favored 'Trans proline' 0 N--CA 1.496 1.654 0 C-N-CA 122.888 2.392 . . . . 0.0 113.338 -179.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.815 ' O ' HG23 ' A' ' 69' ' ' VAL . 94.0 m-20 -53.02 164.94 0.35 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.684 179.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 1.033 HD21 HG23 ' A' ' 133' ' ' VAL . 89.1 mt -63.81 -45.37 89.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.285 -179.307 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.17 -36.84 84.95 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.473 -0.491 . . . . 0.0 111.071 -178.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -63.04 -29.91 71.18 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.498 0.666 . . . . 0.0 109.478 178.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.815 HG23 ' O ' ' A' ' 65' ' ' ASP . 38.7 t -76.71 -46.27 30.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.108 179.245 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -73.08 -9.01 58.27 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.811 -1.086 . . . . 0.0 111.438 -179.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 96.8 m-20 -106.43 -12.89 15.51 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.525 0.678 . . . . 0.0 109.655 178.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.4 139.71 55.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.044 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 35.5 t -59.06 103.17 0.15 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.013 179.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.663 ' C ' HD23 ' A' ' 74' ' ' LEU . 6.9 tt -70.16 123.79 22.49 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.266 0.555 . . . . 0.0 111.068 -179.281 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.613 ' N ' HD23 ' A' ' 74' ' ' LEU . 84.9 m-20 -96.35 80.11 3.16 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.044 -179.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.655 ' O ' HG12 ' A' ' 79' ' ' VAL . 64.5 pttt -79.49 -15.67 57.36 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.742 0.782 . . . . 0.0 109.539 178.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 21.2 mtmt -65.82 -36.28 83.04 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.764 -1.107 . . . . 0.0 111.41 -178.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -87.04 0.07 55.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.941 0.4 . . . . 0.0 111.333 -179.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.655 HG12 ' O ' ' A' ' 76' ' ' LYS . 2.3 p -68.36 132.43 32.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.534 0.683 . . . . 0.0 110.683 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 8.6 pt -111.4 -5.81 11.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.427 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -171.74 176.9 44.78 Favored Glycine 0 CA--C 1.531 1.036 0 N-CA-C 111.162 -0.775 . . . . 0.0 111.162 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.408 ' NH2' ' HB3' ' A' ' 91' ' ' GLU . 51.1 ttt85 -135.92 154.42 51.13 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.715 HG22 ' O ' ' A' ' 92' ' ' LEU . 20.1 tt -119.07 137.02 54.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 CA-C-O 121.6 0.714 . . . . 0.0 110.124 179.108 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 8.6 t -135.15 125.35 26.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.771 -178.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.54 ' CG2' HG22 ' A' ' 88' ' ' VAL . 81.0 mt -135.56 90.23 20.5 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.203 179.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -56.38 -32.04 87.35 Favored 'Trans proline' 0 N--CA 1.494 1.535 0 C-N-CA 123.069 2.513 . . . . 0.0 112.637 -179.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 10.7 t -54.77 -42.44 71.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.294 -179.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.54 HG22 ' CG2' ' A' ' 85' ' ' ILE . 27.2 m -113.81 11.28 8.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.328 0.585 . . . . 0.0 110.351 179.135 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 50.19 48.08 22.68 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.265 179.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 47.8 tp -109.75 132.1 54.46 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.472 0.653 . . . . 0.0 110.802 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.408 ' HB3' ' NH2' ' A' ' 82' ' ' ARG . 97.6 mt-10 -144.13 113.78 7.13 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.083 -178.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.715 ' O ' HG22 ' A' ' 83' ' ' ILE . 93.7 mt -147.36 147.44 28.34 Favored Pre-proline 0 CA--C 1.537 0.465 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.656 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -74.4 146.92 36.0 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.593 2.195 . . . . 0.0 112.411 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.539 ' C ' HD12 ' A' ' 95' ' ' LEU . 78.8 t -94.44 120.14 43.42 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-O 121.002 0.429 . . . . 0.0 110.929 179.351 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.588 ' N ' HD12 ' A' ' 95' ' ' LEU . 10.6 mp -101.02 126.46 47.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.488 0.661 . . . . 0.0 110.962 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.54 ' O ' ' OG1' ' A' ' 109' ' ' THR . 87.2 tttt -64.07 -44.32 92.77 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.267 -0.879 . . . . 0.0 112.316 -178.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 4.2 m -85.59 130.83 34.48 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 121.039 0.447 . . . . 0.0 111.997 -179.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 3.5 p -90.64 59.04 4.1 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.547 179.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 3.3 m -92.72 164.74 13.26 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 179.077 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -58.21 -43.15 87.49 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 120.568 -0.453 . . . . 0.0 111.143 -179.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -64.96 -36.94 86.02 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.542 0.687 . . . . 0.0 110.009 178.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -64.4 -38.61 91.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.565 -179.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.405 ' HA ' HD23 ' A' ' 103' ' ' LEU . 96.9 mt -63.9 -11.97 32.72 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.913 -178.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 88.9 mt -73.95 -20.74 60.27 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.477 -0.489 . . . . 0.0 110.463 179.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 76.2 p -74.41 -4.77 38.5 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.169 -179.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 85.79 -19.25 26.15 Favored Glycine 0 CA--C 1.529 0.931 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.894 178.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -146.65 123.69 11.42 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.588 0.709 . . . . 0.0 111.804 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -146.21 137.15 24.38 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.159 178.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.54 ' OG1' ' O ' ' A' ' 96' ' ' LYS . 68.1 p -64.14 133.93 53.89 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.043 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.564 HG13 ' CG ' ' B' ' 703' ' ' PRO . 37.7 t -81.43 -56.92 5.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.29 0.567 . . . . 0.0 110.568 -179.503 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.415 ' HB3' ' NE2' ' A' ' 114' ' ' GLN . 85.5 tttt -93.07 128.44 38.97 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.988 -179.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -67.01 -31.25 71.67 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 -177.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 72.4 m-80 -82.98 11.61 5.96 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 114.238 1.199 . . . . 0.0 114.238 -176.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.461 ' OE1' ' N ' ' A' ' 122' ' ' ALA . 32.8 mt-30 -81.49 143.52 32.0 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.207 -0.597 . . . . 0.0 111.528 178.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 54.7 t -123.64 125.21 71.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.575 179.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . 0.437 ' CG ' ' CZ ' ' A' ' 121' ' ' TYR . 97.3 mtp -57.58 130.43 46.31 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.99 0.424 . . . . 0.0 111.602 -179.313 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.426 ' HA3' ' CE2' ' A' ' 156' ' ' TYR . . . 80.64 -2.97 76.68 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 120.935 -0.65 . . . . 0.0 111.839 178.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 55.6 tttm -139.22 126.87 21.86 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.12 0.486 . . . . 0.0 110.655 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 74.86 -164.01 54.43 Favored Glycine 0 CA--C 1.529 0.962 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 -179.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 64.4 t-20 -92.7 106.79 18.71 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.978 0.418 . . . . 0.0 110.562 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.668 ' CE2' HD11 ' A' ' 123' ' ' LEU . 4.0 t80 -83.98 144.58 29.05 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.474 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.82 ' C ' HD12 ' A' ' 123' ' ' LEU . . . -146.83 140.3 25.66 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 119.777 -0.769 . . . . 0.0 112.575 -177.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.82 HD12 ' C ' ' A' ' 122' ' ' ALA . 7.2 mp -139.09 144.74 38.86 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.509 -179.525 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -108.51 139.9 42.6 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . 0.408 ' N ' ' HG2' ' B' ' 705' ' ' B27 . . . -144.6 159.36 27.77 Favored Glycine 0 CA--C 1.53 0.977 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 -179.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 60.5 m-70 -99.08 137.14 38.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.35 0.595 . . . . 0.0 111.932 -179.236 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 64.8 t-20 -131.69 120.2 22.43 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.941 179.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.548 ' CE ' HE21 ' A' ' 63' ' ' GLN . 64.1 mtt -92.88 -4.48 52.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.189 0.518 . . . . 0.0 111.021 -179.182 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.476 ' CB ' ' O ' ' A' ' 128' ' ' MET . 0.9 OUTLIER 79.25 11.75 1.35 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.846 -0.615 . . . . 0.0 112.149 179.03 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.881 ' O ' HG12 ' A' ' 133' ' ' VAL . 58.8 pttt -126.67 128.31 46.52 Favored 'General case' 0 C--O 1.222 -0.346 0 CA-C-O 122.1 0.952 . . . . 0.0 112.801 -179.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.482 ' O ' ' O ' ' A' ' 130' ' ' LYS . 29.5 tptt -37.54 162.64 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.833 -1.076 . . . . 0.0 110.289 178.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.431 ' H ' ' HG3' ' A' ' 131' ' ' LYS . . . 73.78 -24.18 1.02 Allowed Glycine 0 CA--C 1.529 0.911 0 N-CA-C 111.837 -0.505 . . . . 0.0 111.837 178.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 1.033 HG23 HD21 ' A' ' 66' ' ' LEU . 2.9 p -91.16 175.86 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 O-C-N 122.325 -0.515 . . . . 0.0 111.535 -178.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.79 ' O ' ' N ' ' A' ' 136' ' ' SER . 3.9 mm? -60.11 167.09 2.49 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 121.209 0.528 . . . . 0.0 112.349 -177.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.592 ' CG ' HD12 ' A' ' 138' ' ' ILE . 3.7 m-30 22.4 21.01 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 113.947 -1.478 . . . . 0.0 113.868 178.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . 0.79 ' N ' ' O ' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -64.37 -44.88 90.01 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 113.69 0.996 . . . . 0.0 113.69 -178.318 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -89.25 -3.88 58.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.98 0.419 . . . . 0.0 111.516 -178.178 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.592 HD12 ' CG ' ' A' ' 135' ' ' PHE . 0.2 OUTLIER -61.47 -40.69 87.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.569 179.697 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -65.26 -10.67 34.06 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 120.284 -0.567 . . . . 0.0 110.144 179.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 5.9 p -85.34 -2.6 58.26 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.432 179.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 73.0 mt -63.39 143.44 57.81 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-O 121.203 0.525 . . . . 0.0 110.262 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.439 ' N ' ' OD2' ' A' ' 145' ' ' ASP . 89.0 tttt -119.41 155.0 32.81 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.44 0.638 . . . . 0.0 111.873 -178.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -50.75 133.74 25.71 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.424 179.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.56 ' N ' ' O ' ' A' ' 160' ' ' VAL . . . 79.33 7.95 88.13 Favored Glycine 0 CA--C 1.528 0.88 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.603 179.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.439 ' OD2' ' N ' ' A' ' 142' ' ' LYS . 77.2 m-20 -75.35 137.63 41.22 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 119.31 -0.956 . . . . 0.0 110.568 -179.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -79.12 139.99 37.92 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.526 -0.761 . . . . 0.0 112.799 -178.236 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.457 HG23 HG12 ' A' ' 85' ' ' ILE . 97.2 mt -139.12 137.52 41.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 114.762 -1.108 . . . . 0.0 108.346 178.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . 0.641 ' C ' HD23 ' A' ' 149' ' ' LEU . 93.2 m-85 -123.65 137.58 54.7 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.022 -0.671 . . . . 0.0 112.556 -178.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.641 HD23 ' C ' ' A' ' 148' ' ' TYR . 0.8 OUTLIER -115.7 136.61 52.89 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 177.704 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.418 ' CD2' ' HB2' ' A' ' 155' ' ' GLU . 77.6 m-85 -112.94 113.27 25.26 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 119.98 -0.688 . . . . 0.0 111.561 179.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . 0.589 ' OD1' ' N ' ' A' ' 152' ' ' ASN . 66.2 t0 -87.53 162.03 17.44 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 177.247 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . 0.589 ' N ' ' OD1' ' A' ' 151' ' ' ASP . 65.2 m-20 -55.37 -24.19 28.27 Favored 'General case' 0 C--N 1.315 -0.893 0 C-N-CA 119.337 -0.945 . . . . 0.0 110.047 -178.172 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -108.3 -30.16 8.49 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 113.699 1.0 . . . . 0.0 113.699 -177.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . 0.446 ' O ' ' N ' ' A' ' 151' ' ' ASP . 0.3 OUTLIER -148.93 -178.13 6.19 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 119.089 -1.044 . . . . 0.0 113.736 -177.328 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.418 ' HB2' ' CD2' ' A' ' 150' ' ' TYR . 0.0 OUTLIER -130.43 144.33 51.33 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 114.478 -1.237 . . . . 0.0 110.05 178.921 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . 0.426 ' CE2' ' HA3' ' A' ' 117' ' ' GLY . 82.5 m-85 -120.97 139.89 52.63 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 120.972 0.415 . . . . 0.0 111.573 -178.541 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -96.43 115.65 27.77 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.564 179.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 50.1 m-85 -116.97 151.57 36.43 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.001 0.429 . . . . 0.0 111.416 179.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.405 ' HB2' HG21 ' A' ' 204' ' ' VAL . . . -124.45 124.82 43.14 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.132 179.076 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.56 ' O ' ' N ' ' A' ' 144' ' ' GLY . 96.4 t -60.08 136.62 23.51 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 178.103 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 7.6 p -105.1 -23.19 12.97 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.666 178.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 159.37 -168.13 35.22 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 120.488 -0.863 . . . . 0.0 111.969 179.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 15.0 p -137.73 146.72 26.98 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 179.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 28.3 m -142.3 172.03 13.24 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 120.955 0.407 . . . . 0.0 111.174 -179.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -111.26 125.74 54.15 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.477 0.656 . . . . 0.0 111.534 -179.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 30.6 m -137.36 164.74 28.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.559 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -82.69 158.73 65.08 Favored Pre-proline 0 CA--C 1.536 0.408 0 CA-C-O 121.047 0.451 . . . . 0.0 110.996 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.486 ' O ' ' CB ' ' B' ' 702' ' ' LEU . 44.3 Cg_endo -67.05 -15.98 48.11 Favored 'Trans proline' 0 N--CA 1.497 1.679 0 C-N-CA 122.85 2.367 . . . . 0.0 111.6 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . 0.409 ' OD1' ' C ' ' A' ' 169' ' ' ASP . 40.9 p-10 -93.17 -6.43 47.83 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.911 179.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.654 ' O ' HG22 ' A' ' 173' ' ' VAL . 16.7 mttm -74.64 82.65 2.05 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.46 0.648 . . . . 0.0 111.397 -179.573 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' TRP . . . . . . . . . . . . . 21.9 t90 -73.12 -14.14 61.32 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.803 179.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.487 ' OE1' ' OE1' ' A' ' 175' ' ' GLU . 52.1 tp10 -58.58 -31.25 67.84 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 115.052 -0.976 . . . . 0.0 111.831 -179.386 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . 0.654 HG22 ' O ' ' A' ' 170' ' ' LYS . 28.2 m -64.2 -20.78 27.56 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 120.618 -0.433 . . . . 0.0 112.04 -178.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.468 ' O ' HG12 ' A' ' 174' ' ' VAL . 49.5 t -98.74 -9.11 9.0 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -178.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.487 ' OE1' ' OE1' ' A' ' 172' ' ' GLU . 98.1 mt-10 -74.86 148.28 40.34 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 121.394 0.616 . . . . 0.0 111.585 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 46.6 p-10 -60.2 141.6 55.74 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.363 -179.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' HIS . . . . . 0.482 ' CE1' ' O ' ' A' ' 175' ' ' GLU . 80.5 m80 -117.67 16.85 14.49 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.537 -179.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 66.51 39.08 93.9 Favored Glycine 0 CA--C 1.532 1.102 0 N-CA-C 111.361 -0.696 . . . . 0.0 111.361 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 15.7 ptmt -163.26 167.1 22.4 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.997 -0.372 . . . . 0.0 109.997 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -87.05 92.31 9.0 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 178.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . 0.447 ' HG2' ' N ' ' A' ' 182' ' ' ILE . 82.9 tt0 -124.62 164.62 19.47 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.404 0.621 . . . . 0.0 111.441 -179.24 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.511 HG22 ' O ' ' A' ' 201' ' ' GLY . 18.1 tt -130.7 138.61 53.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.286 178.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 85.9 m -129.5 125.98 37.59 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 121.145 0.498 . . . . 0.0 111.877 -179.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 93.7 mt -109.53 130.59 55.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.874 178.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.717 HD13 HD21 ' B' ' 702' ' ' LEU . 83.0 mt -113.94 124.07 70.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.205 0.526 . . . . 0.0 111.287 -179.114 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . 0.625 ' OG1' ' CZ ' ' A' ' 197' ' ' TYR . 0.1 OUTLIER -139.51 167.48 21.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.558 -0.747 . . . . 0.0 110.142 179.448 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' CYS . . . . . . . . . . . . . 8.9 m -95.49 142.2 28.12 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 45.2 t -60.66 -44.39 96.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 120.641 -0.424 . . . . 0.0 110.74 -179.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 47.5 t -166.64 148.69 6.46 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.163 -0.615 . . . . 0.0 111.613 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 10.9 p -65.2 -22.35 31.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.403 179.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -92.93 -13.28 29.06 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.598 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -143.67 98.32 3.22 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 121.179 0.514 . . . . 0.0 110.938 179.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -103.83 9.16 37.03 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.592 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 89.3 p -59.67 -33.82 72.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.018 -179.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -130.77 146.48 52.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.258 0.551 . . . . 0.0 110.925 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -125.36 135.42 52.42 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.28 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . 0.625 ' CZ ' ' OG1' ' A' ' 186' ' ' THR . 35.6 p90 -98.22 151.06 20.85 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.402 -0.519 . . . . 0.0 110.309 179.393 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 53.0 t -127.05 133.32 68.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.287 0.565 . . . . 0.0 111.549 -179.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 42.1 t -107.48 130.29 59.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.211 178.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -119.55 152.25 37.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.463 0.649 . . . . 0.0 111.976 -178.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . 0.511 ' O ' HG22 ' A' ' 182' ' ' ILE . . . -138.98 151.58 21.81 Favored Glycine 0 CA--C 1.533 1.175 0 N-CA-C 110.593 -1.003 . . . . 0.0 110.593 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . 0.552 ' OD1' ' N ' ' A' ' 203' ' ' LEU . 67.1 t0 -113.77 137.39 51.71 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 120.877 0.37 . . . . 0.0 111.182 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . 0.552 ' N ' ' OD1' ' A' ' 202' ' ' ASP . 53.6 tp -59.96 131.57 51.26 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.405 HG21 ' HB2' ' A' ' 159' ' ' ALA . 86.0 t -112.85 -19.78 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.969 -179.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . 0.482 ' O ' HD11 ' A' ' 203' ' ' LEU . . . -178.6 174.49 46.68 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 120.92 -0.657 . . . . 0.0 111.801 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 26.9 m -138.81 132.31 30.39 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -142.71 116.4 9.22 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.526 0.679 . . . . 0.0 112.239 -179.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -63.55 144.88 56.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.328 -0.851 . . . . 0.0 112.139 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 23.6 ttpt -78.68 109.6 13.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.528 178.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 59.2 pttt . . . . . 0 C--O 1.218 -0.565 0 CA-C-O 118.207 -0.901 . . . . 0.0 110.082 178.998 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 701' ' ' BOC . . . . . 0.438 ' O1 ' ' O ' ' B' ' 702' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 702' ' ' LEU . . . . . 0.717 HD21 HD13 ' A' ' 185' ' ' ILE . 1.3 mt 45.3 102.89 0.03 OUTLIER Pre-proline 0 CA--C 1.542 0.663 0 CA-C-O 120.67 0.272 . . . . 20.0 111.416 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 703' ' ' PRO . . . . . 0.579 ' O ' ' O ' ' B' ' 704' ' ' ALA . 4.0 Cg_exo -64.8 -170.04 0.13 Allowed 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 121.97 1.78 . . . . 20.0 113.562 -179.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 704' ' ' ALA . . . . . 0.579 ' O ' ' O ' ' B' ' 703' ' ' PRO . . . -36.58 -178.81 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 114.256 -1.338 . . . . 20.0 113.458 -179.099 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 705' ' ' B27 . . . . . 0.408 ' HG2' ' N ' ' A' ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.308 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 20.5 t -62.29 -43.29 99.17 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 120.86 0.362 . . . . 0.0 111.12 -179.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 99.6 m-70 -113.02 146.08 39.73 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 121.077 0.465 . . . . 0.0 110.95 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 67.4 mtt -75.41 139.07 42.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.398 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.536 ' O ' ' OD1' ' A' ' 57' ' ' ASP . 38.1 p30 -166.43 96.56 0.57 Allowed 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 121.335 0.588 . . . . 0.0 111.322 -179.435 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -96.12 -11.11 26.74 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 121.026 0.441 . . . . 0.0 111.359 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.48 ' CB ' ' O ' ' B' ' 702' ' ' LEU . 3.9 p -82.01 21.07 0.91 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.123 -0.489 . . . . 0.0 112.073 -179.145 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 58.4 mtpt -106.73 23.67 13.93 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.137 0.494 . . . . 0.0 111.449 -179.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.6 mt -55.62 136.67 17.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 122.227 1.013 . . . . 0.0 112.189 -177.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -76.88 131.68 38.72 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 113.783 -1.553 . . . . 0.0 108.266 178.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.737 ' N ' HE21 ' A' ' 63' ' ' GLN . 0.0 OUTLIER -77.11 148.7 78.67 Favored Pre-proline 0 C--N 1.325 -0.469 0 C-N-CA 120.363 -0.535 . . . . 0.0 110.622 -178.679 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.541 ' CB ' ' OE1' ' A' ' 68' ' ' GLU . 65.2 Cg_endo -70.79 163.29 39.62 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 123.291 2.661 . . . . 0.0 113.878 -178.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -58.58 168.63 1.11 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.001 -1.0 . . . . 0.0 111.434 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 96.0 mt -70.36 -15.04 62.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.291 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -69.72 -40.3 76.32 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.346 0.593 . . . . 0.0 110.658 178.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.815 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 82.2 tt0 -66.42 -28.84 68.93 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.464 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 59.8 t -69.73 -45.29 77.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.288 179.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.42 -10.78 59.74 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.658 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -116.12 -2.81 12.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.299 0.571 . . . . 0.0 110.429 179.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.815 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -68.9 -172.34 0.38 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.712 0.767 . . . . 0.0 112.085 -178.598 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.6 p -101.4 104.38 15.35 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.016 178.31 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 42.8 tp -70.22 129.62 39.85 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.273 0.559 . . . . 0.0 111.503 -178.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -118.99 77.39 1.18 Allowed 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 177.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.692 ' O ' HG12 ' A' ' 79' ' ' VAL . 82.6 tttt -84.46 -35.8 22.74 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.297 -0.865 . . . . 0.0 112.542 -179.368 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 50.1 mmtt -75.03 -11.45 60.1 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.0 0.429 . . . . 0.0 111.132 -177.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -91.93 -0.51 57.5 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.09 0.471 . . . . 0.0 110.459 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.692 HG12 ' O ' ' A' ' 76' ' ' LYS . 9.5 p -76.86 128.5 37.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.147 0.498 . . . . 0.0 110.941 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.507 HD13 ' CE ' ' A' ' 96' ' ' LYS . 18.2 pt -106.55 -8.33 10.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.307 0.575 . . . . 0.0 110.066 179.354 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -171.19 169.38 42.43 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 109.894 -1.283 . . . . 0.0 109.894 179.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.722 ' HA ' HG23 ' A' ' 94' ' ' VAL . 33.7 ptt-85 -146.71 154.58 41.59 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.364 0.602 . . . . 0.0 112.01 -179.605 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 19.0 tt -103.69 141.63 19.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.645 -179.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 47.9 t -136.7 129.87 31.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.671 -179.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.61 ' CG2' HG22 ' A' ' 88' ' ' VAL . 93.7 mt -138.07 87.25 16.53 Favored Pre-proline 0 CA--C 1.535 0.381 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.839 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_exo -56.64 -30.76 84.86 Favored 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 122.801 2.334 . . . . 0.0 112.034 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 44.2 m -53.27 -42.09 66.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.75 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.61 HG22 ' CG2' ' A' ' 85' ' ' ILE . 17.6 m -114.25 11.23 7.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.719 179.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.511 ' O ' ' OG ' ' A' ' 89' ' ' SER . 1.6 p 51.31 51.29 17.18 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.128 179.686 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 59.0 tp -119.14 133.67 55.65 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 121.375 0.607 . . . . 0.0 111.183 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -147.09 124.94 11.91 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.102 179.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.504 HD13 ' HA3' ' A' ' 106' ' ' GLY . 78.0 mt -149.55 146.73 21.33 Favored Pre-proline 0 CA--C 1.539 0.524 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.341 -179.442 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -74.17 145.11 34.44 Favored 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 122.555 2.17 . . . . 0.0 111.389 178.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.722 HG23 ' HA ' ' A' ' 82' ' ' ARG . 18.3 t -96.41 120.18 45.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-O 121.137 0.494 . . . . 0.0 112.091 -179.332 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.56 HD12 ' C ' ' A' ' 94' ' ' VAL . 10.2 mp -102.67 138.71 39.21 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.735 179.376 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.507 ' CE ' HD13 ' A' ' 80' ' ' ILE . 98.2 mttt -62.12 -82.22 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.372 0.606 . . . . 0.0 112.104 -179.163 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 31.3 m -56.89 134.55 55.52 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.587 -178.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 74.0 p -92.27 70.23 5.21 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.791 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 63.2 p -92.73 170.44 9.71 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.537 178.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -60.75 -43.07 98.42 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 178.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -65.75 -41.68 91.84 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.496 179.451 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -64.49 -37.47 87.64 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.989 -179.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 74.4 mt -64.71 -14.37 58.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.042 -0.526 . . . . 0.0 112.062 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 94.8 mt -72.42 -28.43 62.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.986 0.422 . . . . 0.0 111.317 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.401 ' O ' HD22 ' A' ' 92' ' ' LEU . 86.8 p -73.42 -3.98 30.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.393 0.616 . . . . 0.0 109.813 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.504 ' HA3' HD13 ' A' ' 92' ' ' LEU . . . 92.29 -18.52 54.1 Favored Glycine 0 CA--C 1.533 1.209 0 CA-C-N 115.432 -0.804 . . . . 0.0 113.946 177.324 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -145.47 128.16 16.21 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 118.294 1.047 . . . . 0.0 113.147 -178.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -145.67 140.95 27.66 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 114.924 -1.034 . . . . 0.0 110.087 178.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.514 ' HA ' HD23 ' A' ' 123' ' ' LEU . 30.2 p -68.6 140.25 55.55 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.311 0.577 . . . . 0.0 111.443 -179.17 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.733 HG11 HG11 ' A' ' 174' ' ' VAL . 71.6 t -79.88 -58.17 4.22 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 CA-C-N 115.723 -0.672 . . . . 0.0 111.539 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.598 ' H ' ' NE2' ' A' ' 114' ' ' GLN . 68.5 mmtt -105.06 138.69 40.87 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 121.862 0.839 . . . . 0.0 111.838 179.488 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -65.74 -30.36 71.01 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 114.848 -1.069 . . . . 0.0 113.071 -178.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -79.83 13.93 1.96 Allowed 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.373 -0.531 . . . . 0.0 112.283 -178.129 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.598 ' NE2' ' H ' ' A' ' 111' ' ' LYS . 33.6 mt-30 -81.02 134.04 35.6 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 120.928 0.394 . . . . 0.0 111.599 179.336 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.408 ' O ' ' O ' ' A' ' 118' ' ' LYS . 72.4 t -125.73 126.11 69.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 178.351 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 96.1 mtp -57.15 131.18 49.18 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 121.092 0.472 . . . . 0.0 111.903 -179.334 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 78.75 -3.55 63.87 Favored Glycine 0 CA--C 1.531 1.033 0 N-CA-C 111.685 -0.566 . . . . 0.0 111.685 179.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.408 ' O ' ' O ' ' A' ' 115' ' ' VAL . 64.6 tttm -139.18 126.43 21.4 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.221 0.534 . . . . 0.0 110.924 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 77.16 -170.45 55.1 Favored Glycine 0 CA--C 1.531 1.039 0 N-CA-C 111.181 -0.767 . . . . 0.0 111.181 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 60.9 t-20 -87.82 104.94 17.06 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.953 0.406 . . . . 0.0 110.296 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -88.43 99.14 12.04 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 120.955 0.407 . . . . 0.0 110.574 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.763 ' CB ' HG12 ' A' ' 174' ' ' VAL . . . -91.83 137.68 32.16 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.101 0.477 . . . . 0.0 111.314 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.514 HD23 ' HA ' ' A' ' 109' ' ' THR . 78.9 mt -134.99 139.7 45.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.816 179.521 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.638 ' HB1' ' HG2' ' B' ' 705' ' ' B27 . . . -115.52 144.91 43.16 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-O 121.324 0.583 . . . . 0.0 110.757 -179.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . 0.459 ' O ' HG2B ' B' ' 705' ' ' B27 . . . -142.08 -162.17 9.09 Favored Glycine 0 CA--C 1.532 1.094 0 N-CA-C 110.154 -1.178 . . . . 0.0 110.154 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.526 ' O ' ' O ' ' A' ' 134' ' ' LEU . 91.5 m-70 -134.6 160.24 38.71 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.411 0.624 . . . . 0.0 111.981 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 28.7 t30 -142.12 120.23 12.16 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.275 179.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.476 ' O ' ' CB ' ' A' ' 129' ' ' SER . 61.8 mtt -96.23 -5.31 40.69 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.446 0.641 . . . . 0.0 109.757 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.476 ' CB ' ' O ' ' A' ' 128' ' ' MET . 1.1 p 78.72 17.07 1.04 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.206 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.819 ' O ' HG12 ' A' ' 133' ' ' VAL . 7.6 ptpt -125.76 116.87 22.29 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 121.833 0.825 . . . . 0.0 112.827 -179.01 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -45.71 130.39 9.16 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.212 179.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 109.08 -16.92 32.48 Favored Glycine 0 N--CA 1.444 -0.826 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 -179.243 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.819 HG12 ' O ' ' A' ' 130' ' ' LYS . 7.2 p -90.88 160.27 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.178 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.878 ' H ' HD13 ' A' ' 134' ' ' LEU . 0.0 OUTLIER -70.69 141.95 51.56 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 115.016 1.487 . . . . 0.0 115.016 -177.122 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 59.67 9.37 1.58 Allowed 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 112.922 -1.944 . . . . 0.0 115.008 177.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 12.9 p -70.42 -30.29 67.12 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 120.041 -0.664 . . . . 0.0 112.125 179.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -90.59 -0.54 57.72 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 113.296 0.851 . . . . 0.0 113.296 -177.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 2.4 pp -58.67 -33.6 49.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 120.362 -0.535 . . . . 0.0 111.106 -179.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -66.44 -13.22 60.45 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.066 0.46 . . . . 0.0 110.954 -179.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 67.0 p -83.55 -4.54 58.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.099 -179.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 88.9 mt -63.98 141.06 58.91 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 121.067 0.461 . . . . 0.0 110.047 179.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -117.03 154.79 30.33 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.462 0.648 . . . . 0.0 111.325 -179.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -47.42 133.7 12.46 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.849 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 160' ' ' VAL . . . 76.8 7.99 86.34 Favored Glycine 0 CA--C 1.53 0.979 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.81 178.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -70.9 135.2 47.85 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 119.832 -0.747 . . . . 0.0 110.587 -179.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -79.98 139.8 36.86 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.895 0.855 . . . . 0.0 112.354 -178.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 98.4 mt -136.48 137.51 47.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 177.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -124.29 138.13 54.42 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 119.708 -0.797 . . . . 0.0 113.061 -177.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 18.6 mt -110.72 133.13 53.6 Favored 'General case' 0 C--O 1.223 -0.3 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 177.368 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.547 ' CZ ' ' OE2' ' A' ' 155' ' ' GLU . 64.5 m-85 -109.77 107.63 17.69 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 119.957 -0.697 . . . . 0.0 111.06 179.462 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -89.19 164.43 14.98 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 178.232 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 69.6 m-20 -57.68 -22.72 47.65 Favored 'General case' 0 C--N 1.312 -1.034 0 C-N-CA 119.823 -0.751 . . . . 0.0 110.657 -178.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -113.21 -28.26 7.69 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 113.804 1.039 . . . . 0.0 113.804 -178.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -147.97 179.15 7.94 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 119.147 -1.021 . . . . 0.0 113.47 -176.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.547 ' OE2' ' CZ ' ' A' ' 150' ' ' TYR . 85.7 tt0 -126.58 135.69 51.57 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 114.35 -1.296 . . . . 0.0 110.002 178.466 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -109.67 132.83 53.78 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 121.157 0.503 . . . . 0.0 111.687 -179.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -94.0 112.04 23.83 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.789 -0.642 . . . . 0.0 111.943 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -114.13 148.71 36.75 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.013 0.435 . . . . 0.0 111.249 179.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -125.11 122.04 36.01 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 121.24 0.543 . . . . 0.0 110.752 179.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.544 ' O ' ' N ' ' A' ' 144' ' ' GLY . 59.9 t -60.44 137.33 22.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.7 178.3 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 81.0 p -108.8 -25.05 11.0 Favored 'General case' 0 N--CA 1.463 0.182 0 O-C-N 123.415 0.447 . . . . 0.0 111.534 179.415 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 159.31 -167.12 34.94 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 120.532 -0.842 . . . . 0.0 111.285 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.925 HG12 HG22 ' A' ' 199' ' ' VAL . 35.5 m -131.45 160.69 42.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.956 0.408 . . . . 0.0 110.145 179.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 22.8 p -141.41 162.6 35.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.439 0.637 . . . . 0.0 111.77 -178.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -103.17 115.17 30.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.577 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 17.1 m -136.77 161.78 35.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.316 0.579 . . . . 0.0 111.218 -179.027 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -86.98 157.99 53.64 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.817 -179.758 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.455 ' O ' ' CB ' ' B' ' 702' ' ' LEU . 33.1 Cg_endo -64.81 -15.89 52.57 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 C-N-CA 122.996 2.464 . . . . 0.0 111.565 178.65 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . 0.46 ' O ' ' CD1' ' A' ' 171' ' ' TRP . 38.4 p-10 -96.62 -2.85 43.96 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.724 179.029 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.478 ' O ' HG22 ' A' ' 173' ' ' VAL . 7.0 mttp -74.03 87.5 1.86 Allowed 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 121.433 0.635 . . . . 0.0 110.994 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' TRP . . . . . 0.514 ' CD1' ' N ' ' A' ' 171' ' ' TRP . 22.3 m0 -73.14 -14.42 61.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.1 -179.521 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -61.26 -27.04 68.17 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.825 -179.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . 0.791 HG23 HG13 ' A' ' 174' ' ' VAL . 22.9 m -61.99 -23.85 32.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -178.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.791 HG13 HG23 ' A' ' 173' ' ' VAL . 23.3 m -107.96 -5.29 10.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -178.594 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -72.11 148.75 45.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.0 0.428 . . . . 0.0 110.317 179.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . 0.425 ' OD1' ' O ' ' A' ' 176' ' ' ASP . 44.1 p-10 -76.08 129.97 37.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.145 0.497 . . . . 0.0 110.957 -179.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 74.6 m80 -100.94 -17.1 16.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.781 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 104.05 36.68 3.1 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 110.109 -1.196 . . . . 0.0 110.109 -179.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -153.48 164.36 38.33 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.926 -0.637 . . . . 0.0 110.311 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -87.51 105.66 17.46 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 177.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . 0.423 ' HG2' ' N ' ' A' ' 182' ' ' ILE . 76.0 tt0 -138.79 161.69 36.61 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.507 0.67 . . . . 0.0 111.944 -177.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.423 ' N ' ' HG2' ' A' ' 181' ' ' GLU . 17.8 tt -128.99 136.92 58.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.142 178.454 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 70.9 m -129.25 123.69 32.58 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.109 0.481 . . . . 0.0 110.915 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 85.2 mt -109.47 131.71 54.81 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.349 0.595 . . . . 0.0 109.524 178.616 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.459 HD13 ' CD2' ' B' ' 702' ' ' LEU . 82.6 mt -112.46 124.38 69.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.134 -179.484 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . 0.485 HG22 ' N ' ' A' ' 187' ' ' CYS . 90.8 m -138.11 156.87 47.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.152 -179.566 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' CYS . . . . . 0.485 ' N ' HG22 ' A' ' 186' ' ' THR . 17.4 m -87.66 139.52 30.45 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.594 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.721 HG22 ' CD2' ' A' ' 197' ' ' TYR . 62.3 t -62.59 -46.86 95.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.731 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 18.1 t -172.59 155.06 3.24 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.696 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 55.3 t -68.85 -17.07 21.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.395 179.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -98.88 -9.07 24.71 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.104 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 65.5 t0 -134.73 95.1 3.28 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.769 -0.373 . . . . 0.0 111.009 -179.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -105.98 5.89 30.81 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.135 0.493 . . . . 0.0 110.755 179.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 57.1 m -60.51 -40.9 93.09 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.484 -179.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -131.67 153.2 50.23 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.797 -0.361 . . . . 0.0 110.527 -179.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . 0.831 ' NH2' HD22 ' B' ' 702' ' ' LEU . 59.2 ttp180 -131.27 125.92 34.07 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 120.806 -0.358 . . . . 0.0 110.175 179.442 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . 0.721 ' CD2' HG22 ' A' ' 188' ' ' VAL . 29.2 m-85 -87.76 142.7 27.62 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.166 0.508 . . . . 0.0 110.759 -179.336 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 43.2 t -122.04 130.16 74.8 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.648 179.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.925 HG22 HG12 ' A' ' 163' ' ' VAL . 50.4 t -99.57 132.98 44.0 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.516 -179.439 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -118.9 149.21 41.96 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 121.166 0.508 . . . . 0.0 111.39 -179.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -145.34 146.09 15.99 Favored Glycine 0 CA--C 1.534 1.256 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -105.57 143.55 33.58 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 121.062 0.458 . . . . 0.0 111.954 -179.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 38.5 tp -65.97 132.04 47.65 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 178.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 2.1 p -112.38 -19.49 6.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 120.471 -0.492 . . . . 0.0 111.598 -179.194 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -179.82 173.98 45.57 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 120.497 -0.858 . . . . 0.0 112.038 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 90.8 m -142.31 139.19 31.75 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 179.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -144.03 118.36 9.61 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 120.152 -0.619 . . . . 0.0 111.233 179.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -64.19 143.28 58.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.824 -179.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 48.9 mtpt -81.64 107.7 14.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.57 178.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 20.0 pttp . . . . . 0 C--N 1.326 -0.426 0 CA-C-O 117.942 -1.027 . . . . 0.0 110.399 179.814 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 701' ' ' BOC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 702' ' ' LEU . . . . . 0.831 HD22 ' NH2' ' A' ' 196' ' ' ARG . 2.1 mt -101.79 109.32 59.24 Favored Pre-proline 0 CA--C 1.538 0.512 0 N-CA-C 110.577 -0.157 . . . . 20.0 110.577 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 703' ' ' PRO . . . . . 0.634 ' CD ' HG13 ' A' ' 110' ' ' VAL . 3.7 Cg_exo -62.93 -160.92 0.03 OUTLIER 'Trans proline' 0 N--CA 1.488 1.199 0 C-N-CA 122.303 2.002 . . . . 20.0 113.836 -179.372 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 704' ' ' ALA . . . . . 0.606 ' C ' HG2A ' B' ' 705' ' ' B27 . . . -44.79 -153.99 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.04 -1.436 . . . . 20.0 114.708 -178.037 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 705' ' ' B27 . . . . . 0.688 ' HXA' HH11 ' A' ' 196' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.364 0 N-CA-C 109.161 -1.576 . . . . 0.0 109.161 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 86.7 p -77.2 164.76 25.33 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.24 0.543 . . . . 0.0 110.431 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 48.4 t-80 -130.4 146.94 52.04 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.473 -179.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 78.5 mtm -87.43 134.49 33.58 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 121.383 0.611 . . . . 0.0 111.692 -179.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.476 ' OD1' ' N ' ' A' ' 58' ' ' ALA . 62.2 t0 -63.45 136.29 57.5 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.544 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.476 ' N ' ' OD1' ' A' ' 57' ' ' ASP . . . -95.25 8.13 44.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.919 -179.273 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.517 ' CB ' ' O ' ' B' ' 702' ' ' LEU . 93.0 p -80.35 20.07 0.72 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.955 0.407 . . . . 0.0 111.56 -179.407 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -102.69 12.72 35.93 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.633 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.1 mt -56.17 142.31 11.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 122.197 0.999 . . . . 0.0 113.078 -177.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 51.1 t0 -78.27 125.91 30.03 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 113.983 -1.462 . . . . 0.0 109.438 179.134 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.499 HE22 ' HB2' ' A' ' 103' ' ' LEU . 0.1 OUTLIER -79.23 128.65 75.1 Favored Pre-proline 0 C--N 1.325 -0.469 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 -179.875 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -52.37 149.87 21.88 Favored 'Trans proline' 0 N--CA 1.486 1.043 0 C-N-CA 121.307 1.338 . . . . 0.0 112.097 -179.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -51.94 175.62 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.624 0.726 . . . . 0.0 111.923 -178.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.565 ' N ' HD12 ' A' ' 66' ' ' LEU . 10.9 mp -70.17 -10.08 57.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.695 -178.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -67.19 -34.39 77.41 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.547 0.689 . . . . 0.0 110.007 178.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.491 ' O ' ' CB ' ' A' ' 72' ' ' ALA . 78.9 mm-40 -77.53 -20.95 53.4 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.26 -179.58 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 96.7 t -71.31 -46.58 64.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.316 0.579 . . . . 0.0 110.69 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -89.11 -10.58 46.8 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.876 -179.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -105.42 -26.16 12.06 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 120.465 -0.494 . . . . 0.0 112.132 -179.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.491 ' CB ' ' O ' ' A' ' 68' ' ' GLU . . . -68.28 136.59 53.72 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.728 0.775 . . . . 0.0 112.31 -179.02 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 7.8 m -59.82 102.8 0.17 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.133 179.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -68.62 129.15 39.1 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.104 0.478 . . . . 0.0 110.777 -179.685 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -98.02 80.48 2.72 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.171 0.51 . . . . 0.0 110.443 179.16 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -62.56 -36.57 83.07 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.311 0.577 . . . . 0.0 111.314 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.584 ' CD ' ' H ' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -70.2 -18.39 63.18 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.415 -177.062 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 99.0 mm-40 -90.61 0.61 57.31 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 121.239 0.542 . . . . 0.0 110.029 179.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 75.4 t -87.76 128.37 40.26 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.981 179.104 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.642 HD13 ' HE3' ' A' ' 96' ' ' LYS . 39.6 pt -111.4 -5.13 11.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.846 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -166.03 168.35 39.73 Favored Glycine 0 CA--C 1.535 1.31 0 C-N-CA 120.56 -0.829 . . . . 0.0 112.061 -179.491 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 61.7 ttp180 -137.85 154.91 49.45 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 121.127 0.489 . . . . 0.0 111.272 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.535 HG22 ' O ' ' A' ' 92' ' ' LEU . 14.6 tt -119.52 140.65 42.78 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.955 178.638 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 47.5 t -136.26 130.45 33.06 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.378 0.609 . . . . 0.0 111.813 -178.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.51 ' CG2' HG22 ' A' ' 88' ' ' VAL . 57.2 mt -136.91 86.07 21.87 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.839 179.429 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -56.34 -31.97 86.8 Favored 'Trans proline' 0 N--CA 1.497 1.706 0 C-N-CA 123.076 2.517 . . . . 0.0 112.666 -179.057 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 70.9 m -53.83 -41.24 67.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.275 0.559 . . . . 0.0 110.76 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.51 HG22 ' CG2' ' A' ' 85' ' ' ILE . 27.2 m -113.78 12.83 8.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.032 178.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.7 m 48.26 48.8 18.47 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.421 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 64.5 tp -114.04 133.27 55.63 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.949 -179.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -148.07 127.51 13.15 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.862 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.545 HD13 ' HA3' ' A' ' 106' ' ' GLY . 90.2 mt -151.55 151.09 28.12 Favored Pre-proline 0 N--CA 1.471 0.61 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.563 -179.128 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -75.62 147.42 31.65 Favored 'Trans proline' 0 N--CA 1.495 1.601 0 C-N-CA 122.713 2.275 . . . . 0.0 111.712 178.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.599 ' C ' HD12 ' A' ' 95' ' ' LEU . 49.6 t -97.15 119.17 44.85 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-O 121.19 0.519 . . . . 0.0 111.896 -179.598 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.6 ' N ' HD12 ' A' ' 95' ' ' LEU . 10.0 mp -104.69 141.08 37.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.527 179.182 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.642 ' HE3' HD13 ' A' ' 80' ' ' ILE . 98.5 mttt -64.37 -84.88 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -178.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 82.5 p -62.75 142.27 58.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.177 0.513 . . . . 0.0 111.502 -178.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 46.8 m -97.13 76.14 2.64 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.244 -179.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.594 HG22 ' N ' ' A' ' 100' ' ' GLU . 52.2 m -92.53 168.27 11.37 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 178.485 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.594 ' N ' HG22 ' A' ' 99' ' ' THR . 78.2 tt0 -57.53 -44.73 85.32 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 119.686 -0.806 . . . . 0.0 110.118 -179.532 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -62.93 -41.89 99.63 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.497 179.114 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -63.41 -36.66 84.46 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.681 -178.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.499 ' HB2' HE22 ' A' ' 63' ' ' GLN . 89.8 mt -63.26 -21.97 66.58 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.302 -0.408 . . . . 0.0 112.097 -179.224 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 96.6 mt -70.17 -23.0 62.91 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.899 0.38 . . . . 0.0 110.309 179.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 6.1 m -72.5 -10.28 59.6 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 121.271 0.558 . . . . 0.0 110.036 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.545 ' HA3' HD13 ' A' ' 92' ' ' LEU . . . 90.99 -18.23 51.98 Favored Glycine 0 CA--C 1.531 1.075 0 CA-C-N 115.642 -0.708 . . . . 0.0 113.43 177.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -145.03 124.9 13.42 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 119.418 -0.913 . . . . 0.0 112.688 -179.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -147.45 141.49 25.99 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.043 -0.98 . . . . 0.0 109.883 178.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.647 ' HA ' HD23 ' A' ' 123' ' ' LEU . 19.0 p -69.33 136.51 51.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.243 0.544 . . . . 0.0 111.568 -179.161 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.607 HG13 ' CD ' ' B' ' 703' ' ' PRO . 69.4 t -75.76 -45.8 37.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.394 179.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.421 ' O ' ' HG2' ' A' ' 114' ' ' GLN . 97.4 mttt -111.98 144.71 40.87 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 122.312 1.054 . . . . 0.0 113.11 179.273 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -66.69 -32.41 73.71 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.276 -1.329 . . . . 0.0 112.374 -178.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -85.34 18.82 2.51 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 -177.12 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.497 ' OE1' ' O ' ' A' ' 120' ' ' ASN . 98.0 mm-40 -76.43 137.84 39.97 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 121.73 -0.606 . . . . 0.0 111.678 179.698 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 25.3 t -128.47 120.38 52.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.443 179.214 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . 0.563 ' SD ' ' OD1' ' A' ' 151' ' ' ASP . 47.1 mtt -57.67 135.81 56.77 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.708 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.427 ' O ' ' OD2' ' A' ' 180' ' ' ASP . . . 75.15 -6.01 30.75 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 121.152 -0.546 . . . . 0.0 112.606 178.37 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -137.35 126.99 25.28 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.496 0.665 . . . . 0.0 111.436 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 77.18 -169.45 54.93 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 110.768 -0.933 . . . . 0.0 110.768 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.497 ' O ' ' OE1' ' A' ' 114' ' ' GLN . 59.1 t-20 -87.97 106.34 18.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.997 0.427 . . . . 0.0 110.27 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.462 ' CE2' HD21 ' A' ' 123' ' ' LEU . 9.5 t80 -85.13 145.77 27.46 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 179.493 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -147.6 140.05 24.58 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.719 0.771 . . . . 0.0 111.587 -179.023 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.647 HD23 ' HA ' ' A' ' 109' ' ' THR . 71.3 mt -137.62 144.14 41.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.475 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -106.88 136.85 46.02 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.051 0.453 . . . . 0.0 109.826 179.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -144.77 131.99 4.54 Favored Glycine 0 CA--C 1.532 1.143 0 N-CA-C 110.233 -1.147 . . . . 0.0 110.233 -179.197 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.522 ' O ' ' O ' ' A' ' 134' ' ' LEU . 0.5 OUTLIER -78.71 151.76 31.96 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -178.651 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 46.3 t30 -141.63 121.14 13.27 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 115.415 -0.812 . . . . 0.0 110.173 178.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.484 ' O ' ' CB ' ' A' ' 129' ' ' SER . 61.5 mtt -97.03 -3.25 41.78 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.104 0.478 . . . . 0.0 110.66 -179.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.484 ' CB ' ' O ' ' A' ' 128' ' ' MET . 1.2 p 78.76 19.57 0.85 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.377 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.664 ' O ' HG12 ' A' ' 133' ' ' VAL . 8.7 ptpt -123.29 104.94 9.44 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.964 0.888 . . . . 0.0 112.706 -178.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.406 ' C ' ' O ' ' A' ' 130' ' ' LYS . 29.4 tptp -34.58 125.23 0.52 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.269 -1.332 . . . . 0.0 111.067 179.451 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 109.5 -10.03 32.92 Favored Glycine 0 N--CA 1.449 -0.475 0 N-CA-C 108.973 -1.651 . . . . 0.0 108.973 -178.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.664 HG12 ' O ' ' A' ' 130' ' ' LYS . 9.0 p -93.09 161.68 2.51 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.796 HD23 ' N ' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -69.76 139.46 53.3 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.78 0.8 . . . . 0.0 113.038 -177.686 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.495 ' CD2' HD12 ' A' ' 138' ' ' ILE . 3.6 m-85 63.17 9.1 3.69 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 114.434 -1.257 . . . . 0.0 113.297 178.46 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . 0.403 ' HB3' HG13 ' A' ' 133' ' ' VAL . 0.0 OUTLIER -66.18 -35.26 80.0 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -179.806 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -92.62 0.73 57.47 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 121.108 0.48 . . . . 0.0 111.623 -178.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.495 HD12 ' CD2' ' A' ' 135' ' ' PHE . 3.4 tt -60.27 -37.72 74.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.069 -179.463 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.46 ' N ' ' CG2' ' A' ' 138' ' ' ILE . . . -65.99 -10.56 40.64 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.929 0.395 . . . . 0.0 111.148 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 5.8 m -82.53 -4.38 57.48 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.975 0.417 . . . . 0.0 111.126 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.479 HD21 HG21 ' A' ' 85' ' ' ILE . 76.6 mt -64.53 145.07 56.69 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 121.284 0.564 . . . . 0.0 111.258 -179.415 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -123.88 157.66 33.71 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.895 -179.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -50.14 134.59 22.07 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.519 -0.764 . . . . 0.0 112.085 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.601 ' N ' ' O ' ' A' ' 160' ' ' VAL . . . 77.02 7.39 86.65 Favored Glycine 0 CA--C 1.532 1.096 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.307 178.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -73.54 137.47 44.39 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 119.631 -0.828 . . . . 0.0 110.605 -179.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -81.16 140.48 34.97 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.667 0.746 . . . . 0.0 111.973 -178.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.461 HG23 HG12 ' A' ' 85' ' ' ILE . 88.3 mt -137.15 138.03 45.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 114.751 -1.113 . . . . 0.0 108.221 178.232 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . 0.557 ' C ' HD23 ' A' ' 149' ' ' LEU . 96.2 m-85 -123.5 137.94 54.68 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 113.464 0.913 . . . . 0.0 113.464 -177.457 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.557 HD23 ' C ' ' A' ' 148' ' ' TYR . 0.9 OUTLIER -112.49 133.24 54.66 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 177.467 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.443 ' CZ ' ' OE2' ' A' ' 155' ' ' GLU . 58.7 m-85 -109.5 109.36 20.15 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.172 -0.611 . . . . 0.0 111.618 179.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . 0.563 ' OD1' ' SD ' ' A' ' 116' ' ' MET . 7.8 m-20 -89.53 166.61 13.55 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 177.439 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -58.6 -23.67 59.29 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 120.246 -0.581 . . . . 0.0 111.143 -178.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -109.78 -28.76 8.63 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -178.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -150.5 -174.95 4.91 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 -177.135 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.443 ' OE2' ' CZ ' ' A' ' 150' ' ' TYR . 86.8 tt0 -131.88 139.25 48.72 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 114.122 -1.399 . . . . 0.0 110.083 178.612 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -113.57 137.84 51.0 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 121.073 0.463 . . . . 0.0 111.648 -179.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -94.24 112.89 24.73 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.392 179.248 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 41.3 m-85 -114.51 148.39 37.99 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 120.975 0.417 . . . . 0.0 111.436 179.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -121.5 121.37 37.35 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.446 179.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.601 ' O ' ' N ' ' A' ' 144' ' ' GLY . 97.4 t -59.97 137.2 22.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.942 177.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 24.1 p -105.68 -23.94 12.64 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 120.749 -0.38 . . . . 0.0 111.343 179.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 154.55 -161.67 30.3 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 120.649 -0.786 . . . . 0.0 111.355 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.931 HG12 HG22 ' A' ' 199' ' ' VAL . 25.3 m -132.58 162.41 39.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-O 120.832 0.348 . . . . 0.0 110.349 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 83.1 p -146.87 163.96 34.42 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.404 0.621 . . . . 0.0 111.518 -179.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -100.88 117.65 35.37 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.704 -179.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 16.4 m -137.8 158.79 33.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.235 0.54 . . . . 0.0 111.372 179.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -94.0 158.41 36.26 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.592 179.327 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.458 ' O ' ' CB ' ' B' ' 702' ' ' LEU . 29.0 Cg_endo -61.9 -17.15 53.95 Favored 'Trans proline' 0 C--N 1.301 -1.949 0 C-N-CA 122.619 2.213 . . . . 0.0 113.555 -179.619 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 51.1 p-10 -93.02 -6.03 49.2 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 119.501 -0.879 . . . . 0.0 112.511 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -75.47 96.17 3.42 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 119.878 -0.729 . . . . 0.0 111.421 179.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' TRP . . . . . 0.432 ' CD1' ' N ' ' A' ' 171' ' ' TRP . 23.1 m0 -78.7 -15.46 58.44 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.817 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -58.28 -28.88 65.36 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.917 -179.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . 0.854 HG13 HG23 ' A' ' 174' ' ' VAL . 10.5 p -62.39 -25.1 36.93 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 CA-C-O 121.031 0.444 . . . . 0.0 111.192 -179.237 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.854 HG23 HG13 ' A' ' 173' ' ' VAL . 59.6 t -105.56 -8.11 10.03 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -178.628 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.44 ' O ' ' CE1' ' A' ' 177' ' ' HIS . 96.7 mt-10 -73.49 144.2 46.3 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 122.08 -0.387 . . . . 0.0 110.663 179.72 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 34.0 p-10 -62.74 144.5 56.36 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.329 0.585 . . . . 0.0 111.661 -179.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' HIS . . . . . 0.44 ' CE1' ' O ' ' A' ' 175' ' ' GLU . 68.8 m80 -122.14 19.73 10.7 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.922 -179.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 64.7 39.06 96.4 Favored Glycine 0 CA--C 1.532 1.095 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 179.461 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 13.1 ptmt -161.67 166.93 26.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.858 0.361 . . . . 0.0 110.15 179.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.854 ' OD2' HD22 ' A' ' 203' ' ' LEU . 48.1 t0 -90.19 100.23 13.09 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.18 0.514 . . . . 0.0 110.195 178.625 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . 0.433 ' HG2' ' N ' ' A' ' 182' ' ' ILE . 84.1 tt0 -131.33 164.59 25.31 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.448 -179.062 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.523 HG22 ' O ' ' A' ' 201' ' ' GLY . 21.2 tt -128.18 137.26 57.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.928 179.251 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . 0.761 HG21 HG22 ' A' ' 173' ' ' VAL . 94.3 m -124.64 122.44 37.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.061 -179.265 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.443 ' HB3' HD11 ' A' ' 138' ' ' ILE . 69.5 mt -111.35 128.99 56.14 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 178.498 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.554 HD13 HD21 ' B' ' 702' ' ' LEU . 93.3 mt -110.09 123.67 66.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.397 0.618 . . . . 0.0 111.068 -179.267 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 3.6 t -138.95 158.82 43.51 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.825 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' CYS . . . . . . . . . . . . . 1.3 m -101.63 143.8 31.15 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.164 0.507 . . . . 0.0 111.247 -179.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.685 HG22 ' CD2' ' A' ' 197' ' ' TYR . 95.5 t -62.71 -47.6 92.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.691 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 20.4 t -168.4 144.55 3.75 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.309 179.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . 0.544 HG22 ' O ' ' A' ' 190' ' ' VAL . 10.8 p -60.99 -6.28 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.138 0.494 . . . . 0.0 110.69 -179.6 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -101.66 -35.43 9.11 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.848 179.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -99.11 110.14 22.76 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.476 -179.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -110.73 7.71 22.24 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.646 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 6.1 t -61.53 -47.18 86.75 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.995 0.426 . . . . 0.0 111.864 -178.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -146.82 158.78 44.0 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.919 -179.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 83.9 mtt85 -128.14 141.45 51.48 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.159 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . 0.685 ' CD2' HG22 ' A' ' 188' ' ' VAL . 43.1 m-85 -90.91 144.45 25.67 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 120.948 0.404 . . . . 0.0 110.844 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 39.4 t -127.42 133.94 66.82 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-O 121.361 0.601 . . . . 0.0 111.032 179.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.931 HG22 HG12 ' A' ' 163' ' ' VAL . 39.1 t -105.25 131.38 54.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.502 179.489 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -119.66 148.27 43.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.466 0.65 . . . . 0.0 111.588 -179.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . 0.523 ' O ' HG22 ' A' ' 182' ' ' ILE . . . -142.63 152.32 23.75 Favored Glycine 0 CA--C 1.533 1.16 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 179.296 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . 0.432 ' O ' ' OD1' ' A' ' 202' ' ' ASP . 52.7 p-10 -113.11 155.35 25.08 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.377 -0.529 . . . . 0.0 110.988 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . 0.854 HD22 ' OD2' ' A' ' 180' ' ' ASP . 60.3 tp -74.3 130.22 39.28 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.314 -0.554 . . . . 0.0 109.562 179.281 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 16.9 m -116.6 -18.24 7.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 C-N-CA 120.371 -0.532 . . . . 0.0 111.357 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -179.98 174.65 46.05 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 120.419 -0.896 . . . . 0.0 112.304 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 40.4 m -140.61 136.59 32.91 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.486 -0.357 . . . . 0.0 110.219 179.367 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 51.6 mttp -141.25 114.62 8.78 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.29 -0.564 . . . . 0.0 111.996 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -64.43 145.81 55.5 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.335 0.588 . . . . 0.0 111.076 179.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 21.2 ttpt -81.07 112.44 18.45 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.616 178.34 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 98.7 mttt . . . . . 0 C--O 1.22 -0.457 0 CA-C-O 118.027 -0.987 . . . . 0.0 110.675 -179.879 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 701' ' ' BOC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 702' ' ' LEU . . . . . 0.554 HD21 HD13 ' A' ' 185' ' ' ILE . 1.0 OUTLIER -108.13 105.48 56.57 Favored Pre-proline 0 CA--C 1.541 0.611 0 N-CA-C 110.193 -0.299 . . . . 20.0 110.193 . . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 703' ' ' PRO . . . . . 0.607 ' CD ' HG13 ' A' ' 110' ' ' VAL . 4.0 Cg_exo -63.0 -174.4 0.18 Allowed 'Trans proline' 0 N--CA 1.492 1.441 0 C-N-CA 122.125 1.884 . . . . 20.0 113.896 -178.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 704' ' ' ALA . . . . . 0.531 ' C ' HG2A ' B' ' 705' ' ' B27 . . . -39.49 -176.01 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.084 -1.416 . . . . 20.0 113.26 -178.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 705' ' ' B27 . . . . . 0.531 HG2A ' C ' ' B' ' 704' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.501 0 N-CA-C 110.183 -1.167 . . . . 0.0 110.183 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 77.7 p -69.27 -35.41 76.03 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 121.16 0.505 . . . . 0.0 110.517 179.5 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 72.9 m80 -118.19 138.54 52.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.39 179.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 68.3 mtt -81.16 137.89 35.89 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.949 -179.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -64.67 144.48 57.2 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.475 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -99.06 1.25 45.09 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.237 0.541 . . . . 0.0 110.991 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.489 ' CB ' ' O ' ' B' ' 702' ' ' LEU . 52.1 p -80.65 17.64 1.1 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.532 -179.146 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 59.1 pttt -105.68 21.11 17.81 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.162 0.505 . . . . 0.0 111.334 -179.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.0 mt -56.59 139.47 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-O 122.366 1.079 . . . . 0.0 113.141 -177.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.448 ' OD1' ' N ' ' A' ' 62' ' ' ASP . 24.6 p-10 -76.84 130.08 37.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 113.576 -1.647 . . . . 0.0 109.819 179.028 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.508 ' NE2' ' O ' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -77.19 151.56 81.42 Favored Pre-proline 0 C--N 1.325 -0.472 0 C-N-CA 120.148 -0.621 . . . . 0.0 110.437 -179.393 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -72.78 168.98 23.13 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.669 2.246 . . . . 0.0 111.729 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.674 ' O ' HG23 ' A' ' 69' ' ' VAL . 85.5 m-20 -52.18 166.58 0.16 Allowed 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.102 0.477 . . . . 0.0 111.685 -178.578 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 56.8 tp -64.9 -46.88 79.88 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.459 -178.492 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.22 -39.33 94.33 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.502 -0.479 . . . . 0.0 111.618 -178.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -57.13 -25.38 58.74 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.02 -0.672 . . . . 0.0 109.745 179.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.674 HG23 ' O ' ' A' ' 65' ' ' ASP . 20.0 t -79.42 -45.64 23.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.463 179.542 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -77.06 -9.43 58.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 114.837 -1.074 . . . . 0.0 111.796 -179.153 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 24.5 m120 -103.56 -14.24 16.25 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.371 0.605 . . . . 0.0 110.097 179.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -69.06 145.32 53.58 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.374 -0.83 . . . . 0.0 112.027 -179.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 25.9 p -59.5 104.04 0.24 Allowed 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 121.701 0.762 . . . . 0.0 111.033 -179.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.66 130.52 42.6 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.008 -0.996 . . . . 0.0 111.315 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.518 ' OD2' ' NE2' ' A' ' 78' ' ' GLN . 59.8 t0 -104.38 77.46 1.4 Allowed 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 121.168 0.509 . . . . 0.0 110.64 178.411 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -69.3 -31.11 69.38 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.898 -0.592 . . . . 0.0 112.31 179.049 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 41.0 mmtt -67.6 -29.16 68.43 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -175.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.518 ' NE2' ' OD2' ' A' ' 75' ' ' ASP . 76.7 mt-30 -88.63 -1.66 58.19 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 120.324 -0.551 . . . . 0.0 111.258 -179.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 53.3 t -72.72 128.91 35.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.038 178.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.442 HD13 ' HE2' ' A' ' 96' ' ' LYS . 36.0 pt -113.94 -4.4 11.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 C-N-CA 120.671 -0.411 . . . . 0.0 112.045 179.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.415 ' O ' HG22 ' A' ' 94' ' ' VAL . . . -164.74 169.96 39.65 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 120.214 -0.993 . . . . 0.0 111.629 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 62.6 ttp180 -142.84 141.59 31.63 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.36 0.6 . . . . 0.0 111.573 -179.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.464 HG22 ' O ' ' A' ' 92' ' ' LEU . 19.5 tt -103.2 140.33 21.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.263 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 47.3 t -135.6 129.95 33.68 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.274 -0.875 . . . . 0.0 111.156 -179.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.419 HG12 HG23 ' A' ' 147' ' ' ILE . 96.7 mt -140.49 93.93 8.6 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 114.702 -1.135 . . . . 0.0 109.608 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -66.46 -22.95 51.23 Favored 'Trans proline' 0 N--CA 1.493 1.457 0 C-N-CA 121.574 1.516 . . . . 0.0 113.027 -178.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 94.4 p -55.23 -42.26 73.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.186 0.517 . . . . 0.0 110.215 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.434 HG11 ' O ' ' A' ' 137' ' ' ASP . 31.7 m -114.03 5.4 7.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.416 0.627 . . . . 0.0 110.294 179.046 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 2.4 m 56.12 52.57 10.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.779 179.266 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.403 HD11 ' CD1' ' A' ' 92' ' ' LEU . 54.6 tp -114.5 131.93 56.47 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.155 179.286 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -144.75 118.68 9.33 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.618 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.464 ' O ' HG22 ' A' ' 83' ' ' ILE . 91.1 mt -148.71 151.36 35.38 Favored Pre-proline 0 CA--C 1.538 0.495 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.628 -178.042 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -79.39 146.0 19.21 Favored 'Trans proline' 0 N--CA 1.492 1.399 0 C-N-CA 122.597 2.198 . . . . 0.0 111.31 178.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.579 HG23 ' O ' ' A' ' 94' ' ' VAL . 3.1 m -94.4 121.08 44.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-O 121.239 0.543 . . . . 0.0 111.269 179.614 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.559 ' N ' HD12 ' A' ' 95' ' ' LEU . 10.7 mp -100.24 139.65 35.6 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.604 -179.604 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.532 ' O ' ' OG1' ' A' ' 109' ' ' THR . 99.0 mttt -60.54 -91.1 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 121.427 0.632 . . . . 0.0 112.01 -179.263 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.435 ' OG ' ' ND2' ' A' ' 102' ' ' ASN . 6.5 p -58.87 143.39 47.77 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 121.617 0.722 . . . . 0.0 112.742 -178.258 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 87.5 p -92.39 69.94 5.08 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.037 -0.983 . . . . 0.0 111.284 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.427 HG23 ' OG ' ' A' ' 97' ' ' SER . 62.8 p -91.39 168.34 11.63 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 178.305 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -62.58 -43.46 98.75 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 119.797 -0.761 . . . . 0.0 109.529 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -65.84 -40.79 92.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.872 179.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.435 ' ND2' ' OG ' ' A' ' 97' ' ' SER . 93.4 m-20 -64.2 -37.38 87.25 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.984 -179.455 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 54.7 mt -68.47 -8.4 40.57 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.951 -179.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.507 ' HB3' HG13 ' A' ' 69' ' ' VAL . 96.1 mt -72.84 -23.19 60.73 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.814 0.34 . . . . 0.0 110.444 179.07 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 95.2 p -75.32 -2.94 30.66 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.143 0.497 . . . . 0.0 110.199 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.473 ' HA3' HD12 ' A' ' 134' ' ' LEU . . . 83.76 -13.01 50.43 Favored Glycine 0 CA--C 1.531 1.036 0 CA-C-N 115.632 -0.713 . . . . 0.0 113.384 178.185 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -145.02 126.1 14.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 117.467 0.634 . . . . 0.0 111.81 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -148.13 141.43 25.18 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.356 178.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.611 ' HA ' HD23 ' A' ' 123' ' ' LEU . 36.3 p -64.67 138.1 58.2 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.432 0.634 . . . . 0.0 110.888 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.578 HG13 ' CD ' ' B' ' 703' ' ' PRO . 42.1 t -75.76 -24.74 17.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.624 -179.524 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.463 ' HG3' HG12 ' A' ' 110' ' ' VAL . 97.3 mttt -141.23 149.51 41.45 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 122.394 1.092 . . . . 0.0 112.43 178.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 77.8 mt-10 -65.35 -32.39 74.01 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.008 -1.451 . . . . 0.0 112.296 -178.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 21.9 m120 -82.06 10.98 5.64 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 113.083 0.772 . . . . 0.0 113.083 -177.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.429 ' OE1' ' O ' ' A' ' 120' ' ' ASN . 86.5 mm-40 -77.08 132.5 38.93 Favored 'General case' 0 C--N 1.329 -0.285 0 O-C-N 121.955 -0.466 . . . . 0.0 110.667 179.174 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 56.4 t -123.94 124.68 69.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.519 0 CA-C-O 121.245 0.545 . . . . 0.0 110.78 179.163 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . 0.671 ' SD ' ' CZ ' ' A' ' 121' ' ' TYR . 94.7 mmm -54.12 126.15 21.71 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -179.389 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 72.53 6.76 67.01 Favored Glycine 0 CA--C 1.531 1.092 0 CA-C-N 115.941 -0.572 . . . . 0.0 112.751 177.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -136.93 127.99 27.74 Favored 'General case' 0 C--N 1.328 -0.341 0 O-C-N 122.389 -0.477 . . . . 0.0 111.419 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 71.76 -164.19 54.18 Favored Glycine 0 CA--C 1.531 1.069 0 N-CA-C 110.388 -1.085 . . . . 0.0 110.388 -179.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.429 ' O ' ' OE1' ' A' ' 114' ' ' GLN . 64.8 t-20 -87.59 103.4 15.52 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.48 -0.488 . . . . 0.0 109.794 179.266 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.671 ' CZ ' ' SD ' ' A' ' 116' ' ' MET . 17.4 t80 -86.79 145.95 26.42 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.76 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -147.49 143.39 27.82 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.735 0.779 . . . . 0.0 111.473 -179.183 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.611 HD23 ' HA ' ' A' ' 109' ' ' THR . 42.9 mt -139.38 145.99 39.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.765 -179.488 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -110.66 139.64 45.75 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -136.27 144.92 16.79 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.314 -1.114 . . . . 0.0 110.314 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.463 ' O ' ' O ' ' A' ' 134' ' ' LEU . 21.7 m-70 -88.49 150.69 22.99 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.881 0.372 . . . . 0.0 111.253 -179.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.654 HD21 ' N ' ' A' ' 187' ' ' CYS . 41.5 p30 -146.71 152.57 39.04 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.226 0.536 . . . . 0.0 110.43 179.183 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.544 ' CG ' HG21 ' A' ' 133' ' ' VAL . 58.4 mtt -116.42 -2.29 12.08 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.166 -179.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.5 ' CB ' ' O ' ' A' ' 128' ' ' MET . 0.7 OUTLIER 80.18 5.75 1.76 Allowed 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.201 179.83 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.834 ' O ' HG12 ' A' ' 133' ' ' VAL . 8.5 ptpt -114.5 122.76 47.56 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.613 0.72 . . . . 0.0 112.479 -179.61 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 14.6 tmtt? -44.3 127.51 5.74 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.202 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 106.29 -11.08 43.6 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.834 HG12 ' O ' ' A' ' 130' ' ' LYS . 9.0 p -94.02 172.85 0.96 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.135 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.595 ' H ' HG22 ' A' ' 133' ' ' VAL . 3.8 mm? -68.76 133.09 47.86 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 116.165 1.913 . . . . 0.0 116.165 -176.48 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.428 ' CD2' HD13 ' A' ' 138' ' ' ILE . 2.7 m-85 53.69 16.19 0.94 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 113.524 -1.671 . . . . 0.0 114.291 176.496 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 5.3 t -68.94 -39.07 79.77 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.434 ' O ' HG11 ' A' ' 88' ' ' VAL . 68.0 m-20 -91.33 2.01 56.7 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 -176.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.56 HD11 ' HB ' ' A' ' 186' ' ' THR . 28.4 pt -65.86 -22.88 31.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 119.073 -1.051 . . . . 0.0 109.922 -179.326 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -70.31 -8.64 51.97 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.194 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 33.6 t -83.04 -5.29 59.05 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.589 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 86.2 mt -63.26 147.79 50.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.808 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 99.9 mttt -124.25 158.89 31.43 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.438 0.637 . . . . 0.0 111.551 -178.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -49.9 131.3 22.5 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.048 179.044 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 160' ' ' VAL . . . 80.43 9.01 86.99 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 120.408 -0.901 . . . . 0.0 112.273 178.379 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.492 ' OD1' ' N ' ' A' ' 146' ' ' LYS . 62.8 t0 -75.04 131.53 40.65 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 120.219 -0.592 . . . . 0.0 110.584 -179.302 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.492 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 74.8 mmtt -77.08 137.03 38.69 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 121.84 0.828 . . . . 0.0 112.232 -178.588 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.419 HG23 HG12 ' A' ' 85' ' ' ILE . 94.7 mt -138.61 140.17 39.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 114.529 -1.214 . . . . 0.0 108.574 178.345 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . 0.547 ' C ' HD23 ' A' ' 149' ' ' LEU . 12.8 m-85 -127.3 140.99 51.83 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 119.583 -0.847 . . . . 0.0 113.196 -177.726 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.547 HD23 ' C ' ' A' ' 148' ' ' TYR . 1.4 mt -114.54 131.72 56.56 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 177.462 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -107.67 112.68 25.5 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 120.007 -0.677 . . . . 0.0 111.007 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . 0.557 ' OD1' ' N ' ' A' ' 152' ' ' ASN . 58.4 t0 -90.21 163.1 14.93 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 177.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . 0.557 ' N ' ' OD1' ' A' ' 151' ' ' ASP . 8.6 t30 -56.32 -22.58 31.6 Favored 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 119.629 -0.828 . . . . 0.0 110.966 -178.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -110.36 -29.2 8.22 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -178.012 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -148.73 -176.97 5.53 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 119.359 -0.936 . . . . 0.0 113.32 -176.293 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 65.4 mt-10 -131.44 136.36 47.9 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 114.758 -1.11 . . . . 0.0 109.538 179.147 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -111.3 135.84 51.26 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.149 0.499 . . . . 0.0 111.741 -179.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . 0.41 ' O ' HD12 ' A' ' 203' ' ' LEU . 98.7 mt-10 -92.65 112.59 24.6 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.4 179.138 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -114.96 147.05 40.55 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.007 0.432 . . . . 0.0 110.523 179.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -122.85 123.46 41.05 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.063 0.459 . . . . 0.0 110.776 179.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.51 ' O ' ' N ' ' A' ' 144' ' ' GLY . 84.5 t -58.24 134.43 23.01 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.036 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 78.0 p -118.08 11.38 13.29 Favored 'General case' 0 CA--C 1.534 0.357 0 O-C-N 123.658 0.599 . . . . 0.0 111.415 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.433 ' H ' HG12 ' A' ' 160' ' ' VAL . . . 124.78 -175.26 17.18 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 120.747 -0.739 . . . . 0.0 111.895 179.073 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.461 HG12 HG22 ' A' ' 199' ' ' VAL . 28.5 m -128.15 160.88 37.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 179.52 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 68.2 m -135.98 159.67 40.98 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.571 0.7 . . . . 0.0 111.601 -179.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -105.31 116.09 31.35 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.596 -179.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.59 HG11 ' CG1' ' A' ' 173' ' ' VAL . 35.5 m -133.89 162.99 38.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.148 -179.696 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . 0.429 ' H ' ' HD2' ' A' ' 170' ' ' LYS . 0.1 OUTLIER -91.99 163.99 25.31 Favored Pre-proline 0 CA--C 1.538 0.511 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.222 179.379 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.459 ' O ' ' CB ' ' B' ' 702' ' ' LEU . 36.3 Cg_exo -61.09 -19.02 61.47 Favored 'Trans proline' 0 N--CA 1.502 1.982 0 C-N-CA 122.548 2.165 . . . . 0.0 113.479 179.447 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . 0.403 ' OD1' ' C ' ' A' ' 169' ' ' ASP . 41.0 p-10 -95.68 -6.33 40.21 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -178.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.734 ' O ' HG22 ' A' ' 173' ' ' VAL . 96.6 mttt -76.46 82.92 3.17 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 119.392 -0.923 . . . . 0.0 111.396 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' TRP . . . . . 0.51 ' O ' HG22 ' A' ' 174' ' ' VAL . 67.0 p-90 -70.72 -10.2 58.91 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.949 0.881 . . . . 0.0 109.521 179.259 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -62.69 -31.85 72.83 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.771 -1.104 . . . . 0.0 111.158 -179.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . 0.734 HG22 ' O ' ' A' ' 170' ' ' LYS . 34.6 m -62.58 -17.35 18.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-N 116.047 -0.524 . . . . 0.0 112.397 -179.081 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.684 HG13 HG23 ' A' ' 173' ' ' VAL . 30.3 m -112.87 -2.56 10.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -178.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -74.98 165.82 24.66 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 121.103 0.477 . . . . 0.0 110.949 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . 0.494 ' OD1' ' O ' ' A' ' 176' ' ' ASP . 36.5 p30 -67.33 137.49 56.07 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.075 179.582 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' HIS . . . . . 0.428 ' ND1' ' ND2' ' A' ' 120' ' ' ASN . 40.7 m80 -119.01 13.53 13.02 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.559 -179.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 62.39 41.61 99.75 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 121.003 -0.618 . . . . 0.0 111.627 179.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 12.9 ptmt -163.35 168.11 20.87 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.998 0.428 . . . . 0.0 110.832 179.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -88.15 93.48 9.51 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 178.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . 0.446 ' HG2' ' N ' ' A' ' 182' ' ' ILE . 84.6 tt0 -131.88 163.66 27.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.43 0.633 . . . . 0.0 112.106 -178.511 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.488 HG22 ' O ' ' A' ' 201' ' ' GLY . 18.0 tt -130.78 138.09 54.44 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.036 178.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 80.4 m -130.72 124.63 31.94 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.135 -179.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 87.6 mt -109.21 135.51 50.19 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.65 178.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 92.1 mt -113.21 127.69 70.36 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 CA-C-O 121.129 0.49 . . . . 0.0 110.983 -179.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . 0.56 ' HB ' HD11 ' A' ' 138' ' ' ILE . 13.6 t -139.77 156.81 46.56 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.623 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' CYS . . . . . 0.654 ' N ' HD21 ' A' ' 127' ' ' ASN . 2.3 m -93.19 143.68 26.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.388 0.613 . . . . 0.0 110.257 179.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.87 HG22 ' CE2' ' A' ' 197' ' ' TYR . 40.5 t -61.97 -46.99 95.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.429 -179.11 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 41.3 p -164.97 161.34 19.9 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.335 0.588 . . . . 0.0 110.903 -179.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . 0.456 ' O ' HG12 ' A' ' 190' ' ' VAL . 71.4 t -71.96 -13.08 16.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.321 179.347 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -97.71 -13.74 21.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.338 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -142.14 99.92 3.61 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.306 -0.558 . . . . 0.0 112.085 -179.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -103.78 11.35 35.91 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.577 178.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 41.1 m -63.64 -42.0 98.19 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.684 -179.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 43.3 mtmt -123.28 149.71 44.44 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.271 0.558 . . . . 0.0 111.183 -179.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . 0.546 ' HE ' ' CX ' ' B' ' 705' ' ' B27 . 85.0 mtt85 -133.23 139.98 47.27 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.431 -179.085 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . 0.87 ' CE2' HG22 ' A' ' 188' ' ' VAL . 42.8 m-85 -91.41 155.24 18.61 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.153 0.502 . . . . 0.0 111.021 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 3.0 m -131.46 129.25 61.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.603 178.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.461 HG22 HG12 ' A' ' 163' ' ' VAL . 58.9 t -97.12 130.43 45.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 178.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -107.81 131.71 54.19 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.217 0.532 . . . . 0.0 111.205 -178.239 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . 0.488 ' O ' HG22 ' A' ' 182' ' ' ILE . . . -132.23 131.9 6.44 Favored Glycine 0 CA--C 1.53 1.008 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -103.07 143.17 32.94 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 121.238 0.542 . . . . 0.0 111.247 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . 0.41 HD12 ' O ' ' A' ' 157' ' ' GLU . 35.8 tp -69.5 133.52 47.8 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.897 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 4.1 p -116.52 -17.53 7.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.69 -179.103 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 179.19 174.45 45.32 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 120.588 -0.815 . . . . 0.0 111.775 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 72.6 m -145.54 140.81 27.72 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.111 -0.545 . . . . 0.0 110.009 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -145.52 119.59 9.43 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 119.943 -0.703 . . . . 0.0 111.511 179.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -63.72 145.05 56.49 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.318 -0.855 . . . . 0.0 112.442 -179.191 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 8.6 ttpt -79.38 106.67 11.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.47 178.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 98.5 mttt . . . . . 0 C--O 1.22 -0.451 0 CA-C-O 117.93 -1.033 . . . . 0.0 110.287 -179.752 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 701' ' ' BOC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 702' ' ' LEU . . . . . 0.489 ' O ' ' CB ' ' A' ' 59' ' ' SER . 0.0 OUTLIER 57.66 94.56 0.05 OUTLIER Pre-proline 0 CA--C 1.542 0.671 0 N-CA-C 110.222 -0.288 . . . . 20.0 110.222 . . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 703' ' ' PRO . . . . . 0.578 ' CD ' HG13 ' A' ' 110' ' ' VAL . 3.8 Cg_exo -69.43 -173.39 0.66 Allowed 'Trans proline' 0 C--N 1.316 -1.158 0 C-N-CA 122.155 1.903 . . . . 20.0 112.202 179.76 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 704' ' ' ALA . . . . . 0.507 ' O ' ' O ' ' B' ' 703' ' ' PRO . . . -41.22 -179.52 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.962 -1.017 . . . . 20.0 113.506 -178.645 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 705' ' ' B27 . . . . . 0.546 ' CX ' ' HE ' ' A' ' 196' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.233 0 N-CA-C 109.038 -1.625 . . . . 0.0 109.038 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 42.4 t -70.31 144.96 51.56 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.309 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -68.3 -42.56 79.27 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.204 -0.598 . . . . 0.0 110.231 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 97.4 mtp -91.15 143.25 26.88 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.231 179.011 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 83.6 m-20 -64.91 144.23 57.42 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.399 0.619 . . . . 0.0 111.133 -179.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -95.73 0.59 52.65 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.815 179.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 85.2 p -85.72 4.92 34.53 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.65 -179.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -104.49 16.21 26.56 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 -178.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.0 mt -56.05 144.78 7.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 122.337 1.065 . . . . 0.0 112.931 -177.579 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 59.8 t0 -79.04 125.17 29.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 113.614 -1.63 . . . . 0.0 109.578 178.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.454 ' HB2' ' CG ' ' A' ' 126' ' ' HIS . 7.2 tp60 -78.7 136.17 59.35 Favored Pre-proline 0 C--N 1.322 -0.616 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -61.42 159.29 32.11 Favored 'Trans proline' 0 C--N 1.311 -1.399 0 C-N-CA 121.725 1.616 . . . . 0.0 113.083 -179.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.777 ' O ' HG23 ' A' ' 69' ' ' VAL . 97.6 m-20 -52.0 162.25 0.48 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.473 -178.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.493 ' N ' HD12 ' A' ' 66' ' ' LEU . 9.9 mp -62.75 -44.34 96.46 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.964 -178.436 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.58 -36.72 84.72 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 119.768 -0.773 . . . . 0.0 110.18 -179.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -62.91 -33.71 75.91 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.889 0.852 . . . . 0.0 108.812 177.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.777 HG23 ' O ' ' A' ' 65' ' ' ASP . 60.6 t -76.09 -45.65 35.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 114.607 -1.179 . . . . 0.0 110.923 179.288 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -72.31 -8.88 57.26 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.749 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -105.06 -10.54 17.11 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.631 0.729 . . . . 0.0 109.363 178.389 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.92 138.11 57.04 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.778 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 9.0 t -57.25 99.0 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.76 HD13 ' C ' ' A' ' 74' ' ' LEU . 3.2 tm? -65.16 120.21 12.27 Favored 'General case' 0 C--N 1.334 -0.087 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.368 -178.692 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.552 ' N ' HD13 ' A' ' 74' ' ' LEU . 34.1 t0 -99.08 82.5 2.74 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.551 0.691 . . . . 0.0 111.616 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.406 ' N ' HD13 ' A' ' 74' ' ' LEU . 47.8 tttp -65.31 -32.22 73.76 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.258 -0.883 . . . . 0.0 112.429 179.218 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 31.4 mmtt -68.19 -16.53 64.02 Favored 'General case' 0 C--N 1.314 -0.943 0 C-N-CA 119.997 -0.681 . . . . 0.0 110.972 -175.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.454 ' CD ' ' OD2' ' A' ' 75' ' ' ASP . 94.8 mt-30 -92.02 -5.91 52.07 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 121.087 0.47 . . . . 0.0 111.388 178.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 86.0 t -78.6 129.0 38.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.19 0.519 . . . . 0.0 110.192 179.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 5.3 pt -112.02 -4.47 11.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.107 -179.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -172.68 174.96 45.82 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 120.249 -0.977 . . . . 0.0 111.717 -179.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.583 ' NH2' ' OE1' ' A' ' 91' ' ' GLU . 75.1 ttt180 -136.4 154.9 50.67 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.362 0.601 . . . . 0.0 110.836 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.718 HG22 ' O ' ' A' ' 92' ' ' LEU . 19.4 tt -123.8 141.4 44.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.167 -179.501 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 14.6 t -136.69 130.45 32.14 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 121.43 0.634 . . . . 0.0 111.798 -178.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.527 HG22 HG22 ' A' ' 88' ' ' VAL . 89.3 mt -137.94 86.19 18.38 Favored Pre-proline 0 CA--C 1.536 0.44 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.94 -179.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -56.47 -30.15 80.91 Favored 'Trans proline' 0 N--CA 1.497 1.69 0 C-N-CA 123.221 2.614 . . . . 0.0 113.207 -178.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 18.0 m -52.8 -42.14 64.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.213 0.53 . . . . 0.0 110.704 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.527 HG22 HG22 ' A' ' 85' ' ' ILE . 23.4 m -115.53 10.91 7.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.713 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.45 ' O ' ' OG ' ' A' ' 89' ' ' SER . 5.3 p 52.04 50.49 18.41 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.047 0.451 . . . . 0.0 110.93 179.569 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 56.2 tp -116.02 133.33 56.14 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.285 0.564 . . . . 0.0 110.146 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.583 ' OE1' ' NH2' ' A' ' 82' ' ' ARG . 98.0 mt-10 -147.27 124.2 11.32 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.763 -179.186 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.718 ' O ' HG22 ' A' ' 83' ' ' ILE . 71.0 mt -151.25 152.61 31.39 Favored Pre-proline 0 N--CA 1.471 0.62 0 C-N-CA 120.154 -0.618 . . . . 0.0 111.681 -179.307 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_endo -75.0 150.26 37.88 Favored 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 122.771 2.314 . . . . 0.0 111.244 178.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.551 ' C ' HD12 ' A' ' 95' ' ' LEU . 91.1 t -98.01 123.5 50.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -178.751 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.551 HD12 ' C ' ' A' ' 94' ' ' VAL . 9.7 mp -109.61 136.22 49.32 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-O 120.901 0.381 . . . . 0.0 111.083 178.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 85.7 mttt -67.33 -78.88 0.05 Allowed 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.439 0.638 . . . . 0.0 112.234 -179.229 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 30.6 t -61.95 139.25 58.41 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.952 -178.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 7.5 t -95.44 72.93 3.24 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.364 0.602 . . . . 0.0 110.547 -179.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 39.7 p -90.25 166.85 13.11 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 178.183 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -60.42 -42.21 95.53 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.68 0.752 . . . . 0.0 109.273 179.059 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -64.88 -41.82 95.32 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.988 179.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -65.13 -38.23 89.95 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.151 -179.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 84.2 mt -64.01 -12.92 42.54 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.784 -179.36 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 89.6 mt -72.41 -23.22 61.06 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.279 0.561 . . . . 0.0 109.852 179.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 96.5 p -74.46 -6.11 46.46 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 121.442 0.639 . . . . 0.0 110.893 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.473 ' HA3' HD12 ' A' ' 134' ' ' LEU . . . 87.4 -19.79 30.07 Favored Glycine 0 CA--C 1.533 1.203 0 CA-C-N 115.642 -0.708 . . . . 0.0 112.85 178.469 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -145.28 123.71 12.37 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 119.65 -0.82 . . . . 0.0 111.956 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -144.53 135.33 24.88 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.512 179.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.627 ' HA ' HD23 ' A' ' 123' ' ' LEU . 2.3 m -62.44 135.41 57.42 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 121.034 0.445 . . . . 0.0 110.765 -179.074 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.547 HG13 ' CG ' ' B' ' 703' ' ' PRO . 79.8 t -77.37 -48.84 23.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.765 179.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.507 ' HB2' ' NE2' ' A' ' 114' ' ' GLN . 69.3 mmtt -96.18 132.2 41.86 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.577 0.703 . . . . 0.0 110.854 179.59 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -65.56 -32.77 74.54 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 114.974 -1.012 . . . . 0.0 112.195 -178.315 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 69.0 m-80 -84.55 12.4 7.08 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 -178.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.811 ' N ' HE21 ' A' ' 114' ' ' GLN . 0.0 OUTLIER -81.28 143.72 32.06 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.905 0.383 . . . . 0.0 111.494 179.853 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.459 ' O ' ' O ' ' A' ' 118' ' ' LYS . 41.4 t -126.38 123.79 64.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.982 179.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 98.3 mtp -57.11 137.51 55.73 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 121.241 0.543 . . . . 0.0 111.387 179.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 77.95 -5.01 55.71 Favored Glycine 0 CA--C 1.531 1.058 0 N-CA-C 111.522 -0.631 . . . . 0.0 111.522 179.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.459 ' O ' ' O ' ' A' ' 115' ' ' VAL . 98.5 mttt -141.85 132.28 25.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.208 0.528 . . . . 0.0 111.471 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 72.42 -173.23 46.78 Favored Glycine 0 CA--C 1.528 0.904 0 N-CA-C 110.524 -1.031 . . . . 0.0 110.524 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.541 HD22 ' CE1' ' A' ' 177' ' ' HIS . 56.0 t-20 -84.12 101.92 12.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.165 0.507 . . . . 0.0 109.802 179.492 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.683 ' CE2' HD21 ' A' ' 123' ' ' LEU . 27.0 t80 -88.92 99.53 12.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.362 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.715 ' HB1' HG12 ' A' ' 174' ' ' VAL . . . -92.4 143.0 26.82 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.172 0.51 . . . . 0.0 111.634 -179.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.683 HD21 ' CE2' ' A' ' 121' ' ' TYR . 62.2 mt -136.7 141.42 43.1 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.835 179.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -109.66 130.83 55.48 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.373 0.606 . . . . 0.0 110.201 179.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -136.79 141.29 12.26 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.518 ' O ' ' O ' ' A' ' 134' ' ' LEU . 0.3 OUTLIER -80.04 146.31 32.03 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.067 -0.653 . . . . 0.0 112.23 -178.849 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 61.8 t-20 -136.07 121.3 19.07 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.305 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.61 ' HB2' HG21 ' A' ' 133' ' ' VAL . 58.5 mtt -97.69 -4.51 37.15 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.04 -179.443 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.429 ' CB ' ' O ' ' A' ' 128' ' ' MET . 0.9 OUTLIER 78.09 6.59 2.63 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.419 179.527 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.781 ' O ' HG12 ' A' ' 133' ' ' VAL . 6.9 ptpt -113.08 116.03 29.26 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 121.468 0.651 . . . . 0.0 111.714 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -40.69 127.66 2.52 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.851 -179.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 105.44 -11.5 47.09 Favored Glycine 0 N--CA 1.444 -0.813 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.781 HG12 ' O ' ' A' ' 130' ' ' LYS . 7.7 p -92.43 173.84 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.058 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.598 ' H ' HG22 ' A' ' 133' ' ' VAL . 3.8 mm? -67.26 131.57 46.02 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 115.773 1.768 . . . . 0.0 115.773 -175.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.9 m-30 50.55 21.33 0.85 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 113.266 -1.788 . . . . 0.0 113.956 176.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 4.5 t -72.18 -34.06 68.14 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 119.764 -0.774 . . . . 0.0 112.523 179.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.484 ' O ' HG11 ' A' ' 88' ' ' VAL . 83.9 m-20 -88.91 -1.53 58.14 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.433 0.635 . . . . 0.0 111.388 -179.063 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.876 HD11 HD13 ' A' ' 184' ' ' LEU . 4.7 tt -62.7 -34.97 68.39 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.286 -179.538 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -66.43 -7.31 18.58 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 121.532 0.682 . . . . 0.0 110.234 179.432 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 4.8 m -84.67 -6.1 59.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.175 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 72.8 mt -63.39 142.17 58.49 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.014 -179.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -117.16 159.91 21.86 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 121.817 0.818 . . . . 0.0 112.243 -178.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 65.2 tttm -52.65 133.56 36.33 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.515 178.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.482 ' N ' ' O ' ' A' ' 160' ' ' VAL . . . 77.67 8.53 87.19 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 120.167 -1.016 . . . . 0.0 110.892 179.233 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.413 ' O ' HG23 ' A' ' 160' ' ' VAL . 55.5 t0 -81.96 125.8 31.19 Favored 'General case' 0 C--O 1.222 -0.374 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -79.91 151.0 30.38 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 115.107 1.521 . . . . 0.0 115.107 -176.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 97.6 mt -138.37 137.96 43.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 112.518 -2.128 . . . . 0.0 108.204 179.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . 0.457 ' C ' HD23 ' A' ' 149' ' ' LEU . 68.2 m-85 -121.73 135.85 54.94 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 120.094 -0.642 . . . . 0.0 111.903 -178.039 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.515 HD11 HD12 ' A' ' 182' ' ' ILE . 4.0 mt -114.59 134.29 55.16 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 177.78 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.56 ' CE2' ' CD ' ' A' ' 155' ' ' GLU . 94.4 m-85 -110.16 110.96 22.01 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 120.192 -0.603 . . . . 0.0 111.529 179.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . 0.477 ' N ' ' O ' ' A' ' 154' ' ' ASN . 9.6 m-20 -87.59 166.94 14.35 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 177.39 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -56.89 -24.2 50.24 Favored 'General case' 0 C--N 1.312 -1.031 0 C-N-CA 120.088 -0.645 . . . . 0.0 111.058 -178.183 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -112.69 -25.8 8.92 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 113.758 1.021 . . . . 0.0 113.758 -179.128 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . 0.477 ' O ' ' N ' ' A' ' 151' ' ' ASP . 0.3 OUTLIER -148.73 -176.3 5.27 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 118.904 -1.119 . . . . 0.0 113.533 -176.303 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.56 ' CD ' ' CE2' ' A' ' 150' ' ' TYR . 84.4 tt0 -131.94 137.39 47.92 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 114.812 -1.086 . . . . 0.0 110.197 179.038 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . 0.425 ' CD1' HG23 ' A' ' 206' ' ' THR . 94.1 m-85 -110.37 136.03 50.17 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.267 0.556 . . . . 0.0 112.311 -179.038 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -94.67 110.6 22.42 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.287 179.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -113.16 146.22 39.62 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 120.918 0.389 . . . . 0.0 110.823 179.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.511 ' HB2' HG21 ' A' ' 204' ' ' VAL . . . -120.75 120.79 36.65 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.068 179.611 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.482 ' O ' ' N ' ' A' ' 144' ' ' GLY . 69.0 t -59.32 134.28 24.46 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.331 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 178.273 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 10.2 p -106.91 -25.03 11.83 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 123.507 0.505 . . . . 0.0 111.041 179.124 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 159.64 -168.08 35.37 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 120.323 -0.942 . . . . 0.0 112.111 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.915 HG12 HG22 ' A' ' 199' ' ' VAL . 35.6 m -129.47 159.41 41.54 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 179.323 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 47.0 t -141.16 162.32 35.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.413 0.625 . . . . 0.0 111.704 -178.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -102.31 119.09 38.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.991 -178.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.481 HG21 HG21 ' A' ' 198' ' ' VAL . 22.3 m -136.47 161.17 37.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.509 -179.661 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . 0.442 ' H ' ' HD2' ' A' ' 170' ' ' LYS . 0.2 OUTLIER -98.56 168.33 9.99 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.148 -179.432 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.452 ' O ' ' CB ' ' B' ' 702' ' ' LEU . 31.3 Cg_exo -59.96 -22.21 68.0 Favored 'Trans proline' 0 N--CA 1.499 1.813 0 C-N-CA 122.614 2.209 . . . . 0.0 113.496 179.367 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . 0.424 ' OD1' ' OG1' ' A' ' 167' ' ' THR . 44.9 p-10 -94.16 -1.44 54.19 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -179.041 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.536 ' O ' HG22 ' A' ' 173' ' ' VAL . 17.7 mttm -76.65 85.49 3.3 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.432 0.634 . . . . 0.0 111.613 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' TRP . . . . . 0.475 ' O ' HG22 ' A' ' 174' ' ' VAL . 59.9 p-90 -78.39 -12.11 59.99 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.479 179.471 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -65.54 -27.12 68.22 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.117 -179.124 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . 0.74 HG23 HG13 ' A' ' 174' ' ' VAL . 33.4 m -63.01 -21.28 27.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 120.74 -0.384 . . . . 0.0 111.766 -179.132 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.74 HG13 HG23 ' A' ' 173' ' ' VAL . 26.9 m -107.49 -2.97 10.07 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 -178.699 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -74.84 162.98 28.16 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.2 0.524 . . . . 0.0 110.835 179.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . 0.447 ' N ' ' OD1' ' A' ' 176' ' ' ASP . 33.6 p-10 -62.88 141.69 58.58 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.82 179.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' HIS . . . . . 0.541 ' CE1' HD22 ' A' ' 120' ' ' ASN . 49.1 m80 -118.63 10.5 12.52 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.801 -179.494 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 62.68 41.62 99.8 Favored Glycine 0 CA--C 1.531 1.031 0 C-N-CA 121.323 -0.465 . . . . 0.0 112.195 179.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -167.94 174.49 7.39 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.771 0.319 . . . . 0.0 110.37 178.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 -86.72 97.62 10.69 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 177.043 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . 0.437 ' HG2' ' N ' ' A' ' 182' ' ' ILE . 83.5 tt0 -134.16 161.07 35.9 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.591 0.71 . . . . 0.0 111.877 -178.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.515 HD12 HD11 ' A' ' 149' ' ' LEU . 19.5 tt -129.25 136.05 60.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 114.936 -1.029 . . . . 0.0 108.701 178.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 90.6 m -130.61 125.21 33.52 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.968 0.413 . . . . 0.0 110.717 -179.428 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.876 HD13 HD11 ' A' ' 138' ' ' ILE . 70.1 mt -109.36 135.36 50.55 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 179.573 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.585 HD13 HD21 ' B' ' 702' ' ' LEU . 99.0 mt -112.72 123.86 68.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.461 0.648 . . . . 0.0 110.84 -179.336 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 1.2 t -137.62 155.17 49.47 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.47 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' CYS . . . . . . . . . . . . . 19.9 m -88.07 140.14 29.79 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.299 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.81 HG22 ' CD2' ' A' ' 197' ' ' TYR . 55.9 t -62.74 -49.0 85.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 C-N-CA 120.444 -0.502 . . . . 0.0 110.864 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 57.2 p -160.99 166.67 27.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.57 0.7 . . . . 0.0 111.245 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 27.2 t -82.67 -16.94 11.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.699 179.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.48 ' O ' ' OD1' ' A' ' 192' ' ' ASP . 99.6 mttt -95.25 -13.62 24.73 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 121.055 0.455 . . . . 0.0 111.206 -179.288 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . 0.48 ' OD1' ' O ' ' A' ' 191' ' ' LYS . 91.5 m-20 -139.97 101.22 4.12 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.316 -179.683 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -97.26 7.88 45.67 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 121.552 0.691 . . . . 0.0 110.438 179.18 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 58.4 m -61.64 -37.1 82.76 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.462 179.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -127.1 150.33 49.53 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 121.338 0.589 . . . . 0.0 111.836 -178.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . 0.537 ' NE ' ' SG ' ' B' ' 705' ' ' B27 . 99.8 mtt180 -132.89 140.53 47.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.004 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . 0.81 ' CD2' HG22 ' A' ' 188' ' ' VAL . 25.6 m-85 -93.91 139.62 30.68 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.144 0.497 . . . . 0.0 110.623 178.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.481 HG21 HG21 ' A' ' 166' ' ' VAL . 40.9 t -129.72 131.09 66.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.178 179.253 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.915 HG22 HG12 ' A' ' 163' ' ' VAL . 56.0 t -103.11 134.88 43.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-O 121.07 0.462 . . . . 0.0 110.736 -179.478 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -115.87 141.61 47.87 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.324 0.583 . . . . 0.0 110.901 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -138.58 142.55 13.17 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 110.836 -0.906 . . . . 0.0 110.836 -179.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 81.4 m-20 -105.83 142.94 34.69 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.962 0.411 . . . . 0.0 110.671 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 46.9 tp -68.29 132.64 47.45 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.511 HG21 ' HB2' ' A' ' 159' ' ' ALA . 64.0 t -115.14 -21.55 5.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -178.782 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -176.04 173.59 46.36 Favored Glycine 0 CA--C 1.523 0.58 0 C-N-CA 120.155 -1.021 . . . . 0.0 111.76 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . 0.425 HG23 ' CD1' ' A' ' 156' ' ' TYR . 9.2 m -143.16 139.53 30.38 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.238 -0.481 . . . . 0.0 109.802 179.686 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -141.69 115.42 9.11 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 121.58 0.705 . . . . 0.0 112.335 -179.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -64.12 142.26 58.47 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.286 -0.87 . . . . 0.0 112.325 -179.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -76.57 159.23 30.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.977 178.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 98.9 mttt . . . . . 0 C--O 1.222 -0.351 0 CA-C-O 117.965 -1.016 . . . . 0.0 111.154 -179.827 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 701' ' ' BOC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 702' ' ' LEU . . . . . 0.585 HD21 HD13 ' A' ' 185' ' ' ILE . 1.0 OUTLIER -47.54 104.65 0.42 Allowed Pre-proline 0 CA--C 1.542 0.647 0 CA-C-O 120.552 0.215 . . . . 20.0 110.735 . . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 703' ' ' PRO . . . . . 0.56 ' O ' ' O ' ' B' ' 704' ' ' ALA . 3.9 Cg_exo -64.8 -178.46 0.74 Allowed 'Trans proline' 0 N--CA 1.491 1.338 0 C-N-CA 122.132 1.888 . . . . 20.0 113.848 -178.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 704' ' ' ALA . . . . . 0.624 ' C ' HG2A ' B' ' 705' ' ' B27 . . . -26.64 162.39 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 114.238 -1.347 . . . . 20.0 114.103 -178.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 705' ' ' B27 . . . . . 0.624 HG2A ' C ' ' B' ' 704' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.215 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 20.0 m -58.79 -38.38 78.43 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.088 0.47 . . . . 0.0 110.636 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 15.7 m80 -126.34 147.27 49.77 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.317 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 97.1 mmm -88.93 7.14 36.07 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.198 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -70.3 88.39 0.63 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.259 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -110.79 11.63 22.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.569 -0.742 . . . . 0.0 111.191 -179.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.655 ' OG ' ' H13' ' B' ' 701' ' ' BOC . 44.3 p -80.77 23.28 0.54 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 121.313 0.578 . . . . 0.0 110.814 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -109.49 25.07 12.22 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.665 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 94.6 mt -56.09 136.28 18.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 122.36 1.076 . . . . 0.0 113.003 -177.05 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -79.53 128.01 32.84 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 113.552 -1.658 . . . . 0.0 108.39 177.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -79.22 149.81 73.3 Favored Pre-proline 0 C--N 1.325 -0.489 0 C-N-CA 120.546 -0.462 . . . . 0.0 110.211 -179.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -69.66 158.64 56.38 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 122.399 2.066 . . . . 0.0 112.385 -179.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.706 ' O ' HG23 ' A' ' 69' ' ' VAL . 92.5 m-20 -53.35 174.76 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.883 -178.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 89.8 mt -63.78 -46.78 83.67 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 -177.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.26 -37.8 86.83 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 119.819 -0.752 . . . . 0.0 111.238 -177.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.575 ' N ' ' OE1' ' A' ' 68' ' ' GLU . 35.3 mp0 -60.81 -27.54 68.11 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.416 0.627 . . . . 0.0 109.709 178.664 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.706 HG23 ' O ' ' A' ' 65' ' ' ASP . 26.2 t -78.98 -46.01 24.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.476 179.216 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -73.3 -9.21 58.46 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.879 -1.055 . . . . 0.0 111.365 -179.284 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -110.14 -8.67 14.75 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.526 0.679 . . . . 0.0 109.412 178.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.413 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -71.74 144.91 49.1 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 115.137 -0.938 . . . . 0.0 112.042 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 24.1 m -56.92 109.67 0.68 Allowed 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.744 -179.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 37.9 tp -70.12 131.25 43.99 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.773 -179.443 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -116.4 77.75 1.13 Allowed 'General case' 0 C--O 1.232 0.157 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 176.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -82.45 -33.39 28.54 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.989 -1.005 . . . . 0.0 113.176 -178.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 48.6 mmtt -73.2 -10.61 59.95 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 119.954 -0.699 . . . . 0.0 110.905 -176.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -92.52 -1.17 57.14 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.659 179.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 13.5 t -81.64 127.84 39.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.377 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 21.6 pt -107.84 -2.65 10.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.943 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -161.9 171.23 37.79 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 120.188 -1.006 . . . . 0.0 111.632 -179.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 58.4 ttp180 -140.65 142.0 35.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.219 0.533 . . . . 0.0 111.155 -179.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.582 HG22 ' O ' ' A' ' 92' ' ' LEU . 7.5 tp -105.2 136.59 38.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.976 179.43 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 10.0 t -137.05 127.94 27.42 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-O 121.431 0.634 . . . . 0.0 111.231 -179.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.497 ' CG2' HG22 ' A' ' 88' ' ' VAL . 56.1 mt -138.8 86.44 15.57 Favored Pre-proline 0 CA--C 1.537 0.47 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.291 -179.451 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -54.74 -30.38 66.67 Favored 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 123.044 2.496 . . . . 0.0 112.739 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 67.3 m -54.12 -41.96 68.94 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 121.118 0.485 . . . . 0.0 111.133 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.497 HG22 ' CG2' ' A' ' 85' ' ' ILE . 27.2 m -116.1 12.3 7.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.808 179.52 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 13.2 t 50.77 51.54 16.77 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.856 179.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 63.3 tp -115.62 132.24 56.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.27 0.557 . . . . 0.0 111.066 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -147.08 123.28 10.86 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.38 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.582 ' O ' HG22 ' A' ' 83' ' ' ILE . 84.4 mt -150.97 150.67 28.17 Favored Pre-proline 0 N--CA 1.47 0.575 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.428 -179.54 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -72.38 146.01 44.16 Favored 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 122.511 2.141 . . . . 0.0 111.699 178.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.463 ' C ' HD12 ' A' ' 95' ' ' LEU . 54.2 t -96.42 120.68 46.1 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-O 121.194 0.521 . . . . 0.0 110.86 179.736 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.531 ' N ' HD12 ' A' ' 95' ' ' LEU . 11.2 mp -99.81 138.61 36.66 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.337 -179.74 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.485 ' O ' ' OG1' ' A' ' 109' ' ' THR . 34.0 tttm -67.08 -77.86 0.07 Allowed 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.526 -179.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 38.2 m -61.83 136.82 58.14 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.144 0.497 . . . . 0.0 111.303 -178.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -92.79 65.6 4.22 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 121.664 0.745 . . . . 0.0 110.103 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.437 ' HG1' ' CG ' ' A' ' 102' ' ' ASN . 73.4 p -91.51 165.55 13.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.775 178.442 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 57.1 mp0 -60.39 -42.08 95.15 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.294 -0.562 . . . . 0.0 110.362 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -64.55 -40.45 95.6 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.473 0.654 . . . . 0.0 110.288 179.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.437 ' CG ' ' HG1' ' A' ' 99' ' ' THR . 8.6 m120 -65.0 -34.09 77.62 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.734 -179.353 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 65.2 mt -70.02 -10.14 57.65 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.636 -179.13 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 96.0 mt -74.42 -22.42 59.16 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.015 0.436 . . . . 0.0 110.352 178.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 82.8 p -77.58 -1.96 33.33 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 121.321 0.581 . . . . 0.0 110.391 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 87.53 -19.16 33.89 Favored Glycine 0 CA--C 1.534 1.226 0 CA-C-N 115.732 -0.667 . . . . 0.0 113.706 177.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -146.2 126.12 13.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 117.975 0.888 . . . . 0.0 112.729 -179.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -147.34 143.52 28.09 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.484 178.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.664 ' HA ' HD23 ' A' ' 123' ' ' LEU . 18.9 p -68.35 138.63 55.55 Favored 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 120.338 -0.545 . . . . 0.0 109.879 179.747 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.646 HG13 ' CG ' ' B' ' 703' ' ' PRO . 70.2 t -76.55 -49.62 23.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.906 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.631 ' CE ' ' HE1' ' A' ' 171' ' ' TRP . 96.4 mttt -104.22 143.1 33.4 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 122.345 1.069 . . . . 0.0 113.254 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -66.47 -31.63 72.49 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 114.465 -1.243 . . . . 0.0 111.679 -178.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 21.8 m120 -84.99 14.94 4.38 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 -177.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.457 ' OE1' ' O ' ' A' ' 120' ' ' ASN . 89.6 mm-40 -75.16 136.43 41.06 Favored 'General case' 0 N--CA 1.467 0.404 0 O-C-N 121.672 -0.643 . . . . 0.0 111.332 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 46.8 t -127.36 120.72 55.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.533 178.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 51.0 mtt -57.57 132.43 53.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.899 179.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 77.79 -4.48 56.93 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 121.152 -0.547 . . . . 0.0 112.211 178.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -136.91 125.21 23.23 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.308 0.575 . . . . 0.0 110.857 -179.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 76.61 -165.96 53.96 Favored Glycine 0 CA--C 1.527 0.842 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 -179.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.457 ' O ' ' OE1' ' A' ' 114' ' ' GLN . 50.9 t-20 -91.81 106.47 18.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.17 0.51 . . . . 0.0 110.27 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.445 ' HE2' HD21 ' A' ' 123' ' ' LEU . 14.5 t80 -83.75 145.53 28.67 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.91 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -146.01 138.99 25.8 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.645 0.736 . . . . 0.0 112.465 -178.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.664 HD23 ' HA ' ' A' ' 109' ' ' THR . 74.2 mt -135.11 141.57 46.03 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.319 179.313 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -110.68 132.52 54.12 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.03 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -134.32 146.39 18.38 Favored Glycine 0 CA--C 1.529 0.962 0 N-CA-C 111.031 -0.828 . . . . 0.0 111.031 -178.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.409 ' O ' ' CB ' ' A' ' 134' ' ' LEU . 29.3 m-70 -87.24 150.37 23.95 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.443 0.64 . . . . 0.0 111.725 -179.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.784 ' ND2' ' H ' ' A' ' 187' ' ' CYS . 2.9 p30 -147.82 159.29 44.0 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.764 178.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.419 ' CG ' HG21 ' A' ' 133' ' ' VAL . 65.1 mtt -124.95 4.57 8.01 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.162 0.506 . . . . 0.0 110.772 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 76.63 9.24 3.01 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.819 179.156 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.887 ' O ' HG12 ' A' ' 133' ' ' VAL . 62.5 pttt -123.6 131.05 53.52 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 122.01 0.909 . . . . 0.0 112.927 -178.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.501 ' O ' ' O ' ' A' ' 130' ' ' LYS . 74.4 mmtt -40.57 165.05 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.184 -0.917 . . . . 0.0 109.171 178.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 70.19 -21.04 0.53 Allowed Glycine 0 CA--C 1.532 1.103 0 C-N-CA 120.673 -0.775 . . . . 0.0 111.748 179.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.887 HG12 ' O ' ' A' ' 130' ' ' LYS . 3.9 p -88.65 173.57 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 C-N-CA 119.651 -0.819 . . . . 0.0 110.058 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.655 ' H ' HG22 ' A' ' 133' ' ' VAL . 4.0 mm? -67.49 130.44 43.04 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 115.37 1.618 . . . . 0.0 115.37 -176.361 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.4 m-30 58.08 21.94 8.45 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 113.97 -1.468 . . . . 0.0 113.21 177.017 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.28 -39.38 92.49 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -179.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -91.47 -1.22 57.62 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 113.904 1.075 . . . . 0.0 113.904 -177.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 1.6 pp -61.2 -30.19 47.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 119.316 -0.954 . . . . 0.0 110.911 -179.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -66.6 -10.35 44.69 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.318 0.58 . . . . 0.0 110.356 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 3.1 m -83.89 -3.01 57.59 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.849 -179.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.41 HD23 ' HA ' ' A' ' 141' ' ' LEU . 91.4 mt -63.65 141.85 58.61 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 121.118 0.485 . . . . 0.0 111.241 -179.257 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 56.7 mttp -120.42 156.8 30.67 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-O 121.556 0.693 . . . . 0.0 111.74 -179.259 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -50.77 133.64 25.93 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.33 179.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 160' ' ' VAL . . . 79.88 8.29 87.8 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 120.352 -0.928 . . . . 0.0 111.564 179.066 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.442 ' OD1' ' N ' ' A' ' 146' ' ' LYS . 61.8 t0 -74.38 128.3 35.19 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 120.106 -0.638 . . . . 0.0 110.394 -179.43 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.442 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 75.6 mmtt -77.89 140.18 39.29 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.817 0.818 . . . . 0.0 112.197 -178.291 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.441 HG23 HG12 ' A' ' 85' ' ' ILE . 89.7 mt -139.62 139.95 37.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 114.615 -1.175 . . . . 0.0 108.832 179.023 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . 0.653 ' C ' HD23 ' A' ' 149' ' ' LEU . 97.6 m-85 -124.95 136.91 54.19 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 119.459 -0.896 . . . . 0.0 112.955 -178.402 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.653 HD23 ' C ' ' A' ' 148' ' ' TYR . 0.3 OUTLIER -112.11 134.34 53.72 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 177.296 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.604 ' CZ ' ' OE2' ' A' ' 155' ' ' GLU . 79.7 m-85 -110.66 112.94 25.17 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 119.966 -0.694 . . . . 0.0 111.278 -179.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . 0.445 ' N ' ' O ' ' A' ' 154' ' ' ASN . 38.1 t70 -89.03 165.42 14.55 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 177.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 66.1 m-20 -57.06 -23.98 50.59 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 119.836 -0.746 . . . . 0.0 110.568 -178.279 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -114.35 -25.51 8.39 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 113.534 0.939 . . . . 0.0 113.534 -178.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . 0.445 ' O ' ' N ' ' A' ' 151' ' ' ASP . 0.1 OUTLIER -146.65 -178.94 6.44 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 118.572 -1.251 . . . . 0.0 113.455 -176.859 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.604 ' OE2' ' CZ ' ' A' ' 150' ' ' TYR . 83.9 tt0 -131.27 133.79 45.76 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 114.674 -1.148 . . . . 0.0 109.988 179.082 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -110.01 136.24 49.58 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 121.109 0.481 . . . . 0.0 111.695 -179.282 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . 0.401 ' O ' HD12 ' A' ' 203' ' ' LEU . 77.1 tt0 -94.79 113.62 25.4 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.776 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 39.8 m-85 -114.86 149.03 37.75 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.172 0.51 . . . . 0.0 111.581 179.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.542 ' HB2' HG21 ' A' ' 204' ' ' VAL . . . -123.81 122.74 38.84 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.97 179.343 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.454 ' O ' ' N ' ' A' ' 144' ' ' GLY . 60.8 t -60.65 137.81 22.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 177.752 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 18.1 p -106.78 -24.69 12.0 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 120.801 -0.359 . . . . 0.0 111.649 179.364 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 160.37 -166.39 35.27 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 120.531 -0.843 . . . . 0.0 111.756 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.952 HG12 HG22 ' A' ' 199' ' ' VAL . 35.0 m -131.98 159.06 43.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-O 120.888 0.375 . . . . 0.0 110.856 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 82.2 p -147.31 162.0 39.85 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 121.095 0.474 . . . . 0.0 110.991 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -110.47 121.16 44.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.37 0.605 . . . . 0.0 110.843 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 28.1 m -138.43 159.75 31.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.821 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.32 158.63 63.42 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.702 179.653 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.503 ' O ' ' CB ' ' B' ' 702' ' ' LEU . 35.9 Cg_endo -64.48 -17.71 60.51 Favored 'Trans proline' 0 N--CA 1.499 1.809 0 C-N-CA 123.103 2.536 . . . . 0.0 113.035 -178.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 43.7 p-10 -91.19 -3.57 56.87 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 120.094 -0.642 . . . . 0.0 111.211 179.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.575 ' O ' HG22 ' A' ' 173' ' ' VAL . 73.1 mmtt -74.36 78.03 1.87 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.526 0.679 . . . . 0.0 110.804 179.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' TRP . . . . . 0.631 ' HE1' ' CE ' ' A' ' 111' ' ' LYS . 29.4 t90 -70.3 -15.25 62.87 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.046 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -64.26 -29.29 70.39 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.612 -0.722 . . . . 0.0 112.244 -179.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . 0.623 HG23 HG13 ' A' ' 174' ' ' VAL . 14.8 m -63.24 -21.2 27.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -179.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.623 HG13 HG23 ' A' ' 173' ' ' VAL . 27.2 m -105.6 -3.48 9.83 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 C-N-CA 120.372 -0.531 . . . . 0.0 112.162 -179.176 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.579 ' OE2' ' CE3' ' A' ' 171' ' ' TRP . 95.7 mt-10 -71.97 150.29 44.22 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.164 0.507 . . . . 0.0 110.634 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . 0.488 ' OD1' ' O ' ' A' ' 176' ' ' ASP . 54.3 p-10 -56.74 142.27 41.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.908 -179.595 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 61.7 m80 -120.46 12.91 11.7 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.863 -179.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 62.54 42.38 99.7 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 120.666 -0.778 . . . . 0.0 111.175 179.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -164.4 168.76 18.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.89 0.376 . . . . 0.0 110.631 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -87.1 99.38 11.88 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 177.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . 0.45 ' HG2' ' N ' ' A' ' 182' ' ' ILE . 84.1 tt0 -135.3 161.91 34.07 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.259 0.552 . . . . 0.0 111.521 -178.275 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.459 HG22 ' O ' ' A' ' 201' ' ' GLY . 18.7 tt -129.7 139.19 52.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.741 178.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 94.0 m -130.41 125.44 34.52 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.412 0.625 . . . . 0.0 111.72 -179.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 82.7 mt -109.32 131.14 55.35 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.416 178.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.447 HD13 ' CD2' ' B' ' 702' ' ' LEU . 77.5 mt -111.55 122.05 65.22 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 CA-C-O 121.571 0.7 . . . . 0.0 111.384 -179.534 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . 0.497 HG22 ' ND2' ' A' ' 127' ' ' ASN . 12.1 m -135.08 157.13 47.71 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.032 179.301 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' CYS . . . . . 0.784 ' H ' ' ND2' ' A' ' 127' ' ' ASN . 1.7 m -97.08 144.84 26.56 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 120.913 0.387 . . . . 0.0 110.945 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.571 HG13 ' N ' ' A' ' 189' ' ' SER . 7.6 p -62.71 -46.83 95.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-O 121.057 0.456 . . . . 0.0 110.852 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . 0.571 ' N ' HG13 ' A' ' 188' ' ' VAL . 36.3 p -159.62 162.36 35.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.113 0.483 . . . . 0.0 110.867 179.656 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . 0.492 HG22 ' O ' ' A' ' 190' ' ' VAL . 7.9 p -80.9 -7.67 10.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.533 179.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -96.71 -13.46 22.71 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 121.07 0.462 . . . . 0.0 110.621 179.208 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . 0.529 ' OD1' ' OG ' ' A' ' 194' ' ' SER . 67.8 t0 -148.59 103.39 3.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.315 0.579 . . . . 0.0 111.389 179.634 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -102.64 3.83 37.61 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.372 179.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . 0.529 ' OG ' ' OD1' ' A' ' 192' ' ' ASP . 78.6 p -64.49 -24.36 67.59 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.653 -179.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -130.71 133.31 45.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.165 0.507 . . . . 0.0 110.575 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . 0.49 ' CZ ' ' HX ' ' B' ' 705' ' ' B27 . 99.6 mtt180 -129.01 139.65 51.98 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.515 -179.319 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 37.5 p90 -100.94 135.43 42.41 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.2 0.524 . . . . 0.0 110.021 178.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 25.6 t -114.18 135.49 53.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -178.1 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.952 HG22 HG12 ' A' ' 163' ' ' VAL . 57.4 t -104.3 132.63 50.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.698 179.066 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -121.28 150.03 42.0 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 121.483 0.658 . . . . 0.0 112.269 -179.028 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . 0.459 ' O ' HG22 ' A' ' 182' ' ' ILE . . . -149.98 159.7 28.21 Favored Glycine 0 CA--C 1.532 1.105 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 179.503 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 55.4 p-10 -116.37 158.7 23.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.203 0.525 . . . . 0.0 111.201 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . 0.401 HD12 ' O ' ' A' ' 157' ' ' GLU . 60.1 tp -76.01 131.17 39.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.746 179.413 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.542 HG21 ' HB2' ' A' ' 159' ' ' ALA . 15.0 t -111.98 -21.04 5.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -178.583 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -178.55 174.64 46.83 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 120.514 -0.85 . . . . 0.0 111.988 -179.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 23.6 m -144.55 139.86 28.45 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.38 -0.41 . . . . 0.0 110.142 179.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -143.24 118.2 10.01 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.155 -0.618 . . . . 0.0 111.339 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -63.88 141.96 58.58 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.408 -178.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 53.8 mtpt -77.35 159.79 29.26 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.046 178.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 53.4 mtpt . . . . . 0 C--O 1.219 -0.533 0 CA-C-O 118.037 -0.983 . . . . 0.0 110.736 179.381 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 701' ' ' BOC . . . . . 0.655 ' H13' ' OG ' ' A' ' 59' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 702' ' ' LEU . . . . . 0.503 ' CB ' ' O ' ' A' ' 168' ' ' PRO . 2.3 mt 44.36 100.44 0.03 OUTLIER Pre-proline 0 CA--C 1.542 0.662 0 CA-C-O 120.795 0.331 . . . . 20.0 111.737 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 703' ' ' PRO . . . . . 0.646 ' CG ' HG13 ' A' ' 110' ' ' VAL . 4.8 Cg_exo -64.92 -164.91 0.07 OUTLIER 'Trans proline' 0 N--CA 1.491 1.355 0 C-N-CA 122.627 2.218 . . . . 20.0 113.606 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 704' ' ' ALA . . . . . 0.508 ' O ' ' O ' ' B' ' 703' ' ' PRO . . . -42.31 -176.76 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 114.269 -1.332 . . . . 20.0 112.678 -179.26 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 705' ' ' B27 . . . . . 0.49 ' HX ' ' CZ ' ' A' ' 196' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.336 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 34.6 t -66.15 145.23 56.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.781 0.324 . . . . 0.0 110.581 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 43.0 t-80 -125.4 126.82 45.6 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 121.219 0.533 . . . . 0.0 111.565 179.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 66.9 mtt -83.78 138.75 33.1 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.132 179.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -69.25 146.6 52.18 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 121.619 0.724 . . . . 0.0 111.236 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.409 ' C ' ' H ' ' A' ' 60' ' ' LYS . . . -89.35 -2.94 58.62 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.48 179.779 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.605 ' C ' HH22 ' A' ' 196' ' ' ARG . 2.8 p -78.15 19.44 0.44 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.25 -179.146 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.409 ' H ' ' C ' ' A' ' 58' ' ' ALA . 99.6 mttt -95.75 13.38 26.73 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.927 179.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 94.0 mt -55.43 141.71 11.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 122.035 0.921 . . . . 0.0 112.949 -177.7 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.403 ' O ' ' OD1' ' A' ' 62' ' ' ASP . 35.1 p-10 -78.53 129.78 35.23 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 114.034 -1.439 . . . . 0.0 109.198 178.435 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.661 ' NE2' ' H ' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -79.98 146.87 64.55 Favored Pre-proline 0 CA--C 1.539 0.527 0 CA-C-O 120.99 0.424 . . . . 0.0 111.222 -179.071 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.23 157.97 59.4 Favored 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 123.079 2.519 . . . . 0.0 113.113 -179.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.816 ' O ' HG23 ' A' ' 69' ' ' VAL . 90.4 m-20 -55.45 168.67 0.36 Allowed 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.685 -179.481 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.404 HD23 ' HA ' ' A' ' 66' ' ' LEU . 92.1 mt -64.18 -45.06 90.03 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.047 -178.535 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.52 -39.41 94.36 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 119.81 -0.756 . . . . 0.0 110.893 -178.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -60.75 -29.39 69.36 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 178.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.816 HG23 ' O ' ' A' ' 65' ' ' ASP . 50.9 t -75.57 -45.11 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.981 179.101 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -72.6 -9.1 58.18 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.683 -1.144 . . . . 0.0 111.037 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 27.1 m120 -105.84 -10.35 16.72 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.524 0.678 . . . . 0.0 110.226 178.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.09 137.04 54.66 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.634 -179.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -60.35 98.71 0.06 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.236 0.541 . . . . 0.0 109.94 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -68.52 131.1 44.68 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.389 -179.493 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -97.88 80.65 2.77 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.395 178.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.832 ' O ' HG12 ' A' ' 79' ' ' VAL . 87.5 tttt -63.95 -42.39 97.32 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -179.379 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.537 ' H ' ' CE ' ' A' ' 77' ' ' LYS . 1.1 mtmt -69.66 -8.21 45.67 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.446 0.641 . . . . 0.0 111.104 -176.666 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.524 ' CD ' ' N ' ' A' ' 78' ' ' GLN . 18.6 mp0 -94.56 3.85 54.59 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.784 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.832 HG12 ' O ' ' A' ' 76' ' ' LYS . 14.9 p -86.91 122.71 39.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 120.434 -0.506 . . . . 0.0 111.258 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.615 ' O ' ' ND2' ' A' ' 152' ' ' ASN . 24.0 pt -108.14 -6.11 10.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.1 179.125 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.44 ' O ' HG22 ' A' ' 94' ' ' VAL . . . -167.61 166.18 39.16 Favored Glycine 0 CA--C 1.53 1.012 0 N-CA-C 110.813 -0.915 . . . . 0.0 110.813 -179.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 62.6 ttp180 -140.19 142.57 35.88 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 121.207 0.527 . . . . 0.0 111.646 -179.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.466 HG22 ' O ' ' A' ' 92' ' ' LEU . 19.5 tt -103.9 141.71 19.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.48 -179.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 5.0 t -136.91 129.72 30.59 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 121.335 0.588 . . . . 0.0 111.539 -179.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.48 HG22 HG22 ' A' ' 88' ' ' VAL . 89.3 mt -140.29 89.37 10.86 Favored Pre-proline 0 CA--C 1.542 0.657 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.329 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -57.86 -27.67 79.4 Favored 'Trans proline' 0 N--CA 1.502 2.016 0 C-N-CA 123.279 2.653 . . . . 0.0 113.106 -179.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 9.7 t -53.83 -43.0 69.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.262 0.553 . . . . 0.0 110.378 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.48 HG22 HG22 ' A' ' 85' ' ' ILE . 27.8 m -112.89 8.88 8.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.816 179.065 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 40.7 p 52.74 53.86 11.47 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.524 -179.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 54.8 tp -116.83 134.42 54.8 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 121.461 0.648 . . . . 0.0 111.732 -179.127 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -147.46 117.8 7.39 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.239 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.474 HD13 ' HA3' ' A' ' 106' ' ' GLY . 84.2 mt -149.14 149.63 30.09 Favored Pre-proline 0 CA--C 1.542 0.641 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.447 -179.048 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -75.18 149.6 36.2 Favored 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 123.026 2.484 . . . . 0.0 112.825 179.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.662 HG23 ' O ' ' A' ' 94' ' ' VAL . 3.1 m -96.75 116.56 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-O 121.029 0.442 . . . . 0.0 111.214 179.752 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.561 ' N ' HD12 ' A' ' 95' ' ' LEU . 10.9 mp -100.09 136.37 40.09 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 120.955 0.407 . . . . 0.0 111.294 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.535 ' HE3' HG21 ' A' ' 80' ' ' ILE . 98.4 mttt -61.72 -80.42 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.346 0.593 . . . . 0.0 111.438 -179.536 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.59 ' OG ' ' ND2' ' A' ' 102' ' ' ASN . 6.4 p -60.86 132.74 54.84 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.172 -178.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.419 ' OG ' ' O ' ' A' ' 109' ' ' THR . 58.1 m -93.46 73.56 4.45 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.335 0.588 . . . . 0.0 110.391 179.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.484 HG23 HD22 ' A' ' 102' ' ' ASN . 44.0 p -87.38 169.68 12.05 Favored 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.585 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -58.31 -45.57 87.75 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 119.335 -0.946 . . . . 0.0 108.94 179.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -65.8 -40.31 91.78 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.979 179.19 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.59 ' ND2' ' OG ' ' A' ' 97' ' ' SER . 97.9 m-20 -62.61 -39.42 93.72 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.123 0.487 . . . . 0.0 111.531 -178.749 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 62.4 mt -63.43 -19.39 64.66 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.994 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.68 ' HB3' HG13 ' A' ' 69' ' ' VAL . 45.3 mt -73.1 -14.16 61.33 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.629 -179.447 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 74.4 p -75.33 -6.98 52.69 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 178.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.49 ' O ' ' CE1' ' A' ' 135' ' ' PHE . . . 90.21 -19.44 42.99 Favored Glycine 0 CA--C 1.533 1.216 0 CA-C-N 115.116 -0.947 . . . . 0.0 112.147 179.244 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -146.27 125.64 13.12 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.264 0.554 . . . . 0.0 111.762 179.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -145.5 140.53 27.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.344 178.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.596 ' HA ' HD23 ' A' ' 123' ' ' LEU . 21.0 p -72.0 133.0 45.06 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 119.996 -0.682 . . . . 0.0 110.684 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.689 HG22 ' HG2' ' B' ' 703' ' ' PRO . 39.0 t -80.57 -48.47 19.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.155 179.591 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.607 ' O ' ' NE2' ' A' ' 114' ' ' GLN . 87.6 tttt -89.41 128.44 35.93 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.503 0.668 . . . . 0.0 111.213 -178.69 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -66.64 -36.58 82.91 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.058 -0.974 . . . . 0.0 111.731 -178.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 68.8 m-80 -89.27 31.21 0.91 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.72 -179.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.62 ' H ' ' CD ' ' A' ' 114' ' ' GLN . 0.0 OUTLIER -75.3 138.11 41.61 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 120.954 0.407 . . . . 0.0 111.719 -179.501 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 42.9 t -120.7 105.79 17.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-O 120.893 0.378 . . . . 0.0 110.714 179.434 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . 0.417 ' HG2' ' CZ ' ' A' ' 121' ' ' TYR . 85.4 mtp -55.18 130.32 41.62 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.141 0.496 . . . . 0.0 111.664 -179.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 88.21 -4.72 85.37 Favored Glycine 0 CA--C 1.53 1.013 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.819 179.106 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -142.7 136.32 28.88 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 121.254 0.55 . . . . 0.0 111.95 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 75.11 -166.17 54.8 Favored Glycine 0 CA--C 1.534 1.243 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 -179.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 59.3 t-20 -92.0 108.34 19.86 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 121.001 0.429 . . . . 0.0 110.295 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.417 ' CZ ' ' HG2' ' A' ' 116' ' ' MET . 2.5 t80 -85.57 102.47 13.56 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 121.02 0.438 . . . . 0.0 111.009 -179.399 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -91.9 130.82 37.58 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.911 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.596 HD23 ' HA ' ' A' ' 109' ' ' THR . 84.5 mt -132.45 137.67 47.34 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.62 179.715 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -113.33 144.43 42.76 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.003 0.43 . . . . 0.0 110.129 179.23 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . 0.48 ' C ' ' HG2' ' B' ' 705' ' ' B27 . . . -152.34 155.04 25.9 Favored Glycine 0 CA--C 1.531 1.057 0 N-CA-C 110.279 -1.128 . . . . 0.0 110.279 -179.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.432 ' ND1' HG2B ' B' ' 705' ' ' B27 . 47.6 m-70 -100.75 145.49 28.42 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.654 0.74 . . . . 0.0 111.959 -179.19 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.494 ' O ' ' OD1' ' A' ' 127' ' ' ASN . 38.0 p-10 -149.64 124.26 9.76 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.788 178.517 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.523 ' CG ' ' OE1' ' A' ' 63' ' ' GLN . 70.7 mtm -84.58 0.38 50.25 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.306 -0.558 . . . . 0.0 110.26 179.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.482 ' CB ' ' O ' ' A' ' 128' ' ' MET . 1.1 m 80.17 12.54 1.0 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.254 179.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.897 ' O ' HG12 ' A' ' 133' ' ' VAL . 21.3 ptmt -104.91 124.71 49.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.996 0.903 . . . . 0.0 111.91 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -46.14 120.37 2.73 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.78 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 116.29 -18.72 13.64 Favored Glycine 0 N--CA 1.445 -0.748 0 N-CA-C 109.979 -1.249 . . . . 0.0 109.979 -179.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.897 HG12 ' O ' ' A' ' 130' ' ' LYS . 11.4 p -88.6 159.68 2.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.654 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.821 HD23 ' N ' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -71.22 144.04 50.23 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 122.156 0.979 . . . . 0.0 113.639 -177.314 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.49 ' CE1' ' O ' ' A' ' 106' ' ' GLY . 4.0 m-85 59.69 9.56 1.66 Allowed 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 113.902 -1.499 . . . . 0.0 114.726 177.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 5.7 t -69.77 -40.46 76.07 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 179.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -89.17 7.36 35.67 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 -176.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.7 HD11 ' OH ' ' A' ' 197' ' ' TYR . 35.0 pt -61.78 -26.45 39.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 C-N-CA 119.185 -1.006 . . . . 0.0 109.102 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -65.92 -14.56 61.77 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.551 179.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 64.3 p -83.0 -4.51 58.39 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.328 -179.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 81.2 mt -63.78 142.2 58.49 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 120.94 0.4 . . . . 0.0 110.977 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 63.9 mttm -118.05 153.3 33.95 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.639 0.733 . . . . 0.0 111.807 -178.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -50.21 130.74 23.24 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.955 178.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.444 ' N ' ' O ' ' A' ' 160' ' ' VAL . . . 81.42 8.7 86.77 Favored Glycine 0 CA--C 1.526 0.746 0 C-N-CA 120.219 -0.991 . . . . 0.0 110.985 179.467 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 146' ' ' LYS . 58.8 t0 -76.95 129.04 35.62 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.295 0.569 . . . . 0.0 110.229 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.504 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 72.8 mmtt -79.26 143.11 35.59 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 121.826 0.822 . . . . 0.0 112.754 -177.624 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.441 HD11 ' CG2' ' A' ' 160' ' ' VAL . 94.7 mt -138.1 139.31 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-N 114.608 -1.178 . . . . 0.0 108.322 178.565 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . 0.535 ' C ' HD22 ' A' ' 149' ' ' LEU . 90.9 m-85 -121.11 136.99 54.87 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -177.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.535 HD22 ' C ' ' A' ' 148' ' ' TYR . 4.6 mm? -114.0 132.74 55.88 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 177.629 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.573 ' CZ ' ' OE2' ' A' ' 155' ' ' GLU . 96.3 m-85 -112.02 107.94 17.08 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.006 -0.678 . . . . 0.0 111.783 -179.63 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . 0.523 ' OD1' ' N ' ' A' ' 152' ' ' ASN . 54.2 t0 -88.16 164.0 15.89 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 177.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . 0.666 ' N ' HD22 ' A' ' 152' ' ' ASN . 1.4 m120 -58.49 -23.66 58.47 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 119.556 -0.858 . . . . 0.0 110.993 -178.364 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.402 ' HB2' ' ND2' ' A' ' 154' ' ' ASN . 80.2 mm-40 -109.36 -29.75 8.31 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 -177.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . 0.459 ' O ' ' N ' ' A' ' 151' ' ' ASP . 0.2 OUTLIER -149.77 -179.26 6.98 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 119.181 -1.008 . . . . 0.0 113.503 -176.712 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.573 ' OE2' ' CZ ' ' A' ' 150' ' ' TYR . 79.1 tt0 -126.26 133.09 51.55 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 114.48 -1.236 . . . . 0.0 110.159 178.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . 0.41 ' CD1' HG23 ' A' ' 206' ' ' THR . 83.2 m-85 -107.11 132.33 53.12 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 121.376 0.608 . . . . 0.0 111.323 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -93.54 112.76 24.73 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.81 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -113.05 145.29 41.14 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.01 0.434 . . . . 0.0 111.404 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -120.1 121.43 38.82 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.868 179.107 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.444 ' O ' ' N ' ' A' ' 144' ' ' GLY . 98.1 t -60.58 135.68 25.02 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 177.542 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 6.8 p -108.48 -24.76 11.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.174 0.511 . . . . 0.0 110.716 179.046 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 160.6 -170.43 36.55 Favored Glycine 0 CA--C 1.532 1.126 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 -179.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 35.0 m -133.49 158.79 42.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 179.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 39.6 t -142.9 162.5 35.3 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 121.348 0.594 . . . . 0.0 111.784 -179.216 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -109.31 121.24 44.75 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.79 179.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.546 HG21 HG11 ' A' ' 173' ' ' VAL . 31.3 m -136.12 161.08 38.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.605 -179.41 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.41 158.75 65.8 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.918 -179.537 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.479 ' O ' ' CB ' ' B' ' 702' ' ' LEU . 36.4 Cg_endo -64.86 -16.73 56.82 Favored 'Trans proline' 0 N--CA 1.496 1.673 0 C-N-CA 123.198 2.599 . . . . 0.0 113.054 -179.155 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 32.6 p-10 -94.79 -7.22 41.03 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.185 -0.606 . . . . 0.0 112.571 -179.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.443 ' O ' HG22 ' A' ' 173' ' ' VAL . 97.4 mttt -77.29 92.21 3.87 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 119.832 -0.747 . . . . 0.0 112.004 -179.785 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' TRP . . . . . 0.405 ' CD1' ' N ' ' A' ' 171' ' ' TRP . 6.3 m0 -75.19 -1.87 25.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.657 0.741 . . . . 0.0 109.677 178.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -61.72 -37.3 83.69 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.719 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . 0.546 HG11 HG21 ' A' ' 166' ' ' VAL . 26.9 m -63.23 -12.84 11.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.127 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.458 HG23 HG23 ' A' ' 173' ' ' VAL . 77.3 t -105.62 -23.56 4.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 N-CA-C 112.665 0.616 . . . . 0.0 112.665 -178.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -74.53 135.1 42.17 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.15 0.5 . . . . 0.0 111.148 -179.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . 0.505 ' OD1' ' O ' ' A' ' 176' ' ' ASP . 43.4 p30 -70.16 135.0 48.69 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 121.123 0.487 . . . . 0.0 110.498 179.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 66.8 m80 -97.89 -8.93 27.22 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.622 -0.431 . . . . 0.0 112.158 -178.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 105.11 39.9 2.21 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 109.864 -1.295 . . . . 0.0 109.864 -179.337 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 13.6 ptmt -156.42 166.01 34.68 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.919 -0.64 . . . . 0.0 110.485 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -88.6 97.18 10.96 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 178.079 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . 0.478 ' HG2' ' N ' ' A' ' 182' ' ' ILE . 73.6 tt0 -131.52 162.21 30.79 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 121.519 0.676 . . . . 0.0 111.891 -178.612 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.478 ' N ' ' HG2' ' A' ' 181' ' ' GLU . 18.6 tt -129.24 137.82 56.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.67 179.337 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 89.7 m -134.5 125.69 27.87 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 121.417 0.627 . . . . 0.0 111.778 -179.229 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 73.2 mt -106.61 132.06 53.04 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.075 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.701 HD13 HD21 ' B' ' 702' ' ' LEU . 77.0 mt -113.02 119.4 60.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.325 0.583 . . . . 0.0 110.694 -179.024 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . 0.671 HG22 ' N ' ' A' ' 187' ' ' CYS . 48.7 m -141.36 167.81 21.27 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.708 179.634 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' CYS . . . . . 0.671 ' N ' HG22 ' A' ' 186' ' ' THR . 92.7 m -92.7 140.76 29.19 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.944 179.328 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 54.6 t -60.78 -47.74 91.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.14 -179.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 17.4 t -167.56 152.95 7.23 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.287 0.565 . . . . 0.0 110.507 179.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 78.2 t -67.51 -20.13 26.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.503 -179.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -96.53 -8.32 32.27 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.021 -179.509 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -136.92 98.8 3.85 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 121.141 0.495 . . . . 0.0 110.442 179.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 49.4 p-10 -106.61 13.92 27.63 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.6 -179.216 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 84.1 p -59.1 -45.14 91.64 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.91 0.386 . . . . 0.0 111.522 -178.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 26.3 pttm -142.41 149.92 39.96 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 121.269 0.557 . . . . 0.0 111.522 -179.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . 0.605 HH22 ' C ' ' A' ' 59' ' ' SER . 99.7 mtt180 -105.34 135.9 45.87 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.24 179.431 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . 0.7 ' OH ' HD11 ' A' ' 138' ' ' ILE . 21.0 p90 -96.11 150.3 20.66 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.491 -0.484 . . . . 0.0 110.102 179.599 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 4.4 m -130.52 138.51 53.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.11 0.481 . . . . 0.0 111.976 -178.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 49.4 t -98.79 130.69 47.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 178.188 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -116.45 140.52 49.27 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 121.261 0.553 . . . . 0.0 111.294 -179.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -136.18 151.57 20.82 Favored Glycine 0 CA--C 1.532 1.138 0 N-CA-C 110.421 -1.071 . . . . 0.0 110.421 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . 0.438 ' OD1' ' N ' ' A' ' 203' ' ' LEU . 65.0 t0 -116.99 130.43 56.69 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.152 0.501 . . . . 0.0 110.571 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . 0.438 ' N ' ' OD1' ' A' ' 202' ' ' ASP . 50.4 tp -58.33 131.09 49.63 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.217 -179.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 14.0 m -116.27 -16.65 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.919 -179.525 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -178.89 173.92 46.11 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 119.965 -1.112 . . . . 0.0 112.477 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . 0.41 HG23 ' CD1' ' A' ' 156' ' ' TYR . 31.4 m -144.81 138.87 27.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.616 -0.792 . . . . 0.0 109.377 179.235 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -144.95 121.52 11.08 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.112 -0.635 . . . . 0.0 111.737 179.324 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -63.0 140.88 58.92 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.638 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 18.4 ttpt -81.0 110.96 17.04 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.308 179.13 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt . . . . . 0 C--O 1.219 -0.524 0 CA-C-O 118.139 -0.934 . . . . 0.0 110.717 179.997 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 701' ' ' BOC . . . . . 0.407 ' O1 ' ' O ' ' B' ' 702' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 702' ' ' LEU . . . . . 0.701 HD21 HD13 ' A' ' 185' ' ' ILE . 1.2 mt 51.8 102.15 0.03 OUTLIER Pre-proline 0 CA--C 1.544 0.732 0 CA-C-O 120.55 0.214 . . . . 20.0 110.61 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 703' ' ' PRO . . . . . 0.689 ' HG2' HG22 ' A' ' 110' ' ' VAL . 2.9 Cg_endo -65.97 -176.91 0.67 Allowed 'Trans proline' 0 N--CA 1.491 1.361 0 C-N-CA 122.397 2.065 . . . . 20.0 113.84 -178.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 704' ' ' ALA . . . . . 0.535 ' O ' ' O ' ' B' ' 703' ' ' PRO . . . -33.62 175.03 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 114.223 -1.353 . . . . 20.0 113.975 -179.136 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 705' ' ' B27 . . . . . 0.612 ' SG ' ' N ' ' A' ' 187' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.498 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 47.2 t -153.17 154.51 34.89 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 121.253 0.549 . . . . 0.0 111.536 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 78.6 t60 -129.76 127.27 40.04 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.263 -179.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 99.0 mtp -82.98 146.38 28.81 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.089 179.36 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -62.2 145.62 53.01 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 121.179 0.514 . . . . 0.0 110.726 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -79.77 -3.97 49.95 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.28 0.562 . . . . 0.0 110.76 -179.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 10.8 p -79.53 25.66 0.32 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.017 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -96.21 3.74 52.92 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.436 -179.467 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.0 mt -55.98 137.8 17.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 122.199 1.0 . . . . 0.0 113.351 -176.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -77.46 133.02 38.71 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 113.692 -1.595 . . . . 0.0 109.37 178.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.717 ' NE2' ' CE1' ' A' ' 126' ' ' HIS . 0.0 OUTLIER -79.8 150.85 73.13 Favored Pre-proline 0 CA--C 1.537 0.451 0 C-N-CA 119.901 -0.72 . . . . 0.0 109.798 -179.989 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.64 ' CG ' HD11 ' A' ' 104' ' ' LEU . 83.0 Cg_endo -73.37 163.02 38.86 Favored 'Trans proline' 0 N--CA 1.499 1.826 0 C-N-CA 123.427 2.751 . . . . 0.0 114.086 -178.05 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.7 ' O ' HG23 ' A' ' 69' ' ' VAL . 88.0 m-20 -54.51 164.0 0.8 Allowed 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.753 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 53.4 tp -64.28 -47.37 79.79 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 121.102 0.477 . . . . 0.0 111.118 -178.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.43 -36.51 82.63 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.079 -0.648 . . . . 0.0 110.865 -178.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -61.21 -29.27 69.72 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.033 -0.667 . . . . 0.0 109.652 179.144 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.7 HG23 ' O ' ' A' ' 65' ' ' ASP . 50.8 t -74.05 -43.71 51.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 121.825 0.821 . . . . 0.0 109.729 179.145 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -76.42 -8.23 56.71 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.745 -1.116 . . . . 0.0 111.434 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -105.41 -8.15 18.32 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.038 0.447 . . . . 0.0 110.38 179.008 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.22 137.5 54.84 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 121.369 0.604 . . . . 0.0 111.109 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 32.2 t -60.29 102.19 0.16 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.486 179.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.92 128.45 36.71 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.372 -179.4 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 -96.43 84.33 3.69 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 177.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -62.98 -41.49 99.56 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.272 0.558 . . . . 0.0 111.899 -179.528 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.511 ' CD ' ' H ' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -71.16 -8.5 53.96 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.869 -176.27 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -94.68 -13.34 25.9 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 121.211 0.529 . . . . 0.0 110.093 178.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 86.9 t -76.2 128.59 37.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.966 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.669 HD13 ' CE ' ' A' ' 96' ' ' LYS . 39.3 pt -113.54 -7.9 12.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.428 179.565 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -174.21 -175.12 41.57 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 110.431 -1.067 . . . . 0.0 110.431 179.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 39.9 ptt180 -152.1 166.71 30.81 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.472 0.653 . . . . 0.0 111.168 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 19.5 tt -114.5 142.87 25.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.223 178.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 66.1 m -135.64 126.89 28.26 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.47 0.653 . . . . 0.0 111.174 -179.342 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.492 ' CG2' HG22 ' A' ' 88' ' ' VAL . 43.3 mt -137.45 89.39 15.93 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.481 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_exo -56.5 -30.18 81.37 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.589 2.192 . . . . 0.0 112.831 -179.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 47.0 m -51.86 -40.94 61.42 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 121.185 0.516 . . . . 0.0 110.593 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.492 HG22 ' CG2' ' A' ' 85' ' ' ILE . 18.6 m -114.0 8.46 7.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.888 179.057 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.483 ' O ' ' OG ' ' A' ' 89' ' ' SER . 3.7 t 54.08 54.13 10.09 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 -179.498 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 66.5 tp -118.43 133.52 55.81 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 121.543 0.687 . . . . 0.0 111.166 -179.152 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -148.03 120.03 8.23 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.329 -0.851 . . . . 0.0 110.452 -179.306 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.615 HD13 ' O ' ' A' ' 105' ' ' SER . 74.6 mt -149.64 152.95 35.96 Favored Pre-proline 0 CA--C 1.537 0.479 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.644 -179.539 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -75.38 150.72 36.95 Favored 'Trans proline' 0 N--CA 1.497 1.735 0 C-N-CA 123.127 2.551 . . . . 0.0 112.471 179.142 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.567 ' C ' HD12 ' A' ' 95' ' ' LEU . 53.0 t -99.17 120.91 49.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-O 121.173 0.511 . . . . 0.0 112.058 -179.261 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.567 HD12 ' C ' ' A' ' 94' ' ' VAL . 10.4 mp -104.38 134.5 47.48 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.324 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.669 ' CE ' HD13 ' A' ' 80' ' ' ILE . 98.7 mttt -61.7 -80.29 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.217 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 12.0 t -56.45 133.02 52.85 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.952 -178.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.8 m -92.53 70.5 5.0 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.756 179.35 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.59 HG22 ' N ' ' A' ' 100' ' ' GLU . 41.2 m -92.37 169.98 10.14 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 178.769 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.59 ' N ' HG22 ' A' ' 99' ' ' THR . 96.7 mt-10 -64.3 -42.46 96.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.264 0.554 . . . . 0.0 110.018 179.503 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 61.6 mttm -65.59 -38.67 90.14 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.887 179.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -64.75 -33.6 76.35 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.378 -0.828 . . . . 0.0 112.18 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 83.5 mt -68.83 -6.79 29.01 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -178.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.64 HD11 ' CG ' ' A' ' 64' ' ' PRO . 3.9 mm? -74.77 -16.36 60.73 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 121.187 0.517 . . . . 0.0 109.635 178.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.615 ' O ' HD13 ' A' ' 92' ' ' LEU . 79.2 p -81.18 -10.04 59.69 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.751 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.605 ' O ' ' CE1' ' A' ' 135' ' ' PHE . . . 92.87 -19.42 51.85 Favored Glycine 0 CA--C 1.532 1.151 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.636 178.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -145.72 127.35 15.18 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 119.605 -0.838 . . . . 0.0 112.661 -179.463 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -147.69 138.56 23.38 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.272 -0.877 . . . . 0.0 110.11 178.255 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.671 ' HA ' HD23 ' A' ' 123' ' ' LEU . 12.3 p -69.06 135.49 50.89 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 121.316 0.579 . . . . 0.0 110.928 -179.751 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.588 HG22 ' HG2' ' B' ' 703' ' ' PRO . 78.7 t -78.0 -48.86 22.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.226 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.535 ' NZ ' ' CD ' ' A' ' 175' ' ' GLU . 98.5 mttt -99.06 140.14 33.67 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.801 0.81 . . . . 0.0 112.52 -179.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -65.86 -36.21 82.82 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.625 -1.17 . . . . 0.0 111.47 -179.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 73.7 m-80 -84.6 11.0 9.63 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -177.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.705 ' N ' HE21 ' A' ' 114' ' ' GLN . 0.0 OUTLIER -78.92 139.19 38.32 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 120.799 0.333 . . . . 0.0 111.296 179.569 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 38.8 t -125.8 125.85 69.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 CA-C-O 121.069 0.461 . . . . 0.0 111.227 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . 0.431 ' CG ' ' CZ ' ' A' ' 121' ' ' TYR . 93.1 mtp -57.11 133.56 55.11 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.126 0.489 . . . . 0.0 111.657 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 78.14 -2.7 64.58 Favored Glycine 0 CA--C 1.529 0.922 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.643 179.162 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -138.49 132.37 31.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.615 0.722 . . . . 0.0 111.784 179.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 71.14 -167.06 52.05 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 110.18 -1.168 . . . . 0.0 110.18 -179.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 64.7 t-20 -87.83 104.69 16.82 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.196 0.522 . . . . 0.0 109.714 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.64 ' CE2' HD21 ' A' ' 123' ' ' LEU . 5.3 t80 -87.06 99.37 11.86 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.115 -179.479 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.3 135.12 33.88 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.829 -179.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.671 HD23 ' HA ' ' A' ' 109' ' ' THR . 68.3 mt -135.37 139.78 44.5 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.735 -179.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -111.37 140.87 45.59 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 178.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -141.16 129.66 4.15 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 110.482 -1.047 . . . . 0.0 110.482 -179.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.717 ' CE1' ' NE2' ' A' ' 63' ' ' GLN . 1.8 m-70 -82.11 131.52 35.24 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.336 0.589 . . . . 0.0 112.098 -179.208 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.588 ' ND2' ' OG1' ' A' ' 186' ' ' THR . 7.2 p30 -138.79 152.21 47.71 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.634 179.322 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.611 ' O ' ' N ' ' A' ' 130' ' ' LYS . 79.4 mtm -119.28 42.04 2.94 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.598 0.713 . . . . 0.0 110.161 179.179 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 38.64 15.84 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 114.919 -1.037 . . . . 0.0 112.304 178.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.877 ' O ' HG12 ' A' ' 133' ' ' VAL . 19.2 ptmt -110.61 127.32 55.19 Favored 'General case' 0 C--O 1.226 -0.176 0 CA-C-O 122.025 0.917 . . . . 0.0 112.323 -179.723 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.458 ' C ' ' O ' ' A' ' 130' ' ' LYS . 55.8 tptt -38.37 150.71 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.915 179.413 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 79.58 -17.56 8.32 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 121.045 -0.598 . . . . 0.0 112.127 179.224 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.877 HG12 ' O ' ' A' ' 130' ' ' LYS . 9.9 p -87.87 153.08 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-N 117.753 0.777 . . . . 0.0 110.342 -179.561 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.773 HD23 ' N ' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -69.45 143.53 53.54 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.594 0.711 . . . . 0.0 112.832 -177.889 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.605 ' CE1' ' O ' ' A' ' 106' ' ' GLY . 3.5 m-85 66.39 8.34 5.63 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 114.139 -1.391 . . . . 0.0 114.493 177.712 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 5.2 t -76.88 -42.68 38.9 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 179.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -91.82 1.31 57.26 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 114.055 1.132 . . . . 0.0 114.055 -176.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.607 HD11 ' HB ' ' A' ' 186' ' ' THR . 48.6 pt -66.92 -23.73 31.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 C-N-CA 119.43 -0.908 . . . . 0.0 110.877 -179.431 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -66.53 -10.68 47.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.551 0.691 . . . . 0.0 109.856 179.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 94.0 p -81.34 -2.77 50.47 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.625 -179.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 67.8 mt -62.73 143.54 57.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.47 0.652 . . . . 0.0 111.059 -179.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -121.57 156.83 32.05 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.216 -179.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -50.86 133.08 26.9 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.061 -0.972 . . . . 0.0 112.116 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 160' ' ' VAL . . . 79.96 8.69 87.44 Favored Glycine 0 CA--C 1.53 0.979 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.239 178.518 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.463 ' OD1' ' N ' ' A' ' 146' ' ' LYS . 60.5 t0 -74.12 133.47 42.82 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 120.277 -0.569 . . . . 0.0 110.277 -179.62 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.463 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 71.1 mmtt -79.06 140.44 37.89 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 121.84 0.829 . . . . 0.0 111.908 -179.033 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.453 HD11 ' CG2' ' A' ' 160' ' ' VAL . 92.6 mt -140.13 140.12 35.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 114.899 -1.046 . . . . 0.0 108.587 179.511 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -128.64 140.95 51.51 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 119.384 -0.927 . . . . 0.0 113.226 -177.08 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.537 HD11 HD12 ' A' ' 182' ' ' ILE . 19.1 mt -112.51 131.98 55.32 Favored 'General case' 0 CA--C 1.519 -0.233 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 176.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.608 ' CZ ' ' OE2' ' A' ' 155' ' ' GLU . 49.2 m-85 -108.18 107.87 18.68 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.028 -0.669 . . . . 0.0 112.468 -178.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -88.19 158.74 18.43 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 106.641 -1.615 . . . . 0.0 106.641 176.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 33.7 p-10 -57.45 -16.11 8.63 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 119.137 -1.025 . . . . 0.0 111.365 -177.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -114.22 -29.13 7.04 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -179.098 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -146.47 178.97 7.87 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 -176.616 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.608 ' OE2' ' CZ ' ' A' ' 150' ' ' TYR . 84.3 tt0 -130.65 136.03 48.43 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 114.681 -1.145 . . . . 0.0 109.597 178.537 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . 0.406 ' CD1' HG23 ' A' ' 206' ' ' THR . 80.6 m-85 -108.94 133.62 52.69 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.779 0.288 . . . . 0.0 111.779 -178.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -93.2 112.51 24.47 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 121.262 0.553 . . . . 0.0 111.983 179.423 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -112.9 146.06 39.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.176 179.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -121.18 120.72 36.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.207 179.128 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.527 ' O ' ' N ' ' A' ' 144' ' ' GLY . 90.8 t -59.78 136.66 23.16 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.301 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 178.399 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 7.9 p -105.63 -25.39 12.28 Favored 'General case' 0 C--N 1.328 -0.356 0 O-C-N 123.581 0.551 . . . . 0.0 110.86 179.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 158.61 -166.09 34.22 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 120.622 -0.799 . . . . 0.0 111.405 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.757 HG12 HG22 ' A' ' 199' ' ' VAL . 32.7 m -134.08 163.1 38.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.036 -0.582 . . . . 0.0 109.722 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 11.8 p -148.87 161.1 42.52 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.315 0.578 . . . . 0.0 111.477 -179.428 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.403 ' HG2' ' CE2' ' A' ' 197' ' ' TYR . 95.5 mt-10 -103.39 117.18 33.89 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.759 179.151 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 22.7 m -135.18 156.16 38.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.802 -179.226 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -85.14 157.59 59.32 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.508 179.438 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.502 ' O ' ' CB ' ' B' ' 702' ' ' LEU . 19.5 Cg_endo -62.71 -15.66 48.01 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 C-N-CA 122.78 2.32 . . . . 0.0 113.665 -179.685 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . 0.626 ' O ' ' NE1' ' A' ' 171' ' ' TRP . 39.3 p-10 -92.84 -6.72 48.17 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 119.48 -0.888 . . . . 0.0 111.917 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.749 ' O ' HG22 ' A' ' 173' ' ' VAL . 96.5 mttt -78.1 85.07 4.32 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.357 -0.537 . . . . 0.0 111.824 179.429 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' TRP . . . . . 0.626 ' NE1' ' O ' ' A' ' 169' ' ' ASP . 0.0 OUTLIER -75.02 -8.51 56.72 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.428 0.632 . . . . 0.0 110.185 179.159 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 53.3 tp10 -64.77 -29.1 70.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.537 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . 0.749 HG22 ' O ' ' A' ' 170' ' ' LYS . 35.1 m -62.88 -22.21 29.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.37 -179.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.628 HG13 HG23 ' A' ' 173' ' ' VAL . 31.5 m -105.2 -3.46 9.76 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.535 ' CD ' ' NZ ' ' A' ' 111' ' ' LYS . 63.3 mm-40 -71.96 150.68 43.88 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.31 0.576 . . . . 0.0 111.202 179.586 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 38.7 p-10 -67.97 141.8 56.17 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.051 -179.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 78.7 m80 -117.43 23.26 11.9 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.914 0.388 . . . . 0.0 111.411 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 62.06 43.2 99.47 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 110.759 -0.937 . . . . 0.0 110.759 -179.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 12.5 ptmt -164.87 168.44 17.69 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.064 0.459 . . . . 0.0 110.301 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -86.99 100.9 12.94 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 177.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 77.5 tt0 -132.55 160.95 35.09 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.335 0.588 . . . . 0.0 111.32 -178.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.682 HG22 ' O ' ' A' ' 201' ' ' GLY . 18.7 tt -128.65 138.17 55.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.619 179.244 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 60.6 m -132.52 126.18 32.29 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.883 -179.178 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 70.7 mt -111.97 134.44 53.52 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.633 179.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.649 HD13 HD21 ' B' ' 702' ' ' LEU . 92.9 mt -115.9 123.42 71.19 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 CA-C-O 121.482 0.658 . . . . 0.0 110.732 -179.462 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . 0.607 ' HB ' HD11 ' A' ' 138' ' ' ILE . 13.2 t -138.69 158.65 43.84 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.97 -179.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' CYS . . . . . 0.674 ' N ' ' SG ' ' B' ' 705' ' ' B27 . 91.7 m -89.57 139.2 30.78 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.886 0.374 . . . . 0.0 110.591 -179.331 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.592 HG13 ' N ' ' A' ' 189' ' ' SER . 11.9 p -62.33 -44.56 99.31 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-O 120.968 0.414 . . . . 0.0 110.806 -179.259 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . 0.592 ' N ' HG13 ' A' ' 188' ' ' VAL . 23.9 m -167.52 153.43 7.61 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.252 0.548 . . . . 0.0 111.286 -179.626 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 70.1 t -72.43 -17.69 18.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.256 178.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -96.04 -11.86 25.78 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.251 179.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . 0.499 ' O ' ' CG1' ' A' ' 188' ' ' VAL . 49.5 t0 -141.15 98.62 3.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.171 0.51 . . . . 0.0 111.307 -179.409 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -98.81 9.83 42.58 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.542 0.687 . . . . 0.0 109.75 179.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 25.3 m -60.13 -42.68 95.33 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.785 -178.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt -133.89 150.19 51.34 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 120.979 0.419 . . . . 0.0 111.346 -179.36 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . 0.74 HH22 HD22 ' B' ' 702' ' ' LEU . 42.7 mtm180 -128.26 141.45 51.45 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 121.122 0.487 . . . . 0.0 110.48 179.548 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . 0.403 ' CE2' ' HG2' ' A' ' 165' ' ' GLU . 48.4 m-85 -98.04 137.6 36.59 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.331 0.586 . . . . 0.0 111.708 -179.708 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 35.1 t -118.27 134.93 60.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.428 178.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.757 HG22 HG12 ' A' ' 163' ' ' VAL . 68.6 t -103.45 134.51 44.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.013 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -117.0 138.21 51.72 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 121.449 0.642 . . . . 0.0 111.666 -179.124 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . 0.682 ' O ' HG22 ' A' ' 182' ' ' ILE . . . -139.81 130.98 4.93 Favored Glycine 0 CA--C 1.529 0.95 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 179.609 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -95.89 142.07 28.57 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.253 0.549 . . . . 0.0 111.049 -179.411 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 52.0 tp -67.03 133.22 49.49 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 121.527 0.679 . . . . 0.0 110.186 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 74.9 t -105.6 -51.6 7.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.233 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -152.36 174.94 31.2 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 120.193 -1.003 . . . . 0.0 112.576 -178.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . 0.406 HG23 ' CD1' ' A' ' 156' ' ' TYR . 18.0 m -142.4 138.33 31.06 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 114.892 -0.654 . . . . 0.0 110.711 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 54.6 mtmt -146.35 128.0 15.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.262 0.554 . . . . 0.0 111.885 178.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -62.04 142.07 57.73 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.61 -179.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -79.24 108.23 12.59 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.429 178.613 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 99.2 mttt . . . . . 0 C--O 1.218 -0.588 0 CA-C-O 117.921 -1.038 . . . . 0.0 110.537 -179.98 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 701' ' ' BOC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 702' ' ' LEU . . . . . 0.74 HD22 HH22 ' A' ' 196' ' ' ARG . 0.6 OUTLIER -46.5 113.39 2.21 Favored Pre-proline 0 CA--C 1.543 0.675 0 CA-C-O 120.378 0.132 . . . . 20.0 110.81 . . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 703' ' ' PRO . . . . . 0.621 ' HD2' HD23 ' B' ' 702' ' ' LEU . 2.4 Cg_endo -64.55 -172.64 0.2 Allowed 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 122.053 1.835 . . . . 20.0 113.482 -178.497 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 704' ' ' ALA . . . . . 0.41 ' O ' ' O ' ' B' ' 703' ' ' PRO . . . -48.69 -172.55 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.098 -1.41 . . . . 20.0 112.424 -179.657 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 705' ' ' B27 . . . . . 0.674 ' SG ' ' N ' ' A' ' 187' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.205 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 59.4 p -72.14 159.5 34.04 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.059 0.457 . . . . 0.0 110.392 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 -67.07 -40.79 87.1 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.232 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 98.5 mmm -97.07 65.39 2.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.277 -179.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 67.2 t0 -61.9 121.97 14.26 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.307 -179.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -98.21 16.26 21.91 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 121.049 0.452 . . . . 0.0 111.383 -179.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 3.9 p -83.18 21.3 1.12 Allowed 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.124 0.488 . . . . 0.0 111.347 -179.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -106.04 15.8 25.94 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.877 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.3 mt -55.37 137.0 17.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 122.315 1.055 . . . . 0.0 112.527 -177.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -77.84 133.38 38.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 113.687 -1.597 . . . . 0.0 109.097 179.057 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.627 ' H ' ' CD ' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -77.57 152.16 80.69 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-O 121.109 0.48 . . . . 0.0 110.813 -178.476 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -74.01 156.42 47.53 Favored 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 123.249 2.632 . . . . 0.0 113.151 -179.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.442 ' O ' ' OE1' ' A' ' 68' ' ' GLU . 39.0 t70 -54.0 172.83 0.07 Allowed 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.073 179.724 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.411 HD11 ' HE2' ' A' ' 130' ' ' LYS . 86.1 mt -69.55 -13.36 62.29 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.199 -178.509 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -68.11 -37.62 81.35 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.5 0.667 . . . . 0.0 110.455 179.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.869 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 58.9 mp0 -68.16 -31.33 70.81 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.841 -1.072 . . . . 0.0 110.546 179.364 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 8.3 t -71.27 -44.85 72.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.575 -179.457 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -81.92 -13.14 57.93 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.031 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -114.88 1.45 14.06 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 121.252 0.549 . . . . 0.0 110.345 178.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.869 ' HB2' ' O ' ' A' ' 68' ' ' GLU . . . -67.77 -173.5 0.35 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.517 0.675 . . . . 0.0 112.161 -179.019 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.6 t -102.3 95.38 6.25 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 114.887 -1.051 . . . . 0.0 109.786 179.073 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.552 HD13 ' C ' ' A' ' 74' ' ' LEU . 0.5 OUTLIER -68.79 103.39 1.76 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.899 -179.376 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.454 ' OD2' ' CD ' ' A' ' 78' ' ' GLN . 46.0 t0 -93.2 82.62 4.54 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.623 0.725 . . . . 0.0 109.751 178.483 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -80.15 -30.32 38.91 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.068 -0.969 . . . . 0.0 112.011 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 35.7 mmtt -68.16 -30.92 70.16 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.13 -176.159 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.454 ' CD ' ' OD2' ' A' ' 75' ' ' ASP . 86.0 mt-30 -87.47 2.32 50.94 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.441 -0.504 . . . . 0.0 111.688 -179.101 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 67.8 t -75.65 130.51 36.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.323 0.582 . . . . 0.0 109.927 179.291 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.492 HD13 ' CE ' ' A' ' 96' ' ' LYS . 16.2 pt -107.29 -7.35 10.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.994 -179.235 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -175.27 179.27 46.62 Favored Glycine 0 CA--C 1.527 0.793 0 C-N-CA 120.693 -0.765 . . . . 0.0 111.26 179.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.459 ' HA ' HG23 ' A' ' 94' ' ' VAL . 38.7 ptt180 -152.69 155.35 37.09 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.474 0.654 . . . . 0.0 111.569 179.381 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 20.4 tt -105.05 147.83 10.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.793 -179.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 9.2 t -136.03 131.4 34.9 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.473 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.547 ' CG2' HG22 ' A' ' 88' ' ' VAL . 96.3 mt -137.19 88.71 17.13 Favored Pre-proline 0 CA--C 1.54 0.584 0 CA-C-N 115.41 -0.813 . . . . 0.0 110.846 -179.173 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -56.31 -31.03 83.18 Favored 'Trans proline' 0 N--CA 1.499 1.804 0 C-N-CA 123.043 2.495 . . . . 0.0 112.683 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 99.1 p -53.6 -44.18 69.23 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 121.333 0.587 . . . . 0.0 110.738 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.547 HG22 ' CG2' ' A' ' 85' ' ' ILE . 12.5 m -113.72 11.61 8.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.891 178.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.4 t 44.74 57.0 4.81 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.651 -179.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 57.7 tp -117.78 136.64 53.26 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.296 179.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -146.13 124.79 12.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.68 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.526 HD13 ' HA3' ' A' ' 106' ' ' GLY . 77.4 mt -148.72 150.13 32.45 Favored Pre-proline 0 CA--C 1.535 0.38 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.53 -178.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.07 148.11 34.57 Favored 'Trans proline' 0 N--CA 1.491 1.351 0 C-N-CA 122.526 2.151 . . . . 0.0 111.707 178.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.564 ' C ' HD12 ' A' ' 95' ' ' LEU . 88.9 t -96.81 116.73 39.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 CA-C-O 121.006 0.432 . . . . 0.0 111.587 -179.674 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.58 ' N ' HD12 ' A' ' 95' ' ' LEU . 8.7 mp -100.37 138.79 36.95 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.151 0.5 . . . . 0.0 110.7 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.492 ' CE ' HD13 ' A' ' 80' ' ' ILE . 98.3 mttt -66.13 -79.28 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.425 0.631 . . . . 0.0 112.181 -179.005 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 40.7 t -57.54 133.66 55.44 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.935 -178.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 43.4 p -88.41 66.05 8.17 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.549 179.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.441 ' OG1' ' CG ' ' A' ' 102' ' ' ASN . 31.6 p -86.7 167.45 14.46 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 178.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -63.78 -41.39 97.96 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.233 0.539 . . . . 0.0 110.239 179.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -66.28 -39.83 89.66 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.589 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.441 ' CG ' ' OG1' ' A' ' 99' ' ' THR . 8.9 m120 -63.72 -34.79 78.66 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -178.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.403 ' HB3' ' CD2' ' A' ' 126' ' ' HIS . 70.4 mt -62.71 -17.16 60.23 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -178.512 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.533 ' N ' HD12 ' A' ' 104' ' ' LEU . 10.8 mp -73.21 -16.29 61.42 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 120.286 -0.565 . . . . 0.0 110.403 179.505 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.447 ' O ' HD13 ' A' ' 92' ' ' LEU . 1.5 m -78.43 -7.28 57.2 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 178.718 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.526 ' HA3' HD13 ' A' ' 92' ' ' LEU . . . 91.54 -18.8 51.14 Favored Glycine 0 CA--C 1.534 1.262 0 CA-C-N 114.926 -1.034 . . . . 0.0 113.233 177.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -146.72 127.07 13.96 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 119.563 -0.855 . . . . 0.0 113.08 -179.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -144.73 137.06 26.26 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.922 178.323 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.511 ' HA ' HD23 ' A' ' 123' ' ' LEU . 69.2 p -69.95 138.43 52.33 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.364 0.602 . . . . 0.0 111.189 -179.493 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.594 HG22 ' HG2' ' B' ' 703' ' ' PRO . 74.1 t -79.16 -53.05 14.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.71 -179.77 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.741 ' H ' ' NE2' ' A' ' 114' ' ' GLN . 53.6 mtmt -100.69 134.71 43.26 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 121.831 0.824 . . . . 0.0 112.645 -179.002 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -66.63 -30.63 70.94 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 114.51 -1.223 . . . . 0.0 112.477 -179.194 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 75.1 m-80 -84.37 11.21 8.85 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 -177.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.741 ' NE2' ' H ' ' A' ' 111' ' ' LYS . 22.2 mt-30 -81.16 143.3 32.48 Favored 'General case' 0 C--N 1.328 -0.326 0 O-C-N 121.904 -0.497 . . . . 0.0 111.347 178.762 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.424 ' O ' ' O ' ' A' ' 118' ' ' LYS . 51.4 t -122.54 124.28 70.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.246 -0.434 . . . . 0.0 109.92 178.638 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 99.3 mtp -58.25 127.0 29.92 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 121.324 0.583 . . . . 0.0 111.471 -179.281 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 91.62 -4.75 79.73 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 110.606 -0.997 . . . . 0.0 110.606 179.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.424 ' O ' ' O ' ' A' ' 115' ' ' VAL . 87.5 tttt -142.48 130.96 22.4 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.113 0.482 . . . . 0.0 110.614 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 80.39 -174.28 54.94 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 -179.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 63.9 t-20 -90.75 107.1 18.96 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 179.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -85.41 99.31 11.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.242 0.544 . . . . 0.0 110.23 -179.384 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.84 136.16 33.25 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.479 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.511 HD23 ' HA ' ' A' ' 109' ' ' THR . 67.4 mt -134.07 139.14 45.77 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.491 -0.484 . . . . 0.0 111.469 -179.417 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -112.77 143.72 43.53 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 178.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . 0.48 ' O ' ' CG2' ' B' ' 705' ' ' B27 . . . -142.42 151.82 23.28 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.164 -1.174 . . . . 0.0 110.164 -178.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.403 ' CD2' ' HB3' ' A' ' 103' ' ' LEU . 4.7 m-70 -89.24 126.03 35.33 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.592 0.711 . . . . 0.0 111.874 -179.468 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.433 ' ND2' ' HA ' ' A' ' 136' ' ' SER . 35.1 t30 -129.12 125.18 36.56 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 114.931 -1.031 . . . . 0.0 110.681 179.504 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.513 ' O ' ' OG ' ' A' ' 129' ' ' SER . 78.1 mtm -102.53 -1.72 29.94 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.351 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.513 ' OG ' ' O ' ' A' ' 128' ' ' MET . 6.2 p 77.78 10.23 2.24 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.473 179.77 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.76 ' O ' HG12 ' A' ' 133' ' ' VAL . 5.9 ptmt -110.42 118.15 35.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.474 0.654 . . . . 0.0 112.427 -179.274 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.496 ' C ' ' O ' ' A' ' 130' ' ' LYS . 29.1 tptt -32.98 149.89 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 114.926 -1.034 . . . . 0.0 109.554 178.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.436 ' N ' ' HG3' ' A' ' 131' ' ' LYS . . . 82.82 -15.49 31.43 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 111.064 -0.814 . . . . 0.0 111.064 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.76 HG12 ' O ' ' A' ' 130' ' ' LYS . 8.0 p -94.22 151.68 3.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.04 -0.664 . . . . 0.0 111.174 -179.041 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.593 HD23 ' N ' ' A' ' 134' ' ' LEU . 0.1 OUTLIER -68.04 147.16 52.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.88 0.848 . . . . 0.0 112.96 -177.774 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.449 ' CE1' ' O ' ' A' ' 106' ' ' GLY . 3.0 m-85 65.2 4.85 2.76 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 113.943 -1.481 . . . . 0.0 114.266 177.528 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . 0.433 ' HA ' ' ND2' ' A' ' 127' ' ' ASN . 28.1 p -76.51 -35.22 58.46 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 120.147 -0.621 . . . . 0.0 111.908 178.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.421 ' N ' ' OD1' ' A' ' 137' ' ' ASP . 36.6 p-10 -94.75 2.09 55.5 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 114.543 1.312 . . . . 0.0 114.543 -177.533 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 45.6 pt -69.22 -20.38 24.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 C-N-CA 119.06 -1.056 . . . . 0.0 110.466 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -68.38 -9.91 51.46 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.191 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 49.7 m -82.96 -5.01 58.9 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.554 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 89.0 mt -64.56 143.77 57.68 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 121.276 0.56 . . . . 0.0 110.764 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.419 ' HG2' ' N ' ' A' ' 143' ' ' LYS . 88.2 tttt -119.79 157.46 28.57 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.569 -179.003 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . 0.419 ' N ' ' HG2' ' A' ' 142' ' ' LYS . 87.8 tttt -50.02 129.52 20.78 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.381 179.366 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.464 ' N ' ' O ' ' A' ' 160' ' ' VAL . . . 83.13 8.96 84.78 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 120.358 -0.925 . . . . 0.0 112.371 178.531 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 47.5 t0 -73.66 130.25 39.63 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 120.076 -0.65 . . . . 0.0 110.679 -179.372 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -76.61 141.05 41.21 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 121.602 0.715 . . . . 0.0 111.485 -179.001 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 95.5 mt -137.67 138.66 44.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.063 -0.971 . . . . 0.0 108.815 178.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . 0.517 ' C ' HD22 ' A' ' 149' ' ' LEU . 95.2 m-85 -119.89 133.94 55.41 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 -177.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.517 HD22 ' C ' ' A' ' 148' ' ' TYR . 4.4 mm? -111.38 132.29 54.54 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 114.594 -1.184 . . . . 0.0 108.022 177.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -112.18 108.26 17.44 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.205 -0.598 . . . . 0.0 112.119 -178.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . 0.577 ' OD1' ' N ' ' A' ' 152' ' ' ASN . 57.1 t0 -89.42 158.35 17.78 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 177.54 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . 0.577 ' N ' ' OD1' ' A' ' 151' ' ' ASP . 36.8 p-10 -54.85 -20.07 7.9 Favored 'General case' 0 C--N 1.312 -1.042 0 C-N-CA 120.118 -0.633 . . . . 0.0 110.897 -177.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -112.49 -29.69 7.4 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 -178.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . 0.425 ' O ' ' N ' ' A' ' 151' ' ' ASP . 0.2 OUTLIER -148.86 -178.42 6.35 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.957 0.885 . . . . 0.0 113.244 -177.205 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -128.52 137.85 51.96 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 114.483 -1.235 . . . . 0.0 109.813 179.193 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -113.61 138.28 50.39 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 121.155 0.503 . . . . 0.0 111.296 -179.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . 0.465 ' O ' HD12 ' A' ' 203' ' ' LEU . 84.1 tt0 -98.99 114.95 27.85 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 121.296 0.57 . . . . 0.0 111.917 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 45.8 m-85 -113.49 147.11 38.5 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.238 0.542 . . . . 0.0 111.033 179.108 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -120.22 120.27 35.65 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.576 179.347 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.464 ' O ' ' N ' ' A' ' 144' ' ' GLY . 73.1 t -58.37 136.28 21.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 178.075 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 34.0 p -105.07 -26.79 11.97 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 123.425 0.453 . . . . 0.0 111.803 -179.532 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 167.1 -175.95 42.16 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 120.143 -1.027 . . . . 0.0 111.882 -179.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.975 HG22 HG22 ' A' ' 199' ' ' VAL . 47.7 t -129.22 138.12 55.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 114.8 -0.7 . . . . 0.0 109.465 179.311 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 20.9 t -137.28 167.51 21.44 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.554 0.692 . . . . 0.0 111.91 -178.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.421 ' CG ' ' CE2' ' A' ' 197' ' ' TYR . 95.5 mt-10 -107.95 122.84 47.65 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.06 -179.619 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 32.6 m -136.93 160.97 36.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.882 179.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -84.76 158.72 59.1 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.357 179.322 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.434 ' O ' HD12 ' B' ' 702' ' ' LEU . 37.0 Cg_endo -65.99 -13.43 39.81 Favored 'Trans proline' 0 C--N 1.303 -1.826 0 C-N-CA 123.169 2.579 . . . . 0.0 113.363 -179.638 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 35.7 p30 -96.54 -6.89 35.93 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 -179.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.841 ' O ' HD23 ' B' ' 702' ' ' LEU . 96.8 mttt -75.55 113.22 12.73 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 -177.605 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' TRP . . . . . 0.405 ' N ' ' CD1' ' A' ' 171' ' ' TRP . 35.4 m0 -83.24 -22.06 33.2 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.862 179.075 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -54.53 -38.79 66.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.534 -177.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . 0.647 HG23 HG23 ' A' ' 174' ' ' VAL . 31.0 m -64.51 -13.41 14.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.022 0.439 . . . . 0.0 111.338 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.647 HG23 HG23 ' A' ' 173' ' ' VAL . 76.4 t -111.58 -20.23 6.38 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -178.162 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -70.35 142.4 52.15 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.386 0.613 . . . . 0.0 111.773 -179.384 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . 0.434 ' OD1' ' O ' ' A' ' 176' ' ' ASP . 46.0 p-10 -66.44 138.34 57.48 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 115.641 -0.708 . . . . 0.0 111.175 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 79.7 m80 -111.68 25.42 11.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.357 179.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 65.28 42.82 96.01 Favored Glycine 0 CA--C 1.532 1.102 0 N-CA-C 111.099 -0.801 . . . . 0.0 111.099 179.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 11.8 ptmt -161.4 166.93 26.61 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 120.94 0.4 . . . . 0.0 110.585 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -85.57 104.83 15.68 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 177.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . 0.451 ' HG2' ' N ' ' A' ' 182' ' ' ILE . 82.9 tt0 -136.15 162.0 34.16 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.395 0.617 . . . . 0.0 111.667 -178.411 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.451 ' N ' ' HG2' ' A' ' 181' ' ' GLU . 18.4 tt -129.32 137.79 56.07 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.038 178.078 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 52.4 m -133.94 127.4 32.35 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 120.979 0.419 . . . . 0.0 111.232 -179.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 71.2 mt -108.65 130.87 55.33 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.13 179.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 91.2 mt -113.68 125.93 71.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.136 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 2.2 t -142.08 163.22 33.46 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.884 179.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' CYS . . . . . . . . . . . . . 4.8 m -86.12 140.83 29.86 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.61 HG13 ' N ' ' A' ' 189' ' ' SER . 9.9 p -62.48 -48.55 87.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.093 0.473 . . . . 0.0 111.129 -179.198 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . 0.61 ' N ' HG13 ' A' ' 188' ' ' VAL . 79.0 p -167.71 156.08 9.24 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.092 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 13.8 p -70.6 -18.81 21.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.21 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -96.84 -15.12 21.42 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . 0.558 ' O ' ' CG1' ' A' ' 188' ' ' VAL . 63.5 t0 -130.73 105.68 7.96 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 120.638 -0.425 . . . . 0.0 111.456 -179.728 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 48.8 p-10 -107.33 12.79 27.74 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 120.78 0.324 . . . . 0.0 111.345 179.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 9.6 t -60.83 -46.66 89.67 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-O 120.951 0.405 . . . . 0.0 111.906 -179.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 63.3 pttt -144.51 155.64 43.79 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 179.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . 0.708 ' NE ' ' SG ' ' B' ' 705' ' ' B27 . 84.9 mtt85 -127.38 149.51 50.04 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.363 0.601 . . . . 0.0 111.914 -179.046 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . 0.421 ' CE2' ' CG ' ' A' ' 165' ' ' GLU . 53.3 m-85 -92.93 142.58 27.15 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.741 -178.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 25.0 t -129.21 133.52 65.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.696 179.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.975 HG22 HG22 ' A' ' 163' ' ' VAL . 53.0 t -101.84 132.67 47.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.236 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -118.15 147.86 42.91 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.125 0.488 . . . . 0.0 110.462 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -148.61 143.07 10.55 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 -179.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 50.9 p30 -107.1 156.3 18.93 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.282 0.563 . . . . 0.0 111.48 -179.367 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . 0.465 HD12 ' O ' ' A' ' 157' ' ' GLU . 46.7 tp -77.59 130.87 37.45 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.266 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 15.7 m -114.91 -15.91 9.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.376 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -178.39 173.19 45.64 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 119.522 -1.323 . . . . 0.0 113.097 179.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 57.4 m -142.26 137.95 31.04 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.238 -0.981 . . . . 0.0 109.864 179.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 52.6 mtmt -144.03 114.83 7.74 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.184 0.516 . . . . 0.0 111.529 -179.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -65.77 148.59 51.52 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.551 0.691 . . . . 0.0 111.986 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -79.63 109.1 13.7 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.848 178.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 98.0 mttt . . . . . 0 C--O 1.221 -0.422 0 CA-C-O 117.883 -1.056 . . . . 0.0 110.682 179.712 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 701' ' ' BOC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 702' ' ' LEU . . . . . 0.841 HD23 ' O ' ' A' ' 170' ' ' LYS . 0.1 OUTLIER 52.08 81.53 0.26 Allowed Pre-proline 0 CA--C 1.535 0.399 0 CA-C-O 121.34 0.591 . . . . 20.0 111.101 . . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 703' ' ' PRO . . . . . 0.594 ' HG2' HG22 ' A' ' 110' ' ' VAL . 3.6 Cg_exo -77.01 -161.66 0.14 Allowed 'Trans proline' 0 C--N 1.305 -1.739 0 C-N-CA 123.305 2.67 . . . . 20.0 113.831 -179.612 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 704' ' ' ALA . . . . . 0.541 ' O ' ' OG1' ' B' ' 705' ' ' B27 . . . -42.54 -175.73 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 113.863 -1.517 . . . . 20.0 112.744 -179.388 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 705' ' ' B27 . . . . . 0.708 ' SG ' ' NE ' ' A' ' 196' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.232 0 N-CA-C 108.852 -1.699 . . . . 0.0 108.852 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 10.2 p -154.75 166.24 34.06 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.265 0.555 . . . . 0.0 110.455 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 80.4 m-70 -66.93 -40.79 87.7 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.57 -179.587 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 66.5 mtt -94.61 135.08 36.48 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.32 179.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -65.96 146.07 55.15 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.293 0.568 . . . . 0.0 110.191 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.435 ' C ' ' H ' ' A' ' 60' ' ' LYS . . . -90.66 1.86 56.43 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.637 -179.741 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.468 ' O ' ' NH2' ' A' ' 196' ' ' ARG . 3.7 p -79.02 22.59 0.39 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.266 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.435 ' H ' ' C ' ' A' ' 58' ' ' ALA . 98.9 mttt -102.15 9.72 39.95 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.128 -179.365 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.8 mt -55.23 139.8 13.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 122.416 1.103 . . . . 0.0 111.869 -177.404 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.536 ' OD1' ' N ' ' A' ' 62' ' ' ASP . 20.0 p-10 -76.45 128.69 35.29 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 113.528 -1.669 . . . . 0.0 109.551 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.547 ' H ' ' CD ' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -78.86 129.02 74.85 Favored Pre-proline 0 CA--C 1.542 0.654 0 C-N-CA 120.449 -0.5 . . . . 0.0 110.536 -179.025 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -53.41 147.86 35.79 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 C-N-CA 122.129 1.886 . . . . 0.0 112.855 178.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.655 ' O ' HG23 ' A' ' 69' ' ' VAL . 27.4 t70 -53.2 177.84 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.77 -179.489 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.414 ' H ' ' CG ' ' A' ' 65' ' ' ASP . 92.1 mt -63.6 -43.8 95.85 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.196 -178.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.09 -36.68 82.43 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 119.761 -0.776 . . . . 0.0 110.336 -179.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -61.31 -35.21 76.73 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.751 0.786 . . . . 0.0 109.042 178.22 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.655 HG23 ' O ' ' A' ' 65' ' ' ASP . 62.0 t -73.87 -43.26 53.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.917 179.003 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -70.53 -9.71 57.38 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.624 -179.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -118.33 -1.82 11.23 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 121.526 0.679 . . . . 0.0 109.837 179.189 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -70.05 -175.51 0.96 Allowed 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.648 -179.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 6.6 t -94.9 105.42 17.34 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.119 179.15 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 42.0 tp -69.95 135.02 48.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.691 -179.016 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.417 ' OD2' ' OD1' ' A' ' 102' ' ' ASN . 91.3 m-20 -116.06 77.57 1.11 Allowed 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 121.845 0.831 . . . . 0.0 109.36 177.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.78 ' O ' HG12 ' A' ' 79' ' ' VAL . 86.5 tttt -84.89 -40.32 17.19 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.678 -1.146 . . . . 0.0 112.148 -179.753 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.423 ' H ' ' HG2' ' A' ' 77' ' ' LYS . 52.1 mmtt -73.14 -12.89 61.05 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.707 -176.444 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -94.92 2.1 55.36 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.224 0.535 . . . . 0.0 110.194 179.51 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.78 HG12 ' O ' ' A' ' 76' ' ' LYS . 11.6 p -72.06 115.1 11.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 121.371 0.605 . . . . 0.0 110.833 -179.576 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 32.8 pt -102.84 -7.78 9.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.807 179.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -163.31 158.53 30.94 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 120.637 -0.792 . . . . 0.0 111.339 179.16 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 33.6 ttm180 -133.43 140.01 47.06 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 121.309 0.576 . . . . 0.0 111.334 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 5.1 tt -111.31 142.52 23.44 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.615 179.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 73.8 m -137.45 133.7 34.98 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 115.138 -0.937 . . . . 0.0 112.946 -178.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.575 ' CG2' HG22 ' A' ' 88' ' ' VAL . 66.6 mt -135.61 87.62 25.89 Favored Pre-proline 0 CA--C 1.54 0.558 0 CA-C-O 121.444 0.64 . . . . 0.0 111.034 179.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -55.87 -33.17 87.77 Favored 'Trans proline' 0 N--CA 1.498 1.757 0 C-N-CA 123.309 2.672 . . . . 0.0 112.431 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 28.2 m -52.78 -41.11 63.79 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 121.143 0.497 . . . . 0.0 110.415 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.575 HG22 ' CG2' ' A' ' 85' ' ' ILE . 30.6 m -115.51 13.0 7.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.754 179.267 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 2.5 p 47.37 52.24 12.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.269 0.557 . . . . 0.0 111.101 -179.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 60.0 tp -119.93 135.25 54.97 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.379 0.609 . . . . 0.0 110.834 179.48 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -148.92 127.46 12.35 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.866 179.338 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.654 HD13 ' HA3' ' A' ' 106' ' ' GLY . 83.5 mt -149.84 147.85 23.72 Favored Pre-proline 0 CA--C 1.541 0.629 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.458 -178.516 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -74.12 150.25 42.45 Favored 'Trans proline' 0 N--CA 1.501 1.949 0 C-N-CA 122.881 2.387 . . . . 0.0 112.117 179.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.666 ' C ' HD12 ' A' ' 95' ' ' LEU . 89.4 t -95.0 125.36 47.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-O 121.26 0.553 . . . . 0.0 111.279 179.613 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.666 HD12 ' C ' ' A' ' 94' ' ' VAL . 10.1 mp -109.34 142.1 40.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.838 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.536 ' O ' ' OG1' ' A' ' 109' ' ' THR . 19.1 ttmt -74.5 -76.19 0.14 Allowed 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 116.103 -0.499 . . . . 0.0 112.148 -178.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 33.4 t -59.62 129.59 42.66 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.185 0.517 . . . . 0.0 111.982 -178.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.407 ' OG ' ' O ' ' A' ' 109' ' ' THR . 23.0 m -87.19 69.48 10.08 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.947 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.545 HG22 ' N ' ' A' ' 100' ' ' GLU . 44.4 m -90.27 165.1 14.11 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 178.721 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.545 ' N ' HG22 ' A' ' 99' ' ' THR . 83.3 tt0 -58.2 -45.57 87.35 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 119.972 -0.691 . . . . 0.0 110.185 -179.477 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -65.06 -41.59 95.0 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.217 178.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.446 ' HB2' ' H ' ' A' ' 99' ' ' THR . 94.9 m-20 -62.98 -39.71 95.55 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.103 -179.646 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.475 HD13 ' HB3' ' B' ' 704' ' ' ALA . 65.3 mt -61.59 -28.39 69.31 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.695 179.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.573 HD13 HG22 ' A' ' 69' ' ' VAL . 98.6 mt -73.98 -15.73 61.1 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.194 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.59 -7.64 48.99 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.466 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.654 ' HA3' HD13 ' A' ' 92' ' ' LEU . . . 98.84 -22.11 42.61 Favored Glycine 0 CA--C 1.531 1.057 0 CA-C-N 114.701 -1.136 . . . . 0.0 113.447 177.039 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -147.2 125.86 12.56 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 119.643 -0.823 . . . . 0.0 112.211 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -142.03 135.99 29.79 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.698 179.235 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.575 ' HA ' HD23 ' A' ' 123' ' ' LEU . 71.6 p -69.59 132.16 45.79 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 121.224 0.535 . . . . 0.0 110.515 -179.554 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.575 HG22 ' HG2' ' B' ' 703' ' ' PRO . 53.6 t -79.07 -50.7 18.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.174 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.798 ' H ' ' NE2' ' A' ' 114' ' ' GLN . 82.5 mttt -102.91 138.19 40.11 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.57 0.7 . . . . 0.0 112.349 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -66.17 -32.58 74.11 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.016 -0.993 . . . . 0.0 112.862 -178.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -82.42 13.51 3.58 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -178.217 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.798 ' NE2' ' H ' ' A' ' 111' ' ' LYS . 31.4 mt-30 -80.22 136.06 36.39 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.238 0.542 . . . . 0.0 111.341 179.709 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 71.3 t -123.59 127.91 74.28 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.759 179.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . 0.659 ' SD ' ' CE2' ' A' ' 121' ' ' TYR . 85.3 mmm -55.1 126.02 22.98 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -179.178 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 82.86 -3.27 84.31 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.456 178.098 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -137.21 131.85 33.03 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.063 -0.655 . . . . 0.0 110.867 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 75.03 -174.33 51.81 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 110.226 -1.15 . . . . 0.0 110.226 -179.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.593 ' ND2' ' ND1' ' A' ' 177' ' ' HIS . 62.4 m-20 -84.53 105.04 15.05 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.363 -0.535 . . . . 0.0 109.739 179.548 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.659 ' CE2' ' SD ' ' A' ' 116' ' ' MET . 2.2 t80 -86.34 98.71 11.13 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 120.539 -0.465 . . . . 0.0 110.209 -179.797 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -90.59 138.05 31.87 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.275 0.56 . . . . 0.0 111.288 -179.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.575 HD23 ' HA ' ' A' ' 109' ' ' THR . 67.7 mt -135.14 138.59 43.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.435 -179.49 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -106.82 134.95 49.19 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 178.553 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -134.6 148.43 19.51 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 -179.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 8.0 m-70 -91.83 136.11 33.4 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.53 0.681 . . . . 0.0 111.805 -179.176 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 39.2 t30 -132.6 124.96 29.36 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 114.966 -1.016 . . . . 0.0 111.341 -179.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.443 ' O ' ' CB ' ' A' ' 129' ' ' SER . 65.1 mtt -100.78 -5.81 25.8 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.517 0.675 . . . . 0.0 110.322 179.49 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.443 ' CB ' ' O ' ' A' ' 128' ' ' MET . 0.9 OUTLIER 77.62 12.23 2.01 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.747 178.886 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.794 ' O ' HG12 ' A' ' 133' ' ' VAL . 64.1 pttt -109.85 122.78 48.31 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 122.274 1.035 . . . . 0.0 112.303 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -44.29 119.05 1.69 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.898 179.228 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 117.42 -15.33 13.05 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 -179.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.794 HG12 ' O ' ' A' ' 130' ' ' LYS . 10.6 p -92.73 153.34 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 CA-C-O 120.991 0.424 . . . . 0.0 109.941 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.825 HD23 ' N ' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -71.43 146.47 48.65 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.816 0.817 . . . . 0.0 113.088 -177.936 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.482 ' CE1' ' O ' ' A' ' 106' ' ' GLY . 3.6 m-85 66.4 5.34 3.69 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 113.984 -1.462 . . . . 0.0 114.452 178.225 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 23.6 p -75.71 -29.37 58.94 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 119.936 -0.705 . . . . 0.0 112.509 179.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 31.6 p-10 -92.05 4.79 52.32 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 -176.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.421 HD11 ' OG1' ' A' ' 186' ' ' THR . 39.2 pt -67.43 -25.73 34.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 C-N-CA 119.016 -1.073 . . . . 0.0 110.493 -179.578 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -68.02 -13.79 62.47 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.451 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 54.6 p -83.53 -5.63 59.22 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.164 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 88.6 mt -63.43 145.66 55.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.37 0.605 . . . . 0.0 111.275 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -119.32 151.67 38.06 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.574 -179.253 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -48.98 130.59 18.51 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.114 179.388 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.609 ' N ' ' O ' ' A' ' 160' ' ' VAL . . . 79.85 8.34 87.76 Favored Glycine 0 CA--C 1.524 0.651 0 C-N-CA 120.847 -0.692 . . . . 0.0 111.453 179.061 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.541 ' OD1' ' N ' ' A' ' 146' ' ' LYS . 53.0 t0 -71.37 130.68 41.95 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 119.519 -0.872 . . . . 0.0 109.866 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.541 ' N ' ' OD1' ' A' ' 145' ' ' ASP . 74.8 mmtt -78.61 142.12 37.5 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 122.044 0.925 . . . . 0.0 111.958 -178.269 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 95.6 mt -136.65 138.49 46.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 114.168 -1.378 . . . . 0.0 108.538 178.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -130.54 143.13 50.56 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 119.981 -0.688 . . . . 0.0 112.537 -178.24 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.789 ' C ' HD22 ' A' ' 149' ' ' LEU . 0.0 OUTLIER -143.96 157.77 44.13 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.097 176.788 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.498 ' CD1' ' N ' ' A' ' 150' ' ' TYR . 0.5 OUTLIER -123.53 133.14 54.04 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -177.775 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -91.04 168.4 11.67 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 105.991 -1.855 . . . . 0.0 105.991 175.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 -58.5 -25.76 62.71 Favored 'General case' 0 C--N 1.307 -1.274 0 C-N-CA 119.183 -1.007 . . . . 0.0 110.798 -179.448 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 -110.03 -27.16 9.34 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -178.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -145.31 -172.72 3.93 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 114.608 1.336 . . . . 0.0 114.608 -176.268 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 77.5 tt0 -133.75 134.56 43.12 Favored 'General case' 0 C--N 1.339 0.145 0 CA-C-N 114.508 -1.223 . . . . 0.0 110.045 179.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . 0.433 ' HB2' HD11 ' A' ' 149' ' ' LEU . 58.9 m-85 -114.68 136.37 53.13 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-O 121.34 0.59 . . . . 0.0 110.92 -179.574 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . 0.589 ' O ' HG22 ' A' ' 204' ' ' VAL . 97.7 mt-10 -96.63 114.83 26.52 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.392 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 -114.62 147.95 38.8 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 120.755 0.312 . . . . 0.0 110.868 179.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -126.57 126.66 44.01 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.269 0.557 . . . . 0.0 110.622 178.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.609 ' O ' ' N ' ' A' ' 144' ' ' GLY . 42.8 t -59.79 134.99 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.624 178.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 68.4 p -107.49 -28.75 9.62 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.253 0.549 . . . . 0.0 110.483 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 165.97 -172.34 41.33 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 111.352 -0.699 . . . . 0.0 111.352 179.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 2.3 p -134.39 148.91 29.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 179.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 22.9 t -138.29 167.71 21.29 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.465 0.65 . . . . 0.0 111.43 -179.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 75.0 tt0 -111.35 119.43 38.83 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.796 -179.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.479 HG21 HG11 ' A' ' 173' ' ' VAL . 32.3 m -136.2 157.54 37.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.01 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -80.65 160.72 66.3 Favored Pre-proline 0 C--N 1.32 -0.676 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.147 -179.418 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.469 ' O ' ' CB ' ' B' ' 702' ' ' LEU . 33.8 Cg_endo -65.51 -18.11 58.81 Favored 'Trans proline' 0 N--CA 1.502 1.983 0 C-N-CA 122.977 2.451 . . . . 0.0 113.461 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 42.6 p-10 -91.23 -1.6 57.65 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 120.21 -0.596 . . . . 0.0 111.866 179.473 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.754 ' O ' HG22 ' A' ' 173' ' ' VAL . 71.6 mmtt -75.96 87.15 2.9 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.951 -179.772 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' TRP . . . . . 0.587 ' O ' HG22 ' A' ' 174' ' ' VAL . 31.3 m0 -76.69 -12.12 59.95 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.43 0.633 . . . . 0.0 109.943 179.589 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -62.87 -32.59 73.87 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.365 -179.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . 0.754 HG22 ' O ' ' A' ' 170' ' ' LYS . 33.3 m -62.48 -18.32 20.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.911 -178.465 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.742 HG13 HG23 ' A' ' 173' ' ' VAL . 35.5 m -110.23 -4.78 10.95 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -179.162 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -73.26 139.69 46.34 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 120.911 0.386 . . . . 0.0 110.611 179.227 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . 0.516 ' OD1' ' O ' ' A' ' 176' ' ' ASP . 53.1 p-10 -70.83 136.22 48.59 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 121.257 0.551 . . . . 0.0 110.91 -179.649 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' HIS . . . . . 0.593 ' ND1' ' ND2' ' A' ' 120' ' ' ASN . 78.5 m80 -102.34 -15.37 16.58 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.131 0.491 . . . . 0.0 111.219 -179.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 105.09 39.74 2.24 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 -179.365 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -152.96 167.61 28.59 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 114.795 -0.702 . . . . 0.0 111.232 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -88.65 98.99 11.98 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 177.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . 0.442 ' HG2' ' N ' ' A' ' 182' ' ' ILE . 81.8 tt0 -137.24 164.03 29.49 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.694 0.759 . . . . 0.0 111.423 -178.629 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.442 ' N ' ' HG2' ' A' ' 181' ' ' GLU . 16.8 tt -130.74 140.61 48.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 114.689 -1.141 . . . . 0.0 109.258 178.686 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . 0.401 HG23 ' CG1' ' A' ' 198' ' ' VAL . 51.7 m -132.96 126.57 32.32 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.203 0.525 . . . . 0.0 111.249 -179.136 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 91.4 mt -107.53 130.86 54.82 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.068 179.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.747 HD13 HD21 ' B' ' 702' ' ' LEU . 81.1 mt -109.56 121.32 62.36 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-O 121.234 0.54 . . . . 0.0 110.637 -179.647 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . 0.625 HG22 ' N ' ' A' ' 187' ' ' CYS . 43.7 m -139.44 168.17 20.42 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.281 179.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' CYS . . . . . 0.625 ' N ' HG22 ' A' ' 186' ' ' THR . 1.6 m -101.91 148.46 25.31 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.288 179.701 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 71.4 t -60.85 -46.89 95.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-O 120.981 0.419 . . . . 0.0 111.44 -178.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 86.0 p -170.08 159.5 7.59 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.205 179.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 57.7 t -65.75 -18.82 24.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.489 0.661 . . . . 0.0 109.687 179.324 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -96.74 -13.32 22.77 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.939 -179.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -131.67 96.05 3.87 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.421 179.362 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' ASN . . . . . . . . . . . . . 43.2 p-10 -110.29 5.01 21.35 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 112.23 0.456 . . . . 0.0 112.23 -179.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 11.5 t -63.93 -40.95 97.63 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.954 0.407 . . . . 0.0 111.326 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -126.73 151.74 47.77 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 121.158 0.504 . . . . 0.0 110.749 -179.24 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . 0.468 ' NH2' ' O ' ' A' ' 59' ' ' SER . 99.8 mtt180 -126.19 137.76 53.58 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.386 -179.503 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 43.9 p90 -98.34 144.29 27.89 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.698 178.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.401 ' CG1' HG23 ' A' ' 183' ' ' THR . 50.2 t -121.27 133.39 67.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.439 0.638 . . . . 0.0 111.573 -178.548 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 51.0 t -103.67 132.1 50.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.638 179.233 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -118.92 147.76 43.66 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.469 0.652 . . . . 0.0 112.141 -178.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -134.82 140.27 11.58 Favored Glycine 0 CA--C 1.532 1.113 0 N-CA-C 110.422 -1.071 . . . . 0.0 110.422 179.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 54.8 t0 -100.93 136.61 40.51 Favored 'General case' 0 C--N 1.329 -0.304 0 O-C-N 122.626 -0.337 . . . . 0.0 110.804 -179.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 51.7 tp -65.29 127.25 30.96 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.589 HG22 ' O ' ' A' ' 157' ' ' GLU . 28.6 m -110.52 -18.8 7.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 C-N-CA 120.6 -0.44 . . . . 0.0 112.181 -178.65 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -179.21 174.34 46.3 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 120.002 -1.095 . . . . 0.0 112.602 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 97.3 m -143.59 138.74 29.27 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 114.991 -0.605 . . . . 0.0 110.439 179.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -142.37 115.8 9.03 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 120.644 -0.423 . . . . 0.0 111.512 178.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -63.36 147.48 51.03 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.498 0.666 . . . . 0.0 111.467 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 52.9 mtmt -79.27 106.72 11.51 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.556 179.327 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 97.9 mttt . . . . . 0 C--O 1.219 -0.538 0 CA-C-O 117.827 -1.082 . . . . 0.0 110.613 179.794 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 701' ' ' BOC . . . . . 0.423 ' O1 ' ' H12' ' B' ' 701' ' ' BOC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 702' ' ' LEU . . . . . 0.747 HD21 HD13 ' A' ' 185' ' ' ILE . 0.5 OUTLIER -86.5 118.16 69.82 Favored Pre-proline 0 CA--C 1.546 0.819 0 N-CA-C 110.806 -0.072 . . . . 20.0 110.806 . . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 703' ' ' PRO . . . . . 0.695 ' HD2' HD23 ' B' ' 702' ' ' LEU . 3.2 Cg_exo -66.15 -177.31 0.79 Allowed 'Trans proline' 0 N--CA 1.496 1.652 0 C-N-CA 122.042 1.828 . . . . 20.0 113.96 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 704' ' ' ALA . . . . . 0.507 ' O ' ' O ' ' B' ' 703' ' ' PRO . . . -39.3 -174.9 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 114.531 1.308 . . . . 20.0 114.531 -178.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 705' ' ' B27 . . . . . 0.545 ' SG ' ' N ' ' A' ' 187' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.423 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 23.0 t -131.12 142.16 50.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.214 0.53 . . . . 0.0 110.554 179.735 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -64.42 -44.15 92.14 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.082 -179.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 99.4 mmm -88.38 112.29 22.73 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.19 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -64.98 143.52 57.9 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.097 179.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -100.66 -3.11 31.0 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.308 0.575 . . . . 0.0 110.609 179.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 2.0 p -77.54 7.96 4.9 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.544 -178.31 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.416 ' HA ' HH21 ' A' ' 196' ' ' ARG . 59.3 pttt -85.59 26.94 0.88 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.35 0.595 . . . . 0.0 110.926 179.42 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 45.1 mm -55.89 139.76 14.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 122.345 1.069 . . . . 0.0 113.357 -176.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -81.12 124.33 29.14 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 113.584 -1.644 . . . . 0.0 108.128 178.051 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.631 ' H ' ' CD ' ' A' ' 63' ' ' GLN . 1.1 pm0 -77.52 151.71 80.54 Favored Pre-proline 0 C--N 1.324 -0.517 0 C-N-CA 120.064 -0.654 . . . . 0.0 110.855 -178.663 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -68.31 154.75 71.4 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 122.616 2.211 . . . . 0.0 112.084 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -57.98 171.4 0.52 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 121.38 0.61 . . . . 0.0 111.906 -179.027 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 89.3 mt -64.64 -45.58 86.2 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.946 -178.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.09 -37.9 89.13 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 119.924 -0.71 . . . . 0.0 110.323 -178.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -62.9 -32.81 74.16 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 178.037 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.1 t -75.85 -45.33 37.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-N 114.137 -1.392 . . . . 0.0 110.675 179.031 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -75.99 -8.98 58.21 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.819 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -106.18 -13.0 15.55 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 121.436 0.636 . . . . 0.0 109.931 179.158 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -70.22 145.73 51.19 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.41 -0.814 . . . . 0.0 112.189 -179.555 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.5 m -56.67 109.95 0.71 Allowed 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 115.641 -0.708 . . . . 0.0 109.991 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 32.2 tp -69.28 131.97 45.72 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.804 -178.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -109.01 76.63 1.02 Allowed 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 177.471 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -84.11 -36.53 22.89 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.524 -0.762 . . . . 0.0 112.453 -179.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 42.3 mmtt -74.64 -13.37 60.63 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.035 0.445 . . . . 0.0 111.417 -176.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -92.01 -0.1 57.47 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.377 0.608 . . . . 0.0 109.792 179.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 21.9 t -79.58 129.45 37.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.44 -179.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 11.6 pt -110.83 -10.33 11.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.805 179.347 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -157.81 163.64 32.78 Favored Glycine 0 CA--C 1.523 0.555 0 C-N-CA 120.225 -0.988 . . . . 0.0 111.81 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 61.8 ttp180 -133.71 156.42 47.97 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.756 -0.722 . . . . 0.0 109.91 179.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.582 HG22 ' O ' ' A' ' 92' ' ' LEU . 18.6 tt -126.07 143.08 40.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.6 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 13.2 t -137.51 133.26 34.37 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 121.504 0.669 . . . . 0.0 112.305 -178.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.461 HG22 HG22 ' A' ' 88' ' ' VAL . 65.0 mt -139.33 84.37 16.48 Favored Pre-proline 0 CA--C 1.538 0.498 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.31 -179.772 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -57.37 -29.7 85.19 Favored 'Trans proline' 0 N--CA 1.499 1.818 0 C-N-CA 123.081 2.52 . . . . 0.0 112.919 -179.21 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 96.1 p -52.16 -41.66 62.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.32 0.581 . . . . 0.0 111.088 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.461 HG22 HG22 ' A' ' 85' ' ' ILE . 22.5 m -115.83 10.33 7.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.043 179.068 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.479 ' O ' ' OG ' ' A' ' 89' ' ' SER . 3.5 t 53.48 53.49 11.54 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.68 179.553 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 62.7 tp -121.98 133.73 54.82 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.656 0.741 . . . . 0.0 111.024 -179.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -148.76 130.85 15.39 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.926 179.368 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.582 ' O ' HG22 ' A' ' 83' ' ' ILE . 84.1 mt -152.2 151.28 27.32 Favored Pre-proline 0 N--CA 1.471 0.621 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.368 -178.517 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -76.02 147.99 30.9 Favored 'Trans proline' 0 N--CA 1.494 1.554 0 C-N-CA 122.584 2.189 . . . . 0.0 111.516 178.214 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.518 ' C ' HD12 ' A' ' 95' ' ' LEU . 98.5 t -96.45 118.12 42.17 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-O 120.975 0.417 . . . . 0.0 111.563 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.544 ' N ' HD12 ' A' ' 95' ' ' LEU . 10.6 mp -101.74 136.91 40.78 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.394 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -61.7 -81.36 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 121.253 0.549 . . . . 0.0 112.263 -179.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 91.1 p -62.39 135.12 57.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.488 0.661 . . . . 0.0 112.134 -178.238 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.419 ' OG ' ' O ' ' A' ' 109' ' ' THR . 1.3 m -90.83 68.66 6.39 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.219 178.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 33.8 p -88.57 168.41 12.59 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.069 179.283 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.429 ' O ' ' CD1' ' A' ' 104' ' ' LEU . 52.6 tp10 -62.9 -45.5 92.24 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.169 -0.612 . . . . 0.0 110.435 179.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -65.12 -40.67 94.82 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 121.339 0.59 . . . . 0.0 111.487 179.535 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -65.23 -30.35 71.23 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.134 -0.485 . . . . 0.0 112.226 -179.301 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.417 HD23 ' HA ' ' A' ' 103' ' ' LEU . 56.7 mt -67.03 -14.02 62.49 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 120.773 -0.371 . . . . 0.0 111.673 -179.321 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.534 ' N ' HD12 ' A' ' 104' ' ' LEU . 10.5 mp -75.69 -12.17 60.14 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 121.008 -0.277 . . . . 0.0 111.44 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.415 ' O ' HD22 ' A' ' 92' ' ' LEU . 92.5 p -81.17 -6.24 58.62 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 121.352 0.596 . . . . 0.0 110.356 179.677 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.547 ' HA3' HD13 ' A' ' 92' ' ' LEU . . . 89.76 -20.02 37.89 Favored Glycine 0 CA--C 1.533 1.196 0 CA-C-N 115.51 -0.768 . . . . 0.0 113.254 177.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -145.72 125.49 13.43 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 117.814 0.807 . . . . 0.0 112.136 -179.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -145.71 141.64 28.23 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.703 179.236 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.706 ' HA ' HD23 ' A' ' 123' ' ' LEU . 8.7 p -71.93 132.34 44.22 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.238 0.542 . . . . 0.0 110.667 179.631 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.655 HG23 ' CG ' ' B' ' 703' ' ' PRO . 7.3 p -81.7 -33.95 12.52 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 -179.533 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.506 ' O ' ' NE2' ' A' ' 114' ' ' GLN . 88.2 tttt -90.36 153.34 20.51 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 121.357 0.598 . . . . 0.0 111.939 -177.243 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -66.0 -35.06 79.54 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -178.036 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -141.27 53.36 1.55 Allowed 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 114.234 1.198 . . . . 0.0 114.234 -176.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.752 ' NE2' ' H ' ' A' ' 114' ' ' GLN . 1.6 pm0 -74.34 157.71 35.26 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 120.891 0.377 . . . . 0.0 111.192 179.151 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 61.4 t -128.64 120.89 53.65 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-O 121.149 0.499 . . . . 0.0 111.694 -179.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 66.3 mtt -60.57 134.45 57.08 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.992 -0.549 . . . . 0.0 112.226 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 77.72 -0.91 69.3 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.698 -0.561 . . . . 0.0 111.698 178.206 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -142.0 127.94 19.48 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.358 0.599 . . . . 0.0 110.851 179.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 75.28 -168.99 54.78 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 110.482 -1.047 . . . . 0.0 110.482 -179.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 42.9 t-20 -90.21 103.5 16.17 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.78 0.324 . . . . 0.0 110.2 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.513 ' HE2' HD21 ' A' ' 123' ' ' LEU . 11.8 t80 -89.69 99.02 12.1 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -179.696 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.463 ' HB3' ' CG1' ' A' ' 110' ' ' VAL . . . -91.65 137.41 32.39 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 112.462 0.541 . . . . 0.0 112.462 -178.404 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.706 HD23 ' HA ' ' A' ' 109' ' ' THR . 71.6 mt -134.76 138.92 44.74 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.584 179.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -108.72 131.7 54.67 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 121.142 0.496 . . . . 0.0 110.02 179.324 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -137.22 151.08 20.93 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 110.045 -1.222 . . . . 0.0 110.045 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.752 ' O ' HD23 ' A' ' 134' ' ' LEU . 37.5 m-70 -88.73 144.78 26.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.61 0.719 . . . . 0.0 112.522 -178.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.879 ' ND2' ' H ' ' A' ' 129' ' ' SER . 1.5 t-20 -137.8 121.24 17.14 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.982 178.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.518 ' HB2' HG21 ' A' ' 133' ' ' VAL . 57.7 mtt -95.51 -1.42 50.71 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.069 -178.578 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.879 ' H ' ' ND2' ' A' ' 127' ' ' ASN . 1.4 p 78.17 5.52 2.7 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.974 -0.29 . . . . 0.0 111.339 179.247 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.876 ' O ' HG12 ' A' ' 133' ' ' VAL . 62.5 pttt -120.58 130.7 54.3 Favored 'General case' 0 C--O 1.222 -0.377 0 CA-C-O 121.885 0.85 . . . . 0.0 113.105 -178.55 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.462 ' O ' ' O ' ' A' ' 130' ' ' LYS . 74.6 mmtt -41.13 162.6 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 178.232 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 76.49 -24.73 1.76 Allowed Glycine 0 CA--C 1.535 1.337 0 C-N-CA 120.396 -0.907 . . . . 0.0 111.379 179.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.876 HG12 ' O ' ' A' ' 130' ' ' LYS . 3.7 p -90.18 158.13 2.94 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 O-C-N 122.217 -0.578 . . . . 0.0 111.215 -178.702 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.852 ' H ' HD13 ' A' ' 134' ' ' LEU . 0.0 OUTLIER -70.71 145.36 50.57 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 114.903 1.446 . . . . 0.0 114.903 -177.283 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 61.0 7.04 1.37 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 112.866 -1.97 . . . . 0.0 113.854 177.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 5.1 t -72.8 -34.07 66.66 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.143 -0.623 . . . . 0.0 112.385 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.418 ' OD1' ' N ' ' A' ' 137' ' ' ASP . 44.0 p-10 -92.43 4.6 53.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.433 0.635 . . . . 0.0 110.381 -179.329 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.46 HD11 HD13 ' A' ' 184' ' ' LEU . 5.2 tt -64.49 -35.83 75.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.896 -179.506 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.419 ' N ' ' CG2' ' A' ' 138' ' ' ILE . . . -70.33 -9.88 57.41 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 121.091 0.472 . . . . 0.0 111.072 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 19.1 m -81.99 -3.21 53.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.225 0.535 . . . . 0.0 110.223 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.401 HD21 HG21 ' A' ' 85' ' ' ILE . 78.5 mt -63.69 145.08 56.41 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.564 179.739 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -120.97 155.49 34.16 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 121.389 0.614 . . . . 0.0 112.021 -178.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 40.5 tttp -49.85 132.76 22.45 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.978 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.554 ' N ' ' O ' ' A' ' 160' ' ' VAL . . . 80.21 7.33 88.63 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.314 178.691 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -73.41 136.87 44.34 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 118.921 -1.112 . . . . 0.0 109.553 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -80.26 141.33 35.65 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.838 0.828 . . . . 0.0 112.28 -178.36 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.449 HD11 ' CG2' ' A' ' 160' ' ' VAL . 87.6 mt -137.39 137.74 45.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 114.735 -1.121 . . . . 0.0 108.679 178.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 43.0 m-85 -123.1 136.25 54.72 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.028 -0.669 . . . . 0.0 112.508 -177.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.544 HD11 HD11 ' A' ' 182' ' ' ILE . 11.7 mt -110.97 133.5 53.34 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 177.072 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . 0.526 ' CE1' ' CD ' ' A' ' 155' ' ' GLU . 82.1 m-85 -111.87 109.39 19.18 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 119.836 -0.746 . . . . 0.0 111.845 -179.638 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . 0.614 ' OD1' ' N ' ' A' ' 152' ' ' ASN . 66.3 t0 -89.59 163.87 15.0 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 177.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . 0.614 ' N ' ' OD1' ' A' ' 151' ' ' ASP . 34.5 p-10 -57.36 -19.61 24.02 Favored 'General case' 0 C--N 1.318 -0.785 0 C-N-CA 119.962 -0.695 . . . . 0.0 111.159 -177.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -114.27 -27.83 7.48 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 -178.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -148.18 179.87 7.45 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 -176.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.526 ' CD ' ' CE1' ' A' ' 150' ' ' TYR . 83.0 tt0 -127.79 132.96 49.44 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 114.366 -1.288 . . . . 0.0 109.745 179.122 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . 0.501 ' CD1' HG23 ' A' ' 206' ' ' THR . 95.5 m-85 -108.44 133.87 52.02 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.027 0.442 . . . . 0.0 111.225 -179.395 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . 0.644 ' O ' HG12 ' A' ' 204' ' ' VAL . 92.4 mt-10 -93.85 113.15 25.12 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.121 179.54 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -115.44 150.16 36.88 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 120.828 0.347 . . . . 0.0 110.585 179.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -124.45 124.62 42.7 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.048 0.451 . . . . 0.0 111.215 179.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.554 ' O ' ' N ' ' A' ' 144' ' ' GLY . 71.4 t -60.93 135.47 25.65 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.215 177.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 22.0 p -105.36 -24.95 12.57 Favored 'General case' 0 CA--C 1.533 0.315 0 O-C-N 123.308 0.38 . . . . 0.0 110.202 178.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 157.46 -165.17 33.33 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 120.842 -0.694 . . . . 0.0 111.718 179.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 3.0 p -134.97 155.26 37.87 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 179.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 87.8 p -138.75 167.17 22.57 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.633 0.73 . . . . 0.0 112.212 -178.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -100.19 118.87 37.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 114.99 -1.004 . . . . 0.0 110.204 179.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.475 HG21 ' CG2' ' A' ' 198' ' ' VAL . 27.6 m -137.05 161.7 35.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.225 0.536 . . . . 0.0 111.009 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -96.73 157.07 35.83 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.32 178.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.503 ' O ' ' CB ' ' B' ' 702' ' ' LEU . 20.7 Cg_endo -60.83 -18.02 54.0 Favored 'Trans proline' 0 C--N 1.3 -1.995 0 C-N-CA 122.605 2.204 . . . . 0.0 113.552 -179.627 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 45.5 p-10 -92.27 -5.26 52.71 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 119.45 -0.9 . . . . 0.0 112.313 179.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.561 ' O ' HG22 ' A' ' 173' ' ' VAL . 97.0 mttt -76.1 85.56 2.97 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 121.655 0.741 . . . . 0.0 111.373 179.438 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' TRP . . . . . 0.591 ' CZ3' ' OE2' ' A' ' 175' ' ' GLU . 1.2 p-90 -73.97 -7.44 52.41 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.034 -0.984 . . . . 0.0 110.041 179.42 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -61.77 -35.83 79.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.75 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . 0.561 HG22 ' O ' ' A' ' 170' ' ' LYS . 19.8 m -63.03 -17.77 20.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.781 -179.702 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 37.0 t -101.47 -17.77 6.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.922 -179.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.591 ' OE2' ' CZ3' ' A' ' 171' ' ' TRP . 76.3 mm-40 -76.26 153.94 35.58 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.246 0.546 . . . . 0.0 111.779 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . 0.491 ' OD1' ' O ' ' A' ' 176' ' ' ASP . 47.0 p-10 -60.27 142.86 53.98 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.719 0.771 . . . . 0.0 111.802 -179.345 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' HIS . . . . . . . . . . . . . 73.6 m80 -115.36 12.71 16.42 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.707 179.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 64.13 41.66 98.34 Favored Glycine 0 CA--C 1.528 0.856 0 N-CA-C 111.105 -0.798 . . . . 0.0 111.105 179.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -165.2 172.47 12.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.1 0.476 . . . . 0.0 110.882 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -88.28 93.99 9.69 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 177.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . 0.447 ' HG2' ' N ' ' A' ' 182' ' ' ILE . 79.9 tt0 -130.45 161.64 30.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.85 0.833 . . . . 0.0 112.052 -178.078 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.544 HD11 HD11 ' A' ' 149' ' ' LEU . 1.1 mm -125.97 134.5 66.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 114.598 -1.183 . . . . 0.0 110.55 179.608 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 86.3 m -126.3 124.41 40.26 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 121.291 0.567 . . . . 0.0 111.23 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.46 HD13 HD11 ' A' ' 138' ' ' ILE . 83.4 mt -113.32 133.41 55.14 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.7 179.143 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.668 HD13 HD21 ' B' ' 702' ' ' LEU . 77.0 mt -113.53 124.77 70.5 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 CA-C-O 121.36 0.6 . . . . 0.0 111.028 -179.581 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 5.1 t -135.56 156.34 49.03 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 115.254 -0.884 . . . . 0.0 110.492 179.337 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' CYS . . . . . . . . . . . . . 4.5 m -87.11 141.45 28.65 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.234 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . 0.758 HG22 ' CD2' ' A' ' 197' ' ' TYR . 41.9 t -61.97 -47.32 93.74 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 CA-C-O 120.945 0.402 . . . . 0.0 111.005 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 94.6 p -162.23 164.42 27.71 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 121.038 0.447 . . . . 0.0 110.977 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . 0.501 ' CG1' ' O ' ' A' ' 128' ' ' MET . 18.0 m -69.16 -17.58 21.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.244 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -101.8 -34.69 9.33 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.519 -0.472 . . . . 0.0 111.049 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 49.6 t0 -99.63 103.13 14.81 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 120.984 0.421 . . . . 0.0 111.465 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' ASN . . . . . 0.577 ' O ' ' NH1' ' A' ' 196' ' ' ARG . 27.2 m120 -110.45 -7.22 14.79 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 121.298 0.57 . . . . 0.0 110.639 179.058 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 76.3 p -68.4 -16.68 64.01 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.953 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -136.73 143.03 43.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.468 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . 0.577 ' NH1' ' O ' ' A' ' 193' ' ' ASN . 76.9 mtt85 -136.05 145.15 45.69 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 121.108 0.48 . . . . 0.0 111.959 -179.494 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . 0.758 ' CD2' HG22 ' A' ' 188' ' ' VAL . 35.8 m-85 -96.41 144.57 26.42 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 115.949 -0.568 . . . . 0.0 111.471 179.034 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.475 ' CG2' HG21 ' A' ' 166' ' ' VAL . 39.2 t -128.97 130.69 68.45 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-O 121.083 0.468 . . . . 0.0 110.645 178.365 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 21.6 t -102.66 134.62 43.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.866 179.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -122.32 147.66 45.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.316 0.579 . . . . 0.0 111.387 -178.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -145.01 152.6 24.63 Favored Glycine 0 CA--C 1.53 1.024 0 N-CA-C 110.079 -1.208 . . . . 0.0 110.079 179.24 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . 0.422 ' O ' ' OD1' ' A' ' 202' ' ' ASP . 51.7 p-10 -111.92 151.39 29.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.994 0.426 . . . . 0.0 110.092 179.673 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 52.7 tp -71.52 131.47 43.32 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.644 HG12 ' O ' ' A' ' 157' ' ' GLU . 5.2 p -113.88 -19.5 6.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 120.333 -0.547 . . . . 0.0 111.589 -178.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . -176.97 172.03 44.96 Favored Glycine 0 CA--C 1.527 0.799 0 C-N-CA 120.088 -1.053 . . . . 0.0 112.055 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . 0.501 HG23 ' CD1' ' A' ' 156' ' ' TYR . 10.4 m -144.19 137.68 27.57 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.963 -0.618 . . . . 0.0 109.503 179.019 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -145.37 122.17 11.24 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.115 0.483 . . . . 0.0 111.276 179.621 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -62.39 139.83 58.55 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.491 0.662 . . . . 0.0 111.448 -179.289 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 9.5 tttt -79.2 109.32 13.42 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.552 179.563 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 98.5 mttt . . . . . 0 C--O 1.218 -0.558 0 CA-C-O 118.107 -0.949 . . . . 0.0 110.339 179.205 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 701' ' ' BOC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 702' ' ' LEU . . . . . 0.668 HD21 HD13 ' A' ' 185' ' ' ILE . 1.0 OUTLIER -154.12 103.95 2.44 Favored Pre-proline 0 CA--C 1.546 0.805 0 C-N-CA 120.681 -0.408 . . . . 20.0 111.323 . . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 703' ' ' PRO . . . . . 0.655 ' CG ' HG23 ' A' ' 110' ' ' VAL . 4.9 Cg_exo -69.41 -168.06 0.24 Allowed 'Trans proline' 0 N--CA 1.489 1.21 0 C-N-CA 122.906 2.404 . . . . 20.0 114.15 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 704' ' ' ALA . . . . . 0.544 ' O ' ' O ' ' B' ' 703' ' ' PRO . . . -36.79 -179.68 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 113.902 -1.499 . . . . 20.0 113.659 -179.078 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 705' ' ' B27 . . . . . 0.498 HG2A ' C ' ' B' ' 704' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 stop_ save_